PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oberdorfer, G; Binter, A; Ginj, C; Macheroux, P; Gruber, K				Oberdorfer, Gustav; Binter, Alexandra; Ginj, Cristian; Macheroux, Peter; Gruber, Karl			Structural and Functional Characterization of NikO, an Enolpyruvyl Transferase Essential in Nikkomycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; PROTEIN HOMOLOGY DETECTION; INDUCED-FIT MECHANISM; CO-TRANSCRIBED GENES; MOLECULAR CHARACTERIZATION; CONFORMATIONAL-CHANGES; METABOLIC PRODUCTS; PEPTIDYL MOIETY; TARGET; PHOSPHOENOLPYRUVATE	Nikkomycins are peptide-nucleoside compounds with fungicidal, acaricidal, and insecticidal properties because of their strong inhibition of chitin synthase. Thus, they are potential antibiotics especially for the treatment of immunosuppressed patients, for those undergoing chemotherapy, or after organ transplants. Although their chemical structure has been known for more than 30 years, only little is known about their complex biosynthesis. The genes encoding for proteins involved in the biosynthesis of the nucleoside moiety of nikkomycins are co-transcribed in the same operon, comprising the genes nikI-JKLMNO. The gene product NikO was shown to belong to the family of enolpyruvyl transferases and to catalyze the transfer of an enolpyruvyl moiety from phosphoenolpyruvate to the 3'-hydroxyl group of UMP. Here, we report activity and inhibition studies of the wild-type enzyme and the variants C130A and D342A. The x-ray crystal structure revealed differences between NikO and its homologs. Furthermore, our studies led to conclusions concerning substrate binding and preference as well as to conclusions about inhibition/alkylation by the antibiotic fosfomycin.	[Binter, Alexandra; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Oberdorfer, Gustav; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Ginj, Cristian] Dales Prod Dev & Regulatory Specialists, Dundas, ON L9H 5P2, Canada	Graz University of Technology; University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12, A-8010 Graz, Austria.	peter.macheroux@tugraz.at; karl.gruber@uni-graz.at	Macheroux, Peter/AAB-5157-2019; Gruber, Karl/GPP-6706-2022	Macheroux, Peter/0000-0002-0242-454X; Gruber, Karl/0000-0002-3485-9740; Oberdorfer, Gustav/0000-0002-6144-9114	Fonds zur Furderung der wissenschaftlichen Forschung (FWF) [P19858]; Ph. D. program "Molecular Enzymology" [FWF W901]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Furderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Ph. D. program "Molecular Enzymology"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Fonds zur Furderung der wissenschaftlichen Forschung (FWF) through grant P19858 and the Ph. D. program "Molecular Enzymology" (FWF W901 to K. G. and P. M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 2011, PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BORMANN C, 1989, J ANTIBIOT, V42, P913, DOI 10.7164/antibiotics.42.913; BRILLINGER GU, 1979, ARCH MICROBIOL, V121, P71, DOI 10.1007/BF00409207; Bruntner C, 1999, MOL GEN GENET, V262, P102; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DAHN U, 1976, ARCH MICROBIOL, V107, P143, DOI 10.1007/BF00446834; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenburg S, 2003, J BIOL CHEM, V278, P49215, DOI 10.1074/jbc.M309741200; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Eschenburg S, 2005, J BIOL CHEM, V280, P14070, DOI 10.1074/jbc.M414412200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ginj C, 2005, CHEMBIOCHEM, V6, P1974, DOI 10.1002/cbic.200500208; HECTOR RF, 1993, CLIN MICROBIOL REV, V6, P1; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Kim MK, 2002, YEAST, V19, P341, DOI 10.1002/yea.837; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lauer B, 2001, MOL GEN GENET, V264, P662, DOI 10.1007/s004380000352; Lauer B, 2000, J ANTIBIOT, V53, P385, DOI 10.7164/antibiotics.53.385; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Samland AK, 1999, BIOCHEMISTRY-US, V38, P13162, DOI 10.1021/bi991041e; Samland AK, 2001, BIOCHEMISTRY-US, V40, P9950, DOI 10.1021/bi0107041; Schonbrunn E, 1998, EUR J BIOCHEM, V253, P406, DOI 10.1046/j.1432-1327.1998.2530406.x; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Schonbrunn E, 1996, STRUCTURE, V4, P1065, DOI 10.1016/S0969-2126(96)00113-X; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Schonbrunn E, 2000, BIOCHEMISTRY-US, V39, P2164, DOI 10.1021/bi991091j; Schrodinger LLC, 2011, MAESTR V 9 1; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Walsh CT, 1996, CHEM BIOL, V3, P83, DOI 10.1016/S1074-5521(96)90282-3; WEBB MR, 1992, BIOCHEM J, V287, P555, DOI 10.1042/bj2870555; Zhu JY, 2012, J BIOL CHEM, V287, P12657, DOI 10.1074/jbc.M112.342725	49	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31427	31436		10.1074/jbc.M112.352096	http://dx.doi.org/10.1074/jbc.M112.352096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810238	Green Published, hybrid			2022-12-28	WOS:000308791300053
J	Schuchmann, K; Muller, V				Schuchmann, Kai; Mueller, Volker			A Bacterial Electron-bifurcating Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-CONSERVATION; THERMOTOGA-MARITIMA; INTERMEDIATE STEP; IRON-HYDROGENASE; FERREDOXIN; NADH; COMPLEX; REDUCTION; EVOLUTION; QUANTITATION	The Wood-Ljungdahl pathway of anaerobic CO2 fixation with hydrogen as reductant is considered a candidate for the first life-sustaining pathway on earth because it combines carbon dioxide fixation with the synthesis of ATP via a chemiosmotic mechanism. The acetogenic bacterium Acetobacterium woodii uses an ancient version of the pathway that has only one site to generate the electrochemical ion potential used to drive ATP synthesis, the ferredoxin-fueled, sodium-motive Rnf complex. However, hydrogen-based ferredoxin reduction is endergonic, and how the steep energy barrier is overcome has been an enigma for a long time. We have purified a multimeric [FeFe]-hydrogenase from A. woodii containing four subunits (HydABCD) which is predicted to have one [H]-cluster, three [2Fe2S]-, and six [4Fe4S]-clusters consistent with the experimental determination of 32 mol of Fe and 30 mol of acid-labile sulfur. The enzyme indeed catalyzed hydrogen-based ferredoxin reduction, but required NAD(+) for this reaction. NAD(+) was also reduced but only in the presence of ferredoxin. NAD(+) and ferredoxin reduction both required flavin. Spectroscopic analyses revealed that NAD(+) and ferredoxin reduction are strictly coupled and that they are reduced in a 1: 1 stoichiometry. Apparently, the multimeric hydrogenase of A. woodii is a soluble energy-converting hydrogenase that uses electron bifurcation to drive the endergonic ferredoxin reduction by coupling it to the exergonic NAD(+) reduction.	[Schuchmann, Kai; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; DANGEL W, 1987, ARCH MICROBIOL, V148, P52, DOI 10.1007/BF00429647; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fritz M, 2008, FEBS J, V275, P1999, DOI 10.1111/j.1742-4658.2008.06354.x; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1111/j.1574-6968.1986.tb01859.x; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Hungate RE., 1969, METHODS MICROBIOLO B, Vvol 3, P117, DOI 10.1016/S0580-9517(08)70503-8; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Ljungdahl LG, 1994, ACETOGENESIS, P63, DOI [10.1007/978-1-4615-1777-1_2, DOI 10.1007/978-1-4615-1777-1_2]; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; RAGSDALE SW, 1984, ARCH MICROBIOL, V139, P361, DOI 10.1007/BF00408380; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Verhagen MFJM, 1999, BBA-BIOENERGETICS, V1412, P212, DOI 10.1016/S0005-2728(99)00062-6; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Welte C, 2010, FEBS J, V277, P3396, DOI 10.1111/j.1742-4658.2010.07744.x; WOOD HG, 1986, FEMS MICROBIOL LETT, V39, P345, DOI 10.1016/0378-1097(86)90022-4	38	141	145	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31165	31171		10.1074/jbc.M112.395038	http://dx.doi.org/10.1074/jbc.M112.395038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810230	Green Published, hybrid			2022-12-28	WOS:000308791300029
J	Chikwana, VM; Stec, B; Lee, BWK; de Crecy-Lagard, V; Iwata-Reuyl, D; Swairjo, MA				Chikwana, Vimbai M.; Stec, Boguslaw; Lee, Bobby W. K.; de Crecy-Lagard, Valerie; Iwata-Reuyl, Dirk; Swairjo, Manal A.			Structural Basis of Biological Nitrile Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUEUOSINE-BIOSYNTHESIS; ENZYME; MECHANISM; QUEF; OXIDOREDUCTASE; CYCLOHYDROLASE; NITROGENASE; REFINEMENT; FOLD	The enzyme QueF catalyzes the reduction of the nitrile group of 7-cyano-7-deazaguanine (preQ(0)) to 7-aminomethyl-7-deazaguanine (preQ(1)), the only nitrile reduction reaction known in biology. We describe here two crystal structures of Bacillus subtilis QueF, one of the wild-type enzyme in complex with the substrate preQ(0), trapped as a covalent thioimide, a putative intermediate in the reaction, and the second of the C55A mutant in complex with the substrate preQ(0) bound noncovalently. The QueF enzyme forms an asymmetric tunnel-fold homodecamer of two head-to-head facing pentameric subunits, harboring 10 active sites at the intersubunit interfaces. In both structures, a preQ(0) molecule is bound at eight sites, and in the wild-type enzyme, it forms a thioimide covalent linkage to the catalytic residue Cys-55. Both structural and transient kinetic data show that preQ(0) binding, not thioimide formation, induces a large conformational change in and closure of the active site. Based on these data, we propose a mechanism for the activation of the Cys-55 nucleophile and subsequent hydride transfer.	[Chikwana, Vimbai M.; Lee, Bobby W. K.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Stec, Boguslaw] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Swairjo, Manal A.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA	Portland State University; Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Florida; Western University of Health Sciences	Iwata-Reuyl, D (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	iwatard@pdx.edu; mswairjo@westernu.edu	Swairjo, Manal/AAR-9137-2021; de Crecy-Lagard, Valerie/AAN-8995-2020	Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [GM70641]; Department of Energy, the National Institutes of Health; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, the National Institutes of Health; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70641 (to D. I. R. and V. d. C. L.).; We thank Drs. A. Gonzalez and B. Sankaran for preliminary work on x-ray data collection, K. Shah for preliminary work on QueF crystals, Dr. P. Kuzmic for helpful discussions on data analysis with DynaFit, and Prof. A. Osterman for general support. The Stanford Synchrotron Research Laboratory Structural Molecular Biology Program is supported by the Department of Energy, the National Institutes of Health, and the National Institute of General Medical Sciences.	Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Cole J. L., 2012, HETEROANALYSIS VERSI; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher K, 2006, BIOCHEMISTRY-US, V45, P4190, DOI 10.1021/bi0514109; Hayes D. B., 2012, SEDNTERP VERSION 2 4; HWANG JC, 1972, BIOCHIM BIOPHYS ACTA, V283, P339, DOI 10.1016/0005-2728(72)90250-2; Iwata-Reuyl D, 2009, DNA RNA MODIFICATION, P379; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKADA N, 1979, J BIOL CHEM, V254, P3067; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Retailleau P, 2004, ACTA CRYSTALLOGR D, V60, P453, DOI 10.1107/S0907444903029718; Sankaran B, 2009, J BACTERIOL, V191, P6936, DOI 10.1128/JB.00287-09; STEVENSON DE, 1990, FEBS LETT, V277, P112, DOI 10.1016/0014-5793(90)80821-Y; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Swairjo MA, 2005, ACTA CRYSTALLOGR F, V61, P945, DOI 10.1107/S1744309105029246; Tanaka Y, 2005, J BIOCHEM, V138, P263, DOI 10.1093/jb/mvi120; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102	24	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30560	30570		10.1074/jbc.M112.388538	http://dx.doi.org/10.1074/jbc.M112.388538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787148	Green Published, hybrid			2022-12-28	WOS:000308579800048
J	Jung, SM; Moroi, M; Soejima, K; Nakagaki, T; Miura, Y; Berndt, MC; Gardiner, EE; Howes, JM; Pugh, N; Bihan, D; Watson, SP; Farndale, RW				Jung, Stephanie M.; Moroi, Masaaki; Soejima, Kenji; Nakagaki, Tomohiro; Miura, Yoshiki; Berndt, Michael C.; Gardiner, Elizabeth E.; Howes, Joanna-Marie; Pugh, Nicholas; Bihan, Dominique; Watson, Steve P.; Farndale, Richard W.			Constitutive Dimerization of Glycoprotein VI (GPVI) in Resting Platelets Is Essential for Binding to Collagen and Activation in Flowing Blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RECEPTOR; IDENTIFICATION; PATIENT; AGGREGATION; RECOGNIZES; PEPTIDES; RESIDUES; SURFACE; SITE	The platelet collagen receptor glycoprotein VI (GPVI) has been suggested to function as a dimer, with increased affinity for collagen. Dissociation constants (K-d) obtained by measuring recombinant GPVI binding to collagenous substrates showed that GPVI dimers bind with high affinity to tandem GPO (Gly-Pro-Hyp) sequences in collagen, whereas the markedly lower affinity of the monomer for all substrates implies that it is not the collagen-binding form of GPVI. Dimer binding required a high density of immobilized triple-helical (GPO)(10)-containing peptide, suggesting that the dimer binds multiple, discrete peptide helices. Differential inhibition of dimer binding by dimer-specific antibodies, m-Fab-F and 204-11 Fab, suggests that m-Fab-F binds at the collagen-binding site of the dimer, and 204-11 Fab binds to a discrete site. Flow cytometric quantitation indicated that GPVI dimers account for similar to 29% of total GPVI in resting platelets, whereas activation by either collagen-related peptide or thrombin increases the number of dimers to similar to 39 and similar to 44%, respectively. m-Fab-F inhibits both GPVI-dependent static platelet adhesion to collagen and thrombus formation on collagen under low and high shear, indicating that pre-existing dimeric GPVI is required for the initial interaction with collagen because affinity of the monomer is too low to support binding and that interaction through the dimer is essential for platelet activation. These GPVI dimers in resting circulating platelets will enable them to bind injury-exposed subendothelial collagen to initiate platelet activation. The GPVI-specific agonist collagen-related peptide or thrombin further increases the number of dimers, thereby providing a feedback mechanism for reinforcing binding to collagen and platelet activation.	[Jung, Stephanie M.; Moroi, Masaaki; Howes, Joanna-Marie; Pugh, Nicholas; Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Soejima, Kenji; Nakagaki, Tomohiro] Chemoserotherapeut Res Inst, Blood Prod Res Dept, Kumamoto 8608568, Japan; [Miura, Yoshiki] Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390864, Japan; [Berndt, Michael C.] Dublin City Univ, Biomed Diagnost Inst, Natl Ctr Sensor Res, Dublin 9, Ireland; [Gardiner, Elizabeth E.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Cambridge; Kurume University; Dublin City University; Monash University; University of Birmingham	Jung, SM (corresponding author), Univ Cambridge, Dept Biochem, Downing Site,Tennis Court Rd, Cambridge CB2 1QW, England.	smj52@cam.ac.uk	Gardiner, Elizabeth/P-8716-2019; Miura, Yoshiki/U-8875-2019; Watson, Stephen P/Q-6292-2016	Gardiner, Elizabeth/0000-0001-9453-9688; Miura, Yoshiki/0000-0002-7596-0482; Watson, Stephen P/0000-0002-7846-7423; Pugh, Nicholas/0000-0002-6916-4199	British Heart Foundation [PG/10/011/28199]; MRC [G0500707] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707, G9818340B] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grant PG/10/011/28199 from the British Heart Foundation (to S. M. J.).	Al-Tamimi M, 2009, PLATELETS, V20, P75, DOI 10.1080/09537100802645029; Arthur JF, 2007, J BIOL CHEM, V282, P30434, DOI 10.1074/jbc.M701330200; Berlanga O, 2007, J THROMB HAEMOST, V5, P1026, DOI 10.1111/j.1538-7836.2007.02449.x; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; de Groot PG, 2003, THROMBOSIS: FUNDAMENTAL AND CLINICAL ASPECTS, P37; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Hermans C, 2009, J THROMB HAEMOST, V7, P1356, DOI 10.1111/j.1538-7836.2009.03520.x; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Jung SM, 2009, J THROMB HAEMOST, V7, P1347, DOI 10.1111/j.1538-7836.2009.03496.x; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Jung SM, 2008, PLATELETS, V19, P32, DOI 10.1080/09537100701609027; Kehrel B, 1998, BLOOD, V91, P491; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Moroi M, 2003, THROMB HAEMOSTASIS, V89, P996; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; O'Connor MN, 2006, J BIOL CHEM, V281, P33505, DOI 10.1074/jbc.M606480200; O'Connor MN, 2006, J THROMB HAEMOST, V4, P869, DOI 10.1111/j.1538-7836.2005.01764.x; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; SUGIYAMA T, 1987, BLOOD, V69, P1712; Wagner CL, 1996, BLOOD, V88, P907; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x	32	56	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					30000	30013		10.1074/jbc.M112.359125	http://dx.doi.org/10.1074/jbc.M112.359125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773837	Green Published, hybrid			2022-12-28	WOS:000308286900073
J	Nie, MH; Aslanian, A; Prudden, J; Heideker, J; Vashisht, AA; Wohlschlegel, JA; Yates, JR; Boddy, MN				Nie, Minghua; Aslanian, Aaron; Prudden, John; Heideker, Johanna; Vashisht, Ajay A.; Wohlschlegel, James A.; Yates, John R., III; Boddy, Michael N.			Dual Recruitment of Cdc48 (p97)-Ufd1-Npl4 Ubiquitin-selective Segregase by Small Ubiquitin-like Modifier Protein (SUMO) and Ubiquitin in SUMO-targeted Ubiquitin Ligase-mediated Genome Stability Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; AAA-ATPASE; AURORA-B; FISSION YEAST; REPLICATION; DEGRADATION; REPAIR; SUMOYLATION; CHECKPOINT	Protein modification by SUMO and ubiquitin critically impacts genome stability via effectors that "read" their signals using SUMO interaction motifs or ubiquitin binding domains, respectively. A novel mixed SUMO and ubiquitin signal is generated by the SUMO-targeted ubiquitin ligase (STUbL), which ubiquitylates SUMO conjugates. Herein, we determine that the "ubiquitin-selective" segregase Cdc48-Ufd1-Npl4 also binds SUMO via aSUMOinteraction motif in Ufd1 and can thus act as a selective receptor for STUbL targets. Indeed, we define key cooperative DNA repair functions for Cdc48-Ufd1-Npl4 and STUbL, thereby revealing a new signaling mechanism involving dual recruitment by SUMO and ubiquitin for Cdc48-Ufd1-Npl4 functions in maintaining genome stability.	[Nie, Minghua; Prudden, John; Heideker, Johanna; Boddy, Michael N.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Aslanian, Aaron] Salk Inst Biol Sci, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nboddy@scripps.edu			National Institutes of Health [GM068608, GM081840, GM093600, P41 RR011823]; Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081840, R01GM089778, R01GM068608, F32GM093600, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM068608, GM081840 (to M. N. B.), GM093600 (to M. N.), and P41 RR011823 (to J. R. Y., III).; Supported by a Scholar Award from the Leukemia and Lymphoma Society.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2010, BIOCHEM CELL BIOL, V88, P23, DOI [10.1139/o09-119, 10.1139/O09-119]; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morris JR, 2010, BIOCHEM SOC T, V38, P92, DOI 10.1042/BST0380092; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parnas O, 2011, CELL CYCLE, V10, P2894, DOI 10.4161/cc.10.17.16778; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Ramanathan HN, 2011, MOL CELL, V44, P3, DOI 10.1016/j.molcel.2011.09.006; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003	50	63	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29610	29619		10.1074/jbc.M112.379768	http://dx.doi.org/10.1074/jbc.M112.379768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22730331	Green Published, hybrid			2022-12-28	WOS:000308286900036
J	Steinkellner, T; Yang, JW; Montgomery, TR; Chen, WQ; Winkler, MT; Sucic, S; Lubec, G; Freissmuth, M; Elgersma, Y; Sitte, HH; Kudlacek, O				Steinkellner, Thomas; Yang, Jae-Won; Montgomery, Therese R.; Chen, Wei-Qiang; Winkler, Marie-Therese; Sucic, Sonja; Lubec, Gert; Freissmuth, Michael; Elgersma, Ype; Sitte, Harald H.; Kudlacek, Oliver			Ca2+/Calmodulin-dependent Protein Kinase II alpha (alpha CaMKII) Controls the Activity of the Dopamine Transporter IMPLICATIONS FOR ANGELMAN SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; MOUSE MODEL; AMPHETAMINE; HIPPOCAMPAL; INHIBITION; MECHANISMS; PLASTICITY; TERMINUS; INSIGHTS; DEFICITS	The dopamine transporter (DAT) is a crucial regulator of dopaminergic neurotransmission, controlling the length and brevity of dopaminergic signaling. DAT is also the primary target of psychostimulant drugs such as cocaine and amphetamines. Conversely, methylphenidate and amphetamine are both used clinically in the treatment of attention-deficit hyperactivity disorder and narcolepsy. The action of amphetamines, which induce transport reversal, relies primarily on the ionic composition of the intra-and extracellular milieus. Recent findings suggest that DAT interacting proteins may also play a significant role in the modulation of reverse dopamine transport. The pharmacological inhibition of the serine/threonine kinase alpha CaMKII attenuates amphetamine-triggered DAT-mediated 1-methyl-4-phenylpyridinium (MPP+) efflux. More importantly, alpha CaMKII has also been shown to bind DAT in vitro and is therefore believed to be an important player within the DAT interactome. Herein, we show that alpha CaMKII co-immunoprecipitates with DAT in mouse striatal synaptosomes. Mice, which lack alpha CaMKII or which express a permanently self-inhibited alpha CaMKII (alpha CaMKIIT305D), exhibit significantly reduced amphetamine-triggered DAT-mediated MPP+ efflux. Additionally, we investigated mice that mimic a neurogenetic disease known as Angelman syndrome. These mice possess reduced alpha CaMKII activity. Angelman syndrome mice demonstrated an impaired DAT efflux function, which was comparable with that of the alpha CaMKII mutant mice, indicating that DAT-mediated dopaminergic signaling is affected in Angelman syndrome.	[Sucic, Sonja; Freissmuth, Michael; Sitte, Harald H.; Kudlacek, Oliver] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Chen, Wei-Qiang; Lubec, Gert] Med Univ Vienna, Neuroprote Div, Dept Pediat, A-1090 Vienna, Austria; [Montgomery, Therese R.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Elgersma, Ype] Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Medical University of Vienna; Medical University of Vienna; University College Dublin; Erasmus University Rotterdam; Erasmus MC	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; Elgersma, Ype/F-5164-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Elgersma, Ype/0000-0002-3758-1297; Montgomery, Therese/0000-0003-2749-5376; Yang, Jae-Won/0000-0001-8928-0130; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765; CHEN, Weiqiang/0000-0002-7720-4816; Lubec, Gert/0000-0002-6333-9461; Steinkellner, Thomas/0000-0003-4591-4992; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Foundation/FWF Grants [SFB35, DK W1232-B11]; Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Austrian Science Foundation/FWF Grants; Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation/FWF Grants SFB35 (to H. H. S. and M. F.) and DK W1232-B11 (to H. H. S.).; Recipient of a Health Research Board (HRB)-Marie Curie postdoctoral mobility fellowship.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Hornykiewicz O, 2006, J NEURAL TRANSM-SUPP, P9; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Owens WA, 2012, J NEUROSCI, V32, P2637, DOI 10.1523/JNEUROSCI.3759-11.2012; Quick MW, 2006, HANDB EXP PHARM, V175, P181; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams CA, 2010, AM J MED GENET C, V154C, P432, DOI 10.1002/ajmg.c.30278; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274	40	45	45	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29627	29635		10.1074/jbc.M112.367219	http://dx.doi.org/10.1074/jbc.M112.367219			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778257	hybrid, Green Published			2022-12-28	WOS:000308286900038
J	Bishop, DF; Tchaikovskii, V; Hoffbrand, AV; Fraser, ME; Margolis, S				Bishop, David F.; Tchaikovskii, Vassili; Hoffbrand, A. Victor; Fraser, Marie E.; Margolis, Steven			X-linked Sideroblastic Anemia Due to Carboxyl-terminal ALAS2 Mutations That Cause Loss of Binding to the beta-Subunit of Succinyl-CoA Synthetase (SUCLA2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; NUCLEOSIDE-DIPHOSPHATE KINASE; 5-AMINOLEVULINATE SYNTHASE; IRON OVERLOAD; PYRIDOXINE RESPONSIVENESS; HEME-BIOSYNTHESIS; GENE; ENCEPHALOMYOPATHY; ENZYME; SUBSTITUTION	Mutations in the erythroid-specific aminolevulinic acid synthase gene (ALAS2) cause X-linked sideroblastic anemia (XLSA) by reducing mitochondrial enzymatic activity. Surprisingly, a patient with the classic XLSA phenotype had a novel exon 11 mutation encoding a recombinant enzyme (p.Met567Val) with normal activity, kinetics, and stability. Similarly, both an expressed adjacent XLSA mutation, p.Ser568Gly, and a mutation (p.Phe557Ter) lacking the 31 carboxyl-terminal residues also had normal or enhanced activity, kinetics, and stability. Because ALAS2 binds to the beta subunit of succinyl-CoA synthetase (SUCLA2), the mutant proteins were tested for their ability to bind to this protein. Wild type ALAS2 bound strongly to a SUCLA2 affinity column, but the adjacent XLSA mutant enzymes and the truncated mutant did not bind. In contrast, vitamin B6-responsive XLSA mutations p. Arg452Cys and p.Arg452His, with normal in vitro enzyme activity and stability, did not interfere with binding to SUCLA2 but instead had loss of positive cooperativity for succinyl-CoA binding, an increased Km for succinyl-CoA, and reduced vitamin B6 affinity. Consistent with the association of SUCLA2 binding with in vivo ALAS2 activity, the p. Met567GlufsX2 mutant protein that causes X-linked protoporphyria bound strongly to SUCLA2, highlighting the probable role of an ALAS2-succinyl-CoA synthetase complex in the regulation of erythroid heme biosynthesis.	[Bishop, David F.; Tchaikovskii, Vassili; Margolis, Steven] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Hoffbrand, A. Victor] Royal Free Hosp, Dept Haematol, London NW3 2QG, England; [Fraser, Marie E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Icahn School of Medicine at Mount Sinai; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Calgary	Bishop, DF (corresponding author), 1425 Madison Ave, New York, NY 10029 USA.	david.bishop@mssm.edu	Bishop, David F./X-4102-2019	Bishop, David/0000-0003-1958-8601; Fraser, Marie/0000-0001-8501-1494	National Institutes of Health [R01DK40895]; New York State Department of Health [C024404]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK40895. This work was also supported by New York State Department of Health Research Grant C024404 and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada.	Anderson K. E., 2001, METABOLIC MOL BASES, P2991; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bertoldi M, 2005, BIOCHEM J, V389, P885, DOI 10.1042/BJ20050279; BISHOP DF, 1978, BIOCHIM BIOPHYS ACTA, V524, P109, DOI 10.1016/0005-2744(78)90109-2; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Bottomley SS, 2009, WINTROBES CLIN HEMAT, P835; Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x; Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389; Cazzola M, 2002, BLOOD, V100, P4236, DOI 10.1182/blood-2002-03-0685; Collins TS, 2004, AM J MED, V116, P501, DOI 10.1016/j.amjmed.2003.10.032; Cotter PD, 1999, BLOOD, V93, P1757, DOI 10.1182/blood.V93.5.1757.405a12_1757_1769; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; COTTER PD, 1995, J CLIN INVEST, V96, P2090, DOI 10.1172/JCI118258; Cox TC, 2004, INT J BIOCHEM CELL B, V36, P281, DOI 10.1016/S1357-2725(03)00246-2; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; Dzikaite V, 2000, BLOOD, V96, P740; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Furuyama K, 2006, EUR J HAEMATOL, V76, P33, DOI 10.1111/j.1600-0609.2005.00541.x; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Harigae H, 1999, BRIT J HAEMATOL, V106, P175, DOI 10.1046/j.1365-2141.1999.01479.x; Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883; Koc S, 1997, BLOOD, V90, P2756; Lee PL, 2006, BLOOD CELL MOL DIS, V36, P292, DOI 10.1016/j.bcmd.2005.12.004; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; May A, 1998, HAEMATOLOGICA, V83, P56; Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383; Pereira J. C., 2004, HUM GENET, V115, P533; Segel I. H., 1975, ENZYME KINETICS, P360; URATA G, 1963, J BIOL CHEM, V238, P811; Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003	41	38	42	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28943	28955		10.1074/jbc.M111.306423	http://dx.doi.org/10.1074/jbc.M111.306423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740690	hybrid, Green Published			2022-12-28	WOS:000308074600063
J	Jalak, J; Kurasin, M; Teugjas, H; Valjamae, P				Jalak, Juergen; Kurasin, Mihhail; Teugjas, Hele; Vaeljamaee, Priit			Endo-exo Synergism in Cellulose Hydrolysis Revisited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI CELLOBIOHYDROLASE; PHANEROCHAETE-CHRYSOSPORIUM CEL7D; CRYSTALLINE CELLULOSE; MICROCRYSTALLINE CELLULOSE; ENZYMATIC DECONSTRUCTION; LIGNOCELLULOSIC BIOMASS; INSOLUBLE CELLULOSE; ENDOGLUCANASE-I; CELLULASES	Synergistic cooperation of different enzymes is a prerequisite for efficient degradation of cellulose. The conventional mechanistic interpretation of the synergism between randomly acting endoglucanases (EGs) and chain end-specific processive cellobiohydrolases (CBHs) is that EG-generated new chain ends on cellulose surface serve as starting points for CBHs. Here we studied the hydrolysis of bacterial cellulose (BC) by CBH TrCel7A and EG TrCel5A from Trichoderma reesei under both single-turnover and "steady state" conditions. Unaccountable by conventional interpretation, the presence of EG increased the rate constant of TrCel7A-catalyzed hydrolysis of BC in steady state. At optimal enzyme/substrate ratios, the "steady state" rate of synergistic hydrolysis became limited by the velocity of processive movement of TrCel7A on BC. A processivity value of 66 +/- 7 cellobiose units measured for TrCel7A on C-14-labeled BC was close to the leveling off degree of polymerization of BC, suggesting that TrCel7A cannot pass through the amorphous regions on BC and stalls. We propose a mechanism of endo-exo synergism whereby the degradation of amorphous regions by EG avoids the stalling of TrCel7A and leads to its accelerated recruitment. Hydrolysis of pretreated wheat straw suggested that this mechanism of synergism is operative also in the degradation of lignocellulose. Although both mechanisms of synergism are used in parallel, the contribution of conventional mechanism is significant only at high enzyme/substrate ratios.	[Jalak, Juergen; Kurasin, Mihhail; Teugjas, Hele; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51014 Tartu, Estonia	University of Tartu	Valjamae, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Vanemuise 46-138, EE-51014 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	European Union Commission [213139]; Estonian Science Foundation [9227]	European Union Commission(European Commission); Estonian Science Foundation	This work was supported by the European Union Commission (FP7/2007-2013, Grant 213139) and Estonian Science Foundation (Grant 9227).	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boisset C, 2001, BIOTECHNOL BIOENG, V72, P339, DOI 10.1002/1097-0290(20010205)72:3<339::AID-BIT11>3.0.CO;2-#; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chanzy H, 2011, CELLULOSE, V18, P853, DOI 10.1007/s10570-011-9547-6; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; FAGERSTAM LG, 1980, FEBS LETT, V119, P97, DOI 10.1016/0014-5793(80)81006-4; Fenske JJ, 1999, J THEOR BIOL, V199, P113, DOI 10.1006/jtbi.1999.0938; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao L, 2012, J BIOL CHEM, V287, P15906, DOI 10.1074/jbc.M111.332890; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hoshino E, 1997, J FERMENT BIOENG, V84, P300, DOI 10.1016/S0922-338X(97)89248-3; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; MEDVE J, 1994, BIOTECHNOL BIOENG, V44, P1064, DOI 10.1002/bit.260440907; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Nishiyama Y, 2003, BIOMACROMOLECULES, V4, P1013, DOI 10.1021/bm025772x; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Riedel K, 1998, MOL MICROBIOL, V28, P767, DOI 10.1046/j.1365-2958.1998.00834.x; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Samejima M, 1997, CARBOHYD RES, V305, P281, DOI 10.1016/S0008-6215(97)10034-9; SELBY K, 1967, BIOCHEM J, V104, P716, DOI 10.1042/bj1040716; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; STORVICK WO, 1960, J BIOL CHEM, V235, P303; Thomsen MH, 2006, APPL BIOCHEM BIOTECH, V130, P448; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; WOOD TM, 1972, BIOCHEM J, V128, P1183, DOI 10.1042/bj1281183; WOODWARD J, 1988, BIO-TECHNOL, V6, P301, DOI 10.1038/nbt0388-301; WOODWARD J, 1991, BIORESOURCE TECHNOL, V36, P67, DOI 10.1016/0960-8524(91)90100-X; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	69	159	161	2	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28802	28815		10.1074/jbc.M112.381624	http://dx.doi.org/10.1074/jbc.M112.381624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733813	Green Published, hybrid			2022-12-28	WOS:000308074600053
J	Zeng, LL; Li, T; Xu, DC; Liu, J; Mao, GZ; Cui, MZ; Fu, XQ; Xu, XM				Zeng, Linlin; Li, Ting; Xu, Derek C.; Liu, Jennifer; Mao, Guozhang; Cui, Mei-Zhen; Fu, Xueqi; Xu, Xuemin			Death Receptor 6 Induces Apoptosis Not through Type I or Type II Pathways, but via a Unique Mitochondria-dependent Pathway by Interacting with Bax Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR; CELL-DEATH; DR6; FAMILY	Cells undergo apoptosis through two major pathways, the extrinsic pathway (death receptor pathway) and the intrinsic pathway (the mitochondrial pathway). These two pathways can be linked by caspase-8-activated truncated Bid formation. Very recently, death receptor 6 (DR6) was shown to be involved in the neurodegeneration observed in Alzheimer disease. DR6, also known as TNFRSF21, is a relatively new member of the death receptor family, and it was found that DR6 induces apoptosis when it is overexpressed. However, how the death signal mediated by DR6 is transduced intracellularly is not known. To this end, we have examined the roles of caspases, apoptogenic mitochondrial factor cytochrome c, and the Bcl-2 family proteins in DR6-induced apoptosis. Our data demonstrated that Bax translocation is absolutely required for DR6-induced apoptosis. On the other hand, inhibition of caspase-8 and knockdown of Bid have no effect on DR6-induced apoptosis. Our results strongly suggest that DR6-induced apoptosis occurs through a new pathway that is different from the type I and type II pathways through interacting with Bax.	[Zeng, Linlin; Li, Ting; Mao, Guozhang; Cui, Mei-Zhen; Xu, Xuemin] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Zeng, Linlin; Li, Ting; Fu, Xueqi] Jilin Univ, Edmond H Fischer Signal Transduct Lab, Coll Life Sci, Changchun 130012, Peoples R China; [Xu, Derek C.; Liu, Jennifer] Farragut High Sch, Knoxville, TN 37934 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University	Xu, XM (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	xmx@utk.edu		Cui, Mei-Zhen/0000-0003-4745-6999; Xu, Derek/0000-0003-3446-0331	National Institutes of Health [R181741110, R21AG039596, 0355339B]; Alzheimer's Association; American Health Assistance Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R181741110 and R21AG039596 (to X. X.) and 0355339B (to M.-Z.C.). This work was also supported by an Alzheimer's Association grant and a grant from the American Health Assistance Foundation (to X. X.).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; Klima M, 2009, BBA-MOL CELL RES, V1793, P1579, DOI 10.1016/j.bbamcr.2009.07.008; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pucci B, 2009, J CELL BIOCHEM, V108, P1166, DOI 10.1002/jcb.22345; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	19	66	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29125	29133		10.1074/jbc.M112.362038	http://dx.doi.org/10.1074/jbc.M112.362038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761420	Green Published, hybrid			2022-12-28	WOS:000308074600078
J	Zhou, YY; Zhang, HM; He, B; Du, JT; Lin, HN; Cerione, RA; Hao, Q				Zhou, Yeyun; Zhang, Hongmin; He, Bin; Du, Jintang; Lin, Hening; Cerione, Richard A.; Hao, Quan			The Bicyclic Intermediate Structure Provides Insights into the Desuccinylation Mechanism of Human Sirtuin 5 (SIRT5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; LIFE-SPAN; NICOTINAMIDE; INHIBITION; NAD; GENE; DEACETYLASES; FAMILY; CANCER	Sirtuins are pivotal regulators in various cellular processes, including transcription, DNA repair, genome stability, and energy metabolism. Their functions have been generally attributed to NAD-dependent deacetylase activity. However, human SIRT5 (sirtuin 5), which has been reported to exhibit little deacetylase activity, was recently identified as an NAD-dependent demalonylase and desuccinylase. Biochemical studies suggested that the mechanism of SIRT5-catalyzed demalonylation and desuccinylation is similar to that of deacetylation catalyzed by other sirtuins. Previously, we solved the crystal structure of a SIRT5-succinyl-lysine peptide-NAD complex. Here, we present two more structures: a binary complex of SIRT5 with an H3K9 succinyl peptide and a binary complex of SIRT5 with a bicyclic intermediate obtained by incubating SIRT5-H3K9 thiosuccinyl peptide co-crystals with NAD. To our knowledge, this represents the first bicyclic intermediate for a sirtuin-catalyzed deacylation reaction that has been captured in a crystal structure, thus providing unique insights into the reaction mechanism. The structural information should benefit the design of specific inhibitors for SIRT5 and help in exploring the therapeutic potential of targeting sirtuins for treating human diseases.	[Zhang, Hongmin; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Yeyun] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Coll Vet Med, Ithaca, NY 14853 USA; [He, Bin; Du, Jintang; Lin, Hening; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Coll Vet Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	University of Hong Kong; Cornell University; Cornell University; Cornell University	Hao, Q (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	qhao@hku.hk	Zhang, Hongmin/S-9953-2017; Hao, Quan/C-4304-2009; Zhang, Hongmin/C-4503-2009	Zhang, Hongmin/0000-0003-4356-3615; Hao, Quan/0000-0002-9642-0514; Zhang, Hongmin/0000-0001-6357-4106	National Institutes of Health [RR01646, CA163255, DMR-0225180]; Hong Kong Research Grants Council [GRF766510]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA163255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants RR01646 (to R. A. C. and Q. H.) and CA163255 (to H. L.). This work was also supported by Hong Kong Research Grants Council Grant GRF766510 (to Q. H.).; The crystallographic data were collected at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and National Institutes of Health through Award DMR-0225180.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Garske AL, 2007, ACS CHEM BIOL, V2, P529, DOI 10.1021/cb700160d; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; He B, 2012, J AM CHEM SOC, V134, P1922, DOI 10.1021/ja2090417; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	43	62	62	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28307	28314		10.1074/jbc.M112.384511	http://dx.doi.org/10.1074/jbc.M112.384511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767592	hybrid, Green Published			2022-12-28	WOS:000308074600008
J	Bond, D; Foley, E				Bond, David; Foley, Edan			Autocrine Platelet-derived Growth Factor-Vascular Endothelial Growth Factor Receptor-related (Pvr) Pathway Activity Controls Intestinal Stem Cell Proliferation in the Adult Drosophila Midgut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; PDGF/VEGF RECEPTOR; MULTIPLE PATHWAYS; MESSENGER-RNA; HOST-DEFENSE; MIGRATION; EGFR; REGENERATION; CANCER	A dynamic pool of undifferentiated somatic stem cells proliferate and differentiate to replace dead or dying mature cell types and maintain the integrity and function of adult tissues. Intestinal stem cells (ISCs) in the Drosophila posterior midgut are a well established model to study the complex genetic circuitry that governs stem cell homeostasis. Exposure of the intestinal epithelium to environmental toxins results in the expression of cytokines and growth factors that drive the rapid proliferation and differentiation of ISCs. In the absence of stress signals, ISC homeostasis is maintained through intrinsic pathways. In this study, we uncovered the PDGF- and VEGF-receptor related (Pvr) pathway as an essential regulator of ISC homeostasis under unstressed conditions in the posterior midgut. We found that Pvr is coexpressed with its ligand Pvf2 in ISCs and that hyperactivation of the Pvr pathway distorts the ISC developmental program and drives intestinal dysplasia. In contrast, we show that mutant ISCs in the Pvf/Pvr pathway are defective in homeostatic proliferation and differentiation, resulting in a failure to generate mature cell types. Additionally, we determined that extrinsic stress signals generated by enteropathogenic infection are epistatic to the hypoplasia generated in Pvf/Pvr mutants, making the Pvr pathway unique among all previously studied intrinsic pathways. Our findings illuminate an evolutionarily conserved signal transduction pathway with essential roles in metazoan embryonic development and direct involvement in numerous disease states.	[Bond, David; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			Canadian Institute for Heath Research Grant [MOP 77746]; Alberta Innovates Heath Solutions grant	Canadian Institute for Heath Research Grant; Alberta Innovates Heath Solutions grant	This work was supported by Canadian Institute for Heath Research Grant MOP 77746 and a Alberta Innovates Heath Solutions grant.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Weber U, 2000, DEVELOPMENT, V127, P3619; Wu YJ, 2009, CURR BIOL, V19, P1473, DOI 10.1016/j.cub.2009.07.019; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661	65	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27359	27370		10.1074/jbc.M112.378018	http://dx.doi.org/10.1074/jbc.M112.378018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722927	Green Published, hybrid			2022-12-28	WOS:000307840700008
J	Culham, DE; Meinecke, M; Wood, JM				Culham, Doreen E.; Meinecke, Michael; Wood, Janet M.			Impacts of the Osmolality and the Lumenal Ionic Strength on Osmosensory Transporter ProP in Proteoliposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETAINE CARRIER BETP; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; OSMOTIC ACTIVATION; COILED-COIL; WATER; ROLES; SOLUTES; PROTEIN; K+	H+ symporter ProP serves as a paradigm for the study of osmosensing. ProP attains the same activity at the same osmolality when the medium outside cells or proteoliposomes is supplemented with diverse, membrane-impermeant solutes. The osmosensory mechanism of ProP has been probed by varying the solvent within membrane vesicles and proteoliposomes. ProP activation was not ion specific, did not require K+, and could be elicited by large, uncharged solutes polyethylene glycols (PEGS). We hypothesized that ProP is an ionic strength sensor and lumenal macromolecules activate ProP by altering ion activities. The attainable range of lumenal ionic strength was expanded by lowering the phosphate concentration within proteoliposomes. ProP activity at high osmolality, but not the osmolality, yielding half-maximal activity (Pi(1/2)/RT), decreased with the lumenal phosphate concentration. This was attributed to acidification of the proteoliposome lumen due to H+-proline symport. The ionic strength yielding half-maximal ProP activity was more anion-dependent than Pi(1/2)/RT for proteoliposomes loaded with citrate, sulfate, phosphate, chloride, or iodide. The anion effects followed the Hofmeister series. Lumenal bovine serum albumin (BSA) lowered the lumenal ionic strength at which ProP became active. Osmolality measurements documented the non-idealities of solutions including potassium phosphate and other solutes. The impacts of PEGS and BSA on ion activities did not account for their impacts on ProP activity. The effects of the tested solutes on ProP appear to be non-coulombic in nature. They may arise from effects of preferential interactions and macromolecular crowding on the membrane or on ProP.	[Culham, Doreen E.; Meinecke, Michael; Wood, Janet M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wood, JM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jwood@uoguelph.ca	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951	Canadian Institutes for Health Research Operating [MOP-89990]	Canadian Institutes for Health Research Operating(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Operating Grant MOP-89990 (to J. M. W.) and by a travel award by the Muhlenhoff Stiftung (to M. M.).	[Anonymous], 1888, ARCH EXP PATHOL PHAR, DOI DOI 10.1007/BF01918191; BENGA G, 1984, PROG BIOPHYS MOL BIO, V43, P195, DOI 10.1016/0079-6107(84)90014-2; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; Culham DE, 2000, J MOL RECOGNIT, V13, P309, DOI 10.1002/1099-1352(200009/10)13:5<309::AID-JMR505>3.3.CO;2-I; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; ERTEL A, 1993, BIOPHYS J, V64, P426, DOI 10.1016/S0006-3495(93)81383-3; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haussinger D, 2007, METHOD ENZYMOL, V428, P1; Karasawa A, 2011, J BIOL CHEM, V286, P37280, DOI 10.1074/jbc.M111.284059; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; Konopka MC, 2007, METHOD ENZYMOL, V428, P487, DOI 10.1016/S0076-6879(07)28027-9; Koynova R, 1997, EUR BIOPHYS J BIOPHY, V25, P261, DOI 10.1007/s002490050038; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Parsegian VA, 2002, INT REV CYTOL, V215, P1; Pegram LM, 2007, J PHYS CHEM B, V111, P5411, DOI 10.1021/jp070245z; Pegram Laurel M., 2009, V490, P179, DOI 10.1007/978-1-59745-367-7_8; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Poolman B, 2002, MOL MICROBIOL, V44, P889, DOI 10.1046/j.1365-2958.2002.02894.x; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; ROBINSON DR, 1965, J AM CHEM SOC, V87, P2470, DOI 10.1021/ja01089a029; Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SANDERSON PW, 1991, BIOCHIM BIOPHYS ACTA, V1067, P43, DOI 10.1016/0005-2736(91)90024-3; Schiller D, 2006, J BIOL CHEM, V281, P7737, DOI 10.1074/jbc.M513052200; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SEIGNEURET M, 1985, FEBS LETT, V188, P101, DOI 10.1016/0014-5793(85)80883-8; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Von Hippel P. H., 1969, STRUCTURE STABILITY, P417; Waggoner A S, 1979, Methods Enzymol, V55, P689; White GF, 2000, BBA-BIOMEMBRANES, V1468, P175, DOI 10.1016/S0005-2736(00)00255-8; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zhang WT, 1996, BIOCHEMISTRY-US, V35, P10506, DOI 10.1021/bi960795f; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	49	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27813	27822		10.1074/jbc.M112.387936	http://dx.doi.org/10.1074/jbc.M112.387936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740696	Green Published, hybrid			2022-12-28	WOS:000307840700055
J	Joo, HM; Nam, SY; Yang, KH; Kim, CS; Jin, YW; Kim, JY				Joo, Hae Mi; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Jin, Young Woo; Kim, Ji Young			The Effects of Low-dose Ionizing Radiation in the Activated Rat Basophilic Leukemia (RBL-2H3) Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNE-SYSTEM; ATOPIC-DERMATITIS; LIPID RAFTS; IGE; SUPPRESSION; RECEPTOR; RELEASE; ALPHA	Mast cells play important roles in many biological responses, such as those during allergic diseases and inflammatory disorders. Although laser and UV irradiation have immunosuppressive effects on inflammatory diseases by suppressing mast cells, little is known about the effects of gamma-ionizing radiation on mast cells. In this study, we investigated the effects of gamma-ionizing radiation on RBL-2H3 cells, a convenient model system for studying regulated secretion by mast cells. Low-dose radiation ( < 0.1 gray (Gy)) did not induce cell death, but high-dose radiation ( > 0.5 Gy) induced apoptosis. Low-dose ionizing radiation significantly suppressed the release of mediators (histamine, beta-hexosaminidase, IL-4, and tumor necrosis factor-alpha) from immunoglobulin E (IgE)-sensitized RBL-2H3 cells. To determine the mechanism of mediator release inhibition by ionizing radiation, we examined the activation of intracellular signaling molecules such as Lyn, Syk, phospholipase C gamma, PKCs, and MAPK, and intracellular free calcium concentrations ([Ca2+](i)). The phosphorylation of signaling molecules following stimulation of high-affinity IgE receptor I (Fc epsilon RI) was specifically inhibited by low-dose ionizing radiation (0.01 Gy). These results were due to the suppression of Fc epsilon RI expression by the low-dose ionizing radiation. Therefore, low-dose ionizing radiation (0.01 Gy) may function as a novel inhibitor of mast cell activation.	[Joo, Hae Mi; Nam, Seon Young; Yang, Kwang Hee; Kim, Cha Soon; Jin, Young Woo; Kim, Ji Young] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Radiat Effect Res Team, Seoul 132703, South Korea	Korea Hydro & Nuclear Power	Kim, JY (corresponding author), Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Radiat Effect Res Team, 388-1 Ssangmun Dong, Seoul 132703, South Korea.	jykim@khnp.co.kr			Korea Hydro and Nuclear Power Co., Ltd. [E09NS02]; Ministry of Knowledge Economy, Republic of Korea [2010T100100303]	Korea Hydro and Nuclear Power Co., Ltd.; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by Grant E09NS02 from the Korea Hydro and Nuclear Power Co., Ltd. and Grant 2010T100100303 from the Ministry of Knowledge Economy, Republic of Korea.	AKIYAMA M, 1995, INT J RADIAT BIOL, V68, P497, DOI 10.1080/09553009514551491; Asai K, 2000, J HISTOCHEM CYTOCHEM, V48, P1705, DOI 10.1177/002215540004801213; BARANES D, 1991, BLOOD, V78, P2354; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Hanneman KK, 2006, DERMATOL CLIN, V24, P19, DOI 10.1016/j.det.2005.08.003; Harrington NP, 1997, CLIN EXP IMMUNOL, V107, P417, DOI 10.1111/j.1365-2249.1997.272-ce1158.x; JECKLER J, 1988, BRIT J DERMATOL, V119, P697, DOI 10.1111/j.1365-2133.1988.tb03490.x; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Molfetta R, 2010, MOL IMMUNOL, V47, P2427, DOI 10.1016/j.molimm.2010.06.003; Molfetta R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005604; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Nowosielska EM, 2010, DOSE-RESPONSE, V8, P209, DOI 10.2203/dose-response.09-016.Nowosielska; Oka T, 2004, AM J PHYSIOL-CELL PH, V286, pC256, DOI 10.1152/ajpcell.00197.2003; Oliver C, 2007, J HISTOCHEM CYTOCHEM, V55, P315, DOI 10.1369/jhc.6A7037.2006; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Souza AMMS, 2008, EXP CELL RES, V314, P2515, DOI 10.1016/j.yexcr.2008.05.014; Siraganian R. P., 1980, HISTAMINE RELEASE AS; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Wulf HC, 1998, PHOTODERMATOL PHOTO, V14, P1, DOI 10.1111/j.1600-0781.1998.tb00001.x; Zhang C, 1997, J BIOL CHEM, V272, P13397, DOI 10.1074/jbc.272.20.13397	28	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27789	27795		10.1074/jbc.M112.378497	http://dx.doi.org/10.1074/jbc.M112.378497			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700973	hybrid, Green Published			2022-12-28	WOS:000307840700052
J	Paleskava, A; Konevega, AL; Rodnina, MV				Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.			Thermodynamics of the GTP-GDP-operated Conformational Switch of Selenocysteine-specific Translation Factor SelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR SELB; ISOTHERMAL TITRATION CALORIMETRY; CRYSTAL-STRUCTURE; FACTOR TU; TRANSFER-RNA; RECOGNITION; PROTEINS; BINDING; NUCLEOTIDES; RIBOSOME	SelB is a specialized translation factor that binds GTP and GDP and delivers selenocysteyl-tRNA (Sec-tRNA(Sec)) to the ribosome. By analogy to elongation factor Tu (EF-Tu), SelB is expected to control the delivery and release of Sec-tRNA(Sec) to the ribosome by the structural switch between GTP- and GDP-bound conformations. However, crystal structures of SelB suggested a similar domain arrangement in the apo form and GDP- and GTP-bound forms of the factor, raising the question of how SelB can fulfill its delivery function. Here, we studied the thermodynamics of guanine nucleotide binding to SelB by isothermal titration calorimetry in the temperature range between 10 and 25 degrees C using GTP, GDP, and two nonhydrolyzable GTP analogs, guanosine 5'-O-(gamma-thio) triphosphate (GTP gamma S) and guanosine 5'-(beta,gamma-imido)-triphosphate (GDPNP). The binding of SelB to either guanine nucleotide is characterized by a large heat capacity change (-621, -467, -235, and -275 cal x mol(-1) x K-1, with GTP, GTP gamma S, GDPNP, and GDP, respectively), associated with compensatory changes in binding entropy and enthalpy. Changes in heat capacity indicate a large decrease of the solvent-accessible surface area in SelB, amounting to 43 or 32 amino acids buried upon binding of GTP or GTP gamma S, respectively, and 15-19 amino acids upon bindingGDP or GDPNP. The similarity of the GTP and GDP forms in the crystal structures can be attributed to the use of GDPNP, which appears to induce a structure of SelB that is more similar to the GDP than to the GTP-bound form.	[Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Paleskava, Alena/AAO-7332-2020; Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Paleskava, Alena/0000-0001-8623-8404	Deutsche Forschungsgemeinschaft; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and by the funding of the Max Planck Society.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Doyle M, 1999, CURRENT PROTOCOLS PR, P2041; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; Hauryliuk V, 2009, J MOL BIOL, V394, P621, DOI 10.1016/j.jmb.2009.10.015; Hilgenfeld R, 1996, BIOCHIMIE, V78, P971, DOI 10.1016/S0300-9084(97)86719-3; Hilgenfeld R, 1995, CURR OPIN STRUC BIOL, V5, P810, DOI 10.1016/0959-440X(95)80015-8; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Keeling PJ, 1998, J MOL EVOL, V47, P649, DOI 10.1007/PL00006422; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Paleskava A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081380; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Samanta U, 2002, PROTEIN ENG, V15, P659, DOI 10.1093/protein/15.8.659; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Thanbichler M, 2003, PROTEIN EXPRES PURIF, V31, P265, DOI 10.1016/S1046-5928(03)00167-0; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	36	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27906	27912		10.1074/jbc.M112.366120	http://dx.doi.org/10.1074/jbc.M112.366120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740700	Green Published, hybrid			2022-12-28	WOS:000307840700064
J	Wheatley, RW; Zheng, RB; Richards, MR; Lowary, TL; Ng, KKS				Wheatley, Robert W.; Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.; Ng, Kenneth K. S.			Tetrameric Structure of the GlfT2 Galactofuranosyltransferase Reveals a Scaffold for the Assembly of Mycobacterial Arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CRYSTAL-STRUCTURE; TUBERCULOSIS ARABINOGALACTAN; LENGTH CONTROL; UDP-GALNAC; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; IDENTIFICATION; POLYMERASE; TARGET	Biosynthesis of the mycobacterial cell wall relies on the activities of many enzymes, including several glycosyltransferases (GTs). The polymerizing galactofuranosyltransferase GlfT2 (Rv3808c) synthesizes the bulk of the galactan portion of the mycolyl-arabinogalactan complex, which is the largest component of the mycobacterial cell wall. We used x-ray crystallography to determine the 2.45-angstrom resolution crystal structure of GlfT2, revealing an unprecedented multidomain structure in which an N-terminal beta-barrel domain and two primarily alpha-helical C-terminal domains flank a central GT-A domain. The kidney- shaped protomers assemble into a C-4-symmetric homotetramer with an open central core and a surface containing exposed hydrophobic and positively charged residues likely involved with membrane binding. The structure of a 3.1-angstrom resolution complex of GlfT2 withUDPreveals a distinctive mode of nucleotide recognition. In addition, models for the binding of UDP-galactofuranose and acceptor substrates in combination with site-directed mutagenesis and kinetic studies suggest a mechanism that explains the unique ability of GlfT2 to generate alternating beta-(1 -> 5) and beta-(1 -> 6) glycosidic linkages using a single active site. The topology imposed by docking a tetrameric assembly onto a membrane bilayer also provides novel insights into aspects of processivity and chain length regulation in this and possibly other polymerizing GTs.	[Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Wheatley, Robert W.; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Wheatley, Robert W.; Zheng, Ruixiang Blake; Richards, Michele R.; Lowary, Todd L.; Ng, Kenneth K. S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Calgary; University of Calgary	Lowary, TL (corresponding author), Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada.	tlowary@ualberta.ca; ngk@ucalgary.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Ng, Kenneth K.S./0000-0001-7280-8445	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council; Alberta Heritage Foundation for Medical Research Senior Scholar Award; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; NCRR [P41RR001209]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research Senior Scholar Award(Alberta Heritage Foundation for Medical Research); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Alberta Glycomics Centre, the Natural Sciences and Engineering Research Council Discovery grants (to T. L. L. and K. K. S. N.), and the Alberta Heritage Foundation for Medical Research Senior Scholar Award (to K. K. S. N.).; We acknowledge the help of the staff at the Stanford Synchrotron Radiation Laboratory and the Canadian Light Source for providing access to the synchrotron radiation beamlines used for crystal screening and data collection at various stages of this project. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS and Grant P41RR001209 from NCRR. Portions of the research described in this paper were performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burkert U., 1982, MOL MECH, DOI 10.1002/jcc.540040420; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Dover LG, 2011, J MED CHEM, V54, P6157, DOI 10.1021/jm200305q; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; May JF, 2012, BIOCHEMISTRY-US, V51, P1148, DOI 10.1021/bi201820p; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Petrova P, 2001, BIOPOLYMERS, V58, P617, DOI 10.1002/1097-0282(200106)58:7<617::AID-BIP1035>3.0.CO;2-1; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Poulin MB, 2012, ORG BIOMOL CHEM, V10, P4074, DOI 10.1039/c2ob25159k; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rose NL, 2008, CARBOHYD RES, V343, P2130, DOI 10.1016/j.carres.2008.03.023; Rose NL, 2006, J AM CHEM SOC, V128, P6721, DOI 10.1021/ja058254d; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sunna A, 2001, BIOCHEM J, V356, P791, DOI 10.1042/0264-6021:3560791; Szczepina MG, 2010, BIOORGAN MED CHEM, V18, P5123, DOI 10.1016/j.bmc.2010.05.069; Szczepina MG, 2009, CHEMBIOCHEM, V10, P2052, DOI 10.1002/cbic.200900202; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839	54	49	51	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28132	28143		10.1074/jbc.M112.347484	http://dx.doi.org/10.1074/jbc.M112.347484			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22707726	Green Published, hybrid			2022-12-28	WOS:000307840700086
J	Wilhelms, M; Fulton, KM; Twine, SM; Tomas, JM; Merino, S				Wilhelms, Markus; Fulton, Kelly M.; Twine, Susan M.; Tomas, Juan M.; Merino, Susana			Differential Glycosylation of Polar and Lateral Flagellins in Aeromonas hydrophila AH-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GLYCOSYLATION; BIOSYNTHESIS; MOTILITY; PATHWAY; ISLAND	Polar and lateral flagellin proteins from Aeromonas hydrophila strain AH-3 (serotype O34) were found to be glycosylated with different carbohydrate moieties. The lateral flagellin was modified at three sites in O-linkage, with a single monosaccharide of 376 Da, which we show to be a pseudaminic acid derivative. The polar flagellin was modified with a heterogeneous glycan, comprised of a heptasaccharide, linked through the same 376-Da sugar to the protein backbone, also in O-linkage. In-frame deletion mutants of pseudaminic acid biosynthetic genes pseB and pseF homologues resulted in abolition of polar and lateral flagellar formation by posttranscriptional regulation of the flagellins, which was restored by complementation with wild type pseB or F homologues or Campylobacter pseB and F.	[Wilhelms, Markus; Tomas, Juan M.; Merino, Susana] Univ Barcelona, Fac Biol, Dept Microbiol, E-08071 Barcelona, Spain; [Fulton, Kelly M.; Twine, Susan M.] CNR, Ottawa, ON K1A 0R1, Canada	University of Barcelona; National Research Council Canada	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 643, E-08071 Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia); National Research Council Canada	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); National Research Council Canada	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain), Generalitat de Catalunya (Centre de Referencia en Biotecnologia), and the National Research Council Canada.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arora SK, 2004, J BACTERIOL, V186, P2115, DOI 10.1128/JB.186.7.2115-2122.2004; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Canals R, 2007, MICROBIOL-SGM, V153, P1165, DOI 10.1099/mic.0.2006/000687-0; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Gavin R, 2002, MOL MICROBIOL, V43, P383, DOI 10.1046/j.1365-2958.2002.02750.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nogueras MM, 2000, INFECT IMMUN, V68, P1849, DOI 10.1128/IAI.68.4.1849-1854.2000; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; SHIMADA T, 1985, JPN J MED SCI BIOL, V38, P141, DOI 10.7883/yoken1952.38.141; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2012, BACTERIAL GLYCOMICS: CURRENT RESEARCH, TECHNOLOGY AND APPLICATIONS, P69; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wilhelms M, 2011, J BACTERIOL, V193, P5179, DOI 10.1128/JB.05355-11	37	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27851	27862		10.1074/jbc.M112.376525	http://dx.doi.org/10.1074/jbc.M112.376525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733809	Green Published, hybrid			2022-12-28	WOS:000307840700059
J	Zhong, YW; Fang, SY				Zhong, Yongwang; Fang, Shengyun			Live Cell Imaging of Protein Dislocation from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; QUALITY-CONTROL; MUTANT ALPHA-1-ANTITRYPSIN; MISFOLDED GLYCOPROTEINS; RETRO-TRANSLOCATION; LIGASE COMPLEX; IMPORTIN-BETA; EGF RECEPTOR; AAA-ATPASE	Misfolded proteins in the endoplasmic reticulum (ER) are dislocated to the cytosol to be degraded by the proteasomes. Various plant and bacterial toxins and certain viruses hijack this dislocation pathway to exert their toxicity or to infect cells. In this study, we report a dislocation-dependent reconstituted GFP (drGFP) assay that allows, for the first time, imaging proteins dislocated from the ER lumen to the cytosol in living cells. Our results indicate that both luminal and membrane-spanning ER proteins can be fully dislocated from the ER to the cytosol. By combining the drGFP assay with RNAi or chemical inhibitors of proteins in the Hrd1 ubiquitin ligase complex, we demonstrate that the Sel1L, Hrd1, p97/VCP, and importin beta proteins are required for the dislocation of misfolded luminal alpha-1 antitrypsin. The strategy described in this work is broadly applicable to the study of other types of transmembrane transport of proteins and likely also of viruses and toxins in living cells.	[Fang, Shengyun] Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol,BioMET, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Fang, SY (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol,BioMET, 725 W Lombard St, Baltimore, MD 21201 USA.	sfang@umaryland.edu	Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012	Fang, Shengyun/0000-0001-7280-5463	NSF [1120833]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 1120833 (to S.F.).	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906	63	23	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28057	28066		10.1074/jbc.M112.381798	http://dx.doi.org/10.1074/jbc.M112.381798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722934	Green Published, hybrid			2022-12-28	WOS:000307840700079
J	Clementi, EA; Marks, LR; Duffey, ME; Hakansson, AP				Clementi, Emily A.; Marks, Laura R.; Duffey, Michael E.; Hakansson, Anders P.			A Novel Initiation Mechanism of Death in Streptococcus pneumoniae Induced by the Human Milk Protein-Lipid Complex HAMLET and Activated during Physiological Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-LACTALBUMIN; CALCIUM REGULATION; GENOME SEQUENCE; ION CHANNELS; APOPTOSIS; BIOFILMS; MEMBRANE; KINASE; K+; TRANSFORMATION	To cause colonization or infection, most bacteria grow in biofilms where differentiation and death of subpopulations is critical for optimal survival of the whole population. However, little is known about initiation of bacterial death under physiological conditions. Membrane depolarization has been suggested, but never shown to be involved, due to the difficulty of performing such studies in bacteria and the paucity of information that exists regarding ion transport mechanisms in prokaryotes. In this study, we performed the first extensive investigation of ion transport and membrane depolarization in a bacterial system. We found that HAMLET, a human milk protein-lipid complex, kills Streptococcus pneumoniae (the pneumococcus) in a manner that shares features with activation of physiological death from starvation. Addition of HAMLET to pneumococci dissipated membrane polarity, but depolarization per se was not enough to trigger death. Rather, both HAMLET- and starvation-induced death of pneumococci specifically required a sodium-dependent calcium influx, as shown using calcium and sodium transport inhibitors. This mechanism was verified under low sodium conditions, and in the presence of ionomycin or monensin, which enhanced pneumococcal sensitivity to HAMLET- and starvation-induced death. Pneumococcal death was also inhibited by kinase inhibitors, and indicated the involvement of Ser/Thr kinases in these processes. The importance of this activation mechanism was made evident, as dysregulation and manipulation of physiological death was detrimental to biofilm formation, a hallmark of bacterial colonization. Overall, our findings provide novel information on the role of ion transport during bacterial death, with the potential to uncover future antimicrobial targets.	[Clementi, Emily A.; Marks, Laura R.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Duffey, Michael E.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA; [Hakansson, Anders P.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hakansson, AP (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, 145 BRB,3435 Main St, Buffalo, NY 14214 USA.	andersh@buffalo.edu	Hakansson, Anders P/AAX-1225-2020; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Hakansson, Anders/0000-0002-2834-6009; Marks, Laura/0000-0002-5317-443X	National Institutes of Health (NIDCD) Fellowship [F31DC011218]; Bill and Melinda Gates Foundation Grant [53085]; J. R. Oishei Foundation; American Lung Association Grant [RG-123721-N]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011218] Funding Source: NIH RePORTER	National Institutes of Health (NIDCD) Fellowship; Bill and Melinda Gates Foundation Grant(Bill & Melinda Gates Foundation); J. R. Oishei Foundation; American Lung Association Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIDCD) Fellowship F31DC011218 (to E. A. C.), Bill and Melinda Gates Foundation Grant 53085, the J. R. Oishei Foundation, and American Lung Association Grant RG-123721-N (to A. P. H.).	Andres MT, 2008, ANTIMICROB AGENTS CH, V52, P4081, DOI 10.1128/AAC.01597-07; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BAKKER EP, 1980, J BIOL CHEM, V255, P433; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brnjic S, 2010, MOL BIOSYST, V6, P767, DOI 10.1039/b920805d; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; FUTSAETHER CM, 1994, CAN J MICROBIOL, V40, P439, DOI 10.1139/m94-072; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Giorgi C, 2008, CURR MOL MED, V8, P119; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson A, 1999, THESIS LUND U LUND; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; HAROLD FM, 1972, BACTERIOL REV, V36, P172, DOI 10.1128/MMBR.36.2.172-230.1972; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Johansen HK, 2000, J ANTIMICROB CHEMOTH, V46, P973, DOI 10.1093/jac/46.6.973; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Margulis L, 1975, Symp Soc Exp Biol, P21; Marks L. R., 2012, INFECT IMMU IN PRESS; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; Nashida T, 2011, NEUROCHEM INT, V59, P51, DOI 10.1016/j.neuint.2011.03.026; Neef J, 2011, INFECT IMMUN, V79, P2314, DOI 10.1128/IAI.00677-10; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; Smith R J, 1995, Adv Microb Physiol, V37, P83, DOI 10.1016/S0065-2911(08)60144-7; Spat A, 2009, ACTA PHYSIOL, V195, P139, DOI 10.1111/j.1748-1716.2008.01928.x; Spangler SK, 1997, J ANTIMICROB CHEMOTH, V39, P141, DOI 10.1093/jac/39.2.141; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; SZABO I, 1992, BIOCHIM BIOPHYS ACTA, V1112, P29, DOI 10.1016/0005-2736(92)90250-P; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; TISA LS, 1995, J BACTERIOL, V177, P7112, DOI 10.1128/jb.177.24.7112-7118.1995; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROMBE MC, 1992, J GEN MICROBIOL, V138, P77, DOI 10.1099/00221287-138-1-77; TROMBE MC, 1994, J BACTERIOL, V176, P1992, DOI 10.1128/jb.176.7.1992-1996.1994; TROMBE MC, 1984, J BACTERIOL, V158, P1109, DOI 10.1128/JB.158.3.1109-1114.1984; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Werthen M, 2001, J BIOL CHEM, V276, P6468, DOI 10.1074/jbc.M009223200; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; ZORATTI M, 1990, BIOCHEM BIOPH RES CO, V168, P443, DOI 10.1016/0006-291X(90)92341-V	65	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27168	27182		10.1074/jbc.M112.371070	http://dx.doi.org/10.1074/jbc.M112.371070			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700972	hybrid, Green Published			2022-12-28	WOS:000307386000069
J	Parvatiyar, MS; Landstrom, AP; Figueiredo-Freitas, C; Potter, JD; Ackerman, MJ; Pinto, JR				Parvatiyar, Michelle S.; Landstrom, Andrew P.; Figueiredo-Freitas, Cicero; Potter, James D.; Ackerman, Michael J.; Pinto, Jose Renato			A Mutation in TNNC1-encoded Cardiac Troponin C, TNNC1-A31S, Predisposes to Hypertrophic Cardiomyopathy and Ventricular Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; CA2+ SENSITIVITY; CROSS-BRIDGES; ADENOSINE-TRIPHOSPHATASE; FORCE DEVELOPMENT; REGULATORY SITES; CALCIUM-BINDING; THIN FILAMENT; SUDDEN-DEATH; AFFINITY	Defined as clinically unexplained hypertrophy of the left ventricle, hypertrophic cardiomyopathy (HCM) is traditionally understood as a disease of the cardiac sarcomere. Mutations in TNNC1-encoded cardiac troponin C (cTnC) are a relatively rare cause of HCM. Here, we report clinical and functional characterization of a novel TNNC1 mutation, A31S, identified in a pediatric HCM proband with multiple episodes of ventricular fibrillation and aborted sudden cardiac death. Diagnosed at age 5, the proband is family history-negative for HCM or sudden cardiac death, suggesting a de novo mutation. TnC-extracted cardiac skinned fibers were reconstituted with the cTnC-A31S mutant, which increased Ca2+ sensitivity with no effect on the maximal contractile force generation. Reconstituted actomyosin ATPase assays with 50% cTnC-A31S:50% cTnC-WT-demonstrated Ca2+ sensitivity that was intermediate between 100% cTnC-A31S and 100% cTnC-WT, whereas the mutant increased the activation of the actomyosin ATPase without affecting the inhibitory qualities of the ATPase. The secondary structure of the cTnC mutant was evaluated by circular dichroism, which did not indicate global changes in structure. Fluorescence studies demonstrated increased Ca2+ affinity in isolated cTnC, the troponin complex, thin filament, and to a lesser degree, thin filament with myosin subfragment 1. These results suggest that this mutation has a direct effect on the Ca2+ sensitivity of the myofilament, which may alter Ca2+ handling and contribute to the arrhythmogenesis observed in the proband. In summary, we report a novel mutation in the TNNC1 gene that is associated with HCM pathogenesis and may predispose to the pathogenesis of a fatal arrhythmogenic subtype of HCM.	[Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Parvatiyar, Michelle S.; Figueiredo-Freitas, Cicero; Potter, James D.; Pinto, Jose Renato] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Landstrom, Andrew P.; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Ackerman, Michael J.] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat, Div Pediat Cardiol, Rochester, MN 55905 USA	State University System of Florida; Florida State University; University of Miami; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Rm 1350-H,1115 W Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	Landstrom, Andrew/A-9221-2017; Pinto, Jose Renato/H-2631-2017; parvatiyar, michelle/ABH-7542-2020	Landstrom, Andrew/0000-0002-1878-9631; Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL42325, P01-HL94291]; American Heart Association [09POST2300030]; Fondation Leducq Award; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; James and Esther King Biomedical Foundation [1KN13-34001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, P01HL094291, F32HL110632, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq Award; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; James and Esther King Biomedical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL42325 (to J. D. P.). M. J. A. is a consultant for Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Inc., and Transgenomic. Intellectual property derived from M. J. A.'s research program resulted in license agreements in 2004 between Mayo Clinic Health Solutions (formerly Mayo Medical Ventures) and PGxHealth (formerly Genaissance Pharmaceuticals, now Transgenomic).; Received support from the American Heart Association Postdoctoral Fellowship 09POST2300030. Present address: Dept. of Anesthesiology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095.; Supported by National Institutes of Health Grant P01-HL94291, the Fondation Leducq Award to the Alliance for Calmodulin Kinase Signaling in Heart Disease, and the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program.; Supported by the James and Esther King Biomedical Foundation Grant 1KN13-34001. To whom correspondence should be addressed: Dept. of Biomedical Sciences, College of Medicine, Florida State University, Rm. 1350-H, 1115 West Call St., Tallahassee, FL 32306-4300. Tel.: 850-645-0016; Fax: 850-644-9399; E-mail: jose.pinto@med.fsu.edu.	Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Bers D.M., 2001, CALCIUM SOURCES SINK; Bos JM, 2009, J AM COLL CARDIOL, V54, P201, DOI 10.1016/j.jacc.2009.02.075; Chung WK, 2011, CARDIOL YOUNG, V21, P345, DOI 10.1017/S1047951110001927; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUTH K, 1987, J BIOL CHEM, V262, P13627; HARTSHORNE DJ, 1967, BIOCHEM J, V104, P907, DOI 10.1042/bj1040907; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOFMANN PA, 1987, AM J PHYSIOL, V253, pC90; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; JOHNSON JD, 1978, J BIOL CHEM, V253, P6451; Jouven X, 2002, HEART, V88, P153, DOI 10.1136/heart.88.2.153; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Landstrom AP, 2010, CIRCULATION, V122, P2441, DOI 10.1161/CIRCULATIONAHA.110.954446; LEAVIS PC, 1978, ARCH BIOCHEM BIOPHYS, V186, P411, DOI 10.1016/0003-9861(78)90453-8; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; MARTIN AB, 1994, AM HEART J, V127, P64, DOI 10.1016/0002-8703(94)90510-X; Martyn DA, 2001, BIOPHYS J, V80, P360, DOI 10.1016/S0006-3495(01)76020-1; Martyn DA, 1999, BIOPHYS J, V76, P1480, DOI 10.1016/S0006-3495(99)77308-X; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Neulen A, 2009, BASIC RES CARDIOL, V104, P751, DOI 10.1007/s00395-009-0038-y; Parvatiyar MS, 2010, J BIOL CHEM, V285, P27785, DOI 10.1074/jbc.M110.112326; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2008, PFLUG ARCH EUR J PHY, V456, P1177, DOI 10.1007/s00424-008-0480-y; Pinto JR, 2011, J BIOL CHEM, V286, P1005, DOI 10.1074/jbc.M110.168583; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	49	42	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31845	31855		10.1074/jbc.M112.377713	http://dx.doi.org/10.1074/jbc.M112.377713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815480	Green Published, hybrid			2022-12-28	WOS:000309059400025
J	Visacka, K; Hofr, C; Willcox, S; Necasova, I; Pavlouskova, J; Sepsiova, R; Wimmerova, M; Simonicova, L; Nosek, J; Fajkus, J; Griffith, JD; Tomaska, L				Visacka, Katarina; Hofr, Ctirad; Willcox, Smaranda; Necasova, Ivona; Pavlouskova, Jana; Sepsiova, Regina; Wimmerova, Michaela; Simonicova, Lucia; Nosek, Jozef; Fajkus, Jiri; Griffith, Jack D.; Tomaska, Lubomir			Synergism of the Two Myb Domains of Tay1 Protein Results in High Affinity Binding to Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; ARABIDOPSIS-THALIANA; COMPLEX; TRF1; IDENTIFICATION; RECOGNITION; SPECIFICITY; PROTECTION; EVOLUTION; GENOME	Double-stranded regions of the telomeres are recognized by proteins containing Myb-like domains conferring specificity toward telomeric repeats. Although biochemical and structural studies revealed basic molecular principles involved in DNA binding, relatively little is known about evolutionary pathways leading to various types of Myb domain-containing proteins in divergent species of eukaryotes. Recently we identified a novel type of telomere-binding protein YlTay1p from the yeast Yarrowia lipolytica containing two Myb domains (Myb1, Myb2) very similar to the Myb domain of mammalian TRF1 and TRF2. In this study we prepared mutant versions of YlTay1p lacking Myb1, Myb2, or both Myb domains and found that YlTay1p carrying either Myb domain exhibits preferential affinity to both Y. lipolytica (GGGTTAGTCA)(n) and human (TTAGGG)(n) telomeric sequences. Quantitative measurements of the protein binding to telomeric DNA revealed that the presence of both Myb domains is required for a high affinity of YlTay1p to either telomeric repeat. Additionally, we performed detailed thermodynamic analysis of the YlTay1p interaction with its cognate telomeric DNA, which is to our knowledge the first energetic description of a full-length telomeric-protein binding to DNA. Interestingly, when compared with human TRF1 and TRF2 proteins, YlTay1p exhibited higher affinity not only for Y. lipolytica telomeres but also for human telomeric sequences. The duplication of the Myb domain region in YlTay1p thus produces a synergistic effect on its affinity toward the cognate telomeric sequence, alleviating the need for homodimerization observed in TRF-like proteins possessing a single Myb domain.	[Visacka, Katarina; Sepsiova, Regina; Simonicova, Lucia; Nosek, Jozef; Tomaska, Lubomir] Comenius Univ, Dept Genet, Fac Nat Sci, Bratislava 84215, Slovakia; [Visacka, Katarina; Sepsiova, Regina; Simonicova, Lucia; Nosek, Jozef; Tomaska, Lubomir] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia; [Hofr, Ctirad; Necasova, Ivona; Pavlouskova, Jana; Wimmerova, Michaela; Fajkus, Jiri] Masaryk Univ, Fac Sci, CZ-62500 Brno, Czech Republic; [Hofr, Ctirad; Necasova, Ivona; Pavlouskova, Jana; Wimmerova, Michaela; Fajkus, Jiri] Masaryk Univ, Cent European Inst Technol, CZ-62500 Brno, Czech Republic; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Comenius University Bratislava; Comenius University Bratislava; Masaryk University Brno; Masaryk University Brno; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tomaska, L (corresponding author), Comenius Univ, Dept Genet, Fac Nat Sci, Mlynska Dolina B-1, Bratislava 84215, Slovakia.	tomaska@fns.uniba.sk	Hofr, Ctirad/E-3322-2012; Fajkus, Jiří/D-2499-2012; Wimmerova, Michaela/A-4114-2010; Nosek, Jozef/A-7581-2008; Nečasová, Ivona/ABB-7674-2020; Prochazkova, Katarina/ABE-1222-2021; Tomaska, Lubomir/I-3071-2014	Fajkus, Jiří/0000-0002-3112-1716; Wimmerova, Michaela/0000-0002-7108-4198; Nosek, Jozef/0000-0002-1020-5451; Prochazkova, Katarina/0000-0003-4147-6577; Tomaska, Lubomir/0000-0003-4886-1910; Sepsiova, Regina/0000-0002-8709-7882	Slovak Research and Development Agency [0035-11, 0123-10]; Scientific Grant Agency [1/0311/12, 1/0405/11]; National Institutes of Health [ES 03773, GM 31819]; European Regional Development Fund; Czech Science Foundation [P205/12/0550];  [CZ.1.05/1.1.00/02.0068]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Regional Development Fund(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from Slovak Research and Development Agency 0035-11 (to L. T.) and 0123-10 (to J. N.), Scientific Grant Agency 1/0311/12 (to L. T.) and 1/0405/11 (to J. N.), and by National Institutes of Health Grants ES 03773 and GM 31819 (to J. D. G.).; We thank Ladislav Kovac (Comenius University, Bratislava, Slovak Republic) for inspiration and continuous support, members of our laboratories for discussions, Prof. Titia de Lange (Rockefeller University) for providing the hTRF2 protein construct, and Michal Zimmermann for preparation of the hTRF1 protein construct. This work was realized in part in the Central European Institute of Technology with research infrastructure supported by the project CZ.1.05/1.1.00/02.0068 financed from the European Regional Development Fund and the project of the Czech Science Foundation (P205/12/0550).	Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hofr C, 2009, BIOCHEM J, V419, P221, DOI 10.1042/BJ20082195; Karamysheva ZN, 2004, J BIOL CHEM, V279, P47799, DOI 10.1074/jbc.M407938200; Kinsky S, 2010, CURR GENET, V56, P413, DOI 10.1007/s00294-010-0310-6; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1998, NUCLEIC ACIDS RES, V26, P1731, DOI 10.1093/nar/26.7.1731; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Kramara J, 2010, J BIOL CHEM, V285, P38078, DOI 10.1074/jbc.M110.127605; Kuchar M, 2004, FEBS LETT, V578, P311, DOI 10.1016/j.febslet.2004.11.021; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Lukes J, 2011, IUBMB LIFE, V63, P528, DOI 10.1002/iub.489; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nishikawa T, 1998, STRUCT FOLD DES, V6, P1057, DOI 10.1016/S0969-2126(98)00106-3; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Oda M, 1998, J MOL BIOL, V276, P571, DOI 10.1006/jmbi.1997.1564; Oda N, 2000, GENES CELLS, V5, P319, DOI 10.1046/j.1365-2443.2000.00335.x; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Peska V, 2011, CURR PROTEIN PEPT SC, V12, P75, DOI 10.2174/138920311795684968; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506	34	15	16	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32206	32215		10.1074/jbc.M112.385591	http://dx.doi.org/10.1074/jbc.M112.385591			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815473	Green Published, hybrid			2022-12-28	WOS:000309059400057
J	Becker, K; Braune, M; Benderska, N; Buratti, E; Baralle, F; Villmann, C; Stamm, S; Eulenburg, V; Becker, CM				Becker, Kristina; Braune, Marlen; Benderska, Natalya; Buratti, Emanuele; Baralle, Francisco; Villmann, Carmen; Stamm, Stefan; Eulenburg, Volker; Becker, Cord-Michael			A Retroelement Modifies Pre-mRNA Splicing THE MURINE Glrb(spa) ALLELE IS A SPLICING SIGNAL POLYMORPHISM AMPLIFIED BY LONG INTERSPERSED NUCLEAR ELEMENT INSERTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRONIC INSERTION; L1 RETROTRANSPOSON; GLYCINE RECEPTORS; LINE-1 ELEMENT; SPASTIC MOUSE; GENE; DISEASE; EXON; HYPEREKPLEXIA; LOCALIZATION	The glycine receptor-deficient mutant mouse spastic carries a full-length long interspersed nuclear element (LINE1) retrotransposon in intron 6 of the glycine receptor beta subunit gene, Glrb(spa). The mutation arose in the C57BL/6J strain and is associated with skipping of exon 6 or a combination of the exons 5 and 6, thus resulting in a translational frameshift within the coding regions of the GlyR beta subunit. The effect of the Glrb(spa) LINE1 insertion on pre-mRNA splicing was studied using a minigene approach. Sequence comparison as well as motif prediction and mutational analysis revealed that in addition to the LINE1 insertion the inactivation of an exonic splicing enhancer (ESE) within exon 6 is required for skipping of exon 6. Reconstitution of the ESE by substitution of a single residue was sufficient to prevent exon skipping. In addition to the ESE, two regions within the 5' and 3' UTR of the LINE1 were shown to be critical determinants for exon skipping, indicating that LINE1 acts as efficient modifier of subtle endogenous splicing phenotypes. Thus, the spastic allele of the murine glycine receptor beta subunit gene is a two-hit mutation, where the hypomorphic alteration in an ESE is amplified by the insertion of a LINE1 element in the adjacent intron. Conversely, the LINE1 effect on splicing may be modulated by individual polymorphisms, depending on the insertional environment within the host genome.	[Becker, Kristina; Braune, Marlen; Benderska, Natalya; Villmann, Carmen; Stamm, Stefan; Eulenburg, Volker; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Buratti, Emanuele; Baralle, Francisco] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy	University of Erlangen Nuremberg; International Center for Genetic Engineering & Biotechnology (ICGEB)	Eulenburg, V (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	Volker.eulenburg@biochem.uni-erlangen.de	Buratti, Emanuele/K-4691-2016; Eulenburg, Volker/B-7263-2013; Eulenburg, Volker/B-7263-2013	Buratti, Emanuele/0000-0002-1356-9074; Eulenburg, Volker/0000-0002-4878-5746; Eulenburg, Volker/0000-0001-6314-566X	Deutsche Forschungsgemeinschaft [BE 1138/5-3]; Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation [BMBF/DIP G3.2]; NIH [GM083187]; Fonds der Chemischen Industrie [160-43]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083187] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft (BE 1138/5-3), the Bundesministerium fur Forschung und Bildung/Deutsch Israelische Projektkooperation (BMBF/DIP G3.2), the NIH (GM083187), and Fonds der Chemischen Industrie (160-43).	Babushok DV, 2007, CELL MOL LIFE SCI, V64, P542, DOI 10.1007/s00018-006-6453-4; BECKER CM, 1986, J NEUROSCI, V6, P1358; Becker Kristina, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9455; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4359, DOI 10.1093/nar/gkm444; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Humeny A, 2002, EUR J HUM GENET, V10, P188, DOI 10.1038/sj.ejhg.5200779; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030	31	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31185	31194		10.1074/jbc.M112.375691	http://dx.doi.org/10.1074/jbc.M112.375691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782896	Green Published, hybrid			2022-12-28	WOS:000308791300031
J	Cala-De Paepe, D; Layre, E; Giacometti, G; Garcia-Alles, LF; Mori, L; Hanau, D; de Libero, G; de la Salle, H; Puzo, G; Gilleron, M				Cala-De Paepe, Diane; Layre, Emilie; Giacometti, Gaelle; Garcia-Alles, Luis F.; Mori, Lucia; Hanau, Daniel; de Libero, Gennaro; de la Salle, Henri; Puzo, Germain; Gilleron, Martine			Deciphering the Role of CD1e Protein in Mycobacterial Phosphatidyl-myo-inositol Mannosides (PIM) Processing for Presentation by CD1b to T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; ANTIGEN PRESENTATION; ACTIVATOR PROTEIN; DENDRITIC CELLS; ACYLATION STATE; LIPID TRANSFER; SAPOSIN-B; MOLECULES; MEMBRANES; PURIFICATION	Lipids are important antigens that induce T cell-mediated specific immune responses. They are presented to T lymphocytes by a specific class of MHC-Ilike proteins, termed CD1. The majority of the described CD1-presented mycobacterial antigens are presented by the CD1b isoform. We previously demonstrated that the stimulation of CD1b-restricted T cells by the hexamannosylated phosphatidyl-myo-inositol (PIM6), a family of mycobacterial antigens, requires a prior partial digestion of the antigen oligomannoside moiety by alpha-mannosidase and that CD1e is an accessory protein absolutely required for the generation of the lipid immunogenic form. Here, we show that CD1e behaves as a lipid transfer protein influencing lipid immunoediting and membrane transfer of PIM lipids. CD1e selectively assists the alpha-mannosidase-dependent digestion of PIM6 species according to their degree of acylation. Moreover, CD1e transfers only diacylated PIM from donor to acceptor liposomes and also from membranes to CD1b. This study provides new insight into the molecular mechanisms by which CD1e contributes to lipid immunoediting and CD1-restricted presentation to T cells.	[Gilleron, Martine] CNRS, UMR5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France; [Cala-De Paepe, Diane; Layre, Emilie; Garcia-Alles, Luis F.; Puzo, Germain; Gilleron, Martine] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Giacometti, Gaelle; Hanau, Daniel; de la Salle, Henri] INSERM, U725, Etab Francais Sang Alsace, Strasbourg, France; [Giacometti, Gaelle; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg, F-67000 Strasbourg, France; [Mori, Lucia; de Libero, Gennaro] Univ Basel Hosp, Dept Biomed, Div Expt Immunol, CH-4031 Basel, Switzerland; [Mori, Lucia; de Libero, Gennaro] Singapore Immunol Network Agcy Sci Technol & Res, Singapore 138648, Singapore	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Gilleron, M (corresponding author), CNRS, UMR5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse 4, France.	martine.gilleron@ipbs.fr	De La Salle, Henri/H-9353-2016; De Libero, Gennaro/P-2694-2017	De La Salle, Henri/0000-0001-5136-0776; Layre, Emilie/0000-0003-3044-1299; Garcia-Alles, Luis/0000-0002-1141-0393; GILLERON, Martine/0000-0002-2581-3302; De Libero, Gennaro/0000-0003-0853-7868	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche Emergence [ANR-05-MIIM-006]; Etablissement Francais du Sang-Alsace; European Community's Seventh Framework Program [241745]; Swiss National Foundation [3100AO-122464/1]; Sinergia [CRS133-124819]; Association de Recherche et de Developpement en Medecine et Sante Publique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche Emergence(French National Research Agency (ANR)); Etablissement Francais du Sang-Alsace; European Community's Seventh Framework Program; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Sinergia; Association de Recherche et de Developpement en Medecine et Sante Publique	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche Emergence (ANR-05-MIIM-006), the Etablissement Francais du Sang-Alsace, European Community's Seventh Framework Program Grant 241745, and Swiss National Foundation Grants 3100AO-122464/1 and Sinergia CRS133-124819.; Supported by an Association de Recherche et de Developpement en Medecine et Sante Publique grant.	Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; CONZELMANN E, 1982, EUR J BIOCHEM, V123, P455, DOI 10.1111/j.1432-1033.1982.tb19789.x; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; De Libero G, 2009, EUR J IMMUNOL, V39, P2648, DOI 10.1002/eji.200939425; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Alles LF, 2011, P NATL ACAD SCI USA, V108, P13230, DOI 10.1073/pnas.1105627108; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Leon L, 2012, P NATL ACAD SCI USA, V109, P4357, DOI 10.1073/pnas.1200764109; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; Wendeler M, 2006, FEBS J, V273, P982, DOI 10.1111/j.1742-4658.2006.05126.x; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	30	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31494	31502		10.1074/jbc.M112.386300	http://dx.doi.org/10.1074/jbc.M112.386300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782895	Green Published, hybrid			2022-12-28	WOS:000308791300062
J	Harsman, A; Niemann, M; Pusnik, M; Schmidt, O; Burmann, BM; Hiller, S; Meisinger, C; Schneider, A; Wagner, R				Harsman, Anke; Niemann, Moritz; Pusnik, Mascha; Schmidt, Oliver; Burmann, Bjoern M.; Hiller, Sebastian; Meisinger, Chris; Schneider, Andre; Wagner, Richard			Bacterial Origin of a Mitochondrial Outer Membrane Protein Translocase NEW PERSPECTIVES FROM COMPARATIVE SINGLE CHANNEL ELECTROPHYSIOLOGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; FUNCTIONAL DOMAINS; BROWNIAN DYNAMICS; CONDUCTING PORE; OMP85 FAMILY; TOM40 FORMS; IMPORT; TRANSPORTER	Mitochondria are of bacterial ancestry and have to import most of their proteins from the cytosol. This process is mediated by Tom40, an essential protein that forms the protein-translocating pore in the outer mitochondrial membrane. Tom40 is conserved in virtually all eukaryotes, but its evolutionary origin is unclear because bacterial orthologues have not been identified so far. Recently, it was shown that the parasitic protozoon Trypanosoma brucei lacks a conventional Tom40 and instead employs the archaic translocase of the outer mitochondrial membrane (ATOM), a protein that shows similarities to both eukaryotic Tom40 and bacterial protein translocases of the Omp85 family. Here we present electrophysiological single channel data showing that ATOM forms a hydrophilic pore of large conductance and high open probability. Moreover, ATOM channels exhibit a preference for the passage of cationic molecules consistent with the idea that it may translocate unfolded proteins targeted by positively charged N-terminal presequences. This is further supported by the fact that the addition of a presequence peptide induces transient pore closure. An in-depth comparison of these single channel properties with those of other protein translocases reveals that ATOM closely resembles bacterial-type protein export channels rather than eukaryotic Tom40. Our results support the idea that ATOM represents an evolutionary intermediate between a bacterial Omp85-like protein export machinery and the conventional Tom40 that is found in mitochondria of other eukaryotes.	[Wagner, Richard] Univ Osnabruck, Fachbereich Biol Chem, D-49076 Osnabruck, Germany; [Niemann, Moritz; Pusnik, Mascha; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Schmidt, Oliver; Meisinger, Chris] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Schmidt, Oliver; Meisinger, Chris] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Burmann, Bjoern M.; Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University Osnabruck; University of Bern; University of Freiburg; University of Freiburg; University of Basel	Wagner, R (corresponding author), Barbarastr 13, D-49076 Osnabruck, Germany.	wagner@uos.de	Burmann, Björn M./AAR-7399-2020; Hiller, Sebastian/B-3573-2008; Meisinger, Chris/J-1110-2014; Burmann, Björn/M-8913-2015; Burmann, Björn M./AAI-7760-2021	Hiller, Sebastian/0000-0002-6709-4684; Meisinger, Chris/0000-0002-8326-3548; Burmann, Björn/0000-0002-3135-7964; Burmann, Björn M./0000-0002-3135-7964; Schmidt, Oliver/0000-0002-7921-4663	Deutsche Forschungsgemeinschaft (DFG) [WA681/2-1, FOR967, ME1921]; Swiss National Science Foundation (SNSF) [31003A_13855, PP00P3_128419]; European Research Council FP7 Contract [MOMP 281764]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council FP7 Contract(European Research Council (ERC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant WA681/2-1 (to R. W.) and DFG Grant FOR967 (to R. W.), by DFG Grant ME1921 (to C. M.), by Swiss National Science Foundation (SNSF) Grant 31003A_13855 (to A. S.) as well as by Swiss National Science Foundation grant PP00P3_128419 and European Research Council FP7 Contract MOMP 281764 (to S. H.).	Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; DARGENT B, 1986, EMBO J, V5, P773, DOI 10.1002/j.1460-2075.1986.tb04280.x; Delcour AH, 2002, J MOL MICROB BIOTECH, V4, P1; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; ENGEL A, 1985, NATURE, V317, P643, DOI 10.1038/317643a0; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Flinner N, 2012, BIOL LETTERS, V8, P446, DOI 10.1098/rsbl.2011.1121; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Harsman A, 2011, EUR J CELL BIOL, V90, P721, DOI 10.1016/j.ejcb.2011.04.012; Harsman A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454102; Hauser R, 1996, J CELL SCI, V109, P517; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hille B, 1992, IONIC CHANNELS EXCIT, P291; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Mahendran KR, 2012, BIOPHYS J, V102, P39, DOI 10.1016/j.bpj.2011.11.4003; MAURO A, 1988, P NATL ACAD SCI USA, V85, P1071, DOI 10.1073/pnas.85.4.1071; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shah TD, 2011, MOL BIOCHEM PARASIT, V179, P100, DOI 10.1016/j.molbiopara.2011.07.001; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004; Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057	47	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31437	31445		10.1074/jbc.M112.392118	http://dx.doi.org/10.1074/jbc.M112.392118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22778261	Green Published, hybrid			2022-12-28	WOS:000308791300054
J	Park, J; Kim, MI; Park, YD; Shin, I; Cha, J; Kim, CH; Rhee, S				Park, Jinseo; Kim, Myung-Il; Park, Young-Don; Shin, Inchul; Cha, Jaeho; Kim, Chul Ho; Rhee, Sangkee			Structural and Functional Basis for Substrate Specificity and Catalysis of Levan Fructotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR FRUCTOSYL TRANSFER; ARTHROBACTER-UREAFACIENS K2032; CRYSTAL-STRUCTURE; INSIGHTS; CLASSIFICATION; FRUCTANS; CLONING; SYSTEM; ENZYME; SUITE	Levan is beta-2,6-linked polymeric fructose and serves as reserve carbohydrate in some plants and microorganisms. Mobilization of fructose is usually mediated by enzymes such as glycoside hydrolase (GH), typically releasing a monosaccharide as a product. The enzyme levan fructotransferase (LFTase) of the GH32 family catalyzes an intramolecular fructosyl transfer reaction and results in production of cyclic difructose dianhydride, thus exhibiting a novel substrate specificity. The mechanism by which LFTase carries out these functions via the structural fold conserved in the GH32 family is unknown. Here, we report the crystal structure of LFTase from Arthrobacter ureafaciens in apo form, as well as in complexes with sucrose and levanbiose, a difructosacchride with a beta-2,6-glycosidic linkage. Despite the similarity of its two-domain structure to members of the GH32 family, LFTase contains an active site that accommodates a difructosaccharide using the -1 and -2 subsites. This feature is unique among GH32 proteins and is facilitated by small side chain residues in the loop region of a catalytic beta-propeller N-domain, which is conserved in the LFTase family. An additional oligosaccharide-binding site was also characterized in the beta-sandwich C-domain, supporting its role in carbohydrate recognition. Together with functional analysis, our data provide a molecular basis for the catalytic mechanism of LFTase and suggest functional variations from other GH32 family proteins, notwithstanding the conserved structural elements.	[Rhee, Sangkee] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Park, Young-Don; Cha, Jaeho] Pusan Natl Univ, Dept Microbiol, Pusan 609735, South Korea; [Kim, Chul Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Rhee, S (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	Cha, Jaeho/AAP-6886-2020		Next-Generation BioGreen 21 Program Plant Molecular Breeding Center [PJ008059]; Rural Development Administration; National Research Foundation [R11-2008-062-01002-0, 2010-0025883]; Korean Ministry of Education, Science and Technology; Pohang Accelerator Laboratory through the Abroad Beamtime Program of Synchrotron Radiation Facility Project under the Ministry of Education, Science and Technology [2010G703]	Next-Generation BioGreen 21 Program Plant Molecular Breeding Center(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pohang Accelerator Laboratory through the Abroad Beamtime Program of Synchrotron Radiation Facility Project under the Ministry of Education, Science and Technology	This work was supported by a grant from Next-Generation BioGreen 21 Program Plant Molecular Breeding Center PJ008059, the Rural Development Administration, and from National Research Foundation Grants R11-2008-062-01002-0 and 2010-0025883, the Korean Ministry of Education, Science and Technology and in part by Proposal 2010G703 from the Pohang Accelerator Laboratory through the Abroad Beamtime Program of Synchrotron Radiation Facility Project under the Ministry of Education, Science and Technology.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha J, 2001, J BIOTECHNOL, V91, P49, DOI 10.1016/S0168-1656(01)00288-7; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Garcia-Moreno MI, 2008, MOLECULES, V13, P1640, DOI 10.3390/molecules13081640; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Kim CH, 2005, LETT APPL MICROBIOL, V40, P228, DOI 10.1111/j.1472-765X.2005.01658.x; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; LIU JH, 1992, CARBOHYD RES, V232, P1, DOI 10.1016/S0008-6215(00)90990-X; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Moon KO, 2008, J MICROBIOL BIOTECHN, V18, P1064; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Naumoff DG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P622, DOI 10.1134/S0006297911060022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pijning T, 2011, J MOL BIOL, V412, P80, DOI 10.1016/j.jmb.2011.07.031; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Song EK, 2002, GENE, V291, P45, DOI 10.1016/S0378-1119(02)00630-3; Song KB, 2000, ENZYME MICROB TECH, V27, P212, DOI 10.1016/S0141-0229(00)00135-6; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	20	20	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31233	31241		10.1074/jbc.M112.389270	http://dx.doi.org/10.1074/jbc.M112.389270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810228	Green Published, hybrid			2022-12-28	WOS:000308791300036
J	Pan, XC; Yue, JJ; Ding, GF; Li, B; Liu, X; Zheng, XC; Yu, MC; Li, J; Jiang, WW; Wu, C; Zheng, J; Zhou, H				Pan, Xichun; Yue, Junjie; Ding, Guofu; Li, Bin; Liu, Xin; Zheng, Xinchuan; Yu, Mengchen; Li, Jun; Jiang, Weiwei; Wu, Chong; Zheng, Jiang; Zhou, Hong			Leucine-rich Repeat 11 of Toll-like Receptor 9 Can Tightly Bind to CpG-containing Oligodeoxynucleotides, and the Positively Charged Residues Are Critical for the High Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN RECOGNITION; REAL-TIME; DNA; ACTIVATION; PROTEIN; TLR9; ELECTROSTATICS; IDENTIFICATION; RNA	TLR9 is a receptor for sensing bacterial DNA/CpG-containing oligonucleotides (CpG ODN). The extracellular domain (ECD) of human TLR9 (hTLR9) is composed of 25 leucine-rich repeats (LRR) contributing to the binding of CpG ODN. Herein, we showed that among LRR2, -5, -8, and -11, LRR11 of hTLR9 had the highest affinity for CpG ODN followed by LRR2 and -5, whereas LRR8 had almost no affinity. In vitro, preincubation with LRR11 more significantly decreased CpG ODN internalization, subsequent NF-kappa B activation, and cytokine release than with LRR2 and -5 in mouse peritoneal macrophages treated with CpG ODN. The LRR11 deletion mutant of hTLR9 conferred decreased cellular responses to CpG ODN. Single- or multiple-site mutants at five positively charged residues of LRR11 (LRR11m1-9), especially Arg-337 and Lys-367, were shown to contribute to hTLR9 binding of CpG ODN. LRR11m1-9 showed reduced inhibition of CpG ODN internalization and CpG ODN/TLR9 signaling, supporting the above findings. Prediction of whole hTLR9 ECD-CpG ODN interactions revealed that Arg-337 and Lys-338 directly contact CpG ODN through hydrogen bonding, whereas Lys-347, Arg-348, and His-353 contribute to stabilizing the shape of the ligand binding region. These findings suggested that although all five positively charged residues within LRR11 contributed to its high affinity, only Arg-337 and Lys-338 directly interacted with CpG ODN. In conclusion, the results suggested that LRR11 could strongly bind to CpG ODN, whereas mutations at the five positively charge residues reduced this high affinity. LRR11 may be further investigated as an antagonist of hTLR9.	[Liu, Xin; Zheng, Xinchuan; Zheng, Jiang] Third Mil Med Univ, Med Res Ctr, Southwestern Hosp, Chongqing 400038, Peoples R China; [Pan, Xichun; Ding, Guofu; Li, Bin; Yu, Mengchen; Li, Jun; Jiang, Weiwei; Wu, Chong; Zhou, Hong] Third Mil Med Univ, Coll Pharm, Dept Pharmacol, Chongqing 400038, Peoples R China; [Yue, Junjie] Acad Mil Med Sci, Inst Biotechnol, Beijing 100071, Peoples R China	Army Medical University; Army Medical University; Academy of Military Medical Sciences - China	Zheng, J (corresponding author), Third Mil Med Univ, Med Res Ctr, Southwestern Hosp, Gaotanyan St 30, Chongqing 400038, Peoples R China.	zhengj99219@gmail.com; zhouh64@163.com		Yue, Junjie/0000-0002-2549-9261	National Natural Science Foundation of China [30973545]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 30973545.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Guo YB, 2005, BIOCHEM PHARMACOL, V70, P209, DOI 10.1016/j.bcp.2005.04.040; Jin MS, 2008, CURR OPIN IMMUNOL, V20, P414, DOI 10.1016/j.coi.2008.06.002; Jung I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-298; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li B, 2008, INT IMMUNOPHARMACOL, V8, P379, DOI 10.1016/j.intimp.2007.10.024; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu X, 2011, BRIT J PHARMACOL, V162, P1274, DOI 10.1111/j.1476-5381.2010.01114.x; Liu X, 2009, INT IMMUNOPHARMACOL, V9, P1021, DOI 10.1016/j.intimp.2009.03.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang J, 2009, ANAL CHEM, V81, P4914, DOI 10.1021/ac900591k; Zhou H, 2004, INT IMMUNOPHARMACOL, V4, P223, DOI 10.1016/j.intimp.2003.12.006	28	17	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30596	30609		10.1074/jbc.M112.396432	http://dx.doi.org/10.1074/jbc.M112.396432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822061	Green Published, hybrid			2022-12-28	WOS:000308579800051
J	Watanabe, S; Takahashi, N; Uchida, H; Wakasugi, K				Watanabe, Seiji; Takahashi, Nozomu; Uchida, Hiroyuki; Wakasugi, Keisuke			Human Neuroglobin Functions as an Oxidative Stress-responsive Sensor for Neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PROTECTS PC12 CELLS; LIPID RAFTS; OXYGEN; SURFACE; GLOBIN; IDENTIFICATION; ACTIVATION; G-ALPHA(O); RESISTANT	Mammalian neuroglobin (Ngb) protects neuronal cells under conditions of oxidative stress. The mechanism underlying this function is only partly understood. Here, we report that human Ngb exists in lipid rafts only during oxidative stress and that lipid rafts are crucial for neuroprotection by Ngb. The ferrous oxygen-bound form of Ngb, which exists under normoxia, is converted to the ferric bis-His conformation during oxidative stress, inducing large tertiary structural changes. We clarified that ferric bis-His Ngb, but not ferrous ligand-bound Ngb, specifically binds to flotillin-1, a lipid raft microdomain-associated protein, as well as to alpha-subunits of heterotrimeric G proteins (G alpha(i/o)). Moreover, we found that human ferric bis-His Ngb acts as a guanine nucleotide dissociation inhibitor for G alpha(i/o) that has been modified by oxidative stress. In addition, our data shows that Ngb inhibits the decrease in cAMP concentration that occurs under oxidative stress, leading to protection against cell death. Furthermore, by using a mutated Ngb protein that cannot form the bis-His conformation, we demonstrate that the oxidative stress-induced structural changes of human Ngb are essential for its neuroprotective activity.	[Watanabe, Seiji; Takahashi, Nozomu; Uchida, Hiroyuki; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616; Watanabe, Seiji/0000-0001-8038-7919	PRESTO program of Japan Science and Technology (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan [23117704]; JSPS	PRESTO program of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the PRESTO program of Japan Science and Technology (JST) (to K. W.) and a Grant-in-Aid 23117704 for Scientific Research (to K. W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the JSPS Research Fellowships for Young Scientists.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anselmi M, 2007, BIOPHYS J, V93, P434, DOI 10.1529/biophysj.106.099648; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2002, J BIOL CHEM, V277, P9036, DOI 10.1074/jbc.M107392200; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stuermer CAO, 2010, TRENDS CELL BIOL, V20, P6, DOI 10.1016/j.tcb.2009.10.003; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; Uno T, 2004, J BIOL CHEM, V279, P5886, DOI 10.1074/jbc.M311748200; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wakasugi K, 2005, BIOCHEM BIOPH RES CO, V330, P591, DOI 10.1016/j.bbrc.2005.03.021; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P2943, DOI 10.1021/bi0477539; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wakasugi K., 2011, AM J NEUROPROTEC NEU, V3, P42; Wakasugi K, 2011, MAR GENOM, V4, P137, DOI 10.1016/j.margen.2011.03.001; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Watanabe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016808; Watanabe S, 2010, FEBS LETT, V584, P2467, DOI 10.1016/j.febslet.2010.04.054; Yang B., 2006, FASEB J, V20, pE688; Yuyama K, 2007, J BIOL CHEM, V282, P26392, DOI 10.1074/jbc.M705046200; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479	55	45	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30128	30138		10.1074/jbc.M112.373381	http://dx.doi.org/10.1074/jbc.M112.373381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787149	Green Published, hybrid			2022-12-28	WOS:000308579800008
J	DiCostanzo, AC; Thompson, JR; Peterson, FC; Volkman, BF; Ramirez-Alvarado, M				DiCostanzo, Ara Celi; Thompson, James R.; Peterson, Francis C.; Volkman, Brian F.; Ramirez-Alvarado, Marina			Tyrosine Residues Mediate Fibril Formation in a Dynamic Light Chain Dimer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOIDOSIS; STABILITY; PROTEIN; AMYLOIDOGENICITY; AGGREGATION	Light chain amyloidosis is an incurable protein misfolding disease where monoclonal immunoglobulin light chains misfold and deposit as amyloid fibrils, causing organ failure and death. Previously, we determined that amyloidogenic light chains AL-09 and AL-103 do not form fibrils at pH 10 (tyrosine pK(a)). There are three tyrosine residues (32, 91, and 96) clustered in the dimer interface, interacting differently in the two light chain proteins due to their two different dimer conformations. These tyrosines may be ionized at pH 10, causing repulsion and inhibiting fibril formation. Here, we characterize single and double Tyr-to-Phe mutations in AL-09 and AL-103. All AL-09 Tyr-to-Phe mutants form fibrils at pH 10, whereas none of the AL-103 mutants form fibrils at pH 10. NMR studies suggest that although both AL-09 and AL-103 present conformational heterogeneity, only AL-09 favors dimer conformations where tyrosine residues mediate crucial interactions for amyloid formation.	[DiCostanzo, Ara Celi; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Mayo Clinic; Mayo Clinic; Medical College of Wisconsin	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ramirez-Alvarado, Marina/0000-0003-2325-6773	NIAID NIH HHS [R56 AI063325, R01 AI063325] Funding Source: Medline; NIGMS NIH HHS [R01 GM071514] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063325, R56AI063325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBINSSON B, 1992, J PHYS CHEM-US, V96, P6204, DOI 10.1021/j100194a023; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; HALSALL HB, 1982, J CHEM EDUC, V59, P1076; Hu DM, 2008, BIOCHEMISTRY-US, V47, P8665, DOI 10.1021/bi800806d; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kumar SK, 2011, MAYO CLIN PROC, V86, P12, DOI 10.4065/mcp.2010.0480; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Martin DJ, 2010, CONTEMP HEMATOL, P1, DOI 10.1007/978-1-60761-631-3_1; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Meng XY, 2008, J MOL BIOL, V381, P989, DOI 10.1016/j.jmb.2008.06.062; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sikkink LA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.75; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; UEDAIRA H, 1970, J PHYS CHEM-US, V74, P2211, DOI 10.1021/j100909a030; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wechalekar AD, 2008, BRIT J HAEMATOL, V140, P365, DOI 10.1111/j.1365-2141.2007.06936.x	33	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27997	28006		10.1074/jbc.M112.362921	http://dx.doi.org/10.1074/jbc.M112.362921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740699	Green Published, hybrid			2022-12-28	WOS:000307840700073
J	Haines, RJ; Corbin, KD; Pendleton, LC; Eichler, DC				Haines, Ricci J.; Corbin, Karen D.; Pendleton, Laura C.; Eichler, Duane C.			Protein Kinase C alpha Phosphorylates a Novel Argininosuccinate Synthase Site at Serine 328 during Calcium-dependent Stimulation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; PKC-ALPHA; ACTIVATION; ENOS; EXPRESSION; RELEASE; CA2+; AKT	Endothelial nitric-oxide synthase (eNOS) utilizes L-arginine as its principal substrate, converting it to L-citrulline and nitric oxide (NO). L-Citrulline is recycled to L-arginine by two enzymes, argininosuccinate synthase (AS) and argininosuccinate lyase, providing the substrate arginine for eNOS and NO production in endothelial cells. Together, these three enzymes, eNOS, AS, and argininosuccinate lyase, make up the citrulline-NO cycle. Although AS catalyzes the rate-limiting step in NO production, little is known about the regulation of AS in endothelial cells beyond the level of transcription. In this study, we showed that AS Ser-328 phosphorylation was coordinately regulated with eNOS Ser-1179 phosphorylation when bovine aortic endothelial cells were stimulated by either a calcium ionophore or thapsigargin to produce NO. Furthermore, using in vitro kinase assay, kinase inhibition studies, as well as protein kinase C alpha (PKC alpha) knockdown experiments, we demonstrate that the calcium-dependent phosphorylation of AS Ser-328 is mediated by PKC alpha. Collectively, these findings suggest that phosphorylation of AS at Ser-328 is regulated in accordance with the calcium-dependent regulation of eNOS under conditions that promote NO production and are in keeping with the rate-limiting role of AS in the citrulline-NO cycle of vascular endothelial cells.	[Haines, Ricci J.; Pendleton, Laura C.; Eichler, Duane C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Corbin, Karen D.] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Corbin, Karen D.] Univ N Carolina Chapel Hill, Dept Nutr, Kannapolis, NC 28081 USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Eichler, DC (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	deichler@health.usf.edu		Corbin, Karen/0000-0003-2065-0003	National Institutes of Health [R01 HL083153-01A2]; James Esther King Biomedical Research Program Grant, Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Esther King Biomedical Research Program Grant, Florida Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL083153-01A2 (to Duane C. Eichler). This work was also supported by the James Esther King Biomedical Research Program Grant, Florida Department of Health (to Duane C. Eichler).	Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Collingwood MA, 2008, OLIGONUCLEOTIDES, V18, P187, DOI 10.1089/oli.2008.0123; Corbin KD, 2008, BIOCHEM BIOPH RES CO, V377, P1042, DOI 10.1016/j.bbrc.2008.10.056; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Goodwin BL, 2008, BIOCHEM BIOPH RES CO, V370, P254, DOI 10.1016/j.bbrc.2008.03.089; Goodwin BL, 2007, AM J PHYSIOL-HEART C, V293, pH1115, DOI 10.1152/ajpheart.01100.2006; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; Haines RJ, 2012, BIOCHEM BIOPH RES CO, V421, P9, DOI 10.1016/j.bbrc.2012.03.074; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Kroll J, 1999, BIOCHEM BIOPH RES CO, V265, P636, DOI 10.1006/bbrc.1999.1729; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Pendleton LC, 2002, J BIOL CHEM, V277, P25363, DOI 10.1074/jbc.M111677200; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Simon A, 2003, CIRC RES, V93, P813, DOI 10.1161/01.RES.0000097761.19223.0D; Tran Q. -K., 2006, V176, P145; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	34	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26168	26176		10.1074/jbc.M112.378794	http://dx.doi.org/10.1074/jbc.M112.378794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696221	Green Published, hybrid			2022-12-28	WOS:000306916300044
J	Berger, CE; Qian, YJ; Liu, G; Chen, HW; Chen, XB				Berger, Crystal E.; Qian, Yingjuan; Liu, Gang; Chen, Hongwu; Chen, Xinbin			p53, a Target of Estrogen Receptor (ER) alpha, Modulates DNA Damage-induced Growth Suppression in ER-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADJUVANT ENDOCRINE THERAPY; HISTOLOGIC GRADE; GENE-EXPRESSION; BINDING; ACTIVATION; BETA; TRANSCRIPTION; MUTATIONS; SEQUENCE; ELEMENT	In response to genotoxic stress, the p53 tumor suppressor induces target genes for cell cycle arrest, apoptosis, and DNA repair. Although p53 is the most commonly mutated gene in all human cancers, it is only mutated in about 20% of breast cancers. 70% of all breast cancer cases are estrogen receptor (ER)positive and express ER alpha. ER-positive breast cancer generally indicates good patient prognosis and treatment responsiveness with antiestrogens, such as tamoxifen. However, ER-positive breast cancer patients can experience loss or a reduction in ER alpha, which is associated with aggressive tumor growth, increased invasiveness, poor prognosis, and loss of p53 function. Consistent with this, we found that p53 is a target gene of ER alpha. Specifically, we found that knockdown of ER alpha decreases expression of p53 and its downstream targets, MDM2 and p21. In addition, we found that ER alpha activates p53 transcription via binding to estrogen response element half-sites within the p53 promoter. Moreover, we found that loss of ER alpha desensitizes, whereas ectopic expression of ER alpha sensitizes, breast cancer cells to DNA damage-induced growth suppression in a p53-dependent manner. Altogether, this study provides an insight into a feedback loop between ER alpha and p53 and a biological role of p53 in the DNA damage response in ER-positive breast cancers.	[Berger, Crystal E.; Qian, Yingjuan; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA; [Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Chen, Hongwu] Univ Calif Davis, UC Davis Canc Ctr Basic Sci, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Qian, YJ (corresponding author), Univ Calif Davis, Comparat Oncol Lab, 2128A Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	yqian@ucdavis.edu; xbchen@ucdavis.edu		Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [CA076069]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA076069.	Agrawal A, 2006, EXP MOL PATHOL, V81, P115, DOI 10.1016/j.yexmp.2006.07.001; AITKEN SC, 1985, CANCER RES, V45, P1611; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Allegra J C, 1980, Recent Results Cancer Res, V71, P20; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fernandez-Cuesta L, 2011, BREAST CANCER RES TR, V125, P35, DOI 10.1007/s10549-010-0819-x; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Gretarsdottir S, 1996, BRIT J CANCER, V74, P555, DOI 10.1038/bjc.1996.400; Gu GW, 2012, J CELL PHYSIOL, V227, P3363, DOI 10.1002/jcp.24035; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; HUBAY CA, 1985, J STEROID BIOCHEM, V23, P1147, DOI 10.1016/0022-4731(85)90034-2; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Leygue E, 1998, CANCER RES, V58, P3197; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; PARKER MG, 1993, ANN NY ACAD SCI, V684, P119, DOI 10.1111/j.1749-6632.1993.tb32276.x; PARL FF, 1984, CANCER, V54, P2237, DOI 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Qian YJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207241; Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; SASA M, 1994, J SURG ONCOL, V56, P46, DOI 10.1002/jso.2930560110; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; SLUYSER M, 1974, CANCER RES, V34, P3253; STANFORD JL, 1986, EPIDEMIOL REV, V8, P42, DOI 10.1093/oxfordjournals.epirev.a036295; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Thompson AM, 2010, J PATHOL, V220, P401, DOI 10.1002/path.2674; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Velculescu VE, 1996, CLIN CHEM, V42, P858; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	68	52	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30117	30127		10.1074/jbc.M112.367326	http://dx.doi.org/10.1074/jbc.M112.367326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787161	Green Published, hybrid			2022-12-28	WOS:000308579800007
J	Corradi, GR; Pinto, FD; Mazzitelli, LR; Adamo, HP				Corradi, Gerardo R.; de Tezanos Pinto, Felicitas; Mazzitelli, Luciana R.; Adamo, Hugo P.			Shadows of an Absent Partner ATP HYDROLYSIS AND PHOSPHOENZYME TURNOVER OF THE Spf1 (SENSITIVITY TO PICHIA FARINOSA KILLER TOXIN) P5-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PLASMA-MEMBRANE CA2+; SARCOPLASMIC-RETICULUM; ATP; ATPASES; ATP13A2; PUMP; PHOSPHORYLATION; HOMEOSTASIS; MUTATIONS	The P5-ATPases are important components of eukaryotic cells. They have been shown to influence protein biogenesis, folding, and transport. The knowledge of their biochemical properties is, however, limited, and the transported ions are still unknown. We expressed in Saccharomyces cerevisiae the yeast Spf1 P5A-ATPase containing the GFP fused at the N-terminal end. The GFP-Spf1 protein was localized in the yeast endoplasmic reticulum. Purified preparations of GFP-Spf1 hydrolyzed ATP at a rate of similar to 0.3-1 mu mol of P-i/mg/min and formed a phosphoenzyme in a simple reaction medium containing no added metal ions except Mg2+. No significant differences were found between the ATPase activity of GFP-Spf1 and recombinant Spf1. Omission of protease inhibitors from the purification buffers resulted in a high level of endogenous proteolysis at the C-terminal portion of the GFP-Spf1 molecule that abolished phosphoenzyme formation. The Mg2+ dependence of the GFP-Spf1 ATPase was similar to that of other P-ATPases where Mg2+ acts as a cofactor. The addition of Mn2+ to the reaction medium decreased the ATPase activity. The enzyme manifested optimal activity at a near neutral pH. When chased by the addition of cold ATP, 90% of the phosphoenzyme remained stable after 5 s. In contrast, the phosphoenzyme rapidly decayed to less than 20% when chased for 3 s by the addition of ADP. The greater effect of ADP accelerating the disappearance of EP suggests that GFP-Spf1 accumulated the E1 similar to P phosphoenzyme. This behavior may reflect a limiting countertransported substrate needed to promote turnover or a missing regulatory factor.	[Corradi, Gerardo R.; de Tezanos Pinto, Felicitas; Mazzitelli, Luciana R.; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), IQUIFIB Fac Farm & Bioquim, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Corradi, Gerardo Raul/0000-0003-0354-7709	Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT 2134]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [2122]; Universidad de Buenos Aires [UBACyT B009]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grant BID PICT 2134 from Agencia Nacional de Promocion Cientifica y Tecnologica, Grant 2122 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas, and Universidad de Buenos Aires Grant UBACyT B009.	ADAMO HP, 1988, J BIOL CHEM, V263, P17548; Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clarke RJ, 2007, BIOCHEMISTRY-US, V46, P7034, DOI 10.1021/bi700619s; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Cura CI, 2008, BBA-BIOMEMBRANES, V1778, P2757, DOI 10.1016/j.bbamem.2008.08.020; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FROEHLICH JP, 1985, BIOCHEMISTRY-US, V24, P126, DOI 10.1021/bi00322a018; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Greie JC, 2011, EUR J CELL BIOL, V90, P705, DOI 10.1016/j.ejcb.2011.04.011; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; Mazzitelli LR, 2010, ARCH BIOCHEM BIOPHYS, V495, P62, DOI 10.1016/j.abb.2009.12.021; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Niggli V, 2008, TRENDS BIOCHEM SCI, V33, P156, DOI 10.1016/j.tibs.2007.12.005; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pinto F. de Tezanos, 2011, J LIFE SCI, V5, P1; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; ROSSI JPFC, 1985, BIOCHIM BIOPHYS ACTA, V816, P379, DOI 10.1016/0005-2736(85)90505-X; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j	41	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30477	30484		10.1074/jbc.M112.363465	http://dx.doi.org/10.1074/jbc.M112.363465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22745129	Green Published, hybrid			2022-12-28	WOS:000308579800040
J	Ray, S; Taylor, M; Banerjee, T; Tatulian, SA; Teter, K				Ray, Supriyo; Taylor, Michael; Banerjee, Tuhina; Tatulian, Suren A.; Teter, Ken			Lipid Rafts Alter the Stability and Activity of the Cholera Toxin A1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; INTESTINAL MICROVILLUS MEMBRANE; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; A(1) DOMAIN; RETRO-TRANSLOCATION; SIGNAL-TRANSDUCTION; THERMAL-STABILITY; SHIGA TOXIN; C-TERMINUS	Cholera toxin (CT) travels from the cell surface to the endoplasmic reticulum (ER) as an AB holotoxin. ER-specific conditions then promote the dissociation of the catalytic CTA1 subunit from the rest of the toxin. CTA1 is held in a stable conformation by its assembly in the CT holotoxin, but the dissociated CTA1 subunit is an unstable protein that spontaneously assumes a disordered state at physiological temperature. This unfolding event triggers the ER-to-cytosol translocation of CTA1 through the quality control mechanism of ER-associated degradation. The translocated pool of CTA1 must regain a folded, active structure to modify its G protein target which is located in lipid rafts at the cytoplasmic face of the plasma membrane. Here, we report that lipid rafts place disordered CTA1 in a functional conformation. The hydrophobic C-terminal domain of CTA1 is essential for binding to the plasma membrane and lipid rafts. These interactions inhibit the temperature-induced unfolding of CTA1. Moreover, lipid rafts could promote a gain of structure in the disordered, 37 degrees C conformation of CTA1. This gain of structure corresponded to a gain of function: whereas CTA1 by itself exhibited minimal in vitro activity at 37 degrees C, exposure to lipid rafts resulted in substantial toxin activity at 37 degrees C. In vivo, the disruption of lipid rafts with filipin substantially reduced the activity of cytosolic CTA1. Lipid rafts thus exhibit a chaperone-like function that returns disordered CTA1 to an active state and is required for the optimal in vivo activity of CTA1.	[Ray, Supriyo; Taylor, Michael; Banerjee, Tuhina; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI073783 (to K. T.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Boon JM, 2002, MED RES REV, V22, P251, DOI 10.1002/med.10009; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; D'Antuono C, 2000, ARCH BIOCHEM BIOPHYS, V382, P39, DOI 10.1006/abbi.2000.1979; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Debnath D, 2003, BIOCHEM BIOPH RES CO, V301, P979, DOI 10.1016/S0006-291X(03)00066-4; Delaunay JL, 2008, BBA-BIOMEMBRANES, V1778, P105, DOI 10.1016/j.bbamem.2007.09.017; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; FORSTNER GG, 1968, BIOCHEM J, V106, P381, DOI 10.1042/bj1060381; FORSTNER GG, 1968, BIOCHEM J, V109, P51, DOI 10.1042/bj1090051; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Grzybek M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005053; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Kamata K, 2008, AM J HEMATOL, V83, P371, DOI 10.1002/ajh.21126; KASSIS S, 1982, J BIOL CHEM, V257, P2148; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; LENCER WI, 1987, INFECT IMMUN, V55, P3126, DOI 10.1128/IAI.55.12.3126-3130.1987; Liang W, 2000, J ANIM SCI, V78, P2329; LITMAN BJ, 1975, BIOCHIM BIOPHYS ACTA, V394, P166, DOI 10.1016/0005-2736(75)90254-0; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Menikh A, 1997, BIOCHEMISTRY-US, V36, P15865, DOI 10.1021/bi970944+; Mills SE, 2003, J ANIM SCI, V81, P122; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; PROULX P, 1991, BIOCHIM BIOPHYS ACTA, V1071, P255, DOI 10.1016/0304-4157(91)90016-P; Qin S, 2004, J MOL BIOL, V344, P71, DOI 10.1016/j.jmb.2004.09.034; Ray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023692; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Saleh MT, 1996, BIOCHEMISTRY-US, V35, P9325, DOI 10.1021/bi960177z; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SCHROEDER F, 1995, MOL MEMBR BIOL, V12, P113, DOI 10.3109/09687689509038505; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor ME, 2011, APPL MATH SCI, V116, P1, DOI 10.1007/978-1-4419-7052-7_1; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waheed AA, 1998, LIPIDS, V33, P1093, DOI 10.1007/s11745-998-0310-y; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200	66	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30395	30405		10.1074/jbc.M112.385575	http://dx.doi.org/10.1074/jbc.M112.385575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787142	Green Published, hybrid			2022-12-28	WOS:000308579800032
J	Zhang, X; Zhang, Z; Cheng, JW; Li, M; Wang, W; Xu, WR; Wang, H; Zhang, RW				Zhang, Xu; Zhang, Zhuo; Cheng, Jianwen; Li, Mao; Wang, Wei; Xu, Wenrong; Wang, Hui; Zhang, Ruiwen			Transcription Factor NFAT1 Activates the mdm2 Oncogene Independent of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PANCREATIC-CANCER; NUCLEAR FACTOR; T-CELLS; C-MYC; PATHWAY; GROWTH; CALCINEURIN; EXPRESSION; INDUCTION	Although the MDM2-p53 interaction has been well documented, MDM2 overexpression is observed in human cancers with little or no functional p53, suggesting that mdm2 expression is regulated by mechanisms independent of p53. Dysregulation of NFAT signaling is associated with malignant transformation and cancer development and progression. In this study, we demonstrate that the human mdm2 P2 promoter contains a consensus binding site for the NFAT1 transcription factor. NFAT1 directly binds the mdm2 P2 promoter in vitro and in vivo, resulting in the up-regulation of mdm2 transcription. Enforced expression of NFAT1 results in an elevated MDM2 protein level and reduces p53 activation and function in response to DNA damage. Both NFAT1 and MDM2 are highly expressed in human hepatocellular carcinoma tissues, compared with adjacent normal liver tissues. There is a positive correlation between the NFAT1 and MDM2 levels in tumor tissues. The novel function of NFAT1 in the control of MDM2 expression provides a basis for future investigations of the role of NFAT1 in cancer development, progression, and therapy.	[Zhang, Xu; Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA; [Zhang, Xu; Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Sch Pharm, Amarillo, TX 79106 USA; [Zhang, Xu; Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Ctr Clin Lab, Sch Med Sci & Lab Med, Zhenjiang 212001, Jiangsu, Peoples R China; [Zhang, Zhuo; Li, Mao] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Cheng, Jianwen] Fudan Univ, Zhong Shan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Jiangsu University; University of Alabama System; University of Alabama Birmingham; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, RW (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Sch Pharm, 1300 Coulter Dr, Amarillo, TX 79106 USA.	ruiwen.zhang@ttuhsc.edu			National Institutes of Health [R01 CA112029, R01 CA121211]; Susan G. Komen Foundation [BCTR0707731]; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants R01 CA112029 and R01 CA121211. This work was also supported by Susan G. Komen Foundation Grant BCTR0707731 (to R. Z.).; Supported by the One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation Grants 30870513, 31070680, 91029715, and 81025017; Ministry of Science and Technology of China Grant 2007CB947100; and Science and Technology Commission of Shanghai Municipality Grants 08391910800 and 10391902100.	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Chebel A, 2009, J BIOL CHEM, V284, P35725, DOI 10.1074/jbc.M109.009183; Chen Zhao-Li, 2011, Chin J Cancer, V30, P62; CORDONCARDO C, 1994, CANCER RES, V54, P794; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Gerlach K., 2012, CANC RES; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li M, 2005, CANCER RES, V65, P8200, DOI 10.1158/0008-5472.CAN-05-1302; Li M, 2007, CANCER RES, V67, P1988, DOI 10.1158/0008-5472.CAN-06-3066; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Maxeiner JH, 2009, CANCER RES, V69, P3069, DOI 10.1158/0008-5472.CAN-08-1678; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Truong AHL, 2005, ONCOGENE, V24, P962, DOI 10.1038/sj.onc.1208323; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200	40	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30468	30476		10.1074/jbc.M112.373738	http://dx.doi.org/10.1074/jbc.M112.373738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787160	Green Published, hybrid			2022-12-28	WOS:000308579800039
J	Giri, PK; Jing-Song, F; Shanmugam, MK; Ding, JL; Sethi, G; Swaminathan, K; Sivaraman, J				Giri, Pankaj Kumar; Jing-Song, Fan; Shanmugam, Muthu K.; Ding, Jeak Ling; Sethi, Gautam; Swaminathan, Kunchithapadam; Sivaraman, J.			NMR Structure of Carcinoscorpius rotundicauda Thioredoxin-related Protein 16 and Its Role in Regulating Transcription Factor NF-kappa B Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; REDOX REGULATION; PHYSIOLOGICAL FUNCTIONS; BIOLOGICAL-ACTIVITIES; LIPID-PEROXIDATION; DNA-DAMAGE; ACTIVATION; ANTIOXIDANT; HOMODIMER; DISULFIDE	Thioredoxins (Trxs), which play a key role in maintaining a redox environment in the cell, are found in almost all organisms. Trxs act as potential reducing agents of disulfide bonds and contain two vicinal cysteines in a CXXC motif at the active site. Trx is also known to activate the DNA binding activity of NF-kappa B, an important transcription factor. Previously, Trx-related protein 16 from Carcinoscorpius rotundicauda (Cr-TRP16), a 16-kDa Trx-like protein that contains a WCPPC motif, was reported. Here we present the NMR structure of the reduced form of Cr-TRP16, along with its regulation of NF-kappa B activity. Unlike other 16-kDa Trx-like proteins, Cr-TRP16 contains an additional Cys residue (Cys-15, at the N terminus), through which it forms a homodimer. Moreover, we have explored the molecular basis of Cr-TRP16-mediated activation of NF-kappa B and showed that Cr-TRP16 exists as a dimer under physiological conditions, and only the dimeric form binds to NF-kappa B and enhances its DNA binding activity by directly reducing the cysteines in the DNA-binding motif of NF-kappa B. The C15S mutant of Cr-TRP16 was unable to dimerize and hence does not bind to NF-kappa B. Based on our finding and combined with the literature, we propose a model of how Cr-TRP16 is likely to bind to NF-kappa B. These findings elucidate the molecular mechanism by which NF-kappa B activation is regulated through Cr-TRP16.	[Giri, Pankaj Kumar; Jing-Song, Fan; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Shanmugam, Muthu K.; Sethi, Gautam] Natl Univ Singapore, Dept Pharmacol, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012; Ding, Jeak/H-8057-2012; Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council, Singapore [R154000461305, R154-000-424-305]; Singapore Ministry of Health National Medical Research Council; National University of Singapore	Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National University of Singapore(National University of Singapore)	This work was supported in part by a grant from the Biomedical Research Council, Singapore, Grants R154000461305 (to J. S.) and R154-000-424-305 (to K. S.). This project was also supported in part by a grant from Singapore Ministry of Health National Medical Research Council (to. G. S.) under its Individual Research Grant (IRG) funding scheme.; Supported by a graduate research scholarship from the National University of Singapore.	Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Aviram M, 2000, FREE RADICAL RES, V33, pS85; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; FUJII S, 1991, CANCER, V68, P1583, DOI 10.1002/1097-0142(19911001)68:7<1583::AID-CNCR2820680720>3.0.CO;2-N; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; GASDASKA PY, 1994, BBA-GENE STRUCT EXPR, V1218, P292, DOI 10.1016/0167-4781(94)90180-5; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Goddard T. D., SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hirota K, 2002, ANN NY ACAD SCI, V957, P189, DOI 10.1111/j.1749-6632.2002.tb02916.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Matsuo Y, 2002, DRUG NEWS PERSPECT, V15, P575, DOI 10.1358/dnp.2002.15.9.840062; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MENON SD, 1995, J BIOL CHEM, V270, P18881; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Montemartini Marisa, 2000, Biofactors, V11, P65; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; OCHMAN H, 1988, GENETICS, V120, P621; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wang XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI 10.1016/j.freeradbiomed.2008.04.028; Wang XW, 2007, FREE RADICAL BIO MED, V42, P247, DOI 10.1016/j.freeradbiomed.2006.10.040; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	61	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29417	29428		10.1074/jbc.M112.379859	http://dx.doi.org/10.1074/jbc.M112.379859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22763700	hybrid, Green Published			2022-12-28	WOS:000308286900020
J	Moretti, J; Chastagner, P; Liang, CC; Cohn, MA; Israel, A; Brou, C				Moretti, Julien; Chastagner, Patricia; Liang, Chih-Chao; Cohn, Martin A.; Israel, Alain; Brou, Christel			The Ubiquitin-specific Protease 12 (USP12) Is a Negative Regulator of Notch Signaling Acting on Notch Receptor Trafficking toward Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA; LIGAND; ENDOCYTOSIS; ACTIVATION; CLEAVAGE; PATHWAY; DOMAIN; RNAI	Notch signaling is critical for development and adult tissue physiology, controlling cell fate in a context-dependent manner. Upon ligand binding, the transmembrane Notch receptor undergoes two ordered proteolytic cleavages releasing Notch intracellular domain, which regulates the transcription of Notch target genes. The strength of Notch signaling is of crucial importance and depends notably on the quantity of Notch receptor at the cell surface. Using an shRNA library screen monitoring Notch trafficking and degradation in the absence of ligand, we identified mammalian USP12 and its Drosophila melanogaster homolog as novel negative regulators of Notch signaling. USP12 silencing specifically interrupts Notch trafficking to the lysosomes and, as a consequence, leads to an increased amount of receptor at the cell surface and to a higher Notch activity. At the biochemical level, USP12 with its activator UAF1 deubiquitinate the nonactivated form of Notch in cell culture and in vitro. These results characterize a new level of conserved regulation of Notch signaling by the ubiquitin system.	[Moretti, Julien; Chastagner, Patricia; Israel, Alain; Brou, Christel] Inst Pasteur, F-75724 Paris 15, France; [Moretti, Julien; Chastagner, Patricia; Israel, Alain; Brou, Christel] CNRS, Unite Rech Associee URA Signalisat Mol & Activat, F-75724 Paris 15, France; [Moretti, Julien] Univ Paris 06, Cellule Pasteur UPMC, F-75724 Paris 15, France; [Liang, Chih-Chao; Cohn, Martin A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Brou, C (corresponding author), Inst Pasteur, 25 Rue Docteur Roux, F-75724 Paris 15, France.	christel.brou@pasteur.fr		Cohn, Martin/0000-0002-2988-3009; Moretti, Julien/0000-0002-3415-9058; Liang, Chih-Chao/0000-0001-5039-7008	Institut Pasteur; CNRS; Association pour la Recherche sur le Cancer [SFI20101201664]; Ligue Nationale Contre le Cancer [LNCC RS11/75-21]; European Community [018683]; French Ministry of Research	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Community(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported in part by the Institut Pasteur, CNRS, Association pour la Recherche sur le Cancer (Grant SFI20101201664, to C. B.), Ligue Nationale Contre le Cancer (Grant LNCC RS11/75-21, to C. B.), and the European Community (Grant 018683, Network of Excellence RUBICON, to A. I.).; Recipient of fellowships from the French Ministry of Research and from the Association pour la Recherche sur le Cancer.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Couturier L, 2012, NAT CELL BIOL, V14, P131, DOI 10.1038/ncb2419; Dirac AMG, 2005, METHOD ENZYMOL, V398, P554, DOI 10.1016/S0076-6879(05)98045-2; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vodovar Nicolas, 2008, J Biol, V7, P7, DOI 10.1186/jbiol68	30	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29429	29441		10.1074/jbc.M112.366807	http://dx.doi.org/10.1074/jbc.M112.366807			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778262	Green Published, hybrid			2022-12-28	WOS:000308286900021
J	Onal, M; Xiong, JH; Chen, XR; Thostenson, JD; Almeida, M; Manolagas, SC; O'Brien, CA				Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Thostenson, Jeff D.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.			Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; OSTEOCLAST FORMATION; ESTROGEN DEFICIENCY; T-CELLS; ACCELERATED OSTEOCLASTOGENESIS; MESSENGER-RNA; MICE; OSTEOPROTEGERIN; LYMPHOPOIESIS; MARROW	Production of the cytokine receptor activator of NF kappa B ligand (RANKL) by lymphocytes has been proposed as a mechanism by which sex steroid deficiency causes bone loss. However, there have been no studies that functionally link RANKL expression in lymphocytes with bone loss in this condition. Herein, we examined whether RANKL expression in either B or T lymphocytes contributes to ovariectomy-induced bone loss in mice. Mice harboring a conditional RANKL allele were crossed with CD19-Cre or Lck-Cre mice to delete RANKL in B or T lymphocytes, respectively. Deletion of RANKL from either cell type had no impact on bone mass in estrogen-replete mice up to 7 months of age. However, mice lacking RANKL in B lymphocytes were partially protected from the bone loss caused by ovariectomy. This protection occurred in cancellous, but not cortical, bone and was associated with a failure to increase osteoclast numbers in the conditional knock-out mice. Deletion of RANKL from T lymphocytes had no impact on ovariectomy-induced bone loss. These results demonstrate that lymphocyte RANKL is not involved in basal bone remodeling, but B cell RANKL does contribute to the increase in osteoclasts and cancellous bone loss that occurs after loss of estrogen.	[Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Onal, Melda; Xiong, Jinhu; Chen, Xinrong; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Thostenson, Jeff D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; xiong, jinhu/E-1849-2011; Liu, Juan/J-5155-2015	Warren, Aaron D./0000-0002-0042-9021; Almeida, Maria/0000-0002-6722-9200	Central Arkansas Veterans Healthcare System [5I01BX000294-04]; National Institutes of Health [AR049794, AG13918]; University of Arkansas for Medical Sciences (UAMS) Translational Research Institute [UL1 RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	Central Arkansas Veterans Healthcare System(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences (UAMS) Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the Central Arkansas Veterans Healthcare System, Merit Review 5I01BX000294-04 (to C. A. O.). This work was also supported by National Institutes of Health Grants AR049794 (to C. A. O.) and AG13918 (to S. C. M.), by the University of Arkansas for Medical Sciences (UAMS) Translational Research Institute Grant UL1 RR029884, and UAMS tobacco settlement funds.	Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Blin-Wakkach C, 2004, J BONE MINER RES, V19, P1137, DOI 10.1359/JBMR.040318; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Farrugia AN, 2003, CANCER RES, V63, P5438; Han XZ, 2006, J IMMUNOL, V176, P625, DOI 10.4049/jimmunol.176.1.625; Heider U, 2004, J CANCER RES CLIN, V130, P469, DOI 10.1007/s00432-004-0578-3; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Horowitz MC, 2010, BONE, V47, P472, DOI 10.1016/j.bone.2010.06.011; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Ishimi Y, 1999, ENDOCRINOLOGY, V140, P1893, DOI 10.1210/en.140.4.1893; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321; Katavic V, 2003, BONE, V32, P581, DOI 10.1016/S8756-3282(03)00097-8; KIMBLE RB, 1995, ENDOCRINOLOGY, V136, P3054, DOI 10.1210/en.136.7.3054; KINCADE PW, 1994, IMMUNOL REV, V137, P119, DOI 10.1111/j.1600-065X.1994.tb00661.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SK, 2006, J BONE MINER RES, V21, P695, DOI 10.1359/JBMR.060117; Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Li XD, 2009, BONE, V45, P669, DOI 10.1016/j.bone.2009.06.011; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541; Pacifici R, 2012, J BONE MINER RES, V27, P231, DOI 10.1002/jbmr.1500; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Proell V, 2009, BONE, V45, P677, DOI 10.1016/j.bone.2009.05.024; Pugliese LS, 2012, IMMUNOBIOLOGY, V217, P336, DOI 10.1016/j.imbio.2011.07.014; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Taxel P, 2008, OSTEOPOROSIS INT, V19, P193, DOI 10.1007/s00198-007-0452-7; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	53	161	172	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29851	29860		10.1074/jbc.M112.377945	http://dx.doi.org/10.1074/jbc.M112.377945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782898	Green Published, hybrid			2022-12-28	WOS:000308286900059
J	Li, Q; Ramirez-Bergeron, DL; Dunwoodie, SL; Yang, YC				Li, Qiang; Ramirez-Bergeron, Diana L.; Dunwoodie, Sally L.; Yang, Yu-Chung			Cited2 Gene Controls Pluripotency and Cardiomyocyte Differentiation of Murine Embryonic Stem Cells through Oct4 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC-CELLS; HEMATOPOIETIC DIFFERENTIATION; TRANSCRIPTION FACTOR; ESSENTIAL REGULATOR; SIGNALING PATHWAYS; SELF-RENEWAL; MOUSE; EXPRESSION; HYPOXIA; COACTIVATOR	Cited2 (CBP/p300-interacting transactivator with glutamic acid (E)/aspartic acid (D)-rich tail 2) is a transcriptional modulator critical for the development of multiple organs. Although many Cited2-mediated phenotypes and molecular events have been well characterized using in vivo genetic murine models, Cited2-directed cell fate decision in embryonic stem cells (ESCs) remains elusive. In this study, we examined the role of Cited2 in the maintenance of stemness and pluripotency of murine ESCs by a gene-targeting approach. Cited2 knock-out (Cited2(Delta/-), KO) ESCs display defective differentiation. Loss of Cited2 in differentiating ESCs results in delayed silencing of the genes involved in the maintenance of pluripotency and self-renewal of stem cells (Oct4, Klf4, Sox2, and c-Myc) and the disturbance in cardiomyocyte, hematopoietic, and neuronal differentiation. In addition, Cited2 KO ESCs experience a delayed induction of cardiomyocyte differentiation-associated proteins, NFAT3 (along with the reduced expression of NFAT3 target genes, Nkx2.5 and beta-MHC), N-cadherin, and smooth muscle actin. CITED2 is recruited to the Oct4 promoter to regulate its expression during early ESC differentiation. This is the first demonstration that Cited2 controls ESC pluripotency and differentiation via direct regulation of Oct4 gene expression.	[Yang, Yu-Chung] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Ramirez-Bergeron, Diana L.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ramirez-Bergeron, Diana L.; Yang, Yu-Chung] Case Western Reserve Univ, Ctr Canc, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Yang, YC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave,W444, Cleveland, OH 44106 USA.	yu-chung.yang@case.edu	Li, Qiang/O-8055-2014; Dunwoodie, Sally L/M-4019-2018	Li, Qiang/0000-0002-1779-0737; Dunwoodie, Sally L/0000-0002-2069-7349	National Institutes of Health [R01HL091896, R01HL096597]; National Health and Medical Research Council [514900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091896, R01HL096597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL091896 (to Y.-C. Y.) and R01HL096597 (to D. R.-B.). This work was also supported by National Health and Medical Research Council Senior Research Fellowship 514900 (to S. L. D.).	Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bai SM, 2011, MOL CELL BIOL, V31, P3068, DOI 10.1128/MCB.00925-10; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Camara-Clayette V, 2006, STEM CELLS, V24, P1937, DOI 10.1634/stemcells.2005-0067; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Y, 2009, BIOL CELL, V101, P335, DOI 10.1042/BC20080108; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kami D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002407; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Macdonald S. T., 2012, EUR HEART J IN PRESS; MacDonald ST, 2008, CARDIOVASC RES, V79, P448, DOI 10.1093/cvr/cvn101; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Preis JI, 2006, GENESIS, V44, P579, DOI 10.1002/dvg.20251; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Ramirez-Bergeron DL, 2006, DEV CELL, V11, P81, DOI 10.1016/j.devcel.2006.04.018; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Regel I, 2012, GASTROENTEROLOGY, V143, P99, DOI 10.1053/j.gastro.2012.03.035; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Simon MC, 2002, COLD SPRING HARB SYM, V67, P127, DOI 10.1101/sqb.2002.67.127; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	61	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29088	29100		10.1074/jbc.M112.378034	http://dx.doi.org/10.1074/jbc.M112.378034			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761414	hybrid, Green Published			2022-12-28	WOS:000308074600075
J	Raynes, R; Leckey, BD; Nguyen, K; Westerheide, SD				Raynes, Rachel; Leckey, Bruce D., Jr.; Kevin Nguyen; Westerheide, Sandy D.			Heat Shock and Caloric Restriction Have a Synergistic Effect on the Heat Shock Response in a sir2.1-dependent Manner in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DIETARY RESTRICTION; MESSENGER-RNA; DECREASED EXPRESSION; GENE-TRANSCRIPTION; CELL-SURVIVAL; FACTOR-I; PROTEIN; STRESS; HEAT-SHOCK-PROTEIN-70	The heat shock response (HSR) is responsible for maintaining cellular and organismal health through the regulation of proteostasis. Recent data demonstrating that the mammalian HSR is regulated by SIRT1 suggest that this response may be under metabolic control. To test this hypothesis, we have determined the effect of caloric restriction in Caenorhabditis elegans on activation of the HSR and have found a synergistic effect on the induction of hsp70 gene expression. The homolog of mammalian SIRT1 in C. elegans is Sir2.1. Using a mutated C. elegans strain with a sir2.1 deletion, we show that heat shock and caloric restriction cooperate to promote increased survivability and fitness in a sir2.1-dependent manner. Finally, we show that caloric restriction increases the ability of heat shock to preserve movement in a polyglutamine toxicity neurodegenerative disease model and that this effect is dependent on sir2.1.	[Raynes, Rachel; Leckey, Bruce D., Jr.; Kevin Nguyen; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, 4202 E Fowler Ave,ISA2015, Tampa, FL 33620 USA.	swesterheide@usf.edu			Department of Cell Biology, Microbiology and Molecular of the University of South Florida; National Institutes of Health; Canadian Institutes of Health Research; Genome Canada; Genome BC; Michael Smith Foundation; National Institutes of Health National Center for Research Resources	Department of Cell Biology, Microbiology and Molecular of the University of South Florida; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Genome BC; Michael Smith Foundation(Michael Smith Foundation for Health Research); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a departmental start-up grant from the Department of Cell Biology, Microbiology and Molecular of the University of South Florida (to S. D. W.).; We thank Dr. R. I. Morimoto (Northwestern University, Evanston, IL) for providing the C. elegans C12C8.1::GFP, Q0-YFP, Q24-YFP, and Q35-YFP strains. The sir2.1(ok434) IV and sir2.3(ok444) X strains were provided by the C. elegans Gene Knockout Consortium (C. elegans Gene Knockout Facility at the Oklahoma Medical Research Foundation, which is funded by the National Institutes of Health, and the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is funded by the Canadian Institutes of Health Research, Genome Canada, Genome BC, the Michael Smith Foundation, and the National Institutes of Health). Other strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank Dr. C. Voisine (Northwestern University) and Dr. James West (College of Wooster, Wooster, OH) for helpful comments and advice.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; ANGELIDIS CE, 1991, EUR J BIOCHEM, V199, P35, DOI 10.1111/j.1432-1033.1991.tb16088.x; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; CAMPANINI C, 1992, ANN NY ACAD SCI, V663, P442, DOI 10.1111/j.1749-6632.1992.tb38695.x; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DEGUCHI Y, 1988, BIOCHEM BIOPH RES CO, V157, P580, DOI 10.1016/S0006-291X(88)80289-4; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Ehrenfried JA, 1996, ANN SURG, V223, P592, DOI 10.1097/00000658-199605000-00015; FAASSEN AE, 1989, EXP CELL RES, V183, P326, DOI 10.1016/0014-4827(89)90393-5; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Heydari AR, 1996, DEV GENET, V18, P114, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;114::AID-DVG4&gt;3.0.CO;2-C; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; Johnson TE, 2008, EXP GERONTOL, V43, P1, DOI 10.1016/j.exger.2007.09.008; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LIU AYC, 1989, J BIOL CHEM, V264, P12037; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCCAY CM, 1989, NUTRITION, V5, P155; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; PAHLAVANI MA, 1995, EXP CELL RES, V218, P310, DOI 10.1006/excr.1995.1160; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Torok Z, 2003, P NATL ACAD SCI USA, V100, P3131, DOI 10.1073/pnas.0438003100; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	54	48	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29045	29053		10.1074/jbc.M112.353714	http://dx.doi.org/10.1074/jbc.M112.353714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778258	hybrid, Green Published			2022-12-28	WOS:000308074600071
J	Tanimizu, N; Kikkawa, Y; Mitaka, T; Miyajima, A				Tanimizu, Naoki; Kikkawa, Yamato; Mitaka, Toshihiro; Miyajima, Atsushi			alpha 1-and alpha 5-containing Laminins Regulate the Development of Bile Ducts via beta 1 Integrin Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL HEPATIC-FIBROSIS; CELL-ADHESION MOLECULE; EPITHELIAL POLARITY; LIVER DEVELOPMENT; CAROLIS-DISEASE; MOUSE-LIVER; MORPHOGENESIS; EXPRESSION; INTEGRINS; KIDNEY	Signals derived from basal lamina components are important for developing three-dimensional architecture of epithelial tissues. Laminins consisting of alpha, beta, and gamma subunits in basal lamina play pivotal roles in the formation and maintenance of epithelial tissue structures. However, it remains unclear which laminin iso-forms transmit signals and how epithelial cells receive them to regulate multiple developmental processes. In three-dimensional culture of a liver progenitor cell line, Hepatic Progenitor Cells Proliferating on Laminin (HPPL), the cells establish apicobasal polarity and form cysts with a central lumen. Neutralizing antibody against beta 1 integrin blocked the formation and maintenance of the cyst structure, indicating that beta 1 integrin signaling was necessary throughout the morphogenesis. Although the addition of alpha 1-containing laminin, a ligand of beta 1 integrin, induced cyst formation, it was dispensable for the maintenance of the cyst, suggesting that HPPL produces another ligand for beta 1 integrin to maintain the structure. Indeed, we found that HPPL produced alpha 5-containing laminin, and siRNA against laminin alpha 5 partially inhibited the lumen formation. In fetal liver, p75NTR(+) periportal fibroblasts and bile duct epithelial cells, known as cholangiocytes, expressed alpha 1- and alpha 5-containing laminins, respectively. In laminin alpha 5 KO liver, cholangiocytes normally emerged, but the number of bile ducts was decreased. These results suggest that alpha 1-containing laminin is sufficient as a component of the basal lamina for the commitment of bipotential liver progenitors to cholangiocytes and the apicobasal polarization, whereas alpha 5-containing laminin is necessary for the formation of mature duct structures. Thus, alpha 1- and alpha 5-containing laminins differentially regulate the sequential events to form epithelial tissues via beta 1 integrin signals.	[Tanimizu, Naoki; Mitaka, Toshihiro] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kikkawa, Yamato] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan; [Tanimizu, Naoki; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Sapporo Medical University; Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Tanimizu, N (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tanimizu@sapmed.ac.jp	Kikkawa, Yamato/D-1503-2010; Mitaka, Toshihiro/K-9424-2013	Mitaka, Toshihiro/0000-0001-9467-4871	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to N. T., A. M., and T. M.).	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Bombardelli L, 2010, GASTROENTEROLOGY, V138, P2531, DOI 10.1053/j.gastro.2010.02.043; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Fernandez-Minan A, 2008, INT J DEV BIOL, V52, P925, DOI 10.1387/IJDB.072418af; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kikkawa Y, 2005, EXP CELL RES, V305, P99, DOI 10.1016/j.yexcr.2005.01.005; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2006, DEV BIOL, V296, P265, DOI 10.1016/j.ydbio.2006.04.463; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Rebustini IT, 2007, DEV BIOL, V308, P15, DOI 10.1016/j.ydbio.2007.04.031; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Shiojiri N, 1997, MICROSC RES TECHNIQ, V39, P328, DOI 10.1002/(SICI)1097-0029(19971115)39:4<328::AID-JEMT3>3.0.CO;2-D; Shiojiri N, 2004, HEPATOLOGY, V40, P346, DOI 10.1002/hep.20303; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Yasoshima M, 2009, J PATHOL, V217, P442, DOI 10.1002/path.2472; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	30	50	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28586	28597		10.1074/jbc.M112.350488	http://dx.doi.org/10.1074/jbc.M112.350488			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761447	hybrid, Green Published			2022-12-28	WOS:000308074600033
J	Wang, HF; Ying, Z; Wang, GH				Wang, Hongfeng; Ying, Zheng; Wang, Guanghui			Ataxin-3 Regulates Aggresome Formation of Copper-Zinc Superoxide Dismutase (SOD1) by Editing K63-linked Polyubiquitin Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME ATAXIN-3; LEWY-BODY FORMATION; UBIQUITIN CHAINS; ALPHA-SYNUCLEIN; MISFOLDED PROTEINS; INCLUSION-BODIES; MUTANT SOD1; MOUSE MODEL	Polyubiquitination of misfolded proteins, especially K63-linked polyubiquitination, is thought to be associated with the formation of inclusion bodies. However, it is not well explored whether appropriate editing of the different types of ubiquitin linkages by deubiquitinating enzymes (DUBs) affects the dynamics of inclusion bodies. In this study, we report that a specific DUB, ataxin-3, is required for the efficient recruitment of the neurodegenerative disease-associated protein copper-zinc superoxide dismutase (SOD1) to aggresomes. The overexpression of ataxin-3 promotes mutant SOD1 aggresome formation by trimming K63-linked polyubiquitin chains. Moreover, knockdown of ataxin-3 decreases mutant SOD1 aggresome formation and increases cell death induced by mutant SOD1. Thus, our data suggest that the sequestration of misfolded SOD1 into aggresomes, which is driven by ataxin-3, plays an important role in attenuating protein misfolding-induced cell toxicity.	[Wang, Hongfeng; Ying, Zheng; Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Lab Mol Neuropathol, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Wang, GH (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Lab Mol Neuropathol, Suzhou 215123, Jiangsu, Peoples R China.	wanggh@suda.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468	National High-tech Research and Development Program of China 973 [2011CB504102]; National Natural Sciences Foundation of China [30970921, 31000473]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National High-tech Research and Development Program of China 973; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by the National High-tech Research and Development Program of China 973 (Project 2011CB504102), the National Natural Sciences Foundation of China (No. 30970921 and 31000473), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Corcoran LJ, 2004, CURR BIOL, V14, P488, DOI 10.1016/j.cub.2004.03.003; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Miki Y, 2011, NEUROPATHOLOGY, V31, P561, DOI 10.1111/j.1440-1789.2011.01200.x; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ren HG, 2010, CANCER LETT, V297, P101, DOI 10.1016/j.canlet.2010.05.001; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380	44	48	48	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28576	28585		10.1074/jbc.M111.299990	http://dx.doi.org/10.1074/jbc.M111.299990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761419	Green Published, hybrid			2022-12-28	WOS:000308074600032
J	Knaus, T; Eger, E; Koop, J; Stipsits, S; Kinsland, CL; Ealick, SE; Macheroux, P				Knaus, Tanja; Eger, Elisabeth; Koop, Julia; Stipsits, Steve; Kinsland, Cynthia L.; Ealick, Steven E.; Macheroux, Peter			Reverse Structural Genomics AN UNUSUAL FLAVIN-BINDING SITE IN A PUTATIVE PROTEASE FROM BACTEROIDES THETAIOTAOMICRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FLAVOPROTEINS; FLAVOENZYMES; DODECIN; DJ-1; MECHANISM; CHAPERONE; DISEASE	The structure of a putative protease from Bacteroides thetaiotaomicron features an unprecedented binding site for flavin mononucleotide. The flavin isoalloxazine ring is sandwiched between two tryptophan residues in the interface of the dimeric protein. We characterized the recombinant protein with regard to its affinity for naturally occurring flavin derivatives and several chemically modified flavin analogs. Dissociation constants were determined by isothermal titration calorimetry. The protein has high affinity to naturally occurring flavin derivatives, such as riboflavin, FMN, and FAD, as well as lumichrome, a photodegradation product of flavins. Similarly, chemically modified flavin analogs showed high affinity to the protein in the nanomolar range. Replacement of the tryptophan by phenylalanine gave rise to much weaker binding, whereas in the tryptophan to alanine variant, flavin binding was abolished. We propose that the protein is an unspecific scavenger of flavin compounds and may serve as a storage protein in vivo.	[Knaus, Tanja; Eger, Elisabeth; Koop, Julia; Stipsits, Steve; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Kinsland, Cynthia L.; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Graz University of Technology; Cornell University	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Macheroux, Peter/AAB-5157-2019	Macheroux, Peter/0000-0002-0242-454X; Knaus, Tanja/0000-0001-9942-9226	Graz University of Technology	Graz University of Technology	This work was supported by funds from Graz University of Technology (to P.M.).	Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; CAIRNS WL, 1971, J AM CHEM SOC, V93, P2772; CHOONG YS, 1981, J BIOL CHEM, V256, P8671; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; FITZPATRICK PF, 1985, J BIOL CHEM, V260, P8483; GHISLA S, 1986, BIOCHEM J, V239, P1; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huerta C, 2009, J MOL BIOL, V389, P388, DOI 10.1016/j.jmb.2009.04.022; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; Macheroux P, 1999, METH MOL B, V131, P1; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MATSUI K, 1974, J NUTR SCI VITAMINOL, V20, P411; MCCORMICK DB, 1977, PHOTOCHEM PHOTOBIOL, V26, P169, DOI 10.1111/j.1751-1097.1977.tb07471.x; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Meissner B, 2007, J BIOL CHEM, V282, P33142, DOI 10.1074/jbc.M704951200; Muller F., 1988, VITAMINE; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; SPENCER R, 1977, BIOCHEMISTRY-US, V16, P3586, DOI 10.1021/bi00635a014; SPENCER R, 1976, BIOCHEMISTRY-US, V15, P1043, DOI 10.1021/bi00650a015; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; WHITBY LG, 1954, BIOCHEM J, V57, P390, DOI 10.1042/bj0570390	32	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27490	27498		10.1074/jbc.M112.355388	http://dx.doi.org/10.1074/jbc.M112.355388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718753	Green Published, hybrid			2022-12-28	WOS:000307840700025
J	Ren, H; Zhao, YL; Dwyer, DS; Peoples, RW				Ren, Hong; Zhao, Yulin; Dwyer, Donard S.; Peoples, Robert W.			Interactions among Positions in the Third and Fourth Membrane-associated Domains at the Intersubunit Interface of the N-Methyl-D-aspartate Receptor Forming Sites of Alcohol Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NR1/NR2B NMDA RECEPTORS; ETHANOL INHIBITION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SINGLE-CHANNEL; NR2A SUBUNIT; FYN-KINASE; M4 DOMAINS; M3; SENSITIVITY	The N-methyl-D-aspartate (NMDA) glutamate receptor is a major target of ethanol in the brain. Previous studies have identified positions in the third and fourth membrane-associated (M) domains of the NMDA receptor GluN1 and GluN2A subunits that influence alcohol sensitivity. The predicted structure of the NMDA receptor, based on that of the related GluA2 subunit, indicates a close apposition of the alcohol-sensitive positions in M3 and M4 between the two subunit types. We tested the hypothesis that these positions interact to regulate receptor kinetics and ethanol sensitivity by using dual substitution mutants. In single-substitution mutants, we found that a position in both subunits adjacent to one previously identified, GluN1(Gly-638) and GluN2A(Phe-636), can strongly regulate ethanol sensitivity. Significant interactions affecting ethanol inhibition and receptor deactivation were observed at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824, Met-818/Phe-636, and Leu-819/Phe-637; the latter pair also interacted with respect to desensitization. Two interactions involved a position in M4 of both subunits, GluN1(Met-818) and GluN2A(Leu-824), that does not by itself alter ethanol sensitivity, whereas a previously identified ethanol-sensitive position, GluN2A(Ala-825), did not unequivocally interact with any other position tested. These results also indicate a shift by one position of the predicted alignment of the GluN1 M4 domain. These findings have allowed for the refinement of the NMDA receptor M domain structure, demonstrate that this region can influence apparent agonist affinity, and support the existence of four sites of alcohol action on the NMDA receptor, each consisting of five amino acids at the M3-M4 domain intersubunit interfaces.	[Ren, Hong; Zhao, Yulin; Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Dwyer, Donard S.] Louisiana State Univ, Hlth Sci Ctr, Dept Psychiat, Shreveport, LA 71130 USA	Marquette University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Peoples, RW (corresponding author), Marquette Univ, Dept Biomed Sci, SC 446,POB 1881, Milwaukee, WI 53201 USA.	robert.peoples@marquette.edu			National Institutes of Health [AA015203-01A1, AA015203-06A1]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA015203-01A1 and AA015203-06A1 (to R.W.P.).	Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Anders DL, 1999, J NEUROCHEM, V72, P1389, DOI 10.1046/j.1471-4159.1999.721389.x; BALSTER RL, 1992, EUR J PHARMACOL, V222, P39, DOI 10.1016/0014-2999(92)90460-L; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Chang HR, 2008, J NEUROSCI, V28, P1546, DOI 10.1523/JNEUROSCI.3485-07.2008; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dickerson D, 2010, J PSYCHOPHARMACOL, V24, P203, DOI 10.1177/0269881108098612; DILDY JE, 1989, BRAIN RES, V499, P383, DOI 10.1016/0006-8993(89)90789-0; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GOTHERT M, 1989, N-S ARCH PHARMACOL, V340, P516; GRANT KA, 1991, BEHAV PHARMACOL, V2, P87; GRANT KA, 1993, J PHARMACOL EXP THER, V264, P1241; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Honse Y, 2004, NEUROPHARMACOLOGY, V46, P647, DOI 10.1016/j.neuropharm.2003.11.006; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupitsky EM, 2007, AM J PSYCHIAT, V164, P519, DOI 10.1176/appi.ajp.164.3.519; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Krystal JH, 1998, ARCH GEN PSYCHIAT, V55, P354, DOI 10.1001/archpsyc.55.4.354; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Peoples R.W., 2003, GLUTAMATE ADDICTION, P343; Peoples RW, 2000, NEUROPHARMACOLOGY, V39, P1681, DOI 10.1016/S0028-3908(00)00067-8; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Peoples RW, 1997, BRIT J PHARMACOL, V122, P1035, DOI 10.1038/sj.bjp.0701483; Qian A, 2002, PHYSIOL BEHAV, V77, P577, DOI 10.1016/S0031-9384(02)00906-X; Ren H, 2007, BRIT J PHARMACOL, V151, P749, DOI 10.1038/sj.bjp.0707254; Ren H, 2003, J BIOL CHEM, V278, P48815, DOI 10.1074/jbc.M302097200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ren H, 2008, J BIOL CHEM, V283, P8250, DOI 10.1074/jbc.M705933200; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Salous AK, 2009, BRIT J PHARMACOL, V158, P1395, DOI 10.1111/j.1476-5381.2009.00397.x; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SANGER DJ, 1993, BEHAV PHARMACOL, V4, P523; SCHECHTER MD, 1993, ALCOHOL, V10, P197, DOI 10.1016/0741-8329(93)90035-M; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Smothers CT, 2006, ALCOHOL CLIN EXP RES, V30, P523, DOI 10.1111/j.1530-0277.2006.00058.x; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Terhag J, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00117; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Woodward JJ, 1999, NEUROCHEM INT, V35, P107, DOI 10.1016/S0197-0186(99)00052-2; Wright JM, 1996, BRAIN RES, V738, P249, DOI 10.1016/S0006-8993(96)00780-9; Xu MF, 2012, J PHARMACOL EXP THER, V340, P218, DOI 10.1124/jpet.111.187179; Yaka R, 2003, ALCOHOL CLIN EXP RES, V27, P1736, DOI 10.1097/01.ALC.0000095924.87729.D8; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zhou Y, 2005, J NEUROSCI, V25, P7914, DOI 10.1523/JNEUROSCI.1471-05.2005	58	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27302	27312		10.1074/jbc.M111.338921	http://dx.doi.org/10.1074/jbc.M111.338921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715100	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000307840700003
J	Scheer, E; Delbac, F; Tora, L; Moras, D; Romier, C				Scheer, Elisabeth; Delbac, Frederic; Tora, Laszlo; Moras, Dino; Romier, Christophe			TFIID TAF6-TAF9 Complex Formation Involves the HEAT Repeat-containing C-terminal Domain of TAF6 and Is Modulated by TAF5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; HISTONE-FOLD; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; YEAST; COMPONENTS; OCTAMER; CORE; IDENTIFICATION	The general transcription factor TFIID recognizes specifically the core promoter of genes transcribed by eukaryotic RNA polymerase II, nucleating the assembly of the preinitiation complex at the transcription start site. However, the understanding in molecular terms of TFIID assembly and function remains poorly understood. Histone fold motifs have been shown to be extremely important for the heterodimerization of many TFIID subunits. However, these subunits display several evolutionary conserved noncanonical features when compared with histones, including additional regions whose role is unknown. Here we show that the conserved additional C-terminal region of TFIID subunit TAF6 can be divided into two domains: a small middle domain (TAF6M) and a large C-terminal domain (TAF6C). Our crystal structure of the TAF6C domain from Antonospora locustae at 1.9 angstrom resolution reveals the presence of five conserved HEAT repeats. Based on these data, we designed several mutants that were introduced into full-length human TAF6. Surprisingly, the mutants affect the interaction between TAF6 and TAF9, suggesting that the formation of the complex between these two TFIID subunits do not only depend on their histone fold motifs. In addition, the same mutants affect even more strongly the interaction between TAF6 and TAF9 in the context of a TAF5-TAF6-TAF9 complex. Expression of these mutants in HeLa cells reveals that most of them are unstable, suggesting their poor incorporation within endogenous TFIID. Taken together, our results suggest that the conserved additional domains in histone fold-containing subunits of TFIID and of co-activator SAGA are important for the assembly of these complexes.	[Moras, Dino; Romier, Christophe] Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Biol Integrat, F-67404 Illkirch Graffenstaden, France; [Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Genom Fonct & Canc, F-67404 Illkirch Graffenstaden, France; [Delbac, Frederic] Univ Clermont Ferrand, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Romier, C (corresponding author), Univ Strasbourg UDS, IGBMC, CNRS, INSERM,Dept Biol Integrat, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	romier@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Romier, Christophe/0000-0002-3680-935X	CNRS; INSERM; Universite de Strasbourg; European Commission SPINE2-Complexes project [LSHG-CT-2006-031220]; Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0052]; European Union (EU) (EUTRACC) [LSHG-CT-2007-037445]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; European Commission SPINE2-Complexes project(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union (EU) (EUTRACC)	This work was supported by institutional funds from the CNRS, the INSERM, and the Universite de Strasbourg. Further funding was provided by the European Commission SPINE2-Complexes project (Contract LSHG-CT-2006-031220) (to C. R. and D. M.) and by grants from the Agence Nationale de la Recherche (ANR) (ANR-09-BLAN-0052) and the European Union (EU) (EUTRACC, LSHG-CT-2007-037445) (to L. T.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Diebold ML, 2010, EMBO J, V29, P3979, DOI 10.1038/emboj.2010.272; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KOKUBO T, 1994, NATURE, V367, P484, DOI 10.1038/367484a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavigne AC, 1999, MOL CELL BIOL, V19, P5050; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WEINZIERL ROJ, 1993, EMBO J, V12, P5303, DOI 10.1002/j.1460-2075.1993.tb06226.x; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	55	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27580	27592		10.1074/jbc.M112.379206	http://dx.doi.org/10.1074/jbc.M112.379206			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22696218	hybrid, Green Published			2022-12-28	WOS:000307840700033
J	Ding, JJ; Wang, W; Feng, H; Zhang, Y; Wang, DC				Ding, Jingjin; Wang, Wei; Feng, Han; Zhang, Ying; Wang, Da-Cheng			Structural Insights into the Pseudomonas aeruginosa Type VI Virulence Effector Tse1 Bacteriolysis and Self-protection Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAILED PHAGES; SECRETION; SUPERFAMILY; SUBSTRATE; ENZYMES; RIPA	Recently, it was identified that Pseudomonas aeruginosa competes with rival cells to gain a growth advantage using a novel mechanism that includes two interrelated processes as follows: employing type VI secretion system (T6SS) virulence effectors to lyse other bacteria, and at the same time producing specialized immunity proteins to inactivate their cognate effectors for self-protection against mutual toxicity. To explore the structural basis of these processes in the context of functional performance, the crystal structures of the T6SS virulence effector Tse1 and its complex with the corresponding immunity protein Tsi1 were determined, which, in association with mutagenesis and Biacore analyses, provided a molecular platform to resolve the relevant structural questions. The results indicated that Tse1 features a papain-like structure and conserved catalytic site with distinct substrate-binding sites to hydrolyze its murein peptide substrate. The immunity protein Tsi1 interacts with Tse1 via a unique interactive recognition mode to shield Tse1 from its physiological substrate. These findings reveal both the structural mechanisms for bacteriolysis and the self-protection against the T6SS effector Tse1. These mechanisms are significant not only by contributing to a novel understanding of niche competition among bacteria but also in providing a structural basis for antibacterial agent design and the development of new strategies to fight P. aeruginosa.	[Ding, Jingjin; Wang, Wei; Feng, Han; Zhang, Ying; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 10010, Peoples R China; [Wang, Wei; Feng, Han] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, DC (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	dcwang@ibp.ac.cn	Wang, Wei/W-3720-2019	Wang, Wei/0000-0002-6346-2216; Ding, Jingjin/0000-0001-9941-7997	Chinese Ministry of Science and Technology 973 Program [2011CB910304, 2011CB911103]; National Natural Science Foundation of China [31100535]; Chinese Academy of Sciences [KSCX2-EW-J-3]	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Chinese Ministry of Science and Technology 973 Program Grants 2011CB910304 and 2011CB911103, National Natural Science Foundation of China Grant 31100535, and Chinese Academy of Sciences Grant KSCX2-EW-J-3.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Both D, 2011, J MOL BIOL, V413, P247, DOI 10.1016/j.jmb.2011.08.014; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Nakajima Y, 2008, J BACTERIOL, V190, P7819, DOI 10.1128/JB.02010-07; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008	34	36	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26911	26920		10.1074/jbc.M112.368043	http://dx.doi.org/10.1074/jbc.M112.368043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700987	hybrid, Green Published			2022-12-28	WOS:000307386000039
J	Newman, ER; Kneale, GG; Ravelli, RBG; Karuppasamy, M; Nejadasl, FK; Taylor, IA; McGeehan, JE				Newman, Emily R.; Kneale, G. Geoff; Ravelli, Raimond B. G.; Karuppasamy, Manikandan; Nejadasl, Fatemeh Karimi; Taylor, Ian A.; McGeehan, John E.			Large Multimeric Assemblies of Nucleosome Assembly Protein and Histones Revealed by Small-angle X-ray Scattering and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; IN-VITRO; CHROMATIN; CHAPERONE; PARTICLE; NAP1; COMPLEXES; BINDING; STATES	The nucleosome assembly protein (NAP) family represents a key group of histone chaperones that are essential for cell viability. Several x-ray structures of NAP1 dimers are available; however, there are currently no structures of this ubiquitous chaperone in complex with histones. We have characterized NAP1 from Xenopus laevis and reveal that it forms discrete multimers with histones H2A/H2B and H3/H4 at a stoichiometry of one NAP dimer to one histone fold dimer. These complexes have been characterized by size exclusion chromatography, analytical ultracentrifugation, multiangle laser light scattering, and small-angle x-ray scattering to reveal their oligomeric assembly states in solution. By employing single-particle cryo-electron microscopy, we visualized these complexes for the first time and show that they form heterogeneous ring-like structures, potentially acting as large scaffolds for histone assembly and exchange.	[Newman, Emily R.; Kneale, G. Geoff; McGeehan, John E.] Univ Portsmouth, Sch Biol Sci, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England; [Ravelli, Raimond B. G.; Karuppasamy, Manikandan; Nejadasl, Fatemeh Karimi] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Taylor, Ian A.] MRC Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England	University of Portsmouth; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; MRC National Institute for Medical Research	McGeehan, JE (corresponding author), Univ Portsmouth, Sch Biol Sci, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DY, Hants, England.	john.mcgeehan@port.ac.uk	Karuppasamy, Manikandan/D-2053-2014	McGeehan, John/0000-0002-6750-1462; Ravelli, Raimond/0000-0001-6056-5888	Research Councils UK fellowship; University of Portsmouth Institute of Biomedical and Biomolecular Science bursary; Netherlands Organisation for Scientific Research [016.072.321]; MRC [MC_U117565647] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; Medical Research Council [MC_U117565647] Funding Source: researchfish	Research Councils UK fellowship(UK Research & Innovation (UKRI)); University of Portsmouth Institute of Biomedical and Biomolecular Science bursary; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Research Councils UK fellowship (to J. E. M.), a University of Portsmouth Institute of Biomedical and Biomolecular Science bursary (to E. R. N.), and Netherlands Organisation for Scientific Research Project 016.072.321 (to R. B. G. R., M. K., and F. K. N.).	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; De Carlo S, 2010, METHOD ENZYMOL, V481, P127, DOI 10.1016/S0076-6879(10)81006-7; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friedeberg C., 2005, THESIS U PORTSMOUTH; Friedeberg C, 2006, NUCLEIC ACIDS RES, V34, P4893, DOI 10.1093/nar/gkl434; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gill J, 2009, J BIOL CHEM, V284, P10076, DOI 10.1074/jbc.M808633200; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; ISHIMI Y, 1983, J BIOCHEM-TOKYO, V94, P735, DOI 10.1093/oxfordjournals.jbchem.a134414; Ito T, 1996, MOL CELL BIOL, V16, P3112; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; Karuppasamy M, 2011, J SYNCHROTRON RADIAT, V18, P398, DOI 10.1107/S090904951100820X; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krogan NJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-313; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McBryant SJ, 2004, BIOCHEMISTRY-US, V43, P10592, DOI 10.1021/bi035881b; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Noda M, 2011, BIOCHEM J, V436, P101, DOI 10.1042/BJ20102063; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Park YJ, 2008, J MOL BIOL, V375, P1076, DOI 10.1016/j.jmb.2007.11.031; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Santos SF, 2003, J COLLOID INTERF SCI, V262, P400, DOI 10.1016/S0021-9797(03)00109-7; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	48	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26657	26665		10.1074/jbc.M112.340422	http://dx.doi.org/10.1074/jbc.M112.340422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707715	Green Published, hybrid			2022-12-28	WOS:000307386000017
J	Buchthal, B; Lau, D; Weiss, U; Weislogel, JM; Bading, H				Buchthal, Bettina; Lau, David; Weiss, Ursula; Weislogel, Jan-Marek; Bading, Hilmar			Nuclear Calcium Signaling Controls Methyl-CpG-binding Protein 2 (MeCP2) Phosphorylation on Serine 421 following Synaptic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; DNA METHYLATION; RETT-SYNDROME; KINASE-II; BDNF TRANSCRIPTION; MEMORY FORMATION; NMDA RECEPTORS; BRAIN; IDENTIFICATION	The function of MeCP2, a methylated DNA-interacting protein that may act as a global chromatin modifier, is controlled by its phosphorylation on serine 421. Here we show that in hippocampal neurons, nuclear calcium signaling controls synaptic activity-induced phosphorylation of MeCP2 on serine 421. Pharmacological inhibition of calcium/calmodulin-dependent protein (CaM) kinases blocked activity-induced MeCP2 serine 421 phosphorylation. CaM kinase II (CaMKII) but not CaMKIV, the major nuclear CaM kinase in hippocampal neurons, appeared to mediate this phosphorylation event. Biochemical subcellular fractionations and immunolocalization studies revealed that several isoforms of CaMKII (i.e. CaMKII alpha, -beta, -gamma, and -delta) are expressed in the cytosol but are also detectable in the cell nucleus of hippocampal neurons, suggesting that nuclear CaMKII catalyzes MeCP2 serine 421 phosphorylation. Thus, in addition to the classical nuclear calcium-CaMKIV-CREB/CBP (cAMP-response element-binding protein/CREB-binding protein) pathway that regulates transcription of specific target genes, nuclear calcium may also modulate genome-wide the chromatin state in response to synaptic activity via nuclear CaMKII-MeCP2 signaling.	[Bading, Hilmar] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; Univ Heidelberg, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de			Deutsche Forschungsgemeinschaft (DFG); Alexander von Humboldt Foundation; European Research Council Advanced Grant; Sonderforschungsbereich (SFB) of the DFG [488, SFB 636]; Graduate Academy (Excellence Initiative) of Heidelberg University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council Advanced Grant(European Research Council (ERC)); Sonderforschungsbereich (SFB) of the DFG(German Research Foundation (DFG)); Graduate Academy (Excellence Initiative) of Heidelberg University	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), the Alexander von Humboldt Foundation (Wolfgang Paul Prize to H. B.), an European Research Council Advanced Grant (to H. B.), the Sonderforschungsbereich (SFB) 488 and SFB 636 of the DFG, and the Graduate Academy (Excellence Initiative) of Heidelberg University.	Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mishra S, 2011, CIRC RES, V109, P1354, DOI 10.1161/CIRCRESAHA.111.248401; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; SIHRA TS, 1995, NEUROPHARMACOLOGY, V34, P731, DOI 10.1016/0028-3908(95)00051-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Takeuchi Y, 1999, J NEUROCHEM, V72, P815, DOI 10.1046/j.1471-4159.1999.0720815.x; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30967	30974		10.1074/jbc.M112.382507	http://dx.doi.org/10.1074/jbc.M112.382507			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822052	Green Published, hybrid			2022-12-28	WOS:000308791300010
J	Egenberger, B; Gorboulev, V; Keller, T; Gorbunov, D; Gottlieb, N; Geiger, D; Mueller, TD; Koepsell, H				Egenberger, Brigitte; Gorboulev, Valentin; Keller, Thorsten; Gorbunov, Dmitry; Gottlieb, Neha; Geiger, Dietmar; Mueller, Thomas D.; Koepsell, Hermann			A Substrate Binding Hinge Domain Is Critical for Transport-related Structural Changes of Organic Cation Transporter 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSE COTRANSPORTER; HIGH-AFFINITY; AMINO-ACIDS; MEMBRANE CAPACITANCE; RAT; GLUTAMATE; SELECTIVITY; ROCT1; SPECIFICITY; INHIBITORS	Organic cation transporters are membrane potential-dependent facilitative diffusion systems. Functional studies, extensive mutagenesis, and homology modeling indicate the following mechanism. A transporter conformation with a large outward-open cleft binds extracellular substrate, passes a state in which the substrate is occluded, turns to a conformation with an inward-open cleft, releases substrate, and subsequently turns back to the outward-open state. In the rat organic cation transporter (rOct1), voltage- and ligand-dependent movements of fluorescence-labeled cysteines were measured by voltage clamp fluorometry. For fluorescence detection, cysteine residues were introduced in extracellular parts of cleft-forming transmembrane alpha-helices (TMHs) 5, 8, and 11. Following expression of the mutants in Xenopus laevis oocytes, cysteines were labeled with tetramethylrhodamine-6-maleimide, and voltage-dependent conformational changes were monitored by voltage clamp fluorometry. One cysteine was introduced in the central domain of TMH 11 replacing glycine 478. This domain contains two amino acids that are involved in substrate binding and two glycine residues (Gly-477 and Gly-478) allowing for helix bending. Cys-478 could be modified with the transported substrate analog [2-(trimethylammonium)-ethyl]methanethiosulfonate but was inaccessible to tetramethylrhodamine-6-maleimide. Voltage-dependent movements at the indicator positions of TMHs 5, 8, and 11 were altered by substrate applications indicating large conformational changes during transport. The G478C exchange decreased transporter turnover and blocked voltage-dependent movements of TMHs 5 and 11. [2-(Trimethylammonium)-ethyl] methanethiosulfonate modification of Cys-478 blocked substrate binding, transport activity, and movement of TMH8. The data suggest that Gly-478 is located within a mechanistically important hinge domain of TMH 11 in which substrate binding induces transport-related structural changes.	[Egenberger, Brigitte; Gorboulev, Valentin; Keller, Thorsten; Gorbunov, Dmitry; Gottlieb, Neha; Koepsell, Hermann] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Geiger, Dietmar; Mueller, Thomas D.] Univ Wurzburg, Julius von Sachs Inst, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Koepsell, H (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany.	Hermann@Koepsell.de	Geiger, Dietmar/D-6914-2014; Gorbunov, Dmitry/F-2295-2014; Geiger, Dietmar/AAH-8140-2019	Geiger, Dietmar/0000-0003-0715-5710; Geiger, Dietmar/0000-0003-0715-5710; Mueller, Thomas/0000-0003-1862-7357; Keller, Thorsten/0000-0002-2897-5761	Deutsche Forschungsgemeinschaft [SFB 487/A4, KO 872/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants SFB 487/A4 and KO 872/6-1.	Budiman T, 2000, J BIOL CHEM, V275, P29413, DOI 10.1074/jbc.M004645200; Busch AE, 1996, J BIOL CHEM, V271, P32599, DOI 10.1074/jbc.271.51.32599; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; GRUNDEMANN D, 1994, ANAL BIOCHEM, V216, P459, DOI 10.1006/abio.1994.1069; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Kanner BI, 2005, NATURE, V437, P203, DOI 10.1038/437203a; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Koepsell H, 1999, J MEMBRANE BIOL, V167, P103, DOI 10.1007/s002329900475; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pelis RM, 2012, AM J PHYSIOL-RENAL, V303, pF313, DOI 10.1152/ajprenal.00038.2012; Perry JL, 2006, J BIOL CHEM, V281, P38071, DOI 10.1074/jbc.M608834200; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Schmitt BM, 2009, AM J PHYSIOL-RENAL, V296, pF709, DOI 10.1152/ajprenal.90323.2008; Schmitt BM, 2005, J BIOL CHEM, V280, P24481, DOI 10.1074/jbc.M414550200; Schmitt BM, 2002, BIOPHYS J, V82, P1345, DOI 10.1016/S0006-3495(02)75490-8; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Valentin M, 2000, BBA-BIOMEMBRANES, V1468, P367, DOI 10.1016/S0005-2736(00)00277-7; Vernaleken A, 2007, J BIOL CHEM, V282, P28501, DOI 10.1074/jbc.M705416200; VEYHL M, 1993, J BIOL CHEM, V268, P25041; Volk C, 2003, MOL PHARMACOL, V64, P1037, DOI 10.1124/mol.64.5.1037; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200	35	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31561	31573		10.1074/jbc.M112.388793	http://dx.doi.org/10.1074/jbc.M112.388793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810231	Green Published, hybrid			2022-12-28	WOS:000308791300068
J	Long, JM; Ray, B; Lahiri, DK				Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.			MicroRNA-153 Physiologically Inhibits Expression of Amyloid-beta Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY VARIANT; MESSENGER-RNA; ALPHA-SYNUCLEIN; POSTTRANSCRIPTIONAL REGULATION; 5'-UNTRANSLATED REGION; 3-UNTRANSLATED REGION; TARGET PREDICTION; COGNITIVE DECLINE; STEM-CELLS; GENE	Regulation of amyloid-beta (A beta) precursor protein (APP) expression is complex. MicroRNAs (miRNAs) are expected to participate in the molecular network that controls this process. The composition of this network is, however, still undefined. Elucidating the complement of miRNAs that regulate APP expression should reveal novel drug targets capable of modulating A beta production in AD. Here, we investigated the contribution of miR-153 to this regulatory network. A miR-153 target site within the APP 3'-untranslated region (3'-UTR) was predicted by several bioinformatic algorithms. We found that miR-153 significantly reduced reporter expression when co-transfected with an APP 3'-UTR reporter construct. Mutation of the predicted miR-153 target site eliminated this reporter response. miR-153 delivery in both HeLa cells and primary human fetal brain cultures significantly reduced APP expression. Delivery of a miR-153 antisense inhibitor to human fetal brain cultures significantly elevated APP expression. miR-153 delivery also reduced expression of the APP paralog APLP2. High functional redundancy between APP and APLP2 suggests that miR-153 may target biological pathways in which they both function. Interestingly, in a subset of human AD brain specimens with moderate AD pathology, miR-153 levels were reduced. This same subset also exhibited elevated APP levels relative to control specimens. Therefore, endogenous miR-153 inhibits expression of APP in human neurons by specifically interacting with the APP 3'-UTR. This regulatory interaction may have relevance to AD etiology, where low miR-153 levels may drive increased APP expression in a subset of AD patients.	[Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lahiri, DK (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 791 Union Dr, Indianapolis, IN 46202 USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020	Long, Justin/0000-0003-0769-604X	National Institutes of Health [AG18379, AG18884]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG018379, R01AG018884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG18379 and AG18884 (to D. K. L.). This work was also supported by the Alzheimer's Association (Zenith award and investigator-initiated research grant).	Baba M, 1998, AM J PATHOL, V152, P879; Bao BL, 2012, J NUTR BIOCHEM, V23, P635, DOI 10.1016/j.jnutbio.2011.03.007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; DESAUVAGE F, 1992, EMBO J, V11, P3099, DOI 10.1002/j.1460-2075.1992.tb05382.x; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FORSTL H, 1993, BRIT J PSYCHIAT, V162, P385, DOI 10.1192/bjp.162.3.385; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; HANSEN L, 1990, NEUROLOGY, V40, P1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heyman A, 1999, NEUROLOGY, V52, P1839, DOI 10.1212/WNL.52.9.1839; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kraybill ML, 2005, NEUROLOGY, V64, P2069, DOI 10.1212/01.WNL.0000165987.89198.65; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; LAHIRI DK, 1991, MOL BRAIN RES, V9, P253, DOI 10.1016/0169-328X(91)90009-M; Lahiri DK, 2005, FASEB J, V19, P653, DOI 10.1096/fj.04-2900fje; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lesne S, 2003, J BIOL CHEM, V278, P18408, DOI 10.1074/jbc.M300819200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Long JM, 2011, CURR MED CHEM, V18, P3314, DOI 10.2174/092986711796504592; Long JM, 2012, EXP NEUROL, V235, P402, DOI 10.1016/j.expneurol.2011.12.043; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Mbella EGM, 2000, MOL CELL BIOL, V20, P4572, DOI 10.1128/MCB.20.13.4572-4579.2000; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukaetova-Ladinska EB, 2009, THESCIENTIFICWORLDJO, V9, P1463, DOI 10.1100/tsw.2009.151; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; QUITSCHKE WW, 1992, J BIOL CHEM, V267, P17362; Rajagopalan LE, 1998, NUCLEIC ACIDS RES, V26, P3418, DOI 10.1093/nar/26.14.3418; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007	91	139	148	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31298	31310		10.1074/jbc.M112.366336	http://dx.doi.org/10.1074/jbc.M112.366336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22733824	hybrid, Green Published			2022-12-28	WOS:000308791300041
J	Mignot, I; Pecqueur, L; Dorleans, A; Karuppasamy, M; Ravelli, RBG; Dreier, B; Pluckthun, A; Knossow, M; Gigant, B				Mignot, Ingrid; Pecqueur, Ludovic; Dorleans, Audrey; Karuppasamy, Manikandan; Ravelli, Raimond B. G.; Dreier, Birgit; Plueckthun, Andreas; Knossow, Marcel; Gigant, Benoit			Design and Characterization of Modular Scaffolds for Tubulin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATHMIN FAMILY PROTEINS; MICROTUBULE; COMPLEX; RECOGNIZE; ALIGNMENT; DYNAMICS; BIND; CAPS	In cells, microtubule dynamics is regulated by stabilizing and destabilizing factors. Whereas proteins in both categories have been identified, their mechanism of action is rarely understood at the molecular level. This is due in part to the difficulties faced in structural approaches to obtain atomic models when tubulin is involved. Here, we design and characterize new stathmin-like domain (SLD) proteins that sequester tubulins in numbers different from two, the number of tubulins bound by stathmin or by the SLD of RB3, two stathmin family members that have been extensively studied. We established rules for the design of tight tubulin-SLD assemblies and applied them to complexes containing one to four tubulin heterodimers. Biochemical and structural experiments showed that the engineered SLDs behaved as expected. The new SLDs will be tools for structural studies of microtubule regulation. The larger complexes will be useful for cryo-electron microscopy, whereas crystallography or nuclear magnetic resonance will benefit from the 1: 1 tubulin-SLD assembly. Finally, our results provide new insight into SLD function, suggesting that a major effect of these phosphorylatable proteins is the programmed release of sequestered tubulin for microtubule assembly at the specific cellular locations of members of the stathmin family.	[Mignot, Ingrid; Pecqueur, Ludovic; Dorleans, Audrey; Knossow, Marcel; Gigant, Benoit] CNRS, LEBS, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Karuppasamy, Manikandan; Ravelli, Raimond B. G.] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Dreier, Birgit; Plueckthun, Andreas] Univ Zurich, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich	Gigant, B (corresponding author), CNRS, LEBS, Ctr Rech Gif, Bat 34,1 Av Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr	Plückthun, Andreas/C-2746-2009; Karuppasamy, Manikandan/D-2053-2014	Plückthun, Andreas/0000-0003-4191-5306; Ravelli, Raimond/0000-0001-6056-5888; Gigant, Benoit/0000-0002-5946-6759; Pecqueur, Ludovic/0000-0002-0396-699X	Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale [DEQ20081213979]; Netherlands Organisation For Scientific Research [016.072.321]; Agence Nationale de la Recherche [ANR-09-BLAN-0071]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Netherlands Organisation For Scientific Research(Netherlands Organization for Scientific Research (NWO)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche Grant ANR-09-BLAN-0071 and the Fondation pour la Recherche Medicale Grant DEQ20081213979.; Supported by The Netherlands Organisation For Scientific Research, Project 016.072.321.	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; Bricogne G., 2011, BUSTER VERSION 2 8 0; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2002, FEBS LETT, V529, P341, DOI 10.1016/S0014-5793(02)03421-X; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dorleans Audrey, 2007, Methods Mol Med, V137, P235, DOI 10.1007/978-1-59745-442-1_16; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Frank J, 2006, 3 DIMENSIONAL ELECT, P139; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastritis PL, 2011, PROTEIN SCI, V20, P482, DOI 10.1002/pro.580; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krouglova T, 2003, FEBS LETT, V546, P365, DOI 10.1016/S0014-5793(03)00636-7; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Segerman B, 2000, J BIOL CHEM, V275, P35759, DOI 10.1074/jbc.M005875200; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	45	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31085	31094		10.1074/jbc.M112.383869	http://dx.doi.org/10.1074/jbc.M112.383869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791712	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308791300021
J	Dogra, N; Mukhopadhyay, T				Dogra, Nilambra; Mukhopadhyay, Tapas			Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells A NOVEL ANTIPROLIFERATIVE AGENT WITH A POTENTIAL THERAPEUTIC IMPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PANCREATIC-CANCER CELLS; CYTOCHROME-C RELEASE; MULTIPLE-MYELOMA; ER STRESS; CASPASE ACTIVATION; LUNG-CANCER; IN-VITRO; APOPTOSIS; INHIBITION	In recent years, there has been a great deal of interest in proteasome inhibitors as a novel class of anticancer drugs. We report that fenbendazole (FZ) (methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate) exhibits a potent growth-inhibitory activity against cancer cell lines but not normal cells. We show here, using fluorogenic substrates, that FZ treatment leads to the inhibition of proteasomal activity in the cells. Succinyl-Leu-Leu-Val-Tyr-methylcoumarinamide (MCA), benzyloxycarbonyl-Leu-Leu-Glu-7-amido-4-MCA, and t-butoxycarbonyl-Gln-Ala-Arg-7-amido-4-MCA fluorescent derivatives were used to assess chymotrypsin-like, post-glutamyl peptidyl-hydrolyzing, and trypsin-like protease activities, respectively. Non-small cell lung cancer cells transiently transfected with an expression plasmid encoding pd1EGFP and treated with FZ showed an accumulation of the green fluorescent protein in the cells due to an increase in its half-life. A number of apoptosis regulatory proteins that are normally degraded by the ubiquitin-proteasome pathway like cyclins, p53, and I kappa B alpha were found to be accumulated in FZ-treated cells. In addition, FZ induced distinct ER stress-associated genes like GRP78, GADD153, ATF3, IRE1 alpha, and NOXA in these cells. Thus, treatment of human NSCLC cells with fenbendazole induced endoplasmic reticulum stress, reactive oxygen species production, decreased mitochondrial membrane potential, and cytochrome c release that eventually led to cancer cell death. This is the first report to demonstrate the inhibition of proteasome function and induction of endoplasmic reticulum stress/reactive oxygen species-dependent apoptosis in human lung cancer cell lines by fenbendazole, which may represent a new class of anticancer agents showing selective toxicity against cancer cells.	[Dogra, Nilambra; Mukhopadhyay, Tapas] Panjab Univ, Natl Ctr Human Genome Studies & Res, Chandigarh 160014, India	Panjab University	Mukhopadhyay, T (corresponding author), Panjab Univ, Natl Ctr Human Genome Studies & Res, Pharm Extens Block, Chandigarh 160014, India.	tmukhopa@pu.ac.in			University Grants Commission; Indian Council of Agricultural Research, Government of India; Council of Scientific and Industrial Research, Government of India	University Grants Commission(University Grants Commission, India); Indian Council of Agricultural Research, Government of India(Indian Council of Agricultural Research (ICAR)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the University Grants Commission and Indian Council of Agricultural Research, Government of India (to T. M.).; Supported by a research fellowship from the Council of Scientific and Industrial Research, Government of India.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; AMMANN RW, 1994, HEPATOLOGY, V19, P735, DOI 10.1002/hep.1840190328; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Eckert J, 2000, INT J PARASITOL, V30, P1283, DOI 10.1016/S0020-7519(00)00130-2; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; El-On J, 2003, ACTA TROP, V85, P243, DOI 10.1016/S0001-706X(02)00217-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Gao P, 2008, J AM ASSOC LAB ANIM, V47, P37; GOLD R, 1994, LAB INVEST, V71, P219; GULL K, 1987, BIOCHEM SOC T, V15, P59, DOI 10.1042/bst0150059; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; LACEY E, 1985, BIOCHEM PHARMACOL, V34, P1073, DOI 10.1016/0006-2952(85)90611-2; LACEY E, 1994, ACTA TROP, V56, P245, DOI 10.1016/0001-706X(94)90066-3; LACLETTE JP, 1980, BIOCHEM BIOPH RES CO, V92, P417, DOI 10.1016/0006-291X(80)90349-6; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lomonosova E, 2009, MOL CANCER RES, V7, P1268, DOI 10.1158/1541-7786.MCR-08-0183; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; MARRINER SE, 1986, EUR J CLIN PHARMACOL, V30, P705, DOI 10.1007/BF00608219; Maxwell SA, 1995, GENE, V166, P339, DOI 10.1016/0378-1119(95)00578-1; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Morris DL, 2001, ONCOLOGY-BASEL, V61, P42, DOI 10.1159/000055351; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; MULLER E, 1982, HEPATO-GASTROENTEROL, V29, P236; Nakamura S, 2002, ONCOGENE, V21, P2102, DOI 10.1038/sj.onc.1205251; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Pourgholami MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-143; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Robinson MW, 2004, J MOL GRAPH MODEL, V23, P275, DOI 10.1016/j.jmgm.2004.08.001; Sasaki J, 2002, MOL CANCER THER, V1, P1201; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Williamson MJ, 2009, MOL CANCER THER, V8, P3234, DOI 10.1158/1535-7163.MCT-09-0239; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	58	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30625	30640		10.1074/jbc.M111.324228	http://dx.doi.org/10.1074/jbc.M111.324228			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22745125	hybrid, Green Published			2022-12-28	WOS:000308579800053
J	Santostefano, KE; Hamazaki, T; Pardo, CE; Kladde, MP; Terada, N				Santostefano, Katherine E.; Hamazaki, Takashi; Pardo, Carolina E.; Kladde, Michael P.; Terada, Naohiro			Fibroblast Growth Factor Receptor 2 Homodimerization Rapidly Reduces Transcription of the Pluripotency Gene Nanog without Dissociation of Activating Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE ENDODERM; CELLS; METHYLATION; CHROMATIN; EPIBLAST; ELEMENT	Nanog or Gata6-positive cells co-exist and are convertible within the inner cell mass of murine blastocysts and embryonic stem (ES) cells. Previous studies demonstrate fibroblast growth factor receptor 2 (FGFR2) triggers Nanog gene down-regulation and differentiation to primitive endoderm (PE); however, the underlying mechanisms responsible for reversible and fluctuating cell fate are poorly understood. Using an inducible FGFR2 dimerization system in ES cells, we demonstrate that FGFR2 activation rapidly down-regulated Nanog gene transcription through activation of the Mek pathway and subsequently differentiated ES cells into PE cells. FGFR2 rather selectively repressed the Nanog gene with minimal effect on other pluripotency genes, including Oct4 and Sox2. We determined the Nanog promoter region containing minimum Oct4/Sox2 binding sites was sufficient for this transcriptional down-regulation by FGFR2, when the reporter transgenes were integrated with insulators. Of interest, FGFR2-mediated Nanog transcriptional reduction occurred without dissociation of RNA polymerase II, p300, Oct4, Sox2, and Tet1 from the Nanog proximal promoter region and with no increase in repressive histone methylation marks or DNA methylation, implying the gene repression is in the early and transient phase. Furthermore, addition of a specific FGFR inhibitor readily reversed this Nanog repression status. These findings illustrate well how FGFR2 induces rapid but reversible Nanog repression within ES cells.	[Santostefano, Katherine E.; Hamazaki, Takashi; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Pardo, Carolina E.; Kladde, Michael P.] Univ Florida, Coll Med, Dept Biochem, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Terada, N (corresponding author), Univ Florida, Coll Med, Dept Pathol, POB 100275, Gainesville, FL 32610 USA.	terada@pathology.ufl.edu			National Institutes of Health [DK059699, GM091238, T32 CA009126]; NATIONAL CANCER INSTITUTE [R01CA155390, T32CA009126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants DK059699 and GM091238 (to N. T.).; Recipient of Predoctoral Fellowship T32 CA009126 from the National Institutes of Health.	Alfa RW, 2009, J NEUROSCI RES, V87, P2624, DOI 10.1002/jnr.22101; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Brower JV, 2009, BBA-GENE REGUL MECH, V1789, P198, DOI 10.1016/j.bbagrm.2008.12.005; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Darst RP, 2012, METHODS MOL BIOL, V833, P125, DOI 10.1007/978-1-61779-477-3_9; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Xian W, 2009, CANCER RES, V69, P2244, DOI 10.1158/0008-5472.CAN-08-3398; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138	32	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30507	30517		10.1074/jbc.M112.388181	http://dx.doi.org/10.1074/jbc.M112.388181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787153	Green Published, hybrid			2022-12-28	WOS:000308579800043
J	Emberley, ED; Mosadeghi, R; Deshaies, RJ				Emberley, Ethan D.; Mosadeghi, Ruzbeh; Deshaies, Raymond J.			Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; COMPLEX; CANCER; ACTIVATION; DEGRADATION; INSIGHTS; CLEAVAGE; MOTIF; CONJUGATION; PROGRESSION	COP9 signalosome (CSN) mediates deconjugation of the ubiquitin-like protein Nedd8 from the cullin subunits of SCF and other cullin-RING ubiquitin ligases (CRLs). This process is essential to maintain the proper activity of CRLs in cells. Here, we report a detailed kinetic characterization of CSN-mediated deconjugation of Nedd8 from SCF. CSN is an efficient enzyme, with a k(cat) of similar to 1 s(-1) and K-m for neddylated Cul1-Rbx1 of similar to 200 nM, yielding a k(cat)/K-m near the anticipated diffusion-controlled limit. Assembly with an F-box-Skp1 complex markedly inhibited deneddylation, although the magnitude varied considerably, with Fbw7-Skp1 inhibiting by similar to 5-fold but Skp2-Cks1-Skp1 by only similar to 15%. Deneddylation of both SCFFbw7 and SCFSkp2-Cks1 was further inhibited similar to 2.5-fold by the addition of substrate. Combined, the inhibition by Fbw7-Skp1 plus its substrate cyclin E was greater than 10-fold. Unexpectedly, our results also uncover significant product inhibition by deconjugated Cul1, which results from the ability of Cul1 to bind tightly to CSN. Reciprocally, CSN inhibits the ubiquitin ligase activity of deneddylated Cul1. We propose a model in which assembled CRL complexes engaged with substrate are normally refractory to deneddylation. Upon consumption of substrate and subsequent deneddylation, CSN can remain stably bound to the CRL and hold it in low state of reduced activity.	[Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health [GM065997]; Canadian Institutes of Health Research postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA164803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065997.; Supported in part by a Canadian Institutes of Health Research postdoctoral fellowship.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Helmstaedt K, 2011, MOL BIOL CELL, V22, P153, DOI 10.1091/mbc.E10-08-0732; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Min KW, 2005, BIOCHEM BIOPH RES CO, V334, P867, DOI 10.1016/j.bbrc.2005.06.188; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SPILBURG CA, 1977, BIOCHEMISTRY-US, V16, P1142, DOI 10.1021/bi00625a018; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Yamoah K, 2005, METHOD ENZYMOL, V398, P509, DOI 10.1016/S0076-6879(05)98042-7; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	55	84	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29679	29689		10.1074/jbc.M112.352484	http://dx.doi.org/10.1074/jbc.M112.352484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767593	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308286900044
J	Lisa-Santamaria, P; Jimenez, A; Revuelta, JL				Lisa-Santamaria, Patricia; Jimenez, Alberto; Revuelta, Jose L.			The Protein Factor-arrest 11 (Far11) Is Essential for the Toxicity of Human Caspase-10 in Yeast and Participates in the Regulation of Autophagy and the DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATG1 KINASE COMPLEX; SACCHAROMYCES-CEREVISIAE; FAMILY PROTEINS; APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; PATHWAYS; DEATH; TOR; CROSSTALK	The heterologous expression of human caspase-10 in Saccharomyces cerevisiae induces a lethal phenotype, which includes some hallmarks of apoptosis and autophagy, alterations in the intra-S checkpoint, and cell death. To determine the cellular processes and pathways that are responsible of the caspase-10-induced cell death we have designed a loss-of-function screening system to identify genes that are essential for the lethal phenotype. We observed that the ER-Golgi-localized family of proteins Far, MAPK signaling, the autophagy machinery, and several kinases and phosphatases are essential for caspase-10 toxicity. We also found that the expression of caspase-10 elicits a simultaneous activation of the MAP kinases Fus3, Kss1, and Slt2. Furthermore, the protein Far11, which is a target of MAP kinases, is essential for the dephosphorylation of Atg13 and, consequently, for the induction of autophagy. In addition, Far11 participates in the regulation of the DNA damage response through the dephosphorylation of Rad53. Finally, we have also demonstrated that Far11 is able to physically interact with the phosphatases Pph21, Pph22, and Pph3. Overall, our results indicate that the expression of human caspase-10 in S. cerevisiae activates an intracellular death signal that depends on the Far protein complex and that Far11 may function as a regulator subunit of phosphatases in different processes, thus representing a mechanistic link between them.	[Jimenez, Alberto] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37007 Salamanca, Spain; Univ Salamanca, CSIC, Dept Microbiol & Genet, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca	Jimenez, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	alji@usal.es; revuelta@usal.es	Revuelta, Jose Luis/ABG-1502-2020; Jiménez, Alberto/A-6234-2009; Revuelta, Jose L/C-2324-2012	Revuelta, Jose Luis/0000-0001-7838-5308; Jiménez, Alberto/0000-0003-3685-6479; Revuelta, Jose L/0000-0001-7838-5308	Junta de Castilla y Leon Grants [SA008B08, GR147]; Ministerio de Ciencia y Innovacion [BIO2008-00194]; FPU predoctoral fellowship from Spanish Ministerio de Educacion y Ciencia	Junta de Castilla y Leon Grants(Junta de Castilla y Leon); Ministerio de Ciencia y Innovacion(Spanish Government); FPU predoctoral fellowship from Spanish Ministerio de Educacion y Ciencia(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG))	This work was supported in part by Junta de Castilla y Leon Grants SA008B08 (to A. J.) and GR147 (to J. L. R.) and Ministerio de Ciencia y Innovacion Grant BIO2008-00194.; Recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educacion y Ciencia.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Braun RJ, 2010, TRENDS BIOCHEM SCI, V35, P135, DOI 10.1016/j.tibs.2009.10.005; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Greenwood MT, 2010, CELL DEATH DIFFER, V17, P737, DOI 10.1038/cdd.2009.177; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lisa-Santamaria P, 2009, BBA-MOL CELL RES, V1793, P561, DOI 10.1016/j.bbamcr.2008.12.016; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puryer MA, 2006, APOPTOSIS, V11, P509, DOI 10.1007/s10495-006-5114-2; Rodriguez-Pachon JM, 2002, J BIOL CHEM, V277, P27094, DOI 10.1074/jbc.M201527200; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stephan JS, 2010, AUTOPHAGY, V6, P294, DOI 10.4161/auto.6.2.11129; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	56	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29636	29647		10.1074/jbc.M112.344192	http://dx.doi.org/10.1074/jbc.M112.344192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782902	hybrid, Green Published			2022-12-28	WOS:000308286900039
J	Scott, NE; Nothaft, H; Edwards, AVG; Labbate, M; Djordjevic, SP; Larsen, MR; Szymanski, CM; Cordwell, SJ				Scott, Nichollas E.; Nothaft, Harald; Edwards, Alistair V. G.; Labbate, Maurizio; Djordjevic, Steven P.; Larsen, Martin R.; Szymanski, Christine M.; Cordwell, Stuart J.			Modification of the Campylobacter jejuni N-Linked Glycan by EptC Protein-mediated Addition of Phosphoethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIUM; NEISSERIA-GONORRHOEAE; GLYCOSYLATION PATHWAY; MASS-SPECTROMETRY; ESCHERICHIA-COLI; IV PILI; POSTTRANSLATIONAL MODIFICATION; CHEMICAL-STRUCTURE; IDENTIFICATION; LIPOPOLYSACCHARIDE	Campylobacter jejuni is the major worldwide cause of bacterial gastroenteritis. C. jejuni possesses an extensive repertoire of carbohydrate structures that decorate both protein and nonprotein surface-exposed structures. An N-linked glycosylation system encoded by the pgl gene cluster mediates the synthesis of a rigidly conserved heptasaccharide that is attached to protein substrates or released as free oligosaccharide in the periplasm. Removal of N-glycosylation results in reduced virulence and impeded host cell attachment. Since the N-glycan is conserved, the N-glycosylation system is also an attractive option for glycoengineering recombinant vaccines in Escherichia coli. To determine whether non-canonical N-glycans are present in C. jejuni, we utilized high throughput glycoproteomics to characterize C. jejuni JHH1 and identified 93 glycosylation sites, including 34 not previously reported. Interrogation of these data allowed the identification of a phosphoethanolamine (pEtN)-modified variant of the N-glycan that was attached to multiple proteins. The pEtN moiety was attached to the terminal GalNAc of the canonical N-glycan. Deletion of the pEtN transferase eptC removed all evidence of the pEtN-glycan but did not globally influence protein reactivity to patient sera, whereas deletion of the pglB oligosaccharyltransferase significantly reduced reactivity. Transfer of eptC and the pgl gene cluster to E. coli confirmed the addition of the pEtN-glycan to a target C. jejuni protein. Significantly reduced, yet above background levels of pEtN-glycan were also observed in E. coli not expressing eptC, suggesting that endogenous E. coli pEtN transferases can mediate the addition of pEtN to N-glycans. The addition of pEtN must be considered in the context of glycoengineering and may alter C. jejuni glycan-mediated structure-function interactions.	[Scott, Nichollas E.; Cordwell, Stuart J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Scott, Nichollas E.; Cordwell, Stuart J.] Univ Sydney, Sch Med Sci, Discipline Pathol, Sydney, NSW 2006, Australia; [Scott, Nichollas E.; Nothaft, Harald; Szymanski, Christine M.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2E9, Canada; [Scott, Nichollas E.; Nothaft, Harald; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Edwards, Alistair V. G.; Larsen, Martin R.] Univ So Denmark, Dept Biochem & Mol Biol, Prot Res Grp, DK-5000 Odense, Denmark; [Labbate, Maurizio; Djordjevic, Steven P.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia	University of Sydney; University of Sydney; University of Alberta; University of Alberta; University of Southern Denmark; University of Technology Sydney	Cordwell, SJ (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg GO8, Sydney, NSW 2006, Australia.	stuart.cordwell@sydney.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013; Larsen, Martin Rossel/F-1411-2015	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Labbate, Maurizio/0000-0003-1428-3382; Larsen, Martin Rossel/0000-0001-6203-0123; Cordwell, Stuart/0000-0002-0995-0171; Scott, Nichollas/0000-0003-2556-8316	Australian Research Council [ARC DP110103573]; Australian Postgraduate Award; National Health and Medical Research Council of Australia Overseas (Biomedical) [APP1037373]	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council of Australia Overseas (Biomedical)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Discovery Project Grant ARC DP110103573 (to S. J. C.).; Supported by an Australian Postgraduate Award and a current National Health and Medical Research Council of Australia Overseas (Biomedical) Fellow (APP1037373).	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Anonsen JH, 2012, INFECT IMMUN, V80, P22, DOI 10.1128/IAI.05920-11; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Davis Lindsay, 2008, Curr Protoc Microbiol, VChapter 8, DOI [10.1002/9780471729259.mc08a01s10, 10.1002/9780471729259.mc08a02s10]; Ding W, 2009, MOL CELL PROTEOMICS, V8, P2170, DOI 10.1074/mcp.M900088-MCP200; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gilbert M, 2008, CAMPYLOBACTER, 3RD EDITION, P483; Glover KJ, 2006, BIOCHEMISTRY-US, V45, P5343, DOI 10.1021/bi0602056; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; Hanniffy OM, 2001, CARBOHYD RES, V330, P223, DOI 10.1016/S0008-6215(00)00281-0; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; Hannu T, 2004, J RHEUMATOL, V31, P528; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Howard SL, 2009, INFECT IMMUN, V77, P2544, DOI 10.1128/IAI.01425-08; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Ihssen J, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-61; Karlyshev AV, 2008, CAMPYLOBACTER, 3RD EDITION, P505; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Karlyshev AV, 2004, MICROBIOL-SGM, V150, P1957, DOI 10.1099/mic.0.26721-0; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Konkel M E, 2001, Curr Issues Intest Microbiol, V2, P55; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Nothaft H, 2008, CAMPYLOBACTER, 3RD EDITION, P447; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Pawelec D, 1998, LETT APPL MICROBIOL, V26, P69, DOI 10.1046/j.1472-765X.1998.00276.x; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Reid CW, 2008, ANAL CHEM, V80, P5468, DOI 10.1021/ac800079r; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Scott NE, 2009, J PROTEOME RES, V8, P4654, DOI 10.1021/pr900544x; Snelling WJ, 2005, LETT APPL MICROBIOL, V41, P297, DOI 10.1111/j.1472-765X.2005.01788.x; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Stimson E, 1996, BIOCHEM J, V316, P29, DOI 10.1042/bj3160029; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; van Sorge NM, 2009, CELL MICROBIOL, V11, P1768, DOI 10.1111/j.1462-5822.2009.01370.x; Vijayakumar S, 2006, J BIOL CHEM, V281, P27733, DOI 10.1074/jbc.M511714200; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wenzel CQ, 2010, J BACTERIOL, V192, P208, DOI 10.1128/JB.00558-09; Wyszynska A, 2007, ACTA BIOCHIM POL, V54, P143; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	65	53	53	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29384	29396		10.1074/jbc.M112.380212	http://dx.doi.org/10.1074/jbc.M112.380212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761430	hybrid, Green Published			2022-12-28	WOS:000308286900017
J	Yoon, SH; Lee, YD; Ha, J; Lee, Y; Kim, HH				Yoon, Soo-Hyun; Lee, Yong Deok; Ha, Jeongim; Lee, Youngkyun; Kim, Hong-Hee			TLT-1s, Alternative Transcripts of Triggering Receptor Expressed on Myeloid Cell-like Transcript-1 (TLT-1), Inhibits the Triggering Receptor Expressed on Myeloid Cell-2 (TREM-2)-mediated Signaling Pathway during Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREM-LIKE TRANSCRIPT-1; CUTTING EDGE; FAMILY; ITAM; IMMUNORECEPTOR; RESORPTION; PROTEINS; KINASE; MICE	Triggering receptor expressed on myeloid cells (TREM)-like transcript-1 (TLT-1) is an immunoreceptor tyrosine-based inhibitory motif (ITIM)-baring TREM family protein. In this study, we identified an alternative transcript form of TLT-1, namely TLT-1s, which has very short extracellular immunoglobulin domain consisting of only 202 amino acids. TLT-1s was mainly expressed in macrophages and osteoclast precursor cells. Upon receptor activator of nuclear factor-kappa B ligand stimulation, TLT-1s mRNA and protein levels were gradually decreased in BMMs. We also showed the TLT-1s is localized to the cytoplasmic membrane in osteoclast precursor cells. TLT-1s silencing strongly enhanced the formation and resorption activity of osteoclast. In addition, forced expression of TLT-1s showed reduced formation of osteoclast. Because ITIM-baring proteins inhibit immunoreceptor tyrosine-based activation motif (ITAM)-mediated receptor signaling, we tested whether TLT-1s physically interacted with TREM-2, the ITAM-associated co-stimulatory receptor essential for osteoclast differentiation. We showed that TLT-1s is associated with TREM-2 in osteoclast precursor cells. TLT-1s is also associated with tyrosine Src homology 2 domain-containing phosphatase-1 and SH2 domain-containing inositol phosphatase-1 and recruited them to the TREM2-ITAM signaling complex. In addition, knockdown of TLT-1s markedly elevated the intracellular calcium concentration and oscillation in osteoclast precursor cells. In addition, calcium-mediated induction of nuclear factor of activated T cells was also increased by TLT-1s silencing. Furthermore, TREM-2-mediated Akt activation and proliferation of osteoclast precursor cells were also enhanced in TLT-1s silenced cells. In this paper, we found the noble ITIM-baring inhibitory membrane protein; TLT-1s, which regulates ITAM-mediated signaling on osteoclastogenesis.	[Yoon, Soo-Hyun; Lee, Yong Deok; Ha, Jeongim; Kim, Hong-Hee] Seoul Natl Univ, Dept Cell & Dev Biol, BK21, Seoul, South Korea; [Lee, Youngkyun] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Taegu 700422, South Korea; [Yoon, Soo-Hyun; Lee, Yong Deok; Ha, Jeongim; Kim, Hong-Hee] Seoul Natl Univ, DRI, Seoul, South Korea	Seoul National University (SNU); Kyungpook National University; Seoul National University (SNU)	Kim, HH (corresponding author), Seoul Natl Univ, Dept Cell & Dev Biol, BK21, Seoul, South Korea.	hhbkim@snu.ac.kr			21C Frontier Functional Proteomics Project Grant [FPR08B1-170]; Science Research Center Grant [2009-0063269]	21C Frontier Functional Proteomics Project Grant; Science Research Center Grant	This work was supported by 21C Frontier Functional Proteomics Project Grant FPR08B1-170 and Science Research Center Grant 2009-0063269.	Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Chang EJ, 2008, J CELL SCI, V121, P2555, DOI 10.1242/jcs.028217; Chung DH, 2002, EUR J IMMUNOL, V32, P59, DOI 10.1002/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Hayashi M, 2010, BIOCHEM BIOPH RES CO, V393, P432, DOI 10.1016/j.bbrc.2010.02.013; Kim HJ, 2007, MOL PHARMACOL, V72, P418, DOI 10.1124/mol.107.034173; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; Zou W, 2010, J CELL SCI, V123, P2955, DOI 10.1242/jcs.069872	22	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29620	29626		10.1074/jbc.M112.351239	http://dx.doi.org/10.1074/jbc.M112.351239			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761415	Green Published, hybrid			2022-12-28	WOS:000308286900037
J	Hua, T; Wu, D; Ding, W; Wang, JY; Shaw, N; Liu, ZJ				Hua, Tian; Wu, Dong; Ding, Wei; Wang, Jiangyun; Shaw, Neil; Liu, Zhi-Jie			Studies of Human 2,4-Dienoyl CoA Reductase Shed New Light on Peroxisomal beta-Oxidation of Unsaturated Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYSTEROID DEHYDROGENASE; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURES; ACTIVE-SITE; OBESITY; EXPRESSION; CLONING; ENZYME	Peroxisomes play an essential role in maintaining fatty acid homeostasis. Although mitochondria are also known to participate in the catabolism of fatty acids via beta-oxidation, differences exist between the peroxisomal and mitochondrial beta-oxidation. Only peroxisomes, but not mitochondrion, can shorten very long chain fatty acids. Here, we describe the crystal structure of a ternary complex of peroxisomal 2,4-dienoyl CoA reductases (pDCR) with hexadienoyl CoA and NADP, as a prototype for comparison with the mitochondrial 2,4-dienoyl CoA reductase (mDCR) to shed light on the differences between the enzymes from the two organelles at the molecular level. Unexpectedly, the structure of pDCR refined to 1.84 angstrom resolution reveals the absence of the tyrosine-serine pair seen in the active site of mDCR, which together with a lysine and an asparagine have been deemed a hallmark of the SDR family of enzymes. Instead, aspartate hydrogen-bonded to the C alpha hydroxyl via a water molecule seems to perturb the water molecule for protonation of the substrate. Our studies provide the first structural evidence for participation of water in the DCR-catalyzed reactions. Biochemical studies and structural analysis suggest that pDCRs can catalyze the shortening of six-carbon-long substrates in vitro. However, the K-m values of pDCR for short chain acyl CoAs are at least 6-fold higher than those for substrates with 10 or more aliphatic carbons. Unlike mDCR, hinge movements permit pDCR to process very long chain polyunsaturated fatty acids.	[Shaw, Neil] Nankai Univ, Sch Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Hua, Tian; Wu, Dong; Ding, Wei; Wang, Jiangyun; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wu, Dong; Liu, Zhi-Jie] Kunming Med Univ, Inst Mol & Clin Med, Kunming 650500, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Kunming Medical University	Shaw, N (corresponding author), Nankai Univ, Sch Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China.	neilshaw@moon.ibp.ac.cn; zjliu@ibp.ac.cn	Wang, Jiangyun/J-4131-2012; Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893; wang, jiang yun/0000-0002-5974-1562; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [31070660, 31021062, 31000334]; Ministry of Science and Technology of China [2009DFB30310, 2009CB918803, 2011CB911103]; Chinese Academy of Sciences [YZ200839, KSCX2-EW-J-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31070660, 31021062, and 31000334; Ministry of Science and Technology of China Grants 2009DFB30310, 2009CB918803, 2011CB911103, and 2009CB918803; and Chinese Academy of Sciences Research Grants YZ200839 and KSCX2-EW-J-3.	Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; Berg J.M., 2002, FATTY ACID METABOLIS; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blomkalns AL, 2011, CHALLENGING AND EMERGING CONDITIONS IN EMERGENCY MEDICINE, P204; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferdinandusse S, 1999, BIOCHEM BIOPH RES CO, V263, P213, DOI 10.1006/bbrc.1999.1340; Fidaleo M, 2010, EXP TOXICOL PATHOL, V62, P615, DOI 10.1016/j.etp.2009.08.008; Fillgrove KL, 2000, BIOCHEMISTRY-US, V39, P7001, DOI 10.1021/bi0000566; Fillgrove KL, 2001, BIOCHEMISTRY-US, V40, P12412, DOI 10.1021/bi0111606; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kerner J., 2004, ENCY BIOL CHEM; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce M.L., 1971, LANCET, V297, P455; Penning TM, 1997, STEROIDS, V62, P101, DOI 10.1016/S0039-128X(96)00167-5; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Schulz H., 2002, NEW COMPREHENSIVE BI; Sobhi HF, 2010, ANAL BIOCHEM, V401, P114, DOI 10.1016/j.ab.2010.02.026; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stulnig TM, 2004, LIPIDS, V39, P1171, DOI 10.1007/s11745-004-1344-x; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; THOMASON SC, 1968, J CHEM EDUC, V45, P546, DOI 10.1021/ed045p546; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001; Yu WH, 2005, ARCH BIOCHEM BIOPHYS, V434, P195, DOI 10.1016/j.abb.2004.10.018	36	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28956	28965		10.1074/jbc.M112.385351	http://dx.doi.org/10.1074/jbc.M112.385351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745130	Green Published, hybrid			2022-12-28	WOS:000308074600064
J	Jeon, J; Leibiger, I; Moede, T; Walter, B; Faul, C; Maiguel, D; Villarreal, R; Guzman, J; Berggren, PO; Mundel, P; Ricordi, C; Merscher-Gomez, S; Fornoni, A				Jeon, Jongmin; Leibiger, Ingo; Moede, Tilo; Walter, Britta; Faul, Christian; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Berggren, Per-Olof; Mundel, Peter; Ricordi, Camillo; Merscher-Gomez, Sandra; Fornoni, Alessia			Dynamin-mediated Nephrin Phosphorylation Regulates Glucose-stimulated Insulin Release in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIT DIAPHRAGM; TYROSINE PHOSPHORYLATION; ACTIN REORGANIZATION; PROTEIN; KINASE; SECRETION; ENDOCYTOSIS; RECRUITMENT; EXPRESSION; COMPONENT	We have previously demonstrated a role for Nephrin in glucose stimulated insulin release (GSIR). We now hypothesize that Nephrin phosphorylation is required for GSIR and that Dynamin influences Nephrin phosphorylation and function. MIN6-C3 Nephrin-deficient pancreatic beta cells and human islets were transfected with WT-Nephrin or with a mutant Nephrin in which the tyrosine residues responsible for SH2 domain binding were substituted with phenylalanine (3YF-Nephrin). GSIR and live images of Nephrin and vesicle trafficking were studied. Immunoprecipitation experiments and overexpression of WT-Dynamin or dominant negative Dynamin mutant (K44A-Dynamin) in WT-Nephrin, 3YF-Nephrin, or Nephrin siRNA-transfected cells were utilized to study Nephrin-Dynamin interaction. In contrast to WT-Nephrin or to single tyrosine mutants, 3YF-Nephrin did not positively affect GSIR and led to impaired cell-cell contacts and vesicle trafficking. K44A-Dynamin prevented the effect of Nephrin on GSIR in the absence of protein-protein interaction between Nephrin and Dynamin. Nephrin gene silencing abolished the positive effects of WT-Dynamin on GSIR. The effects of protamine sulfate and vanadate on Nephrin phosphorylation and GSIR were studied in MIN6 cells and human islets. WT-Nephrin phosphorylation after glucose occurred at Tyr-1176/1193 and resulted in improved GSIR. On the contrary, protamine sulfate-induced phosphorylation at Tyr-1176/1193/1217 was associated with Nephrin degradation and impaired GSIR. Vanadate, which prevented Nephrin dephosphorylation after glucose stimulation, improved GSIR in human islets and MIN6 cells. In conclusion, Dynamin-dependent Nephrin phosphorylation occurs in response to glucose and is necessary for Nephrin-mediated augmentation of GSIR. Pharmacological modulation of Nephrin phosphorylation may thus facilitate pancreatic beta cell function.	[Jeon, Jongmin; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Berggren, Per-Olof; Ricordi, Camillo; Fornoni, Alessia] Univ Miami, L Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Jeon, Jongmin; Walter, Britta; Faul, Christian; Maiguel, Dony; Villarreal, Rodrigo; Guzman, Johanna; Merscher-Gomez, Sandra; Fornoni, Alessia] Univ Miami, L Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USA; [Leibiger, Ingo; Moede, Tilo; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17177 Stockholm, Sweden; [Mundel, Peter] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	University of Miami; University of Miami; Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fornoni, A (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, 1450 NW 10th Ave, Miami, FL 33136 USA.	afornoni@med.miami.edu	Fornoni, Alessia/F-8350-2013; Faul, Christian/AFL-7858-2022; Faul, Christian/AAG-7800-2022; RICORDI, CAMILLO/AAA-4740-2019	Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Ricordi, Camillo/0000-0001-8092-7153; fornoni, Alessia/0000-0002-1313-7773; Berggren, Per-Olof/0000-0001-8991-413X; Moede, Tilo/0000-0002-2045-9244; Merscher, Sandra/0000-0002-4757-7494	National Institutes of Health [DK82636, DK70460, U42 RR016603]; American Diabetes Association [7-09-JF-23]; Forest County Potawatomi Community Foundation; Max and Yetta Karasik Family Foundation; Diabetes Research Institute Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg's Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Peggy and Harold Katz Family Foundation; City of Hope, Duarte, CA; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683, R01DK091218, K08DK082636, U01DK070460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Forest County Potawatomi Community Foundation; Max and Yetta Karasik Family Foundation; Diabetes Research Institute Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg's Foundation; Swedish Diabetes Association; Family Erling-Persson Foundation; Peggy and Harold Katz Family Foundation; City of Hope, Duarte, CA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK82636, DK70460, and U42 RR016603. This work was also supported by American Diabetes Association Grant 7-09-JF-23, the Forest County Potawatomi Community Foundation, the Max and Yetta Karasik Family Foundation, the Diabetes Research Institute Foundation, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Torsten and Ragnar Soderberg's Foundation, the Swedish Diabetes Association, the Family Erling-Persson Foundation, the Peggy and Harold Katz Family Foundation, and the City of Hope, Duarte, CA.	Aoudjit Lamine, 2011, J Signal Transduct, V2011, P376543, DOI 10.1155/2011/376543; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Coward RJM, 2007, DIABETES, V56, P1127, DOI 10.2337/db06-0693; Fan QF, 2009, NEPHRON EXP NEPHROL, V111, pE92, DOI 10.1159/000209209; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu XL, 2004, J AM SOC NEPHROL, V15, P1731, DOI 10.1097/01.ASN.0000129826.28932.FD; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Min L, 2007, J BIOL CHEM, V282, P33530, DOI 10.1074/jbc.M703402200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wojtusciszyn A, 2008, DIABETOLOGIA, V51, P1843, DOI 10.1007/s00125-008-1103-z; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	52	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28932	28942		10.1074/jbc.M112.389452	http://dx.doi.org/10.1074/jbc.M112.389452			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718751	Green Published, hybrid			2022-12-28	WOS:000308074600062
J	Kim, HK; Kim, CW; Vo, MT; Lee, HH; Lee, JY; Yoon, NA; Lee, CY; Moon, CH; Min, YJ; Park, JW; Cho, WJ				Kim, Hong Kyeung; Kim, Chae Won; Vo, Mai-Tram; Lee, Hyun Hee; Lee, Ji Young; Yoon, Nal Ae; Lee, Chae Yeong; Moon, Chang Hoon; Min, Young Joo; Park, Jeong Woo; Cho, Wha Ja			Expression of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (Pim-1) Is Post-transcriptionally Regulated by Tristetraprolin in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; MESSENGER-RNA; PROTEIN-KINASES; PROTOONCOGENE PIM-1; HEMATOPOIETIC-CELLS; BINDING-PROTEINS; C-MYC; STABILITY; PHOSPHORYLATION; SURVIVAL	The proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is an oncogenic serine/threonine kinase that is up-regulated in several human cancers, facilitates cell cycle progression, and suppresses apoptosis. Previously, it has been reported that the Pim-1 3'-UTR plays important roles in the regulation of Pim-1 mRNA stability. However, the mechanisms explaining how Pim-1 mRNA stability is determined by its 3'-UTR are not well known. Here, we demonstrate that tristetraprolin (TTP) plays a critical role in the regulation of Pim-1 mRNA stability. Our results show that the level of Pim-1 expression is inversely correlated with TTP expression in human cancer cells. Pim-1 mRNA contains two AU-rich elements (ARE1 and ARE2) in the 3'-UTR. TTP bound to ARE2 and enhanced the decay of Pim-1 mRNA. Overexpression of TTP decreased Pim-1 expression and p21 and p27 phosphorylation and inhibited cell growth. Overexpression of Pim-1 cDNA without the 3'-UTR attenuated the inhibitory effects of TTP on p21 phosphorylation and cell growth. In addition, inhibition of p21 by siRNA attenuated the inhibitory effect of TTP on cell growth. Our results suggest that TTP post-transcriptionally down-regulates Pim-1 expression and that the overexpression of TTP may contribute to tumor suppression in part by down-regulating Pim-1 expression.	[Kim, Hong Kyeung; Kim, Chae Won; Vo, Mai-Tram; Lee, Hyun Hee; Lee, Ji Young; Yoon, Nal Ae; Lee, Chae Yeong; Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Moon, Chang Hoon; Min, Young Joo; Cho, Wha Ja] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 682060, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Park, JW (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	jwpark@ulsan.ac.kr; wjcho26@ulsan.ac.kr			Korean Research Foundation [NRF-2008-C00249, BRL-2009-0087350, 2009-0070260, 2010-0023905, 2011-0030746]; Korean Government (MOEHRD); Ministry of Health and Welfare, Korea [A101086]	Korean Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korean Research Foundation Grants NRF-2008-C00249, BRL-2009-0087350, 2009-0070260, 2010-0023905, and 2011-0030746 funded by the Korean Government (MOEHRD) and Korean Health 21 R&D Project Grant A101086 from the Ministry of Health and Welfare, Korea.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Cheney IW, 2007, BIOORG MED CHEM LETT, V17, P1679, DOI 10.1016/j.bmcl.2006.12.086; Chiang WF, 2006, INT J ORAL MAX SURG, V35, P740, DOI 10.1016/j.ijom.2006.01.027; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; CUYPERS HT, 1984, CELL, V37, P141; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DOMEN J, 1987, ONCOGENE RES, V1, P103; Guo SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-161; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lilly M, 1997, CANCER RES, V57, P5348; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; MEEKER TC, 1987, J CELL BIOCHEM, V35, P105, DOI 10.1002/jcb.240350204; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; WINGETT D, 1991, J IMMUNOL, V147, P3653; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	43	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28770	28778		10.1074/jbc.M112.376483	http://dx.doi.org/10.1074/jbc.M112.376483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22700982	Green Published, hybrid			2022-12-28	WOS:000308074600050
J	Kitagawa, M; Takebe, A; Ono, Y; Imai, T; Nakao, K; Nishikawa, SI; Era, T				Kitagawa, Michinori; Takebe, Atsushi; Ono, Yuichi; Imai, Toshio; Nakao, Kazuki; Nishikawa, Shin-Ichi; Era, Takumi			Phf14, a Novel Regulator of Mesenchyme Growth via Platelet-derived Growth Factor (PDGF) Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIFFERENTIATION CULTURE; PULMONARY-FIBROSIS; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; DEFICIENT MICE; LUNG FIBROSIS; UP-REGULATION; STEM-CELLS; IN-VIVO; BLEOMYCIN	The regulation of mesenchymal cell growth by signaling molecules plays an important role in maintaining tissue functions. Aberrant mesenchymal cell proliferation caused by disruption of this regulatory process leads to pathogenetic events such as fibrosis. In the current study we have identified a novel nuclear factor, Phf14, which controls the proliferation of mesenchymal cells by regulating PDGFR alpha expression. Phf14-null mice died just after birth due to respiratory failure. Histological analyses of the lungs of these mice showed interstitial hyperplasia with an increased number of PDGFR alpha(+) mesenchymal cells. PDGFR alpha expression was elevated in Phf14-null mesenchymal fibroblasts, resulting in increased proliferation. We demonstrated that Phf14 acts as a transcription factor that directly represses PDGFR alpha expression. Based on these results, we used an antibody against PDGFR alpha to successfully treat mouse lung fibrosis. This study shows that Phf14 acts as a negative regulator of PDGFR alpha expression in mesenchymal cells undergoing normal and abnormal proliferation, and is a potential target for new treatments of lung fibrosis.	[Kitagawa, Michinori; Era, Takumi] Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Kitagawa, Michinori] Hiroshima Univ, Div Integrated Med Sci, Programs Biomed Res, Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348553, Japan; [Takebe, Atsushi] Yodogawa Christians Hosp, Dept Surg, Higashi Yodogawa Ku, Osaka 5330032, Japan; [Ono, Yuichi; Imai, Toshio] KAN Res Inst Inc, 3F, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kumamoto University; Hiroshima University; KAN Research Institute; RIKEN; RIKEN	Era, T (corresponding author), Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	tera@kumamoto-u.ac.jp	Kitagawa, Michinori/B-1792-2013	Kitagawa, Michinori/0000-0003-1660-6421	Ministry of Health, Labor, and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Afink G, 2004, BIOCHEM BIOPH RES CO, V315, P313, DOI 10.1016/j.bbrc.2004.01.056; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bleyl SB, 2007, EUR J HUM GENET, V15, P950, DOI 10.1038/sj.ejhg.5201872; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bonner JC, 1998, AM J PHYSIOL-LUNG C, V274, pL72, DOI 10.1152/ajplung.1998.274.1.L72; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Day RM, 2002, AM J PHYSIOL-LUNG C, V282, pL1349, DOI 10.1152/ajplung.00338.2001; ERA T, 1995, GENE CHROMOSOME CANC, V13, P25, DOI 10.1002/gcc.2870130105; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; Gurujeyalakshmi G, 1999, AM J PHYSIOL-LUNG C, V276, pL311, DOI 10.1152/ajplung.1999.276.2.L311; HAWLEY RG, 1994, GENE THER, V1, P136; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; KELLEY J, 1985, BIOCHEM BIOPH RES CO, V131, P836, DOI 10.1016/0006-291X(85)91315-4; Kitagawa M, 2010, INT J HEMATOL, V91, P373, DOI 10.1007/s12185-010-0518-8; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Lasky JA, 1998, AM J RESP CRIT CARE, V157, P1652, DOI 10.1164/ajrccm.157.5.9704116; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; NAGAOKA I, 1990, J CLIN INVEST, V85, P2023, DOI 10.1172/JCI114669; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; OBERLEY LW, 1979, FEBS LETT, V97, P47, DOI 10.1016/0014-5793(79)80049-6; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Sun T, 2000, DEVELOPMENT, V127, P4519; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Wang YM, 2006, FEBS LETT, V580, P3787, DOI 10.1016/j.febslet.2006.05.065; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	49	24	25	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27983	27996		10.1074/jbc.M112.350074	http://dx.doi.org/10.1074/jbc.M112.350074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730381	Green Published, hybrid			2022-12-28	WOS:000307840700072
J	Kwak, TK; Lee, MS; Ryu, J; Choi, YJ; Kang, M; Jeong, D; Lee, JW				Kwak, Tae Kyoung; Lee, Mi-Sook; Ryu, Jihye; Choi, Yoon-Ju; Kang, Minkyung; Jeong, Doyoung; Lee, Jung Weon			Cell Adhesion-dependent Serine 85 Phosphorylation of Paxillin Modulates Focal Adhesion Formation and Haptotactic Migration via Association with the C-terminal Tail Domain of Talin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN-BINDING; FAK; INVADOPODIA; PROGRESSION; METASTASIS; MACHINERY; PODOSOMES; DYNAMICS; INVASION; KINASES	Integrin-mediated adhesion to extracellular matrix proteins is dynamically regulated during morphological changes and cell migration. Upon cell adhesion, protein-protein interactions among molecules at focal adhesions (FAs) play major roles in the regulation of cell morphogenesis and migration. Although tyrosine phosphorylation of paxillin is critically involved in adhesion-mediated signaling, the significance of paxillin phosphorylation at Ser-85 and the mechanism by which it regulates cell migration remain unclear. In this study, we examined how Ser-85 phosphorylation of paxillin affects FA formation and cell migration. We found that paxillin phosphorylation at Ser-85 occurred during HeLa cell adhesion to collagen I and was concomitant with tyrosine phosphorylation of both focal adhesion kinase and talin. However, the non-phosphorylatable S85A mutant of paxillin impaired cell spreading, FA turnover, and migration toward collagen I but not toward serum. Furthermore, whereas the (presumably indirect) interaction between paxillin and the C-terminal tail of talin led to dynamic FAs at the cell boundary, S85A paxillin did not bind talin and caused stabilized FAs in the central region of cells. Together, these observations suggest that cell adhesion-dependent Ser-85 phosphorylation of paxillin is important for its interaction with talin and regulation of dynamic FAs and cell migration.	[Kwak, Tae Kyoung; Lee, Mi-Sook; Ryu, Jihye; Choi, Yoon-Ju; Kang, Minkyung; Jeong, Doyoung; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Pharmaceut Sci Res Inst,Dept Pharm, Seoul 151742, South Korea; [Kang, Minkyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, JW (corresponding author), Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Pharmaceut Sci Res Inst,Dept Pharm, Seoul 151742, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; 	Ministry of Education & Human Resources Development (MOEHRD) Basic Research Promotion Fund [KRF-2008-013-C00054]; National Research Foundation Grant from the Korean Ministry of Education, Science and Technology [2012-0004891]; LEAP Research Senior Researchers Program Grant Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea [2011-0016446/2012-0005606]; Global Frontier Project Grant from Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea [NRF-M1AXA002-2011-0028411]; Korean Health Technology R&D Project Grant from Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea [A100727]	Ministry of Education & Human Resources Development (MOEHRD) Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation Grant from the Korean Ministry of Education, Science and Technology; LEAP Research Senior Researchers Program Grant Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea; Global Frontier Project Grant from Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea; Korean Health Technology R&D Project Grant from Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea	This work was supported by Ministry of Education & Human Resources Development (MOEHRD) Basic Research Promotion Fund Grant KRF-2008-013-C00054, National Research Foundation Grant 2012-0004891 from the Korean Ministry of Education, Science and Technology (to the Tumor Microenvironment Global Core Research Center), LEAP Research Senior Researchers Program Grant 2011-0016446/2012-0005606, Global Frontier Project Grant NRF-M1AXA002-2011-0028411, and Korean Health Technology R&D Project Grant A100727 from the Ministry for Health, Welfare and Family Affairs (MHWFA), Republic of Korea (to J. W. L.).	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Danen EHJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe58; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Desiniotis A, 2011, INT REV CEL MOL BIO, V289, P117, DOI 10.1016/B978-0-12-386039-2.00004-3; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Lee SA, 2010, J CELL BIOCHEM, V111, P59, DOI 10.1002/jcb.22662; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128	25	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27499	27509		10.1074/jbc.M111.323360	http://dx.doi.org/10.1074/jbc.M111.323360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22761432	Green Published, hybrid			2022-12-28	WOS:000307840700026
J	Ruhl, M; Le Coq, D; Aymerich, S; Sauer, U				Ruehl, Martin; Le Coq, Dominique; Aymerich, Stephane; Sauer, Uwe			C-13-flux Analysis Reveals NADPH-balancing Transhydrogenation Cycles in Stationary Phase of Nitrogen-starving Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC-FLUX ANALYSIS; ESCHERICHIA-COLI; GENE-EXPRESSION; INTRACELLULAR METABOLITES; CATABOLITE REPRESSION; MASS-SPECTROMETRY; CARBON FLUXES; TIME-SCALE; LIMITATION; TRANSCRIPTOME	In their natural habitat, microorganisms are typically confronted with nutritional limitations that restrict growth and force them to persevere in a stationary phase. Despite the importance of this phase, little is known about the metabolic state(s) that sustains it. Here, we investigate metabolically active but non-growing Bacillus subtilis during nitrogen starvation. In the absence of biomass formation as the major NADPH sink, the intracellular flux distribution in these resting B. subtilis reveals a large apparent catabolic NADPH overproduction of 5.0 +/- 0.6 mmol.g(-1).h(-1) that was partly caused by high pentose phosphate pathway fluxes. Combining transcriptome analysis, stationary C-13-flux analysis in metabolic deletion mutants, H-2-labeling experiments, and kinetic flux profiling, we demonstrate that about half of the catabolic excess NADPH is oxidized by two transhydrogenation cycles, i.e. isoenzyme pairs of dehydrogenases with different cofactor specificities that operate in reverse directions. These transhydrogenation cycles were constituted by the combined activities of the glyceraldehyde 3-phosphate dehydrogenases GapA/GapB and the malic enzymes MalS/YtsJ. At least an additional 6% of the overproduced NADPH is reoxidized by continuous cycling between ana-and catabolism of glutamate. Furthermore, in vitro enzyme data show that a not yet identified transhydrogenase could potentially reoxidize similar to 20% of the overproduced NADPH. Overall, we demonstrate the interplay between several metabolic mechanisms that concertedly enable network-wide NADPH homeostasis under conditions of high catabolic NADPH production in the absence of cell growth in B. subtilis.	[Ruehl, Martin; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Ruehl, Martin] Life Sci Zurich Grad Sch, Zurich, Switzerland; [Le Coq, Dominique; Aymerich, Stephane] INRA, Inst Micalis UMR 1319, F-78350 Jouy En Josas, France; [Le Coq, Dominique; Aymerich, Stephane] AgroParisTech, Inst Micalis UMR, F-78350 Jouy En Josas, France; [Le Coq, Dominique] CNRS, F-78350 Jouy En Josas, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Sauer, U (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	sauer@imsb.biol.ethz.ch	Sauer, Uwe/Y-3556-2019		European Union [LSHG-CT-2006-037469]	European Union(European Commission)	This work was supported by European Union BaSysBio Program Grant LSHG-CT-2006-037469.	[Anonymous], 1991, AM SOC MICROBIOL N; Auriol C, 2011, P NATL ACAD SCI USA, V108, P1278, DOI 10.1073/pnas.1010431108; BERGSMA J, 1982, EUR J BIOCHEM, V128, P151; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P132, DOI 10.1002/bit.1153; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Furch T, 2007, BIOPROC BIOSYST ENG, V30, P47, DOI 10.1007/s00449-006-0095-7; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Hayes CS, 2009, CURR OPIN MICROBIOL, V12, P667, DOI 10.1016/j.mib.2009.09.006; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; Lerondel G, 2006, J BACTERIOL, V188, P4727, DOI 10.1128/JB.00167-06; Licht A, 2005, MOL MICROBIOL, V58, P189, DOI 10.1111/j.1365-2958.2005.04810.x; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Maier K, 2008, BIOTECHNOL BIOENG, V100, P355, DOI 10.1002/bit.21746; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Marzan LW, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-39; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Noh K, 2007, J BIOTECHNOL, V129, P249, DOI 10.1016/j.jbiotec.2006.11.015; Overkamp KM, 2002, YEAST, V19, P813, DOI 10.1002/yea.878; Rantanen A, 2002, METAB ENG, V4, P285, DOI 10.1006/mben.2002.0232; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Roger O, 2004, J BIOL CHEM, V279, P24923, DOI 10.1074/jbc.M401232200; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Ruhl M, 2010, BIOTECHNOL BIOENG, V105, P795, DOI 10.1002/bit.22591; Sandiford BR, 1931, BIOCHEM J, V25, P2172, DOI 10.1042/bj0252172; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schaub J, 2008, BIOTECHNOL BIOENG, V99, P1170, DOI 10.1002/bit.21675; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Sonderegger M, 2005, METAB ENG, V7, P4, DOI 10.1016/j.ymben.2004.05.005; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Tannler S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-19; Tam LT, 2007, J MOL MICROB BIOTECH, V12, P121, DOI 10.1159/000096467; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Toya Y, 2007, J CHROMATOGR A, V1159, P134, DOI 10.1016/j.chroma.2007.04.011; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Wiechert W, 2007, CURR OPIN PLANT BIOL, V10, P323, DOI 10.1016/j.pbi.2007.04.015; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zamboni N, 2005, BIOTECHNOL BIOENG, V89, P219, DOI 10.1002/bit.20338; Zamboni N, 2004, J BACTERIOL, V186, P4528, DOI 10.1128/JB.186.14.4528-4534.2004; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; ZHANG HL, 1995, J BIOL CHEM, V270, P16023, DOI 10.1074/jbc.270.27.16023	65	43	43	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27959	27970		10.1074/jbc.M112.366492	http://dx.doi.org/10.1074/jbc.M112.366492			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740702	Green Published, hybrid			2022-12-28	WOS:000307840700070
J	Bai, Y; Liu, SP; Li, JG; Lakshminarayanan, R; Sarawathi, P; Tang, C; Ho, DC; Verma, C; Beuerman, RW; Pervushin, K				Bai, Yang; Liu, Shouping; Li, Jianguo; Lakshminarayanan, Rajamani; Sarawathi, Padmanabhan; Tang, Charles; Ho, Duncun; Verma, Chandra; Beuerman, Roger W.; Pervushin, Konstantin			Progressive Structuring of a Branched Antimicrobial Peptide on the Path to the Inner Membrane Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE PEPTIDES; OUTER-MEMBRANE; PORE FORMATION; COMBINATORIAL DESIGN; MECHANISTIC-INSIGHTS; BILAYER STRUCTURE; LIPID-BILAYERS; NMR STRUCTURES; FORCE-FIELD; LIPOPOLYSACCHARIDE	In recent years, interest has grown in the antimicrobial properties of certain natural and non-natural peptides. The strategy of inserting a covalent branch point in a peptide can improve its antimicrobial properties while retaining host biocompatibility. However, little is known regarding possible structural transitions as the peptide moves on the access path to the presumed target, the inner membrane. Establishing the nature of the interactions with the complex bacterial outer and inner membranes is important for effective peptide design. Structure-activity relationships of an amphiphilic, branched antimicrobial peptide (B2088) are examined using environment-sensitive fluorescent probes, electron microscopy, molecular dynamics simulations, and high resolution NMR in solution and in condensed states. The peptide is reconstituted in bacterial outer membrane lipopolysaccharide extract as well as in a variety of lipid media mimicking the inner membrane of Gram-negative pathogens. Progressive structure accretion is observed for the peptide in water, LPS, and lipid environments. Despite inducing rapid aggregation of bacteria-derived lipopolysaccharides, the peptide remains highly mobile in the aggregated lattice. At the inner membranes, the peptide undergoes further structural compaction mediated by interactions with negatively charged lipids, probably causing redistribution of membrane lipids, which in turn results in increased membrane permeability and bacterial lysis. These findings suggest that peptides possessing both enhanced mobility in the bacterial outer membrane and spatial structure facilitating its interactions with the membrane-water interface may provide excellent structural motifs to develop new antimicrobials that can overcome antibiotic-resistant Gram-negative pathogens.	[Bai, Yang; Liu, Shouping; Lakshminarayanan, Rajamani; Sarawathi, Padmanabhan; Beuerman, Roger W.] Singapore Eye Res Inst, Singapore 168751, Singapore; [Bai, Yang; Ho, Duncun; Verma, Chandra; Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Li, Jianguo; Verma, Chandra] Bioinformat Inst A STAR, Singapore 138671, Singapore; [Tang, Charles] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Beuerman, Roger W.] Duke NUS, SRP Neurosci & Behav Disorders, Singapore 168751, Singapore	National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Singapore General Hospital; National University of Singapore; National University of Singapore	Beuerman, RW (corresponding author), Singapore Eye Res Inst, Singapore 168751, Singapore.	rwbeuerman@gmail.com; kpervushin@ntu.edu.sg	Rajamani, Lakshminarayanan/AAG-5541-2019; Pervushin, Konstantin/AAJ-6580-2020	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Pervushin, Konstantin/0000-0002-6393-4340	Flagship (Exploit) funding [X031];  [NIG/NMRC/R753];  [NMRC/TCR/002-SER1/2088R618];  [BMRC-SCAMP-2/08/1/35/19/586R652,]	Flagship (Exploit) funding; ; ; 	This work was supported by NIG/NMRC/R753, NMRC/TCR/002-SER1/2088R618, BMRC-SCAMP-2/08/1/35/19/586R652, and Flagship (Exploit) funding X031. The authors also thank A* STAR Computational Resource Center for providing the computational facilities.	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bhattacharjya S, 2009, FEBS J, V276, P6465, DOI 10.1111/j.1742-4658.2009.07357.x; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; Bland JM, 2001, MOL CELL BIOCHEM, V218, P105, DOI 10.1023/A:1007293816634; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brandenburg K, 1997, BBA-BIOMEMBRANES, V1329, P183, DOI 10.1016/S0005-2736(97)00109-0; Campopiano DJ, 2004, J BIOL CHEM, V279, P48671, DOI 10.1074/jbc.M404690200; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Dewan PC, 2009, BIOCHEMISTRY-US, V48, P5642, DOI 10.1021/bi900272r; Diebold Y, 2003, INVEST OPHTH VIS SCI, V44, P4263, DOI 10.1167/iovs.03-0560; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Eun SY, 2006, MOL CELLS, V21, P229; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heller WT, 1998, BIOCHEMISTRY-US, V37, P17331, DOI 10.1021/bi981314q; Heller WT, 1997, BIOPHYS J, V73, P239, DOI 10.1016/S0006-3495(97)78064-0; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; HUANG HW, 1991, BIOPHYS J, V60, P1079, DOI 10.1016/S0006-3495(91)82144-0; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kolusheva S, 2008, PEPTIDES, V29, P1620, DOI 10.1016/j.peptides.2008.05.012; Leptihn S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-22; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Li SH, 2010, J PHYS CHEM B, V114, P4063, DOI 10.1021/jp912283r; Liu SP, 2010, INT J PEPT RES THER, V16, P199, DOI 10.1007/s10989-010-9230-z; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Liu ZG, 2006, J MED CHEM, V49, P3436, DOI 10.1021/jm0601452; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Pieters RJ, 2007, MED RES REV, V27, P796, DOI 10.1002/med.20089; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; Rapaport D, 1996, BIOPHYS J, V70, P2502, DOI 10.1016/S0006-3495(96)79822-3; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Tamba Y, 2005, BIOCHEMISTRY-US, V44, P15823, DOI 10.1021/bi051684w; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Tencza SB, 1999, J ANTIMICROB CHEMOTH, V44, P33, DOI 10.1093/jac/44.1.33; Thomas CJ, 1999, J BIOL CHEM, V274, P29624, DOI 10.1074/jbc.274.42.29624; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104; Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8	79	27	28	4	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26606	26617		10.1074/jbc.M112.363259	http://dx.doi.org/10.1074/jbc.M112.363259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700968	Green Published, hybrid			2022-12-28	WOS:000307386000013
J	Holdsworth, G; Slocombe, P; Doyle, C; Sweeney, B; Veverka, V; Le Riche, K; Franklin, RJ; Compson, J; Brookings, D; Turner, J; Kennedy, J; Garlish, R; Shi, JY; Newnham, L; McMillan, D; Muzylak, M; Carr, MD; Henry, AJ; Ceska, T; Robinson, MK				Holdsworth, Gill; Slocombe, Patrick; Doyle, Carl; Sweeney, Bernadette; Veverka, Vaclav; Le Riche, Kelly; Franklin, Richard J.; Compson, Joanne; Brookings, Daniel; Turner, James; Kennedy, Jeffery; Garlish, Rachael; Shi, Jiye; Newnham, Laura; McMillan, David; Muzylak, Mariusz; Carr, Mark D.; Henry, Alistair J.; Ceska, Thomas; Robinson, Martyn K.			Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; BONE-FORMATION; CATENIN; CANCER; SOST; INHIBITION; MECHANISM; DISEASE; COMPLEX; DOMAIN	LRP5 and LRP6 are proteins predicted to contain four six-bladed beta-propeller domains and both bind the bone-specific Wnt signaling antagonist sclerostin. Here, we report the crystal structure of the amino-terminal region of LRP6 and using NMR show that the ability of sclerostin to bind to this molecule is mediated by the central core of sclerostin and does not involve the amino- and carboxyl-terminal flexible arm regions. We show that this structured core region interacts with LRP5 and LRP6 via an NXI motif (found in the sequence PNAIG) within a flexible loop region (loop 2) within the central core region. This sequence is related closely to a previously identified motif in laminin that mediates its interaction with the beta-propeller domain of nidogen. However, the NXI motif is not involved in the interaction of sclerostin with LRP4 (another beta-propeller containing protein in the LRP family). A peptide derived from the loop 2 region of sclerostin blocked the interaction of sclerostin with LRP5/6 and also inhibited Wnt1 but not Wnt3A or Wnt9B signaling. This suggests that these Wnts interact with LRP6 in different ways.	[Holdsworth, Gill; Slocombe, Patrick; Doyle, Carl; Sweeney, Bernadette; Le Riche, Kelly; Compson, Joanne; Kennedy, Jeffery; Newnham, Laura; McMillan, David; Muzylak, Mariusz; Henry, Alistair J.; Ceska, Thomas; Robinson, Martyn K.] UCB Pharma, Dept Biol, Slough SL1 4EN, Berks, England; [Franklin, Richard J.; Brookings, Daniel; Turner, James; Garlish, Rachael; Robinson, Martyn K.] UCB Pharma, Dept Chem, Slough SL1 4EN, Berks, England; [Shi, Jiye] UCB Pharma, Dept Informat, Slough SL1 4EN, Berks, England; [Veverka, Vaclav; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	UCB Pharma SA; UCB Pharma SA; UCB Pharma SA; University of Leicester	Robinson, MK (corresponding author), UCB Pharma, Dept Biol, 216 Bath Rd, Slough SL1 4EN, Berks, England.	martyn.robinson@ucb.com	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014; Shi, Jiye/G-2745-2012	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996; Shi, Jiye/0000-0002-9628-8680	UCB Pharma	UCB Pharma(UCB Pharma SA)	Supported by UCB Pharma.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chen JL, 2011, STRUCTURE, V19, P313, DOI 10.1016/j.str.2011.01.010; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Collins MN, 2011, STRUCTURE, V19, P324, DOI 10.1016/j.str.2010.11.017; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Johnson ML, 2005, CRIT REV EUKAR GENE, V15, P229, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.50; Kohler C, 2011, STRUCTURE, V19, P337, DOI 10.1016/j.str.2010.12.022; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WY, 2010, BIOCHEMISTRY-US, V49, P4635, DOI 10.1021/bi1001486; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062	46	64	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26464	26477		10.1074/jbc.M112.350108	http://dx.doi.org/10.1074/jbc.M112.350108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696217	Green Published, hybrid			2022-12-28	WOS:000307386000001
J	Kaniakova, M; Krausova, B; Vyklicky, V; Korinek, M; Lichnerova, K; Vyklicky, L; Horak, M				Kaniakova, Martina; Krausova, Barbora; Vyklicky, Vojtech; Korinek, Miloslav; Lichnerova, Katarina; Vyklicky, Ladislav; Horak, Martin			Key Amino Acid Residues within the Third Membrane Domains of NR1 and NR2 Subunits Contribute to the Regulation of the Surface Delivery of N-methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL NMDA RECEPTORS; ER RETENTION SIGNAL; ENDOPLASMIC-RETICULUM; CELL-SURFACE; TERMINAL DOMAIN; LURCHER MUTATION; TRAFFICKING; EXPRESSION; CHANNELS; KAINATE	N-methyl-D-aspartate (NMDA) receptors are glutamate ionotropic receptors that play critical roles in synaptic transmission, plasticity, and excitotoxicity. The functional NMDA receptors, heterotetramers composed mainly of two NR1 and two NR2 subunits, likely pass endoplasmic reticulum quality control before they are released from the endoplasmic reticulum and trafficked to the cell surface. However, the mechanism underlying this process is not clear. Using truncated and mutated NMDA receptor subunits expressed in heterologous cells, we found that the M3 domains of both NR1 and NR2 subunits contain key amino acid residues that contribute to the regulation of the number of surface functional NMDA receptors. These key residues are critical neither for the interaction between the NR1 and NR2 subunits nor for the formation of the functional receptors, but rather they regulate the early trafficking of the receptors. We also found that the identified key amino acid residues within both NR1 and NR2 M3 domains contribute to the regulation of the surface expression of unassembled NR1 and NR2 subunits. Thus, our data identify the unique role of the membrane domains in the regulation of the number of surface NMDA receptors.	[Kaniakova, Martina; Krausova, Barbora; Vyklicky, Vojtech; Korinek, Miloslav; Lichnerova, Katarina; Vyklicky, Ladislav; Horak, Martin] Acad Sci Czech Republic, Inst Physiol, Vvi, CR-14220 Prague 4, Czech Republic; [Vyklicky, Vojtech] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Horak, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic.	mhorak@biomed.cas.cz	Krausová, Barbora/AAL-9528-2021; Kaniakova, Martina/C-2593-2012; Horak, Martin/F-9819-2010; Vyklicky, Ladislav/C-1851-2012; Vyklicky, Vojtech/D-2022-2016; Korinek, Miloslav/C-5401-2012	Krausová, Barbora/0000-0001-5395-982X; Kaniakova, Martina/0000-0002-7956-3265; Horak, Martin/0000-0002-4359-051X; Vyklicky, Ladislav/0000-0002-0015-0098; Vyklicky, Vojtech/0000-0002-7763-850X; Korinek, Miloslav/0000-0001-5115-4489	Grant Agency of the Czech Republic [P303/11/0075, P304/12/G069, P303/12/1464]; Marie Curie International Reintegration Grant [PIRG-GA-2010-276827]; Research Project of the AS; Research Project of the CR [AV0Z50110509, RVO:67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Marie Curie International Reintegration Grant(European Commission); Research Project of the AS; Research Project of the CR	This work was supported by the Grant Agency of the Czech Republic Grants P303/11/0075, P304/12/G069, and P303/12/1464); by Marie Curie International Reintegration Grant PIRG-GA-2010-276827; and by Research Projects of the AS CR AV0Z50110509 and RVO:67985823.	Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Cais O, 2008, NEUROSCIENCE, V151, P428, DOI 10.1016/j.neuroscience.2007.11.002; Cao JY, 2011, J BIOL CHEM, V286, P27698, DOI 10.1074/jbc.M111.235333; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Horak M, 2004, J NEUROSCI, V24, P10318, DOI 10.1523/JNEUROSCI.2099-04.2004; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Okabe S, 1999, J NEUROSCI, V19, P7781; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petralia RS, 2009, FRONT NEUROSCI, P149; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Salussolia CL, 2011, J BIOL CHEM, V286, P40205, DOI 10.1074/jbc.M111.268839; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Schwarz MK, 2001, EUR J NEUROSCI, V14, P861, DOI 10.1046/j.0953-816x.2001.01705.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	41	29	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26423	26434		10.1074/jbc.M112.339085	http://dx.doi.org/10.1074/jbc.M112.339085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22711533	hybrid, Green Published			2022-12-28	WOS:000306916300067
J	Szekeres, M; Nadasy, GL; Turu, G; Soltesz-Katona, E; Toth, ZE; Balla, A; Catt, KJ; Hunyady, L				Szekeres, Maria; Nadasy, Gyoergy L.; Turu, Gabor; Soltesz-Katona, Eszter; Toth, Zsuzsanna E.; Balla, Andras; Catt, Kevin J.; Hunyady, Laszlo			Angiotensin II Induces Vascular Endocannabinoid Release, Which Attenuates Its Vasoconstrictor Effect via CB1 Cannabinoid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CARDIOVASCULAR PHARMACOLOGY; NITRIC-OXIDE; RAT AORTA; CORONARY; MECHANISMS; RESISTANCE; REACTIVITY; ARTERY; VASORELAXATION	In the vascular system angiotensin II (Ang II) causes vasoconstriction via the activation of type 1 angiotensin receptors. Earlier reports have shown that in cellular expression systems diacylglycerol produced during type 1 angiotensin receptor signaling can be converted to 2-arachidonoylglycerol, an important endocannabinoid. Because activation of CB1 cannabinoid receptors (CB1R) induces vasodilation and reduces blood pressure, we have tested the hypothesis that Ang II-induced 2-arachidonoylglycerol release can modulate its vasoconstrictor action in vascular tissue. Rat and mouse skeletal muscle arterioles and mouse saphenous arteries were isolated, pressurized, and subjected to microangiometry. Vascular expression of CB1R was demonstrated using Western blot and RT-PCR. In accordance with the functional relevance of these receptors WIN55212, a CB1R agonist, caused vasodilation, which was absent in CB1R knock-out mice. Inhibition of CB(1)Rs using O2050, a neutral antagonist, enhanced the vasoconstrictor effect of Ang II in wild type but not in CB1R knock-out mice. Inverse agonists of CB1R (SR141716 and AM251) and inhibition of diacylglycerol lipase using tetrahydrolipstatin also augmented the Ang II-induced vasoconstriction, suggesting that endocannabinoid release modulates this process via CB1R activation. This effect was independent of nitric-oxide synthase activity and endothelial function. These data demonstrate that Ang II stimulates vascular endocannabinoid formation, which attenuates its vasoconstrictor effect, suggesting that endocannabinoid release from the vascular wall and CB1R activation reduces the vasoconstrictor and hypertensive effects of Ang II.	[Hunyady, Laszlo] Semmelweis Univ, Fac Med, Dept Physiol, H-1444 Budapest, Hungary; [Nadasy, Gyoergy L.] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1444 Budapest, Hungary; [Toth, Zsuzsanna E.] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, H-1444 Budapest, Hungary; [Balla, Andras; Hunyady, Laszlo] Semmelweis Univ, Lab Mol Physiol, H-1444 Budapest, Hungary; Hungarian Acad Sci, H-1444 Budapest, Hungary; [Catt, Kevin J.] NICHD, Sect Hormonal Regulat, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, POB 259, H-1444 Budapest, Hungary.	Hunyady@eok.sote.hu	Toth, Zsuzsanna/U-2579-2019; Soltész-Katona, Eszter/H-1897-2019	Soltész-Katona, Eszter/0000-0002-9054-740X; Turu, Gabor/0000-0002-4421-3812; Balla, Andras/0000-0002-6450-2793	Hungarian National Science Foundation [OTKA NK-100883, NK-72661, OTKA TO32019]; Hungarian Ministry of National Resources [ETT 495/09]; National Development Agency, Hungary [TAMOP 4.2.1.B-09/1/KMR-2010-0001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000184] Funding Source: NIH RePORTER	Hungarian National Science Foundation; Hungarian Ministry of National Resources; National Development Agency, Hungary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Hungarian National Science Foundation (OTKA NK-100883, NK-72661, OTKA TO32019), Hungarian Ministry of National Resources (ETT 495/09), and from the National Development Agency, Hungary (TAMOP 4.2.1.B-09/1/KMR-2010-0001).	Bagi Z, 2006, LUPUS, V15, P326, DOI 10.1191/0961203306lu2297oa; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Begg M, 2003, J BIOL CHEM, V278, P46188, DOI 10.1074/jbc.M307258200; Chataigneau T, 1998, BRIT J PHARMACOL, V123, P968, DOI 10.1038/sj.bjp.0701690; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Dannert MT, 2007, VASC PHARMACOL, V46, P16, DOI 10.1016/j.vph.2006.06.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; Gyombolai P, 2012, MOL CELL ENDOCRINOL, V353, P29, DOI 10.1016/j.mce.2011.10.011; Haendeler J, 2000, REGUL PEPTIDES, V95, P1, DOI 10.1016/S0167-0115(00)00133-6; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hiley CR, 2009, J CARDIOVASC PHARM, V53, P267, DOI 10.1097/FJC.0b013e318192671d; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; Hogestatt ED, 2002, PROSTAG LEUKOTR ESS, V66, P343, DOI 10.1054/plef.2001.0346; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lopez-Miranda V, 2008, CURR VASC PHARMACOL, V6, P335, DOI 10.2174/157016108785909706; Massett MP, 2002, AM J PHYSIOL-HEART C, V283, pH2282, DOI 10.1152/ajpheart.00544.2002; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nadasy GL, 2001, MICROVASC RES, V61, P282, DOI 10.1006/mvre.2000.2297; Niederhoffer N, 2003, N-S ARCH PHARMACOL, V367, P434, DOI 10.1007/s00210-003-0755-y; O'Sullivan SE, 2007, J PHARMACOL EXP THER, V321, P663, DOI 10.1124/jpet.106.116566; O'Sullivan SE, 2004, BRIT J PHARMACOL, V142, P435, DOI 10.1038/sj.bjp.0705810; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Phillips SA, 2006, J APPL PHYSIOL, V100, P1117, DOI 10.1152/japplphysiol.00994.2005; Quignard JF, 2001, J BIOL CHEM, V276, P32545, DOI 10.1074/jbc.M102582200; Rademacher DJ, 2005, AM J PHYSIOL-HEART C, V288, pH2694, DOI 10.1152/ajpheart.00978.2004; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; SUN D, 1994, AM J PHYSIOL, V266, pH1177, DOI 10.1152/ajpheart.1994.266.3.H1177; Szekeres M, 2004, J CARDIOVASC PHARM, V43, P242, DOI 10.1097/00005344-200402000-00012; Szekeres M, 2001, J CARDIOVASC PHARM, V38, P584, DOI 10.1097/00005344-200110000-00011; Szekeres M, 2010, ENDOCRINOLOGY, V151, P1695, DOI 10.1210/en.2009-1060; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Varbiro S, 2000, J HYPERTENS, V18, P1587, DOI 10.1097/00004872-200018110-00009; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Weber DS, 2001, AM J PHYSIOL-HEART C, V280, pH2196, DOI 10.1152/ajpheart.2001.280.5.H2196; White R, 2001, BRIT J PHARMACOL, V134, P921, DOI 10.1038/sj.bjp.0704333; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	50	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31540	31550		10.1074/jbc.M112.346296	http://dx.doi.org/10.1074/jbc.M112.346296			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22787147	hybrid, Green Published			2022-12-28	WOS:000308791300066
J	Wiedemann, A; Rosselin, M; Mijouin, L; Bottreau, E; Velge, P				Wiedemann, Agnes; Rosselin, Manon; Mijouin, Lily; Bottreau, Elisabeth; Velge, Philippe			Involvement of c-Src Tyrosine Kinase Upstream of Class I Phosphatidylinositol (PI) 3-Kinases in Salmonella Enteritidis Rck Protein-mediated Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SIGNALING MOLECULES; FAMILY; REQUIRES; TYPHIMURIUM; LISTERIA; CELLS; ENTRY	The Salmonella outer membrane protein Rck mediates a Zipper entry mechanism controlled by tyrosine phosphorylation and class I phosphatidylinositol 3-kinase (PI 3-kinase). However, the underlying mechanism leading to this signaling cascade remains unclear. The present study showed that using Rck-coated beads or Rck-overexpressing Escherichia coli, Rck-mediated actin polymerization and invasion were blocked by PP2, a Src family tyrosine kinase inhibitor. In addition, phosphorylation of Src family kinases significantly increased after stimulation with Rck. The specific contribution of c-Src, one member of the Src family kinases, was demonstrated using c-Src-deficient fibroblasts or c-Src siRNA transfected epithelial cells. We also observed that Rck-mediated internalization led to the formation of a complex between c-Src and at least one tyrosine-phosphorylated protein. Furthermore, our results revealed that the c-Src signal molecule was upstream of PI 3-kinase during the Rck-mediated signaling pathway as Rck-mediated PI 3-kinase activation was blocked by PP2, and PI 3-kinase inhibitor had no effect on the Src phosphorylation. These results demonstrate the involvement of c-Src upstream of the PI 3-kinase in the Zipper entry process mediated by Rck.	[Wiedemann, Agnes; Rosselin, Manon; Mijouin, Lily; Bottreau, Elisabeth; Velge, Philippe] INRA, UMR Infectiol & Sante Publ 1282, F-37380 Nouzilly, France; [Wiedemann, Agnes; Bottreau, Elisabeth; Velge, Philippe] Univ Tours, UMR Infectiol & Sante Publ 1282, F-37000 Tours, France	INRAE; Universite de Tours	Wiedemann, A (corresponding author), INRA Tours Nouzilly, UMR Infectiol & Sante Publ 1282, F-37380 Nouzilly, France.	Agnes.Wiedemann@tours.inra.fr	velge, philippe/AAK-4165-2021	Wiedemann, Agnes/0000-0001-8237-3545				Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Chen MC, 2002, AM J PHYSIOL-GASTR L, V283, pG893, DOI 10.1152/ajpgi.00429.2001; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dumenil G, 1998, J CELL BIOL, V143, P1003, DOI 10.1083/jcb.143.4.1003; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; KEFALAS P, 1995, INT J BIOCHEM CELL B, V27, P551, DOI 10.1016/1357-2725(95)00024-J; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Manon R, 2012, SALMONELLA - DISTRIBUTION, ADAPTATION, CONTROL MEASURES AND MOLECULAR TECHNOLOGIES, P339; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Shi J, 2006, MOL BIOL CELL, V17, P4698, DOI 10.1091/mbc.E06-06-0492; Slanina H, 2010, INFECT IMMUN, V78, P1905, DOI 10.1128/IAI.01267-09; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Van Langendonck N, 1998, FEMS MICROBIOL LETT, V162, P169, DOI 10.1016/S0378-1097(98)00111-6; Velge P., 2012, MICROBIOLOG IN PRESS	24	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31148	31154		10.1074/jbc.M112.392134	http://dx.doi.org/10.1074/jbc.M112.392134			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810232	Green Published, hybrid			2022-12-28	WOS:000308791300027
J	Gao, R; Huang, SYN; Marchand, C; Pommier, Y				Gao, Rui; Huang, Shar-yin N.; Marchand, Christophe; Pommier, Yves			Biochemical Characterization of Human Tyrosyl-DNA Phosphodiesterase 2 (TDP2/TTRAP) A Mg2+/Mn2+-DEPENDENT PHOSPHODIESTERASE SPECIFIC FOR THE REPAIR OF TOPOISOMERASE CLEAVAGE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; RECEPTOR-ASSOCIATED FACTORS; BODIES-ASSOCIATED PROTEIN; DIVALENT METAL-IONS; VERTEBRATE CELLS; ACTIVE-SITE; I-TASSER; TTRAP; DAMAGE; TDP1	TDP2 is a multifunctional enzyme previously known for its role in signal transduction as TRAF and TNF receptor-associated protein (TTRAP) and ETS1-associated protein 2 (EAPII). The gene has recently been renamed TDP2 because it plays a critical role for the repair of topoisomerase II cleavage complexes (Top2cc) and encodes an enzyme that hydrolyzes 5'-tyrosine-DNA adducts that mimic abortive Top2cc. Here we further elucidate the DNA-processing activities of human recombinant TDP2 and its biochemical characteristics. The preferred substrate for TDP2 is single-stranded DNA or duplex DNA with a four-base pair overhang, which is consistent with the known structure of Top2cc or Top3cc. The k(cat)/K-m of TDP1 and TDP2 was determined. It was found to be 4 x 10(5) s(-1)M(-1) for TDP2 using single-stranded 5'-tyrosyl-DNA. The processing of substrates as short as five nucleotides long suggests that TDP2 can directly bind DNA ends. 5'-Phosphodiesterase activity requires a phosphotyrosyl linkage and tolerates an extended group attached to the tyrosine. TDP2 requires Mg2+ or Mn2+ for efficient catalysis but is weakly active with Ca2+ or Zn2+. Titration with Ca2+ demonstrates a two-metal binding site in TDP2. Sequence alignment suggests that TDP2 contains four conserved catalytic motifs shared by Mg2+-dependent endonucleases, such as APE1. Substitutions at each of the four catalytic motifs identified key residues Asn-120, Glu-152, Asp-262, and His-351, whose mutation to alanine significantly reduced or completely abolished enzymatic activity. Our study characterizes the substrate specificity and kinetic parameters of TDP2. In addition, a two-metal catalytic mechanism is proposed.	[Gao, Rui; Huang, Shar-yin N.; Marchand, Christophe; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov			Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health.	Adhikari Sanjay, 2012, BMC Res Notes, V5, P134, DOI 10.1186/1756-0500-5-134; Adhikari S, 2011, ANAL BIOCHEM, V416, P112, DOI 10.1016/j.ab.2011.05.008; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dexheimer TS, 2008, NUCLEIC ACIDS RES, V36, P4128, DOI 10.1093/nar/gkn334; Dexheimer TS, 2008, ANTI-CANCER AGENT ME, V8, P381, DOI 10.2174/187152008784220357; Dexheimer TS, 2010, NUCLEIC ACIDS RES, V38, P2444, DOI 10.1093/nar/gkp1206; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Kim WC, 2011, J MOL BIOL, V411, P960, DOI 10.1016/j.jmb.2011.06.050; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li C, 2011, ONCOGENE, V30, P3802, DOI 10.1038/onc.2011.94; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Rothwell DG, 2000, NUCLEIC ACIDS RES, V28, P2207, DOI 10.1093/nar/28.11.2207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabourin M, 2000, NUCLEIC ACIDS RES, V28, P1947, DOI 10.1093/nar/28.9.1947; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Velez-Cruz R, 2005, BIOCHEMISTRY-US, V44, P3972, DOI 10.1021/bi0478289; Vilotti S, 2012, CELL DEATH DIFFER, V19, P488, DOI 10.1038/cdd.2011.118; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; WANG JC, 1991, J BIOL CHEM, V266, P6659; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhang JQ, 2009, BIOCHEM BIOPH RES CO, V387, P256, DOI 10.1016/j.bbrc.2009.06.153; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	51	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30842	30852		10.1074/jbc.M112.393983	http://dx.doi.org/10.1074/jbc.M112.393983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822062	hybrid, Green Published			2022-12-28	WOS:000308579800072
J	Nakagawa, N; Manya, H; Toda, T; Endo, T; Oka, S				Nakagawa, Naoki; Manya, Hiroshi; Toda, Tatsushi; Endo, Tamao; Oka, Shogo			Human Natural Killer-1 Sulfotransferase (HNK-1ST)-induced Sulfate Transfer Regulates Laminin-binding Glycans on alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; CARBOHYDRATE EPITOPE HNK-1; WALKER-WARBURG-SYNDROME; CELL-ADHESION MOLECULE; SKELETAL-MUSCLE; O-GLYCAN; ABNORMAL GLYCOSYLATION; GLYCOPROTEIN COMPLEX; GLUCURONIC-ACID; MELANOMA-CELLS	Retinoic acid (RA) is a well established anti-tumor agent inducing differentiation in various cancer cells. Recently, a robust up-regulation of human natural killer-1 sulfotransferase (HNK-1ST) was found in several subsets of melanoma cells during RA-mediated differentiation. However, the molecular mechanism underlying the tumor suppression mediated by HNK-1ST remains unclear. Here, we show that HNK-1ST changed the glycosylation state and reduced the ligand binding activity of alpha-dystroglycan (alpha-DG) in RA-treated S91 melanoma cells, which contributed to an attenuation of cell migration. Knockdown of HNK-1ST restored the glycosylation of alpha-DG and the migration of RA-treated S91 cells, indicating that HNK-1ST functions through glycans on alpha-DG. Using CHO-K1 cells, we provide direct evidence that HNK-1ST but not other homologous sulfotransferases (C4ST1 and GalNAc4ST1) suppresses the glycosylation of alpha-DG. The activity-abolished mutant of HNK-1ST did not show the alpha-DG-modulating function, indicating that the sulfotransferase activity of HNK-1ST is essential. Finally, the HNK-1ST-dependent incorporation of [S-35]sulfate groups was detected on alpha-DG. These findings suggest a novel role for HNK-1ST as a tumor suppressor controlling the functional glycans on alpha-DG and the importance of sulfate transfer in the glycosylation of alpha-DG.	[Nakagawa, Naoki; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Tokyo 1730015, Japan; [Manya, Hiroshi; Endo, Tamao] Inst Gerontol, Tokyo 1730015, Japan; [Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan	Kyoto University; Tokyo Metropolitan Institute of Gerontology; Kobe University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Manya, Hiroshi/0000-0003-1573-9177	Japan Society for the Promotion of Science [23659153]; Ministry of Education, Culture, Sports, Science and Technology [23110006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Challenging Exploratory Research 23659153 (to S. O.) from Japan Society for the Promotion of Science and for Scientific Research on Innovative Areas and Grant 23110006 (to S. O.) from Ministry of Education, Culture, Sports, Science and Technology.	ARIGA T, 1987, J BIOL CHEM, V262, P848; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Casado JG, 2008, TUMOR BIOL, V29, P304, DOI 10.1159/000156707; Chiba A, 1997, J BIOL CHEM, V272, P2156; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Girard JP, 1998, FASEB J, V12, P603, DOI 10.1096/fasebj.12.7.603; Hakomori S, 1996, CANCER RES, V56, P5309; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Meany Danni L, 2011, Clin Proteomics, V8, P7, DOI 10.1186/1559-0275-8-7; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; MOOY CM, 1995, HUM PATHOL, V26, P1185, DOI 10.1016/0046-8177(95)90191-4; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okuda T, 2000, J BIOL CHEM, V275, P40605, DOI 10.1074/jbc.M007983200; Ong E, 1999, J BIOL CHEM, V274, P25608, DOI 10.1074/jbc.274.36.25608; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Spanjaard RA, 1997, J BIOL CHEM, V272, P18990, DOI 10.1074/jbc.272.30.18990; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhao XS, 2009, CANCER RES, V69, P5218, DOI 10.1158/0008-5472.CAN-09-0705	53	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30823	30832		10.1074/jbc.M112.363036	http://dx.doi.org/10.1074/jbc.M112.363036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22801424	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000308579800070
J	Nakai, Y; Harada, A; Hashiguchi, Y; Nakai, M; Hayashi, H				Nakai, Yumi; Harada, Akiko; Hashiguchi, Yasuyuki; Nakai, Masato; Hayashi, Hideyuki			Arabidopsis Molybdopterin Biosynthesis Protein Cnx5 Collaborates with the Ubiquitin-like Protein Urm11 in the Thio-modification of tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; CYTOSOLIC TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; SULFUR TRANSFER; MODIFIER URM1; YEAST; PATHWAY; ACTIVATION; SYNTHASE; GENOME	The thio-modification of tRNA that occurs in virtually all organisms affects the accuracy and efficiency of protein translation and is therefore biologically important. However, the molecular mechanism responsible for this tRNA modification in plants is largely unclear. We demonstrate here that Arabidopsis sulfurtransferase Cnx5, a ubiquitin-activating enzyme-like (UBA) protein involved in molybdopterin (MPT) biosynthesis, is strictly required for the thio-modification of cytosolic tRNAs in vivo. A previously uncharacterized ubiquitin-like (Ubl) protein Urm11 is also essential for tRNA thio-modification in Arabidopsis. When expressed in Saccharomyces cerevisiae, Cnx5 and Urm11 can substitute for the corresponding yeast orthologs ScUba4 and ScUrm1, respectively, in the thio-modification of yeast cytosolic tRNAs. However, another Ubl protein, Cnx7 of Arabidopsis, which is involved in MPT biosynthesis in conjunction with Cnx5, cannot replace yeast ScUrm1. Interestingly, the expression of a mutant form of Cnx7 in which the carboxyl-terminal six amino acids are substituted by those of Urm11 can significantly restore the thio-modification of tRNAs in the yeast urm1 Delta mutant. These findings suggest that in Arabidopsis the common UBA protein Cnx5 collaborates with two functionally differentiated Ubl proteins, Urm11 and Cnx7, in the thio-modification of tRNA and MPT biosynthesis, respectively. Phylogenetic analysis revealed that although most eukaryotes contained a Cnx5-Urm11 ortholog pair and the tRNA thio-modification some fungi, including S. cerevisiae, had lost the Cnx7 ortholog and the ability to synthesize the molybdenum cofactor.	[Nakai, Yumi; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan; [Harada, Akiko; Hashiguchi, Yasuyuki] Osaka Med Coll, Dept Biol, Takatsuki, Osaka 5698686, Japan; [Nakai, Masato] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka Medical College; Osaka Medical College; Osaka University	Nakai, Y (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigaku Cho, Takatsuki, Osaka 5698686, Japan.	med004@art.osaka-med.ac.jp	Hashiguchi, Yasuyuki/AAA-4179-2019		Ministry of Education, Culture, Sports, Science and Technology of Japan [21570150, 21570040, 21570120, 22770046, 22770236]; Grants-in-Aid for Scientific Research [22770046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (C) 21570150 (to Y. N.), 21570040 (to M. N.), and 21570120 (to H. H.) and for Young Scientists (B) 22770046 (to A. H.) and 22770236 (to Y. H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Dai XH, 2005, P NATL ACAD SCI USA, V102, P3129, DOI 10.1073/pnas.0500185102; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; GABARD J, 1987, MOL GEN GENET, V209, P596, DOI 10.1007/BF00331169; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Singh S, 2005, PROTEIN SCI, V14, P2095, DOI 10.1110/ps.051577605; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	37	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30874	30884		10.1074/jbc.M112.350090	http://dx.doi.org/10.1074/jbc.M112.350090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22810225	Green Published, hybrid			2022-12-28	WOS:000308579800075
J	Eberhardt, MJ; Filipovic, MR; Leffler, A; de la Roche, J; Kistner, K; Fischer, MJ; Fleming, T; Zimmermann, K; Ivanovic-Burmazovic, I; Nawroth, PP; Bierhaus, A; Reeh, PW; Sauer, SK				Eberhardt, Mirjam J.; Filipovic, Milos R.; Leffler, Andreas; de la Roche, Jeanne; Kistner, Katrin; Fischer, Michael J.; Fleming, Thomas; Zimmermann, Katharina; Ivanovic-Burmazovic, Ivana; Nawroth, Peter P.; Bierhaus, Angelika; Reeh, Peter W.; Sauer, Susanne K.			Methylglyoxal Activates Nociceptors through Transient Receptor Potential Channel A1 (TRPA1) A POSSIBLE MECHANISM OF METABOLIC NEUROPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAINFUL DIABETIC-NEUROPATHY; CHRONIC KIDNEY-DISEASE; GENE-RELATED PEPTIDE; SENSORY NEURONS; ION-CHANNEL; IN-VITRO; OXIDATIVE STRESS; PERIPHERAL-NERVE; COLD HYPERSENSITIVITY; COVALENT MODIFICATION	Neuropathic pain can develop as an agonizing sequela of diabetes mellitus and chronic uremia. A chemical link between both conditions of altered metabolism is the highly reactive compound methylglyoxal (MG), which accumulates in all cells, in particular neurons, and leaks into plasma as an index of the severity of the disorder. The electrophilic structure of this cytotoxic ketoaldehyde suggests TRPA1, a receptor channel deeply involved in inflammatory and neuropathic pain, as a molecular target. We demonstrate that extracellularly applied MG accesses specific intracellular binding sites of TRPA1, activating inward currents and calcium influx in transfected cells and sensory neurons, slowing conduction velocity in unmyelinated peripheral nerve fibers, and stimulating release of proinflammatory neuropeptides from and action potential firing in cutaneous nociceptors. Using a model peptide of the N terminus of human TRPA1, we demonstrate the formation of disulfide bonds based on MG-induced modification of cysteines as a novel mechanism. In conclusion, MG is proposed to be a candidate metabolite that causes neuropathic pain in metabolic disorders and thus is a promising target for medicinal chemistry.	[Zimmermann, Katharina; Reeh, Peter W.; Sauer, Susanne K.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Eberhardt, Mirjam J.; Filipovic, Milos R.; Ivanovic-Burmazovic, Ivana] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Leffler, Andreas; de la Roche, Jeanne] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-30625 Hannover, Germany; [Fleming, Thomas; Nawroth, Peter P.; Bierhaus, Angelika] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Hannover Medical School; Ruprecht Karls University Heidelberg	Sauer, SK (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany.	sauer@physiologie1.uni-erlangen.de	Sauer, Susanne/K-1145-2012; Leffler, Andreas/K-1191-2012; Filipovic, Milos/D-5482-2014; Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Leffler, Andreas/0000-0003-1121-6387; Filipovic, Milos/0000-0003-0060-0041; Reeh, Peter W./0000-0002-4367-094X; Sauer, Susanne Katharina/0000-0002-9734-885X; Zimmermann, Katharina/0000-0003-2529-0692; Fischer, Michael J.M./0000-0002-3811-7066	Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; Dr. Robert Pfleger-Stiftung; Deutsche Forschungsgemeinschaft [BI-1281/3-1, NA 138/7-1, LU 728/3-1]; Dietmar-Hopp-Stiftung	Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; Dr. Robert Pfleger-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung	This work was supported by the Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; the Dr. Robert Pfleger-Stiftung (to K. K.); Deutsche Forschungsgemeinschaft Grants BI-1281/3-1 (to A. B.), NA 138/7-1 (to P. P. N.), and LU 728/3-1 (to P. W. R.); and the Dietmar-Hopp-Stiftung (to A. B. and P. P. N.).	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Axson JL, 2010, P NATL ACAD SCI USA, V107, P6687, DOI 10.1073/pnas.0912121107; Babes A, 2010, METHODS MOL BIOL, V617, P237, DOI 10.1007/978-1-60327-323-7_19; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Belvisi MG, 2011, CHEST, V140, P1040, DOI 10.1378/chest.10-3327; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chaplen FWR, 1996, ANAL BIOCHEM, V238, P171, DOI 10.1006/abio.1996.0271; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016/0304-3959(93)90059-X; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaun N, 2006, J AM SOC NEPHROL, V17, P943, DOI 10.1681/ASN.2005121256; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V138, P19, DOI 10.1113/jphysiol.1957.sp005835; Dubreuil AS, 2004, J NEUROSCI, V24, P8480, DOI 10.1523/JNEUROSCI.1598-04.2004; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Ergul A, 2011, PHARMACOL RES, V63, P477, DOI 10.1016/j.phrs.2011.01.012; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Foulkes T, 2007, CHANNELS, V1, P154, DOI 10.4161/chan.4692; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; Fukunaga M, 2004, BIOCHEM BIOPH RES CO, V320, P689, DOI 10.1016/j.bbrc.2004.06.011; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Ji G, 2008, NEUROSCIENCE, V154, P1054, DOI 10.1016/j.neuroscience.2008.04.039; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Kikuchi S, 1999, J NEUROSCI RES, V57, P280, DOI 10.1002/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOOP DR, 1982, J BIOL CHEM, V257, P8472; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Krizner HE, 2009, J PHYS CHEM A, V113, P6994, DOI 10.1021/jp903213k; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P267, DOI 10.1196/annals.1333.032; LEPPALUOTO J, 1992, ANN MED, V24, P153, DOI 10.3109/07853899209147813; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; LO TWC, 1994, J BIOL CHEM, V269, P32299; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Namer B, 2008, PAIN, V137, P41, DOI 10.1016/j.pain.2007.08.008; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sauer SK, 1999, NEUROSCIENCE, V92, P319, DOI 10.1016/S0306-4522(98)00731-3; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; SCOTT AR, 1987, CAN J PHYSIOL PHARM, V65, P1365, DOI 10.1139/y87-215; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki Y, 2002, NEUROSCI RES, V43, P171, DOI 10.1016/S0168-0102(02)00033-0; Suzuki Y, 2002, PAIN, V99, P475, DOI 10.1016/S0304-3959(02)00244-0; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Traverso N, 1998, DIABETOLOGIA, V41, P265, DOI 10.1007/s001250050902; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang R, 2011, J PHYSIOL-LONDON, V589, P2229, DOI 10.1113/jphysiol.2010.203463; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wei H, 2011, PAIN, V152, P582, DOI 10.1016/j.pain.2010.11.031; Wei H, 2010, NEUROSCI LETT, V479, P253, DOI 10.1016/j.neulet.2010.05.073; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	90	145	151	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28291	28306		10.1074/jbc.M111.328674	http://dx.doi.org/10.1074/jbc.M111.328674			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740698	Green Published, hybrid			2022-12-28	WOS:000308074600007
J	Gimenez, C; Perez-Siles, G; Martinez-Villarreal, J; Arribas-Gonzalez, E; Jimenez, E; Nunez, E; de Juan-Sanz, J; Fernandez-Sanchez, E; Garcia-Tardon, N; Ibanez, I; Romanelli, V; Nevado, J; James, VM; Topf, M; Chung, SK; Thomas, RH; Desviat, LR; Aragon, C; Zafra, F; Rees, MI; Lapunzina, P; Harvey, RJ; Lopez-Corcuera, B				Gimenez, Cecilio; Perez-Siles, Gonzalo; Martinez-Villarreal, Jaime; Arribas-Gonzalez, Esther; Jimenez, Esperanza; Nunez, Enrique; de Juan-Sanz, Jaime; Fernandez-Sanchez, Enrique; Garcia-Tardon, Noemi; Ibanez, Ignacio; Romanelli, Valeria; Nevado, Julian; James, Victoria M.; Topf, Maya; Chung, Seo-Kyung; Thomas, Rhys H.; Desviat, Lourdes R.; Aragon, Carmen; Zafra, Francisco; Rees, Mark I.; Lapunzina, Pablo; Harvey, Robert J.; Lopez-Corcuera, Beatriz			A Novel Dominant Hyperekplexia Mutation Y705C Alters Trafficking and Biochemical Properties of the Presynaptic Glycine Transporter GlyT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTOR; SENSING ION CHANNELS; PROTEIN-KINASE-C; SUBCELLULAR-LOCALIZATION; STARTLE DISEASE; PLASMA-MEMBRANE; MOLECULAR-BASIS; SUBTYPE 1B; ZN2+; MATURATION	Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, producing hypertonia and apnea episodes. Although rare, this orphan disorder can have serious consequences, including sudden infant death. Dominant and recessive mutations in the human glycine receptor (GlyR) alpha 1 gene (GLRA1) are the major cause of this disorder. However, recessive mutations in the presynaptic Na+/Cl--dependent glycine transporter GlyT2 gene (SLC6A5) are rapidly emerging as a second major cause of startle disease. In this study, systematic DNA sequencing of SLC6A5 revealed a new dominant GlyT2 mutation: pY705C (c.2114A3 -> G) in transmembrane domain 11, in eight individuals from Spain and the United Kingdom. Curiously, individuals harboring this mutation show significant variation in clinical presentation. In addition to classical hyperekplexia symptoms, some individuals had abnormal respiration, facial dysmorphism, delayed motor development, or intellectual disability. We functionally characterized this mutation using molecular modeling, electrophysiology, [H-3]glycine transport, cell surface expression, and cysteine labeling assays. We found that the introduced cysteine interacts with the cysteine pair Cys-311-Cys-320 in the second external loop of GlyT2. This interaction impairs transporter maturation through the secretory pathway, reduces surface expression, and inhibits transport function. Additionally, Y705C presents altered H+ and Zn2+ dependence of glycine transport that may affect the function of glycinergic neurotransmission in vivo.	[Gimenez, Cecilio; Perez-Siles, Gonzalo; Martinez-Villarreal, Jaime; Arribas-Gonzalez, Esther; Jimenez, Esperanza; Nunez, Enrique; de Juan-Sanz, Jaime; Fernandez-Sanchez, Enrique; Garcia-Tardon, Noemi; Ibanez, Ignacio; Desviat, Lourdes R.; Aragon, Carmen; Zafra, Francisco; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Gimenez, Cecilio; Perez-Siles, Gonzalo; Martinez-Villarreal, Jaime; Jimenez, Esperanza; Nunez, Enrique; de Juan-Sanz, Jaime; Garcia-Tardon, Noemi; Romanelli, Valeria; Nevado, Julian; Aragon, Carmen; Zafra, Francisco; Lapunzina, Pablo; Lopez-Corcuera, Beatriz] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Romanelli, Valeria; Nevado, Julian; Lapunzina, Pablo] Univ Autonoma Madrid, IdiPAZ Hosp Univ La Paz, Inst Genet Med & Mol, Madrid 28046, Spain; [James, Victoria M.; Harvey, Robert J.] UCL, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Topf, Maya] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Chung, Seo-Kyung; Thomas, Rhys H.; Rees, Mark I.] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz; University of London; University College London; University of London School of Pharmacy; University of London; Birkbeck University London; Swansea University	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain.	blopez@cbm.uam.es	Thomas, Rhys/I-3840-2019; Aragon, Carmen/K-9783-2014; Harvey, Robert/D-3994-2016; Chung, Seo-Kyung/I-3329-2017; Chung, Seo-Kyung/AAT-4693-2021; Rees, Mark I/J-3129-2012; Gimenez, Cecilio/K-8027-2014; nevado, julian/ADX-5844-2022; Zafra, Francisco/A-6121-2008; Corcuera, Beatriz López/D-5188-2009; Lapunzina, Pablo/L-7075-2014; de Juan-Sanz, Jaime/L-7990-2017; DESVIAT, LOURDES R/L-3055-2013	Thomas, Rhys/0000-0003-2062-8623; Aragon, Carmen/0000-0001-8287-9386; Harvey, Robert/0000-0001-5956-6664; Chung, Seo-Kyung/0000-0002-5008-8384; Chung, Seo-Kyung/0000-0002-5008-8384; Rees, Mark I/0000-0003-3570-5986; Gimenez, Cecilio/0000-0001-6726-8405; nevado, julian/0000-0001-5611-2659; Zafra, Francisco/0000-0003-3801-3109; Corcuera, Beatriz López/0000-0002-0383-4241; Lapunzina, Pablo/0000-0002-6324-4825; Arribas Gonzalez, Esther/0000-0001-6579-3396; de Juan-Sanz, Jaime/0000-0002-1212-5623; Martinez Villarreal, Jaime/0000-0002-3003-7766; James, Victoria/0000-0002-9265-5914; DESVIAT, LOURDES R/0000-0003-0492-3323; Topf, Maya/0000-0002-8185-1215	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica [BFU2005-05931/BMC, BIO2005-05786]; Ministerio de Ciencia e Innovacion [SAF2008-05436]; Comunidad Autonoma de Madrid [11/BCB/010, S-SAL-0253/2006]; Ministerio de Economia y Competitividad [SAF2011-28674]; Centro de Investigacion Biomedica en Red de Enfermedades Raras Intramural [U-751/U-753]; Fundacion Ramon Areces; Medical Research Council [G0601585]; Action Medical Research Grant [1966]; European Regional Development Fund [BFU2007-30688-E/BFI]; Medical Research Council [G0600084] Funding Source: researchfish; Action Medical Research [1966] Funding Source: researchfish; MRC [G0600084, G0601585] Funding Source: UKRI	Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Economia y Competitividad(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Raras Intramural; Fundacion Ramon Areces; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research Grant; European Regional Development Fund(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Spanish Direccion General de Ensenanza Superior e Investigacion Cientifica Grants BFU2005-05931/BMC and BIO2005-05786, Ministerio de Ciencia e Innovacion Grant SAF2008-05436, Comunidad Autonoma de Madrid Grants 11/BCB/010 and S-SAL-0253/2006, Ministerio de Economia y Competitividad Grant SAF2011-28674, Centro de Investigacion Biomedica en Red de Enfermedades Raras Intramural Project U-751/U-753, an institutional grant from the Fundacion Ramon Areces, Medical Research Council Grant G0601585, and Action Medical Research Grant 1966. The group is member of the European Regional Development Fund Grant BFU2007-30688-E/BFI.	ANDERMANN F, 1980, BRAIN, V103, P985, DOI 10.1093/brain/103.4.985; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Aubrey KR, 2000, MOL PHARMACOL, V58, P129, DOI 10.1124/mol.58.1.129; Baron A, 2008, J NEUROSCI, V28, P1498, DOI 10.1523/JNEUROSCI.4975-07.2008; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Chen ZL, 2004, J BIOL CHEM, V279, P876, DOI 10.1074/jbc.M307684200; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; DUNN SMJ, 1986, BIOCHEM BIOPH RES CO, V139, P830, DOI 10.1016/S0006-291X(86)80065-1; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Forlani G, 2001, J PHYSIOL-LONDON, V536, P479, DOI 10.1111/j.1469-7793.2001.0479c.xd; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, CURR OPIN DRUG DISC, V6, P675; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Grossman TR, 2003, NEUROCHEM INT, V43, P431, DOI 10.1016/S0197-0186(03)00032-9; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P3606, DOI 10.1093/nar/17.9.3606; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hepojoki J, 2010, J VIROL, V84, P227, DOI 10.1128/JVI.00481-09; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laube B, 2002, EUR J NEUROSCI, V16, P1025, DOI 10.1046/j.1460-9568.2002.02170.x; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Li YF, 2003, J PHYSIOL-LONDON, V552, P73, DOI 10.1113/jphysiol.2003.047324; Lopez-Corcuera B, 1998, J NEUROCHEM, V71, P2211; Lynch JW, 1998, J NEUROCHEM, V71, P2159; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Perez-Siles G, 2012, BIOCHEM J, V442, P323, DOI 10.1042/BJ20110247; Perez-Siles G, 2011, J NEUROCHEM, V118, P195, DOI 10.1111/j.1471-4159.2011.07309.x; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Toth K, 2011, ANNU REV NUTR, V31, P139, DOI 10.1146/annurev-nutr-072610-145218; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	55	31	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28986	29002		10.1074/jbc.M111.319244	http://dx.doi.org/10.1074/jbc.M111.319244			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753417	Green Published, hybrid			2022-12-28	WOS:000308074600067
J	Moreno-Sanchez, D; Hernandez-Ruiz, L; Ruiz, FA; Docampo, R				Moreno-Sanchez, David; Hernandez-Ruiz, Laura; Ruiz, Felix A.; Docampo, Roberto			Polyphosphate Is a Novel Pro-inflammatory Regulator of Mast Cells and Is Located in Acidocalcisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULES IN-SITU; INORGANIC POLYPHOSPHATE; SECRETORY GRANULES; CALCIUM; GROWTH; MICROANALYSIS; FLUORESCENCE; COAGULATION; MOLECULE; BACTERIA	Polyphosphate (polyP) is a pro-inflammatory agent and a potent modulator of the human blood-clotting system. The presence of polyP of 60 phosphate units was identified in rat basophilic leukemia (RBL-2H3) mast cells using specific enzymatic assays, urea-polyacrylamide gel electrophoresis of cell extracts, and staining of cells with 4,6-diamidino-2-phenylindole (DAPI), and the polyP-binding domain of Escherichia coli exopolyphosphatase. PolyP co-localizes with serotonin-but not with histamine-containinggranules. PolyP levels greatly decreased in mast cells stimulated to degranulate by IgE. Mast cell granules were isolated and found to be acidic and decrease their polyP content upon alkalinization. In agreement with these results, when RBL-2H3 mast cells were loaded with the fluorescent calcium indicator fura-2 acetoxymethyl ester to measure their intracellular Ca2+ concentration ([Ca2+](i)), they were shown to possess a significant amount of Ca2+ stored in an acidic compartment different from lysosomes. PolyP derived from RBL-2H3 mast cells stimulated bradykinin formation, and it was also detected in human basophils. All of these characteristics of mast cell granules, together with their known elemental composition, and high density, are similar to those of acidocalcisomes. The results suggest that mast cells polyP could be an important mediator of their pro-inflammatory and pro-coagulant activities.	[Moreno-Sanchez, David; Hernandez-Ruiz, Laura; Ruiz, Felix A.] Univ Cadiz, Fac Med, Hosp Univ Puerta del Mar, Unidad Invest, Cadiz 11009, Spain; [Moreno-Sanchez, David; Hernandez-Ruiz, Laura; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Moreno-Sanchez, David; Hernandez-Ruiz, Laura; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidad de Cadiz; Hospital Universitario Puerta del Mar; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ruiz, FA (corresponding author), Univ Cadiz, Fac Med, Hosp Univ Puerta del Mar, Unidad Invest, 9A Planta,Ave Ana de Viya 21, Cadiz 11009, Spain.	felix.ruiz@uca.es; rdocampo@uga.edu	Ruiz, Felix A./B-1032-2008	Ruiz, Felix A./0000-0003-0748-5015; Hernandez, Laura/0000-0002-1967-959X	European Regional Development Fund; Spanish Ministry of Economy and Competitiveness [FIS/PI10/01222]; Junta de Andalucia [P07-CTS-02765, C.S.0257/09]; Barbara and Sanford Orkin/Georgia Research Alliance Endowment	European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); Barbara and Sanford Orkin/Georgia Research Alliance Endowment	This work was supported by grants from European Regional Development Fund and Spanish Ministry of Economy and Competitiveness Grant FIS/PI10/01222 and Junta de Andalucia Grants P07-CTS-02765 and C.S.0257/09 (to F. A. R.) and by the Barbara and Sanford Orkin/Georgia Research Alliance Endowment (to R. D.).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; Babes V., 1895, Z HYG INFEKTIONSKR, V20, P412, DOI DOI 10.1007/BF02216664; CHAKRAVARTY N, 1980, EXP CELL RES, V130, P175, DOI 10.1016/0014-4827(80)90054-3; Chodaczek G, 2009, MOL IMMUNOL, V46, P2505, DOI 10.1016/j.molimm.2009.05.023; Cugno M, 2010, INTERN EMERG MED, V5, P97, DOI 10.1007/s11739-009-0333-5; Cutler DF, 2002, SEMIN CELL DEV BIOL, V13, P261, DOI 10.1016/S108495210200054X; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Jimenez-Nunez M. D., 2012, HAEMATOLOGI IN PRESS; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; KENDALL MD, 1986, J CELL SCI, V83, P77; Kovanen PT, 2009, CURR ATHEROSCLER REP, V11, P214, DOI 10.1007/s11883-009-0033-7; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Lindstedt K. A., 2006, CURR PROTOC CELL BIO; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Meininger C J, 1992, Semin Cancer Biol, V3, P73; Meyer A., 1904, BOT Z, V62, P113; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; MULLER AD, 1993, THROMB RES, V72, P263, DOI 10.1016/0049-3848(93)90193-R; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; ORNBERG RL, 1988, J BIOL CHEM, V263, P1488; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Raison S, 1999, CELL CALCIUM, V26, P111, DOI 10.1054/ceca.1999.0062; Ramos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027276; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saito K, 2005, APPL ENVIRON MICROB, V71, P5692, DOI 10.1128/AEM.71.10.5692-5701.2005; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; SOMLYO AV, 1988, P NATL ACAD SCI USA, V85, P6222, DOI 10.1073/pnas.85.16.6222; Teshima R, 2007, INT IMMUNOPHARMACOL, V7, P205, DOI 10.1016/j.intimp.2006.09.017; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WIAME JM, 1947, BIOCHIM BIOPHYS ACTA, V1, P234, DOI 10.1016/0006-3002(47)90137-6	49	89	92	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28435	28444		10.1074/jbc.M112.385823	http://dx.doi.org/10.1074/jbc.M112.385823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761438	hybrid, Green Published			2022-12-28	WOS:000308074600019
J	Bali, M; Akabas, MH				Bali, Moez; Akabas, Myles H.			Gating-induced Conformational Rearrangement of the gamma-Aminobutyric Acid Type A Receptor beta-alpha Subunit Interface in the Membrane-spanning Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-LINING RESIDUES; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; ANESTHETIC BINDING-SITE; X-RAY-STRUCTURE; GABA(A) RECEPTOR; M2 SEGMENT; PROTEIN MOBILITY; M1 SEGMENT; OPEN STATE	GABA(A) receptors mediate fast inhibitory synaptic transmission. The transmembrane ion channel is lined by a ring of five alpha helices, M2 segments, one from each subunit. An outer ring of helices comprising the alternating M1, M3, and M4 segments from each subunit surrounds the inner ring and forms the interface with the lipid bilayer. The structural rearrangements that follow agonist binding and culminate in opening of the ion pore remain incompletely characterized. Propofol and other intravenous general anesthetics bind at the beta M3-alpha M1 subunit interface. We sought to determine whether this region undergoes conformational changes during GABA activation. We measured the reaction rate of p-chloromercuribenzenesulfonate (pCMBS) with cysteines substituted in the GABA(A) receptor alpha 1M1 and beta 2M3 segments. In the presence of GABA, the pCMBS reaction rate increased significantly in a cluster of residues in the extracellular third of the alpha 1M1 segment facing the beta 2M3 segment. Mutation of the beta 2M2 segment 19' position, R269Q, altered the pCMBS reaction rate with several alpha 1M1 Cys, some only in the resting state and others only in the GABA-activated state. Thus, beta 2R269 is charged in both states. GABA activation induced disulfide bond formation between beta 2R269C and alpha 1I228C. The experiments demonstrate that alpha 1M1 moves in relationship to beta 2M2R269 during gating. Thus, channel gating does not involve rigid body movements of the entire transmembrane domain. Channel gating causes changes in the relative position of transmembrane segments both within a single subunit and relative to the neighboring subunits.	[Bali, Moez; Akabas, Myles H.] Yeshiva Univ, Dept Physiol & Biophys, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Dept Neurosci & Med, Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Yeshiva Univ, Dept Physiol & Biophys, Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [R01 NS030808]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS030808 (to M. H. A.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bera AK, 2005, J BIOL CHEM, V280, P35506, DOI 10.1074/jbc.M504645200; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	47	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27762	27770		10.1074/jbc.M112.363341	http://dx.doi.org/10.1074/jbc.M112.363341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730325	hybrid, Green Published			2022-12-28	WOS:000307840700050
J	Tam, JP; Wong, CTT				Tam, James P.; Wong, Clarence T. T.			Chemical Synthesis of Circular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNPROTECTED PEPTIDE SEGMENTS; ENZYMATIC CYCLIZATION; STAUDINGER LIGATION; CYCLIC-PEPTIDES; ALPHA-DEFENSINS; STRATEGY; SUBTILIGASE; CYCLOTIDES; PRECURSOR; DESULFURIZATION	Circular proteins, once thought to be rare, are now commonly found in plants. Their chemical synthesis, once thought to be difficult, is now readily achievable. The enabling methodology is largely due to the advances in entropic chemical ligation to overcome the entropy barrier in coupling the N- and C-terminal ends of large peptide segments for either intermolecular ligation or intramolecular ligation in end-to-end cyclization. Key elements of an entropic chemical ligation consist of a chemoselective capture step merging the N and C termini as a covalently linked O/S-ester intermediate to permit the subsequent step of an intramolecular O/S-N acyl shift to form an amide. Many ligation methods exploit the supernucleophilicity of a thiol side chain at the N terminus for the capture reaction, which makes cysteine-rich peptides ideal candidates for the entropy-driven macrocyclization. Advances in desulfurization and modification of the thiol-containing amino acids at the ligation sites to other amino acids add extra dimensions to the entropy-driven ligation methods. This minireview describes recent advances of entropy-driven ligation to prepare circular proteins with or without a cysteinyl side chain.	[Tam, James P.; Wong, Clarence T. T.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Wong, Clarence Tsun Ting/AAH-6159-2020; Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Wong, Clarence Tsun Ting/0000-0001-8950-0033	Biomedical Research Council from A*STAR [09/1/22/19/612]; Ministry of Education, Singapore [ARC21/08]	Biomedical Research Council from A*STAR; Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported in part by Biomedical Research Council Grant 09/1/22/19/612 from A*STAR and Academic Research Fund Grant ARC21/08 from the Ministry of Education, Singapore. This is the fourth article in the Thematic Minireview Series on Circular Proteins.	Aboye TL, 2008, CHEMBIOCHEM, V9, P103, DOI 10.1002/cbic.200700357; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bergmann M, 1938, J BIOL CHEM, V124, P321; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Botti P, 1996, J AM CHEM SOC, V118, P10018, DOI 10.1021/ja954278g; Braisted AC, 1997, METHOD ENZYMOL, V289, P298; Brik A, 2006, J AM CHEM SOC, V128, P5626, DOI 10.1021/ja061165w; Camarero JA, 1999, J AM CHEM SOC, V121, P5597, DOI 10.1021/ja990929n; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Chen J, 2008, ANGEW CHEM INT EDIT, V47, P8521, DOI 10.1002/anie.200803523; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Craik DJ, 2011, J ORG CHEM, V76, P4805, DOI 10.1021/jo200520v; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; Crich D, 2007, J AM CHEM SOC, V129, P10064, DOI 10.1021/ja072804l; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Gunasekera S, 2009, ANTIOXID REDOX SIGN, V11, P971, DOI [10.1089/ars.2008.2295, 10.1089/ARS.2008.2295]; Haase C, 2008, ANGEW CHEM INT EDIT, V47, P6807, DOI 10.1002/anie.200801590; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hanson S, 2004, TRENDS BIOCHEM SCI, V29, P656, DOI 10.1016/j.tibs.2004.10.004; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; JACKSON DY, 1995, J AM CHEM SOC, V117, P819, DOI 10.1021/ja00107a027; Johnson ECB, 2007, J MOL BIOL, V373, P573, DOI 10.1016/j.jmb.2007.07.054; Kadokura H, 2006, ANTIOXID REDOX SIGN, V8, P731, DOI 10.1089/ars.2006.8.731; KEMP DS, 1981, BIOPOLYMERS, V20, P1793, DOI 10.1002/bip.1981.360200904; Li XC, 2010, ORG LETT, V12, P1724, DOI 10.1021/ol1003109; LIU CF, 1994, J AM CHEM SOC, V116, P4149, DOI 10.1021/ja00089a001; LIU CF, 1994, P NATL ACAD SCI USA, V91, P6584, DOI 10.1073/pnas.91.14.6584; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; Muttenthaler M, 2010, J AM CHEM SOC, V132, P3514, DOI 10.1021/ja910602h; Nakamura K, 2009, J PEPT SCI, V15, P731, DOI 10.1002/psc.1164; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; Severinov K, 1998, J BIOL CHEM, V273, P16205, DOI 10.1074/jbc.273.26.16205; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; Tam JP, 1999, BIOPOLYMERS, V51, P311, DOI 10.1002/(SICI)1097-0282(1999)51:5<311::AID-BIP2>3.0.CO;2-A; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1995, P NATL ACAD SCI USA, V92, P12485, DOI 10.1073/pnas.92.26.12485; Tam JP, 1999, J AM CHEM SOC, V121, P4316, DOI 10.1021/ja984480u; Tam JP, 1998, BIOPOLYMERS, V46, P319, DOI 10.1002/(SICI)1097-0282(19981015)46:5<319::AID-BIP3>3.0.CO;2-S; Tam JP, 1997, TETRAHEDRON LETT, V38, P5599, DOI 10.1016/S0040-4039(97)01271-9; Tan XH, 2008, TETRAHEDRON LETT, V49, P2891, DOI 10.1016/j.tetlet.2008.03.028; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Villain M, 2003, EUR J ORG CHEM, V2003, P3267, DOI 10.1002/ejoc.200300032; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; WIELAND T, 1953, LIEBIGS ANN CHEM, V580, P159; Wong CTT, 2011, BIOCHEMISTRY-US, V50, P7275, DOI 10.1021/bi2007004; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m; Yang RL, 2009, J AM CHEM SOC, V131, P13592, DOI 10.1021/ja905491p; Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943; Zhang LS, 1997, TETRAHEDRON LETT, V38, P3, DOI 10.1016/S0040-4039(96)02260-5; Zhang LS, 1997, TETRAHEDRON LETT, V38, P4375, DOI 10.1016/S0040-4039(97)00935-0	61	52	56	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27020	27025		10.1074/jbc.R111.323568	http://dx.doi.org/10.1074/jbc.R111.323568			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700959	hybrid, Green Published			2022-12-28	WOS:000307386000051
J	Dong, YS; Zhang, LJ; Zhang, S; Bai, YP; Chen, HY; Sun, XX; Yong, WD; Li, W; Colvin, SC; Rhodes, SJ; Shou, WN; Zhang, ZY				Dong, Yuanshu; Zhang, Lujuan; Zhang, Sheng; Bai, Yunpeng; Chen, Hanying; Sun, Xiaoxin; Yong, Weidong; Li, Wei; Colvin, Stephanie C.; Rhodes, Simon J.; Shou, Weinian; Zhang, Zhong-Yin			Phosphatase of Regenerating Liver 2 (PRL2) Is Essential for Placental Development by Down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and Activating Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR; CELL-MIGRATION; GLYCOGEN CELLS; INVASION; METASTASIS; EXPRESSION; STABILITY; BINDING	The PRL (phosphatase of regenerating liver) phosphatases are implicated in the control of cell proliferation and invasion. Aberrant PRL expression is associated with progression and metastasis of multiple cancers. However, the specific in vivo function of the PRLs remains elusive. Here we show that deletion of PRL2, the most ubiquitously expressed PRL family member, leads to impaired placental development and retarded growth at both embryonic and adult stages. Ablation of PRL2 inactivates Akt and blocks glycogen cell proliferation, resulting in reduced spongiotrophoblast and decidual layers in the placenta. These structural defects cause placental hypotrophy and insufficiency, leading to fetal growth retardation. We demonstrate that the tumor suppressor PTEN is elevated in PRL2-deficient placenta. Biochemical analyses indicate that PRL2 promotes Akt activation by down-regulating PTEN through the proteasome pathway. This study provides the first evidence that PRL2 is required for extra-embryonic development and associates the oncogenic properties of PRL2 with its ability to negatively regulate PTEN, thereby activating the PI3K-Akt pathway.	[Dong, Yuanshu; Zhang, Lujuan; Zhang, Sheng; Bai, Yunpeng; Shou, Weinian; Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chen, Hanying; Sun, Xiaoxin; Yong, Weidong; Li, Wei; Shou, Weinian] Indiana Univ Sch Med, Riley Heart Res Ctr, Dept Pediat, Indianapolis, IN 46202 USA; [Colvin, Stephanie C.; Rhodes, Simon J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, ZY (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu			National Institutes of Health [CA69202, HL85098, HD42024]; Indiana University Collaborative Research Grant (IUCRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042024] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, P01HL085098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Collaborative Research Grant (IUCRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA69202 (to Z. Y. Z.), HL85098 (to W. S.), and HD42024 (to S. J. R.). This work was also supported by an Indiana University Collaborative Research Grant (IUCRG) pilot grant.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dackor J, 2009, GENETICS, V183, P207, DOI 10.1534/genetics.109.104372; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dumaual CM, 2006, J HISTOCHEM CYTOCHEM, V54, P1401, DOI 10.1369/jhc.6A7019.2006; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Franco D, 2001, EUR J MORPHOL, V39, P169, DOI 10.1076/ejom.39.3.169.4670; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lopez MF, 1996, ENDOCRINOLOGY, V137, P2100, DOI 10.1210/en.137.5.2100; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Okada T, 1996, BIOCHEM J, V317, P475, DOI 10.1042/bj3170475; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Werner SR, 2003, CANCER LETT, V202, P201, DOI 10.1016/S0304-3835(03)00517-2; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhao ZY, 1996, GENOMICS, V35, P172, DOI 10.1006/geno.1996.0336	36	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32172	32179		10.1074/jbc.M112.393462	http://dx.doi.org/10.1074/jbc.M112.393462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22791713	Green Published, hybrid			2022-12-28	WOS:000309059400054
J	Lovering, AL; Gretes, MC; Safadi, SS; Danel, F; de Castro, L; Page, MGP; Strynadka, NCJ				Lovering, Andrew L.; Gretes, Michael C.; Safadi, Susan S.; Danel, Franck; de Castro, Liza; Page, Malcolm G. P.; Strynadka, Natalie C. J.			Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM ANTIBIOTICS; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; ESCHERICHIA-COLI; IN-VITRO; CLASS-A; CRYSTALLOGRAPHY; PEPTIDASE; KINETICS	Methicillin-resistant Staphylococcus aureus (MRSA) is an antibiotic-resistant strain of S. aureus afflicting hospitals and communities worldwide. Of greatest concern is its development of resistance to current last-line-of-defense antibiotics; new therapeutics are urgently needed to combat this pathogen. Ceftobiprole is a recently developed, latest generation cephalosporin and has been the first to show activity against MRSA by inhibiting essential peptidoglycan transpeptidases, including the beta-lactam resistance determinant PBP2a, from MRSA. Here we present the structure of the complex of ceftobiprole bound to PBP2a. This structure provides the first look at the molecular details of an effective beta-lactam-resistant PBP interaction, leading to new insights into the mechanism of ceftobiprole efficacy against MRSA.	[Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Danel, Franck; Strynadka, Natalie C. J.] Basilea Pharmaceut Int Ltd, CH-4058 Basel, Switzerland	University of British Columbia; University of British Columbia; Basilea Pharmaceutica Ltd.	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Lovering, Andrew/0000-0002-1856-7975	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Michael Smith Foundation of Health Research; Canada Foundation for Innovation; Royal Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation of Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Royal Society(Royal Society of London)	This work was supported by operating grants from the Canadian Institutes of Health Research and Howard Hughes Medical Institute and infrastructure grants from the Michael Smith Foundation of Health Research and the Canada Foundation for Innovation (to N. C. J. S.).; Supported by a New Investigator award from the Royal Society.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECK WD, 1986, J BACTERIOL, V165, P373, DOI 10.1128/jb.165.2.373-378.1986; Bogdanovich T, 2005, ANTIMICROB AGENTS CH, V49, P4210, DOI 10.1128/AAC.49.10.4210-4219.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chambers HF, 2003, TRENDS MICROBIOL, V11, P145, DOI 10.1016/S0966-842X(03)00046-5; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Davies TA, 2007, ANTIMICROB AGENTS CH, V51, P2621, DOI 10.1128/AAC.00029-07; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doshi RK, 2009, MT SINAI J MED, V76, P84, DOI 10.1002/msj.20070; FRERE JM, 1975, EUR J BIOCHEM, V57, P343, DOI 10.1111/j.1432-1033.1975.tb02307.x; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Gales AC, 2006, INT J ANTIMICROB AG, V27, P300, DOI 10.1016/j.ijantimicag.2005.11.008; GEORGOPAPADAKOU NH, 1993, ANTIMICROB AGENTS CH, V37, P2045, DOI 10.1128/AAC.37.10.2045; Ghuysen Jean-Marie, 1994, Trends in Microbiology, V2, P372, DOI 10.1016/0966-842X(94)90614-9; GHUYSEN JM, 1986, BIOCHEM J, V235, P159, DOI 10.1042/bj2350159; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Hebeisen P, 2001, ANTIMICROB AGENTS CH, V45, P825, DOI 10.1128/AAC.45.3.825-836.2001; Jones ME, 2007, CLIN MICROBIOL INFEC, V13, P17, DOI 10.1111/j.1469-0691.2007.01722.x; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Livermore DM, 2006, CLIN MICROBIOL INFEC, V12, P11, DOI 10.1111/j.1469-0691.2006.01403.x; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Lu WP, 1999, BIOCHEMISTRY-US, V38, P6537, DOI 10.1021/bi990025e; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Macheboeuf P, 2005, P NATL ACAD SCI USA, V102, P577, DOI 10.1073/pnas.0407186102; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Page MG, 2004, EXPERT OPIN INV DRUG, V13, P973, DOI 10.1517/13543784.13.8.973; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyykko P, 2009, CHEM-EUR J, V15, P12770, DOI 10.1002/chem.200901472; Queenan AM, 2007, ANTIMICROB AGENTS CH, V51, P3089, DOI 10.1128/AAC.00218-07; REYNOLDS PE, 1985, FEBS LETT, V192, P28, DOI 10.1016/0014-5793(85)80036-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Silvaggi NR, 2005, J MOL BIOL, V345, P521, DOI 10.1016/j.jmb.2004.10.076; SUMITA Y, 1995, J ANTIMICROB CHEMOTH, V35, P473, DOI 10.1093/jac/35.4.473; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; UTSUI Y, 1985, ANTIMICROB AGENTS CH, V28, P397, DOI 10.1128/AAC.28.3.397	45	65	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32096	32102		10.1074/jbc.M112.355644	http://dx.doi.org/10.1074/jbc.M112.355644			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815485	hybrid, Green Published			2022-12-28	WOS:000309059400047
J	Petrushanko, IY; Yakushev, S; Mitkevich, VA; Kamanina, YV; Ziganshin, RH; Meng, XY; Anashkina, AA; Makhro, A; Lopina, OD; Gassmann, M; Makarov, AA; Bogdanova, A				Petrushanko, Irina Yu.; Yakushev, Sergej; Mitkevich, Vladimir A.; Kamanina, Yuliya V.; Ziganshin, Rustam H.; Meng, Xianyu; Anashkina, Anastasiya A.; Makhro, Asya; Lopina, Olga D.; Gassmann, Max; Makarov, Alexander A.; Bogdanova, Anna			S-Glutathionylation of the Na,K-ATPase Catalytic alpha Subunit Is a Determinant of the Enzyme Redox Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE OXIDATIVE MODIFICATION; OXYGEN-INDUCED REGULATION; NA-K-ATPASE; CARDIAC MYOCYTES; PUMP; INHIBITION; CYSTEINE; GLUTATHIOLATION; NITROSYLATION; NA+,K+-ATPASE	Na,K-ATPase is highly sensitive to changes in the redox state, and yet the mechanisms of its redox sensitivity remain unclear. We have explored the possible involvement of S-glutathionylation of the catalytic alpha subunit in redox-induced responses. For the first time, the presence of S-glutathionylated cysteine residues was shown in the alpha subunit in duck salt glands, rabbit kidneys, and rat myocardium. Exposure of the Na, K-ATPase to oxidized glutathione (GSSG) resulted in an increase in the number of S-glutathionylated cysteine residues. Increase in S-glutathionylation was associated with dose- and time-dependent suppression of the enzyme function up to its complete inhibition. The enzyme inhibition concurred with S-glutathionylation of the Cys-454, -458, -459, and -244. Upon binding of glutathione to these cysteines, the enzyme was unable to interact with adenine nucleotides. Inhibition of the Na, K-ATPase by GSSG did not occur in the presence of ATP at concentrations above 0.5 mM. Deglutathionylation of the alpha subunit catalyzed by glutaredoxin or dithiothreitol resulted in restoration of the Na,K-ATPase activity. Oxidation of regulatory cysteines made them inaccessible for glutathionylation but had no profound effect on the enzyme activity. Regulatory S-glutathionylation of the alpha subunit was induced in rat myocardium in response to hypoxia and was associated with oxidative stress and ATP depletion. S-Glutathionylation was followed by suppression of the Na, K-ATPase activity. The rat alpha 2 isoform was more sensitive to GSSG than the alpha 1 isoform. Our findings imply that regulatory S-glutathionylation of the catalytic subunit plays a key role in the redox-induced regulation of Na,K-ATPase activity.	[Petrushanko, Irina Yu.; Mitkevich, Vladimir A.; Anashkina, Anastasiya A.; Makarov, Alexander A.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 11999, Russia; [Bogdanova, Anna] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, CH-8057 Zurich, Switzerland; [Yakushev, Sergej; Makhro, Asya; Gassmann, Max; Bogdanova, Anna] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kamanina, Yuliya V.; Meng, Xianyu; Lopina, Olga D.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119234, Russia; [Ziganshin, Rustam H.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Makarov, AA (corresponding author), RAS, VA Engelhardt Mol Biol Inst, 32 Vavilova St, Moscow 119991, Russia.	aamakarov@eimb.ru; annab@access.uzh.ch	Lopina, Olga/ABE-6918-2021; Bogdanova, Anna Yu/M-1977-2017; Makarov, Alexander/P-5279-2016; Ziganshin, Rustam/Q-7445-2016; Mitkevich, Vladimir A/M-3897-2017; Anashkina, Anastasia/E-6078-2016; Mitkevich, Vladimir/AAA-4160-2022	Lopina, Olga/0000-0001-9608-0196; Bogdanova, Anna Yu/0000-0003-0502-5381; Ziganshin, Rustam/0000-0002-7931-519X; Mitkevich, Vladimir A/0000-0002-1517-1983; Anashkina, Anastasia/0000-0003-1763-300X; Mitkevich, Vladimir/0000-0002-1517-1983; Gassmann, Max/0000-0003-2750-8878	Swiss Academy of Sciences [112449, 310030_124970/1]; Forschungskredit scholarship; Russian Foundation for Basic Research [07-04-01355, 08-04-01321]; Molecular and Cellular Biology Program of the Russian Academy of Sciences; Russian Federal Program [16.512.11.2280]	Swiss Academy of Sciences; Forschungskredit scholarship; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cellular Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federal Program	This work was supported by Swiss Academy of Sciences Grants 112449 and 310030_124970/1 (to A. B.), a Forschungskredit scholarship (to S. Y.), Russian Foundation for Basic Research Grants 07-04-01355 (to I. P.) and 08-04-01321 (to O. L.), the Molecular and Cellular Biology Program of the Russian Academy of Sciences, and by Russian Federal Program Contract 16.512.11.2280 (to A. M. and I. P.).	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bers DM, 2006, J PHARMACOL SCI, V100, P315, DOI 10.1254/jphs.CPJ06001X; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bogdanova A., 2006, CURRENT ENZYME INHIB, V2, P37, DOI [10.2174/157340806775473490, DOI 10.2174/157340806775473490]; Bogdanova AY, 2003, J MEMBRANE BIOL, V195, P33, DOI 10.1007/s00232-003-2042-8; CAPPEL RE, 1986, J BIOL CHEM, V261, P5385; Cappiello M, 1996, J BIOL CHEM, V271, P33539, DOI 10.1074/jbc.271.52.33539; Cortes A, 2001, BIOCHEM J, V357, P263, DOI 10.1042/0264-6021:3570263; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fuller W, 2003, CARDIOVASC RES, V57, P1044, DOI 10.1016/S0008-6363(02)00810-6; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; Grycova L, 2009, BBA-BIOMEMBRANES, V1788, P1081, DOI 10.1016/j.bbamem.2009.02.004; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Komniski MS, 2011, AM J PHYSIOL-HEART C, V300, pH1645, DOI 10.1152/ajpheart.00220.2010; Kurella EG, 1999, CELL MOL NEUROBIOL, V19, P133, DOI 10.1023/A:1006976810642; Lancel S, 2009, CIRC RES, V104, P720, DOI 10.1161/CIRCRESAHA.108.188441; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mitkevich VA, 2006, NUCLEIC ACIDS RES, V34, P3947, DOI 10.1093/nar/gkl549; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Petrushanko I, 2006, AM J PHYSIOL-REG I, V290, pR916, DOI 10.1152/ajpregu.00038.2005; Petrushanko IY, 2007, J GEN PHYSIOL, V130, P389, DOI 10.1085/jgp.200709783; Rasmussen HH, 2010, TRENDS CARDIOVAS MED, V20, P85, DOI 10.1016/j.tcm.2010.06.002; RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi HLG, 2000, BBA-BIOMEMBRANES, V1464, P177, DOI 10.1016/S0005-2736(99)00245-X; SMITH TW, 1988, METHOD ENZYMOL, V156, P46; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; XIE Z, 1995, BIOCHEM BIOPH RES CO, V207, P155, DOI 10.1006/bbrc.1995.1166; Xu KY, 1997, ANN NY ACAD SCI, V834, P680, DOI 10.1111/j.1749-6632.1997.tb52349.x	39	85	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32195	32205		10.1074/jbc.M112.391094	http://dx.doi.org/10.1074/jbc.M112.391094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22798075	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000309059400056
J	Crespo, R; Rocha, FA; Damas, AM; Martins, PM				Crespo, Rosa; Rocha, Fernando A.; Damas, Ana M.; Martins, Pedro M.			A Generic Crystallization-like Model That Describes the Kinetics of Amyloid Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; ATOMIC-FORCE MICROSCOPY; PROTEIN AGGREGATION; APOLIPOPROTEIN-E; CRYSTAL-GROWTH; PRION PROTEIN; LAG TIME; NUCLEATION; MECHANISM; BETA(2)-MICROGLOBULIN	Associated with neurodegenerative disorders such as Alzheimer, Parkinson, or prion diseases, the conversion of soluble proteins into amyloid fibrils remains poorly understood. Extensive "in vitro" measurements of protein aggregation kinetics have been reported, but no consensus mechanism has emerged until now. This contribution aims at overcoming this gap by proposing a theoretically consistent crystallization-like model (CLM) that is able to describe the classic types of amyloid fibrillization kinetics identified in our literature survey. Amyloid conversion represented as a function of time is shown to follow different curve shapes, ranging from sigmoidal to hyperbolic, according to the relative importance of the nucleation and growth steps. Using the CLM, apparently unrelated data are deconvoluted into generic mechanistic information integrating the combined influence of seeding, nucleation, growth, and fibril breakage events. It is notable that this complex assembly of interdependent events is ultimately reduced to a mathematically simple model, whose two parameters can be determined by little more than visual inspection. The good fitting results obtained for all cases confirm the CLM as a good approximation to the generalized underlying principle governing amyloid fibrillization. A perspective is presented on possible applications of the CLM during the development of new targets for amyloid disease therapeutics.	[Damas, Ana M.; Martins, Pedro M.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal; [Crespo, Rosa; Rocha, Fernando A.; Martins, Pedro M.] Univ Porto, Fac Engn, Dept Engn Quim, LEPAE, P-4200465 Oporto, Portugal; [Damas, Ana M.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Martins, PM (corresponding author), Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	pmmartins@icbas.up.pt	Martins, Pedro M/J-3765-2013; Rocha, Fernando A/D-4324-2014; Martins, Pedro/GWC-7702-2022	Rocha, Fernando A/0000-0002-2778-8374; Crespo Rodriguez, Rosa/0000-0003-4980-2074; Martins, Pedro Miguel/0000-0002-6908-1828	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-PRO/101260/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Project PTDC/BIA-PRO/101260/2008 from the Fundacao para a Ciencia e a Tecnologia, Portugal.	Auer S, 2010, PROTEINS, V78, P2412, DOI 10.1002/prot.22762; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Bondos SE, 2006, CURR ANAL CHEM, V2, P157, DOI 10.2174/157341106776359140; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Fandrich M, 2007, J MOL BIOL, V365, P1266, DOI 10.1016/j.jmb.2006.11.009; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Heldt CL, 2011, PROTEINS, V79, P92, DOI 10.1002/prot.22861; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ionescu-Zanetti C, 1999, P NATL ACAD SCI USA, V96, P13175, DOI 10.1073/pnas.96.23.13175; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; Kashchiev D., 2000, NUCL BASIC THEORY AP; Kashchiev D, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447891; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P2027; Knowles TPJ, 2007, P NATL ACAD SCI USA, V104, P10016, DOI 10.1073/pnas.0610659104; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Markov I. V., 2003, CRYSTAL GROWTH BEGGI; Martins PM, 2007, SURF SCI, V601, P5466, DOI 10.1016/j.susc.2007.09.008; Martins PM, 2007, SURF SCI, V601, P3400, DOI 10.1016/j.susc.2007.06.016; Martins PM, 2008, CRYST RES TECHNOL, V43, P1258, DOI 10.1002/crat.200800301; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Naiki H, 1998, BIOCHEMISTRY-US, V37, P17882, DOI 10.1021/bi980550y; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Patil SM, 2011, BIOCHEMISTRY-US, V50, P2808, DOI 10.1021/bi101908m; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Radford SE, 2005, BBA-PROTEINS PROTEOM, V1753, P51, DOI 10.1016/j.bbapap.2005.07.006; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Schmidt H, 2008, BIOINFORMATICS, V24, P848, DOI 10.1093/bioinformatics/btn035; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Watzky MA, 1997, J AM CHEM SOC, V119, P10382, DOI 10.1021/ja9705102; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zhang TH, 2009, ANGEW CHEM INT EDIT, V48, P1308, DOI 10.1002/anie.200804743	69	66	66	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30585	30594		10.1074/jbc.M112.375345	http://dx.doi.org/10.1074/jbc.M112.375345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767606	Green Published, hybrid			2022-12-28	WOS:000308579800050
J	Moir, RD; Lee, J; Willis, IM				Moir, Robyn D.; Lee, Jaehoon; Willis, Ian M.			Recovery of RNA Polymerase III Transcription from the Glycerol-repressed State REVISITING THE ROLE OF PROTEIN KINASE CK2 IN MAF1 PHOSPHOREGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SENSITIVE PHOSPHOPROTEOME REVEALS; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; MAF1; PHOSPHORYLATION; CK2; SCH9; DEPHOSPHORYLATION; ACTIVATION	Maf1 is a conserved regulator of RNA polymerase (pol) III transcription and is required for transcriptional repression under diverse stress conditions. In yeast, Maf1 function is negatively regulated at seven phosphosites by the overlapping action of protein kinase A (PKA) and the TORC1-regulated kinase Sch9. Under stress conditions, Maf1 is dephosphorylated at these sites leading to its nuclear accumulation, increased association with pol III genes and direct physical interactions with the polymerase which ultimately inhibit transcription. These changes are reversed upon return to optimal growth conditions. Transcription in this system is also regulated by protein kinase CK2. CK2 stimulates pol III transcription in yeast and human cells via phosphorylation of the initiation factor TFIIIB. Recently it was proposed that CK2 phosphorylation of Maf1 is required for reactivation of pol III transcription following growth on glycerol. We have examined this hypothesis using two Maf1 mutants (Maf1-id S388A and Maf1-ck20) which lack all of the CK2 phosphosites implicated in the response. Both mutant proteins are phosphoregulated, function normally during repression and transcription is fully restored to the wild-type level upon transfer from glycerol to glucose. Additionally, phostag gel analysis of Maf1 7SA, a functional mutant that cannot be phosphorylated by PKA/Sch9, did not reveal any evidence for differential phosphorylation of Maf1 during carbon source switching. Together, these data do not support the proposed requirement for CK2 phosphorylation of Maf1 during derepression of pol III transcription.	[Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ian.willis@einstein.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [R01 GM085177]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085177 (to I. M. W.).	Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Clelland BW, 2010, TRANSCR-AUSTIN, V1, P115, DOI 10.4161/trns.1.3.13735; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Michels AA, 2010, MOL CELL BIOL, V30, P3749, DOI 10.1128/MCB.00319-10; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nika Heinz, 2012, J Biomol Tech, V23, P51, DOI 10.7171/jbt.2012-2302-002; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wei YH, 2010, NUCLEUS-PHILA, V1, P162, DOI 10.4161/nucl.1.2.11179; Wei YH, 2009, CELL CYCLE, V8, P4085, DOI 10.4161/cc.8.24.10170; Willis IM, 2007, TRENDS BIOCHEM SCI, V32, P51, DOI 10.1016/j.tibs.2006.12.001; Willis IM, 2011, P NATL ACAD SCI USA, V108, pE300, DOI 10.1073/pnas.1107306108; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485	35	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30833	30841		10.1074/jbc.M112.378828	http://dx.doi.org/10.1074/jbc.M112.378828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22810236	Green Published, hybrid			2022-12-28	WOS:000308579800071
J	Lecat, A; Di Valentin, E; Somja, J; Jourdan, S; Fillet, M; Kufer, TA; Habraken, Y; Sadzot, C; Louis, E; Delvenne, P; Piette, J; Legrand-Poels, S				Lecat, Aurore; Di Valentin, Emmanuel; Somja, Joan; Jourdan, Samuel; Fillet, Marianne; Kufer, Thomas A.; Habraken, Yvette; Sadzot, Catherine; Louis, Edouard; Delvenne, Philippe; Piette, Jacques; Legrand-Poels, Sylvie			The c-Jun N-terminal Kinase (JNK)-binding Protein (JNKBP1) Acts as a Negative Regulator of NOD2 Protein Signaling by Inhibiting Its Oligomerization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURAMYL DIPEPTIDE RECOGNITION; INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; CROHNS-DISEASE; PANETH CELLS; EXPRESSION; INNATE; GENE; SUSCEPTIBILITY; RECRUITMENT	NOD2 is one of the best characterized members of the cytosolic NOD-like receptor family. NOD2 is able to sense muramyl dipeptide, a specific bacterial cell wall component, and to subsequently induce various signaling pathways leading to NF-kappa B activation and autophagy, both events contributing to an efficient innate and adaptive immune response. Interestingly, loss-of-function NOD2 variants were associated with a higher susceptibility for Crohn disease, which highlights the physiological importance of proper regulation of NOD2 activity. We performed a biochemical screen to search for new NOD2 regulators. We identified a new NOD2 partner, c-Jun N-terminal kinase-binding protein 1 (JNKBP1), a scaffold protein characterized by an N-terminal WD-40 domain. JNKBP1, through its WD-40 domain, binds to NOD2 following muramyl dipeptide activation. This interaction attenuates NOD2-mediated NF-kappa B activation and IL-8 secretion as well as NOD2 antibacterial activity. JNKBP1 exerts its repressor effect by disturbing NOD2 oligomerization and RIP2 tyrosine phosphorylation, both steps required for downstream NOD2 signaling. We furthermore showed that JNKBP1 and NOD2 are co-expressed in the human intestinal epithelium and in immune cells recruited in the lamina propria, which suggests that JNKBP1 contributes to maintain NOD2-mediated intestinal immune homeostasis.	[Lecat, Aurore; Di Valentin, Emmanuel; Habraken, Yvette; Sadzot, Catherine; Piette, Jacques; Legrand-Poels, Sylvie] Univ Liege, GIGA R, Lab Virol & Immunol, B-4000 Liege, Belgium; [Somja, Joan; Delvenne, Philippe] Univ Liege, Dept Anat & Pathol Cytol, B-4000 Liege, Belgium; [Jourdan, Samuel] Univ Liege, Inst Chim B6a, Ctr Prot Engn, B-4000 Liege, Belgium; [Fillet, Marianne] Univ Liege, Dept Pharmaceut Analyt Chem, B-4000 Liege, Belgium; [Louis, Edouard] Univ Liege, Dept Gastroenterol, B-4000 Liege, Belgium; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Cologne	Legrand-Poels, S (corresponding author), Univ Liege, GIGA R, Lab Virol & Immunol, B-4000 Liege, Belgium.	S.Legrand@ulg.ac.be	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412; Di Valentin, Emmanuel/0000-0002-5287-7950; Jourdan, Samuel/0000-0001-8270-3620; Fillet, Marianne/0000-0002-1453-6282	"Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion); "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium); Leon Fredericq Foundation (University of Liege, Belgium); Inter-University Attraction Poles (Brussels, Belgium) [IAP6/18]; Deutsche Forschungsgemeinschaft [SFB670-N01]	"Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion); "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation (University of Liege, Belgium)(University of Liege); Inter-University Attraction Poles (Brussels, Belgium)(Belgian Federal Science Policy Office); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "Fonds Speciaux de l'Universite de Liege" (Credit d'Impulsion), by the "Fonds pour la Recherche dans l'Industrie et l'Agriculture" (FRIA, Brussels, Belgium), by the "Fonds National pour la Recherche Scientifique" (FNRS, Brussels, Belgium), by the Leon Fredericq Foundation (University of Liege, Belgium), and by the Inter-University Attraction Poles (IAP6/18) (Brussels, Belgium).; Supported by Deutsche Forschungsgemeinschaft Grant SFB670-N01.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koyano S, 1999, FEBS LETT, V457, P385, DOI 10.1016/S0014-5793(99)01084-4; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Perez LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010915; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yamaguchi T, 2009, CELL BIOL INT, V33, P364, DOI 10.1016/j.cellbi.2009.01.003	36	19	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29213	29226		10.1074/jbc.M112.355545	http://dx.doi.org/10.1074/jbc.M112.355545			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22700971	Green Published, hybrid			2022-12-28	WOS:000308286900001
J	Schaub, RE; Poole, SJ; Garza-Sanchez, F; Benbow, S; Hayes, CS				Schaub, Ryan E.; Poole, Stephen J.; Garza-Sanchez, Fernando; Benbow, Sarah; Hayes, Christopher S.			Proteobacterial ArfA Peptides Are Synthesized from Non-stop Messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANS-TRANSLATION; ESCHERICHIA-COLI; RIBOSOME-RESCUE; STOP CODONS; A-SITE; BACILLUS-SUBTILIS; RIBONUCLEASE-III; TAGGED PROTEINS; QUALITY-CONTROL; TAGGING SYSTEM	The translation of non-stop mRNA (which lack in-frame stop codons) represents a significant quality control problem for all organisms. In eubacteria, the transfer-messenger RNA (tmRNA) system facilitates recycling of stalled ribosomes from non-stop mRNA in a process termed trans-translation or ribosome rescue. During rescue, the nascent chain is tagged with the tmRNA-encoded ssrA peptide, which promotes polypeptide degradation after release from the stalled ribosome. Escherichia coli possesses an additional ribosome rescue pathway mediated by the ArfA peptide. The E. coli arfA message contains a hairpin structure that is cleaved by RNase III to produce a non-stop transcript. Therefore, ArfA levels are controlled by tmRNA through ssrA-peptide tagging and proteolysis. Here, we examine whether ArfA homologues from other bacteria are also regulated by RNase III and tmRNA. We searched 431 arfA coding sequences for mRNA secondary structures and found that 82.8% of the transcripts contain predicted hairpins in their 3'-coding regions. The arfA hairpins from Haemophilus influenzae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as predicted, whereas the hairpin from Neisseria gonorrhoeae functions as an intrinsic transcription terminator to generate non-stop mRNA. Each ArfA homologue is ssrA-tagged and degraded when expressed in wild-type E. coli cells, but accumulates in mutants lacking tmRNA. Together, these findings show that ArfA synthesis from non-stop mRNA is a conserved mechanism to regulate the alternative ribosome rescue pathway. This strategy ensures that ArfA homologues are only deployed when the tmRNA system is incapacitated or overwhelmed by stalled ribosomes.	[Schaub, Ryan E.; Poole, Stephen J.; Garza-Sanchez, Fernando; Benbow, Sarah; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu			National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078634.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Baranov PV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-28; Barends S, 2011, WIRES RNA, V2, P233, DOI 10.1002/wrna.48; BECKWITH JR, 1966, J MOL BIOL, V19, P254, DOI 10.1016/S0022-2836(66)80003-7; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Felden B, 2011, RNA BIOL, V8, P440, DOI 10.4161/rna.8.3.15387; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Wiegert T, 2001, J BACTERIOL, V183, P3885, DOI 10.1128/JB.183.13.3885-3889.2001; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Zhang KJ, 1997, P NATL ACAD SCI USA, V94, P13437, DOI 10.1073/pnas.94.25.13437	43	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29765	29775		10.1074/jbc.M112.374074	http://dx.doi.org/10.1074/jbc.M112.374074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791716	hybrid, Green Published			2022-12-28	WOS:000308286900052
J	Steffan, JJ; Koul, S; Meacham, RB; Koul, HK				Steffan, Joshua J.; Koul, Sweaty; Meacham, Randall B.; Koul, Hari K.			The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE B EXPRESSION; ETS FACTOR; CANCER-CELLS; BREAST-CANCER; MATRIX METALLOPROTEINASES; AGGRESSIVE PHENOTYPE; PROGNOSTIC MARKER; GENE-EXPRESSION; CARCINOMA CELLS; FACTOR PDEF	Emerging evidence suggests that the SAM pointed domain containing ETS transcription factor (SPDEF) plays a significant role in tumorigenesis in prostate, breast, colon, and ovarian cancer. However, there are no in vivo studies with respect to the role of SPDEF in tumor metastasis. The present study examined the effects of SPDEF on tumor cell metastasis using prostate tumor cells as a model. Utilizing two experimental metastasis models, we demonstrate that SPDEF inhibits cell migration and invasion in vitro and acts a tumor metastasis suppressor in vivo. Using stable expression of SPDEF in PC3-Luc cells and shRNA-mediated knockdown of SPDEF in LNCaP-Luc cells, we demonstrate for the first time that SPDEF diminished the ability of disseminated tumors cells to survive at secondary sites and establish micrometastases. These effects on tumor metastasis were not a result of the effect of SPDEF on cell growth as SPDEF expression had no effect on cell growth in vitro or subcutaneous tumor xenograft-growth in vivo. Transcriptional analysis of several genes associated with tumor metastasis, invasion, and the epithelial-mesenchymal transition demonstrated that SPDEF expression selectively down-regulated MMP9 and MMP13 in prostate cancer cells. Further analysis indicated that forced MMP9 or MMP13 expression rescued the invasive phenotype in SPDEF expressing PC3 cells in vitro, suggesting that the effects of SPDEF on tumor invasion are mediated, in part, through the suppression of MMP9 and MMP13 expression. These results demonstrate for the first time, in any system, that SPDEF functions as a tumor metastasis suppressor in vivo.	[Steffan, Joshua J.; Koul, Sweaty; Meacham, Randall B.; Koul, Hari K.] Univ Colorado, Sch Med, Dept Surg, Program Urosci,Div Urol, Aurora, CO 80045 USA; [Steffan, Joshua J.; Koul, Sweaty; Koul, Hari K.] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Koul, HK (corresponding author), 12700 E 19th Ave,RC2-6001,MS-C317, Aurora, CO 80045 USA.	hari.koul@ucdenver.edu			Department of Surgery (School of Medicine Academic Enrichment Funds); Veterans Affairs Merit Award [01BX001258]; National Institutes of Health [DK54084]; National Institutes of Health/NCI [R01CA161880]; NATIONAL CANCER INSTITUTE [R01CA161880, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054084] Funding Source: NIH RePORTER	Department of Surgery (School of Medicine Academic Enrichment Funds); Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by chair commitment (to H. K. K.) and Department of Surgery (School of Medicine Academic Enrichment Funds) (to H. K. K.).; Supported in part by Veterans Affairs Merit Award 01BX001258, National Institutes of Health Grant DK54084, and National Institutes of Health/NCI Grant R01CA161880. To whom correspondence should be addressed: 12700 E. 19th Ave, RC2-6001; MS-C317, Aurora, CO 80045. Tel.: 303-724-6300; Fax: 303-724-6330; E-mail: hari.koul@ucdenver.edu.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Bendardaf R, 2010, CANCER INVEST, V28, P38, DOI 10.3109/07357900802672761; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bodenstine TM, 2008, CANCER MICROENVIRON, V1, P1, DOI 10.1007/s12307-008-0001-8; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Feldman RJ, 2003, CANCER RES, V63, P4626; Findlay Victoria J, 2011, Genes Cancer, V2, P120, DOI 10.1177/1947601911410424; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; Ghadersohi A, 2011, PROSTATE, V71, P1178, DOI 10.1002/pros.21333; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Itoh T, 1999, CLIN EXP METASTAS, V17, P177, DOI 10.1023/A:1006603723759; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Liu Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-270; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Moussa O, 2009, J CELL BIOCHEM, V108, P1389, DOI 10.1002/jcb.22371; Naumov GN, 2002, CANCER RES, V62, P2162; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Rodabaugh KJ, 2007, INT J GYNECOL PATHOL, V26, P10, DOI 10.1097/01.pgp.0000225386.41244.bd; Schaefer JS, 2010, J BIOL CHEM, V285, P11258, DOI 10.1074/jbc.M109.073932; Sehgal G, 1998, AM J PATHOL, V152, P591; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Sood AK, 2012, PROSTATE, V72, P592, DOI 10.1002/pros.21461; Steffan JJ, 2011, CANCER LETT, V310, P109, DOI 10.1016/j.canlet.2011.06.011; Steffan JJ, 2010, TRAFFIC, V11, P274, DOI 10.1111/j.1600-0854.2009.01012.x; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Tsujimoto Y, 2002, INT J UROL, V9, P167, DOI 10.1046/j.1442-2042.2002.00444.x; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Turner DP, 2011, PROSTATE, V71, P1723, DOI 10.1002/pros.21389; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Zhang L, 2004, PROSTATE CANCER P D, V7, P327, DOI 10.1038/sj.pcan.4500750; Zhao ZS, 2009, PATHOL ONCOL RES, V15, P589, DOI 10.1007/s12253-009-9158-9	44	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29968	29978		10.1074/jbc.M112.379396	http://dx.doi.org/10.1074/jbc.M112.379396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761428	hybrid, Green Published			2022-12-28	WOS:000308286900070
J	Meier, FMP; Frommer, KW; Peters, MA; Brentano, F; Lefevre, S; Schroder, D; Kyburz, D; Steinmeyer, J; Rehart, S; Gay, S; Muller-Ladner, U; Neumann, E				Meier, Florian M. P.; Frommer, Klaus W.; Peters, Marvin A.; Brentano, Fabia; Lefevre, Stephanie; Schroeder, Dirk; Kyburz, Diego; Steinmeyer, Juergen; Rehart, Stefan; Gay, Steffen; Mueller-Ladner, Ulf; Neumann, Elena			Visfatin/Pre-B-cell Colony-enhancing Factor (PBEF), a Proinflammatory and Cell Motility-changing Factor in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SYNOVIAL FIBROBLASTS; ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; GENE-EXPRESSION; ADIPOSE-TISSUE; TNF-ALPHA; ANGIOGENESIS; INFLAMMATION	Adipokines such as adiponectin and visfatin/pre-B-cell colony-enhancing factor (PBEF) have been recently shown to contribute to synovial inflammation in rheumatoid arthritis (RA). In this study, we evaluated the pathophysiological implication of visfatin/PBEF in the molecular patterns of RA synovial tissue, focusing on RA synovial fibroblasts (RASFs), key players in RA synovium. Expression of visfatin/PBEF in synovial fluid and tissue of RA patients was detected by immunoassays and immunohistochemistry. RASFs were stimulated with different concentrations of visfatin/PBEF over varying time intervals, and changes in gene expression were evaluated at the RNA and protein levels using Affymetrix array, real-time PCR, and immunoassays. The signaling pathways involved were identified. The influence of visfatin/PBEF on fibroblast motility and migration was analyzed. In RA synovium, visfatin/PBEF was predominantly expressed in the lining layer, lymphoid aggregates, and interstitial vessels. In RASFs, visfatin/PBEF induced high amounts of chemokines such as IL-8 and MCP-1, proinflammatory cytokines such as IL-6, and matrix metalloproteinases such as MMP-3. Phosphorylation of p38 MAPK was observed after visfatin/PBEF stimulation, and inhibition of p38 MAPK showed strong reduction of visfatin-induced effects. Directed as well as general fibroblast motility was increased by visfatin/PBEF-induced factors. The results of this study indicate that visfatin/PBEF is involved in synovial fibroblast activation by triggering fibroblast motility and promoting cytokine synthesis at central sites in RA synovium.	[Meier, Florian M. P.; Frommer, Klaus W.; Peters, Marvin A.; Lefevre, Stephanie; Schroeder, Dirk; Mueller-Ladner, Ulf; Neumann, Elena] Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Klin, D-61231 Bad Nauheim, Germany; [Brentano, Fabia; Kyburz, Diego; Gay, Steffen] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8006 Zurich, Switzerland; [Steinmeyer, Juergen] Univ Hosp Giessen & Marburg, Dept Expt Orthopaed, D-35392 Giessen, Germany; [Rehart, Stefan] Markus Hosp, Dept Orthopaed & Orthopaed Surg, D-60431 Frankfurt, Germany	Justus Liebig University Giessen; Kerckhoff Clinic; University of Zurich; University Zurich Hospital; University Hospital of Giessen & Marburg	Neumann, E (corresponding author), Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Klin, Benekestr 2-8, D-61231 Bad Nauheim, Germany.	e.neumann@kerckhoff-klinik.de	Neumann, Elena/A-1418-2011; Frommer, Klaus/K-9244-2019; Frommer, Klaus W/B-4592-2019	Frommer, Klaus/0000-0003-2374-964X; Frommer, Klaus W/0000-0003-2374-964X; Kyburz, Diego/0000-0002-9560-109X; Meier, Florian/0000-0001-5533-8146	Deutsche Forschungsgemeinschaft [NE1174/3-1]; FP6 AutoCure; FP7 Masterswitch; Institute for Arthritis Research (Epalinges, Switzerland)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 AutoCure; FP7 Masterswitch; Institute for Arthritis Research (Epalinges, Switzerland)	This work was supported by Deutsche Forschungsgemeinschaft Grant NE1174/3-1, FP6 AutoCure, FP7 Masterswitch, and the Institute for Arthritis Research (Epalinges, Switzerland).	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S; Bae YH, 2009, BIOCHEM BIOPH RES CO, V379, P206, DOI 10.1016/j.bbrc.2008.12.042; Bodolay E, 2002, J CELL MOL MED, V6, P357, DOI 10.1111/j.1582-4934.2002.tb00514.x; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Brown JEP, 2010, J MOL ENDOCRINOL, V44, P171, DOI 10.1677/JME-09-0071; Bruhl H, 2008, RHEUMATOLOGY, V47, P1771, DOI 10.1093/rheumatology/ken383; Chiu YC, 2008, MOL IMMUNOL, V45, P1587, DOI 10.1016/j.molimm.2007.10.004; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; DIBATTISTA JA, 1994, MOL CELL ENDOCRINOL, V103, P139, DOI 10.1016/0303-7207(94)90081-7; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim SR, 2007, BIOCHEM BIOPH RES CO, V357, P150, DOI 10.1016/j.bbrc.2007.03.105; Knedla A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2140; Kunisch E, 2007, ANN RHEUM DIS, V66, P1043, DOI 10.1136/ard.2006.062521; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Matsui H, 2008, ANN RHEUM DIS, V67, P571, DOI 10.1136/ard.2007.077578; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Muller-Ladner U, 2009, NAT REV RHEUMATOL, V5, P659, DOI 10.1038/nrrheum.2009.232; Muller-Ladner U, 1999, ARTHRITIS RHEUM, V42, P490, DOI 10.1002/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L; Neumann E, 2002, GENE THER, V9, P1508, DOI 10.1038/sj.gt.3301811; Neumann E, 2002, ARTHRITIS RHEUM-US, V46, P52, DOI 10.1002/1529-0131(200201)46:1<52::AID-ART10048>3.0.CO;2-1; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Ospelt C, 2004, FRONT BIOSCI-LANDMRK, V9, P2323, DOI 10.2741/1399; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; Rofstad EK, 2000, CANCER RES, V60, P4932; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schaffler A, 2006, ENDOCR REV, V27, P449, DOI 10.1210/er.2005-0022; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Storka A, 2008, EUR J CLIN INVEST, V38, P820, DOI 10.1111/j.1365-2362.2008.02025.x; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Szekanecz Zoltan, 2009, Front Biosci (Elite Ed), V1, P44; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200	48	46	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28378	28385		10.1074/jbc.M111.312884	http://dx.doi.org/10.1074/jbc.M111.312884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767598	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308074600014
J	Ramakrishnan, B; Boeggeman, E; Qasba, PK				Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.			Binding of N-Acetylglucosamine (GlcNAc) beta 1-6-branched Oligosaccharide Acceptors to beta 4-Galactosyltransferase I Reveals a New Ligand Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LACTALBUMIN; CRYSTAL-STRUCTURE; LACTOSE SYNTHETASE; GALACTOSYLTRANSFERASE; BETA-1,4-GALACTOSYLTRANSFERASE-I; COMPLEX; MUTANT; IDENTIFICATION; SPECIFICITY; METASTASIS	N-Acetyllactosamine is the most prevalent disaccharide moiety in the glycans on the surface of mammalian cells and often found as repeat units in the linear and branched polylactosamines, known as i- and I-antigen, respectively. The beta 1-4-galactosyltransferase- I (beta 4Gal-T1) enzyme is responsible for the synthesis of the N-acetyllactosamine moiety. To understand its oligosaccharide acceptor specificity, we have previously investigated the binding of tri- and pentasaccharides of N-glycan with a GlcNAc at their nonreducing end and found that the extended sugar moiety in these acceptor substrates binds to the crevice present at the acceptor substrate binding site of the beta 4Gal-T1 molecule. Here we report seven crystal structures of beta 4Gal-T1 in complex with an oligosaccharide acceptor with a nonreducing end GlcNAc that has a beta 1-6-glycosidic link and that are analogous to either N-glycan or i/I-antigen. In the crystal structure of the complex of beta 4Gal-T1 with I-antigen analog pentasaccharide, the beta 1-6-branched GlcNAc moiety is bound to the sugar acceptor binding site of the beta 4Gal-T1 molecule in a way similar to the crystal structures described previously; however, the extended linear tetrasaccharide moiety does not interact with the previously found extended sugar binding site on the beta 4Gal-T1 molecule. Instead, it interacts with the different hydrophobic surface of the protein molecule formed by the residues Tyr-276, Trp-310, and Phe-356. Results from the present and previous studies suggest that beta 4Gal-T1 molecule has two different oligosaccharide binding regions for the binding of the extended oligosaccharide moiety of the acceptor substrate.	[Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.] NIH, Struct Glycobiol Sect, SAIC Frederick Inc,Ctr Canc Res Nanobiol Program, Ctr Canc Res,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy; Boeggeman, Elizabeth] NIH, Basic Sci Program, SAIC Frederick Inc,Ctr Canc Res Nanobiol Program, Ctr Canc Res,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), Frederick Natl Lab, Struct Glycobiol Sect, CCRNP, CCR, Bldg 469,Rm 221, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Institutes of Health through the NCI [HHSN261200800001E]; National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010742, ZIABC009304] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E through the NCI. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, Frederick National Laboratory for Cancer Research.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Boeggeman E, 2009, BIOCONJUGATE CHEM, V20, P1228, DOI 10.1021/bc900103p; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; Chakraborty AK, 2003, CLIN EXP METASTAS, V20, P365, DOI 10.1023/A:1024007915938; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; KLEE WA, 1970, BIOCHEM BIOPH RES CO, V39, P833, DOI 10.1016/0006-291X(70)90398-0; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Ouzzine M, 2002, J BIOL CHEM, V277, P25439, DOI 10.1074/jbc.M201912200; POWELL JT, 1976, J BIOL CHEM, V251, P3653; PRIEELS JP, 1976, EUR J BIOCHEM, V66, P579, DOI 10.1111/j.1432-1033.1976.tb10584.x; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Ramakrishnan B, 2010, CURR OPIN STRUC BIOL, V20, P536, DOI 10.1016/j.sbi.2010.07.004; Ramasamy V, 2005, J MOL BIOL, V353, P53, DOI 10.1016/j.jmb.2005.07.050; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; Rao V.S.R., 1998, CONFORMATION CARBOHY, P131; Renkonen O, 2000, CELL MOL LIFE SCI, V57, P1423, DOI 10.1007/PL00000627; Shaper NL, 1997, J BIOL CHEM, V272, P31389, DOI 10.1074/jbc.272.50.31389; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Varki A., 2009, ESSENTIALS GLYCOBIOL, P1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	11	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28666	28674		10.1074/jbc.M112.373514	http://dx.doi.org/10.1074/jbc.M112.373514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740701	Green Published, hybrid			2022-12-28	WOS:000308074600040
J	Yan, S; Bleuler-Martinez, S; Plaza, DF; Kunzler, M; Aebi, M; Joachim, A; Razzazi-Fazeli, E; Jantsch, V; Geyer, R; Wilson, IBH; Paschinger, K				Yan, Shi; Bleuler-Martinez, Silvia; Plaza, David Fernando; Kuenzler, Markus; Aebi, Markus; Joachim, Anja; Razzazi-Fazeli, Ebrahim; Jantsch, Verena; Geyer, Rudolf; Wilson, Iain B. H.; Paschinger, Katharina			Galactosylated Fucose Epitopes in Nematodes INCREASED EXPRESSION IN A CAENORHABDITIS MUTANT ASSOCIATED WITH ALTERED LECTIN SENSITIVITY AND OCCURRENCE IN PARASITIC SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; LOBES GENE ENCODES; OESOPHAGOSTOMUM-DENTATUM; CORE FUCOSE; GLYCANS; ELEGANS; PHOSPHORYLCHOLINE; BETA; ACETYLGLUCOSAMINIDASE; GLYCOPROTEIN	The modification of alpha 1,6-linked fucose residues attached to the proximal (reducing-terminal) core N-acetylglucosamine residue of N-glycans by beta 1,4-linked galactose ("GalFuc" epitope) is a feature of a number of invertebrate species including the model nematode Caenorhabditis elegans. A pre-requisite for both core alpha 1,6-fucosylation and beta 1,4-galactosylation is the presence of a nonreducing terminal N-acetylglucosamine; however, this residue is normally absent from the final glycan structure in invertebrates due to the action of specific hexosaminidases. Previously, we have identified two hexosaminidases (HEX-2 and HEX-3) in C. elegans, which process N-glycans. In the present study, we have prepared a hex-2; hex-3 double mutant, which possesses a radically altered N-glycomic profile. Whereas in the double mutant core alpha 1,3-fucosylation of the proximal N-acetylglucosamine was abolished, the degree of galactosylation of core alpha 1,6-fucose increased, and a novel Gal alpha 1,2Fuc alpha 1,3 moiety attached to the distal core N-acetylglucosamine residue was detected. Both galactosylated fucose moieties were also found in two parasitic nematodes, Ascaris suum and Oesophagostomum dentatum. As core modifications of N-glycans are known targets for fungal nematotoxic lectins, the sensitivity of the C. elegans double hexosaminidase mutant was assessed. Although this mutant displayed hypersensitivity to the GalFuc-binding lectin CGL2 and the N-acetylglucosamine-binding lectin XCL, the mutant was resistant to CCL2, which binds core alpha 1,3-fucose. Thus, the use of C. elegans mutants aids the identification of novel N-glycan modifications and the definition of in vivo specificities of nematotoxic lectins with potential as anthelmintic agents.	[Yan, Shi; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Bleuler-Martinez, Silvia; Plaza, David Fernando; Kuenzler, Markus; Aebi, Markus] Swiss Fed Inst Technol, Inst Mikrobiol, CH-8093 Zurich, Switzerland; [Joachim, Anja] Vet Med Univ, Inst Parasitol, A-1210 Vienna, Austria; [Razzazi-Fazeli, Ebrahim] Vet Med Univ, Vetom Core Facil Res, A-1210 Vienna, Austria; [Jantsch, Verena] Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria; [Geyer, Rudolf] Univ Giessen, Fachbereich Med, Inst Biochem, D-35292 Giessen, Germany	University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Justus Liebig University Giessen	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Yan, Shi/H-9091-2013; Jantsch, Verena/A-3910-2017; Wilson, Iain/B-3326-2009	Yan, Shi/0000-0003-4949-9140; Jantsch, Verena/0000-0002-1978-682X; Wilson, Iain/0000-0001-8996-1518; Plaza, David Fernando/0000-0003-0366-4112; Paschinger, Katharina/0000-0002-3594-7136; Kunzler, Markus/0000-0003-1275-0629; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Fonds zur Forderung der wissenschaftlichen Forschung [P21946]; European Union Euroglycoarrays Initial Training Network [PITN-GA-2008-215536]; Swiss National Science Foundation [31003A-130671]; ETH Zurich; Austrian Science Fund (FWF) [P 21946] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); European Union Euroglycoarrays Initial Training Network; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant P21946 (to K. P.), European Union Euroglycoarrays Initial Training Network Grant PITN-GA-2008-215536, Swiss National Science Foundation Grant 31003A-130671, and the ETH Zurich.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BRENNER S, 1974, GENETICS, V77, P71; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; GEYER R, 1994, METHOD ENZYMOL, V230, P86; Goodey T., 1924, Journal of Helminthology, V2, P1, DOI 10.1017/S0022149X00002960; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Haslam SM, 1997, MOL BIOCHEM PARASIT, V85, P53, DOI 10.1016/S0166-6851(96)02807-1; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Joachim A, 1997, PARASITOL RES, V83, P646, DOI 10.1007/s004360050313; Joachim A, 2001, PARASITOL INT, V50, P41, DOI 10.1016/S1383-5769(00)00070-2; Joachim A, 1999, PARASITOLOGY, V119, P491, DOI 10.1017/S0031182099004965; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Maduzia LL, 2011, J BIOL CHEM, V286, P4371, DOI 10.1074/jbc.M110.188581; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Morelle W, 2000, GLYCOBIOLOGY, V10, P941, DOI 10.1093/glycob/10.9.941; PARENTE JP, 1985, CARBOHYD RES, V141, P41, DOI 10.1016/S0008-6215(00)90753-5; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; Sarkar M, 2010, P NATL ACAD SCI USA, V107, P9677, DOI 10.1073/pnas.1004431107; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Shi H, 2006, METHOD ENZYMOL, V417, P359, DOI 10.1016/S0076-6879(06)17022-6; Singh RS, 2011, CRIT REV BIOTECHNOL, V31, P193, DOI 10.3109/07388551.2010.505911; Slotved HC, 1996, VET PARASITOL, V63, P237, DOI 10.1016/0304-4017(95)00916-7; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; van Stijn CMW, 2010, INT J PARASITOL, V40, P215, DOI 10.1016/j.ijpara.2009.07.009; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Zeleny R, 1997, ANAL BIOCHEM, V246, P96, DOI 10.1006/abio.1996.9973; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153; Zhao S, 2009, ENVIRON TOXICOL PHAR, V28, P265, DOI 10.1016/j.etap.2009.05.003	44	37	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28276	28290		10.1074/jbc.M112.353128	http://dx.doi.org/10.1074/jbc.M112.353128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733825	Green Published, hybrid			2022-12-28	WOS:000308074600006
J	Corradi, V; Singh, G; Tieleman, DP				Corradi, Valentina; Singh, Gurpreet; Tieleman, D. Peter			The Human Transporter Associated with Antigen Processing MOLECULAR MODELS TO DESCRIBE PEPTIDE BINDING COMPETENT STATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; OUTWARD FACING STATE; HUMAN P-GLYCOPROTEIN; MHC CLASS-I; ABC-TRANSPORTER; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CASSETTE TRANSPORTERS; STRUCTURE VALIDATION; AUTOMATED DOCKING	The human transporter associated with antigen processing (TAP) is a member of the ATP binding cassette (ABC) transporter superfamily. TAP plays an essential role in the antigen presentation pathway by translocating cytosolic peptides derived from proteasomal degradation into the endoplasmic reticulum lumen. Here, the peptides are loaded into major histocompatibility class I molecules to be in turn exposed at the cell surface for recognition by T-cells. TAP is a heterodimer formed by the association of two half-transporters, TAP1 and TAP2, with a typical ABC transporter core that consists of two nucleotide binding domains and two transmembrane domains. Despite the availability of biological data, a full understanding of the mechanism of action of TAP is limited by the absence of experimental structures of the full-length transporter. Here, we present homology models of TAP built on the crystal structures of P-glycoprotein, ABCB10, and Sav1866. The models represent the transporter in inward-and outward-facing conformations that could represent initial and final states of the transport cycle, respectively. We described conserved regions in the endoplasmic reticulum-facing loops with a role in the opening and closing of the cavity. We also identified conserved pi-stacking interactions in the cytosolic part of the transmembrane domains that could explain the experimental data available for TAP1-Phe265. Electrostatic potential calculations gave structural insights into the role of residues involved in peptide binding, such as TAP1-Val-288, TAP2-Cys-213, TAP2-Met-218. Moreover, these calculations identified additional residues potentially involved in peptide binding, in turn verified with replica exchange simulations performed on a peptide bound to the inward-facing models.	[Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Tieleman, DP (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	tieleman@ucalgary.ca	Tieleman, D. Peter/A-4790-2011; Corradi, Valentina/N-9312-2019; Singh, Gurpreet/S-7265-2019; Corradi, Valentina/G-3937-2017	Tieleman, D. Peter/0000-0001-5507-0688; Singh, Gurpreet/0000-0002-6091-6411; 	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research.	Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Armandola EA, 1996, EUR J IMMUNOL, V26, P1748, DOI 10.1002/eji.1830260813; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldauf C, 2010, P NATL ACAD SCI USA, V107, P9135, DOI 10.1073/pnas.1001308107; Beinert D, 1997, BIOCHEMISTRY-US, V36, P4694, DOI 10.1021/bi962940v; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Chen R, 2011, J PHYS CHEM B, V115, P1038, DOI 10.1021/jp110002q; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Denschlag R, 2009, CHEM PHYS LETT, V473, P193, DOI 10.1016/j.cplett.2009.03.053; Deverson EV, 1998, J IMMUNOL, V160, P2767; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Galocha B, 1997, J EXP MED, V185, P1565, DOI 10.1084/jem.185.9.1565; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gaudet R, 2001, TECHNOL REV, V104, P20; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Haffke M, 2010, ACTA CRYSTALLOGR D, V66, P979, DOI 10.1107/S0907444910028593; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Herget M, 2011, P NATL ACAD SCI USA, V108, P1349, DOI 10.1073/pnas.1012355108; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koch J, 2005, FEBS LETT, V579, P4413, DOI 10.1016/j.febslet.2005.07.006; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Momburg F, 1996, J IMMUNOL, V156, P1756; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neumann L, 1997, J MOL BIOL, V272, P484, DOI 10.1006/jmbi.1997.1282; Neves-Petersen MT, 2003, BIOTECHNOL ANN REV, V9, P315, DOI 10.1016/S1387-2656(03)09010-0; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Norel R, 2001, PROTEIN SCI, V10, P2147, DOI 10.1110/ps.12901; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfander R, 1999, BIOCHEMISTRY-US, V38, P13692, DOI 10.1021/bi9909647; Pleban K, 2005, MOL PHARMACOL, V67, P365, DOI 10.1124/mol.104.006973; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qian F, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS18, DOI 10.1134/S0006297906130037; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Ravna AW, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-20; Ravna AW, 2008, BIOORG MED CHEM LETT, V18, P3481, DOI 10.1016/j.bmcl.2008.05.047; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Ritz U, 2003, J IMMUNOL, V170, P941, DOI 10.4049/jimmunol.170.2.941; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 1996, CRIT REV BIOCHEM MOL, V31, P127, DOI 10.3109/10409239609106582; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; UEBEL S, 1995, J BIOL CHEM, V270, P18512, DOI 10.1074/jbc.270.31.18512; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507	108	22	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28099	28111		10.1074/jbc.M112.381251	http://dx.doi.org/10.1074/jbc.M112.381251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700967	Green Published, hybrid			2022-12-28	WOS:000307840700083
J	Leyn, SA; Gao, F; Yang, C; Rodionov, DA				Leyn, Semen A.; Gao, Fang; Yang, Chen; Rodionov, Dmitry A.			N-Acetylgalactosamine Utilization Pathway and Regulon in Proteobacteria GENOMIC RECONSTRUCTION AND EXPERIMENTAL CHARACTERIZATION IN SHEWANELLA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENES; GALACTOSAMINE; METABOLISM; ACID	We used a comparative genomics approach to reconstruct the N-acetyl-D-galactosamine (GalNAc) and galactosamine (GalN) utilization pathways and transcriptional regulons in Proteobacteria. The reconstructed GalNAc/GalN utilization pathways include multiple novel genes with specific functional roles. Most of the pathway variations were attributed to the amino sugar transport, phosphorylation, and deacetylation steps, whereas the downstream catabolic enzymes in the pathway were largely conserved. The predicted GalNAc kinase AgaK, the novel variant of GalNAc-6-phosphate deacetylase AgaA(II) and the GalN-6-phosphate deaminase AgaS from Shewanella sp. ANA-3 were validated in vitro using individual enzymatic assays and reconstitution of the three-step pathway. By using genetic techniques, we confirmed that AgaS but not AgaI functions as the main GalN-6-P deaminase in the GalNAc/GalN utilization pathway in Escherichia coli. Regulons controlled by AgaR repressors were reconstructed by bioinformatics in most proteobacterial genomes encoding GalNAc pathways. Candidate AgaR-binding motifs share a common sequence with consensus CTTTC that was found in multiple copies and arrangements in regulatory regions of aga genes. This study provides comprehensive insights into the common and distinctive features of the GalNAc/GalN catabolism and its regulation in diverse Proteobacteria.	[Gao, Fang; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Leyn, Semen A.; Rodionov, Dmitry A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Leyn, Semen A.; Rodionov, Dmitry A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Yang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.	chenyang@sibs.ac.cn; rodionov@burnham.org	Leyn, Semen A/J-1069-2019; Rodionov, Dmitry/V-2688-2018	Leyn, Semen A/0000-0002-9886-9120; Rodionov, Dmitry/0000-0002-0939-390X	National Institutes of Health through the NIGMS [R01GM077402]; Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE) [DE-SC0004999]; Sanford-Burnham Medical Research Institute (SBMRI); National Science Foundation of China [30970035, 31070033]; Russian Foundation for Basic Research [10-04-01768]; Chinese Academy of Sciences [KSCX2-EW-G-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE)(United States Department of Energy (DOE)); Sanford-Burnham Medical Research Institute (SBMRI); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM077402 through the NIGMS. This work was also supported by the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), U.S. Dept. of Energy (DOE) under Contract DE-SC0004999 with the Sanford-Burnham Medical Research Institute (SBMRI) and as a contribution of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area, and by the National Science Foundation of China Grants 30970035 and 31070033), the Russian Foundation for Basic Research Grant 10-04-01768, and the Knowledge Innovation Program of the Chinese Academy of Sciences Grant KSCX2-EW-G-5.	Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARR J, 1980, BIOCHEM J, V192, P569, DOI 10.1042/bj1920569; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Brinkkotter A, 2002, ARCH MICROBIOL, V177, P410, DOI 10.1007/s00203-002-0406-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARRAWAY K L, 1991, Glycobiology, V1, P131, DOI 10.1093/glycob/1.2.131; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Freymond PP, 2006, MICROBIOL-SGM, V152, P1709, DOI 10.1099/mic.0.28814-0; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Mukherjee A, 2008, J BACTERIOL, V190, P1710, DOI 10.1128/JB.01737-07; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pinchuk GE, 2008, APPL ENVIRON MICROB, V74, P1198, DOI 10.1128/AEM.02026-07; Qin ZHS, 2003, NAT BIOTECHNOL, V21, P435, DOI 10.1038/nbt802; Ray WK, 2004, MOL MICROBIOL, V51, P813, DOI 10.1046/j.1365-2958.2003.03868.x; REISSIG JL, 1956, J BIOL CHEM, V219, P753; Reizer J, 1996, MICROBIOL-SGM, V142, P231, DOI 10.1099/13500872-142-2-231; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; SADLER JE, 1979, J BIOL CHEM, V254, P2112; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07	37	26	28	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28047	28056		10.1074/jbc.M112.382333	http://dx.doi.org/10.1074/jbc.M112.382333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711537	Green Published, hybrid			2022-12-28	WOS:000307840700078
J	Townson, SA; Martinez-Hackert, E; Greppi, C; Lowden, P; Sako, D; Liu, J; Ucran, JA; Liharska, K; Underwood, KW; Seehra, J; Kumar, R; Grinberg, AV				Townson, Sharon A.; Martinez-Hackert, Erik; Greppi, Chloe; Lowden, Patricia; Sako, Dianne; Liu, June; Ucran, Jeffrey A.; Liharska, Katia; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.			Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; BONE MORPHOGENETIC PROTEINS; SUPPRESSES TUMOR-GROWTH; CRYSTAL-STRUCTURE; ENDOTHELIAL-CELLS; ANGIOGENESIS; ACTIVATION; EXPRESSION; BMP9; MECHANISM	Activin receptor-like kinase 1 (ALK1), an endothelial cell-specific type I receptor of the TGF-beta superfamily, is an important regulator of normal blood vessel development as well as pathological tumor angiogenesis. As such, ALK1 is an important therapeutic target. Thus, several ALK1-directed agents are currently in clinical trials as anti-angiogenic cancer therapeutics. Given the biological and clinical importance of the ALK1 signaling pathway, we sought to elucidate the biophysical and structural basis underlying ALK1 signaling. The TGF-beta family ligands BMP9 and BMP10 as well as the three type II TGF-beta family receptors ActRIIA, ActRIIB, and BMPRII have been implicated in ALK1 signaling. Here, we provide a kinetic and thermodynamic analysis of BMP9 and BMP10 interactions with ALK1 and type II receptors. Our data show that BMP9 displays a significant discrimination in type II receptor binding, whereas BMP10 does not. We also report the crystal structure of a fully assembled ternary complex of BMP9 with the extracellular domains of ALK1 and ActRIIB. The structure reveals that the high specificity of ALK1 for BMP9/10 is determined by a novel orientation of ALK1 with respect to BMP9, which leads to a unique set of receptor-ligand interactions. In addition, the structure explains how BMP9 discriminates between low and high affinity type II receptors. Taken together, our findings provide structural and mechanistic insights into ALK1 signaling that could serve as a basis for novel anti-angiogenic therapies.	[Townson, Sharon A.; Martinez-Hackert, Erik; Greppi, Chloe; Lowden, Patricia; Sako, Dianne; Liu, June; Ucran, Jeffrey A.; Liharska, Katia; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.] Acceleron Pharma, Cambridge, MA 02139 USA	Acceleron Pharma	Grinberg, AV (corresponding author), 129 Sidney St, Cambridge, MA 02139 USA.	agrinberg@acceleronpharma.com		Martinez-Hackert, Erik/0000-0002-6182-7023				Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scotti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026431; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	34	121	131	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27313	27325		10.1074/jbc.M112.377960	http://dx.doi.org/10.1074/jbc.M112.377960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718755	Green Published, hybrid			2022-12-28	WOS:000307840700004
J	Goransson, U; Burman, R; Gunasekera, S; Stromstedt, AA; Rosengren, KJ				Goransson, Ulf; Burman, Robert; Gunasekera, Sunithi; Stromstedt, Adam A.; Rosengren, K. Johan			Circular Proteins from Plants and Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLOTIDE KALATA B1; TRYPSIN-INHIBITOR SFTI-1; CYCLIC CYSTINE KNOT; OLDENLANDIA-AFFINIS; CYCLOVIOLACIN O2; SCANNING MUTAGENESIS; AMANITA MUSHROOMS; SUNFLOWER SEEDS; BIOSYNTHESIS; TOXINS	Circular proteins, defined as head-to-tail cyclized polypeptides originating from ribosomal synthesis, represent a novel class of natural products attracting increasing interest. From a scientific point of view, these compounds raise questions of where and why they occur in nature and how they are formed. From a rational point of view, these proteins and their structural concept may be exploited for crop protection and novel pharmaceuticals. Here, we review the current knowledge of three protein families: cyclotides and circular sunflower trypsin inhibitors from the kingdom of plants and the Amanita toxins from fungi. A particular emphasis is placed on their biological origin, structure, and activity. In addition, the opportunity for discovery of novel circular proteins and recent insights into their mechanism of action are discussed.	[Goransson, Ulf; Burman, Robert; Gunasekera, Sunithi] Uppsala Univ, Dept Med Chem, Biomed Ctr, Div Pharmacognosy, SE-75123 Uppsala, Sweden; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Uppsala University; University of Queensland	Goransson, U (corresponding author), Uppsala Univ, Dept Med Chem, Biomed Ctr, Div Pharmacognosy, SE-75123 Uppsala, Sweden.	ulf.goransson@fkog.uu.se	Rosengren, K. Johan/P-4450-2016; Strömstedt, Adam/I-8820-2018	Rosengren, K. Johan/0000-0002-5007-8434; Strömstedt, Adam/0000-0001-9070-6944; Goransson, Ulf/0000-0002-5005-9612	Swedish Research Council [621-2007-5167]; Swedish Foundation for Strategic Research [F06-0058]; National Medical and Health Research Council (Australia)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Medical and Health Research Council (Australia)	Supported by Swedish Research Council Grant 621-2007-5167 and Swedish Foundation for Strategic Research Grant F06-0058. To whom correspondence should be addressed. E-mail: ulf.goransson@fkog.uu.se.; National Medical and Health Research Council (Australia) Career Development Award Fellow. Recipient of an Uppsala University visiting researcher fellowship.	Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2010, PHYTOCHEMISTRY, V71, P13, DOI 10.1016/j.phytochem.2009.09.023; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Colgrave ML, 2010, BIOPOLYMERS, V94, P665, DOI 10.1002/bip.21415; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2011, J ORG CHEM, V76, P4805, DOI 10.1021/jo200520v; Craik DJ, 2010, TOXICON, V56, P1092, DOI 10.1016/j.toxicon.2010.02.021; Craik DJ, 2009, TRENDS PLANT SCI, V14, P328, DOI 10.1016/j.tplants.2009.03.003; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Goransson U, 2009, CHEMBIOCHEM, V10, P2354, DOI 10.1002/cbic.200900342; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2010, J NAT PROD, V73, P1610, DOI 10.1021/np1000413; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kaplan C, 2008, NATION, V286, P30; Korsinczky MLJ, 2005, BIOCHEMISTRY-US, V44, P1145, DOI 10.1021/bi048297r; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Luo H, 2010, EUKARYOT CELL, V9, P1891, DOI 10.1128/EC.00161-10; Mohimani H, 2011, J PROTEOME RES, V10, P4505, DOI 10.1021/pr200323a; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Mylne JS, 2010, BIOPOLYMERS, V94, P635, DOI 10.1002/bip.21419; Ovesen RG, 2011, ENVIRON TOXICOL CHEM, V30, P1190, DOI 10.1002/etc.496; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Qin QP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-111; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Trabi M, 2004, J NAT PROD, V67, P806, DOI 10.1021/np034068e; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Vetter J, 1998, TOXICON, V36, P13, DOI 10.1016/S0041-0101(97)00074-3; Walton JD, 2010, BIOPOLYMERS, V94, P659, DOI 10.1002/bip.21416; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wong CTT, 2011, BIOCHEMISTRY-US, V50, P7275, DOI 10.1021/bi2007004	50	52	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27001	27006		10.1074/jbc.R111.300129	http://dx.doi.org/10.1074/jbc.R111.300129			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700984	hybrid, Green Published			2022-12-28	WOS:000307386000048
J	Ortega, B; Mason, AK; Welling, PA				Ortega, Bernardo; Mason, Amanda K.; Welling, Paul A.			A Tandem Di-hydrophobic Motif Mediates Clathrin-dependent Endocytosis via Direct Binding to the AP-2 alpha sigma 2 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL EXPLANATION; POTASSIUM CHANNELS; ADAPTER COMPLEX; SIGNALS; MEMBRANE; CELLS; PHOSPHORYLATION; INTERNALIZATION; RECOGNITION; ENDOSOMES	Select plasma membrane proteins can be marked as cargo for inclusion into clathrin-coated pits by common internalization signals (e. g. Y Chi Chi Phi, dileucine motifs, NPXY) that serve as universal recognition sites for the AP-2 adaptor complex or other clathrin-associated sorting proteins. However, some surface proteins, such as the Kir2.3 potassium channel, lack canonical signals but are still targeted for clathrin-dependent endocytosis. Here, we explore the mechanism. We found an unusual endocytic signal in Kir2.3 that is based on two consecutive pairs of hydrophobic residues. Characterized by the sequence Phi Phi Chi Phi Phi (a tandem di-hydrophobic (TDH) motif, where Phi is a hydrophobic amino acid), the signal shows no resemblance to other endocytic motifs, yet it directly interacts with AP-2 to target the Kir2.3 potassium channel into the endocytic pathway. We found that the tandem di-hydrophobic motif directly binds to the alpha sigma 2 subunits of AP-2, interacting within a large hydrophobic cleft that encompasses part of the docking site for di-Leu signals, but includes additional structures. These observations expand the repertoire of clathrin-dependent internalization signals and the ways in which AP-2 can coordinate endocytosis of cargo proteins.	[Ortega, Bernardo; Mason, Amanda K.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			National Institutes of Health [DK63049, DK54231]; National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK054231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK63049 and DK54231. This work was also supported the National Kidney Foundation of Maryland.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Doray B, 2008, TRAFFIC, V9, P1551, DOI 10.1111/j.1600-0854.2008.00786.x; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Karschin C, 1996, J NEUROSCI, V16, P3559; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Leser GP, 1999, VIROLOGY, V262, P79, DOI 10.1006/viro.1999.9890; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Millar ID, 2006, J MEMBRANE BIOL, V211, P173, DOI 10.1007/s00232-006-0036-z; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Welling PA, 1997, AM J PHYSIOL-RENAL, V273, pF825, DOI 10.1152/ajprenal.1997.273.5.F825; Welling PA, 2010, PHYSIOLOGY, V25, P280, DOI 10.1152/physiol.00022.2010; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	32	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26867	26875		10.1074/jbc.M112.341990	http://dx.doi.org/10.1074/jbc.M112.341990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711530	hybrid, Green Published			2022-12-28	WOS:000307386000035
J	Wennman, A; Jerneren, F; Hamberg, M; Oliw, EH				Wennman, Anneli; Jerneren, Fredrik; Hamberg, Mats; Oliw, Ernst H.			Catalytic Convergence of Manganese and Iron Lipoxygenases by Replacement of a Single Amino Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CHIRAL COLUMN CHROMATOGRAPHY; POSITIONAL SPECIFICITY; HUMAN 5-LIPOXYGENASE; ENANTIOMERIC SEPARATION; MASS-SPECTROMETRY; PROTEIN-STRUCTURE; PICHIA-PASTORIS; LINOLEIC-ACID; OXYGENATION	Lipoxygenases (LOXs) contain a hydrophobic substrate channel with the conserved Gly/Ala determinant of regio- and stereospecificity and a conserved Leu residue near the catalytic non-heme iron. Our goal was to study the importance of this region (Gly(332), Leu(336), and Phe(337)) of a lipoxygenase with catalytic manganese (13R-MnLOX). Recombinant 13R-MnLOX oxidizes 18:2n-6 and 18:3n-3 to 13R-, 11(S or R)-, and 9S-hydroperoxy metabolites (similar to 80-85, 15-20, and 2-3%, respectively) by suprafacial hydrogen abstraction and oxygenation. Replacement of Phe(337) with Ile changed the stereochemistry of the 13-hydroperoxy metabolites of 18:2n-6 and 18:3n-3 (from similar to 100% R to 69-74% S) with little effect on regiospecificity. The abstraction of the pro-S hydrogen of 18:2n-6 was retained, suggesting antarafacial hydrogen abstraction and oxygenation. Replacement of Leu(336) with smaller hydrophobic residues (Val, Ala, and Gly) shifted the oxygenation from C-13 toward C-9 with formation of 9S- and 9R-hydroperoxy metabolites of 18:2n-6 and 18:3n-3. Replacement of Gly(332) and Leu(336) with larger hydrophobic residues (G332A and L336F) selectively augmented dehydration of 13R-hydroperoxyoctadeca-9Z,11E,15Z-trienoic acid and increased the oxidation at C-13 of 18:1n-6. We conclude that hydrophobic replacements of Leu(336) can modify the hydroperoxide configurations at C-9 with little effect on the R configuration at C-13 of the 18:2n-6 and 18:3n-3 metabolites. Replacement of Phe(337) with Ile changed the stereospecific oxidation of 18:2n-6 and 18:3n-3 with formation of 13S-hydroperoxides by hydrogen abstraction and oxygenation in analogy with soybean LOX-1.	[Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Solna, Sweden	Uppsala University; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, Biomed Ctr, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se		Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130; Jerneren, Fredrik/0000-0003-0897-7177	Vetenskapsradet Grant [03X-06523]; SciLifeLab; Knut and Alice Wallenberg Foundation [KAW 2004.0123]	Vetenskapsradet Grant; SciLifeLab; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Vetenskapsradet Grant 03X-06523, SciLifeLab, and Knut and Alice Wallenberg Foundation Grant KAW 2004.0123.	Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; GARDNER HW, 1989, BIOCHIM BIOPHYS ACTA, V1001, P274, DOI 10.1016/0005-2760(89)90111-2; Garreta A., 2011, RECENT ADV PHARM SCI, P247; Garscha U, 2008, J CHROMATOGR B, V872, P90, DOI 10.1016/j.jchromb.2008.07.013; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldsmith CR, 2006, INORG CHEM, V45, P6048, DOI 10.1021/ic060621e; Haas U, 2011, P NATL ACAD SCI USA, V108, P20479, DOI 10.1073/pnas.1117094108; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; HAMBERG M, 1971, ANAL BIOCHEM, V43, P515, DOI 10.1016/0003-2697(71)90282-X; Hamberg M, 2011, LIPIDS, V46, P201, DOI 10.1007/s11745-010-3510-4; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Hughes RK, 2001, EUR J BIOCHEM, V268, P1030, DOI 10.1046/j.1432-1327.2001.01964.x; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jansen C, 2011, J BIOL CHEM, V286, P37804, DOI 10.1074/jbc.M111.259242; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; McClellan JE, 2002, ANAL CHEM, V74, P402, DOI 10.1021/ac015610b; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200; Oliw EH, 2011, BBA-MOL CELL BIOL L, V1811, P138, DOI 10.1016/j.bbalip.2010.12.002; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Rickert KW, 1999, BIOCHEMISTRY-US, V38, P12218, DOI 10.1021/bi990834y; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2000, BIOCHEMISTRY-US, V39, P14515, DOI 10.1021/bi001447n; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Youn B, 2006, PROTEINS, V65, P1008, DOI 10.1002/prot.21182; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	52	19	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31757	31765		10.1074/jbc.M112.364331	http://dx.doi.org/10.1074/jbc.M112.364331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822060	Green Published, hybrid			2022-12-28	WOS:000309059400017
J	Albrecht, DW; Herdendorf, TJ; Nelson, SW				Albrecht, Dustin W.; Herdendorf, Timothy J.; Nelson, Scott W.			Disruption of the Bacteriophage T4 Mre11 Dimer Interface Reveals a Two-state Mechanism for Exonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; HOMOLOGOUS RECOMBINATION; DNA-REPLICATION; ATP HYDROLYSIS; PROTEINS; INSIGHTS; ENZYME; EXO1	The Mre11-Rad50 (MR) complex is a central player in DNA repair and is implicated in the processing of DNA ends caused by double strand breaks. Recent crystal structures of the MR complex suggest that several conformational rearrangements occur during its ATP hydrolysis cycle. A comparison of the Mre11 dimer interface from these structures suggests that the interface is dynamic in nature and may adopt several different arrangements. To probe the functional significance of the Mre11 dimer interface, we have generated and characterized a dimer disruption Mre11 mutant (L101D-Mre11). Although L101D-Mre11 binds to Rad50 and dsDNA with affinity comparable with the wild-type enzyme, it does not activate the ATP hydrolysis activity of Rad50, suggesting that the allosteric communication between Mre11 and Rad50 has been interrupted. Additionally, the dsDNA exonuclease activity of the L101D-MR complex has been reduced by 10-fold under conditions where processive exonuclease activity is required. However, we unexpectedly found that under steady state conditions, the nuclease activity of the L101D-MR complex is significantly greater than that of the wild-type complex. Based on steady state and single-turnover nuclease assays, we have assigned the rate-determining step of the steady state nuclease reaction to be the productive assembly of the complex at the dsDNA end. Together, our data suggest that the Mre11 dimer interface adopts at least two different states during the exonuclease reaction.	[Albrecht, Dustin W.; Herdendorf, Timothy J.; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu			Carver Trust Young Investigator Grant [10-3603]; Iowa State University institutional support; National Science Foundation Grant [MCB-1121693]; Div Of Molecular and Cellular Bioscience [1121693] Funding Source: National Science Foundation	Carver Trust Young Investigator Grant; Iowa State University institutional support; National Science Foundation Grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S.W.N.), Iowa State University institutional support (to S.W.N.), and National Science Foundation Grant MCB-1121693 (to S.W.N.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Herdendorf TJ, 2011, BIOCHEMISTRY-US, V50, P6030, DOI 10.1021/bi200184w; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	40	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31371	31381		10.1074/jbc.M112.392316	http://dx.doi.org/10.1074/jbc.M112.392316			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22798142	Green Published, hybrid			2022-12-28	WOS:000308791300048
J	Hartmann, J; Tran, TV; Kaudeer, J; Oberle, K; Herrmann, J; Quagliano, I; Abel, T; Cohnen, A; Gatterdam, V; Jacobs, A; Wollscheid, B; Tampe, R; Watzl, C; Diefenbach, A; Koch, J				Hartmann, Jessica; Thuy-Van Tran; Kaudeer, Janina; Oberle, Karin; Herrmann, Julia; Quagliano, Isabell; Abel, Tobias; Cohnen, Andre; Gatterdam, Volker; Jacobs, Andrea; Wollscheid, Bernd; Tampe, Robert; Watzl, Carsten; Diefenbach, Andreas; Koch, Joachim			The Stalk Domain and the Glycosylation Status of the Activating Natural Killer Cell Receptor NKp30 Are Important for Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-ASSOCIATED TRANSCRIPT-3; VIRUS-INFECTED CELLS; HEPARAN-SULFATE; DENDRITIC CELLS; NK CELLS; CYTOTOXICITY RECEPTORS; SURFACE-MOLECULE; TUMOR; RECOGNITION; NKP46	The natural cytotoxicity receptors are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. The human natural cytotoxicity receptor family comprises the three type I membrane proteins NKp30, NKp44, and NKp46. Especially NKp30 is critical for the cytotoxicity of NK cells against different targets including tumor, virus-infected, and immature dendritic cells. Although the crystal structure of NKp30 was recently solved (Li, Y., Wang, Q., and Mariuzza, R. A. (2011) J. Exp. Med. 208, 703-714; Joyce, M. G., Tran, P., Zhuravleva, M. A., Jaw, J., Colonna, M., and Sun, P. D. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 6223-6228), a key question, how NKp30 recognizes several non-related ligands, remains unclear. Therefore, we investigated the parameters that impact ligand recognition of NKp30. Based on various NKp30-hIgG1-Fc fusion proteins, which were optimized for minimal background binding to cellular Fc gamma receptors, we identified the flexible stalk region of NKp30 as an important but so far neglected module for ligand recognition and related signaling of the corresponding full-length receptor proteins. Moreover, we found that the ectodomain of NKp30 is N-linked glycosylated at three different sites. Mutational analyses revealed differential binding affinities and signaling capacities of mono-, di-, or triglycosylated NKp30, suggesting that the degree of glycosylation could provide a switch to modulate the ligand binding properties of NKp30 and NK cell cytotoxicity.	[Hartmann, Jessica; Thuy-Van Tran; Kaudeer, Janina; Herrmann, Julia; Quagliano, Isabell; Koch, Joachim] Inst Biomed Res, D-60596 Frankfurt, Germany; [Oberle, Karin; Diefenbach, Andreas] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Abel, Tobias] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Cohnen, Andre; Watzl, Carsten] Leibniz Res Ctr Working Environm & Human Factors, IfADo, D-44139 Dortmund, Germany; [Gatterdam, Volker; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Jacobs, Andrea; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Freiburg; Paul Ehrlich Institute; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich	Koch, J (corresponding author), Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de	Diefenbach, Andreas/T-2589-2018; Wollscheid, Bernd/E-8909-2010; Tampé, Robert/H-2953-2015; Hartmann, Jessica/AAL-8849-2021; Watzl, Carsten/B-4911-2013	Diefenbach, Andreas/0000-0002-9176-9530; Wollscheid, Bernd/0000-0002-3923-1610; Tampé, Robert/0000-0002-0403-2160; Hartmann, Jessica/0000-0001-9372-8954; Watzl, Carsten/0000-0001-5195-0995; Gatterdam, Volker/0000-0001-7078-9885	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004]; German Federal Ministry of Health (Bundesministerium fur Gesundheit); Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst)	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; German Federal Ministry of Health (Bundesministerium fur Gesundheit); Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst)	This work was supported in part by grants from the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) Center for Cell and Gene Therapy Frankfurt funded by Hessisches Ministerium fur Wissenschaft und Kunst funding reference number III L 4-518/17.004 (2010).; We thank Alexander Steinle for critical review of the manuscript and helpful discussions. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (Bundesministerium fur Gesundheit) and the Ministry of Higher Education, Research and the Arts of the State of Hessen (Hessisches Ministerium fur Wissenschaft und Kunst).	Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200; ANDERSON CL, 1982, J EXP MED, V156, P1794, DOI 10.1084/jem.156.6.1794; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni Roberto, 2009, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1410s84; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Byrd A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001339; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Funke J, 2011, AIDS REV, V13, P67; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hershkovitz O, 2008, GLYCOBIOLOGY, V18, P28, DOI 10.1093/glycob/cwm125; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McCann FE, 2002, IMMUNOL REV, V189, P179, DOI 10.1034/j.1600-065X.2002.18915.x; MCCOOL D, 1985, J IMMUNOL, V135, P1975; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Ponnampalam AP, 2008, EUR J IMMUNOL, V38, P216, DOI 10.1002/eji.200636429; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; Srivastava BIS, 2006, LEUKEMIA RES, V30, P37, DOI 10.1016/j.leukres.2005.06.020; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923; Zheng XX, 1999, J IMMUNOL, V163, P4041	53	31	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31527	31539		10.1074/jbc.M111.304238	http://dx.doi.org/10.1074/jbc.M111.304238			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807449	Green Published, hybrid			2022-12-28	WOS:000308791300065
J	Lu, YL; Kwan, AH; Jeffries, CM; Guss, JM; Trewhella, J				Lu, Yanling; Kwan, Ann H.; Jeffries, Cy M.; Guss, J. Mitchell; Trewhella, Jill			The Motif of Human Cardiac Myosin-binding Protein C Is Required for Its Ca2+-dependent Interaction with Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RAY-SCATTERING REVEALS; TARGET RECOGNITION; REGULATORY DOMAIN; PHOSPHORYLATION; MUSCLE; MUTATIONS; COMPLEX; IDENTIFICATION	The N-terminal modules of cardiac myosin-binding protein C (cMyBP-C) play a regulatory role in mediating interactions between myosin and actin during heart muscle contraction. The so-called "motif," located between the second and third immunoglobulin modules of the cardiac isoform, is believed to modulate contractility via an "on-off" phosphorylation-dependent tether to myosin Delta S2. Here we report a novel Ca2+-dependent interaction between the motif and calmodulin (CaM) based on the results of a combined fluorescence, NMR, and light and x-ray scattering study. We show that constructs of cMyBP-C containing the motif bind to Ca2+/CaM with a moderate affinity (K-D similar to 10 mu M), which is similar to the affinity previously determined for myosin Delta S2. However, unlike the interaction with myosin Delta S2, the Ca2+/CaM interaction is unaffected by substitution with a triphosphorylated motif mimic. Further, Ca2+/CaM interacts with the highly conserved residues (Glu(319)-Lys(341)) toward the C-terminal end of the motif. Consistent with the Ca2+ dependence, the binding of CaM to the motif is mediated via the hydrophobic clefts within the N- and C-lobes that are known to become more exposed upon Ca2+ binding. Overall, Ca2+/CaM engages with the motif in an extended clamp configuration as opposed to the collapsed binding mode often observed in other CaM-protein interactions. Our results suggest that CaM may act as a structural conduit that links cMyBP-C with Ca2+ signaling pathways to help coordinate phosphorylation events and synchronize the multiple interactions between cMyBP-C, myosin, and actin during the heart muscle contraction.	[Lu, Yanling; Kwan, Ann H.; Jeffries, Cy M.; Guss, J. Mitchell; Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Trewhella, J (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	Jill.Trewhella@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; /0000-0002-8718-7343; Kwan, Ann/0000-0002-1506-2226; Trewhella, Jill/0000-0002-8555-6766	Australian Research Council [DP120103841]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP120103841.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Andre I, 2004, BIOPHYS J, V87, P1929, DOI 10.1529/biophysj.104.040998; BLUMENTHAL DK, 1988, BIOCHEM BIOPH RES CO, V156, P860, DOI 10.1016/S0006-291X(88)80923-9; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Cheng LH, 2003, CIRCULATION, V108, P90; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Govada L, 2008, J MOL BIOL, V378, P387, DOI 10.1016/j.jmb.2008.02.044; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; Howarth JW, 2012, J BIOL CHEM, V287, P8254, DOI 10.1074/jbc.M111.309591; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Kelly M, 2009, CIRC-CARDIOVASC GENE, V2, P182, DOI 10.1161/CIRCGENETICS.108.836478; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Koster S, 2011, J BIOL CHEM, V286, P40954, DOI 10.1074/jbc.M111.286906; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026; Lu YL, 2011, BIOPOLYMERS, V95, P505, DOI 10.1002/bip.21624; Matsushima N, 2000, BIOCHEM J, V347, P211, DOI 10.1042/0264-6021:3470211; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Muino PL, 2009, J PHYS CHEM B, V113, P2572, DOI 10.1021/jp711513b; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tong CW, 2004, J PHYSIOL-LONDON, V558, P927, DOI 10.1113/jphysiol.2004.062539; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weljie AM, 2000, PROTEIN ENG, V13, P59, DOI 10.1093/protein/13.1.59; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	61	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31596	31607		10.1074/jbc.M112.383299	http://dx.doi.org/10.1074/jbc.M112.383299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801425	Green Published, hybrid			2022-12-28	WOS:000308791300071
J	Hill, DR; Kessler, SP; Rho, HK; Cowman, MK; de la Motte, CA				Hill, David R.; Kessler, Sean P.; Rho, Hyunjin K.; Cowman, Mary K.; de la Motte, Carol A.			Specific-sized Hyaluronan Fragments Promote Expression of Human beta-Defensin 2 in Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HYALURONAN; TOLL-LIKE RECEPTOR-4; SMOOTH-MUSCLE-CELLS; HUMAN BETA-DEFENSIN-2; MESSENGER-RNA; ANTIMICROBIAL PEPTIDES; MURINE MACROPHAGES; DENDRITIC CELLS; CACO-2 CELLS; CD44	Hyaluronan (HA) is a glycosaminoglycan polymer found in the extracellular matrix of virtually all mammalian tissues. Recent work has suggested a role for small, fragmented HA polymers in initiating innate defense responses in immune cells, endothelium, and epidermis through interaction with innate molecular pattern recognition receptors, such as TLR4. Despite these advances, little is known regarding the effect of fragmented HA at the intestinal epithelium, where numerous pattern recognition receptors act as sentinels of an innate defense response that maintains epithelial barrier integrity in the presence of abundant and diverse microbial challenges. Here we report that HA fragments promote expression of the innate antimicrobial peptide human beta-defensin 2 (H beta D2) in intestinal epithelial cells. Treatment of HT-29 colonic epithelial cells with HA fragment preparations resulted in time- and dose-dependent up-regulated expression of H beta D2 protein in a fragment size-specific manner, with 35-kDa HA fragment preparations emerging as the most potent inducers of intracellular H beta D2. Furthermore, oral administration of specific-sized HA fragments promotes the expression of an H beta D2 ortholog in the colonic epithelium of both wild-type and CD44-deficient mice but not in TLR4-deficient mice. Together, our observations suggest that a highly size-specific, TLR4-dependent, innate defense response to fragmented HA contributes to intestinal epithelium barrier defense through the induction of intracellular H beta D2 protein.	[Hill, David R.; Kessler, Sean P.; Rho, Hyunjin K.; de la Motte, Carol A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Hill, David R.; de la Motte, Carol A.] Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44195 USA; [Cowman, Mary K.] NYU, Dept Chem & Biol Sci, Polytech Inst, Brooklyn, NY 11201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; New York University; New York University Tandon School of Engineering	de la Motte, CA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC2, Cleveland, OH 44195 USA.	delamoc@ccf.org	Hill, David/H-9285-2019	Hill, David/0000-0002-1626-6079	National Institutes of Health [HD061918]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061918] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD061918 (to C. A. de la M.). Carol A. de la Motte and Sean P. Kessler are co-inventors on pending and issued patents held by the Cleveland Clinic. Relating to these technologies, they have a financial interest in Lifecore Biomedical, LLC.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Asari A, 2010, J BIOL CHEM, V285, P24751, DOI 10.1074/jbc.M110.104950; Balogh L, 2008, J AGR FOOD CHEM, V56, P10582, DOI 10.1021/jf8017029; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Barrera GJ, 2009, IMMUNOL LETT, V123, P52, DOI 10.1016/j.imlet.2009.02.001; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Coppa GV, 2011, GLYCOBIOLOGY, V21, P295, DOI 10.1093/glycob/cwq164; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Frye M, 2000, EUR J CLIN INVEST, V30, P695; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Garreis F, 2010, HISTOCHEM CELL BIOL, V134, P59, DOI 10.1007/s00418-010-0713-y; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kawana H, 2008, J IMMUNOL, V180, P4235, DOI 10.4049/jimmunol.180.6.4235; Lee SK, 2005, BIOCHEM BIOPH RES CO, V337, P457, DOI 10.1016/j.bbrc.2005.09.071; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Menendez A, 2007, CURR OPIN IMMUNOL, V19, P385, DOI 10.1016/j.coi.2007.06.008; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; O'Neil DA, 1999, J IMMUNOL, V163, P6718; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; O'Neill LAJ, 2009, GASTROENTEROLOGY, V137, P1889, DOI 10.1053/j.gastro.2009.10.015; Ogushi K, 2004, J BIOL CHEM, V279, P12213, DOI 10.1074/jbc.M307944200; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Peterson E., 2008, HISTOLOGIC, V41, P38; Platz J, 2004, J IMMUNOL, V173, P1219, DOI 10.4049/jimmunol.173.2.1219; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schlee M, 2008, CLIN EXP IMMUNOL, V151, P528, DOI 10.1111/j.1365-2249.2007.03587.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Seo ES, 2009, PROTEIN EXPRES PURIF, V65, P179, DOI 10.1016/j.pep.2008.11.007; Sharma R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/305879; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stober H, 2010, INT J FOOD MICROBIOL, V144, P133, DOI 10.1016/j.ijfoodmicro.2010.09.010; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055; Zhuravel E., 2011, Experimental Oncology, V33, P114	68	54	58	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30610	30624		10.1074/jbc.M112.356238	http://dx.doi.org/10.1074/jbc.M112.356238			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22761444	Green Published, hybrid			2022-12-28	WOS:000308579800052
J	Vats, A; Singh, AK; Mukherjee, R; Chopra, T; Ravindran, MS; Mohanty, D; Chatterji, D; Reyrat, JM; Gokhale, RS				Vats, Archana; Singh, Anil Kumar; Mukherjee, Raju; Chopra, Tarun; Ravindran, Madhu Sudhan; Mohanty, Debasisa; Chatterji, Dipankar; Reyrat, Jean-Marc; Gokhale, Rajesh S.			Retrobiosynthetic Approach Delineates the Biosynthetic Pathway and the Structure of the Acyl Chain of Mycobacterial Glycopeptidolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; POLYKETIDE SYNTHASES; FATTY-ACIDS; SMEGMATIS; IDENTIFICATION; TUBERCULOSIS; SURFACE; LIPIDS; METHYLTRANSFERASE; CONSTRUCTION	Glycopeptidolipids (GPLs) are dominant cell surface molecules present in several non-tuberculous and opportunistic mycobacterial species. GPLs from Mycobacterium smegmatis are composed of a lipopeptide core unit consisting of a modified C-26-C-34 fatty acyl chain that is linked to a tetrapeptide (Phe-Thr-Ala-alaninol). The hydroxyl groups of threonine and terminal alaninol are further modified by glycosylations. Although chemical structures have been reported for 16 GPLs from diverse mycobacteria, there is still ambiguity in identifying the exact position of the hydroxyl group on the fatty acyl chain. Moreover, the enzymes involved in the biosynthesis of the fatty acyl component are unknown. In this study we show that a bimodular polyketide synthase in conjunction with a fatty acyl-AMP ligase dictates the synthesis of fatty acyl chain of GPL. Based on genetic, biochemical, and structural investigations, we determine that the hydroxyl group is present at the C-5 position of the fatty acyl component. Our retrobiosynthetic approach has provided a means to understand the biosynthesis of GPLs and also resolve the long-standing debate on the accurate structure of mycobacterial GPLs.	[Vats, Archana; Gokhale, Rajesh S.] CSIR Inst Genom & Integrat Biol, Delhi 110007, India; [Singh, Anil Kumar; Reyrat, Jean-Marc] Univ Paris 05, Fac Med Paris Descartes, INSERM, U570, F-75730 Paris 15, France; [Singh, Anil Kumar] CSIR NE Inst Sci & Technol, Dept Biotechnol, Jorhat 785006, Assam, India; [Mukherjee, Raju; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vats, Archana; Chopra, Tarun; Ravindran, Madhu Sudhan; Mohanty, Debasisa; Gokhale, Rajesh S.] Natl Inst Immunol, New Delhi 110067, India; [Gokhale, Rajesh S.] Jawarharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Gokhale, RS (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.	rsg@igib.res.in	Ravindran, Madhu Sudhan/I-5325-2019; Mohanty, Debasisa/A-1428-2009	Ravindran, Madhu Sudhan/0000-0001-7450-2001; Chatterji, Dipankar/0000-0002-9985-0632; MOHANTY, DEBASISA/0000-0002-3374-0588	Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR) [3403-03]; Department of Biotechnology, Government of India; CEFIPRA/IFCPAR	Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CEFIPRA/IFCPAR	This work was supported by Le Centre Indo-Francais Pour la Recherche Avancee (CEFIPRA)/Indo-French Centre for the Promotion of Advanced Research (IFCPAR) Grant 3403-03 (to J.-M. R. and R. S. G.); Supported by a Department of Biotechnology, Government of India, post-doctoral fellowship.; Supported by CEFIPRA/IFCPAR.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Aspinall GO, 1995, ADV CARBOHYD CHEM BI, V51, P169, DOI 10.1016/S0065-2318(08)60194-8; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; BRENNAN PJ, 1979, J BIOL CHEM, V254, P4205; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chopra T, 2008, PLOS BIOL, V6, P1584, DOI 10.1371/journal.pbio.0060163; Deshayes C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r20; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; Griffiths WJ, 2001, BIOCHEM J, V355, P545, DOI 10.1042/bj3550545; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jeevarajah D, 2002, MICROBIOL-SGM, V148, P3079, DOI 10.1099/00221287-148-10-3079; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; KHOO KH, 1995, CARBOHYD RES, V276, P449, DOI 10.1016/0008-6215(95)00184-U; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; MARIN LML, 1991, BIOCHEMISTRY-US, V30, P10536, DOI 10.1021/bi00107a024; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Miyamoto Y, 2006, J BACTERIOL, V188, P86, DOI 10.1128/JB.188.1.86-95.2006; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Mukherjee R, 2005, MICROBIOL-SGM, V151, P2385, DOI 10.1099/mic.0.27908-0; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Patterson JH, 2000, J BIOL CHEM, V275, P24900, DOI 10.1074/jbc.M000147200; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Prod'hom G, 1998, FEMS MICROBIOL LETT, V158, P75, DOI 10.1111/j.1574-6968.1998.tb12803.x; Recht J, 2001, Acta Cient Venez, V52 Suppl 1, P45; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; SMITH DONALD W., 1960, NATURE, V186, P887, DOI 10.1038/186887a0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; Stinear TP, 2005, J BACTERIOL, V187, P1668, DOI 10.1128/JB.187.5.1668-1676.2005; Tang YY, 2006, BIOCHEMISTRY-US, V45, P14085, DOI 10.1021/bi061187v; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	43	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30677	30687		10.1074/jbc.M112.384966	http://dx.doi.org/10.1074/jbc.M112.384966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798073	hybrid, Green Published			2022-12-28	WOS:000308579800057
J	Lasry, I; Seo, YA; Ityel, H; Shalva, N; Pode-Shakked, B; Glaser, F; Berman, B; Berezovsky, I; Goncearenco, A; Klar, A; Levy, J; Anikster, Y; Kelleher, SL; Assaraf, YG				Lasry, Inbal; Seo, Young Ah; Ityel, Hadas; Shalva, Nechama; Pode-Shakked, Ben; Glaser, Fabian; Berman, Bluma; Berezovsky, Igor; Goncearenco, Alexander; Klar, Aharon; Levy, Jacob; Anikster, Yair; Kelleher, Shannon L.; Assaraf, Yehuda G.			A Dominant Negative Heterozygous G87R Mutation in the Zinc Transporter, ZnT-2 (SLC30A2), Results in Transient Neonatal Zinc Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND; PROTEIN; ACRODERMATITIS; GENE; EXPRESSION; LACTATION; IDENTIFICATION; LOCALIZATION; SUBSTITUTION; METABOLISM	Zinc is an essential mineral, and infants are particularly vulnerable to zinc deficiency as they require large amounts of zinc for their normal growth and development. We have recently described the first loss-of-function mutation (H54R) in the zinc transporter ZnT-2 (SLC30A2) in mothers with infants harboring transient neonatal zinc deficiency (TNZD). Here we identified and characterized a novel heterozygous G87R ZnT-2 mutation in two unrelated Ashkenazi Jewish mothers with infants displaying TNZD. Transient transfection of G87R ZnT-2 resulted in endoplasmic reticulum-Golgi retention, whereas the WT transporter properly localized to intracellular secretory vesicles in HC11 and MCF-7 cells. Consequently, G87R ZnT-2 showed decreased stability compared with WT ZnT-2 as revealed by Western blot analysis. Three-dimensional homology modeling based on the crystal structure of YiiP, a close zinc transporter homologue from Escherichia coli, revealed that the basic arginine residue of the mutant G87R points toward the membrane lipid core, suggesting misfolding and possible loss-of-function. Indeed, functional assays including vesicular zinc accumulation, zinc secretion, and cytoplasmic zinc pool assessment revealed markedly impaired zinc transport in G87R ZnT-2 transfectants. Moreover, co-transfection experiments with both mutant and WT transporters revealed a dominant negative effect of G87R ZnT-2 over the WT ZnT-2; this was associated with mislocalization, decreased stability, and loss of zinc transport activity of the WT ZnT-2 due to homodimerization observed upon immunoprecipitation experiments. These findings establish that inactivating ZnT-2 mutations are an underlying basis of TNZD and provide the first evidence for the dominant inheritance of heterozygous ZnT-2 mutations via negative dominance due to homodimer formation.	[Lasry, Inbal; Berman, Bluma; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Seo, Young Ah; Kelleher, Shannon L.] Penn State Univ Pk, Dept Nutr Sci, Penn State, PA 16802 USA; [Seo, Young Ah; Kelleher, Shannon L.] Penn State Univ Pk, Dept Surg, Penn State, PA 16802 USA; [Seo, Young Ah; Kelleher, Shannon L.] Penn State Univ Pk, Dept Cell & Mol Physiol, Penn State, PA 16802 USA; [Ityel, Hadas; Shalva, Nechama; Pode-Shakked, Ben; Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, IL-52621 Ramat Gan, Israel; [Ityel, Hadas; Anikster, Yair] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Glaser, Fabian] Technion Israel Inst Technol, Ctr Life Sci & Engn, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel; [Berezovsky, Igor; Goncearenco, Alexander] Univ Bergen, Computat Biol Unit Uni Res, N-5008 Bergen, Norway; [Klar, Aharon] Bikur Cholim Gen Hosp, Dept Pediat, IL-91004 Jerusalem, Israel; [Levy, Jacob] Soroka Univ, Med Ctr, Pediat Immunol Unit, IL-84101 Beer Sheva, Israel	Technion Israel Institute of Technology; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology; University of Bergen; Ben Gurion University; Soroka Medical Center	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il	Goncearenco, Alexander/M-3946-2015; Seo, Young Ah/AAT-5022-2020; Goncearenco, Alexander/AAA-5426-2020	Goncearenco, Alexander/0000-0002-9738-7146; Seo, Young Ah/0000-0003-3884-0665; Goncearenco, Alexander/0000-0002-9738-7146				AGGETT PJ, 1983, J INHERIT METAB DIS, V6, P39, DOI 10.1007/BF01811322; AGGETT PJ, 1980, ARCH DIS CHILD, V55, P547, DOI 10.1136/adc.55.7.547; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baljuls A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194167; Berger-Achituv S, 2005, ISR MED ASSOC J, V7, P515; Bhatnagar S, 2001, BRIT J NUTR, V85, pS139, DOI 10.1079/BJN2000306; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Dorea JG, 2000, NUTR RES, V20, P1645, DOI 10.1016/S0271-5317(00)00243-8; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; ERWAY LC, 1984, J HERED, V75, P480, DOI 10.1093/oxfordjournals.jhered.a109990; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hou ZJ, 2009, J BIOL CHEM, V284, P3285, DOI 10.1074/jbc.M807206200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; Kalman M, 2010, BIOINFORMATICS, V26, P1299, DOI 10.1093/bioinformatics/btq114; KASPEREK K, 1977, EUR J PEDIATR, V126, P199, DOI 10.1007/BF00477045; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; Kelleher SL, 2003, J NUTR, V133, P3378, DOI 10.1093/jn/133.11.3378; KREBS NF, 1995, AM J CLIN NUTR, V61, P1030, DOI 10.1093/ajcn/61.5.1030; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEE DY, 1992, J NUTR, V122, P2233, DOI 10.1093/jn/122.11.2233; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Michalczyk A, 2003, HUM GENET, V113, P202, DOI 10.1007/s00439-003-0952-2; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; MOYNAHAN EJ, 1974, LANCET, V2, P399; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; PARKER PH, 1982, AM J DIS CHILD, V136, P77, DOI 10.1001/archpedi.1982.03970370079024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PILETZ JE, 1978, SCIENCE, V199, P181, DOI 10.1126/science.619449; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Rothem L, 2005, MOL PHARMACOL, V68, P616, DOI 10.1124/mol.105.013540; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Schushan M., 2010, INTRO PROTEIN STRUCT, P369; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tan AE, 2008, BIOCHEMISTRY-US, V47, P12095, DOI 10.1021/bi801436a; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weijers RNM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-33; ZIMMERMAN AW, 1982, PEDIATRICS, V69, P176	53	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29348	29361		10.1074/jbc.M112.368159	http://dx.doi.org/10.1074/jbc.M112.368159			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22733820	Green Published, hybrid			2022-12-28	WOS:000308286900014
J	Liu, C; Zhang, X; Huang, F; Yang, B; Li, J; Liu, BF; Luo, HH; Zhang, P; Zhang, H				Liu, Chao; Zhang, Xue; Huang, Feng; Yang, Bin; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui			APOBEC3G Inhibits MicroRNA-mediated Repression of Translation by Interfering with the Interaction between Argonaute-2 and MOV10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; REVERSE TRANSCRIPTION; PROTEIN-SYNTHESIS; STRESS GRANULES; 7SL RNA; DROSOPHILA; GW182; BIOGENESIS; COMPLEXES; FAMILY	The apolipoprotein-B-mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G or A3G) is a potent restrictive factor for human immunodeficiency virus type 1 (HIV-1) and many other retroviruses. It belongs to the cytidine deaminase family. Recent studies have shown that A3G significantly inhibits microRNA (miRNA)-mediated repression of translation. However, the mechanism underlying this action must be clarified. In this report, we have demonstrated that A3G counteracts miRNA-mediated repression of translation by inhibiting the interaction between moloney leukemia virus 10 (MOV10) protein and Argonaute-2 (AGO2), causing either abnormal assembly or abnormal maturation of miRNA-inducing silencing complex (miRISC). Through a series of MOV10 deletions, we found that A3G binds to a domain at the C terminus in MOV10, where it competitively inhibits the binding of AGO2 to that same domain. The interaction between A3G and MOV10 relies on its association with a small RNA named 7SL RNA. The A3G mutant W127L, which is unable to bind to 7SL RNA, shows significantly incapability to counteract the miRNA-mediated repression of translation. Our data demonstrate a novel mechanism involved in the regulation of miRISC activity. Although both A3G and MOV10 belong to the interferon antiviral system and inhibit HIV-1 and other retroviruses, their opposing effects on the cellular miRNA activity suggest that they play much more complicated regulatory roles in various cellular functions.	[Liu, Chao; Zhang, Xue; Huang, Feng; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Chao; Zhang, Xue; Huang, Feng; Li, Jun; Liu, Bingfeng; Luo, Haihua; Zhang, Ping; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Yang, Bin; Zhang, Hui] Thomas Jefferson Univ, Dept Med, Div Infect Dis, Ctr Human Virol, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Jefferson University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.	chaoliulc@yahoo.com.cn; hz08043@gmail.com		Li, Jun/0000-0002-2611-8918	National Institutes of Health [AI078812]; Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; Natural Science Foundation of China [30972620, 81101255]; Natural Science Foundation of Guangdong [9251008901000022, 10451008901004204]; Research Fund for the Doctoral Program of Higher Education of China [20090171110083, 20100171120056]; China Postdoctoral Science Foundation [20100470045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, National Institutes of Health Grant AI078812 (to H. Z.), Guangdong Innovative Research Team Program (2009010058), National Basic Research Program of China (973 Program, 2010CB912202), Natural Science Foundation of China (30972620, 81101255), Natural Science Foundation of Guangdong (9251008901000022, 10451008901004204), Research Fund for the Doctoral Program of Higher Education of China (20090171110083, 20100171120056), and China Postdoctoral Science Foundation (20100470045).	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mary C, 2010, RNA, V16, P969, DOI 10.1261/rna.2040410; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pei YF, 2009, J THEOR BIOL, V261, P17, DOI 10.1016/j.jtbi.2009.07.022; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Tian CJ, 2007, NUCLEIC ACIDS RES, V35, P7288, DOI 10.1093/nar/gkm816; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; WOLIN SL, 1983, CELL, V32, P735, DOI 10.1016/0092-8674(83)90059-4; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519	44	41	45	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29373	29383		10.1074/jbc.M112.354001	http://dx.doi.org/10.1074/jbc.M112.354001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791714	hybrid, Green Published			2022-12-28	WOS:000308286900016
J	Mizuno, N; Varkey, J; Kegulian, NC; Hegde, BG; Cheng, NQ; Langen, R; Steven, AC				Mizuno, Naoko; Varkey, Jobin; Kegulian, Natalie C.; Hegde, Balachandra G.; Cheng, Naiqian; Langen, Ralf; Steven, Alasdair C.			Remodeling of Lipid Vesicles into Cylindrical Micelles by alpha-Synuclein in an Extended alpha-Helical Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE STRUCTURES; NEURONAL DYSFUNCTION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BROKEN HELIX; BINDING; PROTEIN; CELLS; CURVATURE; PHOSPHATIDYLCHOLINE	alpha-Synuclein (alpha S) is a protein with multiple conformations and interactions. Natively unfolded in solution, alpha S accumulates as amyloid in neurological tissue in Parkinson disease and interacts with membranes under both physiological and pathological conditions. Here, we used cryoelectron microscopy in conjunction with electron paramagnetic resonance (EPR) and other techniques to characterize the ability of alpha S to remodel vesicles. At molar ratios of 1: 5 to 1: 40 for protein/lipid (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol), large spherical vesicles are converted into cylindrical micelles similar to 50 angstrom in diameter. Other lipids of the same charge (negative) exhibit generally similar behavior, although bilayer tubes of 150-500 angstrom in width are also produced, depending on the lipid acyl chains. At higher protein/lipid ratios, discoid particles, 70-100 angstrom across, are formed. EPR data show that, on cylindrical micelles, alpha S adopts an extended amphipathic alpha-helical conformation, with its long axis aligned with the tube axis. The observed geometrical relationship between alpha S and the micelle suggests that the wedging of its long alpha-helix into the outer leaflet of a membrane may cause curvature and an anisotropic partition of lipids, leading to tube formation.	[Mizuno, Naoko; Cheng, Naiqian; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Varkey, Jobin; Kegulian, Natalie C.; Hegde, Balachandra G.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Southern California	Mizuno, N (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mizuno@biochem.mpg.de; langen@med.usc.edu; stevena@mail.nih.gov	Hegde, Balachandra/GPS-6028-2022; Mizuno, Naoko/AAY-1926-2021; Varkey, Jobin/I-5845-2019; Kegulian, Natalie/AFF-8981-2022	Mizuno, Naoko/0000-0002-1594-2821; Kegulian, Natalie/0000-0002-8574-1099	National Institutes of Health [2 R01 GM063915]; Intramural Research Program of NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 GM063915 (to R. L.) and the Intramural Research Program of NIAMS.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; EDWARDS K, 1993, J COLLOID INTERF SCI, V161, P299, DOI 10.1006/jcis.1993.1470; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Kanazawa T, 2012, BRAIN PATHOL, V22, P67, DOI 10.1111/j.1750-3639.2011.00509.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lewy F.H., 2017, HDB NEUROLOGIE, V3, P920; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SHIBAYAMAIMAZU T, 1993, BRAIN RES, V622, P17, DOI 10.1016/0006-8993(93)90796-P; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	71	85	85	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29301	29311		10.1074/jbc.M112.365817	http://dx.doi.org/10.1074/jbc.M112.365817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767608	hybrid, Green Published			2022-12-28	WOS:000308286900010
J	Monteferrante, CG; Miethke, M; van der Ploeg, R; Glasner, C; van Dijl, JM				Monteferrante, Carmine G.; Miethke, Marcus; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten			Specific Targeting of the Metallophosphoesterase YkuE to the Bacillus Cell Wall Requires the Twin-arginine Translocation System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; SUBTILIS TAT PATHWAY; PROTEIN SECRETION; ESCHERICHIA-COLI; SIGNAL PEPTIDES; ALKALINE-PHOSPHATASE; STREPTOCOCCUS-PNEUMONIAE; STREPTOMYCES-COELICOLOR; FOLDED PROTEINS; EXPORT PATHWAY	The twin-arginine translocation (Tat) pathway is dedicated to the transport of fully folded proteins across the cytoplasmic membranes of many bacteria and the chloroplast thylakoidal membrane. Accordingly, Tat-dependently translocated proteins are known to be delivered to the periplasm of Gram-negative bacteria, the growth medium of Gram-positive bacteria, and the thylakoid lumen. Here, we present the first example of a protein, YkuE of Bacillus subtilis, that is specifically targeted by the Tat pathway to the cell wall of a Gram-positive bacterium. The cell wall binding of YkuE is facilitated by electrostatic interactions. Interestingly, under particular conditions, YkuE can also be targeted to the cell wall in a Tat-independent manner. The biological function of YkuE was so far unknown. Our present studies show that YkuE is a metal-dependent phosphoesterase that preferentially binds manganese and zinc.	[Monteferrante, Carmine G.; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Monteferrante, Carmine G.; van der Ploeg, Rene; Glasner, Corinna; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Miethke, Marcus] Univ Marburg, Dept Chem Biochem, D-35032 Marburg, Germany	University of Groningen; University of Groningen; Philipps University Marburg	van Dijl, JM (corresponding author), Univ Groningen, Dept Med Microbiol, Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	j.m.van.dijl01@umcg.nl	van Dijl, Jan Maarten/G-1205-2013	van der Ploeg, Rene/0000-0003-2490-9262	Commission of the European Union [LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524, PITN-GA-2008-244093]; Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research; LOEWE Center for Synthetic Microbiology (Synmikro), Germany	Commission of the European Union(European Commission); Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research; LOEWE Center for Synthetic Microbiology (Synmikro), Germany	This work was supported in part by Commission of the European Union Projects LSHG-CT-2004-005257, LSHM-CT-2006-019064, LSHG-CT-2006-037469, PITN-GA-2008-215524, and -244093 and Transnational SysMO Initiative Projects BACELL SysMO1 and -2 through the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research (to C. G. M., R. v. d. P., C. G., and J. M. v. D.).; Supported by the LOEWE Center for Synthetic Microbiology (Synmikro), Germany.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eickhorst T, 2004, J CHROMATOGR A, V1050, P103, DOI 10.1016/j.chroma.2004.04.084; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; GASSON MJ, 1983, J BACTERIOL, V154, P1; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; HATEFI Y, 1969, P NATL ACAD SCI USA, V62, P1129, DOI 10.1073/pnas.62.4.1129; HULL WE, 1976, BIOCHEMISTRY-US, V15, P1547, DOI 10.1021/bi00652a028; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Joshi MV, 2010, MOL MICROBIOL, V77, P252, DOI 10.1111/j.1365-2958.2010.07206.x; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Li HM, 2005, MICROBIOL-SGM, V151, P2189, DOI 10.1099/mic.0.27893-0; Muller JP, 1997, MICROBIOL-SGM, V143, P947, DOI 10.1099/00221287-143-3-947; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; Novak R, 2000, MOL MICROBIOL, V36, P1504, DOI 10.1046/j.1365-2958.2000.01959.x; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Sambrook J., 2002, MOL CLONING LAB MANU; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Taylor PD, 2006, BIOINFORMATION, V1, P184, DOI 10.6026/97320630001184; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; van Dijl JM, 2012, J BACTERIOL, V194, P2779, DOI 10.1128/JB.00270-12; van Dijl JM, 2002, J BIOTECHNOL, V98, P243, DOI 10.1016/S0168-1656(02)00135-9; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Widdick DA, 2008, J MOL BIOL, V375, P595, DOI 10.1016/j.jmb.2007.11.002; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09	70	19	22	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29789	29800		10.1074/jbc.M112.378190	http://dx.doi.org/10.1074/jbc.M112.378190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767609	Green Published, hybrid			2022-12-28	WOS:000308286900054
J	Alvarez, L; Gonzalez-Iglesias, H; Garcia, M; Ghosh, S; Sanz-Medel, A; Coca-Prados, M				Alvarez, Lydia; Gonzalez-Iglesias, Hector; Garcia, Montserrat; Ghosh, Sikha; Sanz-Medel, Alfredo; Coca-Prados, Miguel			The Stoichiometric Transition from Zn6Cu1-Metallothionein to Zn-7-Metallothionein Underlies the Up-regulation of Metallothionein (MT) Expression QUANTITATIVE ANALYSIS OF MT-METAL LOAD IN EYE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROATOM-TAGGED PROTEOMICS; GROWTH-INHIBITORY FACTOR; HPLC-ICP-MS; INFLAMMATORY RESPONSE; SPECIATION ANALYSIS; BUFFERING CAPACITY; EPITHELIAL-CELLS; GENE-EXPRESSION; RAT-BRAIN; ZINC	We examined the profiling of gene expression of metallothioneins (MTs) in human tissues from cadaver eyes with microarray-based analysis. All MT1 isoforms, with the exception of MT1B, were abundantly expressed in lens and corneal tissue. Along with MT1B, MT4 was not detected in any tissues. Antibodies to MT1/2 labeled the corneal epithelial and endothelial cells, whereas MT3 label the retinal ganglion cells. We studied the effects of zinc and cytokines on the gene expression of MT isoforms in a corneal epithelial cell line (HCEsv). Zinc exerted an up-regulation of the expression of MT isoforms, and this effect was further potentiated in the presence of IL1 alpha or TNF alpha. Zinc also elicited a strong down-regulation of the expression of inflammatory cytokines, and this effect was blocked in the presence of TNF alpha or IL1 alpha. The concentration of MTs, bound zinc, and the metal stoichiometry of MTs in cultured HCEsv were determined by mass spectrometry. The total concentration of MTs was 0.24 +/- 0.03 mu M and, after 24 h of zinc exposure, increased to 0.96 +/- 0.01 mu M. The combination of zinc and IL1 alpha further enhanced the level of MTs to 1.13 +/- 0.03 mu M. The average metal stoichiometry of MTs was Zn6Cu1-MT, and after exposure to the different treatments, it changed to Zn-7-MT. Actinomycin D blocked transcription, and cycloheximide attenuated synthesis of MTs in the presence or absence of zinc, suggesting transcriptional regulation. Overall the data provide molecular and analytical evidence on the interplay between zinc, MTs, and proinflammatory cytokines in HCEsv cells, with potential implications on cell-based inflammatory eye diseases.	[Ghosh, Sikha; Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Alvarez, Lydia; Gonzalez-Iglesias, Hector; Garcia, Montserrat; Coca-Prados, Miguel] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo 33012, Spain; [Sanz-Medel, Alfredo] Univ Oviedo, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain	Yale University; University of Oviedo	Coca-Prados, M (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 300 George St,R8100A, New Haven, CT 06510 USA.	Miguel.Coca-Prados@yale.edu	García Diaz, Montserrat/GXV-7857-2022; Alvarez, Lydia/AAA-7736-2019; Gonzalez-Iglesias, Hector/K-2447-2014; Garcia, Montserrat/AAA-7781-2019; Gonzalez-Iglesias, Hector/AAB-5993-2019	Gonzalez-Iglesias, Hector/0000-0001-5251-0967; Garcia, Montserrat/0000-0001-9983-546X; /0000-0003-2899-1347; Alvarez Fernandez, Lydia/0000-0002-0604-7411	CENIT-CeyeC Research from the Spanish Ministry of Innovation and Development [CEN-20091021]; Fundacion de Investigacion Oftalmologica Fernandez-Vega; Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson; Fundacion Rafael del Pino	CENIT-CeyeC Research from the Spanish Ministry of Innovation and Development; Fundacion de Investigacion Oftalmologica Fernandez-Vega; Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson; Fundacion Rafael del Pino	This work was supported in part by a CENIT-CeyeC Research Grant CEN-20091021 from the Spanish Ministry of Innovation and Development, Fundacion de Investigacion Oftalmologica Fernandez-Vega, Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson, and Fundacion Rafael del Pino.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Benedicto A, 2011, J AGR FOOD CHEM, V59, P8829, DOI 10.1021/jf2002574; Bettmer J, 2010, ANAL BIOANAL CHEM, V397, P3495, DOI 10.1007/s00216-010-3861-y; Cabreiro F, 2008, EXP GERONTOL, V43, P483, DOI 10.1016/j.exger.2007.10.007; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Duncan KER, 2006, J INORG BIOCHEM, V100, P2101, DOI 10.1016/j.jinorgbio.2006.09.005; Finamore A, 2005, EUR J CLIN NUTR, V59, pS68, DOI 10.1038/sj.ejcn.1602302; Maltez HF, 2009, ANAL CHIM ACTA, V650, P234, DOI 10.1016/j.aca.2009.07.052; GALIN MA, 1962, INVEST OPHTH VISUAL, V1, P142; GASULL T, 1994, AM J PHYSIOL, V266, pE760, DOI 10.1152/ajpendo.1994.266.5.E760; Martinez-Sierra JG, 2010, J ANAL ATOM SPECTROM, V25, P989, DOI 10.1039/b925366a; Iglesias HG, 2007, ANAL BIOANAL CHEM, V389, P707, DOI 10.1007/s00216-007-1499-1; Gonzalez-Iglesias H., 2012, ELECTROPHOR IN PRESS; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; Infante HG, 2002, J ANAL ATOM SPECTROM, V17, P79, DOI 10.1039/b108354f; Kantorow M, 1998, INVEST OPHTH VIS SCI, V39, P2344; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Krezel A, 2007, BIOCHEM J, V402, P551, DOI 10.1042/BJ20061044; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Li Y, 2008, J ANAL ATOM SPECTROM, V23, P1055, DOI 10.1039/b802220h; Lu HS, 2002, EXP EYE RES, V74, P83, DOI 10.1006/exer.2001.1101; Malavolta M, 2007, J ANAL ATOM SPECTROM, V22, P1193, DOI 10.1039/b704577h; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; MASTERS BA, 1994, J NEUROSCI, V14, P5844; Meija J, 2006, ANAL BIOANAL CHEM, V385, P486, DOI 10.1007/s00216-006-0298-4; Miceli MV, 1999, INVEST OPHTH VIS SCI, V40, P1238; Mocchegiani Eugenio, 2006, Immun Ageing, V3, P6, DOI 10.1186/1742-4933-3-6; Muniz CS, 2001, J ANAL ATOM SPECTROM, V16, P587, DOI 10.1039/b100947h; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Murgia C, 2011, NUTRIENTS, V3, P910, DOI 10.3390/nu3110910; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Oppermann B, 2001, INVEST OPHTH VIS SCI, V42, P188; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Polec K, 2002, J INORG BIOCHEM, V88, P197, DOI 10.1016/S0162-0134(01)00380-4; Prange A, 2002, ANAL BIOANAL CHEM, V373, P441, DOI 10.1007/s00216-002-1350-7; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Rodriguez-Cea A, 2003, J ANAL ATOM SPECTROM, V18, P1357, DOI 10.1039/b306746g; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Schaumloffel D, 2002, ANAL BIOANAL CHEM, V372, P155, DOI 10.1007/s00216-001-1164-z; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Suemori S, 2006, INVEST OPHTH VIS SCI, V47, P3975, DOI 10.1167/iovs.06-0275; Szpunar J, 2005, ANALYST, V130, P442, DOI 10.1039/b418265k; Thiersch M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-73; Uchida Y, 2002, J BIOL CHEM, V277, P32353, DOI 10.1074/jbc.M111263200; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Varin A, 2008, EXP GERONTOL, V43, P472, DOI 10.1016/j.exger.2007.12.008; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Wang RY, 2007, ANAL CHEM, V79, P4433, DOI 10.1021/ac062309s; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Yamada M, 1996, BRAIN RES, V735, P257, DOI 10.1016/0006-8993(96)00586-0; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zangger K., 2004, HDB METALLOPROTEINS, V3, P353	63	23	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28456	28469		10.1074/jbc.M112.365015	http://dx.doi.org/10.1074/jbc.M112.365015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722935	hybrid, Green Published			2022-12-28	WOS:000308074600021
J	Bastin, G; Singh, K; Dissanayake, K; Mighiu, AS; Nurmohamed, A; Heximer, SP				Bastin, Guillaume; Singh, Kevin; Dissanayake, Kaveesh; Mighiu, Alexandra S.; Nurmohamed, Aliya; Heximer, Scott P.			Amino-terminal Cysteine Residues Differentially Influence RGS4 Protein Plasma Membrane Targeting, Intracellular Trafficking, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; PROTEASOME DEGRADATION; ALPHA-SUBUNITS; SIGNALING RGS; IN-VITRO; PALMITOYLATION; REGULATOR; DOMAIN; CELLS; INHIBITION	Regulator of G-protein signaling (RGS) proteins are potent inhibitors of heterotrimeric G-protein signaling. RGS4 attenuates G-protein activity in several tissues. Previous work demonstrated that cysteine palmitoylation on residues in the amino-terminal (Cys-2 and Cys-12) and core domains (Cys-95) of RGS4 is important for protein stability, plasma membrane targeting, and GTPase activating function. To date Cys-2 has been the priority target for RGS4 regulation by palmitoylation based on its putative role in stabilizing the RGS4 protein. Here, we investigate differences in the contribution of Cys-2 and Cys-12 to the intracellular localization and function of RGS4. Inhibition of RGS4 palmitoylation with 2-bromopalmitate dramatically reduced its localization to the plasma membrane. Similarly, mutation of the RGS4 amphipathic helix (L23D) prevented membrane localization and its G(q) inhibitory function. Together, these data suggest that both RGS4 palmitoylation and the amphipathic helix domain are required for optimal plasma membrane targeting and function of RGS4. Mutation of Cys-12 decreased RGS4 membrane targeting to a similar extent as 2-bromopalmitate, resulting in complete loss of its G(q) inhibitory function. Mutation of Cys-2 did not impair plasma membrane targeting but did partially impair its function as a G(q) inhibitor. Comparison of the endosomal distribution pattern of wild type and mutant RGS4 proteins with TGN38 indicated that palmitoylation of these two cysteines contributes differentially to the intracellular trafficking of RGS4. These data show for the first time that Cys-2 and Cys-12 play markedly different roles in the regulation of RGS4 membrane localization, intracellular trafficking, and Gq inhibitory function via mechanisms that are unrelated to RGS4 protein stabilization.	[Bastin, Guillaume; Singh, Kevin; Dissanayake, Kaveesh; Mighiu, Alexandra S.; Nurmohamed, Aliya; Heximer, Scott P.] Univ Toronto, Dept Physiol, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 1A8, Canada; [Bastin, Guillaume] Univ Lille 1, USR CNRS Miniaturizat Synth Anal & Prote 3290, F-59655 Villeneuve Dascq, France	University of Toronto; Universite de Lille - ISITE; Universite de Lille	Heximer, SP (corresponding author), Univ Toronto, Dept Physiol, Heart & Stroke Richard Lewar Ctr Excellence Cardi, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.heximer@utoronto.ca			Heart and Stroke Foundation of Canada [T6799]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Heart and Stroke Foundation of Canada grant-in-aid program (T6799, to S. P. H.).	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Osterhout JL, 2003, J BIOL CHEM, V278, P19309, DOI 10.1074/jbc.M210124200; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rush DB, 2012, BIOCHEM J, V442, P39, DOI 10.1042/BJ20110679; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Tu YP, 1999, J BIOL CHEM, V274, P38260, DOI 10.1074/jbc.274.53.38260; Wang JC, 2010, FEBS LETT, V584, P4570, DOI 10.1016/j.febslet.2010.10.052; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Zimmermann L, 2010, J BIOL CHEM, V285, P6063, DOI 10.1074/jbc.M109.025981	33	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28966	28974		10.1074/jbc.M112.345629	http://dx.doi.org/10.1074/jbc.M112.345629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753418	hybrid, Green Published			2022-12-28	WOS:000308074600065
J	Demirkhanyan, LH; Marin, M; Padilla-Parra, S; Zhan, CY; Miyauchi, K; Jean-Baptiste, M; Novitskiy, G; Lu, WY; Melikyan, GB				Demirkhanyan, Lusine H.; Marin, Mariana; Padilla-Parra, Sergi; Zhan, Changyou; Miyauchi, Kosuke; Jean-Baptiste, Maikha; Novitskiy, Gennadiy; Lu, Wuyuan; Melikyan, Gregory B.			Multifaceted Mechanisms of HIV-1 Entry Inhibition by Human alpha-Defensin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FLUORESCENCE CORRELATION SPECTROSCOPY; CORECEPTOR-BINDING-SITE; MEMBRANE-FUSION; INNATE IMMUNITY; IN-VITRO; TYPE-1 REPLICATION; PLASMA-MEMBRANE; THETA-DEFENSINS; PHORBOL ESTERS	The human neutrophil peptide 1 (HNP-1) is known to block the human immunodeficiency virus type 1 (HIV-1) infection, but the mechanism of inhibition is poorly understood. We examined the effect of HNP-1 on HIV-1 entry and fusion and found that, surprisingly, this alpha-defensin inhibited multiple steps of virus entry, including: (i) Env binding to CD4 and coreceptors; (ii) refolding of Env into the final 6-helix bundle structure; and (iii) productive HIV-1 uptake but not internalization of endocytic markers. Despite its lectin-like properties, HNP-1 could bind to Env, CD4, and other host proteins in a glycan- and serum-independent manner, whereas the fusion inhibitory activity was greatly attenuated in the presence of human or bovine serum. This demonstrates that binding of alpha-defensin to molecules involved in HIV-1 fusion is necessary but not sufficient for blocking the virus entry. We therefore propose that oligomeric forms of defensin, which may be disrupted by serum, contribute to the anti-HIV-1 activity perhaps through cross-linking virus and/or host glycoproteins. This notion is supported by the ability of HNP-1 to reduce the mobile fraction of CD4 and coreceptors in the plasma membrane and to precipitate a core subdomain of Env in solution. The ability of HNP-1 to block HIV-1 uptake without interfering with constitutive endocytosis suggests a novel mechanism for broad activity against this and other viruses that enter cells through endocytic pathways.	[Demirkhanyan, Lusine H.; Marin, Mariana; Padilla-Parra, Sergi; Melikyan, Gregory B.] Emory Univ, Dept Pediat Infect Dis, Childrens Ctr, Atlanta, GA 30322 USA; [Zhan, Changyou; Novitskiy, Gennadiy; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; [Zhan, Changyou; Novitskiy, Gennadiy; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Jean-Baptiste, Maikha] Natl Parkinson Fdn Inc, Miami, FL 33136 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; RIKEN; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, Childrens Ctr, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Padilla-Parra, Sergi/N-8725-2019; Zhan, Changyou/G-3667-2011; Lu, Wuyuan/J-8452-2017; Padilla-Parra, Sergi/S-3017-2018; Lu, Wuyuan/B-2268-2010	Padilla-Parra, Sergi/0000-0002-8010-9481; Lu, Wuyuan/0000-0003-1318-9968; 	National Institutes of Health [AI087453, AI072732]; Emory and Children's Pediatric Research Center Flow Cytometry Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087453, R01AI072732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory and Children's Pediatric Research Center Flow Cytometry Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI087453 (to G. B. M.) and AI072732 (to W. L.). This work was also supported by Emory and Children's Pediatric Research Center Flow Cytometry Core.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Biscone MJ, 2006, VIROLOGY, V351, P226, DOI 10.1016/j.virol.2006.03.017; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong TX, 2010, ARCH VIROL, V155, P491, DOI 10.1007/s00705-010-0608-1; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; HARRIS RJ, 1990, EUR J BIOCHEM, V194, P611, DOI 10.1111/j.1432-1033.1990.tb15660.x; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HOXIE JA, 1988, J IMMUNOL, V140, P786; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kwaaitaal M, 2011, METHODS MOL BIOL, V779, P225, DOI 10.1007/978-1-61779-264-9_13; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Murakami T, 1999, J VIROL, V73, P7489, DOI 10.1128/JVI.73.9.7489-7496.1999; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rodriguez-Garcia M, 2009, CLIN IMMUNOL, V131, P374, DOI 10.1016/j.clim.2009.01.012; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; Thompson, 1991, FLUORESCENCE CORRELA, P337; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257	76	62	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28821	28838		10.1074/jbc.M112.375949	http://dx.doi.org/10.1074/jbc.M112.375949			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733823	Green Published, hybrid			2022-12-28	WOS:000308074600055
J	Di, YP; Zhao, JM; Harper, R				Di, Y. Peter; Zhao, Jinming; Harper, Richart			Cigarette Smoke Induces MUC5AC Protein Expression through the Activation of Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TRANSCRIPTION FACTORS; MUCIN GENE; TOBACCO-SMOKE; 5'-FLANKING REGION; MOLECULAR-CLONING; EPITHELIAL-CELLS; CANCER-CELLS; SP-FAMILY; MUCUS	Cigarette smoke (CS) exposure is associated with increased mucus production and chronic obstructive pulmonary disease (COPD). MUC5AC is the major inducible mucus gene in the airway. The purpose of this investigation was to elucidate the mechanisms of CS-induced activation of MUC5AC gene transcription. We observed that the region -3724/-3224 of the MUC5AC promoter is critical for CS-induced gene transcriptional activity and that this region contains two Sp1 binding sites. Using a lung-relevant model, we observed that CS increased nuclear Sp1 protein expression. Consequently, CS exposure resulted in enhanced Sp1-DNA binding activity and Sp1 trans-activation. Co-transfection of the MUC5AC-luc reporter with Sp1 expression plasmids resulted in significantly increased MUC5AC-luc activity, whereas co-treatment with mithramycin A, a Sp1 inhibitor, abolished CS-induced MUC5AC promoter activity. Using mobility shift assay and chromatin immunoprecipitation, we demonstrated that two Sp1 binding sites in the MUC5AC promoter are functional and responsive to CS exposure. A mutation of either Sp1 binding site in the MUC5AC promoter significantly decreased CS-induced promoter activity. Together, these data indicate that CS induces MUC5AC gene transcription predominantly through increased Sp1 nuclear protein levels and increased Sp1 binding to its promoter region.	[Di, Y. Peter; Zhao, Jinming] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Harper, Richart] Univ Calif Davis, Div Pulm & Crit Care Med, Davis, CA 95616 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Di, YP (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,Rm 322, Pittsburgh, PA 15219 USA.	peterdi@pitt.edu	Harper, Richart W/F-9359-2013; Di, Yuanpu Peter/H-4191-2016	Harper, Richart W/0000-0001-8097-6465; Di, Yuanpu Peter/0000-0003-2028-2087; Zhao, Jinming/0000-0003-4700-9734	National Institutes of Health (NIH) [ES011033, HL091938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009573, R01HL085655, R01HL091938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011033] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) Grants ES011033 and HL091938.	Aslam F, 2001, CANCER RES, V61, P570; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Caramori G, 2004, HISTOPATHOLOGY, V45, P477, DOI 10.1111/j.1365-2559.2004.01952.x; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Csernok E, 2006, NAT CLIN PRACT RHEUM, V2, P174, DOI 10.1038/ncprheum0159; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Giovacchini G, 2009, TUMORI J, V95, P177; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Henke MO, 2007, AM J RESP CRIT CARE, V175, P816, DOI 10.1164/rccm.200607-1011OC; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Higuchi T, 2004, J BIOL CHEM, V279, P1968, DOI 10.1074/jbc.M304558200; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Jonckheere N, 2004, BIOCHEM J, V377, P797, DOI 10.1042/bj20030948; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Mauad T, 2008, CURR OPIN PULM MED, V14, P31, DOI 10.1097/MCP.0b013e3282f19846; Mebratu YA, 2011, AM J RESP CRIT CARE, V183, P1531, DOI 10.1164/rccm.201011-1930OC; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; MURATA Y, 1994, J BIOL CHEM, V269, P20674; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Perrais M, 2002, J BIOL CHEM, V277, P32258, DOI 10.1074/jbc.M204862200; Rogers DF, 2003, PEDIATR PULM, V36, P178, DOI 10.1002/ppul.10322; Rogers DF, 2007, RESP CARE, V52, P1134; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Rubin BK, 2010, OTOLARYNG CLIN N AM, V43, P27, DOI 10.1016/j.otc.2009.11.002; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Wilson R, 2000, Semin Respir Infect, V15, P208; Witschi H, 1997, ANNU REV PHARMACOL, V37, P29, DOI 10.1146/annurev.pharmtox.37.1.29; Zhao JM, 2007, AM J PHYSIOL-LUNG C, V293, pL480, DOI 10.1152/ajplung.00345.2006	40	64	68	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27948	27958		10.1074/jbc.M111.334375	http://dx.doi.org/10.1074/jbc.M111.334375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700966	Green Published, hybrid			2022-12-28	WOS:000307840700069
J	Larsen, LHG; Rasmussen, A; Giessing, AMB; Jogl, G; Kirpekar, F				Larsen, Line H. G.; Rasmussen, Anette; Giessing, Anders M. B.; Jogl, Gerwald; Kirpekar, Finn			Identification and Characterization of the Thermus thermophilus 5-Methylcytidine (m(5)C) Methyltransferase Modifying 23 S Ribosomal RNA (rRNA) Base C1942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; PSEUDOURIDINE RESIDUES; SUBSTRATE SELECTIVITY; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; PRERIBOSOMAL RNA; METHYLATION; COMPLEX; CONTRIBUTES	Methylation of cytidines at carbon-5 is a common posttranscriptional RNA modification encountered across all domains of life. Here, we characterize the modifications of C1942 and C1962 in Thermus thermophilus 23 S rRNA as 5-methylcytidines (m(5)C) and identify the two associated methyltransferases. The methyltransferase modifying C1942, named RlmO, has not been characterized previously. RlmO modifies naked 23 S rRNA, but not the assembled 50 S subunit or 70 S ribosomes. The x-ray crystal structure of this enzyme in complex with the S-adenosyl-L-methionine cofactor at 1.7 angstrom resolution confirms that RlmO is structurally related to other m(5)C rRNA methyltransferases. Key residues in the active site are located similar to the further distant 5-methyluridine methyltransferase RlmD, suggestive of a similar enzymatic mechanism. RlmO homologues are primarily found in mesophilic bacteria related to T. thermophilus. In accordance, we find that growth of the T. thermophilus strain with an inactivated C1942 methyltransferase gene is not compromised at non-optimal temperatures.	[Jogl, Gerwald] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Larsen, Line H. G.; Rasmussen, Anette; Giessing, Anders M. B.; Kirpekar, Finn] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Brown University; University of Southern Denmark	Jogl, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu; f.kir@bmb.sdu.dk	Jogl, Gerwald/AAJ-5783-2021; Larsen, Line H. G./ABF-5932-2020	Jogl, Gerwald/0000-0002-5465-5315; Kirpekar, Finn/0000-0003-1901-2266	National Institutes of Health [GM094157]; Danish National science Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National science Foundation(Danmarks Grundforskningsfond); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094157 (to G. J.) and by a grant from the Danish National science Foundation (to F. K.).; We thank John Schwanof and Randy Abramowitz for access to the X4A beamline at the National Synchrotron Light Source. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; Andersen TE, 2004, RNA, V10, P907, DOI 10.1261/rna.5259404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barneche F, 2001, J MOL BIOL, V311, P57, DOI 10.1006/jmbi.2001.4851; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Del Lampo M, 2005, RNA, V11, P210, DOI 10.1261/rna.7209905; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demirci H, 2010, RNA, V16, P1584, DOI 10.1261/rna.2088310; Douthwaite S, 2007, METHOD ENZYMOL, V425, P3, DOI 10.1016/S0076-6879(07)25001-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PG, 2003, STRUCTURE, V11, P1609, DOI 10.1016/j.str.2003.10.014; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Giessing AMB, 2011, J AM SOC MASS SPECTR, V22, P1242, DOI 10.1007/s13361-011-0126-8; Gustafsson C, 1998, J BACTERIOL, V180, P359, DOI 10.1128/JB.180.2.359-365.1998; Hallberg BM, 2006, J MOL BIOL, V360, P774, DOI 10.1016/j.jmb.2006.05.047; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Havelund JF, 2011, J MOL BIOL, V411, P529, DOI 10.1016/j.jmb.2011.06.036; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kimura S, 2012, NUCLEIC ACIDS RES, V40, P4071, DOI 10.1093/nar/gkr1287; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; MADEN BEH, 1988, J MOL BIOL, V201, P289, DOI 10.1016/0022-2836(88)90139-8; Massenet S, 1999, FEBS LETT, V462, P94, DOI 10.1016/S0014-5793(99)01524-0; Mengel-Jorgensen J, 2006, J BIOL CHEM, V281, P22108, DOI 10.1074/jbc.M600377200; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; O'Connor M, 2011, J BACTERIOL, V193, P154, DOI 10.1128/JB.00970-10; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Pioszak AA, 2005, ACTA CRYSTALLOGR F, V61, P867, DOI 10.1107/S1744309105029842; Purta E, 2008, J MOL BIOL, V383, P641, DOI 10.1016/j.jmb.2008.08.061; RAUE HA, 1988, PROG BIOPHYS MOL BIO, V51, P77, DOI 10.1016/0079-6107(88)90011-9; SIRUMCONNOLLY K, 1995, BIOCHIMIE, V77, P30, DOI 10.1016/0300-9084(96)88101-6; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Sun W, 2005, PROTEIN SCI, V14, P3121, DOI 10.1110/ps.051821805; Sunita S, 2008, J MOL BIOL, V383, P652, DOI 10.1016/j.jmb.2008.08.062; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180	50	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27593	27600		10.1074/jbc.M112.376160	http://dx.doi.org/10.1074/jbc.M112.376160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711535	Green Published, hybrid			2022-12-28	WOS:000307840700034
J	Stravalaci, M; Bastone, A; Beeg, M; Cagnotto, A; Colombo, L; Di Fede, G; Tagliavini, F; Cantu, L; Del Favero, E; Mazzanti, M; Chiesa, R; Salmona, M; Diomede, L; Gobbi, M				Stravalaci, Matteo; Bastone, Antonio; Beeg, Marten; Cagnotto, Alfredo; Colombo, Laura; Di Fede, Giuseppe; Tagliavini, Fabrizio; Cantu, Laura; Del Favero, Elena; Mazzanti, Michele; Chiesa, Roberto; Salmona, Mario; Diomede, Luisa; Gobbi, Marco			Specific Recognition of Biologically Active Amyloid-beta Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION PROTEIN; ALZHEIMERS-DISEASE; A-BETA(1-42); ASSEMBLIES; ANTIBODIES; LINK	Soluble oligomers of the amyloid-beta (A beta) peptide play a key role in the pathogenesis of Alzheimer's disease, but their elusive nature makes their detection challenging. Here we describe a novel immunoassay based on surface plasmon resonance (SPR) that specifically recognizes biologically active A beta oligomers. As a capturing agent, we immobilized on the sensor chip the monoclonal antibody 4G8, which targets a central hydrophobic region of A beta. This SPR assay allows specific recognition of oligomeric intermediates that rapidly appear and disappear during the incubation of synthetic A beta(1-42), discriminating them from monomers and higher order aggregates. The species recognized by SPR generate ionic currents in artificial lipid bilayers and inhibit the physiological pharyngeal contractions in Caenorhabditis elegans, a new method for testing the toxic potential of A beta oligomers. With these assays we found that the formation of biologically relevant A beta oligomers is inhibited by epigallocatechin gallate and increased by the A2V mutation, previously reported to induce early onset dementia. The SPR-based immunoassay provides new opportunities for detection of toxic A beta oligomers in biological samples and could be adapted to study misfolding proteins in other neurodegenerative disorders.	[Stravalaci, Matteo; Bastone, Antonio; Beeg, Marten; Cagnotto, Alfredo; Colombo, Laura; Chiesa, Roberto; Salmona, Mario; Diomede, Luisa; Gobbi, Marco] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, I-20156 Milan, Italy; [Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy; [Di Fede, Giuseppe; Tagliavini, Fabrizio] Fdn Ist Ricovero & Cura Carattere Sci, Ist Neurol Carlo Besta, I-20133 Milan, Italy; [Cantu, Laura; Del Favero, Elena] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy; [Mazzanti, Michele] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; University of Milan; University of Milan	Gobbi, M (corresponding author), Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, Lab Pharmacodynam & Pharmacokinet, Via La Masa 19, I-20156 Milan, Italy.	marco.gobbi@marionegri.it	Tagliavini, Fabrizio/AAO-7891-2021; Stravalaci, Matteo/AAB-8963-2019; Di Fede, Giuseppe/K-1394-2016; DEL FAVERO, ELENA/R-4991-2017; salmona, mario/AAA-7116-2020; Beeg, Marten/AAA-9269-2020; Gobbi, Marco/J-2638-2016; Di Fede, Giuseppe/O-7772-2016; salmona, mario/ABI-4066-2020; Di Fede, Giuseppe/A-4471-2019; Cagnotto, Alfredo/AAB-3083-2020; Diomede, Luisa/P-3417-2014; Chiesa, Roberto/G-1561-2017; colombo, laura/AAA-6716-2020; DEL FAVERO, ELENA/AAR-3567-2020	Tagliavini, Fabrizio/0000-0003-1039-7315; Stravalaci, Matteo/0000-0002-5636-4204; Di Fede, Giuseppe/0000-0003-3537-6713; DEL FAVERO, ELENA/0000-0002-6584-1869; salmona, mario/0000-0002-9098-9873; Beeg, Marten/0000-0001-7201-6704; Gobbi, Marco/0000-0003-1014-6225; Di Fede, Giuseppe/0000-0003-3537-6713; Di Fede, Giuseppe/0000-0003-3537-6713; Cagnotto, Alfredo/0000-0002-1390-8240; Diomede, Luisa/0000-0002-2258-0531; Chiesa, Roberto/0000-0002-3842-3733; colombo, laura/0000-0002-3243-0270; DEL FAVERO, ELENA/0000-0002-6584-1869; Mazzanti, Michele/0000-0002-1819-3811; Del Favero, jurgen/0000-0002-7427-7489	Cariplo Foundation [2009-2543]; Telethon Foundation [GGP10120]; MIUR [RPAB11FRE9]; Italian Ministry of Health [PS 2007.39]; Italian Ministry of University and Scientific Research [20078RWJBN]; Alzheimer's Association [NIRG-10-171655]; Mario Negri Foundation and Banca Intesa	Cariplo Foundation(Fondazione Cariplo); Telethon Foundation(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Alzheimer's Association(Alzheimer's Association); Mario Negri Foundation and Banca Intesa	This work was supported in part by Cariplo Foundation Project 2009-2543, Telethon Foundation Project GGP10120, MIUR Grant RPAB11FRE9 (to F. T.), Italian Ministry of Health Grant PS 2007.39 (to F. T.), Italian Ministry of University and Scientific Research Grant 20078RWJBN (to M. M.), and Alzheimer's Association Project NIRG-10-171655, and by the Mario Negri Foundation and Banca Intesa.	[Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P304583, DOI 10.4061/2011/304583; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; LAGO P, 1993, REV SCI INSTRUM, V64, P1797, DOI 10.1063/1.1144013; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Paulis D, 2011, NEUROCHEM INT, V59, P168, DOI 10.1016/j.neuint.2011.04.008; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramakrishnan M, 2009, BIOCHEMISTRY-US, V48, P10405, DOI 10.1021/bi900523q; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Shirwany Najeeb A, 2007, Neuropsychiatr Dis Treat, V3, P597; Sohma Y, 2005, J PEPT SCI, V11, P441, DOI 10.1002/psc.649; Stepanek J, 2006, SPRINGER SER CHEM SE, V4, P69, DOI 10.1007/5346_015; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	45	45	47	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27796	27805		10.1074/jbc.M111.334979	http://dx.doi.org/10.1074/jbc.M111.334979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736768	Green Published, hybrid			2022-12-28	WOS:000307840700053
J	Baek, GH; Cheng, HL; Kim, I; Rao, H				Baek, Guem Hee; Cheng, Haili; Kim, Ikjin; Rao, Hai			The Cdc48 Protein and Its Cofactor Vms1 Are Involved in Cdc13 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; COMPLEXES; YEAST; UFD2; TURNOVER; ATPASE; SYSTEM	Vms1 is a newly identified Cdc48-binding protein. The biological function of Vms1 remains obscure. Here, we show that both Cdc48 and Vms1, but not Cdc48 cofactors Ufd1 and Ufd2, are crucial for the degradation of Cdc13, a telomere regulator. Interestingly, both autophagy and the proteasome are involved in Cdc13 turnover. Toxicity associated with accumulation of large amounts of Cdc13 in vms1 Delta or autophagy mutants underscores the significance of the proteolytic regulation of Cdc13. Because few ubiquitylated yeast proteins are known to be degraded by autophagy under non-stress conditions, the identification of Cdc13 as a target of autophagy provides a valuable tool to unravel the mechanism of autophagy-mediated selective protein degradation.	[Baek, Guem Hee; Cheng, Haili; Kim, Ikjin; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Rao, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; RAO, HAI/0000-0002-4235-2210	National Institutes of Health [GM078085, P30 CA054174]; United States Department of Defense [W911NF-11-10466]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078085 and P30 CA054174 and United States Department of Defense Grant W911NF-11-10466 (to H. R.).	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683; Ramanathan HN, 2011, MOL CELL, V44, P3, DOI 10.1016/j.molcel.2011.09.006; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	24	14	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26788	26795		10.1074/jbc.M112.351825	http://dx.doi.org/10.1074/jbc.M112.351825			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718752	Green Published, hybrid			2022-12-28	WOS:000307386000028
J	Caillet-Saguy, C; Piccioli, M; Turano, P; Lukat-Rodgers, G; Wolff, N; Rodgers, KR; Izadi-Pruneyre, N; Delepierre, M; Lecroisey, A				Caillet-Saguy, Celia; Piccioli, Mario; Turano, Paola; Lukat-Rodgers, Gudrun; Wolff, Nicolas; Rodgers, Kenton R.; Izadi-Pruneyre, Nadia; Delepierre, Muriel; Lecroisey, Anne			Role of the Iron Axial Ligands of Heme Carrier HasA in Heme Uptake and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPHORE HASA; SERRATIA-MARCESCENS; RESONANCE RAMAN; BINDING PROTEIN; OUTER-MEMBRANE; ACQUISITION-SYSTEM; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; RECEPTOR HASR; CYTOCHROME-C	The hemophore protein HasA from Serratia marcescens cycles between two states as follows: the heme-bound holoprotein, which functions as a carrier of the metal cofactor toward the membrane receptor HasR, and the heme-free apoprotein fishing for new porphyrin to be taken up after the heme has been delivered to HasR. Holo- and apo-forms differ for the conformation of the two loops L1 and L2, which provide the axial ligands of the iron through His(32) and Tyr(75), respectively. In the apo-form, loop L1 protrudes toward the solvent far away from loop L2; in the holoprotein, closing of the loops on the heme occurs upon establishment of the two axial coordination bonds. We have established that the two variants obtained via single point mutations of either axial ligand (namely H32A and Y75A) are both in the closed conformation. The presence of the heme and one out of two axial ligands is sufficient to establish a link between L1 and L2, thanks to the presence of coordinating solvent molecules. The latter are stabilized in the iron coordination environment by H-bond interactions with surrounding protein residues. The presence of such a water molecule in both variants is revealed here through a set of different spectroscopic techniques. Previous studies had shown that heme release and uptake processes occur via intermediate states characterized by a Tyr(75)-iron-bound form with open conformation of loop L1. Here, we demonstrate that these states do not naturally occur in the free protein but can only be driven by the interaction with the partner proteins.	[Caillet-Saguy, Celia; Wolff, Nicolas; Izadi-Pruneyre, Nadia; Delepierre, Muriel; Lecroisey, Anne] Inst Pasteur, CNRS, URA 2185, Unite RMN Biomol, F-75015 Paris, France; [Piccioli, Mario; Turano, Paola] Univ Florence, Ctr Nucl Magnet Resonance, I-50019 Florence, Italy; [Piccioli, Mario; Turano, Paola] Univ Florence, Dept Chem, I-50019 Florence, Italy; [Lukat-Rodgers, Gudrun; Rodgers, Kenton R.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Florence; University of Florence; North Dakota State University Fargo	Caillet-Saguy, C (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite RMN Biomol, 28 Rue Docteur Roux, F-75015 Paris, France.	ccaillet@pasteur.fr	Piccioli, Mario/M-1994-2015; Turano, Paola/F-9089-2011; Caillet-Saguy, Célia/AAC-1249-2022	Piccioli, Mario/0000-0001-9882-9754; Turano, Paola/0000-0002-7683-8614; Izadi-Pruneyre, Nadia/0000-0002-6864-2961	National Institutes of Health [GM094039, AI072719]; Pasteur Institute; Bio-NMR Project [261686]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pasteur Institute; Bio-NMR Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094039 (to G. S. L. R.) and AI072719 (to K. R. R.).; Recipient of a Bourse Roux postdoctoral fellowship from Pasteur Institute.; We thank B. Guigliarelli for EPR data. Bio-NMR Project (Contract 261686) is acknowledged for providing access to NMR and NMRD instrumentations available at Center of Nuclear Magnetic Resonance.	Aime S, 1996, BIOPHYS J, V70, P482, DOI 10.1016/S0006-3495(96)79593-0; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Arnoux P, 2000, PROTEINS, V41, P202, DOI 10.1002/1097-0134(20001101)41:2<202::AID-PROT50>3.0.CO;2-8; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bertini I, 1999, J BIOL INORG CHEM, V4, P515, DOI 10.1007/s007750050337; Bertini I, 2003, CHEM-EUR J, V9, P2316, DOI 10.1002/chem.200204562; Bertini I., 2001, SOLUTION NMR PARAMAG; Bertini I, 2007, BIOL INORGANIC CHEM, P31; Bondon A, 1998, J MAGN RESON, V134, P154, DOI 10.1006/jmre.1998.1523; BRUSCHI M, 1992, BIOCHEMISTRY-US, V31, P3281, DOI 10.1021/bi00127a033; Caillet-Saguy C, 2006, J AM CHEM SOC, V128, P150, DOI 10.1021/ja054902h; Caillet-Saguy C, 2008, J BIOL CHEM, V283, P5960, DOI 10.1074/jbc.M703795200; Caillet-Saguy C, 2009, J AM CHEM SOC, V131, P1736, DOI 10.1021/ja804783x; CHAKRABARTI P, 1990, PROTEIN ENG, V4, P57, DOI 10.1093/protein/4.1.57; Dawson R., 1986, DATA BIOCH RES, P233; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Deniau C, 2001, J BIOMOL NMR, V21, P189, DOI 10.1023/A:1012438610532; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; Franzen S, 2001, BIOCHEMISTRY-US, V40, P5299, DOI 10.1021/bi0023403; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Gsponer J, 2006, P NATL ACAD SCI USA, V103, P99, DOI 10.1073/pnas.0508667102; Heering HA, 2001, BIOCHEMISTRY-US, V40, P10360, DOI 10.1021/bi0106033; HILDEBRAND DP, 1995, BIOCHEMISTRY-US, V34, P1997, DOI 10.1021/bi00006a021; HU SH, 1992, FEBS LETT, V314, P293, DOI 10.1016/0014-5793(92)81492-5; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Idei A, 1999, J BACTERIOL, V181, P7545, DOI 10.1128/JB.181.24.7545-7551.1999; Ikezaki A, 2002, INORG CHEM, V41, P6225, DOI 10.1021/ic020378t; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jin YY, 2004, BIOCHEMISTRY-US, V43, P8517, DOI 10.1021/bi036170g; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Lukat-Rodgers GS, 2008, BIOCHEMISTRY-US, V47, P2087, DOI 10.1021/bi7019518; MOTIE M, 1990, BIOCHEMISTRY-US, V29, P1932, DOI 10.1021/bi00459a038; Phillips W D, 1972, Methods Enzymol, V24, P304; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Siebel JF, 2012, CHEMBIOCHEM, V13, P879, DOI 10.1002/cbic.201100808; Smulevich G, 1996, BIOSPECTROSCOPY, V2, P365, DOI 10.1002/(SICI)1520-6343(1996)2:6<365::AID-BSPY3>3.0.CO;2-2; Stevens JM, 2006, J BIOL CHEM, V281, P6144, DOI 10.1074/jbc.M508765200; Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; Wolff N, 2002, PROTEIN SCI, V11, P757, DOI 10.1110/ps.3630102; Wolff N, 2008, J MOL BIOL, V376, P517, DOI 10.1016/j.jmb.2007.11.072; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987	48	31	32	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26932	26943		10.1074/jbc.M112.366385	http://dx.doi.org/10.1074/jbc.M112.366385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700962	Green Published, hybrid			2022-12-28	WOS:000307386000041
J	Bos, MHA; Camire, RM				Bos, Mettine H. A.; Camire, Rodney M.			A Bipartite Autoinhibitory Region within the B-domain Suppresses Function in Factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-CATALYZED ACTIVATION; XA-BINDING-SITE; BOVINE FACTOR-V; VENOM FACTOR-V; BLOOD-COAGULATION; FACTOR-VIII; EXOSITE-I; ELECTRON-MICROSCOPY; COFACTOR FUNCTION; HEAVY-CHAIN	Activation of blood coagulation factor V (FV) is a key reaction of hemostasis. FV circulates in plasma as an inactive procofactor, and proteolytic removal of a large central B-domain converts it to an active cofactor (FVa) for factor Xa (FXa). Here we show that two short evolutionary conserved segments of the B-domain, together termed the procofactor regulatory region, serve an essential autoinhibitory function. This newly identified motif consists of a basic (963-1008) and an acidic (1493-1537) region and defines the minimal sequence requirements to maintain FV as a procofactor. Our data suggest that dismantling this autoinhibitory region via deletion or proteolysis is the driving force to unveil a high affinity binding site(s) for FXa. These findings document an unexpected sequence-specific role for the B-domain by negatively regulating FV function and preventing activity of the procofactor. These new mechanistic insights point to new ways in which the FV procofactor to cofactor transition could be modulated to alter hemostasis.	[Camire, Rodney M.] Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, Div Hematol, Philadelphia, PA 19104 USA; [Camire, Rodney M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, Div Hematol, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Bos, Mettine/S-5317-2016	Bos, Mettine/0000-0002-8164-817X	National Institutes of Health [R01 HL88010, P01 HL74124]; National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088010, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL88010 and P01 HL74124, Project 2 (to R. M. C.). This work was also supported by the National Hemophilia Foundation (Judith Graham Pool Postdoctoral Research Fellowship; to M. H. A. B.).	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Corral-Rodriguez MA, 2011, BLOOD, V117, P7164, DOI 10.1182/blood-2010-10-315309; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington PR., 2002, DATA REDUCTION ERROR; Bos MHA, 2010, TOXINS, V2, P1554, DOI 10.3390/toxins2061554; Bos MHA, 2009, BLOOD, V114, P686, DOI 10.1182/blood-2009-02-202663; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Duckers C, 2009, BRIT J HAEMATOL, V146, P17, DOI 10.1111/j.1365-2141.2009.07708.x; ESMON CT, 1979, J BIOL CHEM, V254, P964; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; FOWLER WE, 1990, P NATL ACAD SCI USA, V87, P7648, DOI 10.1073/pnas.87.19.7648; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1998, PROTEIN SCI, V7, P815; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; LAMPE PD, 1984, J BIOL CHEM, V259, P9959; LAUE TM, 1984, BIOCHEMISTRY-US, V23, P1339, DOI 10.1021/bi00302a001; Mann K G, 1976, Methods Enzymol, V45, P123; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; MOSESSON MW, 1985, BLOOD, V65, P1158; MOSESSON MW, 1990, J BIOL CHEM, V265, P8863; NESHEIM ME, 1979, J BIOL CHEM, V254, P508; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; Pierre LS, 2005, MOL BIOL EVOL, V22, P1853, DOI 10.1093/molbev/msi181; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; RAND MD, 1995, BLOOD, V86, P2616; Rao VS, 2003, BLOOD, V102, P1347, DOI 10.1182/blood-2002-12-3839; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Siigur J, 2001, HAEMOSTASIS, V31, P123; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Vos H. L., 2009, J THROMB HAEMOST, V7, P368; Welton RE, 2005, TOXICON, V46, P328, DOI 10.1016/j.toxicon.2005.05.001; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	65	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26342	26351		10.1074/jbc.M112.377168	http://dx.doi.org/10.1074/jbc.M112.377168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707727	Green Published, hybrid			2022-12-28	WOS:000306916300060
J	Eiseler, T; Kohler, C; Nimmagadda, SC; Jamali, A; Funk, N; Joodi, G; Storz, P; Seufferlein, T				Eiseler, Tim; Koehler, Conny; Nimmagadda, Subbaiah Chary; Jamali, Arsia; Funk, Nancy; Joodi, Golsa; Storz, Peter; Seufferlein, Thomas			Protein Kinase D1 Mediates Anchorage-dependent and -independent Growth of Tumor Cells via the Zinc Finger Transcription Factor Snail1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER; CYCLIN D1; MESENCHYMAL TRANSITION; MITOTIC COMMITMENT; DNA-SYNTHESIS; E-CADHERIN; AURORA-A; PKC-MU; PHOSPHORYLATION; PROLIFERATION	We here identify protein kinase D1 (PKD1) as a major regulator of anchorage-dependent and -independent growth of cancer cells controlled via the transcription factor Snail1. Using FRET, we demonstrate that PKD1, but not PKD2, efficiently interacts with Snail1 in nuclei. PKD1 phosphorylates Snail1 at Ser-11. There was no change in the nucleocytoplasmic distribution of Snail1 using wild type Snail1 and Ser-11 phosphosite mutants in different tumor cells. Regardless of its phosphorylation status or following co-expression of constitutively active PKD, Snail1 was predominantly localized to cell nuclei. We also identify a novel mechanism of PKD1-mediated regulation of Snail1 transcriptional activity in tumor cells. The interaction of the co-repressors histone deacetylases 1 and 2 as well as lysyl oxidase-like protein 3 with Snail1 was impaired when Snail1 was not phosphorylated at Ser-11, which led to reduced Snail1-associated histone deacetylase activity. Additionally, lysyl oxidase-like protein 3 expression was up-regulated by ectopic PKD1 expression, implying a synergistic regulation of Snail1-driven transcription. Ectopic expression of PKD1 also up-regulated proliferation markers such as Cyclin D1 and Ajuba. Accordingly, Snail1 and its phosphorylation at Ser-11 were required and sufficient to control PKD1-mediated anchorage-independent growth and anchorage-dependent proliferation of different tumor cells. In conclusion, our data show that PKD1 is crucial to support growth of tumor cells via Snail1.	[Eiseler, Tim; Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Eiseler, Tim; Koehler, Conny; Nimmagadda, Subbaiah Chary; Jamali, Arsia; Funk, Nancy; Joodi, Golsa] Univ Halle Wittenberg, Univ Clin Halle, Dept Internal Med 1, D-06120 Halle, Saale, Germany; [Jamali, Arsia; Joodi, Golsa] Univ Tehran Med Sci, Student Sci Res Ctr, Tehran 1417613151, Iran; [Storz, Peter] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Ulm University; Martin Luther University Halle Wittenberg; Tehran University of Medical Sciences; Mayo Clinic	Seufferlein, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany.	thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018	Joodi, Golsa/0000-0002-6371-433X	National Institutes of Health [R01CA140182, R01GM86435]; Deutsche Krebshilfe [109222]; Wilhelm-Roux-Program [FKZ 23/19, FKZ 23/08]; Florida Department of Health Bankhead-Coley Cancer Research Program [FLA07BN-08]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [NGFN plus/PKB-01GS08209-4]; NATIONAL CANCER INSTITUTE [R01CA140182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Roux-Program; Florida Department of Health Bankhead-Coley Cancer Research Program; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA140182 and R01GM86435 (to P. S.). This work was also supported by Deutsche Krebshilfe Grant 109222, Wilhelm-Roux-Program Grants FKZ 23/19 and FKZ 23/08 (to T. E.), Florida Department of Health Bankhead-Coley Cancer Research Program Grant FLA07BN-08 (to P. S.), and German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) Grant NGFN plus/PKB-01GS08209-4 (to T. S.).	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Guha S, 2002, CANCER RES, V62, P1632; Guha S, 2010, BIOCHEM PHARMACOL, V80, P1946, DOI 10.1016/j.bcp.2010.07.002; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson LN, 2006, BIOCHEM BIOPH RES CO, V348, P945, DOI 10.1016/j.bbrc.2006.07.142; Kimura Masashi, 2005, Gan To Kagaku Ryoho, V32, P1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prigent C, 2003, CELL, V114, P531, DOI 10.1016/S0092-8674(03)00685-8; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Seufferlein T, 2002, J GASTROINTEST CANC, V31, P15, DOI 10.1385/IJGC:31:1-3:15; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1653; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zwijsen RML, 1996, MOL CELL BIOL, V16, P2554	40	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32367	32380		10.1074/jbc.M112.370999	http://dx.doi.org/10.1074/jbc.M112.370999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22791710	Green Published, hybrid			2022-12-28	WOS:000309168300008
J	Benktander, J; Angstrom, J; Breimer, ME; Teneberg, S				Benktander, John; Angstrom, Jonas; Breimer, Michael E.; Teneberg, Susann			Redefinition of the Carbohydrate Binding Specificity of Helicobacter pylori BabA Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-A; HUMAN SMALL-INTESTINE; MASS-SPECTROMETRY; GROUP ANTIGENS; GLYCOSPHINGOLIPIDS; EXPRESSION; DETERMINANTS; GLYCOLIPIDS; ABH; OLIGOSACCHARIDES	Certain Helicobacter pylori strains adhere to the human gastric epithelium using the blood group antigen-binding adhesin (BabA). All BabA-expressing H. pylori strains bind to the blood group O determinants on type 1 core chains, i.e. to the Lewis b antigen (Fuc alpha 2Gal beta 3(Fuc alpha 4) GlcNAc; Le(b)) and the H type 1 determinant (Fuc alpha 2Gal beta 3GlcNAc). Recently, BabA strains have been categorized into those recognizing only Le(b) and H type 1 determinants (designated specialist strains) and those that also bind to A and B type 1 determinants (designated generalist strains). Here, the structural requirements for carbohydrate recognition by generalist and specialist BabA were further explored by binding of these types of strains to a panel of different glycosphingolipids. Three glycosphingolipids recognized by both specialist and generalist BabA were isolated from the small intestine of a blood group O pig and characterized by mass spectrometry and proton NMR as H type 1 pentaglycosylceramide (Fuc alpha 2Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), Globo H hexaglycosylceramide (Fuc alpha 2Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), and a mixture of three complex glycosphingolipids (Fuc alpha 2Gal beta 4GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer, Fuc alpha 2Gal beta 3GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer, and Fuc alpha 2Gal beta 4(Fuc alpha 3)GlcNAc beta 6(Fuc alpha 2Gal beta 3GlcNAc beta 3)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer). In addition to the binding of both strains to the Globo H hexaglycosylceramide, i.e. a blood group O determinant on a type 4 core chain, the generalist strain bound to the Globo A heptaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), i.e. a blood groupAdeterminant on a type 4 core chain. The binding of BabA to the two sets of isoreceptors is due to conformational similarities of the terminal disaccharides of H type 1 and Globo H and of the terminal trisaccharides of A type 1 and Globo A.	[Benktander, John; Angstrom, Jonas; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, S-40530 Gothenburg, Sweden; [Breimer, Michael E.] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Teneberg, S (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, POB 440, S-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Research Council [342-2004-4434, 12628]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson) and the Varian 600-MHz machine at the Swedish NMR Centre, Hasselblad Laboratory, University of Gothenburg, is gratefully acknowledged.; This study was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants (to the Sahlgrenska University Hospital).	Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Angstrom J, 2000, J BIOL CHEM, V275, P3231, DOI 10.1074/jbc.275.5.3231; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; BJORK S, 1987, J BIOL CHEM, V262, P6758; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BREIMER ME, 1982, J BIOL CHEM, V257, P906; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; CEDERBERG A, 1991, SCAND J GASTROENTERO, V26, P33, DOI 10.3109/00365529109103985; Chai WG, 2002, J AM SOC MASS SPECTR, V13, P670, DOI 10.1016/S1044-0305(02)00363-X; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Chang WW, 2008, P NATL ACAD SCI USA, V105, P11667, DOI 10.1073/pnas.0804979105; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Coddens A, 2009, J BIOL CHEM, V284, P9713, DOI 10.1074/jbc.M807866200; Diswall M, 2008, TRANSPL P, V40, P543, DOI 10.1016/j.transproceed.2008.01.032; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; Fagerberg D, 2009, GLYCOBIOLOGY, V19, P182, DOI 10.1093/glycob/cwn125; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HOLGERSSON J, 1990, J BIOCHEM-TOKYO, V108, P766, DOI 10.1093/oxfordjournals.jbchem.a123279; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Ishijima N, 2011, J BIOL CHEM, V286, P25256, DOI 10.1074/jbc.M111.233601; ITO M, 1989, J BIOL CHEM, V264, P9510; IWAMORI M, 1981, BIOCHIM BIOPHYS ACTA, V665, P205, DOI 10.1016/0005-2760(81)90004-7; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KOSCIELAK J, 1973, EUR J BIOCHEM, V37, P214, DOI 10.1111/j.1432-1033.1973.tb02978.x; Koscielak J., 1970, BLOOD TISSUE ANTIGEN, P163; Kundu S. K., 1993, GLYCOCONJUGATES COMP, P203; Li YT, 2009, GLYCOCONJUGATE J, V26, P929, DOI 10.1007/s10719-008-9125-9; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; MCKIBBIN JM, 1982, J BIOL CHEM, V257, P755; Nyholm P G, 1989, J Mol Recognit, V2, P103, DOI 10.1002/jmr.300020302; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; STELLNER K, 1973, BIOCHEMISTRY-US, V12, P656, DOI 10.1021/bi00728a014; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Waldi D., 1962, THIN LAYER CHROMATOG, P496; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; ZHOU B, 1989, J BIOL CHEM, V264, P12272	47	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31712	31724		10.1074/jbc.M112.387654	http://dx.doi.org/10.1074/jbc.M112.387654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822069	Green Published, hybrid			2022-12-28	WOS:000309059400013
J	Palty, R; Hershfinkel, M; Sekler, I				Palty, Raz; Hershfinkel, Michal; Sekler, Israel			Molecular Identity and Functional Properties of the Mitochondrial Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SODIUM-CALCIUM EXCHANGE; HEART-MITOCHONDRIA; NA+-CA2+ EXCHANGER; INTRACELLULAR CA2+; EFFLUX MECHANISM; POSTTETANIC POTENTIATION; ESSENTIAL COMPONENT; INSULIN-SECRETION; INHIBITORY-ACTION; CEREBRAL-CORTEX	The mitochondrial membrane potential that powers the generation of ATP also facilitates mitochondrial Ca2+ shuttling. This process is fundamental to a wide range of cellular activities, as it regulates ATP production, shapes cytosolic and endoplasmic recticulum Ca2+ signaling, and determines cell fate. Mitochondrial Ca2+ transport is mediated primarily by two major transporters: a Ca2+ uniporter that mediates Ca2+ uptake and a Na+/Ca2+ exchanger that subsequently extrudes mitochondrial Ca2+. In this minireview, we focus on the specific role of the mitochondrial Na+/Ca2+ exchanger and describe its ion exchange mechanism, regulation by ions, and putative partner proteins. We discuss the recent molecular identification of the mitochondrial exchanger and how its activity is linked to physiological and pathophysiological processes.	[Palty, Raz] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, IL-84105 Beer Sheva, Israel; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, IL-84105 Beer Sheva, Israel	University of California System; University of California Berkeley; Ben Gurion University; Ben Gurion University	Palty, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	palty35@berkeley.edu; sekler@bgu.ac.il	Palty, Raz/HCH-3978-2022	Hershfinkel, Michal/0000-0003-1652-1989				AFFOLTER H, 1980, BIOCHEM BIOPH RES CO, V95, P193, DOI 10.1016/0006-291X(80)90723-8; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BAYSAL K, 1991, ARCH BIOCHEM BIOPHYS, V291, P383, DOI 10.1016/0003-9861(91)90150-H; BAYSAL K, 1994, AM J PHYSIOL, V266, pC800, DOI 10.1152/ajpcell.1994.266.3.C800; BRAND MD, 1985, BIOCHEM J, V229, P161, DOI 10.1042/bj2290161; Brandenburger Y, 1996, ENDOCRINOLOGY, V137, P5544, DOI 10.1210/en.137.12.5544; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Carrithers LM, 2011, FEMS IMMUNOL MED MIC, V63, P319, DOI 10.1111/j.1574-695X.2011.00853.x; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; CHIESI M, 1988, BIOCHEM PHARMACOL, V37, P4399, DOI 10.1016/0006-2952(88)90623-5; Chin JH, 2006, BRAIN CELL BIOL, V35, P173, DOI 10.1007/s11068-007-9010-7; COX DA, 1993, J BIOL CHEM, V268, P938; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1976, BIOCHEM J, V154, P735, DOI 10.1042/bj1540735; CROMPTON M, 1980, FEBS LETT, V115, P257, DOI 10.1016/0014-5793(80)81181-1; CROMPTON M, 1978, EUR J BIOCHEM, V91, P599, DOI 10.1111/j.1432-1033.1978.tb12713.x; Czyz A, 2003, BIOCHEM PHARMACOL, V66, P2409, DOI 10.1016/j.bcp.2003.08.024; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; Das AM, 2003, MOL GENET METAB, V79, P71, DOI 10.1016/S1096-7192(03)00069-6; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; Fekete A, 2009, J NEUROCHEM, V111, P745, DOI 10.1111/j.1471-4159.2009.06368.x; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Garcia-Chacon LE, 2006, J PHYSIOL-LONDON, V574, P663, DOI 10.1113/jphysiol.2006.110841; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Griffiths EJ, 1999, FEBS LETT, V453, P400, DOI 10.1016/S0014-5793(99)00726-7; Griffiths EJ, 2010, BBA-BIOENERGETICS, V1797, P856, DOI 10.1016/j.bbabio.2010.02.022; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hashiatni H, 2010, BRIT J PHARMACOL, V161, P680, DOI 10.1111/j.1476-5381.2010.00902.x; HAYAT LH, 1985, FEBS LETT, V182, P281, DOI 10.1016/0014-5793(85)80316-1; Hernandez-SanMiguel E, 2006, CELL CALCIUM, V40, P53, DOI 10.1016/j.ceca.2006.03.009; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; JURKOWITZ MS, 1983, FEBS LETT, V162, P262, DOI 10.1016/0014-5793(83)80768-6; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kar P, 2009, ARCH BIOCHEM BIOPHYS, V482, P66, DOI 10.1016/j.abb.2008.11.024; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Kim B, 2012, J PHYSIOL-LONDON, V590, P459, DOI 10.1113/jphysiol.2011.222927; Kim BJ, 2006, WORLD J GASTROENTERO, V12, P796, DOI 10.3748/wjg.v12.i5.796; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; LI WH, 1992, J BIOL CHEM, V267, P17983; LIGETI E, 1981, BIOCHIM BIOPHYS ACTA, V656, P177; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Luciani DS, 2007, EUR J PHARMACOL, V576, P18, DOI 10.1016/j.ejphar.2007.07.055; LUKACS GL, 1986, BIOCHIM BIOPHYS ACTA, V858, P125, DOI 10.1016/0005-2736(86)90298-1; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; MATLIB MA, 1983, EUR J PHARMACOL, V89, P327, DOI 10.1016/0014-2999(83)90518-6; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Neumann JT, 2011, MOL PHARMACOL, V79, P141, DOI 10.1124/mol.110.067165; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Olson ML, 2012, BIOCHEM SOC T, V40, P158, DOI 10.1042/BST20110705; Osibow K, 2006, BIOCHEM J, V396, P173, DOI 10.1042/BJ20060099; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Palty R, 2006, BIOCHEMISTRY-US, V45, P11856, DOI 10.1021/bi060633b; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Papa M, 2003, J COMP NEUROL, V461, P31, DOI 10.1002/cne.10665; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Paucek P, 2004, BBA-BIOENERGETICS, V1659, P83, DOI 10.1016/j.bbabio.2004.03.019; Pilitsis JG, 2002, NEUROSCI LETT, V321, P1, DOI 10.1016/S0304-3940(01)02377-1; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Reyes RC, 2008, J NEUROSCI, V28, P9682, DOI 10.1523/JNEUROSCI.3484-08.2008; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROTTENBERG H, 1992, CELL CALCIUM, V13, P41, DOI 10.1016/0143-4160(92)90028-Q; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Ryan D, 2009, J NEUROSCI, V29, P2053, DOI 10.1523/JNEUROSCI.4212-08.2009; Scanlon JM, 2000, CELL CALCIUM, V28, P317, DOI 10.1054/ceca.2000.0171; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; White RJ, 1996, J NEUROSCI, V16, P5688; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; WOLKOWICZ PE, 1983, AM J PHYSIOL, V244, pH644, DOI 10.1152/ajpheart.1983.244.5.H644; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zhang YL, 1999, J NEUROSCI, V19, P3307; Zhu LP, 2001, J MOL CELL CARDIOL, V33, P2135, DOI 10.1006/jmcc.2001.1476	100	43	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31650	31657		10.1074/jbc.R112.355867	http://dx.doi.org/10.1074/jbc.R112.355867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822063	Green Published, hybrid			2022-12-28	WOS:000309059400006
J	Vanaman, T; Carafoli, E				Vanaman, Thomas; Carafoli, Ernesto			Introduction to Thematic Minireview Series on Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RAT KIDNEY MITOCHONDRIA		[Vanaman, Thomas] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Carafoli, Ernesto] Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy	University of Kentucky; University of Padua; Veneto Institute Molecular Medicine	Vanaman, T (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tvanaman@asbmb.org	Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094				Bailey K, 1942, BIOCHEM J, V36, P121, DOI 10.1042/bj0360121; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P107, DOI 10.1093/oxfordjournals.jbchem.a128157; EBASHI S, 1968, J BIOCHEM-TOKYO, V64, P465, DOI 10.1093/oxfordjournals.jbchem.a128918; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HEILBRUNN L. V., 1940, PHYSIOL ZOOL, V13, P88; Ringer S, 1883, J Physiol, V4, P29; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670	9	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31623	31623		10.1074/jbc.R112.402354	http://dx.doi.org/10.1074/jbc.R112.402354			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822054	Green Published, hybrid			2022-12-28	WOS:000309059400002
J	Goh, LL; Manser, E				Goh, Liuh Ling; Manser, Ed			The GTPase-deficient Rnd Proteins Are Stabilized by Their Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; ORNITHINE DECARBOXYLASE; PROTEASOMAL DEGRADATION; MEDIATES DEGRADATION; ACTIVATING PROTEIN; P190 RHOGAP; IN-VIVO; R-RAS; RHOE; BINDING	Rnd proteins are Rho family GTP-binding proteins with cellular functions that antagonize RhoA signaling. We recently described a new Rnd3 effector Syx, also named PLEKHG5, that interacts with Rnds via a Raf1-like "Ras-binding domain." Syx is a multidomain RhoGEF that participates in early zebrafish development. Here we demonstrated that Rnd1, Rnd2, and Rnd3 stability is acutely dependent on interaction with their effectors such as Syx or p190 RhoGAP. Although Rnd3 turnover is blocked by treatment of cells with MG132, we provide evidence that such turnover is mediated indirectly by effects on the Rnd3 effectors, rather than on Rnd3 itself, which is not significantly ubiquitinated. The minimal regions of Syx and p190 RhoGAP that bind Rnd3 are not sequence-related but have similar effects. We have identified features that allow for Rnd3 turnover including a conserved Lys-45 close to the switch I region and the C-terminal membrane-binding domain of Rnd3, which cannot be substituted by the equivalent Cdc42 CAAX sequence. By contrast, an effector binding-defective mutant of Rnd3 when overexpressed undergoes turnover at normal rates. Interestingly the activity of the RhoA-regulated kinase ROCK stimulates Rnd3 turnover. This study suggests that Rnd proteins are regulated through feedback mechanisms in cells where the level of effectors and RhoA activity influence the stability of Rnd proteins. This effector feedback behavior is analogous to the ability of ACK1 and PAK1 to prolong the lifetime of the active GTP-bound state of Cdc42 and Rac1.	[Goh, Liuh Ling; Manser, Ed] Inst Med Biol, Rho GTPases Signaling Grp, Singapore 138648, Singapore; [Manser, Ed] Astar Neurosci Res Partnership, Small G Prot Signaling & Kinases Grp, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR)	Manser, E (corresponding author), Inst Med Biol, Rho GTPases Signaling Grp, 8A Biomed Grove,06-06 Immunos Bldg, Singapore 138648, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020					Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bonet R, 2009, J MOL BIOL, V389, P230, DOI 10.1016/j.jmb.2009.04.035; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Foster R, 1996, MOL CELL BIOL, V16, P2689; GLASS JR, 1987, J CELL PHYSIOL, V130, P133, DOI 10.1002/jcp.1041300119; Goda T, 2009, DEV DYNAM, V238, P2867, DOI 10.1002/dvdy.22099; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Karkkainen S, 2010, FEBS LETT, V584, P3867, DOI 10.1016/j.febslet.2010.07.060; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2012, MOL BIOL CELL, V23, P1593, DOI 10.1091/mbc.E11-11-0900; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Ryan K. R., 2012, J CELL SCI, DOI 10/1242/jcs.101931; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Villalonga P, 2009, J BIOL CHEM, V284, P35287, DOI 10.1074/jbc.M109.050120; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xie C, 2011, J BIOL CHEM, V286, P35933, DOI 10.1074/jbc.M111.270199; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	58	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31311	31320		10.1074/jbc.M111.327056	http://dx.doi.org/10.1074/jbc.M111.327056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807448	hybrid, Green Published			2022-12-28	WOS:000308791300042
J	Kim, JH; Tonelli, M; Frederick, RO; Chow, DCF; Markley, JL				Kim, Jin Hae; Tonelli, Marco; Frederick, Ronnie O.; Chow, Darius C. -F.; Markley, John L.			Specialized Hsp70 Chaperone (HscA) Binds Preferentially to the Disordered Form, whereas J-protein (HscB) Binds Preferentially to the Structured Form of the Iron-Sulfur Cluster Scaffold Protein (IscU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEPENDENT REACTION; NMR-SPECTROSCOPY; UNFOLDING STORY; REACTION CYCLE; SYSTEM; DNAK; SUBSTRATE; MECHANISM; MYOPATHY	The Escherichia coli protein IscU serves as the scaffold for Fe-S cluster assembly and the vehicle for Fe-S cluster transfer to acceptor proteins, such as apoferredoxin. IscU populates two conformational states in solution, a structured conformation (S) that resembles the conformation of the holoproteinIsc U-[2Fe-2S] and a dynamically disordered conformation (D) that does not bind metal ions. NMR spectroscopic results presented here show that the specialized Hsp70 chaperone (HscA), alone or as the HscA-ADP complex, preferentially binds to and stabilizes the D-state of IscU. IscU is released when HscA binds ATP. By contrast, the J-protein HscB binds preferentially to the S-state of IscU. Consistent with these findings, we propose a mechanism in which cluster transfer is coupled to hydrolysis of ATP bound to HscA, conversion of IscU to the D-state, and release of HscB.	[Kim, Jin Hae; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Frederick, Ronnie O.; Chow, Darius C. -F.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	jmarkley@wisc.edu		Kim, Jin Hae/0000-0002-6776-2451	National Institutes of Health [R01 GM58667, U01 GM94622]; National Magnetic Resonance Facility at Madison; NIH grants from the National Center for Research Resources [5P41RR002301-27, RR02301-26S1]; National Institute for General Medical Sciences [8 P41 GM103399-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, U01GM094622, R01GM058667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Magnetic Resonance Facility at Madison; NIH grants from the National Center for Research Resources; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM58667 and U01 GM94622 in collaboration with the National Magnetic Resonance Facility at Madison, which is supported by NIH grants from the National Center for Research Resources (5P41RR002301-27 and RR02301-26S1) and the National Institute for General Medical Sciences (8 P41 GM103399-27).	Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Bonomi F, 2005, J BIOL CHEM, V280, P29513, DOI 10.1074/jbc.M504344200; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chylla RA, 2011, ANAL CHEM, V83, P4871, DOI 10.1021/ac200536b; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fuzery AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-3; Goddard D., 2008, SPARKY 3; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kim JH, 2012, P NATL ACAD SCI USA, V109, P454, DOI 10.1073/pnas.1114372109; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kuloglu ES, 2002, J BIOL CHEM, V277, P17863, DOI 10.1074/jbc.M200402200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Tyler RC, 2011, BIOCHEMISTRY-US, V50, P7077, DOI 10.1021/bi200750k; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	42	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31406	31413		10.1074/jbc.M112.352617	http://dx.doi.org/10.1074/jbc.M112.352617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782893	Green Published, hybrid			2022-12-28	WOS:000308791300051
J	Jaenecke, I; Boissel, JP; Lemke, M; Rupp, J; Gasnier, B; Closs, EI				Jaenecke, Isabel; Boissel, Jean-Paul; Lemke, Matthias; Rupp, Johanna; Gasnier, Bruno; Closs, Ellen I.			A Chimera Carrying the Functional Domain of the Orphan Protein SLC7A14 in the Backbone of SLC7A2 Mediates Trans-stimulated Arginine Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; CYSTINOSIS; CYSTEAMINE; LYSOSOMES; MEMBRANE; SUBUNIT; CATS	In human skin fibroblasts, a lysosomal transport system specific for cationic amino acids has been described and named system c. We asked if SLC7A14 (solute carrier family 7 member A14), an orphan protein assigned to the SLC7 subfamily of cationic amino acid transporters (CATs) due to sequence homology, may represent system c. Fusion proteins between SLC7A14 and enhanced GFP localized to intracellular vesicles, co-staining with the lysosomal marker LysoTracker (R). To perform transport studies, we first tried to redirect SLC7A14 to the plasma membrane (by mutating putative lysosomal targeting motifs) but without success. We then created a chimera carrying the backbone of human (h) CAT-2 and the protein domain of SLC7A14 corresponding to the so-called "functional domain" of the hCAT proteins, a protein stretch of 81 amino acids that determines the apparent substrate affinity, sensitivity to trans-stimulation, and (as revealed in this study) pH dependence. The chimera mediated arginine transport and exhibited characteristics similar but not identical to hCAT-2A (the low affinity hCAT-2 isoform). Western blot and microscopic analyses confirmed localization of the chimera in the plasma membrane of Xenopus laevis oocytes. Noticeably, arginine transport by the hCAT-2/SLC7A14 chimera was pH-dependent, trans-stimulated, and inhibited by alpha-trimethyl-L-lysine, properties assigned to lysosomal transport system c in human skin fibroblasts. Expression analysis showed strong expression of SLC7A14 mRNA in these cells. Taken together, these data strongly suggest that SLC7A14 is a lysosomal transporter for cationic amino acids.	[Gasnier, Bruno] Univ Paris 05, CNRS, UMR 8192, F-75006 Paris, France; [Jaenecke, Isabel; Boissel, Jean-Paul; Lemke, Matthias; Rupp, Johanna; Closs, Ellen I.] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-55131 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz	Closs, EI (corresponding author), Univ Med Ctr Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	closs@uni-mainz.de	Closs, Ellen/ABD-5217-2020; Gasnier, Bruno/AAD-9124-2022	Closs, Ellen/0000-0002-9505-2289; Gasnier, Bruno/0000-0003-4458-6296	Deutsche Forschungsgemeinschaft (DFG) [Cl 100/4-3]; Cystinosis Research Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cystinosis Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant Cl 100/4-3 (to E. I. C.) and a Cystinosis Research Foundation common grant (to B. G. and E. I. C.).	Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 1997, BIOCHEMISTRY-US, V36, P6462, DOI 10.1021/bi962829p; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Habermeier A, 2003, J BIOL CHEM, V278, P19492, DOI 10.1074/jbc.M210254200; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Levtchenko EN, 2006, PEDIATR NEPHROL, V21, P110, DOI 10.1007/s00467-005-2052-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; PISONI RL, 1987, J BIOL CHEM, V262, P15011; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Rotmann A, 2007, AM J PHYSIOL-CELL PH, V292, pC2259, DOI 10.1152/ajpcell.00323.2006; SCHULMAN JD, 1969, SCIENCE, V166, P1152, DOI 10.1126/science.166.3909.1152; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Terry J., 2002, PHARM J, V269, P615; Vekony N, 2001, BIOCHEMISTRY-US, V40, P12387, DOI 10.1021/bi011345c; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wolf S, 2002, BIOCHEM J, V364, P767, DOI 10.1042/BJ20020084	19	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30853	30860		10.1074/jbc.M112.350322	http://dx.doi.org/10.1074/jbc.M112.350322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787143	hybrid, Green Published			2022-12-28	WOS:000308579800073
J	Liu, SP; Li, LL; Zhang, YY; Zhang, YW; Zhao, Y; You, XN; Lin, ZH; Zhang, XD; Ye, LH				Liu, Shuangping; Li, Leilei; Zhang, Yingyi; Zhang, Yiwen; Zhao, Yu; You, Xiaona; Lin, Zhenhua; Zhang, Xiaodong; Ye, Lihong			The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN GENE; GASTRIC-CARCINOMA; BINDING-PROTEIN; DNA-BINDING; STAT4; PROLIFERATION; METHYLATION; METASTASIS; ACTIVATION; POPULATION	We have reported that hepatitis B X-interacting protein (HBXIP) promotes the proliferation and migration of breast cancer cells. However, the underlying mechanism is poorly understood. In this study, we report that HBXIP works in the event through up-regulating S100A4. We observed that HBXIP expression was positively correlated to that of S100A4 in 87 clinical breast cancer tissue samples. Then, we identified that HBXIP was able to up-regulate S100A4 expression in breast cancer cells. Notably, we observed the HBXIP nuclear localization, implying that HBXIP may be associated with the promoter of S100A4. Chromatin immunoprecipitation assay (ChIP) and electrophoretic mobility shift assay (EMSA) showed that HBXIP was able to bind to the nucleotides +200 similar to+239 region of S100A4 promoter, containing two putative recognition motif of transcription factor STAT4 and GR beta. It suggests that HBXIP is able to activate S100A4 promoter via interacting with STAT4 in breast cancer cells, leading to the up-regulation of S100A4. In addition, we identified another pathway of S100A4 up-regulation mediated by HBXIP. We found that HBXIP activated the PTEN/PI3K/AKT signaling by inducing DNA methylation of PTEN, which subsequently boosted S100A4 expression. In function, we demonstrated that HBXIP enhanced the growth or migration of breast cancer cells through S100A4 in vivo and in vitro. Collectively, we conclude that HBXIP up-regulates S100A4 through activating S100A4 promoter involving STAT4 and inducing PTEN/PI3K/AKT signaling to promote growth and migration of breast cancer cells. Our finding provides new insight into the mechanism of HBXIP in promotion of the development of breast cancer.	[Liu, Shuangping; Lin, Zhenhua] Yanbian Univ, Coll Med, Dept Pathol, Yanji 133002, Peoples R China; [Liu, Shuangping; Li, Leilei; Zhang, Yingyi; Zhang, Yiwen; Zhao, Yu; Ye, Lihong] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [You, Xiaona; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Yanbian University; Nankai University; Nankai University	Lin, ZH (corresponding author), Yanbian Univ, Coll Med, Dept Pathol, Yanji 133002, Peoples R China.	zhlin720@ybu.edu.cn; zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	zhao, yu/AAD-9494-2021	Liu, Shuangping/0000-0001-6029-3245; You, Xiaona/0000-0001-9996-1466	National Basic Research Program of China (973 Program) [2011CB512113, 2009CB521702]; Natural Scientific Foundation of China [81071623, 81071624, 30960120]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program, No. 2011CB512113, No. 2009CB521702) and the Natural Scientific Foundation of China (No. 81071623, No. 81071624, No. 30960120).	Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fan XP, 2010, MOL MED REP, V3, P775, DOI 10.3892/mmr.2010.337; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Goltsov A, 2012, CELL SIGNAL, V24, P493, DOI 10.1016/j.cellsig.2011.09.030; Hernan R, 2003, CANCER RES, V63, P140; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Ismail NI, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-12; Kawata T, 2011, DEV GROWTH DIFFER, V53, P548, DOI 10.1111/j.1440-169X.2010.01243.x; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lupov IP, 2011, BLOOD, V118, P6097, DOI 10.1182/blood-2011-03-341867; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Minczuk M, 2005, FEBS J, V272, P5008, DOI 10.1111/j.1742-4658.2005.04910.x; Miranda KJ, 2010, J BIOL CHEM, V285, P31517, DOI 10.1074/jbc.M110.125898; Nguyen TTP, 2011, BREAST CANCER RES TR, V130, P73, DOI 10.1007/s10549-010-1304-2; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Rizvi MMA, 2011, J CANCER RES CLIN, V137, P1255, DOI 10.1007/s00432-011-0994-0; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Torpey N, 2004, J BIOL CHEM, V279, P26789, DOI 10.1074/jbc.M401517200; Ushiku T, 2007, INT J CANCER, V120, P60, DOI 10.1002/ijc.22275; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang FZ, 2011, EXP BIOL MED, V236, P62, DOI 10.1258/ebm.2010.010179; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wiencke JK, 2007, NEURO-ONCOLOGY, V9, P271, DOI 10.1215/15228517-2007-003; Yamamoto K, 1997, BIOCHEM BIOPH RES CO, V233, P126, DOI 10.1006/bbrc.1997.6415; Yang H, 2012, J INT MED RES, V40, P475, DOI 10.1177/147323001204000209; Yang J, 2012, INT J CANCER, V130, P959, DOI 10.1002/ijc.26095; Zhang GY, 2011, ASIAN PAC J CANCER P, V12, P2075	39	72	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30228	30239		10.1074/jbc.M112.343947	http://dx.doi.org/10.1074/jbc.M112.343947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740693	Green Published, hybrid			2022-12-28	WOS:000308579800017
J	Ravilious, GE; Jez, JM				Ravilious, Geoffrey E.; Jez, Joseph M.			Nucleotide Binding Site Communication in Arabidopsis thaliana Adenosine 5 '-Phosphosulfate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APS-KINASE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; CRYSTAL-STRUCTURE; ATP SULFURYLASE; P-LOOP; DIRECTED MUTAGENESIS; STRUCTURAL BASIS; MECHANISM; REDUCTASE	Adenosine 5'-phosphosulfate kinase (APSK) catalyzes the ATP-dependent synthesis of adenosine 3'-phosphate 5'-phosphosulfate (PAPS), which is an essential metabolite for sulfur assimilation in prokaryotes and eukaryotes. Using APSK from Arabidopsis thaliana, we examine the energetics of nucleotide binary and ternary complex formation and probe active site features that coordinate the order of ligand addition. Calorimetric analysis shows that binding can occur first at either nucleotide site, but that initial interaction at the ATP/ADP site was favored and enhanced affinity for APS in the second site by 50-fold. The thermodynamics of the two possible binding models (i.e. ATP first versus APS first) differs and implies that active site structural changes guide the order of nucleotide addition. The ligand binding analysis also supports an earlier suggestion of intermolecular interactions in the dimeric APSK structure. Crystallographic, site-directed mutagenesis, and energetic analyses of oxyanion recognition by the P-loop in the ATP/ADP binding site and the role of Asp(136), which bridges the ATP/ADP and APS/PAPS binding sites, suggest how the ordered nucleotide binding sequence and structural changes are dynamically coordinated for catalysis.	[Ravilious, Geoffrey E.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			National Science Foundation [MCB-0904215]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0904215.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Kopriva S, 2009, PLANT CELL REP, V28, P1769, DOI 10.1007/s00299-009-0793-0; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; MacRae IJ, 1998, J BIOL CHEM, V273, P28583, DOI 10.1074/jbc.273.44.28583; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Martin MN, 2005, PHOTOSYNTH RES, V86, P309, DOI 10.1007/s11120-005-9006-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Ravilious G. E., 2012, NAT PROD RE IN PRESS; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V284, P30, DOI 10.1016/0003-9861(91)90258-K; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Satishchandran C, 2000, ARCH BIOCHEM BIOPHYS, V378, P210, DOI 10.1006/abbi.2000.1841; Scheerer U, 2010, J EXP BOT, V61, P609, DOI 10.1093/jxb/erp327; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Sekulic N, 2007, J BIOL CHEM, V282, P22112, DOI 10.1074/jbc.M701713200; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	43	22	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30385	30394		10.1074/jbc.M112.387001	http://dx.doi.org/10.1074/jbc.M112.387001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22810229	Green Published, hybrid			2022-12-28	WOS:000308579800031
J	Wang, L; Jia, Y; Rogers, H; Wu, YP; Huang, SM; Noguchi, CT				Wang, Li; Jia, Yi; Rogers, Heather; Wu, Yun-Ping; Huang, Suming; Noguchi, Constance Tom			GATA-binding Protein 4 (GATA-4) and T-cell Acute Leukemia 1 (TAL1) Regulate Myogenic Differentiation and Erythropoietin Response via Cross-talk with Sirtuin1 (Sirt1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART TUBE FORMATION; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; VENTRAL MORPHOGENESIS; HISTONE DEACETYLASES; GENE DISRUPTION; SATELLITE CELLS; MYOD; EXPRESSION; RECEPTOR	Erythropoietin (EPO), the cytokine required for erythrocyte production, contributes to muscle progenitor cell proliferation and delay myogenic differentiation. However, the underlying mechanism is not yet fully understood. Here, we report that EPO changes the skeletal myogenic regulatory factor expression program and delays differentiation via induction of GATA-4 and the basic helix-loop-helix TAL1 and that knockdown of both factors promotes differentiation. EPO increases the Sirt1 level, a NAD(+)-dependent deacetylase, and also induces the NAD(+)/NADH ratio that further increases Sirt1 activity. Sirt1 knockdown reduced GATA-4 and TAL1 expression, impaired EPO effect on delayed myogenic differentiation, and the Sirt1 knockdown effect was abrogated when combined with overexpression of GATA-4 or TAL1. GATA-4 interacts with Sirt1 and targets Sirt1 to the myogenin promoter and represses myogenin expression, whereas TAL1 inhibits myogenin expression by decreasing MyoD binding to and activation of the myogenin promoter. Sirt1 was found to bind to the GATA-4 promoter to directly regulate GATA-4 expression and GATA-4 binds to the TAL1 promoter to regulate TAL1 expression positively. These data suggest that GATA-4, TAL1, and Sirt1 cross-talk each other to regulate myogenic differentiation and mediate EPO activity during myogenic differentiation with Sirt1 playing a role upstream of GATA-4 and TAL1. Taken together, our findings reveal a novel role for GATA-4 and TAL1 to affect skeletal myogenic differentiation and EPO response via cross-talk with Sirt1.	[Wang, Li; Jia, Yi; Rogers, Heather; Noguchi, Constance Tom] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Wu, Yun-Ping] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Noguchi, CT (corresponding author), Bldg 10,Rm 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@niddk.nih.gov			National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK.	ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOLDFARB AN, 1995, BLOOD, V85, P465; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hofmann TJ, 1996, ONCOGENE, V13, P617; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hu X, 2009, EPIGENETICS-US, V4, P257, DOI 10.4161/epi.4.6.9711; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jia Y, 2012, FASEB J, V26, P2847, DOI 10.1096/fj.11-196618; Jia Y, 2009, FASEB J, V23, P3089, DOI 10.1096/fj.09-130237; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LECOINTE N, 1994, ONCOGENE, V9, P2623; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Ravet E, 2004, BLOOD, V103, P3326, DOI 10.1182/blood-2003-05-1689; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Suzuki YJ, 2004, LIFE SCI, V74, P1829, DOI 10.1016/j.lfs.2003.10.002; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; von Salisch S, 2011, J CELL MOL MED, V15, P1963, DOI 10.1111/j.1582-4934.2010.01193.x; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wen J, 2005, J BIOL CHEM, V280, P12956, DOI 10.1074/jbc.M412721200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144	55	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30157	30169		10.1074/jbc.M112.376640	http://dx.doi.org/10.1074/jbc.M112.376640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773876	Green Published, hybrid			2022-12-28	WOS:000308579800011
J	Wu, Q; DiBona, VL; Bernard, LP; Zhang, HY				Wu, Qian; DiBona, Victoria L.; Bernard, Laura P.; Zhang, Huaye			The Polarity Protein Partitioning-defective 1 (PAR-1) Regulates Dendritic Spine Morphogenesis through Phosphorylating Postsynaptic Density Protein 95 (PSD-95)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE; LOCALIZATION; DROSOPHILA; MAINTENANCE; DISORDERS; PATHOLOGY; BAZOOKA; GENES; MARK	The polarity protein PAR-1 plays an essential role in many cellular contexts, including embryogenesis, asymmetric cell division, directional migration, and epithelial morphogenesis. Despite its known importance in different cellular processes, the role of PAR-1 in neuronal morphogenesis is less well understood. In particular, its role in the morphogenesis of dendritic spines, which are sites of excitatory synaptic inputs, has been unclear. Here, we show that PAR-1 is required for normal spine morphogenesis in hippocampal neurons. We further show that PAR-1 functions through phosphorylating the synaptic scaffolding protein PSD-95 in this process. Phosphorylation at a conserved serine residue in the KXGS motif in PSD-95 regulates spine morphogenesis, and a phosphomimetic mutant of this site can rescue the defects of kinase-dead PAR-1. Together, our findings uncover a role of PAR-1 in spine morphogenesis in hippocampal neurons through phosphorylating PSD-95.	[Wu, Qian; DiBona, Victoria L.; Bernard, Laura P.; Zhang, Huaye] UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane W, Piscataway, NJ 08854 USA.	zhang29@umdnj.edu			National Institutes of Health [NS065183]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183, K99NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS065183 (to H. Z.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to H. Z.).	Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hayashi K, 2011, J NEUROSCI, V31, P12094, DOI 10.1523/JNEUROSCI.0751-11.2011; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	24	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30781	30788		10.1074/jbc.M112.351452	http://dx.doi.org/10.1074/jbc.M112.351452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807451	Green Published, hybrid			2022-12-28	WOS:000308579800066
J	Foster, JD; Yang, JW; Moritz, AE; ChallaSivaKanaka, S; Smith, MA; Holy, M; Wilebski, K; Sitte, HH; Vaughan, RA				Foster, James D.; Yang, Jae-Won; Moritz, Amy E.; ChallaSivaKanaka, Sathyavathi; Smith, Margaret A.; Holy, Marion; Wilebski, Kyle; Sitte, Harald H.; Vaughan, Roxanne A.			Dopamine Transporter Phosphorylation Site Threonine 53 Regulates Substrate Reuptake and Amphetamine-stimulated Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-DIRECTED PHOSPHORYLATION; INDUCED REVERSE TRANSPORT; CELL-SURFACE EXPRESSION; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; DEPENDENT MECHANISMS; EPITHELIAL-CELLS; COCAINE ANALOG; SYNTAXIN 1A; KINASE	In the central nervous system, levels of extraneuronal dopamine are controlled primarily by the action of the dopamine transporter (DAT). Multiple signaling pathways regulate transport activity, substrate efflux, and other DAT functions through currently unknown mechanisms. DAT is phosphorylated by protein kinase C within a serine cluster at the distal end of the cytoplasmic N terminus, whereas recent work in model cells revealed proline-directed phosphorylation of rat DAT at membrane-proximal residue Thr(53). In this report, we use mass spectrometry and a newly developed phospho-specific antibody to positively identify DAT phosphorylation at Thr(53) in rodent striatal tissue and heterologous expression systems. Basal phosphorylation of Thr(53) occurred with a stoichiometry of similar to 50% and was strongly increased by phorbol esters and protein phosphatase inhibitors, demonstrating modulation of the site by signaling pathways that impact DAT activity. Mutations of Thr(53) to prevent phosphorylation led to reduced dopamine transport V-max and total apparent loss of amphetamine-stimulated substrate efflux, supporting a major role for this residue in the transport kinetic mechanism.	[Foster, James D.; Moritz, Amy E.; ChallaSivaKanaka, Sathyavathi; Smith, Margaret A.; Wilebski, Kyle; Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA; [Yang, Jae-Won; Holy, Marion; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of North Dakota Grand Forks; Medical University of Vienna	Sitte, HH (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA.	harald.sitte@meduniwien.ac.at; roxanne.vaughan@med.und.edu	Sitte, Harald/O-7025-2019; ChallaSivaKanaka, Sathyavathi/AAL-7212-2021; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; ChallaSivaKanaka, Sathyavathi/0000-0001-8487-5485; Sitte, Harald/0000-0002-1339-7444; Yang, Jae-Won/0000-0001-8928-0130	National Institutes of Health, NIDA [R01 DA13147]; ND EPSCoR IIG; COBRE program of National Center for Research Resources [P20 RR017699]; IDeA Networks of Biomedical Research Excellence (INBRE) program of National Center for Research Resources [P20 RR016741]; Austrian Research Funds/FWF Grants [F3506, P22893-B1, P23670-B09]; EPSCoR [0814442] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013147] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23670, F 3506] Funding Source: researchfish	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ND EPSCoR IIG; COBRE program of National Center for Research Resources; IDeA Networks of Biomedical Research Excellence (INBRE) program of National Center for Research Resources; Austrian Research Funds/FWF Grants; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health, Grant R01 DA13147 from NIDA (to R. A. V.), ND EPSCoR IIG (to R. A. V. and J. D. F.), P20 RR017699 from the COBRE program of the National Center for Research Resources (to the University of North Dakota), and P20 RR016741 from the IDeA Networks of Biomedical Research Excellence (INBRE) program of the National Center for Research Resources (to the University of North Dakota). This work was also supported by Austrian Research Funds/FWF Grants F3506 and P22893-B1 (to H. H. S.) and P23670-B09 (to J.-W. Y.).	Ando S, 1997, J BIOCHEM, V122, P409; Bannon Michael J., 1995, P179; Bauman AL, 2000, J NEUROSCI, V20, P7571; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Giambalvo CT, 2003, SYNAPSE, V49, P125, DOI 10.1002/syn.10223; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; GU H, 1994, J BIOL CHEM, V269, P7124; Guerrero C, 2001, AM J PHYSIOL-LUNG C, V281, pL79, DOI 10.1152/ajplung.2001.281.1.L79; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Hoover BR, 2007, J NEUROCHEM, V101, P1258, DOI 10.1111/j.1471-4159.2007.04522.x; Huff RA, 1997, J NEUROCHEM, V68, P225; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2000, FASEB J, V14, P715, DOI 10.1096/fasebj.14.5.715; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Mayer BJ, 2001, J CELL SCI, V114, P1253; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Moron JA, 2003, J NEUROSCI, V23, P8480; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Shi X, 2006, NEUROSCIENCE, V138, P1289, DOI 10.1016/j.neuroscience.2005.12.024; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 2004, J PHARMACOL EXP THER, V310, P1, DOI 10.1124/jpet.103.052423; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	77	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29702	29712		10.1074/jbc.M112.367706	http://dx.doi.org/10.1074/jbc.M112.367706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22722938	hybrid, Green Published			2022-12-28	WOS:000308286900046
J	Itoh, S; Saito, T; Hirata, M; Ushita, M; Ikeda, T; Woodgett, JR; Algul, H; Schmid, RM; Chung, U; Kawaguchi, H				Itoh, Shozo; Saito, Taku; Hirata, Makoto; Ushita, Masahiro; Ikeda, Toshiyuki; Woodgett, James R.; Alguel, Hana; Schmid, Roland M.; Chung, Ung-il; Kawaguchi, Hiroshi			GSK-3 alpha and GSK-3 beta Proteins Are Involved in Early Stages of Chondrocyte Differentiation with Functional Redundancy through RelA Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3-BETA; ENDOCHONDRAL OSSIFICATION; TRANSCRIPTIONAL INDUCTION; GENE-EXPRESSION; CELL-SURVIVAL; GROWTH-PLATE; PATHWAY; KINASE; MICE	Here we examine the roles of two isoforms of glycogen synthase kinase-3 (GSK-3), GSK-3 alpha and GSK-3 beta, in skeletal development. Both isoforms were unphosphorylated and active in chondrocyte differentiation stages during SOX9 and type II collagen (COL2A1) expression. Although knock-out of both alleles of Gsk3a (Gsk3a(-/-)) or a single allele of Gsk3b (Gsk3b(+/-)) in mice did not significantly affect skeletal development, compound knock-out (Gsk3a(-/-); Gsk3b(+/-)) caused dwarfism with impairment of chondrocyte differentiation. GSK-3 alpha and GSK-3 beta induced differentiation of cultured chondrocytes with functional redundancy in a cell-autonomous fashion, independently of the Wnt/beta-catenin signal. Computational predictions followed by SOX9 and COL2A1 transcriptional assays identified RelA (NF-kappa B p65) as a key phosphorylation target of GSK-3. Among several phosphorylation residues in RelA, Thr-254 was identified as the critical phosphorylation site for GSK-3 that modulated chondrocyte differentiation. In conclusion, redundant functions of GSK-3 alpha and GSK-3 beta through phosphorylation of RelA at Thr-254 play a crucial role in early stages of chondrocyte differentiation.	[Itoh, Shozo; Saito, Taku; Hirata, Makoto; Ushita, Masahiro; Ikeda, Toshiyuki; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo 1138655, Japan; [Saito, Taku] Univ Tokyo, Fac Med, Dept Bone & Cartilage Regenerat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Hirata, Makoto; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Woodgett, James R.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Alguel, Hana; Schmid, Roland M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80333 Munich, Germany	University of Tokyo; University of Tokyo; University of Tokyo; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Technical University of Munich	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022; Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Algul, Hana/0000-0002-5067-7031	Japanese Ministry of Education, Culture, Sports, Science and Technology [21390416, 22659267, 22390286]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research 21390416, 22659267, and 22390286 from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Baryawno N, 2010, CANCER RES, V70, P266, DOI 10.1158/0008-5472.CAN-09-0578; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; IWAMOTO M, 1993, J BIOL CHEM, V268, P9645; James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693; Janssen R, 2004, J EXP MED, V200, P559, DOI 10.1084/jem.20040773; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Li TF, 2004, EXP CELL RES, V300, P159, DOI 10.1016/j.yexcr.2004.06.019; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	45	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29227	29236		10.1074/jbc.M112.372086	http://dx.doi.org/10.1074/jbc.M112.372086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761446	Green Published, hybrid			2022-12-28	WOS:000308286900002
J	Pastar, I; Khan, AA; Stojadinovic, O; Lebrun, EA; Medina, MC; Brem, H; Kirsner, RS; Jimenez, JJ; Leslie, C; Tomic-Canic, M				Pastar, Irena; Khan, Aly Azeem; Stojadinovic, Olivera; Lebrun, Elizabeth A.; Medina, Mayrin Correa; Brem, Harold; Kirsner, Robert S.; Jimenez, Joaquin J.; Leslie, Christina; Tomic-Canic, Marjana			Induction of Specific MicroRNAs Inhibits Cutaneous Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTORS; KERATINOCYTE MIGRATION; PROTEIN-SYNTHESIS; HUMAN GENES; SKIN; TARGET; LEPTIN; PROLIFERATION; BIOGENESIS; EXPRESSION	Chronic nonhealing wounds, such as venous ulcers (VUs), are a widespread and serious medical problem with high morbidity and mortality. The molecular pathology of VUs remains poorly understood, impeding the development of effective treatment strategies. Using mRNA expression profiling of VUs biopsies and computational analysis, we identified a candidate set of microRNAs with lowered target gene expression. Among these candidates, miR-16, -20a, -21, -106a -130a, and -203 were confirmed to be aberrantly overexpressed in a cohort study of 10 VU patients by quantitative PCR and in situ hybridizations. These microRNAs were predicted to target multiple genes important for wound healing, including early growth response factor 3, vinculin, and leptin receptor (LepR). Overexpression of the top up-regulated miRNAs, miR-21 and miR-130a, in primary human keratinocytes down-regulated expression of the endogenous LepR and early growth response factor 3. The luciferase reporter assay verified LepR as a direct target for miR-21 and miR-130a. Both miR-21 and miR-130a delayed epithelialization in an acute human skin wound model. Furthermore, in vivo overexpression of miR-21 inhibited epithelialization and granulation tissue formation in a rat wound model. Our results identify a novel mechanism in which overexpression of specific set of microRNAs inhibits wound healing, resulting in new potential molecular markers and targets for therapeutic intervention.	[Pastar, Irena; Stojadinovic, Olivera; Lebrun, Elizabeth A.; Kirsner, Robert S.; Jimenez, Joaquin J.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Medina, Mayrin Correa] Univ Miami, Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Khan, Aly Azeem; Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Brem, Harold] Winthrop Univ Hosp, Div Wound Healing & Regenerat Med, Mineola, NY 11501 USA	University of Miami; University of Miami; Memorial Sloan Kettering Cancer Center; Winthrop University Hospital	Tomic-Canic, M (corresponding author), 1600 NW 10th Ave,RMSB,Rm 2023-A, Miami, FL 33136 USA.	MTCanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [NR013881, ULIRR024996, 1-U24-CA143840]; Starr Cancer Consortium [I4-A411]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grants NR013881 (to M. T.-C.) and ULIRR024996 Clinical and Translational Science Center pilot grant (to M. T.-C.) and Grant 1-U24-CA143840 (to C. L.). This work was also supported by Starr Cancer Consortium Grant I4-A411 (to C. L.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019; Bertero T, 2011, FASEB J, V25, P3092, DOI 10.1096/fj.10-168401; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Brem H, 2007, EXP GERONTOL, V42, P523, DOI 10.1016/j.exger.2006.11.018; Brem H, 2007, MOL MED, V13, P30, DOI 10.2119/2006-00054.Brem; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brem H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-75; BURRIDGE K, 1989, BIOESSAYS, V10, P104, DOI 10.1002/bies.950100403; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Herschthal Jordana, 2008, Surg Technol Int, V17, P77; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Meisgen F, 2012, EXP DERMATOL, V21, P312, DOI 10.1111/j.1600-0625.2012.01462.x; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pastar I., 2012, SURG TECHNOL INT, VXXI, P51; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Robson M. C., 1995, Wound Repair and Regeneration, V3, P157, DOI 10.1046/j.1524-475X.1995.30207.x; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shilo S, 2007, DNA CELL BIOL, V26, P227, DOI 10.1089/dna.2006.0568; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SPORN MB, 1993, J CLIN INVEST, V92, P2565, DOI 10.1172/JCI116868; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; TAKAHASHI K, 1995, J BIOL CHEM, V270, P18581, DOI 10.1074/jbc.270.31.18581; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P673; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	63	96	98	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29324	29335		10.1074/jbc.M112.382135	http://dx.doi.org/10.1074/jbc.M112.382135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773832	hybrid, Green Published			2022-12-28	WOS:000308286900012
J	Lv, J; Du, CS; Wei, W; Wu, ZY; Zhao, GX; Li, ZX; Xie, X				Lv, Jie; Du, Changsheng; Wei, Wei; Wu, Zhiying; Zhao, Guixian; Li, Zhenxin; Xie, Xin			The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; MULTIPLE-SCLEROSIS; IMMUNE HOMEOSTASIS; TRICHOSTATIN-A; TGF-BETA; APOPTOSIS; THERAPY; SYSTEM; BCL-2; HDAC	Maintaining a constant number and ratio of immune cells is one critical aspect of the tight regulation of immune homeostasis. Breakdown of this balance will lead to autoimmune diseases such as multiple sclerosis (MS). The antiepileptic drug valproic acid (VPA) was reported to regulate the growth, survival, and differentiation of many cells. However, its function in T cell homeostasis and MS treatment remains unknown. In this study, VPA was found to reduce spinal cord inflammation, demyelination, and disease scores in experimental autoimmune encephalomyelitis, a mouse model of MS. Further study indicated that VPA induces apoptosis in activated T cells and maintains the immune homeostasis. This effect was found to be mainly mediated by the caspase-8/caspase-3 pathway. Interestingly, this phenomenon was also confirmed in T cells from normal human subjects and MS patients. Considering the long history of clinical use and our new findings, we believe VPA might be a safe and effective therapy for autoimmune diseases, such as multiple sclerosis.	[Lv, Jie; Du, Changsheng; Wei, Wei; Xie, Xin] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Lab Receptor Based Biomed, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wei, Wei; Xie, Xin] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wu, Zhiying; Zhao, Guixian; Li, Zhenxin] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Wu, Zhiying; Zhao, Guixian; Li, Zhenxin] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Inst Neurol, Shanghai 200040, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University; Fudan University	Xie, X (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	xxie@mail.shcnc.ac.cn	Du, Changsheng/E-1552-2011		National Natural Science Foundation of China [31000399, 31171348, 31071227, 81100963]; 973 Program [2012CB910404]; Ministry of Science and Technology of China [2009ZX09302-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 31000399, 31171348, 31071227, and 81100963, 973 Program Grant 2012CB910404), and the Ministry of Science and Technology of China Grant 2009ZX09302-001.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; AMANO R, 1990, JPN J PSYCHIAT NEUR, V44, P343; Anderson AC, 2004, J IMMUNOL, V173, P828, DOI 10.4049/jimmunol.173.2.828; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Campas-Moya C, 2009, DRUG TODAY, V45, P787, DOI 10.1358/dot.2009.45.11.1437052; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Fan Hong-cui, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P222; Guerrini Renzo, 2006, Paediatr Drugs, V8, P113, DOI 10.2165/00148581-200608020-00004; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Maksimow M, 2006, J LEUKOCYTE BIOL, V79, P369, DOI 10.1189/jlb.0505238; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mars LT, 2011, BBA-MOL BASIS DIS, V1812, P151, DOI 10.1016/j.bbadis.2010.07.006; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Massacesi L, 2002, CLIN NEUROL NEUROSUR, V104, P177, DOI 10.1016/S0303-8467(02)00035-5; Matsuoka H, 2007, INT IMMUNOPHARMACOL, V7, P1422, DOI 10.1016/j.intimp.2007.05.022; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Saint Fleur S, 2009, BLOOD, V114, P1355, DOI 10.1182/blood-2008-11-189118; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sonobe Y, 2007, TOHOKU J EXP MED, V213, P329, DOI 10.1620/tjem.213.329; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Swamy R. K., 2005, Indian Journal of Experimental Biology, V43, P686; Takahashi I, 1996, J ANTIBIOT, V49, P453, DOI 10.7164/antibiotics.49.453; TAKAHASHI K, 1992, VIRCHOWS ARCH B, V62, P105, DOI 10.1007/BF02899671; Van Parijs L, 1998, SCIENCE, V280, P243; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; York NR, 2010, J AUTOIMMUN, V35, P33, DOI 10.1016/j.jaut.2010.01.003	39	38	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28656	28665		10.1074/jbc.M112.356584	http://dx.doi.org/10.1074/jbc.M112.356584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733814	Green Published, hybrid			2022-12-28	WOS:000308074600039
J	Bishe, B; Syed, GH; Field, SJ; Siddiqui, A				Bishe, Bryan; Syed, Gulam H.; Field, Seth J.; Siddiqui, Aleem			Role of Phosphatidylinositol 4-Phosphate (PI4P) and Its Binding Protein GOLPH3 in Hepatitis C Virus Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; GOLGI-COMPLEX; ENDOPLASMIC-RETICULUM; MEMBRANE-TRAFFICKING; APOLIPOPROTEIN-B; LIPID-TRANSFER; CORE PROTEIN; REPLICATION; INFECTION; TRANSPORT	Hepatitis C virus (HCV) RNA replicates within the ribonucleoprotein complex, assembled on the endoplasmic reticulum (ER)-derived membranous structures closely juxtaposed to the lipid droplets that facilitate the post-replicative events of virion assembly and maturation. It is widely believed that the assembled virions piggy-back onto the very low density lipoprotein particles for secretion. Lipid phosphoinositides are important modulators of intracellular trafficking. Golgi-localized phosphatidylinositol 4-phosphate (PI4P) recruits proteins involved in Golgi trafficking to the Golgi membrane and promotes anterograde transport of secretory proteins. Here, we sought to investigate the role of Golgi-localized PI4P in the HCV secretion process. Depletion of the Golgi-specific PI4P pool by Golgi-targeted PI4P phosphatase hSac1 K2A led to significant reduction in HCV secretion without any effect on replication. We then examined the functional role of a newly identified PI4P binding protein GOLPH3 in the viral secretion process. GOLPH3 is shown to maintain a tensile force on the Golgi, required for vesicle budding via its interaction with an unconventional myosin, MYO18A. Silencing GOLPH3 led to a dramatic reduction in HCV virion secretion, as did the silencing of MYO18A. The reduction in virion secretion was accompanied by a concomitant accumulation of intracellular virions, suggesting a stall in virion egress. HCV-infected cells displayed a fragmented and dispersed Golgi pattern, implicating involvement in virion morphogenesis. These studies establish the role of PI4P and its interacting protein GOLPH3 in HCV secretion and strengthen the significance of the Golgi secretory pathway in this process.	[Bishe, Bryan; Syed, Gulam H.; Siddiqui, Aleem] Univ Calif San Diego, Moores Canc Ctr, Div Infect Dis, La Jolla, CA 92093 USA; [Bishe, Bryan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Field, Seth J.] Univ Calif San Diego, Div Endocrinol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Siddiqui, A (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Div Infect Dis, 9500 Gilman Dr,Stein Clin Res Bldg,Rm 409, La Jolla, CA 92093 USA.	asiddiqui@ucsd.edu	Syed, Gulam/N-7842-2013; Bishe, Bryan/AAG-2892-2019	Field, Seth/0000-0002-8893-4806; Bishe, Bryan/0000-0003-4385-5634; Syed, Gulam/0000-0001-8540-6162	National Institutes of Health [AI085087, DK077704, DK08379]; Burroughs Wellcome Fund Career Award; National Institutes of Health New Innovator Award [OD004265]; Department of Defense Era of Hope Scholar Award [W81XWH-10-1-0822]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085087, R01AI085087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077704, R01DK083479] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Scholar Award(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI085087, DK077704, and DK08379 (to A. S.), the Burroughs Wellcome Fund Career Award, National Institutes of Health New Innovator Award OD004265, and Department of Defense Era of Hope Scholar Award W81XWH-10-1-0822 (to S. J. F.).	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Asp L, 2005, ARTERIOSCL THROM VAS, V25, P566, DOI 10.1161/01.ATV.0000154135.21689.47; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Beske O, 2007, J CELL SCI, V120, P3207, DOI 10.1242/jcs.03483; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; de Matteis MA, 2007, BIOCHEM SOC SYMP, V74, P107, DOI 10.1042/BSS2007c10; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Quiner CA, 2010, VIROLOGY, V407, P185, DOI 10.1016/j.virol.2010.08.012; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	60	69	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27637	27647		10.1074/jbc.M112.346569	http://dx.doi.org/10.1074/jbc.M112.346569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22745132	hybrid, Green Published			2022-12-28	WOS:000307840700038
J	Glowacka, WK; Alberts, P; Ouchida, R; Wang, JY; Rotin, D				Glowacka, Wioletta K.; Alberts, Philipp; Ouchida, Rika; Wang, Ji-Yang; Rotin, Daniela			LAPTM5 Protein Is a Positive Regulator of Proinflammatory Signaling Pathways in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; TNF RECEPTOR-1; ENZYME A20; UBIQUITIN; RECRUITMENT; ACTIVATION; CANCER; ALPHA	LAPTM5 (lysosomal-associated protein transmembrane 5) is a protein that is preferentially expressed in immune cells, and it interacts with the Nedd4 family of ubiquitin ligases. Recent studies in T and B cells identified LAPTM5 as a negative regulator of T and B cell receptor levels at the plasma membrane. Here we investigated the function of LAPTM5 in macrophages. We demonstrate that expression of LAPTM5 is required for the secretion of proinflammatory cytokines in response to Toll-like receptor ligands. We also show that RAW264.7 cells knocked down for LAPTM5 or macrophages from LAPTM5(-/-) mice exhibit reduced activation of NF-kappa B and MAPK signaling pathways mediated by the TNF receptor, as well as multiple pattern recognition receptors in various cellular compartments. TNF stimulation of LAPTM5-deficient macrophages leads to reduced ubiquitination of RIP1 (receptor-interacting protein 1), suggesting a role for LAPTM5 at the receptor-proximate level. Interestingly, we find that macrophages from LAPTM5(-/-) mice display up-regulated levels of A20, a ubiquitin-editing enzyme responsible for deubiquitination of RIP1 and subsequent termination of NF-kappa B activation. Our studies thus indicate that, in contrast to its negative role in T and B cell activation, LAPTM5 acts as a positive modulator of inflammatory signaling pathways and hence cytokine secretion in macrophages. They also highlight a role for the endosomal/lysosomal system in regulating signaling via cytokine and pattern recognition receptors.	[Rotin, Daniela] Hosp Sick Children, TMDT MaRS, Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Glowacka, Wioletta K.; Alberts, Philipp; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada; [Ouchida, Rika; Wang, Ji-Yang] Riken Res Ctr Allergy & Immunol, Lab Immune Divers, Yokohama, Kanagawa 2300045, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; RIKEN	Rotin, D (corresponding author), Hosp Sick Children, TMDT MaRS, Cell Biol Program, 11-305,101 Coll St, Toronto, ON M5G 1L7, Canada.	drotin@sickkids.ca			Canadian Institute of Health Research [MOP-13494]; Ontario Graduate Scholarship; RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships	This work was supported by the Canadian Institute of Health Research Grant MOP-13494 (to D. R.).; Supported by Ontario Graduate Scholarship and by RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brudzewsky D, 2009, SCAND J IMMUNOL, V69, P437, DOI 10.1111/j.1365-3083.2009.02243.x; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Myles MH, 2007, INFLAMM BOWEL DIS, V13, P822, DOI 10.1002/ibd.20138; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Scott LM, 1996, BLOOD, V88, P2517, DOI 10.1182/blood.V88.7.2517.bloodjournal8872517; Seimiya M, 2003, INT J ONCOL, V22, P301; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	36	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27691	27702		10.1074/jbc.M112.355917	http://dx.doi.org/10.1074/jbc.M112.355917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733818	Green Published, hybrid			2022-12-28	WOS:000307840700043
J	Wang, DH; Prakash, J; Nguyen, P; Davis-Dusenbery, BN; Hill, NS; Layne, MD; Hata, A; Lagna, G				Wang, Dahai; Prakash, Jamunabai; Nguyen, Peter; Davis-Dusenbery, Brandi N.; Hill, Nicholas S.; Layne, Matthew D.; Hata, Akiko; Lagna, Giorgio			Bone Morphogenetic Protein Signaling in Vascular Disease ANTI-INFLAMMATORY ACTION THROUGH MYOCARDIN-RELATED TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-ARTERIAL-HYPERTENSION; MUSCLE-CELL PROLIFERATION; FACTOR-KAPPA-B; GROWTH-FACTOR-BETA; SMOOTH-MUSCLE; EXPRESSION; RECEPTOR; INTERLEUKIN-6; FAMILY; SMAD	Pulmonary artery hypertension (PAH) patients exhibit elevated levels of inflammatory cytokines and infiltration of inflammatory cells in the lung. Concurrently, mutations of bmpr2, the gene encoding the type II receptor of bone morphogenetic proteins (BMP), are found in similar to 75% of patients with familial PAH, but a possible nexus between increased inflammation and diminished BMP signaling has hitherto remained elusive. We previously showed that BMP4 triggers nuclear localization of the Myocardin-related transcription factor A (MRTF-A) in human pulmonary artery smooth muscle cells (PASMC), resulting in the induction of contractile proteins. Here we report the BMPR2-dependent repression of a set of inflammatory mediators in response to BMP4 stimulation of PASMC. Forced expression of MRTF-A precisely emulates the anti-inflammatory effect of BMP4, while MRTF-A depletion precludes BMP4-mediated cytokine inhibition. BMP4 and MRTF-A block signaling through NF-kappa B, the keystone of most pathways leading to inflammatory responses, at the level of chromatin recruitment and promoter activation. Moreover, MRTF-A physically interacts with RelA/p65, the NF-kappa B subunit endowed with a transcription activation domain. Interestingly, the MRTF-A-NF-kappa B interaction is mutually antagonistic: stimulation of NF-kappa B signaling by TNF alpha, as well as p65 overexpression, hinders MRTF-A activity and the expression of contractile genes. Thus, a molecular inhibitory pathway linking BMP4 signaling, activation of MRTF-A, and inhibition of NF-kappa B provides insights into the etiology of PAH and a potential focus of therapeutic intervention.	[Wang, Dahai; Prakash, Jamunabai; Nguyen, Peter; Davis-Dusenbery, Brandi N.; Hata, Akiko; Lagna, Giorgio] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Hill, Nicholas S.] Tufts Univ, Sch Med, Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Layne, Matthew D.] Boston Univ, Dept Biochem, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; Boston University	Lagna, G (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, MC 3118,555 Mission Bay Blvd S,Room 252V, San Francisco, CA 94158 USA.	giorgio.lagna@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613; Layne, Matthew/0000-0003-0007-4870	National Institutes of Health [HL086572, HL082854, HL093154, HL078869]; American Heart Association; Molecular Cardiology Research Institute at Tufts University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093154, R01HL078869, R21HL086572, R01HL082854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Molecular Cardiology Research Institute at Tufts University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086572 (to G. L.), HL082854 (to A. H. and G. L.), HL093154 (to A. H.), and HL078869 (to M. D. L.). Further support was provided by the American Heart Association and the Molecular Cardiology Research Institute at Tufts University.	Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Burton DGA, 2010, EXP GERONTOL, V45, P819, DOI 10.1016/j.exger.2010.07.005; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Fartoukh M, 1998, CHEST, V114, p50S, DOI 10.1378/chest.114.1_Supplement.50S; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; Gupta V, 2007, CANCER RES, V67, P2747, DOI 10.1158/0008-5472.CAN-06-2312; Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Preston IR, 2006, AM J PHYSIOL-LUNG C, V290, pL367, DOI 10.1152/ajplung.00114.2005; Pullamsetti SS, 2011, CLIN MICROBIOL INFEC, V17, P7, DOI 10.1111/j.1469-0691.2010.03285.x; Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC; Sawada H, 2007, CHEST, V132, P1265, DOI 10.1378/chest.06-2243; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taraseviciene-Stewart L, 2007, AM J RESP CRIT CARE, V175, P1280, DOI 10.1164/rccm.200608-1189OC; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Toshner M, 2010, BRIT MED BULL, V94, P21, DOI 10.1093/bmb/ldq012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhang Y, 2008, J IMMUNOL, V181, P503, DOI 10.4049/jimmunol.181.1.503	44	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28067	28077		10.1074/jbc.M112.379487	http://dx.doi.org/10.1074/jbc.M112.379487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718766	Green Published, hybrid			2022-12-28	WOS:000307840700080
J	Wirtz, M; Beard, KFM; Lee, CP; Boltz, A; Schwarzlander, M; Fuchs, C; Meyer, AJ; Heeg, C; Sweetlove, LJ; Ratcliffe, RG; Hell, R				Wirtz, Markus; Beard, Katherine F. M.; Lee, Chun Pong; Boltz, Achim; Schwarzlaender, Markus; Fuchs, Christopher; Meyer, Andreas J.; Heeg, Corinna; Sweetlove, Lee J.; Ratcliffe, R. George; Hell, Ruediger			Mitochondrial Cysteine Synthase Complex Regulates O-Acetylserine Biosynthesis in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE GENE FAMILY; SERINE ACETYLTRANSFERASE; KINETIC-PROPERTIES; THIOL LYASE; ARABIDOPSIS; PROTEIN; EXPRESSION; TRANSPORT; O-ACETYLSERINE(THIOL)LYASE; MECHANISM	Cysteine synthesis is catalyzed by serine acetyltransferase (SAT) and O-acetylserine (thiol) lyase (OAS-TL) in the cytosol, plastids, and mitochondria of plants. Biochemical analyses of recombinant plant SAT and OAS-TL indicate that the reversible association of the proteins in the cysteine synthase complex (CSC) controls cellular sulfur homeostasis. However, the relevance of CSC formation in each compartment for flux control of cysteine synthesis remains controversial. Here, we demonstrate the interaction between mitochondrial SAT3 and OAS-TL C in planta by FRET and establish the role of the mitochondrial CSC in the regulation of cysteine synthesis. NMR spectroscopy of isolated mitochondria from WT, serat2;2, and oastl-C plants showed the SAT-dependent export of OAS. The presence of cysteine resulted in reduced OAS export in mitochondria of oastl-C mutants but not in WT mitochondria. This is in agreement with the stronger in vitro feedback inhibition of free SAT by cysteine compared with CSC-bound SAT and explains the high OAS export rate of WT mitochondria in the presence of cysteine. The predominant role of mitochondrial OAS synthesis was validated in planta by feeding [H-3] serine to the WT and loss-of-function mutants for OAS-TLs in the cytosol, plastids, and mitochondria. On the basis of these results, we propose a new model in which the mitochondrial CSC acts as a sensor that regulates the level of SAT activity in response to sulfur supply and cysteine demand.	[Wirtz, Markus; Lee, Chun Pong; Boltz, Achim; Fuchs, Christopher; Meyer, Andreas J.; Heeg, Corinna; Hell, Ruediger] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, D-69120 Heidelberg, Germany; [Beard, Katherine F. M.; Schwarzlaender, Markus; Sweetlove, Lee J.; Ratcliffe, R. George] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Ruprecht Karls University Heidelberg; University of Oxford	Hell, R (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	ruediger.hell@cos.uni-heidelberg.de	Wirtz, Markus/G-5917-2010; Schwarzländer, Markus/HGE-3726-2022; Lee, Alex/AAZ-8602-2020; Lee, Chun Pong/G-6021-2010; Meyer, Andreas J/C-4734-2013; Hell, Ruediger/E-5436-2014; Lee, Chun Pong/AAZ-8558-2020	Wirtz, Markus/0000-0001-7790-4022; Lee, Alex/0000-0002-8760-5779; Meyer, Andreas J/0000-0001-8144-4364; Lee, Chun Pong/0000-0002-8760-5779; Hell, Ruediger/0000-0002-6238-4818; Schwarzlander, Markus/0000-0003-0796-8308; Ratcliffe, R. George/0000-0001-8394-1575; Doerner, Achim/0000-0002-4741-8039	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines); Schmeil-Stiftung (Heidelberg); Deutsche Forschungsgemeinschaft [He 1848/5-2, He 1848/13-1]; UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom); New College Oxford Weston junior research fellowship	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines); Schmeil-Stiftung (Heidelberg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom); New College Oxford Weston junior research fellowship	This work was supported by the Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines), the Schmeil-Stiftung (Heidelberg), and Deutsche Forschungsgemeinschaft Grants He 1848/5-2 and He 1848/13-1) (to C.H.); a UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom) (to K.F.M.B.); and a New College Oxford Weston junior research fellowship (to M.S.).	Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Birke H, 2012, BIOCHEM J, V445, P275, DOI 10.1042/BJ20120038; CAVALIERI AJ, 1980, PLANT PHYSIOL, V66, P588, DOI 10.1104/pp.66.4.588; CYBULSKI RL, 1977, BIOCHEMISTRY-US, V16, P5116, DOI 10.1021/bi00642a026; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; FOX GG, 1989, J MAGN RESON, V82, P360, DOI 10.1016/0022-2364(89)90039-5; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Hell Rudiger, 2011, Arabidopsis Book, V9, pe0154, DOI 10.1199/tab.0154; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Khan MS, 2010, PLANT CELL, V22, P1216, DOI 10.1105/tpc.110.074088; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Morgan MJ, 2008, PLANT PHYSIOL, V147, P101, DOI 10.1104/pp.107.113613; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; Saito K, 2000, CURR OPIN PLANT BIOL, V3, P188, DOI 10.1016/S1369-5266(00)00063-7; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; Smith A. M., 2004, THESIS U OXFORD; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; Wirtz M, 2010, AMINO ACIDS, V39, P1077, DOI 10.1007/s00726-010-0694-0	35	50	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27941	27947		10.1074/jbc.M112.372656	http://dx.doi.org/10.1074/jbc.M112.372656			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730323	Green Published, hybrid			2022-12-28	WOS:000307840700068
J	Morfouace, M; Lalier, L; Bahut, M; Bonnamain, V; Naveilhan, P; Guette, C; Oliver, L; Gueguen, N; Reynier, P; Vallette, FM				Morfouace, Marie; Lalier, Lisenn; Bahut, Muriel; Bonnamain, Virginie; Naveilhan, Philippe; Guette, Catherine; Oliver, Lisa; Gueguen, Naig; Reynier, Pascal; Vallette, Francois M.			Comparison of Spheroids Formed by Rat Glioma Stem Cells and Neural Stem Cells Reveals Differences in Glucose Metabolism and Promising Therapeutic Applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL MUTATIONS; MALIGNANT GLIOMA; CANCER; GROWTH; DICHLOROACETATE; RESISTANCE; APOPTOSIS; BAX; P53; PHOSPHORYLATION	Cancer stem cells (CSCs) are thought to be partially responsible for cancer resistance to current therapies and tumor recurrence. Dichloroacetate (DCA), a compound capable of shifting metabolism from glycolysis to glucose oxidation, via an inhibition of pyruvate dehydrogenase kinase was used. We show that DCA is able to shift the pyruvate metabolism in rat glioma CSCs but has no effect in rat neural stem cells. DCA forces CSCs into oxidative phosphorylation but does not trigger the production of reactive oxygen species and consecutive anti-cancer apoptosis. However, DCA, associated with etoposide or irradiation, induced a Bax-dependent apoptosis in CSCs in vitro and decreased their proliferation in vivo. The former phenomenon is related to DCA-induced Foxo3 and p53 expression, resulting in the overexpression of BH3-only proteins (Bad, Noxa, and Puma), which in turn facilitates Bax-dependent apoptosis. Our results demonstrate that a small drug available for clinical studies potentiates the induction of apoptosis in glioma CSCs.	[Morfouace, Marie; Lalier, Lisenn; Guette, Catherine; Oliver, Lisa; Vallette, Francois M.] Ctr Rech Cancerol Nantes Angers, UMR INSERM 892, CNRS 6299, F-44000 Nantes, France; [Morfouace, Marie; Lalier, Lisenn; Bonnamain, Virginie; Naveilhan, Philippe; Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Fac Med, F-44000 Nantes, France; [Lalier, Lisenn; Guette, Catherine; Vallette, Francois M.] Inst Cancerol Ouest, F-44035 St Herblain, France; [Bahut, Muriel] Univ Angers, F-49100 Angers, France; [Bonnamain, Virginie; Naveilhan, Philippe] ITUN, Inst Transplantat & Rech Transplantat, UMR INSERM 643, F-44000 Nantes, France; [Gueguen, Naig; Reynier, Pascal] Univ Angers, INSERM 771, UMR CNRS 6214, F-49000 Angers, France; [Gueguen, Naig; Reynier, Pascal] CHU Angers, Dept Biochim & Genet, F-49000 Angers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Vallette, FM (corresponding author), Univ Nantes, CRCNA, CNRS 6299, UMR INSERM 892, 8 Quai Moncousu, F-44007 Nantes 1, France.	francois.vallette@inserm.fr	Naveilhan, Philippe/K-2377-2015; Oliver, Lisa J/L-3070-2015; Vallette, Francois M/K-9047-2015; Lalier, Lisenn/K-9230-2015; Guette, Catherine/L-2519-2015; Reynier, Pascal/K-3677-2015; Vallette, Francois/N-2361-2018; Morfouace, Marie/AAB-3916-2021	Naveilhan, Philippe/0000-0003-4093-4513; Oliver, Lisa J/0000-0002-5588-7564; Vallette, Francois M/0000-0002-3296-8572; Guette, Catherine/0000-0003-1779-9931; Vallette, Francois/0000-0003-0802-0519	INSERM; Canceropole Grand Ouest; Ligue Nationale contre le Cancer (Programme Equipe Labelisee)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Canceropole Grand Ouest; Ligue Nationale contre le Cancer (Programme Equipe Labelisee)	This work was supported in part by grants from INSERM, Canceropole Grand Ouest, and a special grant from the Ligue Nationale contre le Cancer (Programme Equipe Labelisee).	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cartron P. F., 2012, EUR J CANC IN PRESS; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Das AV, 2004, DEV BIOL, V273, P87, DOI 10.1016/j.ydbio.2004.05.023; Desquiret-Dumas V, 2012, BBA-MOL BASIS DIS, V1822, P1019, DOI 10.1016/j.bbadis.2012.01.010; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hervouet E, 2009, CLIN CANCER RES, V15, P3519, DOI 10.1158/1078-0432.CCR-08-2062; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Pouliquen D, 2008, INT J CANCER, V123, P288, DOI 10.1002/ijc.23513; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Srivastava VK, 2008, CYTOM PART A, V73A, P940, DOI 10.1002/cyto.a.20633; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Turner DA, 2011, J NEUROPATH EXP NEUR, V70, P167, DOI 10.1097/NEN.0b013e31820e1152; Vella S, 2012, INT J CANCER, V130, P1484, DOI 10.1002/ijc.26173; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie J, 2011, INT J ONCOL, V38, P409, DOI 10.3892/ijo.2010.851; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	47	47	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33664	33674		10.1074/jbc.M111.320028	http://dx.doi.org/10.1074/jbc.M111.320028			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22782899	Green Published, hybrid			2022-12-28	WOS:000309602100050
J	Chavan, H; Krishnamurthy, P				Chavan, Hemantkumar; Krishnamurthy, Partha			Polycyclic Aromatic Hydrocarbons (PAHs) Mediate Transcriptional Activation of the ATP Binding Cassette Transporter ABCB6 Gene via the Aryl Hydrocarbon Receptor (AhR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; DELTA-AMINOLEVULINATE SYNTHASE; PREGNANE-X RECEPTOR; NUCLEAR RECEPTORS; HEPATOCELLULAR-CARCINOMA; HEME-BIOSYNTHESIS; CELL-SURVIVAL; EXPRESSION; INDUCTION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	Liver is endowed with a mechanism to induce hepatic cytochromes P450 (CYP450s) in response to therapeutic drugs and environmental contaminants, leading to increased detoxification and elimination of the xenobiotics. Each CYP450 is composed of an apoprotein moiety and a heme prosthetic group, which is required for CYP450 activity. Thus, under conditions of CYP450 induction, there is a coordinate increase in heme biosynthesis to compensate for the increased expression of CYP450s. ABCB6, a mitochondrial ATP binding cassette transporter, which regulates coproporphyrinogen transport from the cytoplasm into the mitochondria to complete heme biosynthesis, represents a previously unrecognized rate-limiting step in heme biosynthesis. However, it is not known if exposure to drugs and environmental contaminants induces ABCB6 expression, to assure an adequate and apparently coordinated supply of heme for the generation of functional cytochrome holoprotein. In the present study, we demonstrate that polycyclic aromatic hydrocarbons (PAHs), the widely distributed environmental toxicants shown to induce porphyrin accumulation causing hepatic porphyria, up-regulate ABCB6 expression in both mice and humans. Using siRNA technology and Abcb6 knock-out mice, we demonstrate that PAH-mediated increase in hepatic porphyrins is compromised in the absence of ABCB6. Moreover, in vivo studies in aryl hydrocarbon receptor (AhR) knock-out mice demonstrate that PAH induction of ABCB6 is mediated by AhR. Promoter activation studies combined with electrophoretic mobility shift assay and chromatin immunoprecipitation assay demonstrate direct interactions between the AhR binding sites in the ABCB6 promoter and the AhR receptor, implicating drug activation mechanisms for ABCB6 similar to those found in inducible cytochrome P450s. These studies are the first to describe direct transcriptional activation of both mouse and human ABCB6 by xenobiotics.	[Chavan, Hemantkumar; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Krishnamurthy, P (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pkasturi@kumc.edu	Chavan, Hemantkumar/AAN-6756-2020; Chavan, Hemant/ABA-4925-2021	Chavan, Hemantkumar/0000-0002-9963-6230; 	National Institutes of Health [P20RR021940, T32ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR021940 and T32ES007079.	AFT RL, 1984, J BIOL CHEM, V259, P301; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bian K, 2003, P NATL ACAD SCI USA, V100, P5712, DOI 10.1073/pnas.0931291100; Boffetta P, 2011, CRIT REV TOXICOL, V41, P622, DOI 10.3109/10408444.2011.560141; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; CANTONI L, 1987, ANN NY ACAD SCI, V514, P128; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Davies R, 2008, CHEM RES TOXICOL, V21, P330, DOI 10.1021/tx700176r; Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008; Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200; Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200; Giles AS, 1996, CARCINOGENESIS, V17, P1331, DOI 10.1093/carcin/17.6.1331; GRANICK S, 1975, J BIOL CHEM, V250, P9215; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Jover R, 1996, BIOCHEM BIOPH RES CO, V226, P152, DOI 10.1006/bbrc.1996.1325; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; LABBEBOIS R, 1980, BIOCHEM BIOPH RES CO, V95, P1357, DOI 10.1016/0006-291X(80)91623-X; LAMBRECHT RW, 1988, TOXICOL APPL PHARM, V96, P507, DOI 10.1016/0041-008X(88)90010-5; Lin T, 2008, TOXICOLOGY, V245, P147, DOI 10.1016/j.tox.2007.12.020; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; MAINES MD, 1975, J BIOL CHEM, V250, P2363; MALKINSON AM, 1983, ENVIRON MUTAGEN, V5, P353, DOI 10.1002/em.2860050313; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MUNAKATA H, 1993, J BIOCHEM, V114, P103, DOI 10.1093/oxfordjournals.jbchem.a124123; NEBERT DW, 1989, INT J BIOCHEM, V21, P243, DOI 10.1016/0020-711X(89)90182-1; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Oya E, 2011, MUTAGENESIS, V26, P697, DOI 10.1093/mutage/ger035; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Safe S, 1995, Arch Toxicol Suppl, V17, P99; Salas VM, 1998, TOXICOL APPL PHARM, V151, P367, DOI 10.1006/taap.1998.8455; Sassa S, 2002, PHOTODERMATOL PHOTO, V18, P56, DOI 10.1034/j.1600-0781.2002.180202.x; Sassa S, 1996, INT J HEMATOL, V63, P167; Sassa S, 2000, INT J HEMATOL, V71, P1; Sassa S, 2000, J INTERN MED, V247, P169, DOI 10.1046/j.1365-2796.2000.00618.x; SCHOENHAUT DS, 1986, GENE, V48, P55, DOI 10.1016/0378-1119(86)90351-3; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Tan KP, 2010, MOL PHARMACOL, V78, P175, DOI 10.1124/mol.110.065078; Tompkins LM, 2010, BIOCHEM PHARMACOL, V80, P1754, DOI 10.1016/j.bcp.2010.08.016; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Uribe-Hernandez R, 2008, ENVIRON TOXICOL PHAR, V26, P237, DOI 10.1016/j.etap.2008.05.002; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	57	20	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32054	32068		10.1074/jbc.M112.371476	http://dx.doi.org/10.1074/jbc.M112.371476			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22761424	hybrid, Green Published			2022-12-28	WOS:000309059400043
J	Hilge, M				Hilge, Mark			Ca2+ Regulation of Ion Transport in the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGER; MOLECULAR DETERMINANTS; CA2+-BINDING DOMAIN; DYNAMIC PROPERTIES; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; SPLICE VARIANTS; BINDING DOMAINS; STEADY-STATE	The binding of Ca2+ to two adjacent Ca2+-binding domains, CBD1 and CBD2, regulates ion transport in the Na+/Ca2+ exchanger. As sensors for intracellular Ca2+, the CBDs form electrostatic switches that induce the conformational changes required to initiate and sustain Na+/Ca2+ exchange. Depending on the presence of a few key residues in the Ca2+-binding sites, zero to four Ca2+ ions can bind with affinities between 0.1 to 20 mu M. Importantly, variability in CBD2 as a consequence of alternative splicing modulates not only the number and affinities of the Ca2+-binding sites in CBD2 but also the Ca2+ affinities in CBD1.	Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland	University of Basel	Hilge, M (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.	mark.hilge@unibas.ch			Swiss National Science Foundation (National Centres of Competence for Research (NCCRs) Structural Biology and TransCure); Swiss Initiative for Systems Biology (SystemsX.ch); EPSRC [EP/D032210/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D032210/1] Funding Source: researchfish	Swiss National Science Foundation (National Centres of Competence for Research (NCCRs) Structural Biology and TransCure); Swiss Initiative for Systems Biology (SystemsX.ch); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from the Swiss National Science Foundation (National Centres of Competence for Research (NCCRs) Structural Biology and TransCure) and the Swiss Initiative for Systems Biology (SystemsX.ch). This article is part of the Thematic Minireview Series on Ins and Outs of Calcium Transport.	Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001; BAKER PF, 1968, BIOCHIM BIOPHYS ACTA, V150, P167, DOI 10.1016/0005-2736(68)90023-0; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Brini M, 2011, COLD SPRING HARB PER, V3, P2, DOI DOI 10.1101/CSHPERSPECT.A004168; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; DIPOLO R, 1979, J GEN PHYSIOL, V73, P91, DOI 10.1085/jgp.73.1.91; DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481; Doering AE, 1996, ANN NY ACAD SCI, V779, P182, DOI 10.1111/j.1749-6632.1996.tb44786.x; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; FernandezBusquets X, 1996, J BIOL CHEM, V271, P23558, DOI 10.1074/jbc.271.38.23558; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; He ZP, 2000, AM J PHYSIOL-CELL PH, V278, pC661, DOI 10.1152/ajpcell.2000.278.4.C661; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2007, ANN NY ACAD SCI, V1099, P7, DOI 10.1196/annals.1387.030; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Hurtado C, 2006, AM J PHYSIOL-HEART C, V290, pH2155, DOI 10.1152/ajpheart.00958.2005; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto T, 2004, MOL CELL BIOCHEM, V259, P157, DOI 10.1023/B:MCBI.0000021367.42752.54; Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; Lee C, 2005, CAN J CARDIOL, V21, P509; LEE SL, 1994, J BIOL CHEM, V269, P14849; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; LI ZP, 1991, J BIOL CHEM, V266, P1014; LI ZP, 1994, J BIOL CHEM, V269, P17434; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	79	25	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31641	31649		10.1074/jbc.R112.353573	http://dx.doi.org/10.1074/jbc.R112.353573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822067	Green Published, hybrid			2022-12-28	WOS:000309059400005
J	Monteith, GR; Davis, FM; Roberts-Thomson, SJ				Monteith, Gregory R.; Davis, Felicity M.; Roberts-Thomson, Sarah J.			Calcium Channels and Pumps in Cancer: Changes and Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SQUAMOUS-CELL TUMORS; RECEPTOR POTENTIAL VANILLOID-1; PLASMA-MEMBRANE; PROSTATE-CANCER; ION CHANNELS; ENDOPLASMIC-RETICULUM; COLON-CANCER; MITOCHONDRIAL CALCIUM; EPITHELIAL-CELLS; DOWN-REGULATION	Increases in intracellular free Ca2+ play a major role in many cellular processes. The deregulation of Ca2+ signaling is a feature of a variety of diseases, and modulators of Ca2+ signaling are used to treat conditions as diverse as hypertension to pain. The Ca2+ signal also plays a role in processes important in cancer, such as proliferation and migration. Many studies in cancer have identified alterations in the expression of proteins involved in the movement of Ca2+ across the plasma membrane and subcellular organelles. In some cases, these Ca2+ channels or pumps are potential therapeutic targets for specific cancer subtypes or correlate with prognosis.	[Monteith, Gregory R.; Davis, Felicity M.; Roberts-Thomson, Sarah J.] Univ Queensland, Sch Pharm, Brisbane, Qld 4075, Australia	University of Queensland	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4075, Australia.	gregm@uq.edu.au	Monteith, Gregory/B-1626-2008; Davis, Felicity M/P-1387-2016; Roberts-Thomson, Sarah/W-5676-2019; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Davis, Felicity M/0000-0001-9112-118X; Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786	National Health and Medical Research Council [631347, 569645]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Grants 631347 and 569645. This article is part of the Thematic Minireview Series on Calcium Function and Disease.	Anantamongkol U, 2007, BIOCHEM BIOPH RES CO, V352, P537, DOI 10.1016/j.bbrc.2006.11.055; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DeWald DB, 2005, CANCER RES, V65, P713; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Gao HX, 2011, CELL CALCIUM, V50, P559, DOI 10.1016/j.ceca.2011.09.003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gelebart P, 2002, J BIOL CHEM, V277, P26310, DOI 10.1074/jbc.M201747200; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henshall SM, 2003, CANCER RES, V63, P4196; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalogris C, 2010, HISTOPATHOLOGY, V57, P744, DOI 10.1111/j.1365-2559.2010.03683.x; Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V337, P779, DOI 10.1016/j.bbrc.2005.09.119; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Liu LH, 2001, J BIOL CHEM, V276, P26737, DOI 10.1074/jbc.C100275200; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Murata T, 2011, CANCER RES, V71, P6633, DOI 10.1158/0008-5472.CAN-11-0034; Natrajan R, 2006, CLIN CANCER RES, V12, P7284, DOI 10.1158/1078-0432.CCR-06-1567; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Papp B, 2011, BREAST CANCER-BASIC, V5, P163, DOI 10.4137/BCBCR.S7481; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Pla AF, 2012, AM J PHYSIOL-CELL PH, V302, pC9, DOI 10.1152/ajpcell.00280.2011; Prasad V, 2005, CANCER RES, V65, P8655, DOI 10.1158/0008-5472.CAN-05-0026; Prevarskaya N, 2007, CELL DEATH DIFFER, V14, P1295, DOI 10.1038/sj.cdd.4402162; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Ribiczey P, 2007, CELL CALCIUM, V42, P590, DOI 10.1016/j.ceca.2007.02.003; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; Rybarczyk P, 2012, INT J CANCER, V131, pE851, DOI 10.1002/ijc.27487; Schmidt U, 2006, PROSTATE, V66, P1521, DOI 10.1002/pros.20490; Shi Y, 2009, GUT, V58, P1443, DOI 10.1136/gut.2009.181735; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Tsavaler L, 2001, CANCER RES, V61, P3760; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; VanHouten J, 2010, P NATL ACAD SCI USA, V107, P11405, DOI 10.1073/pnas.0911186107; Wanajo A, 2008, GASTROENTEROLOGY, V135, P580, DOI 10.1053/j.gastro.2008.05.041; Wang XT, 2000, AM J PATHOL, V157, P1549, DOI 10.1016/S0002-9440(10)64792-X; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Wissenbach U., 2007, V179, P221; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yee NS, 2010, CANCER LETT, V297, P49, DOI 10.1016/j.canlet.2010.04.023; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	100	262	265	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31666	31673		10.1074/jbc.R112.343061	http://dx.doi.org/10.1074/jbc.R112.343061			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822055	hybrid, Green Published			2022-12-28	WOS:000309059400008
J	Popovic, A; Wu, B; Arrowsmith, CH; Edwards, AM; Davidson, AR; Maxwell, KL				Popovic, Ana; Wu, Bin; Arrowsmith, Cheryl H.; Edwards, Aled M.; Davidson, Alan R.; Maxwell, Karen L.			Structural and Biochemical Characterization of Phage lambda FI Protein (gpFI) Reveals a Novel Mechanism of DNA Packaging Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDIMENSIONAL NMR METHODS; BACTERIOPHAGE-LAMBDA; HEAD MORPHOGENESIS; BACILLUS-SUBTILIS; GENE-PRODUCT; DOMAINS; INVITRO; SYSTEM; GENOME; IDENTIFICATION	One of the final steps in the morphogenetic pathway of phage lambda is the packaging of a single genome into a preformed empty head structure. In addition to the terminase enzyme, the packaging chaperone, FI protein (gpFI), is required for efficient DNA packaging. In this study, we demonstrate an interaction between gpFI and the major head protein, gpE. Amino acid substitutions in gpFI that reduced the strength of this interaction also decreased the biological activity of gpFI, implying that this head binding activity is essential for the function of gpFI. We also show that gpFI is a two-domain protein, and the C-terminal domain is responsible for the head binding activity. Using nuclear magnetic resonance spectroscopy, we determined the three-dimensional structure of the C-terminal domain and characterized the helical nature of the N-terminal domain. Through structural comparisons, we were able to identify two previously unannotated prophage-encoded proteins with tertiary structures similar to gpFI, although they lack significant pairwise sequence identity. Sequence analysis of these diverse homologues led us to identify related proteins in a variety of myo- and siphophages, revealing that gpFI function has a more highly conserved role in phage morphogenesis than was previously appreciated. Finally, we present a novel model for the mechanism of gpFI chaperone activity in the DNA packaging reaction of phage lambda.	[Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Popovic, Ana; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Edwards, Aled M.; Davidson, Alan R.; Maxwell, Karen L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wu, Bin; Arrowsmith, Cheryl H.; Edwards, Aled M.] Ontario Canc Inst, Div Canc Genom & Prote, Toronto, ON M5G 2M9, Canada; [Wu, Bin; Arrowsmith, Cheryl H.] Univ Toronto, Dept Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Maxwell, KL (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St,Rm 508, Toronto, ON M5S 3E1, Canada.	karen.maxwell@utoronto.ca	Popovic, Ana/AAF-8508-2021	Popovic, Ana/0000-0003-0137-7400; Edwards, Aled/0000-0002-4782-6016; Maxwell, Karen/0000-0002-0211-5480; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research [MOP-6279, MOP-77680]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Quebec Ministere de la Recherche en Science et Technologie; McGill University	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Quebec Ministere de la Recherche en Science et Technologie; McGill University	This work was supported in part by Canadian Institutes for Health Research Operating Grants MOP-6279 (to K. L. M. and A. M. E.) and MOP-77680 (to A. R. D.) and by the Natural Sciences and Engineering Research Council of Canada (to C. H. A.).; We thank Diane Bona for technical assistance, Mike Feiss for the gift of the gpFI antibody, Gabe Lander for providing the coordinates of Protein Data Bank code 3BQW modeled into the lambda prohead cryoelectron density, Jonathan Lukin and Tara Sprules for NMR data collection, and Paul Sadowski and Lisa Pell for critical reading of the manuscript. NMR experiments were recorded at the Quebec/Eastern Canada High Field NMR Facility, supported by grants from the Canada Foundation for Innovation, the Quebec Ministere de la Recherche en Science et Technologie, and McGill University.	BECKER A, 1977, VIROLOGY, V78, P291, DOI 10.1016/0042-6822(77)90100-3; BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; BECKER A, 1988, J MOL BIOL, V199, P597, DOI 10.1016/0022-2836(88)90304-X; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; CATALANO CE, 1995, BIOCHEMISTRY-US, V34, P10036, DOI 10.1021/bi00031a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIDSON A, 1987, VIROLOGY, V161, P305, DOI 10.1016/0042-6822(87)90122-X; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; FEISS M, 1988, VIROLOGY, V167, P323, DOI 10.1016/0042-6822(88)90090-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fraser JS, 2006, J MOL BIOL, V359, P496, DOI 10.1016/j.jmb.2006.03.043; Goddard D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOHN B, 1975, J MOL BIOL, V98, P93, DOI 10.1016/S0022-2836(75)80103-3; HOHN T, 1975, J MOL BIOL, V98, P107, DOI 10.1016/S0022-2836(75)80104-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HWANG Y, 1995, VIROLOGY, V211, P367, DOI 10.1006/viro.1995.1419; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KATSURA I, 1986, J MOL BIOL, V190, P577, DOI 10.1016/0022-2836(86)90243-3; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kilcher S, 2010, J BACTERIOL, V192, P5441, DOI 10.1128/JB.00709-10; Krogh S, 1996, MICROBIOL-UK, V142, P2031, DOI 10.1099/13500872-142-8-2031; Kumaraswami M, 2011, J BIOL CHEM, V286, P35852, DOI 10.1074/jbc.M111.269860; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; MURIALDO H, 1991, ANNU REV BIOCHEM, V60, P125; MURIALDO H, 1978, MICROBIOL REV, V42, P529, DOI 10.1128/MMBR.42.3.529-576.1978; Murialdo H, 1997, MOL MICROBIOL, V24, P341, DOI 10.1046/j.1365-2958.1997.3321698.x; MURIALDO H, 1981, J MOL BIOL, V145, P375, DOI 10.1016/0022-2836(81)90211-4; Murialdo H, 1997, MOL MICROBIOL, V24, P937, DOI 10.1046/j.1365-2958.1997.4011769.x; MURIALDO H, 1972, VIROLOGY, V48, P785, DOI 10.1016/0042-6822(72)90162-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OKAMOTO K, 1968, J MOL BIOL, V34, P429, DOI 10.1016/0022-2836(68)90170-8; OKAMOTO K, 1968, J MOL BIOL, V34, P413, DOI 10.1016/0022-2836(68)90169-1; Rajagopala SV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-213; RAY P, 1975, VIROLOGY, V64, P247, DOI 10.1016/0042-6822(75)90096-3; Sippy J, 2004, MOL MICROBIOL, V52, P501, DOI 10.1111/j.1365-2958.2004.03990.x; STEENSMA HY, 1978, A VAN LEEUW J MICROB, V44, P353, DOI 10.1007/BF00394312; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; WITKIEWICZ H, 1986, BIOSCIENCE REP, V6, P103, DOI 10.1007/BF01145185; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zimmer M, 2003, MOL MICROBIOL, V50, P303, DOI 10.1046/j.1365-2958.2003.03684.x	44	6	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32085	32095		10.1074/jbc.M112.378349	http://dx.doi.org/10.1074/jbc.M112.378349			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22801427	hybrid, Green Published			2022-12-28	WOS:000309059400046
J	Buggele, WA; Johnson, KE; Horvath, CM				Buggele, William A.; Johnson, Karen E.; Horvath, Curt M.			Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; POSTTRANSCRIPTIONAL REGULATION; CELLULAR MICRORNAS; MESSENGER-RNAS; ANTIVIRAL IMMUNITY; SIGNALING PROTEINS; INNATE IMMUNITY; DEADENYLATION; REPLICATION; RECOGNITION	The cellular response to virus infection is initiated by recognition of the invading pathogen and subsequent changes in gene expression mediated by both transcriptional and translational mechanisms. In addition to well established means of regulating antiviral gene expression, it has been demonstrated that RNA interference (RNAi) can play an important role in antiviral responses. Virus-derived small interfering RNA (siRNA) is a primary antiviral response exploited by plants and invertebrate animals, and host-encoded microRNA (miRNA) species have been clearly implicated in the regulation of innate and adaptive immune responses in mammals and other vertebrates. Examination of miRNA abundance in human lung cell lines revealed endogenous miRNAs, including miR-7, miR-132, miR-146a, miR-187, miR-200c, and miR-1275, to specifically accumulate in response to infection with two influenza A virus strains, A/Udorn/72 and A/WSN/33. Known antiviral response pathways, including Toll-like receptor, RIG-I-like receptor, and direct interferon or cytokine stimulation did not alter the abundance of the tested miRNAs to the extent of influenza A virus infection, which initiates primary miRNA transcription via a secondary response pathway. Gene expression profiling identified 26 cellular mRNAs targeted by these miRNAs, including IRAK1, MAPK3, and other components of innate immune signaling systems.	[Buggele, William A.; Johnson, Karen E.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Horvath, CM (corresponding author), Northwestern Univ, Dept Mol Biosci, Pancoe Pavil,Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	National Institutes of Health from the NIAID IMVC program [U01AI082984]; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant [T32 GM008061]; Robert H. Lurie Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID IMVC program; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert H. Lurie Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01AI082984 from the NIAID IMVC program.; Supported by a predoctoral fellowship from the National Institutes of Health Cellular and Molecular Basis of Disease Training Grant T32 GM008061 and a Malkin Scholar award from the Robert H. Lurie Comprehensive Cancer Center.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-512; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com	52	91	96	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31027	31040		10.1074/jbc.M112.387670	http://dx.doi.org/10.1074/jbc.M112.387670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822053	Green Published, hybrid			2022-12-28	WOS:000308791300016
J	Marino, ML; Pellegrini, P; Di Lernia, G; Djavaheri-Mergny, M; Brnjic, S; Zhang, XN; Hagg, M; Linder, S; Fais, S; Codogno, P; De Milito, A				Marino, Maria Lucia; Pellegrini, Paola; Di Lernia, Giuseppe; Djavaheri-Mergny, Mojgan; Brnjic, Slavica; Zhang, Xiaonan; Hagg, Maria; Linder, Stig; Fais, Stefano; Codogno, Patrice; De Milito, Angelo			Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR-PH; TUMOR HYPOXIA; MAMMALIAN TARGET; CULTURED-CELLS; CANCER-CELLS; TUMORIGENESIS; INHIBITION; GROWTH; METABOLISM; SURVIVAL	Cyclic hypoxia and alterations in oncogenic signaling contribute to switch cancer cell metabolism from oxidative phosphorylation to aerobic glycolysis. A major consequence of up-regulated glycolysis is the increased production of metabolic acids responsible for the presence of acidic areas within solid tumors. Tumor acidosis is an important determinant of tumor progression and tumor pH regulation is being investigated as a therapeutic target. Autophagy is a cellular catabolic pathway leading to lysosomal degradation and recycling of proteins and organelles, currently considered an important survival mechanism in cancer cells under metabolic stress or subjected to chemotherapy. We investigated the response of human melanoma cells cultured in acidic conditions in terms of survival and autophagy regulation. Melanoma cells exposed to acidic culture conditions (7.0 < pH < 6.2) promptly accumulated LC3+ autophagic vesicles. Immunoblot analysis showed a consistent increase of LC3-II in acidic culture conditions as compared with cells at normal pH. Inhibition of lysosomal acidification by bafilomycin A1 further increased LC3-II accumulation, suggesting an active autophagic flux in cells under acidic stress. Acute exposure to acidic stress induced rapid inhibition of the mammalian target of rapamycin signaling pathway detected by decreased phosphorylation of p70S6K and increased phosphorylation of AMP-activated protein kinase, associated with decreased ATP content and reduced glucose and leucine uptake. Inhibition of autophagy by knockdown of the autophagic gene ATG5 consistently reduced melanoma cell survival in low pH conditions. These observations indicate that induction of autophagy may represent an adaptation mechanism for cancer cells exposed to an acidic environment. Our data strengthen the validity of therapeutic strategies targeting tumor pH regulation and autophagy in progressive malignancies.	[Pellegrini, Paola; Di Lernia, Giuseppe; Brnjic, Slavica; Zhang, Xiaonan; Hagg, Maria; Linder, Stig; De Milito, Angelo] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Marino, Maria Lucia; Fais, Stefano; De Milito, Angelo] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Unit Antitumor Drugs, I-00161 Rome, Italy; [Djavaheri-Mergny, Mojgan] VINCO Inst Bergonie, INSERM, U916, F-33076 Bordeaux, France; [Codogno, Patrice] Univ Paris 11, INSERM, U984, F-92296 Chatenay Malabry, France	Karolinska Institutet; Istituto Superiore di Sanita (ISS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	De Milito, A (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm, Sweden.	angelo.de-milito@ki.se	Codogno, Patrice/G-1384-2013; Djavaheri-Mergny, Mojgan/L-3890-2019; Djavaheri-Mergny, Mojgan/N-6315-2017; Fais, Stefano/J-8638-2016	Codogno, Patrice/0000-0002-5492-3180; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Djavaheri-Mergny, Mojgan/0000-0003-4893-6505; Fais, Stefano/0000-0001-9060-2766; De Milito, Angelo/0000-0003-2591-2914	Italian Association for Cancer Research Grant [5940]; Association for International Cancer Research Grant [11-0522]; Alex and Eva Wallstroms Foundation; Sigurd and Elsa Goljes Foundation; Axel Donation Fondation; Signe Lagermans Donation Fondation; INSERM; University Paris-Sud 11	Italian Association for Cancer Research Grant(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research Grant; Alex and Eva Wallstroms Foundation; Sigurd and Elsa Goljes Foundation; Axel Donation Fondation; Signe Lagermans Donation Fondation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud 11	This work was supported by Italian Association for Cancer Research Grant 5940, Association for International Cancer Research Grant 11-0522, the Alex and Eva Wallstroms Foundation, the Sigurd and Elsa Goljes Foundation, the Axel and Signe Lagermans Donation Fondations, and grants from INSERM and the University Paris-Sud 11 (to P. C.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Espina V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010240; Fais S, 2010, J INTERN MED, V267, P515, DOI 10.1111/j.1365-2796.2010.02225.x; Fais S, 2010, LEUKEMIA RES, V34, P843, DOI 10.1016/j.leukres.2010.02.006; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giammarioli AM, 2012, INT J CANCER, V131, pE337, DOI 10.1002/ijc.26420; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Grant RL, 1997, IN VITRO CELL DEV-AN, V33, P256; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Harguindey S, 2009, ANTICANCER RES, V29, P2127; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Huber V, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-57; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; KAMINSKAS E, 1978, BIOCHEM J, V174, P453, DOI 10.1042/bj1740453; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Koukourakis MI, 2010, BRIT J CANCER, V103, P1209, DOI 10.1038/sj.bjc.6605904; Lazova R, 2012, CLIN CANCER RES, V18, P370, DOI 10.1158/1078-0432.CCR-11-1282; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; MORITA T, 1992, MUTAT RES, V268, P297, DOI 10.1016/0027-5107(92)90235-T; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; NEWELL KJ, 1989, CANCER RES, V49, P4477; Orive G, 2003, BRIT J CANCER, V89, P1395, DOI 10.1038/sj.bjc.6601286; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Reichert M, 2002, CANCER, V95, P1113, DOI 10.1002/cncr.10767; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; ROTIN D, 1986, CANCER RES, V46, P2821; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Sivridis E, 2011, MELANOMA RES, V21, P188, DOI 10.1097/CMR.0b013e328346612c; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Suk J, 2011, J CELL BIOCHEM, V112, P2566, DOI 10.1002/jcb.23181; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TANNOCK IF, 1989, CANCER RES, V49, P4373; Wahl ML, 2002, MOL CANCER THER, V1, P617; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Williams AC, 1999, ONCOGENE, V18, P3199, DOI 10.1038/sj.onc.1202660; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Xu T, 2011, AUTOPHAGY, V7, P1316, DOI 10.4161/auto.7.11.17785; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	80	132	137	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30664	30676		10.1074/jbc.M112.339127	http://dx.doi.org/10.1074/jbc.M112.339127			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22761435	Green Published, hybrid			2022-12-28	WOS:000308579800056
J	Gawlowski, T; Suarez, J; Scott, B; Torres-Gonzalez, M; Wang, H; Schwappacher, R; Han, XM; Yates, JR; Hoshijima, M; Dillmann, W				Gawlowski, Thomas; Suarez, Jorge; Scott, Brian; Torres-Gonzalez, Moises; Wang, Hong; Schwappacher, Raphaela; Han, Xuemei; Yates, John R., III; Hoshijima, Masahiko; Dillmann, Wolfgang			Modulation of Dynamin-related Protein 1 (DRP1) Function by Increased O-linked-beta-N-acetylglucosamine Modification (O-GlcNAc) in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES MITOCHONDRIAL FISSION; MAMMALIAN-CELLS; MASS-SPECTROMETRY; CROSS-TALK; PHOSPHORYLATION; GLCNACYLATION; MORPHOLOGY; GLUCOSE; KINASE; FUSION	O-linked-N-acetyl-glucosamine glycosylation (O-GlcNAcylation) of the serine and threonine residues of cellular proteins is a dynamic process and affects phosphorylation. Prolonged O-GlcNAcylation has been linked to diabetes-related complications, including mitochondrial dysfunction. Mitochondria are dynamically remodeling organelles, that constantly fuse (fusion) and divide (fission). An imbalance of this process affects mitochondrial function. In this study, we found that dynamin-related protein 1 (DRP1) is O-GlcNAcylated in cardiomyocytes at threonine 585 and 586. O-GlcNAcylation was significantly enhanced by the chemical inhibition of N-acetyl-glucosaminidase. Increased O-GlcNAcylation decreases the phosphorylation of DRP1 at serine 637, which is known to regulate DRP1 function. In fact, increased O-GlcNAcylation augments the level of the GTP-bound active form of DRP1 and induces translocation of DRP1 from the cytoplasm to mitochondria. Mitochondrial fragmentation and decreased mitochondrial membrane potential also accompany the increased O-GlcNAcylation. In conclusion, this report shows, for the first time, that O-GlcNAcylation modulates DRP1 functionality in cardiac muscle cells.	[Dillmann, Wolfgang] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92039 USA; [Hoshijima, Masahiko] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92039 USA; [Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Dillmann, W (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92039 USA.	wdillmann@ucsd.edu		Scott, Brian/0000-0002-1321-7204	National Institutes of Health from the San Diego EXPORT Center [HL066917, 3R01HL066917-10S1, P41 RR011823, P60 MD00220]; National Center of Minority Health and Health Disparities; UCSD Neuroscience Microscopy Facility [P30 NS047101]; Deutsche Forschungsgemeinschaft; P. Robert Majumder Charitable Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health from the San Diego EXPORT Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UCSD Neuroscience Microscopy Facility; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); P. Robert Majumder Charitable Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL066917 (to W. H. D.), 3R01HL066917-10S1 (to J. S.), P41 RR011823 (to J. R. Y.), P60 MD00220 from the San Diego EXPORT Center, National Center of Minority Health and Health Disparities, and the UCSD Neuroscience Microscopy Facility grant P30 NS047101. This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (to T. G.) and by the P. Robert Majumder Charitable Foundation.	Bimboese P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206482; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Hui L, 2010, FREE RADICAL BIO MED, V49, P467, DOI 10.1016/j.freeradbiomed.2010.05.002; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Kane LA, 2010, J MOL MED, V88, P971, DOI 10.1007/s00109-010-0674-6; Karunakaran Udayakumar, 2010, Korean Diabetes J, V34, P211, DOI 10.4093/kdj.2010.34.4.211; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; Singh LP, 2000, AM J PHYSIOL-RENAL, V279, pF646, DOI 10.1152/ajprenal.2000.279.4.F646; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	47	125	129	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					30024	30034		10.1074/jbc.M112.390682	http://dx.doi.org/10.1074/jbc.M112.390682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22745122	hybrid, Green Published			2022-12-28	WOS:000308286900075
J	Lara, H; Wang, YH; Beltran, AS; Juarez-Moreno, K; Yuan, XN; Kato, S; Leisewitz, AV; Fredes, MC; Licea, AF; Connolly, DC; Huang, L; Blancafort, P				Lara, Haydee; Wang, Yuhua; Beltran, Adriana S.; Juarez-Moreno, Karla; Yuan, Xinni; Kato, Sumie; Leisewitz, Andrea V.; Cuello Fredes, Mauricio; Licea, Alexei F.; Connolly, Denise C.; Huang, Leaf; Blancafort, Pilar			Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MASPIN EXPRESSION; FUNCTIONAL-CHARACTERIZATION; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; C/EBP-DELTA; CHROMATIN; MAMMARY; CELLS; MRP-1/CD9	Ovarian cancer is the leading cause of death among gynecological malignancies. It is detected at late stages when the disease is spread through the abdominal cavity in a condition known as peritoneal carcinomatosis. Thus, there is an urgent need to develop novel therapeutic interventions to target advanced stages of ovarian cancer. Mammary serine protease inhibitor (Maspin) represents an important metastasis suppressor initially identified in breast cancer. Herein we have generated a sequence-specific zinc finger artificial transcription factor (ATF) to up-regulate the Maspin promoter in aggressive ovarian cancer cell lines and to interrogate the therapeutic potential of Maspin in ovarian cancer. We found that although Maspin was expressed in some primary ovarian tumors, the promoter was epigenetically silenced in cell lines derived from ascites. Transduction of the ATF in MOVCAR 5009 cells derived from ascitic cultures of a TgMISIIR-TAg mouse model of ovarian cancer resulted in tumor cell growth inhibition, impaired cell invasion, and severe disruption of actin cytoskeleton. Systemic delivery of lipid-protamine-RNA nanoparticles encapsulating a chemically modified ATF mRNA resulted in inhibition of ovarian cancer cell growth in nude mice accompanied with Maspin re-expression in the treated tumors. Gene expression microarrays of ATF-transduced cells revealed an exceptional specificity for the Maspin promoter. These analyses identified novel targets co-regulated with Maspin in human short-term cultures derived from ascites, such as TSPAN12, that could mediate the anti-metastatic phenotype of the ATF. Our work outlined the first targeted, non-viral delivery of ATFs into tumors with potential clinical applications for metastatic ovarian cancers.	[Blancafort, Pilar] Univ N Carolina, UNC Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Wang, Yuhua; Huang, Leaf] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Beltran, Adriana S.; Blancafort, Pilar] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lara, Haydee; Licea, Alexei F.] Ctr Invest Cient & Educ Super Ensenada, Dept Biotecnol Marina, Ensenada 22860, Baja California, Mexico; [Lara, Haydee] Univ Autonoma Baja California, Programa Doctorado Ecol Mol & Biotecnol, Ensenada 22860, Baja California, Mexico; [Kato, Sumie; Cuello Fredes, Mauricio] Pontificia Univ Catolica Chile 686 3409, Fac Med, Lab Obstet & Ginecol, Ctr Invest Med, Santiago, Chile; [Leisewitz, Andrea V.] Pontificia Univ Catolica Chile 686 3409, Fac Med, Dept Hematol Oncol, Santiago, Chile; [Connolly, Denise C.] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Juarez-Moreno, Karla] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada 22860, Baja California, Mexico	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; Fox Chase Cancer Center; Universidad Nacional Autonoma de Mexico	Blancafort, P (corresponding author), Univ N Carolina, UNC Sch Med, Dept Pharmacol, 4009 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	pilar_blancafort@med.unc.edu	Cuello, Mauricio A/M-9817-2015; Navaro, Alexei Fedorovish Licea/B-4106-2016; Juarez-Moreno, Karla Oyuky/E-2730-2016; Blancafort, Pilar/K-9029-2012	Cuello, Mauricio A/0000-0003-2812-0015; Navaro, Alexei Fedorovish Licea/0000-0003-4022-7405; Juarez-Moreno, Karla Oyuky/0000-0002-6171-8601; Blancafort, Pilar/0000-0002-3881-7396	National Institutes of Health [1R01CA125273, 3R01CA125273-03S1, CA129835, CA136596, CA083638, CA006927]; Department of of Defense [W81XWH-10-1-0265]; Fondo Nacional de Ciencia y Tecnologia [1080163]; National Council of Science and Technology of Mexico; Baja California Sur State Government; Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; NATIONAL CANCER INSTITUTE [R01CA170370, R01CA125273, P30CA006927, R01CA136596, P50CA083638, R01CA129835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of of Defense(United States Department of Defense); Fondo Nacional de Ciencia y Tecnologia; National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Baja California Sur State Government; Centro de Investigacion Cientifica y de Educacion Superior de Ensenada(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA125273 and 3R01CA125273-03S1 (NCI; to P. B.), CA129835 (to L. H.), and CA136596, CA083638, and CA006927 (NCI; to D. C. C.). This work was also supported by Department of of Defense Grant W81XWH-10-1-0265 (to P. B.), Fondo Nacional de Ciencia y Tecnologia Grant 1080163 (to M. C. F.), the National Council of Science and Technology of Mexico, and The Baja California Sur State Government and Centro de Investigacion Cientifica y de Educacion Superior de Ensenada (to H. L.).	Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Banerjee R, 2004, INT J CANCER, V112, P693, DOI 10.1002/ijc.20452; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Beltran A, 2006, ASSAY DRUG DEV TECHN, V4, P317, DOI 10.1089/adt.2006.4.317; Beltran AS, 2008, MOL CANCER THER, V7, P1080, DOI 10.1158/1535-7163.MCT-07-0526; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Beltran AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024595; Beltran AS, 2011, EPIGENETICS-US, V6, P224, DOI 10.4161/epi.6.2.13700; Beltran AS, 2010, METHODS MOL BIOL, V649, P163, DOI 10.1007/978-1-60761-753-2_10; Berkenblit A, 2005, J REPROD MED, V50, P426; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Blancafort P, 2008, COMB CHEM HIGH T SCR, V11, P146, DOI 10.2174/138620708783744453; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Connolly DC, 2009, CANCER TREAT RES, V149, P353, DOI 10.1007/978-0-387-98094-2_17; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Endsley MP, 2011, METHOD ENZYMOL, V499, P149, DOI 10.1016/B978-0-12-386471-0.00008-0; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Furuya M, 2005, CANCER RES, V65, P2617, DOI 10.1158/0008-5472.CAN-04-3123; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gardner GJ, 2011, CANCER CONTROL, V18, P44, DOI 10.1177/107327481101800106; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Havrilesky L, 2003, J CLIN ONCOL, V21, P3814, DOI 10.1200/JCO.2003.11.052; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Higashiyama M, 1997, INT J CANCER, V74, P205, DOI 10.1002/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang CI, 1998, AM J PATHOL, V153, P973, DOI 10.1016/S0002-9440(10)65639-8; Huang CL, 2004, ONCOGENE, V23, P7475, DOI 10.1038/sj.onc.1208063; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liu J, 2010, ONCOLOGY-NY, V24, P721; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Lonardo F, 2006, LUNG CANCER, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Lonardo F, 2010, CURR PHARM DESIGN, V16, P1877, DOI 10.2174/138161210791208974; Lu YC, 2006, J BIOL CHEM, V281, P39081, DOI 10.1074/jbc.M606687200; MacLachlan Timothy K, 2003, Methods Mol Biol, V223, P129; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Min Y, 2011, ONCOGENE, V30, P4901, DOI 10.1038/onc.2011.187; Miosge N, 2001, HISTOCHEM J, V33, P523, DOI 10.1023/A:1014995523521; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Mussolino C., 2012, CURR OPIN B IN PRESS; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Quinn BA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-24; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; Richardson MM, 2011, CLIN EXP METASTAS, V28, P261, DOI 10.1007/s10585-010-9365-5; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Seftor REB, 1998, CANCER RES, V58, P5681; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Solomon LA, 2006, GYNECOL ONCOL, V101, P385, DOI 10.1016/j.ygyno.2005.11.049; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Sopel M, 2010, FOLIA MORPHOL, V69, P204; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Svirshchevskaya EV, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-176; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wright MH, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-29; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	76	34	35	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29873	29886		10.1074/jbc.M112.360768	http://dx.doi.org/10.1074/jbc.M112.360768			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782891	Green Published, hybrid			2022-12-28	WOS:000308286900061
J	Rostovtseva, TK; Gurnev, PA; Chen, MY; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Chen, Meng-Yang; Bezrukov, Sergey M.			Membrane Lipid Composition Regulates Tubulin Interaction with Mitochondrial Voltage-dependent Anion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-VESICLES; BIOLOGICAL-MEMBRANES; PROTEIN INTERACTIONS; VDAC; APOPTOSIS; MICROTUBULES; CONDUCTANCE; CARDIOLIPIN; CURVATURE; ROLES	Elucidating molecular mechanisms by which lipids regulate protein function within biological membranes is critical for understanding the many cellular processes. Recently, we have found that dimeric alpha beta-tubulin, a subunit of microtubules, regulates mitochondrial respiration by blocking the voltage-dependent anion channel (VDAC) of mitochondrial outer membrane. Here, we show that the mechanism of VDAC blockage by tubulin involves tubulin interaction with the membrane as a critical step. The on-rate of the blockage varies up to 100-fold depending on the particular lipid composition used for bilayer formation in reconstitution experiments and increases with the increasing content of dioleoylphosphatidylethanolamine (DOPE) in dioleoylphosphatidylcholine (DOPC) bilayers. At physiologically low salt concentrations, the on-rate is decreased by the charged lipid. The off-rate of VDAC blockage by tubulin does not depend on the lipid composition. Using confocal fluorescence microscopy, we compared tubulin binding to the membranes of giant unilamellar vesicles (GUVs) made from DOPC and DOPC/DOPE mixtures. We found that detectable binding of the fluorescently labeled dimeric tubulin to GUV membranes requires the presence of DOPE. We propose that prior to the characteristic blockage of VDAC, tubulin first binds to the membrane in a lipid-dependent manner. We thus reveal a new potent regulatory role of the mitochondrial lipids in control of the mitochondrial outer membrane permeability and hence mitochondrial respiration through tuning VDAC sensitivity to blockage by tubulin. More generally, our findings give an example of the lipid-controlled protein-protein interaction where the choice of lipid species is able to change the equilibrium binding constant by orders of magnitude.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Chen, Meng-Yang; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rostovtseva, TK (corresponding author), NICHD, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov			National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, Eunice Kennedy Shriver NICHD.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BERNIERVALENTIN F, 1983, J CELL BIOL, V97, P209, DOI 10.1083/jcb.97.1.209; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Bezrukov SM, 1998, FARADAY DISCUSS, V111, P173; BEZRUKOV SM, 1993, BIOPHYS J, V64, P16, DOI 10.1016/S0006-3495(93)81336-5; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; CARON JM, 1979, J CELL BIOL, V81, P665, DOI 10.1083/jcb.81.3.665; CARON JM, 1987, BIOCHEMISTRY-US, V26, P3681, DOI 10.1021/bi00386a063; CARON JM, 1980, J CELL BIOL, V87, pA255; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Furt F, 2009, INT J BIOCHEM CELL B, V41, P1828, DOI 10.1016/j.biocel.2009.02.005; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; HARGREAVES AJ, 1988, INT J BIOCHEM, V20, P1133, DOI 10.1016/0020-711X(88)90259-5; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; KUMAR N, 1981, J BIOL CHEM, V256, P5886; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Monge C., 2008, MOL CELL BIOCHEM, V318, P94; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2008, BIOPHYS J, V94, pL23, DOI 10.1529/biophysj.107.120261; Rostovtseva TK, 2007, BIOPHYS J, p436A; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Smith AW, 2012, BBA-BIOMEMBRANES, V1818, P172, DOI 10.1016/j.bbamem.2011.06.015; Sobko AA, 2004, FEBS LETT, V576, P205, DOI 10.1016/j.febslet.2004.09.016; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	56	53	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29589	29598		10.1074/jbc.M112.378778	http://dx.doi.org/10.1074/jbc.M112.378778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22763701	hybrid, Green Published			2022-12-28	WOS:000308286900034
J	Trevino, RS; Lauckner, JE; Sourigues, Y; Pearce, MM; Bousset, L; Melki, R; Kopito, RR				Trevino, R. Sean; Lauckner, Jane E.; Sourigues, Yannick; Pearce, Margaret M.; Bousset, Luc; Melki, Ronald; Kopito, Ron R.			Fibrillar Structure and Charge Determine the Interaction of Polyglutamine Protein Aggregates with the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; MAMMALIAN-CELLS; PRIONS; NEURODEGENERATION; EXPRESSION; AMYLOIDS; PEPTIDES	The pathogenesis of most neurodegenerative diseases, including transmissible diseases like prion encephalopathy, inherited disorders like Huntington disease, and sporadic diseases like Alzheimer and Parkinson diseases, is intimately linked to the formation of fibrillar protein aggregates. It is becoming increasingly appreciated that prion-like intercellular transmission of protein aggregates can contribute to the stereotypical spread of disease pathology within the brain, but the mechanisms underlying the binding and uptake of protein aggregates by mammalian cells are largely uninvestigated. We have investigated the properties of polyglutamine (polyQ) aggregates that endow them with the ability to bind to mammalian cells in culture and the properties of the cell surface that facilitate such uptake. Binding and internalization of polyQ aggregates are common features of mammalian cells and depend upon both trypsin-sensitive and trypsin-resistant saturable sites on the cell surface, suggesting the involvement of cell surface proteins in this process. polyQ aggregate binding depends upon the presence of a fibrillar amyloid-like structure and does not depend upon electrostatic interaction of fibrils with the cell surface. Sequences in the huntingtin protein that flank the amyloid-forming polyQ tract also influence the extent to which aggregates are able to bind to cell surfaces.	[Trevino, R. Sean; Lauckner, Jane E.; Pearce, Margaret M.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sourigues, Yannick; Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kopito@stanford.edu		bousset, luc/0000-0002-0433-4337; Panning Pearce, Margaret/0000-0002-5846-9632	National Institutes of Health [NS042842, GM007276]; Agence Nationale de la Recherche [ANR-09-MNPS-013-01]; Coup d'Elan a la Recherche Francaise award from Bettencourt Schueller Foundation; Human Frontiers Science Program; Hereditary Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842, R56NS042842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Coup d'Elan a la Recherche Francaise award from Bettencourt Schueller Foundation; Human Frontiers Science Program(Human Frontier Science Program); Hereditary Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042842 (to R. R. K.) and Predoctoral Training Grant GM007276 (to R. S. T.). This work was also supported by Agence Nationale de la Recherche Grant ANR-09-MNPS-013-01 and a Coup d'Elan a la Recherche Francaise award from the Bettencourt Schueller Foundation (to R. M.), the Human Frontiers Science Program (to R. R. K. and R. M.), and a postdoctoral fellowship from the Hereditary Disease Foundation (to J. E. L.).	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Sorolla MA, 2010, FREE RADICAL BIO MED, V49, P612, DOI 10.1016/j.freeradbiomed.2010.05.016; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; PRUSINER SB, 1994, ANNU REV MICROBIOL, V48, P655, DOI 10.1146/annurev.mi.48.100194.003255; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	23	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29722	29728		10.1074/jbc.M112.372474	http://dx.doi.org/10.1074/jbc.M112.372474			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22753412	Green Published, hybrid			2022-12-28	WOS:000308286900048
J	Jahnke, M; Trowsdale, J; Kelly, AP				Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.			Structural Requirements for Recognition of Major Histocompatibility Complex Class II by Membrane-associated RING-CH (MARCH) Protein E3 Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; INVARIANT CHAIN; UBIQUITIN LIGASES; DOWN-REGULATION; IMMUNE RECOGNITION; PLASMA-MEMBRANE; AMINO-ACIDS; HLA-DM; SURFACE	MARCH E3 ligases play a key role in controlling MHC class II surface expression by regulated ubiquitination of a lysine residue in the beta-chain. Little is known concerning how these enzymes target their specific substrates. Here we show that recognition of HLA-DR by MARCH proteins is complex. Several features associated with the transmembrane domain and bordering regions influence the overall efficiency of receptor internalization. A cluster of residues at the interface of the lipid bilayer and the cytosol plays the most important role in MARCH8 recognition of HLA-DR beta. Variation in this sequence also determines specificity of MARCH9 for HLA-DQ. Residues located in helical face four of HLA-DR beta together with a charged residue at the boundary with the stalk region also contribute significantly to recognition. Truncation analysis suggested that a dileucine-like motif in the DR beta cytoplasmic tail influences the efficiency of co-localization of HLA-DR with MARCH8. The DR beta-encoded acceptor lysine functioned optimally when placed in its natural location relative to the bilayer. In the DR alpha/DR beta dimer most other amino acids in the cytoplasmic tail could be substituted for alanine with minimal influence on function. Our data support a model whereby multiple features of HLA-DR are involved in substrate recognition by MARCH8. The single most important region is located at the interface between the transmembrane domain and the cytosol. Variation in sequence in this location between different class II isotypes controls efficiency of recognition by different MARCH E3 ligases.	[Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Kelly, AP (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	apk23@mole.bio.cam.ac.uk			Wellcome Trust; Medical Research Council; National Institute of Health Research Cambridge Biomedical Research Centre; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the Medical Research Council, and the National Institute of Health Research Cambridge Biomedical Research Centre.	BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; FERMAND JP, 1986, SCAND J IMMUNOL, V24, P313; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jahnke M, 2012, J BIOL CHEM, V287, P7256, DOI 10.1074/jbc.M111.305961; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rhodes DA, 2010, P NATL ACAD SCI USA, V107, P16240, DOI 10.1073/pnas.1003421107; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; ten Broeke T, 2010, TRAFFIC, V11, P324, DOI 10.1111/j.1600-0854.2009.01024.x; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	33	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28779	28789		10.1074/jbc.M112.381541	http://dx.doi.org/10.1074/jbc.M112.381541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761441	Green Published, hybrid			2022-12-28	WOS:000308074600051
J	Karaskova, M; Gunisova, S; Herrmannova, A; Wagner, S; Munzarova, V; Valasek, LS				Karaskova, Martina; Gunisova, Stanislava; Herrmannova, Anna; Wagner, Susan; Munzarova, Vanda; Valasek, Leos Shivaya			Functional Characterization of the Role of the N-terminal Domain of the c/Nip1 Subunit of Eukaryotic Initiation Factor 3 (eIF3) in AUG Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; 40S RIBOSOMAL-SUBUNIT; TRANSLATION INITIATION; MESSENGER-RNA; PREINITIATION COMPLEX; MULTIFACTOR COMPLEX; BINDING; GCN4; YEAST; REINITIATION	In eukaryotes, for a protein to be synthesized, the 40 S subunit has to first scan the 5'-UTR of the mRNA until it has encountered the AUG start codon. Several initiation factors that ensure high fidelity of AUG recognition were identified previously, including eIF1A, eIF1, eIF2, and eIF5. In addition, eIF3 was proposed to coordinate their functions in this process as well as to promote their initial binding to 40 S subunits. Here we subjected several previously identified segments of the N-terminal domain (NTD) of the eIF3c/Nip1 subunit, which mediates eIF3 binding to eIF1 and eIF5, to semirandom mutagenesis to investigate the molecular mechanism of eIF3 involvement in these reactions. Three major classes of mutant substitutions or internal deletions were isolated that affect either the assembly of preinitiation complexes (PICs), scanning for AUG, or both. We show that eIF5 binds to the extreme c/Nip1-NTD (residues 1-45) and that impairing this interaction predominantly affects the PIC formation. eIF1 interacts with the region (60-137) that immediately follows, and altering this contact deregulates AUG recognition. Together, our data indicate that binding of eIF1 to the c/Nip1-NTD is equally important for its initial recruitment to PICs and for its proper functioning in selecting the translational start site.	[Karaskova, Martina; Gunisova, Stanislava; Herrmannova, Anna; Wagner, Susan; Munzarova, Vanda; Valasek, Leos Shivaya] Acad Sci Czech Republ, Inst Microbiol, Lab Regulat Gene Express, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Valasek, LS (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Regulat Gene Express, Videnska 1083, CR-14220 Prague 4, Czech Republic.	valasekl@biomed.cas.cz	Valášek, Leoš Shivaya/I-5743-2014; Wagner, Susan/K-8240-2014; Herrmannová, Anna/I-1745-2014; Gunišová, Stanislava/I-1765-2014; Wagner, Susan/ABA-1307-2021	Valášek, Leoš Shivaya/0000-0001-8123-8667; Herrmannová, Anna/0000-0003-3500-3212; Wagner, Susan/0000-0002-7492-7541	Wellcome Trust [076456/Z/05/Z, 090812/B/09/Z]; Czech Science Foundation [305/10/0335]	Wellcome Trust(Wellcome TrustEuropean Commission); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by The Wellcome Trust Grants 076456/Z/05/Z and 090812/B/09/Z and Czech Science Foundation Grant 305/10/0335.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GRANT CM, 1994, MOL CELL BIOL, V14, P606, DOI 10.1128/MCB.14.1.606; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Kouba T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040464; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Munzarova V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002137; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Nielsen KH, 2007, METHOD ENZYMOL, V431, P15, DOI 10.1016/S0076-6879(07)31002-1; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Valasek L, 1998, J BIOL CHEM, V273, P21253, DOI 10.1074/jbc.273.33.21253; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102	46	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28420	28434		10.1074/jbc.M112.386656	http://dx.doi.org/10.1074/jbc.M112.386656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718758	Green Published, hybrid			2022-12-28	WOS:000308074600018
J	Komori, H; Nitta, Y; Ueno, H; Higuchi, Y				Komori, Hirofumi; Nitta, Yoko; Ueno, Hiroshi; Higuchi, Yoshiki			Structural Study Reveals That Ser-354 Determines Substrate Specificity on Human Histidine Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; DOPA DECARBOXYLASE; LOCOMOTOR-ACTIVITY; IMPORTANT RESIDUES; BRAIN HISTAMINE; PURIFICATION; COENZYME; LIVER; MICE	Histamine is an important chemical mediator for a wide variety of physiological reactions. L-Histidine decarboxylase (HDC) is the primary enzyme responsible for histamine synthesis and produces histamine from histidine in a one-step reaction. In this study, we determined the crystal structure of human HDC (hHDC) complexed with the inhibitor histidine methyl ester. This structure shows the detailed features of the pyridoxal-5'-phosphate inhibitor adduct (external aldimine) at the active site of HDC. Moreover, a comparison of the structures of hHDC and aromatic L-amino acid (L-DOPA) decarboxylase showed that Ser-354 was a key residue for substrate specificity. The S354G mutation at the active site enlarged the size of the hHDC substrate-binding pocket and resulted in a decreased affinity for histidine, but an acquired ability to bind and act on L-DOPA as a substrate. These data provide insight into the molecular basis of substrate recognition among the group II pyridoxal-5'-phosphate-dependent decarboxylases.	[Komori, Hirofumi; Higuchi, Yoshiki] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795248, Japan; [Nitta, Yoko] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Ueno, Hiroshi] Nara Womens Univ, Lab Appl Microbiol & Biochem, Kitauoyanishi, Nara 6308506, Japan	University of Hyogo; RIKEN; University of Hyogo; Nara Womens University	Komori, H (corresponding author), Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	komori@sci.u-hyogo.ac.jp; nitta@shse.u-hyogo.ac.jp	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Higuchi, Yoshiki/0000-0001-8284-5709	Kawanishi Memorial ShinMaywa Education Foundation; Japan Society for the Promotion of Science; Academia Sinica; National Synchrotron Radiation Research Center (Hsinchu City, Taiwan); Grants-in-Aid for Scientific Research [24650495] Funding Source: KAKEN	Kawanishi Memorial ShinMaywa Education Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Hsinchu City, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Kawanishi Memorial ShinMaywa Education Foundation and a grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science.; We thank the staff at beamline BL44XU at SPring-8 (Harima, Japan). The MX225-HE (Rayonix) CCD detector at BL44XU was financially supported by Academia Sinica and by the National Synchrotron Radiation Research Center (Hsinchu City, Taiwan).	Andersson K, 1998, YALE J BIOL MED, V71, P183; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fleming JV, 2004, BIOCHEM J, V379, P253, DOI 10.1042/BJ20031525; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; Ishii S, 1996, J BIOCHEM, V120, P369; KELLEY JL, 1977, J MED CHEM, V20, P506, DOI 10.1021/jm00214a009; KIYONO S, 1985, PHYSIOL BEHAV, V34, P615, DOI 10.1016/0031-9384(85)90057-5; KOLLONITSCH J, 1978, NATURE, V274, P906, DOI 10.1038/274906a0; Komori H, 2012, ACTA CRYSTALLOGR F, V68, P675, DOI 10.1107/S1744309112015692; Kubota Y, 2002, J NEUROCHEM, V83, P837, DOI 10.1046/j.1471-4159.2002.01189.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Montioli R, 2011, J INHERIT METAB DIS, V34, P1213, DOI 10.1007/s10545-011-9340-6; Morimoto T, 1999, PHYSIOL BEHAV, V67, P679, DOI 10.1016/S0031-9384(99)00123-7; Moya-Garcia AA, 2008, J BIOL CHEM, V283, P12393, DOI 10.1074/jbc.M707434200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitta Y, 2010, J BIOL MACROMOL, V10, P73; Nitta Y, 2007, J AGR FOOD CHEM, V55, P299, DOI 10.1021/jf062392k; Nuutinen S, 2010, ADV EXP MED BIOL, V709, P95; OHMORI E, 1990, J BIOCHEM, V107, P834, DOI 10.1093/oxfordjournals.jbchem.a123134; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Okigami H., 2006, J BIOL MACROMOL, V6, P11; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parmentier R, 2002, J NEUROSCI, V22, P7695; Pino-Angeles A, 2010, PROTEINS, V78, P154, DOI 10.1002/prot.22587; Rodriguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3; SAKAI N, 1992, LIFE SCI, V51, P397, DOI 10.1016/0024-3205(92)90406-F; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; TAGUCHI Y, 1984, J BIOL CHEM, V259, P5214; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Yatsunami K, 1995, J BIOL CHEM, V270, P30813, DOI 10.1074/jbc.270.51.30813	45	54	58	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29175	29183		10.1074/jbc.M112.381897	http://dx.doi.org/10.1074/jbc.M112.381897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767596	hybrid, Green Published			2022-12-28	WOS:000308074600083
J	Bullock, HD; Hower, S; Fields, KA				Bullock, Holly D.; Hower, Suzanne; Fields, Kenneth A.			Domain Analyses Reveal That Chlamydia trachomatis CT694 Protein Belongs to the Membrane-localized Family of Type III Effector Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; HOST-CELLS; PLASMA-MEMBRANE; YERSINIA-YOPE; SECRETION; ENTRY; EXOS; CYTOTOXIN; CYCLE; APPARATUS	The Chlamydia trachomatis type three-secreted effector protein CT694 is expressed during late-cycle development yet is secreted by infectious particles during the invasion process. We have previously described the presence of at least two functional domains within CT694. CT694 was found to interact with the human protein Ahnak through a C-terminal domain and affect formation of host-cell actin stress fibers. Immunolocalization analyses of ectopically expressed pEGFP-CT694 also revealed plasma membrane localization for CT694 that was independent of Ahnak binding. Here we provide evidence that CT694 contains multiple functional domains. Plasma membrane localization and CT694-induced alterations in host cell morphology are dependent on an N-terminal domain. We demonstrate that membrane association of CT694 is dependent on a domain resembling a membrane localization domain (MLD) found in anti-host proteins from Yersinia, Pseudomonas, and Salmonella spp. This domain is necessary and sufficient for localization and morphology changes but is not required for Ahnak binding. Further, the CT694 MLD is able to complement ExoS Delta MLD when ectopically expressed. Taken together, our data indicate that CT694 is a multidomain protein with the potential to modulate multiple host cell processes.	[Bullock, Holly D.; Hower, Suzanne; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Fields, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, 1600 NW 10th Ave, Miami, FL 33136 USA.	kfields@med.miami.edu			Public Health Service from NIAID, National Institutes of Health [AI065530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065530] Funding Source: NIH RePORTER	Public Health Service from NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI065530 from NIAID, National Institutes of Health (to K.A.F.).	Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burton M. J., 2009, TRAVEL MED INFECT, V3, pe460; Cain RJ, 2004, MOL MICROBIOL, V54, P887, DOI 10.1111/j.1365-2958.2004.04336.x; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Deng Q, 2007, TRAFFIC, V8, P1331, DOI 10.1111/j.1600-0854.2007.00626.x; Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hoffman K., 2011, J BIOL CHEM, P374; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Maniatis T., 1982, MOL CLONING; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; McGuffie EM, 1999, INFECT IMMUN, V67, P3494, DOI 10.1128/IAI.67.7.3494-3503.1999; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Pederson KJ, 2002, MOL MICROBIOL, V46, P1381, DOI 10.1046/j.1365-2958.2002.03256.x; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; U.S. Department of Health and Human Services CfDCaP Division of STD Prevention, 2010, SEX TRANSM DIS SURV; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Zhang Y, 2005, INFECT IMMUN, V73, P7938, DOI 10.1128/IAI.73.12.7938-7945.2005; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	42	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28078	28086		10.1074/jbc.M112.386904	http://dx.doi.org/10.1074/jbc.M112.386904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711538	hybrid, Green Published			2022-12-28	WOS:000307840700081
J	Flemmig, J; Zschaler, J; Remmler, J; Arnhold, J				Flemmig, Joerg; Zschaler, Josefin; Remmler, Johannes; Arnhold, Juegen			The Fluorescein-derived Dye Aminophenyl Fluorescein Is a Suitable Tool to Detect Hypobromous Acid (HOBr)-producing Activity in Eosinophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEME PEROXIDASES; HYPOCHLOROUS ACID; HUMAN MYELOPEROXIDASE; CHLORINATING ACTIVITY; SPECTRAL PROPERTIES; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; RATIONAL DESIGN; NITRIC-OXIDE; COMPOUND-I	The specific detection of peroxidase activity in human granulocytes is essential to elucidate their role in innate immune responses, immune regulation, and inflammatory diseases. The halogenating activity of myeloperoxidase in neutrophils can be determined by the novel fluorescent probe aminophenyl fluorescein (APF). Thereby non-fluorescent APF is oxidized by HOCl to form fluorescein. We successfully verified that APF equally detects the hypobromous acid (HOBr)-producing activity of eosinophil granulocytes. This was revealed by three different approaches. First, we investigated the conversion of non-fluorescent APF into fluorescein by HOCl and HOBr by means of fluorescence and mass spectrometry approaches. Thereby comparable chemical mechanisms were observed for both acids. Furthermore in vitro kinetic studies were used to detect the halogenating activity of myeloperoxidase and eosinophil peroxidase by using APF. Here the dye well reflected the different substrate specificities of myeloperoxidase and eosinophil peroxidase regarding chloride and bromide. Finally, peroxidase activities were successfully detected in phorbol ester-stimulated neutrophils and eosinophils using flow cytometry. Thereby inhibitory studies confirmed the peroxidase-dependent oxidation of APF. To sum up, APF is a promising tool for further evaluation of the halogenating activity of peroxidases in both neutrophils and eosinophils.	[Flemmig, Joerg; Zschaler, Josefin; Remmler, Johannes; Arnhold, Juegen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Flemmig, Joerg; Zschaler, Josefin] Univ Leipzig, Translat Ctr Regenerat Med Leipzig, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Flemmig, J (corresponding author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	joerg.flemmig@medizin.uni-leipzig.de		Remmler, Johannes/0000-0003-2598-3616; Flemmig, Jorg/0000-0001-5872-3373	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [0315883]	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF))	This work was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883).	Arnhold J, 2003, REDOX REP, V8, P179, DOI 10.1179/135100003225002664; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Azadniv M, 2001, INHAL TOXICOL, V13, P485, DOI 10.1080/08958370151131855; BEERS RF, 1952, J BIOL CHEM, V195, P133; Chapman ALP, 2009, BIOCHEM J, V417, P773, DOI 10.1042/BJ20071563; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Chen XQ, 2008, CHEM-EUR J, V14, P4719, DOI 10.1002/chem.200701677; CHIHARA J, 1995, ALLERGY, V50, P11, DOI 10.1111/j.1398-9995.1995.tb02477.x; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Doughty MJ, 2010, OPHTHAL PHYSL OPT, V30, P167, DOI 10.1111/j.1475-1313.2009.00703.x; Fierro IM, 1999, J LEUKOCYTE BIOL, V65, P508, DOI 10.1002/jlb.65.4.508; Flemmig J, 2008, CELL PHYSIOL BIOCHEM, V21, P287, DOI 10.1159/000129387; Franck T, 2009, VET IMMUNOL IMMUNOP, V130, P243, DOI 10.1016/j.vetimm.2009.02.015; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Ge FY, 2008, J FLUORESC, V18, P741, DOI 10.1007/s10895-007-0305-y; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grant DC, 2007, RAPID COMMUN MASS SP, V21, P837, DOI 10.1002/rcm.2899; HANSEL TT, 1989, J IMMUNOL METHODS, V122, P97, DOI 10.1016/0022-1759(89)90339-6; HURST JK, 1984, J BIOL CHEM, V259, P4812; Ilmarinen P, 2009, PULM PHARMACOL THER, V22, P167, DOI 10.1016/j.pupt.2008.11.012; Ilmarinen-Salo P, 2010, PULM PHARMACOL THER, V23, P365, DOI 10.1016/j.pupt.2010.04.001; Izumi S, 2009, J AM CHEM SOC, V131, P10189, DOI 10.1021/ja902511p; Kankaanranta H, 2000, J ALLERGY CLIN IMMUN, V106, P77; Kankaanranta Hannu, 2005, Current Drug Targets - Inflammation and Allergy, V4, P433, DOI 10.2174/1568010054526395; Kenmoku S, 2007, J AM CHEM SOC, V129, P7313, DOI 10.1021/ja068740g; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Kirchner T, 2010, ARCH BIOCHEM BIOPHYS, V495, P21, DOI 10.1016/j.abb.2009.12.013; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X; Koppenol WH, 1998, CHEM RES TOXICOL, V11, P87, DOI 10.1021/tx970200x; KUMAR K, 1987, INORG CHEM, V26, P2706, DOI 10.1021/ic00263a030; Leszyk John D, 2010, J Biomol Tech, V21, P81; Lou XD, 2011, CHEM COMMUN, V47, P3189, DOI 10.1039/c0cc04911e; Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Martinez VM, 2008, J AM CHEM SOC, V130, P13192, DOI 10.1021/ja804606m; Merenyi G, 1997, CHEM RES TOXICOL, V10, P1216, DOI 10.1021/tx970101j; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Nagano T, 2010, P JPN ACAD B-PHYS, V86, P837, DOI 10.2183/pjab.86.837; Nagano T, 2009, J CLIN BIOCHEM NUTR, V45, P111, DOI 10.3164/jcbn.R09-66; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; Nakajima Y, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-4; Nakazato T, 2007, CLIN CANCER RES, V13, P5436, DOI 10.1158/1078-0432.CCR-07-0481; OFLaherty JT, 1996, J IMMUNOL, V157, P336; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Persike M, 2010, ANAL CHEM, V82, P922, DOI 10.1021/ac902130h; ROMANCHUK KG, 1982, SURV OPHTHALMOL, V26, P269, DOI 10.1016/0039-6257(82)90163-1; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SCHAUENSTEIN K, 1978, J HISTOCHEM CYTOCHEM, V26, P277, DOI 10.1177/26.4.77868; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shepherd J, 2007, CHEM BIOL, V14, P1221, DOI 10.1016/j.chembiol.2007.10.005; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Someya A, 1997, ARCH BIOCHEM BIOPHYS, V345, P207, DOI 10.1006/abbi.1997.0252; Spalteholz H, 2006, ARCH BIOCHEM BIOPHYS, V445, P225, DOI 10.1016/j.abb.2005.06.025; Spalteholz H, 2008, BIOCHEM BIOPH RES CO, V371, P810, DOI 10.1016/j.bbrc.2008.04.139; Sun ZN, 2008, ORG LETT, V10, P2171, DOI 10.1021/ol800507m; Tanaka K, 2001, J AM CHEM SOC, V123, P2530, DOI 10.1021/ja0035708; Ueno T, 2004, J AM CHEM SOC, V126, P14079, DOI 10.1021/ja048241k; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; vanDalen CJ, 1997, BIOCHEM J, V327, P487; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEVER R, 1981, FEBS LETT, V123, P327, DOI 10.1016/0014-5793(81)80320-1; Yang YK, 2009, ORG LETT, V11, P859, DOI 10.1021/ol802822t; Zhang XF, 2010, PHOTOCHEM PHOTOBIOL, V86, P492, DOI 10.1111/j.1751-1097.2010.00706.x; Zhu XD, 1998, J IMMUNOL, V161, P2574	70	30	30	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27913	27923		10.1074/jbc.M112.364299	http://dx.doi.org/10.1074/jbc.M112.364299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718769	Green Published, hybrid			2022-12-28	WOS:000307840700065
J	Hawkes, WC; Alkan, Z				Hawkes, Wayne Chris; Alkan, Zeynep			Delayed Cell Cycle Progression in Selenoprotein W-depleted Cells Is Regulated by a Mitogen-activated Protein Kinase Kinase 4-p38/c-Jun NH2-terminal Kinase-p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; MAP KINASES; SIGNAL INTEGRATION; INDUCED APOPTOSIS; EPITHELIAL-CELLS; P53; JNK; CANCER; PHOSPHORYLATION; STRESS	Selenoprotein W (SEPW1) is a ubiquitous, highly conserved thioredoxin-like protein whose depletion causes a transient p53- and p21(Cip1)-dependent G(1)-phase cell cycle arrest in breast and prostate epithelial cells. SEPW1 depletion increases phosphorylation of Ser-33 in p53, which is associated with decreased p53 ubiquitination and stabilization of p53. We report here that delayed cell cycle progression, Ser-33 phosphorylation, and p53 nuclear accumulation from SEPW1 depletion require mitogen-activated protein kinase kinase 4 (MKK4). Silencing MKK4 rescued G(1) arrest, Ser-33 phosphorylation, and nuclear accumulation of p53 induced by SEPW1 depletion, but silencing MKK3, MKK6, or MKK7 did not. SEPW1 silencing did not change the phosphorylation state of MKK4 but increased total MKK4 protein. Silencing p38 gamma, p38 delta, or JNK2 partially rescued G(1) arrest from SEPW1 silencing, suggesting they signal downstream from MKK4. These results imply that SEPW1 silencing increases MKK4, which activates p38 gamma, p38 delta, and JNK2 to phosphorylate p53 on Ser-33 and cause a transient G(1) arrest.	[Hawkes, Wayne Chris; Alkan, Zeynep] Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis	Hawkes, WC (corresponding author), Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	wayne.hawkes@ars.usda.gov			United States Department of Agriculture CRIS Project [5306-51530-018-00D]	United States Department of Agriculture CRIS Project	This work was supported by United States Department of Agriculture CRIS Project 5306-51530-018-00D.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Bruckmann A, 2007, J PROTEOME RES, V6, P1689, DOI 10.1021/pr0605522; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; Cunningham SC, 2010, AGING-US, V2, P752, DOI 10.18632/aging.100233; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ge WW, 2007, MOL CELL NEUROSCI, V34, P80, DOI 10.1016/j.mcn.2006.10.001; Hawkes WC, 2012, J CELL BIOCHEM, V113, P61, DOI 10.1002/jcb.23328; Hawkes WC, 2011, BIOCHEM BIOPH RES CO, V413, P36, DOI 10.1016/j.bbrc.2011.08.032; Hawkes WC, 2009, BIOL TRACE ELEM RES, V131, P229, DOI 10.1007/s12011-009-8367-0; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Larance M, 2010, MOL CELL PROTEOMICS, V9, P682, DOI 10.1074/mcp.M900435-MCP200; Lee JH, 2011, J BIOL CHEM, V286, P5136, DOI 10.1074/jbc.M110.190470; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; McGonigle S, 2002, BIOCHEMISTRY-US, V41, P579, DOI 10.1021/bi011407z; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Nguyen HT, 2006, NEPHRON EXP NEPHROL, V102, P49, DOI 10.1159/000088401; Nishina H, 1999, DEVELOPMENT, V126, P505; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ria R, 2009, CLIN CANCER RES, V15, P5369, DOI 10.1158/1078-0432.CCR-09-0040; Robinson VL, 2008, MOL CANCER RES, V6, P501, DOI 10.1158/1541-7786.MCR-07-2075; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Schwacke JH, 2007, J THEOR BIOL, V246, P604, DOI 10.1016/j.jtbi.2006.12.035; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Song LB, 2010, CELL SIGNAL, V22, P857, DOI 10.1016/j.cellsig.2010.01.009; Spillman MA, 2007, GYNECOL ONCOL, V105, P312, DOI 10.1016/j.ygyno.2006.12.017; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Szmulewitz RZ, 2012, INT J CANCER, V130, P509, DOI 10.1002/ijc.26005; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Taylor J. K., 1987, QUALITY ASSURANCE CH, P24; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Topisirovic I, 2009, P NATL ACAD SCI USA, V106, P12676, DOI 10.1073/pnas.0900596106; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zheng QL, 2004, J BIOL CHEM, V279, P8787, DOI 10.1074/jbc.M310212200; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; Zuo SA, 2010, J PROTEOME RES, V9, P3465, DOI 10.1021/pr9011377	67	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27371	27379		10.1074/jbc.M112.346593	http://dx.doi.org/10.1074/jbc.M112.346593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730327	hybrid, Green Published			2022-12-28	WOS:000307840700009
J	Himmel, S; Zschiedrich, CP; Becker, S; Hsiao, HH; Wolff, S; Diethmaier, C; Urlaub, H; Lee, D; Griesinger, C; Stulke, J				Himmel, Sebastian; Zschiedrich, Christopher P.; Becker, Stefan; Hsiao, He-Hsuan; Wolff, Sebastian; Diethmaier, Christine; Urlaub, Henning; Lee, Donghan; Griesinger, Christian; Stuelke, Joerg			Determinants of Interaction Specificity of the Bacillus subtilis GlcT Antitermination Protein FUNCTIONALITY AND PHOSPHORYLATION SPECIFICITY DEPEND ON THE ARRANGEMENT OF THE REGULATORY DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; RNA-BINDING DOMAIN; PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; TRANSCRIPTIONAL ANTITERMINATOR; PHOSPHOPROTEIN HPR-SER46-P; SIGNAL-TRANSDUCTION; PTSGHI OPERON; BGL OPERON; LICT	The control of several catabolic operons in bacteria by transcription antitermination is mediated by RNA-binding proteins that consist of an RNA-binding domain and two reiterated phosphotransferase system regulation domains (PRDs). The Bacillus subtilis GlcT antitermination protein regulates the expression of the ptsG gene, encoding the glucose-specific enzyme II of the phosphotransferase system. In the absence of glucose, GlcT becomes inactivated by enzyme II-dependent phosphorylation at its PRD1, whereas the phosphotransferase HPr phosphorylates PRD2. However, here we demonstrate by NMR analysis and mass spectrometry that HPr also phosphorylates PRD1 in vitro but with low efficiency. Size exclusion chromatography revealed that non-phosphorylated PRD1 forms dimers that dissociate upon phosphorylation. The effect of HPr on PRD1 was also investigated in vivo. For this purpose, we used GlcT variants with altered domain arrangements or domain deletions. Our results demonstrate that HPr can target PRD1 when this domain is placed at the C terminus of the protein. In agreement with the in vitro data, HPr exerts a negative control on PRD1. This work provides the first insights into how specificity is achieved in a regulator that contains duplicated regulatory domains with distinct dimerization properties that are controlled by phosphorylation by different phosphate donors. Moreover, the results suggest that the domain arrangement of the PRD-containing antitermination proteins is under selective pressure to ensure the proper regulatory output, i.e. transcription antitermination of the target genes specifically in the presence of the corresponding sugar.	[Himmel, Sebastian; Becker, Stefan; Wolff, Sebastian; Lee, Donghan; Griesinger, Christian] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Hsiao, He-Hsuan; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Zschiedrich, Christopher P.; Diethmaier, Christine; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Griesinger, C (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	cigr@nmr.mpibpc.mpg.de; jstuelk@gwdg.de	Stülke, Jörg/AAD-1600-2021	Lee, Donghan/0000-0002-6530-8060; Stulke, Jorg/0000-0001-5881-5390; Lee, Donghan/0000-0002-3971-986X	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB860]; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society (to C. G.) and by Deutsche Forschungsgemeinschaft Grant SFB860 and the Fonds der Chemischen Industrie (to J. S. and C. G.).	AMSTERCHODER O, 1990, SCIENCE, V249, P540, DOI 10.1126/science.2200123; ARNAUD M, 1992, J BACTERIOL, V174, P3161, DOI 10.1128/jb.174.10.3161-3170.1992; Bachem S, 1998, J BACTERIOL, V180, P5319, DOI 10.1128/JB.180.20.5319-5326.1998; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; DEBARBOUILLE M, 1991, P NATL ACAD SCI USA, V88, P2212, DOI 10.1073/pnas.88.6.2212; Declerck N, 2001, J MOL BIOL, V314, P671, DOI 10.1006/jmbi.2001.5185; Demene H, 2008, J BIOL CHEM, V283, P30838, DOI 10.1074/jbc.M805955200; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorke B, 1999, EMBO J, V18, P3370, DOI 10.1093/emboj/18.12.3370; Gorke B, 2003, J BIOL CHEM, V278, P46219, DOI 10.1074/jbc.M308002200; Graille M, 2005, J BIOL CHEM, V280, P14780, DOI 10.1074/jbc.M414642200; Greenberg DB, 2002, RES MICROBIOL, V153, P519, DOI 10.1016/S0923-2508(02)01362-1; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Himmel S, 2010, ANGEW CHEM INT EDIT, V49, P8971, DOI 10.1002/anie.201003965; Hubner S, 2011, NUCLEIC ACIDS RES, V39, P4360, DOI 10.1093/nar/gkr021; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Langbein I, 1999, J MOL BIOL, V293, P795, DOI 10.1006/jmbi.1999.3176; Lindner C, 2002, J BACTERIOL, V184, P4819, DOI 10.1128/JB.184.17.4819-4828.2002; Lindner C, 1999, MOL MICROBIOL, V31, P995, DOI 10.1046/j.1365-2958.1999.01262.x; Manival X, 1997, EMBO J, V16, P5019, DOI 10.1093/emboj/16.16.5019; MARTINVERSTRAETE I, 1994, J MOL BIOL, V241, P178, DOI 10.1006/jmbi.1994.1487; Matthews KS, 1996, SCIENCE, V271, P1245, DOI 10.1126/science.271.5253.1245; Muller W, 2006, FEBS J, V273, P1251, DOI 10.1111/j.1742-4658.2006.05148.x; Pompeo F, 2007, J BACTERIOL, V189, P1154, DOI 10.1128/JB.01575-06; Poncet S, 2009, J BIOL CHEM, V284, P28188, DOI 10.1074/jbc.M109.046334; Raveh H, 2009, P NATL ACAD SCI USA, V106, P13523, DOI 10.1073/pnas.0902559106; Reizer J, 1998, MOL MICROBIOL, V27, P1157, DOI 10.1046/j.1365-2958.1998.00747.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schilling O, 2004, NUCLEIC ACIDS RES, V32, P2853, DOI 10.1093/nar/gkh611; Schilling O, 2006, NUCLEIC ACIDS RES, V34, P6102, DOI 10.1093/nar/gkl733; Schmalisch MH, 2003, J BIOL CHEM, V278, P51108, DOI 10.1074/jbc.M309972200; SCHNETZ K, 1990, P NATL ACAD SCI USA, V87, P5074, DOI 10.1073/pnas.87.13.5074; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Tortosa P, 2001, MOL MICROBIOL, V41, P1381, DOI 10.1046/j.1365-2958.2001.02608.x; van Tilbeurgh H, 2001, CURR OPIN STRUC BIOL, V11, P685, DOI 10.1016/S0959-440X(01)00267-6; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	48	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27731	27742		10.1074/jbc.M112.388850	http://dx.doi.org/10.1074/jbc.M112.388850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722928	Green Published, hybrid			2022-12-28	WOS:000307840700047
J	Rasooly, R; He, XH; Friedman, M				Rasooly, Reuven; He, Xiaohua; Friedman, Mendel			Milk Inhibits the Biological Activity of Ricin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-GROUND BEEF; SHIGA TOXIN; BINDING; LACTOSE; GALACTOSE; TOXICITY; CHAIN	Ricin is a highly toxic protein produced by the castor plant Ricinus communis. The toxin is relatively easy to isolate and can be used as a biological weapon. There is great interest in identifying effective inhibitors for ricin. In this study, we demonstrated by three independent assays that a component of reconstituted powdered milk has a high binding affinity to ricin. We discovered that milk can competitively bind to and reduce the amount of toxin available to asialofetuin type II, which is used as a model to study the binding of ricin to galactose cell-surface receptors. Milk also removes ricin bound to the microtiter plate. In parallel experiments, we demonstrated by activity assay and by immuno-PCR that milk can bind competitively to 1 ng/ml ricin, reducing the amount of toxin uptake by the cells, and thus inhibit the biological activity of ricin. The inhibitory effect of milk on ricin activity in Vero cells was at the same level as by anti-ricin antibodies. We also found that (a) milk did not inhibit ricin at concentrations of 10 or 100 ng/ml; (b) autoclaving 10 and 100 ng/ml ricin in DMEM at 121 degrees C for 30 min completely abolished activity; and (c) milk did not affect the activity of another ribosome inactivating protein, Shiga toxin type 2 (Stx2), produced by pathogenic Escherichia coli O157:H7. Unlike ricin, which is internalized into the cells via a galactose-binding site, Stx2 is internalized through the cell surface receptor glycolipid globotriasylceramides Gb3 and Gb4. These observations suggest that ricin toxicity may possibly be reduced at room temperature by a widely consumed natural liquid food.	[Rasooly, Reuven; He, Xiaohua] ARS, Foodborne Contaminants Unit, USDA, Albany, CA 94710 USA; [Friedman, Mendel] ARS, USDA, Unit Produce Safety & Microbiol Res, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Rasooly, R (corresponding author), ARS, Foodborne Contaminants Unit, USDA, Albany, CA 94710 USA.	reuven.rasooly@ars.usda.gov						Al Mijan M, 2011, KOREAN J FOOD SCI AN, V31, P631, DOI 10.5851/kosfa.2011.31.5.631; Bai Y, 2009, ARCH BIOCHEM BIOPHYS, V483, P23, DOI 10.1016/j.abb.2008.12.013; Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; Benson JM, 2011, INHAL TOXICOL, V23, P247, DOI 10.3109/08958378.2011.565490; BLUM JS, 1991, J BIOL CHEM, V266, P22091; Brandon DL, 2011, TOXINS, V3, P398, DOI 10.3390/toxins3040398; Brown-Esters O, 2012, INT DAIRY J, V22, P98, DOI 10.1016/j.idairyj.2011.09.010; Casado B, 2009, J PROTEOMICS, V73, P196, DOI 10.1016/j.jprot.2009.09.018; El-Hawiet A, 2011, GLYCOBIOLOGY, V21, P1217, DOI 10.1093/glycob/cwr055; Forsum E., 1975, PROTEIN NUTRITIONA 2, P433; Garber EAE, 2008, J FOOD PROTECT, V71, P1875, DOI 10.4315/0362-028X-71.9.1875; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; He LL, 2011, J FOOD SCI, V76, pN49, DOI 10.1111/j.1750-3841.2011.02196.x; He XH, 2010, J FOOD PROTECT, V73, P695, DOI 10.4315/0362-028X-73.4.695; Horner TW, 2011, J DAIRY SCI, V94, P3242, DOI 10.3168/jds.2010-3742; Jackson LS, 2006, J AGR FOOD CHEM, V54, P7300, DOI 10.1021/jf061199n; Jasheway K, 2011, TOXINS, V3, P1233, DOI 10.3390/toxins3101233; Labuza T. P., 2011, ANN M INT ASS FOOD P; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; Matsumura T, 2007, BIOCHEM BIOPH RES CO, V352, P867, DOI 10.1016/j.bbrc.2006.11.095; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Nagatsuka T, 2010, ACS APPL MATER INTER, V2, P1081, DOI 10.1021/am900846r; Poore C, 2009, J HAZARD MATER, V172, P559, DOI 10.1016/j.jhazmat.2009.05.142; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Rao RD, 2004, J FOOD PROTECT, V67, P403, DOI 10.4315/0362-028X-67.2.403; Rasooly R, 2010, J AGR FOOD CHEM, V58, P9281, DOI 10.1021/jf101744z; Rasooly R, 2010, J FOOD SCI, V75, pM296, DOI 10.1111/j.1750-3841.2010.01615.x; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Wang ML, 2011, J AGR FOOD CHEM, V59, P9250, DOI 10.1021/jf202949v; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	32	17	18	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27924	27929		10.1074/jbc.M112.362988	http://dx.doi.org/10.1074/jbc.M112.362988			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733821	hybrid, Green Published			2022-12-28	WOS:000307840700066
J	Schaedler, TA; Tong, Z; van Veen, HW				Schaedler, Theresia A.; Tong, Zhen; van Veen, Hendrik W.			The Multidrug Transporter LmrP Protein Mediates Selective Calcium Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; LACTOCOCCUS-LACTIS; MEMBRANE-VESICLES; ESCHERICHIA-COLI; BINDING; RESISTANCE; ANTIPORTER; MECHANISM; FURA-2; SITE	LmrP is a major facilitator superfamily multidrug transporter from Lactococcus lactis that mediates the efflux of cationic amphiphilic substrates from the cell in a proton-motive force-dependent fashion. Interestingly, motif searches and docking studies suggested the presence of a putative Ca2+-binding site close to the interface between the two halves of inward facing LmrP. Binding experiments with radioactive Ca-45(2+) demonstrated the presence of a high affinity Ca2+-binding site in purified LmrP, with an apparent K-d of 7.2 mu M, which is selective for Ca2+ and Ba2+ but not for Mn2+, Mg2+, or Co2+. Consistent with our structure model and analogous to crystal structures of EF hand Ca2+-binding proteins, two carboxylates (Asp-235 and Glu-327) were found to be critical for Ca-45(2+) binding. Using Ca-45(2+) and a fluorescent Ca2+-selective probe, calcium transport measurements in intact cells, inside-out membrane vesicles, and proteoliposomes containing functionally reconstituted purified protein provided strong evidence for active efflux of Ca2+ by LmrP with an apparent K-t of 8.6 mu M via electrogenic exchange with three or more protons. These observations demonstrate for the first time that LmrP mediates selective calcium/proton antiport and raise interesting questions about the functional and physiological links between this reaction and that of multidrug transport.	[Schaedler, Theresia A.; Tong, Zhen; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; Schaedler, Theresia/0000-0002-7247-4091	Biotechnology and Biological Sciences Research Council; Pembroke College; Cambridge European Trusts; Kurt Hahn Trust; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish; BBSRC [BB/I002383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pembroke College; Cambridge European Trusts; Kurt Hahn Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council.; Recipient of awards from Pembroke College, the Cambridge European Trusts, and the Kurt Hahn Trust.	AMBUDKAR SV, 1986, J BIOL CHEM, V261, P5596; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; CHENG JB, 1994, J BIOL CHEM, V269, P27365; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; DRIESSEN AJM, 1986, EUR J BIOCHEM, V159, P149, DOI 10.1111/j.1432-1033.1986.tb09845.x; Fujisawa M, 2009, ARCH MICROBIOL, V191, P649, DOI 10.1007/s00203-009-0494-7; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Guffanti AA, 1998, J BIOL CHEM, V273, P26447, DOI 10.1074/jbc.273.41.26447; HAGIWARA S, 1974, J GEN PHYSIOL, V63, P564, DOI 10.1085/jgp.63.5.564; KOBAYASHI H, 1978, J BIOL CHEM, V253, P2085; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; MATSUSHITA T, 1986, EUR J BIOCHEM, V156, P95, DOI 10.1111/j.1432-1033.1986.tb09553.x; MCDONOUGH PM, 1989, CELL CALCIUM, V10, P171, DOI 10.1016/0143-4160(89)90071-7; MOLENAAR D, 1992, J BACTERIOL, V174, P3118, DOI 10.1128/jb.174.10.3118-3124.1992; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; PROCYSHYN RM, 1994, J BIOL CHEM, V269, P1641; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; ROSEN BP, 1974, P NATL ACAD SCI USA, V71, P5042, DOI 10.1073/pnas.71.12.5042; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TISA LS, 1995, P NATL ACAD SCI USA, V92, P10777, DOI 10.1073/pnas.92.23.10777; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2000, PRACT APPROACH SER, P141; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Yang JJ, 2003, PROTEIN PEPTIDE LETT, V10, P331, DOI 10.2174/0929866033478852; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Yokota A, 2000, J BACTERIOL, V182, P5196, DOI 10.1128/JB.182.18.5196-5201.2000	45	20	22	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27682	27690		10.1074/jbc.M112.372334	http://dx.doi.org/10.1074/jbc.M112.372334			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730320	Green Published, hybrid			2022-12-28	WOS:000307840700042
J	Ma, JC; Tang, WK; Esser, L; Pastan, I; Xia, D				Ma, Jichun; Tang, Wai Kwan; Esser, Lothar; Pastan, Ira; Xia, Di			Recognition of Mesothelin by the Therapeutic Antibody MORAb-009 STRUCTURAL AND MECHANISTIC INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-REPLACEMENT; MONOCLONAL-ANTIBODY; EXPRESSION; ADENOCARCINOMAS; PANCREAS; AFFINITY; BINDING; CLONING	Mesothelin is a tumor differentiation antigen that is highly expressed in many epithelial cancers, with limited expression in normal human tissues. Binding of mesothelin on normal mesothelial cells lining the pleura or peritoneum to the tumor-associated cancer antigen 125 (CA-125) can lead to heterotypic cell adhesion and tumor metastasis within the pleural and peritoneal cavities. This binding can be prevented by MORAb-009, a humanized monoclonal antibody against mesothelin currently under clinical trials. Weshow here that MORAb-009 recognizes a non-linear epitope that is contained in the first 64-residue fragment of the mesothelin. We further demonstrate that the recognition is independent of glycosylation state of the protein but sensitive to the loss of a disulfide bond linking residues Cys-7 and Cys-31. The crystal structure of the complex between the mesothelin N-terminal fragment and Fab of MORAb-009 at 2.6 angstrom resolution reveals an epitope encompassing multiple secondary structural elements of the mesothelin, including residues from helix alpha 1, the loops linking helices alpha 1 and alpha 2, and between helices alpha 4 and alpha 5. The mesothelin fragment has a compact, right-handed superhelix structure consisting of five short helices and connecting loops. A residue essential for complex formation has been identified as Phe-22, which projects its side chain into a hydrophobic niche formed on the antibody recognition surface upon antigen-antibody contact. The overlapping binding footprints of both the monoclonal antibody and the cancer antigen CA-125 explains the therapeutic effect and provides a basis for further antibody improvement.	[Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, D (corresponding author), 37 Convent Dr,Bldg 37,Rm 2122C, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012; pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Cooperative Research and Development Agreement CRADA with Morphotek; NATIONAL CANCER INSTITUTE [ZIABC010600, ZIABC008753, ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cooperative Research and Development Agreement CRADA with Morphotek; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. This work was also supported by a Cooperative Research and Development Agreement CRADA with Morphotek.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Argani P, 2001, CLIN CANCER RES, V7, P3862; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Bateman AC, 1997, HISTOPATHOLOGY, V30, P49, DOI 10.1046/j.1365-2559.1996.d01-562.x; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan Raffit, 2007, Cancer Immun, V7, P20; Hassan R, 2010, LUNG CANCER, V68, P455, DOI 10.1016/j.lungcan.2009.07.016; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma JC, 2008, J APPL CRYSTALLOGR, V41, P1150, DOI 10.1107/S0021889808033797; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Sathyanarayana BK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-1; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sundberg E. J., 2004, MOL BIOL B CELLS, VVII, P491; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yen MJ, 2006, CLIN CANCER RES, V12, P827, DOI 10.1158/1078-0432.CCR-05-1397; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346	33	23	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33123	33131		10.1074/jbc.M112.381756	http://dx.doi.org/10.1074/jbc.M112.381756			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22787150	Green Published, hybrid			2022-12-28	WOS:000309602100004
J	Munari, F; Soeroes, S; Zenn, HM; Schomburg, A; Kost, N; Schroder, S; Klingberg, R; Rezaei-Ghaleh, N; Stutzer, A; Gelato, KA; Walla, PJ; Becker, S; Schwarzer, D; Zimmermann, B; Fischle, W; Zweckstetter, M				Munari, Francesca; Soeroes, Szabolcs; Zenn, Hans Michael; Schomburg, Adrian; Kost, Nils; Schroeder, Sabrina; Klingberg, Rebecca; Rezaei-Ghaleh, Nasrollah; Stuetzer, Alexandra; Gelato, Kathy Ann; Walla, Peter Jomo; Becker, Stefan; Schwarzer, Dirk; Zimmermann, Bastian; Fischle, Wolfgang; Zweckstetter, Markus			Methylation of Lysine 9 in Histone H3 Directs Alternative Modes of Highly Dynamic Interaction of Heterochromatin Protein hHP1 beta with the Nucleosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATED TARGET LOCATION; HP1 BINDING; STRUCTURAL BASIS; DNA-BINDING; IN-VITRO; DOMAIN; CHROMATIN; CHROMODOMAIN; NMR; HP1-ALPHA	Binding of heterochromatin protein 1 (HP1) to the histone H3 lysine 9 trimethylation (H3K9me3) mark is a hallmark of establishment and maintenance of heterochromatin. Although genetic and cell biological aspects have been elucidated, the molecular details of HP1 binding to H3K9me3 nucleosomes are unknown. Using a combination of NMR spectroscopy and biophysical measurements on fully defined recombinant experimental systems, we demonstrate that H3K9me3 works as an on/off switch regulating distinct binding modes of hHP1 beta to the nucleosome. The methyl-mark determines a highly flexible and very dynamic interaction of the chromodomain of hHP1 beta with the H3-tail. There are no other constraints of interaction or additional multimerization interfaces. In contrast, in the absence of methylation, the hinge region and the N-terminal tail form weak nucleosome contacts mainly with DNA. In agreement with the high flexibility within the hHP1 beta-H3K9me3 nucleosome complex, the chromoshadow domain does not provide a direct binding interface. Our results report the first detailed structural analysis of a dynamic protein-nucleosome complex directed by a histone modification and provide a conceptual framework for understanding similar interactions in the context of chromatin.	[Soeroes, Szabolcs; Schomburg, Adrian; Kost, Nils; Schroeder, Sabrina; Stuetzer, Alexandra; Gelato, Kathy Ann; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Munari, Francesca; Rezaei-Ghaleh, Nasrollah; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zenn, Hans Michael; Zimmermann, Bastian] Biaffin GmbH & Co KG, D-34132 Kassel, Germany; [Klingberg, Rebecca; Schwarzer, Dirk] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Walla, Peter Jomo] Tech Univ Carolo Wilhelmina Braunschweig, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Braunschweig University of Technology; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Fischle, W (corresponding author), Max Planck Inst Biophys Chem, Lab Chromatin Biochem, Fassberg 11, D-37077 Gottingen, Germany.	wfischl@gwdg.de; markus.zweckstetter@dzne.de	Rezaei-Ghaleh, Nasrollah/B-9443-2008	Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Zweckstetter, Markus/0000-0002-2536-6581; Schwarzer, Dirk/0000-0002-7477-3319; Munari, Francesca/0000-0002-8217-1481	Max Planck Society; European Union Marie Curie reintegration fellowship; NET fellowship of the NOE Epigenome; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [ZW 71/2-2, ZW 71/3-2, SFB 860]; Heisenberg scholarship	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union Marie Curie reintegration fellowship; NET fellowship of the NOE Epigenome; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg scholarship(German Research Foundation (DFG))	This work was supported in part by the Max Planck Society (to P. J. W., W. F., and M. Z.), the European Union Marie Curie reintegration fellowship and NET fellowship of the NOE Epigenome (to W. F.), the Fonds der Chemischen Industrie (to P. J. W.), the Deutsche Forschungsgemeinschaft (to P. J. W.), Heisenberg scholarship (to M. Z.), and Deutsche Forschungsgemeinschaft Grants ZW 71/2-2 and 3-2, SFB 860 (to M. Z.).	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dialynas GK, 2006, J BIOL CHEM, V281, P14350, DOI 10.1074/jbc.M600558200; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Halle B, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269991; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kwon SH, 2008, MOL CELLS, V26, P217; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Seeliger D, 2012, ACS CHEM BIOL, V7, P150, DOI 10.1021/cb200363r; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Singh P B, 2010, Genetika, V46, P1424; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Sugimoto K, 1996, J BIOCHEM, V120, P153; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Yamada T, 1999, J BIOCHEM, V125, P832, DOI 10.1093/oxfordjournals.jbchem.a022356; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zhao T, 2000, J BIOL CHEM, V275, P28332	50	48	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33756	33765		10.1074/jbc.M112.390849	http://dx.doi.org/10.1074/jbc.M112.390849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22815475	Green Published, hybrid			2022-12-28	WOS:000309602100058
J	Perez-Berna, AJ; Ortega-Esteban, A; Menendez-Conejero, R; Winkler, DC; Menendez, M; Steven, AC; Flint, SJ; de Pablo, PJ; San Martin, C				Perez-Berna, Ana J.; Ortega-Esteban, Alvaro; Menendez-Conejero, Rosa; Winkler, Dennis C.; Menendez, Margarita; Steven, Alasdair C.; Flint, S. Jane; de Pablo, Pedro J.; San Martin, Carmen			The Role of Capsid Maturation on Adenovirus Priming for Sequential Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; VIRAL-DNA; VIRUS ENTRY; CELL ENTRY; TYPE-2; STABILITY; MICROSCOPY; TRANSPORT; PROTEASE; RECONSTRUCTIONS	Adenovirus assembly concludes with proteolytic processing of several capsid and core proteins. Immature virions containing precursor proteins lack infectivity because they cannot properly uncoat, becoming trapped in early endosomes. Structural studies have shown that precursors increase the network of interactions maintaining virion integrity. Using different biophysical techniques to analyze capsid disruption in vitro, we show that immature virions are more stable than the mature ones under a variety of stress conditions and that maturation primes adenovirus for highly cooperative DNA release. Cryoelectron tomography reveals that under mildly acidic conditions mimicking the early endosome, mature virions release pentons and peripheral core contents. At higher stress levels, both mature and immature capsids crack open. The virus core is completely released from cracked capsids in mature virions, but it remains connected to shell fragments in the immature particle. The extra stability of immature adenovirus does not equate with greater rigidity, because in nanoindentation assays immature virions exhibit greater elasticity than the mature particles. Our results have implications for the role of proteolytic maturation in adenovirus assembly and uncoating. Precursor proteins favor assembly by establishing stable interactions with the appropriate curvature and preventing premature ejection of contents by tightly sealing the capsid vertices. Upon maturation, core organization is looser, particularly at the periphery, and interactions preserving capsid curvature are weakened. The capsid becomes brittle, and pentons are more easily released. Based on these results, we hypothesize that changes in core compaction during maturation may increase capsid internal pressure to trigger proper uncoating of adenovirus.	[Perez-Berna, Ana J.; Menendez-Conejero, Rosa; San Martin, Carmen] Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Macromol Struct, E-28049 Madrid, Spain; [Ortega-Esteban, Alvaro; de Pablo, Pedro J.] Univ Autonoma Madrid, Dept Condensed Matter Phys, E-28049 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Menendez, Margarita] CIBER Enfermedades Resp, Madrid 28006, Spain; [Winkler, Dennis C.; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Princeton University	San Martin, C (corresponding author), Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Macromol Struct, Darwin 3, E-28049 Madrid, Spain.	carmen@cnb.csic.es	Perez-Berna, Ana/G-2789-2016; Menendez, Margarita/M-1795-2014; de Pablo, Pedro/L-9392-2014; Ortega-Esteban, Alvaro/M-7458-2015; San Martín, Carmen/A-4074-2010	Menendez, Margarita/0000-0002-3267-4443; de Pablo, Pedro/0000-0003-2386-3186; Ortega-Esteban, Alvaro/0000-0001-9642-0568; San Martín, Carmen/0000-0001-9799-175X; Perez-Berna, Ana/0000-0003-4145-532X; Winkler, Dennis/0000-0003-1445-6554	National Institutes of Health [GM037705, AI1058172]; Ministry of Science and Innovation of Spain [BFU2010-16382/BMC, MAT2008-02533, PIB2010US-00233, FIS2011-29493, FIS2010-10552-E, FIS2011-16090-E, BFU2009-10052]; Local Madrid Government [P2009/MAT-1467]; Juan de la Cierva Postdoctoral Contract from the Ministry of Science and Innovation of Spain [JCI-2009-05187]; Spain CSIC Travel Grant [PA1002892]; Ministry of Education of Spain; Instituto de Salud Carlos III of Spain [FI08/00035]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Local Madrid Government; Juan de la Cierva Postdoctoral Contract from the Ministry of Science and Innovation of Spain; Spain CSIC Travel Grant; Ministry of Education of Spain(Spanish Government); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM037705 and AI1058172 (to S. J. F.). This work was also supported by Ministry of Science and Innovation of Spain Grants BFU2010-16382/BMC (to C. S. M.), MAT2008-02533, PIB2010US-00233, and FIS2011-29493 (to P. J. P.), FIS2010-10552-E and FIS2011-16090-E (to C. S. M. and P. J. P.), and BFU2009-10052 (to M. M.), and by Local Madrid Government Grant P2009/MAT-1467 (to P. J. P.).; Recipient of Juan de la Cierva Postdoctoral Contract JCI-2009-05187 from the Ministry of Science and Innovation of Spain and recipient of additional support from Spain CSIC Travel Grant PA1002892.; Recipient of FPU predoctoral fellowship from the Ministry of Education of Spain.; Recipient of Predoctoral Fellowship FI08/00035 from the Instituto de Salud Carlos III of Spain.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Baclayon M, 2011, NANO LETT, V11, P4865, DOI 10.1021/nl202699r; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carreira A, 2004, J BIOL CHEM, V279, P6517, DOI 10.1074/jbc.M307662200; CHATTERJEE PK, 1985, J VIROL, V55, P379, DOI 10.1128/JVI.55.2.379-386.1985; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; COTTEN M, 1995, VIROLOGY, V213, P494, DOI 10.1006/viro.1995.0022; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HANNAN C, 1983, INTERVIROLOGY, V19, P213, DOI 10.1159/000149363; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Huang RK, 2011, J MOL BIOL, V408, P541, DOI 10.1016/j.jmb.2011.01.016; Ihnat PM, 2005, BBA-GEN SUBJECTS, V1726, P138, DOI 10.1016/j.bbagen.2005.06.006; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leen AM, 2005, BRIT J HAEMATOL, V128, P135, DOI 10.1111/j.1365-2141.2004.05218.x; Lindert S, 2009, J VIROL, V83, P11491, DOI 10.1128/JVI.01214-09; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Ortega-Esteban A, 2012, ULTRAMICROSCOPY, V114, P56, DOI 10.1016/j.ultramic.2012.01.007; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; RANCOURT C, 1995, VIROLOGY, V209, P167, DOI 10.1006/viro.1995.1240; Rexroad J, 2006, J PHARM SCI-US, V95, P237, DOI 10.1002/jps.20496; Rexroad J, 2003, J PHARM SCI, V92, P665, DOI 10.1002/jps.10340; Rexroad J, 2006, J PHARM SCI-US, V95, P1469, DOI 10.1002/jps.20617; Roos WH, 2012, P NATL ACAD SCI USA, V109, P2342, DOI 10.1073/pnas.1109590109; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2009, STRUCTURE, V17, P1563, DOI 10.1016/j.str.2009.10.009; Seki T, 2002, J VIROL, V76, P1100, DOI 10.1128/JVI.76.3.1100-1108.2002; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; Singh R, 2009, TRENDS BIOTECHNOL, V27, P220, DOI 10.1016/j.tibtech.2009.01.003; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Teschke CM, 2003, BIOPHYS J, V84, P2585, DOI 10.1016/S0006-3495(03)75063-2; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; Weber J. M., 1999, MED INTELL UNIT, P79; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614; Zandi R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021917; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028	65	70	73	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31582	31595		10.1074/jbc.M112.389957	http://dx.doi.org/10.1074/jbc.M112.389957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791715	Green Published, hybrid			2022-12-28	WOS:000308791300070
J	Tokutsu, R; Kato, N; Bui, KH; Ishikawa, T; Minagawa, J				Tokutsu, Ryutaro; Kato, Nobuyasu; Bui, Khanh Huy; Ishikawa, Takashi; Minagawa, Jun			Revisiting the Supramolecular Organization of Photosystem II in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; OXYGEN-EVOLVING COMPLEX; ELECTRON-MICROSCOPY; STATE TRANSITIONS; THYLAKOID MEMBRANE; GREEN PLANTS; IN-VIVO; CRYSTAL-STRUCTURE; GRANA MEMBRANES; 16-KDA PROTEINS	Photosystem II (PSII) is a multiprotein complex that splits water and initiates electron transfer in photosynthesis. The central part of PSII, the PSII core, is surrounded by light-harvesting complex II proteins (LHCIIs). In higher plants, two or three LHCII trimers are seen on each side of the PSII core whereas only one is seen in the corresponding positions in Chlamydomonas reinhardtii, probably due to the absence of CP24, a minor monomeric LHCII. Here, we re-examined the supramolecular organization of the C. reinhardtii PSII-LHCII supercomplex by determining the effect of different solubilizing detergents. When we solubilized the thylakoid membranes with n-dodecyl-beta-D-maltoside (beta-DM) or n-dodecyl-alpha-D-maltoside (alpha-DM) and subjected them to gel filtration, we observed a clear difference in molecular mass. The alpha-DM-solubilized PSII-LHCII supercomplex bound twice more LHCII than the beta-DM-solubilized supercomplex and retained higher oxygen-evolving activity. Single-particle image analysis from electron micrographs of the alpha-DM-solubilized and negatively stained supercomplex revealed that the PSII-LHCII supercomplex had a novel supramolecular organization, with three LHCII trimers attached to each side of the core.	[Tokutsu, Ryutaro; Minagawa, Jun] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Kato, Nobuyasu] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Bui, Khanh Huy; Ishikawa, Takashi] ETH, Dept Biol, CH-8093 Zurich, Switzerland	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Hokkaido University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Minagawa, J (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Environm Photobiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/GRF-0208-2022; Ishikawa, Takashi/E-5023-2017; Tokutsu, Ryutaro/V-7596-2019	Ishikawa, Takashi/0000-0002-1976-7477; Tokutsu, Ryutaro/0000-0003-2037-255X; Bui, Khanh Huy/0000-0001-8231-3016; Minagawa, Jun/0000-0002-3028-3203; Bui, Khanh Huy/0000-0003-2814-9889	Japan Society for the Promotion of Science [21001384]; Council for Science and Technology [GS026]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology	This work was in part supported by the Japan Society for the Promotion of Science through Research Fellowship for Young Scientists 21001384 to (R. T.) and Funding Program for Next Generation World-Leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy Grant GS026 (to J. M.).	Bertos NR, 1998, J PHYCOL, V34, P1009, DOI 10.1046/j.1529-8817.1998.341009.x; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Boekema EJ, 1998, EUR J BIOCHEM, V252, P268, DOI 10.1046/j.1432-1327.1998.2520268.x; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOODENOUGH UW, 1969, PLANT PHYSIOL, V44, P990, DOI 10.1104/pp.44.7.990; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Nicholson WV, 1996, BIOCHEM J, V315, P543, DOI 10.1042/bj3150543; Nicholson WV, 1996, BIOSCIENCE REP, V16, P159, DOI 10.1007/BF01206204; Nield J, 2000, J BIOL CHEM, V275, P27940; Nield J, 2000, NAT STRUCT BIOL, V7, P44; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Sugiura M, 1998, FEBS LETT, V426, P140, DOI 10.1016/S0014-5793(98)00328-7; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; WRIGLEY NG, 1968, J ULTRA MOL STRUCT R, V24, P454, DOI 10.1016/S0022-5320(68)80048-6; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x	47	72	72	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31574	31581		10.1074/jbc.M111.331991	http://dx.doi.org/10.1074/jbc.M111.331991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801422	Green Published, hybrid			2022-12-28	WOS:000308791300069
J	Chen, XY; Gu, XT; Saiyin, HXG; Wan, B; Zhang, YJ; Li, J; Wang, YL; Gao, R; Wang, YF; Dong, WP; Najjar, SM; Zhang, CY; Ding, HF; Liu, JO; Yu, L				Chen, Xin-Ya; Gu, Xiu-Ting; Saiyin, Hexige; Wan, Bo; Zhang, Yu-Jing; Li, Jing; Wang, Ying-Li; Gao, Rui; Wang, Yu-Fan; Dong, Wei-Ping; Najjar, Sonia M.; Zhang, Chen-Yu; Ding, Han-Fei; Liu, Jun O.; Yu, Long			Brain-selective Kinase 2 (BRSK2) Phosphorylation on PCTAIRE1 Negatively Regulates Glucose-stimulated Insulin Secretion in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CA2+ CHANNELS; LKB1 DELETION; PURIFICATION; EXPRESSION; POLARITY; FAMILY; SAD	Brain-selective kinase 2 (BRSK2) has been shown to play an essential role in neuronal polarization. In the present study, we show that BRSK2 is also abundantly expressed in pancreatic islets and MIN6 beta-cell line. Yeast two-hybrid screening, GST fusion protein pull-down, and co-immunoprecipitation assays reveal that BRSK2 interacts with CDK-related protein kinase PCTAIRE1, a kinase involved in neurite outgrowth and neurotransmitter release. In MIN6 cells, BRSK2 co-localizes with PCTAIRE1 in the cytoplasm and phosphorylates one of its serine residues, Ser-12. Phosphorylation of PCTAIRE1 by BRSK2 reduces glucose-stimulated insulin secretion (GSIS) in MIN6 cells. Conversely, knockdown of BRSK2 by siRNA increases serum insulin levels in mice. Our results reveal a novel function of BRSK2 in the regulation of GSIS in beta-cells via a PCTAIRE1-dependent mechanism and suggest that BRSK2 is an attractive target for developing novel diabetic drugs.	[Chen, Xin-Ya; Gu, Xiu-Ting; Saiyin, Hexige; Wan, Bo; Wang, Ying-Li; Gao, Rui; Yu, Long] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Yu-Jing; Li, Jing; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Yu-Fan; Dong, Wei-Ping] Shanghai First Peoples Hosp, Dept Endocrinol, Shanghai 200080, Peoples R China; [Najjar, Sonia M.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Ding, Han-Fei] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Ding, Han-Fei] Georgia Hlth Sci Univ, Dept Pathol, Augusta, GA 30912 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Fudan University; Nanjing University; University System of Ohio; University of Toledo; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Johns Hopkins University	Yu, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Inst Biomed Sci, Handan Rd 220, Shanghai 200433, Peoples R China.	Longyu@fudan.edu.cn	Wan, Bo/AAE-6352-2021; Najjar, Sonia M/GXW-2217-2022	Saiyin, Hexige/0000-0003-2993-6817; Ding, Han-Fei/0000-0001-5702-3439	National Institutes of Health [R01DK054254, R01DK083850, CA124982]; National 973 Program of China; 863 Projects of China; National Natural Science Foundation of China [30024001]; NATIONAL CANCER INSTITUTE [R01CA124982] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK083850, R01DK054254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National 973 Program of China(National Basic Research Program of China); 863 Projects of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part by grants from the National Institutes of Health (R01DK054254 and R01DK083850 (to S. M. N.), and CA124982 (to H. F. D.), by the National 973 Program of China, the 863 Projects of China, and the National Natural Science Foundation of China (30024001).	Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; Besset V, 1999, CELL GROWTH DIFFER, V10, P173; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bradley SP, 2005, PANCREAS, V31, P373, DOI 10.1097/01.mpa.0000179730.69081.64; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Graeser R, 2002, J CELL SCI, V115, P3479; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morgan A, 2004, CURR BIOL, V14, pR968, DOI 10.1016/j.cub.2004.10.045; OKUDA T, 1992, ONCOGENE, V7, P2249; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Woodman PG, 1997, BBA-MOL CELL RES, V1357, P155, DOI 10.1016/S0167-4889(97)00039-6; Xavier GD, 2003, BIOCHEM J, V371, P761	36	34	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30368	30375		10.1074/jbc.M112.375618	http://dx.doi.org/10.1074/jbc.M112.375618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798068	hybrid, Green Published			2022-12-28	WOS:000308579800029
J	Valenti, A; De Felice, M; Perugino, G; Bizard, A; Nadal, M; Rossi, M; Ciaramella, M				Valenti, Anna; De Felice, Mariarita; Perugino, Giuseppe; Bizard, Anna; Nadal, Marc; Rossi, Mose; Ciaramella, Maria			Synergic and Opposing Activities of Thermophilic RecQ-like Helicase and Topoisomerase 3 Proteins in Holliday Junction Processing and Replication Fork Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; DNA-BINDING-PROTEIN; REVERSE GYRASE; III-ALPHA; STRAND-EXCHANGE; BLM; INTERACTS; MAINTENANCE; REGRESSION; RESOLUTION	RecQ family helicases and topoisomerase 3 enzymes form evolutionary conserved complexes that play essential functions in DNA replication, recombination, and repair, and in vitro, show coordinate activities on model recombination and replication intermediates. Malfunctioning of these complexes in humans is associated with genomic instability and cancer-prone syndromes. Although both RecQ-like and topoisomerase 3 enzymes are present in archaea, only a few of them have been studied, and no information about their functional interaction is available. We tested the combined activities of the RecQ-like helicase, Hel112, and the topoisomerase 3, SsTop3, from the thermophilic archaeon Sulfolobus solfataricus. Hel112 showed coordinate DNA unwinding and annealing activities, a feature shared by eukaryotic RecQ homologs, which resulted in processing of synthetic Holliday junctions and stabilization of model replication forks. SsTop3 catalyzed DNA relaxation and annealing. When assayed in combination, SsTop3 inhibited the Hel112 helicase activity on Holliday junctions and stimulated formation and stabilization of such structures. In contrast, Hel112 did not affect the SsTop3 DNA relaxation activity. RecQ-topoisomerase 3 complexes show structural similarity with the thermophile-specific enzyme reverse gyrase, which catalyzes positive supercoiling of DNA and was suggested to play a role in genome stability at high temperature. Despite such similarity and the high temperature of reaction, the SsTop3-Hel112 complex does not induce positive supercoiling and is thus likely to play different roles. We propose that the interplay between Hel112 and SsTop3 might regulate the equilibrium between recombination and anti-recombination activities at replication forks.	[Valenti, Anna; De Felice, Mariarita; Perugino, Giuseppe; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Bizard, Anna; Nadal, Marc] Univ Versailles St Quentin, F-78035 Versailles, France; [Bizard, Anna; Nadal, Marc] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Ciaramella, Maria/O-1152-2015	Ciaramella, Maria/0000-0003-1583-1694; Valenti, Anna/0000-0002-5278-3524; Perugino, Giuseppe/0000-0003-3266-4744; NADAL, Marc/0000-0001-9637-7694; Bizard, Anna/0000-0003-1858-3999	Ministero degli Affari Esteri [L.401/1990];  [RBNE08YFN3]	Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy)); 	This work was supported in part by Merit Grant RBNE08YFN3 and Ministero degli Affari Esteri (Grant L.401/1990).	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Bizard A, 2011, J MOL BIOL, V408, P839, DOI 10.1016/j.jmb.2011.03.030; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Chen CF, 2010, EMBO J, V29, P1713, DOI 10.1038/emboj.2010.61; Chen L, 2006, MOL MICROBIOL, V60, P783, DOI 10.1111/j.1365-2958.2006.05133.x; Chester N, 2006, MOL CELL BIOL, V26, P6713, DOI 10.1128/MCB.00296-06; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Dai PG, 2003, J BACTERIOL, V185, P5500, DOI 10.1128/JB.185.18.5500-5507.2003; De Felice M, 2007, BIOCHEM J, V408, P87, DOI 10.1042/BJ20070134; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Laine JP, 2003, CANCER RES, V63, P7136; Li XY, 2011, J GENET GENOMICS, V38, P253, DOI 10.1016/j.jgg.2011.05.001; Li Z, 2008, J BACTERIOL, V190, P3006, DOI 10.1128/JB.01662-07; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Nadal M, 2007, BIOCHIMIE, V89, P447, DOI 10.1016/j.biochi.2006.12.010; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Rezazadeh S, 2012, MOL BIOL REP, V39, P4527, DOI 10.1007/s11033-011-1243-y; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Russell B, 2011, CANCER RES, V71, P561, DOI 10.1158/0008-5472.CAN-10-1727; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Vindigni A, 2010, BIOPHYS CHEM, V149, P67, DOI 10.1016/j.bpc.2010.03.012; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Woodman IL, 2009, BIOCHEM SOC T, V37, P74, DOI 10.1042/BST0370074; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	49	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30282	30295		10.1074/jbc.M112.366377	http://dx.doi.org/10.1074/jbc.M112.366377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22722926	Green Published, hybrid			2022-12-28	WOS:000308579800021
J	Zhao, ZH; Hong, W; Zeng, ZY; Wu, YL; Hu, KH; Tian, XH; Li, WX; Cao, ZJ				Zhao, Zhenhuan; Hong, Wei; Zeng, Zhengyang; Wu, Yingliang; Hu, Kanghong; Tian, Xiaohui; Li, Wenxin; Cao, Zhijian			Mucroporin-M1 Inhibits Hepatitis B Virus Replication by Activating the Mitogen-activated Protein Kinase (MAPK) Pathway and Down-regulating HNF4 alpha in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; FACTOR 4 ALPHA; GENE-EXPRESSION; ANTIMICROBIAL PEPTIDES; TRANSCRIPTION FACTORS; 3 BETA; INFECTION; VENOM; PROMOTER; RECEPTORS	Hepatitis B virus (HBV) is a noncytopathic human hepadnavirus that causes acute, chronic hepatitis and hepatocellular carcinoma (HCC). As the clinical utility of current therapies is limited, new anti-HBV agents and sources for such agents are still highly sought after. Here, we report that Mucroporin-M1, a scorpion venom-derived peptide, reduces the amount of extracellular HBsAg, HBeAg, and HBV DNA productions of HepG2.2.15 cells in a dose-dependent manner and inhibits HBV capsid DNA, HBV intracellular RNA replication intermediates and the HBV Core protein in the cytoplasm of HepG2.2.15 cells. Using a mouse model of HBV infection, we found that HBV replication was significantly inhibited by intravenous injection of the Mucroporin-M1 peptide. This inhibitory activity was due to a reduction in HBV promoter activity caused by a decrease in the binding of HNF4 alpha to the precore/core promoter region. Furthermore, we confirmed that Mucroporin-M1 could selectively activate mitogen-activated protein kinases (MAPKs) and lead to the down-regulation of HNF4 alpha expression, which explains the decreased binding of HNF4 alpha to the HBV promoter. Moreover, when the protein phosphorylation activity of the MAPK pathway was inhibited, both HNF4 alpha expression and HBV replication recovered. Finally, we proved that treatment with the Mucroporin-M1 peptide increased phosphorylation of the MAPK proteins in HBV-harboring mice. These results implicate Mucroporin-M1 peptide can activate the MAPK pathway and then reduce the expression of HNF4 alpha, resulting in the inhibition of HBV replication in vitro and in vivo. Our work also opens new doors to discovering novel anti-HBV agents or sources.	[Zhao, Zhenhuan; Hong, Wei; Zeng, Zhengyang; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Hu, Kanghong; Tian, Xiaohui] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Hu, Kanghong/AAL-3011-2020; Hong, Wei/AAJ-6912-2020	Hong, Wei/0000-0001-7410-4679	National Key Basic Research Program in China [2010CB529800, 2010CB530100]; National Natural Science Foundation of China [31071942, 30971500]; China Specific Project for Developing New Drugs [2011ZX09401-302, 2011ZX09102-001-32]; Fundamental Research Funds for the Central Universities of China [1102001]	National Key Basic Research Program in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Specific Project for Developing New Drugs; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Key Basic Research Program in China (2010CB529800 and 2010CB530100), National Natural Science Foundation of China (31071942 and 30971500), China Specific Project for Developing New Drugs (2011ZX09401-302 and 2011ZX09102-001-32), and Fundamental Research Funds for the Central Universities of China (1102001).	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Chen EQ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-23; Chen HS, 2009, J PAIN, V10, P201, DOI 10.1016/j.jpain.2008.08.011; Dai C, 2008, ANTIMICROB AGENTS CH, V52, P3967, DOI 10.1128/AAC.00542-08; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Fan Z, 2011, ANTIMICROB AGENTS CH, V55, P5220, DOI 10.1128/AAC.00369-11; Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Ishida H, 2000, J VIROL, V74, P1241, DOI 10.1128/JVI.74.3.1241-1251.2000; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kovalchuk LV, 2007, ADV EXP MED BIOL, V601, P369; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005489; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Li Ying, 2005, Antiviral Chemistry & Chemotherapy, V16, P193; Long Y, 2009, J VIRAL HEPATITIS, V16, P537, DOI 10.1111/j.1365-2893.2009.01089.x; Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002; McGibbon Emily, 2012, Morbidity and Mortality Weekly Report, V61, P6; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Torres HA, 2012, NAT REV CLIN ONCOL, V9, P156, DOI 10.1038/nrclinonc.2012.1; VanCompernolle SE, 2005, J VIROL, V79, P11598, DOI 10.1128/JVI.79.18.11598-11606.2005; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wang ZY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-128; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Ying CX, 2007, P NATL ACAD SCI USA, V104, P8526, DOI 10.1073/pnas.0609883104; Yu XM, 2003, J VIROL, V77, P2489, DOI 10.1128/JVI.77.4.2489-2499.2003; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004; Zheng YY, 2003, J VIROL, V77, P7707, DOI 10.1128/JVI.77.14.7707-7712.2003	39	48	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30181	30190		10.1074/jbc.M112.370312	http://dx.doi.org/10.1074/jbc.M112.370312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791717	Green Published, hybrid			2022-12-28	WOS:000308579800013
J	Fauvet, B; Fares, MB; Samuel, F; Dikiy, I; Tandon, A; Eliezer, D; Lashuel, HA				Fauvet, Bruno; Fares, Mohamed-Bilal; Samuel, Filsy; Dikiy, Igor; Tandon, Anurag; Eliezer, David; Lashuel, Hilal A.			Characterization of Semisynthetic and Naturally N-alpha-Acetylated alpha-Synuclein in Vitro and in Intact Cells IMPLICATIONS FOR AGGREGATION AND CELLULAR PROPERTIES OF alpha-SYNUCLEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TERMINAL ACETYLTRANSFERASE; POSTTRANSLATIONAL MODIFICATIONS; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; MUTATION; YEAST; PATHOGENESIS; BINDING	N-terminal acetylation is a very common post-translational modification, although its role in regulating protein physical properties and function remains poorly understood. alpha-Synuclein (alpha-syn), a protein that has been linked to the pathogenesis of Parkinson disease, is constitutively N-alpha-acetylated in vivo. Nevertheless, most of the biochemical and biophysical studies on the structure, aggregation, and function of alpha-syn in vitro utilize recombinant alpha-syn from Escherichia coli, which is not N-terminally acetylated. To elucidate the effect of N-alpha-acetylation on the biophysical and biological properties of alpha-syn, we produced N-alpha-acetylated alpha-syn first using a semisynthetic methodology based on expressed protein ligation (Berrade, L., and Camarero, J. A. (2009) Cell. Mol. Life Sci. 66, 3909-3922) and then a recombinant expression strategy, to compare its properties to unacetylated alpha-syn. We demonstrate that both WT and N-alpha-acetylated alpha-syn share a similar secondary structure and oligomeric state using both purified protein preparations and in-cell NMR on E. coli overexpressing N-alpha-acetylated alpha-syn. The two proteins have very close aggregation propensities as shown by thioflavin T binding and sedimentation assays. Furthermore, both N-alpha-acetylated and WT alpha-syn exhibited similar ability to bind synaptosomal membranes in vitro and in HeLa cells, where both internalized proteins exhibited prominent cytosolic subcellular distribution. We then determined the effect of attenuating N-alpha-acetylation in living cells, first by using a nonacetylable mutant and then by silencing the enzyme responsible for alpha-syn N-alpha-acetylation. Both approaches revealed similar subcellular distribution and membrane binding for both the nonacetylable mutant and WT alpha-syn, suggesting that N-terminal acetylation does not significantly affect its structure in vitro and in intact cells.	[Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Stn 19, CH-1015 Lausanne, Switzerland; [Samuel, Filsy; Tandon, Anurag] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Dikiy, Igor; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Dikiy, Igor; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Toronto; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Stn 19, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Dikiy, Igor/M-1031-2019	Dikiy, Igor/0000-0002-8155-7788	National Institutes of Health [AG019391]; Swiss Federal Institute of Technology, Lausanne; European Research Council [243182]; NATIONAL INSTITUTE ON AGING [R37AG019391, R01AG019391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Federal Institute of Technology, Lausanne; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019391 (to D. E.). This work was also supported by the Swiss Federal Institute of Technology, Lausanne (to H. A. L.), and European Research Council Starting Grant 243182 (to H. A. L. and B. F.).	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Berrade L, 2009, CELL MOL LIFE SCI, V66, P3909, DOI 10.1007/s00018-009-0122-3; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; Brown DR, 2007, FEBS J, V274, P3766, DOI 10.1111/j.1742-4658.2007.05917.x; BROWN JL, 1979, J BIOL CHEM, V254, P1447; BROWN JL, 1976, J BIOL CHEM, V251, P1009; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hejjaoui M, 2012, J AM CHEM SOC, V134, P5196, DOI 10.1021/ja210866j; Hejjaoui M, 2011, ANGEW CHEM INT EDIT, V50, P405, DOI 10.1002/anie.201005546; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Huang H, 1999, J PEPT RES, V53, P548, DOI 10.1034/j.1399-3011.1999.00059.x; Ito Y, 2010, CURR OPIN STRUC BIOL, V20, P640, DOI 10.1016/j.sbi.2010.07.006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kikuchi J, 2010, PROTEOMICS, V10, P2769, DOI 10.1002/pmic.200900283; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LEE FJS, 1989, FEBS LETT, V256, P139, DOI 10.1016/0014-5793(89)81734-X; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Maldonado AY, 2011, PROG NUCL MAG RES SP, V59, P197, DOI 10.1016/j.pnmrs.2010.11.002; Manning LR, 2001, BIOCHEMISTRY-US, V40, P1635, DOI 10.1021/bi002157+; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martinez M, 1998, J NEUROCHEM, V71, P2528; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; PERSSON B, 1985, EUR J BIOCHEM, V152, P523, DOI 10.1111/j.1432-1033.1985.tb09227.x; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soppa J., 2010, ARCHAEA; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wislet-Gendebien S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-92; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	75	120	120	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28243	28262		10.1074/jbc.M112.383711	http://dx.doi.org/10.1074/jbc.M112.383711			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718772	hybrid, Green Published			2022-12-28	WOS:000308074600004
J	Kim, JH; Wang, AB; Conti, MA; Adelstein, RS				Kim, Jong Hyun; Wang, Aibing; Conti, Mary Anne; Adelstein, Robert S.			Nonmuscle Myosin II Is Required for Internalization of the Epidermal Growth Factor Receptor and Modulation of Downstream Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; KINASE; ACTIVATION; ISOFORM; CELLS; IDENTIFICATION; ENDOCYTOSIS; DOMAIN; PROLIFERATION; TRAFFICKING	Ligand-induced internalization of the epidermal growth factor receptor (EGFR) is an important process for regulating signal transduction, cellular dynamics, and cell-cell communication. Here, we demonstrate that nonmuscle myosin II (NM II) is required for the internalization of the EGFR and to trigger the EGFR-dependent activation of ERK and AKT. The EGFR was identified as a protein that interacts with with NM II by co-immunoprecipitation and mass spectrometry analysis. This interaction requires both the regulatory light chain 20 (RLC20) of NM II and the kinase domain of the EGFR. Two paralogs of NM II, NM II-A, and NM II-B can act to internalize the EGFR, depending on the cell type and paralog content of the cell line. Loss (siRNA) or inhibition (25 mu M blebbistatin) of NM II attenuates the internalization of the EGFR and impairs EGFR-dependent activation of ERK and AKT. Both internalization of the EGFR and downstream signaling to ERK and AKT can be partially restored in siRNA-treated cells by introduction of wild type (WT) GFP-NM II, but cannot be restored by motor mutant NM II. Taken together, these results suggest that NM II plays a role in the internalization of the EGFR and EGFR-mediated signaling pathways.	[Kim, Jong Hyun; Wang, Aibing; Conti, Mary Anne; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, JH (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea.	nr.kimjohn@gmail.com; adelster@mail.nih.gov		Adelstein, Robert/0000-0002-8683-2144	Division of Intramural Research, NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL004230, ZIAHL004218, ZICHL006019] Funding Source: NIH RePORTER	Division of Intramural Research, NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, NHLBI, National Institutes of Health.	Andzelm MM, 2007, J EXP MED, V204, P2285, DOI 10.1084/jem.20071143; Bajaj G, 2009, J BIOL CHEM, V284, P1252, DOI 10.1074/jbc.M801861200; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267; Hosaka K, 2009, KIDNEY INT, V75, P1308, DOI 10.1038/ki.2009.85; Hours MC, 2010, J CELL SCI, V123, P1449, DOI 10.1242/jcs.057687; Hu AH, 2002, J BIOL CHEM, V277, P46512, DOI 10.1074/jbc.M208506200; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Lambert S, 2008, J CELL PHYSIOL, V217, P834, DOI 10.1002/jcp.21563; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Ma XF, 2007, MOL BIOL CELL, V18, P2305, DOI 10.1091/mbc.E07-01-0073; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; MAUPIN P, 1994, J CELL SCI, V107, P3077; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Moulder SL, 2001, CANCER RES, V61, P8887; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Rey M, 2007, J CELL SCI, V120, P1126, DOI 10.1242/jcs.03415; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang Y., 2002, SCI STKE, V161, pl17; WILEY HS, 1982, J BIOL CHEM, V257, P4222	50	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27345	27358		10.1074/jbc.M111.304824	http://dx.doi.org/10.1074/jbc.M111.304824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718763	Green Published, hybrid			2022-12-28	WOS:000307840700007
J	Wu, LS; Cheng, WC; Shen, CKJ				Wu, Lien-Szu; Cheng, Wei-Cheng; Shen, C. -K. James			Targeted Depletion of TDP-43 Expression in the Spinal Cord Motor Neurons Leads to the Development of Amyotrophic Lateral Sclerosis-like Phenotypes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MICE; SUPEROXIDE-DISMUTASE; FAMILIAL ALS; GENE-EXPRESSION; FTLD-U; DISEASE; PROTEIN; NEURODEGENERATION; INCLUSIONS	ALS, or amyotrophic lateral sclerosis, is a progressive and fatal motor neuron disease with no effective medicine. Importantly, the majority of the ALS cases are with TDP-43 proteinopathies characterized with TDP-43-positive, ubiquitin-positive inclusions (UBIs) in the cytosol. However, the role of the mismetabolism of TDP-43 in the pathogenesis of ALS with TDP-43 proteinopathies is unclear. Using the conditional mouse gene targeting approach, we show that mice with inactivation of the Tardbp gene in the spinal cord motor neurons (HB9:Cre-Tardbp(1x/-)) exhibit progressive and male-dominant development of ALS-related phenotypes including kyphosis, motor dysfunctions, muscle weakness/atrophy, motor neuron loss, and astrocytosis in the spinal cord. Significantly, ubiquitinated proteins accumulate in the TDP-43-depleted motor neurons of the spinal cords of HB9:Cre-Tardbp(1x/-) mice with the ALS phenotypes. This study not only establishes an important role of TDP-43 in the long term survival and functioning of the mammalian spinal cord motor neurons, but also establishes that loss of TDP-43 function could be one major cause for neurodegeneration in ALS with TDP-43 proteinopathies.	[Wu, Lien-Szu; Cheng, Wei-Cheng; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11574, Taiwan; [Wu, Lien-Szu; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015; wu, Lien szu/N-8942-2014	wu, Lien szu/0000-0003-0216-882X	National Science Council; Academia Sinica (AS), Taipei Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (AS), Taipei Taiwan(Academia Sinica - Taiwan)	This work was supported by a Frontiers of Science Award from the National Science Council and the Academia Sinica (AS), Taipei Taiwan.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; BURKE RE, 1977, J NEUROPHYSIOL, V40, P667, DOI 10.1152/jn.1977.40.3.667; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, PATHOL BIOL, V44, P51; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; HUDSON AJ, 1993, BRAIN RES BULL, V30, P359, DOI 10.1016/0361-9230(93)90265-D; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lin MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020371; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853; Mulder D W, 1982, Adv Neurol, V36, P15; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; NEWMAN DS, 1995, J NEUROL SCI, V129, P38, DOI 10.1016/0022-510X(95)00058-A; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhou C, 2007, AMYOTROPH LATERAL SC, V8, P366, DOI 10.1080/17482960701538759; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	58	113	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27335	27344		10.1074/jbc.M112.359000	http://dx.doi.org/10.1074/jbc.M112.359000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718760	hybrid, Green Published			2022-12-28	WOS:000307840700006
J	He, L; Naik, K; Meng, SM; Cao, J; Sidhaye, AR; Ma, AL; Radovick, S; Wondisford, FE				He, Ling; Naik, Karuna; Meng, Shumei; Cao, Jia; Sidhaye, Aniket R.; Ma, Anlin; Radovick, Sally; Wondisford, Fredric E.			Transcriptional Co-activator p300 Maintains Basal Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; GLUCOSE-PRODUCTION; SREBP FAMILY; PHOSPHORYLATION; CBP; ACETYLATION; KINASE; MICE; GLYCOGENOLYSIS; SUPPRESSION	A major cause of fasting hyperglycemia in diabetes mellitus is unregulated hepatic glucose production (HGP). Insulin suppresses HGP by phosphorylating CBP and disassembling the CREB-CBP complex from gluconeogenic genes. p300 is closely related to CBP; but in contrast to CBP, p300 binds constitutively to CREB due to the absence of phosphorylation site found in CBP. In a phosphorylation-competent p300(G442S) knock-in mouse model, we demonstrate that HGP is now exquisitely sensitive to insulin suppression. p300(G422S) and hepatic-deleted p300 mice exhibited significant lower blood glucose levels in the fasted and post-prandial states, indicating a role for p300 in maintaining basal HGP.	[He, Ling; Meng, Shumei; Cao, Jia; Sidhaye, Aniket R.; Ma, Anlin; Wondisford, Fredric E.] Johns Hopkins Univ, Sch Med, Div Metab, Dept Pediat, Baltimore, MD 21287 USA; [He, Ling; Meng, Shumei; Cao, Jia; Sidhaye, Aniket R.; Ma, Anlin; Wondisford, Fredric E.] Johns Hopkins Univ, Sch Med, Div Metab, Dept Physiol, Baltimore, MD 21287 USA; [He, Ling; Meng, Shumei; Cao, Jia; Sidhaye, Aniket R.; Ma, Anlin; Wondisford, Fredric E.] Johns Hopkins Univ, Sch Med, Div Metab, Dept Med, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Div Endocrinol, Dept Pediat, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Div Endocrinol, Dept Physiol, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Div Endocrinol, Dept Med, Baltimore, MD 21287 USA; [Radovick, Sally] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Chicago	He, L (corresponding author), Johns Hopkins Univ, Sch Med, Div Metab, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu; fwondis1@jhmi.edu	Meng, Shumei/J-8891-2013		NIDDK, National Institutes of Health [K99DK085142, R00DK085142, R01DK063349]; Baltimore Diabetes Research and Training Center [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, K99DK085142, P60DK079637, R01DK063349, R00DK085142] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Baltimore Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIDDK, National Institutes of Health Grants K99DK085142 (to L. H.), R00DK085142 (to L. H.), and R01DK063349 (to F. E. W.). This work was also supported by Baltimore Diabetes Research and Training Center Grant P60DK079637 (to F. E. W.).	Adkins A, 2003, DIABETES, V52, P2213, DOI 10.2337/diabetes.52.9.2213; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bedford DC, 2011, CELL METAB, V14, P219, DOI 10.1016/j.cmet.2011.06.010; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Chan HM, 2001, J CELL SCI, V114, P2363; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Einarsdottir AB, 2009, LANCET, V373, P1316, DOI 10.1016/S0140-6736(09)60750-9; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Goodman RH, 2000, GENE DEV, V14, P1553; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS EG, 1989, JAMA-J AM MED ASSOC, V262, P1815, DOI 10.1001/jama.262.13.1815; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ramnanan CJ, 2010, DIABETES, V59, P1302, DOI 10.2337/db09-1625; Sundqvist A, 2003, P NATL ACAD SCI USA, V100, P13833, DOI 10.1073/pnas.2335135100; Vannucci R C, 2001, Semin Neonatol, V6, P147, DOI 10.1053/siny.2001.0044; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	29	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32069	32077		10.1074/jbc.M112.385864	http://dx.doi.org/10.1074/jbc.M112.385864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815486	Green Published, hybrid			2022-12-28	WOS:000309059400044
J	Nakayama, Y; Nakamura, N; Oki, S; Wakabayashi, M; Ishihama, Y; Miyake, A; Itoh, N; Kurosaka, A				Nakayama, Yoshiaki; Nakamura, Naosuke; Oki, Sayoko; Wakabayashi, Masaki; Ishihama, Yasushi; Miyake, Ayumi; Itoh, Nobuyuki; Kurosaka, Akira			A Putative Polypeptide N-Acetylgalactosaminyltransferase/Williams-Beuren Syndrome Chromosome Region 17 (WBSCR17) Regulates Lamellipodium Formation and Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GALNAC; CELL-ADHESION; GLYCOSYLATION; EXPRESSION; IDENTIFICATION; GENE; PROLIFERATION; VISUALIZATION; TRAFFICKING; COMPLETION	We previously identified a novel polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) gene, which is designated Williams-Beuren syndrome chromosome region 17 (WBSCR17) because it is located in the chromosomal flanking region of the Williams-Beuren syndrome deletion. Recent genome-scale analysis of HEK293T cells treated with a high concentration of N-acetylglucosamine (GlcNAc) demonstrated that WBSCR17 was one of the up-regulated genes possibly involved in endocytosis (Lau, K. S., Khan, S., and Dennis, J. W. (2008) Genome-scale identification of UDP-GlcNAc-dependent pathways. Proteomics 8, 3294-3302). To assess its roles, we first expressed recombinant WBSCR17 in COS7 cells and demonstrated that it was N-glycosylated and localized mainly in the Golgi apparatus, as is the case for the other GalNAc-Ts. Assay of recombinant WBSCR17 expressed in insect cells showed very low activity toward typical mucin peptide substrates. We then suppressed the expression of endogenous WBSCR17 in HEK293T cells using siRNAs and observed phenotypic changes of the knockdown cells with reduced lamellipodium formation, altered O-glycan profiles, and unusual accumulation of glycoconjugates in the late endosomes/lysosomes. Analyses of endocytic pathways revealed that macropinocytosis, but neither clathrin-nor caveolin-dependent endocytosis, was elevated in the knockdown cells. This was further supported by the findings that the overexpression of recombinant WBSCR17 stimulated lamellipodium formation, altered O-glycosylation, and inhibited macropinocytosis. WBSCR17 therefore plays important roles in lamellipodium formation and the regulation of macropinocytosis as well as lysosomes. Our study suggests that a subset of O-glycosylation produced by WBSCR17 controls dynamic membrane trafficking, probably between the cell surface and the late endosomes through macropinocytosis, in response to the nutrient concentration as exemplified by environmental GlcNAc.	[Nakayama, Yoshiaki; Nakamura, Naosuke; Oki, Sayoko; Kurosaka, Akira] Kyoto Sangyo Univ, Lab Neuroglycobiol, Dept Mol Sci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan; [Wakabayashi, Masaki; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Sakyo Ku, Kyoto 6068501, Japan; [Miyake, Ayumi; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan	Kyoto Sangyo University; Kyoto University; Kyoto University	Kurosaka, A (corresponding author), Kyoto Sangyo Univ, Lab Neuroglycobiol, Dept Mol Sci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan.	kurosaka@cc.kyoto-su.ac.jp	Ishihama, Yasushi/B-3101-2016	Ishihama, Yasushi/0000-0001-7714-203X; Nakayama, Yoshiaki/0000-0003-2187-3292	Japan Society for the Promotion of Science [24110516, 23770159]; Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Private University Strategic Research Foundation Support Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This work was in part supported by Grants-in-Aid for Scientific Research on Innovative Areas 24110516 (to Y. N.), and for Young Scientists (B) 23770159 (to Y. N.), the Protein 3000 Project from the Japan Society for the Promotion of Science (to A. K.), and the Private University Strategic Research Foundation Support Program (to A. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; CANTZ M, 1990, J INHERIT METAB DIS, V13, P523, DOI 10.1007/BF01799510; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Elhammer AP, 1999, GLYCOCONJUGATE J, V16, P171, DOI 10.1023/A:1026465232149; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Gerloni M, 2005, J IMMUNOL, V175, P6551, DOI 10.4049/jimmunol.175.10.6551; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hisatsune A, 2009, BIOCHEM BIOPH RES CO, V388, P677, DOI 10.1016/j.bbrc.2009.08.059; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kabayama H, 2011, J NEUROSCI, V31, P7357, DOI 10.1523/JNEUROSCI.2718-10.2011; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Lau KS, 2008, PROTEOMICS, V8, P3294, DOI 10.1002/pmic.200800208; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Nakamura N, 2005, BIOL PHARM BULL, V28, P429, DOI 10.1248/bpb.28.429; OGATA S, 1992, CANCER RES, V52, P5971; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Rottger S, 1998, J CELL SCI, V111, P45; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tenno M, 2007, FEBS J, V274, P6037, DOI 10.1111/j.1742-4658.2007.06124.x; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	39	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32222	32235		10.1074/jbc.M112.370932	http://dx.doi.org/10.1074/jbc.M112.370932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22787146	hybrid, Green Published			2022-12-28	WOS:000309059400059
J	Ijuin, T; Takenawa, T				Ijuin, Takeshi; Takenawa, Tadaomi			Role of Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) 5-Phosphatase Skeletal Muscle- and Kidney-enriched Inositol Polyphosphate Phosphatase (SKIP) in Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; MYOGENIC DIFFERENTIATION; C2C12 MYOGENESIS; IGF-II; MYOD; GENE; MICE; TRANSCRIPTION; 3-KINASE; BINDING	Insulin-like growth factors (IGFs) are essential for the development, regeneration, and hypertrophy of skeletal muscles. IGF-II promotes myoblast differentiation through phosphatidylinositol 3-kinase (PI 3-kinase), Akt, and mTOR signaling. Here, we report that skeletal muscle-and kidney-enriched inositol polyphosphate phosphatase (SKIP) negatively regulates myogenesis through inhibition of IGF-II production and attenuation of the IGF-II-Akt-mTOR signaling pathway. We also demonstrate that SKIP expression, which was markedly elevated during differentiation, was controlled by MyoD in C2C12 cells. Expression of SKIP inhibited IGF-II at the transcription level. These results indicate that SKIP regulates MyoD-mediated muscle differentiation. Silencing of SKIP increased IGF-II transcription and myoblast differentiation. Furthermore, knockdown of SKIP resulted in thick myotubes with a larger number of nuclei than that in control C2C12 cells. Taken together, these data indicate that SKIP controls the IGF-II-PI 3-kinase-Akt-mTOR auto-regulation loop during myogenesis. Our findings identify SKIP as a key regulator of muscle cell differentiation.	[Ijuin, Takeshi; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 6500017, Japan	Kobe University	Takenawa, T (corresponding author), Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Ijuin, Takeshi/H-7016-2017	Ijuin, Takeshi/0000-0002-0618-1776	Japan Diabetes Foundation; Hyogo Science and Technology Association	Japan Diabetes Foundation; Hyogo Science and Technology Association	This work was supported in part by grants from the Japan Diabetes Foundation and the Hyogo Science and Technology Association (to T. I.).	Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Ijuin T, 2012, J BIOL CHEM, V287, P6991, DOI 10.1074/jbc.M111.335539; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Xiong Q, 2011, MOL BIOL REP, V38, P267, DOI 10.1007/s11033-010-0104-4	36	8	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31330	31341		10.1074/jbc.M112.388785	http://dx.doi.org/10.1074/jbc.M112.388785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815484	Green Published, hybrid			2022-12-28	WOS:000308791300044
J	Bai, FW; Asojo, OA; Cirillo, P; Ciustea, M; Ledizet, M; Aristoff, PA; Leng, L; Koski, RA; Powell, TJ; Bucala, R; Anthony, KG				Bai, Fengwei; Asojo, Oluwatoyin A.; Cirillo, Pier; Ciustea, Mihai; Ledizet, Michel; Aristoff, Paul A.; Leng, Lin; Koski, Raymond A.; Powell, Thomas J.; Bucala, Richard; Anthony, Karen G.			A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RHEUMATOID-ARTHRITIS; REGULATORY ROLE; FACTOR GENE; MATRIX METALLOPROTEINASES; TAUTOMERASE INHIBITORS; SYNOVIAL FIBROBLASTS; CRYSTAL-STRUCTURE; DISCOVERY; REVEALS	Macrophage migration inhibitory factor (MIF) is a catalytic cytokine and an upstream mediator of the inflammatory pathway. MIF has broad regulatory properties, dysregulation of which has been implicated in the pathology of multiple immunological diseases. Inhibition of MIF activity with small molecules has proven beneficial in a number of disease models. Known small molecule MIF inhibitors typically bind in the tautomerase site of the MIF trimer, often covalently modifying the catalytic proline. Allosteric MIF inhibitors, particularly those that associate with the protein by noncovalent interactions, could reveal novel ways to block MIF activity for therapeutic benefit and serve as chemical probes to elucidate the structural basis for the diverse regulatory properties of MIF. In this study, we report the identification and functional characterization of a novel allosteric MIF inhibitor. Identified from a high throughput screening effort, this sulfonated azo compound termed p425 strongly inhibited the ability of MIF to tautomerize 4-hydroxyphenyl pyruvate. Furthermore, p425 blocked the interaction of MIF with its receptor, CD74, and interfered with the pro-inflammatory activities of the cytokine. Structural studies revealed a unique mode of binding for p425, with a single molecule of the inhibitor occupying the interface of two MIF trimers. The inhibitor binds MIF mainly on the protein surface through hydrophobic interactions that are stabilized by hydrogen bonding with four highly specific residues from three different monomers. The mode of p425 binding reveals a unique way to block the activity of the cytokine for potential therapeutic benefit in MIF-associated diseases.	[Bai, Fengwei; Cirillo, Pier; Ciustea, Mihai; Ledizet, Michel; Aristoff, Paul A.; Koski, Raymond A.; Powell, Thomas J.; Anthony, Karen G.] L2 Diagnost LLC, New Haven, CT 06511 USA; [Asojo, Oluwatoyin A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Bai, Fengwei] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Powell, Thomas J.] Artificial Cell Technol, New Haven, CT 06511 USA; [Asojo, Oluwatoyin A.] Baylor Coll Med, Dept Pediat & Trop Med, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Medical Center; Yale University; University of Southern Mississippi; Baylor College of Medicine	Anthony, KG (corresponding author), L2 Diagnost LLC, 300 George St,Ste 309, New Haven, CT 06511 USA.	Karen.Anthony@L2dx.com	Asojo, Oluwatoyin/H-1324-2019	Asojo, Oluwatoyin/0000-0002-4043-2700; Leng, Lin/0000-0002-0605-358X	National Institutes of Health from the NIAMS [1R43AR056908]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR056908, R01AR050498] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R43AR056908 from the NIAMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ainola MM, 2005, CLIN EXP RHEUMATOL, V23, P644; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Atsumi T, 2007, J IMMUNOL, V179, P5399, DOI 10.4049/jimmunol.179.8.5399; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cherepkova OA, 2004, NEUROCHEM RES, V29, P1399, DOI 10.1023/B:NERE.0000026403.06238.73; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; Dabideen DR, 2007, J MED CHEM, V50, P1993, DOI 10.1021/jm061477+; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Garai J, 2009, CURR MED CHEM, V16, P1091, DOI 10.2174/092986709787581842; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gregersen PK, 2003, ARTHRITIS RHEUM-US, V48, P1171, DOI 10.1002/art.10880; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Nunez C, 2007, GENES IMMUN, V8, P168, DOI 10.1038/sj.gene.6364365; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Pakozdi A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2021; Pinto DJP, 1996, BIOORG MED CHEM LETT, V6, P2907, DOI 10.1016/S0960-894X(96)00513-6; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Rich AR, 1932, B JOHNS HOPKINS HOSP, V50, P115; ROSETH S, 1995, J NEUROCHEM, V65, P96; Sanchez E, 2006, GENES IMMUN, V7, P433, DOI 10.1038/sj.gene.6364310; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Soares TA, 2002, BIOPOLYMERS, V65, P313, DOI 10.1002/bip.10252; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun HW, 1996, PROTEIN ENG, V9, P631, DOI 10.1093/protein/9.8.631; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; XU Q, 1992, J BIOL CHEM, V267, P11968; Xue CB, 1997, J MED CHEM, V40, P2064, DOI 10.1021/jm960799i; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	76	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30653	30663		10.1074/jbc.M112.385583	http://dx.doi.org/10.1074/jbc.M112.385583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22782901	hybrid, Green Published			2022-12-28	WOS:000308579800055
J	Chander, P; Gentleman, S; Poliakov, E; Redmond, TM				Chander, Preethi; Gentleman, Susan; Poliakov, Eugenia; Redmond, T. Michael			Aromatic Residues in the Substrate Cleft of RPE65 Protein Govern Retinol Isomerization and Modulate Its Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL CYCLE; ISOMEROHYDROLASE ACTIVITY; CAROTENOID OXYGENASE; PIGMENT EPITHELIUM; ISOMERASE; MODEL; COMPLEXES; EFFICIENT; ENZYME; SERVER	Previously, we showed that mutating RPE65 residue Phe-103 preferentially produces 13-cis-retinol instead of 11-cis-retinol, supporting a carbocation/radical cation mechanism of retinol isomerization. We asked whether this modulation of specificity can occur with residues other than Phe-103 and what role it plays in substrate binding and isomerization. We modeled the substrate-binding cleft of RPE65 to identify residues lining its surface. Many are phenylalanines and tyrosines, including three Phe residues (Phe-61, Phe-312, and Phe-526) forming an arch-like arrangement astride the cleft and Tyr-338. Also, Phe-418 sits at the neck of the cleft, lending a bend to the volume enclosed by the cleft. All mutations of Phe-61, Phe-312, and Phe-418 result in severely impaired or inactive enzyme. However, mutation of Phe-526 and Tyr-338, like Phe-103, decreases 11-cis-retinol formation, whereas increasing the 13-cis isomer. Significantly, 2 of these 3 residues, Phe-103 and Tyr-338, are located on putatively mobile interstrand loops. We propose that residual densities located in the binding cleft of the RPE65 structure represents a post-cleavage snapshot consistent not only with a fatty acid product, as originally modeled, but also an 11-cis-retinol product. Substrate docking simulations permit 11-cis- or 13-cis-retinyl ester binding in this relatively closed cleft, with the latter favored in F103L, F526A, and Y338A mutant structures, but prohibit binding of all-trans-retinyl ester, suggesting that isomerization occurs early in the temporal sequence, with O-alkyl ester cleavage occurring later. These findings provide insight into the mechanism of isomerization central to the visual cycle.	[Chander, Preethi; Gentleman, Susan; Poliakov, Eugenia; Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Redmond, TM (corresponding author), NEI, Lab Retinal Cell & Mol Biol, NIH, Bldg 6,Rm 117A, Bethesda, MD 20892 USA.	redmond@helix.nih.gov		Redmond, T. Michael/0000-0002-1813-5291	National Institutes of Health Intramural Research Program of the NEI; NATIONAL EYE INSTITUTE [ZIAEY000260] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NEI.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Fischer M, 2011, NUCLEIC ACIDS RES, V39, pW357, DOI 10.1093/nar/gkr468; Garcia-Martin A, 2008, J MOL BIOL, V382, P154, DOI 10.1016/j.jmb.2008.07.002; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047	31	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30552	30559		10.1074/jbc.M112.364596	http://dx.doi.org/10.1074/jbc.M112.364596			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22745121	Green Published, hybrid			2022-12-28	WOS:000308579800047
J	Illing, AC; Shawki, A; Cunningham, CL; Mackenzie, B				Illing, Anthony C.; Shawki, Ali; Cunningham, Christopher L.; Mackenzie, Bryan			Substrate Profile and Metal-ion Selectivity of Human Divalent Metal-ion Transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CADMIUM ABSORPTION; CACO-2 CELLS; DIETARY IRON; INTESTINAL-ABSORPTION; PROXIMAL TUBULE; APICAL MEMBRANE; PLASMA-MEMBRANE; DMT1; MANGANESE	Divalent metal-ion transporter-1 (DMT1) is a H+-coupled metal-ion transporter that plays essential roles in iron homeostasis. DMT1exhibits reactivity (based on evoked currents) with a broad range of metal ions; however, direct measurement of transport is lacking for many of its potential substrates. We performed a comprehensive substrate-profile analysis for human DMT1 expressed in RNA-injected Xenopus oocytes by using radiotracer assays and the continuous measurement of transport by fluorescence with the metal-sensitive PhenGreen SK fluorophore. We provide validation for the use of PhenGreen SK fluorescence quenching as a reporter of cellular metal-ion uptake. We determined metal-ion selectivity under fixed conditions using the voltage clamp. Radiotracer and continuous measurement of transport by fluorescence assays revealed that DMT1 mediates the transport of several metal ions that were ranked in selectivity by using the ratio I-max/K-0.5 (determined from evoked currents at -70 mV): Cd2+ > Fe2+ > Co2+, Mn2+ >> Zn2+, Ni2+, VO2+. DMT1 expression did not stimulate the transport of Cr2+, Cr3+, Cu+, Cu2+, Fe3+, Ga3+, Hg2+, or VO+. Fe-55(2+) transport was competitively inhibited by Co2+ and Mn2+. Zn2+ only weakly inhibited Fe-55(2+) transport. Our data reveal that DMT1 selects Fe2+ over its other physiological substrates and provides a basis for predicting the contribution of DMT1 to intestinal, nasal, and pulmonary absorption of metal ions and their cellular uptake in other tissues. Whereas DMT1 is a likely route of entry for the toxic heavy metal cadmium, and may serve the metabolism of cobalt, manganese, and vanadium, we predict that DMT1 should contribute little if at all to the absorption or uptake of zinc. The conclusion in previous reports that copper is a substrate of DMT1 is not supported.	[Illing, Anthony C.; Shawki, Ali; Cunningham, Christopher L.; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Shawki, Ali] Univ Cincinnati, Coll Med, Syst Biol & Physiol Program, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Mackenzie, B (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, POB 670576, Cincinnati, OH 45267 USA.	bryan.mackenzie@uc.edu		Mackenzie, Bryan/0000-0002-9661-8838; Cunningham, Christopher/0000-0002-9619-4190; Shawki, Ali/0000-0002-6413-5313	National Institutes of Health from USPHS [R01 DK080047]; National Institutes of Health from NIDDK [P30 DK078392]; National Institutes of Health PHS from the NCI [R24 CA086307]; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080047, P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NIDDK; National Institutes of Health PHS from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK080047 from USPHS (to B. M.).; We thank Sarah R. Anthony (University of Cincinnati) and students Matthew T. Coombs, Colin J. Mitchell, Eric J. Niespodzany, and Brian K. Sparkman (University of Cincinnati) for their help in the laboratory; Amy G. Aslamkhan and David S. Miller (NIEHS, National Institutes of Health, Research Triangle Park, NC) for help with preliminary experiments involving PGSK; and Chet Closson (Live Imaging Core, University of Cincinnati) for assistance with microscopy. The SIH used in this study was a gracious gift from Prem Ponka (McGill University). Part of this study was presented at Experimental Biology Meeting, April 28 to May 2, 2007, Washington, D. C. (73). The Digestive Health Center, Cincinnati Children's Hospital and University of Cincinnati was the recipient of National Institutes of Health Grant P30 DK078392 from NIDDK. The production of copper-64 at Washington University, St. Louis School of Medicine, was supported by National Institutes of Health PHS Grant R24 CA086307 from the NCI.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Aduayom I, 2005, J BIOCHEM MOL TOXIC, V19, P256, DOI 10.1002/jbt.20085; Akesson A, 2002, AM J PUBLIC HEALTH, V92, P284, DOI 10.2105/AJPH.92.2.284; Arredondo M, 2003, AM J PHYSIOL-CELL PH, V284, pC1525, DOI 10.1152/ajpcell.00480.2002; Bannon DI, 2003, AM J PHYSIOL-CELL PH, V284, pC44, DOI 10.1152/ajpcell.00184.2002; Bannon DI, 2002, BIOCHEM BIOPH RES CO, V295, P978, DOI 10.1016/S0006-291X(02)00756-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGLUND M, 1994, ENVIRON HEALTH PERSP, V102, P1058, DOI 10.2307/3431993; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Conrad ME, 2000, AM J PHYSIOL-GASTR L, V279, pG767, DOI 10.1152/ajpgi.2000.279.4.G767; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; EIDELMAN O, 1989, METHOD ENZYMOL, V172, P122; Elisma F, 2001, BIOCHEM BIOPH RES CO, V285, P662, DOI 10.1006/bbrc.2001.5245; Espinoza A, 2012, BIOL TRACE ELEM RES, V146, P281, DOI 10.1007/s12011-011-9243-2; FLANAGAN PR, 1978, GASTROENTEROLOGY, V74, P841; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Garrick Michael D, 2002, Methods Mol Biol, V196, P147; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Garrick MD, 2011, GENES NUTR, V6, P45, DOI 10.1007/s12263-010-0184-8; Ghio AJ, 2005, AM J PHYSIOL-LUNG C, V289, pL460, DOI 10.1152/ajplung.00154.2005; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haugland R. P., 2005, HDB GUIDE FLUORESCEN, P875; Heilig E, 2005, AM J PHYSIOL-LUNG C, V288, pL887, DOI 10.1152/ajplung.00382.2004; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Illing AC, 2007, FASEB J, V21, pA1325; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kim DW, 2007, ARCH TOXICOL, V81, P327, DOI 10.1007/s00204-006-0160-7; Kippler M, 2009, ENVIRON RES, V109, P914, DOI 10.1016/j.envres.2009.07.006; Knopfel M, 2005, BIOCHEMISTRY-US, V44, P3454, DOI 10.1021/bi048768; Knopfel M, 2005, BIOCHEM BIOPH RES CO, V330, P645, DOI 10.1016/j.bbrc.2005.03.023; Leazer TM, 2002, TOXICOL APPL PHARM, V185, P18, DOI 10.1006/taap.2002.9505; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mackenzie B., 1999, BIOMEMBRANE TRANSPOR, P327; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mukherjee B, 2004, TOXICOL LETT, V150, P135, DOI 10.1016/j.toxlet.2004.01.009; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Okubo M, 2003, TOXICOL APPL PHARM, V187, P162, DOI 10.1016/S0041-008X(02)00078-9; Park JD, 2002, TOXICOL SCI, V68, P288, DOI 10.1093/toxsci/68.2.288; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Reynolds IJ, 2004, ANN NY ACAD SCI, V1012, P27, DOI 10.1196/annals.1306.003; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Ryu DY, 2004, TOXICOL LETT, V152, P19, DOI 10.1016/j.toxlet.2004.03.015; Sacher A, 2001, J EXP BIOL, V204, P1053; SCHADE SG, 1970, J LAB CLIN MED, V75, P435; Segel I. H., 1975, BIOCH CALCULATIONS, P246; Shawki A, 2010, BIOCHEM BIOPH RES CO, V393, P471, DOI 10.1016/j.bbrc.2010.02.025; Shingles R, 2002, PLANT PHYSIOL, V128, P1022, DOI 10.1104/pp.010858; Shingles R, 2001, ANAL BIOCHEM, V296, P106, DOI 10.1006/abio.2001.5209; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Tallkvist J, 2001, TOXICOL LETT, V122, P171, DOI 10.1016/S0378-4274(01)00363-0; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; THOMSON ABR, 1971, J CLIN INVEST, V50, P2384, DOI 10.1172/JCI106737; Tjalve H, 1999, NEUROTOXICOLOGY, V20, P181; Ueki T, 2011, BBA-GEN SUBJECTS, V1810, P457, DOI 10.1016/j.bbagen.2010.12.006; Van Winkle LJ., 1999, BIOMEMBRANE TRANSPOR, P65; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	72	167	170	1	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30485	30496		10.1074/jbc.M112.364208	http://dx.doi.org/10.1074/jbc.M112.364208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22736759	Green Published, hybrid			2022-12-28	WOS:000308579800041
J	Buey, RM; Sen, I; Kortt, O; Mohan, R; Gfeller, D; Veprintsev, D; Kretzschmar, I; Scheuermann, J; Neri, D; Zoete, V; Michielin, O; de Pereda, JM; Akhmanova, A; Volkmer, R; Steinmetz, MO				Buey, Ruben M.; Sen, Indrani; Kortt, Oliver; Mohan, Renu; Gfeller, David; Veprintsev, Dmitry; Kretzschmar, Ines; Scheuermann, Joerg; Neri, Dario; Zoete, Vincent; Michielin, Olivier; Maria de Pereda, Jose; Akhmanova, Anna; Volkmer, Rudolf; Steinmetz, Michel O.			Sequence Determinants of a Microtubule Tip Localization Signal (MtLS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-TRACKING PROTEINS; EUKARYOTIC LINEAR MOTIFS; PLUS-END; MEMBRANE SUPPORTS; PEPTIDE ARRAYS; SPOT SYNTHESIS; IN-VITRO; EB1; DYNAMICS; BINDING	Microtubule plus-end-tracking proteins (+TIPs) specifically localize to the growing plus-ends of microtubules to regulate microtubule dynamics and functions. A large group of +TIPs contain a short linear motif, SXIP, which is essential for them to bind to end-binding proteins (EBs) and target microtubule ends. The SXIP sequence site thus acts as a widespread microtubule tip localization signal (MtLS). Here we have analyzed the sequence-function relationship of a canonical MtLS. Using synthetic peptide arrays on membrane supports, we identified the residue preferences at each amino acid position of the SXIP motif and its surrounding sequence with respect to EB binding. We further developed an assay based on fluorescence polarization to assess the mechanism of the EB-SXIP interaction and to correlate EB binding and microtubule tip tracking of MtLS sequences from different +TIPs. Finally, we investigated the role of phosphorylation in regulating the EB-SXIP interaction. Together, our results define the sequence determinants of a canonical MtLS and provide the experimental data for bioinformatics approaches to carry out genome-wide predictions of novel +TIPs in multiple organisms.	[Buey, Ruben M.; Sen, Indrani; Veprintsev, Dmitry; Steinmetz, Michel O.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Kortt, Oliver; Kretzschmar, Ines; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10117 Berlin, Germany; [Mohan, Renu; Akhmanova, Anna] Univ Utrecht, Fac Sci, Div Cell Biol, NL-3508 TC Utrecht, Netherlands; [Gfeller, David; Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Scheuermann, Joerg; Neri, Dario] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8092 Zurich, Switzerland; [Buey, Ruben M.; Maria de Pereda, Jose] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utrecht University; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Buey, RM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain.	ruben.martinez@usal.es; michel.steinmetz@psi.ch	Steinmetz, Michel O/AAA-3349-2022; de Pereda, Jose M/F-1733-2010; Akhmanova, Anna S/B-8896-2011; Martinez-Buey, Ruben/K-4296-2014; Michielin, Olivier/ABE-7924-2020; gfeller, david/D-3395-2009; Veprintsev, Dmitry B/H-2228-2012; Scheuermann, Joerg/N-8693-2016; Neri, Dario/P-4368-2016; de Pereda, Jose M/AAE-5226-2022; Gfeller, David/A-6493-2019	Steinmetz, Michel O/0000-0001-6157-3687; de Pereda, Jose M/0000-0002-8912-6739; Akhmanova, Anna S/0000-0002-9048-8614; Martinez-Buey, Ruben/0000-0003-1263-0221; gfeller, david/0000-0002-3952-0930; Veprintsev, Dmitry B/0000-0002-3583-5409; Scheuermann, Joerg/0000-0001-7746-4717; Neri, Dario/0000-0001-5234-7370; de Pereda, Jose M/0000-0002-8912-6739; Gfeller, David/0000-0002-3952-0930; Volkmer, Rudolf/0000-0003-4710-1143	Federation of European Biochemical Societies (FEBS); Juan de la Cierva program; Marie Curie Career Integration grant (EB-SxIP) [293831]; Marie Curie IIF grant (MT-TIP Inhibitors) [253818]; EMBO grant; Swiss National Science Foundation [31003A_122545, 310030B_138659]	Federation of European Biochemical Societies (FEBS); Juan de la Cierva program; Marie Curie Career Integration grant (EB-SxIP); Marie Curie IIF grant (MT-TIP Inhibitors); EMBO grant(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a Federation of European Biochemical Societies (FEBS) postdoctoral fellowship and a contract from the Juan de la Cierva program and a Marie Curie Career Integration grant (EB-SxIP; 293831) (to R. M. B.), by a Marie Curie IIF grant (MT-TIP Inhibitors; 253818) (to R. M.), by an EMBO grant (to D. G.), and by Swiss National Science Foundation Grants 31003A_122545 and 310030B_138659 (to M. O. S.).	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Applewhite DA, 2010, MOL BIOL CELL, V21, P1714, DOI 10.1091/mbc.E10-01-0011; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Heald R, 2002, J CELL SCI, V115, P3; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Liu M, 2009, MOL CARCINOGEN, V48, P212, DOI 10.1002/mc.20471; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Volkmer R, 2009, CHEMBIOCHEM, V10, P1431, DOI 10.1002/cbic.200900078; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiser AA, 2005, ANAL BIOCHEM, V342, P300, DOI 10.1016/j.ab.2005.04.033; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zimniak T, 2012, CURR BIOL, V22, P787, DOI 10.1016/j.cub.2012.03.007; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	55	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28227	28242		10.1074/jbc.M112.373928	http://dx.doi.org/10.1074/jbc.M112.373928			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22696216	hybrid, Green Published			2022-12-28	WOS:000308074600003
J	Ho, JJD; Metcalf, JL; Yan, MS; Turgeon, PJ; Wang, JJ; Chalsev, M; Petruzziello-Pellegrini, TN; Tsui, AKY; He, JZ; Dhamko, H; Man, HSJ; Robb, GB; Teh, BT; Ohh, M; Marsden, PA				Ho, J. J. David; Metcalf, Julie L.; Yan, Matthew S.; Turgeon, Paul J.; Wang, Jenny Jing; Chalsev, Maria; Petruzziello-Pellegrini, Tania N.; Tsui, Albert K. Y.; He, Jeff Z.; Dhamko, Helena; Man, H. S. Jeffrey; Robb, G. Brett; Teh, Bin T.; Ohh, Michael; Marsden, Philip A.			Functional Importance of Dicer Protein in the Adaptive Cellular Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; REGULATORY ELEMENT DATABASE; MESSENGER-RNA STABILITY; INDUCIBLE FACTOR-I; PROMOTES ANGIOGENESIS; TUMOR ANGIOGENESIS; GENE-EXPRESSION; CELLS; MICRORNAS; RECEPTOR	The processes by which cells sense and respond to ambient oxygen concentration are fundamental to cell survival and function, and they commonly target gene regulatory events. To date, however, little is known about the link between the microRNA pathway and hypoxia signaling. Here, we show in vitro and in vivo that chronic hypoxia impairs Dicer (DICER1) expression and activity, resulting in global consequences on microRNA biogenesis. We show that von Hippel-Lindau-dependent down-regulation of Dicer is key to the expression and function of hypoxia-inducible factor alpha (HIF-alpha) subunits. Specifically, we show that EPAS1/HIF-2 alpha is regulated by the Dicer-dependent microRNA miR-185, which is down-regulated by hypoxia. Full expression of hypoxia-responsive/HIF target genes in chronic hypoxia (e. g. VEGFA, FLT1/VEGFR1, KDR/VEGFR2, BNIP3L, and SLC2A1/GLUT1), the function of which is to regulate various adaptive responses to compromised oxygen availability, is also dependent on hypoxia-mediated down-regulation of Dicer function and changes in post-transcriptional gene regulation. Therefore, functional deficiency of Dicer in chronic hypoxia is relevant to both HIF-alpha isoforms and hypoxia-responsive/HIF target genes, especially in the vascular endothelium. These findings have relevance to emerging therapies given that we show that the efficacy of RNA interference under chronic hypoxia, but not normal oxygen availability, is Dicer-dependent. Collectively, these findings show that the down-regulation of Dicer under chronic hypoxia is an adaptive mechanism that serves to maintain the cellular hypoxic response through HIF-alpha- and microRNA-dependent mechanisms, thereby providing an essential mechanistic insight into the oxygen-dependent microRNA regulatory pathway.	[Ho, J. J. David; Yan, Matthew S.; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Dept Med, Dept Med Biophys, Toronto, ON M5B 1W8, Canada; [Metcalf, Julie L.; Turgeon, Paul J.; Wang, Jenny Jing; Petruzziello-Pellegrini, Tania N.; He, Jeff Z.; Ohh, Michael; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Dept Med, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada; [Ho, J. J. David; Yan, Matthew S.; Turgeon, Paul J.; Wang, Jenny Jing; Chalsev, Maria; Petruzziello-Pellegrini, Tania N.; Tsui, Albert K. Y.; Dhamko, Helena; Man, H. S. Jeffrey; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Dept Med, Keenan Res Ctr,Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Robb, G. Brett] New England Biolabs Inc, Div RNA Biol, Ipswich, MA 01938 USA; [Teh, Bin T.] Van Andel Res Inst, Grand Rapids, MI 49503 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; New England Biolabs; Van Andel Institute	Marsden, PA (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Dept Med Biophys, 30 Bond St, Toronto, ON M5B 1W8, Canada.	p.marsden@utoronto.ca		, Jeffrey/0000-0001-6628-0007; Teh, Bin Tean/0000-0003-1514-1124	Heart and Stroke Foundation [T-6777]; Canadian Institutes of Health Research [CIHR MOP77718]; Ontario graduate scholarship award	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario graduate scholarship award(Ontario Graduate Scholarship)	This work was supported in part by Heart and Stroke Foundation Grant T-6777 (to P. A. M.) and Canadian Institutes of Health Research Grant CIHR MOP77718 (to M. O.).; Recipient of an Ontario graduate scholarship award.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chamboredon S, 2011, MOL BIOL CELL, V22, P3366, DOI 10.1091/mbc.E10-07-0617; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; He JZ, 2010, J BIOL CHEM, V285, P9452, DOI 10.1074/jbc.M109.077230; Ho JJD, 2008, J AM SOC NEPHROL, V19, P2043, DOI 10.1681/ASN.2008090986; Ho JJD, 2012, J MOL MED, V90, P217, DOI 10.1007/s00109-012-0880-5; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Matskevich AA, 2008, BIOCHEM J, V412, P527, DOI 10.1042/BJ20071461; Mawji IA, 2004, J BIOL CHEM, V279, P8655, DOI 10.1074/jbc.M312190200; Mazure NM, 2002, CANCER RES, V62, P1158; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Merritt WM, 2010, CANCER RES, V70, P2571, DOI 10.1158/0008-5472.CAN-09-2536; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pioli PA, 2001, J BIOL CHEM, V276, P40346, DOI 10.1074/jbc.M105391200; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Singh MK, 2011, J BIOL CHEM, V286, P41036, DOI 10.1074/jbc.M111.268573; Singh S, 2005, BIOCHEM BIOPH RES CO, V335, P643, DOI 10.1016/j.bbrc.2005.07.138; Skuli N, 2009, CELL CYCLE, V8, P3252, DOI 10.4161/cc.8.20.9618; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	82	114	120	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29003	29020		10.1074/jbc.M112.373365	http://dx.doi.org/10.1074/jbc.M112.373365			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745131	hybrid, Green Published			2022-12-28	WOS:000308074600068
J	Hoffmann, F; Muller, W; Schutz, D; Penfold, ME; Wong, YH; Schulz, S; Stumm, R				Hoffmann, Frauke; Mueller, Wiebke; Schuetz, Dagmar; Penfold, Mark E.; Wong, Yung H.; Schulz, Stefan; Stumm, Ralf			Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; BETA-ARRESTIN; INTERNALIZATION; MIGRATION; PHOSPHORYLATION; LIGANDS; SIGNALS; CELLS; SDF-1; MICE	CXCL12 signaling through G protein-coupled CXCR4 regulates cell migration during ontogenesis and disease states including cancer and inflammation. The second CXCL12-receptor CXCR7 modulates the CXCL12/CXCR4 pathway by acting as a CXCL12 scavenger and exerts G protein-independent functions. Given the distinct properties of CXCR4 and CXCR7, we hypothesized that the distinct C-terminal domains differently regulate receptor trafficking and stability. Here, we examined epitope-tagged wild type and C-terminal mutant receptors in human embryonic kidney cells (HEK293) with respect to trafficking, stability, I-125-CXCL12 degradation, and G protein-coupling. The 24CXCR7C-terminal residues were sufficient to promote rapid spontaneous internalization. Replacement of the CXCR7 C terminus with that of CXCR4 (CXCR7-4tail mutant) abolished spontaneous internalization but permitted ligand-induced internalization and phosphorylation at the heterologous domain. The reverse tail-swap caused ligand-independent internalization of the resulting CXCR4-7tail mutant. Receptormediated I-125-CXCL12 uptake and release of I-125-CXCL12 degradation products were accelerated with receptors bearing the CXCR7 C terminus and impaired after conversion of CXCR7 C-terminal serine/threonine residues into alanines. C-terminal lysine residues were dispensable for plasma membrane targeting and the CXCL12 scavenger function but involved in constitutive degradation of CXCR7. Although the CXCR7 C terminus abolished G protein coupling in the CXCR4-7tail mutant, replacement of the CXCR7C terminus, CXCR7 second intracellular loop, or both domains with the corresponding CXCR4 domain did not result in a G protein-coupled CXCR7 chimera. Taken together, we provide evidence that the CXCR7 C terminus influences the ligand-uptake/degradation rate, G protein coupling, and receptor stability. Regulatory pathways targeting CXCR7 C-terminal serine/threonine sites may control the CXCL12 scavenger activity of CXCR7.	[Hoffmann, Frauke; Mueller, Wiebke; Schuetz, Dagmar; Schulz, Stefan; Stumm, Ralf] Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, D-07747 Jena, Germany; [Penfold, Mark E.] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Wong, Yung H.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Friedrich Schiller University of Jena; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Stumm, R (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, Drackendorfer Str 1, D-07747 Jena, Germany.	ralf.stumm@med.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885; Wong, Yung Hou/0000-0002-0123-7697	Federal State Sachsen-Anhalt; European Fund for Regional Development Grant [EFRE 2007-2013]; Deutsche Forschungsgemeinschaft (DFG) [STU295/5-1]; Dr. Robert-Pfleger Stiftung	Federal State Sachsen-Anhalt; European Fund for Regional Development Grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dr. Robert-Pfleger Stiftung	This work was supported by Federal State Sachsen-Anhalt with the European Fund for Regional Development Grant EFRE 2007-2013, Deutsche Forschungsgemeinschaft (DFG) Grant STU295/5-1, and Dr. Robert-Pfleger Stiftung (all to R. S.).	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kleemann P, 2008, N-S ARCH PHARMACOL, V378, P261, DOI 10.1007/s00210-008-0313-8; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Mody SM, 2000, MOL PHARMACOL, V57, P13; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ray P, 2012, INT J BIOCHEM CELL B, V44, P669, DOI 10.1016/j.biocel.2012.01.007; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	44	66	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28362	28377		10.1074/jbc.M111.335679	http://dx.doi.org/10.1074/jbc.M111.335679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736769	hybrid, Green Published			2022-12-28	WOS:000308074600013
J	Lee, JK; Matthews, RT; Lim, JM; Swanier, K; Wells, L; Pierce, JM				Lee, Jin Kyu; Matthews, Russell T.; Lim, Jae-Min; Swanier, Kiara; Wells, Lance; Pierce, J. Michael			Developmental Expression of the Neuron-specific N-Acetylglucosaminyltransferase Vb (GnT-Vb/IX) and Identification of Its in Vivo Glycan Products in Comparison with Those of Its Paralog, GnT-V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; EYE-BRAIN DISEASE; FUKUTIN-RELATED PROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN; REDUCTIVE ALKALINE-HYDROLYSIS; RABBIT SKELETAL-MUSCLE; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; BASEMENT-MEMBRANE	The severe phenotypic effects of altered glycosylation in the congenital muscular dystrophies, including Walker-Warburg syndrome, muscle-eye-brain disease, Fukuyama congenital muscular dystrophy, and congenital muscular dystrophy 1D, are caused by mutations resulting in altered glycans linked to proteins through O-linked mannose. A glycosyltransferase that branches O-Man, N-acetylglucosaminyltransferase Vb (GnT-Vb), is highly expressed in neural tissues. To understand the expression and function of GnT-Vb, we studied its expression during neuromorphogenesis and generated GnT-Vb null mice. A paralog of GnT-Vb, N-acetylglucosaminyltransferase (GnT-V), is expressed in many tissues and brain, synthesizing N-linked, beta 1,6-branched glycans, but its ability to synthesize O-mannosyl-branched glycans is unknown; conversely, although GnT-Vb can synthesizeN-linked glycans in vitro, its contribution to their synthesis in vivo is unknown. Our results showed that deleting both GnT-V and GnT-Vb results in the total loss of both N-linked and O-Man-linked beta 1,6-branched glycans. GnT-V null brains lacked N-linked, beta 1,6-glycans but had normal levels of O-Man beta 1,6-branched structures, showing that GnT-Vb could not compensate for the loss of GnT-V. By contrast, GnT-Vb null brains contained normal levels of N-linked beta 1,6-glycans but low levels of some O-Man beta 1,6-branched glycans. Therefore, GnT-V could partially compensate for GnT-Vb activity in vivo. We found no apparent change in alpha-dystroglycan binding of glycan-specific antibody IIH6C4 or binding to laminin in GnT-Vb null mice. These results demonstrate that GnT-V is involved in synthesizing branched O-mannosyl glycans in brain, but the function of these branched O-mannosyl structures is unresolved using mice that lack these glycosyltransferases.	[Lee, Jin Kyu; Lim, Jae-Min; Swanier, Kiara; Wells, Lance; Pierce, J. Michael] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30605 USA; [Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Pierce, JM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30605 USA.	hawkeye@uga.edu	Wells, Lance/H-3118-2013	Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P41GM103490, RO1CA064462, RO1NS069660]; NATIONAL CANCER INSTITUTE [R01CA064462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103490, RO1CA064462, and RO1NS069660.	Abbott KL, 2008, J PROTEOME RES, V7, P1470, DOI 10.1021/pr700792g; Abbott KL, 2006, EXP CELL RES, V312, P2837, DOI 10.1016/j.yexcr.2006.05.022; Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Alvarez-Manilla G, 2010, GLYCOBIOLOGY, V20, P166, DOI 10.1093/glycob/cwp158; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Chiba A, 1997, J BIOL CHEM, V272, P2156; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; Currier SC, 2005, AM J MED GENET A, V133A, P53, DOI 10.1002/ajmg.a.30487; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Bernabe DBV, 2003, J MED GENET, V40, P845; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DENNIS JW, 1989, CANCER RES, V49, P945; DOBYNS WB, 1985, AM J MED GENET, V22, P157, DOI 10.1002/ajmg.1320220118; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; GEE SH, 1993, J BIOL CHEM, V268, P14972; Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Hu HY, 2011, J COMP NEUROL, V519, P1320, DOI 10.1002/cne.22572; Hu HY, 2010, MOL VIS, V16, P1415; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Inamori KI, 2006, BBA-GEN SUBJECTS, V1760, P678, DOI 10.1016/j.bbagen.2005.11.019; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kim DS, 2004, NEUROLOGY, V62, P1009, DOI 10.1212/01.WNL.0000115386.28769.65; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Kurahashi H, 2005, NEUROBIOL DIS, V19, P208, DOI 10.1016/j.nbd.2004.12.018; Lee I, 2006, J NEUROCHEM, V97, P947, DOI 10.1111/j.1471-4159.2006.03785.x; Li X, 2008, NEUROSCIENCE, V152, P391, DOI 10.1016/j.neuroscience.2007.06.041; Lian GW, 2006, CURR OPIN PEDIATR, V18, P614, DOI 10.1097/MOP.0b013e328010542d; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya Hiroshi, 2004, Tanpakushitsu Kakusan Koso, V49, P2451; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; PARANO E, 1995, PEDIATR NEUROL, V13, P97, DOI 10.1016/0887-8994(95)00148-9; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; van Reeuwijk J, 2005, CLIN GENET, V67, P281, DOI 10.1111/j.1399-0004.2004.00368.x; vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yang Y, 2007, J COMP NEUROL, V505, P459, DOI 10.1002/cne.21474; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153	74	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28526	28536		10.1074/jbc.M112.367565	http://dx.doi.org/10.1074/jbc.M112.367565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22715095	Green Published, hybrid			2022-12-28	WOS:000308074600028
J	Samai, P; Shuman, S				Samai, Poulami; Shuman, Stewart			Kinetic Analysis of DNA Strand Joining by Chlorella Virus DNA Ligase and the Role of Nucleotidyltransferase Motif VI in Ligase Adenylylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA CAPPING ENZYMES; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; NICK RECOGNITION; DUPLEX DNA; T4 DNA; MECHANISM; ADENYLATE; COMPONENT; LIGATION	Chlorella virus DNA ligase (ChVLig) is an instructive model for mechanistic studies of the ATP-dependent DNA ligase family. ChVLig seals 3'-OH and 5'-PO4 termini via three chemical steps: 1) ligase attacks the ATP alpha phosphorus to release PPi and form a covalent ligase-adenylate intermediate; 2) AMP is transferred to the nick 5'-phosphate to form DNA-adenylate; 3) the 3'-OH of the nick attacks DNA-adenylate to join the polynucleotides and release AMP. Each chemical step requires Mg2+. Kinetic analysis of nick sealing by ChVLig-AMP revealed that the rate constant for phosphodiester synthesis (k(step3) = 25 s(-1)) exceeds that for DNA adenylylation (k(step2) = 2.4 s(-1)) and that Mg2+ binds with similar affinity during step 2 (K-d = 0.77 mM) and step 3 (K-d = 0.87 mM). The rates of DNA adenylylation and phosphodiester synthesis respond differently to pH, such that step 3 becomes rate-limiting at pH <= 6.5. The pH profiles suggest involvement of one and two protonation-sensitive functional groups in catalysis of steps 2 and 3, respectively. We suggest that the 5'-phosphate of the nick is the relevant protonation-sensitive moiety and that a dianionic 5'-phosphate is necessary for productive step 2 catalysis. Motif VI, located at the C terminus of the OB-fold domain of ChVLig, is a conserved feature of ATP-dependent DNA ligases and GTP-dependent mRNA capping enzymes. Presteady state and burst kinetic analysis of the effects of deletion and missense mutations highlight the catalytic contributions of ChVLig motif VI, especially the Asp-297 carboxylate, exclusively during the ligase adenylylation step.	[Samai, Poulami; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611.	Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Cherepanov AV, 2002, J BIOL CHEM, V277, P1695, DOI 10.1074/jbc.M109616200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; HARVEY CL, 1971, J BIOL CHEM, V246, P4523; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; LEHMAN IR, 1974, SCIENCE, V186, P790; Lohman GJS, 2011, J BIOL CHEM, V286, P44187, DOI 10.1074/jbc.M111.284992; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Samai P, 2011, J BIOL CHEM, V286, P22642, DOI 10.1074/jbc.M111.245399; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Sawaya R, 2003, BIOCHEMISTRY-US, V42, P8240, DOI 10.1021/bi034396d; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9661, DOI 10.1074/jbc.M110613200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; Yin SM, 2004, VIROLOGY, V319, P141, DOI 10.1016/j.virol.2003.10.037	29	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28609	28618		10.1074/jbc.M112.380428	http://dx.doi.org/10.1074/jbc.M112.380428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745124	Green Published, hybrid			2022-12-28	WOS:000308074600035
J	Boura, E; Ivanov, V; Carlson, LA; Mizuuchi, K; Hurley, JH				Boura, Evzen; Ivanov, Vassili; Carlson, Lars-Anders; Mizuuchi, Kiyoshi; Hurley, James H.			Endosomal Sorting Complex Required for Transport (ESCRT) Complexes Induce Phase-separated Microdomains in Supported Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; UBIQUITIN RECOGNITION; MOLECULAR-MECHANISM; STRUCTURAL BASIS; PLASMA-MEMBRANE; III PROTEIN; CHOLESTEROL; CURVATURE; VESICLES; DOMAINS	The endosomal sorting complex required for transport (ESCRT) system traffics ubiquitinated cargo to lysosomes via an unusual membrane budding reaction that is directed away from the cytosol. Here, we show that human ESCRT-II self-assembles into clusters of 10-100 molecules on supported lipid bilayers. The ESCRT-II clusters are functional in that they bind to ubiquitin and the ESCRT-III subunit VPS20 at nanomolar concentrations on membranes with the same stoichiometries observed in solution and in crystals. The clusters only form when cholesterol is included in the lipid mixture at >10 mol %. The clusters induce the formation of ordered membrane domains that exclude the dye 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbo-cyanine perchlorate. These results show that ESCRT complexes are capable of inducing lateral lipid phase separation under conditions where the lipids themselves do not spontaneously phase-separate. This property could facilitate ESCRT-mediated membrane budding.	[Boura, Evzen; Ivanov, Vassili; Carlson, Lars-Anders; Mizuuchi, Kiyoshi; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bldg 50,Rm 4517, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Boura, Evzen/G-5275-2014	Carlson, Lars-Anders/0000-0003-2342-6488; Boura, Evzen/0000-0002-9652-4065	National Institutes of Health Intramural Program, NIDDK; Intramural AIDS Targeted Anti-viral Program of the Office of the Director; Intramural AIDS Research Fellowship; Human Frontier Science Program postdoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program, NIDDK; Intramural AIDS Targeted Anti-viral Program of the Office of the Director; Intramural AIDS Research Fellowship; Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Program, NIDDK (to K. M. and J. H. H.), and the Intramural AIDS Targeted Anti-viral Program of the Office of the Director (to J. H. H.).; Supported by an Intramural AIDS Research Fellowship. Present address: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Flemingovo nam. 2., 166 10 Praha 6, Czech Republic.; Supported by a Human Frontier Science Program postdoctoral fellowship.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; Boura E, 2011, P NATL ACAD SCI USA, V108, P9437, DOI 10.1073/pnas.1101763108; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; LIPOWSKY R, 1992, J PHYS II, V2, P1825, DOI 10.1051/jp2:1992238; MacDonald C, 2012, EMBO REP, V13, P331, DOI 10.1038/embor.2012.18; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mayers Jonathan R, 2012, Commun Integr Biol, V5, P50; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Mobius W, 2003, TRAFFIC, V4, P222; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227	47	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28144	28151		10.1074/jbc.M112.378646	http://dx.doi.org/10.1074/jbc.M112.378646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718754	Green Published, hybrid			2022-12-28	WOS:000307840700087
J	Little, SC; Biesiadecki, BJ; Kilic, A; Higgins, RSD; Janssen, PML; Davis, JP				Little, Sean C.; Biesiadecki, Brandon J.; Kilic, Ahmet; Higgins, Robert S. D.; Janssen, Paul M. L.; Davis, Jonathan P.			The Rates of Ca2+ Dissociation and Cross-bridge Detachment from Ventricular Myofibrils as Reported by a Fluorescent Cardiac Troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSITIZING MUTATIONS; LOAD-DEPENDENT KINETICS; SKELETAL-MUSCLE FIBERS; RATE-LIMITING STEP; RELAXATION KINETICS; PHOSPHATE RELEASE; FORCE DEVELOPMENT; STRIATED-MUSCLE; REGULATED ACTIN; HEART-FAILURE	The rate-limiting step of cardiac muscle relaxation has been proposed to reside in the myofilament. Both the rates of cross-bridge detachment and Ca2+ dissociation from troponin C (TnC) have been hypothesized to rate-limit myofilament inactivation. In this study we used a fluorescent TnC to measure both the rate of Ca2+ dissociation from TnC and the rate of cross-bridge detachment from several different species of ventricular myofibrils. The fluorescently labeled TnC was sensitive to both Ca2+ dissociation and cross-bridge detachment at low Ca2+ (presence of EGTA), allowing for a direct comparison between the two proposed rates of myofilament inactivation. Unlike Ca2+ dissociation from TnC, cross-bridge detachment varied in myofibrils from different species and was rate-limited by ADP release. At subphysiological temperatures (<20 degrees C), the rate of Ca2+ dissociation from TnC was faster than the rate of cross-bridge detachment in the presence of ADP. These results support the hypothesis that cross-bridge detachment rate-limits relaxation. However, Ca2+ dissociation from TnC was not as temperature-sensitive as cross-bridge detachment. At a near physiological temperature (35 degrees C) and ADP, the rate of cross-bridge detachment may actually be faster than the rate of Ca2+ dissociation. This provides evidence that there may not be a simple, single rate-limiting step of myofilament inactivation.	[Little, Sean C.; Biesiadecki, Brandon J.; Janssen, Paul M. L.; Davis, Jonathan P.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert S. D.] Ohio State Univ, Coll Med, Div Cardiac Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Davis, JP (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 1645 Neil Ave, Columbus, OH 43210 USA.	davis.812@osu.edu	Higgins, Robert/AGZ-7064-2022; Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014	National Center for Research Resources Award [TL1RR025753, HL091986, HL091056, RC1 HL099538]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025753] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091056, R00HL091056, RC1HL099538, R56HL091986, R01HL091986] Funding Source: NIH RePORTER	National Center for Research Resources Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Center for Research Resources Award TL1RR025753 and Grants HL091986 (to J.P.D., HL091056 (to B.J.B.), and RC1 HL099538 (to P.M.L.J.).	ALLEN DG, 1988, J PHYSIOL-LONDON, V407, P489, DOI 10.1113/jphysiol.1988.sp017427; BACKX PH, 1995, J GEN PHYSIOL, V105, P1, DOI 10.1085/jgp.105.1.1; Belus A, 2003, J MUSCLE RES CELL M, V24, P261; Belus A, 2008, J PHYSIOL-LONDON, V586, P3639, DOI 10.1113/jphysiol.2008.155952; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Borrego-Diaz E, 2010, BIOPHYS J, V98, P2601, DOI 10.1016/j.bpj.2010.02.030; BRENNER B, 1995, BIOPHYS J, V68, pS106; Candau R, 2011, J MUSCLE RES CELL M, V32, P315, DOI 10.1007/s10974-011-9264-7; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 2004, J BIOL CHEM, V279, P17348, DOI 10.1074/jbc.M314095200; de Tombe PP, 2007, J PHYSIOL-LONDON, V584, P591, DOI 10.1113/jphysiol.2007.138693; Dong WJ, 1996, J BIOL CHEM, V271, P688, DOI 10.1074/jbc.271.2.688; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; Fitzsimons DP, 1998, J PHYSIOL-LONDON, V513, P171, DOI 10.1111/j.1469-7793.1998.171by.x; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107; GROSSMAN W, 1990, EUR HEART J, V11, P2, DOI 10.1093/eurheartj/11.suppl_C.2; HAMILTON N, 1991, MOL CELL BIOCHEM, V106, P133; Han YS, 2011, CYTOSKELETON, V68, P18, DOI 10.1002/cm.20491; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; HOUSMANS PR, 1983, SCIENCE, V221, P159, DOI 10.1126/science.6857274; Ingwall J. S., 2002, ATP HEART, P21; James J, 2010, J MOL CELL CARDIOL, V48, P999, DOI 10.1016/j.yjmcc.2009.10.013; Janssen PML, 2007, J MOL CELL CARDIOL, V43, P523, DOI 10.1016/j.yjmcc.2007.08.012; Janssen PML, 2002, AM J PHYSIOL-HEART C, V282, pH499, DOI 10.1152/ajpheart.00595.2001; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lee RS, 2010, AM J PHYSIOL-CELL PH, V299, pC1091, DOI 10.1152/ajpcell.00491.2009; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lionne C, 2003, J MUSCLE RES CELL M, V24, P139, DOI 10.1023/A:1026045328949; Lionne C, 2002, BIOCHEMISTRY-US, V41, P13297, DOI 10.1021/bi0260278; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; MARTIN H, 1994, BIOPHYS J, V66, P1115, DOI 10.1016/S0006-3495(94)80892-6; Martyn DA, 1999, BIOPHYS J, V76, P1480, DOI 10.1016/S0006-3495(99)77308-X; Maughan D, 1998, ADV EXP MED BIOL, V453, P471; McCurdy DT, 2001, AM J PHYSIOL-HEART C, V281, pH1390, DOI 10.1152/ajpheart.2001.281.3.H1390; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Palmiter KA, 1999, J PHYSIOL-LONDON, V519, P669, DOI 10.1111/j.1469-7793.1999.0669n.x; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Simnett SJ, 1998, AM J PHYSIOL-HEART C, V275, pH951, DOI 10.1152/ajpheart.1998.275.3.H951; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Swartz DR, 1999, AM J PHYSIOL-HEART C, V276, pH1460, DOI 10.1152/ajpheart.1999.276.5.H1460; Tesi C, 2002, BIOPHYS J, V83, P2142, DOI 10.1016/S0006-3495(02)73974-X; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; YATES LD, 1983, J MOL BIOL, V168, P123, DOI 10.1016/S0022-2836(83)80326-X; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	64	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27930	27940		10.1074/jbc.M111.337295	http://dx.doi.org/10.1074/jbc.M111.337295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718768	hybrid, Green Published			2022-12-28	WOS:000307840700067
J	Lu, HL; Efremov, AK; Bookwalter, CS; Krementsova, EB; Driver, JW; Trybus, KM; Diehl, MR				Lu, Hailong; Efremov, Artem K.; Bookwalter, Carol S.; Krementsova, Elena B.; Driver, Jonathan W.; Trybus, Kathleen M.; Diehl, Michael R.			Collective Dynamics of Elastically Coupled Myosin V Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; IN-VITRO; INTRACELLULAR-TRANSPORT; CARGO TRANSPORT; COORDINATION; MICROTUBULES; MOVEMENT; PROCESSIVITY; PROTEINS	Characterization of the collective behaviors of different classes of processive motor proteins has become increasingly important to understand various intracellular trafficking and transport processes. This work examines the dynamics of structurally-defined motor complexes containing two myosin Va (myoVa) motors that are linked together via a molecular scaffold formed from a single duplex of DNA. Dynamic changes in the filament-bound configuration of these complexes due to motor binding, stepping, and detachment were monitored by tracking the positions of different color quantum dots that report the position of one head of each myoVa motor on actin. As in studies of multiple kinesins, the run lengths produced by two myosins are only slightly larger than those of single motor molecules. This suggests that internal strain within the complexes, due to asynchronous motor stepping and the resultant stretching of motor linkages, yields net negative cooperative behaviors. In contrast to multiple kinesins, multiple myosin complexes move with appreciably lower velocities than a single-myosin molecule. Although similar trends are predicted by a discrete state stochastic model of collective motor dynamics, these analyses also suggest that multiple myosin velocities and run lengths depend on both the compliance and the effective size of their cargo. Moreover, it is proposed that this unique collective behavior occurs because the large step size and relatively small stalling force of myoVa leads to a high sensitivity of motor stepping rates to strain.	[Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Efremov, Artem K.; Driver, Jonathan W.; Diehl, Michael R.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Efremov, Artem K.; Diehl, Michael R.] Rice Univ, Dept Chem, Houston, TX 77005 USA	University of Vermont; Rice University; Rice University	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu; diehl@rice.edu	lu, hailong/C-7754-2009	Efremov, Artem/0000-0002-1603-610X	National Institutes of Health [GM078097, 1R01GM094489-01]; National Science Foundation [MCB-0643832]; Welch Foundation [C-1625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078097 (to K. M. T.) and 1R01GM094489-01 (to M. R. D.). This work was also supported by the National Science Foundation (MCB-0643832), and the Welch Foundation (C-1625 to M. R. D.).	Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Diehl MR, 2006, SCIENCE, V311, P1468, DOI 10.1126/science.1122125; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Jamison DK, 2012, J BIOL CHEM, V287, P3357, DOI 10.1074/jbc.M111.296582; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rovner AS, 2006, BIOCHEMISTRY-US, V45, P5280, DOI 10.1021/bi060154c; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schweller RM, 2008, BIOCONJUGATE CHEM, V19, P2304, DOI 10.1021/bc8003606; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27753	27761		10.1074/jbc.M112.371393	http://dx.doi.org/10.1074/jbc.M112.371393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718762	Green Published, hybrid			2022-12-28	WOS:000307840700049
J	Ma, J; Wei, M; Wang, Q; Li, JM; Wang, H; Liu, WH; Lacefield, JC; Greer, PA; Karmazyn, M; Fan, GC; Peng, TQ				Ma, Jian; Wei, Meng; Wang, Qiang; Li, Jianmin; Wang, Hao; Liu, Weihua; Lacefield, James C.; Greer, Peter A.; Karmazyn, Morris; Fan, Guo-Chang; Peng, Tianqing			Deficiency of Capn4 Gene Inhibits Nuclear Factor-kappa B (NF-kappa B) Protein Signaling/Inflammation and Reduces Remodeling after Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CALPAIN ACTIVATION; HEART-FAILURE; INFLAMMATORY RESPONSE; CARDIOMYOCYTE DEATH; DYSFUNCTION; DEGRADATION; CALPASTATIN; EXPRESSION; APOPTOSIS	Calpain has been implicated in acute myocardial injury after myocardial infarction (MI). However, the causal relationship between calpain and post-MI myocardial remodeling has not been fully understood. This study examined whether deletion of Capn4, essential for calpain-1 and calpain-2 activities, reduces myocardial remodeling and dysfunction following MI, and if yes, whether these effects of Capn4 deletion are associated with NF-kappa B signaling and inflammatory responses in the MI heart. A novel mouse model with cardiomyocyte-specific deletion of Capn4 (Capn4-ko) was employed. MI was induced by left coronary artery ligation. Deficiency of Capn4 dramatically reduced the protein levels and activities of calpain-1 and calpain-2 in the Capn4-ko heart. In vivo cardiac function was relatively improved in Capn4-ko mice at 7 and 30 days after MI when compared with their wild-type littermates. Deletion of Capn4 reduced apoptosis, limited infarct expansion, prevented left ventricle dilation, and reduced mortality in Capn4-ko mice. Furthermore, cardiomyocyte cross-sectional areas and myocardial collagen deposition were significantly attenuated in Capn4-ko mice, which were accompanied by down-regulation of hypertrophic genes and profibrotic genes. These effects of Capn4 knock-out correlated with restoration of I kappa B protein and inhibition of NF-kappa B activation, leading to suppression of proinflammatory cytokine expression and inflammatory cell infiltration in the Capn4-ko heart after MI. In conclusion, deficiency of Capn4 reduces adverse myocardial remodeling and myocardial dysfunction after MI. These effects of Capn4 deletion may be mediated through prevention of I kappa B degradation and NF-kappa B activation, resulting in inhibition of inflammatory responses.	[Ma, Jian; Peng, Tianqing] Univ Western Ontario, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; [Ma, Jian; Peng, Tianqing] Univ Western Ontario, Dept Med, London, ON N6A 4G5, Canada; [Wang, Hao; Liu, Weihua; Peng, Tianqing] Univ Western Ontario, Dept Pathol, London, ON N6A 4G5, Canada; [Wang, Hao] Univ Western Ontario, Dept Surg, London, ON N6A 4G5, Canada; [Karmazyn, Morris] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 4G5, Canada; [Lacefield, James C.] Univ Western Ontario, Dept Elect & Comp Engn, London, ON N6A 4G5, Canada; [Lacefield, James C.] Univ Western Ontario, Dept Med Biophys, London, ON N6A 4G5, Canada; [Lacefield, James C.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 4G5, Canada; [Ma, Jian; Wei, Meng] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 6, Shanghai 200233, Peoples R China; [Wang, Qiang] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai 200032, Peoples R China; [Li, Jianmin] Wenzhou Med Coll, Affiliated Hosp 1, Dept Pathol, Wenzhou 325027, Zhejiang, Peoples R China; [Greer, Peter A.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Shanghai Jiao Tong University; Fudan University; Wenzhou Medical University; McMaster University; Queens University - Canada; University System of Ohio; University of Cincinnati	Peng, TQ (corresponding author), Victoria Res Labs, A6-140,800 Commissioners Rd, London, ON N6A 4G5, Canada.	tpeng2@uwo.ca	Lacefield, James C./B-5002-2015; Peng, Tianqing/G-3340-2011; Fan, Guo-Chang/E-1153-2012	Fan, Guo-Chang/0000-0002-0439-8277	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research [T6717, CCI109612]; National Natural Science Foundation of China [81070110]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Heart and Stroke Foundation of Ontario and the Canadian Institutes of Health Research (Grants T6717 and CCI109612) (to T. P.) and by the National Natural Science Foundation of China (Grant 81070110) (to M. W.).	Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Chen F, 2000, AM J PHYSIOL-CELL PH, V279, pC709, DOI 10.1152/ajpcell.2000.279.3.C709; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Ke L, 2008, J MOL CELL CARDIOL, V45, P685, DOI 10.1016/j.yjmcc.2008.08.012; Kent MP, 2004, J ANIM SCI, V82, P794; Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Li Y, 2009, CARDIOVASC RES, V84, P100, DOI 10.1093/cvr/cvp189; Li Y, 2009, FREE RADICAL BIO MED, V46, P51, DOI 10.1016/j.freeradbiomed.2008.09.025; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Papanicolaou KN, 2010, J MOL CELL CARDIOL, V49, P196, DOI 10.1016/j.yjmcc.2010.04.002; Perrin C, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL497; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Shan LM, 2010, FREE RADICAL BIO MED, V49, P1804, DOI 10.1016/j.freeradbiomed.2010.09.018; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; Takemura G, 2004, PHARMACOL THERAPEUT, V104, P1, DOI 10.1016/j.pharmthera.2004.07.005; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Timmers L, 2009, CIRC RES, V104, P699, DOI 10.1161/CIRCRESAHA.108.189746; Tissier S, 2004, SHOCK, V21, P352, DOI 10.1097/00024382-200404000-00010; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Wang H, 2007, J IMMUNOL, V179, P4451, DOI 10.4049/jimmunol.179.7.4451; Xiang FL, 2009, CIRCULATION, V120, P1065, DOI 10.1161/CIRCULATIONAHA.108.839068; Yang DC, 2010, INT J MOL MED, V26, P159, DOI 10.3892/ijmm_00000448; Yoshikawa Y, 2005, AM J PHYSIOL-HEART C, V288, pH1690, DOI 10.1152/ajpheart.00666.2004	43	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27480	27489		10.1074/jbc.M112.358929	http://dx.doi.org/10.1074/jbc.M112.358929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22753411	Green Published, hybrid			2022-12-28	WOS:000307840700024
J	Daee, DL; Ferrari, E; Longerich, S; Zheng, XF; Xue, XY; Branzei, D; Sung, P; Myung, K				Daee, Danielle L.; Ferrari, Elisa; Longerich, Simonne; Zheng, Xiao-feng; Xue, Xiaoyu; Branzei, Dana; Sung, Patrick; Myung, Kyungjae			Rad5-dependent DNA Repair Functions of the Saccharomyces cerevisiae FANCM Protein Homolog Mph1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTRAND CROSS-LINKS; CELL NUCLEAR ANTIGEN; FREE POSTREPLICATION REPAIR; STALLED REPLICATION FORKS; STRAND BREAK REPAIR; GROSS CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; RAD6 PATHWAY; ERROR-PRONE	Interstrand cross-links (ICLs) covalently link complementary DNA strands, block DNA replication, and transcription and must be removed to allow cell survival. Several pathways, including the Fanconi anemia (FA) pathway, can faithfully repair ICLs and maintain genomic integrity; however, the precise mechanisms of most ICL repair processes remain enigmatic. In this study we genetically characterized a conserved yeast ICL repair pathway composed of the yeast homologs (Mph1, Chl1, Mhf1, Mhf2) of four FA proteins (FANCM, FANCJ, MHF1, MHF2). This pathway is epistatic with Rad5-mediated DNA damage bypass and distinct from the ICL repair pathways mediated by Rad18 and Pso2. In addition, consistent with the FANCM role in stabilizing ICL-stalled replication forks, we present evidence that Mph1 prevents ICL-stalled replication forks from collapsing into double-strand breaks. This unique repair function of Mph1 is specific for ICL damage and does not extend to other types of damage. These studies reveal the functional conservation of the FA pathway and validate the yeast model for future studies to further elucidate the mechanism of the FA pathway.	[Daee, Danielle L.; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Ferrari, Elisa; Branzei, Dana] Fdn IFOM, Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Longerich, Simonne; Zheng, Xiao-feng; Xue, Xiaoyu; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); IFOM - FIRC Institute of Molecular Oncology; Yale University	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	kmyung@mail.nih.gov	Branzei, Dana/GOG-9093-2022; xue, xiaoyu/G-9574-2012; Branzei, Dana/A-2806-2015	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Zheng, Xiao-Feng/0000-0001-8769-4604	National Institutes of Health Grant [HG012003-09]; European Research Council Grant [REPSUBREP 242928]; Associazione Italiana per la Ricerca sul Cancuro Grant [IG 10637]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, Z01HG012003] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council Grant(European Research Council (ERC)); Associazione Italiana per la Ricerca sul Cancuro Grant(Fondazione AIRC per la ricerca sul cancro); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant HG012003-09 (National Human Genome Research Institute; to K. M.). This work was also supported by European Research Council Grant REPSUBREP 242928 and Associazione Italiana per la Ricerca sul Cancuro Grant IG 10637 (to D. B.).	Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Das-Bradoo S, 2010, NAT CELL BIOL, V12, P74, DOI 10.1038/ncb2007; Donahue SL, 2003, J BIOL CHEM, V278, P29487, DOI 10.1074/jbc.M213251200; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Evdokimova VN, 2005, AM J MED GENET A, V135A, P59, DOI 10.1002/ajmg.a.30687; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; GEIDUSCH.E, 1961, P NATL ACAD SCI USA, V47, P950, DOI 10.1073/pnas.47.7.950; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Helleday T, 1998, CARCINOGENESIS, V19, P973, DOI 10.1093/carcin/19.6.973; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hlavin EM, 2010, ENVIRON MOL MUTAGEN, V51, P604, DOI 10.1002/em.20559; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; HUANG H, 1993, J AM CHEM SOC, V115, P9402, DOI 10.1021/ja00074a005; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Kao WH, 2011, J INVEST DERMATOL, V131, P2139, DOI 10.1038/jid.2011.181; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kats ES, 2009, MOL CELL BIOL, V29, P5226, DOI 10.1128/MCB.00894-09; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Lage C, 2003, MUTAT RES-REV MUTAT, V544, P143, DOI 10.1016/j.mrrev.2003.06.003; Laha S, 2006, NUCLEIC ACIDS RES, V34, P5880, DOI 10.1093/nar/gkl749; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Legerski RJ, 2010, ENVIRON MOL MUTAGEN, V51, P540, DOI 10.1002/em.20566; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; MAGANASCHWENCKE N, 1982, P NATL ACAD SCI-BIOL, V79, P1722, DOI 10.1073/pnas.79.6.1722; Malagon F, 1996, CURR GENET, V30, P101, DOI 10.1007/s002940050107; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; McHugh PJ, 2000, MOL CELL BIOL, V20, P3425, DOI 10.1128/MCB.20.10.3425-3433.2000; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; Moertl S, 2008, DNA REPAIR, V7, P1893, DOI 10.1016/j.dnarep.2008.07.016; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; OCONNOR PM, 1990, CANCER COMMUN, V2, P387, DOI 10.3727/095535490820873949; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Panico ER, 2010, YEAST, V27, P11, DOI 10.1002/yea.1727; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rahn JJ, 2010, ENVIRON MOL MUTAGEN, V51, P567, DOI 10.1002/em.20583; ROBERTS JJ, 1982, CHEM-BIOL INTERACT, V39, P181, DOI 10.1016/0009-2797(82)90120-X; SALATREPAT M, 1993, MUTAT RES, V289, P115, DOI 10.1016/0027-5107(93)90137-5; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Schmidt KH, 2010, EUKARYOT CELL, V9, P315, DOI 10.1128/EC.00260-09; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Shen X, 2010, ENVIRON MOL MUTAGEN, V51, P493, DOI 10.1002/em.20558; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Thyagarajan B, 1997, J BIOL CHEM, V272, P23328, DOI 10.1074/jbc.272.37.23328; Ulrich HD, 2003, J BIOL CHEM, V278, P7051, DOI 10.1074/jbc.M212195200; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; WILBORN F, 1989, CURR GENET, V16, P331, DOI 10.1007/BF00340711; Wood RD, 2010, ENVIRON MOL MUTAGEN, V51, P520, DOI 10.1002/em.20569; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Xiao W, 2000, GENETICS, V155, P1633; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan FH, 2010, FRONT BIOSCI-LANDMRK, V15, P1131, DOI 10.2741/3666; Zheng XF, 2011, DNA REPAIR, V10, P1034, DOI 10.1016/j.dnarep.2011.08.002	90	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26563	26575		10.1074/jbc.M112.369918	http://dx.doi.org/10.1074/jbc.M112.369918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696213	Green Published, hybrid			2022-12-28	WOS:000307386000009
J	Yoon, SI; Jones, BC; Logsdon, NJ; Harris, BD; Kuruganti, S; Walter, MR				Yoon, Sung Il; Jones, Brandi C.; Logsdon, Naomi J.; Harris, Bethany D.; Kuruganti, Srilalitha; Walter, Mark R.			Epstein-Barr Virus IL-10 Engages IL-10R1 by a Two-step Mechanism Leading to Altered Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INTERLEUKIN-10 RECEPTOR; STIMULATORY FACTOR; UP-REGULATION; EXPRESSION; REVEALS; BINDING; CELL; HOMOLOGY; COMPLEX	Human interleukin-10 (hIL-10) is a pleiotropic cytokine that is able to suppress or activate cellular immune responses to protect the host from invading pathogens. Epstein-Barr virus (EBV) encodes a viral IL-10 (ebvIL-10) in its genome that has retained the immunosuppressive activities of hIL-10 but lost the ability to induce immunostimulatory activities on some cells. These functional differences are at least partially due to the similar to 1000-fold difference in hIL-10 and ebvIL-10 binding affinity for the IL-10R1.IL-10R2 cell surface receptors. Despite weaker binding to IL-10R1, ebvIL-10 is more active than hIL-10 in inducing B-cell proliferation. To explore this counterintuitive observation further, a series of monomeric and dimeric ebvIL-10.hIL-10 chimeric proteins were produced and characterized for receptor binding and cellular proliferation on TF-1/hIL-10R1 cells that express high levels of the IL-10R1 chain. On this cell line, monomeric chimeras elicited cell proliferation in accordance with how tightly they bound to the IL-10R1 chain. In contrast, dimeric chimeras exhibiting the highest affinity for IL-10R1 exhibited reduced proliferative activity. These distinct activity profiles are correlated with kinetic analyses that reveal that the ebvIL-10 dimer is impaired in its ability to form a 1:2 ebvIL-10.IL-10R1 complex. As a result, the ebvIL-10 dimer functions like a monomer at low IL-10R1 levels, which prevents efficient signaling. At high IL-10R1 levels, the ebvIL-10 dimer is able to induce signaling responses greater than hIL-10. Thus, the ebvIL-10 dimer scaffold is essential to prevent activation of cells with low IL-10R1 levels but to maintain or enhance activity on cells with high IL-10R1 levels.	[Yoon, Sung Il; Kuruganti, Srilalitha; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Yoon, Sung Il; Jones, Brandi C.; Logsdon, Naomi J.; Harris, Bethany D.; Walter, Mark R.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Yoon, Sung Il] Kangwon Natl Univ, Dept Syst Immunol, Coll Biomed Sci, Chunchon 200701, South Korea; [Yoon, Sung Il] Kangwon Natl Univ, Inst Antibody Res, Coll Biomed Sci, Chunchon 200701, South Korea	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Kangwon National University; Kangwon National University	Walter, MR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	walter@uab.edu			National Institutes of Health Grants [RO1 AI047300, RO 1AI047300-S1]; National Science Foundation of Korea Grant [2012R1A1A1003701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of Korea Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI047300 and RO 1AI047300-S1 (to M.R.W.). This work was also supported by National Science Foundation of Korea Grant 2012R1A1A1003701 (to S.I.Y.).	Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; DING L, 1993, J IMMUNOL, V151, P1224; Ding YZ, 2000, J EXP MED, V191, P213, DOI 10.1084/jem.191.2.213; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; Il Yoon S, 2007, PROTEIN EXPRES PURIF, V53, P132, DOI 10.1016/j.pep.2006.12.001; Jiang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027464; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; KITAMURA T, 1991, INT IMMUNOL, V3, P571, DOI 10.1093/intimm/3.6.571; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kumar KGS, 2003, EMBO J, V22, P5480; Liu Y, 1997, J IMMUNOL, V158, P604; Logsdon NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028127; Logsdon NJ, 2002, J INTERF CYTOK RES, V22, P1099, DOI 10.1089/10799900260442520; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Rich RL, 2000, CURR OPIN BIOTECH, V11, P54, DOI 10.1016/S0958-1669(99)00054-3; Roughan JE, 2010, J VIROL, V84, P1158, DOI 10.1128/JVI.01780-09; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Salek-Ardakani S, 2002, VIROLOGY, V304, P342, DOI 10.1006/viro.2002.1716; STUART AD, 1995, ONCOGENE, V11, P1711; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Thorley-Lawson DA, 2008, TRENDS IMMUNOL, V29, P195, DOI 10.1016/j.it.2008.01.006; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Wei SHY, 2006, J INTERF CYTOK RES, V26, P281, DOI 10.1089/jir.2006.26.281; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	48	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26586	26595		10.1074/jbc.M112.376707	http://dx.doi.org/10.1074/jbc.M112.376707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22692218	hybrid, Green Published			2022-12-28	WOS:000307386000011
J	Simoni, R; Mukhopadhyay, R				Simoni, Robert; Mukhopadhyay, Rajendrani			From DNA Enzymes to Cone Snail Venom: The Work of Baldomero M. Olivera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23020	23023		10.1074/jbc.O112.000004	http://dx.doi.org/10.1074/jbc.O112.000004			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22753891	Green Published, hybrid			2022-12-28	WOS:000306495000058
J	Rathmann, D; Lindner, D; DeLuca, SH; Kaufmann, KW; Meiler, J; Beck-Sickinger, AG				Rathmann, Daniel; Lindner, Diana; DeLuca, Stephanie H.; Kaufmann, Kristian W.; Meiler, Jens; Beck-Sickinger, Annette G.			Ligand-mimicking Receptor Variant Discloses Binding and Activation Mode of Prolactin-releasing Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; NEUROPEPTIDE-Y RECEPTOR; TOGGLE SWITCH MODEL; CONSTITUTIVE ACTIVITY; THYROTROPIN RECEPTOR; RFAMIDE PEPTIDES; TRANSMEMBRANE DOMAIN; TISSUE DISTRIBUTION; DRUG DISCOVERY	The prolactin-releasing peptide receptor and its bioactive RFamide peptide (PrRP20) have been investigated to explore the ligand binding mode of peptide G-protein-coupled receptors (GPCRs). By receptor mutagenesis, we identified the conserved aspartate in the upper transmembrane helix 6 (Asp(6.59)) of the receptor as the first position that directly interacts with arginine 19 of the ligand (Arg(19)). Replacement of Asp(6.59) with Arg(19) of PrRP20 led to D6.59R, which turned out to be a constitutively active receptor mutant (CAM). This suggests that the mutated residue at the top of transmembrane helix 6 mimics Arg(19) by interacting with additional binding partners in the receptor. Next, we generated an initial comparative model of this CAM because no ligand docking was required, and we selected the next set of receptor mutants to find the engaged partners of the binding pocket. In an iterative process, we identified two acidic residues and two hydrophobic residues that form the peptide ligand binding pocket. As all residues are localized on top or in the upper part of the transmembrane domains, we clearly can show that the extracellular surface of the receptor is sufficient for full signal transduction for prolactin-releasing peptide, rather than a deep, membrane-embedded binding pocket. This contributes to the knowledge of the binding of peptide ligands to GPCRs and might facilitate the development of GPCR ligands, but it also provides new targeting of CAMs involved in hereditary diseases.	[Rathmann, Daniel; Lindner, Diana; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany; [DeLuca, Stephanie H.; Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	beck-sickinger@uni-leipzig.de	Lindner, Diana/AAL-9856-2021	Lindner, Diana/0000-0001-5477-769X; Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [R01 MH090192, R01 GM080403]; Deutsche Forschungsgemeinschaft [SFB 610, BE 1264-11]; Office Of Internatl Science &Engineering [1157751] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH090192 and R01 GM080403 (to J. M.) and Deutsche Forschungsgemeinschaft Grant SFB 610, BE 1264-11 (to A. B. S.).	ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bohme I, 2008, CELL SIGNAL, V20, P1740, DOI 10.1016/j.cellsig.2008.05.017; Bohme I, 2007, PEPTIDES, V28, P226, DOI 10.1016/j.peptides.2006.08.042; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Boyle RG, 2005, J PEPT SCI, V11, P161, DOI 10.1002/psc.612; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conner AC, 2011, METHODS MOL BIOL, V746, P85, DOI 10.1007/978-1-61779-126-0_5; Cotecchia S, 2003, ASSAY DRUG DEV TECHN, V1, P311, DOI 10.1089/15406580360545125; D'Antona AM, 2006, BRAIN RES, V1108, P1, DOI 10.1016/j.brainres.2006.05.042; D'Ursi AM, 2002, J MED CHEM, V45, P5483, DOI 10.1021/jm020975p; Danho W., 2003, 18 AM PEPT S BOST MA; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Donohue PJ, 1999, BIOCHEMISTRY-US, V38, P9366, DOI 10.1021/bi990544h; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Findeisen M, 2011, PHARMACEUTICALS, V4, P1248, DOI 10.3390/ph4091248; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Flanagan CA, 2000, BIOCHEMISTRY-US, V39, P8133, DOI 10.1021/bi000085g; Ford DJ, 2002, J PHARMACOL EXP THER, V300, P810, DOI 10.1124/jpet.300.3.810; Fujii R, 1999, REGUL PEPTIDES, V83, P1, DOI 10.1016/S0167-0115(99)00028-2; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gromoll J, 1996, MOL CELL ENDOCRINOL, V125, P177, DOI 10.1016/S0303-7207(96)03949-4; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hofliger MM, 2003, J RECEPT SIG TRANSD, V23, P351, DOI 10.1081/RRS-120026974; HOGGER P, 1995, J BIOL CHEM, V270, P7405; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Koglin N, 2003, J MED CHEM, V46, P4369, DOI 10.1021/jm0341251; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lagerstrom MC, 2005, GENOMICS, V85, P688, DOI 10.1016/j.ygeno.2005.02.007; Lang M, 2006, J PEPT SCI, V12, P258, DOI 10.1002/psc.716; Langmead CJ, 2000, BRIT J PHARMACOL, V131, P683, DOI 10.1038/sj.bjp.0703617; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lin Steven H., 2008, V46, P57, DOI 10.1007/400_2007_048; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Madsen KL, 2012, J BIOL CHEM, V287, P12293, DOI 10.1074/jbc.M111.294702; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okzaki R, 1999, J CLIN ENDOCR METAB, V84, P363; Osugi T, 2006, FEBS J, V273, P1731, DOI 10.1111/j.1742-4658.2006.05187.x; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; Rohl CA, 2005, METHOD ENZYMOL, V394, P244, DOI 10.1016/S0076-6879(05)94009-3; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sanger F, 1992, Biotechnology, V24, P104; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ukena K, 2011, CELL TISSUE RES, V343, P475, DOI 10.1007/s00441-010-1116-z; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WELCH SK, 1995, BIOCHEM BIOPH RES CO, V209, P606, DOI 10.1006/bbrc.1995.1543	70	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32181	32194		10.1074/jbc.M112.349852	http://dx.doi.org/10.1074/jbc.M112.349852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22778259	hybrid, Green Published			2022-12-28	WOS:000309059400055
J	Willander, H; Presto, J; Askarieh, G; Biverstal, H; Frohm, B; Knight, SD; Johansson, J; Linse, S				Willander, Hanna; Presto, Jenny; Askarieh, Glareh; Biverstal, Henrik; Frohm, Birgitta; Knight, Stefan D.; Johansson, Jan; Linse, Sara			BRICHOS Domains Efficiently Delay Fibrillation of Amyloid beta-Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; A-BETA; EXTRACELLULAR CHAPERONE; POLYMERIC NANOPARTICLES; TRANSMEMBRANE SEGMENT; LUNG-DISEASE; TOXICITY; INHIBITION; DEMENTIA	Amyloid diseases such as Alzheimer, Parkinson, and prion diseases are associated with a specific form of protein mis-folding and aggregation into oligomers and fibrils rich in beta-sheet structure. The BRICHOS domain consisting of similar to 100 residues is found in membrane proteins associated with degenerative and proliferative disease, including lung fibrosis (surfactant protein C precursor; pro-SP-C) and familial dementia (Bri2). We find that recombinant BRICHOS domains from Bri2 and pro-SP-C prevent fibril formation of amyloid beta-peptides (A beta(40) and A beta(42)) far below the stoichiometric ratio. Kinetic experiments show that a main effect of BRICHOS is to prolong the lag time in a concentration-dependent, quantitative, and reproducible manner. An ongoing aggregation process is retarded if BRICHOS is added at any time during the lag phase, but it is too late to interfere at the end of the process. Results from circular dichroism and NMR spectroscopy, as well as analytical size exclusion chromatography, imply that A beta is maintained as an unstructured monomer during the extended lag phase in the presence of BRICHOS. Electron microscopy shows that although the process is delayed, typical amyloid fibrils are eventually formed also when BRICHOS is present. Structural BRICHOS models display a conserved array of tyrosine rings on a five-stranded beta-sheet, with inter-hydroxyl distances suited for hydrogen-bonding peptides in an extended beta-conformation. Our data imply that the inhibitory mechanism is reliant on BRICHOS interfering with molecular events during the lag phase.	[Willander, Hanna; Presto, Jenny; Johansson, Jan] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Willander, Hanna; Presto, Jenny; Biverstal, Henrik; Johansson, Jan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Dis Res Ctr, S-14186 Stockholm, Sweden; [Askarieh, Glareh; Knight, Stefan D.] Swedish Univ Agr Sci, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Frohm, Birgitta; Linse, Sara] Lund Univ, Ctr Chem, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden	Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish University of Agricultural Sciences; Lund University	Johansson, J (corresponding author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.	Janne.Johansson@ki.se; Sara.Linse@biochemistry.lu.se	Knight, Stefan/D-4315-2015	Presto, Jenny/0000-0001-5102-6815; Biverstal, Henrik/0000-0002-2097-7658; Knight, Stefan/0000-0002-7180-8758; Linse, Sara/0000-0001-9629-7109; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Casals C, 2008, FEBS J, V275, P536, DOI 10.1111/j.1742-4658.2007.06220.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; El-Agnaf O, 2004, PROTEIN PEPTIDE LETT, V11, P207, DOI 10.2174/0929866043407156; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2006, J BIOL CHEM, V281, P21032, DOI 10.1074/jbc.M603001200; Johansson H, 2009, PROTEIN SCI, V18, P1175, DOI 10.1002/pro.123; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kinghorn KJ, 2006, J BIOL CHEM, V281, P29268, DOI 10.1074/jbc.M600690200; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; Nerelius C, 2008, BIOCHEM J, V416, P201, DOI 10.1042/BJ20080981; Nilsson LNG, 2001, J NEUROSCI, V21, P1444, DOI 10.1523/JNEUROSCI.21-05-01444.2001; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; POWERS JM, 1981, J NEUROPATH EXP NEUR, V40, P592, DOI 10.1097/00005072-198111000-00002; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Xue WF, 2006, J MOL BIOL, V358, P1244, DOI 10.1016/j.jmb.2006.02.069; Yamin G, 2008, CURR PHARM DESIGN, V14, P3231, DOI 10.2174/138161208786404137; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	68	108	109	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31608	31617		10.1074/jbc.M112.393157	http://dx.doi.org/10.1074/jbc.M112.393157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801430	Green Published, hybrid			2022-12-28	WOS:000308791300072
J	Yu, YL; Chou, RH; Wu, CH; Wang, YN; Chang, WJ; Tseng, YJ; Chang, WC; Lai, CC; Lee, HJ; Huo, LF; Chen, CH; Hung, MC				Yu, Yung-Luen; Chou, Ruey-Hwang; Wu, Chia-Han; Wang, Ying-Nai; Chang, Wei-Jung; Tseng, Yen-Ju; Chang, Wei-Chao; Lai, Chien-Chen; Lee, Hong-Jen; Huo, Longfei; Chen, Chung-Hsuan; Hung, Mien-Chie			Nuclear EGFR Suppresses Ribonuclease Activity of Polynucleotide Phosphorylase through DNAPK-mediated Phosphorylation at Serine 776	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN-MELANOMA CELLS; C-MYC EXPRESSION; BREAST-CANCER; ONCOGENE EXPRESSION; CELLULAR SENESCENCE; POLY(A) POLYMERASE; RADIATION RESPONSE; LUNG-CARCINOMA; PROTEIN-KINASE	Nuclear existence of epidermal growth factor receptor (EGFR) has been documented for more than two decades. Resistance of cancer to radiotherapy is frequently correlated with elevated EGFR expression, activity, and nuclear translocation. However, the role of nuclear EGFR (nEGFR) in radioresistance of cancers remains elusive. In the current study, we identified a novel nEGFR-associated protein, polynucleotide phosphorylase (PNPase), which possesses 3' to 5' exoribonuclease activity toward c-MYC mRNA. Knockdown of PNPase increased radioresistance. Inactivation or knock-down of EGFR enhanced PNPase-mediated c-MYC mRNA degradation in breast cancer cells, and also increased its radiosensitivity. Interestingly, the association of nEGFR with PNPase and DNA-dependent protein kinase (DNAPK) increased significantly in breast cancer cells after exposure to ionizing radiation (IR). We also demonstrated that DNAPK phosphorylates PNPase at Ser-776, which is critical for its ribonuclease activity. The phosphomimetic S776D mutant of PNPase impaired its ribonuclease activity whereas the nonphosphorylatable S776A mutant effectively degraded c-MYC mRNA. Here, we uncovered a novel role of nEGFR in radioresistance, and that is, upon ionizing radiation, nEGFR inactivates the ribonuclease activity of PNPase toward c-MYC mRNA through DNAPK-mediated Ser-776 phosphorylation, leading to increase of c-MYC mRNA, which contributes to radioresistance of cancer cells.	[Yu, Yung-Luen; Chou, Ruey-Hwang; Wu, Chia-Han; Wang, Ying-Nai; Chang, Wei-Jung; Tseng, Yen-Ju; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang; Wu, Chia-Han; Wang, Ying-Nai; Chang, Wei-Jung; Tseng, Yen-Ju; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Lai, Chien-Chen] China Med Univ, Grad Inst Chinese Med Sci, Taichung 404, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Wang, Ying-Nai; Lee, Hong-Jen; Huo, Longfei; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lai, Chien-Chen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; National Chung Hsing University	Yu, YL (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan.	ylyu@mail.cmu.edu.tw; mhung@mdanderson.org	Chou, Ruey-Hwang/K-8541-2013; /AGZ-4617-2022; Chen, Chung-Hsuan/F-7940-2012; Huo, Longfei/F-9233-2010; Hung, Mien-Chie/ABD-5911-2021	Chou, Ruey-Hwang/0000-0002-2297-2180; /0000-0002-7133-8266; Hung, Mien-Chie/0000-0003-4317-4740; Wang, Ying-Nai/0000-0002-5275-6729	National Institutes of Health [RO1 CA109311, PO1 CA099031]; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund [(DMR-101-115]; Cancer Research Center of Excellence (Taiwan) [DOH101-TD-C-111-005]; Private University grant (Taiwan) [NSC99-2632-B-039-001-MY3]; Program for Stem Cell and Regenerative Medicine Frontier Research (Taiwan) [NSC100-2321-B-039-002]; International Research-Intensive Centers of Excellence in Taiwan (Taiwan) [NSC101-2911-I-002-303]; Personal Research Grant for New Faculty (Taiwan) [CMU100-N2-09]; Project for Junior Researcher (Taiwan) [NSC 101-2311-B-039-001]; NATIONAL CANCER INSTITUTE [R01CA109311, P01CA099031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Cancer Research Center of Excellence (Taiwan); Private University grant (Taiwan); Program for Stem Cell and Regenerative Medicine Frontier Research (Taiwan); International Research-Intensive Centers of Excellence in Taiwan (Taiwan); Personal Research Grant for New Faculty (Taiwan); Project for Junior Researcher (Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by the following grants: the National Institutes of Health (RO1 CA109311, PO1 CA099031), The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (DMR-101-115, to M.-C. H. and Y.-L. Y.), Cancer Research Center of Excellence (DOH101-TD-C-111-005, Taiwan), Private University grant (NSC99-2632-B-039-001-MY3, Taiwan), Program for Stem Cell and Regenerative Medicine Frontier Research (NSC100-2321-B-039-002, Taiwan), International Research-Intensive Centers of Excellence in Taiwan (NSC101-2911-I-002-303, Taiwan), Personal Research Grant for New Faculty (to R.-H. C., CMU100-N2-09; Taiwan), and Project for Junior Researcher (to R.-H. C., NSC 101-2311-B-039-001, Taiwan).	Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Calaf GM, 2004, INT J ONCOL, V25, P1859; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chiang CS, 1998, MOL DIAGN, V3, P21, DOI 10.1016/S1084-8592(98)80023-4; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Klaus HD, 2008, INT J RADIAT ONCOL, V70, P203, DOI 10.1016/j.ijrobp.2007.08.065; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Fukuhara N, 2006, CANCER SCI, V97, P499, DOI 10.1111/j.1349-7006.2006.00209.x; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Hirouchi T, 2008, EXP HEMATOL, V36, P871, DOI 10.1016/j.exphem.2008.01.015; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Imaoka T, 2005, INT J CANCER, V115, P187, DOI 10.1002/ijc.20904; Kirschner LS, 1999, GENOMICS, V62, P21, DOI 10.1006/geno.1999.5957; Klein C, 2004, BIOCHEMISTRY-US, V43, P15873, DOI 10.1021/bi048604t; Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lo HW, 2005, CANCER RES, V65, P338; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Miura S, 2008, CANCER-AM CANCER SOC, V112, P2143, DOI 10.1002/cncr.23414; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Navolanic PM, 2003, INT J ONCOL, V22, P237; Pfeifer A, 1998, BIOCHEM BIOPH RES CO, V252, P481, DOI 10.1006/bbrc.1998.9660; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Psyrri A, 2008, CANCER EPIDEM BIOMAR, V17, P1486, DOI 10.1158/1055-9965.EPI-07-2684; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Sarkar D, 2006, CELL DEATH DIFFER, V13, P1541, DOI 10.1038/sj.cdd.4401829; Sarkar D, 2005, MOL CELL BIOL, V25, P7333, DOI 10.1128/MCB.25.16.7333-7343.2005; Sarkar D, 2003, J BIOL CHEM, V278, P24542, DOI 10.1074/jbc.M302421200; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; SHIU RP, 1993, CLIN CHEM, V39, P353; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2012, J BIOL CHEM, V287, P16869, DOI 10.1074/jbc.M111.314799; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Wanner G, 2008, RADIOTHER ONCOL, V86, P383, DOI 10.1016/j.radonc.2007.10.041; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001	48	39	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31015	31026		10.1074/jbc.M112.358077	http://dx.doi.org/10.1074/jbc.M112.358077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815474	hybrid, Green Published			2022-12-28	WOS:000308791300015
J	Zaferani, A; Vives, RR; van der Pol, P; Navis, GJ; Daha, MR; van Kooten, C; Lortat-Jacob, H; Seelen, MA; van den Born, J				Zaferani, Azadeh; Vives, Romain R.; van der Pol, Pieter; Navis, Gerjan J.; Daha, Mohamed R.; van Kooten, Cees; Lortat-Jacob, Hugues; Seelen, Marc A.; van den Born, Jacob			Factor H and Properdin Recognize Different Epitopes on Renal Tubular Epithelial Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; ALTERNATIVE PATHWAY; AMPLIFICATION CONVERTASE; MACULAR DEGENERATION; IGA NEPHROPATHY; BRUCHS MEMBRANE; KIDNEY INJURY; BINDING; ACTIVATION; CELLS	During proteinuria, renal tubular epithelial cells become exposed to ultrafiltrate-derived serum proteins, including complement factors. Recently, we showed that properdin binds to tubular heparan sulfates (HS). We now document that factor H also binds to tubular HS, although to a different epitope than properdin. Factor H was present on the urinary side of renal tubular cells in proteinuric, but not in normal renal tissues and colocalized with properdin in proteinuric kidneys. Factor H dose-dependently bound to proximal tubular epithelial cells (PTEC) in vitro. Preincubation of factor H with exogenous heparin and pretreatment of PTECs with heparitinase abolished the binding to PTECs. Surface plasmon resonance experiments showed high affinity of factor H for heparin and HS (K-D values of 32 and 93 nM, respectively). Using a library of HS-like polysaccharides, we showed that chain length and high sulfation density are the most important determinants for glycosaminoglycan-factor H interaction and clearly differ from properdin-heparinoid interaction. Coincubation of properdin and factor H did not hamper HS/heparin binding of one another, indicating recognition of different nonoverlapping epitopes on HS/heparin by factor H and properdin. Finally we showed that certain low anticoagulant heparinoids can inhibit properdin binding to tubular HS, with a minor effect on factor H binding to tubular HS. As a result, these heparinoids can control the alternative complement pathway. In conclusion, factor H and properdin interact with different HS epitopes of PTECs. These interactions can be manipulated with some low anticoagulant heparinoids, which can be important for preventing complement-derived tubular injury in proteinuric renal diseases.	[Zaferani, Azadeh; Navis, Gerjan J.; Daha, Mohamed R.; Seelen, Marc A.; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Vives, Romain R.; Lortat-Jacob, Hugues] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38000 Grenoble, France; [van der Pol, Pieter; Daha, Mohamed R.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands	University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zaferani, A (corresponding author), Expt Nephrol Lab, Antonius Deusinglaan 1,Fb 20, NL-9713 AV Groningen, Netherlands.	a.zaferani@umcg.nl	van Kooten, Cees/E-5694-2018; Vives, Romain/I-9372-2012	van Kooten, Cees/0000-0002-6257-0899; 	NWO [40-00506-98-9021, 175-010-2009-023]	NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by NWO Grants 40-00506-98-9021 and 175-010-2009-023.	Abbate M, 2008, J AM SOC NEPHROL, V19, P1158, DOI 10.1681/ASN.2007060686; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Berger SP, 2005, NEPHROL DIAL TRANSPL, V20, P2613, DOI 10.1093/ndt/gfi166; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BLONDIN C, 1994, MOL IMMUNOL, V31, P247, DOI 10.1016/0161-5890(94)90121-X; Borgenstrom M, 2007, SEMIN THROMB HEMOST, V33, P547, DOI 10.1055/s-2007-982087; BROOIMANS RA, 1989, J IMMUNOL, V142, P2024; Buelli S, 2009, KIDNEY INT, V75, P1050, DOI 10.1038/ki.2009.8; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Clark SJ, 2010, J BIOL CHEM, V285, P30192, DOI 10.1074/jbc.M110.103986; DAHA MR, 1982, J IMMUNOL, V128, P1839; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; He C, 2005, J IMMUNOL, V174, P5750, DOI 10.4049/jimmunol.174.9.5750; IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Kelly U, 2010, J IMMUNOL, V185, P5486, DOI 10.4049/jimmunol.0903596; Kirschfink M, 1997, J IMMUNOL, V158, P1324; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; MAILLET F, 1983, MOL IMMUNOL, V20, P1401, DOI 10.1016/0161-5890(83)90172-4; MAILLET F, 1988, MOL IMMUNOL, V25, P917, DOI 10.1016/0161-5890(88)90130-7; Onda K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-64; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; REJ RN, 1991, CARBOHYD RES, V210, P299, DOI 10.1016/0008-6215(91)80130-F; Renner B, 2011, KIDNEY INT, V80, P166, DOI 10.1038/ki.2011.115; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Rook M, 2005, NEPHROL DIAL TRANSPL, V20, P59, DOI 10.1093/ndt/gfh579; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; Schmidt C, 2008, REV ECON POLIT, V118, P3; Siezenga MA, 2010, NEPHROL DIAL TRANSPL, V25, P1157, DOI 10.1093/ndt/gfp630; Tamano M, 2002, NEPHRON, V92, P705, DOI 10.1159/000064090; Turk H, 2004, BIOCONJUGATE CHEM, V15, P162, DOI 10.1021/bc034044j; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Timmeren MM, 2006, AM J PHYSIOL-RENAL, V291, pF456, DOI 10.1152/ajprenal.00403.2005; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vieyra MB, 2010, KIDNEY INT, V77, P495, DOI 10.1038/ki.2009.491; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WEILER JM, 1992, J IMMUNOL, V148, P3210; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Zaferani A, 2011, J BIOL CHEM, V286, P5359, DOI 10.1074/jbc.M110.167825; Zhang JJ, 2009, SCAND J IMMUNOL, V69, P457, DOI 10.1111/j.1365-3083.2009.02234.x; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015	49	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31471	31481		10.1074/jbc.M112.380386	http://dx.doi.org/10.1074/jbc.M112.380386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815489	Green Published, hybrid			2022-12-28	WOS:000308791300060
J	Gao, H; Wu, XM; Sun, Y; Zhou, SH; Silberstein, LE; Zhu, ZL				Gao, Hong; Wu, Xiaoming; Sun, Yan; Zhou, Shuanhu; Silberstein, Leslie E.; Zhu, Zhenglun			Suppression of Homeobox Transcription Factor VentX Promotes Expansion of Human Hematopoietic Stem/Multipotent Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EX-VIVO EXPANSION; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN; DIFFERENTIATION; PROLIFERATION; REPOPULATION; QUIESCENCE; XOM	Mechanisms that regulate proliferation and expansion of human hematopoietic stem/multipotent progenitor cells (HSC/MPPs) are targets of intensive investigations. Several cell intrinsic factors and signaling pathways have been implicated in the proliferation and differentiation of human HSC/MPPs. Nevertheless, expansion of human HSC/MPPs for clinical application remains a critical challenge. VentX is a human homeobox transcription factor that was recently identified as an anti-proliferation and pro-differentiation factor in human hematopoietic cells. Here, we report that VentX expression is up-regulated during ontogenesis of human hematopoietic cells. Strikingly, suppression of VentX expression led to significant expansion of HSC/MPPs ex vivo and a 20-fold increase in engraftment potential in the NOD/SCID/IL2R gamma 2(null) mouse model. VentX suppression helped preserve the HSC/MPP pools and promote clonogenicity of hematopoietic progenitor cells. Mechanistically, we show that VentX regulates critical cell cycle regulators and Wnt downstream genes previously implicated in HSC/MPP proliferation and expansion.	[Gao, Hong; Wu, Xiaoming; Zhu, Zhenglun] Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; [Zhou, Shuanhu] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Sun, Yan; Silberstein, Leslie E.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Zhu, ZL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gastroenterol, 75 Francis St, Boston, MA 02115 USA.	zzhu@partners.org	Zhou, Shuanhu/Q-7137-2019; Zhou, Shuanhu/AAW-4405-2021	Zhou, Shuanhu/0000-0003-4745-5347	National Institutes of Health [1R03HD064617]; Department of Defense; American Cancer Society; Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD064617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Brigham and Women's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by National Institutes of Health Grant 1R03HD064617, the Department of Defense, the American Cancer Society, and a research fund from Brigham and Women's Hospital. To whom correspondence should be addressed. Tel.: 617-732-5467; Fax: 617-730-5807; E-mail: zzhu@partners.org.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunstein CG, 2006, ANNU REV MED, V57, P403, DOI 10.1146/annurev.med.57.051804.123642; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Ko KH, 2011, STEM CELLS, V29, P108, DOI 10.1002/stem.551; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Sorrentino BP, 2004, NAT REV IMMUNOL, V4, P878, DOI 10.1038/nri1487; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556; Wu XM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206078; Yang YZ, 2007, CELL RES, V17, P307, DOI 10.1038/cr.2007.29; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	32	11	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29979	29987		10.1074/jbc.M112.383018	http://dx.doi.org/10.1074/jbc.M112.383018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22791709	hybrid, Green Published			2022-12-28	WOS:000308286900071
J	Hachiya, A; Marchand, B; Kirby, KA; Michailidis, E; Tu, XY; Palczewski, K; Ong, YT; Li, Z; Griffin, DT; Schuckmann, MM; Tanuma, J; Oka, S; Singh, K; Kodama, EN; Sarafianos, SG				Hachiya, Atsuko; Marchand, Bruno; Kirby, Karen A.; Michailidis, Eleftherios; Tu, Xiongying; Palczewski, Krzysztof; Ong, Yee Tsuey; Li, Zhe; Griffin, Daniel T.; Schuckmann, Matthew M.; Tanuma, Junko; Oka, Shinichi; Singh, Kamalendra; Kodama, Eiichi N.; Sarafianos, Stefan G.			HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; THYMIDINE ANALOG MUTATIONS; TREATMENT-NAIVE PATIENTS; CONNECTION SUBDOMAIN; RNASE-H; NEVIRAPINE RESISTANCE; MOLECULAR-MECHANISMS; VIROLOGICAL FAILURE; DUAL RESISTANCE; TERMINATED DNA	Polymorphisms have poorly understood effects on drug susceptibility and may affect the outcome of HIV treatment. We have discovered that an HIV-1 reverse transcriptase (RT) polymorphism (RT172K) is present in clinical samples and in widely used laboratory strains (BH10), and it profoundly affects HIV-1 susceptibility to both nucleoside (NRTIs) and non-nucleoside RT inhibitors (NNRTIs) when combined with certain mutations. Polymorphism 172K significantly suppressed zidovudine resistance caused by excision (e.g. thymidine-associated mutations) and not by discrimination mechanism mutations (e.g. Q151M complex). Moreover, it attenuated resistance to nevirapine or efavirenz imparted by NNRTI mutations. Although 172K favored RT-DNA binding at an excisable pre-translocation conformation, it decreased excision by thymidine-associated mutation-containing RT. 172K affected DNA handling and decreased RT processivity without significantly affecting the k(cat)/K-m values for dNTP. Surface plasmon resonance experiments revealed that RT172K decreased DNA binding by increasing the dissociation rate. Hence, the increased zidovudine susceptibility of RT172K results from its increased dissociation from the chain-terminated DNA and reduced primer unblocking. We solved a high resolution (2.15 angstrom) crystal structure of RT mutated at 172 and compared crystal structures of RT172R and RT172K bound to NNRTIs or DNA/dNTP. Our structural analyses high-light differences in the interactions between alpha-helix E (where 172 resides) and the active site beta 9-strand that involve the YMDD loop and the NNRTI binding pocket. Such changes may increase dissociation of DNA, thus suppressing excision-based NRTI resistance and also offset the effect of NNRTI resistance mutations thereby restoring NNRTI binding.	[Hachiya, Atsuko; Marchand, Bruno; Kirby, Karen A.; Michailidis, Eleftherios; Ong, Yee Tsuey; Li, Zhe; Griffin, Daniel T.; Schuckmann, Matthew M.; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher S Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Hachiya, Atsuko; Tanuma, Junko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1628655, Japan; [Tu, Xiongying; Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Sendai, Miyagi 9808575, Japan; [Li, Zhe; Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; National Center for Global Health & Medicine - Japan; Case Western Reserve University; Tohoku University; University of Missouri System; University of Missouri Columbia	Sarafianos, SG (corresponding author), 471D Christopher S Bond Life Sci Ctr, 1201 E Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009; Tanuma, Junko/AAE-5395-2020; Tu, Xiongying/H-7983-2012	Kodama, Eiichi N/0000-0002-6622-2752; Ong, Yee Tsuey/0000-0001-9361-2855; Sarafianos, Stefan G/0000-0002-5840-154X; Kirby, Karen A./0000-0003-2468-4796; Michailidis, Eleftherios/0000-0002-9907-4346; Oka, Shinichi/0000-0002-9283-2167	National Institutes of Health [AI094715, AI076119, AI079801, AI074389]; Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; Korea Food and Drug Administration; Ministry of Knowledge and Economy; Canadian Institutes of Health Research; American Foundation for AIDS Research Mathilde Krim fellowship; Canadian Institutes of Health Research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094715, R01AI074389, R21AI079801, R01AI076119, R33AI079801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Ministry of Knowledge and Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Foundation for AIDS Research Mathilde Krim fellowship; Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Research Grants AI094715, AI076119, AI079801, and AI074389 (to S. G. S.). This work was also supported by a grant for the promotion of AIDS research from the Ministry of Health, Labor, and Welfare (to E. K., A. H., and S. O.), by a grant for the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology (to J. T. and S. O.), and by a grant for Bilateral International Collaborative R&D Program from the Korea Food and Drug Administration and the Ministry of Knowledge and Economy (to S. G. S.).; Recipient of an American Foundation for AIDS Research Mathilde Krim fellowship and a Canadian Institutes of Health Research fellowship.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Bauman JD, 2008, NUCLEIC ACIDS RES, V36, P5083, DOI 10.1093/nar/gkn464; Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BYRNES VW, 1994, ANTIMICROB AGENTS CH, V38, P1404, DOI 10.1128/AAC.38.6.1404; Clark SA, 2006, AIDS, V20, P981, DOI 10.1097/01.aids.0000222069.14878.44; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Delviks-Frankenberry KA, 2007, J VIROL, V81, P6837, DOI 10.1128/JVI.02820-06; Delviks-Frankenberry KA, 2010, VIRUSES-BASEL, V2, P1476, DOI 10.3390/v2071476; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frankel FA, 2005, ANTIMICROB AGENTS CH, V49, P2657, DOI 10.1128/AAC.49.7.2657-2664.2005; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Garriga C, 2009, J ANTIMICROB CHEMOTH, V64, P251, DOI 10.1093/jac/dkp200; Geleziunas Romas, 2003, Antiviral Chemistry & Chemotherapy, V14, P49; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2004, VIROLOGY, V327, P215, DOI 10.1016/j.virol.2004.07.001; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016242; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Hammond JL, 2005, ANTIMICROB AGENTS CH, V49, P3930, DOI 10.1128/AAC.49.9.3930-3932.2005; Hanson Kimberly, 2006, Curr HIV/AIDS Rep, V3, P93, DOI 10.1007/s11904-006-0024-z; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Lanier ER, 2004, HIV MED, V5, P394, DOI 10.1111/j.1468-1293.2004.00243.x; LARDER BA, 1994, J GEN VIROL, V75, P951, DOI 10.1099/0022-1317-75-5-951; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LIN PF, 1994, J INFECT DIS, V170, P1157, DOI 10.1093/infdis/170.5.1157; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Miranda LR, 2005, ANTIMICROB AGENTS CH, V49, P2648, DOI 10.1128/AAC.49.7.2648-2656.2005; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Paredes R, 2011, J INFECT DIS, V204, P741, DOI 10.1093/infdis/jir385; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Selmi B, 2003, J BIOL CHEM, V278, P40464, DOI 10.1074/jbc.M302928200; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Svicher V, 2006, J VIROL, V80, P7186, DOI 10.1128/JVI.02084-05; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; Whitcomb JM, 2003, J INFECT DIS, V188, P992, DOI 10.1086/378281; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zelina S, 2008, ANTIMICROB AGENTS CH, V52, P157, DOI 10.1128/AAC.00904-07	64	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29988	29999		10.1074/jbc.M112.351551	http://dx.doi.org/10.1074/jbc.M112.351551			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761416	Green Published, hybrid			2022-12-28	WOS:000308286900072
J	Moon, SH; Jenkins, CM; Kiebish, MA; Sims, HF; Mancuso, DJ; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Kiebish, Michael A.; Sims, Harold F.; Mancuso, David J.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma (iPLA(2)gamma) Attenuates Calcium-induced Opening of the Mitochondrial Permeability Transition Pore and Resultant Cytochrome c Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; ARACHIDONIC-ACID RELEASE; CYCLOPHILIN-D; CELL-DEATH; CYCLOSPORINE-A; LIVER-MITOCHONDRIA; HEART-MITOCHONDRIA; INSULIN-RESISTANCE; OXIDATIVE-PHOSPHORYLATION; MEMBRANE-PERMEABILITY	Herein, we demonstrate that calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) is a critical mechanistic participant in the calcium-induced opening of the mitochondrial permeability transition pore (mPTP). Liver mitochondria from iPLA(2)gamma(-/-) mice were markedly resistant to calcium-induced swelling in the presence or absence of phosphate in comparison with wild-type littermates. Furthermore, the iPLA(2)gamma enantioselective inhibitor (R)-(E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one ((R)-BEL) was markedly more potent than (S)-BEL in inhibiting mPTP opening in mitochondria from wild-type liver in comparison with hepatic mitochondria from iPLA(2)gamma(-/-) mice. Intriguingly, low micromolar concentrations of long chain fatty acyl-CoAs and the non-hydrolyzable thioether analog of palmitoyl-CoA markedly accelerated Ca2+-induced mPTP opening in liver mitochondria from wild-type mice. The addition of L-carnitine enabled the metabolic channeling of acyl-CoA through carnitine palmitoyltransferases (CPT-1/2) and attenuated the palmitoyl-CoA-mediated amplification of calcium-induced mPTP opening. In contrast, mitochondria from iPLA(2)gamma(-/-) mice were insensitive to fatty acyl-CoA-mediated augmentation of calcium-induced mPTP opening. Moreover, mitochondria from iPLA(2)gamma(-/-) mouse liver were resistant to Ca2+/t-butyl hydroperoxide-induced mPTP opening in comparison with wild-type littermates. In support of these findings, cytochrome c release from iPLA(2)gamma(-/-) mitochondria was dramatically decreased in response to calcium in the presence or absence of either t-butyl hydroperoxide or phenylarsine oxide in comparison with wild-type littermates. Collectively, these results identify iPLA(2)gamma as an important mechanistic component of the mPTP, define its downstream products as potent regulators of mPTP opening, and demonstrate the integrated roles of mitochondrial bioenergetics and lipidomic flux in modulating mPTP opening promoting the activation of necrotic and necroapoptotic pathways of cell death.	[Moon, Sung Ho; Jenkins, Christopher M.; Kiebish, Michael A.; Sims, Harold F.; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Bradley JM, 2011, J AM CHEM SOC, V133, P19676, DOI 10.1021/ja209144h; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Cooney GJ, 2002, ANN NY ACAD SCI, V967, P196; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1988, BIOCHEM J, V255, P357; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Di Paola M, 2006, FEBS LETT, V580, P775, DOI 10.1016/j.febslet.2005.12.090; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HANSFORD RG, 1985, BIOCHEM J, V227, P129, DOI 10.1042/bj2270129; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Huang YX, 2006, BBA-GEN SUBJECTS, V1760, P1827, DOI 10.1016/j.bbagen.2006.08.013; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; KIM DK, 1991, AM J PHYSIOL, V260, pH1767, DOI 10.1152/ajpheart.1991.260.6.H1767; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; LERNER E, 1972, J BIOL CHEM, V247, P1513; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; MITTNACHT S, 1981, J BIOL CHEM, V256, P3199; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; ONTKO JA, 1983, BIOCHEM BIOPH RES CO, V116, P173, DOI 10.1016/0006-291X(83)90397-2; OTTO DA, 1978, J BIOL CHEM, V253, P789; Oyanagi E, 2011, BIOCHEM BIOPH RES CO, V412, P61, DOI 10.1016/j.bbrc.2011.07.039; Palomba L, 2001, J NEUROSCI RES, V65, P387, DOI 10.1002/jnr.1165; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schonfeld P, 1997, FEBS LETT, V420, P167, DOI 10.1016/S0014-5793(97)01511-1; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; Sinibaldi F, 2010, J BIOL INORG CHEM, V15, P689, DOI 10.1007/s00775-010-0636-z; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tanveer A, 1996, EUR J BIOCHEM, V238, P166, DOI 10.1111/j.1432-1033.1996.0166q.x; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Vay L, 2009, CELL CALCIUM, V45, P243, DOI 10.1016/j.ceca.2008.10.007; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22	83	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29837	29850		10.1074/jbc.M112.373654	http://dx.doi.org/10.1074/jbc.M112.373654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778252	Green Published, hybrid			2022-12-28	WOS:000308286900058
J	Robal, T; Larsson, M; Martin, M; Olivecrona, G; Lookene, A				Robal, Terje; Larsson, Mikael; Martin, Miina; Olivecrona, Gunilla; Lookene, Aivar			Fatty Acids Bind Tightly to the N-terminal Domain of Angiopoietin-like Protein 4 and Modulate Its Interaction with Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; ADIPOSE-TISSUE; SERUM-ALBUMIN; RISK-FACTORS; TARGET GENE; PLASMA; ANGPTL4; TRIGLYCERIDES; LIPOLYSIS; INSIGHTS	Angiopoietin-like protein 4 (Angptl4), a potent regulator of plasma triglyceride metabolism, binds to lipoprotein lipase (LPL) through its N-terminal coiled-coil domain (ccd-Angptl4) inducing dissociation of the dimeric enzyme to inactive monomers. In this study, we demonstrate that fatty acids reduce the inactivation of LPL by Angptl4. This was the case both with ccd-Angptl4 and full-length Angptl4, and the effect was seen in human plasma or in the presence of albumin. The effect decreased in the sequence oleic acid > palmitic acid > myristic acid > linoleic acid > linolenic acid. Surface plasmon resonance, isothermal titration calorimetry, fluorescence, and chromatography measurements revealed that fatty acids bind with high affinity to ccd-Angptl4. The interactions were characterized by fast association and slow dissociation rates, indicating formation of stable complexes. The highest affinity for ccd-Angptl4 was detected for oleic acid with a subnanomolar equilibrium dissociation constant (K-d). The K-d values for palmitic and myristic acid were in the nanomolar range. Linoleic and linolenic acid bound with much lower affinity. On binding of fatty acids, ccd-Angptl4 underwent conformational changes resulting in a decreased helical content, weakened structural stability, dissociation of oligomers, and altered fluorescence properties of the Trp-38 residue that is located close to the putative LPL-binding region. Based on these results, we propose that fatty acids play an important role in modulating the effects of Angptl4.	[Robal, Terje; Martin, Miina; Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci, SE-90187 Umea, Sweden	Tallinn University of Technology; Umea University	Lookene, A (corresponding author), Tallinn Univ Technol, Dept Chem, Akad Tee 15, EE-12618 Tallinn, Estonia.	aivar.lookene@ttu.ee			Estonian Ministry of Education and Research; Estonian Science Foundation [8300]; Swedish Research Council [12203]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Estonian Ministry of Education and Research, Estonian Science Foundation Grant 8300, and by the Swedish Research Council Grant 12203.	AKI H, 1994, J PHARM SCI, V83, P1712, DOI 10.1002/jps.2600831213; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P557, DOI 10.1111/j.1432-1033.1980.tb04603.x; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Bojesen E, 1996, J PHYS CHEM-US, V100, P17981, DOI 10.1021/jp962141m; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; De Caterina R, 2010, J AM COLL CARDIOL, V55, P198, DOI 10.1016/j.jacc.2009.07.062; Demant EJF, 2002, BIOCHEM J, V363, P809, DOI 10.1042/0264-6021:3630809; Dutton S, 2008, BRIT J NUTR, V100, P18, DOI 10.1017/S0007114507882961; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hultin M, 1996, J LIPID RES, V37, P1022; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Kim YJ, 2006, ANN NY ACAD SCI, V1086, P11, DOI 10.1196/annals.1377.021; Kleinfeld AM, 1996, AM J CARDIOL, V78, P1350, DOI 10.1016/S0002-9149(96)00651-0; Labreuche J, 2010, ATHEROSCLEROSIS, V212, P9, DOI 10.1016/j.atherosclerosis.2010.02.011; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P954, DOI DOI 10.1007/978-0-387-46312-4; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Nilsson S. K, 2009, 15 INT S ATH BOST MA, pe238; RICHIERI GV, 1995, J LIPID RES, V36, P229; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; SAXENA U, 1989, J BIOL CHEM, V264, P4349; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; SHIMADA K, 1982, BIOCHIM BIOPHYS ACTA, V710, P117, DOI 10.1016/0005-2760(82)90140-0; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	60	22	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29739	29752		10.1074/jbc.M111.303529	http://dx.doi.org/10.1074/jbc.M111.303529			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773878	Green Published, hybrid			2022-12-28	WOS:000308286900050
J	Wang, YG; Tang, RT; Tao, J; Wang, XN; Zheng, BS; Feng, Y				Wang, Yuguo; Tang, Rentao; Tao, Jin; Wang, Xiaonan; Zheng, Baisong; Feng, Yan			Chimeric Cellulase Matrix for Investigating Intramolecular Synergism between Non-hydrolytic Disruptive Functions of Carbohydrate-binding Modules and Catalytic Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-HYDROLYSIS; DOMAINS; PROTEIN; SIMULATIONS; RESIDUES; SMART; CEL5A	The conversion of renewable cellulosic biomass is of considerable interest for the production of biofuels and materials. The bottleneck in the efficient conversion is the compactness and resistance of crystalline cellulose. Carbohydrate-binding modules (CBMs), which disrupt crystalline cellulose via non-hydrolytic mechanisms, are expected to overcome this bottleneck. However, the lack of convenient methods for quantitative analysis of the disruptive functions of CBMs have hindered systematic studies and molecular modifications. Here we established a practical and systematic platform for quantifying and comparing the non-hydrolytic disruptive activities of CBMs via the synergism of CBMs and a catalytic module within designed chimeric cellulase molecules. Bioinformatics and computational biology were also used to provide a deeper understanding. A convenient vector was constructed to serve as a cellulase matrix into which heterologous CBM sequences can be easily inserted. The resulting chimeric cellulases were suitable for studying disruptive functions, and their activities quantitatively reflected the disruptive functions of CBMs on crystalline cellulose. In addition, this cellulase matrix can be used to construct novel chimeric cellulases with high hydrolytic activities toward crystalline cellulose.	[Feng, Yan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Feng, Yan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Wang, Yuguo; Tang, Rentao; Tao, Jin; Wang, Xiaonan; Zheng, Baisong; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130012, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yfeng2009@mail.sjtu.edu.cn			National Basic Research Program of China (973 Program) [2012CB721000, 2011CBA00800]; Natural Science Foundation of China; Science and Technology Commission of the Shanghai Municipality	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China ( 973 Program, No. 2012CB721000 and 2011CBA00800), Natural Science Foundation of China, and Science and Technology Commission of the Shanghai Municipality.	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bae HJ, 2003, FEMS MICROBIOL LETT, V227, P175, DOI 10.1016/S0378-1097(03)00593-7; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Case D. A., 2021, AMBER 2022; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Chhabra SR, 2002, FEBS LETT, V531, P375, DOI 10.1016/S0014-5793(02)03493-2; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Doi RH, 2003, J BACTERIOL, V185, P5907, DOI 10.1128/JB.185.20.5907-5914.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mahadevan SA, 2008, FEMS MICROBIOL LETT, V287, P205, DOI 10.1111/j.1574-6968.2008.01324.x; Mattinen ML, 1997, PROTEIN SCI, V6, P294; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; United States Department of Energy, 2006, US DEP EN PUBL; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	49	10	11	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29568	29578		10.1074/jbc.M111.320358	http://dx.doi.org/10.1074/jbc.M111.320358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778256	Green Published, hybrid			2022-12-28	WOS:000308286900032
J	Yuan, MS; Pino, E; Wu, LF; Kacergis, M; Soukas, AA				Yuan, Minsheng; Pino, Elizabeth; Wu, Lianfeng; Kacergis, Michael; Soukas, Alexander A.			Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; MOTIF PHOSPHORYLATION; TRANSCRIPTION FACTORS; DIABETES-MELLITUS; LIPID-METABOLISM; KINASE-B; RICTOR; MICE; AKT/PKB; LIVER	Mammalian target of rapamycin complex 2 (mTORC2) is a key activator of protein kinases that act downstream of insulin and growth factor signaling. Here we report that mice lacking the essential mTORC2 component rictor in liver (Lrictor(KO)) are unable to respond normally to insulin. In response to insulin, Lrictor(KO) mice failed to inhibit hepatic glucose output. Lrictor(KO) mice also fail to develop hepatic steatosis on a high fat diet and manifest half-normal serum cholesterol levels. This is accompanied by lower levels of expression of SREBP-1c and SREBP-2 and genes of fatty acid and cholesterol biosynthesis. Lrictor(KO) mice had defects in insulin-stimulated Akt Ser-473 and Thr-308 phosphorylation, leading to decreased phosphorylation of Akt substrates FoxO, GSK-3 beta, PRAS40, AS160, and Tsc2. Lrictor(KO) mice also manifest defects in insulin-activated mTORC1 activity, evidenced by decreased S6 kinase and Lipin1 phosphorylation. Glucose intolerance and insulin resistance of Lrictor(KO) mice could be fully rescued by hepatic expression of activated Akt2 or dominant negative FoxO1. However, in the absence of mTORC2, forced Akt2 activation was unable to drive hepatic lipogenesis. Thus, we have identified an Akt-independent relay from mTORC2 to hepatic lipogenesis that separates the effects of insulin on glucose and lipid metabolism.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet & Diabet Unit,Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Soukas, AA (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN6224, Boston, MA 02114 USA.	asoukas@chgr.mgh.harvard.edu		Pino, Elizabeth/0000-0003-0626-5221	National Institutes of Health Career Development Award through NIDDK [K08DK087941]; Charles H. Hood Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087941] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award through NIDDK; Charles H. Hood Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Career Development Award K08DK087941 through the NIDDK ( to A. A. S.). This work was also supported by a Child Health Research Award from the Charles H. Hood Foundation ( to A. A. S).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	41	122	125	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29579	29588		10.1074/jbc.M112.386854	http://dx.doi.org/10.1074/jbc.M112.386854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773877	Green Published, hybrid			2022-12-28	WOS:000308286900033
J	Curry, MC; Luk, NA; Kenny, PA; Roberts-Thomson, SJ; Monteith, GR				Curry, Merril C.; Luk, Nicole A.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Distinct Regulation of Cytoplasmic Calcium Signals and Cell Death Pathways by Different Plasma Membrane Calcium ATPase Isoforms in MDA-MB-231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; SPERM MOTILITY; CA2+ ATPASE; BCL-2; ACTIVATION; RESISTANCE; EXPRESSION; PMCA	Plasma membrane calcium ATPases (PMCAs) actively extrude Ca2+ from the cell and are essential components in maintaining intracellular Ca2+ homeostasis. There are four PMCA isoforms (PMCA1-4), and alternative splicing of the PMCA genes creates a suite of calcium efflux pumps. The role of these different PMCA isoforms in the control of calcium-regulated cell death pathways and the significance of the expression of multiple isoforms of PMCA in the same cell type are not well understood. In these studies, we assessed the impact of PMCA1 and PMCA4 silencing on cytoplasmic free Ca2+ signals and cell viability in MDA-MB-231 breast cancer cells. The PMCA1 isoform was the predominant regulator of global Ca2+ signals in MDA-MB-231 cells. PMCA4 played only a minor role in the regulation of bulk cytosolic Ca2+, which was more evident at higher Ca2+ loads. Although PMCA1 or PMCA4 knockdown alone had no effect on MDA-MB-231 cell viability, silencing of these isoforms had distinct consequences on caspase-independent (ionomycin) and -dependent (ABT-263) cell death. PMCA1 knockdown augmented necrosis mediated by the Ca2+ ionophore ionomycin, whereas apoptosis mediated by the Bcl-2 inhibitor ABT-263 was enhanced by PMCA4 silencing. PMCA4 silencing was also associated with an inhibition of NF kappa B nuclear translocation, and an NF kappa B inhibitor phenocopied the effects of PMCA4 silencing in promoting ABT-263-induced cell death. This study demonstrates distinct roles for PMCA1 and PMCA4 in the regulation of calcium signaling and cell death pathways despite the widespread distribution of these two isoforms. The targeting of some PMCA isoforms may enhance the effectiveness of therapies that act through the promotion of cell death pathways in cancer cells.	[Curry, Merril C.; Luk, Nicole A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Queensland; Yeshiva University; Albert Einstein College of Medicine	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.	gregm@uq.edu.au	Roberts-Thomson, Sarah/W-5676-2019; Roberts-Thomson, Sarah J/B-4282-2011; Monteith, Gregory/B-1626-2008	Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Monteith, Gregory/0000-0002-4345-530X	National Health and Medical Research Council [631347]; Susan G. Komen for the Cure [KG100888]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	This work was supported by National Health and Medical Research Council Grant 631347 and Susan G. Komen for the Cure Grant KG100888.	Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Braunstein S, 2008, MOL CANCER RES, V6, P78, DOI 10.1158/1541-7786.MCR-07-0339; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fernandes D, 2007, J NEUROCHEM, V102, P454, DOI 10.1111/j.1471-4159.2007.04592.x; Ghosh RN, 2005, J BIOMOL SCREEN, V10, P476, DOI 10.1177/1087057105274896; Gribbon P, 2003, DRUG DISCOV TODAY, V8, P1035, DOI 10.1016/S1359-6446(03)02895-2; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holton M, 2007, FEBS LETT, V581, P4115, DOI 10.1016/j.febslet.2007.07.054; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kurnellas MP, 2010, CELL DEATH DIFFER, V17, P1501, DOI 10.1038/cdd.2010.54; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Monteith GR, 2005, TRENDS PHARMACOL SCI, V26, P218, DOI 10.1016/j.tips.2005.02.002; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Schlotter CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2112; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Signorelli P, 2001, FASEB J, V15, P2401, DOI 10.1096/fj.01-0244com; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; VanHouten J, 2010, P NATL ACAD SCI USA, V107, P11405, DOI 10.1073/pnas.0911186107; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warr MR, 2008, CURR ONCOL, V15, P256; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693	57	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28598	28608		10.1074/jbc.M112.364737	http://dx.doi.org/10.1074/jbc.M112.364737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733819	Green Published, hybrid			2022-12-28	WOS:000308074600034
J	Goetz, R; Ohnishi, M; Kir, S; Kurosu, H; Wang, L; Pastor, J; Ma, JH; Gai, WM; Kuro-o, M; Razzaque, MS; Mohammadi, M				Goetz, Regina; Ohnishi, Mutsuko; Kir, Serkan; Kurosu, Hiroshi; Wang, Lei; Pastor, Johanne; Ma, Jinghong; Gai, Weiming; Kuro-o, Makoto; Razzaque, Mohammed S.; Mohammadi, Moosa			Conversion of a Paracrine Fibroblast Growth Factor into an Endocrine Fibroblast Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; C-TERMINAL TAIL; FGF RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BETA-KLOTHO; 3-DIMENSIONAL STRUCTURE; METABOLIC-ACTIVITY; PPAR-ALPHA; SPECIFICITY	FGFs 19, 21, and 23 are hormones that regulate in a Klotho co-receptor-dependent fashion major metabolic processes such as glucose and lipid metabolism (FGF21) and phosphate and vitamin D homeostasis (FGF23). The role of heparan sulfate glycosaminoglycan in the formation of the cell surface signaling complex of endocrine FGFs has remained unclear. Here we show that heparan sulfate is not a component of the signal transduction unit of FGF19 and FGF23. In support of our model, we convert a paracrine FGF into an endocrine ligand by diminishing heparan sulfate-binding affinity of the paracrine FGF and substituting its C-terminal tail for that of an endocrine FGF containing the Klotho co-receptor-binding site to home the ligand into the target tissue. In addition to serving as a proof of concept, the ligand conversion provides a novel strategy for engineering endocrine FGF-like molecules for the treatment of metabolic disorders, including global epidemics such as type 2 diabetes and obesity.	[Goetz, Regina; Ma, Jinghong; Gai, Weiming; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Ohnishi, Mutsuko; Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Kir, Serkan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kurosu, Hiroshi; Wang, Lei; Pastor, Johanne; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	New York University; Harvard University; Harvard School of Dental Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mohammadi, M (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 1st Ave, New York, NY 10016 USA.	Moosa.Mohammadi@nyumc.org	Mohammadi, Moosa/ABA-6745-2020; Razzaque, Mohammed S./K-4282-2019; kasaei, fahime/T-7197-2018; Goetz, Regina/M-2411-2019	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703	National Institutes of Health [DE13686, DK077276, AG019712, DK091392, P30 NS050276, DK067158]; Texas Higher Education Coordinating Board [NHRP 010019-0043-2009]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276, R01DK067158, R01DK091392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13686 (to M. M.), DK077276 (to M. S. R.), and AG019712 and DK091392 (to M. K.). This work was also supported by Texas Higher Education Coordinating Board Grant NHRP 010019-0043-2009 (to M. K.) and National Institutes of Health Grant P30 NS050276 covering the maintenance of the Biacore 2000 SPR instrument.; Supported by National Institutes of Health Grant DK067158.	AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FINZEL BC, 1989, J MOL BIOL, V209, P779, DOI 10.1016/0022-2836(89)90606-2; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2012, MOL CELL BIOL, V32, P1944, DOI 10.1128/MCB.06603-11; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohnishi M, 2011, FASEB J, V25, P2031, DOI 10.1096/fj.10-167056; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	65	68	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29134	29146		10.1074/jbc.M112.342980	http://dx.doi.org/10.1074/jbc.M112.342980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733815	hybrid, Green Published			2022-12-28	WOS:000308074600079
J	Kawamura, I; Maeda, S; Imamura, K; Setoguchi, T; Yokouchi, M; Ishidou, Y; Komiya, S				Kawamura, Ichiro; Maeda, Shingo; Imamura, Katsuyuki; Setoguchi, Takao; Yokouchi, Masahiro; Ishidou, Yasuhiro; Komiya, Setsuro			SnoN Suppresses Maturation of Chondrocytes by Mediating Signal Cross-talk between Transforming Growth Factor-beta and Bone Morphogenetic Protein Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X COLLAGEN GENE; ARTICULAR-CARTILAGE; HYPERTROPHIC DIFFERENTIATION; MURINE CHONDROCYTES; STEM-CELLS; IN-VIVO; EXPRESSION; OSTEOARTHRITIS; CHONDROGENESIS; SMAD3	Hypertrophic maturation of chondrocytes is a crucial step in endochondral ossification, whereas abnormally accelerated differentiation of hypertrophic chondrocytes in articular cartilage is linked to pathogenesis of osteoarthritis. This cellular process is promoted or inhibited by bone morphogenetic protein (BMP) or transforming growth factor-beta (TGF-beta) signaling, respectively, suggesting that these signaling pathways cross-talk during chondrocyte maturation. Here, we demonstrated that expression of Tgfb1 was increased, followed by phosphorylation of Smad2, during BMP-2-induced hypertrophic maturation of ATDC5 chondrocytes. Application of a TGF-beta type I receptor inhibitor compound, SB431542, increased the expression of Id1, without affecting the phosphorylation status of Smad1/5/8, indicating that the activated endogenous TGF-beta pathway inhibited BMP signaling downstream of the Smad activation step. We searched for TGF-beta-inducible effectors that are able to inhibit BMP signaling in ATDC5 cells and identified SnoN. Overexpression of SnoN suppressed the activity of a BMP-responsive luciferase reporter in COS-7 cells as well as expression of Id1 in ATDC5 cells and, subsequently, the expression of Col10a1, a hallmark of hypertrophic chondrocyte maturation. siRNA-mediated loss of SnoN showed opposite effects in BMP-treated ATDC5 cells. In adult mice, we found the highest level of SnoN expression in articular cartilage. Importantly, SnoN was expressed, in combination with phosphorylated Smad2/3, in prehypertrophic chondrocytes in the growth plate of mouse embryo bones and in chondrocytes around the ectopically existing hypertrophic chondrocytes of human osteoarthritis cartilage. Our results indicate that SnoN mediates a negative feedback mechanism evoked by TGF-beta to inhibit BMP signaling and, subsequently, hypertrophic maturation of chondrocytes.	[Kawamura, Ichiro; Maeda, Shingo; Imamura, Katsuyuki; Ishidou, Yasuhiro; Komiya, Setsuro] Kagoshima Univ, Dept Med Joint Mat, Kagoshima 8908544, Japan; [Kawamura, Ichiro; Imamura, Katsuyuki; Yokouchi, Masahiro; Komiya, Setsuro] Kagoshima Univ, Dept Orthoped Surg, Kagoshima 8908544, Japan; [Setoguchi, Takao] Kagoshima Univ, Near Future Locomotor Organ Med Creat Course, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Maeda, S (corresponding author), Kagoshima Univ, Dept Med Joint Mat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	s-maeda@m3.kufm.kagoshima-u.ac.jp			Japan Orthopedics and Traumatology Foundation, Inc. [254];  [23592221];  [23592222]	Japan Orthopedics and Traumatology Foundation, Inc.; ; 	This work was supported by Grants-in-Aid for Scientific Research (Scientific Research (C) (General)) 23592221 (to S. M.) and 23592222 (to Y.I.) and Japan Orthopedics and Traumatology Foundation, Inc., Grant 254.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Kempf H, 2007, DEV DYNAM, V236, P1954, DOI 10.1002/dvdy.21205; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Kuroki H, 2004, ARTHRITIS RES THER, V6, pR492, DOI 10.1186/ar1219; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Li TF, 2010, ARTHRITIS RHEUM-US, V62, P2359, DOI 10.1002/art.27537; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	53	39	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29101	29113		10.1074/jbc.M112.349415	http://dx.doi.org/10.1074/jbc.M112.349415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22767605	hybrid, Green Published			2022-12-28	WOS:000308074600076
J	Liu, JS; Sudom, A; Min, XS; Cao, ZD; Gao, X; Ayres, M; Lee, F; Cao, P; Johnstone, S; Plotnikova, O; Walker, N; Chen, GQ; Wang, ZL				Liu, Jinsong; Sudom, Athena; Min, Xiaoshan; Cao, Zhaodan; Gao, Xiong; Ayres, Merrill; Lee, Fei; Cao, Ping; Johnstone, Sheree; Plotnikova, Olga; Walker, Nigel; Chen, Guoqing; Wang, Zhulun			Structure of the Nuclear Factor kappa B-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; ACTIVATION PATHWAYS; IKK-ALPHA; INSIGHTS	NF-kappa B-inducing kinase (NIK) is a central component in the non-canonical NF-kappa B signaling pathway. Excessive NIK activity is implicated in various disorders, such as autoimmune conditions and cancers. Here, we report the first crystal structure of truncated human NIK in complex with adenosine 5'-O-(thiotriphosphate) at a resolution of 2.5 angstrom. This truncated protein is a catalytically active construct, including an N-terminal extension of 60 residues prior to the kinase domain, the kinase domain, and 20 residues afterward. The structure reveals that the NIK kinase domain assumes an active conformation in the absence of any phosphorylation. Analysis of the structure uncovers a unique role for the N-terminal extension sequence, which stabilizes helix alpha C in the active orientation and keeps the kinase domain in the catalytically competent conformation. Our findings shed light on the long-standing debate over whether NIK is a constitutively active kinase. They also provide a molecular basis for the recent observation of gain-of-function activity for an N-terminal deletion mutant (Delta N324) of NIK, leading to constitutive non-canonical NF-kappa B signaling with enhanced B-cell adhesion and apoptosis resistance.	[Liu, Jinsong; Sudom, Athena; Min, Xiaoshan; Cao, Zhaodan; Gao, Xiong; Ayres, Merrill; Lee, Fei; Cao, Ping; Johnstone, Sheree; Plotnikova, Olga; Walker, Nigel; Chen, Guoqing; Wang, Zhulun] Amgen Inc, San Francisco, CA 94080 USA	Amgen	Wang, ZL (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	zwang@amgen.com			United States Department of Energy [DE-AC03-76SF00098]	United States Department of Energy(United States Department of Energy (DOE))	We thank David Goeddel for valuable guidance and advice. The Advanced Light Source at the Lawrence Berkeley National Laboratory is supported by United States Department of Energy Contract DE-AC03-76SF00098.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	46	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27326	27334		10.1074/jbc.M112.366658	http://dx.doi.org/10.1074/jbc.M112.366658			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718757	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000307840700005
J	Grewer, C; Zhang, Z; Mwaura, J; Albers, T; Schwartz, A; Gameiro, A				Grewer, Christof; Zhang, Zhou; Mwaura, Juddy; Albers, Thomas; Schwartz, Alexander; Gameiro, Armanda			Charge Compensation Mechanism of a Na+-coupled, Secondary Active Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CATION INTERACTIONS; EXTRACELLULAR GATE; CONFORMATIONAL-CHANGES; RAT-BRAIN; BINDING; SUBSTRATE; EAAC1; RESIDUE; ASPARTATE; KINETICS	Forward glutamate transport by the excitatory amino acid carrier EAAC1 is coupled to the inward movement of three Na+ and one proton and the subsequent outward movement of one K+ in a separate step. Based on indirect evidence, it was speculated that the cation binding sites bear a negative charge. However, little is known about the electrostatics of the transport process. Valences calculated using the Poisson-Boltzmann equation indicate that negative charge is transferred across the membrane when only one cation is bound. Consistently, transient currents were observed in response to voltage jumps when K+ was the only cation on both sides of the membrane. Furthermore, rapid extracellular K+ application to EAAC1 under single turnover conditions (K+ inside) resulted in outward transient current. We propose a charge compensation mechanism, in which the C-terminal transport domain bears an overall negative charge of -1.23. Charge compensation, together with distribution of charge movement over many steps in the transport cycle, as well as defocusing of the membrane electric field, may be combined strategies used by Na+-coupled transporters to avoid prohibitive activation barriers for charge translocation.	[Grewer, Christof; Mwaura, Juddy; Albers, Thomas; Schwartz, Alexander; Gameiro, Armanda] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Zhang, Zhou] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu			National Institutes of Health [2R01NS049335-06A1]; Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01NS049335-06A1 (to C. G.). This work was also supported by Binational Science Foundation Grant 2007051 (to C. G. and B. I. Kanner).	Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	41	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26921	26931		10.1074/jbc.M112.364059	http://dx.doi.org/10.1074/jbc.M112.364059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707712	hybrid, Green Published			2022-12-28	WOS:000307386000040
J	Ohnishi, T; Godza, B; Watanabe, B; Fujioka, S; Hategan, L; Ide, K; Shibata, K; Yokota, T; Szekeres, M; Mizutani, M				Ohnishi, Toshiyuki; Godza, Blanka; Watanabe, Bunta; Fujioka, Shozo; Hategan, Lidia; Ide, Kouhei; Shibata, Kiyomi; Yokota, Takao; Szekeres, Miklos; Mizutani, Masaharu			CYP90A1/CPD, a Brassinosteroid Biosynthetic Cytochrome P450 of Arabidopsis, Catalyzes C-3 Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; STEPS; DEHYDROGENASE; HYDROXYLATION; BRASSINOLIDE; ELONGATION; METABOLISM; THALIANA; CYP90C1; ENCODES	Brassinosteroids (BRs) are steroidal phytohormones that regulate plant growth and development. Whereas in Arabidopsis the network-like routes of BR biosynthesis have been elucidated in considerable detail, the roles of some of the biosynthetic enzymes and their participation in the different subpathways remained to be clarified. We investigated the function of the cytochrome P450 monooxygenase CYP90A1/CPD, which earlier had been proposed to act as a BR C-23 hydroxylase. Our GC-MS and genetic analyses demonstrated that the cpd mutation arrests BR synthesis upstream of the DET2-mediated 5 alpha reduction step and that overexpression of the C-23 hydroxylase CYP90C1 does not alleviate BR deficiency in the cpd mutant. In line with these results, we found that CYP90A1/CPD heterologously expressed in a baculovirus-insect cell system catalyzes C-3 oxidation of the early BR intermediates (22S)-22-hydroxycampesterol and (22R, 23R)-22,23-dihydroxycampesterol, as well as of 6-deoxocathasterone and 6-deoxoteasterone. Enzyme kinetic data of CYP90A1/CPD and DET2, together with those of the earlier studied CYP90B1, CYP90C1, and CYP90D1, suggest that BR biosynthesis proceeds mainly via the campestanol-independent pathway.	[Ohnishi, Toshiyuki] Shizuoka Univ, Div Global Res Leaders, Suruga Ku, Shizuoka 4228529, Japan; [Godza, Blanka; Hategan, Lidia; Szekeres, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Watanabe, Bunta; Ide, Kouhei] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Shibata, Kiyomi; Yokota, Takao] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Shizuoka University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Kyoto University; RIKEN; Teikyo University; Kobe University	Ohnishi, T (corresponding author), Shizuoka Univ, Div Global Res Leaders, Suruga Ku, Shizuoka 4228529, Japan.	dtonish@ipc.shizuoka.ac.jp; szekeres@brc.hu		Szekeres, Miklos/0000-0002-6354-1790; Mizutani, Masaharu/0000-0002-4321-0644; Watanabe, Bunta/0000-0003-3645-5712	Hungarian Scientific Research Fund [T68201]; "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19380069, 23380066, 18580091]; Collaborative Research Program of the Institute for Chemical Research, Kyoto University [2010-16, 2011-17]; MEXT-supported Program for the Strategic Research Foundation at Private Universities [2008-2012]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Collaborative Research Program of the Institute for Chemical Research, Kyoto University; MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Hungarian Scientific Research Fund Grant T68201 (to M. S.), "BRAVISSIMO" Marie Curie Initial Training Grant of the European Union (to B. G.), Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 19380069 and 23380066 (to S. F.) and Grant 18580091 (to M. M.), Collaborative Research Program of the Institute for Chemical Research, Kyoto University, Grants 2010-16 and 2011-17 (to T. O.), and MEXT-supported Program for the Strategic Research Foundation at Private Universities Grant 2008-2012 (to T. Y.).	Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bajguz A, 2007, PLANT PHYSIOL BIOCH, V45, P95, DOI 10.1016/j.plaphy.2007.01.002; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Bishop GJ, 2001, PLANT CELL PHYSIOL, V42, P114, DOI 10.1093/pcp/pce018; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Finsterbusch A, 1999, PLANTA, V209, P478, DOI 10.1007/s004250050751; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fujioka S, 2000, PHYTOCHEMISTRY, V53, P549, DOI 10.1016/S0031-9422(99)00582-8; Fujita S, 2006, PLANT J, V45, P765, DOI 10.1111/j.1365-313X.2005.02639.x; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; KONCZ C, 1994, PLANT MOL BIOL MAN B, V2, P1; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Nomura T, 2001, PHYTOCHEMISTRY, V57, P171, DOI 10.1016/S0031-9422(00)00440-4; Nomura T, 2007, PLANT PHYSIOL, V143, P1680, DOI 10.1104/pp.106.093096; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Shimada Y, 2001, PLANT PHYSIOL, V126, P770, DOI 10.1104/pp.126.2.770; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Stundl U, 2001, PHYTOCHEMISTRY, V58, P989, DOI 10.1016/S0031-9422(01)00387-9; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; YOKOTA T, 1990, AGR BIOL CHEM TOKYO, V54, P1107, DOI 10.1080/00021369.1990.10870046	31	93	109	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31551	31560		10.1074/jbc.M112.392720	http://dx.doi.org/10.1074/jbc.M112.392720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822057	hybrid, Green Published			2022-12-28	WOS:000308791300067
J	Parisotto, D; Malsam, J; Scheutzow, A; Krause, JM; Sollner, TH				Parisotto, Daniel; Malsam, Joerg; Scheutzow, Andrea; Krause, Jean Michel; Soellner, Thomas H.			SNAREpin Assembly by Munc18-1 Requires Previous Vesicle Docking by Synaptotagmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; 3-DIMENSIONAL STRUCTURE; SYNTAXIN 1A; CAENORHABDITIS-ELEGANS; SECRETORY VESICLES; DOCKED VESICLES; TERMINAL DOMAIN; UNC-13 GENE; T-SNARE; COMPLEX	Regulated exocytosis requires the general membrane fusion machinery-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) and Sec1/Munc18 (SM) proteins. Using reconstituted giant unilamellar vesicles containing preassembled t-SNARE proteins (syntaxin 1.SNAP-25), we determined how Munc18-1 controls the docking, priming, and fusion of small unilamellar vesicles containing the v-SNARE VAMP2 and the Ca2+ sensor synaptotagmin 1. In vitro assays allowed us to position Munc18-1 in the center of a sequential reaction cascade; vesicle docking by synaptotagmin 1 is a prerequisite for Munc18-1 to accelerate trans-SNARE complex (SNAREpin) assembly and membrane fusion. Complexin II stalls SNAREpin zippering at a late stage and, hence, contributes to synchronize membrane fusion in a Ca2+- and synaptotagmin 1-dependent manner. Thus, at the neuronal synapse, the priming factor Munc18-1 may accelerate the conversion of docked synaptic vesicles into a readily releasable pool by activating SNAREs for efficient membrane fusion.	[Parisotto, Daniel; Malsam, Joerg; Scheutzow, Andrea; Krause, Jean Michel; Soellner, Thomas H.] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sollner, TH (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	thomas.soellner@bzh.uni-heidelberg.de			German Research Foundation [SFB/TRR 83]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of German Research Foundation (SFB/TRR 83; to D.P. and T.H.S.).	BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; MacDonald C, 2010, BIOCHEM SOC T, V38, P209, DOI 10.1042/BST0380209; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Malsam J, 2012, EMBO J, V31, P3270, DOI 10.1038/emboj.2012.164; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	68	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31041	31049		10.1074/jbc.M112.386805	http://dx.doi.org/10.1074/jbc.M112.386805			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810233	hybrid, Green Published			2022-12-28	WOS:000308791300017
J	Yoo, SM; Antonyak, MA; Cerione, RA				Yoo, Sungsoo M.; Antonyak, Marc A.; Cerione, Richard A.			The Adaptor Protein and Arf GTPase-activating Protein Cat-1/Git-1 Is Required for Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN-KINASE-LINKER; EPIDERMAL-GROWTH-FACTOR; P21-ACTIVATED KINASE; TYROSINE PHOSPHORYLATION; FOCAL ADHESIONS; EXCHANGE FACTOR; LD4 MOTIF; GIT1; PIX; COMPLEX	Cat-1/Git-1 is a multifunctional protein that acts as a GTPase-activating protein (GAP) for Arf GTPases, as well as serves as a scaffold for a number of different signaling proteins. Cat-1 is best known for its role in regulating cell shape and promoting cell migration. However, whether Cat-1 might also contribute to cellular transformation is currently unknown. Here we show that similar to 95% of cervical tumor samples examined overexpress Cat-1, suggesting that the up-regulation of Cat-1 expression is a frequent occurrence in this type of cancer. We demonstrate further that knocking down Cat-1 from NIH3T3 fibroblasts expressing an activated form of Cdc42 (Cdc42 F28L), or from the human cervical carcinoma (HeLa) cell line, inhibits the ability of these cells to form colonies in soft agar, an in vitro measure of tumorgenicity. The requirement for Cat-1 when assaying the anchorage-independent growth of transformed fibroblasts and HeLa cells is dependent on its ability to bind paxillin, while being negatively impacted by its Arf-GAP activity. Moreover, the co-expression of Cat-1 and an activated form of Arf6 in fibroblasts was sufficient to induce their transformation. These findings highlight novel roles for Cat-1 and its interactions with the Arf GTPases and paxillin in oncogenic transformation.	[Yoo, Sungsoo M.; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS NIH HHS [R01 GM047458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Tu SS, 2002, BIOCHEMISTRY-US, V41, P12350, DOI 10.1021/bi026167h; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Wade R, 2011, J BIOL CHEM, V286, P37932, DOI 10.1074/jbc.M111.294504; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yu JXA, 2009, MOL BIOL CELL, V20, P4706, DOI 10.1091/mbc.E09-07-0548; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	40	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31462	31470		10.1074/jbc.M112.353615	http://dx.doi.org/10.1074/jbc.M112.353615			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807447	Green Published, hybrid			2022-12-28	WOS:000308791300059
J	Lim, PJ; Chatterji, U; Cordek, D; Sharma, SD; Garcia-Rivera, JA; Cameron, CE; Lin, K; Targett-Adams, P; Gallay, PA				Lim, Precious J.; Chatterji, Udayan; Cordek, Daniel; Sharma, Suresh D.; Garcia-Rivera, Jose A.; Cameron, Craig E.; Lin, Kai; Targett-Adams, Paul; Gallay, Philippe A.			Correlation between NS5A Dimerization and Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; RNA REPLICATION; CYCLOSPORINE-A; CELL-CULTURE; MEMBRANE ASSOCIATION; DOMAIN; BINDING; CYCLOPHILIN; INHIBITORS; PARTICLES	Hepatitis C virus (HCV) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. The current standard therapy has limited efficacy and serious side effects. Thus, the development of alternate therapies is of tremendous importance. HCV NS5A (nonstructural 5A protein) is a pleiotropic protein with key roles in HCV replication and cellular signaling pathways. Here we demonstrate that NS5A dimerization occurs through Domain I (amino acids 1-240). This interaction is not mediated by nucleic acids because benzonase, RNase, and DNase treatments do not prevent NS5A-NS5A interactions. Importantly, DTT abrogates NS5A-NS5A interactions but does not affect NS5A-cyclophilin A interactions. Other reducing agents such as tris(2-carboxyethyl) phosphine and 2-mercaptoethanol also abrogate NS5A-NS5A interactions, implying that disulfide bridges may play a role in this interaction. Cyclophilin inhibitors, cyclosporine A, and alisporivir and NS5A inhibitor BMS-790052 do not block NS5A dimerization, suggesting that their antiviral effects do not involve the disruption of NS5A-NS5A interactions. Four cysteines, Cys-39, Cys-57, Cys-59, and Cys-80, are critical for dimerization. Interestingly, the four cysteines have been proposed to form a zinc-binding motif. Supporting this notion, NS5A dimerization is greatly facilitated by Zn2+ but not by Mg2+ or Mn2+. Importantly, the four cysteines are vital not only for viral replication but also critical for NS5A binding to RNA, revealing a correlation between NS5A dimerization, RNA binding, and HCV replication. Altogether our data suggest that NS5A-NS5A dimerization and/or multimerization could represent a novel target for the development of HCV therapies.	[Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Cordek, Daniel; Sharma, Suresh D.; Cameron, Craig E.] Penn State Univ, Philadelphia, PA 16802 USA; [Lin, Kai] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA; [Targett-Adams, Paul] Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England	Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Novartis; Pfizer	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 9,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gallay@scripps.edu	Cordek, Daniel/A-3494-2013; SHARMA, Suresh/C-4431-2008; SHARMA, Suresh D./AAD-7723-2022	SHARMA, Suresh/0000-0002-8633-4145; SHARMA, Suresh D./0000-0002-8633-4145; Targett-Adams, Paul/0000-0003-4967-1668	U.S. Public Health Service [AI087746, GM089001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service Grants AI087746 (to P. A. G.) and GM089001 (to C. E. C.).	Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brass V, 2007, J VIROL, V81, P2745, DOI 10.1128/JVI.01279-06; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Di Bisceglie AM, 2002, HEPATOLOGY, V35, P224, DOI 10.1053/jhep.2002.30531; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lemm JA, 2011, ANTIMICROB AGENTS CH, V55, P3795, DOI 10.1128/AAC.00146-11; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Qiu DK, 2011, J GEN VIROL, V92, P2502, DOI 10.1099/vir.0.034801-0; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Waller H, 2010, J VIROL METHODS, V165, P202, DOI 10.1016/j.jviromet.2010.01.020; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	43	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30861	30873		10.1074/jbc.M112.376822	http://dx.doi.org/10.1074/jbc.M112.376822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22801423	Green Published, hybrid			2022-12-28	WOS:000308579800074
J	Senior, AE				Senior, Alan E.			Two ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; DEFECTIVE PROTON-ATPASE; OLIGOMYCIN-INSENSITIVE ATPASE; N-TERMINAL REGION; OCCLUDED NUCLEOTIDE CONFORMATION; PHOSPHATE-BINDING SUBDOMAIN; CATALYTIC TRANSITION-STATE; ISOLATED BETA-SUBUNIT; P-GLYCOPROTEIN; ALPHA-SUBUNIT	In this article, I reflect on research on two ATPases. The first is F1F0-ATPase, also known as ATP synthase. It is the terminal enzyme in oxidative phosphorylation and famous as a nanomotor. Early work on mitochondrial enzyme involved purification in large amount, followed by deduction of subunit composition and stoichiometry and determination of molecular sizes of holoenzyme and individual subunits. Later work on Escherichia coli enzyme utilized mutagenesis and optical probes to reveal the molecular mechanism of ATP hydrolysis and detailed facets of catalysis. The second ATPase is P-glycoprotein, which confers multidrug resistance, notably to anticancer drugs, in mammalian cells. Purification of the protein in large quantity allowed detailed characterization of catalysis, formulation of an alternating sites mechanism, and recently, advances in structural characterization.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Senior, AE (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	alan_senior@urmc.rochester.edu						Ahmad Z, 2005, J BIOL CHEM, V280, P27981, DOI 10.1074/jbc.M503955200; Ahmad Z, 2005, FEBS LETT, V579, P523, DOI 10.1016/j.febslet.2004.12.022; Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1990, J BIOL CHEM, V265, P5595; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P886, DOI 10.1021/bi00118a034; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P878, DOI 10.1021/bi00118a033; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; BROOKS JC, 1971, ARCH BIOCHEM BIOPHYS, V147, P467, DOI 10.1016/0003-9861(71)90402-4; BROOKS JC, 1972, BIOCHEMISTRY-US, V11, P4675, DOI 10.1021/bi00775a006; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; DUNCAN TM, 1986, FEBS LETT, V208, P1, DOI 10.1016/0014-5793(86)81519-8; HAZARD AL, 1994, J BIOL CHEM, V269, P427; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li WZ, 2009, J BIOL CHEM, V284, P10747, DOI 10.1074/jbc.M809209200; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; MAGGIO MB, 1988, J BIOL CHEM, V263, P4619; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; PARSONAGE D, 1987, J BIOL CHEM, V262, P8022; PARSONAGE D, 1987, J BIOL CHEM, V262, P6301; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; RAO R, 1988, J BIOL CHEM, V263, P5569; RAO R, 1987, J BIOL CHEM, V262, P17450; Sankaran B, 1997, FEBS LETT, V417, P119, DOI 10.1016/S0014-5793(97)01268-4; Schulz H, 1981, Methods Enzymol, V72, P604; Senior A E, 1971, J Bioenerg, V2, P141, DOI 10.1007/BF01648909; SENIOR AE, 1971, FEBS LETT, V17, P327, DOI 10.1016/0014-5793(71)80178-3; SENIOR AE, 1985, CURR TOP MEMBR TRANS, V23, P135; Senior AE, 2004, NAT STRUCT MOL BIOL, V11, P110, DOI 10.1038/nsmb0204-110; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1979, BIOCHEM J, V180, P111, DOI 10.1042/bj1800111; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; SENIOR AE, 1979, BIOCHEM J, V180, P103, DOI 10.1042/bj1800103; SENIOR AE, 1970, ARCH BIOCHEM BIOPHYS, V140, P257, DOI 10.1016/0003-9861(70)90030-5; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Senior AE, 2000, J BIOENERG BIOMEMBR, V32, P523, DOI 10.1023/A:1005625326721; Senior AE, 2000, J EXP BIOL, V203, P35; SENIOR AE, 1973, BIOCHIM BIOPHYS ACTA, V301, P249, DOI 10.1016/0304-4173(73)90006-2; SENIOR AE, 1970, J BIOL CHEM, V245, P5086; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Senior AE, 2006, BIOCHEMISTRY-US, V45, P15893, DOI 10.1021/bi0619730; Senior AE, 2011, P NATL ACAD SCI USA, V108, P15015, DOI 10.1073/pnas.1111863108; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; SHERRATT HSA, 1986, TRENDS PHARMACOL SCI, V7, P186, DOI 10.1016/0165-6147(86)90310-X; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1994, J BIOL CHEM, V269, P20462; Weber J, 2004, J BIOL CHEM, V279, P25673, DOI 10.1074/jbc.M402738200; Weber J, 2003, J BIOL CHEM, V278, P13409, DOI 10.1074/jbc.M212037200; WEBER J, 1992, J BIOL CHEM, V267, P1712; Weber J, 2002, J BIOL CHEM, V277, P18390, DOI 10.1074/jbc.M201047200; WEBER J, 1994, J BIOL CHEM, V269, P11261; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2004, J BIOL CHEM, V279, P11253, DOI 10.1074/jbc.M312576200; Weber J, 2003, J BIOL CHEM, V278, P13623, DOI 10.1074/jbc.C300061200; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P21045, DOI 10.1074/jbc.270.36.21045; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Weber J, 1998, BIOCHEMISTRY-US, V37, P12042, DOI 10.1021/bi981089c; Weber J, 1998, BIOCHEMISTRY-US, V37, P608, DOI 10.1021/bi972370e; Weber J, 2001, J BIOL CHEM, V276, P35422, DOI 10.1074/jbc.M104946200; Weber J, 1996, BBA-BIOENERGETICS, V1275, P101, DOI 10.1016/0005-2728(96)00057-6; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; WILKEMOUNTS S, 1994, ARCH BIOCHEM BIOPHYS, V309, P363, DOI 10.1006/abbi.1994.1125; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; WISE JG, 1984, BIOCHEMISTRY-US, V23, P1426, DOI 10.1021/bi00302a014; WISE JG, 1981, J BIOL CHEM, V256, P383; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343	87	20	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30049	30062		10.1074/jbc.X112.402313	http://dx.doi.org/10.1074/jbc.X112.402313			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22822068	Green Published, hybrid			2022-12-28	WOS:000308579800001
J	Chen, J; Feng, WJ; Jiang, J; Deng, YQ; Huen, MSY				Chen, Jie; Feng, Wanjuan; Jiang, Jun; Deng, Yiqun; Huen, Michael S. Y.			Ring Finger Protein RNF169 Antagonizes the Ubiquitin-dependent Signaling Cascade at Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE RNF8; 53BP1 RECRUITMENT; REPAIR; REPLICATION; BREAKS	Ubiquitin signals emanating from DNA double-strand breaks (DSBs) trigger the ordered assembly of DNA damage mediator and repair proteins. This highly orchestrated process is accomplished, in part, through the concerted action of the RNF8 and RNF168 E3 ligases, which have emerged as core signaling intermediates that promote DSB-associated ubiquitylation events. In this study, we report the identification of RNF169 as a negative regulator of the DNA damage signaling cascade. We found that RNF169 interacted with ubiquitin structures and relocalized to DSBs in an RNF8/RNF168-dependent manner. Moreover, ectopic expression of RNF169 attenuated ubiquitin signaling and compromised 53BP1 accumulation at DNA damage sites, suggesting that RNF169 antagonizes RNF168 functions at DSBs. Our study unveils RNF169 as a component in DNA damage signal transduction and adds to the complexity of regulatory ubiquitylation in genome stability maintenance.	[Feng, Wanjuan; Jiang, Jun; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China	South China Agricultural University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn; huen.michael@hku.hk	Deng, Yiqun/K-7709-2013; /GNW-5666-2022	Deng, Yiqun/0000-0002-6838-3779; /0000-0003-2752-2098; Huen, Michael Shing-Yan/0000-0003-1774-2425	University of Hong Kong Seed Fund Project [201009159006]; Research Grants Council General Research Fund Project [767811]; National Basic Research Program of China 973 Program [2009CB18802]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	University of Hong Kong Seed Fund Project; Research Grants Council General Research Fund Project; National Basic Research Program of China 973 Program(National Basic Research Program of China); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	This work supported by University of Hong Kong Seed Fund Project 201009159006 and Research Grants Council General Research Fund Project 767811 (to M. S. Y. H.), National Basic Research Program of China 973 Program Grant 2009CB18802 (to M. S. Y. H. and Y. D.), and the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2009) (to Y. D.).	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Luijsterburg MS, 2012, EMBO J, V31, P2511, DOI 10.1038/emboj.2012.104; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	31	51	55	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27715	27722		10.1074/jbc.M112.373530	http://dx.doi.org/10.1074/jbc.M112.373530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733822	Green Published, hybrid			2022-12-28	WOS:000307840700045
J	Takayama, Y; Clore, GM				Takayama, Yuki; Clore, G. Marius			Impact of Protein/Protein Interactions on Global Intermolecular Translocation Rates of the Transcription Factors Sox2 and Oct1 between DNA Cognate Sites Analyzed by z-Exchange NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; CHEMICAL-EXCHANGE; HETERONUCLEAR CORRELATION; CRYSTAL-STRUCTURE; POU DOMAIN; BINDING; COMPLEXES; ACTIVATION; HOMEODOMAIN; PROTEINS	Oct1 and Sox2 synergistically regulate developmental genes by binding to adjacent sites within promoters. We have investigated the kinetics of global intermolecular translocation of Sox2 and Oct1 between cognate sites located on different DNA molecules by z-exchange NMR spectroscopy. In the Hoxb1 promoter, the Sox2 and Oct1 sites are immediately adjacent to one another, and the intermolecular translocation rates are too slow to be measured by z-exchange spectroscopy. By introducing a 3-bp insertion between the Sox2 and Oct1 sites to mimic the spacing in the FGF4 enhancer, the interprotein contact surface is reduced, and the translocation rates are increased. Interaction between Sox2 and the POU-specific domain (POUS) of Oct1 does not affect the translocation mechanism but modulates the rates. Translocation involves only jumping (dissociation and reassociation) for Sox2, but both jumping and direct intersegment transfer (no dissociation into free solution) for Oct1. The dissociation (k(off) similar to 1.5 s(-1)) and association (k(on) similar to 5.1 x 10(9) M(-1)s(-1)) rate constants for Sox2 are reduced 4-fold and increased 5-fold, respectively, in the presence of Oct1. k(off) (similar to 3.5 s(-1)) for Oct1 is unaffected by Sox2, whereas k(on) (similar to 1.3 x 10(9) M(-1)s(-1)) is increased similar to 13-fold. The direct intermolecular translocation rate (k(inter) similar to 1.8 x 10(4)M(-1)s(-1)) for the POUS domain of Oct1 is reduced 2-fold by Sox2, whereas that for the POU homeodomain (POUHD) of Oct1 (k(inter) similar to 1.7 x 10(4) M(-1)s(-1)) remains unaltered, consistent with the absence of contacts between Sox2 and POUHD. The data suggest a model for the sequence of binding events involved in synergistic gene regulation by Sox2 and Oct1.	[Takayama, Yuki; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NIDDK, National Institutes of Health; AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of NIDDK, National Institutes of Health and by the AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).; Recipient of a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Clore GM, 2011, J BIOMOL NMR, V51, P209, DOI 10.1007/s10858-011-9555-8; Clore GM, 2011, PROTEIN SCI, V20, P229, DOI 10.1002/pro.576; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Takayama Y, 2012, J BIOL CHEM, V287, P14349, DOI 10.1074/jbc.M112.352864; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Zhang J, 2012, HUM PATHOL, V43, P1405, DOI 10.1016/j.humpath.2011.10.016	36	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26962	26970		10.1074/jbc.M112.382960	http://dx.doi.org/10.1074/jbc.M112.382960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718759	Green Published, hybrid			2022-12-28	WOS:000307386000044
J	Wojtaszek, J; Liu, JX; D'Souza, S; Wang, S; Xue, YH; Walker, GC; Zhou, P				Wojtaszek, Jessica; Liu, Jiangxin; D'Souza, Sanjay; Wang, Su; Xue, Yaohua; Walker, Graham C.; Zhou, Pei			Multifaceted Recognition of Vertebrate Rev1 by Translesion Polymerases zeta and kappa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY DNA-POLYMERASES; SACCHAROMYCES-CEREVISIAE; PCNA UBIQUITINATION; C-TERMINUS; PROTEIN; REPAIR; MECHANISMS; TOLERANCE; COMPLEX; HREV1	Translesion synthesis is a fundamental biological process that enables DNA replication across lesion sites to ensure timely duplication of genetic information at the cost of replication fidelity, and it is implicated in development of cancer drug resistance after chemotherapy. The eukaryotic Y-family polymerase Rev1 is an essential scaffolding protein in translesion synthesis. Its C-terminal domain (CTD), which interacts with translesion polymerase zeta through the Rev7 subunit and with polymerases kappa, iota, and eta in vertebrates through the Rev1-interacting region (RIR), is absolutely required for function. We report the first solution structures of the mouse Rev1 CTD and its complex with the Pol kappa RIR, revealing an atypical four-helix bundle. Using yeast two-hybrid assays, we have identified a Rev7-binding surface centered at the alpha 2-alpha 3 loop and N-terminal half of alpha 3 of the Rev1 CTD. Binding of the mouse Pol kappa RIR to the Rev1 CTD induces folding of the disordered RIR peptide into a three-turn alpha-helix, with the helix stabilized by an N-terminal cap. RIR binding also induces folding of a disordered N-terminal loop of the Rev1 CTD into a beta-hairpin that projects over the shallow alpha 1-alpha 2 surface and creates a deep hydrophobic cavity to interact with the essential FF residues juxtaposed on the same side of the RIR helix. Our combined structural and biochemical studies reveal two distinct surfaces of the Rev1 CTD that separately mediate the assembly of extension and insertion translesion polymerase complexes and provide a molecular framework for developing novel cancer therapeutics to inhibit translesion synthesis.	[Wojtaszek, Jessica; Liu, Jiangxin; Wang, Su; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [D'Souza, Sanjay; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Xue, Yaohua] Duke Univ, Trinity Coll Arts & Sci, Durham, NC 27708 USA	Duke University; Massachusetts Institute of Technology (MIT); Duke University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Wojtaszek, Jessica/0000-0002-9108-2886; /0000-0001-7243-8261; Xue, Jenny/0000-0003-1192-1836	National Institutes of Health; NIGMS [GM-079376]; Stewart Trust Foundation; NIEHS [ES-015818]; American Cancer Society Research professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES015818, R01ES015818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stewart Trust Foundation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society Research professorship(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, NIGMS GM-079376 and Stewart Trust Foundation (to P. Z.) and National Institutes of Health, NIEHS ES-015818 and an American Cancer Society Research professorship (to G. C. W.).	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Coggins BE, 2008, J BIOMOL NMR, V42, P225, DOI 10.1007/s10858-008-9275-x; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Dumstorf CA, 2009, MOL CANCER RES, V7, P247, DOI 10.1158/1541-7786.MCR-08-0399; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Goddard D., 2008, SPARKY 3; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; James P, 1996, GENETICS, V144, P1425; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kosarek JN, 2008, DNA REPAIR, V7, P439, DOI 10.1016/j.dnarep.2007.11.016; Krijger PHL, 2011, DNA REPAIR, V10, P1051, DOI 10.1016/j.dnarep.2011.08.005; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LAWRENCE CW, 1985, MOL GEN GENET, V200, P80, DOI 10.1007/BF00383316; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LEMONTT JF, 1971, GENETICS, V68, P21; Lin XJ, 2006, MOL CANCER THER, V5, P1239, DOI 10.1158/1535-7163.MCT-05-0491; Lin XJ, 2006, MOL PHARMACOL, V69, P1748, DOI 10.1124/mol.105.020446; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; LYU PC, 1993, BIOCHEMISTRY-US, V32, P421, DOI 10.1021/bi00053a006; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Okuda T, 2005, MOL PHARMACOL, V67, P1852, DOI 10.1124/mol.104.010579; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107	52	67	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26400	26408		10.1074/jbc.M112.380998	http://dx.doi.org/10.1074/jbc.M112.380998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700975	hybrid, Green Published			2022-12-28	WOS:000306916300065
J	Bradford, HN; Krishnaswamy, S				Bradford, Harlan N.; Krishnaswamy, Sriram			Meizothrombin Is an Unexpectedly Zymogen-like Variant of Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTHROMBINASE-CATALYZED ACTIVATION; PROTEIN-C; MACROMOLECULAR SUBSTRATE; ACTIVE-SITE; CRYSTAL-STRUCTURE; EXOSITE-I; FACTOR XA; BINDING; COMPLEX; THROMBOMODULIN	Thrombin is produced by the ordered action of prothrombinase on two cleavage sites in prothrombin. Meizothrombin, a proteinase precursor of thrombin, is a singly cleaved species that accumulates abundantly as an intermediate. We now show that covalent linkage of the N-terminal propiece with the proteinase domain in meizothrombin imbues it with exceptionally zymogen-like character. Meizothrombin exists in a slowly reversible equilibrium between two equally populated states, differing by as much as 140-fold in their affinity for active site-directed ligands. The distribution between the two forms, designated zymogen-like and proteinase-like, is affected by Na+, thrombomodulin binding, or active site ligation. In rapid kinetic measurements with prothrombinase, we also show that the zymogen-like form is produced following the initial cleavage reaction and slowly equilibrates with the proteinase-like form in a previously unanticipated rate-limiting step before it can be further cleaved to thrombin. The reversible equilibration of meizothrombin between zymogen-and proteinase-like states provides new insights into its ability to selectively exhibit the anticoagulant function of thrombin and the mechanistic basis for its accumulation during prothrombin activation. Our findings also provide unexpected insights into the regulation of proteinase function and how the formation of meizothrombin may yield a long lived intermediate with an important regulatory role in coagulation.	[Bradford, Harlan N.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-74124, HL-108933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL108933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74124 and HL-108933.	Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington P. R, 1992, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DEGEN SJF, 1983, BIOCHEMISTRY-US, V22, P2087, DOI 10.1021/bi00278a008; Di Cera E, 1998, TRENDS CARDIOVAS MED, V8, P340, DOI 10.1016/S1050-1738(98)00030-9; Di Cera E, 2003, CHEST, V124, p11S, DOI 10.1378/chest.124.3_suppl.11S; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Elbrecht A., 1987, BMBIOCHEMICA, V4, P12; Esmon CT, 2011, ANNU REV PHYSIOL, V73, P503, DOI 10.1146/annurev-physiol-012110-142300; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Gomori G, 1942, J LAB CLIN MED, V27, P955; HIBBARD LS, 1982, BIOCHEMISTRY-US, V21, P2285, DOI 10.1021/bi00539a003; HIGGINS DL, 1983, J BIOL CHEM, V258, P9276; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; MANN KG, 1990, BLOOD, V76, P1; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Pozzi N., 2012, CURR OPIN STRUC BIOL, V22, P1; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; Shim K, 2004, BLOOD, V104, P415, DOI 10.1182/blood-2004-02-0478; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER RK, 1994, J BIOL CHEM, V269, P27441; YE J, 1991, J BIOL CHEM, V266, P23016	59	11	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30414	30425		10.1074/jbc.M112.394809	http://dx.doi.org/10.1074/jbc.M112.394809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22815477	Green Published, hybrid			2022-12-28	WOS:000308579800034
J	Song, CH; Yang, SH; Park, E; Cho, SH; Gong, EY; Khadka, DB; Cho, WJ; Lee, K				Song, Chin-Hee; Yang, Su Hui; Park, Eunsook; Cho, Suk Hee; Gong, Eun-Yeung; Khadka, Daulat Bikram; Cho, Won-Jea; Lee, Keesook			Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; LIGAND-DEPENDENT TRANSACTIVATION; NECROSIS-FACTOR-ALPHA; LNCAP CELLS; BINDING DOMAIN; IN-VIVO; TRANSCRIPTIONAL COACTIVATOR; NEOPLASTIC PROSTATE; DEPRIVATION THERAPY; CYPROTERONE-ACETATE	Hormonal therapies, mainly combinations of anti-androgens and androgen deprivation, have been the mainstay treatment for advanced prostate cancer because the androgen-androgen receptor (AR) system plays a pivotal role in the development and progression of prostate cancers. However, the emergence of androgen resistance, largely due to inefficient anti-hormone action, limits the therapeutic usefulness of these therapies. Here, we report that 6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide (DIMN) acts as a novel anti-androgenic compound that may be effective in the treatment of both androgen-dependent and androgen-independent prostate cancers. Through AR structure-based virtual screening using the FlexX docking model, fifty-four compounds were selected and further screened for AR antagonism via cell-based tests. One compound, DIMN, showed an antagonistic effect specific to AR with comparable potency to that of the classical AR antagonists, hydroxyflutamide and bicalutamide. Consistent with their anti-androgenic activity, DIMN inhibited the growth of androgen-dependent LNCaP prostate cancer cells. Interestingly, the compound also suppressed the growth of androgen-independent C4-2 and CWR22rv prostate cancer cells, which express a functional AR, but did not suppress the growth of the AR-negative prostate cancer cells PPC-1, DU145, and R3327-AT3.1. Taken together, the results suggest that the synthetic compound DIMN is a novel anti-androgen and strong candidate for useful therapeutic agent against early stage to advanced prostate cancer.	[Yang, Su Hui; Cho, Suk Hee; Khadka, Daulat Bikram; Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Yang, Su Hui; Cho, Suk Hee; Khadka, Daulat Bikram; Cho, Won-Jea] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Song, Chin-Hee; Park, Eunsook; Gong, Eun-Yeung; Lee, Keesook] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Cho, WJ (corresponding author), Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea.	wjcho@chonnam.ac.kr; klee@chonnam.ac.kr	Yang, Suhui/S-4240-2019	Khadka, Daulat Bikram/0000-0002-6634-5824; Yang, Suhui/0000-0003-3424-2692	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2012R1A2A2A01008388, NRF-2011-0015551]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2012R1A2A2A01008388, NRF-2011-0015551).	Ai JK, 2009, MOL ENDOCRINOL, V23, P1963, DOI 10.1210/me.2009-0188; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Anderson J, 2003, BJU INT, V91, P455, DOI 10.1046/j.1464-410X.2003.04026.x; Axerio-Cilies P, 2011, J MED CHEM, V54, P6197, DOI 10.1021/jm200532b; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Butler LM, 2000, CANCER RES, V60, P5165; Chattopadhyay S, 2006, MOL ENDOCRINOL, V20, P984, DOI 10.1210/me.2005-0240; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Craft N, 1998, CANCER METAST REV, V17, P421, DOI 10.1023/A:1006141806801; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; CULIG Z, 1994, CANCER RES, V54, P5474; Eder Iris E, 2005, Future Oncol, V1, P93; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Furutani T, 2002, BIOCHEM BIOPH RES CO, V294, P779, DOI 10.1016/S0006-291X(02)00564-8; Gao WQ, 2006, PHARM RES-DORDR, V23, P1641, DOI 10.1007/s11095-006-9024-3; Georget V, 2002, BIOCHEMISTRY-US, V41, P11824, DOI 10.1021/bi0259150; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P4315; Grigoryev DN, 2000, J STEROID BIOCHEM, V75, P1, DOI 10.1016/S0960-0760(00)00131-X; HAMANN LG, 1995, ANN NY ACAD SCI, V761, P383, DOI 10.1111/j.1749-6632.1995.tb31398.x; Hara T, 2003, CANCER RES, V63, P149; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hong CY, 2005, MOL ENDOCRINOL, V19, P2245, DOI 10.1210/me.2004-0400; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Jung ME, 2010, J MED CHEM, V53, P2779, DOI 10.1021/jm901488g; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; Kawata H, 2011, PROSTATE, V71, P1344, DOI 10.1002/pros.21351; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kinoyama I, 2006, J MED CHEM, V49, P716, DOI 10.1021/jm050293c; Kinoyama I, 2005, CHEM PHARM BULL, V53, P402, DOI 10.1248/cpb.53.402; Kokontis JM, 1999, VITAM HORM, V55, P219; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V367, P481, DOI 10.1016/j.bbrc.2007.12.162; Lee SJ, 2004, MOL THER, V10, P1051, DOI 10.1016/j.ymthe.2004.08.028; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Lee YS, 2002, BIOL REPROD, V67, P1580, DOI 10.1095/biolreprod.102.006155; Lefort M, 2005, UROL INT, V74, P301, DOI 10.1159/000084427; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; Manin M, 2002, BIOCHEM J, V366, P729, DOI 10.1042/BJ20020585; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Mikhailova M, 2008, ADV EXP MED BIOL, V617, P397, DOI 10.1007/978-0-387-69080-3_38; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Miyamoto H, 1998, P NATL ACAD SCI USA, V95, P7379, DOI 10.1073/pnas.95.13.7379; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; ONATE SA, 1995, SCIENCE, V270, P1354; Osguthorpe DJ, 2011, BIOCHEMISTRY-US, V50, P4105, DOI 10.1021/bi102059z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POYET P, 1985, MOL CELL ENDOCRINOL, V42, P283, DOI 10.1016/0303-7207(85)90059-0; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Reid P, 1999, INVEST NEW DRUG, V17, P271, DOI 10.1023/A:1006344807086; Rodriguez-Berriguete G., 2012, J SIGNAL TRANSDUCT, V2012; Rowland JG, 2007, PROTEOMICS, V7, P47, DOI 10.1002/pmic.200600697; Salvati ME, 2005, BIOORG MED CHEM LETT, V15, P271, DOI 10.1016/j.bmcl.2004.10.085; SCHER HI, 1995, UROLOGY, V46, P142, DOI 10.1016/S0090-4295(99)80182-4; Setlur SR, 2005, ADV ANAT PATHOL, V12, P265, DOI 10.1097/01.pap.0000184179.50672.f7; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Soderholm AA, 2008, J CHEM INF MODEL, V48, P1882, DOI 10.1021/ci800149w; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Suh JH, 2008, J STEROID BIOCHEM, V112, P117, DOI 10.1016/j.jsbmb.2008.09.003; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Terouanne B, 2002, MOL CELL ENDOCRINOL, V198, P143, DOI 10.1016/S0303-7207(02)00377-5; Thalmann GN, 2000, PROSTATE, V44, P91; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wen Y, 2000, CANCER RES, V60, P6841; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WILDING G, 1989, PROSTATE, V14, P103, DOI 10.1002/pros.2990140204; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Yang J, 2006, J PHARMACOL EXP THER, V317, P402, DOI 10.1124/jpet.105.094334; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yeh SY, 1998, P NATL ACAD SCI USA, V95, P5527, DOI 10.1073/pnas.95.10.5527; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817	97	32	32	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30769	30780		10.1074/jbc.M112.379107	http://dx.doi.org/10.1074/jbc.M112.379107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798067	hybrid, Green Published			2022-12-28	WOS:000308579800065
J	Bonet, C; Giuliano, S; Ohanna, M; Bille, K; Allegra, M; Lacour, JP; Bahadoran, P; Rocchi, S; Ballotti, R; Bertolotto, C				Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Lacour, Jean-Philippe; Bahadoran, Philippe; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine			Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; INHIBITOR; EXPRESSION; OVEREXPRESSION; CENTROMERE; APOPTOSIS; MITF; RAF	Metastatic melanoma is a deadly skin cancer and is resistant to almost all existing treatment. Vemurafenib, which targets the BRAFV600E mutation, is one of the drugs that improves patient outcome, but the patients next develop secondary resistance and a return to cancer. Thus, new therapeutic strategies are needed to treat melanomas and to increase the duration of v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitor response. The ERK pathway controls cell proliferation, and Aurora B plays a pivotal role in cell division. Here, we confirm that Aurora B is highly expressed in metastatic melanoma cells and that Aurora B inhibition triggers both senescence-like phenotypes and cell death in melanoma cells. Furthermore, we show that the BRAF/ERK axis controls Aurora B expression at the transcriptional level, likely through the transcription factor FOXM1. Our results provide insight into the mechanism of Aurora B regulation and the first molecular basis of Aurora B regulation in melanoma cells. The inhibition of Aurora B expression that we observed in vemurafenib-sensitive melanoma cells was rescued in cells resistant to this drug. Consistently, these latter cells remain sensitive to the effect of the Aurora B inhibitor. Noteworthy, wild-type BRAF melanoma cells are also sensitive to Aurora B inhibition. Collectively, our findings, showing that Aurora B is a potential target in melanoma cells, particularly in those vemurafenib-resistant, may open new avenues to improve the treatment of metastatic melanoma.	[Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] INSERM, Ctr Mediterraneen Med Mol, Equipe 1, Biol & Pathol Melanocytes Pigmentat Cutanee Melan, F-06204 Nice, France; [Bonet, Caroline; Giuliano, Sandy; Ohanna, Mickael; Bille, Karine; Allegra, Maryline; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] Univ Nice Sophia Antipolis, UFR Med, F-06107 Nice, France; [Lacour, Jean-Philippe; Bahadoran, Philippe; Rocchi, Stephane; Ballotti, Robert; Bertolotto, Corine] Ctr Hosp Univ Nice, Serv Dermatol, F-06204 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Bertolotto, C (corresponding author), INSERM, Ctr Mediterraneen Med Mol, Equipe 1, Biol & Pathol Melanocytes Pigmentat Cutanee Melan, F-06204 Nice, France.	bertolot@unice.fr	BALLOTTI, Robert/F-8825-2013; Ohanna, Mickael/O-5784-2016; Rocchi, Stephane/O-4152-2016; Bertolotto, Corine/AAF-6634-2021; Giuliano, Sandy/U-2498-2019; Bertolotto-Ballotti, Corine/O-2155-2016	Ohanna, Mickael/0000-0002-7751-9164; Rocchi, Stephane/0000-0002-0943-1304; Bertolotto, Corine/0000-0001-6971-7753; Bahadoran, Philippe/0000-0002-2481-0556; Lacour, Jean-Philippe/0000-0001-7663-2053; BALLOTTI, Robert/0000-0002-7322-4908	INSERM; Fondation de France; Societe Francaise de Dermatologie; Fondation pour la Recherche Medicale; La Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); Societe Francaise de Dermatologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by INSERM, the "Fondation de France," and the "Societe Francaise de Dermatologie."; Supported by the Fondation pour la Recherche Medicale.; Supported by La Ligue Nationale Contre le Cancer.	Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Boone B, 2011, J CUTAN PATHOL, V38, P492, DOI 10.1111/j.1600-0560.2011.01673.x; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon NK, 2003, GENES IMMUN, V4, P336, DOI 10.1038/sj.gene.6363973; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jani JP, 2010, MOL CANCER THER, V9, P883, DOI 10.1158/1535-7163.MCT-09-0915; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Kurai M, 2005, HUM PATHOL, V36, P1281, DOI 10.1016/j.humpath.2005.09.014; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Otsuka T, 1998, CANCER RES, V58, P5157; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pirker C, 2010, EXP DERMATOL, V19, P1040, DOI 10.1111/j.1600-0625.2010.01182.x; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Song LP, 2007, CELL BIOL INT, V31, P1184, DOI 10.1016/j.cellbi.2007.04.002; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Tomonaga T, 2007, HISTOL HISTOPATHOL, V22, P191, DOI 10.14670/HH-22.191; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang Xiaolei, 2010, Genes Cancer, V1, P952, DOI 10.1177/1947601910388936; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	41	59	61	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29887	29898		10.1074/jbc.M112.371682	http://dx.doi.org/10.1074/jbc.M112.371682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767597	Green Published, hybrid			2022-12-28	WOS:000308286900062
J	Geisler, C; Kotu, V; Sharrow, M; Rendic, D; Poltl, G; Tiemeyer, M; Wilson, IBH; Jarvis, DL				Geisler, Christoph; Kotu, Varshika; Sharrow, Mary; Rendic, Dubravko; Poeltl, Gerald; Tiemeyer, Michael; Wilson, Iain B. H.; Jarvis, Donald L.			The Drosophila Neurally Altered Carbohydrate Mutant Has a Defective Golgi GDP-fucose Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTER; UDP-N-ACETYLGLUCOSAMINE; I-CELL DISEASE; ANEMIA TYPE-II; DEFICIENT GLYCOPROTEIN SYNDROME; PSEUDO-HURLER POLYDYSTROPHY; MANNOSE TRANSPORTER; MOLECULAR-CLONING; HORSERADISH-PEROXIDASE; CONGENITAL DISORDERS	Studying genetic disorders in model organisms can provide insights into heritable human diseases. The Drosophila neurally altered carbohydrate (nac) mutant is deficient for neural expression of the HRP epitope, which consists of N-glycans with core alpha 1,3-linked fucose residues. Here, we show that a conserved serine residue in the Golgi GDP-fucose transporter (GFR) is substituted by leucine in nac(1) flies, which abolishes GDP-fucose transport in vivo and in vitro. This loss of function is due to a biochemical defect, not to destabilization or mistargeting of the mutant GFR protein. Mass spectrometry and HPLC analysis showed that nac(1) mutants lack not only core alpha 1,3-linked, but also core alpha 1,6-linked fucose residues on their N-glycans. Thus, the nac(1) Gfr mutation produces a previously unrecognized general defect in N-glycan core fucosylation. Transgenic expression of a wild-type Gfr gene restored the HRP epitope in neural tissues, directly demonstrating that the Gfr mutation is solely responsible for the neural HRP epitope deficiency in the nac(1) mutant. These results validate the Drosophila nac(1) mutant as a model for the human congenital disorder of glycosylation, CDG-IIc (also known as LAD-II), which is also the result of a GFR deficiency.	[Geisler, Christoph; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Kotu, Varshika; Sharrow, Mary; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Rendic, Dubravko; Poeltl, Gerald; Wilson, Iain B. H.] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria	University of Wyoming; University System of Georgia; University of Georgia; University of Natural Resources & Life Sciences, Vienna	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	dljarvis@uwyo.edu	Wilson, Iain/B-3326-2009; Rendic, Dubravko/A-9368-2010	Wilson, Iain/0000-0001-8996-1518; Jarvis, Donald/0000-0002-8104-7155	National Institutes of Health, NIGMS [R01GM072839, R01GM49734]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant [P17681]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072839, R01GM049734] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants R01GM072839 (to M. T.) and R01GM49734 (to D. L. J.). This work was also supported by Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant P17681 (to I. B. H. W.).	ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Arakawa K, 2006, J GEN APPL MICROBIOL, V52, P137, DOI 10.2323/jgam.52.137; Aumiller JJ, 2002, PROTEIN EXPRES PURIF, V26, P438, DOI 10.1016/S1046-5928(02)00550-8; BACH G, 1979, BIOCHEM BIOPH RES CO, V91, P976, DOI 10.1016/0006-291X(79)91975-2; Baldwin TC, 2001, PLANT CELL, V13, P2283, DOI 10.1105/tpc.13.10.2283; Bentley A, 2000, GENETICS, V156, P1169; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Berninsone P, 1997, J BIOL CHEM, V272, P12616, DOI 10.1074/jbc.272.19.12616; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Cottrell TR, 2007, EUKARYOT CELL, V6, P776, DOI 10.1128/EC.00015-07; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Etzioni A, 2002, AM J MED GENET, V110, P131, DOI 10.1002/ajmg.10423; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; FUKUDA MN, 1984, BRIT J HAEMATOL, V56, P55, DOI 10.1111/j.1365-2141.1984.tb01271.x; FUKUDA MN, 1987, J BIOL CHEM, V262, P7195; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gazit Y, 2010, J CLIN IMMUNOL, V30, P308, DOI 10.1007/s10875-009-9354-0; Geisler C, 2012, J BIOL CHEM, V287, P7084, DOI 10.1074/jbc.M111.296814; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Greene EA, 2003, GENETICS, V164, P731; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Handford MG, 2004, MOL GENET GENOMICS, V272, P397, DOI 10.1007/s00438-004-1071-z; HASILIK A, 1981, BIOCHEM BIOPH RES CO, V98, P761, DOI 10.1016/0006-291X(81)91177-3; HASILIK A, 1980, J BIOL CHEM, V255, P4946; Helmus Y, 2006, BLOOD, V107, P3959, DOI 10.1182/blood-2005-08-3334; Hidalgo A, 2003, BLOOD, V101, P1705, DOI 10.1182/blood-2002-09-2840; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 1996, J BIOCHEM, V120, P1074; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Jackson-Hayes L, 2008, MICROBIOL-SGM, V154, P2037, DOI 10.1099/mic.0.2008/017483-0; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; Kawar Z, 2001, INSECT BIOCHEM MOLEC, V31, P289, DOI 10.1016/S0965-1748(00)00121-1; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; KRIEG DR, 1963, GENETICS, V48, P561; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2004, EXP CELL RES, V301, P242, DOI 10.1016/j.yexcr.2004.08.043; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Morava E, 2011, PROTEIN REV, V13, P97, DOI 10.1007/978-1-4419-6382-6_5; Moriwaki K, 2007, GLYCOBIOLOGY, V17, P1311, DOI 10.1093/glycob/cwm094; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Nishikawa A, 2002, YEAST, V19, P691, DOI 10.1002/yea.854; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P139; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; RABOUILLE C, 1995, J CELL SCI, V108, P1617; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Rendic D, 2006, J BIOL CHEM, V281, P3343, DOI 10.1074/jbc.M508334200; Rendic D, 2010, GLYCOBIOLOGY, V20, P1353, DOI 10.1093/glycob/cwq119; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sarkar M, 2001, BIOL CHEM, V382, P209, DOI 10.1515/BC.2001.028; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; SNOW PM, 1987, J NEUROSCI, V7, P4137; STAUDACHER E, 1992, EUR J BIOCHEM, V207, P987, DOI 10.1111/j.1432-1033.1992.tb17134.x; Sturla L, 2001, PEDIATR RES, V49, P537, DOI 10.1203/00006450-200104000-00016; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Summers MD, 1987, TEXAS AGR EXPT STATI; Thiel C, 2011, J INHERIT METAB DIS, V34, P879, DOI 10.1007/s10545-011-9295-7; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534; Ueki N, 2009, PLANT CELL, V21, P1166, DOI 10.1105/tpc.109.066159; Vadaie N, 2004, J BIOL CHEM, V279, P33501, DOI 10.1074/jbc.M404925200; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VIDAL A, 1995, CARCINOGENESIS, V16, P817, DOI 10.1093/carcin/16.4.817; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651	94	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29599	29609		10.1074/jbc.M112.379313	http://dx.doi.org/10.1074/jbc.M112.379313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22745127	hybrid, Green Published			2022-12-28	WOS:000308286900035
J	Colaianni, G; Sun, L; Di Benedetto, A; Tamma, R; Zhu, LL; Cao, J; Grano, M; Yuen, T; Colucci, S; Cuscito, C; Mancini, L; Li, JH; Nishimori, K; Bab, I; Lee, HJ; Iqbal, J; Young, WS; Rosen, C; Zallone, A; Zaidi, M				Colaianni, Graziana; Sun, Li; Di Benedetto, Adriana; Tamma, Roberto; Zhu, Ling-Ling; Cao, Jay; Grano, Maria; Yuen, Tony; Colucci, Sylvia; Cuscito, Concetta; Mancini, Lucia; Li, Jianhua; Nishimori, Katsuhiko; Bab, Itai; Lee, Heon-Jin; Iqbal, Jameel; Young, W. Scott, III; Rosen, Clifford; Zallone, Alberta; Zaidi, Mone			Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR; EXPRESSION; HORMONE; MICE; LACTATION; GENE; DIFFERENTIATION; PARTURITION; CELLS; ACTH	Estrogen uses two mechanisms to exert its effect on the skeleton: it inhibits bone resorption by osteoclasts and, at higher doses, can stimulate bone formation. Although the antiresorptive action of estrogen arises from the inhibition of the MAPK JNK, the mechanism of its effect on the osteoblast remains unclear. Here, we report that the anabolic action of estrogen in mice occurs, at least in part, through oxytocin (OT) produced by osteoblasts in bone marrow. We show that the absence of OT receptors (OTRs) in OTR-/- osteoblasts or attenuation of OTR expression in silenced cells inhibits estrogen-induced osteoblast differentiation, transcription factor up-regulation, and/or OT production in vitro. In vivo, OTR-/- mice, known to have a bone formation defect, fail to display increases in trabecular bone volume, cortical thickness, and bone formation in response to estrogen. Furthermore, osteoblast-specific Col2.3-Cre(+)/OTRfl/fl mice, but not TRAP-Cre(+)/OTRfl/fl mice, mimic the OTR-/- phenotype and also fail to respond to estrogen. These data attribute the phenotype of OTR deficiency to an osteoblastic rather than an osteoclastic defect. Physiologically, feed-forward OT release in bone marrow by a rising estrogen concentration may facilitate rapid skeletal recovery during the latter phases of lactation.	[Colaianni, Graziana; Di Benedetto, Adriana; Tamma, Roberto; Grano, Maria; Colucci, Sylvia; Cuscito, Concetta; Mancini, Lucia; Zallone, Alberta] Univ Bari, Sch Med, Dept Human Anat & Histol, I-70124 Bari, Italy; [Colaianni, Graziana; Sun, Li; Zhu, Ling-Ling; Yuen, Tony; Li, Jianhua; Iqbal, Jameel; Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Cao, Jay] Grand Forks Human Nutr Res Ctr, ARS, USDA, Grand Forks, ND 58201 USA; [Nishimori, Katsuhiko] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Bab, Itai] Hebrew Univ Jerusalem, Bone Lab, IL-91120 Jerusalem, Israel; [Lee, Heon-Jin] Kyungpook Natl Univ, Dept Oral Microbiol, Sch Dent, Taegu 702701, South Korea; [Young, W. Scott, III] NIMH, Sect Neural Gene Express, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Rosen, Clifford] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Universita degli Studi di Bari Aldo Moro; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA); Tohoku University; Hebrew University of Jerusalem; Kyungpook National University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Maine Medical Center	Zallone, A (corresponding author), Univ Bari, Sch Med, Dept Human Anat & Histol, I-70124 Bari, Italy.	alberta.zallone@fastwebnet.it; mone.zaidi@mssm.edu	tamma, roberto/C-3679-2016; Young, W Scott Scott/A-9333-2009; Young, W Scott/N-3716-2019	Young, W Scott Scott/0000-0001-6614-5112; Young, W Scott/0000-0001-6614-5112; TAMMA, Roberto/0000-0003-4623-5406; Grano, Maria/0000-0002-7121-5899; Lee, Heon-Jin/0000-0002-1911-5014; Colaianni, Graziana/0000-0001-8501-5399	National Institutes of Health from NIA [AG023176, AG040132]; NIDDK [DK080459]; National Institute of Mental Health [Z01-MH-002498-23]; Italian Space Agency; European Space Agency; Ministero dell'Istruzione, dell'Universita della Ricerca; United States Department of Agriculture Agricultural Research Service [5450-51000-046-00D]; American Federation for Aging Research; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002498] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Space Agency(European Space AgencyEuropean Commission); Ministero dell'Istruzione, dell'Universita della Ricerca(Ministry of Education, Universities and Research (MIUR)); United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); American Federation for Aging Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants AG023176 and AG040132 from NIA (to M. Z.) and DK080459 from NIDDK (to M. Z. and L. S.) and by National Institute of Mental Health Intramural Research Program Grant Z01-MH-002498-23 (to H.-J. L. and W. S. Y.). This work was also supported by grants from the Italian Space Agency (Osteoporosis and Muscular Atrophy Project), the European Space Agency (European Research in Space and Terrestrial Osteoporosis Microgravity Application Promotion Project), and the Ministero dell'Istruzione, dell'Universita della Ricerca (to A. Z.); by United States Department of Agriculture Agricultural Research Service Current Research Information System Program Grant 5450-51000-046-00D (to J. C.); and by the American Federation for Aging Research (to J. I.).	ALBRIGHT FULLER, 1940, TRANS ASSOC AMER PHYSICIANS, V55, P298; Assinder SJ, 2000, BIOL REPROD, V63, P448, DOI 10.1095/biolreprod63.2.448; Blair HC, 2011, ANN NY ACAD SCI, V1240, P26, DOI 10.1111/j.1749-6632.2011.06287.x; Blanks AM, 2003, BJOG-INT J OBSTET GY, V110, P46, DOI 10.1016/S1470-0328(03)00024-7; Breton C, 2001, J MOL ENDOCRINOL, V27, P175, DOI 10.1677/jme.0.0270175; Colaianni G, 2011, BIOCHEM BIOPH RES CO, V411, P512, DOI 10.1016/j.bbrc.2011.06.158; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Feng M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1059, DOI 10.1152/ajpendo.90609.2008; Isales CM, 2010, ANN NY ACAD SCI, V1192, P110, DOI 10.1111/j.1749-6632.2009.05231.x; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Kiss Alexander, 2005, Endocr Regul, V39, P97; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210/jc.86.6.2344; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Liu X, 2009, BIOCHEM BIOPH RES CO, V388, P161, DOI 10.1016/j.bbrc.2009.07.148; Michalakis K, 2011, Endocr Regul, V45, P43; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Modder UIL, 2004, EUR J ENDOCRINOL, V151, P503, DOI 10.1530/eje.0.1510503; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pequeux C, 2005, LUNG CANCER, V50, P177, DOI 10.1016/j.lungcan.2005.05.027; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Stedronsky K, 2002, J NEUROENDOCRINOL, V14, P472, DOI 10.1046/j.1365-2826.2002.00799.x; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Syed FA, 2010, J BONE MINER RES, V25, P2438, DOI 10.1002/jbmr.129; Syed FA, 2010, INTERD T GERONT GERI, V37, P175, DOI 10.1159/000320001; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; Vincent BH, 2009, GENES IMMUN, V10, P18, DOI 10.1038/gene.2008.69; Zaidi M, 2010, P NATL ACAD SCI USA, V107, P8782, DOI 10.1073/pnas.0912176107; Zingg HH, 2003, TRENDS ENDOCRIN MET, V14, P222, DOI 10.1016/S1043-2760(03)00080-8	33	58	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29159	29167		10.1074/jbc.M112.365049	http://dx.doi.org/10.1074/jbc.M112.365049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761429	hybrid, Green Published			2022-12-28	WOS:000308074600081
J	Fiete, D; Beranek, M; Baenziger, JU				Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.			Peptide-specific Transfer of N-Acetylgalactosamine to O-Linked Glycans by the Glycosyltransferases beta 1,4-N-Acetylgalactosaminyl Transferase 3 (beta 4GalNAc-T3) and beta 4GalNAc-T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATORY HALF-LIFE; BETA 1,4GLCNAC BETA; MOLECULAR-CLONING; IN-VIVO; CORE 2; ASIALOGLYCOPROTEIN RECEPTOR; BOVINE PROOPIOMELANOCORTIN; DIFFERENTIAL EXPRESSION; GALNAC-TRANSFERASE; GAUSSIA LUCIFERASE	N- and O-linked oligosaccharides on pro-opiomelanocortin both bear the unique terminal sequence SO4-4-GalNAc beta 1, 4GlcNAc beta. We previously demonstrated that protein-specific transfer of GalNAc to N-linked oligosaccharides on glycoprotein substrates is dependent on the presence of both an oligosaccharide acceptor and a peptide recognition motif consisting of a cluster of basic amino acids. We characterized how two beta 1,4-N-acetylgalactosaminyltransferases, beta 4GalNAc-T3 and beta 4GalNAc-T4, require the presence of both the peptide recognition motif and the N-linked oligosaccharide acceptors to transfer GalNAc in beta 1,4-linkage to GlcNAc in vivo and in vitro. We now show that beta 4GalNAc-T3 and beta 4GalNAc-T4 are able to utilize the same peptide motif to selectively add GalNAc to beta 1,6-linked GlcNAc in core 2 O-linked oligosaccharide structures to form Gal beta 1,3(GalNAc beta 1,4GlcNAc beta 1,6)GalNAc alpha Ser/Thr. The beta 1,4-linked GalNAc can be further modified with 4-linked sulfate by either GalNAc-4-sulfotransferase 1 (GalNAc-4-ST1) (CHST8) or GalNAc-4-ST2 (CHST9) or with alpha 2,6-linked N-acetylneuraminic acid by alpha 2,6-sialyltransferase 1 (ST6Gal1), thus generating a family of unique GalNAc beta 1,4GlcNAc beta (Lac-diNAc)- containing structures on specific glycoproteins.	[Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med St Louis, Dept Pathol, 660 S Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-HD058474, R01-CA21923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD058474 and R01-CA21923 (to J. U. B.).	BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; Baenziger JU, 2003, BIOCHEM SOC T, V31, P326, DOI 10.1042/BST0310326; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Dell A, 2003, P NATL ACAD SCI USA, V100, P15631, DOI 10.1073/pnas.2635507100; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fiete D, 2012, J BIOL CHEM, V287, P29194, DOI 10.1074/jbc.M112.371567; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Hiraoka N, 2001, GLYCOBIOLOGY, V11, P495, DOI 10.1093/glycob/11.6.495; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Kang HG, 2001, J BIOL CHEM, V276, P10861, DOI 10.1074/jbc.M011560200; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Ma JY, 1997, J BIOL CHEM, V272, P672; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; SICILIANO RA, 1993, GLYCOBIOLOGY, V3, P225, DOI 10.1093/glycob/3.3.225; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Sugahara T, 1996, J BIOL CHEM, V271, P20797, DOI 10.1074/jbc.271.34.20797; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; Xia GQ, 2000, J BIOL CHEM, V275, P38402, DOI 10.1074/jbc.M007821200; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215	51	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29204	29212		10.1074/jbc.M112.371880	http://dx.doi.org/10.1074/jbc.M112.371880			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722940	Green Published, hybrid			2022-12-28	WOS:000308074600086
J	Malloy, LE; Wen, KK; Pierick, AR; Wedemeyer, EW; Bergeron, SE; Vanderpool, ND; McKane, M; Rubenstein, PA; Bartlett, HL				Malloy, Lindsey E.; Wen, Kuo-Kuang; Pierick, Alyson R.; Wedemeyer, Elesa W.; Bergeron, Sarah E.; Vanderpool, Nicole D.; McKane, Melissa; Rubenstein, Peter A.; Bartlett, Heather L.			Thoracic Aortic Aneurysm (TAAD)-causing Mutation in Actin Affects Formin Regulation of Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; YEAST ACTIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HOMOLOGY-2 DOMAIN; IN-VITRO; F-ACTIN; CYTOSKELETON; DISSECTIONS; PHENOTYPE	More than 30 mutations in ACTA2, which encodes alpha-smooth muscle actin, have been identified to cause autosomal dominant thoracic aortic aneurysm and dissection. The mutation R256H is of particular interest because it also causes patent ductus arteriosus and moyamoya disease. R256H is one of the more prevalent mutations and, based on its molecular location near the strand-strand interface in the actin filament, may affect F-actin stability. To understand the molecular ramifications of the R256H mutation, we generated Saccharomyces cerevisiae yeast cells expressing only R256H yeast actin as a model system. These cells displayed abnormal cytoskeletal morphology and increased sensitivity to latrunculin A. After cable disassembly induced by transient exposure to latrunculin A, mutant cells were delayed in reestablishing the actin cytoskeleton. In vitro, mutant actin exhibited a higher than normal critical concentration and a delayed nucleation. Consequently, we investigated regulation of mutant actin by formin, a potent facilitator of nucleation and a protein needed for normal vascular smooth muscle cell development. Mutant actin polymerization was inhibited by the FH1-FH2 fragment of the yeast formin, Bni1. This fragment strongly capped the filament rather than facilitating polymerization. Interestingly, phalloidin or the presence of wild type actin reversed the strong capping behavior of Bni1. Together, the data suggest that the R256H actin mutation alters filament conformation resulting in filament instability and misregulation by formin. These biochemical effects may contribute to abnormal histology identified in diseased arterial samples from affected patients.	[Malloy, Lindsey E.; Pierick, Alyson R.; Wedemeyer, Elesa W.; Bergeron, Sarah E.; Bartlett, Heather L.] Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Wen, Kuo-Kuang; Bergeron, Sarah E.; Vanderpool, Nicole D.; McKane, Melissa; Rubenstein, Peter A.; Bartlett, Heather L.] Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Bartlett, HL (corresponding author), Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Pediat, 200 Hawkins Dr,2801 JPP, Iowa City, IA 52242 USA.	heather-bartlett@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414; Bartlett, Heather/0000-0002-4224-6151	American Heart Association [0830053N]; National Institutes of Health [DC008803]; National Institutes of Health, NCRR [UL1RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008803, R01DC008803] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by supported by American Heart Association Grant 0830053N (to H. L. B.), National Institutes of Health Grant DC008803 (to P. A. R.), and National Institutes of Health, NCRR Grant UL1RR024979 (to H. L. B. and P. A. R.).	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bergeron SE, 2011, J BIOL CHEM, V286, P11356, DOI 10.1074/jbc.M110.203174; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryan KE, 2009, J BIOL CHEM, V284, P18260, DOI 10.1074/jbc.M109.015818; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1991, J BIOL CHEM, V266, P16825; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; Disabella E, 2011, HEART, V97, P321, DOI 10.1136/hrt.2010.204388; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hoffjan S, 2011, EUR J HUM GENET, V19, P520, DOI 10.1038/ejhg.2010.239; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuang B, 1997, J BIOL CHEM, V272, P1237, DOI 10.1074/jbc.272.2.1237; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Le Clainche C, 2010, J BIOL CHEM, V285, P23418, DOI 10.1074/jbc.M110.102830; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nyitrai M, 2000, J BIOL CHEM, V275, P2404, DOI 10.1074/jbc.275.4.2404; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Renard M, 2011, INT J CARDIOL; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Smith MG, 2001, J CELL SCI, V114, P1505; Staus DP, 2011, ARTERIOSCL THROM VAS, V31, P360, DOI 10.1161/ATVBAHA.110.212993; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529; Tananari Y, 2000, JPN CIRC J, V64, P684, DOI 10.1253/jcj.64.684; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wen KK, 2011, J BIOL CHEM, V286, P41745, DOI 10.1074/jbc.M110.217661; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Weng S, 2003, NUCLEIC ACIDS RES, V31, P216, DOI 10.1093/nar/gkg054; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yoo EH, 2010, ANN CLIN LAB SCI, V40, P278	54	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28398	28408		10.1074/jbc.M112.371914	http://dx.doi.org/10.1074/jbc.M112.371914			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753406	Green Published, hybrid			2022-12-28	WOS:000308074600016
J	Bager, R; Kristensen, TK; Jensen, JK; Szczur, A; Christensen, A; Andersen, LM; Johansen, JS; Larsen, N; Baatrup, E; Huang, MD; Ploug, M; Andreasen, PA				Bager, Rene; Kristensen, Thomas K.; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Johansen, Jesper S.; Larsen, Niels; Baatrup, Erik; Huang, Mingdong; Ploug, Michael; Andreasen, Peter A.			Urokinase-type Plasminogen Activator-like Proteases in Teleosts Lack Genuine Receptor-binding Epidermal Growth Factor-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; EVOLUTION; SEQUENCE; GENOME; FISH; PATTERNS; MUTATION; BLOOD; CELLS; CHAIN	Plasminogen activation catalyzed by urokinase-type plasminogen activator (uPA) plays an important role in normal and pathological tissue remodeling processes. Since its discovery in the mid-1980s, the cell membrane-anchored urokinase-type plasminogen activator receptor (uPAR) has been believed to be central to the functions of uPA, as uPA-catalyzed plasminogen activation activity appeared to be confined to cell surfaces through the binding of uPA to uPAR. However, a functional uPAR has so far only been identified in mammals. We have now cloned, recombinantly produced, and characterized two zebrafish proteases, zfuPA-a and zfuPA-b, which by several criteria are the fish orthologs of mammalian uPA. Thus, both proteases catalyze the activation of fish plasminogen efficiently and both proteases are inhibited rapidly by plasminogen activator inhibitor-1 (PAI-1). But zfuPA-a differs from mammalian uPA by lacking the exon encoding the uPAR-binding epidermal growth factor-like domain; zfuPA-b differs from mammalian uPA by lacking two cysteines of the epidermal growth factor-like domain and a uPAR-binding sequence comparable with that found in mammalian uPA. Accordingly, no zfuPA-b binding activity could be found in fish white blood cells or fish cell lines. We therefore propose that the current consensus of uPA-catalyzed plasminogen activation taking place on cell surfaces, derived from observations with mammals, is too narrow. Fish uPAs appear incapable of receptor binding in the manner known from mammals and uPA-catalyzed plasminogen activation in fish may occur mainly in solution. Studies with nonmammalian vertebrate species are needed to obtain a comprehensive understanding of the mechanism of plasminogen activation.	[Bager, Rene; Kristensen, Thomas K.; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Johansen, Jesper S.; Larsen, Niels; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Bager, Rene; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Huang, Mingdong; Ploug, Michael; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark; [Baatrup, Erik] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, Fuzhou 350002, Peoples R China; [Ploug, Michael] Rigshosp, Finsen Lab, DK-2200 Copenhagen N, Denmark; [Ploug, Michael] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark	Aarhus University; Aarhus University; Aarhus University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Rigshospitalet	Andreasen, PA (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, 10 Gustav Wieds Vej, DK-8000 Aarhus C, Denmark.	pa@mb.au.dk	Huang, Mingdong/J-4278-2017; Baatrup, Erik/B-5371-2010	Huang, Mingdong/0000-0003-0085-9141; Baatrup, Erik/0000-0002-5948-4519; Ploug, Michael/0000-0003-2215-4265	Danish Medical Research Council [2107040003]; Danish National Research Foundation [26-331-6]; Novo-Nordisk Foundation [R114-A11382]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo-Nordisk Foundation(Novo Nordisk Foundation)	This work was supported by Danish Medical Research Council Grant 2107040003, Danish National Research Foundation Grant 26-331-6, and Novo-Nordisk Foundation Grant R114-A11382 (to P. A. A.).	Alberti M, 2005, INT J ENVIRON AN CH, V85, P589, DOI 10.1080/03067310500145930; ANDREASEN PA, 1991, FIBRINOLYSIS, V5, P207, DOI 10.1016/0268-9499(91)90002-L; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; APPELLA E, 1987, J BIOL CHEM, V262, P4437; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Barnham KJ, 1998, PROTEIN SCI, V7, P1738, DOI 10.1002/pro.5560070808; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Botkjaer KA, 2009, BIOCHEMISTRY-US, V48, P9606, DOI 10.1021/bi900510f; BRAUNNESJE R, 1981, J FISH DIS, V4, P141, DOI 10.1111/j.1365-2761.1981.tb01118.x; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Culp P. A., 1994, THESIS MIT; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GLIEMANN J, 1994, ANN NY ACAD SCI, V737, P20, DOI 10.1111/j.1749-6632.1994.tb44299.x; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Madsen JB, 2010, BIOCHEMISTRY-US, V49, P4103, DOI 10.1021/bi100066j; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; SALLES FJ, 1990, EMBO J, V9, P2471, DOI 10.1002/j.1460-2075.1990.tb07425.x; Stempien-Otero A, 2006, J BIOL CHEM, V281, P15345, DOI 10.1074/jbc.M512818200; TAKAHASHI K, 1987, CELL STRUCT FUNCT, V12, P11, DOI 10.1247/csf.12.11; Tom Roseanne, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4977; VASSALLI JD, 1987, FEBS LETT, V214, P187, DOI 10.1016/0014-5793(87)80039-X; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	49	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27526	27536		10.1074/jbc.M112.369207	http://dx.doi.org/10.1074/jbc.M112.369207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733817	Green Published, hybrid			2022-12-28	WOS:000307840700028
J	Mu, YX; Prochnow, C; Pham, P; Chen, XS; Goodman, MF				Mu, Yunxiang; Prochnow, Courtney; Phuong Pham; Chen, Xiaojiang S.; Goodman, Myron F.			A Structural Basis for the Biochemical Behavior of Activation-induced Deoxycytidine Deaminase Class-switch Recombination-defective Hyper-IgM-2 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; HYPER-IGM SYNDROME; APOBEC3G CATALYTIC DOMAIN; SOMATIC HYPERMUTATION; FUNCTIONAL IMPLICATIONS; CRYSTAL-STRUCTURE; GENE CONVERSION; WILD-TYPE; AID	Hyper-IgM syndrome type 2 stems from mutations in activation-induced deoxycytidine deaminase (AID) that abolish immunoglobulin class-switch recombination, causing an accumulation of IgM and absence of IgG, IgA, and IgE isotypes. Although hyper-IgM syndrome type 2 is rare, the 23 missense mutations identified in humans span almost the entire gene for AID resulting in a recessive phenotype. Using high resolution x-ray structures for Apo3G-CD2 as a surrogate for AID, we identify three classes of missense mutants as follows: catalysis (class I), substrate interaction (class II), and structural integrity (class III). Each mutant was expressed and purified from insect cells and compared biochemically to wild type (WT) AID. Four point mutants retained catalytic activity at 1/3rd to 1/200th the level of WTAID. These "active" point mutants mimic the behavior of WTAID for motif recognition specificity, deamination spectra, and high deamination processivity. We constructed a series of C-terminal deletion mutants (class IV) that retain catalytic activity and processivity for deletions <= 18 amino acids, with Delta C-10 and Delta C-15 having 2-3-fold higher specific activities than WT AID. Deleting 19 C-terminal amino acids inactivates AID. WT AID and active and inactive point mutants bind cooperatively to single-stranded DNA (Hill coefficients similar to 1.7-3.2) with microscopic dissociation constant values (K-A) ranging between 10 and 250 nM. Active C-terminal deletion mutants bind single-stranded DNA noncooperatively with K-A values similar to wild type AID. A structural analysis is presented that shows how localized defects in different regions of AID can contribute to loss of catalytic function.	[Goodman, Myron F.] Univ So Calif, Mol & Computat Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Mol & Computat Biol Sect, Dept Chem, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Mol & Computat Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA.	mgoodman@usc.edu	Mu, Yunxiang/H-3538-2015	Mu, Yunxiang/0000-0001-9754-2129	National Institutes of Health [GM21422, ES013192, GM087986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422, R01GM087986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192 (to M. F. G.) and GM087986 (to X.S.C.).	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bates PA, 2001, PROTEINS, P39; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Durandy A, 2006, HUM MUTAT, V27, P1185, DOI 10.1002/humu.20414; Durandy A, 2009, PHILOS T R SOC B, V364, P577, DOI 10.1098/rstb.2008.0210; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kracker S, 2011, IMMUNOL LETT, V138, P97, DOI 10.1016/j.imlet.2011.02.004; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Prochnow C, 2009, SCI CHINA SER C, V52, P893, DOI 10.1007/s11427-009-0133-1; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; WYSOCKI LJ, 1989, ANNU REV BIOCHEM, V58, P509; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	40	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28007	28016		10.1074/jbc.M112.370189	http://dx.doi.org/10.1074/jbc.M112.370189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715099	hybrid, Green Published			2022-12-28	WOS:000307840700074
J	Palombo, I; Daley, DO; Rapp, M				Palombo, Isolde; Daley, Daniel O.; Rapp, Mikaela			The Periplasmic Loop Provides Stability to the Open State of the CorA Magnesium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+ TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; SALMONELLA-TYPHIMURIUM; CONSERVED RESIDUES; MEMBRANE DOMAIN; TOPOLOGY; MUTAGENESIS; HOMOLOG; MRS2P	Crystal structures of the CorA Mg2+ channel have suggested that metal binding in the cytoplasmic domain stabilizes the pentamer in a closed conformation. The open "metal free" state of the channel is, however, still structurally uncharacterized. Here, we have attempted to map conformational states of CorA from Thermotoga maritima by determining which residues support the pentameric structure in the presence or absence of Mg2+. We find that when Mg2+ is present, the pentamer is stabilized by the putative gating sites (M1/M2) in the cytoplasmic domain. Strikingly however, we find that the conserved and functionally important periplasmic loop is vital for the integrity of the pentamer when Mg2+ is absent from the M1/M2 sites. Thus, although the periplasmic loops were largely disordered in the x-ray structures of the closed channel, our data suggests a prominent role for the loops in stabilizing the open conformation of the CorA channels.	[Rapp, Mikaela] Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, S-17177 Stockholm, Sweden; [Palombo, Isolde; Daley, Daniel O.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Rapp, M (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, S-17177 Stockholm, Sweden.	mikaela.rapp@ki.se	Rapp, Mikaela/K-2298-2015	Daley, Daniel/0000-0002-6425-5059; Rapp, Mikaela/0000-0002-4401-9518	Swedish Research Council; Jeanssons Stiftelse; Sven och Dagmar Salen; Magnus Bergwall; Helge Axson Johnsson; Lars Hiertas Stiftelser	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeanssons Stiftelse; Sven och Dagmar Salen; Magnus Bergwall; Helge Axson Johnsson; Lars Hiertas Stiftelser	This work was supported by grants from the Swedish Research Council and Jeanssons Stiftelse ( to D. O. D.) and grants from the Sven och Dagmar Salen, Magnus Bergwall, Helge Axson Johnsson, and Lars Hiertas Stiftelser (to M. R.).	Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dalmas O, 2010, STRUCTURE, V18, P868, DOI 10.1016/j.str.2010.04.009; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Moomaw AS, 2010, BIOCHEMISTRY-US, V49, P5998, DOI 10.1021/bi1005656; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Smith RL, 1998, J BIOL CHEM, V273, P28663, DOI 10.1074/jbc.273.44.28663; Stenberg F, 2007, J MOL BIOL, V371, P765, DOI 10.1016/j.jmb.2007.05.045; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233	19	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27547	27555		10.1074/jbc.M112.371484	http://dx.doi.org/10.1074/jbc.M112.371484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722933	Green Published, hybrid			2022-12-28	WOS:000307840700030
J	Kruth, KA; Rubenstein, PA				Kruth, Karina A.; Rubenstein, Peter A.			Two Deafness-causing (DFNA20/26) Actin Mutations Affect Arp2/3-dependent Actin Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; YEAST ARP2/3 COMPLEX; IN-VITRO; HEARING IMPAIRMENT; ACTG1 MUTATIONS; FILAMENT; POLYMERIZATION; GENE; NUCLEATION; DYNAMICS	Hearing requires proper function of the auditory hair cell, which is critically dependent upon its actin-based cytoskeletal structure. Currently, ten point mutations in nonmuscle gamma-actin have been identified as causing progressive autosomal dominant nonsyndromic hearing loss (DFNA20/26), highlighting these ten residues as functionally important to actin structure and/or regulation. Two of the mutations, K118M and K118N, are located near the putative binding site for the ubiquitously expressed Arp2/3 complex. We therefore hypothesized that these mutations may affect Arp2/3-dependent regulation of the actin cytoskeleton. Using in vitro bulk polymerization assays, we show that the Lys-118 mutations notably reduce actin + Arp2/3 polymerization rates compared with WT. Further in vitro analysis of the K118M mutant using TIRF microscopy indicates the actual number of branches formed per filament is reduced compared with WT and, surprisingly, branch location is altered such that the majority of K118M branches form near the pointed end of the filament. These results highlight a previously unknown role for the Lys-118 residue in the actin-Arp2/3 interaction and also further suggest that Lys-118 may play a more significant role in intra-and intermonomer interactions than was initially hypothesized.	[Kruth, Karina A.; Rubenstein, Peter A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, 51 Newton Rd, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Kruth, Karina/0000-0003-2494-0745; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health from NIDCD [DC008803]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health from NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008803 from the NIDCD (to P. A. R.).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689; BREMER A, 1992, Current Opinion in Cell Biology, V4, P20, DOI 10.1016/0955-0674(92)90054-G; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; COOK RK, 1992, J BIOL CHEM, V267, P9430; DRUBIN DG, 1990, CELL MOTIL CYTOSKEL, V15, P7, DOI 10.1002/cm.970150103; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Pfaendtner J, 2012, J MOL BIOL, V416, P148, DOI 10.1016/j.jmb.2011.12.025; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Stapley BJ, 1997, J MOL BIOL, V272, P465, DOI 10.1006/jmbi.1997.1262; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	34	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27217	27226		10.1074/jbc.M112.377283	http://dx.doi.org/10.1074/jbc.M112.377283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718764	Green Published, hybrid			2022-12-28	WOS:000307386000073
J	Wen, Y; Kim, IH; Son, JS; Lee, BH; Kim, KS				Wen, Yancheng; Kim, In Hwang; Son, Jee-Soo; Lee, Byeong-Ha; Kim, Kun-Soo			Iron and Quorum Sensing Coordinately Regulate the Expression of Vulnibactin Biosynthesis in Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; VIRULENCE; CHOLERAE; SIDEROPHORE; FUR; HARVEYI; PROTEIN; SMCR; GENE; IDENTIFICATION	Vibrio vulnificus is a halophilic marine pathogen associated with human diseases such as septicemia and serious wound infections. Genes vvsA and vvsB, which are co-transcribed and encode a member of the nonribosomal peptide synthase family, are required for vulnibactin biosynthesis in V. vulnificus. In this study, we found that quorum sensing represses the transcription of a vvsAB-lux reporter fusion. Gel shift assay and DNaseI foot-printing experiments show that the main regulator of quorum sensing, SmcR, binds to a 22-bp region located between -40 and -19 with respect to the vvsA transcription start site. Mutation of the SmcR binding site abolishes the repression of vvsA::luxAB by SmcR. Fur represses vvsAB transcription in the presence of iron by binding to a 47-bp region located between -45 and +2 with respect to the vvsA transcription start site. A competition gel shift assay and footprinting experiment using Fur and SmcR showed that Fur binds to the vvsA promoter region with higher affinity than SmcR. Studies with the vvsAB:: luxAB transcriptional fusion demonstrate that in the presence of iron, Fur is the key repressor of vvsAB transcription, whereas in iron-limited conditions, SmcR is the key regulator repressing vvsAB transcription. This study demonstrates that the Fe-Fur complex and quorum sensing cooperate to repress the transcription of vvsAB in response to iron conditions, suggesting that fine tuning of the intracellular iron level is important for the survival and pathogenicity of V. vulnificus.	[Wen, Yancheng; Kim, In Hwang; Son, Jee-Soo; Lee, Byeong-Ha; Kim, Kun-Soo] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kim, Kun-Soo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 121742, South Korea	Sogang University; Sogang University	Kim, KS (corresponding author), Sogang Univ, Dept Life Sci, Seoul 121742, South Korea.	kskim@sogang.ac.kr	Lee, Byeong-ha/B-8478-2009	Lee, Byeong-ha/0000-0001-7633-3264; KIM, KUN-SOO/0000-0002-5433-4175	National Research Foundation of Korea Grant [2011-0018115]; Korean Ministry of Education, Science, and Technology (MEST); 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant 2011-0018115 funded by the Korean Ministry of Education, Science, and Technology (MEST) and by the 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea.	Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15522, DOI 10.1021/bi0016523; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim IH, 2008, J MICROBIOL BIOTECHN, V18, P35; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; LITWIN CM, 1993, J BACTERIOL, V175, P706, DOI 10.1128/JB.175.3.706-715.1993; Litwin CM, 1996, INFECT IMMUN, V64, P2834, DOI 10.1128/IAI.64.7.2834-2838.1996; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MORRIS JG, 1987, FEMS MICROBIOL LETT, V40, P55; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ren DC, 2005, APPL MICROBIOL BIOT, V66, P689, DOI 10.1007/s00253-004-1691-6; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; SAITO T, 1991, EUR J BIOCHEM, V197, P43, DOI 10.1111/j.1432-1033.1991.tb15880.x; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SIMPSON LM, 1983, INFECT IMMUN, V41, P644, DOI 10.1128/IAI.41.2.644-649.1983; Sousa F, 2007, ENZYME MICROB TECH, V40, P1772, DOI 10.1016/j.enzmictec.2006.12.017; Watnick PI, 1997, J BACTERIOL, V179, P243, DOI 10.1128/jb.179.1.243-247.1997; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	33	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26727	26739		10.1074/jbc.M112.374165	http://dx.doi.org/10.1074/jbc.M112.374165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696215	Green Published, hybrid			2022-12-28	WOS:000307386000023
J	Hyde, AS; Farmer, EL; Easley, KE; van Lammeren, K; Christoffels, VM; Barycki, JJ; Bakkers, J; Simpson, MA				Hyde, Annastasia S.; Farmer, Erin L.; Easley, Katherine E.; van Lammeren, Kristy; Christoffels, Vincent M.; Barycki, Joseph J.; Bakkers, Jeroen; Simpson, Melanie A.			UDP-glucose Dehydrogenase Polymorphisms from Patients with Congenital Heart Valve Defects Disrupt Enzyme Stability and Quaternary Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; MOLECULAR-CLONING; SITES REACTIVITY; DISEASE; HYALURONAN; ZEBRAFISH; MECHANISM; LIVER; 6-DEHYDROGENASE; MORPHOGENESIS	Cardiac valve defects are a common congenital heart malformation and a significant clinical problem. Defining molecular factors in cardiac valve development has facilitated identification of underlying causes of valve malformation. Gene disruption in zebrafish revealed a critical role for UDP-glucose dehydrogenase (UGDH) in valve development, so this gene was screened for polymorphisms in a patient population suffering from cardiac valve defects. Two genetic substitutions were identified and predicted to encode missense mutations of arginine 141 to cysteine and glutamate 416 to aspartate, respectively. Using a zebrafish model of defective heart valve formation caused by morpholino oligonucleotide knockdown of UGDH, transcripts encoding the UGDH R141C or E416D mutant enzymes were unable to restore cardiac valve formation and could only partially rescue cardiac edema. Characterization of the mutant recombinant enzymes purified from Escherichia coli revealed modest alterations in the enzymatic activity of the mutants and a significant reduction in the half-life of enzyme activity at 37 degrees C. This reduction in activity could be propagated to the wild-type enzyme in a 1:1 mixed reaction. Furthermore, the quaternary structure of both mutants, normally hexameric, was destabilized to favor the dimeric species, and the intrinsic thermal stability of the R141C mutant was highly compromised. The results are consistent with the reduced function of both missense mutations significantly reducing the ability of UGDH to provide precursors for cardiac cushion formation, which is essential to subsequent valve formation. The identification of these polymorphisms in patient populations will help identify families genetically at risk for valve defects.	[Hyde, Annastasia S.; Farmer, Erin L.; Easley, Katherine E.; Barycki, Joseph J.; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [van Lammeren, Kristy; Bakkers, Jeroen] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Lammeren, Kristy; Bakkers, Jeroen] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Christoffels, Vincent M.] Univ Amsterdam, Dept Anat Embryol & Physiol, Heart Failure Res Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Nebraska System; University of Nebraska Lincoln; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Bakkers, J (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Cardiac Dev & Genet Grp, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	j.bakkers@hubrecht.eu; msimpson2@unl.edu	Bakkers, Jeroen/H-5551-2011	Bakkers, Jeroen/0000-0002-9418-0422	National Institutes of Health [CA106584, R01 GM077289]; American Heart Association [0755788Z]; NCRR [P20 RR018759]; NATIONAL CANCER INSTITUTE [R01CA165574, R01CA106584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106584 (to M. A. S.), R01 GM077289 (to J. J. B.), and NCRR P20 RR018759 (to M. A. S.). This work was also supported by American Heart Association Grant 0755788Z (to M. A. S., J. J. B., and J. B.).	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bartman T, 2005, DEV DYNAM, V233, P373, DOI 10.1002/dvdy.20367; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2012, J BIOL CHEM, V287, P2119, DOI 10.1074/jbc.M111.313015; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FISHMAN MC, 1994, CIRC RES, V74, P757, DOI 10.1161/01.RES.74.5.757; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; FRANZEN JS, 1976, BIOCHEMISTRY-US, V15, P5665, DOI 10.1021/bi00670a036; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Gelb BD, 1997, CURR OPIN CARDIOL, V12, P321, DOI 10.1097/00001573-199705000-00014; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Naught LE, 2002, BIOCHEMISTRY-US, V41, P9637, DOI 10.1021/bi025862m; Prydz K, 2000, J CELL SCI, V113, P193; SCHILLER JG, 1972, CARBOHYD RES, V25, P403, DOI 10.1016/S0008-6215(00)81651-1; Smith KA, 2009, CIRCULATION, V119, P3062, DOI 10.1161/CIRCULATIONAHA.108.843714; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Stewart DC, 1998, PLANT PHYSIOL, V116, P349, DOI 10.1104/pp.116.1.349; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Warren KS, 1998, AM J PHYSIOL-HEART C, V275, pH1, DOI 10.1152/ajpheart.1998.275.1.H1; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yelon D, 1999, SEMIN CELL DEV BIOL, V10, P93, DOI 10.1006/scdb.1998.0278	35	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32708	32716		10.1074/jbc.M112.395202	http://dx.doi.org/10.1074/jbc.M112.395202			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22815472	Green Published, hybrid			2022-12-28	WOS:000309168300038
J	Van Petegem, F				Van Petegem, Filip			Ryanodine Receptors: Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CALCIUM-RELEASE CHANNEL; CENTRAL CORE DISEASE; MUSCLE SARCOPLASMIC-RETICULUM; LUMINAL CA2+ ACTIVATION; SUDDEN CARDIAC DEATH; MUTATION HOT-SPOT; SKELETAL-MUSCLE; MALIGNANT HYPERTHERMIA; VENTRICULAR-TACHYCARDIA; 3-DIMENSIONAL STRUCTURE	Ryanodine receptors (RyRs) are huge ion channels that are responsible for the release of Ca2+ from the sarco/endoplasmic reticulum. RyRs form homotetramers with a mushroom-like shape, consisting of a large cytoplasmic head and transmembrane stalk. Ca2+ is a major physiological ligand that triggers opening of RyRs, but a plethora of modulatory proteins and small molecules in the cytoplasm and sarco/endoplasmic reticulum lumen have been recognized. Over 300 mutations in RyRs are associated with severe skeletal muscle disorders or triggered cardiac arrhythmias. With the advent of high-resolution structures of individual domains, many of these can be mapped onto the three-dimensional structure.	Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Van Petegem, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	filip.vanpetegem@gmail.com	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Heart and Stroke Foundation of BC Yukon (HSFBCY); Canadian Institutes of Health Research (CIHR) New Investigator; Michael Smith Foundation for Health Research (MSFHR) Career Investigator	Heart and Stroke Foundation of BC Yukon (HSFBCY); Canadian Institutes of Health Research (CIHR) New Investigator(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR) Career Investigator	Supported by the Heart and Stroke Foundation of BC & Yukon (HSFBCY); Canadian Institutes of Health Research (CIHR) New Investigator and Michael Smith Foundation for Health Research (MSFHR) Career Investigator. To whom correspondence should be addressed. E-mail: filip.vanpetegem@gmail.com.	Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; Capacchione JF, 2010, ANESTHESIOLOGY, V112, P239, DOI 10.1097/ALN.0b013e3181c29504; Capacchione JF, 2009, ANESTH ANALG, V109, P1065, DOI 10.1213/ane.0b013e3181a9d8d9; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; De Crescenzo V, 2012, P NATL ACAD SCI USA, V109, P610, DOI 10.1073/pnas.1115111108; Denborough M. A., 1960, J GERONTOL B-PSYCHOL, V276, P45; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; FUENTES O, 1994, CELL CALCIUM, V15, P305, DOI 10.1016/0143-4160(94)90070-1; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; IKEMOTO T, 1995, J PHYSIOL-LONDON, V487, P573, DOI 10.1113/jphysiol.1995.sp020901; INUI M, 1987, J BIOL CHEM, V262, P1740; Jiang DW, 2008, J BIOL CHEM, V283, P20813, DOI 10.1074/jbc.M801944200; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Kimlicka L, 2011, SCI CHINA LIFE SCI, V54, P712, DOI 10.1007/s11427-011-4198-2; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Muthappan P, 2008, PROG CARDIOVASC DIS, V51, P31, DOI 10.1016/j.pcad.2008.01.002; NAKAI J, 1990, FEBS LETT, V271, P169, DOI 10.1016/0014-5793(90)80399-4; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; OTSU K, 1990, J BIOL CHEM, V265, P13472; PALADE P, 1983, J BIOL CHEM, V258, P8098; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; ROGERS EF, 1948, J AM CHEM SOC, V70, P3086, DOI 10.1021/ja01189a074; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; Tae HS, 2011, J BIOL CHEM, V286, P22589, DOI 10.1074/jbc.M110.205476; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yin CC, 2000, NAT CELL BIOL, V2, P669, DOI 10.1038/35023625; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhou HY, 2010, NEUROMUSCULAR DISORD, V20, P166, DOI 10.1016/j.nmd.2009.12.005; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	100	163	166	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31624	31632		10.1074/jbc.R112.349068	http://dx.doi.org/10.1074/jbc.R112.349068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822064	Green Published, hybrid			2022-12-28	WOS:000309059400003
J	Eixelsberger, T; Sykora, S; Egger, S; Brunsteiner, M; Kavanagh, KL; Oppermann, U; Brecker, L; Nidetzky, B				Eixelsberger, Thomas; Sykora, Sabine; Egger, Sigrid; Brunsteiner, Michael; Kavanagh, Kathryn L.; Oppermann, Udo; Brecker, Lothar; Nidetzky, Bernd			Structure and Mechanism of Human UDP-xylose Synthase EVIDENCE FOR A PROMOTING ROLE OF SUGAR RING DISTORTION IN A THREE-STEP CATALYTIC CONVERSION OF UDP-GLUCURONIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCURONIC ACID; KEY ENZYME; PROTEOGLYCANS; DECARBOXYLASE; BIOSYNTHESIS; ARNA; 4-AMINO-4-DEOXY-L-ARABINOSE; CONFORMATION; CATALYSIS; DYNAMICS	UDP-xylose synthase (UXS) catalyzes decarboxylation of UDP-D-glucuronic acid to UDP-xylose. In mammals, UDP-xylose serves to initiate glycosaminoglycan synthesis on the protein core of extracellular matrix proteoglycans. Lack of UXS activity leads to a defective extracellular matrix, resulting in strong interference with cell signaling pathways. We present comprehensive structural and mechanistic characterization of the human form of UXS. The 1.26-angstrom crystal structure of the enzyme bound with NAD(+) and UDP reveals a homodimeric short-chain dehydrogenase/reductase (SDR), belonging to the NDP-sugar epimerases/dehydratases subclass. We show that enzymatic reaction proceeds in three chemical steps via UDP-4-keto-D-glucuronic acid and UDP-4-keto-pentose intermediates. Molecular dynamics simulations reveal that the D-glucuronyl ring accommodated by UXS features a marked C-4(1) chair to B-O,B-3 boat distortion that facilitates catalysis in two different ways. It promotes oxidation at C-4 (step 1) by aligning the enzymatic base Tyr(147) with the reactive substrate hydroxyl and it brings the carboxylate group at C-5 into an almost fully axial position, ideal for decarboxylation of UDP-4-keto-D-glucuronic acid in the second chemical step. The protonated side chain of Tyr(147) stabilizes the enolate of decarboxylated C-4 keto species (H-2(1) half-chair) that is then protonated from the Si face at C-5, involving water coordinated by Glu(120). Arg(277), which is positioned by a salt-link interaction with Glu(120), closes up the catalytic site and prevents release of the UDP-4-keto-pentose and NADH intermediates. Hydrogenation of the C-4 keto group by NADH, assisted by Tyr(147) as catalytic proton donor, yields UDP-xylose adopting the relaxed C-4(1) chair conformation (step 3).	[Eixelsberger, Thomas; Sykora, Sabine; Egger, Sigrid; Brunsteiner, Michael; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Egger, Sigrid; Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Egger, Sigrid; Nidetzky, Bernd] ACIB, A-8010 Graz, Austria; [Brunsteiner, Michael; Nidetzky, Bernd] RCPE, A-8010 Graz, Austria; [Oppermann, Udo] Univ Oxford, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England; [Brecker, Lothar] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	Graz University of Technology; University of Oxford; Austrian Centre of Industrial Biotechnology; University of Oxford; University of Vienna	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-I, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Brunsteiner, Michael/0000-0002-1149-7847; Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund DK Molecular Enzymology Grant [W901-B05]; SGC; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund DK Molecular Enzymology Grant; SGC; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund DK Molecular Enzymology Grant W901-B05 and the SGC. The SGC is a registered charity (number 1097737) that receives funds from multiple sources.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Choi SH, 2011, CHEM COMMUN, V47, P10130, DOI 10.1039/c1cc13140k; Coyne MJ, 2011, J BACTERIOL, V193, P5252, DOI 10.1128/JB.05337-11; Eames BF, 2010, DEV BIOL, V341, P400, DOI 10.1016/j.ydbio.2010.02.035; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gatzeva-Topalova PZ, 2005, STRUCTURE, V13, P929, DOI 10.1016/j.str.2005.03.018; Gatzeva-Topalova PZ, 2004, BIOCHEMISTRY-US, V43, P13370, DOI 10.1021/bi048551f; GEBB C, 1975, EUR J BIOCHEM, V54, P493, DOI 10.1111/j.1432-1033.1975.tb04161.x; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; He XMM, 2002, ANNU REV BIOCHEM, V71, P701, DOI 10.1146/annurev.biochem.71.110601.135339; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Mikhailov D, 1996, BIOCHEM J, V318, P93, DOI 10.1042/bj3180093; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Moriarity JL, 2002, J BIOL CHEM, V277, P16968, DOI 10.1074/jbc.M109316200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochsenbein P, 2011, ANGEW CHEM INT EDIT, V50, P11637, DOI 10.1002/anie.201105172; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pan YH, 2011, CHEM-EUR J, V17, P8363, DOI 10.1002/chem.201100687; Prydz K, 2000, J CELL SCI, V113, P193; Rosenberger AFN, 2012, MOL BIOCHEM PARASIT, V181, P53, DOI 10.1016/j.molbiopara.2011.10.001; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SCHUTZBA.JS, 1970, J BIOL CHEM, V245, P2476; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Tanner ME, 2008, CURR OPIN CHEM BIOL, V12, P532, DOI 10.1016/j.cbpa.2008.06.016; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200	49	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31349	31358		10.1074/jbc.M112.386706	http://dx.doi.org/10.1074/jbc.M112.386706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810237	Green Published, hybrid			2022-12-28	WOS:000308791300046
J	Moss, BL; Elhammali, A; Fowlkes, T; Gross, S; Vinjamoori, A; Contag, CH; Piwnica-Worms, D				Moss, Britney L.; Elhammali, Adnan; Fowlkes, Tiffanie; Gross, Shimon; Vinjamoori, Anant; Contag, Christopher H.; Piwnica-Worms, David			Interrogation of Inhibitor of Nuclear Factor kappa B alpha/Nuclear Factor kappa B (I kappa B alpha/NF-kappa B) Negative Feedback Loop Dynamics FROM SINGLE CELLS TO LIVE ANIMALS IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TEMPORAL CONTROL; INDUCED STABILIZATION; SIGNALING PATHWAYS; LIVING CELLS; OSCILLATIONS; TNF; STIMULATION; SPECIFICITY; ACTIVATION	Full understanding of the biological significance of negative feedback processes requires interrogation at multiple scales as follows: in single cells, cell populations, and live animals in vivo. The transcriptionally coupled I kappa B alpha/NF-kappa B negative feedback loop, a pivotal regulatory node of innate immunity and inflammation, represents a model system for multiscalar reporters. Using a kappa B-5 -> I kappa B alpha-FLuc bioluminescent reporter, we rigorously evaluated the dynamics of I kappa B alpha degradation and subsequent NF-kappa B transcriptional activity in response to diverse modes of TNF alpha stimulation. Modulating TNF alpha concentration or pulse duration yielded complex, reproducible, and differential I kappa B alpha dynamics in both cell populations and live single cells. Tremendous heterogeneity in the transcriptional amplitudes of individual responding cells was observed, which was greater than the heterogeneity in the transcriptional kinetics of responsive cells. Furthermore, administration of various TNF alpha doses in vivo generated I kappa B alpha dynamic profiles in the liver resembling those observed in single cells and populations of cells stimulated with TNF alpha pulses. This suggested that dose modulation of circulating TNF alpha was perceived by hepatocytes in vivo as pulses of increasing duration. Thus, a robust bioluminescent reporter strategy enabled rigorous quantitation of NF-kappa B/I kappa B alpha dynamics in both live single cells and cell populations and furthermore, revealed reproducible behaviors that informed interpretation of in vivo studies.	[Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Cel, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Dev, St Louis, MO 63110 USA; [Vinjamoori, Anant; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Pediat, Stanford, CA 94305 USA; [Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Radiol, Stanford, CA 94305 USA; [Vinjamoori, Anant; Contag, Christopher H.] Stanford Univ, Sch Med, Mol Imaging Program, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); Stanford University; Stanford University; Stanford University	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, BRIGHT Inst, Mol Imaging Ctr,Mallinckrodt Inst Radiol,Dept Cel, 510 S Kingshighway Blvd,Box 8225, St Louis, MO 63110 USA.	wormsd@mir.wustl.edu		fowlkes, tiffanie/0000-0001-8189-6838; Contag, Christopher/0000-0002-1011-8278; Moss, Britney/0000-0002-1037-5717	National Institutes of Health Grant [P50 CA94056]; National Science Foundation; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 CA94056. This work was also supported by a predoctoral fellowship Award from the National Science Foundation (to B.L.M.).	Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Harper CV, 2010, J CELL SCI, V123, P424, DOI 10.1242/jcs.060434; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Moss BL, 2008, J BIOL CHEM, V283, P8687, DOI 10.1074/jbc.M706831200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nelson G, 2002, J CELL SCI, V115, P1137; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pichler A, 2005, CLIN CANCER RES, V11, P4487, DOI 10.1158/1078-0432.CCR-05-0038; Pichler A, 2008, P NATL ACAD SCI USA, V105, P15932, DOI 10.1073/pnas.0801075105; Place RF, 2003, J CELL PHYSIOL, V195, P470, DOI 10.1002/jcp.10262; Place RF, 2001, BIOCHEM BIOPH RES CO, V283, P813, DOI 10.1006/bbrc.2001.4883; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Sung MH, 2011, WIRES SYST BIOL MED, V3, P167, DOI 10.1002/wsbm.108; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Warrington NM, 2010, CANCER RES, V70, P5717, DOI 10.1158/0008-5472.CAN-09-3769; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	44	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31359	31370		10.1074/jbc.M112.364018	http://dx.doi.org/10.1074/jbc.M112.364018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22807442	Green Published, hybrid			2022-12-28	WOS:000308791300047
J	Zhu, QL; Gibson, MP; Liu, QL; Liu, Y; Lu, YB; Wang, XF; Feng, JQ; Qin, CL				Zhu, Qinglin; Gibson, Monica Prasad; Liu, Qilin; Liu, Ying; Lu, Yongbo; Wang, Xiaofang; Feng, Jian Q.; Qin, Chunlin			Proteolytic Processing of Dentin Sialophosphoprotein (DSPP) Is Essential to Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALOPROTEIN; PHOSPHOPROTEIN; PROTEINS; MUTATION; SEQUENCE; BINDING; GENE; PHOSPHOPHORYN; SUBSTITUTION; PRODUCTS	DSPP, which plays a crucial role in dentin formation, is processed into the NH2-terminal and COOH-terminal fragments. We believe that the proteolytic processing of DSPP is an essential activation step for its biological function in biomineralization. We tested this hypothesis by analyzing transgenic mice expressing the mutant D452A-DSPP in the Dspp-knock-out (Dspp-KO) background (referred to as "Dspp-KO/D452A-Tg" mice). We employed multipronged approaches to characterize the dentin of the Dspp-KO/D452A-Tg mice, in comparison with Dspp-KOmice and mice expressing the normal DSPP transgene in the Dspp-KO background (named Dspp-KO/normal-Tg mice). Our analyses showed that 90% of the D452A-DSPP in the dentin of Dspp-KO/D452A-Tg mice was not cleaved, indicating that D452A substitution effectively blocked the proteolytic processing of DSPP in vivo. While the expression of the normal DSPP fully rescued the dentin defects of the Dspp-KO mice, expressing the D452A-DSPP failed to do so. These results indicate that the proteolytic processing of DSPP is an activation step essential to its biological function in dentinogenesis.	[Zhu, Qinglin; Gibson, Monica Prasad; Liu, Qilin; Liu, Ying; Lu, Yongbo; Wang, Xiaofang; Feng, Jian Q.; Qin, Chunlin] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [Zhu, Qinglin] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Air Force Military Medical University	Qin, CL (corresponding author), Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Lu, Yongbo/0000-0003-3692-1736	National Institutes of Health [DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE005092 (to C. Q.).	Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1981, COLLAGEN REL RES, V1, P187; BUTLER WT, 1992, MATRIX, V12, P343, DOI 10.1016/S0934-8832(11)80030-2; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; DICKSON IR, 1975, CALC TISS RES, V19, P51, DOI 10.1007/BF02563990; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; JONSSON M, 1978, J CHROMATOGR, V157, P235, DOI 10.1016/S0021-9673(00)92338-0; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Malmgren B, 2004, HUM GENET, V114, P491, DOI 10.1007/s00439-004-1084-z; MARSH ME, 1989, BIOCHEMISTRY-US, V28, P346, DOI 10.1021/bi00427a047; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ritchie HH, 1996, J BIOL CHEM, V271, P21695, DOI 10.1074/jbc.271.36.21695; Ritchie HH, 2001, BBA-GENE STRUCT EXPR, V1520, P212, DOI 10.1016/S0167-4781(01)00274-3; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sugars RV, 2006, EUR J ORAL SCI, V114, P89, DOI 10.1111/j.1600-0722.2006.00271.x; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Sun Y, 2010, INT J ORAL MAX SURG, V39, P272, DOI 10.1016/j.ijom.2009.12.017; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu Q, 2010, J DENT RES, V89, P808, DOI 10.1177/0022034510366902; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	47	42	46	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30426	30435		10.1074/jbc.M112.388587	http://dx.doi.org/10.1074/jbc.M112.388587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798071	hybrid, Green Published			2022-12-28	WOS:000308579800035
J	Kakiya, N; Saito, T; Nilsson, P; Matsuba, Y; Tsubuki, S; Takei, N; Nawa, H; Saido, TC				Kakiya, Naomasa; Saito, Takashi; Nilsson, Per; Matsuba, Yukio; Tsubuki, Satoshi; Takei, Nobuyuki; Nawa, Hiroyuki; Saido, Takaomi C.			Cell Surface Expression of the Major Amyloid-beta Peptide (A beta)-degrading Enzyme, Neprilysin, Depends on Phosphorylation by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) and Dephosphorylation by Protein Phosphatase 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; PRECURSOR PROTEIN; A-BETA; NEUTRAL ENDOPEPTIDASE; PLAQUE-FORMATION; IN-VIVO; BRAIN; RECEPTOR; IDENTIFICATION	Neprilysin is one of the major amyloid-beta peptide (A beta)-degrading enzymes, the expression of which declines in the brain during aging. The decrease in neprilysin leads to a metabolic A beta imbalance, which can induce the amyloidosis underlying Alzheimer disease. Pharmacological activation of neprilysin during aging therefore represents a potential strategy to prevent the development of Alzheimer disease. However, the regulatory mechanisms mediating neprilysin activity in the brain remain unclear. To address this issue, we screened for pharmacological regulators of neprilysin activity and found that the neurotrophic factors brain-derived neurotrophic factor, nerve growth factor, and neurotrophins 3 and 4 reduce cell surface neprilysin activity. This decrease was mediated by MEK/ERK signaling, which enhanced phosphorylation at serine 6 in the neprilysin intracellular domain (S6-NEP-ICD). Increased phosphorylation of S6-NEP-ICD in primary neurons reduced the levels of cell surface neprilysin and led to a subsequent increase in extracellular A beta levels. Furthermore, a specific inhibitor of protein phosphatase-1a, tautomycetin, induced extensive phosphorylation of the S6-NEP-ICD, resulting in reduced cell surface neprilysin activity. In contrast, activation of protein phosphatase-1a increased cell surface neprilysin activity and lowered A beta levels. Taken together, these results indicate that the phosphorylation status of S6-NEP-ICD influences the localization of neprilysin and affects extracellular A beta levels. Therefore, maintaining S6-NEP-ICD in a dephosphorylated state, either by inhibition of protein kinases involved in its phosphorylation or by activation of phosphatases catalyzing its dephosphorylation, may represent a new approach to prevent reduction of cell surface neprilysin activity during aging and to maintain physiological levels of A beta in the brain.	[Kakiya, Naomasa; Saito, Takashi; Nilsson, Per; Matsuba, Yukio; Tsubuki, Satoshi; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Kakiya, Naomasa; Takei, Nobuyuki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata 9518585, Japan	RIKEN; Niigata University	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Saito, Takashi/G-2563-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan; Junior Research Associate Program of RIKEN	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Junior Research Associate Program of RIKEN	This study was supported by research grants from RIKEN Brain Science Institute; the Ministry of Education, Culture, Sports, Science, and Technology; and the Ministry of Health, Labor, and Welfare of Japan. This study was also supported by the Junior Research Associate Program of RIKEN.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Carter TL, 2006, NEUROSCI LETT, V392, P235, DOI 10.1016/j.neulet.2005.09.022; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LOEB DM, 1992, NEURON, V9, P1053, DOI 10.1016/0896-6273(92)90065-L; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peng S, 2009, J NEUROSCI, V29, P9321, DOI 10.1523/JNEUROSCI.4736-08.2009; Rajput PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024467; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Reilly CE, 2001, J NEUROL, V248, P159; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siepmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013134; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng ZQ, 2010, J BIOL CHEM, V285, P34708, DOI 10.1074/jbc.M110.150821	46	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29362	29372		10.1074/jbc.M112.340372	http://dx.doi.org/10.1074/jbc.M112.340372			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767595	Green Published, hybrid			2022-12-28	WOS:000308286900015
J	Carta, E; Chung, SK; James, VM; Robinson, A; Gill, JL; Remy, N; Vanbellinghen, JF; Drew, CJG; Cagdas, S; Cameron, D; Cowan, FM; Del Toro, M; Graham, GE; Manzur, AY; Masri, A; Rivera, S; Scalais, E; Shiang, R; Sinclair, K; Stuart, CA; Tijssen, MAJ; Wise, G; Zuberi, SM; Harvey, K; Pearce, BR; Topf, M; Thomas, RH; Supplisson, S; Rees, MI; Harvey, RJ				Carta, Eloisa; Chung, Seo-Kyung; James, Victoria M.; Robinson, Angela; Gill, Jennifer L.; Remy, Nathalie; Vanbellinghen, Jean-Francois; Drew, Cheney J. G.; Cagdas, Sophie; Cameron, Duncan; Cowan, Frances M.; Del Toro, Mireria; Graham, Gail E.; Manzur, Adnan Y.; Masri, Amira; Rivera, Serge; Scalais, Emmanuel; Shiang, Rita; Sinclair, Kate; Stuart, Catriona A.; Tijssen, Marina A. J.; Wise, Grahame; Zuberi, Sameer M.; Harvey, Kirsten; Pearce, Brian R.; Topf, Maya; Thomas, Rhys H.; Supplisson, Stephane; Rees, Mark I.; Harvey, Robert J.			Mutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; NEUROTRANSMITTER TRANSPORTERS; BINDING-SITE; HYPEREKPLEXIA; PROTEIN; DOMINANT; SUBUNIT; NEURONS; DEATH; MICE	Hereditary hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, leading to hypertonia and apnea episodes. Missense, nonsense, frameshift, splice site mutations, and large deletions in the human glycine receptor alpha 1 subunit gene (GLRA1) are the major known cause of this disorder. However, mutations are also found in the genes encoding the glycine receptor beta subunit (GLRB) and the presynaptic Na+/Cl--dependent glycine transporter GlyT2 (SLC6A5). In this study, systematic DNA sequencing of SLC6A5 in 93 new unrelated human hyperekplexia patients revealed 20 sequence variants in 17 index cases presenting with homozygous or compound heterozygous recessive inheritance. Five apparently unrelated cases had the truncating mutation R439X. Genotype-phenotype analysis revealed a high rate of neonatal apneas and learning difficulties associated with SLC6A5 mutations. From the 20 SLC6A5 sequence variants, we investigated glycine uptake for 16 novel mutations, confirming that all were defective in glycine transport. Although the most common mechanism of disrupting GlyT2 function is protein truncation, new pathogenic mechanisms included splice site mutations and missense mutations affecting residues implicated in Cl- binding, conformational changes mediated by extracellular loop 4, and cation-pi interactions. Detailed electrophysiology of mutation A275T revealed that this substitution results in a voltage-sensitive decrease in glycine transport caused by lower Na+ affinity. This study firmly establishes the combination of missense, nonsense, frameshift, and splice site mutations in the GlyT2 gene as the second major cause of startle disease.	[Chung, Seo-Kyung; Robinson, Angela; Drew, Cheney J. G.; Thomas, Rhys H.; Rees, Mark I.] Swansea Univ, Inst Life Sci, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Carta, Eloisa; James, Victoria M.; Gill, Jennifer L.; Harvey, Kirsten; Pearce, Brian R.; Harvey, Robert J.] UCL Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Remy, Nathalie] Liege Univ Hosp, B-4000 Liege, Belgium; [Vanbellinghen, Jean-Francois] Inst Pathol & Genet, B-6041 Gosselies, Belgium; [Cagdas, Sophie] C Poma Hosp, Dept Child Neuropsychiat, I-46100 Mantua, Italy; [Cameron, Duncan] Glan Clwyd Gen Hosp, Dept Paediat, Rhyl LL18 5UJ, Denbigh, Wales; [Cowan, Frances M.] Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London W12 0HS, England; [Del Toro, Mireria] Hosp Gen Univ Vall dHebron, Serv Neurol Pediat, Barcelona 08035, Spain; [Graham, Gail E.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Manzur, Adnan Y.] Great Ormond St Hosp Sick Children, Dept Paediat Neurol, London WC1N 3JH, England; [Masri, Amira] Univ Jordan, Dept Paediat, Amman 11941, Jordan; [Rivera, Serge] Ctr Hosp Cote Basque, Serv Pediat, F-64109 Bayonne, France; [Scalais, Emmanuel] Ctr Hosp Luxembourg, L-1210 Luxembourg, Luxembourg; [Shiang, Rita] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Sinclair, Kate] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Herston, Qld 4029, Australia; [Stuart, Catriona A.] Cumberland Infirm, Carlisle CA2 7HY, Cumbria, England; [Tijssen, Marina A. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands; [Wise, Grahame] Sydney Childrens Hosp, Randwick, NSW 2031, Australia; [Zuberi, Sameer M.] Royal Hosp Sick Children, Paediat Neurosci Res Grp, Glasgow G3 8SJ, Lanark, Scotland; [Topf, Maya] Univ London Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England; [Thomas, Rhys H.; Rees, Mark I.] Swansea Univ, Coll Med, Wales Epilepsy Res Network, Swansea SA2 8PP, W Glam, Wales; [Supplisson, Stephane] Ecole Normale Super, Inst Biol, F-75000 Paris, France; [Supplisson, Stephane] INSERM, U1024, F-75000 Paris, France; [Supplisson, Stephane] CNRS, UMR 8197, F-75000 Paris, France	Swansea University; University of London; University College London; University of Liege; Hospital Carlo Poma; Imperial College London; University of Ottawa; Children's Hospital of Eastern Ontario; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Jordan; Luxembourg Hospital Center; Virginia Commonwealth University; Royal Children's Hospital Brisbane; University of Groningen; University of Glasgow; University of London; Birkbeck University London; Swansea University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Rees, MI (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	m.i.rees@swansea.ac.uk; r.j.harvey@ucl.ac.uk	Harvey, Robert/D-3994-2016; Chung, Seo-Kyung/AAT-4693-2021; SUPPLISSON, Stéphane/AAD-7482-2019; Chung, Seo-Kyung/I-3329-2017; SUPPLISSON, Stéphane/L-6658-2017; Rees, Mark I/J-3129-2012; Thomas, Rhys/I-3840-2019; masri, amira/C-4570-2015	Harvey, Robert/0000-0001-5956-6664; Chung, Seo-Kyung/0000-0002-5008-8384; SUPPLISSON, Stéphane/0000-0002-0062-9752; Chung, Seo-Kyung/0000-0002-5008-8384; SUPPLISSON, Stéphane/0000-0002-0062-9752; Rees, Mark I/0000-0003-3570-5986; Thomas, Rhys/0000-0003-2062-8623; masri, amira/0000-0001-6103-8713; James, Victoria/0000-0002-9265-5914; Topf, Maya/0000-0002-8185-1215	Medical Research Council [G0601585]; Action Medical Research Grant [1966]; Bloomsbury Colleges studentship; Career Development Award [G0600084]; National Institute of Social Care and Health Research; Association Francaise contre les Myopathies; MRC [G0600084, G0601585] Funding Source: UKRI; Medical Research Council [G0600084] Funding Source: researchfish; Action Medical Research [1966] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Medical Research Grant; Bloomsbury Colleges studentship; Career Development Award; National Institute of Social Care and Health Research; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	This work was supported by Medical Research Council Grant G0601585 (to R. J. H., K. H., and M. I. R.), Action Medical Research Grant 1966 (to R. J. H., R. H. T., and M. I. R.), a Bloomsbury Colleges studentship (to V. M. J., M. T., and R. J. H.), Career Development Award G0600084 (to M. T.), a National Institute of Social Care and Health Research grant (to M. I. R., R. H. T., and S. K. C.), and an Association Francaise contre les Myopathies grant (to S. S.).	Al-Owain M, 2012, CLIN GENET, V81, P479, DOI 10.1111/j.1399-0004.2011.01661.x; Bajaj K, 2007, PLOS COMPUT BIOL, V3, P2465, DOI 10.1371/journal.pcbi.0030241; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Bakker MJ, 2009, MOVEMENT DISORD, V24, P1852, DOI 10.1002/mds.22493; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Becker Kristina, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9455; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davies JS, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00008; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mager S, 1998, METHOD ENZYMOL, V296, P551; Manzke T, 2010, J CLIN INVEST, V120, P4118, DOI 10.1172/JCI43029; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; NIGRO MA, 1992, PEDIATR NEUROL, V8, P221, DOI 10.1016/0887-8994(92)90073-8; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Roux MJ, 2001, J BIOL CHEM, V276, P17699, DOI 10.1074/jbc.M009196200; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Siren A, 2006, NEUROLOGY, V67, P137, DOI 10.1212/01.wnl.0000223347.73493.af; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Thomas RH, 2010, J PEDIATR NEUROL, V8, P11, DOI 10.3233/JPN-2010-0359; VIGEVANO F, 1989, LANCET, V1, P216; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	45	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28975	28985		10.1074/jbc.M112.372094	http://dx.doi.org/10.1074/jbc.M112.372094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22700964	Green Published, hybrid			2022-12-28	WOS:000308074600066
J	Jansen, EJR; van Bakel, NHM; Loohuis, NFMO; Hafmans, TGM; Arentsen, T; Coenen, AJM; Scheenen, WJJM; Martens, GJM				Jansen, Eric J. R.; van Bakel, Nick. H. M.; Loohuis, Nikkie F. M. Olde; Hafmans, Theo G. M.; Arentsen, Tim; Coenen, Anthon J. M.; Scheenen, Wim J. J. M.; Martens, Gerard J. M.			Identification of Domains within the V-ATPase Accessory Subunit Ac45 Involved in V-ATPase Transport and Ca2+-dependent Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PRECURSOR PROTEIN APP; SECRETORY PATHWAY; XENOPUS-LAEVIS; MELANOTROPE CELLS; GRANULAR ACIDIFICATION; FURIN; DETERMINANTS; INTERACT; RELEASE	The vacuolar (H+)-ATPase (V-ATPase) is crucial for maintenance of the acidic microenvironment in intracellular organelles, whereas its membrane-bound V-0-sector is involved in Ca2+-dependent membrane fusion. In the secretory pathway, the V-ATPase is regulated by its type I transmembrane and V-0-associated accessory subunit Ac45. To execute its function, the intact-Ac45 protein is proteolytically processed to cleaved-Ac45 thereby releasing its N-terminal domain. Here, we searched for the functional domains within Ac45 by analyzing a set of deletion mutants close to the in vivo situation, namely in transgenic Xenopus intermediate pituitary melanotrope cells. Intact-Ac45 was poorly processed and accumulated in the endoplasmic reticulum of the transgenic melanotrope cells. In contrast, cleaved-Ac45 was efficiently transported through the secretory pathway, caused an accumulation of the V-ATPase at the plasma membrane and reduced dopaminergic inhibition of Ca2+-dependent peptide secretion. Surprisingly, removal of the C-tail from intact-Ac45 caused cellular phenotypes also found for cleaved-Ac45, whereas C-tail removal from cleaved-Ac45 still allowed its transport to the plasma membrane, but abolished V-ATPase recruitment into the secretory pathway and left dopaminergic inhibition of the cells unaffected. We conclude that domains located in the N- and C-terminal portions of the Ac45 protein direct its trafficking, V-ATPase recruitment and Ca2+-dependent-regulated exocytosis.	[Martens, Gerard J. M.] Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol,Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands; [Scheenen, Wim J. J. M.] Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Cellular Anim Physiol, NL-6525 GA Nijmegen, Netherlands; [Martens, Gerard J. M.] Radboud Univ Nijmegen, Fac Sci, NCMLS, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Martens, GJM (corresponding author), Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol,Ctr Neurosci, RT 282,Geert Grootepl Zuid 28, NL-6525 GA Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	Martens, Gerard JM/D-1925-2010; van Bakel, Nick/A-3187-2013; Scheenen, Wim/E-3674-2012; Jansen, Eric J.R./A-3158-2013					Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Berghs CAFM, 1997, J HISTOCHEM CYTOCHEM, V45, P1673, DOI 10.1177/002215549704501211; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Collin RWJ, 2006, BRAIN RES, V1087, P41, DOI 10.1016/j.brainres.2006.02.101; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cuppen E, 1999, J CELL SCI, V112, P3299; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Getlawi F, 1996, NEUROSCI LETT, V219, P13, DOI 10.1016/S0304-3940(96)13151-7; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Holthuis JCM, 1999, EUR J BIOCHEM, V262, P484, DOI 10.1046/j.1432-1327.1999.00396.x; HOLTHUIS JCM, 1995, J CELL SCI, V108, P3295; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; Jansen EJR, 2010, MOL BIOL CELL, V21, P3330, DOI 10.1091/mbc.E10-04-0274; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; Jenks BG, 2003, GEN COMP ENDOCR, V131, P210, DOI 10.1016/S0016-6480(03)00120-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuan YH, 2006, J BIOL CHEM, V281, P40114, DOI 10.1074/jbc.M605407200; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lieste JR, 1998, J BIOL CHEM, V273, P25686, DOI 10.1074/jbc.273.40.25686; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; MARTENS GJM, 1986, NUCLEIC ACIDS RES, V14, P3791, DOI 10.1093/nar/14.9.3791; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Qin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027155; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Roubos EW, 1997, COMP BIOCHEM PHYS A, V118, P533, DOI 10.1016/S0300-9629(97)00035-2; SCHEENEN WJJM, 1994, CELL CALCIUM, V15, P36, DOI 10.1016/0143-4160(94)90102-3; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Schoonderwoert VTG, 2002, EUR J BIOCHEM, V269, P1844, DOI 10.1046/j.1432-1033.2002.02831.x; SHIBUYA I, 1993, ENDOCRINOLOGY, V132, P2166, DOI 10.1210/en.132.5.2166; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Van Herp F, 2005, J MICROSC-OXFORD, V218, P79, DOI 10.1111/j.1365-2818.2005.01456.x; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Zhang HY, 2005, J NEUROENDOCRINOL, V17, P1, DOI 10.1111/j.1365-2826.2005.01267.x; Zhang W, 2008, J BIOL CHEM, V283, P294, DOI 10.1074/jbc.M708058200	51	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27537	27546		10.1074/jbc.M112.356105	http://dx.doi.org/10.1074/jbc.M112.356105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736765	Green Published, hybrid			2022-12-28	WOS:000307840700029
J	Zhang, LJ; Vogel, WK; Liu, X; Topark-Ngarm, A; Arbogast, BL; Maier, CS; Filtz, TM; Leid, M				Zhang, Ling-juan; Vogel, Walter K.; Liu, Xiao; Topark-Ngarm, Acharawan; Arbogast, Brian L.; Maier, Claudia S.; Filtz, Theresa M.; Leid, Mark			Coordinated Regulation of Transcription Factor Bcl11b Activity in Thymocytes by the Mitogen-activated Protein Kinase (MAPK) Pathways and Protein Sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE COMMITMENT; POSITIVE SELECTION; STATISTICAL-MODEL; NURD COMPLEX; TCR SIGNALS; DUAL ROLE; SUMO; DIFFERENTIATION; EXPRESSION; GENE	The transcriptional regulatory protein Bcl11b is essential for T-cell development. We have discovered a dynamic, MAPK-regulated pathway involving sequential, linked, and reversible post-translational modifications of Bcl11b in thymocytes. MAPK-mediated phosphorylation of Bcl11b was coupled to its rapid desumoylation, which was followed by a subsequent cycle of dephosphorylation and resumoylation. Additionally and notably, we report the first instance of direct identification by mass spectrometry of a site of small ubiquitin-like modifier (SUMO) adduction, Lys-679 of Bcl11b, in a protein isolated from a native, mammalian cell. Sumoylation of Bcl11b resulted in recruitment of the transcriptional co-activator p300 to a Bcl11b-repressed promoter with subsequent induction of transcription. Prolonged treatment of native thymocytes with phorbol 12,13-dibutyrate together with the calcium ionophore A23187 also promoted ubiquitination and proteasomal degradation of Bcl11b, providing a mechanism for signal termination. A Bcl11b phospho-deSUMO switch was identified, the basis of which was phosphorylation-dependent recruitment of the SUMO hydrolase SENP1 to phospho-Bcl11b, coupled to hydrolysis of SUMO-Bcl11b. These results define a regulatory pathway in thymocytes that includes the MAPK pathways and upstream signaling components, Bcl11b and the associated nucleosome remodeling and deacetylation (NuRD) complex, SENP proteins, the Bcl11b protein phosphatase 6, the sumoylation machinery, the histone acetyltransferase p300, and downstream transcriptional machinery. This pathway appears to facilitate derepression of repressed Bcl11b target genes as immature thymocytes initiate differentiation programs, biochemically linking MAPK signaling with the latter stages of T-cell development.	[Filtz, Theresa M.; Leid, Mark] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Arbogast, Brian L.; Maier, Claudia S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Arbogast, Brian L.; Maier, Claudia S.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Filtz, TM (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	Theresa.Filtz@oregonstate.edu; Mark.Leid@oregonstate.edu	Zhang, Ling-juan/V-6141-2019; Zhang, Lingjuan/K-3080-2017	Zhang, Ling-juan/0000-0001-6937-4578; Zhang, Lingjuan/0000-0001-6937-4578; Filtz, Theresa/0000-0002-5348-1114; Maier, Claudia S./0000-0003-0743-8956; Vogel, Walter/0000-0002-5663-6660	National Institutes of Health [GM096243]; Medical Research Foundation of Oregon; Oregon State University College of Pharmacy; Environmental Health Sciences Center; NIEHS, National Institutes of Health Center [ES000210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of Oregon; Oregon State University College of Pharmacy; Environmental Health Sciences Center; NIEHS, National Institutes of Health Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM096243 (to T. M. F.). This work was also supported by an award from the Medical Research Foundation of Oregon (to M. L.) and funds provided by the Oregon State University College of Pharmacy.; Partially supported by the Environmental Health Sciences Center during the early phases of this work involving mass spectrometry.; We thank David Brautigan for generously providing expression vectors encoding HA-PP6 subunits and anti-PP6 antibodies, Grace Gill for sharing mammalian expression vector encoding FLAG-SENP protein and bacterial expression vectors for GST-SUMO1 and -SUMO2, and Mark Zabriskie for encouragement and continuous support of this project. The Mass Spectrometry Facility at Oregon State University is supported by NIEHS, National Institutes of Health Center Grant ES000210 to the Environmental Health Sciences Center at Oregon State University.	AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bommhardt U, 1999, J IMMUNOL, V163, P715; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Enomoto T, 2011, J NEUROSCI, V31, P10159, DOI 10.1523/JNEUROSCI.1245-11.2011; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Golonzhka O, 2009, P NATL ACAD SCI USA, V106, P4278, DOI 10.1073/pnas.0900568106; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huang X, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-44; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li YJ, 2010, ONCOGENE, V29, P3509, DOI 10.1038/onc.2010.108; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Takahama Y, 1996, J IMMUNOL, V157, P1508; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Valin A, 2007, BIOCHEM SOC T, V35, P1393, DOI 10.1042/BST0351393; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Witty J, 2010, BIOCHEM J, V428, P247, DOI 10.1042/BJ20091948; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	70	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26971	26988		10.1074/jbc.M112.344176	http://dx.doi.org/10.1074/jbc.M112.344176			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700985	hybrid, Green Published			2022-12-28	WOS:000307386000045
J	Racioppi, L; Means, AR				Racioppi, Luigi; Means, Anthony R.			Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RUNX TRANSCRIPTION FACTORS; GRANULE CELL-DEVELOPMENT; MOLECULAR-CLONING; INFLAMMATORY RESPONSES; NEURONAL DEVELOPMENT; BODY-WEIGHT; FOOD-INTAKE; CAMKK-BETA; BONE MASS; CALMODULIN	Many cellular Ca-2+ -dependent signaling cascades utilize calmodulin (CaM) as the intracellular Ca2+ receptor. Ca2+/CaM binds and activates a plethora of enzymes, including CaM kinases (CaMKs). CaMKK2 is one of the most versatile of the CaMKs and will phosphorylate and activate CaMKI, CaMKIV, and AMP-activated protein kinase. Cell expression of CaMKK2 is limited, yet CaMKK2 is involved in regulating many important physiological and pathophysiological processes, including energy balance, adiposity, glucose homeostasis, hematopoiesis, inflammation, and cancer. Here, we explore known functions of CaMKK2 and discuss its potential as a target for therapeutic intervention.	[Racioppi, Luigi; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Racioppi, Luigi; Means, Anthony R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Racioppi, Luigi] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy	Duke University; Duke University; University of Naples Federico II	Racioppi, L (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	luigi.racioppi@duke.edu; tony.means@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022	racioppi, luigi/0000-0002-9207-6752; 	National Institutes of Health [GM033976, DK074701, 5U19-AI067798-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM033976 and DK074701 (to A. R. M.) and 5U19-AI067798-07 (to L. R.). This article is part of the Thematic Minireview Series on Calcium Function and Disease.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anderson KA, 2012, MOL ENDOCRINOL, V26, P281, DOI 10.1210/me.2011-1299; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Cao WG, 2011, RNA BIOL, V8, P1061, DOI 10.4161/rna.8.6.16691; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Colomer J., 2007, V45, P169; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; GutierrezRamos JC, 1997, IMMUNOL TODAY, V18, P329, DOI 10.1016/S0167-5699(97)01085-2; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hsu LS, 1998, J BIOMED SCI, V5, P141, DOI 10.1007/BF02258368; Hsu LS, 2001, J BIOL CHEM, V276, P31113, DOI 10.1074/jbc.M011720200; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Kukimoto-Niino M, 2011, J BIOL CHEM, V286, P22570, DOI 10.1074/jbc.M111.251710; Lam BS, 2011, BLOOD, V117, P1167, DOI 10.1182/blood-2010-05-286294; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Lim CT, 2011, REV ENDOCR METAB DIS, V12, P173, DOI 10.1007/s11154-011-9169-1; Lin FM, 2011, ENDOCRINOLOGY, V152, P3668, DOI 10.1210/en.2011-1107; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Metcalf D, 2007, STEM CELLS, V25, P2390, DOI 10.1634/stemcells.2007-0544; Michaelsen K, 2010, EUR J NEUROSCI, V32, P218, DOI 10.1111/j.1460-9568.2010.07341.x; Mizuno K, 2007, NEUROSCIENCE, V145, P393, DOI 10.1016/j.neuroscience.2006.11.056; Mizuno K, 2006, MOL CELL BIOL, V26, P9094, DOI 10.1128/MCB.01221-06; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peters M, 2003, J NEUROSCI, V23, P9752; Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Sakagami H, 2000, EUR J NEUROSCI, V12, P89, DOI 10.1046/j.1460-9568.2000.00883.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sato M, 2006, BIOCHEM BIOPH RES CO, V341, P304, DOI 10.1016/j.bbrc.2005.12.184; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Takemoto-Kimura S, 2010, EUR J NEUROSCI, V32, P224, DOI 10.1111/j.1460-9568.2010.07353.x; Teng EC, 2011, J LEUKOCYTE BIOL, V90, P897, DOI 10.1189/jlb.0311152; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Williams DL, 2011, J CLIN INVEST, V121, P2152, DOI 10.1172/JCI58027; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zagami CJ, 2009, J CELL BIOCHEM, V107, P1063, DOI 10.1002/jcb.22221; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	82	183	188	5	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31658	31665		10.1074/jbc.R112.356485	http://dx.doi.org/10.1074/jbc.R112.356485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22778263	Green Published, hybrid			2022-12-28	WOS:000309059400007
J	Bourens, M; Dabir, DV; Tienson, HL; Sorokina, I; Koehler, CM; Barrientos, A				Bourens, Myriam; Dabir, Deepa V.; Tienson, Heather L.; Sorokina, Irina; Koehler, Carla M.; Barrientos, Antoni			Role of Twin Cys-Xaa(9)-Cys Motif Cysteines in Mitochondrial Import of the Cytochrome c Oxidase Biogenesis Factor Cmc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE; PROTEIN IMPORT; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; MIA40; PATHWAY; ERV1; RECOGNITION; OXIDATION	The Mia40 import pathway facilitates the import and oxidative folding of cysteine-rich protein substrates into the mitochondrial intermembrane space. Here we describe the in vitro and in organello oxidative folding of Cmc1, a twin CX9C-containing substrate, which contains an unpaired cysteine. In vitro, Cmc1 can be oxidized by the import receptor Mia40 alone when in excess or at a lower rate by only the sulfhydryl oxidase Erv1. However, physiological and efficient Cmc1 oxidation requires Erv1 and Mia40. Cmc1 forms a stable intermediate with Mia40 and is released from this interaction in the presence of Erv1. The three proteins are shown to form a ternary complex in mitochondria. Our results suggest that this mechanism facilitates efficient formation of multiple disulfides and prevents the formation of non-native disulfide bonds.	[Bourens, Myriam; Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Dabir, Deepa V.; Tienson, Heather L.; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sorokina, Irina] Midwest Bio Serv LLC, Overland Pk, KS 66211 USA	University of Miami; University of Miami; University of California System; University of California Los Angeles	Barrientos, A (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1600 NW 10th Ave,RMSB 2067, Miami, FL 33136 USA.	abarrientos@med.maimi.edu		Sorokina, Irina/0000-0003-1531-1832	National Institutes of Health [GM071775A, GM061721, GM07185, 1F32GM084568-01A1]; Muscular Dysthrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R01GM071775, F32GM084568, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dysthrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071775A (to A. B.), GM061721 (to C. M. K.), GM07185 (to H. L. T.), and 1F32GM084568-01A1 (to D. V. D.). This work was also supported by a Muscular Dysthrophy Association Research Grant (to A. B.).	Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Horn D, 2010, J BIOL CHEM, V285, P15088, DOI 10.1074/jbc.M110.104786; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stuart R.A., 2007, CURRENT PROTOCOLS CE; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Tie JK, 2004, J BIOL CHEM, V279, P54079, DOI 10.1074/jbc.M408945200; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062	30	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31258	31269		10.1074/jbc.M112.383562	http://dx.doi.org/10.1074/jbc.M112.383562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22767599	hybrid, Green Published			2022-12-28	WOS:000308791300038
J	Oh, HM; Yu, CR; Dambuza, I; Marrero, B; Egwuagu, CE				Oh, Hyun-Mee; Yu, Cheng-Rong; Dambuza, Ivy; Marrero, Bernadette; Egwuagu, Charles E.			STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-27; P27(KIP1); SURVIVAL; BINDING	An important feature of the adaptive immune response is its remarkable capacity to regulate the duration of inflammatory responses, and effector T cells have been shown to limit excessive immune responses by producing anti-inflammatory cytokines such as IL-10 and IL-27. However, how anti-inflammatory cytokines mediate their suppressive activities is not well understood. In this study, we show that STAT3 contributes to mechanisms that control the duration of T cell proliferation by regulating the subcellular location of FoxO1 and FoxO3a, two Class O Forkhead transcription factors that mediate lymphocyte quiescence and inhibit T cell activation. We show that active FoxO1 and FoxO3a reside exclusively in the nucleus of naive T cells whereas inactive pFoxO1 and pFoxO3a were most abundant in activated T cells and sequestered in their cytoplasm in association with unphosphorylated STAT3 (U-STAT3) and 14-3-3. We further show that FoxO1/FoxO3a rapidly relocalized into the nucleus in response to pSTAT3 activation by IL-6 or IL-10, and the accumulation of FoxO1/FoxO3a in their nuclei coincided with increased expression of p27(Kip1) and p21(WAF1). STAT3 inhibitors completely abrogated cytokine-induced translocation of FoxO1/FoxO3a into the nucleus. In naive or resting STAT3-deficient T cells, expression of pFoxO1/pFoxO3a was predominantly in the cytoplasm and correlated with defects in p27(Kip1) and p21(WAF1) expression, suggesting requirement of STAT3 for importation or retention of FoxO in the nucleus and attenuation of lymphocyte proliferation. Taken together, these results suggest that U-STAT3 collaborates with 14-3-3 to sequester pFoxO1/pFoxO3a in cytoplasm and thus prolong T cell activation, whereas pSTAT3 activation by anti-inflammatory cytokines would curtail the duration of TCR activation and re-establish lymphocyte quiescence by inducing nuclear localization of FoxO1/FoxO3a and FoxO-mediated expression of growth-inhibitory proteins.	[Egwuagu, Charles E.] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Oh, Hyun-Mee] Korea Res Inst Biosci & BioTechnol, Bioind Proc Res Ctr, Jeongeup Si 580185, Jeonbuk, South Korea	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, Immunol Lab, NIH, Bldg 10,Rm 10N109A,10 Ctr Dr, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Dambuza, Ivy/M-2484-2019	Yu, Cheng-Rong/0000-0001-7246-0362	National Institutes of Health NEI Research Program; National Institutes of Health Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000315] Funding Source: NIH RePORTER	National Institutes of Health NEI Research Program; National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health NEI and Intramural Research Programs.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gao S Paul, 2006, Sci STKE, V2006, ppe30, DOI 10.1126/stke.3432006pe30; Kaplan MH, 1998, MOL CELL BIOL, V18, P1996, DOI 10.1128/MCB.18.4.1996; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu Jun O, 2005, Sci STKE, V2005, pre1; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh HM, 2011, J BIOL CHEM, V286, P30888, DOI 10.1074/jbc.M111.253500; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029742; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029554; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	29	64	67	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30436	30443		10.1074/jbc.M112.359661	http://dx.doi.org/10.1074/jbc.M112.359661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22761423	Green Published, hybrid			2022-12-28	WOS:000308579800036
J	Walls, KC; Coskun, P; Gallegos-Perez, JL; Zadourian, N; Freude, K; Rasool, S; Blurton-Jones, M; Green, KN; LaFerla, FM				Walls, Ken Carlson; Coskun, Pinar; Gallegos-Perez, Jose Luis; Zadourian, Nineli; Freude, Kristine; Rasool, Suhail; Blurton-Jones, Mathew; Green, Kim Nicholas; LaFerla, Frank Michael			Swedish Alzheimer Mutation Induces Mitochondrial Dysfunction Mediated by HSP60 Mislocalization of Amyloid Precursor Protein (APP) and Beta-Amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; MOLECULAR CHAPERONES; DISEASE; ACCUMULATION; TAU; PATHOGENESIS; AGGREGATION; STRESS; BRAIN; MODEL	Alzheimer disease (AD) is a complex disorder that involves numerous cellular and subcellular alterations including impairments in mitochondrial homeostasis. To better understand the role of mitochondrial dysfunction in the pathogenesis of AD, we analyzed brains from clinically well-characterized human subjects and from the 3xTg-AD mouse model of AD. We find A beta and critical components of the gamma-secretase complex, presenilin-1, -2, and nicastrin, accumulate in the mitochondria. We used a proteomics approach to identify binding partners and show that heat shock protein 60 (HSP60), a molecular chaperone localized to mitochondria and the plasma membrane, specifically associates with APP. We next generated stable neural cell lines expressing human wild-type or Swedish APP, and provide corroborating in vitro evidence that HSP60 mediates translocation of APP to the mitochondria. Viral-mediated shRNA knockdown of HSP60 attenuates APP and A beta mislocalization to the mitochondria. Our findings identify a novel interaction between APP and HSP60, which accounts for its translocation to the mitochondria.	[Walls, Ken Carlson; Coskun, Pinar; Gallegos-Perez, Jose Luis; Blurton-Jones, Mathew; Green, Kim Nicholas; LaFerla, Frank Michael] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Walls, Ken Carlson; Coskun, Pinar; Zadourian, Nineli; Freude, Kristine; Blurton-Jones, Mathew; Green, Kim Nicholas; LaFerla, Frank Michael] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Rasool, Suhail] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Walls, KC (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	kwalls@uci.edu; laferla@uci.edu	; Gallegos-Perez, Jose-Luis/I-5200-2013	Blurton-Jones, Mathew/0000-0002-7770-7157; Gallegos-Perez, Jose-Luis/0000-0002-7037-9736; Freude, Kristine/0000-0001-9480-2386	National Institutes of Health [021928, AG027544]; NATIONAL INSTITUTE ON AGING [R01AG027544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 021928 and AG027544 awarded (to F. M. L.).	Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728; Gupta R.S., 2008, NOVARTIS FDN S, V291, P137; Gupta Radhey S, 2008, Novartis Found Symp, V291, P59; GUPTA RS, 1990, TRENDS BIOCHEM SCI, V15, P415, DOI 10.1016/0968-0004(90)90276-H; Gupta RS, 2008, NOVART FDN SYMP, V291, P69; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sultan AS, 1997, J BIOL CHEM, V272, P2866, DOI 10.1074/jbc.272.5.2866; Swerdlow RH, 2002, INT REV NEUROBIOL, V53, P341; Swerdlow RH, 2007, CLIN INTERV AGING, V2, P347; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Walls KC, 2009, J NEUROPATH EXP NEUR, V68, P1326, DOI 10.1097/NEN.0b013e3181c3b9be; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yang TT, 2009, MECH AGEING DEV, V130, P592, DOI 10.1016/j.mad.2009.07.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106	38	61	62	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30317	30327		10.1074/jbc.M112.365890	http://dx.doi.org/10.1074/jbc.M112.365890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22753410	Green Published, hybrid			2022-12-28	WOS:000308579800024
J	Zhang, JZ; Yarov-Yarovoy, V; Scheuer, T; Karbat, I; Cohen, L; Gordon, D; Gurevitz, M; Catterall, WA				Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael; Catterall, William A.			Mapping the Interaction Site for a beta-Scorpion Toxin in the Pore Module of Domain III of Voltage-gated Na+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; K+ CHANNEL; MOLECULAR DETERMINANTS; CRYSTAL-STRUCTURE; RECEPTOR-SITE; SENSOR; PREDICTION; LOOP; ROSETTA; SPECIFICITY	Activation of voltage-gated sodium (Na-v) channels initiates and propagates action potentials in electrically excitable cells. beta-Scorpion toxins, including toxin IV from Centruroides suffusus suffusus (CssIV), enhance activation of Na-V channels. CssIV stabilizes the voltage sensor in domain II in its activated state via a voltage-sensor trapping mechanism. Amino acid residues required for the action of CssIV have been identified in the S1-S2 and S3-S4 extracellular loops of domain II. The extracellular loops of domain III are also involved in toxin action, but individual amino acid residues have not been identified. We used site-directed mutagenesis and voltage clamp recording to investigate amino acid residues of domain III that are involved in CssIV action. In the IIISS2-S6 loop, five substitutions at four positions altered voltage-sensor trapping by CssIV(E15A). Three substitutions (E1438A, D1445A, and D1445Y) markedly decreased voltage-sensor trapping, whereas the other two substitutions (N1436G and L1439A) increased voltage-sensor trapping. These bidirectional effects suggest that residues in IIISS2-S6 make both positive and negative interactions with CssIV. N1436G enhanced voltage-sensor trapping via increased binding affinity to the resting state, whereas L1439A increased voltage-sensor trapping efficacy. Based on these results, a three-dimensional model of the toxin-channel interaction was developed using the Rosetta modeling method. These data provide additional molecular insight into the voltage-sensor trapping mechanism of toxin action and define a three-point interaction site for beta-scorpion toxins on Na-V channels. Binding of alpha- and beta-scorpion toxins to two distinct, pseudo-symmetrically organized receptor sites on Na-V channels acts synergistically to modify channel gating and paralyze prey.	[Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	National Institutes of Health Research [U01 NS058039, R01NS15751]; Binational Agricultural Research and Development Fund of the United States and Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039, R01NS015751] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Agricultural Research and Development Fund of the United States and Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants U01 NS058039 (to W. A. C. and M. G.) and R01NS15751 (to W. A. C.), and a grant from the Binational Agricultural Research and Development Fund of the United States and Israel (to M. G. and W. A. C.).	Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Karbat I, 2010, J BIOL CHEM, V285, P30531, DOI 10.1074/jbc.M110.150888; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sheets MF, 1999, BIOPHYS J, V77, P747, DOI 10.1016/S0006-3495(99)76929-8; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509	32	49	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30719	30728		10.1074/jbc.M112.370742	http://dx.doi.org/10.1074/jbc.M112.370742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22761417	hybrid, Green Published			2022-12-28	WOS:000308579800061
J	Domashevskiy, AV; Miyoshi, H; Goss, DJ				Domashevskiy, Artem V.; Miyoshi, Hiroshi; Goss, Dixie J.			Inhibition of Pokeweed Antiviral Protein (PAP) by Turnip Mosaic Virus Genome-linked Protein (VPg)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; CAP-INDEPENDENT TRANSLATION; TOBACCO ETCH VIRUS; RICIN-A-CHAIN; INITIATION-FACTORS; MESSENGER-RNA; VIRAL RNAS; SARCIN/RICIN LOOP; BINDING; POTYVIRUS	Pokeweed antiviral protein (PAP) from Phytolacca americana is a ribosome-inactivating protein (RIP) and an RNA N-glycosidase that removes specific purine residues from the sarcin/ricin loop of large rRNA, arresting protein synthesis at the translocation step. PAP is also a cap-binding protein and is a potent antiviral agent against many plant, animal, and human viruses. To elucidate the mechanism of RNA depurination, and to understand how PAP recognizes and targets various RNAs, the interactions between PAP and turnip mosaic virus genome-linked protein (VPg) were investigated. VPg can function as a cap analog in cap-independent translation and potentially target PAP to uncapped IRES-containing RNA. In this work, fluorescence spectroscopy and HPLC techniques were used to quantitatively describe PAP depurination activity and PAP-VPg interactions. PAP binds to VPg with high affinity (29.5 nM); the reaction is enthalpically driven and entropically favored. Further, VPg is a potent inhibitor of PAP depurination of RNA in wheat germ lysate and competes with structured RNA derived from tobacco etch virus for PAP binding. VPg may confer an evolutionary advantage by suppressing one of the plant defense mechanisms and also suggests the possible use of this protein against the cytotoxic activity of ribosome-inactivating proteins.	[Domashevskiy, Artem V.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Domashevskiy, Artem V.; Goss, Dixie J.] CUNY Grad Ctr, New York, NY 10065 USA; [Domashevskiy, Artem V.] CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA; [Domashevskiy, Artem V.] CUNY Grad Ctr, New York, NY 10019 USA; [Miyoshi, Hiroshi] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Saint Marianna University	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Domashevskiy, Artem/0000-0001-7511-8191; Miyoshi, Hiroshi/0000-0002-0489-9848	National Science Foundation [MCB 0814051, MCB 1118320]; PSC-CUNY Faculty Awards; CUNY Collaborative Award; Ministry of Education, Science and Culture of Japan [2368042]; Div Of Molecular and Cellular Bioscience [1118320] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); PSC-CUNY Faculty Awards; CUNY Collaborative Award; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB 0814051 and MCB 1118320 (to D. J. G.) and MCB 0919626 (to D. E. F.). This work was also supported by PSC-CUNY Faculty Awards (to D. J. G. and D. E. F.), a CUNY Collaborative Award (to D. J. G. and D. E. F.), and Grant-in-aid for Scientific Research 2368042 from the Ministry of Education, Science and Culture of Japan (to H. M.).	ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; Baldwin AE, 2009, BBA-GENE REGUL MECH, V1789, P109, DOI 10.1016/j.bbagrm.2008.09.001; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; BONNESS MS, 1994, PLANT J, V5, P173, DOI 10.1046/j.1365-313X.1994.05020173.x; BRIGOTTI M, 1989, BIOCHEM J, V257, P723, DOI 10.1042/bj2570723; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P6977, DOI 10.1021/bi00242a024; CHEN ZC, 1993, PHYSIOL MOL PLANT P, V42, P249, DOI 10.1006/pmpp.1993.1023; DALLAL JA, 1978, FEBS LETT, V89, P257, DOI 10.1016/0014-5793(78)80230-0; DUGGAR B. M., 1925, Ann. Mo. Bot. Gdn., V12, P359, DOI 10.2307/2394061; Firpo MA, 1996, J BIOL CHEM, V271, P4693; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; GOSS DJ, 1984, BIOCHEMISTRY-US, V23, P6522, DOI 10.1021/bi00321a038; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; Hudak KA, 1999, J BIOL CHEM, V274, P3859, DOI 10.1074/jbc.274.6.3859; Hudak KA, 2002, RNA, V8, P1148, DOI 10.1017/S1355838202026638; Hudak KA, 2001, VIROLOGY, V279, P292, DOI 10.1006/viro.2000.0647; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; KIM KS, 1969, VIROLOGY, V37, P297, DOI 10.1016/0042-6822(69)90213-X; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, p[52, 277, 530]; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; LEVINE RL, 1977, CLIN CHEM, V23, P2292; Mansouri S, 2006, RNA, V12, P1683, DOI 10.1261/rna.70306; MIURA K, 1991, ANAL BIOCHEM, V196, P84, DOI 10.1016/0003-2697(91)90121-9; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; MURPHY JF, 1991, J VIROL, V65, P511, DOI 10.1128/JVI.65.1.511-513.1991; Nielsen K, 2001, ANNU REV PLANT PHYS, V52, P785, DOI 10.1146/annurev.arplant.52.1.785; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; OBRIG TG, 1973, ARCH BIOCHEM BIOPHYS, V155, P278, DOI 10.1016/0003-9861(73)90116-1; OSBORN RW, 1990, EUR J BIOCHEM, V193, P401, DOI 10.1111/j.1432-1033.1990.tb19353.x; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; READY MP, 1986, P NATL ACAD SCI USA, V83, P5053, DOI 10.1073/pnas.83.14.5053; Ren JH, 1996, NUCLEIC ACIDS RES, V24, P3629, DOI 10.1093/nar/24.18.3629; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; Tumer NE, 1999, CURR TOP MICROBIOL, V240, P139; Tumer NE, 1998, J VIROL, V72, P1036, DOI 10.1128/JVI.72.2.1036-1042.1998; USSERY MA, 1977, ANN NY ACAD SCI, V284, P431, DOI 10.1111/j.1749-6632.1977.tb21979.x; Vivanco JM, 2003, PHYTOPATHOLOGY, V93, P588, DOI 10.1094/PHYTO.2003.93.5.588; Wang M, 2006, NUCLEIC ACIDS RES, V34, P1174, DOI 10.1093/nar/gkj520; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; ZAMBONI M, 1989, BIOCHEM J, V259, P639, DOI 10.1042/bj2590639; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; ZHANG Y, 1991, AM J PHYSIOL, V260, pG658, DOI 10.1152/ajpgi.1991.260.4.G658	52	16	16	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29729	29738		10.1074/jbc.M112.367581	http://dx.doi.org/10.1074/jbc.M112.367581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773840	Green Published, hybrid			2022-12-28	WOS:000308286900049
J	Smith, EC; Gregory, SM; Tamm, LK; Creamer, TP; Dutch, RE				Smith, Everett Clinton; Gregory, Sonia M.; Tamm, Lukas K.; Creamer, Trevor P.; Dutch, Rebecca Ellis			Role of Sequence and Structure of the Hendra Fusion Protein Fusion Peptide in Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE VIRUS FUSION; INFLUENZA HEMAGGLUTININ; F-PROTEIN; NUCLEOTIDE-SEQUENCE; SENDAI-VIRUS; NIPAH VIRUS; GLYCINE RESIDUES; LIPID-BILAYERS; VIRAL FUSION; CATHEPSIN-L	Viral fusion proteins are intriguing molecular machines that undergo drastic conformational changes to facilitate virus-cell membrane fusion. During fusion a hydrophobic region of the protein, termed the fusion peptide (FP), is inserted into the target host cell membrane, with subsequent conformational changes culminating in membrane merger. Class I fusion proteins contain FPs between 20 and 30 amino acids in length that are highly conserved within viral families but not between. To examine the sequence dependence of the Hendra virus (HeV) fusion (F) protein FP, the first eight amino acids were mutated first as double, then single, alanine mutants. Mutation of highly conserved glycine residues resulted in inefficient F protein expression and processing, whereas substitution of valine residues resulted in hypofusogenic F proteins despite wild-type surface expression levels. Synthetic peptides corresponding to a portion of the HeV F FP were shown to adopt an alpha-helical secondary structure in dodecylphosphocholine micelles and small unilamellar vesicles using circular dichroism spectroscopy. Interestingly, peptides containing point mutations that promote lower levels of cell-cell fusion within the context of the whole F protein were less alpha-helical and induced less membrane disorder in model membranes. These data represent the first extensive structure-function relationship of any paramyxovirus FP and demonstrate that the HeV F FP and potentially other paramyxovirus FPs likely require an alpha-helical structure for efficient membrane disordering and fusion.	[Dutch, Rebecca Ellis] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Creamer, Trevor P.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Gregory, Sonia M.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Gregory, Sonia M.; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Kentucky; University of Kentucky; University of Virginia; University of Virginia	Dutch, RE (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	rdutc2@uky.edu	Creamer, Trevor P/A-5252-2008		National Institutes of Health Grants [R01AI051517, 2P20 RR020171, R37AI30557]; Div Of Molecular and Cellular Bioscience [0843551] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030557, R01AI051517, R01AI030557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI051517 and 2P20 RR020171 (National Center for Research Resources; to R. E. D. and T. P. C.) and R37AI30557 ( to L. K. T.).	ASANO K, 1985, BIOCHEM INT, V10, P115; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Carter JR, 2005, J VIROL, V79, P7922, DOI 10.1128/JVI.79.12.7922-7925.2005; Diederich S, 2005, J BIOL CHEM, V280, P29899, DOI 10.1074/jbc.M504598200; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; HORVATH CM, 1992, J VIROL, V66, P2443, DOI 10.1128/JVI.66.4.2443-2455.1992; HSU MC, 1984, P NATL ACAD SCI-BIOL, V81, P7732, DOI 10.1073/pnas.81.24.7732; Kim YH, 2011, P NATL ACAD SCI USA, V108, P20992, DOI 10.1073/pnas.1116034108; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; LI SC, 1992, INT J PEPT PROT RES, V40, P243; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Li YL, 2003, BIOCHEMISTRY-US, V42, P7245, DOI 10.1021/bi0341760; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Martin I, 1996, J VIROL, V70, P298, DOI 10.1128/JVI.70.1.298-304.1996; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MCGINNES LW, 1986, VIRUS RES, V5, P343, DOI 10.1016/0168-1702(86)90028-6; MERSON JR, 1988, VIROLOGY, V167, P97, DOI 10.1016/0042-6822(88)90058-X; Meulendyke KA, 2005, J VIROL, V79, P12643, DOI 10.1128/JVI.79.20.12643-12649.2005; Moll M, 2004, J VIROL, V78, P9705, DOI 10.1128/JVI.78.18.9705-9712.2004; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; NIEVA JL, 1994, BIOCHEMISTRY-US, V33, P3201, DOI 10.1021/bi00177a009; NOVICK SL, 1988, P NATL ACAD SCI USA, V85, P7433, DOI 10.1073/pnas.85.20.7433; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; PATERSON RG, 1984, P NATL ACAD SCI-BIOL, V81, P6706, DOI 10.1073/pnas.81.21.6706; PATERSON RG, 1987, CELL, V48, P441, DOI 10.1016/0092-8674(87)90195-4; Peisajovich SG, 2000, BIOCHEMISTRY-US, V39, P1826, DOI 10.1021/bi991887i; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; RAPAPORT D, 1994, J BIOL CHEM, V269, P15124; RICHARDSON C, 1986, VIROLOGY, V155, P508, DOI 10.1016/0042-6822(86)90212-6; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Saez-Cirion A, 2002, BBA-BIOMEMBRANES, V1564, P57, DOI 10.1016/S0005-2736(02)00400-5; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Sergel TA, 2001, J VIROL, V75, P7934, DOI 10.1128/JVI.75.17.7934-7943.2001; SERGELGERMANO T, 1994, J VIROL, V68, P7654, DOI 10.1128/JVI.68.11.7654-7658.1994; Smith EC, 2010, J VIROL, V84, P10928, DOI 10.1128/JVI.01108-10; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; VARSANYI TM, 1987, VIROLOGY, V157, P241, DOI 10.1016/0042-6822(87)90335-7; WAXHAM MN, 1987, VIROLOGY, V159, P381, DOI 10.1016/0042-6822(87)90477-6; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Yang J, 2001, BIOCHEMISTRY-US, V40, P8126, DOI 10.1021/bi0100283; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102	66	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					30035	30048		10.1074/jbc.M112.367862	http://dx.doi.org/10.1074/jbc.M112.367862			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761418	hybrid, Green Published			2022-12-28	WOS:000308286900076
J	Hudson, RP; Chong, PA; Protasevich, II; Vernon, R; Noy, E; Bihler, H; An, JL; Kalid, O; Sela-Culang, I; Mense, M; Senderowitz, H; Brouillette, CG; Forman-Kay, JD				Hudson, Rhea P.; Chong, P. Andrew; Protasevich, Irina I.; Vernon, Robert; Noy, Efrat; Bihler, Hermann; An, Jian Li; Kalid, Ori; Sela-Culang, Inbal; Mense, Martin; Senderowitz, Hanoch; Brouillette, Christie G.; Forman-Kay, Julie D.			Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; DELTA-F508 CFTR; IN-VITRO; R-DOMAIN; HIGH-THROUGHPUT; PROTEIN-KINASE; CL-CHANNEL; MUTATION; PHOSPHORYLATION; IDENTIFICATION	Deletion of Phe-508 (F508del) in the first nucleotide binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) leads to defects in folding and channel gating. NMR data on human F508del NBD1 indicate that an H620Q mutant, shown to increase channel open probability, and the dual corrector/potentiator CFFT-001 similarly disrupt interactions between beta-strands S3, S9, and S10 and the C-terminal helices H8 and H9, shifting a preexisting conformational equilibrium from helix to coil. CFFT-001 appears to interact with beta-strands S3/S9/S10, consistent with docking simulations. Decreases in T-m from differential scanning calorimetry with H620Q or CFFT-001 suggest direct compound binding to a less thermostable state of NBD1. We hypothesize that, in full-length CFTR, shifting the conformational equilibrium to reduce H8/H9 interactions with the uniquely conserved strands S9/S10 facilitates release of the regulatory region from the NBD dimerization interface to promote dimerization and thereby increase channel open probability. These studies enabled by our NMR assignments for F508del NBD1 provide a window into the conformational fluctuations within CFTR that may regulate function and contribute to folding energetics.	[Hudson, Rhea P.; Chong, P. Andrew; Vernon, Robert; Forman-Kay, Julie D.] Univ Toronto, Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5S 1A8, Canada; [Hudson, Rhea P.; Chong, P. Andrew; Vernon, Robert; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Protasevich, Irina I.; An, Jian Li; Brouillette, Christie G.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Noy, Efrat; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel; [Bihler, Hermann; Mense, Martin] Cyst Fibrosis Fdn Therapeut, Bedford, MA 01730 USA; [Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Kalid, Ori; Sela-Culang, Inbal] Epix Pharmaceut, Lexington, MA 02421 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Alabama System; University of Alabama Birmingham; Bar Ilan University; Cystic Fibrosis Foundation; University of Alabama System; University of Alabama Birmingham	Forman-Kay, JD (corresponding author), Hosp Sick Children, Rm 3401,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	forman@sickkids.ca		Bihler, Hermann/0000-0002-8167-1548; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation Therapeutics [FORMAN05XX0, BROUIL08XX0, BROUIL07XX0, SENDER09XX0]; Cystic Fibrosis Canada	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Foundation Therapeutics Grants FORMAN05XX0 (to J. D. F.-K.), BROUIL08XX0 and BROUIL07XX0 (to C. G. B.), and SENDER09XX0 (to H. S.) and Cystic Fibrosis Canada (J. D. F.-K.).	Accelrys, 2005, DISC STUD MOD ENV; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, SCHROD SUIT 2010 IND; [Anonymous], 2010, MAESTR VERS 9 1; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Billet A, 2010, J BIOL CHEM, V285, P22132, DOI 10.1074/jbc.M110.120683; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Chang P., 2010, Patent WO, Patent No. [2010/151747 A1, 2010151747]; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chong P. A., 2012, CYSTIC FIBROSIS MOL; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goddard T. D., 2008, SPARKY 3 VERSION 3; Hadida R. S., 2007, Patent WO, Patent No. [2007/021982 A2, 2007021982]; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2011, METHODS MOL BIOL, V741, P377, DOI 10.1007/978-1-61779-117-8_25; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rule GS, 2006, FUNDAMENTALS PROTEIN; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Seavilleklein G, 2008, AM J PHYSIOL-CELL PH, V295, pC1366, DOI 10.1152/ajpcell.00034.2008; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Van Goor F, 2011, PEDIATR PULM, P215; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vankeerberghen A, 1998, FEBS LETT, V437, P1, DOI 10.1016/S0014-5793(98)01042-4; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wei L, 1998, FEBS LETT, V439, P121, DOI 10.1016/S0014-5793(98)01351-9; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	69	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28480	28494		10.1074/jbc.M112.371138	http://dx.doi.org/10.1074/jbc.M112.371138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722932	Green Published, hybrid			2022-12-28	WOS:000308074600023
J	Oberoi-Khanuja, TK; Karreman, C; Larisch, S; Rapp, UR; Rajalingam, K				Oberoi-Khanuja, Tripat Kaur; Karreman, Christiaan; Larisch, Sarit; Rapp, Ulf R.; Rajalingam, Krishnaraj			Role of Melanoma Inhibitor of Apoptosis (ML-IAP) Protein, a Member of the Baculoviral IAP Repeat (BIR) Domain Family, in the Regulation of C-RAF Kinase and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENCING LIVIN GENE; NF-KAPPA-B; LUNG-CANCER; TRANSCRIPTIONAL REGULATOR; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; DEGRADATION; RESISTANCE; PATHWAY; IDENTIFICATION	Inhibitor of apoptosis (IAPs) proteins are characterized by the presence of evolutionarily conserved baculoviral inhibitor of apoptosis repeat (BIR) domains, predominantly known for their role in inhibiting caspases and, thereby, apoptosis. We have shown previously that multi-BIR domain-containing IAPs, cellular IAPs, and X-linked IAP can control tumor cell migration by directly regulating the protein stability of C-RAF kinase. Here, we extend our observations to a single BIR domain containing IAP family member melanoma- IAP (ML-IAP). We show that ML-IAP can directly bind to C-RAF and that ML-IAP depletion leads to an increase in C-RAF protein levels, MAPK activation, and cell migration in melanoma cells. Thus, our results unveil a thus far unknown role for ML-IAP in controlling C-RAF stability and cell migration.	[Oberoi-Khanuja, Tripat Kaur; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, DFG,Emmy Noether Grp, D-60590 Frankfurt, Germany; [Karreman, Christiaan] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Larisch, Sarit] Univ Haifa, Fac Nat Sci, Dept Biol, Cell Death Res Lab, IL-31905 Haifa, Israel; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	German Research Foundation (DFG); Goethe University Frankfurt; University of Konstanz; University of Haifa; Max Planck Society	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, DFG,Emmy Noether Grp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	krishna@biochem2.de		Oberoi, Tripat Kaur/0000-0001-9299-9496	Emmy Noether Program from the Deutsche Forschungs Gemeinschaft [RA1739/1-1]	Emmy Noether Program from the Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	This work was supported by Emmy Noether Program Grant RA1739/1-1 from the Deutsche Forschungs Gemeinschaft (to K. R.).	Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Blankenship JW, 2008, BIOCHEM J, V417, P1; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Crnkovic-Mertens I, 2007, CELL MOL LIFE SCI, V64, P1137, DOI 10.1007/s00018-007-6510-7; Dasgupta A, 2009, ONCOL REP, V22, P831, DOI 10.3892/or_00000506; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Gazzaniga P, 2003, ANN ONCOL, V14, P85, DOI 10.1093/annonc/mdg002; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Kempkensteffen C, 2007, TUMOR BIOL, V28, P132, DOI 10.1159/000103008; Kim DK, 2005, PEDIATR DEVEL PATHOL, V8, P621, DOI 10.1007/s10024-005-4108-3; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun JG, 2011, CANCER BIOTHER RADIO, V26, P585, DOI 10.1089/cbr.2011.0962; Tanabe H, 2004, LUNG CANCER, V46, P299, DOI 10.1016/j.lungcan.2004.05.002; Vaux DL, 2005, CELL DEATH DIFFER, V12, P1205, DOI 10.1038/sj.cdd.4401696; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wang H, 2007, ACTA PHARMACOL SIN, V28, P1968, DOI 10.1111/j.1745-7254.2007.00724.x; Wang R, 2008, CANCER GENE THER, V15, P402, DOI 10.1038/cgt.2008.16; Wang XD, 2010, CLIN BIOCHEM, V43, P655, DOI 10.1016/j.clinbiochem.2010.02.004; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu HH, 2010, CLIN CANCER RES, V16, P5200, DOI 10.1158/1078-0432.CCR-10-0020; Yuan BQ, 2012, J NEURO-ONCOL, V107, P81, DOI 10.1007/s11060-011-0728-9; Yuan D, 2007, MOL CELL BIOCHEM, V306, P171, DOI 10.1007/s11010-007-9567-6; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang QP, 2004, CANCER RES, V64, P7579, DOI 10.1158/0008-5472.CAN-04-0641	46	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28445	28455		10.1074/jbc.M112.341297	http://dx.doi.org/10.1074/jbc.M112.341297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22711539	Green Published, hybrid			2022-12-28	WOS:000308074600020
J	Young, ET; Zhang, C; Shokat, KM; Parua, PK; Braun, KA				Young, Elton T.; Zhang, Chao; Shokat, Kevan M.; Parua, Pabitra K.; Braun, Katherine A.			The AMP-activated Protein Kinase Snf1 Regulates Transcription Factor Binding, RNA Polymerase II Activity, and mRNA Stability of Glucose-repressed Genes in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; DIAUXIC SHIFT; YEAST; DECAY; ADR1; EXPRESSION; TURNOVER; CHROMATIN; PROMOTER; CAT8	AMP-activated protein kinase, the "energy sensor of the cell," responds to low cellular energy stores by regulating enzymes and transcription factors that allow the cell to adapt to limiting nutritional conditions. Snf1, the yeast ortholog of AMP-activated protein kinase, has an essential role in respiratory metabolism in Saccharomyces cerevisiae that includes activating the transcription factor Adr1. How Snf1 regulates Adr1 activity is poorly understood. We used an analog-sensitive allele, SNF1(as)(I132G), that is inhibited by 2-naphthylmethyl pyrazolopyrimidine 1 to study the role of Snf1 in transcriptional regulation of glucose-repressible genes. When Snf1(as) was inhibited at the time of glucose depletion, there was a promoter-specific response with some Snf1-dependent genes being activated by low levels of inhibitor, whereas all Snf1-dependent genes were inhibited at high levels. Transcript accumulation was more sensitive to Snf1(as) inhibition than Adr1 or RNA polymerase (pol) II binding or acetylation of promoter nucleosomes. When Snf1(as) was inhibited after gene activation, Adr1 and RNA pol II remained at promoters, and RNA pol II remained in the ORF with associated nascent transcripts. However, cytoplasmic mRNAs were lost at a rapid rate compared with their decay following chemical or genetic inactivation of RNA pol II. In conclusion, Snf1 appears to affect multiple steps in gene regulation, including transcription factor binding, RNA polymerase II activity, and cytoplasmic mRNA stability.	[Young, Elton T.; Parua, Pabitra K.; Braun, Katherine A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zhang, Chao] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Southern California; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Young, ET (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA.	ety@uw.edu		Parua, Pabitra/0000-0002-1125-4052	National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26079 (to E. T. Y.).	Abate G, 2012, BBA-GENE REGUL MECH, V1819, P419, DOI 10.1016/j.bbagrm.2012.01.009; Andrade RP, 2005, BIOCHEM BIOPH RES CO, V332, P254, DOI 10.1016/j.bbrc.2005.04.119; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; BLUMBERG H, 1988, MOL CELL BIOL, V8, P1868, DOI 10.1128/MCB.8.5.1868; BOSS JM, 1980, J BIOL CHEM, V255, P8623; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; Cherkasova V, 2010, MOL CELL BIOL, V30, P2862, DOI 10.1128/MCB.00183-10; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; de la Cruz BJ, 2002, YEAST, V19, P887, DOI 10.1002/yea.884; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dombek KM, 2004, J BIOL CHEM, V279, P39165, DOI 10.1074/jbc.M400433200; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Infante JJ, 2011, MOL MICROBIOL, V80, P407, DOI 10.1111/j.1365-2958.2011.07583.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Lavoie M, 2012, NUCLEIC ACIDS RES, V40, P871, DOI 10.1093/nar/gkr759; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; MERCADO JJ, 1994, EUR J BIOCHEM, V224, P473, DOI 10.1111/j.1432-1033.1994.00473.x; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Munchel SE, 2011, MOL BIOL CELL, V22, P2787, DOI 10.1091/mbc.E11-01-0028; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; PALMITER RD, 1973, J BIOL CHEM, V248, P8260; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; Passos DO, 2008, METHOD ENZYMOL, V448, P409, DOI 10.1016/S0076-6879(08)02620-7; Prieto S, 2000, J BIOL CHEM, V275, P14155, DOI 10.1074/jbc.275.19.14155; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Scheffler IE, 1998, INT J BIOCHEM CELL B, V30, P1175, DOI 10.1016/S1357-2725(98)00086-7; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shirra MK, 2008, J BIOL CHEM, V283, P35889, DOI 10.1074/jbc.M805325200; Sloan JS, 1999, J BIOL CHEM, V274, P37575, DOI 10.1074/jbc.274.53.37575; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Vyas VK, 2001, GENETICS, V158, P563; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yin ZK, 1996, MOL MICROBIOL, V20, P751, DOI 10.1111/j.1365-2958.1996.tb02514.x; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200; Young ET, 2000, GENE, V245, P299, DOI 10.1016/S0378-1119(00)00035-4; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	70	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29021	29034		10.1074/jbc.M112.380147	http://dx.doi.org/10.1074/jbc.M112.380147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761425	hybrid, Green Published			2022-12-28	WOS:000308074600069
J	Oksayan, S; Wiltzer, L; Rowe, CL; Blondel, D; Jans, DA; Moseley, GW				Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Blondel, Danielle; Jans, David A.; Moseley, Gregory W.			A Novel Nuclear Trafficking Module Regulates the Nucleocytoplasmic Localization of the Rabies Virus Interferon Antagonist, P Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; VESICULAR STOMATITIS-VIRUS; NIPAH-VIRUS; PHOSPHOPROTEIN-P; IMPORTIN-ALPHA; MATRIX PROTEIN; PREVENTING STAT1; EXPORT SIGNALS; MESSENGER-RNA; HENDRA-VIRUS	Regulated nucleocytoplasmic transport of proteins is central to cellular function and dysfunction during processes such as viral infection. Active protein trafficking into and out of the nucleus is dependent on the presence within cargo proteins of intrinsic specific modular signals for nuclear import (nuclear localization signals, NLSs) and export (nuclear export signals, NESs). Rabies virus (RabV) phospho (P) protein, which is largely responsible for antagonising the host anti-viral response, is expressed as five isoforms (P1-P5). The subcellular trafficking of these isoforms is thought to depend on a balance between the activities of a dominant N-terminal NES (N-NES) and a distinct C-terminal NLS (C-NLS). Specifically, the N-NES-containing isoforms P1 and P2 are cytoplasmic, whereas the shorter P3-P5 isoforms, which lack the N-NES, are believed to be nuclear through the activity of the C-NLS. Here, we show for the first time that RabV P contains an additional strong NLS in the N-terminal region (N-NLS), which, intriguingly, overlaps with the N-NES. This arrangement represents a novel nuclear trafficking module where the N-NLS is inactive in P1 but becomes activated in P3, concomitant with truncation of the N-NES, to become the principal targeting signal conferring nuclear accumulation. Understanding this unique switch arrangement of overlapping, co-regulated NES/NLS sequences is vital to delineating the critical role of RabV P protein in viral infection.	[Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Moseley, Gregory W.] Monash Univ, Viral Immune Evas & Pathogen Lab, Clayton, Vic 3800, Australia; [Oksayan, Sibil; Wiltzer, Linda; Rowe, Caitlin L.; Jans, David A.] Monash Univ, Nucl Signaling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Blondel, Danielle] CNRS, Lab Virol Mol & Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Monash University; Monash University; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Moseley, GW (corresponding author), Monash Univ, Viral Immune Evas & Pathogen Lab, Clayton, Vic 3800, Australia.	greg.moseley@monash.edu	Wiltzer-Bach, Linda/D-8064-2015	Rowe, Caitlin/0000-0003-0829-1220; Jans, David/0000-0001-5115-4745; Moseley, Gregory/0000-0003-4516-3906	National Health and Medical Research Council, Australia [1003244, 1002486]; Australian Research Council [DP110101749]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council, Australia, Project Grant 1003244 (to G. W. M.), and Senior Principal Research Fellowship 1002486 (to D.A.J.), and by Australian Research Council Discovery Project DP110101749 (to G. W. M. and D.A.J.).	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Blondel D, 2002, ONCOGENE, V21, P7957, DOI 10.1038/sj.onc.1205931; Bouttier M, 2008, VIROLOGIE, V12, P159, DOI [10.1684/vir.2008.0173, 10.1684/12-3.2011.11041]; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chelbi-Alix MK, 2006, J INTERF CYTOK RES, V26, P271, DOI 10.1089/jir.2006.26.271; CHENIK M, 1995, J VIROL, V69, P707, DOI 10.1128/JVI.69.2.707-712.1995; Chenik M, 1998, J VIROL, V72, P1925, DOI 10.1128/JVI.72.3.1925-1930.1998; CHENIK M, 1994, J GEN VIROL, V75, P2889, DOI 10.1099/0022-1317-75-11-2889; Chumakov SP, 2010, MOL BIOL+, V44, P186, DOI 10.1134/S0026893310020020; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deonarain R, 2002, CURR PHARM DESIGN, V8, P2131, DOI 10.2174/1381612023393288; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Fulcher AJ, 2010, J BIOL CHEM, V285, P17744, DOI 10.1074/jbc.M109.055491; Gale M, 2009, J INTERF CYTOK RES, V29, P475, DOI 10.1089/jir.2009.0078; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Ito N, 2010, J VIROL, V84, P6699, DOI 10.1128/JVI.00011-10; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Marschalek A, 2012, EUR J CELL BIOL, V91, P17, DOI 10.1016/j.ejcb.2011.01.009; Moseley GW, 2007, BIOCHEMISTRY-US, V46, P12053, DOI 10.1021/bi700521m; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2010, J BIOTECHNOL, V145, P222, DOI 10.1016/j.jbiotec.2009.11.015; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Pasdeloup D, 2005, VIROLOGY, V334, P284, DOI 10.1016/j.virol.2005.02.005; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rodriguez JJ, 2004, VIRAL IMMUNOL, V17, P210, DOI 10.1089/0882824041310568; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; Schnell MJ, 2010, NAT REV MICROBIOL, V8, P51, DOI 10.1038/nrmicro2260; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Shimizu K, 2007, VIRUS RES, V123, P154, DOI 10.1016/j.virusres.2006.08.011; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2011, J MOL RECOGNIT, V24, P647, DOI 10.1002/jmr.1093; Vidy A, 2005, J VIROL, V79, P14411, DOI 10.1128/JVI.79.22.14411-14420.2005; Vidy A, 2007, J VIROL, V81, P4255, DOI 10.1128/JVI.01930-06; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984	68	31	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28112	28121		10.1074/jbc.M112.374694	http://dx.doi.org/10.1074/jbc.M112.374694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700958	Green Published, hybrid			2022-12-28	WOS:000307840700084
J	Liu, LW; Wang, LM; Zhang, Z; Wang, S; Chen, HG				Liu, Liangwei; Wang, Linmin; Zhang, Zhang; Wang, Suya; Chen, Hongge			Effect of Codon Message on Xylanase Thermal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; LATERAL GENE-TRANSFER; USAGE; TEMPERATURE; EXPRESSION; PROTEINS; THERMOSTABILITY; TRANSLATION; ADAPTATION; SEQUENCE	Because the genetic codon is known for degeneracy, its effect on enzyme thermal property is seldom investigated. A dataset was constructed for GH10 xylanase coding sequences and optimal temperatures for activity (T-opt). Codon contents and relative synonymous codon usages were calculated and respectively correlated with the enzyme T-opt values, which were used to describe the xylanase thermophilic tendencies without dividing them into two thermophilic and mesophilic groups. After analyses of codon content and relative synonymous codon usages were checked by the Bonferroni correction, we found five codons, with three (AUA, AGA, and AGG) correlating positively and two (CGU and AGC) correlating negatively with the T-opt value. The three positive codons are purine-rich codons, and the two negative codons have A-ends. The two negative codons are pyridine-rich codons, and one has a C-end. Comparable with the codon C- and A-ending features, C- and A-content within mRNA correlated negatively and positively with the T-opt value, respectively. Thereby, codons have effects on enzyme thermal property. When the issue is analyzed at the residual level, the effect of codon message is lost. The codons relating to enzyme thermal property are selected by thermophilic force at nucleotide level.	[Liu, Liangwei] Henan Agr Univ, Life Sci Coll, Zhengzhou 450002, Henan, Peoples R China; [Wang, Linmin; Zhang, Zhang; Chen, Hongge] Henan Agr Univ, Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou 450002, Henan, Peoples R China; [Wang, Suya] Nanjing Univ Econ, Dept Food Sci & Engn, Nanjing 210003, Peoples R China	Henan Agricultural University; Henan Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing University of Finance & Economics	Liu, LW (corresponding author), Henan Agr Univ, Life Sci Coll, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.	LLW321@yahoo.com.cn		liu, liangwei/0000-0002-1896-8437	Natural Science Foundation of China [30972123]; Henan Science and Technology Fund of China [092102110102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Science and Technology Fund of China	This work was supported by Natural Science Foundation of China (Grant 30972123) and Grant 092102110102 from the Henan Science and Technology Fund of China.	Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Basak S, 2005, BIOCHEM BIOPH RES CO, V330, P629, DOI 10.1016/j.bbrc.2005.02.134; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernado P, 2010, NATURE, V468, P1046, DOI 10.1038/4681046a; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Dalboge H, 1997, FEMS MICROBIOL REV, V21, P29, DOI 10.1016/S0168-6445(97)00005-3; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Facchiano AM, 1998, PROTEIN ENG, V11, P753, DOI 10.1093/protein/11.9.753; Farias Savio T, 2003, Genet Mol Res, V2, P383; Fasman KH, 1998, N COMP BIOC, V32, P29; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gomes J, 2000, EXTREMOPHILES, V4, P227, DOI 10.1007/s007920070024; Gubitz GM, 1997, APPL MICROBIOL BIOT, V47, P658, DOI 10.1007/s002530050991; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kidane D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000630; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kumar PR, 2000, J MOL BIOL, V295, P581, DOI 10.1006/jmbi.1999.3348; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu LW, 2008, J BIOTECHNOL, V136, pS201, DOI 10.1016/j.jbiotec.2008.07.423; Liu LW, 2006, PROCESS BIOCHEM, V41, P305, DOI 10.1016/j.procbio.2005.06.027; Liu LW, 2005, PROCESS BIOCHEM, V40, P1389, DOI 10.1016/j.procbio.2004.06.003; Lo Leggio L, 1999, PROTEINS, V36, P295; Lobry JR, 2003, J APPL GENET, V44, P235; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Malkov SN, 2009, PROTEIN J, V28, P74, DOI 10.1007/s10930-009-9166-3; Mendez R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000767; Mozo-Villiarias A, 2006, CURR BIOINFORM, V1, P25, DOI 10.2174/157489306775330561; Musto H, 2004, FEBS LETT, V573, P73, DOI 10.1016/j.febslet.2004.07.056; Musto H, 1999, J MOL EVOL, V49, P27, DOI 10.1007/PL00006531; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Pasamontes A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-257; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; Puigbo P, 2008, TRENDS GENET, V24, P10, DOI 10.1016/j.tig.2007.10.005; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Singer A, 2009, J IND MICROBIOL BIOT, V36, P521, DOI 10.1007/s10295-008-0522-7; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; THOMAS LK, 1988, P NATL ACAD SCI USA, V85, P4242, DOI 10.1073/pnas.85.12.4242; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Waller RF, 2006, MOL BIOL EVOL, V23, P1437, DOI 10.1093/molbev/msl008; Wang HC, 2006, BIOCHEM BIOPH RES CO, V342, P681, DOI 10.1016/j.bbrc.2006.02.037; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Xie T, 1998, FEBS LETT, V434, P93; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	61	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27183	27188		10.1074/jbc.M111.327577	http://dx.doi.org/10.1074/jbc.M111.327577			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707716	hybrid, Green Published			2022-12-28	WOS:000307386000070
J	Ea, CK; Hao, SL; Yeo, KS; Baltimore, D				Ea, Chee-Kwee; Hao, ShengLi; Yeo, Kok Siong; Baltimore, David			EHMT1 Protein Binds to Nuclear Factor-kappa B p50 and Represses Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-H3 LYSINE-9 METHYLATION; INTERFERON RESPONSE; IMMUNE-RESPONSES; METHYLTRANSFERASE; CHROMATIN; SITE; G9A; H3; CELLS; HETEROCHROMATIN	Transcriptional homeostasis relies on the balance between positive and negative regulation of gene transcription. Methylation of histone H3 lysine 9 (H3K9) is commonly correlated with gene repression. Here, we report that a euchromatic H3K9 methyltransferase, EHMT1, functions as a negative regulator in both the NF-kappa B- and type I interferon-mediated gene induction pathways. EHMT1 catalyzes H3K9 methylation at promoters of NF-kappa B target genes. Moreover, EHMT1 interacts with p50, and, surprisingly, p50 appears to repress the expression of type I interferon genes and genes activated by type I interferons by recruiting EHMT1 to catalyze H3K9 methylation at their promoter regions. Silencing the expression of EHMT1 by RNA interference enhances expression of a subset NF-kappa B-regulated genes, augments interferon production, and augments antiviral immunity.	[Hao, ShengLi; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Ea, Chee-Kwee; Yeo, Kok Siong] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	California Institute of Technology; Universiti Malaya	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	YEO, KOK SIONG/D-9910-2010; Yeo, Kok Siong/AAA-8345-2019	Yeo, Kok Siong/0000-0003-2430-2487	National Institutes of Health [2R01GM039458]; University of Malaya HIR [UM.C/625/1/HIR/MOHE/CHAN-02, H-50001-A000022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Malaya HIR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM039458. This work was also supported by the University of Malaya HIR Grant UM.C/625/1/HIR/MOHE/CHAN-02; H-50001-A000022.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PLAKSIN D, 1993, J EXP MED, V177, P1651, DOI 10.1084/jem.177.6.1651; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	39	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31207	31217		10.1074/jbc.M112.365601	http://dx.doi.org/10.1074/jbc.M112.365601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801426	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308791300033
J	Stevens, M; Peigneur, S; Dyubankova, N; Lescrinier, E; Herdewijn, P; Tytgat, J				Stevens, Marijke; Peigneur, Steve; Dyubankova, Natalia; Lescrinier, Eveline; Herdewijn, Piet; Tytgat, Jan			Design of Bioactive Peptides from Naturally Occurring mu-Conotoxin Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; WATER SUPPRESSION; POTENT INHIBITOR; CONUS-STRIATUS; TETRODOTOXIN; KIIIA; BLOCK; EPILEPSY; GIIIA; PIIIA	To date, cone snail toxins ("conotoxins") are of great interest in the pursuit of novel subtype-selective modulators of voltage-gated sodium channels (Na(v)s). Na(v)s participate in a wide range of electrophysiological processes. Consequently, their malfunctioning has been associated with numerous diseases. The development of subtype-selective modulators of Na(v)s remains highly important in the treatment of such disorders. In current research, a series of novel, synthetic, and bioactive compounds were designed based on two naturally occurring mu-conotoxins that target Na(v)s. The initial designed peptide contains solely 13 amino acids and was therefore named "Mini peptide." It was derived from the mu-conotoxins KIIIA and BuIIIC. Based on this Mini peptide, 10 analogues were subsequently developed, comprising 12-16 amino acids with two disulfide bridges. Following appropriate folding and mass verification, blocking effects on Na(v)s were investigated. The most promising compound established an IC50 of 34.1 +/- 0.01 nM (R2-Midi on Na(v)1.2). An NMR structure of one of our most promising compounds was determined. Surprisingly, this structure does not reveal an alpha-helix. We prove that it is possible to design small peptides based on known pharmacophores of mu-conotoxins without losing their potency and selectivity. These data can provide crucial material for further development of conotoxin- based therapeutics.	[Stevens, Marijke; Peigneur, Steve; Tytgat, Jan] Katholieke Univ KU Leuven, Toxicol Lab, B-3000 Louvain, Belgium; [Dyubankova, Natalia; Lescrinier, Eveline; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Tytgat, J (corresponding author), Katholieke Univ KU Leuven, Toxicol Lab, Campus Gasthuisberg O & N2,Herestr 49,Box 922, B-3000 Louvain, Belgium.	Jan.Tytgat@pharm.kuleuven.be	Lescrinier, Eveline/G-9339-2016	Lescrinier, Eveline/0000-0001-7066-4329; Peigneur, Steve/0000-0003-0504-5702; Herdewijn, Piet/0000-0003-3589-8503; Tytgat, Jan/0000-0003-1778-6022	Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0257.08, G.0433.12]; KU Leuven Grant [OT/12/081]; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant [IUAP 7/12]	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); KU Leuven Grant; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant	This work was supported in part by Fonds Wetenschappelijk Onderzoek Vlaanderen Grants G.0257.08 and G.0433.12, KU Leuven Grant OT/12/081, and Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy Grant IUAP 7/12.	Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Clark RJ, 2012, TOXICON, V59, P446, DOI 10.1016/j.toxicon.2010.12.003; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Favreau P, 2012, BRIT J PHARMACOL, V166, P1654, DOI 10.1111/j.1476-5381.2012.01837.x; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; Keller R., 2004, THESIS SWISS FEDERAL; Khoo KK, 2011, J MED CHEM, V54, P7558, DOI 10.1021/jm200839a; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; McArthur JR, 2011, MOL PHARMACOL, V80, P219, DOI 10.1124/mol.111.071779; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Schroeder CI, 2008, J BIOL CHEM, V283, P21621, DOI 10.1074/jbc.M802852200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Shon KJ, 1998, J NEUROSCI, V18, P4473; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SPENCE I, 1977, LIFE SCI, V21, P1759, DOI 10.1016/0024-3205(77)90156-4; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Walewska A, 2008, J AM CHEM SOC, V130, P14280, DOI 10.1021/ja804303p; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j; Zuliani V, 2012, CURR TOP MED CHEM, V12, P962, DOI 10.2174/156802612800229206	55	25	26	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31382	31392		10.1074/jbc.M112.375733	http://dx.doi.org/10.1074/jbc.M112.375733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22773842	Green Published, hybrid			2022-12-28	WOS:000308791300049
J	Stahelin, RV; Kong, KF; Raha, S; Tian, W; Melowic, HR; Ward, KE; Murray, D; Altman, A; Cho, W				Stahelin, Robert V.; Kong, Kok-Fai; Raha, Sumita; Tian, Wen; Melowic, Heather R.; Ward, Katherine E.; Murray, Diana; Altman, Amnon; Cho, Wonhwa			Protein Kinase C theta C2 Domain Is a Phosphotyrosine Binding Module That Plays a Key Role in Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; KAPPA-B ACTIVATION; CYTOSOLIC PHOSPHOLIPASE A(2); MEMBRANE-BINDING; DIFFERENTIAL ROLES; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; PHORBOL ESTERS; ALPHA ACTIVITY; PKC-THETA	Protein kinase C theta (PKC theta) is a novel PKC that plays a key role in T lymphocyte activation. To understand how PKC theta is regulated in T cells, we investigated the properties of its N-terminal C2 domain that functions as an autoinhibitory domain. Our measurements show that a Tyr(P)-containing peptide derived from CDCP1 binds the C2 domain of PKC theta with high affinity and activates the enzyme activity of the intact protein. The Tyr(P) peptide also binds the C2 domain of PKC delta tightly, but no enzyme activation was observed with PKC delta. Mutations of PKC theta-C2 residues involved in Tyr(P) binding abrogated the enzyme activation and association of PKC theta with Tyr-phosphorylated full-length CDCP1 and severely inhibited the T cell receptor/CD28-mediated activation of a PKC theta-dependent reporter gene in T cells. Collectively, these studies establish the C2 domain of PKC theta as a Tyr(P)-binding domain and suggest that the domain may play a major role in PKC theta activation via its Tyr(P) binding.	[Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.; Raha, Sumita; Tian, Wen; Melowic, Heather R.; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Stahelin, Robert V.; Ward, Katherine E.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Murray, Diana] Columbia Univ, Dept Pharmacol, New York, NY 11032 USA; [Kong, Kok-Fai; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Indiana University System; Indiana University South Bend; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Notre Dame; Columbia University; La Jolla Institute for Immunology; Pohang University of Science & Technology (POSTECH)	Stahelin, RV (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu; wcho@uic.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [CA035299, GM76581, AI081077]; World Class University Program through the National Research Foundation of Korea [R31-2008-000-10105-0]; Ministry of Education, Science, and Technology; American Heart Association Predoctoral Fellowship [AHA 11PRE7640028]; National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship [T32GM075762]; NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762, R01GM076581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); American Heart Association Predoctoral Fellowship(American Heart Association); National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA035299 (to A. A.), CA035299 and GM76581 (to W. C.), and AI081077 (to R. S.). This work was also supported by the World Class University Program Grant R31-2008-000-10105-0 (to W. C.) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology.; Supported by American Heart Association Predoctoral Fellowship AHA 11PRE7640028 and National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship T32GM075762.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Corbalan-Garcia S, 2003, BIOCHEMISTRY-US, V42, P11661, DOI 10.1021/bi034850d; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pepio AM, 1998, J BIOL CHEM, V273, P19040, DOI 10.1074/jbc.273.30.19040; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Slater SJ, 2001, BBA-PROTEIN STRUCT M, V1544, P207, DOI 10.1016/S0167-4838(00)00222-3; Slater SJ, 2003, BIOCHEMISTRY-US, V42, P12105, DOI 10.1021/bi034860e; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	60	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30518	30528		10.1074/jbc.M112.391557	http://dx.doi.org/10.1074/jbc.M112.391557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787157	Green Published, hybrid			2022-12-28	WOS:000308579800044
J	Tominaga, M; Kojima, H; Yokota, E; Nakamori, R; Anson, M; Shimmen, T; Oiwa, K				Tominaga, Motoki; Kojima, Hiroaki; Yokota, Etsuo; Nakamori, Rinna; Anson, Michael; Shimmen, Teruo; Oiwa, Kazuhiro			Calcium-induced Mechanical Change in the Neck Domain Alters the Activity of Plant Myosin XI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN ORGANIZATION; CULTURED BY-2 CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR MOTORS; ATPASE ACTIVITY; TAIL DOMAIN; IQ MOTIFS; CALMODULIN; BINDING; CA-2+	Plant myosin XI functions as a motor that generates cytoplasmic streaming in plant cells. Although cytoplasmic streaming is known to be regulated by intracellular Ca2+ concentration, the molecular mechanism underlying this control is not fully understood. Here, we investigated the mechanism of regulation of myosin XI by Ca2+ at the molecular level. Actin filaments were easily detached from myosin XI in an in vitro motility assay at high Ca2+ concentration (pCa 4) concomitant with the detachment of calmodulin light chains from the neck domains. Electron microscopic observations showed that myosin XI at pCa 4 shortened the neck domain by 30%. Single-molecule analysis revealed that the step size of myosin XI at pCa 4 was shortened to 27 nm under low load and to 22 nm under high load compared with 35 nm independent of the load for intact myosin XI. These results indicate that modulation of the mechanical properties of the neck domain is a key factor for achieving the Ca2+-induced regulation of cytoplasmic streaming.	[Tominaga, Motoki; Kojima, Hiroaki; Nakamori, Rinna; Oiwa, Kazuhiro] Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Yokota, Etsuo; Shimmen, Teruo; Oiwa, Kazuhiro] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Harima, Hyogo 6781297, Japan; [Anson, Michael] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England	National Institute of Information & Communications Technology (NICT) - Japan; University of Hyogo; MRC National Institute for Medical Research	Oiwa, K (corresponding author), Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan.	oiwa@nict.go.jp	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X	Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on the priority area "Regulation of Nano-systems in Cells" by the Ministry of Education, Science, and Culture of Japan.	Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; DOREE M, 1980, EXPERIENTIA, V36, P1291; FLICKER PF, 1983, J MOL BIOL, V169, P723, DOI 10.1016/S0022-2836(83)80167-3; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Howard J., 2001, MECH MOTOR PROTEINS; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; KOHNO T, 1988, J CELL BIOL, V106, P1539, DOI 10.1083/jcb.106.5.1539; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu HL, 2006, J BIOL CHEM, V281, P31987, DOI 10.1074/jbc.M605181200; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; MUTO S, 1984, Z PFLANZENPHYSIOL, V114, P421, DOI 10.1016/S0044-328X(84)80062-8; Nguyen H, 2005, NAT STRUCT MOL BIOL, V12, P127, DOI 10.1038/nsmb894; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reddy ASN, 2001, INT REV CYTOL, V204, P97, DOI 10.1016/S0074-7696(01)04004-9; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; SHIMMEN T, 1994, INT REV CYTOL, V155, P97, DOI 10.1016/S0074-7696(08)62097-5; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Stoffler HE, 1998, J BIOL CHEM, V273, P14605, DOI 10.1074/jbc.273.23.14605; TAKAGI S, 1986, PLANT CELL PHYSIOL, V27, P953; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; WOODS CM, 1984, PROTOPLASMA, V121, P17, DOI 10.1007/BF01279748; Yokota E, 1999, PLANT PHYSIOL, V121, P525, DOI 10.1104/pp.121.2.525; Yokota E, 1999, PLANT PHYSIOL, V119, P231, DOI 10.1104/pp.119.1.231; Yokota E, 2009, J EXP BOT, V60, P197, DOI 10.1093/jxb/ern280; Yokota E, 2011, PLANT PHYSIOL, V156, P129, DOI 10.1104/pp.111.175018	43	29	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30711	30718		10.1074/jbc.M112.346668	http://dx.doi.org/10.1074/jbc.M112.346668			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740687	Green Published, hybrid			2022-12-28	WOS:000308579800060
J	Rama, N; Goldschneider, D; Corset, V; Lambert, J; Pays, L; Mehlen, P				Rama, Nicolas; Goldschneider, David; Corset, Veronique; Lambert, Jeremy; Pays, Laurent; Mehlen, Patrick			Amyloid Precursor Protein Regulates Netrin-1-mediated Commissural Axon Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER DCC; ADENOSINE A2B RECEPTOR; NETRIN RECEPTOR; SURVIVAL FACTOR; SONIC HEDGEHOG; GUIDANCE; GENE; ACTIVATION; APOPTOSIS; FAMILY	The multifunctional protein netrin-1 was initially discovered as the main attractive cue for commissural axon guidance by acting through its receptor DCC. Recently, we have shown that netrin-1 also interacts with the orphan transmembrane receptor amyloid precursor protein (APP). APP is cleaved by proteases, generating amyloid-beta peptide, the main component of the amyloid plaques that are associated with Alzheimer disease. Our previous work demonstrated that via its interaction with APP, netrin-1 is a negative regulator of amyloid-beta production in adult brain, but the biological relevance of APP/netrin-1 interaction under non-pathological conditions was unknown. We show here that during commissural axon navigation, APP, expressed at the growth cone, is part of the DCC receptor complex mediating netrin-1-dependent axon guidance. APP interacts with DCC in the presence of netrin-1 and enhances netrin-1-mediated DCC intracellular signaling, such as MAPK activation. Inactivation of APP in mice is associated with reduced commissural axon outgrowth. Thus, APP functionally acts as a co-receptor for DCC to mediate axon guidance.	[Rama, Nicolas; Goldschneider, David; Corset, Veronique; Lambert, Jeremy; Pays, Laurent; Mehlen, Patrick] Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,INSERM CNRS UMR5286 U105, Equipe Labellisee La Ligue,Ctr Cancerol Lyon, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Mehlen, P (corresponding author), Univ Lyon, Ctr Leon Berard, Apoptosis Canc & Dev Lab,INSERM CNRS UMR5286 U105, Equipe Labellisee La Ligue,Ctr Cancerol Lyon, F-69008 Lyon, France.	patrick.mehlen@lyon.unicancer.fr		Pays, Laurent/0000-0003-0720-2273; Rama, Nicolas/0000-0003-1614-7755	CNRS, University of Lyon, Centre Leon Berard; Ligue contre le Cancer, L'Institut National du Cancer (INCa); L'Agence Nationale de la Recherche (ANR)	CNRS, University of Lyon, Centre Leon Berard; Ligue contre le Cancer, L'Institut National du Cancer (INCa); L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by an institutional grant from CNRS, University of Lyon, Centre Leon Berard, and by the Ligue contre le Cancer, L'Institut National du Cancer (INCa), and L'Agence Nationale de la Recherche (ANR).	Castets M, 2010, CELL CYCLE, V9, P1466, DOI 10.4161/cc.9.8.11197; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; Hansen LA, 1997, NEUROBIOL AGING, V18, pS71, DOI 10.1016/S0197-4580(97)00073-0; Heber S, 2000, J NEUROSCI, V20, P7951; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320	38	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					30014	30023		10.1074/jbc.M111.324780	http://dx.doi.org/10.1074/jbc.M111.324780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782894	Green Published, hybrid			2022-12-28	WOS:000308286900074
J	Ling, JQ; Peterson, KM; Simonovic, I; Soll, D; Simonovic, M				Ling, Jiqiang; Peterson, Kaitlyn M.; Simonovic, Ivana; Soell, Dieter; Simonovic, Miljan			The Mechanism of Pre-transfer Editing in Yeast Mitochondrial Threonyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISTRANSLATION; RECOGNITION; TRANSLATION; PRETRANSFER; HYDROLYSIS; ADENYLATES; DOMAIN	Accurate translation of mRNA into protein is a fundamental biological process critical for maintaining normal cellular functions. To ensure translational fidelity, aminoacyl-tRNA synthetases (aaRSs) employ pre-transfer and post-transfer editing activities to hydrolyze misactivated and mischarged amino acids, respectively. Whereas post-transfer editing, which requires either a specialized domain in aaRS or a trans-protein factor, is well described, the mechanism of pre-transfer editing is less understood. Here, we show that yeast mitochondrial threonyl-tRNA synthetase (MST1), which lacks an editing domain, utilizes pre-transfer editing to discriminate against serine. MST1 misactivates serine and edits seryl adenylate (Ser-AMP) in a tRNA-independent manner. MST1 hydrolyzes 80% of misactivated Ser-AMP at a rate 4-fold higher than that for the cognate threonyl adenylate (Thr-AMP) while releasing 20% of Ser-AMP into the solution. To understand the mechanism of pre-transfer editing, we solved the crystal structure of MST1 complexed with an analog of Ser-AMP. The binding of the Ser-AMP analog to MST1 induces conformational changes in the aminoacylation active site, and it positions a potential hydrolytic water molecule more favorably for nucleophilic attack. In addition, inhibition results reveal that the Ser-AMP analog binds the active site 100-fold less tightly than the Thr-AMP analog. In conclusion, we propose that the plasticity of the aminoacylation site in MST1 allows binding of Ser-AMP and the appropriate positioning of the hydrolytic water molecule.	[Ling, Jiqiang; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Peterson, Kaitlyn M.; Simonovic, Ivana; Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	dieter.soll@yale.edu; msimon5@uic.edu	Ling, Jiqiang/AAU-1097-2021; Ling, Jiqiang/B-2885-2009	Ling, Jiqiang/0000-0003-4466-8304; Ling, Jiqiang/0000-0003-4466-8304; Simonovic, Miljan/0000-0002-1576-2222	National Institutes of Health through the NIGMS [GM22854]; American Cancer Society, Illinois Division, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854, R01GM097042] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society, Illinois Division, Inc.(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM22854 through the NIGMS (to D. S.). This work was also supported by the American Cancer Society, Illinois Division, Inc. and by National Institutes of Health through the NIGMS (to M. S.). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guo M, 2012, CURR OPIN STRUC BIOL, V22, P119, DOI 10.1016/j.sbi.2011.11.008; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1978, FEBS LETT, V95, P235, DOI 10.1016/0014-5793(78)81001-1; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Sarkar J, 2011, J AM CHEM SOC, V133, P18510, DOI 10.1021/ja2048122; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Su D, 2011, NUCLEIC ACIDS RES, V39, P4866, DOI 10.1093/nar/gkr073; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	45	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28518	28525		10.1074/jbc.M112.372920	http://dx.doi.org/10.1074/jbc.M112.372920			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773845	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000308074600027
J	Bom, APDA; Rangel, LP; Costa, DCF; de Oliveira, GAP; Sanches, D; Braga, CA; Gava, LM; Ramos, CHI; Cepeda, AOT; Stumbo, AC; Gallo, CVD; Cordeiro, Y; Silva, JL				Bom, Ana P. D. Ano; Rangel, Luciana P.; Costa, Danielly C. F.; de Oliveira, Guilherme A. P.; Sanches, Daniel; Braga, Carolina A.; Gava, Lisandra M.; Ramos, Carlos H. I.; Cepeda, Ana O. T.; Stumbo, Ana C.; De Moura Gallo, Claudia V.; Cordeiro, Yraima; Silva, Jerson L.			Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; TETRAMERIZATION DOMAIN; COMMON MECHANISM; MOLTEN GLOBULE; PROTEIN; NEUROBLASTOMA; ACCUMULATION; ANTIBODIES; HYDRATION; BIOLOGY	Over 50% of all human cancers lose p53 function. To evaluate the role of aggregation in cancer, we asked whether wild-type (WT) p53 and the hot-spot mutant R248Q could aggregate as amyloids under physiological conditions and whether the mutant could seed aggregation of the wild-type form. The central domains (p53C) of both constructs aggregated into a mixture of oligomers and fibrils. R248Q had a greater tendency to aggregate than WT p53. Full-length p53 aggregated into amyloid-like species that bound thioflavin T. The amyloid nature of the aggregates was demonstrated using x-ray diffraction, electron microscopy, FTIR, dynamic light scattering, cell viabilility assay, and anti-amyloid immunoassay. The x-ray diffraction pattern of the fibrillar aggregates was consistent with the typical conformation of cross beta-sheet amyloid fibers with reflexions of 4.7 angstrom and 10 angstrom. A seed of R248Q p53C amyloid oligomers and fibrils accelerated the aggregation of WTp 53C, a behavior typical of a prion. The R248Q mutant co-localized with amyloid-like species in a breast cancer sample, which further supported its prion-like effect. A tumor cell line containing mutant p53 also revealed massive aggregation of p53 in the nucleus. We conclude that aggregation of p53 into a mixture of oligomers and fibrils sequestrates the native protein into an inactive conformation that is typical of a prionoid. This prion-like behavior of oncogenic p53 mutants provides an explanation for the negative dominance effect and may serve as a potential target for cancer therapy.	[Braga, Carolina A.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Bom, Ana P. D. Ano; Rangel, Luciana P.; Costa, Danielly C. F.; de Oliveira, Guilherme A. P.; Sanches, Daniel; Braga, Carolina A.; Gava, Lisandra M.; Ramos, Carlos H. I.; De Moura Gallo, Claudia V.; Cordeiro, Yraima; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; Univ Estadual Campinas, Inst Biol, Inst Quim, BR-13084862 Campinas, SP, Brazil; [De Moura Gallo, Claudia V.] Univ Estado Rio de Janeiro, Dept Genet, IBRAG, BR-20550013 Rio De Janeiro, Brazil; [Stumbo, Ana C.] Univ Estado Rio de Janeiro, Dept Histol & Embriol, IBRAG, BR-20550013 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual de Campinas; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Bloco E Sala 10,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; Ramos, CH/C-1571-2012; Braga, Carolina/E-3471-2013; Silva, Jerson/J-8984-2014; de Oliveira, Guilherme A. P./O-1192-2013; Rangel, Luciana/E-7861-2018; Cordeiro, Yraima/J-7619-2012	SILVA, JERSON Lima/0000-0001-9523-9441; Ramos, CH/0000-0002-7246-9081; Silva, Jerson/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Cordeiro, Yraima/0000-0003-4278-212X; /0000-0002-6154-0815; Stumbo, Ana/0000-0001-8848-7850	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), and the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) of Brazil.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Chen LH, 1999, MOL MED, V5, P21, DOI 10.1007/BF03402136; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cordeiro Y, 2005, BIOPHYS J, V89, P2667, DOI 10.1529/biophysj.105.067603; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; ELLEDGE RM, 1994, CANCER RES, V54, P3752; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Galea C, 2005, PROTEIN SCI, V14, P2993, DOI 10.1110/ps.051622005; Gerweck LE, 1998, SEMIN RADIAT ONCOL, V8, P176, DOI 10.1016/S1053-4296(98)80043-X; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Gomes MPB, 2008, PRION, V2, P64, DOI 10.4161/pri.2.2.6988; Gottifredi V, 2001, SCIENCE, V292, P1851, DOI 10.1126/science.1062238; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Moll UM, 1997, INT J GYNECOL PATHOL, V16, P156, DOI 10.1097/00004347-199704000-00012; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	48	181	184	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28152	28162		10.1074/jbc.M112.340638	http://dx.doi.org/10.1074/jbc.M112.340638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715097	Green Published, hybrid			2022-12-28	WOS:000307840700088
J	Ulrich, T; Gross, LE; Sommer, MS; Schleiff, E; Rapaport, D				Ulrich, Thomas; Gross, Lucia E.; Sommer, Maik S.; Schleiff, Enrico; Rapaport, Doron			Chloroplast beta-Barrel Proteins Are Assembled into the Mitochondrial Outer Membrane in a Process That Depends on the TOM and TOB Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT PATHWAY; IN-VITRO; EVOLUTIONARY CONSERVATION; ARABIDOPSIS-THALIANA; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; ENVELOPE MEMBRANE; ADP/ATP CARRIER; BIOGENESIS; TRANSLOCATION	Membrane-embedded beta-barrel proteins are found in the outer membranes (OM) of Gram-negative bacteria, mitochondria and chloroplasts. In eukaryotic cells, precursors of these proteins are synthesized in the cytosol and have to be sorted to their corresponding organelle. Currently, the signal that ensures their specific targeting to either mitochondria or chloroplasts is ill-defined. To address this issue, we studied targeting of the chloroplast beta-barrel proteins Oep37 and Oep24. We found that both proteins can be integrated in vitro into isolated plant mitochondria. Furthermore, upon their expression in yeast cells Oep37 and Oep24 were exclusively located in the mitochondrial OM. Oep37 partially complemented the growth phenotype of yeast cells lacking Porin, the general metabolite transporter of this membrane. Similarly to mitochondrial beta-barrel proteins, Oep37 and Oep24 expressed in yeast cells were assembled into the mitochondrial OM in a pathway dependent on the TOM and TOB complexes. Taken together, this study demonstrates that the central mitochondrial components that mediate the import of yeast beta-barrel proteins can deal with precursors of chloroplast beta-barrel proteins. This implies that the mitochondrial import machinery does not recognize signals that are unique to mitochondrial beta-barrel proteins. Our results further suggest that dedicated targeting factors had to evolve in plant cells to prevent mis-sorting of chloroplast beta-barrel proteins to mitochondria.	[Ulrich, Thomas; Rapaport, Doron] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Gross, Lucia E.; Sommer, Maik S.; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60438 Frankfurt, Germany; [Gross, Lucia E.; Sommer, Maik S.; Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60438 Frankfurt, Germany	Eberhard Karls University of Tubingen; Goethe University Frankfurt; Goethe University Frankfurt	Rapaport, D (corresponding author), Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	doron.rapaport@uni-tuebingen.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489	Deutsche Forschungsgemeinschaft [RA 1048/4-1, SFB766/TP B11, SFB807/P17]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants RA 1048/4-1 and SFB766/TP B11 (to D.R.) and SFB807/P17 (to E.S.).	Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BRINKS S, 1994, J BIOL CHEM, V269, P16478; DAUM G, 1982, J BIOL CHEM, V257, P3028; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Duncan O., 2012, BIOCH BIPHY IN PRESS; Eckart K, 2002, EMBO REP, V3, P557, DOI 10.1093/embo-reports/kvf110; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Goetze TA, 2006, J BIOL CHEM, V281, P17989, DOI 10.1074/jbc.M600700200; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hausmann N, 2003, PHYTON-ANN REI BOT A, V43, P215; Hemmler R, 2006, J BIOL CHEM, V281, P12020, DOI 10.1074/jbc.M513586200; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; HURT EC, 1986, EMBO J, V5, P1343, DOI 10.1002/j.1460-2075.1986.tb04365.x; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; KIRWIN PM, 1989, EMBO J, V8, P2251, DOI 10.1002/j.1460-2075.1989.tb08349.x; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kozjak-Pavlovic V, 2011, J BIOL CHEM, V286, P27019, DOI 10.1074/jbc.M111.232249; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Kubrich M, 1998, J BIOL CHEM, V273, P16374, DOI 10.1074/jbc.273.26.16374; Lee YJ, 2001, PLANT CELL, V13, P2175, DOI 10.1105/tpc.13.10.2175; Machettira AB, 2011, PLANT MOL BIOL, V77, P381, DOI 10.1007/s11103-011-9818-5; Muller JEN, 2011, MOL BIOL CELL, V22, P1638, DOI 10.1091/mbc.E10-12-0943; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rodiger A, 2010, J PLANT PHYSIOL, V167, P620, DOI 10.1016/j.jplph.2009.11.013; Rohl T, 1999, FEBS LETT, V460, P491, DOI 10.1016/S0014-5793(99)01399-X; Rudhe C, 2002, PLANT J, V30, P213, DOI 10.1046/j.1365-313X.2002.01280.x; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Schleiff E, 1999, FEBS LETT, V461, P9, DOI 10.1016/S0014-5793(99)01415-5; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2001, BBA-MOL CELL RES, V1541, P22, DOI 10.1016/S0167-4889(01)00152-5; Schleiff E, 2001, MOL BIOL CELL, V12, P4090, DOI 10.1091/mbc.12.12.4090; Schleiff E, 2011, BIOL CHEM, V392, P21, DOI 10.1515/BC.2011.005; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; SMITH M, 1994, J BIOL CHEM, V269, P28460; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Sommer MS, 2011, P NATL ACAD SCI USA, V108, P13841, DOI 10.1073/pnas.1108626108; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	58	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27467	27479		10.1074/jbc.M112.382093	http://dx.doi.org/10.1074/jbc.M112.382093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22745120	Green Published, hybrid			2022-12-28	WOS:000307840700023
J	Grande, L; Bretones, G; Rosa-Garrido, M; Garrido-Martin, EM; Hernandez, T; Fraile, S; Botella, L; de Alava, E; Vidal, A; del Muro, XG; Villanueva, A; Delgado, MD; Fernandez-Luna, JL				Grande, Lara; Bretones, Gabriel; Rosa-Garrido, Manuel; Garrido-Martin, Eva M.; Hernandez, Teresa; Fraile, Susana; Botella, Luisa; de Alava, Enrique; Vidal, August; Garcia del Muro, Xavier; Villanueva, Alberto; Dolores Delgado, M.; Fernandez-Luna, Jose L.			Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; UP-REGULATION; FAMILY PROTEINS; BCL-2 FAMILY; CANCER; P53; RESISTANCE; TUMORS; ACTIVATION; DEATH	Testicular germ cell tumors (TGCTs) are highly responsive to and curable by cisplatin-based chemotherapy even in advanced stages. We have studied the molecular mechanisms involved in the induction of apoptosis in response to cisplatin, and found that proapoptotic Noxa is transcriptionally up-regulated following cisplatin exposure, even in the absence of p53, in NTERA2 cisplatin-sensitive cells but not in 1411HP-resistant cells. Blockade of Noxa reduced the apoptotic response of embryonal carcinoma (EC) NTERA2 cells to cisplatin. A detailed analysis of the Noxa promoter revealed that p73 and Sp1-like factors, Sp1 and KLF6, played key roles in the transcriptional control of this gene. Overexpression of TAp73 induced Noxa whereas the dominant negative isoform Delta Np73, reduced the levels of Noxa after cisplatin exposure in NTERA2 and 2102EP. Interestingly, down-regulation of Sp1 increased Noxa expression in response to cisplatin. However, blockade of KLF6 decreased cisplatin-induced up-regulation of Noxa in EC cell lines. In addition, tissue microarray analyses of TGCTs revealed that expression of Noxa correlates with good clinical prognosis in patients with embryonal carcinoma. Thus, our data show the transcriptional network that regulates Noxa in EC cells, which is key for their apoptotic response to cisplatin-based chemotherapy, and propose Noxa as a predictive factor of therapeutic response.	[Grande, Lara; Fernandez-Luna, Jose L.] Hosp Valdecilla, Mol Genet Unit, Santander 39011, Spain; [Grande, Lara; Fernandez-Luna, Jose L.] Inst Formac & Invest Marques Valdecilla IFIMAV, Santander 39011, Spain; [Bretones, Gabriel; Rosa-Garrido, Manuel; Dolores Delgado, M.] Univ Cantabria, Dept Mol Biol, Spanish Natl Res Council CSIC, Santander 39011, Spain; [Bretones, Gabriel; Rosa-Garrido, Manuel; Dolores Delgado, M.] Univ Cantabria, Inst Biomed & Biotecnol Cantabria IBBTEC, Spanish Natl Res Council CSIC, Santander 39011, Spain; [Garrido-Martin, Eva M.; Botella, Luisa] CSIC, Ctr Biol Res CIB, Dept Cellular & Mol Med, E-28040 Madrid, Spain; [de Alava, Enrique] CSIC, Canc Res Ctr CIC, Salamanca 37007, Spain; [Hernandez, Teresa; Fraile, Susana; de Alava, Enrique] Hosp Univ Salamanca IBSAL, Dept Pathol, Salamanca 37007, Spain; [Vidal, August] Bellvitge Univ Hosp, Serv Anat Pathol, Barcelona 08907, Spain; [Garcia del Muro, Xavier; Villanueva, Alberto] Catalan Inst Oncol ICO, Barcelona 08907, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology	Fernandez-Luna, JL (corresponding author), Hosp Valdecilla, Mol Genet Unit, Av Cardenal Herrera Oria S-N, Santander 39011, Spain.	fluna@humv.es	Bretones, Gabriel/AAB-4637-2021; Martín, Susana Fraile/AAC-2028-2021; Martin, Eva Maria Garrido/A-9497-2017; IBIS, SARCOMAS/O-1893-2015; Botella, Luisa M/L-1392-2014; Vidal, August/N-4662-2016; Garrido Martín, Eva María/HHM-3287-2022; Rosa-Garrido, Manuel/AAE-4188-2019; de Alava, Enrique/GOH-0368-2022; Delgado, M. Dolores/K-9056-2014	Bretones, Gabriel/0000-0002-1521-5544; Martín, Susana Fraile/0000-0001-6761-3950; Martin, Eva Maria Garrido/0000-0002-8094-2668; Vidal, August/0000-0001-5727-2099; Garrido Martín, Eva María/0000-0002-8094-2668; Rosa-Garrido, Manuel/0000-0002-2169-3972; de Alava, Enrique/0000-0001-8400-046X; Delgado, M. Dolores/0000-0003-4682-4040	Instituto de Salud Carlos III Grants [RD06/0020/0074, RD06/0020/0059, RD06/0020/0017PI11/00397, PI081491]; Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV) [API2011-04]	Instituto de Salud Carlos III Grants(Instituto de Salud Carlos III); Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV)	This work was supported by Instituto de Salud Carlos III Grants RD06/0020/0074 (to J. L. F.-L.), RD06/0020/0059 (to E. A.), RD06/0020/0017 (to M. D. D.) (Red Tematica de Investigacion Cooperativa en Cancer), PI11/00397 (to M. D. D.), and PI081491 (to X. G.); and a grant from Instituto de Formacion e Investigacion Marques de Valdecilla (IFIMAV), API2011-04 (to J. L. F.-L.).	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Amin ARMR, 2013, ONCOGENE, V32, P920, DOI 10.1038/onc.2012.96; [Anonymous], 2011, CANCER-AM CANCER SOC, V117, P4337, DOI 10.1002/cncr.26546; Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bahrami AR, 2005, MECH DEVELOP, V122, P1034, DOI 10.1016/j.mod.2005.04.011; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Chirakkal H, 2006, ONCOGENE, V25, P7192, DOI 10.1038/sj.onc.1209702; Davidoff AM, 2009, CURR OPIN PEDIATR, V21, P357, DOI 10.1097/MOP.0b013e32832b323a; de Wit R, 2006, J CLIN ONCOL, V24, P5482, DOI 10.1200/JCO.2006.07.9434; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Fernandez-Garcia B, 2007, CELL DEATH DIFFER, V14, P254, DOI 10.1038/sj.cdd.4401945; Fernandez-Luna JL, 2008, CELL SIGNAL, V20, P1921, DOI 10.1016/j.cellsig.2008.04.015; Garcia-Velasco A, 2012, CLIN TRANSL ONCOL, V14, P452, DOI 10.1007/s12094-012-0823-1; Guminski AD, 2002, LANCET ONCOL, V3, P312, DOI 10.1016/S1470-2045(02)00733-7; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Huh SJ, 2010, JNCI-J NATL CANCER I, V102, P1131, DOI 10.1093/jnci/djq218; Hussain SA, 2008, EXPERT REV ANTICANC, V8, P1659, DOI 10.1586/14737140.8.10.1659; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; Mayer F, 2003, CLIN CANCER RES, V9, P767; Mazumdar M, 2003, J CLIN ONCOL, V21, P2679, DOI 10.1200/JCO.2003.03.136; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Mora J, 2012, PEDIATR BLOOD CANCER, V58, P532, DOI 10.1002/pbc.23348; Mueller T, 2003, CANCER RES, V63, P513; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Qin JZ, 2004, MOL CANCER THER, V3, P895; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Schellong G, 1999, J CLIN ONCOL, V17, P3736, DOI 10.1200/JCO.1999.17.12.3736; Schmoll HJ, 2004, ANN ONCOL, V15, P1377, DOI 10.1093/annonc/mdh301; Schweyer S, 2004, BRIT J CANCER, V91, P589, DOI 10.1038/sj.bjc.6601919; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sheridan C, 2010, ONCOGENE, V29, P6428, DOI 10.1038/onc.2010.380; Sudhakar C, 2008, FEBS J, V275, P2200, DOI 10.1111/j.1742-4658.2008.06373.x; Voortman J, 2007, MOL CANCER THER, V6, P1046, DOI 10.1158/1535-7163.MCT-06-0577; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2011, J BIOL CHEM, V286, P22384, DOI 10.1074/jbc.M111.239566; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	50	40	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26495	26505		10.1074/jbc.M112.376319	http://dx.doi.org/10.1074/jbc.M112.376319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22718761	Green Published, hybrid			2022-12-28	WOS:000307386000003
J	Loo, TW; Bartlett, MC; Detty, MR; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Detty, Michael R.; Clarke, David M.			The ATPase Activity of the P-glycoprotein Drug Pump Is Highly Activated When the N-terminal and Central Regions of the Nucleotide-binding Domains Are Linked Closely Together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; TRANSMEMBRANE SEGMENTS; CONFORMATIONAL-CHANGES; MULTIDRUG TRANSPORTER; CATALYTIC CYCLE; COVALENT MODIFICATION; MOLECULAR RULERS; RESISTANCE; SITES; HYDROLYSIS	The P-glycoprotein (P-gp, ABCB1) drug pump protects us from toxic compounds and confers multidrug resistance. Each of the homologous halves of P-gp is composed of a transmembrane domain (TMD) with 6 TM segments followed by a nucleotide-binding domain (NBD). The predicted drug-and ATP-binding sites reside at the interface between the TMDs and NBDs, respectively. Crystal structures and EM projection images suggest that the two halves of P-gp are separated by a central cavity that closes upon binding of nucleotide. Binding of drug substrates may induce further structural rearrangements because they stimulate ATPase activity. Here, we used disulfide cross-linking with short (8 angstrom) or long (22 angstrom) cross-linkers to identify domain-domain interactions that activate ATPase activity. It was found that cross-linking of cysteines that lie close to the LSGGQ (P517C) and Walker A (I1050C) sites of NBD1 and NBD2, respectively, as well as the cytoplasmic extensions of TM segments 3 (D177C or L175C) and 9 (N820C) with a short cross-linker activated ATPase activity over 10-fold. A pyrylium compound that inhibits ATPase activity blocked cross-linking at these sites. Cross-linking between the NBDs was not inhibited by tariquidar, a drug transport inhibitor that stimulates P-gp ATPase activity but is not transported. Cross-linking between extracellular cysteines (T333C/L975C) predicted to lock P-gp into a conformation that prevents close NBD association inhibited ATPase activity. The results suggest that trapping P-gp in a conformation in which the NBDs are closely associated likely mimics the structural rearrangements caused by binding of drug substrates that stimulate ATPase activity.	[Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Detty, Michael R.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	University of Toronto; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	National Institutes of Health [GM-94367]; Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-94367 (to M. R. D.) and by grants from the Canadian Cancer Society (19074) (to D. M. C.), the Canadian Institutes of Health Research (25043) (to D. M. C.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Ebert SP, 2012, J MED CHEM, V55, P4683, DOI 10.1021/jm3004398; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Fox E, 2007, EXPERT REV ANTICANC, V7, P447, DOI 10.1586/14737140.7.4.447; Ghosh P, 2006, ARCH BIOCHEM BIOPHYS, V450, P100, DOI 10.1016/j.abb.2006.02.025; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2007, BIOCHEMISTRY-US, V46, P9328, DOI 10.1021/bi700837y; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mandal D, 2012, BIOCHEMISTRY-US, V51, P2852, DOI 10.1021/bi201479k; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; TANGWAI DF, 1995, BIOCHEMISTRY-US, V34, P32, DOI 10.1021/bi00001a005; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Vigano C, 2002, J BIOL CHEM, V277, P5008, DOI 10.1074/jbc.M107928200; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	66	43	43	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26806	26816		10.1074/jbc.M112.376202	http://dx.doi.org/10.1074/jbc.M112.376202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700974	hybrid, Green Published			2022-12-28	WOS:000307386000030
J	Zong, XG; Krause, S; Chen, CC; Kruger, J; Gruner, C; Cao-Ehlker, X; Fenske, S; Wahl-Schott, C; Biel, M				Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Krueger, Jens; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin			Regulation of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) Channel Activity by cCMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE 3',5'-MONOPHOSPHATE CCMP; LOTI K1 CHANNEL; PACEMAKER CHANNELS; CATION CHANNELS; STRUCTURAL BASIS; BINDING DOMAIN; RAT-TISSUES; PATCH-CLAMP; MODULATION; CAMP	Activation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels is facilitated in vivo by direct binding of the second messenger cAMP. This process plays a fundamental role in the fine-tuning of HCN channel activity and is critical for the modulation of cardiac and neuronal rhythmicity. Here, we identify the pyrimidine cyclic nucleotide cCMP as another regulator of HCN channels. We demonstrate that cCMP shifts the activation curves of two members of the HCN channel family, HCN2 and HCN4, to more depolarized voltages. Moreover, cCMP speeds up activation and slows down deactivation kinetics of these channels. The two other members of the HCN channel family, HCN1 and HCN3, are not sensitive to cCMP. The modulatory effect of cCMP is reversible and requires the presence of a functional cyclic nucleotide-binding domain. We determined an EC50 value of similar to 30 mu M for cCMP compared with 1 mu M for cAMP. Notably, cCMP is a partial agonist of HCN channels, displaying an efficacy of similar to 0.6. cCMP increases the frequency of pacemaker potentials from isolated sinoatrial pacemaker cells in the presence of endogenous cAMP concentrations. Electrophysiological recordings indicated that this increase is caused by a depolarizing shift in the activation curve of the native HCN current, which in turn leads to an enhancement of the slope of the diastolic depolarization of sinoatrial node cells. In conclusion, our findings establish cCMP as a gating regulator of HCN channels and indicate that this cyclic nucleotide has to be considered in HCN channel-regulated processes.	[Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-80539 Munich, Germany; [Zong, Xiangang; Krause, Stefanie; Chen, Cheng-Chang; Gruner, Christian; Cao-Ehlker, Xiaochun; Fenske, Stefanie; Wahl-Schott, Christian; Biel, Martin] Univ Munich, Dept Pharm, Ctr Integrated Prot Sci CIPSM, D-80539 Munich, Germany; [Krueger, Jens] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Appl Bioinformat Grp, D-72076 Tubingen, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen	Biel, M (corresponding author), Univ Munich, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de	Biel, Martin/G-1175-2014; Wahl-Schott, Christian A/J-2623-2015	Biel, Martin/0000-0002-9974-3052; Fenske, Stefanie/0000-0002-6994-8401; Kruger, Jens/0000-0002-2636-3163	Deutsche Forschungsgemeinschaft; Graduate School Life Science Munich (LSM); Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School Life Science Munich (LSM); Bayerische Forschungsstiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Graduate School Life Science Munich (LSM), and a fellowship from the Bayerische Forschungsstiftung (to C.-C.C.).	ANDERSON TR, 1982, MOL CELL ENDOCRINOL, V28, P373, DOI 10.1016/0303-7207(82)90134-4; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BROWN H, 1980, J PHYSIOL-LONDON, V308, P331, DOI 10.1113/jphysiol.1980.sp013474; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bruggemann A, 2006, SMALL, V2, P840, DOI [10.1002/smll.200600083, 10.1002/50111.200600083]; Bucchi A, 2007, J MOL CELL CARDIOL, V43, P39, DOI 10.1016/j.yjmcc.2007.04.017; Burhenne H, 2011, N-S ARCH PHARMACOL, V383, P33; CECH SY, 1977, SCIENCE, V198, P1063, DOI 10.1126/science.22127; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Desch M, 2010, FEBS LETT, V584, P3979, DOI 10.1016/j.febslet.2010.07.059; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; GAION RM, 1979, BIOCHEM BIOPH RES CO, V86, P105, DOI 10.1016/0006-291X(79)90387-5; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; NEWTON RP, 1984, BIOCHEM J, V221, P665, DOI 10.1042/bj2210665; NEWTON RP, 1986, BIOCHEM J, V236, P431, DOI 10.1042/bj2360431; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Rozas I, 1997, J PHYS CHEM A, V101, P9457, DOI 10.1021/jp971893t; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; Shaikh AG, 2005, HEARING RES, V201, P70, DOI 10.1016/j.heares.2004.10.005; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	41	46	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26506	26512		10.1074/jbc.M112.357129	http://dx.doi.org/10.1074/jbc.M112.357129			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22715094	Green Published, hybrid			2022-12-28	WOS:000307386000004
J	Canepa, GE; Mesias, AC; Yu, H; Chen, X; Buscaglia, CA				Canepa, Gaspar E.; Mesias, Andrea C.; Yu, Hai; Chen, Xi; Buscaglia, Carlos A.			Structural Features Affecting Trafficking, Processing, and Secretion of Trypanosoma cruzi Mucins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; EXPRESSION VECTOR; MAMMALIAN-CELLS; TRANS-SIALIDASE; SURFACE MUCINS; FAMILY; BRUCEI	Trypanosoma cruzi is wrapped by a dense coat of mucin-type molecules encoded by complex gene families termed TcSMUG and TcMUC, which are expressed in the insect-and mammal-dwelling forms of the parasite, respectively. Here, we dissect the contribution of distinct post-translational modifications on the trafficking of these glycoconjugates. In vivo tracing and characterization of tagged-variants expressed by transfected epimastigotes indicate that although the N-terminal signal peptide is responsible for targeting TcSMUG products to the endoplasmic reticulum (ER), the glycosyl phosphatidylinositol (GPI)-anchor likely functions as a forward transport signal for their timely progression along the secretory pathway. GPI-minus variants accumulate in the ER, with only a minor fraction being ultimately released to the medium as anchorless products. Secreted products, but not ER-accumulated ones, display several diagnostic features of mature mucin-type molecules including extensive O-type glycosylation, Galf-based epitopes recognized by monoclonal antibodies, and terminal Galp residues that become readily sialylated upon addition of parasite trans-sialidases. Processing of N-glycosylation site(s) is dispensable for the overall TcSMUG mucin-type maturation and secretion. Despite undergoing different O-glycosylation elaboration, TcMUC reporters yielded quite similar results, thus indicating that (i) molecular trafficking signals are structurally and functionally conserved between mucin families, and (ii) TcMUC and TcSMUG products are recognized and processed by a distinct repertoire of stage-specific glycosyltransferases. Thus, using the fidelity of a homologous expression system, we have defined some biosynthetic aspects of T. cruzi mucins, key molecules involved in parasite protection and virulence.	[Canepa, Gaspar E.; Mesias, Andrea C.; Buscaglia, Carlos A.] Inst Invest Biotecnol Dr Rodolfo Ugalde, RA-1650 Buenos Aires, DF, Argentina; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Buscaglia, CA (corresponding author), Inst Invest Biotecnol Dr Rodolfo Ugalde, Av 25 Mayo & Francia,Campus UNSAM, RA-1650 Buenos Aires, DF, Argentina.	cbusca@iib.unsam.edu.ar	Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X; Mesias, Andrea Cecilia/0000-0003-1205-0665; Buscaglia, Carlos/0000-0001-6466-4138; Canepa, Gaspar/0000-0002-4195-8835	UNICEF/UNDP/World Bank/WHO Special Programme for Research; Training in Tropical Diseases (TDR); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Fundacion Florencio Fiorini; UNSAM; Argentinean Research Council (CONICET)	UNICEF/UNDP/World Bank/WHO Special Programme for Research(World Health Organization); Training in Tropical Diseases (TDR); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Fundacion Florencio Fiorini; UNSAM; Argentinean Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Fundacion Florencio Fiorini, and UNSAM (to C. A. B.).; Holds a post-doctoral fellowship from the Argentinean Research Council (CONICET).	Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; Bohme U, 2002, J CELL SCI, V115, P805; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buscaglia CA, 2004, J BIOL CHEM, V279, P15860, DOI 10.1074/jbc.M314051200; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; Campo V, 2004, MOL BIOCHEM PARASIT, V133, P81, DOI 10.1016/j.molbiopara.2003.09.006; Campo VA, 2006, MICROBES INFECT, V8, P401, DOI 10.1016/j.micinf.2005.07.008; Canepa GE, 2012, BIOCHEM J, V444, P211, DOI 10.1042/BJ20120074; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; de Lederkremer RM, 2009, ADV CARBOHYD CHEM BI, V62, P311, DOI 10.1016/S0065-2318(09)00007-9; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Di Noia JM, 1998, J BIOL CHEM, V273, P10843, DOI 10.1074/jbc.273.18.10843; Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Fraering P, 2001, MOL BIOL CELL, V12, P3295, DOI 10.1091/mbc.12.10.3295; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Kawagoe K, 1996, BLOOD, V87, P3600, DOI 10.1182/blood.V87.9.3600.bloodjournal8793600; Labriola CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013141; MacRae JI, 2005, J BIOL CHEM, V280, P12201, DOI 10.1074/jbc.M412939200; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; McGwire BS, 1996, J BIOL CHEM, V271, P7903, DOI 10.1074/jbc.271.14.7903; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakayasu ES, 2012, J PROTEOME RES, V11, P237, DOI 10.1021/pr200806s; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; Pollevick GD, 2000, J BIOL CHEM, V275, P27671; Previato JO, 1998, J BIOL CHEM, V273, P14982, DOI 10.1074/jbc.273.24.14982; Ralton JE, 2002, BIOCHEM J, V363, P365, DOI 10.1042/0264-6021:3630365; Rivier AS, 2010, TRAFFIC, V11, P1017, DOI 10.1111/j.1600-0854.2010.01081.x; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; Schuck S, 2006, J CELL BIOL, V172, P963, DOI 10.1083/jcb.200603015; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Urban I, 2011, BIOCHEM J, V438, P303, DOI 10.1042/BJ20110683; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26365	26376		10.1074/jbc.M112.354696	http://dx.doi.org/10.1074/jbc.M112.354696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707724	hybrid, Green Published			2022-12-28	WOS:000306916300062
J	Naranjo, JR; Mellstrom, B				Naranjo, Jose R.; Mellstroem, Britt			Ca2+-dependent Transcriptional Control of Ca2+ Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLASMA-MEMBRANE CA2+; PROTEIN-KINASE-C; TYPE-1 RECEPTOR EXPRESSION; SODIUM-CALCIUM EXCHANGE; CALCINEURIN CONTROLS; GENE-EXPRESSION; ISCHEMIC-INJURY; PUMP ISOFORMS; CHANNEL; SUBUNIT	Intracellular free Ca2+ ions regulate many cellular functions, and in turn, the cell devotes many genes/proteins to keep tight control of the level of intracellular free Ca2+. Here, we review recent work on Ca2+- dependent mechanisms and effectors that regulate the transcription of genes encoding proteins involved in the maintenance of the homeostasis of Ca2+ in the cell.	[Naranjo, Jose R.] CSIC, Natl Biotechnol Ctr, E-28049 Madrid, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CIBERNED	Naranjo, JR (corresponding author), CSIC, Natl Biotechnol Ctr, Plaza Murillo 2, E-28049 Madrid, Spain.	naranjo@cnb.csic.es	NARANJO, Jose R/K-1950-2014	NARANJO, Jose R/0000-0002-0270-3469	Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [SAF2008-03469, SAF2010-21784]; CIBERNED; Fundacion Reina Sofia Grant [PI 006/09]; European Union 6th Framework Program (NeuroNE) [LSHG-CT-2006-037627]	Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERNED(Instituto de Salud Carlos III); Fundacion Reina Sofia Grant; European Union 6th Framework Program (NeuroNE)	This work was supported by Direccion General de Investigacion Cientifica y Tecnica (DGICYT) Grants SAF2008-03469 and SAF2010-21784, CIBERNED, Fundacion Reina Sofia Grant PI 006/09, and European Union 6th Framework Program (NeuroNE) Grant LSHG-CT-2006-037627. This article is part of the Thematic Minireview Series on Calcium Function and Disease.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bojarski L, 2009, BBA-MOL CELL RES, V1793, P1050, DOI 10.1016/j.bbamcr.2008.11.008; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Brady M, 2003, CARDIOVASC RES, V60, P347, DOI 10.1016/S0008-6363(03)00529-7; Bruno AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.011; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cartwright EJ, 2011, SCI CHINA LIFE SCI, V54, P691, DOI 10.1007/s11427-011-4199-1; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; Davidoff AJ, 1997, J MOL CELL CARDIOL, V29, P1791, DOI 10.1006/jmcc.1997.0406; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Furutama D, 1996, J NEUROCHEM, V66, P1793; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guerini D, 2000, J BIOL CHEM, V275, P3706, DOI 10.1074/jbc.275.5.3706; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Jensen TP, 2009, MOL CELL NEUROSCI, V41, P364, DOI 10.1016/j.mcn.2009.04.011; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Kurokawa K, 2011, J NEUROCHEM, V118, P773, DOI 10.1111/j.1471-4159.2011.07366.x; Kurokawa K, 2010, J NEUROCHEM, V115, P1206, DOI 10.1111/j.1471-4159.2010.07010.x; Kurokawa K, 2010, SYNAPSE, V64, P822, DOI 10.1002/syn.20797; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Marian MJ, 2008, OPEN OPHTHALMOL J, V2, P123, DOI 10.2174/1874364100802010123; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Michael A, 2004, J BIOL CHEM, V279, P21383, DOI 10.1074/jbc.M401413200; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Mondin L, 2009, AM J PHYSIOL-CELL PH, V297, pC1133, DOI 10.1152/ajpcell.00048.2009; Morita M, 2010, GLIA, V58, P1988, DOI 10.1002/glia.21067; Novotny-Diermayr V, 2005, J BIOL CHEM, V280, P12747, DOI 10.1074/jbc.M500175200; Ong HL, 2011, CHANNELS, V5, P422, DOI 10.4161/chan.5.5.16471; Palczewska M, 2011, BBA-MOL CELL RES, V1813, P1050, DOI 10.1016/j.bbamcr.2010.11.001; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Prasad AM, 2011, AM J PHYSIOL-HEART C, V300, pH173, DOI 10.1152/ajpheart.00841.2010; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Ritchie MF, 2011, CELL CALCIUM, V49, P314, DOI 10.1016/j.ceca.2010.10.001; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Rosen MR, 2006, J PHYSIOL-LONDON, V570, P209, DOI 10.1113/jphysiol.2005.097873; Satin J, 2011, CELL CALCIUM, V49, P306, DOI 10.1016/j.ceca.2011.01.001; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; Schroder E, 2007, AM J PHYSIOL-HEART C, V292, pH1906, DOI 10.1152/ajpheart.00793.2006; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tibbits GF, 2002, COMP BIOCHEM PHYS A, V132, P691, DOI 10.1016/S1095-6433(02)00128-9; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Vlasblom R, 2004, CARDIOVASC RES, V63, P537, DOI 10.1016/j.cardiores.2004.04.005; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Xu XF, 2011, J BIOL CHEM, V286, P9677, DOI 10.1074/jbc.M110.187864; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/jbc.M111.234757; Ziviani E, 2011, EMBO J, V30, P194, DOI 10.1038/emboj.2010.279	75	49	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31674	31680		10.1074/jbc.R112.384982	http://dx.doi.org/10.1074/jbc.R112.384982			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822058	Green Published, hybrid			2022-12-28	WOS:000309059400009
J	Little, DJ; Poloczek, J; Whitney, JC; Robinson, H; Nitz, M; Howell, PL				Little, Dustin J.; Poloczek, Joanna; Whitney, John C.; Robinson, Howard; Nitz, Mark; Howell, P. Lynne			The Structure- and Metal-dependent Activity of Escherichia coli PgaB Provides Insight into the Partial De-N-acetylation of Poly-beta-1,6-N-acetyl-D-glucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE ESTERASE; POLYSACCHARIDE DEACETYLASE; CHITIN DEACETYLASE; BPS POLYSACCHARIDE; BIOFILM FORMATION; PROTEIN; MECHANISM; SITE; ELECTROSTATICS; METALLOENZYMES	Exopolysaccharides are required for the development and integrity of biofilms produced by a wide variety of bacteria. In Escherichia coli, partial de-N-acetylation of the exopolysaccharide poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) by the periplasmic protein PgaB is required for polysaccharide intercellular adhesin-dependent biofilm formation. To understand the molecular basis for PNAG de-N-acetylation, the structure of PgaB in complex with Ni2+ and Fe3+ have been determined to 1.9 and 2.1 angstrom resolution, respectively, and its activity on beta-1,6-GlcNAc oligomers has been characterized. The structure of PgaB reveals two (beta/alpha)(x) barrel domains: a metal-binding de-N-acetylase that is a member of the family 4 carbohydrate esterases (CE4s) and a domain structurally similar to glycoside hydrolases. PgaB displays de-N-acetylase activity on beta-1,6-GlcNAc oligomers but not on the beta-1,4-(GlcNAc) 4 oligomer chitotetraose and is the first CE4 member to exhibit this substrate specificity. De-N-acetylation occurs in a length-dependent manor, and specificity is observed for the position of de-N-acetylation. A key aspartic acid involved in de-N-acetylation, normally seen in other CE4s, is missing in PgaB, suggesting that the activity of PgaB is attenuated to maintain the low levels of de-N-acetylation of PNAG observed in vivo. The metal dependence of PgaB is different from most CE4s, because PgaB shows increased rates of de-N-acetylation with Co2+ and Ni2+ under aerobic conditions, and Co2+, Ni2+ and Fe2+ under anaerobic conditions, but decreased activity with Zn2+. The work presented herein will guide inhibitor design to combat biofilm formation by E. coli and potentially a wide range of medically relevant bacteria producing polysaccharide intercellular adhesin-dependent biofilms.	[Poloczek, Joanna; Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Little, Dustin J.; Whitney, John C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Little, Dustin J.; Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Nitz, M (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mnitz@chem.utoronto.ca; howell@sickkids.ca		Jakub, Poloczek/0000-0003-1429-4815	Canadian Institutes of Health Research [89708, 43998]; U.S. Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources; University of Toronto; Natural Sciences and Engineering Research Council of Canada; Cystic Fibrosis Canada; Ontario Graduate Scholarship Program; Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cystic Fibrosis Canada; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by Canadian Institutes of Health Research Grants 43998 (to P. L. H.) and 89708 (to M. N.) and in part by the U.S. Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Center for Research Resources.; These authors contributed equally to this work. Supported by graduate scholarships from the University of Toronto.; Supported in part by the Natural Sciences and Engineering Research Council of Canada, Cystic Fibrosis Canada, the Ontario Graduate Scholarship Program, and the Hospital for Sick Children Foundation Student Scholarship Program.	Abu Khweek A, 2010, MICROBIOL-SGM, V156, P1424, DOI 10.1099/mic.0.036640-0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gantt SL, 2010, J BIOL CHEM, V285, P6036, DOI 10.1074/jbc.M109.033399; Gattis SG, 2010, J BIOL CHEM, V285, P33788, DOI 10.1074/jbc.M110.147173; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Grachev AA, 2011, CARBOHYD RES, V346, P2499, DOI 10.1016/j.carres.2011.08.031; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hernick M, 2010, BIOCHEMISTRY-US, V49, P2246, DOI 10.1021/bi902066t; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kezuka Y, 2010, PROTEINS, V78, P2295, DOI 10.1002/prot.22742; KIDANI Y, 1976, J BIOCHEM-TOKYO, V79, P43, DOI 10.1093/oxfordjournals.jbchem.a131056; KIDANI Y, 1977, J BIOCHEM-TOKYO, V81, P1383; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Labbe G, 2012, J INORG BIOCHEM, V112, P49, DOI 10.1016/j.jinorgbio.2012.02.032; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little DJ, 2012, ACTA CRYSTALLOGR F, V68, P842, DOI 10.1107/S1744309112022075; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Oyama T, 2003, J BIOCHEM, V133, P467, DOI 10.1093/jb/mvg061; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Stutz AE, 2011, ADV CARBOHYD CHEM BI, V66, P187, DOI 10.1016/B978-0-12-385518-3.00004-3; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	72	53	54	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31126	31137		10.1074/jbc.M112.390005	http://dx.doi.org/10.1074/jbc.M112.390005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810235	hybrid, Green Published			2022-12-28	WOS:000308791300025
J	Alli, AA; Song, JZ; Al-Khalili, O; Bao, HF; Ma, HP; Alli, AA; Eaton, DC				Alli, Abdel A.; Song, John Z.; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Alli, Alia A.; Eaton, Douglas C.			Cathepsin B Is Secreted Apically from Xenopus 2F3 Cells and Cleaves the Epithelial Sodium Channel (ENaC) to Increase Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE RECEPTOR; TUMOR-NECROSIS-FACTOR; LIDDLES-SYNDROME; PLASMA-MEMBRANE; GAMMA-SUBUNIT; PROTEOLYTIC ACTIVATION; CYTOCHROME-C; ION CHANNELS; PROTEASE; APOPTOSIS	The epithelial sodium channel (ENaC) plays an important role in regulating sodium balance, extracellular volume, and blood pressure. Evidence suggests the alpha and gamma subunits of ENaC are cleaved during assembly before they are inserted into the apical membranes of epithelial cells, and maximal activity of ENaC depends on cleavage of the extracellular loops of alpha and gamma subunits. Here, we report that Xenopus 2F3 cells apically express the cysteine protease cathepsin B, as indicated by two-dimensional gel electrophoresis and mass spectrometry analysis. Recombinant GST ENaC alpha, beta, and gamma subunit fusion proteins were expressed in Escherichia coli and then purified and recovered from bacterial inclusion bodies. In vitro cleavage studies revealed the full-length ENaC alpha subunit fusion protein was cleaved by active cathepsin B but not the full-length beta or alpha subunit fusion proteins. Both single channel patch clamp studies and short circuit current experiments show ENaC activity decreases with the application of a cathepsin B inhibitor directly onto the apical side of 2F3 cells. We suggest a role for the proteolytic cleavage of ENaC by cathepsin B, and we suggest two possible mechanisms by which cathepsin B could regulate ENaC. Cathepsin B may cleave ENaC extracellularly after being secreted or intracellularly, while ENaC is present in the Golgi or in recycling endosomes.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30345 USA; Ctr Cell & Mol Signaling, Atlanta, GA 30345 USA	Emory University	Alli, AA (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	aalli@emory.edu		Eaton, Douglas/0000-0002-2686-6692	National Institutes of Health [F32 DK093255-01, T32 DK007771, 5R01 DK067110, R37 DK037963]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093255, T32DK007771, R01DK067110, R37DK037963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 DK093255-01 (to Abdel A. Alli), T32 DK007771 (to C. A. Parkos), 5R01 DK067110 (to H.-P. M.), and R37 DK037963 (to D. C. E.).	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Alli A. A., 2012, AM J PHYSL IN PRESS; Alli AA, 2010, J CELL BIOCHEM, V110, P985, DOI 10.1002/jcb.22612; Alli AA, 2009, AM J PHYSIOL-CELL PH, V297, pC1157, DOI 10.1152/ajpcell.00219.2009; Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Eykelbosh AJ, 2010, COMP BIOCHEM PHYS A, V156, P218, DOI 10.1016/j.cbpa.2010.02.005; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Foghsgaard L, 2002, J BIOL CHEM, V277, P39499, DOI 10.1074/jbc.M206669200; Furukawa T, 2007, PHARMACOL THERAPEUT, V115, P106, DOI 10.1016/j.pharmthera.2007.04.008; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Grant Andrew, 2007, P421; GUENETTE RS, 1994, EUR J BIOCHEM, V226, P311, DOI 10.1111/j.1432-1033.1994.tb20055.x; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Haddock RE, 2002, J PHYSIOL-LONDON, V545, P615, DOI 10.1113/jphysiol.2002.027904; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Konstas AA, 2000, PFLUG ARCH EUR J PHY, V441, P341, DOI 10.1007/s004240000430; Korbmacher C, 2009, J MED INVESTIG, V56, P306, DOI 10.2152/jmi.56.306; Krusek J, 2004, PHYSIOL RES, V53, pS103; Lester H A, 1995, Harvey Lect, V91, P79; Lohmuller T, 2003, BIOL CHEM, V384, P899, DOI 10.1515/BC.2003.101; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; MARTELPELLETIER J, 1990, J ORTHOPAED RES, V8, P336, DOI 10.1002/jor.1100080305; Mort J S, 1985, Prog Clin Biol Res, V180, P243; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Schild L, 1996, NEPHROLOGIE, V17, P395; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	49	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30073	30083		10.1074/jbc.M111.338574	http://dx.doi.org/10.1074/jbc.M111.338574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22782900	Green Published, hybrid			2022-12-28	WOS:000308579800003
J	Geng, YY; Monajembashi, S; Shao, AW; Cui, D; He, WY; Chen, ZZ; Hemmerich, P; Tang, J				Geng, Yunyun; Monajembashi, Shamci; Shao, Anwen; Cui, Di; He, Weiyong; Chen, Zhongzhou; Hemmerich, Peter; Tang, Jun			Contribution of the C-terminal Regions of Promyelocytic Leukemia Protein (PML) Isoforms II and V to PML Nuclear Body Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E4 ORF3 PROTEIN; ND10; BODIES; DOMAINS; TRANSCRIPTION; DISRUPTION; MECHANISMS; REPRESSION; INFECTION; SEQUENCE	Promyelocytic leukemia protein (PML) nuclear bodies are dynamic and heterogeneous nuclear protein complexes implicated in various important functions, most notably tumor suppression. PML is the structural component of PML nuclear bodies and has several nuclear splice isoforms that share a common N-terminal region but differ in their C termini. Previous studies have suggested that the coiled-coil motif within the N-terminal region is sufficient for PML nuclear body formation by mediating homo/multi-dimerization of PML molecules. However, it has not been investigated whether any of the C-terminal variants of PML may contribute to PML body assembly. Here we report that the unique C-terminal domains of PML-II and PML-V can target to PML-NBs independent of their N-terminal region. Strikingly, both domains can form nuclear bodies in the absence of endogenous PML. The C-terminal domain of PML-II interacts transiently with unknown binding sites at PML nuclear bodies, whereas the C-terminal domain of PML-V exhibits hyperstable binding to PML bodies via homo-dimerization. This strong interaction is mediated by a putative alpha-helix in the C terminus of PML-V. Moreover, nuclear bodies assembled from the C-terminal domain of PML-V also recruit additional PML body components, including Daxx and Sp100. These observations establish the C-terminal domain of PML-V as an additional important contributor to the assembly mechanism(s) of PML bodies.	[Geng, Yunyun; Shao, Anwen; Cui, Di; He, Weiyong; Tang, Jun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Geng, Yunyun; Cui, Di; Chen, Zhongzhou; Tang, Jun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Monajembashi, Shamci; Hemmerich, Peter] Leibniz Inst Age Res, D-07743 Jena, Germany; [Chen, Zhongzhou] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); China Agricultural University	Tang, J (corresponding author), China Agr Univ, Coll Vet Med, Rm 213,2 Yuanmingyuan W Rd, Beijing 100193, Peoples R China.	jtang@cau.edu.cn	耿, 云云/GSJ-0054-2022; chen, zhong/E-3900-2015; Shao, Anwen/L-4860-2019	chen, zhong/0000-0003-1319-9664; Shao, Anwen/0000-0001-5616-0394	Chinese Universities Scientific Fund [2012RC002]	Chinese Universities Scientific Fund	This work was supported by Chinese Universities Scientific Fund 2012RC002 (to J. T.).	Beech SJ, 2005, EXP CELL RES, V307, P109, DOI 10.1016/j.yexcr.2005.03.012; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Cantrell SR, 2006, J VIROL, V80, P6188, DOI 10.1128/JVI.02676-05; Chung I, 2011, J CELL SCI, V124, P3603, DOI 10.1242/jcs.084681; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Ebrahimian M, 2010, CELLS TISSUES ORGANS, V192, P374, DOI 10.1159/000319466; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; ISHOV AM, 1999, J CELL BIOL, V147, P221, DOI [10.1083/jcb.147.2.221, DOI 10.1083/JCB.147.2.221]; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jul-Larsen A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-89; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Leppard KN, 2009, J GEN VIROL, V90, P95, DOI 10.1099/vir.0.005512-0; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Negorev D, 2001, J CELL SCI, V114, P59; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Oh W, 2009, J CELL SCI, V122, P2613, DOI 10.1242/jcs.048066; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Pandolfi PP, 2001, ONCOGENE, V20, P5726, DOI 10.1038/sj.onc.1204600; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	59	32	35	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30729	30742		10.1074/jbc.M112.374769	http://dx.doi.org/10.1074/jbc.M112.374769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773875	hybrid, Green Published			2022-12-28	WOS:000308579800062
J	Jeong, JH; Lee, KH; Kim, YM; Kim, DH; Oh, BH; Kim, YG				Jeong, Jae-Hee; Lee, Kwang-Hoon; Kim, Young-Mi; Kim, Do-Hyung; Oh, Byung-Ha; Kim, Yeon-Gil			Crystal Structure of the Gtr1p(GTP)-Gtr2p(GDP) Protein Complex Reveals Large Structural Rearrangements Triggered by GTP-to-GDP Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; RAG GTPASES; ACTIVATION; TORC1	The heterodimeric Rag GTPases consisting of RagA (or RagB) and RagC (or RagD) are the key regulator activating the target of rapamycin complex 1 (TORC1) in response to the level of amino acids. The heterodimer between GTP-loaded RagA/B and GDP-loaded RagC/D is the most active form that binds Raptor and leads to the activation of TORC1. Here, we present the crystal structure of Gtr1pGTP-Gtr2pGDP, the active yeast Rag GTPase heterodimer. The structure reveals that GTP-to-GDP conversion on Gtr2p results in a large conformational transition of this subunit, including a large scale rearrangement of a long segment whose corresponding region in RagA is involved in binding to Raptor. In addition, the two GTPase domains of the heterodimer are brought to contact with each other, but without causing any conformational change of the Gtr1p subunit. These features explain how the nucleotide-bound statuses of the two GTPases subunits switch the Raptor binding affinity on and off.	[Jeong, Jae-Hee; Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Lee, Kwang-Hoon; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, Inst Biocentury, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Young-Mi; Kim, Do-Hyung] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Pohang University of Science & Technology (POSTECH); Korea Advanced Institute of Science & Technology (KAIST); University of Minnesota System; University of Minnesota Twin Cities	Kim, YG (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea.	ygkim76@postech.ac.kr	Oh, Byung-Ha/C-2061-2011	Kim, Do-Hyung/0000-0002-2924-4370	Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs; Basic Science Research Program through National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0007201]; Global Research Laboratory (GRL) Program, NRF of Korea [K20815000001]; American Diabetes Association [7-07-CD-08]; National Institutes of Health [DK072004, DK083474]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072004, R01DK072004, R56DK083474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097057] Funding Source: NIH RePORTER	Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs; Basic Science Research Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Global Research Laboratory (GRL) Program, NRF of Korea(National Research Foundation of Korea); American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2011-0007201) (to Y. G. K.), by the Global Research Laboratory (GRL) Program (Grant K20815000001) from the NRF of Korea (to B. H. O.), and by the American Diabetes Association (7-07-CD-08) (to D. H. K.) and by the National Institutes of Health (Grants DK072004 and DK083474) (to D. H. K.).	Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; RENSLAND H, 1991, BIOCHEMISTRY-US, V30, P11181, DOI 10.1021/bi00110a023; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1	20	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29648	29653		10.1074/jbc.C112.384420	http://dx.doi.org/10.1074/jbc.C112.384420			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22807443	hybrid, Green Published			2022-12-28	WOS:000308286900040
J	Runkle, EA; Rice, SJ; Qi, J; Masser, D; Antonetti, DA; Winslow, MM; Mu, D				Runkle, E. Aaron; Rice, Shawn J.; Qi, Ji; Masser, Dustin; Antonetti, David A.; Winslow, Monte M.; Mu, David			Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; TIGHT JUNCTION PROTEIN; DNA RECOGNITION; LUNG-CANCER; PROGNOSTIC-FACTOR; BARRIER FUNCTION; AMINO-ACIDS; EXPRESSION; HOMEODOMAIN; CLAUDIN-1	The thyroid transcription factor 1 gene (TTF-1 or NKX2-1) is essential to lung development; however, it is also a critical factor in lung cancer. TTF-1 is amplified in lung cancers, suggesting that it is a gain-of-function lung oncogene. Conversely, TTF-1 counters epithelial to mesenchymal transition in cell-based studies and inhibits progression of primary lung adenocarcinomas to metastases in an animal model of lung adenocarcinomas. The unifying theory regarding TTF-1 is that it exhibits both pro-oncogenic and anti-metastatic function depending on the cellular context. Occludin is the first discovered constituent of the epithelial tight junction; in recent years, a functional role of occludin as a tumor suppressor has begun to emerge. Here, we demonstrate that TTF-1 transactivated the expression of the epithelial tight junction molecules occludin (OCLN) and claudin-1 (CLDN1). We show that transcriptional activation occurred through a direct interaction of TTF-1 with the OCLN and CLDN1 promoters. Furthermore, in cells that lack TTF-1, exogenous TTF-1 expression dampened the inhibitory effect of TGF-beta on occludin and claudin-1 content. Using cells derived from a genetically engineered mouse model of lung adenocarcinomas, we observed that silenced TTF-1 expression down-regulated occludin, which we supported with additional siRNA experiments. Finally, TTF-1 knockdown conferred human lung cancer cells resistance to anoikis, and expression of occludin restored cellular sensitivity to anoikis. Overexpression of occludin impeded migration and induced anoikis in lung carcinoma cells. Collectively, these data suggest that TTF-1 transcriptionally regulates occludin, which represents another avenue of TTF-1-mediated metastasis suppression.	[Runkle, E. Aaron; Rice, Shawn J.; Qi, Ji; Mu, David] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA 17033 USA; [Qi, Ji; Mu, David] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Masser, Dustin; Mu, David] Penn State Univ, Biomed Sci Grad Program, Coll Med, Hershey, PA 17033 USA; [Mu, David] Penn State Univ, Inst Canc, Coll Med, Hershey, PA 17033 USA; [Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Winslow, Monte M.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Michigan System; University of Michigan; Stanford University	Mu, D (corresponding author), Penn State Univ, Dept Pathol, Coll Med, 500 Univ Dr,H083, Hershey, PA 17033 USA.	dmu234@gmail.com	Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182; antonetti, david/0000-0003-1130-6577	National Institutes of Health [CA127547]; NATIONAL CANCER INSTITUTE [R01CA127547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127547 (to D. M.).	Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; DEFELICE M, 1995, J BIOL CHEM, V270, P26649, DOI 10.1074/jbc.270.44.26649; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Fabbro D, 1996, NUCLEIC ACIDS RES, V24, P3283, DOI 10.1093/nar/24.17.3283; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Felinski EA, 2008, EXP EYE RES, V86, P867, DOI 10.1016/j.exer.2008.01.002; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee JW, 2005, GYNECOL ONCOL, V97, P53, DOI 10.1016/j.ygyno.2004.11.058; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Pellizzari L, 1997, FEBS LETT, V407, P320, DOI 10.1016/S0014-5793(97)00368-2; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; REDDEL RR, 1988, CANCER RES, V48, P1904; Runkle EA, 2011, J BIOL CHEM, V286, P30847, DOI 10.1074/jbc.M111.262857; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Singh AB, 2010, J ONCOL, V2010, DOI 10.1155/2010/541957; Soini Y, 2005, HISTOPATHOLOGY, V46, P551, DOI 10.1111/j.1365-2559.2005.02127.x; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Tang XM, 2011, CLIN CANCER RES, V17, P2434, DOI 10.1158/1078-0432.CCR-10-1412; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Wei L, 2001, CANCER RES, V61, P2439; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008	59	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28790	28801		10.1074/jbc.M112.367987	http://dx.doi.org/10.1074/jbc.M112.367987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761434	hybrid, Green Published			2022-12-28	WOS:000308074600052
J	Siekierska, A; De Baets, G; Reumers, J; Gallardo, R; Rudyak, S; Broersen, K; Couceiro, J; Van Durme, J; Schymkowitz, J; Rousseau, F				Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Gallardo, Rodrigo; Rudyak, Stanislav; Broersen, Kerensa; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic			alpha-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; LYSOSOMAL STORAGE; ENDOPLASMIC-RETICULUM; GAUCHER-DISEASE; FORCE-FIELD; TRAFFICKING; PREDICTION; DEFECT; 1-DEOXYGALACTONOJIRIMYCIN; POLYMORPHISMS	Fabry disease is a lysosomal storage disorder caused by loss of alpha-galactosidase function. More than 500 Fabry disease mutants have been identified, the majority of which are structurally destabilized. A therapeutic strategy under development for lysosomal storage diseases consists of using pharmacological chaperones to stabilize the structure of the mutant protein, thereby promoting lysosomal delivery over retrograde degradation. The substrate analog 1-deoxygalactonojirimycin (DGJ) has been shown to restore activity of mutant alpha-galactosidase and is currently in clinical trial for treatment of Fabry disease. However, only similar to 65% of tested mutants respond to treatment in cultured patient fibroblasts, and the structural underpinnings of DGJ response remain poorly explained. Using computational modeling and cell culture experiments, we show that the DGJ response is negatively affected by protein aggregation of alpha-galactosidase mutants, revealing a qualitative difference between misfolding-associated and aggregation-associated loss of function. A scoring function combining predicted thermodynamic stability and intrinsic aggregation propensity of mutants captures well their aggregation behavior under overexpression in HeLa cells. Interestingly, the same classifier performs well on DGJ response data of patient-derived cultured lymphoblasts, showing that protein aggregation is an important determinant of chemical chaperone efficiency under endogenous expression levels as well. Our observations reinforce the idea that treatment of aggregation-associated loss of function observed for the more severe alpha-galactosidase mutants could be enhanced by combining pharmacological chaperone treatment with the suppression of mutant aggregation, e. g. via proteostatic regulator compounds that increase cellular chaperone expression.	[Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Rudyak, Stanislav; Broersen, Kerensa; Van Durme, Joost] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Siekierska, Aleksandra; De Baets, Greet; Reumers, Joke; Gallardo, Rodrigo; Rudyak, Stanislav; Broersen, Kerensa; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic] VIB SWITCH Lab, Brussels, Belgium; [Siekierska, Aleksandra; De Baets, Greet; Gallardo, Rodrigo; Couceiro, Jose; Van Durme, Joost; Schymkowitz, Joost; Rousseau, Frederic] Univ Louvain, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Schymkowitz, J (corresponding author), Univ Louvain, Dept Mol Cell Biol, SWITCH Lab, B-3000 Louvain, Belgium.	joost.schymkowitz@switch.vib-kuleuven.be; frederic.rousseau@switch.vib-kuleuven.be	Schymkowitz, Joost/AAV-3680-2021; Rudyak, Stanislav/U-1781-2017; Rodríguez Couceiro, Jose/F-1497-2016; Bustelo, Xose R./A-9526-2010; De Baets, Greet/J-1881-2014; Rousseau, Frederic/J-9044-2016; Schymkowitz, Joost/K-7764-2016	Rodríguez Couceiro, Jose/0000-0002-5742-1071; Bustelo, Xose R./0000-0001-9398-6072; De Baets, Greet/0000-0001-8844-800X; Rousseau, Frederic/0000-0002-9189-7399; Schymkowitz, Joost/0000-0003-2020-0168; Siekierska, Aleksandra/0000-0003-4907-605X; Reumers, Joke/0000-0001-5434-6515; Gallardo, Rodrigo/0000-0003-1584-3564	Funds for Scientific Research of Flanders (FWO); Federal Office for Scientific Affairs, Belgium [IUAP P6/43]	Funds for Scientific Research of Flanders (FWO)(FWO); Federal Office for Scientific Affairs, Belgium	This work was supported by the Funds for Scientific Research of Flanders (FWO) and the Federal Office for Scientific Affairs, Belgium, Grant IUAP P6/43 (to the SWITCH Laboratory).	Andreotti G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-66; Andreotti G, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-36; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Bruni S, 2007, Acta Myol, V26, P87; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; ENG CM, 1994, HUM MUTAT, V3, P103, DOI 10.1002/humu.1380030204; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, MOL GENET METAB, V77, P3, DOI 10.1016/S1096-7192(02)00151-8; Hamanaka R, 2008, BBA-MOL BASIS DIS, V1782, P408, DOI 10.1016/j.bbadis.2008.03.001; Ishii S, 1996, BIOCHEM BIOPH RES CO, V220, P812, DOI 10.1006/bbrc.1996.0486; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LEMANSKY P, 1987, J BIOL CHEM, V262, P2062; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shin SH, 2008, PHARMACOGENET GENOM, V18, P773, DOI 10.1097/FPC.0b013e32830500f4; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Sugawara K, 2009, J HUM GENET, V54, P324, DOI 10.1038/jhg.2009.32; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Yam GHF, 2007, BIOCHEM BIOPH RES CO, V360, P375, DOI 10.1016/j.bbrc.2007.06.048; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671	46	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28386	28397		10.1074/jbc.M112.351056	http://dx.doi.org/10.1074/jbc.M112.351056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773828	hybrid, Green Published			2022-12-28	WOS:000308074600015
J	Sivaramakrishnan, V; Fountain, SJ				Sivaramakrishnan, Venketesh; Fountain, Samuel J.			A Mechanism of Intracellular P2X Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; CONTRACTILE VACUOLE COMPLEX; DENSITY-SENSING FACTOR; DICTYOSTELIUM-DISCOIDEUM; ATP; IDENTIFICATION; MEMBRANE; PROTEIN; OSMOREGULATION; CALMODULIN	P2X receptors (P2XRs) are ATP-activated calcium-permeable ligand-gated ion channels traditionally viewed as sensors of extracellular ATP during diverse physiological processes including pain, inflammation, and taste. However, in addition to a cell surface residency P2XRs also populate the membranes of intracellular compartments, including mammalian lysosomes, phagosomes, and the contractile vacuole (CV) of the amoeba Dictyostelium. The function of intracellular P2XRs is unclear and represents a major gap in our understanding of ATP signaling. Here, we exploit the genetic versatility of Dictyostelium to investigate the effects of physiological concentrations of ATP on calcium signaling in isolated CVs. Within the CV, an acidic calcium store, P2XRs are orientated to sense luminal ATP. Application of ATP to isolated vacuoles leads to luminal translocation of ATP and release of calcium. Mechanisms of luminal ATP translocation and ATP-evoked calcium release share common pharmacology, suggesting that they are linked processes. The ability of ATP to mobilize stored calcium is reduced in vacuoles isolated from P2X(A)R knock-out amoeba and ablated in cells devoid of P2XRs. Pharmacological inhibition of luminal ATP translocation or depletion of CV calcium attenuates CV function in vivo, manifesting as a loss of regulatory cell volume decrease following osmotic swelling. We propose that intracellular P2XRs regulate vacuole activity by acting as calcium release channels, activated by translocation of ATP into the vacuole lumen.	[Sivaramakrishnan, Venketesh; Fountain, Samuel J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Fountain, SJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.j.fountain@uea.ac.uk	Sivaramakrishnan, Venketesh/J-2025-2012; Fountain, Samuel J/C-2142-2011	Sivaramakrishnan, Venketesh/0000-0003-3094-5905; 	Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship	Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship personal award (to S. J. F.).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; BERGQUIST BL, 1989, T AM MICROSC SOC, V108, P369, DOI 10.2307/3226267; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bush J, 1996, MOL BIOL CELL, V7, P1623, DOI 10.1091/mbc.7.10.1623; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Deery WJ, 2002, J BIOL CHEM, V277, P31972, DOI 10.1074/jbc.M204539200; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Gabriel D, 1999, J CELL SCI, V112, P3995; Gualix J, 1999, RECEPTOR CHANNEL, V6, P449; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; JAIN R, 1994, J BIOL CHEM, V269, P9128; Jedlitschky G, 2004, BLOOD, V104, P3603, DOI 10.1182/blood-2003-12-4330; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; Malchow D, 2008, CELL CALCIUM, V43, P521, DOI 10.1016/j.ceca.2007.08.002; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; MAY T, 1991, MECH DEVELOP, V33, P147, DOI 10.1016/0925-4773(91)90081-G; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; ROONEY EK, 1994, CELL CALCIUM, V16, P509, DOI 10.1016/0143-4160(94)90081-7; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Stokes L, 2009, EUR J IMMUNOL, V39, P986, DOI 10.1002/eji.200838818; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	43	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28315	28326		10.1074/jbc.M112.372565	http://dx.doi.org/10.1074/jbc.M112.372565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736763	Green Published, hybrid			2022-12-28	WOS:000308074600009
J	Reddy, SDN; Pakala, SB; Molli, PR; Sahni, N; Karanam, NK; Mudvari, P; Kumar, R				Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Molli, Poonam R.; Sahni, Neil; Karanam, Narasimha Kumar; Mudvari, Prakriti; Kumar, Rakesh			Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; CELL-MIGRATION; TRANSCRIPTIONAL REPRESSION; MTA1; KINASE; INVASION; ACTIVATION; PROMOTER; FAMILY	Metastasis-associated protein 1 (MTA1) is widely overexpressed in human cancers and is associated with malignant phenotypic changes contributing to morbidity in the associated diseases. Here we discovered for the first time that MTA1, a master chromatin modifier, transcriptionally represses the expression of phosphatase and tensin homolog (PTEN), a tumor suppressor gene, by recruiting class II histone deacetylase 4 (HDAC4) along with the transcription factor Yin-Yang 1 (YY1) onto the PTEN promoter. We also found evidence of an inverse correlation between the expression levels of MTA1 and PTEN in physiologically relevant breast cancer microarray datasets. We found that MTA1 up-regulation leads to a decreased expression of PTEN protein and stimulation of PI3K as well as phosphorylation of its signaling targets. Accordingly, selective down-regulation of MTA1 in breast cancer cells increases PTEN expression and inhibits stimulation of the PI3K/AKT signaling. Collectively, these findings provide a mechanistic role for MTA1 in transcriptional repression of PTEN, leading to modulation of the resulting signaling pathways.	[Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Molli, Poonam R.; Sahni, Neil; Karanam, Narasimha Kumar; Mudvari, Prakriti; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837; Karanam, Narasimha Kumar/0000-0002-7575-243X	National Institutes of Health [CA 988023]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported, in whole or in part, by National Institutes of Health Grant CA 988023 (to R.K.).	Anderson DH, 2010, CELL CYCLE, V9, P2055, DOI 10.4161/cc.9.11.11926; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, CELL, V133, P550, DOI 10.1016/j.cell.2008.04.023; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chow JYC, 2010, AM J PHYSIOL-GASTR L, V298, pG275, DOI 10.1152/ajpgi.00344.2009; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; He JM, 2010, BIOCHEM BIOPH RES CO, V397, P513, DOI 10.1016/j.bbrc.2010.05.146; Hlobilkova Alice, 2003, Biomedical Papers (Olomouc), V147, P19; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Kawasaki G, 2008, INT J ORAL MAX SURG, V37, P1039, DOI 10.1016/j.ijom.2008.05.020; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Marzook H, 2012, J BIOL CHEM, V287, P5615, DOI 10.1074/jbc.M111.314088; Mise-Omata S, 2005, BIOCHEM BIOPH RES CO, V328, P1034, DOI 10.1016/j.bbrc.2005.01.066; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Saga Y, 2003, INT J ONCOL, V23, P1109; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salot S., 2010, J CANC SCI THERAPY, V2, P114; Sankaran D, 2012, J BIOL CHEM, V287, P5483, DOI 10.1074/jbc.M111.324632; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tamura M, 1999, CANCER RES, V59, P442; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tolkacheva T, 2001, CANCER RES, V61, P4985; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamada KM, 2001, J CELL SCI, V114, P2375; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000	52	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27843	27850		10.1074/jbc.M112.348474	http://dx.doi.org/10.1074/jbc.M112.348474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700976	hybrid, Green Published			2022-12-28	WOS:000307840700058
J	She, K; Ferreira, JS; Carvalho, AL; Craig, AM				She, Kevin; Ferreira, Joana S.; Carvalho, Ana Luisa; Craig, Ann Marie			Glutamate Binding to the GluN2B Subunit Controls Surface Trafficking of N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; LIGAND-BINDING; HIPPOCAMPAL-NEURONS; QUALITY-CONTROL; MOLECULAR DETERMINANTS; DIFFERENTIAL ROLES; AMPA RECEPTORS; ACID RECEPTORS; NR2 SUBUNIT; GLYCINE	Trafficking of NMDA receptors to the surface of neurons and to synapses is critical for proper brain function and activity-dependent plasticity. Recent evidence suggests that surface trafficking of other ionotropic glutamate receptors requires ligand binding for exit from the endoplasmic reticulum. Here, we show that glutamate binding to GluN2 is required for trafficking of NMDA receptors to the cell surface. We expressed a panel of GluN2B ligand binding mutants in heterologous cells with GluN1 or in rat cultured neurons and found that surface expression correlates with glutamate efficacy. Such a correlation was found even in the presence of dominant negative dynamin to inhibit endocytosis and surface expression correlated with Golgi localization, indicating differences in forward trafficking. Co-expression of wild type GluN2B did not enhance surface expression of the mutants, suggesting that glutamate must bind to both GluN2 subunits in a tetramer and that surface expression is limited by the least avid of the two glutamate binding sites. Surface trafficking of a constitutively closed cleft GluN2B was indistinguishable from that of wild type, suggesting that glutamate concentrations are typically not limiting for forward trafficking. YFP-GluN2B expressed in hippocampal neurons from GluN2B(-/-) mice rescued synaptic accumulation at similar levels to wild type. Under these conditions, surface synaptic accumulation of YFP-GluN2B mutants also correlated with apparent glutamate affinity. Altogether, these results indicate that glutamate controls forward trafficking of NMDA receptors to the cell surface and to synapses and raise the intriguing idea that NMDA receptors may be functional at intracellular sites.	[She, Kevin; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [She, Kevin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Ferreira, Joana S.; Carvalho, Ana Luisa] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal; [Ferreira, Joana S.; Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal	University of British Columbia; University of British Columbia; Universidade de Coimbra; Universidade de Coimbra	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Rm F149,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	acraig@mail.ubc.ca	Carvalho, Ana Luisa/K-6367-2013; Ferreira, Joana/AAY-8702-2020; Ferreira, Joana/I-9447-2014; Craig, Ann Marie/M-2054-2014	Carvalho, Ana Luisa/0000-0001-8368-6666; Ferreira, Joana/0000-0002-1049-8063; Ferreira, Joana/0000-0002-1049-8063; 	Canadian Institutes of Health Research (CIHR) [MOP-69096]; Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-NEU/099440/2008]; Canada Research Chair; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-69096 (to A. M. C.), by the Portuguese Foundation for Science and Technology (FCT) Grant PTDC/SAU-NEU/099440/2008 (to A. L. C.), and by salary awards CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (to K. S.) and Canada Research Chair (to A. M. C.).	BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BERGER SJ, 1977, J NEUROCHEM, V28, P149, DOI 10.1111/j.1471-4159.1977.tb07720.x; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Ferreira JS, 2011, J BIOL CHEM, V286, P28331, DOI 10.1074/jbc.M111.222539; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mammen AL, 1997, J NEUROSCI, V17, P7351; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rao A, 1998, J NEUROSCI, V18, P1217; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200	46	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27432	27445		10.1074/jbc.M112.345108	http://dx.doi.org/10.1074/jbc.M112.345108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740692	Green Published, hybrid			2022-12-28	WOS:000307840700016
J	Hubackova, S; Krejcikova, K; Bartek, J; Hodny, Z				Hubackova, Sona; Krejcikova, Katerina; Bartek, Jiri; Hodny, Zdenek			Interleukin 6 Signaling Regulates Promyelocytic Leukemia Protein Gene Expression in Human Normal and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS TYPE-1; ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; PML NUCLEAR-BODIES; TUMOR-SUPPRESSOR; HETEROCHROMATIN FOCI; CELLULAR SENESCENCE; ANTICANCER BARRIER; GROWTH-SUPPRESSOR; SP100 PROTEINS	Tumor suppressor PML is induced under viral and genotoxic stresses by interferons and JAK-STAT signaling. However, the mechanism responsible for its cell type-specific regulation under non-stimulated conditions is poorly understood. To analyze the variation of PML expression, we utilized three human cell types, BJ fibroblasts and HeLa and U2OS cell lines, each with a distinct PML expression pattern. Analysis of JAK-STAT signaling in the three cell lines revealed differences in levels of activated STAT3 but not STAT1 correlating with PML mRNA and protein levels. RNAi-mediated knockdown of STAT3 decreased PML expression; both STAT3 level/activity and PML expression relied on IL6 secreted into culture media. We mapped the IL6-responsive sequence to an ISRE(-595/-628) element of the PML promoter. The PI3K/Akt/NF kappa B branch of IL6 signaling showed also cell-type dependence, being highest in BJ, intermediate in HeLa, and lowest in U2OS cells and correlated with IL6 secretion. RNAi-mediated knockdown of NEMO (NF-kappa-B essential modulator), a key component of NF kappa B activation, suppressed NF kappa B targets LMP2 and IRF1 together with STAT3 and PML. Combined knockdown of STAT3 and NEMO did not further promote PML suppression, and it can be bypassed by exogenous IL6, indicating the NF-kappa B pathway acts upstream of JAK-STAT3 through induction of IL6. Our results indicate that the cell type-specific activity of IL6 signaling pathways governs PML expression under unperturbed growth conditions. As IL6 is induced in response to various viral and genotoxic stresses, this cytokine may regulate autocrine/paracrine induction of PML under these pathophysiological states as part of tissue adaptation to local stress.	[Hubackova, Sona; Krejcikova, Katerina; Bartek, Jiri; Hodny, Zdenek] Acad Sci Czech Republ, Inst Mol Genet, Dept Genome Integr, Vvi, CR-14220 Prague, Czech Republic; [Bartek, Jiri] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Danish Cancer Society	Bartek, J (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Genome Integr, Vvi, Videnska 1083, CR-14220 Prague, Czech Republic.	jb@cancer.dk; hodny@img.cas.cz	Hodny, Zdenek/C-9384-2009; Bartek, Jiri/G-5870-2014	Stemberkova Hubackova, Sona/0000-0002-3454-6840	Grant Agency of the Czech Republic [204/08/1418]; Institutional Grant [RVO 68378050]; Danish Cancer Society; Danish National Research Foundation; Czech Ministry of Education [MSM6198959216]; Novo Nordisk [R153-A12997]; European Commission 7th Framework Programme (Projects Infla-Care, Biomedreg and TRIREME)	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institutional Grant; Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Novo Nordisk(Novo Nordisk); European Commission 7th Framework Programme (Projects Infla-Care, Biomedreg and TRIREME)	This work was supported by Grant Agency of the Czech Republic (Project 204/08/1418), Institutional Grant (Project RVO 68378050), the Danish Cancer Society, the Danish National Research Foundation, the Czech Ministry of Education (MSM6198959216), Novo Nordisk (R153-A12997), and the European Commission 7th Framework Programme (Projects Infla-Care, Biomedreg and TRIREME).	AARDEN LA, 1989, ANN NY ACAD SCI, V557, P192; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x; Bourdeau V, 2009, FRONT BIOSCI-LANDMRK, V14, P475, DOI 10.2741/3256; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Burkham J, 2001, J VIROL, V75, P2353, DOI 10.1128/JVI.75.5.2353-2367.2001; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Carey M., 2008, TRANSCRIPTIONAL REGU, P132; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; Dellaire G, 2009, CELL CYCLE, V8, P3750, DOI 10.4161/cc.8.22.10065; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eda H, 2011, CELL BIOL INT, V35, P355, DOI 10.1042/CBI20100247; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Everett RD, 2006, CELL MICROBIOL, V8, P365, DOI 10.1111/j.1462-5822.2005.00677.x; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gambacorta M, 1996, AM J PATHOL, V149, P2023; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herzer K, 2005, CANCER RES, V65, P10830, DOI 10.1158/0008-5472.CAN-05-0880; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Hubackova S, 2010, CELL CYCLE, V9, P3085, DOI 10.4161/cc.9.15.12521; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Jiang WQ, 1997, CELL GROWTH DIFFER, V8, P513; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; KORIOTH F, 1995, J CELL BIOL, V130, P1, DOI 10.1083/jcb.130.1.1; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; LAVAU C, 1995, ONCOGENE, V11, P871; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lombard DB, 2000, CANCER RES, V60, P2331; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Mallette FA, 2007, J BIOL CHEM, V282, P34938, DOI 10.1074/jbc.M707074200; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Muller S, 1999, J VIROL, V73, P5137; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V221, P448, DOI 10.1006/excr.1995.1396; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; REIN T, 1994, NUCLEIC ACIDS RES, V22, P3033, DOI 10.1093/nar/22.15.3033; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggero D, 2000, BIOESSAYS, V22, P827, DOI 10.1002/1521-1878(200009)22:9<827::AID-BIES8>3.3.CO;2-T; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shtutman Michael, 2002, Cancer Research, V62, P5947; Stadler M, 1995, ONCOGENE, V11, P2565; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; STUURMAN N, 1992, J CELL SCI, V101, P773; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Vlasakova J, 2007, BLOOD, V109, P1373, DOI 10.1182/blood-2006-02-003418; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wang ZG, 1998, SCIENCE, V279, P1547; Wilkinson GWG, 1998, J GEN VIROL, V79, P1233, DOI 10.1099/0022-1317-79-5-1233; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	83	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26702	26714		10.1074/jbc.M111.316869	http://dx.doi.org/10.1074/jbc.M111.316869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711534	hybrid, Green Published			2022-12-28	WOS:000307386000021
J	Liu, TF; Vachharajani, VT; Yoza, BK; McCall, CE				Liu, Tie Fu; Vachharajani, Vidula T.; Yoza, Barbara K.; McCall, Charles E.			NAD(+)-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-MEDIATED INFLAMMATION; T-CELL MEMORY; ENDOTOXIN TOLERANCE; INSULIN-RESISTANCE; SEPSIS; METABOLISM; IMMUNOSUPPRESSION; DIFFERENTIATION; ADIPONECTIN; HOMEOSTASIS	The early initiation phase of acute inflammation is anabolic and primarily requires glycolysis with reduced mitochondrial glucose oxidation for energy, whereas the later adaptation phase is catabolic and primarily requires fatty acid oxidation for energy. We reported previously that switching from the early to the late acute inflammatory response following TLR4 stimulation depends on NAD(+) activation of deacetylase sirtuin 1 (SirT1). Here, we tested whether NAD(+) sensing by sirtuins couples metabolic polarity with the acute inflammatory response. We found in TLR4-stimulated THP-1 promonocytes that SirT1 and SirT 6 support a switch from increased glycolysis to increased fatty acid oxidation as early inflammation converts to late inflammation. Glycolysis enhancement required hypoxia-inducing factor-1 alpha to up-regulate glucose transporter Glut1, phospho-fructose kinase, and pyruvate dehydrogenase kinase 1, which interrupted pyruvate dehydrogenase and reduced mitochondrial glucose oxidation. The shift to late acute inflammation and elevated fatty acid oxidation required peroxisome proliferator-activated receptor gamma coactivators PGC-1 alpha and beta to increase external membrane CD36 and fatty acid mitochondrial transporter carnitine palmitoyl transferase 1. Metabolic coupling between early and late responses also required NAD(+) production from nicotinamide phosphoryltransferase (Nampt) and activation of SirT6 to reduce glycolysis and SirT1 to increase fatty oxidation. We confirmed similar shifts in metabolic polarity during the late immuno-suppressed stage of human sepsis blood leukocytes and murine sepsis splenocytes. We conclude that NAD(+)-dependent bioenergy shifts link metabolism with the early and late stages of acute inflammation.	[Liu, Tie Fu; Yoza, Barbara K.; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Vachharajani, Vidula T.] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27157 USA; [McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tliu@wfubmc.edu; chmccall@wfubmc.edu	Vachharajani, Vidula/AAX-3640-2021	Vachharajani, Vidula/0000-0002-0892-7084	National Institutes of Health [AI-065791, AI-079144, GM086470, MO-1RR 007122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065791, R56AI079144, R56AI065791, R01AI079144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM086470, R01GM102497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants AI-065791 and AI-079144 (to C. E. M.), K08 Grant GM086470 (to V. V.), and MO-1RR 007122 (to the Wake Forest University General Clinical Research Center). The research on human participants was endorsed by Wake Forest University Institutional Review Board protocol BG174. The animal sepsis model was approved by the Institutional Animal Care and Use Committee of the Wake Forest University School of Medicine.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Gao J, 2000, J CELL PHYSIOL, V182, P297; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Munford RS, 2001, J ENDOTOXIN RES, V7, P327, DOI 10.1177/09680519010070040501; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Schumer W, 1974, Surg Annu, V6, P1; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Vachharajani V, 2012, OBESITY, V20, P498, DOI 10.1038/oby.2011.316; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yumoto H, 2005, INFECT IMMUN, V73, P8050, DOI 10.1128/IAI.73.12.8050-8059.2005; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	228	240	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25758	25769		10.1074/jbc.M112.362343	http://dx.doi.org/10.1074/jbc.M112.362343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700961	Green Published, hybrid			2022-12-28	WOS:000306916300007
J	Borthakur, S; Hibbert, RG; Pang, MOY; Yahya, N; Bax, HJ; Kao, MW; Cooper, AM; Beavil, AJ; Sutton, BJ; Gould, HJ; McDonnell, JM				Borthakur, Susmita; Hibbert, Richard G.; Pang, Marie O. Y.; Yahya, Norhakim; Bax, Heather J.; Kao, Michael W.; Cooper, Alison M.; Beavil, Andrew J.; Sutton, Brian J.; Gould, Hannah J.; McDonnell, James M.			Mapping of the CD23 Binding Site on Immunoglobulin E (IgE) and Allosteric Control of the IgE-Fc epsilon RI Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; LECTIN DOMAIN; PROTEIN-A; RECEPTOR; AFFINITY; FRAGMENT; REVEALS; COMPLEX; FLEXIBILITY	IgE, the antibody that mediates allergic responses, acts as part of a self-regulating protein network. Its unique effector functions are controlled through interactions of its Fc region with two cellular receptors, Fc epsilon RI on mast cells and basophils and CD23 on B cells. IgE cross-linked by allergen triggers mast cell activation via Fc epsilon RI, whereas IgE-CD23 interactions control IgE expression levels. We have determined the CD23 binding site on IgE, using a combination of NMR chemical shift mapping and site-directed mutagenesis. We show that the CD23 and Fc epsilon RI interaction sites are at opposite ends of the C epsilon 3 domain of IgE, but that receptor binding is mutually inhibitory, mediated by an allosteric mechanism. This prevents CD23-mediated cross-linking of IgE bound to Fc epsilon RI on mast cells and resulting antigen-independent anaphylaxis. The mutually inhibitory nature of receptor binding provides a degree of autonomy for the individual activities mediated by IgE-Fc epsilon RI and IgE-CD23 interactions.	[Borthakur, Susmita; Pang, Marie O. Y.; Yahya, Norhakim; Bax, Heather J.; Kao, Michael W.; Cooper, Alison M.; Beavil, Andrew J.; Sutton, Brian J.; Gould, Hannah J.; McDonnell, James M.] Kings Coll London, MRC, London SE1 9RT, England; [Borthakur, Susmita; Pang, Marie O. Y.; Yahya, Norhakim; Bax, Heather J.; Kao, Michael W.; Cooper, Alison M.; Beavil, Andrew J.; Sutton, Brian J.; Gould, Hannah J.; McDonnell, James M.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Borthakur, Susmita; Pang, Marie O. Y.; Yahya, Norhakim; Bax, Heather J.; Kao, Michael W.; Cooper, Alison M.; Beavil, Andrew J.; Sutton, Brian J.; Gould, Hannah J.; McDonnell, James M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Hibbert, Richard G.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Oxford	McDonnell, JM (corresponding author), Kings Coll London, MRC, London SE1 9RT, England.	james.mcdonnell@kcl.ac.uk	Beavil, Andrew/B-5624-2009	Beavil, Andrew/0000-0002-0768-122X; Gould, Hannah/0000-0003-0411-688X; McDonnell, James/0000-0001-9037-2980; Cooper, Alison/0000-0002-0815-0084	Wellcome Trust; Medical Research Council; MRC [G0001352, G0400106] Funding Source: UKRI; Medical Research Council [MR/J006742/1, G0001352, G0400106, G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the Wellcome Trust and the Medical Research Council.	AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Babu KS, 2001, ALLERGY, V56, P1121, DOI 10.1034/j.1398-9995.2001.00019.x; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Dehlink E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019098; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Hammond G., 2006, CELL BIOL, P221; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Hunt J, 2005, J BIOL CHEM, V280, P16808, DOI 10.1074/jbc.M500965200; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; KANOWITHKLEIN S, 1988, CLIN IMMUNOL IMMUNOP, V48, P214, DOI 10.1016/0090-1229(88)90085-2; Kelly AE, 1998, J IMMUNOL, V161, P6696; LUO HY, 1991, J IMMUNOL, V146, P2122; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Price NE, 2005, J BIOL CHEM, V280, P2324, DOI 10.1074/jbc.M409458200; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Schon A, 2011, FUTURE MED CHEM, V3, P1129, DOI [10.4155/FMC.11.81, 10.4155/fmc.11.81]; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; SUEMURA M, 1991, ALLERGY PROC, V12, P133, DOI 10.2500/108854191778879403; Taylor AI, 2010, DEV COMP IMMUNOL, V34, P97, DOI 10.1016/j.dci.2009.08.012; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017	33	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31457	31461		10.1074/jbc.C112.397059	http://dx.doi.org/10.1074/jbc.C112.397059			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815482	hybrid, Green Published			2022-12-28	WOS:000308791300058
J	Qi, QG; Gibson, A; Fu, XR; Zheng, MY; Kuehn, R; Wang, YC; Wang, YF; Navarro, S; Morrell, JA; Jiang, DM; Simmons, G; Bell, E; Ivleva, NB; McClerren, AL; Loida, P; Ruff, TG; Petracek, ME; Preuss, SB				Qi, Qungang; Gibson, Ann; Fu, Xiaoran; Zheng, Meiying; Kuehn, Rosemarie; Wang, Yongcheng; Wang, Yanfei; Navarro, Santiago; Morrell, James A.; Jiang, Dongming; Simmons, Grant; Bell, Erin; Ivleva, Natalia B.; McClerren, Amanda L.; Loida, Paul; Ruff, Thomas G.; Petracek, Marie E.; Preuss, Sasha B.			Involvement of the N-terminal B-box Domain of Arabidopsis BBX32 Protein in Interaction with Soybean BBX62 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SALT BRIDGES; CONSTANS; BINDING; TRANSCRIPTION; IDENTIFICATION; MOTIF	Previous studies have demonstrated that Arabidopsis thaliana BBX32 (AtBBX32) represses light signaling in A. thaliana and that expression of AtBBX32 in soybean increases grain yield in multiple locations and multiyear field trials. The BBX32 protein is a member of the B-box zinc finger family from A. thaliana and contains a single conserved Zn2+-binding B-box domain at the N terminus. Although the B-box domain is predicted to be involved in protein-protein interactions, the mechanism of interaction is poorly understood. Here, we provide in vitro and in vivo evidence demonstrating the physical and functional interactions of AtBBX32 with another B-box protein, soybean BBX62 (GmBBX62). Deletion analysis and characterization of the purified B-box domain indicate that the N-terminal B-box region of AtBBX32 interacts with GmBBX62. Computational modeling and site-directed mutagenesis of the AtBBX32 B-box region identified specific residues as critical for mediating the interaction between AtBBX32 and GmBBX62. This study defines the plant B-box as a protein interaction domain and offers novel insight into its role in mediating specific protein-protein interactions between different plant B-box proteins.	[Qi, Qungang; Gibson, Ann; Fu, Xiaoran; Zheng, Meiying; Kuehn, Rosemarie; Wang, Yongcheng; Wang, Yanfei; Navarro, Santiago; Morrell, James A.; Jiang, Dongming; Simmons, Grant; McClerren, Amanda L.; Loida, Paul; Ruff, Thomas G.; Petracek, Marie E.; Preuss, Sasha B.] Monsanto Co, Chesterfield, MO 63017 USA; [Bell, Erin; Ivleva, Natalia B.] Monsanto Co, St Louis, MO 63167 USA	Monsanto; Monsanto	Qi, QG (corresponding author), Monsanto Co, Chesterfield, MO 63017 USA.	qungang.qi@monsanto.com						ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Bagnasco L, 2007, FASEB J, V21, P1256, DOI 10.1096/fj.06-7082com; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Cao TY, 1997, J CELL SCI, V110, P1563; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Craig TJ, 2004, J BIOCHEM BIOPH METH, V60, P49, DOI 10.1016/j.jbbm.2004.04.015; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frizzi A, 2010, PLANT MOL BIOL, V73, P569, DOI 10.1007/s11103-010-9644-1; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kohno Toshiyuki, 2007, V375, P257; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Poetz O, 2009, ANAL BIOCHEM, V395, P244, DOI 10.1016/j.ab.2009.08.002; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Qi QG, 2011, PLANT BIOTECHNOL J, V9, P193, DOI 10.1111/j.1467-7652.2010.00545.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sindelar CV, 1998, PROTEIN SCI, V7, P1898, DOI 10.1002/pro.5560070906; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Vinarov DA, 2006, FEBS J, V273, P4160, DOI 10.1111/j.1742-4658.2006.05434.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zhao Kate Qin, 2007, Journal of Structural and Functional Genomics, V8, P199, DOI 10.1007/s10969-007-9035-2	38	19	22	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31482	31493		10.1074/jbc.M112.346940	http://dx.doi.org/10.1074/jbc.M112.346940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22801428	Green Published, hybrid			2022-12-28	WOS:000308791300061
J	Banos-Sanz, JI; Sanz-Aparicio, J; Whitfield, H; Hamilton, C; Brearley, CA; Gonzalez, B				Ignacio Banos-Sanz, Jose; Sanz-Aparicio, Julia; Whitfield, Hayley; Hamilton, Chris; Brearley, Charles A.; Gonzalez, Beatriz			Conformational Changes in Inositol 1,3,4,5,6-Pentakisphosphate 2-Kinase upon Substrate Binding ROLE OF N-TERMINAL LOBE AND ENANTIOMERIC SUBSTRATE PREFERENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY DIFFRACTION ANALYSIS; CRYSTAL-STRUCTURE; PHOSPHATE KINASE; PROTEIN-KINASE; LOW-PHYTATE; ARABIDOPSIS; HEXAKISPHOSPHATE; PURIFICATION; DOMAIN; PLANT	Inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IP5 2-K) catalyzes the synthesis of inositol 1,2,3,4,5,6-hexakisphosphate from ATP and IP5. Inositol 1,2,3,4,5,6-hexakisphosphate is implicated in crucial processes such as mRNA export, DNA editing, and phosphorus storage in plants. We previously solved the first structure of an IP5 2-K, which shed light on aspects of substrate recognition. However, failure of IP5 2-K to crystallize in the absence of inositide prompted us to study putative conformational changes upon substrate binding. We have made mutations to residues on a region of the protein that produces a clasp over the active site. A W129A mutant allowed us to capture IP5 2-K in its different conformations by crystallography. Thus, the IP5 2-K apo-form structure displays an open conformation, whereas the nucleotide-bound form shows a half-closed conformation, in contrast to the inositide-bound form obtained previously in a closed conformation. Both nucleotide and inositide binding produce large conformational changes that can be understood as two rigid domain movements, although local changes were also observed. Changes in intrinsic fluorescence upon nucleotide and inositide binding are in agreement with the crystallographic findings. Our work suggests that the clasp might be involved in enzyme kinetics, with the N-terminal lobe being essential for inositide binding and subsequent conformational changes. We also show how IP5 2-K discriminates between inositol 1,3,4,5-tetrakisphosphate and 3,4,5,6-tetrakisphosphate enantiomers and that substrate preference can be manipulated by Arg(130) mutation. Altogether, these results provide a framework for rational design of specific inhibitors with potential applications as biological tools for in vivo studies, which could assist in the identification of novel roles for IP5 2-K in mammals.	[Whitfield, Hayley; Brearley, Charles A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Gonzalez, Beatriz] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, E-28006 Madrid, Spain; [Hamilton, Chris] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of East Anglia	Brearley, CA (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	c.brearley@uea.ac.uk; xbeatriz@iqfr.csic.es	Gonzalez, Beatriz/M-1219-2014; Sanz-Aparicio, Julia/F-6201-2013	Gonzalez, Beatriz/0000-0002-0710-0202; Sanz-Aparicio, Julia/0000-0002-6849-8621; Brearley, Charles/0000-0001-6179-9109	Ministerio de Ciencia e Innovacion [BFU200-02897/BMC, BFU2011-24982]; Formacion de Profesorado Universitario Fellowship from the Ministerio de Educacion [AP2008-00916]; Faculty of Science, University of East Anglia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Formacion de Profesorado Universitario Fellowship from the Ministerio de Educacion(German Research Foundation (DFG)); Faculty of Science, University of East Anglia	This work was supported in part by Grants BFU200-02897/BMC and BFU2011-24982 from the Ministerio de Ciencia e Innovacion.; Supported by Formacion de Profesorado Universitario Fellowship AP2008-00916 from the Ministerio de Educacion.; Supported by a Dean's studentship from the Faculty of Science, University of East Anglia.	ABDULLAH M, 1992, J BIOL CHEM, V267, P22340; Agarwal R, 2009, MOL CELL BIOCHEM, V328, P155, DOI 10.1007/s11010-009-0085-6; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brearley CA, 1996, BIOCHEM J, V314, P215, DOI 10.1042/bj3140215; Caddick SEK, 2008, FEBS LETT, V582, P1731, DOI 10.1016/j.febslet.2008.04.034; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Hyeon C, 2009, P NATL ACAD SCI USA, V106, P3023, DOI 10.1073/pnas.0813266106; Banos-Sanz JI, 2012, ACTA CRYSTALLOGR F, V68, P701, DOI 10.1107/S1744309112017307; Banos-Sanz JI, 2010, ACTA CRYSTALLOGR F, V66, P102, DOI 10.1107/S1744309109051057; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Ives EB, 2000, J BIOL CHEM, V275, P36575, DOI 10.1074/jbc.M007586200; Josefsen L, 2007, GENE, V397, P114, DOI 10.1016/j.gene.2007.04.018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nalaskowski MM, 2003, J BIOL CHEM, V278, P19765, DOI 10.1074/jbc.M211059200; PHILLIPPY BQ, 1994, J BIOL CHEM, V269, P28393; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Raboy V, 2007, NAT BIOTECHNOL, V25, P874, DOI 10.1038/nbt0807-874; Rowan AS, 2009, ORG BIOMOL CHEM, V7, P4029, DOI 10.1039/b909729e; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Sun YJ, 2007, PLANT PHYSIOL, V144, P1278, DOI 10.1104/pp.107.095455; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Sweetman D, 2007, FEBS LETT, V581, P4165, DOI 10.1016/j.febslet.2007.07.046; Taylor SS, 1999, PHARMACOL THERAPEUT, V82, P133, DOI 10.1016/S0163-7258(99)00007-8; VANROOIJEN LAA, 1985, BIOCHEM BIOPH RES CO, V126, P150, DOI 10.1016/0006-291X(85)90584-4; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; Verbsky JW, 2002, J BIOL CHEM, V277, P31857, DOI 10.1074/jbc.M205682200; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Xia HJ, 2003, PLANT CELL, V15, P449, DOI 10.1105/tpc.006676	54	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29237	29249		10.1074/jbc.M112.363671	http://dx.doi.org/10.1074/jbc.M112.363671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22745128	Green Published, hybrid			2022-12-28	WOS:000308286900003
J	LaRock, DL; Brzovic, PS; Levin, I; Blanc, MP; Miller, SI				LaRock, Doris L.; Brzovic, Peter S.; Levin, Itay; Blanc, Marie-Pierre; Miller, Samuel I.			A Salmonella typhimurium-translocated Glycerophospholipid: Cholesterol Acyltransferase Promotes Virulence by Binding to the RhoA Protein Switch Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTOR RECOGNITION; ACTIVATION; SSEJ; SIFA; SPECIFICITY; DYNAMICS; INSIGHTS; GTPASE; SYSTEM	Salmonella enterica serovar typhimurium translocates a glycerophospholipid: cholesterol acyltransferase (SseJ) into the host cytosol after its entry into mammalian cells. SseJ is recruited to the cytoplasmic face of the host cell phagosome membrane where it is activated upon binding the small GTPase, RhoA. SseJ is regulated similarly to cognate eukaryotic effectors, as only the GTP-bound form of RhoA family members stimulates enzymatic activity. Using NMR and biochemistry, this work demonstrates that SseJ competes effectively with Rhotekin, ROCK, and PKN1 in binding to a similar RhoA surface. The RhoA surface that binds SseJ includes the regulatory switch regions that control activation of mammalian effectors. These data were used to create RhoA mutants with altered SseJ binding and activation. This structure-function analysis supports a model in which SseJ activation occurs predominantly through binding to residues within switch region II. We further defined the nature of the interaction between SseJ and RhoA by constructing SseJ mutants in the RhoA binding surface. These data indicate that SseJ binding to RhoA is required for recruitment of SseJ to the endosomal network and for full Salmonella virulence for inbred susceptible mice, indicating that regulation of SseJ by small GTPases is an important virulence strategy of this bacterial pathogen. The dependence of a bacterial effector on regulation by a mammalian GTPase defines further how intimately host pathogen interactions have coevolved through similar and divergent evolutionary strategies.	[LaRock, Doris L.; Levin, Itay; Blanc, Marie-Pierre; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brzovic, Peter S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Blanc, Marie-Pierre] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Microbiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	millersi@u.washington.edu		LaRock, Doris/0000-0002-2661-6853	National Institutes of Health [R01 AI048683]; NIGMS (National Institutes of Health) [T32 GM07270]; NIAID (National Institutes of Health) [U54 AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, R01AI048683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported, in whole or in part, by National Institutes of Health Grant R01 AI048683.; Supported in part by National Research Service Award T32 GM07270 from NIGMS (National Institutes of Health).; Supported in part by NIAID (National Institutes of Health) Grant U54 AI057141 for the NWRCE for Biodefense and Emerging Infectious Diseases Research.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Hutchinson CL, 2011, BIOCHEMISTRY-US, V50, P2860, DOI 10.1021/bi200039u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Walker SJ, 2002, J BIOL CHEM, V277, P26260, DOI 10.1074/jbc.M201811200; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	30	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29654	29663		10.1074/jbc.M112.363598	http://dx.doi.org/10.1074/jbc.M112.363598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22740689	Green Published, hybrid			2022-12-28	WOS:000308286900041
J	Li, Y; Chen, L; Kass, RS; Dessauer, CW				Li, Yong; Chen, Lei; Kass, Robert S.; Dessauer, Carmen W.			The A-kinase Anchoring Protein Yotiao Facilitates Complex Formation between Adenylyl Cyclase Type 9 and the I-Ks Potassium Channel in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; SIGNALING COMPLEX; REGULATORY PROPERTIES; MESSENGER-RNA; CAMP; INHIBITION; ISOFORMS; CELLS; PHOSPHORYLATION; IDENTIFICATION	The scaffolding protein Yotiao is a member of a large family of protein A-kinase anchoring proteins with important roles in the organization of spatial and temporal signaling. In heart, Yotiao directly associates with the slow outward potassium ion current (I-Ks) and recruits both PKA and PP1 to regulate I-Ks phosphorylation and gating. Human mutations that disrupt I-Ks-Yotiao interaction result in reduced PKA-dependent phosphorylation of the I-Ks subunit KCNQ1 and inhibition of sympathetic stimulation of I-Ks, which can give rise to long-QT syndrome. We have previously identified a subset of adenylyl cyclase (AC) isoforms that interact with Yotiao, including AC1-3 and AC9, but surprisingly, this group did not include the major cardiac isoforms AC5 and AC6. We now show that either AC2 or AC9 can associate with KCNQ1 in a complex mediated by Yotiao. In transgenic mouse heart expressing KCNQ1-KCNE1, AC activity was specifically associated with the I-Ks-Yotiao complex and could be disrupted by addition of the AC9 N terminus. A survey of all AC isoforms by RT-PCR indicated expression of AC4-6 and AC9 in adult mouse cardiac myocytes. Of these, the only Yotiao-interacting isoform was AC9. Furthermore, the endogenous I-Ks-Yotiao complex from guinea pig also contained AC9. Finally, AC9 association with the KCNQ1-Yotiao complex sensitized PKA phosphorylation of KCNQ1 to beta-adrenergic stimulation. Thus, in heart, Yotiao brings together PKA, PP1, PDE4D3, AC9, and the I-Ks channel to achieve localized temporal regulation of beta-adrenergic stimulation.	[Li, Yong; Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Chen, Lei; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, Ctr Mol Cardiol, New York, NY 10032 USA; [Chen, Lei; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA	University of Texas System; University of Texas Health Science Center Houston; Columbia University; Columbia University	Dessauer, CW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St,MSB 4-202, Houston, TX 77030 USA.	carmen.w.dessauer@uth.tmc.edu	Dessauer, Carmen/N-6933-2018	Dessauer, Carmen/0000-0003-1210-4280	National Institutes of Health [GM60419, HL044365]; American Heart Association [GRNT2200034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60419 (to C. W. D.) and HL044365 (to R. S. K.). This work was also supported by American Heart Association Grant GRNT2200034 (to C. W. D.).	Antoni FA, 2006, NEUROCHEM RES, V31, P287, DOI 10.1007/s11064-005-9019-1; ANTONI FA, 1995, J BIOL CHEM, V270, P28055; Baragli A, 2008, CELL SIGNAL, V20, P480, DOI 10.1016/j.cellsig.2007.10.033; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chen-Goodspeed M, 2005, J BIOL CHEM, V280, P1808, DOI 10.1074/jbc.M409172200; Ciampa EJ, 2011, J BIOL CHEM, V286, P4141, DOI 10.1074/jbc.M110.158865; Cui H, 2001, BIOCHEM BIOPH RES CO, V283, P107, DOI 10.1006/bbrc.2001.4725; Cumbay MG, 2005, BIOCHEM PHARMACOL, V69, P1247, DOI 10.1016/j.bcp.2005.02.001; Cumbay MG, 2004, J PHARMACOL EXP THER, V310, P108, DOI 10.1124/jpet.104.065748; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dessauer CW, 2002, METHOD ENZYMOL, V345, P112; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Hacker BM, 1998, GENOMICS, V50, P97, DOI 10.1006/geno.1998.5293; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; KASS RS, 1982, J PHYSIOL-LONDON, V322, P541, DOI 10.1113/jphysiol.1982.sp014054; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Kurokawa J, 2001, J MOL CELL CARDIOL, V33, P873, DOI 10.1006/jmcc.2001.1377; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lin JW, 1998, J NEUROSCI, V18, P2017; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Ostrom RS, 2003, J BIOL CHEM, V278, P24461, DOI 10.1074/jbc.M212659200; Paterson JM, 2000, J NEUROCHEM, V75, P1358, DOI 10.1046/j.1471-4159.2000.0751358.x; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sampson KJ, 2010, HEART RHYTHM, V7, P1151, DOI 10.1016/j.hrthm.2010.02.013; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	52	73	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29815	29824		10.1074/jbc.M112.380568	http://dx.doi.org/10.1074/jbc.M112.380568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778270	Green Published, hybrid			2022-12-28	WOS:000308286900056
J	Xu, N; Zhang, LY; Meisgen, F; Harada, M; Heilborn, J; Homey, B; Grander, D; Stahle, M; Sonkoly, E; Pivarcsi, A				Xu, Ning; Zhang, Lingyun; Meisgen, Florian; Harada, Masako; Heilborn, Johan; Homey, Bernhard; Grander, Dan; Stahle, Mona; Sonkoly, Eniko; Pivarcsi, Andor			MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGENASE-3 MMP-13; TUMOR-SUPPRESSOR; EXPRESSION; CANCER; MIR-125B; GROWTH; HEAD; METALLOPROTEINASE-13; OVEREXPRESSION; KERATINOCYTE	Cutaneous squamous cell carcinoma (cSCC) is the second most common human cancer. Although dysregulation of microRNAs (miRNAs) is known to be involved in a variety of cancers, the role of miRNAs in cSCC is unclear. In this study, we aimed to identify tumor suppressive and oncogenic miRNAs involved in the pathogenesis of cSCC. MiRNA expression profiles in healthy skins (n = 4) and cSCCs (n = 4) were analyzed using MicroRNA Low Density Array. MiR-125b expression was analyzed by quantitative real-time PCR and in situ hybridization in skin biopsies from 40 healthy donors, 13 actinic keratosis, and 74 cSCC patients. The effect of miR-125b was analyzed in wound closure, colony formation, migration, and invasion assays in two cSCC cell lines, UT-SCC-7 and A431. The genes regulated by miR-125b in cSCC were identified by microarray analysis and its direct target was validated by luciferase reporter assay. Comparing cSCC with healthy skin, we identified four up-regulated miRNAs (miR-31, miR-135b, miR-21, and miR-223) and 54 down-regulated miRNAs, including miR-125b, whose function was further examined. We found that miR-125b suppressed proliferation, colony formation, migratory, and invasive capacity of cSCC cells. Matrix metallopeptidase 13 (MMP13) was identified as a direct target suppressed by miR-125b, and there was an inverse relationship between the expression of miR-125b and MMP13 in cSCC. Knockdown of MMP13 expression phenocopied the effects of miR-125b overexpression. These findings provide a novel molecular mechanism by which MMP13 is up-regulated in cSCCs and indicate that miR-125b plays a tumor suppressive role in cSCC.	[Xu, Ning] Karolinska Inst, Mol Dermatol Res Grp, CMM, Dept Med,Unit Dermatol & Venereol, SE-17176 Stockholm, Sweden; [Zhang, Lingyun] Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Zhang, Lingyun] Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China; [Harada, Masako; Grander, Dan] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden; [Homey, Bernhard] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; [Sonkoly, Eniko; Pivarcsi, Andor] Univ Szeged, Dept Dermatol & Allergol, H-6701 Szeged, Hungary	Karolinska Institutet; Tianjin Medical University; Tianjin Medical University; Karolinska Institutet; Heinrich Heine University Dusseldorf; Szeged University	Xu, N (corresponding author), Karolinska Inst, Mol Dermatol Res Grp, CMM, Dept Med,Unit Dermatol & Venereol, L8 02, SE-17176 Stockholm, Sweden.	ning.xu@ki.se	Pivarcsi, Andor/J-5801-2017; Landén, Ning Xu/AFL-2883-2022; Harada, Masako/V-4884-2019	Pivarcsi, Andor/0000-0003-2196-1102; Landén, Ning Xu/0000-0003-4868-3798; Harada, Masako/0000-0003-0871-1125; Sonkoly, Eniko/0000-0002-4909-5413	Swedish Research Council [K2012-67X-22042-01-3]; Karolinska Institutet; Welander Finsens Foundations; Tore Nilsons Foundation; Konsul ThC Bergh Foundations; Stockholm County Council; Swedish Society for Medical Research; "211" Project Innovation Foundation of Tianjin Medical University [2010GSI12]; LEO Pharma Research Foundation; board of research at Karolinska Institute; research committee at the Karolinska hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Welander Finsens Foundations; Tore Nilsons Foundation; Konsul ThC Bergh Foundations; Stockholm County Council(Stockholm County Council); Swedish Society for Medical Research; "211" Project Innovation Foundation of Tianjin Medical University; LEO Pharma Research Foundation(LEO Pharma); board of research at Karolinska Institute; research committee at the Karolinska hospital	This work was supported by the Swedish Research Council (K2012-67X-22042-01-3), Karolinska Institutet, the Welander Finsens Foundations, Tore Nilsons Foundation, Konsul ThC Bergh Foundations, and the Stockholm County Council.; Supported by Swedish Society for Medical Research. To whom correspondence should be addressed: Molecular Dermatology Research Group, Centre for Molecular Medicine (CMM), L8:02, Department of Medicine, Karolinska Institutet, SE-17176 Stockholm, Sweden. Tel.: 46-8-51772158; Fax: 46-8-51770340; E-mail: ning.xu@ki.se.; Supported by the "211" Project Innovation Foundation of Tianjin Medical University for Ph.D Graduate (No: 2010GSI12).; Supported by LEO Pharma Research Foundation.; We thank Anna-Lena Kastman for excellent technical support, Mari-Anne Hedblad for assistance of clinical sample collection, and Professor Veli-Matti Kahari for the fruitful discussions and suggestions. We also would like to thank the Microarray core facility at Novum, BEA, Bioinformatics and Expression Analysis, which is supported by the board of research at Karolinska Institute and the research committee at the Karolinska hospital.	Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-aho R, 2004, ONCOGENE, V23, P5111, DOI 10.1038/sj.onc.1207678; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Banerjee R, 2011, ONCOGENE, V30, P4339, DOI 10.1038/onc.2011.141; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bostrom PJ, 2000, INT J CANCER, V88, P417, DOI 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.3.CO;2-7; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Chang HJ, 2009, ONCOL REP, V22, P1119, DOI 10.3892/or_00000544; Chen Z., 2012, ORAL ONCOL IN PRESS; Cranmer LD, 2010, ONCOLOGIST, V15, P1320, DOI 10.1634/theoncologist.2009-0210; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Hussain SK, 2010, J INVEST DERMATOL, V130, P1323, DOI 10.1038/jid.2009.426; Impola U, 2004, J PATHOL, V202, P14, DOI 10.1002/path.1479; Johansson N, 2000, J CELL SCI, V113, P227; Johansson N, 1997, AM J PATHOL, V151, P499; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kivisaari AK, 2008, BRIT J DERMATOL, V158, P778, DOI 10.1111/j.1365-2133.2008.08466.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Kurashige J, 2012, BRIT J CANCER, V106, P182, DOI 10.1038/bjc.2011.509; Lauths M, 2004, DRUG DISCOV TODAY DI, V1, P267, DOI DOI 10.1016/J.DDMEC.2004.09.005; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nohata N, 2011, J HUM GENET, V56, P595, DOI 10.1038/jhg.2011.66; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Peschiaroli A., 2012, ONCOGENE; Pivarcsi A, 2007, P NATL ACAD SCI USA, V104, P19055, DOI 10.1073/pnas.0705673104; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Tuckermann JP, 2001, DIFFERENTIATION, V69, P49, DOI 10.1046/j.1432-0436.2001.690105.x; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wells J. L., 2011, AM J CLIN O IN PRESS; Xu N, 2011, J INVEST DERMATOL, V131, P1521, DOI 10.1038/jid.2011.55; Zhang JY, 2007, CANCER RES, V67, P3827, DOI 10.1158/0008-5472.CAN-06-4017; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	43	144	150	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29899	29908		10.1074/jbc.M112.391243	http://dx.doi.org/10.1074/jbc.M112.391243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782903	hybrid, Green Published			2022-12-28	WOS:000308286900063
J	Matsui, T; Ohbayashi, N; Fukuda, M				Matsui, Takahide; Ohbayashi, Norihiko; Fukuda, Mitsunori			The Rab Interacting Lysosomal Protein (RILP) Homology Domain Functions as a Novel Effector Domain for Small GTPase Rab36 Rab36 REGULATES RETROGRADE MELANOSOME TRANSPORT IN MELANOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOSOME DISTRIBUTION; CRITICAL DETERMINANT; STRUCTURAL BASIS; MAMMALIAN RABS; BINDING; TRANSPORT; SLAC2-A/MELANOPHILIN; SPECIFICITY; TRAFFICKING; KINESIN-1	Small GTPase Rab functions as a molecular switch that drives membrane trafficking through specific interaction with its effector molecule. Thus, identification of its specific effector domain is crucial to revealing the molecular mechanism that underlies Rab-mediated membrane trafficking. Because of the large numbers of Rab isoforms in higher eukaryotes, however, the effector domains of most of the vertebrate-or mammalian-specific Rabs have yet to be determined. In this study we screened for effector molecules of Rab36, a previously uncharacterized Rab isoform that is largely conserved in vertebrates, and we succeeded in identifying nine Rab36-binding proteins, including RILP (Rab interacting lysosomal protein) family members. Sequence comparison revealed that five of nine Rab36-binding proteins, i.e. RILP, RILP-L1, RILP-L2, and JIP3/4, contain a conserved coiled-coil domain. We identified the coiled-coil domain as a RILP homology domain (RHD) and characterized it as a common Rab36-binding site. Site-directed mutagenesis of the RHD of RILP revealed the different contributions by amino acids in the RHD to binding activity toward Rab7 and Rab36. Expression of RILP in melanocytes, but not expression of its Rab36 binding-deficient mutants, induced perinuclear aggregation of melanosomes, and this effect was clearly attenuated by knockdown of endogenous Rab36 protein. Moreover, knockdown of Rab36 in Rab27A-deficient melanocytes, which normally exhibit perinuclear melanosome aggregation because of increased retrograde melanosome transport activity, caused dispersion of melanosomes from the perinucleus to the cell periphery, but knockdown of Rab7 did not. Our findings indicated that Rab36 mediates retrograde melanosome transport in melanocytes through interaction with RILP.	[Matsui, Takahide; Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mechanisms, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mechanisms, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Matsui, Takahide/S-4986-2018	Fukuda, MItsunori/0000-0002-8620-5853; Matsui, Takahide/0000-0002-3342-0170	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [24570206, 20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to N. O. and M. F.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Daniele T, 2011, TRAFFIC, V12, P902, DOI 10.1111/j.1600-0854.2011.01194.x; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Mori T, 1999, BIOCHEM BIOPH RES CO, V254, P594, DOI 10.1006/bbrc.1998.9968; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Piccione M, 2011, AM J MED GENET A, V155A, P3054, DOI 10.1002/ajmg.a.34275; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413	45	50	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28619	28631		10.1074/jbc.M112.370544	http://dx.doi.org/10.1074/jbc.M112.370544			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740695	hybrid, Green Published			2022-12-28	WOS:000308074600036
J	Nakatogawa, H; Ohbayashi, S; Sakoh-Nakatogawa, M; Kakuta, S; Suzuki, SW; Kirisako, H; Kondo-Kakuta, C; Noda, NN; Yamamoto, H; Ohsumi, Y				Nakatogawa, Hitoshi; Ohbayashi, Shiran; Sakoh-Nakatogawa, Machiko; Kakuta, Soichiro; Suzuki, Sho W.; Kirisako, Hiromi; Kondo-Kakuta, Chika; Noda, Nobuo N.; Yamamoto, Hayashi; Ohsumi, Yoshinori			The Autophagy-related Protein Kinase Atg1 Interacts with the Ubiquitin-like Protein Atg8 via the Atg8 Family Interacting Motif to Facilitate Autophagosome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; COMPLEX; YEAST; ORGANIZATION; BIOGENESIS; INDUCTION; TRANSPORT; SYSTEM	In autophagy, a cup-shaped membrane called the isolation membrane is formed, expanded, and sealed to complete a double membrane-bound vesicle called the autophagosome that encapsulates cellular constituents to be transported to and degraded in the lysosome/vacuole. The formation of the autophagosome requires autophagy-related (Atg) proteins. Atg8 is a ubiquitin-like protein that localizes to the isolation membrane; a subpopulation of this protein remains inside the autophagosome and is transported to the lysosome/vacuole. In the budding yeast Saccharomyces cerevisiae, Atg1 is a serine/threonine kinase that functions in the initial step of autophagosome formation and is also efficiently transported to the vacuole via autophagy. Here, we explore the mechanism and significance of this autophagic transport of Atg1. In selective types of autophagy, receptor proteins recognize degradation targets and also interact with Atg8, via the Atg8 family interacting motif ( AIM), to link the targets to the isolation membrane. We find that Atg1 contains an AIM and directly interacts with Atg8. Mutations in the AIM disrupt this interaction and abolish vacuolar transport of Atg1. These results suggest that Atg1 associates with the isolation membrane by binding to Atg8, resulting in its incorporation into the autophagosome. We also show that mutations in the Atg1 AIM cause a significant defect in autophagy, without affecting the functions of Atg1 implicated in triggering autophagosome formation. We propose that in addition to its essential function in the initial stage, Atg1 also associates with the isolation membrane to promote its maturation into the autophagosome.	[Nakatogawa, Hitoshi; Ohbayashi, Shiran; Sakoh-Nakatogawa, Machiko; Kakuta, Soichiro; Suzuki, Sho W.; Kirisako, Hiromi; Kondo-Kakuta, Chika; Yamamoto, Hayashi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	Tokyo Institute of Technology	Nakatogawa, H (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan.	hnakatogawa@iri.titech.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Suzuki, Sho/0000-0002-6563-5387; Noda, Nobuo/0000-0002-6940-8069	Funding Program for Next Generation World-Leading Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Funding Program for Next Generation World-Leading Researchers (to H. N.) and grants-in-aid for scientific research (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566	24	78	87	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28503	28507		10.1074/jbc.C112.387514	http://dx.doi.org/10.1074/jbc.C112.387514			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778255	hybrid, Green Published			2022-12-28	WOS:000308074600025
J	Currie, MA; Adams, JJ; Faucher, F; Bayer, EA; Jia, ZC; Smith, SP				Currie, Mark A.; Adams, Jarrett J.; Faucher, Frederick; Bayer, Edward A.; Jia, Zongchao; Smith, Steven P.			Scaffoldin Conformation and Dynamics Revealed by a Ternary Complex from the Clostridium thermocellum Cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL BINDING MODE; CRYSTAL-STRUCTURE; COHESIN DOMAIN; II COHESIN; CELL-WALL; DOCKERIN DOMAIN; LAYER PROTEIN; MECHANISM; INSIGHTS; CELLULOLYTICUM	Cellulosomes are multienzyme complexes responsible for efficient degradation of plant cell wall polysaccharides. The nonenzymatic scaffoldin subunit provides a platform for cellulolytic enzyme binding that enhances the overall activity of the bound enzymes. Understanding the unique quaternary structural elements responsible for the enzymatic synergy of the cellulosome is hindered by the large size and inherent flexibility of these multiprotein complexes. Herein, we have used x-ray crystallography and small angle x-ray scattering to structurally characterize a ternary protein complex from the Clostridium thermocellum cellulosome that comprises a C-terminal trimodular fragment of the CipA scaffoldin bound to the SdbA type II cohesin module and the type I dockerin module from the Cel9D glycoside hydrolase. This complex represents the largest fragment of the cellulosome solved by x-ray crystallography to date and reveals two rigid domains formed by the type I cohesin.dockerin complex and by the X module-type II cohesin.dockerin complex, which are separated by a 13-residue linker in an extended conformation. The type I dockerin modules of the four structural models found in the asymmetric unit are in an alternate orientation to that previously observed that provides further direct support for the dual mode of binding. Conserved intermolecular contacts between symmetry-related complexes were also observed and may play a role in higher order cellulosome structure. SAXS analysis of the ternary complex revealed that the 13-residue intermodular linker of the scaffoldin subunit is highly dynamic in solution. These studies provide fundamental insights into modular positioning, linker flexibility, and higher order organization of the cellulosome.	[Currie, Mark A.; Adams, Jarrett J.; Faucher, Frederick; Jia, Zongchao; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Jia, Zongchao; Smith, Steven P.] Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Weizmann Institute of Science; Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca; steven.smith@queensu.ca		Smith, Steven/0000-0003-2710-4400	Israel Science Foundation; Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research	Israel Science Foundation(Israel Science Foundation); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Israel Science Foundation (to E. A. B.), the Natural Science and Engineering Research Council of Canada (to S. P. S.), and the Canadian Institutes of Health Research (to Z.J.).	Adams JJ, 2010, J MOL BIOL, V396, P833, DOI 10.1016/j.jmb.2010.01.015; Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Bomble YJ, 2011, J BIOL CHEM, V286, P5614, DOI 10.1074/jbc.M110.186031; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Currie MA, 2010, ACTA CRYSTALLOGR F, V66, P327, DOI 10.1107/S1744309110001375; DeLano W.L, PYMOL MOL GRAPHICS S; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Garcia-Alvarez B, 2011, J MOL BIOL, V407, P571, DOI 10.1016/j.jmb.2011.01.060; GERNGROSS UT, 1993, MOL MICROBIOL, V8, P325, DOI 10.1111/j.1365-2958.1993.tb01576.x; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Leibovitz E, 1997, J BACTERIOL, V179, P2519, DOI 10.1128/jb.179.8.2519-2523.1997; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Lemaire M, 1998, MICROBIOL-UK, V144, P211, DOI 10.1099/00221287-144-1-211; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Lytle BL, 2001, J MOL BIOL, V307, P745, DOI 10.1006/jmbi.2001.4522; MAYER F, 1987, APPL ENVIRON MICROB, V53, P2785, DOI 10.1128/AEM.53.12.2785-2792.1987; Molinier AL, 2011, J MOL BIOL, V405, P143, DOI 10.1016/j.jmb.2010.10.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Noach I, 2010, J MOL BIOL, V399, P294, DOI 10.1016/j.jmb.2010.04.013; Noach I, 2009, J MOL BIOL, V391, P86, DOI 10.1016/j.jmb.2009.06.006; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; POOLE DM, 1992, FEMS MICROBIOL LETT, V99, P181, DOI 10.1111/j.1574-6968.1992.tb05563.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Spinelli S, 2000, J MOL BIOL, V304, P189, DOI 10.1006/jmbi.2000.4191; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	56	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26953	26961		10.1074/jbc.M112.343897	http://dx.doi.org/10.1074/jbc.M112.343897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707718	hybrid, Green Published			2022-12-28	WOS:000307386000043
J	Poth, AG; Mylne, JS; Grassl, J; Lyons, RE; Millar, AH; Colgrave, ML; Craik, DJ				Poth, Aaron G.; Mylne, Joshua S.; Grassl, Julia; Lyons, Russell E.; Millar, A. Harvey; Colgrave, Michelle L.; Craik, David J.			Cyclotides Associate with Leaf Vasculature and Are the Products of a Novel Precursor in Petunia (Solanaceae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BACKBONE-CYCLIZED PEPTIDES; SEED STORAGE PROTEINS; CIRCULAR PROTEINS; ASPARAGINYL ENDOPEPTIDASE; MACROCYCLIC PEPTIDES; PLANT CYCLOTIDES; KNOTTED PROTEINS; BIOSYNTHESIS; MINIPROTEINS; EXPRESSION	Cyclotides are a large family of plant peptides that are structurally defined by their cyclic backbone and a trifecta of disulfide bonds, collectively known as the cyclic cystine knot (CCK) motif. Structurally similar cyclotides have been isolated from plants within the Rubiaceae, Violaceae, and Fabaceae families and share the CCK motif with trypsin-inhibitory knottins from a plant in the Cucurbitaceae family. Cyclotides have previously been reported to be encoded by dedicated genes or as a domain within a knottin-encoding PA1-albumin-like gene. Here we report the discovery of cyclotides and related non-cyclic peptides we called "acyclotides" from petunia of the agronomically important Solanaceae plant family. Transcripts for petunia cyclotides and acyclotides encode the shortest known cyclotide precursors. Despite having a different precursor structure, their sequences suggest that petunia cyclotides mature via the same biosynthetic route as other cyclotides. We assessed the spatial distribution of cyclotides within a petunia leaf section by MALDI imaging and observed that the major cyclotide component Phyb A was non-uniformly distributed. Dissected leaf midvein extracts contained significantly higher concentrations of this cyclotide compared with the lamina and outer margins of leaves. This is the third distinct type of cyclotide precursor, and Solanaceae is the fourth phylogenetically disparate plant family to produce these structurally conserved cyclopeptides, suggesting either convergent evolution upon the CCK structure or movement of cyclotide-encoding sequences within the plant kingdom.	[Poth, Aaron G.; Mylne, Joshua S.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Poth, Aaron G.; Lyons, Russell E.; Colgrave, Michelle L.] CSIRO Div Livestock Ind, St Lucia, Qld 4067, Australia; [Grassl, Julia; Millar, A. Harvey] Univ Western Australia, Ctr Comparat Anal Biomol Networks, Crawley, WA 6009, Australia; [Grassl, Julia; Millar, A. Harvey] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Mylne, Josh/GMX-4544-2022; Lyons, Russell/H-7942-2013; Grassl, Julia/O-9417-2016; Poth, Aaron G/D-2060-2017; Lyons, Russell E/A-7051-2011; Grassl, Julia/D-1047-2011; Lyons, Russell E/AAH-4097-2020; Mylne, Joshua S/A-5581-2009; Millar, A. Harvey/A-5452-2008; Craik, David/B-1695-2010; Grassl, Julia/O-9773-2019; Colgrave, Michelle/A-5710-2012	Mylne, Josh/0000-0003-4957-6388; Lyons, Russell/0000-0002-0795-7994; Grassl, Julia/0000-0001-8653-4983; Poth, Aaron G/0000-0002-1497-8347; Lyons, Russell E/0000-0002-0795-7994; Mylne, Joshua S/0000-0003-4957-6388; Millar, A. Harvey/0000-0001-9679-1473; Craik, David/0000-0003-0007-6796; Grassl, Julia/0000-0001-8653-4983; Colgrave, Michelle/0000-0001-8463-805X	Australian Research Council (ARC) [DP0984390, DP0985873, LE0775603, DP0879133, DP0771156]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by an Australian Research Council (ARC) grant for cyclotide analysis (Grant DP0984390), an ARC Grant for development of MALDI-MSI in plants (Grant DP0985873), and equipment purchased under ARC Linkage Grant LE0775603 housed in the ARC Centre of Excellence in Plant Energy Biology at the University of Western Australia.; An ARC Queen Elizabeth II Fellow (Grant DP0879133) and the John S. Mattick Fellow.; An ARC Australian Professorial Fellow (Grant DP0771156).	ABE Y, 1993, J BIOL CHEM, V268, P3525; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; BECERRA JX, 1990, BIOTROPICA, V22, P320, DOI 10.2307/2388545; Beck A, 2001, J PEPT RES, V57, P528, DOI 10.1034/j.1399-3011.2001.00895.x; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Dannenhoffer JM, 2001, PLANTA, V212, P155, DOI 10.1007/s004250000405; DHONDT K, 1993, J BIOL CHEM, V268, P20884; Do HM, 2004, PLANT SCI, V166, P1297, DOI 10.1016/j.plantsci.2004.01.008; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Gemoll T, 2011, MOL MED REP, V4, P1045, DOI 10.3892/mmr.2011.566; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gran L., 1970, MEDDELELSER NORSK FA, V12, P173; Grassl J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-21; Greer T, 2011, J PROTEOMICS, V74, P2617, DOI 10.1016/j.jprot.2011.03.032; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; IUPAC, 1979, NOM ORG CHEM F; IUPAC, 1979, NOM ORG CHEM A; IUPAC, 1979, NOM ORG CHEM C; IUPAC, 1979, NOM ORG CHEM E; IUPAC, 1979, NOM ORG CHEM B; IUPAC, 1979, NOM ORG CHEM D; IUPAC, 1979, NOM ORG CHEM H; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Lindholm P, 2002, MOL CANCER THER, V1, P365; Ljungdahl A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025653; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Menger RF, 2012, ANAL CHEM, V84, P1117, DOI 10.1021/ac202779h; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Murata N., 1987, PROGR PHOTOSYNTHESIS; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Ntanios F, 2001, EUR J LIPID SCI TECH, V103, P102, DOI 10.1002/1438-9312(200102)103:2<102::AID-EJLT102>3.0.CO;2-A; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Ovesen RG, 2011, J CHROMATOGR A, V1218, P7964, DOI 10.1016/j.chroma.2011.08.095; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2008, J CHROMATOGR B, V872, P107, DOI 10.1016/j.jchromb.2008.07.023; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Thurnham DI, 1999, BRIT J NUTR, V82, P255, DOI 10.1017/S0007114599001440; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	78	104	110	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27033	27046		10.1074/jbc.M112.370841	http://dx.doi.org/10.1074/jbc.M112.370841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700981	hybrid, Green Published			2022-12-28	WOS:000307386000053
J	Verma, NK; Dempsey, E; Long, AD; Davies, A; Barry, SP; Fallon, PG; Volkov, Y; Kelleher, D				Verma, Navin K.; Dempsey, Eugene; Long, Aideen; Davies, Anthony; Barry, Sean P.; Fallon, Padraic G.; Volkov, Yuri; Kelleher, Dermot			Leukocyte Function-associated Antigen-1/Intercellular Adhesion Molecule-1 Interaction Induces a Novel Genetic Signature Resulting in T-cells Refractory to Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; AP-1 ACTIVITY; SMAD7; LFA-1; TRANSDUCTION; INFLAMMATION; DISEASE; SKI; IDENTIFICATION; DEGRADATION	The immunesuppressive cytokine TGF-beta plays crucial regulatory roles in the induction and maintenance of immunologic tolerance and prevention of immunopathologies. However, it remains unclear how circulating T-cells can escape from the quiescent state maintained by TGF-beta. Here, we report that the T-cell integrin leukocyte function-associated antigen-1 (LFA-1) interaction with its ligand intercellular adhesion molecule-1 (ICAM-1) induces a genetic signature associated with reduced TGF-beta responsiveness via up-regulation of SKI, E3 ubiquitin-protein ligase SMURF2, and SMAD7 (mothers against decapentaplegic homolog 7) genes and proteins. We confirmed that the expression of these TGF-beta inhibitory molecules was dependent on STAT3 and/or JNK activation. Increased expression of SMAD7 and SMURF2 in LFA-1/ICAM-1 cross-linked T-cells resulted in impaired TGF-beta mediated phosphorylation of SMAD2 and suppression of IL-2 secretion. Expression of SKI caused resistance to TGF-beta-mediated suppression of IL-2, but SMAD2 phosphorylation was unaffected. Blocking LFA-1 by neutralizing antibody or specific knockdown of TGF-beta inhibitory molecules by siRNA substantially restored LFA-1/ICAM-1-mediated alteration in TGF-beta signaling. LFA-1/ICAM-1-stimulated human and mouse T-cells were refractory to TGF-beta-mediated induction of FOXP3(+) (forkhead box P3) and ROR gamma t(+) (retinoic acid-related orphan nuclear receptor gamma t) Th17 differentiation. These mechanistic data suggest an important role for LFA-1/ICAM-1 interactions in immunoregulation concurrent with lymphocyte migration that may have implications at the level of local inflammatory response and for anti-LFA-1-based therapies.	[Kelleher, Dermot] Trinity Coll Dublin, Inst Mol Med, Trinity Ctr Hlth Sci, Dept Clin Med, Dublin 8, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin 12, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Kelleher, D (corresponding author), Trinity Coll Dublin, Inst Mol Med, Trinity Ctr Hlth Sci, Dept Clin Med, Dublin 8, Ireland.	kellehdp@tcd.ie	Verma, Navin Kumar/B-7641-2008; Fallon, Padraic/Y-2711-2019; Volkov, Yuri/N-6774-2014	Verma, Navin Kumar/0000-0002-5940-6633; Fallon, Padraic/0000-0002-8401-7293; Volkov, Yuri/0000-0001-7406-518X; Dempsey, Eugene/0000-0003-2373-689X	Enterprise Ireland; Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3; Science Foundation Ireland (SFI); Health Research Board (HRB) of Ireland	Enterprise Ireland; Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3; Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB) of Ireland	This work was supported by grants from the Enterprise Ireland, Higher Education Authority of Ireland under the Program for Research in Third Level Institutions (PRTLI) Cycle 3, Science Foundation Ireland (SFI), and the Health Research Board (HRB) of Ireland.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Boirivant M, 2006, GASTROENTEROLOGY, V131, P1786, DOI 10.1053/j.gastro.2006.09.016; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Chang JH, 2012, NAT IMMUNOL, V13, P481, DOI 10.1038/ni.2267; Das L, 2008, J IMMUNOL, V180, P1490, DOI 10.4049/jimmunol.180.3.1490; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Guttman-Yassky E, 2008, J INVEST DERMATOL, V128, P1182, DOI 10.1038/jid.2008.4; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koszik F, 2010, J DERMATOL SCI, V60, P159, DOI 10.1016/j.jdermsci.2010.10.003; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Monteleone G, 2005, GASTROENTEROLOGY, V129, P1420, DOI 10.1053/j.gastro.2005.09.005; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 2002, TRENDS MOL MED, V8, P361, DOI 10.1016/S1471-4914(02)02376-6; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shimizu Y, 2003, NAT IMMUNOL, V4, P1052, DOI 10.1038/ni1103-1052; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Verma NK, 2011, J CELL PHYSIOL, V226, P1489, DOI 10.1002/jcp.22478; Verma NK, 2010, CELL MOL BIOL LETT, V15, P342, DOI 10.2478/s11658-010-0008-2; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang YN, 2007, BIOCHEM BIOPH RES CO, V353, P857, DOI 10.1016/j.bbrc.2006.12.104; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	49	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27204	27216		10.1074/jbc.M112.376616	http://dx.doi.org/10.1074/jbc.M112.376616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707713	Green Published, hybrid			2022-12-28	WOS:000307386000072
J	Ye, S; Xu, HM; Jin, J; Yang, MJ; Wang, CM; Yu, YZ; Cao, XT				Ye, Shuo; Xu, Hongmei; Jin, Jing; Yang, Mingjin; Wang, Chunmei; Yu, Yizhi; Cao, Xuetao			The E3 Ubiquitin Ligase Neuregulin Receptor Degradation Protein 1 (Nrdp1) Promotes M2 Macrophage Polarization by Ubiquitinating and Activating Transcription Factor CCAAT/Enhancer-binding Protein beta (C/EBP beta) (Publication with Expression of Concern. See vol. 295, pg. 8884, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TRIGGERED INFLAMMATORY RESPONSES; ALTERNATIVE ACTIVATION; PHOSPHORYLATION; METHYLATION; INDUCTION; STAT6	Macrophage activation, including classical (M1) activation and alternative (M2) activation, plays important roles in host immune response and pathogenesis of diseases. Ubiquitination has been shown to be involved in the differentiation of immune cells and in the regulation of immune responses. However, the role of ubiquitination during M1 versus M2 polarization is poorly explored. Here, we showed that arginase 1 (Arg1), a well recognized marker of M2 macrophages, is highly up-regulated in peritoneal macrophages derived from E3 ubiquitin ligase Nrdp1 transgenic (Nrdp1-TG) mice. Furthermore, other M2 feature markers such as MR, Ym1, and Fizz1, as well as Th2 cytokine IL-10, are also up-regulated in Nrdp1-TG macrophages after IL-4 stimulation. Knockdown of Nrdp1 expression effectively inhibits IL-4-induced expression of M2-related genes in macrophages. Moreover, Nrdp1 inhibits LPS-induced production of inducible NOS and pro-inflammatory cytokines TNF-alpha, IL-1 beta, and IL-6 in macrophages. Immunoprecipitation assays show that Nrdp1 interacts with and ubiquitinates transcriptional factor C/EBP beta via Lys-63-linked ubiquitination. Nrdp1 enhances C/EBP beta-triggered transcriptional activation of the Arg1 reporter gene in the presence of IL-4 stimulation. Thus, we demonstrate that Nrdp1-mediated ubiquitination and activation of C/EBP beta contributes to a ubiquitin-dependent nonproteolytic pathway that up-regulates Arg1 expression and promotes M2 macrophage polarization.	[Xu, Hongmei; Yang, Mingjin; Yu, Yizhi; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Xu, Hongmei; Yang, Mingjin; Yu, Yizhi; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Ye, Shuo; Jin, Jing; Yang, Mingjin; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Chunmei; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Wang, Chunmei; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Mol Biol, Beijing 100005, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, HM (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	xuhongmei90@yahoo.com.cn; caoxt@immunol.org	yu, yizhi/ADP-7854-2022; xu, hong/GSD-8903-2022		National Natural Science Foundation of China [31170863, 81123006]; National 125 Key Project [2012ZX10002-014, 2012AA020901]; National Key Basic Research Program of China [2010CB529901, 2012CB9102023]; Shanghai Committee of Science and Technology Grant [10DZ1910300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project; National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Committee of Science and Technology Grant	This work was supported by National Natural Science Foundation of China Grants 31170863 and 81123006, National 125 Key Project Grants 2012ZX10002-014 and 2012AA020901, National Key Basic Research Program of China Grants 2010CB529901 and 2012CB9102023, and Shanghai Committee of Science and Technology Grant 10DZ1910300.	Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Raesl G, 2007, CURR OPIN IMMUNOL, V19, P454, DOI 10.1016/j.coi.2007.05.007; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319	39	34	38	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26740	26748		10.1074/jbc.M112.383265	http://dx.doi.org/10.1074/jbc.M112.383265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707723	hybrid, Green Published			2022-12-28	WOS:000307386000024
J	Jensen, MH; Morris, EJ; Huang, RJ; Rebowski, G; Dominguez, R; Weitz, DA; Moore, JR; Wang, CLA				Jensen, Mikkel Herholdt; Morris, Eliza J.; Huang, Renjian; Rebowski, Grzegorz; Dominguez, Roberto; Weitz, David A.; Moore, Jeffrey R.; Wang, Chih-Lueh Albert			The Conformational State of Actin Filaments Regulates Branching by Actin-related Protein 2/3 (Arp2/3) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; DEPOLYMERIZING FACTOR; CALDESMON BINDING; TROPOMYOSIN; MOTILITY; COOPERATIVITY; ROLES	Actin is a highly ubiquitous protein in eukaryotic cells that plays a crucial role in cell mechanics and motility. Cell motility is driven by assembling actin as polymerizing actin drives cell protrusions in a process closely involving a host of other actin-binding proteins, notably the actin-related protein 2/3 (Arp2/3) complex, which nucleates actin and forms branched filamentous structures. The Arp2/3 complex preferentially binds specific actin networks at the cell leading edge and forms branched filamentous structures, which drive cell protrusions, but the exact regulatory mechanism behind this process is not well understood. Here we show using in vitro imaging and binding assays that a fragment of the actin-binding protein caldesmon added to polymerizing actin increases the Arp2/3-mediated branching activity, whereas it has no effect on branch formation when binding to aged actin filaments. Because this caldesmon effect is shown to be independent of nucleotide hydrolysis and phosphate release from actin, our results suggest a mechanism by which caldesmon maintains newly polymerized actin in a distinct state that has a higher affinity for the Arp2/3 complex. Our data show that this new state does not affect the level of cooperativity of binding by Arp2/3 complex or its distribution on actin. This presents a novel regulatory mechanism by which caldesmon, and potentially other actin-binding proteins, regulates the interactions of actin with its binding partners.	[Huang, Renjian; Wang, Chih-Lueh Albert] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Jensen, Mikkel Herholdt; Moore, Jeffrey R.] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA; [Jensen, Mikkel Herholdt] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Morris, Eliza J.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rebowski, Grzegorz; Dominguez, Roberto] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Chih-Lueh Albert] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan	Boston Biomedical Research Institute; Boston University; Boston University; Harvard University; University of Pennsylvania; China Medical University Taiwan	Wang, CLA (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	wang@bbri.org		Morris, Eliza/0000-0002-4658-502X; Moore, Jeffrey/0000-0001-7190-9332; Herholdt Jensen, Mikkel/0000-0002-4821-3318	National Institutes of Health [HL92252, HL86655]; National Science Foundation [DMR-1006546]; Harvard Materials Research Science and Engineering Center [DMR-0820484]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL092252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL92252 (to C. L. A. W.) and HL86655 (J. R. M., and R. D.). This work was also supported by the National Science Foundation (Grant DMR-1006546) and the Harvard Materials Research Science and Engineering Center (Grant DMR-0820484).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Arias MP, 2001, BIOCHEMISTRY-US, V40, P12974, DOI 10.1021/bi010098+; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; BRETSCHER A, 1986, NATURE, V321, P726, DOI 10.1038/321726b0; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; Collins Agnieszka, 2011, Bioarchitecture, V1, P127; EGELMAN EH, 1995, J STRUCT BIOL, V115, P159, DOI 10.1006/jsbi.1995.1040; Eves R, 2006, J CELL SCI, V119, P1691, DOI 10.1242/jcs.02881; Foster DB, 2004, J BIOL CHEM, V279, P53387, DOI 10.1074/jbc.M410109200; Galinska-Rakoczy A, 2009, J MOL BIOL, V387, P869, DOI 10.1016/j.jmb.2009.02.011; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Huang RJ, 2010, J BIOL CHEM, V285, P71, DOI 10.1074/jbc.M109.065078; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jiang QF, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-6; Kordowska J, 2005, EXP CELL RES, V312, P95, DOI 10.1016/j.yexcr.2005.09.021; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Lin JJC, 2009, INT REV CEL MOL BIO, V274, P1, DOI 10.1016/S1937-6448(08)02001-7; MARSTON SB, 1996, BIOCH SMOOTH MUSCLE, P77; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; YANG YZ, 1979, J BIOL CHEM, V254, P7137; Yokouchi K, 2006, ARTERIOSCL THROM VAS, V26, P2231, DOI 10.1161/01.ATV.0000239441.29687.97	37	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31447	31453		10.1074/jbc.M112.350421	http://dx.doi.org/10.1074/jbc.M112.350421			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22791711	Green Published, hybrid			2022-12-28	WOS:000308791300055
J	Kashef, F; Li, JD; Wright, P; Snyder, J; Suliman, F; Kilic, A; Higgins, RSD; Anderson, ME; Binkley, PF; Hund, TJ; Mohler, PJ				Kashef, Farshid; Li, Jingdong; Wright, Patrick; Snyder, Jedidiah; Suliman, Faroug; Kilic, Ahmet; Higgins, Robert S. D.; Anderson, Mark E.; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.			Ankyrin-B Protein in Heart Failure IDENTIFICATION OF A NEW COMPONENT OF METAZOAN CARDIOPROTECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; CARDIAC-ARRHYTHMIA; MOLECULAR-BASIS; MEMBRANE; REQUIRES; PROTEOLYSIS; STABILITY; SPECTRIN; NODES; BETA(2)-SPECTRIN	Ankyrins (ankyrin-R, -B, and -G) are adapter proteins linked with defects in metazoan physiology. Ankyrin-B (encoded by ANK2) loss-of-function mutations are directly associated with human cardiovascular phenotypes including sinus node disease, atrial fibrillation, ventricular tachycardia, and sudden cardiac death. Despite the link between ankyrin-B dysfunction and monogenic disease, there are no data linking ankyrin-B regulation with common forms of human heart failure. Here, we report that ankyrin-B levels are altered in both ischemic and non-ischemic human heart failure. Mechanistically, we demonstrate that cardiac ankyrin-B levels are tightly regulated downstream of reactive oxygen species, intracellular calcium, and the calcium-dependent protease calpain, all hallmarks of human myocardial injury and heart failure. Surprisingly, beta(II)-spectrin, previously thought to mediate ankyrin-dependent modulation in the nervous system and heart, is not coordinately regulated with ankyrin-B or its downstream partners. Finally, our data implicate ankyrin-B expression as required for vertebrate myocardial protection as hearts deficient in ankyrin-B show increased cardiac damage and impaired function relative to wild-type mouse hearts following ischemia reperfusion. In summary, our findings provide the data of ankyrin-B regulation in human heart failure, provide insight into candidate pathways for ankyrin-B regulation in acquired human cardiovascular disease, and surprisingly, implicate ankyrin-B as a molecular component for cardioprotection following ischemia.	[Kashef, Farshid; Li, Jingdong; Wright, Patrick; Snyder, Jedidiah; Kilic, Ahmet; Higgins, Robert S. D.; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Coll Engn, Columbus, OH 43210 USA; [Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Coll Engn, Div Cardiovasc Med, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Engn, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert S. D.] Ohio State Univ, Comprehens Transplant Ctr, Coll Engn, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Ohio State Univ Med Ctr, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Suliman, Faroug; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa	Mohler, PJ (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Coll Engn, 473 W 12th Ave,DHLRI 110G, Columbus, OH 43210 USA.	peter.mohler@osumc.edu	Hund, Thomas/C-9222-2012; Higgins, Robert/AGZ-7064-2022		National Institutes of Health [HL084583, HL083422, HL096805]; Saving Tiny Hearts Society; Pew Scholars Trust; American Heart Association Established Investigator Award; Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113001, R01HL083422, K99HL096805, R01HL084583, R00HL096805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; Pew Scholars Trust; American Heart Association Established Investigator Award(American Heart Association); Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease)(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.) and HL096805 (to T. J. H.). This work was also supported by grants from the Saving Tiny Hearts Society (to P. J. M.), Pew Scholars Trust (to P. J. M.), American Heart Association Established Investigator Award (to P. J. M.), and Fondation Leducq (Alliance for Calmodulin Kinase Signaling in Heart Disease (to P. J. M. and M. E. A.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Brundel BJJM, 2002, CARDIOVASC RES, V54, P380, DOI 10.1016/S0008-6363(02)00289-4; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gumina RJ, 2003, AM J PHYSIOL-HEART C, V284, pH2106, DOI 10.1152/ajpheart.00057.2003; Haruna T, 1998, CIRCULATION, V98, P2905, DOI 10.1161/01.CIR.98.25.2905; Hashemi SM, 2009, J MOL CELL CARDIOL, V47, P203, DOI 10.1016/j.yjmcc.2009.04.010; Healy JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000771; Hund TJ, 2011, AM J PHYSIOL-HEART C, V300, pH33, DOI 10.1152/ajpheart.01088.2010; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Ma WL, 2011, J CLIN INVEST, V121, P4548, DOI 10.1172/JCI57734; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2006, J CARDIOVASC ELECTR, V17, P1153, DOI 10.1111/j.1540-8167.2006.00540.x; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Monceau V, 2004, CARDIOVASC RES, V64, P496, DOI 10.1016/j.cardiores.2004.08.003; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Schwartz SM, 2003, PEDIATR RES, V54, P91, DOI 10.1203/01.PDR.0000065730.79610.7D; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	52	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30268	30281		10.1074/jbc.M112.368415	http://dx.doi.org/10.1074/jbc.M112.368415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778271	Green Published, hybrid			2022-12-28	WOS:000308579800020
J	Reinders, A; Sun, Y; Karvonen, KL; Ward, JM				Reinders, Anke; Sun, Ye; Karvonen, Kayla L.; Ward, John M.			Identification of Amino Acids Important for Substrate Specificity in Sucrose Transporters Using Gene Shuffling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; PHLOEM; RICE; EXPRESSION; EVOLUTION; YEAST; TRANSFORMATION; AFFINITY; BARLEY	Plant sucrose transporters (SUTs) are H (+)-coupled uptake transporters. Type I and II (SUTs) are phylogenetically related but have different substrate specificities. Type I SUTs transport sucrose, maltose, and a wide range of natural and synthetic alpha- and beta-glucosides. Type II SUTs are more selective for sucrose and maltose. Here, we investigated the structural basis for this difference in substrate specificity. We used a novel gene shuffling method called synthetic template shuffling to introduce 62 differentially conserved amino acid residues from type I SUTs into OsSUT1, a type II SUT from rice. The OsSUT1 variants were tested for their ability to transport the fluorescent coumarin beta-glucoside esculin when expressed in yeast. Fluorescent yeast cells were selected using fluorescence-activated cell sorting (FACS). Substitution of five amino acids present in type I SUTs in OsSUT1 was found to be sufficient to confer esculin uptake activity. The changes clustered in two areas of the OsSUT1 protein: in the first loop and the top of TMS2 (T80L and A86K) and in TMS5 (S220A, S221A, and T224Y). The substrate specificity of this OsSUT1 variant was almost identical to that of type I SUTs. Corresponding changes in the sugarcane type II transporter ShSUT1 also changed substrate specificity, indicating that these residues contribute to substrate specificity in type II SUTs in general.	[Reinders, Anke; Sun, Ye; Karvonen, Kayla L.; Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ward, JM (corresponding author), Univ Minnesota, Dept Plant Biol, 250 Biol Sci Ctr,1445 Gortner Ave, St Paul, MN 55108 USA.	jward@umn.edu		Ward, John/0000-0001-8185-0434; Reinders, Anke/0000-0001-5351-3940; Karvonen, Kayla/0000-0001-8213-6697	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DE-FG02-10ER15886]; National Institutes of Health [P30 CAO77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant; We are grateful to Nisha Shah from the University Flow Cytometry Resource supported in part by National Institutes of Health Grant P30 CAO77598 for performing the cell sorting and to the College of Biological Sciences' Imaging Center at the University of Minnesota for assistance with fluorescence microscopy. We thank Dr. Robert Furbank (Commonwealth Scientific and Industrial Research Organisation) for supplying the OsSUT1 cDNA and Dr. Christopher P. Grof (University of Newcastle) for supplying the ShSUT1 cDNA.DE-FG02-10ER15886 (to J. M. W.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aoki N, 2003, PLANT CELL PHYSIOL, V44, P223, DOI 10.1093/pcp/pcg030; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; BUSH DR, 1993, ARCH BIOCHEM BIOPHYS, V307, P355, DOI 10.1006/abbi.1993.1600; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gora PJ, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-13; GRIFFIN SDJ, 1993, BIOCHIM BIOPHYS ACTA, V1152, P61, DOI 10.1016/0005-2736(93)90231-N; HITZ WD, 1986, J BIOL CHEM, V261, P1986; Inagaki K, 2006, PIGM CELL RES, V19, P451, DOI 10.1111/j.1600-0749.2006.00332.x; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lu JMY, 1998, P NATL ACAD SCI USA, V95, P9025, DOI 10.1073/pnas.95.15.9025; Moore GL, 2001, P NATL ACAD SCI USA, V98, P3226, DOI 10.1073/pnas.051631498; Reinders A, 2001, MOL MICROBIOL, V39, P445, DOI 10.1046/j.1365-2958.2001.02237.x; Reinders A, 2008, PLANT MOL BIOL, V68, P289, DOI 10.1007/s11103-008-9370-0; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Reinders A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00022; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schulze W, 2000, FEBS LETT, V485, P189, DOI 10.1016/S0014-5793(00)02180-3; Sivitz AB, 2005, PLANT CELL PHYSIOL, V46, P1666, DOI 10.1093/pcp/pci182; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Sun Y, 2012, BIOCHEMISTRY-US, V51, P3284, DOI 10.1021/bi201934h; Sun Y, 2010, PLANT CELL PHYSIOL, V51, P114, DOI 10.1093/pcp/pcp172	36	22	22	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30296	30304		10.1074/jbc.M112.372888	http://dx.doi.org/10.1074/jbc.M112.372888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807445	Green Published, hybrid			2022-12-28	WOS:000308579800022
J	Sawai, H; Yamanaka, M; Sugimoto, H; Shiro, Y; Aono, S				Sawai, Hitomi; Yamanaka, Masaru; Sugimoto, Hiroshi; Shiro, Yoshitsugu; Aono, Shigetoshi			Structural Basis for the Transcriptional Regulation of Heme Homeostasis in Lactococcus lactis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TETR FAMILY; IRON; RESPIRATION; SEQUENCE; ACRR; IDENTIFICATION; REFINEMENT; EFFLUX; SYSTEM	Although heme is a crucial element for many biological processes including respiration, heme homeostasis should be regulated strictly due to the cytotoxicity of free heme molecules. Numerous lactic acid bacteria, including Lactococcus lactis, acquire heme molecules exogenously to establish an aerobic respiratory chain. A heme efflux system plays an important role for heme homeostasis to avoid cytotoxicity of acquired free heme, but its regulatory mechanism is not clear. Here, we report that the transcriptional regulator heme-regulated transporter regulator (HrtR) senses and binds a heme molecule as its physiological effector to regulate the expression of the heme-efflux system responsible for heme homeostasis in L. lactis. To elucidate the molecular mechanisms of how HrtR senses a heme molecule and regulates gene expression for the heme efflux system, we determined the crystal structures of the apo-HrtR.DNA complex, apo-HrtR, and holo-HrtR at a resolution of 2.0, 3.1, and 1.9 angstrom, respectively. These structures revealed that HrtR is a member of the TetR family of transcriptional regulators. The residue pair Arg-46 and Tyr-50 plays a crucial role for specific DNA binding through hydrogen bonding and a CH-pi interaction with the DNA bases. HrtR adopts a unique mechanism for its functional regulation upon heme sensing. Heme binding to HrtR causes a coil-to-helix transition of the alpha 4 helix in the heme-sensing domain, which triggers a structural change of HrtR, causing it to dissociate from the target DNA for derepression of the genes encoding the heme efflux system. HrtR uses a unique heme-sensing motif with bis-His (His-72 and His-149) ligation to the heme, which is essential for the coil-to-helix transition of the alpha 4 helix upon heme sensing.	[Sugimoto, Hiroshi; Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Sawai, Hitomi; Yamanaka, Masaru; Aono, Shigetoshi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Sawai, Hitomi; Yamanaka, Masaru; Aono, Shigetoshi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Sugimoto, H (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	sugimoto@spring8.or.jp; aono@ims.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Sugimoto, Hiroshi/K-4041-2017; Aono, Shigetoshi/ABD-7618-2020; Sugimoto, Hiroshi/AAR-5442-2021; Sawai, Hitomi/AAU-2584-2020; Sawai, Hitomi/AAW-5541-2021; Asano, Yasuhisa/K-5898-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Sugimoto, Hiroshi/0000-0002-3140-8362; Aono, Shigetoshi/0000-0002-2870-3694; Asano, Yasuhisa/0000-0003-3645-3952; Sawai, Hitomi/0000-0002-0714-8337	Japan Society for the Promotion of Science [23350084, 22870043]; Noda Institute for Scientific Research; Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking; Shiseido Co., Ltd.; Grants-in-Aid for Scientific Research [23350084] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute for Scientific Research(Noda Institute for Scientific Research); Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking; Shiseido Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research B 23350084 (to S. A.) and Grant-in-aid for Research Activity Start-up 22870043 (to H. Sawai) from the Japan Society for the Promotion of Science, by the Noda Institute for Scientific Research (to S. A.), by the Fumi Yamamura Memorial Foundation for Female Natural Scientists from Chuo Mitsui Trust and Banking (to H. Sawai), and by the Shiseido Female Researcher Science Grant from Shiseido Co., Ltd. (to H. Sa).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gu RY, 2008, ACTA CRYSTALLOGR F, V64, P584, DOI 10.1107/S1744309108016035; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kimura T, 2002, J AM CHEM SOC, V124, P11596, DOI 10.1021/ja026639f; Kokkinos A, 1998, LAIT, V78, P491, DOI 10.1051/lait:1998546; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lunin VY, 2002, ACTA CRYSTALLOGR A, V58, P270, DOI 10.1107/S0108767302001046; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Stauff DL, 2009, CONTRIB MICROBIOL, V16, P120, DOI 10.1159/000219376; Su CC, 2007, BIOCHEM BIOPH RES CO, V361, P85, DOI 10.1016/j.bbrc.2007.06.175; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; Sugahara M, 2006, ACTA CRYSTALLOGR D, V62, P520, DOI 10.1107/S0907444906009012; TAO X, 1994, MOL MICROBIOL, V14, P191, DOI 10.1111/j.1365-2958.1994.tb01280.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Umezawa Y, 2002, NUCLEIC ACIDS RES, V30, P2183, DOI 10.1093/nar/30.10.2183; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	44	44	44	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30755	30768		10.1074/jbc.M112.370916	http://dx.doi.org/10.1074/jbc.M112.370916			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798069	Green Published, hybrid			2022-12-28	WOS:000308579800064
J	Costa, B; Kean, MJ; Ast, V; Knight, JDR; Mett, A; Levy, Z; Ceccarelli, DF; Badillo, BG; Eils, R; Konig, R; Gingras, AC; Fainzilber, M				Costa, Barbara; Kean, Michelle J.; Ast, Volker; Knight, James D. R.; Mett, Alice; Levy, Zehava; Ceccarelli, Derek F.; Badillo, Beatriz Gonzalez; Eils, Roland; Koenig, Rainer; Gingras, Anne-Claude; Fainzilber, Mike			STK25 Protein Mediates TrkA and CCM2 Protein-dependent Death in Pediatric Tumor Cells of Neural Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; RECENT INSIGHTS; RECEPTORS; KINASE; GOLGI; PURIFICATION; INTERACTS; PATHWAY; COMPLEX; GROWTH	The TrkA receptor tyrosine kinase induces death in medulloblastoma cells via an interaction with the cerebral cavernous malformation 2 (CCM2) protein. We used affinity proteomics to identify the germinal center kinase class III (GCKIII) kinases STK24 and STK25 as novel CCM2 interactors. Down-modulation of STK25, but not STK24, rescued medulloblastoma cells from NGF-induced TrkA-dependent cell death, suggesting that STK25 is part of the death-signaling pathway initiated by TrkA and CCM2. CCM2 can be phosphorylated by STK25, and the kinase activity of STK25 is required for death signaling. Finally, STK25 expression in tumors is correlated with positive prognosis in neuroblastoma patients. These findings delineate a death-signaling pathway downstream of neurotrophic receptor tyrosine kinases that may provide targets for therapeutic intervention in pediatric tumors of neural origin.	[Costa, Barbara; Mett, Alice; Levy, Zehava; Fainzilber, Mike] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kean, Michelle J.; Knight, James D. R.; Ceccarelli, Derek F.; Badillo, Beatriz Gonzalez; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kean, Michelle J.; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Ast, Volker; Eils, Roland; Koenig, Rainer] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Bioquant, D-69120 Heidelberg, Germany; [Ast, Volker; Eils, Roland; Koenig, Rainer] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany	Weizmann Institute of Science; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Costa, B (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	barbara.costa@weizmann.ac.il; mike.fainzilber@weizmann.ac.il	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020; Eils, Roland/B-6121-2009	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Eils, Roland/0000-0002-0034-4036; Fainzilber, Mike/0000-0001-8173-8557; Ceccarelli, Derek/0000-0002-2674-9234; Costa, Barbara/0000-0001-5958-5099	European Union (Endocyte Network); German-Israeli Cooperation in Cancer Research [CA 140]; Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE [01GS0898]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET [0316076C]; Lombroso postdoctoral fellowship; Banting and Best Canada Graduate Scholarship	European Union (Endocyte Network); German-Israeli Cooperation in Cancer Research; Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE(Canadian Institutes of Health Research (CIHR)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET(Federal Ministry of Education & Research (BMBF)); Lombroso postdoctoral fellowship; Banting and Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by the European Union (Endocyte Network), the German-Israeli Cooperation in Cancer Research (CA 140), the Canadian Institutes of Health Research, Nationales Genom-Forschungs-Netz (NGFN+) project ENGINE (01GS0898), and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie CancerSys-Verbundprojekt: MYCNET (0316076C), a Lombroso postdoctoral fellowship (to B. C.), and a Banting and Best Canada Graduate Scholarship (to M. J. K.).	Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Harel L, 2010, DEV NEUROBIOL, V70, P298, DOI 10.1002/dneu.20769; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Hothorn T, 2003, COMPUT STAT DATA AN, V43, P121, DOI 10.1016/S0167-9473(02)00225-6; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Muragaki Y, 1997, J NEUROSCI, V17, P530; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9	20	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29285	29289		10.1074/jbc.C112.345397	http://dx.doi.org/10.1074/jbc.C112.345397			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782892	hybrid, Green Published			2022-12-28	WOS:000308286900008
J	Gimenez, LE; Vishnivetskiy, SA; Baameur, F; Gurevich, VV				Gimenez, Luis E.; Vishnivetskiy, Sergey A.; Baameur, Faiza; Gurevich, Vsevolod V.			Manipulation of Very Few Receptor Discriminator Residues Greatly Enhances Receptor Specificity of Non-visual Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHORYLATION-RECOGNITION; NEOSTRIATAL NEURONS; CLATHRIN ADAPTER; BINDING STATE; LIVING CELLS	Based on the identification of residues that determine receptor selectivity of arrestins and the analysis of the evolution in the arrestin family, we introduced 10 mutations of "receptor discriminator" residues in arrestin-3. The recruitment of these mutants to M2 muscarinic (M2R), D1 (D1R) and D2 (D2R) dopamine, and beta(2)-adrenergic receptors (beta(2)AR) was assessed using bioluminescence resonance energy transfer-based assays in cells. Seven of 10 mutations differentially affected arrestin-3 binding to individual receptors. D260K and Q262P reduced the binding to beta(2)AR, much more than to other receptors. The combination D260K/Q262P virtually eliminated beta(2)AR binding while preserving the interactions with M2R, D1R, and D2R. Conversely, Y239T enhanced arrestin-3 binding to beta(2)AR and reduced the binding to M2R, D1R, and D2R, whereas Q256Y selectively reduced recruitment to D2R. The Y239T/Q256Y combination virtually eliminated the binding to D2R and reduced the binding to beta(2)AR and M2R, yielding a mutant with high selectivity for D1R. Eleven of 12 mutations significantly changed the binding to light-activated phosphorhodopsin. Thus, manipulation of key residues on the receptor-binding surface modifies receptor preference, enabling the construction of non-visual arrestins specific for particular receptor subtypes. These findings pave the way to the construction of signaling-biased arrestins targeting the receptor of choice for research or therapeutic purposes.	[Gimenez, Luis E.; Vishnivetskiy, Sergey A.; Baameur, Faiza; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V.V.G.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; FRANCES B, 1990, EUR J PHARM-MOLEC PH, V189, P1, DOI 10.1016/0922-4106(90)90224-L; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; JAGADEESH G, 1990, J PHARMACOL EXP THER, V252, P1184; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pantel J, 2011, EUR J PHARMACOL, V660, P139, DOI 10.1016/j.ejphar.2011.01.031; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; TIAN WN, 1994, MOL PHARMACOL, V45, P524; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	74	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29495	29505		10.1074/jbc.M112.366674	http://dx.doi.org/10.1074/jbc.M112.366674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787152	Green Published, hybrid			2022-12-28	WOS:000308286900026
J	Smith, SD; Enge, M; Bao, WJ; Thullberg, M; Costa, TDF; Olofsson, H; Gashi, B; Selivanova, G; Stromblad, S				Smith, Stephen D.; Enge, Martin; Bao, Wenjie; Thullberg, Minna; Costa, Tania D. F.; Olofsson, Helene; Gashi, Behxhet; Selivanova, Galina; Stromblad, Staffan			Protein Kinase C alpha (PKC alpha) Regulates p53 Localization and Melanoma Cell Survival Downstream of Integrin alpha v in Three-dimensional Collagen and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; WILD-TYPE P53; CYTOPLASMIC SEQUESTRATION; BCL2 PHOSPHORYLATION; MALIGNANT-MELANOMA; PHORBOL ESTER; DNA-DAMAGE; GROWTH; APOPTOSIS; SUPPRESSION	Protein kinase C alpha (PKC alpha) is overexpressed in numerous types of cancer. Importantly, PKC alpha has been linked to metastasis of malignant melanoma in patients. However, it has been unclear how PKC alpha may be regulated and how it exerts its role in melanoma. Here, we identified a role for PKC alpha in melanoma cell survival in a three-dimensional collagen model mimicking the in vivo pathophysiology of the dermis. A pathway was identified that involved integrin alpha v-mediated up-regulation of PKC alpha and PKC alpha-dependent regulation of p53 localization, which was connected to melanoma cell survival. Melanoma survival and growth in three-dimensional microenvironments requires the expression of integrin alpha v, which acts to suppress p53 activity. Interestingly, microarray analysis revealed that PKC alpha was up-regulated by integrin alpha v in a three-dimensional microenvironment-dependent manner. Integrin alpha v was observed to promote a relocalization of endogenous p53 from the nucleus to the cytoplasm upon growth in three-dimensional collagen as well as in vivo, whereas stable knockdown of PKC alpha inhibited the integrin alpha v-mediated relocalization of p53. Importantly, knockdown of PKC alpha also promoted apoptosis in three-dimensional collagen and in vivo, resulting in reduced tumor growth. This indicates that PKC alpha constitutes a crucial component of the integrin alpha v-mediated pathway(s) that promote p53 relocalization and melanoma survival.	[Smith, Stephen D.; Enge, Martin; Bao, Wenjie; Thullberg, Minna; Costa, Tania D. F.; Olofsson, Helene; Gashi, Behxhet; Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Enge, Martin; Bao, Wenjie; Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Stromblad, S (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	staffan.stromblad@ki.se	Enge, Martin/GYQ-5073-2022	Stromblad, Staffan/0000-0002-1236-6339; Selivanova, Galina/0000-0002-8698-4332; Enge, Martin/0000-0001-8748-8931	Swedish Cancer Society; EU [p53]; Swedish Research Council; Center of Biosciences; Foundation for Allergy and Cancer in Sweden; Portuguese Foundation for Science and Technology [SFRH/BD/47330/2008]	Swedish Cancer Society(Swedish Cancer Society); EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center of Biosciences; Foundation for Allergy and Cancer in Sweden; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Swedish Cancer Society, EU-FP6-Active p53, and the Swedish Research Council (to S. S. and G. S.) and from the Center of Biosciences and the Foundation for Allergy and Cancer in Sweden (to S. S.).; Supported by the Portuguese Foundation for Science and Technology (SFRH/BD/47330/2008).	ALBELDA SM, 1990, CANCER RES, V50, P6757; Bao WJ, 2011, CELL CYCLE, V10, P301, DOI 10.4161/cc.10.2.14538; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byers HR, 2010, MELANOMA RES, V20, P171, DOI 10.1097/CMR.0b013e32832f1581; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Chernov MV, 2001, J BIOL CHEM, V276, P31819, DOI 10.1074/jbc.M103170200; Coutinho I, 2009, FEBS LETT, V583, P3582, DOI 10.1016/j.febslet.2009.10.030; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DANG CV, 1989, J BIOL CHEM, V264, P18019; Delphin C, 1997, EUR J BIOCHEM, V245, P684, DOI 10.1111/j.1432-1033.1997.t01-1-00684.x; DELPHIN C, 1994, J BIOL CHEM, V269, P29579; Dennis JU, 1998, CANCER LETT, V128, P65, DOI 10.1016/S0304-3835(98)00052-4; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haller D, 2010, ONCOGENE, V29, P3079, DOI 10.1038/onc.2010.61; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Jorgensen K, 2005, BIOCHEM BIOPH RES CO, V329, P266, DOI 10.1016/j.bbrc.2005.01.143; Komlodi-Pasztor E, 2009, ONCOGENE, V28, P3111, DOI 10.1038/onc.2009.166; Koren R, 2004, ONCOL REP, V11, P321; Lahn MM, 2004, MELANOMA RES, V14, P85, DOI 10.1097/00008390-200404000-00002; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Luu Y, 2003, ANTICANCER RES, V23, P99; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Petitclerc E, 1999, CANCER RES, V59, P2724; PRICE BD, 1993, ONCOGENE, V8, P3055; Putnam AJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-10; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tsubaki M, 2007, CLIN EXP METASTAS, V24, P431, DOI 10.1007/s10585-007-9080-z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wu CC, 2004, BIOINFORMATICS, V20, P3691, DOI 10.1093/bioinformatics/bth428; Youmell M, 1998, BIOCHEM BIOPH RES CO, V245, P514, DOI 10.1006/bbrc.1998.8471; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	50	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29336	29347		10.1074/jbc.M112.341917	http://dx.doi.org/10.1074/jbc.M112.341917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773839	hybrid, Green Published			2022-12-28	WOS:000308286900013
J	Uner, NE; Nishikawa, Y; Okuno, D; Nakano, M; Yokoyama, K; Noji, H				Uner, Naciye Esma; Nishikawa, Yoshihiro; Okuno, Daichi; Nakano, Masahiro; Yokoyama, Ken; Noji, Hiroyuki			Single-molecule Analysis of Inhibitory Pausing States of V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; F-1 MOTOR; V-ATPASE; ROTATION; F-1-ATPASE; SUBUNIT; ATPASE/SYNTHASE; HYDROLYSIS; CATALYSIS	V-1-ATPase, the hydrophilic V-ATPase domain, is a rotary motor fueled by ATP hydrolysis. Here, we found that Thermus thermophilus V-1-ATPase shows two types of inhibitory pauses interrupting continuous rotation: a short pause (SP, 4.2 s) that occurred frequently during rotation, and a long inhibitory pause (LP, > 30 min) that terminated all active rotations. Both pauses occurred at the same angle for ATP binding and hydrolysis. Kinetic analysis revealed that the time constants of inactivation into and activation from the SP were too short to represent biochemically predicted ADP inhibition, suggesting that SP is a newly identified inhibitory state of V-1-ATPase. The time constant of inactivation into LP was 17 min, consistent with one of the two time constants governing the inactivation process observed in bulk ATPase assay. When forcibly rotated in the forward direction, V-1 in LP resumed active rotation. Solution ADP suppressed the probability of mechanical activation, suggesting that mechanical rotation enhanced inhibitory ADP release. These features were highly consistent with mechanical activation of ADP-inhibited F-1, suggesting that LP represents the ADP-inhibited state of V-1-ATPase. Mechanical activation largely depended on the direction and angular displacement of forced rotation, implying that V-1-ATPase rotation modulates the off rate of ADP.	[Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Uner, Naciye Esma; Nishikawa, Yoshihiro] Osaka Univ, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Okuno, Daichi] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan; [Nakano, Masahiro] Inst Ind & Sci Res, Osaka 5650874, Japan; [Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	University of Tokyo; Osaka University; RIKEN; Kyoto Sangyo University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Yokoyama, Ken/AAJ-3582-2020	Yokoyama, Ken/0000-0002-6813-1096; Tirtom, Naciye Esma/0000-0003-4637-8466	Ministry of Education, Culture, Sports, Science and Technology, Japan;  [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by Grant-in-aid for Scientific Research 18074005 (to H. N.) and by a Special Education and Research Expenses grant (to H. N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pavlova P, 2004, J BIOL CHEM, V279, P9685, DOI 10.1074/jbc.C400014200; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Takeda M, 2009, BIOPHYS J, V96, P1210, DOI 10.1016/j.bpj.2008.10.031; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	28	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28327	28335		10.1074/jbc.M112.381194	http://dx.doi.org/10.1074/jbc.M112.381194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736762	hybrid, Green Published			2022-12-28	WOS:000308074600010
J	Kravets, E; Degrandi, D; Weidtkamp-Peters, S; Ries, B; Konermann, C; Felekyan, S; Dargazanli, JM; Praefcke, GJK; Seidel, CAM; Schmitt, L; Smits, SHJ; Pfeffer, K				Kravets, Elisabeth; Degrandi, Daniel; Weidtkamp-Peters, Stefanie; Ries, Britta; Konermann, Carolin; Felekyan, Suren; Dargazanli, Julia M.; Praefcke, Gerrit J. K.; Seidel, Claus A. M.; Schmitt, Lutz; Smits, Sander H. J.; Pfeffer, Klaus			The GTPase Activity of Murine Guanylate-binding Protein 2 (mGBP2) Controls the Intracellular Localization and Recruitment to the Parasitophorous Vacuole of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNITY-RELATED GTPASE; NUCLEOTIDE-BINDING; ENDOPLASMIC-RETICULUM; DYNAMIN SUPERFAMILY; RESISTANCE GTPASES; CELLULAR-RESPONSE; MOUSE RESISTANCE; DOMAIN MUTANTS; P47 GTPASES; INTERFERON	One of the most abundantly IFN-gamma-induced protein families different cell types is the 65-kDa guanylate-binding protein family that is recruited to the parasitophorous vacuole of the intracellular parasite Toxoplasma gondii. Here, we elucidate the relationship between biochemistry and cellular host defense functions of mGBP2 in response to Toxoplasma gondii. The wild type protein exhibits low affinities to guanine nucleotides, self-assembles upon GTP binding, forming tetramers in the activated state, and stimulates the GTPase activity in a cooperative manner. The products of the two consecutive hydrolysis reactions are both GDP and GMP. The biochemical characterization of point mutants in the GTP-binding motifs of mGBP2 revealed amino acid residues that decrease the GTPase activity by orders of magnitude and strongly impair nucleotide binding and multimerization ability. Live cell imaging employing multiparameter fluorescence image spectroscopy (MFIS) using a Homo-FRET assay shows that the inducible multimerization of mGBP2 is dependent on a functional GTPase domain. The consistent results indicate that GTP binding, self-assembly, and stimulated hydrolysis activity are required for physiological localization of the protein in infected and uninfected cells. Ultimately, we show that the GTPase domain regulates efficient recruitment to T. gondii in response to IFN-gamma.	[Kravets, Elisabeth; Degrandi, Daniel; Konermann, Carolin; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Weidtkamp-Peters, Stefanie] Univ Dusseldorf, Ctr Adv Imaging, D-40225 Dusseldorf, Germany; [Ries, Britta; Schmitt, Lutz; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Felekyan, Suren; Seidel, Claus A. M.] Univ Dusseldorf, Chair Mol Phys Chem, D-40225 Dusseldorf, Germany; [Dargazanli, Julia M.; Praefcke, Gerrit J. K.] Univ Cologne, Inst Genet, Ctr Mol Med Cologne, D-50674 Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne	Pfeffer, K (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany.	klaus.pfeffer@hhu.de	Seidel, Claus A.M./A-3682-2012	Seidel, Claus A.M./0000-0002-5171-149X; Praefcke, Gerrit/0000-0001-8818-1499; Weidtkamp-Peters, Stefanie/0000-0001-7734-3771; Pfeffer, Klaus/0000-0002-5652-6330	Deutsche Forschungsgemeinschaft [PF259/4-1, FOR 729, GRK 1045, SFB 590]; Jurgen Manchot Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jurgen Manchot Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants PF259/4-1, FOR 729, GRK 1045, and SFB 590 (to K. P. and C. A. M. S.) and the Jurgen Manchot Foundation.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Balasubramanian S., 2010, J INTERFERON CYTOKIN, V31, P291; BECKER W, 2005, SPRINGER SERIES CHEM, V81, P1; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Fres JM, 2010, J LIPID RES, V51, P2454, DOI 10.1194/jlr.D005397; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; KOSHIOKA M, 1995, APPL SPECTROSC, V49, P224, DOI 10.1366/0003702953963652; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Kudryavtsev V, 2007, ANAL BIOANAL CHEM, V387, P71, DOI 10.1007/s00216-006-0917-0; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Kunzelmann S, 2006, J BIOL CHEM, V281, P28627, DOI 10.1074/jbc.M604911200; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Neun R, 1996, FEBS LETT, V390, P69, DOI 10.1016/0014-5793(96)00628-X; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Pawlowski N, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-7; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vestal DJ, 2005, J INTERF CYTOK RES, V25, P435, DOI 10.1089/jir.2005.25.435; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Vopel T, 2010, J MOL BIOL, V400, P63, DOI 10.1016/j.jmb.2010.04.053; Vopel T, 2009, FEBS LETT, V583, P1923, DOI 10.1016/j.febslet.2009.05.027; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wehner M, 2012, FEBS J, V279, P203, DOI 10.1111/j.1742-4658.2011.08415.x; Wehner M, 2010, FEBS J, V277, P1597, DOI 10.1111/j.1742-4658.2010.07586.x; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	90	39	39	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27452	27466		10.1074/jbc.M112.379636	http://dx.doi.org/10.1074/jbc.M112.379636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730319	Green Published, hybrid			2022-12-28	WOS:000307840700022
J	Santini, E; Feyder, M; Gangarossa, G; Bateup, HS; Greengard, P; Fisone, G				Santini, Emanuela; Feyder, Michael; Gangarossa, Giuseppe; Bateup, Helen S.; Greengard, Paul; Fisone, Gilberto			Dopamine- and cAMP-regulated Phosphoprotein of 32-kDa (DARPP-32)-dependent Activation of Extracellular Signal-regulated Kinase (ERK) and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Experimental Parkinsonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEVODOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; SYNAPTIC PLASTICITY; HEMIPARKINSONIAN MICE; TUBEROUS SCLEROSIS; PHOSPHORYLATION; STRIATUM; DARPP-32; DISEASE; D1	Dyskinesia, a motor complication caused by prolonged administration of the antiparkinsonian drug L-3,4-dihydroxy-phenylalanine (L-DOPA), is accompanied by activation of cAMP signaling and hyperphosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32). Here, we show that the abnormal phosphorylation of DARPP-32 occurs specifically in medium spiny neurons (MSNs) expressing dopamine D1 receptors (D1R). Using mice in which DARPP-32 is selectively deleted in D1R-expressing MSNs, we demonstrate that this protein is required for L-DOPA-induced activation of the extracellular signal-regulated protein kinases 1 and 2 and the mammalian target of rapamycin complex 1 (mTORC1) pathways, which are implicated in dyskinesia. We also show that mutation of the phosphorylation site for cAMP-dependent protein kinase on DARPP-32 attenuates L-DOPA-induced dyskinesia and reduces the concomitant activations of ERK and mTORC1 signaling. These studies demonstrate that, in D1R-expressing MSNs, L-DOPA-induced activation of ERK and mTORC1 requires DARPP-32 and indicates the importance of the cAMP/DARPP-32 signaling cascade in dyskinesia.	[Santini, Emanuela; Feyder, Michael; Gangarossa, Giuseppe; Fisone, Gilberto] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Bateup, Helen S.; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA	Karolinska Institutet; Rockefeller University	Fisone, G (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	gilberto.fisone@ki.se		Fisone, Gilberto/0000-0002-0719-8000; Greengard, Paul/0000-0002-4437-0893; Gangarossa, Giuseppe/0000-0001-9045-2139	National Institutes of Health [MH 090963, DA 10044]; Swedish Research Council [20715, 13482]; Karolinska Institutet/National Institute of Health Graduate Partnership Program; Italian Ministry of the University [RBIN047W33]; Michael Stern Parkinson Research Foundation; Department of Defense/United States Army Medical Research Acquisition Activity [W81XWH-09-1-0402, W81XWH-10-1-0640]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet/National Institute of Health Graduate Partnership Program; Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR)); Michael Stern Parkinson Research Foundation; Department of Defense/United States Army Medical Research Acquisition Activity(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants MH 090963 and DA 10044 (to P. G.). This work was also supported by Swedish Research Council Grants 20715 and 13482 (to G. F.), Karolinska Institutet/National Institute of Health Graduate Partnership Program (to M. F.), Italian Ministry of the University Grant FIRB Internazionalizzazione RBIN047W33 (to G. F.), The Michael Stern Parkinson Research Foundation (to P. G.), and Department of Defense/United States Army Medical Research Acquisition Activity Grants W81XWH-09-1-0402 and W81XWH-10-1-0640 (to P. G.).	Alcacer C, 2012, J NEUROSCI, V32, P5900, DOI 10.1523/JNEUROSCI.0837-12.2012; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Guigoni C, 2005, PARKINSONISM RELAT D, V11, pS25, DOI 10.1016/j.parkreldis.2004.11.005; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Lebel M, 2010, NEUROBIOL DIS, V38, P59, DOI 10.1016/j.nbd.2009.12.027; Lundblad M, 2004, NEUROBIOL DIS, V16, P110, DOI 10.1016/j.nbd.2004.01.007; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MARSHALL JF, 1977, EUR J PHARMACOL, V41, P361, DOI 10.1016/0014-2999(77)90256-4; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Santini E, 2008, FEBS J, V275, P1392, DOI 10.1111/j.1742-4658.2008.06296.x; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012322; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Schuster S, 2008, J NEUROSCI, V28, P4311, DOI 10.1523/JNEUROSCI.4720-07.2008; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032	36	59	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27806	27812		10.1074/jbc.M112.388413	http://dx.doi.org/10.1074/jbc.M112.388413			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22753408	hybrid, Green Published			2022-12-28	WOS:000307840700054
J	Bar-On, D; Wolter, S; van de Linde, S; Heilemann, M; Nudelman, G; Nachliel, E; Gutman, M; Sauer, M; Ashery, U				Bar-On, Dana; Wolter, Steve; van de Linde, Sebastian; Heilemann, Mike; Nudelman, German; Nachliel, Esther; Gutman, Menachem; Sauer, Markus; Ashery, Uri			Super-resolution Imaging Reveals the Internal Architecture of Nano-sized Syntaxin Clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; NATIVE PLASMA-MEMBRANES; LIPID RAFTS; CHROMAFFIN CELLS; FLUORESCENT-PROBES; SNARE PROTEINS; FUSION; EXOCYTOSIS; 1A; TRAFFICKING	Key synaptic proteins from the soluble SNARE (N-ethylma-leimide-sensitive factor attachment protein receptor) family, among many others, are organized at the plasma membrane of cells as clusters containing dozens to hundreds of protein copies. However, the exact membranal distribution of proteins into clusters or as single molecules, the organization of molecules inside the clusters, and the clustering mechanisms are unclear due to limitations of the imaging and analytical tools. Focusing on syntaxin 1 and SNAP-25, we implemented direct stochastic optical reconstruction microscopy together with quantitative clustering algorithms to demonstrate a novel approach to explore the distribution of clustered and nonclustered molecules at the membrane of PC12 cells with single-molecule precision. Direct stochastic optical reconstruction microscopy images reveal, for the first time, solitary syntaxin/SNAP-25 molecules and small clusters as well as larger clusters. The nonclustered syntaxin or SNAP-25 molecules are mostly concentrated in areas adjacent to their own clusters. In the clusters, the density of the molecules gradually decreases from the dense cluster core to the periphery. We further detected large clusters that contain several density gradients. This suggests that some of the clusters are formed by unification of several clusters that preserve their original organization or reorganize into a single unit. Although syntaxin and SNAP-25 share some common distributional features, their clusters differ markedly from each other. SNAP-25 clusters are significantly larger, more elliptical, and less dense. Finally, this study establishes methodological tools for the analysis of single-molecule-based super-resolution imaging data and paves the way for revealing new levels of membranal protein organization.	[Wolter, Steve; van de Linde, Sebastian; Heilemann, Mike; Sauer, Markus] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany; [Nudelman, German] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Bar-On, Dana; Nachliel, Esther; Gutman, Menachem] Tel Aviv Univ, Dept Biochem, Laser Lab Fast React Biol, IL-69978 Tel Aviv, Israel; [Bar-On, Dana; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Ashery, Uri] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	University of Wurzburg; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Tel Aviv University; Tel Aviv University	Sauer, M (corresponding author), Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany.	m.sauer@uni-wuerzburg.de; uria@post.tau.ac.il	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Heilemann, Mike/0000-0002-9821-3578; Ashery, Uri/0000-0001-6338-7888	Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung; Israel Science Foundation Grant [1211/07]; National Institutes of Health Grant [RO1 NS053978]; German-Israeli Foundation (GIF) Grant [1125-145.1/2010]; Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships; "Converging Technologies" scholarship of the Israeli council for higher education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation Grant(Israel Science Foundation); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German-Israeli Foundation (GIF) Grant; Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships; "Converging Technologies" scholarship of the Israeli council for higher education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Biophotonics Initiative of the Bundesministerium fur Bildung und Forschung (to M. S.), the Israel Science Foundation Grant 1211/07 (to U. A.), National Institutes of Health Grant RO1 NS053978 (to U. A.), and German-Israeli Foundation (GIF) Grant 1125-145.1/2010 (to U. A. and M. S.).; A recipient of the Minerva and European Molecular Biology Organization (EMBO) short-term research fellowships and the "Converging Technologies" scholarship of the Israeli council for higher education.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bar-On D, 2008, FEBS LETT, V582, P3563, DOI 10.1016/j.febslet.2008.08.040; Bar-On D, 2009, J NEUROSCI, V29, P12292, DOI 10.1523/JNEUROSCI.0710-09.2009; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; Dun AR, 2010, CELL MOL NEUROBIOL, V30, P1321, DOI 10.1007/s10571-010-9599-4; Fan J, 2007, BIOCHEM BIOPH RES CO, V359, P245, DOI 10.1016/j.bbrc.2007.05.065; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Locantore NW, 2004, ENVIRON MONIT ASSESS, V94, P249, DOI 10.1023/B:EMAS.0000016892.67527.4c; Lopez I, 2009, TRAFFIC, V10, P172, DOI 10.1111/j.1600-0854.2008.00861.x; Mezer A, 2004, J NEUROSCI, V24, P8838, DOI 10.1523/JNEUROSCI.2815-04.2004; Mezer A, 2006, BBA-MOL CELL RES, V1763, P345, DOI 10.1016/j.bbamcr.2006.02.011; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nudelman G, 2009, MOL IMMUNOL, V46, P3141, DOI 10.1016/j.molimm.2009.03.027; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Torregrosa-Hetland CJ, 2010, CELL MOL NEUROBIOL, V30, P1315, DOI 10.1007/s10571-010-9565-1; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu XW, 1998, PROC INT CONF DATA, P324, DOI 10.1109/ICDE.1998.655795; Yang XF, 2006, J BIOL CHEM, V281, P15457, DOI 10.1074/jbc.M513246200	44	91	92	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27158	27167		10.1074/jbc.M112.353250	http://dx.doi.org/10.1074/jbc.M112.353250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700970	hybrid, Green Published			2022-12-28	WOS:000307386000068
J	Wilhelmsen, K; Mesa, KR; Lucero, J; Xu, FY; Hellman, J				Wilhelmsen, Kevin; Mesa, Kailin R.; Lucero, Jennifer; Xu, Fengyun; Hellman, Judith			ERK5 Protein Promotes, whereas MEK1 Protein Differentially Regulates, the Toll-like Receptor 2 Protein-dependent Activation of Human Endothelial Cells and Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION DATA; TRANSCRIPTIONAL REGULATION; STAPHYLOCOCCUS-AUREUS; KINASE PATHWAYS; SIGNALING SPECIFICITY; TLR2 EXPRESSION; INFLAMMATION; MACROPHAGES	Endothelial cell (EC) Toll-like receptor 2 (TLR2) activation up-regulates the expression of inflammatory mediators and of TLR2 itself and modulates important endothelial functions, including coagulation and permeability. We defined TLR2 signaling pathways in EC and tested the hypothesis that TLR2 signaling differs in EC and monocytes. We found that ERK5, heretofore unrecognized as mediating TLR2 activation in any cell type, is a central mediator of TLR2-dependent inflammatory signaling in human umbilical vein endothelial cells, primary human lung microvascular EC, and human monocytes. Additionally, we observed that, although MEK1 negatively regulates TLR2 signaling in EC, MEK1 promotes TLR2 signaling in monocytes. We also noted that activation of TLR2 led to the up-regulation of intracellularly expressed TLR2 and inflammatory mediators via NF-kappa B, JNK, and p38-MAPK. Finally, we found that p38-MAPK, JNK, ERK5, and NF-kappa B promote the attachment of human neutrophils to lung microvascular EC that were pretreated with TLR2 agonists. This study newly identifies ERK5 as a key regulator of TLR2 signaling in EC and monocytes and indicates that there are fundamental differences in TLR signaling pathways between EC and monocytes.	[Wilhelmsen, Kevin; Mesa, Kailin R.; Lucero, Jennifer; Xu, Fengyun; Hellman, Judith] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Hellman, Judith] Univ Calif San Francisco, Div Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wilhelmsen, K (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	wilhelmsenk@anesthesia.ucsf.edu		Mesa, Kailin/0000-0003-4452-9048	National Institutes of Health Grant [R01AI058106]; University of California San Francisco Department of Anesthesia and Perioperative Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058106] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Department of Anesthesia and Perioperative Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI058106 (NIAID; to J. Hellman). This work was also supported by the University of California San Francisco Department of Anesthesia and Perioperative Care.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Beekhuizen H, 1997, J IMMUNOL, V158, P774; Bertelsen T, 2011, EXP DERMATOL, V20, P140, DOI 10.1111/j.1600-0625.2010.01153.x; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lin Q, 2011, INT IMMUNOPHARMACOL, V11, P1422, DOI 10.1016/j.intimp.2011.04.026; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Petersen B, 2008, AM J PHYSIOL-LUNG C, V294, pL300, DOI 10.1152/ajplung.00243.2007; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schmidt RR, 2011, ORG BIOMOL CHEM, V9, P2040, DOI 10.1039/c0ob00794c; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wilhelmsen K., 2011, INNATE IMMUN IN PRES; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; YEN J, 1991, J IMMUNOTHER, V10, P174, DOI 10.1097/00002371-199106000-00003; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	70	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26478	26494		10.1074/jbc.M112.359489	http://dx.doi.org/10.1074/jbc.M112.359489			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707717	hybrid, Green Published			2022-12-28	WOS:000307386000002
J	Elass-Rochard, E; Rombouts, Y; Coddeville, B; Maes, E; Blervaque, R; Hot, D; Kremer, L; Guerardel, Y				Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Blervaque, Renaud; Hot, David; Kremer, Laurent; Guerardel, Yann			Structural Determination and Toll-like Receptor 2-dependent Proinflammatory Activity of Dimycolyl-diarabino-glycerol from Mycobacterium marinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ACID-CONTAINING GLYCOLIPIDS; BACILLUS-CALMETTE-GUERIN; CELL-WALL COMPONENTS; MYCOLIC ACIDS; CORD FACTOR; INTRACELLULARE COMPLEX; ANTIGEN PRESENTATION; GRANULOMA-FORMATION; ZEBRAFISH EMBRYOS	Although it was identified in the cell wall of several pathogenic mycobacteria, the biological properties of dimycolyl-diarabino-glycerol have not been documented yet. In this study an apolar glycolipid, presumably corresponding to dimycolyl-diarabino-glycerol, was purified from Mycobacterium marinum and subsequently identified as a 5-O-mycolyl-beta-Araf-(1 -> 2)-5-O-mycolyl-alpha-Araf-(1 -> 1')-glycerol (designated Mma_DMAG) using a combination of nuclear magnetic resonance spectroscopy and mass spectrometry analyses. Lipid composition analysis revealed that mycolic acids were dominated by oxygenated mycolates over alpha-mycolates and devoid of trans-cyclopropane functions. Highly purified Mma_DMAG was used to demonstrate its immunomodulatory activity. Mma_DMAG was found to induce the secretion of proinflammatory cytokines (TNF-alpha, IL-8, IL-1 beta) in human macrophage THP-1 cells and to trigger the expression of ICAM-1 and CD40 cell surface antigens. This activation mechanism was dependent on TLR2, but not on TLR4, as demonstrated by (i) the use of neutralizing anti-TLR2 and -TLR4 antibodies and by (ii) the detection of secreted alkaline phosphatase in HEK293 cells co-transfected with the human TLR2 and secreted embryonic alkaline phosphatase reporter genes. In addition, transcriptomic analyses indicated that various genes encoding proinflammatory factors were up-regulated after exposure of THP-1 cells toMma_DMAG. Importantly, a wealth of other regulated genes related to immune and inflammatory responses, including chemokines/cytokines and their respective receptors, adhesion molecules, and metalloproteinases, were found to be modulated by Mma_DMAG. Overall, this study suggests that DMAG may be an active cell wall glycoconjugate driving host-pathogen interactions and participating in the immunopathogenesis of mycobacterial infections.	[Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct, UGSF,IFR 147, F-59650 Villeneuve Dascq, France; [Elass-Rochard, Elisabeth; Rombouts, Yoann; Coddeville, Bernadette; Maes, Emmanuel; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Blervaque, Renaud; Hot, David] Inst Pasteur, Ctr Infect & Immun Lille, Lab Transcript & Genom Appl, U1019,UMR 8204, F-59019 Lille, France; [Kremer, Laurent] Univ Montpellier II & I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, DIMNP, F-34095 Montpellier 05, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Elass-Rochard, E (corresponding author), Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct, UGSF,IFR 147, F-59650 Villeneuve Dascq, France.	elisabeth.elass@univ-lille1.fr	Kremer, Laurent/M-4935-2017; Hot, David/M-6775-2016	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Hot, David/0000-0002-2361-0616; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	National Research Agency [ANR-05-MIIM-025]; Ministere de l'Enseignement Superieur	National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur	This work was supported by National Research Agency Grant ANR-05-MIIM-025 (to Y.G. and L. K.) and a grant from the Ministere de l'Enseignement Superieur (to Y.R.).	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Andersen CAS, 2009, J IMMUNOL, V183, P2294, DOI 10.4049/jimmunol.0804091; Astarie-Dequeker C., 2010, DRUG DISCOV TODAY, pe33; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; CHENSUE SW, 1986, INFECT IMMUN, V52, P341, DOI 10.1128/IAI.52.1.341-343.1986; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma Christine L, 2006, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/0471729256.mc10b02s3; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Ehrt S, 2007, NAT MED, V13, P284, DOI 10.1038/nm0307-284; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujita Y, 2007, MICROB PATHOGENESIS, V43, P10, DOI 10.1016/j.micpath.2007.02.006; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; HONDA I, 1993, RES MICROBIOL, V144, P229, DOI 10.1016/0923-2508(93)90048-7; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishiwata A, 2006, BIOORGAN MED CHEM, V14, P3049, DOI 10.1016/j.bmc.2005.12.037; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Khan AA, 2012, CARBOHYD RES, V356, P25, DOI 10.1016/j.carres.2012.03.010; Komori T, 2011, J BIOL CHEM, V286, P16800, DOI 10.1074/jbc.M110.217224; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Lebedeva T, 2005, CURR OPIN IMMUNOL, V17, P251, DOI 10.1016/j.coi.2005.04.008; Lonnstedt I, 2002, STAT SINICA, V12, P31; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Meena L.S., 2011, BIOTECHNOL RES INT; Miyauchi M, 2011, DRUG DISCOV THER, V5, P130, DOI 10.5582/ddt.2011.v5.3.130; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrini B, 2006, Eur J Clin Microbiol Infect Dis, V25, P609, DOI 10.1007/s10096-006-0201-4; Puttinaowarat S, 1999, AAHRI NEWSLETT, V8, P4; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Raja A, 2004, INDIAN J MED RES, V120, P213; RAMAKRISHNAN L, 1994, INFECT IMMUN, V62, P3222, DOI 10.1128/IAI.62.8.3222-3229.1994; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; ROUANET JM, 1983, ANN INST PASTEUR MIC, VB134, P233, DOI 10.1016/S0769-2609(83)80036-2; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; SILVA CL, 1985, BRAZ J MED BIOL RES, V18, P327; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Watanabe M, 1997, EUR J BIOCHEM, V248, P93, DOI 10.1111/j.1432-1033.1997.00093.x; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; WATANABE M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P53, DOI 10.1016/0005-2760(92)90075-7; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	76	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34432	34444		10.1074/jbc.M112.378083	http://dx.doi.org/10.1074/jbc.M112.378083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22798072	hybrid, Green Published			2022-12-28	WOS:000309654200045
J	Bchini, R; Dubourg-Gerecke, H; Rahuel-Clermont, S; Aubry, A; Branlant, G; Didierjean, C; Talfournier, F				Bchini, Raphael; Dubourg-Gerecke, Helene; Rahuel-Clermont, Sophie; Aubry, Andre; Branlant, Guy; Didierjean, Claude; Talfournier, Francois			Adenine Binding Mode Is a Key Factor in Triggering the Early Release of NADH in Coenzyme A-dependent Methylmalonate Semialdehyde Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ACTIVE-SITE; STEM-CELLS; RAT-LIVER; PURIFICATION; SPECIFICITY; MECHANISM; ISOMERIZATION; INVOLVEMENT	Structural dynamics associated with cofactor binding have been shown to play key roles in the catalytic mechanism of hydrolytic NAD(P)-dependent aldehyde dehydrogenases (ALDH). By contrast, no information is available for their CoA-dependent counterparts. We present here the first crystal structure of a CoA-dependent ALDH. The structure of the methylmalonate semialdehyde dehydrogenase (MSDH) from Bacillus subtilis in binary complex with NAD(+) shows that, in contrast to what is observed for hydrolytic ALDHs, the nicotinamide ring is well defined in the electron density due to direct and H2O-mediated hydrogen bonds with the carboxamide. The structure also reveals that a conformational isomerization of the NMNH is possible in MSDH, as shown for hydrolytic ALDHs. Finally, the adenine ring is substantially more solvent-exposed, a result that could be explained by the presence of a Val residue at position 229 in helix alpha(F) that reduces the depth of the binding pocket and the absence of Gly-225 at the N-terminal end of helix alpha(F). Substitution of glycine for Val-229 and/or insertion of a glycine residue at position 225 resulted in a significant decrease of the rate constant associated with the dissociation of NADH from the NADH/thioacylenzyme complex, thus demonstrating that the weaker stabilization of the adenine ring is a key factor in triggering the early NADH release in the MSDH-catalyzed reaction. This study provides for the first time structural insights into the mechanism whereby the cofactor binding mode is responsible at least in part for the different kinetic behaviors of the hydrolytic and CoA-dependent ALDHs.	[Bchini, Raphael; Rahuel-Clermont, Sophie; Branlant, Guy; Talfournier, Francois] Unite Mixte Rech CNRS Univ Lorraine 7214 AREMS, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Fac Med, F-54506 Vandoeuvre Les Nancy, France; [Dubourg-Gerecke, Helene; Aubry, Andre; Didierjean, Claude] UMR 7036 CNRS Univ Lorraine, Fac Sci & Technol, Equipe Biocristallog, Unite Mixte Rech Cristallog Resonance Magnet & Mo, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine	Branlant, G (corresponding author), Unite Mixte Rech CNRS Univ Lorraine 7214 AREMS, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Fac Med, 9 Ave Foret Haye,BP 184, F-54506 Vandoeuvre Les Nancy, France.	guy.branlant@maem.uhp-nancy.fr; francois.talfournier@maem.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; Rahuel-Clermont, Sophie/AAB-3451-2020	DIDIERJEAN, Claude/0000-0002-3176-8974; Rahuel-Clermont, Sophie/0000-0001-5143-0105; Bchini, Raphael/0000-0002-6017-3152	CNRS; University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine(Region Grand-Est); French Research Ministry(Ministry of Research, France)	This work was supported in part by the CNRS, the University of Nancy I, the Institut Federatif de Recherche 111 Bioingenierie, and local funds from the Region Lorraine.; Both authors contributed equally to this work and were supported by the French Research Ministry.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chambliss KL, 2000, J INHERIT METAB DIS, V23, P497, DOI 10.1023/A:1005616315087; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Dubourg H, 2004, ACTA CRYSTALLOGR D, V60, P1435, DOI 10.1107/S0907444904012533; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; GRAY RGF, 1987, BIOCHEM MED METAB B, V38, P121, DOI 10.1016/0885-4505(87)90069-7; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUPIECKI FP, 1960, BIOCH PREP, V7, P69; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Marchal S, 1999, BIOCHEMISTRY-US, V38, P12950, DOI 10.1021/bi990453k; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; Pailot A, 2006, BIOCHEM J, V400, P521, DOI 10.1042/BJ20060843; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Rahuel-Clermont S, 2005, J BIOL CHEM, V280, P18590, DOI 10.1074/jbc.M414110200; Roussel P. A., 1991, TURBO FRODO SILICON; Sass JO, 2012, J INHERIT METAB DIS, V35, P437, DOI 10.1007/s10545-011-9381-x; SHONE CC, 1981, BIOCHEMISTRY-US, V20, P7494, DOI 10.1021/bi00529a026; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Talfournier F, 2011, J BIOL CHEM, V286, P21971, DOI 10.1074/jbc.M110.213280; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tsybovsky Y, 2011, J BIOL CHEM, V286, P23357, DOI 10.1074/jbc.M111.221069; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Vedadi M, 1997, EUR J BIOCHEM, V246, P698, DOI 10.1111/j.1432-1033.1997.t01-1-00698.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997	41	5	5	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31095	31103		10.1074/jbc.M112.350272	http://dx.doi.org/10.1074/jbc.M112.350272			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22782904	Green Published, hybrid			2022-12-28	WOS:000308791300022
J	Lee, SY; Yoon, J; Lee, MH; Jung, SK; Kim, DJ; Bode, AM; Kim, J; Dong, ZG				Lee, Sung-Young; Yoon, Jaeho; Lee, Mee-Hyun; Jung, Sung Keun; Kim, Dong Joon; Bode, Ann M.; Kim, Jaebong; Dong, Zigang			The Role of Heterodimeric AP-1 Protein Comprised of JunD and c-Fos Proteins in Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; TRANSCRIPTIONAL REGULATION; MESODERM INDUCTION; CELL-PROLIFERATION; XENOPUS; PHOSPHORYLATION; DIFFERENTIATION; INVOLVEMENT; EMBRYOS; BMP-4	Activator protein-1 (AP-1) regulates a wide range of cellular processes including proliferation, differentiation, and apoptosis. As a transcription factor, AP-1 is commonly found as a heterodimer comprised of c-Jun and c-Fos proteins. However, other heterodimers may also be formed. The function of these dimers, specifically the heterodimeric AP-1 comprised of JunD and c-Fos (AP-1(JunD/c-Fos)), has not been elucidated. Here, we identified a function of AP-1(JunD/c-Fos) in Xenopus hematopoiesis. A gain-of-function study performed by overexpressing junD and c-fos and a loss-of-function study using morpholino junD demonstrate a critical role for AP-1(JunD/c-Fos) in hematopoiesis during Xenopus embryogenesis. Additionally, we confirmed that JunD of AP-1(JunD/c-Fos) is required for BMP-4-induced hematopoiesis. We also demonstrated that BMP-4 regulated JunD activity at the transcriptional regulation and post-translational modification levels. Collectively, our findings identify AP-1(JunD/c-Fos) as a novel hematopoietic transcription factor and the requirement of AP-1(JunD/c-Fos) in BMP-4-induced hematopoiesis during Xenopus hematopoiesis.	[Yoon, Jaeho; Kim, Jaebong] Hallym Univ, Dept Biochem, Coll Med, Chunchon 200702, Kangwon Do, South Korea; [Lee, Sung-Young; Lee, Mee-Hyun; Jung, Sung Keun; Kim, Dong Joon; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kim, Dong Joon] Korea Res Inst Biosci & Biotechnol, Med Genom Ctr, Taejon 305806, South Korea	Hallym University; University of Minnesota System; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, J (corresponding author), Hallym Univ, Dept Biochem, Coll Med, 1 Okchon Dong, Chunchon 200702, Kangwon Do, South Korea.	jbkim@hallym.ac.kr; zgdong@hi.umn.edu	Kim, Jaebong/AAV-1986-2021; Kim, Dong Joon/AAL-8967-2020	Kim, Jaebong/0000-0003-1609-338X; Yoon, Jaeho/0000-0003-2730-8606	National Institutes of Health [CA077646, CA111536, CA120388, R37 CA081064, ES016548]; Hormel Foundation; National Research Foundation of Korea [2009-0077052]; Ministry of Education, Science, and Technology; Hallym University [2011 (HRF-201109-058)]; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA077646, R01CA120388, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Hallym University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA111536, CA120388, R37 CA081064, and ES016548. This work was also supported by The Hormel Foundation, the Basic Science Research Program (2009-0077052) through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology, and Hallym University Research Fund, 2011 (HRF-201109-058).	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dong ZG, 1996, J BIOL CHEM, V271, P9942, DOI 10.1074/jbc.271.17.9942; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Huang S, 1998, DEV GROWTH DIFFER, V40, P189; Huber TL, 1998, SEMIN IMMUNOL, V10, P103, DOI 10.1006/smim.1998.0111; Itoh K, 1995, DEVELOPMENT, V121, P3979; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KAU CL, 1983, J IMMUNOL, V131, P2262; Kim J, 1998, J BIOL CHEM, V273, P1542, DOI 10.1074/jbc.273.3.1542; Lee SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021796; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Maeno M, 2003, ZOOL SCI, V20, P939, DOI 10.2108/zsj.20.939; Mangia F, 1970, Acta Embryol. exp., V1970, P163; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang HL, 1996, ONCOGENE, V13, P2639; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Xu RH, 1996, P NATL ACAD SCI USA, V93, P834, DOI 10.1073/pnas.93.2.834; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200	31	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31342	31348		10.1074/jbc.M112.387266	http://dx.doi.org/10.1074/jbc.M112.387266			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822070	Green Published, hybrid			2022-12-28	WOS:000308791300045
J	Mavinakere, MS; Powers, JM; Subramanian, KS; Roggero, VR; Allison, LA				Mavinakere, Manohara S.; Powers, Jeremy M.; Subramanian, Kelly S.; Roggero, Vincent R.; Allison, Lizabeth A.			Multiple Novel Signals Mediate Thyroid Hormone Receptor Nuclear Import and Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL A/B DOMAIN; ONCOPROTEIN V-ERBA; LOCALIZATION SIGNALS; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; TRANSACTIVATION DOMAIN; STRUCTURE PREDICTION; DNA-BINDING; IDENTIFICATION; ALPHA	Thyroid hormone receptor (TR) is a member of the nuclear receptor superfamily that shuttles between the cytosol and nucleus. The fine balance between nuclear import and export of TR has emerged as a critical control point for modulating thyroid hormone-responsive gene expression; however, sequence motifs of TR that mediate shuttling are not fully defined. Here, we characterized multiple signals that direct TR shuttling. Along with the known nuclear localization signal in the hinge domain, we identified a novel nuclear localization signal in the A/B domain of thyroid hormone receptor alpha 1 that is absent in thyroid hormone receptor beta 1 and inactive in the oncoprotein v-ErbA. Our prior studies showed that thyroid hormone receptor alpha 1 exits the nucleus through two pathways, one dependent on the export factor CRM1 and the other CRM1-independent. Here, we identified three novel CRM1-independent nuclear export signal (NES) motifs in the ligand-binding domain as follows: a highly conserved NES in helix 12 (NES-H12) and two additional NES sequences spanning helix 3 and helix 6, respectively. Mutations predicted to disrupt the alpha-helical structure resulted in a significant decrease in NES-H12 activity. The high degree of conservation of helix 12 suggests that this region may function as a key NES in other nuclear receptors. Furthermore, our mutagenesis studies on NES-H12 suggest that altered shuttling of thyroid hormone receptor beta 1 may be a contributing factor in resistance to thyroid hormone syndrome. Taken together, our findings provide a detailed mechanistic understanding of the multiple signals that work together to regulate TR shuttling and transcriptional activity, and they provide important insights into nuclear receptor function in general.	[Mavinakere, Manohara S.; Powers, Jeremy M.; Subramanian, Kelly S.; Roggero, Vincent R.; Allison, Lizabeth A.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	William & Mary	Allison, LA (corresponding author), Coll William & Mary, Dept Biol, 540 Landrum Dr,ISC 3035B, Williamsburg, VA 23187 USA.	laalli@wm.edu	Powers, Jeremy/N-1541-2019	Powers, Jeremy/0000-0001-6839-0058	National Institutes of Health from NIDDK [R15 DK058028-03]; National Science Foundation [MCB0646506, MCB1120513]; ALSAM Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK058028] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Science Foundation(National Science Foundation (NSF)); ALSAM Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 DK058028-03 from NIDDK (to L. A. A.). This work was also supported by National Science Foundation Grants MCB0646506 and MCB1120513 (to L. A. A.).; Recipient of a scholarship from the ALSAM Foundation.	Andersson ML, 1997, FEBS LETT, V416, P291, DOI 10.1016/S0014-5793(97)01223-4; BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Berg P, 2001, J BIOL CHEM, V276, P43231, DOI 10.1074/jbc.M105261200; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Bonamy Ghislain M C, 2006, Nucl Recept Signal, V4, pe008; Bonamy GMC, 2005, MOL ENDOCRINOL, V19, P1213, DOI 10.1210/me.2004-0204; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; CADEPOND F, 1992, EXP CELL RES, V201, P99, DOI 10.1016/0014-4827(92)90352-9; Casas F, 2006, MOL ENDOCRINOL, V20, P749, DOI 10.1210/me.2005-0074; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DANG CV, 1989, J BIOL CHEM, V264, P18019; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DeLong LJ, 2004, J BIOL CHEM, V279, P15356, DOI 10.1074/jbc.M308214200; Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109; Dressel U., 2001, NUCL RECEPTORS DIS, P59; Dzijak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030529; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Eulalio A, 2006, J VIROL, V80, P1393, DOI 10.1128/JVI.80.3.1393-1404.2006; Feng SS, 2006, BIOCHEM BIOPH RES CO, V347, P558, DOI 10.1016/j.bbrc.2006.06.118; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Grespin ME, 2008, J BIOL CHEM, V283, P25576, DOI 10.1074/jbc.M710482200; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hadzic E, 1998, J BIOL CHEM, V273, P10270, DOI 10.1074/jbc.273.17.10270; HADZIC E, 1995, MOL CELL BIOL, V15, P4507; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14274, DOI 10.1074/jbc.270.24.14274; Ishii S, 2004, MOL ENDOCRINOL, V18, P1708, DOI 10.1210/me.2004-0067; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Kanno Y, 2005, BBA-MOL CELL RES, V1745, P215, DOI 10.1016/j.bbamcr.2005.06.012; Kanno Y, 2007, BBA-MOL CELL RES, V1773, P934, DOI 10.1016/j.bbamcr.2007.03.020; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LACASSE EC, 1993, ENDOCRINOLOGY, V132, P1017, DOI 10.1210/en.132.3.1017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; LEE Y, 1993, J BIOL CHEM, V268, P2021; Liu JM, 2000, MOL ENDOCRINOL, V14, P40, DOI 10.1210/me.14.1.40; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2007, J CELL BIOCHEM, V100, P69, DOI 10.1002/jcb.21006; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Tagami T, 1998, MOL ENDOCRINOL, V12, P1888, DOI 10.1210/me.12.12.1888; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P712, DOI 10.1210/jc.74.4.712; TOMURA H, 1995, P NATL ACAD SCI USA, V92, P5600, DOI 10.1073/pnas.92.12.5600; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Umezawa R, 2009, ENDOCRINOLOGY, V150, P3425, DOI 10.1210/en.2008-1738; Vandevyver S, 2012, TRAFFIC, V13, P364, DOI 10.1111/j.1600-0854.2011.01288.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wilkinson JR, 1997, J BIOL CHEM, V272, P23824, DOI 10.1074/jbc.272.38.23824; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhu XG, 1998, J BIOL CHEM, V273, P27058, DOI 10.1074/jbc.273.42.27058	69	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31280	31297		10.1074/jbc.M112.397745	http://dx.doi.org/10.1074/jbc.M112.397745			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815488	Green Published, hybrid			2022-12-28	WOS:000308791300040
J	Chen, R; Xu, M; Hogg, RT; Li, JW; Little, B; Gerard, RD; Garcia, JA				Chen, Rui; Xu, Min; Hogg, Richard T.; Li, Jiwen; Little, Bertis; Gerard, Robert D.; Garcia, Joseph A.			The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL ACTIVITY; FACTOR 1-ALPHA; GENE-EXPRESSION; TARGET GENE; HIF; ERYTHROPOIETIN; ACTIVATION; FAMILY; CELLS	Hypoxia-inducible factors (HIFs) are oxygen-sensitive transcription factors. HIF-1 alpha plays a prominent role in hypoxic gene induction. HIF-2 alpha target genes are more restricted but include erythropoietin (Epo), one of the most highly hypoxia-inducible genes in mammals. We previously reported that HIF-2 alpha is acetylated during hypoxia but is rapidly deacetylated by the stress-responsive deacetylase Sirtuin 1. We now demonstrate that the lysine acetyltransferases cAMP-response element-binding protein-binding protein (CBP) and p300 are required for efficient Epo induction during hypoxia. However, despite close structural similarity, the roles of CBP and p300 differ in HIF signaling. CBP acetylates HIF-2 alpha, is a major coactivator for HIF-2-mediated Epo induction, and is required for Sirt1 augmentation of HIF-2 signaling during hypoxia in Hep3B cells. In comparison, p300 is a major contributor for HIF-1 signaling as indicated by induction of Pgk1. Whereas CBP can bind with HIF-2 alpha independent of the HIF-2 alpha C-terminal activation domain via enzyme/substrate interactions, p300 only complexes with HIF-2 alpha through the C-terminal activation domain. Maximal CBP/HIF-2 signaling requires intact CBP acetyltransferase activity in both Hep3B cells as well as in mice.	[Chen, Rui; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Rui; Xu, Min; Hogg, Richard T.; Li, Jiwen; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Little, Bertis] Tarleton State Univ, Dept Math & Phys, Stephenville, TX 76402 USA; [Little, Bertis] Tarleton State Univ, Dept Engn, Stephenville, TX 76402 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; Tarleton State University; Texas A&M University System; Tarleton State University	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4600 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Chen, Rui/0000-0002-7003-6602; Garcia, Joseph/0000-0002-5621-7538	National Institutes of Health [HL108104]; American Heart Association; Department of Veterans Affairs Award [IBX000446]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HL108104 (to J. G.). This work was also supported by the American Heart Association and Department of Veterans Affairs Award IBX000446.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010002; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wei LL, 2008, BIOCHEM BIOPH RES CO, V368, P279, DOI 10.1016/j.bbrc.2008.01.071; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	41	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30800	30811		10.1074/jbc.M111.244780	http://dx.doi.org/10.1074/jbc.M111.244780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807441	Green Published, hybrid			2022-12-28	WOS:000308579800068
J	Han, S; Kim, S; Bahl, S; Li, L; Burande, CF; Smith, N; James, M; Beauchamp, RL; Bhide, P; DiAntonio, A; Ramesh, V				Han, Sangyeul; Kim, Sun; Bahl, Samira; Li, Lin; Burande, Clara F.; Smith, Nicole; James, Marianne; Beauchamp, Roberta L.; Bhide, Pradeep; DiAntonio, Aaron; Ramesh, Vijaya			The E3 Ubiquitin Ligase Protein Associated with Myc (Pam) Regulates Mammalian/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling in Vivo through N- and C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; SYNAPTIC GROWTH; E3-UBIQUITIN LIGASE; FORMATION REVEALS; ELEGANS RPM-1; HIGHWIRE; KINASE; MEMORY; PHR1; SPHINGOSINE-1-PHOSPHATE	Pam and its homologs (the PHR protein family) are large E3 ubiquitin ligases that function to regulate synapse formation and growth in mammals, zebrafish, Drosophila, and Caenorhabditis elegans. Phr1-deficient mouse models (Phr1(Delta 8,9) and Phr1(Magellan), with deletions in the N-terminal putative guanine exchange factor region and the C-terminal ubiquitin ligase region, respectively) exhibit axon guidance/outgrowth defects and striking defects of major axon tracts in the CNS. Our earlier studies identified Pam to be associated with tuberous sclerosis complex (TSC) proteins, ubiquitinating TSC2 and regulating mammalian/mechanistic target of rapamycin (mTOR) signaling. Here, we examine the potential involvement of the TSC/mTOR complex 1(mTORC1) signaling pathway in Phr1-deficient mouse models. We observed attenuation of mTORC1 signaling in the brains of both Phr1(Delta 8,9) and Phr1(Magellan) mouse models. Our results establish that Pam regulates TSC/mTOR signaling in vitro and in vivo through two distinct domains. To further address whether Pam regulates mTORC1 through two functionally independent domains, we undertook heterozygous mutant crossing between Phr1(Delta 8,9) and Phr1(Magellan) mice to generate a compound heterozygous model to determine whether these two domains can complement each other. mTORC1 signaling was not attenuated in the brains of double mutants (Phr1(Delta 8,9/Mag)), confirming that Pam displays dual regulation of the mTORC1 pathway through two functional domains. Our results also suggest that although dysregulation of mTORC1 signaling may be responsible for the corpus callosum defects, other neurodevelopmental defects observed with Phr1 deficiency are independent of mTORC1 signaling. The ubiquitin ligase complex containing Pam-Fbxo45 likely targets additional synaptic and axonal proteins, which may explain the overlapping neurodevelopmental defects observed in Phr1 and Fbxo45 deficiency.	[Han, Sangyeul; Kim, Sun; Bahl, Samira; Li, Lin; Burande, Clara F.; Smith, Nicole; James, Marianne; Beauchamp, Roberta L.; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Bhide, Pradeep] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [DiAntonio, Aaron] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Richard B Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu		Bhide, Pradeep/0000-0003-4236-9415	National Institutes of Health [NS024279, DA020812]; Autism Speaks, Simons Foundation for Autism Research Initiative; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks, Simons Foundation for Autism Research Initiative; Tuberous Sclerosis Alliance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS024279 (to V. R.) and DA020812 (to A. D.). This work was also supported by a grant from Autism Speaks, Simons Foundation for Autism Research Initiative (to V. R.), and a fellowship from the Tuberous Sclerosis Alliance (to S. B.).	Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Han S, 2008, CELL SIGNAL, V20, P1084, DOI 10.1016/j.cellsig.2008.01.020; Hendricks M, 2009, J NEUROSCI, V29, P6593, DOI 10.1523/JNEUROSCI.1115-09.2009; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Rosa JL, 1996, EMBO J, V15, P4262, DOI 10.1002/j.1460-2075.1996.tb00801.x; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Santos TM, 2006, J NEUROSCI RES, V83, P222, DOI 10.1002/jnr.20723; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	42	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30063	30072		10.1074/jbc.M112.353987	http://dx.doi.org/10.1074/jbc.M112.353987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22798074	hybrid, Green Published			2022-12-28	WOS:000308579800002
J	Satomi-Kobayashi, S; Kinugasa, M; Kobayashi, R; Hatakeyama, K; Kurogane, Y; Ishida, T; Emoto, N; Asada, Y; Takai, Y; Hirata, K; Rikitake, Y				Satomi-Kobayashi, Seimi; Kinugasa, Mitsuo; Kobayashi, Reiko; Hatakeyama, Kinta; Kurogane, Yusuke; Ishida, Tatsuro; Emoto, Noriaki; Asada, Yujiro; Takai, Yoshimi; Hirata, Ken-ichi; Rikitake, Yoshiyuki			Osteoblast-like Differentiation of Cultured Human Coronary Artery Smooth Muscle Cells by Bone Morphogenetic Protein Endothelial Cell Precursor-derived Regulator (BMPER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK; CALCIFICATION; CROSSVEINLESS-2; ACTIVATION; INHIBITION	Differentiation of vascular smooth muscle cells (SMCs) into osteoblast-like cells is considered to be a mechanism of vascular calcification. However, regulators of osteoblast-like differentiation of vascular SMCs are not fully elucidated. Here, we investigated the expression of bone morphogenetic protein (BMP)binding endothelial cell precursor-derived regulator (BMPER), a vertebrate homologue of Drosophila crossveinless-2, in vascular SMCs and the role and mode of action of BMPER in osteoblast-like differentiation of human coronary artery SMCs (HCASMCs). BMPER was expressed in cultured human vascula SMCs, including HCASMCs. Silencing of endogenous BMPER expression by an RNA interference technique inhibited osteoblast-like differentiation of HCASMCs, as evaluated by up-regulation of osteoblast markers such as alkaline phosphatase (ALP) and runt-related transcription factor 2 (Runx2), by down-regulation of a SMC marker alpha-smooth muscle actin (alpha SMA), and by mineralization. Treatment with recombinant BMPER enhanced, whereas BMP-2 reduced osteoblast-like differentiation. BMPER antagonized BMP-2-induced phosphorylation of Smad 1/5/8, suggesting that the effect of BMPER was mediated by antagonizing the action of BMP. BMPER increased I kappa B alpha phosphorylation and NF-kappa B activity and specific NF-kappa B decoy oligonucleotides deteriorated osteoblast-like differentiation of HCASMCs by BMPER. In human coronary artery with atherosclerotic plaque containing calcification, the BMPER-positive signals were observed in the neointimal and medial SMCs in the vicinity of the plaque. These findings indicate that BMPER is a novel regulator of the osteoblast-like differentiation of HCASMCs.	[Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct,Chou Ku, Kobe, Hyogo 6500017, Japan; [Satomi-Kobayashi, Seimi; Kinugasa, Mitsuo; Kurogane, Yusuke; Ishida, Tatsuro; Emoto, Noriaki; Hirata, Ken-ichi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chou Ku, Kobe, Hyogo 6500017, Japan; [Kobayashi, Reiko; Takai, Yoshimi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol,Chou Ku, Kobe, Hyogo 6500017, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki 8891692, Japan; [Emoto, Noriaki] Kobe Pharmaceut Univ, Dept Clin Pharm, Kobe, Hyogo 6588558, Japan	Kobe University; Kobe University; Kobe University; University of Miyazaki; Kobe Pharmaceutical University	Rikitake, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct,Chou Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	rikitake@med.kobe-u.ac.jp		Emoto, Noriaki/0000-0001-6673-2616	Japan Society for the Promotion of Science; Global Center of Excellence; Takeda Science Foundation; Mitsui Life Social Welfare Foundation; Grants-in-Aid for Scientific Research [22590828] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Life Social Welfare Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to Y. R.), and grants from the Global Center of Excellence (to Y. R. and K. H.), Takeda Science Foundation, and Mitsui Life Social Welfare Foundation (to Y. R.).	Armstrong ZB, 2011, CARDIOVASC RES, V90, P165, DOI 10.1093/cvr/cvq391; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Conley CA, 2000, DEVELOPMENT, V127, P3947; Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kikumori T, 1998, ENDOCRINOLOGY, V139, P1715, DOI 10.1210/en.139.4.1715; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Rennenberg RJMW, 2009, VASC HEALTH RISK MAN, V5, P185; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shimizu H, 2006, GENE THER, V13, P933, DOI 10.1038/sj.gt.3302711; van der Zee S, 2009, NAT REV CARDIOL, V6, P580, DOI 10.1038/nrcardio.2009.121; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	26	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30336	30345		10.1074/jbc.M111.329110	http://dx.doi.org/10.1074/jbc.M111.329110			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778264	Green Published, hybrid			2022-12-28	WOS:000308579800026
J	Urbanska, M; Gozdz, A; Swiech, LJ; Jaworski, J				Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Jaworski, Jacek			Mammalian Target of Rapamycin Complex 1 (mTORC1) and 2 (mTORC2) Control the Dendritic Arbor Morphology of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS MTORC2; GENE-EXPRESSION; IN-VIVO; PROTEIN; AKT; PHOSPHORYLATION; KINASE; GROWTH; PATHWAY; RICTOR	Dendrites are the main site of information input into neurons. Their development is a multistep process controlled by mammalian target of rapamycin (mTOR) among other proteins. mTOR is a serine/threonine protein kinase that forms two functionally distinct complexes in mammalian cells: mTORC1 and mTORC2. However, the one that contributes to mammalian neuron development remains unknown. This work used short hairpin RNA against Raptor and Rictor, unique components of mTORC1 and mTORC2, respectively, to dissect mTORC involvement in this process. We provide evidence that both mTOR complexes are crucial for the proper dendritic arbor morphology of hippocampal neurons. These two complexes are required for dendritic development both under basal conditions and upon the induction of mTOR-dependent dendritic growth. We also identified Akt as a downstream effector of mTORC2 needed for proper dendritic arbor morphology, the action of which required mTORC1 and p70S6K1.	[Urbanska, Malgorzata; Gozdz, Agata; Swiech, Lukasz J.; Jaworski, Jacek] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Jaworski, J (corresponding author), 4 Ks Trojdena St, PL-02109 Warsaw, Poland.	jaworski@iimcb.gov.pl	Gozdz, Agata/AAD-2974-2022	Gozdz, Agata/0000-0001-8421-0598; Jaworski, Jacek/0000-0001-8760-7865; Urbanska, Malgorzata/0000-0001-9521-0366	National Centre for Research and Development [ERA-NET-NEURON/03/2010]; European Union; European Social Fund;  [223276];  [229676]	National Centre for Research and Development(National Centre for Research & Development, Poland); European Union(European Commission); European Social Fund(European Social Fund (ESF)); ; 	This work was supported by FP7 Grant 223276 (NeuroGSK3), FP7 Grant 229676 (HealthProt), and ERA-NET-NEURON/03/2010 (co-financed by the National Centre for Research and Development). This work was also supported by European Union funds by the European Social Fund (to M. U.).	BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; David S, 2005, J NEUROSCI, V25, P7048, DOI 10.1523/JNEUROSCI.0006-05.2005; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Fulceri R, 1999, BIOCHEM BIOPH RES CO, V264, P409, DOI 10.1006/bbrc.1999.1532; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koike-Kumagai M, 2009, EMBO J, V28, P3879, DOI 10.1038/emboj.2009.312; Konopka W, 2005, NEUROBIOL DIS, V19, P283, DOI 10.1016/j.nbd.2005.01.018; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo L, 2007, BRAIN RES REV, V55, P220, DOI 10.1016/j.brainresrev.2007.01.012; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SHOLL DA, 1953, J ANAT, V87, P387; Stuart G, 2007, DENDRITES; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Swiech L., 2012, PROTEIN KINASE TECHN, V68, P291; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Warfel NA, 2011, J BIOL CHEM, V286, P39122, DOI 10.1074/jbc.M111.278747; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	52	115	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30240	30256		10.1074/jbc.M112.374405	http://dx.doi.org/10.1074/jbc.M112.374405			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22810227	Green Published, hybrid			2022-12-28	WOS:000308579800018
J	Valton, J; Daboussi, F; Leduc, S; Molina, R; Redondo, P; Macmaster, R; Montoya, G; Duchateau, P				Valton, Julien; Daboussi, Fayza; Leduc, Sophie; Molina, Rafael; Redondo, Pilar; Macmaster, Rachel; Montoya, Guillermo; Duchateau, Philippe			5 '-Cytosine-Phosphoguanine (CpG) Methylation Impacts the Activity of Natural and Engineered Meganucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMING ENDONUCLEASE; MOLECULAR REPLACEMENT; IN-VITRO; DNA; GENE; DERIVATIVES; BINDING; COMPACTION; SITE; PPOI	In this study, we asked whether CpG methylation could influence the DNA binding affinity and activity of meganucleases used for genome engineering applications. A combination of biochemical and structural approaches enabled us to demonstrate that CpG methylation decreases I-CreI DNA binding affinity and inhibits its endonuclease activity in vitro. This inhibition depends on the position of the methylated cytosine within the DNA target and was almost total when it is located inside the central tetrabase. Crystal structures of I-CreI bound to methylated cognate target DNA suggested a molecular basis for such inhibition, although the precise mechanism still has to be specified. Finally, we demonstrated that the efficacy of engineered meganucleases can be diminished by CpG methylation of the targeted endogenous site, and we proposed a rational design of the meganuclease DNA binding domain to alleviate such an effect. We conclude that although activity and sequence specificity of engineered meganucleases are crucial parameters, target DNA epigenetic modifications need to be considered for successful gene editions.	[Valton, Julien; Daboussi, Fayza; Leduc, Sophie; Macmaster, Rachel; Duchateau, Philippe] CELLECTIS SA, F-75012 Paris, France; [Molina, Rafael; Redondo, Pilar; Montoya, Guillermo] Spanish Natl Canc Res Ctr, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Valton, J (corresponding author), CELLECTIS SA, 8 Rue Croix Jarry, F-75012 Paris, France.	julien.valton@cellectis.com; philippe.duchateau@cellectis.com	Redondo, Pilar/L-7612-2014; Molina, Rafael/L-6203-2016; Molina, Rafael/AAG-6552-2019	Redondo, Pilar/0000-0002-6723-0818; Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; Valton, Julien/0000-0003-0826-5401; Daboussi, Fayza/0000-0001-7689-7975	Fundacion Ramon Areces; Ministerio de Ciencia e Innovacion [JCI-2011-09308, BFU2011-23815/BMC]	Fundacion Ramon Areces; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Supported by Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion Grant JCI-2011-09308.; Supported by Grant BFU2011-23815/BMC from Ministerio de Ciencia e Innovacion.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; BRYK M, 1993, EMBO J, V12, P4040, DOI 10.1002/j.1460-2075.1993.tb06082.x; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chapdelaine P, 2010, GENE THER, V17, P846, DOI 10.1038/gt.2010.26; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; ELLISON EL, 1993, MOL CELL BIOL, V13, P7531, DOI 10.1128/MCB.13.12.7531; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hoshaw JP, 2010, METHODS MOL BIOL, V649, P299, DOI 10.1007/978-1-60761-753-2_19; Hudson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020587; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Lakowicz, 2006, PRINCIPLES FLUORESCE, P366; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Molina R, 2012, NUCLEIC ACIDS RES, V40, P6936, DOI 10.1093/nar/gks320; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523	47	18	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30139	30150		10.1074/jbc.M112.379966	http://dx.doi.org/10.1074/jbc.M112.379966			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740697	hybrid, Green Published			2022-12-28	WOS:000308579800009
J	Nishie, W; Jackow, J; Hofmann, SC; Franzke, CW; Bruckner-Tuderman, L				Nishie, Wataru; Jackow, Joanna; Hofmann, Silke C.; Franzke, Claus-Werner; Bruckner-Tuderman, Leena			Coiled Coils Ensure the Physiological Ectodomain Shedding of Collagen XVII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE MICROENVIRONMENT; OLIGOMERIZATION DOMAINS; TRANSMEMBRANE PROTEINS; POSITIONAL PROTEOMICS; BP180 ECTODOMAIN; CELL-SURFACE; DEPENDS; FURIN; KERATINOCYTES; SPECIFICITY	alpha-Helical coiled coils, frequent protein oligomerization motifs, are commonly observed in vital proteins. Here, using collagen XVII as an example, we provide evidence for a novel function of coiled coils in the regulation of ectodomain shedding. Transmembrane collagen XVII, an epithelial cell surface receptor, mediates dermal-epidermal adhesion in the skin, and its dysfunction is linked to human skin blistering diseases. The ectodomain of this collagen is constitutively shed from the cell surface by proteinases of a disintegrin and metalloprotease family; however, the mechanisms regulating shedding remain elusive. Here, we used site-specific mutagenesis to target the coiled-coil heptad repeats within the juxtamembranous, extracellular noncollagenous 16th A (NC16A) domain of collagen XVII. This resulted in a substantial increase of ectodomain shedding, which was not mediated by disintegrin and metalloproteases. Instead, conformational changes induced by the mutation(s) unmasked a furin recognition sequence that was used for cleavage. This study shows that apart from their functions in protein oligomerization, coiled coils can also act as regulators of ectodomain shedding depending on the biological context.	[Nishie, Wataru; Jackow, Joanna; Hofmann, Silke C.; Franzke, Claus-Werner; Bruckner-Tuderman, Leena] Univ Freiburg, Med Ctr, Dept Dermatol, D-79104 Freiburg, Germany; [Nishie, Wataru] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0030835, Japan; [Bruckner-Tuderman, Leena] Univ Freiburg, Sch Life Sci, Freiburg Inst Adv Studies, LifeNet, D-79104 Freiburg, Germany; [Hofmann, Silke C.] Univ Witten Herdecke, Helios Klinikum, Dept Dermatol & Allergy, D-47805 Wuppertal, Germany	University of Freiburg; Hokkaido University; University of Freiburg; Helios Kliniken; Witten Herdecke University	Nishie, W (corresponding author), N15W7,Kita Ku, Sapporo, Hokkaido 0030835, Japan.	nishie@med.hokudai.ac.jp; leena.bruckner-tuderman@uniklinik-freiburg.de		Jackow, Joanna/0000-0002-5744-7896	German Research Foundation [SFB850/B6]; Excellence Initiative of the German Federal and State Governments; Freiburg Institute for Advanced Studies, School of Life Sciences-LifeNet;  [24659514]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Freiburg Institute for Advanced Studies, School of Life Sciences-LifeNet; 	This work was supported in part by Grant-in-aid for Challenging Exploratory Research 24659514 (to W. N.), Grant SFB850/B6 from the German Research Foundation (to C.-W. F. and L. B.-T.), and by the Excellence Initiative of the German Federal and State Governments and Freiburg Institute for Advanced Studies, School of Life Sciences-LifeNet (to L. B.-T.).	Alfalah M, 2001, J BIOL CHEM, V276, P21105, DOI 10.1074/jbc.M100339200; Balding SD, 1997, BIOCHEMISTRY-US, V36, P8821, DOI 10.1021/bi970675n; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Engel J, 2004, INT J BIOCHEM CELL B, V36, P997, DOI 10.1016/j.biocel.2003.12.009; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Franzke CW, 2004, J BIOL CHEM, V279, P24521, DOI 10.1074/jbc.M308835200; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hirako Y, 2003, J INVEST DERMATOL, V121, P1554, DOI 10.1046/j.1523-1747.2003.12607.x; Hirako Y, 2003, J BIOCHEM, V133, P197, DOI 10.1093/jb/mvg024; Hofmann SC, 2009, J INVEST DERMATOL, V129, P1730, DOI 10.1038/jid.2008.424; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lin L, 2012, MATRIX BIOL, V31, P38, DOI 10.1016/j.matbio.2011.09.003; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; McDonald L, 2006, NAT PROTOC, V1, P1790, DOI 10.1038/nprot.2006.317; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishie W, 2011, AM J PATHOL, V179, P829, DOI 10.1016/j.ajpath.2011.04.019; Nishie W, 2010, J IMMUNOL, V185, P4938, DOI 10.4049/jimmunol.1001524; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Snellman A, 2007, J BIOL CHEM, V282, P14898, DOI 10.1074/jbc.M609605200; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; van den Bergh F, 2006, BIOCHEM BIOPH RES CO, V350, P1032, DOI 10.1016/j.bbrc.2006.09.147; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	40	22	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29940	29948		10.1074/jbc.M112.345454	http://dx.doi.org/10.1074/jbc.M112.345454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761443	Green Published, hybrid			2022-12-28	WOS:000308286900067
J	Penniston, JT; Caride, AJ; Strehler, EE				Penniston, John T.; Caride, Ariel J.; Strehler, Emanuel E.			Alternative Pathways for Association and Dissociation of the Calmodulin-binding Domain of Plasma Membrane Ca2+-ATPase Isoform 4b (PMCA4b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ PUMP; CALCIUM-PUMP; ACTIVATION; DYNAMICS; MECHANISM; RECOGNITION; REGION; SLOW	The calmodulin (CaM)-binding domain of isoform 4b of the plasma membrane Ca2+-ATPase (PMCA) pump is represented by peptide C28. CaM binds to either PMCA or C28 by a mechanism in which the primary anchor residue Trp-1093 binds to the C-terminal lobe of the extended CaM molecule, followed by collapse of CaM with the N-terminal lobe binding to the secondary anchor Phe-1110 (Juranic, N., Atanasova, E., Filoteo, A. G., Macura, S., Prendergast, F. G., Penniston, J. T., and Strehler, E. E. (2010) J. Biol. Chem. 285, 4015-4024). This is a relatively rapid reaction, with an apparent half-time of similar to 1 s. The dissociation of CaM from PMCA4b or C28 is much slower, with an overall half-time of similar to 10 min. Using targeted molecular dynamics, we now show that dissociation of Ca2+-CaM from C28 may occur by a pathway in which Trp-1093, although deeply embedded in a pocket in the C-terminal lobe of CaM, leaves first. The dissociation begins by relatively rapid release of Trp-1093, followed by very slow release of Phe-1110, removal of C28, and return of CaM to its conformation in the free state. Fluorescence measurements and molecular dynamics calculations concur in showing that this alternative path of release of the PMCA4b CaM-binding domain is quite different from that of binding. The intermediate of dissociation with exposed Trp-1093 has a long lifetime (minutes) and may keep the PMCA primed for activation.	[Caride, Ariel J.; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Penniston, John T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Mayo Clinic; Harvard University; Massachusetts General Hospital	Strehler, EE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	strehler.emanuel@mayo.edu			National Institutes of Health [NS51769]; Mayo Foundation for Medical Research and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Medical Research and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 ( to E. E. S.). This work was also supported by the Mayo Foundation for Medical Research and Education.	Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Carlsson P, 2006, BIOPHYS J, V91, P3151, DOI 10.1529/biophysj.106.082917; Chocholousova J, 2006, J COMPUT CHEM, V27, P719, DOI 10.1002/jcc.20387; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kranz JK, 2002, BIOCHEMISTRY-US, V41, P2599, DOI 10.1021/bi011818f; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Penheiter AR, 2002, J BIOL CHEM, V277, P17728, DOI 10.1074/jbc.M111608200; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Slaughter BD, 2007, BIOCHEMISTRY-US, V46, P4045, DOI 10.1021/bi602481u; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Sun HY, 2000, J BIOL CHEM, V275, P1731, DOI 10.1074/jbc.275.3.1731; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; VERMA AK, 1994, J BIOL CHEM, V269, P1687	30	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29664	29671		10.1074/jbc.M112.377556	http://dx.doi.org/10.1074/jbc.M112.377556			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767601	Green Published, hybrid			2022-12-28	WOS:000308286900042
J	Penuela, S; Gyenis, L; Ablack, A; Churko, JM; Berger, AC; Litchfield, DW; Lewis, JD; Laird, DW				Penuela, Silvia; Gyenis, Laszlo; Ablack, Amber; Churko, Jared M.; Berger, Amy C.; Litchfield, David W.; Lewis, John D.; Laird, Dale W.			Loss of Pannexin 1 Attenuates Melanoma Progression by Reversion to a Melanocytic Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; C6 GLIOMA-CELLS; QUANTITATIVE-ANALYSIS; BETA-CATENIN; METASTASIS; CHANNELS; MEMBRANE; DIFFERENTIATION; FAMILY; GROWTH	Pannexin 1 (Panx1) is a channel-forming glycoprotein expressed in different cell types of mammalian skin. We examined the role of Panx1 in melanoma tumorigenesis and metastasis since qPCR and Western blots revealed that mouse melanocytes exhibited low levels of Panx1 while increased Panx1 expression was correlated with tumor cell aggressiveness in the isogenic melanoma cell lines (B16-F0, -F10, and -BL6). Panx1 shRNA knockdown (Panx1-KD) generated stable BL6 cell lines, with reduced dye uptake, that showed a marked increase in melanocyte-like cell characteristics including higher melanin production, decreased cell migration and enhanced formation of cellular projections. Western blotting and proteomic analyses using 2D-gel/mass spectroscopy identified vimentin and beta-catenin as two of the markers of malignant melanoma that were down-regulated in Panx1-KD cells. Xenograft Panx1-KD cells grown within the chorioallantoic membrane of avian embryos developed tumors that were significantly smaller than controls. Mouse-Alu qPCR of the excised avian embryonic organs revealed that tumor metastasis to the liver was significantly reduced upon Panx1 knockdown. These data suggest that while Panx1 is present in skin melanocytes it is up-regulated during melanoma tumor progression, and tumorigenesis can be inhibited by the knockdown of Panx1 raising the possibility that Panx1 may be a viable target for the treatment of melanoma.	[Penuela, Silvia; Churko, Jared M.; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Gyenis, Laszlo; Litchfield, David W.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Ablack, Amber; Lewis, John D.] Univ Western Ontario, London Reg Canc Program, London, ON N6A 5C1, Canada; [Berger, Amy C.; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg,Rm 00077, London, ON N6A 5C1, Canada.	Dale.Laird@schulich.uwo.ca	Penuela, Silvia/A-6961-2010; Laird, Dale w/E-4176-2015; Laird, Dale W/AAL-2407-2020; Litchfield, David/E-4636-2015	Penuela, Silvia/0000-0003-4829-5517; Laird, Dale W/0000-0002-4568-3285; Litchfield, David/0000-0002-2425-6620	Canadian Institutes of Health Research; Canada Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs)	This study was supported by the Canadian Institutes of Health Research (to D. W. L. and D. B.) as well as the Canada Research Chair Program (to D. W. L.).	Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Kim JH, 2010, PIGM CELL MELANOMA R, V23, P385, DOI 10.1111/j.1755-148X.2010.00695.x; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Palmer TD, 2011, JOVE-J VIS EXP, V51, P2815; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; POSTE G, 1980, CANCER RES, V40, P1636; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Swayne LA, 2010, J BIOL CHEM, V285, P24977, DOI 10.1074/jbc.M110.130054; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	46	74	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29184	29193		10.1074/jbc.M112.377176	http://dx.doi.org/10.1074/jbc.M112.377176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753409	hybrid, Green Published			2022-12-28	WOS:000308074600084
J	Bolderson, E; Savage, KI; Mahen, R; Pisupati, V; Graham, ME; Richard, DJ; Robinson, PJ; Venkitaraman, AR; Khanna, KK				Bolderson, Emma; Savage, Kienan I.; Mahen, Robert; Pisupati, Venkat; Graham, Mark E.; Richard, Derek J.; Robinson, Phillip J.; Venkitaraman, Ashok R.; Khanna, Kum Kum			Kruppel-associated Box (KRAB)-associated Co-repressor (KAP-1) Ser-473 Phosphorylation Regulates Heterochromatin Protein 1 beta (HP1-beta) Mobilization and DNA Repair in Heterochromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION REPAIR; IN-VIVO; DAMAGE RESPONSE; HP1 PROTEINS; DYNAMIN-I; BINDING; COREPRESSOR; DOMAIN; ATM	The DNA damage response encompasses a complex series of signaling pathways that function to regulate and facilitate the repair of damaged DNA. Recent studies have shown that the repair of transcriptionally inactive chromatin, named heterochromatin, is dependent upon the phosphorylation of the co-repressor, Kruppel-associated box (KRAB) domain-associated protein (KAP-1), by the ataxia telangiectasia-mutated (ATM) kinase. Co-repressors, such as KAP-1, function to regulate the rigid structure of heterochromatin by recruiting histone-modifying enzymes, such HDAC1/2, SETDB1, and nucleosome-remodeling complexes such as CHD3. Here, we have characterized a phosphorylation site in the HP1-binding domain of KAP-1, Ser-473, which is phosphorylated by the cell cycle checkpoint kinase Chk2. Expression of a nonphosphorylatable S473A mutant conferred cellular sensitivity to DNA-damaging agents and led to defective repair of DNA double-strand breaks in heterochromatin. In addition, cells expressing S473A also displayed defective mobilization of the HP1-beta chromodomain protein. The DNA repair defect observed in cells expressing S473A was alleviated by depletion of HP1-beta, suggesting that phosphorylation of KAP-1 on Ser-473 promotes the mobilization of HP1-beta from heterochromatin and subsequent DNA repair. These results suggest a novel mechanism of KAP-1-mediated chromatin restructuring via Chk2-regulated HP1-beta exchange from heterochromatin, promoting DNA repair.	[Bolderson, Emma; Savage, Kienan I.; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Savage, Kienan I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Mahen, Robert; Pisupati, Venkat; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council MRC Canc Cell Unit, Cambridge CB2 OXZ, England; [Graham, Mark E.; Robinson, Phillip J.] Univ Sydney, Cell Signalling Unit, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Bolderson, Emma; Richard, Derek J.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4059, Australia	QIMR Berghofer Medical Research Institute; Queens University Belfast; Children's Medical Research Institute - Australia; University of Sydney; Queensland University of Technology (QUT)	Khanna, KK (corresponding author), Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia.	kumkumk@qimr.edu.au	Robinson, Phillip J/G-4008-2011; Graham, Mark E/A-6480-2014; Richard, Derek/J-1338-2012; Bolderson, Emma/B-8743-2013; Khanna, Kum Kum/I-1747-2013	Robinson, Phillip J/0000-0002-7878-0313; Graham, Mark E/0000-0002-7290-1217; Richard, Derek/0000-0002-4839-8471; Bolderson, Emma/0000-0002-2849-1177; Savage, Kienan/0000-0002-4898-899X; Khanna, Kum Kum/0000-0001-8650-5381	Australian Research Council; United Kingdom Medical Research Council; Medical Research Council [G1001521, G0600332, MC_U105359877, G0700651] Funding Source: researchfish; MRC [G0600332, MC_U105359877, G0700651, G1001521] Funding Source: UKRI	Australian Research Council(Australian Research Council); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a discovery grant from the Australian Research Council and by a grant from the United Kingdom Medical Research Council (to A.R.V.).	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hu C, 2012, J BIOL CHEM, V287, P18937, DOI 10.1074/jbc.M111.313262; Khanna KK, 2006, METH MOLEC MED, V120, P441; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Murray JM, 2012, BIOCHEM SOC T, V40, P173, DOI 10.1042/BST20110631; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	36	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28122	28131		10.1074/jbc.M112.368381	http://dx.doi.org/10.1074/jbc.M112.368381			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715096	Green Published, hybrid			2022-12-28	WOS:000307840700085
J	Craik, DJ; Allewell, NM				Craik, David J.; Allewell, Norma M.			Thematic Minireview Series on Circular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CYCLIC-PEPTIDES	Circular proteins have now been discovered in all kingdoms of life and are characterized by their exceptional stability and the diversity of their biological activities, primarily in the realm of host defense functions. This thematic minireview series provides an overview of the distribution, evolution, activities, and biological synthesis of circular proteins. It also reviews approaches that biological chemists are taking to develop synthetic methods for making circular proteins in the laboratory. These approaches include solid-phase peptide synthesis based on an adaption of native chemical ligation technology and recombinant DNA approaches that are amenable to the in-cell production of cyclic peptide libraries. The thioester-mediated native chemical ligation approach mimics, to some extent, elements of the natural biosynthetic reaction, which, for disulfide-rich cyclic peptides, appears to involve asparaginyl endopeptidase-mediated processing from larger precursor proteins.	[Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Allewell, Norma M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University of Queensland; University System of Maryland; University of Maryland College Park	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010	Craik, David/0000-0003-0007-6796				Condie JA, 2011, PLANT J, V67, P682, DOI 10.1111/j.1365-313X.2011.04626.x; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Sanchez-Hidalgo M, 2011, CELL MOL LIFE SCI, V68, P2845, DOI 10.1007/s00018-011-0724-4; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; van Belkum MJ, 2011, TRENDS MICROBIOL, V19, P411, DOI 10.1016/j.tim.2011.04.004	7	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26999	27000		10.1074/jbc.R112.390344	http://dx.doi.org/10.1074/jbc.R112.390344			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700978	Green Published, hybrid			2022-12-28	WOS:000307386000047
J	Martinelli, S; Nardozza, AP; Delle Vigne, S; Sabetta, G; Torreri, P; Bocchinfuso, G; Flex, E; Venanzi, S; Palleschi, A; Gelb, BD; Cesareni, G; Stella, L; Castagnoli, L; Tartaglia, M				Martinelli, Simone; Nardozza, Aurelio P.; Delle Vigne, Silvia; Sabetta, Gilda; Torreri, Paola; Bocchinfuso, Gianfranco; Flex, Elisabetta; Venanzi, Serenella; Palleschi, Antonio; Gelb, Bruce D.; Cesareni, Gianni; Stella, Lorenzo; Castagnoli, Luisa; Tartaglia, Marco			Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC PTPN11 MUTATIONS; ACUTE MYELOID-LEUKEMIA; LEOPARD-SYNDROME; PHOSPHORYLATION SITES; SH2 DOMAINS; BINDING; DISORDERS; SEQUENCE; MUTANTS; CONSEQUENCES	Activating mutations in PTPN11 cause Noonan syndrome, the most common nonchromosomal disorder affecting development and growth. PTPN11 encodes SHP2, an Src homology 2 (SH2) domain-containing protein-tyrosine phosphatase that positively modulates RAS function. Here, we characterized functionally all possible amino acid substitutions arising from single-base changes affecting codons 62 and 63 to explore the molecular mechanisms lying behind the largely invariant occurrence of the Y62D and Y63C substitutions recurring in Noonan syndrome. We provide structural and biochemical data indicating that the autoinhibitory interaction between the N-SH2 and protein-tyrosine phosphatase (PTP) domains is perturbed in both mutants as a result of an extensive structural rearrangement of the N-SH2 domain. Most mutations affecting Tyr(63) exerted an unpredicted disrupting effect on the structure of the N-SH2 phosphopeptide-binding cleft mediating the interaction of SHP2 with signaling partners. Among all the amino acid changes affecting that codon, the disease-causing mutation was the only substitution that perturbed the stability of the inactive conformation of SHP2 without severely impairing proper phosphopeptide binding of N-SH2. On the other hand, the disruptive effect of the Y62D change on the autoinhibited conformation of the protein was balanced, in part, by less efficient binding properties of the mutant. Overall, our data demonstrate that the selection-by-function mechanism acting as driving force for PTPN11 mutations affecting codons 62 and 63 implies balancing of counteracting effects operating on the allosteric control of the function of SHP2.	[Martinelli, Simone; Delle Vigne, Silvia; Flex, Elisabetta; Venanzi, Serenella; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Nardozza, Aurelio P.; Cesareni, Gianni; Castagnoli, Luisa] Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; [Sabetta, Gilda; Bocchinfuso, Gianfranco; Palleschi, Antonio; Stella, Lorenzo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; [Palleschi, Antonio; Stella, Lorenzo] Ist Ricovero & Cura Carattere Sci Neuromed, I-86077 Pozzilli, IS, Italy; [Torreri, Paola] Ist Super Sanita, Ctr Nazl Malattie Rare, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Cesareni, Gianni] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Neuromed; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai; IRCCS Santa Lucia	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	Martinelli, Simone/J-9432-2018; Cesareni, Gianni/AAW-1382-2020; Bocchinfuso, Gianfranco/E-9014-2011; Stella, Lorenzo/A-7996-2010; TORRERI, PAOLA/A-6656-2015; palleschi, antonio/G-5464-2012; Tartaglia, Marco/K-2955-2018; Flex, Elisabetta/A-5958-2017	Martinelli, Simone/0000-0002-5843-419X; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Stella, Lorenzo/0000-0002-5489-7381; TORRERI, PAOLA/0000-0002-0488-956X; Tartaglia, Marco/0000-0001-7736-9672; Flex, Elisabetta/0000-0002-6802-1356; Cesareni, Gianni/0000-0002-9528-6018; Castagnoli, Luisa/0000-0001-5283-8671; Delle Vigne, Silvia/0000-0001-8571-6662	Telethon-Italy [GGP10020, GGP09243]; ERANet for research programs on rare diseases (NSEuroNet); Programma di collaborazione Italia-USA [11US/10]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 13360]; European Network of Excellence Experimental Network for Functional Integration (ENFIN)	Telethon-Italy(Fondazione Telethon); ERANet for research programs on rare diseases (NSEuroNet); Programma di collaborazione Italia-USA; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Network of Excellence Experimental Network for Functional Integration (ENFIN)	This work was supported by grants from Telethon-Italy (GGP10020), ERANet for research programs on rare diseases 2009 (NSEuroNet), Programma di collaborazione Italia-USA 2010 (11US/10), and Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 13360) (to M. T.) and by grants from Telethon-Italy (GGP09243) and European Network of Excellence Experimental Network for Functional Integration (ENFIN) (to G. C.).	Allanson JE, 2007, AM J MED GENET C, V145C, P274, DOI 10.1002/ajmg.c.30138; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bocchinfuso G, 2007, PROTEINS, V66, P963, DOI 10.1002/prot.21050; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; DECHERT U, 1994, J BIOL CHEM, V269, P5602; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guvench O, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-14; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin CG, 2005, BIOCHEMISTRY-US, V44, P12196, DOI 10.1021/bi050669o; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	20	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27066	27077		10.1074/jbc.M112.350231	http://dx.doi.org/10.1074/jbc.M112.350231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711529	hybrid, Green Published			2022-12-28	WOS:000307386000059
J	Holz-Schietinger, C; Matje, DM; Reich, NO				Holz-Schietinger, Celeste; Matje, Doug M.; Reich, Norbert O.			Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; BINDING; 3A; MECHANISM; OLIGOMERIZATION; ESTABLISHMENT; DECITABINE; EXPRESSION; PATTERNS; MODEL	DNA methylation is a key regulator of gene expression and changes in DNA methylation occur early in tumorigenesis. Mutations in the de novo DNA methyltransferase gene, DNMT3A, frequently occur in adult acute myeloid leukemia patients with poor prognoses. Most of the mutations occur within the dimer or tetramer interface, including Arg-882. We have identified that the most prevalent mutation, R882H, and three additional mutants along the tetramer interface disrupt tetramerization. The processive methylation of multiple CpG sites is disrupted when tetramerization is eliminated. Our results provide a possible mechanism that accounts for how DNMT3A mutations may contribute to oncogenesis and its progression.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Matje, Doug M.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; CHITAMBAR CR, 1991, AM J HEMATOL, V37, P100, DOI 10.1002/ajh.2830370207; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hata K, 2002, DEVELOPMENT, V129, P1983; Hiller DA, 2003, BIOCHEMISTRY-US, V42, P14375, DOI 10.1021/bi035520w; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Hsieh Chih-Lin, 2005, BMC Biochem, V6, P6, DOI 10.1186/1471-2091-6-6; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Markova J, 2012, EUR J HAEMATOL, V88, P128, DOI 10.1111/j.1600-0609.2011.01716.x; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Metzeler KH, 2012, LEUKEMIA, V26, P1106, DOI 10.1038/leu.2011.342; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Senyuk V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020793; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Sharma V, 2005, J BIOMOL STRUCT DYN, V22, P533, DOI 10.1080/07391102.2005.10507023; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Thol F, 2011, HAEMATOL-HEMATOL J, V96, P1238, DOI 10.3324/haematol.2011.046839; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhao ZJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737535	60	93	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30941	30951		10.1074/jbc.M112.366625	http://dx.doi.org/10.1074/jbc.M112.366625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22722925	Green Published, hybrid			2022-12-28	WOS:000308791300008
J	Mise, N; Savai, R; Yu, HY; Schwarz, J; Kaminski, N; Eickelberg, O				Mise, Nikica; Savai, Rajkumar; Yu, Haiying; Schwarz, Johannes; Kaminski, Naftali; Eickelberg, Oliver			Zyxin Is a Transforming Growth Factor-beta (TGF-beta)/Smad3 Target Gene That Regulates Lung Cancer Cell Motility via Integrin alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; ACTIN-POLYMERIZATION; TUMOR-SUPPRESSOR; ALPHA-ACTININ; II RECEPTOR; PROTEIN; ADHESION; TRANSDIFFERENTIATION; SMAD3	Although TGF-beta acts as a tumor suppressor in normal tissues and in early carcinogenesis, these tumor suppressor effects are lost in advanced malignancies. Single cell migration and epithelial-mesenchymal transition (EMT), both of which are regulated by TGF-beta, are critical steps in mediating cancer progression. Here, we sought to identify novel direct targets of TGF-beta signaling in lung cancer cells and have indentified the zyxin gene as a target of Smad3-mediated TGF-beta 1 signaling. Zyxin concentrates at focal adhesions and along the actin cytoskeleton; as such, we hypothesized that cytoskeletal organization, motility, and EMT in response to TGF-beta 1 might be regulated by zyxin expression. We show that TGF-beta 1 treatment of lung cancer cells caused rapid phospho-Smad3-dependent expression of zyxin. Zyxin expression was critical for the formation and integrity of cell adherens junctions. Silencing of zyxin decreased expression of the focal adhesion protein vasodilator-activated phosphoprotein (VASP), although the formation and morphology of focal adhesions remained unchanged. Zyxin-depleted cells displayed significantly increased integrin alpha 5 beta 1 levels, accompanied by enhanced adhesion to fibronectin and acquisition of a mesenchymal phenotype in response to TGF-beta 1. Zyxin silencing led to elevated integrin alpha 5 beta 1-dependent single cell motility. Importantly, these features are mirrored in the K-ras-driven mouse model of lung cancer. Here, lung tumors revealed decreased levels of both zyxin and phospho-Smad3 when compared with normal tissues. Our data thus demonstrate that zyxin is a novel functional target and effector of TGF-beta signaling in lung cancer. By regulating cell-cell junctions, integrin alpha 5 beta 1 expression, and cell-extracellular matrix adhesion, zyxin may regulate cancer cell motility and EMT during lung cancer development and progression.	[Mise, Nikica; Yu, Haiying; Schwarz, Johannes; Eickelberg, Oliver] Univ Munich, Univ Hosp, CPC, D-81377 Munich, Germany; [Mise, Nikica; Yu, Haiying; Schwarz, Johannes; Eickelberg, Oliver] Helmholtz Zentrum Munich, D-81377 Munich, Germany; [Savai, Rajkumar] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Kaminski, Naftali] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mise, N (corresponding author), Univ Munich, Univ Hosp, CPC, Max Lebsche Pl 31, D-81377 Munich, Germany.	nikica.mise@helmholtz-muenchen.de; oliver.eickelberg@helmholtz-muenchen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Kaminski, Naftali/0000-0001-5917-4601	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association.	Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Chan CB, 2007, CELL DEATH DIFFER, V14, P1688, DOI 10.1038/sj.cdd.4402179; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Daly AC, 2010, J BIOL CHEM, V285, P6489, DOI 10.1074/jbc.M109.043877; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Han XS, 2001, ONCOGENE, V20, P7976, DOI 10.1038/sj.onc.1204996; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Piek E, 1999, J CELL SCI, V112, P4557; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Sperry RB, 2010, J CELL PHYSIOL, V222, P612, DOI 10.1002/jcp.21977; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yu YP, 2011, ONCOGENE, V30, P4855, DOI 10.1038/onc.2011.200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang YH, 2011, INT J ORAL SCI, V3, P1, DOI 10.4248/IJOS11003	48	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31393	31405		10.1074/jbc.M112.357624	http://dx.doi.org/10.1074/jbc.M112.357624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22778267	hybrid, Green Published			2022-12-28	WOS:000308791300050
J	Hehemann, JH; Correc, G; Thomas, F; Bernard, T; Barbeyron, T; Jam, M; Helbert, W; Michel, G; Czjzek, M				Hehemann, Jan-Hendrik; Correc, Gaelle; Thomas, Francois; Bernard, Thomas; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam			Biochemical and Structural Characterization of the Complex Agarolytic Enzyme System from the Marine Bacterium Zobellia galactanivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT SYMBIONT; BETA-AGARASE; CELL-WALLS; RED ALGA; BINDING; STARCH; NOMENCLATURE; EXPRESSION; PORPHYRAN; EVOLUTION	Zobellia galactanivorans is an emerging model bacterium for the bioconversion of algal biomass. Notably, this marine Bacteroidetes possesses a complex agarolytic system comprising four beta-agarases and five beta-porphyranases, all belonging to the glycoside hydrolase family 16. Although beta-agarases are specific for the neutral agarobiose moieties, the recently discovered beta-porphyranases degrade the sulfated polymers found in various quantities in natural agars. Here, we report the biochemical and structural comparison of five beta-porphyranases and beta-agarases from Z. galactanivorans. The respective degradation patterns of two beta-porphyranases and three beta-agarases are analyzed by their action on defined hybrid oligosaccharides. In light of the high resolution crystal structures, the biochemical results allowed a detailed mapping of substrate specificities along the active site groove of the enzymes. Although PorA displays a strict requirement for C6-sulfate in the -2- and + 1-binding subsites, PorB tolerates the presence of 3-6-anhydro-L-galactose in subsite -2. Both enzymes do not accept methylation of the galactose unit in the -1 subsite. The beta-agarase AgaD requires at least four consecutive agarose units (DP8) and is highly intolerant to modifications, whereas for AgaB oligosaccharides containing C6-sulfate groups at the -4, +1, and +3 positions are still degraded. Together with a transcriptional analysis of the expression of these enzymes, the structural and biochemical results allow proposition of a model scheme for the agarolytic system of Z. galactanivorans.	[Hehemann, Jan-Hendrik; Correc, Gaelle; Thomas, Francois; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam] Univ Paris 06, F-29682 Roscoff, France; [Correc, Gaelle; Thomas, Francois; Barbeyron, Tristan; Jam, Murielle; Helbert, William; Michel, Gurvan; Czjzek, Mirjam] CNRS, Vegetaux Marins & Biomol UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Hehemann, Jan-Hendrik] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Bernard, Thomas] Swiss Inst Bioinformat, Vital IT Grp, CH-1015 Lausanne, Switzerland	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Victoria; Swiss Institute of Bioinformatics	Michel, G (corresponding author), Univ Paris 06, F-29682 Roscoff, France.	gurvan@sb-roscoff.fr; czjzek@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Thomas, Francois/0000-0003-1896-0774; Bernard, Thomas/0000-0003-3736-1507	Region Bretagne; CNRS; European Marie Curie Ph.D. grant	Region Bretagne(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Marie Curie Ph.D. grant	This work was supported in part by the Region Bretagne and the CNRS.; Supported by a European Marie Curie Ph.D. grant.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; ANDERSON KL, 1989, J BACTERIOL, V171, P3199, DOI 10.1128/jb.171.6.3199-3204.1989; ANDERSON NS, 1965, J CHEM SOC, P5880, DOI 10.1039/jr9650005880; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dong JH, 2006, APPL ENVIRON MICROB, V72, P6399, DOI 10.1128/AEM.00935-06; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hehemann JH, 2010, ACTA CRYSTALLOGR F, V66, P413, DOI 10.1107/S174430911000429X; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Karlsson EN, 2004, FEMS MICROBIOL LETT, V241, P233, DOI 10.1016/j.femsle.2004.10.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; LAHAYE M, 1989, CARBOHYD RES, V190, P249, DOI 10.1016/0008-6215(89)84129-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lechat H, 2000, J PHYCOL, V36, P891, DOI 10.1046/j.1529-8817.2000.00056.x; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; Zobell CE, 1941, J MAR RES, V4, P42	52	89	100	1	89	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30571	30584		10.1074/jbc.M112.377184	http://dx.doi.org/10.1074/jbc.M112.377184			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778272	Green Published, hybrid			2022-12-28	WOS:000308579800049
J	Makarava, N; Kovacs, GG; Savtchenko, R; Alexeeva, I; Budka, H; Rohwer, RG; Baskakov, IV				Makarava, Natallia; Kovacs, Gabor G.; Savtchenko, Regina; Alexeeva, Irina; Budka, Herbert; Rohwer, Robert G.; Baskakov, Ilia V.			Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; SCRAPIE AGENT; MOUSE SCRAPIE; HAMSTERS; PROTEIN; DISEASE; INFECTIVITY; RATS; MICE; REPLICATION	Transmission of prions to a new host is frequently accompanied by strain adaptation, a phenomenon that involves reduction of the incubation period, a change in neuropathological features and, sometimes, tissue tropism. Here we show that a strain of synthetic origin (SSLOW), although serially transmitted within the same species, displayed the key attributes of the strain adaptation process. At least four serial passages were required to stabilize the strain-specific SSLOW phenotype. The biological titration of SSLOW revealed a correlation between clinical signs and accumulation of PrPSc in brains of animals inoculated with high doses (10(-1)-10(-5) diluted brain material), but dissociation between the two processes at low dose inocula (10(-6)-10(-8) diluted brain material). At low doses, several asymptomatic animals harbored large amounts of PrPSc comparable with those seen in the brains of terminally ill animals, whereas one clinically ill animal had very little, if any, PrPSc. In summary, the current study illustrates that the phenomenon of prion strain adaptation is more common than generally thought and could be observed upon serial transmission without changing the host species. When PrPSc is seeded by recombinant PrP structures different from that of authentic PrPSc, PrPSc properties continued to evolve for as long as four serial passages.	[Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Rohwer, Robert G.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kovacs, Gabor G.; Budka, Herbert] Med Univ Vienna, Inst Neurol, AKH 4J, A-1097 Vienna, Austria; [Alexeeva, Irina; Rohwer, Robert G.] Vet Affairs Maryland Hlth Care Syst, Med Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Medical University of Vienna	Baskakov, IV (corresponding author), 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu	Budka, Herbert/I-3486-2019; Kovacs, Gabor/A-7468-2013	Budka, Herbert/0000-0002-1933-1577; Kovacs, Gabor/0000-0003-3841-5511	National Institutes of Health [NS045585, NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585, R56NS074998, R01NS074998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045585 and NS074998 (to I. V. B.).	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; CHANDLER R. L., 1963, RES VET SCI, V4, P276; CHANDLER RL, 1972, RES VET SCI, V31, P219, DOI 10.1016/S0034-5288(18)34031-1; CHANDLER RL, 1963, LANCET, V2, P1165; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collins SJ, 2005, NEUROBIOL DIS, V20, P336, DOI 10.1016/j.nbd.2005.03.014; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dickinson A G, 1976, Front Biol, V44, P209; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; KIMBERLIN RH, 1979, J GEN VIROL, V42, P107, DOI 10.1099/0022-1317-42-1-107; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; PATTISON IH, 1968, RES VET SCI, V9, P408; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; SOMERVILLE RA, 1983, J GEN VIROL, V64, P2045, DOI 10.1099/0022-1317-64-9-2045; Thackray AM, 2012, J COMP PATHOL, V147, P316, DOI 10.1016/j.jcpa.2012.01.009; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; ZLOTNIK I, 1963, LANCET, V2, P1072	50	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30205	30214		10.1074/jbc.M112.392985	http://dx.doi.org/10.1074/jbc.M112.392985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807452	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000308579800015
J	Pehar, M; Jonas, MC; Hare, TM; Puglielli, L				Pehar, Mariana; Jonas, Mary Cabell; Hare, Theresa M.; Puglielli, Luigi			SLC33A1/AT-1 Protein Regulates the Induction of Autophagy Downstream of IRE1/XBP1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA TRANSPORTER; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LYSINE ACETYLATION; MEMBRANE-PROTEIN; ER; STRESS; XBP1; LUMEN; YEAST	One of the main functions of the unfolded protein response is to ensure disposal of large protein aggregates that accumulate in the lumen of the endoplasmic reticulum (ER) whereas avoiding, at least under nonlethal levels of ER stress, cell death. When tightly controlled, autophagy-dependent ER-associated degradation (ERAD(II)) allows the cell to recover from the transient accumulation of protein aggregates; however, when unchecked, it can be detrimental and cause autophagic cell death/type 2 cell death. Here we show that IRE1/XBP1 controls the induction of autophagy/ERAD(II) during the unfolded protein response by activating the ER membrane transporter SLC33A1/AT-1, which ensures continuous supply of acetyl-CoA into the lumen of the ER. Failure to induce AT-1 leads to widespread autophagic cell death. Mechanistically, the regulation of the autophagic process involves N-epsilon-lysine acetylation of Atg9A.	[Puglielli, Luigi] Univ Wisconsin, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Jonas, Mary Cabell; Puglielli, Luigi] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health from the NIA [AG028569, AG033514]; NATIONAL INSTITUTE ON AGING [R01AG028569, P50AG033514] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG028569 and AG033514 from the NIA (to L. P.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matus S, 2009, AUTOPHAGY, V5, P1226, DOI 10.4161/auto.5.8.10247; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Tamura H, 2010, J HISTOCHEM CYTOCHEM, V58, P443, DOI 10.1369/jhc.2010.955690; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	36	56	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29921	29930		10.1074/jbc.M112.363911	http://dx.doi.org/10.1074/jbc.M112.363911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787145	Green Published, hybrid			2022-12-28	WOS:000308286900065
J	Pescatore, LA; Bonatto, D; Forti, FL; Sadok, A; Kovacic, H; Laurindo, FRM				Pescatore, Luciana A.; Bonatto, Diego; Forti, Fabio L.; Sadok, Amine; Kovacic, Herve; Laurindo, Francisco R. M.			Protein Disulfide Isomerase Is Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration, Nox1 NADPH Oxidase Expression, and RhoGTPase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; INTERACTION NETWORKS; BINDING PROTEIN; BALLOON INJURY; RHO; LOCALIZATION; ASSOCIATION; INTERACTOME; ADHESION; SURFACE	Vascular Smooth Muscle Cell (VSMC) migration into vessel neointima is a therapeutic target for atherosclerosis and postinjury restenosis. Nox1 NADPH oxidase-derived oxidants synergize with growth factors to support VSMC migration. We previously described the interaction between NADPH oxidases and the endoplasmic reticulum redox chaperone protein disulfide isomerase (PDI) in many cell types. However, physiological implications, as well as mechanisms of such association, are yet unclear. We show here that platelet-derived growth factor (PDGF) promoted subcellular redistribution of PDI concomitant to Nox1-dependent reactive oxygen species production and that siRNA-mediated PDI silencing inhibited such reactive oxygen species production, while nearly totally suppressing the increase in Nox1 expression, with no change in Nox4. Furthermore, PDI silencing inhibited PDGF-induced VSMC migration assessed by distinct methods, whereas PDI overexpression increased spontaneous basal VSMC migration. To address possible mechanisms of PDI effects, we searched for PDI interactome by systems biology analysis of physical protein-protein interaction networks, which indicated convergence with small GTPases and their regulator RhoGDI. PDI silencing decreased PDGF-induced Rac1 and RhoA activities, without changing their expression. PDI co-immunoprecipitated with RhoGDI at base line, whereas such association was decreased after PDGF. Also, PDI co-immunoprecipitated with Rac1 and RhoA in a PDGF-independent way and displayed detectable spots of perinuclear co-localization with Rac1 and RhoGDI. Moreover, PDI silencing promoted strong cytoskeletal changes: disorganization of stress fibers, decreased number of focal adhesions, and reduced number of RhoGDI-containing vesicular recycling adhesion structures. Overall, these data suggest that PDI is required to support Nox1/redox and GTPase-dependent VSMC migration.	[Pescatore, Luciana A.; Laurindo, Francisco R. M.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Vasc Biol Lab, BR-05403000 Sao Paulo, Brazil; [Bonatto, Diego] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, BR-91509900 Porto Alegre, RS, Brazil; [Forti, Fabio L.] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, Brazil; [Sadok, Amine; Kovacic, Herve] Univ Aix Marseille 1, INSERM, UMR 911, CRO2, F-13385 Marseille, France	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Laurindo, FRM (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Vasc Biol Lab, Av Eneas Carvalho Aguiar 44,Annex 2,9th Floor, BR-05403000 Sao Paulo, Brazil.	francisco.laurindo@incor.usp.br	FORTI, FABIO LUIS/F-8085-2012; Pescatore, Luciana/P-1986-2014; kovacic, hervé/ABF-2451-2020; Bonatto, Diego/F-5893-2010	FORTI, FABIO LUIS/0000-0002-2278-6396; Bonatto, Diego/0000-0001-8679-2448; Kovacic, Herve/0000-0001-6509-4210				Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Azevedo LCP, 2000, CARDIOVASC RES, V47, P436, DOI 10.1016/S0008-6363(00)00091-2; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Delom F, 2001, J BIOL CHEM, V276, P21337, DOI 10.1074/jbc.M101086200; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Haefliger S, 2011, BLOOD, V117, P5931, DOI 10.1182/blood-2010-08-304485; Hashida T, 2011, J TOXICOL SCI, V36, P1, DOI 10.2131/jts.36.1; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Laurindo FRM, 2002, METHOD ENZYMOL, V352, P432; Leite PF, 2003, ARTERIOSCL THROM VAS, V23, P2197, DOI 10.1161/01.ATV.0000093980.46838.41; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maruri-Avidal L, 2008, J VIROL, V82, P5368, DOI 10.1128/JVI.02751-07; Moissoglu K, 2009, CANCER RES, V69, P2838, DOI 10.1158/0008-5472.CAN-08-1397; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Ramirez-Rangel I, 2011, MOL CELL BIOL, V31, P1657, DOI 10.1128/MCB.00824-10; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Souza HP, 2000, FREE RADICAL BIO MED, V28, P1232, DOI 10.1016/S0891-5849(00)00240-9; Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhou M, 2008, CRIT CARE, V12, DOI 10.1186/cc6977; Zimmerman MC, 2011, HYPERTENSION, V58, P446, DOI 10.1161/HYPERTENSIONAHA.111.177006; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	70	56	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29290	29300		10.1074/jbc.M112.394551	http://dx.doi.org/10.1074/jbc.M112.394551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773830	Green Published, hybrid			2022-12-28	WOS:000308286900009
J	Aziz, A; Hess, JF; Budamagunta, MS; Voss, JC; Kuzin, AP; Huang, YPJ; Xiao, R; Montelione, GT; FitzGerald, PG; Hunt, JF				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; Voss, John C.; Kuzin, Alexandre P.; Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.; FitzGerald, Paul G.; Hunt, John F.			The Structure of Vimentin Linker 1 and Rod 1B Domains Characterized by Site-directed Spin-labeling Electron Paramagnetic Resonance (SDSL-EPR) and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; EPIDERMAL KERATIN; ATOMIC-STRUCTURE; CDNA SEQUENCE; CROSS-LINKING; MODEL; MECHANISM; LEVEL; CONSERVATION; DIVERSITY	Despite the passage of similar to 30 years since the complete primary sequence of the intermediate filament (IF) protein vimentin was reported, the structure remains unknown for both an individual protomer and the assembled filament. In this report, we present data describing the structure of vimentin linker 1 (L1) and rod 1B. Electron paramagnetic resonance spectra collected from samples bearing site-directed spin labels demonstrate that L1 is not a flexible segment between coiled-coils (CCs) but instead forms a rigid, tightly packed structure. Anx-ray crystal structure of a construct containing L1 and rod 1B shows that it forms a tetramer comprising two equivalent parallel CC dimers that interact with one another in the form of a symmetrical anti-parallel dimer. Remarkably, the parallel CC dimers are themselves asymmetrical, which enables them to tetramerize rather than undergoing higher order oligomerization. This functionally vital asymmetry in the CC structure, encoded in the primary sequence of rod 1B, provides a striking example of evolutionary exploitation of the structural plasticity of proteins. EPR and crystallographic data consistently suggest that a very short region within L1 represents a minor local distortion in what is likely to be a continuous CC from the end of rod 1A through the entirety of rod 1B. The concordance of this structural model with previously published cross-linking and spectral data supports the conclusion that the crystallographic oligomer represents a native biological structure.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Kuzin, Alexandre P.; Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Kuzin, Alexandre P.; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	University of California System; University of California Davis; University of California System; University of California Davis; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	FitzGerald, PG (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, 1 Shields Ave, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Montelione, Gaetano/0000-0002-9440-3059; Voss, John/0000-0001-9279-209X	National Institutes of Health (NIH) [EY015560]; NEI, NIH [P30-EY012576]; NIH [AG029246, U54-GM094597]; National Center for Research Resources, NIH [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015560, P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant EY015560 (to P. G. F.); NEI, NIH, Core Facilities Grant P30-EY012576 (to the University of California Davis); NIH Grant AG029246 (to J. C. V.), and NIH Grant U54-GM094597 (to G. T. M., J. F. H., and the Northeast Structural Genomics Consortium). Work at the University of California Davis was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR-12088-01 from the National Center for Research Resources, NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Aziz A, 2009, J BIOL CHEM, V284, P7330, DOI 10.1074/jbc.M809029200; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; CREWTHER WG, 1983, INT J BIOL MACROMOL, V5, P267, DOI 10.1016/0141-8130(83)90040-5; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Jansson M, 1996, J BIOMOL NMR, V7, P131; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry D. A. D., 1995, INTERMEDIATE FILAMEN, P2; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; PARRY DAD, 1990, CELLULAR MOL BIOL IN, P175; Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1984, J CELL BIOL, V99, pS22, DOI 10.1083/jcb.99.1.22s; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1976, BIOCHEM BIOPH RES CO, V70, P221, DOI 10.1016/0006-291X(76)91131-1; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strelkov SV, 1999, MOL BIOL CELL, V10, p13A; WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	47	46	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28349	28361		10.1074/jbc.M111.334011	http://dx.doi.org/10.1074/jbc.M111.334011			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740688	Green Published, hybrid			2022-12-28	WOS:000308074600012
J	Biedermannova, L; Prokop, Z; Gora, A; Chovancova, E; Kovacs, M; Damborsky, J; Wade, RC				Biedermannova, Lada; Prokop, Zbynek; Gora, Artur; Chovancova, Eva; Kovacs, Mihaly; Damborsky, Jiri; Wade, Rebecca C.			A Single Mutation in a Tunnel to the Active Site Changes the Mechanism and Kinetics of Product Release in Haloalkane Dehalogenase LinB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY; CATALYTIC MECHANISM; CYTOCHROME P450CAM; LIPASE ENANTIOSELECTIVITY; SUBSTRATES ENTER; ACCESS CHANNELS; EXIT TUNNEL; BINDING	Many enzymes have buried active sites. The properties of the tunnels connecting the active site with bulk solvent affect ligand binding and unbinding and also the catalytic properties. Here, we investigate ligand passage in the haloalkane dehalogenase enzyme LinB and the effect of replacing leucine by a bulky tryptophan at a tunnel-lining position. Transient kinetic experiments show that the mutation significantly slows down the rate of product release. Moreover, the mechanism of bromide ion release is changed from a one-step process in the wild type enzyme to a two-step process in the mutant. The rate constant of bromide ion release corresponds to the overall steady-state turnover rate constant, suggesting that product release became the rate-limiting step of catalysis in the mutant. We explain the experimental findings by investigating the molecular details of the process computationally. Analysis of trajectories from molecular dynamics simulations with a tunnel detection software reveals differences in the tunnels available for ligand egress. Corresponding differences are seen in simulations of product egress using a specialized enhanced sampling technique. The differences in the free energy barriers for egress of a bromide ion obtained using potential of mean force calculations are in good agreement with the differences in rates obtained from the transient kinetic experiments. Interactions of the bromide ion with the introduced tryptophan are shown to affect the free energy barrier for its passage. The study demonstrates how the mechanism of an enzymatic catalytic cycle and reaction kinetics can be engineered by modification of protein tunnels.	[Biedermannova, Lada; Prokop, Zbynek; Gora, Artur; Chovancova, Eva; Damborsky, Jiri] Masaryk Univ, Fac Sci, Loschmidt Labs, Dept Expt Biol, Brno 65200, Czech Republic; [Biedermannova, Lada; Prokop, Zbynek; Gora, Artur; Chovancova, Eva; Damborsky, Jiri] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm, Brno 65200, Czech Republic; [Biedermannova, Lada; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany; [Kovacs, Mihaly] Eotvos Lorand Univ, Hungarian Acad Sci, ELTE MTA, Momentum Motor Enzymol Res Grp,Dept Biochem, H-1117 Budapest, Hungary; [Wade, Rebecca C.] Heidelberg Univ, Ctr Mol Biol, D-69120 Heidelberg, Germany	Masaryk University Brno; Masaryk University Brno; Heidelberg Institute for Theoretical Studies; Eotvos Lorand University; Hungarian Academy of Sciences; Ruprecht Karls University Heidelberg	Damborsky, J (corresponding author), Masaryk Univ, Fac Sci, Loschmidt Labs, Dept Expt Biol, Kamenice 5-A4, Brno 65200, Czech Republic.	jiri@chemi.muni.cz; Rebecca.Wade@h-its.org	Wade, Rebecca/L-1489-2019; Sebestova, Eva/AAA-6108-2020; Damborsky, Jiri/H-3799-2012; Biedermannova, Lada/F-1439-2010; Prokop, Zbynek/H-5707-2012; Kovacs, Mihaly/A-6841-2011; Góra, Artur/D-5041-2012	Wade, Rebecca/0000-0001-5951-8670; Damborsky, Jiri/0000-0002-7848-8216; Biedermannova, Lada/0000-0001-6504-6403; Prokop, Zbynek/0000-0001-9358-4081; Góra, Artur/0000-0003-2530-6957; Kovacs, Mihaly/0000-0002-1200-4741	European Regional Fund [CZ.1.05/2.1.00/01.0001]; Grant Agency of the Czech Academy of Sciences [IAA40163090]; Klaus Tschira Foundation; TAMOP [4.2.1/B-09/1/KMR-2010-0003]; Hungarian Academy of Sciences [LP2011-006/2011]; Deutsches Akademisches Austausch Dienst [A/08/96229]; SoMoPro Programme [SIGA762]; European Commission [229603]; South Moravian Region; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]	European Regional Fund; Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Klaus Tschira Foundation; TAMOP; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Deutsches Akademisches Austausch Dienst; SoMoPro Programme; European Commission(European CommissionEuropean Commission Joint Research Centre); South Moravian Region; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported in part by Grants CZ.1.05/2.1.00/01.0001 from the European Regional Fund (to J. D., Z. P., and E. C.), Grant IAA40163090 from the Grant Agency of the Czech Academy of Sciences (to J. D.), the Klaus Tschira Foundation, Grant 4.2.1/B-09/1/KMR-2010-0003 from TAMOP, and Grant LP2011-006/2011 from the "Momentum" Program of the Hungarian Academy of Sciences (to M. K.).; Recipient of Postdoctoral Fellowship A/08/96229 from Deutsches Akademisches Austausch Dienst. To whom correspondence may be addressed: Laboratory of Biomolecular Recognition, Institute of Biotechnology, Videnska 1083, 14220 Prague 4, Czech Republic. Tel.: 420-241-06-36-24; Fax: 420-296-44-36-10; E-mail: lada.biedermannova@img.cas.cz.; Supported by SoMoPro Programme SIGA762 and recipient of a financial contribution from the European Commission within the 7th FP (FP/2007-2013) under Grant 229603, co-financed by the South Moravian Region.; We thank Vlad Cojocaru for assistance with the RAMD scripts. MetaCentrum is acknowledged for providing access to computing facilities, supported by Grant LM2010005 from the Ministry of Education, Youth, and Sports of the Czech Republic.	Banas P, 2006, J COMPUT AID MOL DES, V20, P375, DOI 10.1007/s10822-006-9071-1; Bui JM, 2004, J AM CHEM SOC, V126, P7198, DOI 10.1021/ja0485715; Case D, 2006, AMBER 9; Case D.A., 2008, AMBER VERSION 10; Chaloupkova R, 2003, J BIOL CHEM, V278, P52622, DOI 10.1074/jbc.M306762200; Chovancova E., 2012, CAVER 3 0 SOFTWARE T; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; D'Angelo P, 2010, INORG CHEM, V49, P4224, DOI 10.1021/ic9025574; Damborsky Jiri, 2007, Biotechnology Journal, V2, P62, DOI 10.1002/biot.200600208; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Delano WL., 2002, PYMOL MOL GRAPHICS S; Doudou S, 2009, J CHEM THEORY COMPUT, V5, P909, DOI 10.1021/ct8002354; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Guieysse D, 2008, CHEMBIOCHEM, V9, P1308, DOI 10.1002/cbic.200700548; Helms V, 1998, PROTEINS, V32, P381, DOI 10.1002/(SICI)1097-0134(19980815)32:3<381::AID-PROT12>3.3.CO;2-6; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jungwirth P, 2008, ANNU REV PHYS CHEM, V59, P343, DOI 10.1146/annurev.physchem.59.032607.093749; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kim BC, 2005, J PHYS CHEM B, V109, P16529, DOI 10.1021/jp051569v; Klvana M, 2009, J MOL BIOL, V392, P1339, DOI 10.1016/j.jmb.2009.06.076; Kmunicek J, 2001, BIOCHEMISTRY-US, V40, P8905, DOI 10.1021/bi010464p; Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405; Lafaquiere V, 2009, CHEMBIOCHEM, V10, P2760, DOI 10.1002/cbic.200900439; Larsen MW, 2010, CHEMBIOCHEM, V11, P796, DOI 10.1002/cbic.200900743; Lu ND, 2004, J COMPUT CHEM, V25, P28, DOI 10.1002/jcc.10369; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; LYBRAND TP, 1985, J AM CHEM SOC, V107, P7793, DOI 10.1021/ja00311a112; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Negri A, 2007, J MOL GRAPH MODEL, V26, P643, DOI 10.1016/j.jmgm.2007.03.010; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Petrone PM, 2008, P NATL ACAD SCI USA, V105, P16549, DOI 10.1073/pnas.0801795105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; PRIES F, 1995, J BIOL CHEM, V270, P10405, DOI 10.1074/jbc.270.18.10405; Prokop Z, 2003, J BIOL CHEM, V278, P45094, DOI 10.1074/jbc.M307056200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmitt J, 2002, PROTEIN ENG, V15, P595, DOI 10.1093/protein/15.7.595; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Yin H, 2010, J PHYS CHEM B, V114, P16290, DOI 10.1021/jp108731r; Zhang HM, 2009, J BIOL CHEM, V284, P25678, DOI 10.1074/jbc.M109.032748	55	48	48	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29062	29074		10.1074/jbc.M112.377853	http://dx.doi.org/10.1074/jbc.M112.377853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745119	Green Published, hybrid			2022-12-28	WOS:000308074600073
J	Boone, TJ; Tyrrell, GJ				Boone, Tyler J.; Tyrrell, Gregory J.			Identification of the Actin and Plasminogen Binding Regions of Group B Streptococcal Phosphoglycerate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; AUTOMATED PROTEIN-STRUCTURE; ALPHA-ENOLASE BINDS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; I-TASSER; BACTERIAL ADHERENCE; GLYCOLYTIC-ENZYMES; PROMOTES ADHERENCE; SURFACE-MOLECULE; C5A PEPTIDASE	Phosphoglycerate kinase (PGK), present on the surface of group B streptococcus (GBS), has previously been demonstrated to bind the host proteins actin and plasminogen. The actin and plasminogen binding sites of GBS-PGK were identified using truncated GBS-PGK molecules, followed by peptide mapping. These experiments identified two actin and plasminogen binding sites located between amino acids 126-134 and 204-208 of the 398-amino acid-long GBS-PGK molecule. Substitution of the lysine residues within these regions with alanine resulted in significantly reduced binding to both actin and plasminogen. In addition, conversion of the glutamic acid residue at amino acid 133 to proline, the amino acid found at this position for the PGK protein of Streptococcus pneumoniae, also resulted in significantly reduced binding to actin and plasminogen. These results demonstrate that the lysine residues at amino acid positions 126, 127, 130, 204, and 208 along with the glutamic acid residue at amino acid position 133 are necessary for actin and plasminogen binding by GBS-PGK.	[Tyrrell, Gregory J.] Univ Alberta, Walter Mackenzie Hlth Sci Ctr, Dept Lab Med & Pathol, Edmonton, AB T6G 2J2, Canada; [Tyrrell, Gregory J.] Prov Lab Publ Hlth Microbiol, Edmonton, AB T6G 2J2, Canada	University of Alberta	Tyrrell, GJ (corresponding author), Univ Alberta, Walter Mackenzie Hlth Sci Ctr, Dept Lab Med & Pathol, Rm 2B3-08, Edmonton, AB T6G 2J2, Canada.	Greg.Tyrrell@albertahealthservices.ca	Tyrrell, Gregory/ABA-7203-2021		University of Alberta Hospital Foundation grant; Alberta Heritage Foundation for Medical Research/Hotchkiss Brain Institute traineeship; Queen Elizabeth II doctoral scholarship; Medical Sciences Graduate Research assistantship from the Faculty of Medicine and Dentistry, University of Alberta	University of Alberta Hospital Foundation grant; Alberta Heritage Foundation for Medical Research/Hotchkiss Brain Institute traineeship; Queen Elizabeth II doctoral scholarship; Medical Sciences Graduate Research assistantship from the Faculty of Medicine and Dentistry, University of Alberta	This work was supported by a University of Alberta Hospital Foundation grant (to G. J. T.).; Supported by an Alberta Heritage Foundation for Medical Research/Hotchkiss Brain Institute traineeship, a Queen Elizabeth II doctoral scholarship, and a Medical Sciences Graduate Research assistantship from the Faculty of Medicine and Dentistry, University of Alberta.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; ARNOLD H, 1971, EUR J BIOCHEM, V22, P121, DOI 10.1111/j.1432-1033.1971.tb01522.x; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; BACH MA, 1986, CELL IMMUNOL, V98, P364, DOI 10.1016/0008-8749(86)90296-0; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Bolduc GR, 2007, MICROBIOL-SGM, V153, P4039, DOI 10.1099/mic.0.2007/009134-0; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Brassard J, 2001, CAN J VET RES, V65, P156; BUCHER T, 1955, METHOD ENZYMOL, V1, P415, DOI 10.1016/0076-6879(55)01068-9; Burnham CAD, 2005, MICROB PATHOGENESIS, V38, P189, DOI 10.1016/j.micpath.2005.02.002; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Esgleas M, 2009, FEMS MICROBIOL LETT, V294, P82, DOI 10.1111/j.1574-6968.2009.01551.x; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Jobin MC, 2004, INFECT IMMUN, V72, P606, DOI 10.1128/IAI.72.1.606-610.2004; Kesimer M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-163; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; MOROIANU J, 1993, P NATL ACAD SCI USA, V90, P3815, DOI 10.1073/pnas.90.9.3815; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; POR SB, 1991, J HISTOCHEM CYTOCHEM, V39, P981, DOI 10.1177/39.7.1865114; ROSENBLATT HM, 1985, J IMMUNOL, V135, P995; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; SANDERS SK, 1983, J IMMUNOL, V131, P370; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Smalheiser NR, 1996, MOL BIOL CELL, V7, P1003, DOI 10.1091/mbc.7.7.1003; Soriani M, 2006, J INFECT DIS, V193, P241, DOI 10.1086/498982; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Tyrrell GJ, 2002, MICROBIOL-SGM, V148, P3921, DOI 10.1099/00221287-148-12-3921; Verani JR, 2010, CLIN PERINATOL, V37, P375, DOI 10.1016/j.clp.2010.02.002; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	62	24	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29035	29044		10.1074/jbc.M112.361261	http://dx.doi.org/10.1074/jbc.M112.361261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761440	hybrid, Green Published			2022-12-28	WOS:000308074600070
J	Kandala, PK; Srivastava, SK				Kandala, Prabodh K.; Srivastava, Sanjay K.			Diindolylmethane-mediated Gli1 Protein Suppression Induces Anoikis in Ovarian Cancer Cells in Vitro and Blocks Tumor Formation Ability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; ANIMAL DEVELOPMENT; PANCREATIC-CANCER; INDUCED APOPTOSIS; DOWN-REGULATION; 3,3'-DIINDOLYLMETHANE; ACTIVATION; PROLIFERATION; METASTASIS; RESISTANCE	Anoikis is a cell death that occurs due to detachment of a cell from the extracellular matrix (ECM). Resistance to anoikis is a primary feature of a cell that undergoes metastasis. In this study for the first time, we demonstrated the potential role of Gli1 in anoikis resistance. Treatment of various ovarian cancer cells by different concentrations of diindolylmethane (DIM), an active ingredient of cruciferous vegetables, reduced the anoikis resistance in a concentration-dependent manner. Reduction in anoikis resistance was associated with a decrease in the expression of Gli1 and an increase in the cleavage of poly(ADP-ribose) polymerase (PARP). Sonic hedgehog (Shh) treatment not only increased the expression of Gli1, but also blocked anoikis induced by DIM and abrogated the change in the expression of Gli1 and cleaved PARP by DIM. To confirm the role of Gli1, hedgehog inhibitor cyclopamine, Gli1 siRNA and Gli1(-/-) mouse embryonic fibroblasts (MEFs) were used. Cyclopamine treatment alone significantly reduced anoikis resistance in A2780 and OVCAR-429 cells. Cyclopamine-mediated reduction in anoikis resistance was associated with reduced expression of Gli1 and induction of cleaved PARP. Shh treatment blocked cyclopamine-induced anoikis. Silencing Gli1 expression induced anoikis and cleavage of PARP in A2780 and OVCAR-429 cells. Furthermore, Gli1(-/-) MEFs were more sensitive to anoikis compared with Gli1(+/+) MEFs. Our in vivo studies established that DIM-or cyclopamine-treated ovarian cancer cells under suspension culture conditions drastically lost their ability of tumor formation in vivo in mice. Taken together, our results establish that Gli1 is a critical player in anoikis resistance in ovarian cancer.	[Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Suite 1103,1406 Coulter, Amarillo, TX 79106 USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020		National Institutes of Health through the NCI [R01 CA106953, CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106953 and CA129038 (to S. K. S.) through the NCI.	Banerjee S, 2011, MUTAT RES-REV MUTAT, V728, P47, DOI 10.1016/j.mrrev.2011.06.001; Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838; Bhatnagar N, 2009, CANCER PREV RES, V2, P581, DOI 10.1158/1940-6207.CAPR-08-0142; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; BUCK RC, 1973, CANCER RES, V33, P3181; Chen XL, 2008, WORLD J GASTROENTERO, V14, P582, DOI 10.3748/wjg.14.582; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cho HJ, 2011, MOL CARCINOGEN, V50, P100, DOI 10.1002/mc.20698; Coates JM, 2010, J SURG RES, V164, P301, DOI 10.1016/j.jss.2009.07.011; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Donahue JK, 2006, GENE THER, V13, P998, DOI 10.1038/sj.gt.3302748; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Elamin MH, 2010, MOL CARCINOGEN, V49, P302, DOI 10.1002/mc.20604; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jin YC, 2011, MOL CELL BIOCHEM, V358, P345, DOI 10.1007/s11010-011-0985-0; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kandala PK, 2012, ONCOTARGET, V3, P435; Kandala PK, 2012, DRUG DISCOV THER, V6, P94, DOI 10.5582/ddt.2012.v6.2.94; Kandala PK, 2012, J PHARMACOL EXP THER, V341, P24, DOI 10.1124/jpet.111.188706; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kaur M, 2006, MOL CANCER THER, V5, P1265, DOI 10.1158/1535-7163.MCT-06-0014; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Vestergaard J, 2008, DNA CELL BIOL, V27, P251, DOI 10.1089/dna.2007.0625; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338	47	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28745	28754		10.1074/jbc.M112.351379	http://dx.doi.org/10.1074/jbc.M112.351379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773833	Green Published, hybrid			2022-12-28	WOS:000308074600048
J	Miyauchi, Y; Miyamoto, H; Yoshida, S; Mori, T; Kanagawa, H; Katsuyama, E; Fujie, A; Hao, W; Hoshi, H; Miyamoto, K; Sato, Y; Kobayashi, T; Akiyama, H; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Miyauchi, Yoshiteru; Miyamoto, Hiroya; Yoshida, Shigeyuki; Mori, Tomoaki; Kanagawa, Hiroya; Katsuyama, Eri; Fujie, Atsuhiro; Hao, Wu; Hoshi, Hiroko; Miyamoto, Kana; Sato, Yuiko; Kobayashi, Tami; Akiyama, Haruhiko; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			Conditional Inactivation of Blimp1 in Adult Mice Promotes Increased Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP1/PRDM1; T-CELL HOMEOSTASIS; KAPPA-B LIGAND; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; PPAR-GAMMA; EXPRESSION; AXIS	Bone resorption, which is regulated by osteoclasts, is excessively activated in bone destructive diseases such as osteoporosis. Thus, controlling osteoclasts would be an effective strategy to prevent pathological bone loss. Although several transcription factors that regulate osteoclast differentiation and function could serve as molecular targets to inhibit osteoclast formation, those factors have not yet been characterized using a loss of function approach in adults. Here we report such a study showing that inactivation of B-lymphocyte induced maturation protein 1 (Blimp1) in adult mice increases bone mass by suppressing osteoclast formation. Using an ex vivo assay, we show that osteoclast differentiation is significantly inhibited by Blimp1 inactivation at an early stage of osteoclastogenesis. Conditional inactivation of Blimp1 inhibited osteoclast formation and increased bone mass in both male and female adult mice. Bone resorption parameters were significantly reduced by Blimp1 inactivation in vivo. Blimp1 reportedly regulates immune cell differentiation and function, but we detected no immune cell failure following Blimp1 inactivation. These data suggest that Blimp1 is a potential target to promote increased bone mass and prevent osteoclastogenesis.	[Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Miyauchi, Yoshiteru; Miyamoto, Hiroya; Yoshida, Shigeyuki; Mori, Tomoaki; Katsuyama, Eri; Fujie, Atsuhiro; Hoshi, Hiroko; Miyamoto, Takeshi] Keio Univ, Sch Med, Ctr Human Metabol Syst Biol, Tokyo 1608582, Japan; [Yoshida, Shigeyuki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo 1608582, Japan; [Miyamoto, Kana; Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Keio Kanrinmaru Project, Tokyo 1608582, Japan; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthoped, Sakyo Ku, Kyoto 6068507, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University; Kyoto University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022; Matsumoto, Morio M/L-6227-2013; Toyama, Yoshiaki/K-5743-2013					Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Furuya Y, 2011, J BIOL CHEM, V286, P37023, DOI 10.1074/jbc.M111.246280; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li CY, 2006, J BONE MINER RES, V21, P865, DOI 10.1359/JBMR.060313; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z; Ninomiya K, 2007, BIOCHEM BIOPH RES CO, V362, P460, DOI 10.1016/j.bbrc.2007.07.193; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	30	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28508	28517		10.1074/jbc.M112.356634	http://dx.doi.org/10.1074/jbc.M112.356634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761448	hybrid, Green Published			2022-12-28	WOS:000308074600026
J	Masaoka, A; Gassman, NR; Kedar, PS; Prasad, R; Hou, EW; Horton, JK; Bustin, M; Wilson, SH				Masaoka, Aya; Gassman, Natalie R.; Kedar, Padmini S.; Prasad, Rajendra; Hou, Esther W.; Horton, Julie K.; Bustin, Michael; Wilson, Samuel H.			HMGN1 Protein Regulates Poly(ADP-ribose) Polymerase-1 (PARP-1) Self-PARylation in Mouse Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; CHROMOSOMAL-PROTEINS; MAMMALIAN-CELLS; CHROMATIN INTERACTIONS; NUCLEAR FUNCTIONS; GLYCOSYLASE-II; LIGASE-III; BETA; EXPRESSION	In mammalian cells, the nucleosome-binding protein HMGN1 (high mobility group N1) affects the structure and function of chromatin and plays a role in repair of damaged DNA. HMGN1 affects the interaction of DNA repair factors with chromatin and their access to damaged DNA; however, not all of the repair factors affected have been identified. Here, we report that HMGN1 affects the self-poly(ADP-ribosyl)ation (i.e., PARylation) of poly(ADP-ribose) polymerase-1 (PARP-1), a multifunctional and abundant nuclear enzyme known to recognize DNA lesions and promote chromatin remodeling, DNA repair, and other nucleic acid transactions. The catalytic activity of PARP-1 is activated by DNA with a strand break, and this results in self-PARylation and PARylation of other chromatin proteins. Using cells obtained from Hmgn1(-/-) and Hmgn1(+/+) littermate mice, we find that in untreated cells, loss of HMGN1 protein reduces PARP-1 self-PARylation. A similar result was obtained after MMS treatment of these cells. In imaging experiments after low energy laser-induced DNA damage, less PARylation at lesion sites was observed in Hmgn1(-/-) than in Hmgn1(+/+) cells. The HMGN1 regulation of PARP-1 activity could be mediated by direct protein-protein interaction as HMGN1 and PARP-1 were found to interact in binding assays. Purified HMGN1 was able to stimulate self-PARylation of purified PARP-1, and in experiments with cell extracts, self-PARylation was greater in Hmgn1(+/+) than in Hmgn1(-/-) extract. The results suggest a regulatory role for HMGN1 in PARP-1 activation.	[Masaoka, Aya; Gassman, Natalie R.; Kedar, Padmini S.; Prasad, Rajendra; Hou, Esther W.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Bustin, Michael] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; Bustin, Michael/G-6155-2015	Wilson, Samuel H/0000-0002-1702-5293; Gassman, Natalie/0000-0002-8488-2332; Bustin, Michael/0000-0002-5147-7242	Intramural Research Program of the National Institutes of Health, NIEHS [Z01-ES050158, Z01-ES050159]; NATIONAL CANCER INSTITUTE [ZIABC004496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050159, ZIAES050159, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Research Projects Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the National Institutes of Health, NIEHS.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Asagoshi K, 2011, CURR CANCER RES, P297, DOI 10.1007/978-1-61737-995-6_14; Asagoshi K, 2010, MOL CANCER RES, V8, P204, DOI 10.1158/1541-7786.MCR-09-0253; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; CRIPPA MP, 1991, J BIOL CHEM, V266, P2712; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; Gagnon SN, 2003, MOL CELL BIOCHEM, V243, P15, DOI 10.1023/A:1021645327079; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hamann I, 2012, MUTAT RES-FUND MOL M, V736, P56, DOI 10.1016/j.mrfmmm.2011.05.006; Hill DA, 2005, J BIOL CHEM, V280, P41777, DOI 10.1074/jbc.M509637200; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kedar PS, 2012, MOL CANCER RES, V10, P360, DOI 10.1158/1541-7786.MCR-11-0477; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lim JH, 2004, METHOD ENZYMOL, V375, P323; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masaoka A, 1999, J BIOL CHEM, V274, P25136, DOI 10.1074/jbc.274.35.25136; Masaoka A, 2009, DNA REPAIR, V8, P1290, DOI 10.1016/j.dnarep.2009.08.004; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Oei SL, 2005, BIOCHEM CELL BIOL, V83, P263, DOI 10.1139/o05-039; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; PASH JM, 1990, J BIOL CHEM, V265, P4197; Pogna EA, 2010, BBA-GENE REGUL MECH, V1799, P93, DOI 10.1016/j.bbagrm.2009.11.018; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Schroder Heinz C, 2006, Methods Mol Biol, V314, P287; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; SRIVASTAVA DK, 1995, J BIOL CHEM, V270, P16402, DOI 10.1074/jbc.270.27.16402; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; TANUMA S, 1983, J BIOL CHEM, V258, P4067; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; West KL, 2004, BIOCHEM SOC T, V32, P918, DOI 10.1042/BST0320918; Wilson SH, 2010, CELL MOL LIFE SCI, V67, P3633, DOI 10.1007/s00018-010-0489-1; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	60	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27648	27658		10.1074/jbc.M112.370759	http://dx.doi.org/10.1074/jbc.M112.370759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736760	Green Published, hybrid			2022-12-28	WOS:000307840700039
J	Venditti, V; Clore, GM				Venditti, Vincenzo; Clore, G. Marius			Conformational Selection and Substrate Binding Regulate the Monomer/Dimer Equilibrium of the C-terminal domain of Escherichia coli Enzyme I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; RESIDUAL DIPOLAR COUPLINGS; CHEMICAL-EXCHANGE; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; PHOSPHOENOLPYRUVATE; TRANSPORT; MACROMOLECULES; RELAXATION	The bacterial phosphotransferase system (PTS) is a signal transduction pathway that couples phosphoryl transfer to active sugar transport across the cell membrane. The PTS is initiated by the binding of phosphoenolpyruvate (PEP) to the C-terminal domain (EIC) of enzyme I (EI), a highly conserved protein that is common to all sugar branches of the PTS. EIC exists in a dynamic monomer/dimer equilibrium that is modulated by ligand binding and is thought to regulate the overall PTS. Isolation of EIC has proven challenging, and conformational dynamics within the EIC domain during the catalytic cycle are still largely unknown. Here, we present a robust protocol for expression and purification of recombinant EIC from Escherichia coli and show that isolated EIC is capable of hydrolyzing PEP. NMR analysis and residual dipolar coupling measurements indicate that the isolated EIC domain in solution adopts a stable tertiary fold and quaternary structure that is consistent with previously reported crystallographic data. NMR relaxation dispersion measurements indicate that residues around the PEP binding site and in the beta 3 alpha 3 turn (residues 333-366), which is located at the dimer interface, undergo a rapid transition on the sub-millisecond time scale (with an exchange rate constant of similar to 1500 s(-1)) between major open (similar to 97%) and minor closed (similar to 3%) conformations. Upon PEP binding, the beta 3 alpha 3 turn is effectively locked in the closed state by the formation of salt bridges between the phosphate group of PEP and the side chains of Lys(340) and Arg(358), thereby stabilizing the dimer.	[Venditti, Vincenzo; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018; Venditti, Vincenzo/A-9411-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; 	National Institutes of Health, NIDDK; Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the National Institutes of Health, NIDDK, and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G.M.C.).	Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; CHAUVIN F, 1994, J BIOL CHEM, V269, P20270; Chauvin F, 1996, RES MICROBIOL, V147, P471, DOI 10.1016/0923-2508(96)84001-0; Chauvin F, 1996, P NATL ACAD SCI USA, V93, P7028, DOI 10.1073/pnas.93.14.7028; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/nchembio.685, 10.1038/NCHEMBIO.685]; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mukhija S, 1997, MOL MICROBIOL, V25, P1159, DOI 10.1046/j.1365-2958.1997.5501910.x; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Navdaeva V, 2011, BIOCHEMISTRY-US, V50, P1184, DOI 10.1021/bi101721f; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patel HV, 2006, J BIOL CHEM, V281, P17579, DOI 10.1074/jbc.M508966200; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200; SAIER MH, 1980, J BIOL CHEM, V255, P8579; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Takayama Y, 2011, J AM CHEM SOC, V133, P424, DOI 10.1021/ja109866w; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Venditti V, 2012, J BIOMOL NMR, V52, P191, DOI 10.1007/s10858-012-9606-9; WAYGOOD EB, 1979, ANAL BIOCHEM, V95, P293, DOI 10.1016/0003-2697(79)90219-7; WEIGEL N, 1982, J BIOL CHEM, V257, P4461; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021	53	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26989	26998		10.1074/jbc.M112.382291	http://dx.doi.org/10.1074/jbc.M112.382291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22722931	hybrid, Green Published			2022-12-28	WOS:000307386000046
J	Fischer, S; Maier, LK; Stoll, B; Brendel, J; Fischer, E; Pfeiffer, F; Dyall-Smith, M; Marchfelder, A				Fischer, Susan; Maier, Lisa-Katharina; Stoll, Britta; Brendel, Jutta; Fischer, Eike; Pfeiffer, Friedhelm; Dyall-Smith, Mike; Marchfelder, Anita			An Archaeal Immune System Can Detect Multiple Protospacer Adjacent Motifs (PAMs) to Target Invader DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOFERAX-VOLCANII; CRISPR RNA; ACQUIRED-RESISTANCE; DYNAMIC PROPERTIES; BACTERIA; DEFENSE; SEQUENCE; REPEATS; GENOME; GENES	The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system provides adaptive and heritable immunity against foreign genetic elements in most archaea and many bacteria. Although this system is widespread and diverse with many subtypes, only a few species have been investigated to elucidate the precise mechanisms for the defense of viruses or plasmids. Approximately 90% of all sequenced archaea encode CRISPR/Cas systems, but their molecular details have so far only been examined in three archaeal species: Sulfolobus solfataricus, Sulfolobus islandicus, and Pyrococcus furiosus. Here, we analyzed the CRISPR/Cas system of Haloferax volcanii using a plasmid-based invader assay. Haloferax encodes a type I-B CRISPR/Cas system with eight Cas proteins and three CRISPR loci for which the identity of protospacer adjacent motifs (PAMs) was unknown until now. We identified six different PAM sequences that are required upstream of the protospacer to permit target DNA recognition. This is only the second archaeon for which PAM sequences have been determined, and the first CRISPR group with such a high number of PAM sequences. Cells could survive the plasmid challenge if their CRISPR/Cas system was altered or defective, e. g. by deletion of the cas gene cassette. Experimental PAM data were supplemented with bioinformatics data on Haloferax and Haloquadratum.	[Fischer, Susan; Maier, Lisa-Katharina; Stoll, Britta; Brendel, Jutta; Fischer, Eike; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Pfeiffer, Friedhelm] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Dyall-Smith, Mike] Charles Sturt Univ, Sch Biomed Sci, Sydney, NSW 2678, Australia	Ulm University; Max Planck Society; Charles Sturt University	Marchfelder, A (corresponding author), Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft in the frame of Research Group 1680, "Unravelling the prokaryotic immune system."	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Burns DG, 2004, APPL ENVIRON MICROB, V70, P5258, DOI 10.1128/AEM.70.9.5258-5265.2004; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dyall-Smith M. L., 2008, HALOHANDBOOK; Dyall-Smith ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020968; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Greve Bo, 2004, Archaea, V1, P231, DOI 10.1155/2004/151926; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nieuwlandt D. T., 1995, P161; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Sambrook J, 2001, MOL CLONING LAB MANU, P633; Santos F, 2010, ENVIRON MICROBIOL, V12, P2965, DOI 10.1111/j.1462-2920.2010.02273.x; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	49	85	109	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33351	33363		10.1074/jbc.M112.377002	http://dx.doi.org/10.1074/jbc.M112.377002			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22767603	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000309602100023
J	Miyajima, D; Hayata, T; Suzuki, T; Hemmi, H; Nakamoto, T; Notomi, T; Amagasa, T; Bottcher, RT; Costell, M; Fassler, R; Ezura, Y; Noda, M				Miyajima, Daisuke; Hayata, Tadayoshi; Suzuki, Takafumi; Hemmi, Hiroaki; Nakamoto, Tetsuya; Notomi, Takuya; Amagasa, Teruo; Boettcher, Ralph T.; Costell, Mercedes; Faessler, Reinhard; Ezura, Yoichi; Noda, Masaki			Profilin1 Regulates Sternum Development and Endochondral Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; CELL-DIVISION; MICE LACKING; CHONDROCYTES; EXPRESSION; MOUSE; CARTILAGE; GROWTH; PROLIFERATION	Bone development is a dynamic process that requires cell motility and morphological adaptation under the control of actin cytoskeleton. This actin cytoskeleton system is regulated by critical modulators including actin-binding proteins. Among them, profilin1 (Pfn1) is a key player to control actin fiber structure, and it is involved in a number of cellular activities such as migration. During the early phase of body development, skeletal stem cells and osteoblastic progenitor cells migrate to form initial rudiments for future skeletons. During this migration, these cells extend their process based on actin cytoskeletal rearrangement to locate themselves in an appropriate location within microenvironment. However, the role of Pfn1 in regulation of mesenchymal progenitor cells (MPCs) during skeletal development is incompletely understood. Here we examined the role of Pfn1 in skeletal development using a genetic ablation of Pfn1 in MPCs by using Prx1-Cre recombinase. We found that Pfn1 deficiency in MPCs caused complete cleft sternum. Notably, Pfn1-deficient mice exhibited an absence of trabecular bone in the marrow space of appendicular long bone. This phenotype is location-specific, as Pfn1 deficiency did not largely affect osteoblasts in cortical bone. Pfn1 deficiency also suppressed longitudinal growth of long bone. In vitro, Pfn1 deficiency induced retardation of osteoblastic cell migration. These observations revealed that Pfn1 is a critical molecule for the skeletal development, and this could be at least in part associated with the retardation of cell migration	[Hayata, Tadayoshi; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Miyajima, Daisuke; Suzuki, Takafumi; Nakamoto, Tetsuya; Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Tokyo 1138510, Japan; [Miyajima, Daisuke; Amagasa, Teruo] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Tokyo 1138510, Japan; [Boettcher, Ralph T.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Costell, Mercedes] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Valencia, Spain	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Max Planck Society; University of Valencia	Hayata, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 5-45 Yushima 1 Chome, Tokyo 1138510, Japan.	thayata.mph@mri.tmd.ac.jp; ezura.mph@mri.tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Hayata, Tadayoshi/AAE-9712-2021; Costell, Mercedes/H-7850-2015; Ezura, Yoichi/L-9485-2016	Costell, Mercedes/0000-0001-6146-996X; 	Grants-in-Aid for Scientific Research [22591680] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; CHEN JM, 1952, J ANAT, V86, P373; CHEN JM, 1952, J ANAT, V86, P387; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawaguchi J, 2002, BIOTECHNIQUES, V32, P66, DOI 10.2144/02321st02; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Modder UI, 2008, J CELL BIOCHEM, V103, P393, DOI 10.1002/jcb.21423; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Roach HI, 1996, CONNECT TISSUE RES, V35, P85, DOI 10.3109/03008209609029178; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Torre M, 2012, EUR J CARDIO-THORAC, V41, P4, DOI 10.1016/j.ejcts.2011.05.049; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YANG F, 1991, BONE, V12, P7, DOI 10.1016/8756-3282(91)90048-N	36	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33545	33553		10.1074/jbc.M111.329938	http://dx.doi.org/10.1074/jbc.M111.329938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22773831	Green Published, hybrid			2022-12-28	WOS:000309602100040
J	Bugg, CW; Isas, JM; Fischer, T; Patterson, PH; Langen, R				Bugg, Charles W.; Isas, J. Mario; Fischer, Torsten; Patterson, Paul H.; Langen, Ralf			Structural Features and Domain Organization of Huntingtin Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BETA-SHEET STRUCTURE; IN-VITRO; POLYGLUTAMINE AGGREGATION; INTRANUCLEAR INCLUSIONS; EXPANDED GLUTAMINE; MUTANT HUNTINGTIN; ALPHA-SYNUCLEIN; CAG REPEAT	Misfolding and aggregation of huntingtin is one of the hallmarks of Huntington disease, but the overall structure of these aggregates and the mechanisms by which huntingtin misfolds remain poorly understood. Here we used site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy to study the structural features of huntingtin exon 1 (HDx1) containing 46 glutamine residues in its polyglutamine ( polyQ) region. Despite some residual structuring in the N terminus, we find that soluble HDx1 is highly dynamic. Upon aggregation, the polyQ domain becomes strongly immobilized indicating significant tertiary or quaternary packing interactions. Analysis of spin-spin interactions does not show the close contact between same residues that is characteristic of the parallel, in-register structure commonly found in amyloids. Nevertheless, the same residues are still within 20 angstrom of each other, suggesting that polyQ domains from different molecules come into proximity in the fibrils. The N terminus has previously been found to take up a helical structure in fibrils. We find that this domain not only becomes structured, but that it also engages in tertiary or quaternary packing interactions. The existence of spin-spin interactions in this region suggests that such contacts could be made between N-terminal domains from different molecules. In contrast, the C-terminal domain is dynamic, contains polyproline II structure, and lacks pronounced packing interactions. This region must be facing away from the core of the fibrils. Collectively, these data provide new constraints for building structural models of HDx1 fibrils.	[Isas, J. Mario; Fischer, Torsten; Langen, Ralf] Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90089 USA; [Bugg, Charles W.; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Southern California; California Institute of Technology	Langen, R (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Keck Sch Med, 1501 San Pablo St,ZNI 119, Los Angeles, CA 90089 USA.	langen@usc.edu			National Institutes of Health through NINDS; Hereditary Disease Foundation	National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation	This work was supported, in whole or in part, by a grant from the National Institutes of Health through the NINDS (to P. H. P.). This work was also supported by grants from the Hereditary Disease Foundation (to R. L. and P. H. P.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Woody R. W., 1992, ADV BIOPHYS CHEM, V2, P37; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	59	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31739	31746		10.1074/jbc.M112.353839	http://dx.doi.org/10.1074/jbc.M112.353839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22801429	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000309059400015
J	Shteingart, S; Hadar, R; Cohen, I; Ravid, T; Tirosh, B				Shteingart, Shimon; Hadar, Rivka; Cohen, Itamar; Ravid, Tommer; Tirosh, Boaz			Endoplasmic Reticulum Stress Induces a Caspase-dependent N-terminal Cleavage of RBX1 Protein in B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; TRANSCRIPTION FACTOR XBP-1; ER-ASSOCIATED DEGRADATION; CULLIN-RING LIGASES; MYELOMA CELLS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL INSIGHTS; NLRP3 INFLAMMASOME; IFN-GAMMA; DIFFERENTIATION	Endoplasmic reticulum (ER) stress develops when the ER is overloaded with too many proteins to fold. This elicits a signaling pathway called the unfolded protein response. The unfolded protein response is physiologically required for the terminal development of B cells into antibody-secreting plasma cells. Ring Box Protein 1 (RBX1) is a 14-kDa protein necessary for ubiquitin ligation activity of the multimeric cullin ring ubiquitin ligases (CRLs). As RBX1 is shared by a large number of CRLs, alterations in its activity may lead to global changes in protein stability. We discovered that RBX1 is cleaved in the course of LPS-induced plasma cell differentiation and in multiple myeloma cell lines upon induction of pharmacological ER stress. The cleavage is executed by several caspase proteases that cleave RBX1 eight amino acids from the N terminus. To address the possible implication of RBX1 cleavage for CRL activity, we replaced the endogenous RBX1 homolog of the yeast Saccharomyces cerevisiae, Roc1, with the wild type or the N-terminal Delta 8 mutant human RBX1. We show that yeast expressing the cleaved RBX1 are hypersensitive to ER stress and are impaired in CRL-mediated ubiquitination and degradation. We propose a model by which N-terminal cleavage of RBX1 impairs its activity and promotes susceptibility to ER stress induction.	[Cohen, Itamar; Ravid, Tommer] Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Shteingart, Shimon; Hadar, Rivka; Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, T (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel.	travid@cc.huji.ac.il; boazt@ekmd.huji.ac.il		Shteingart, Shimon/0000-0002-3975-0138	David R. Bloom Center for Pharmacy; Rosetrees Trust; Israel Cancer Association; Israel Science Foundation [78/09, 786/08]	David R. Bloom Center for Pharmacy; Rosetrees Trust(Rosetrees Trust); Israel Cancer Association; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the David R. Bloom Center for Pharmacy, the Rosetrees Trust, Israel Cancer Association, and Israel Science Foundation Grants 78/09 (to B. T.) and Grant 786/08 (to T. R.).	Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; COZZOLINO F, 1989, BLOOD, V74, P380; Duan HJ, 1999, MOL CELL BIOL, V19, P3145; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Gu QY, 2007, CANCER RES, V67, P3616, DOI 10.1158/0008-5472.CAN-06-4020; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hassan G, 1997, J HEPATOL, V27, P6, DOI 10.1016/S0168-8278(97)80273-5; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KRONHEIM SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P698, DOI 10.1016/0003-9861(92)90629-B; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Obermeier F, 1999, J LEUKOCYTE BIOL, V66, P829, DOI 10.1002/jlb.66.5.829; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai Yien Che, 2010, Genes Cancer, V1, P764; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Wei Dongping, 2010, Genes Cancer, V1, P700, DOI 10.1177/1947601910382776; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	50	0	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31223	31232		10.1074/jbc.M111.314583	http://dx.doi.org/10.1074/jbc.M111.314583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22822056	Green Published, hybrid			2022-12-28	WOS:000308791300035
J	Combeau, G; Kreis, P; Domenichini, F; Amar, M; Fossier, P; Rousseau, V; Barnier, JV				Combeau, Gaelle; Kreis, Patricia; Domenichini, Florence; Amar, Muriel; Fossier, Philippe; Rousseau, Veronique; Barnier, Jean-Vianney			The p21-activated Kinase PAK3 Forms Heterodimers with PAK1 in Brain Implementing Trans-regulation of PAK3 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; MENTAL-RETARDATION; MISSENSE MUTATION; NERVE-TERMINALS; SPLICE VARIANTS; PROTEIN-KINASE; ACTIVATION; PATHWAY; MECHANISM; CDC42	p21-activated kinase 1 (PAK1) and PAK3 belong to group I of the PAK family and control cell movement and division. They also regulate dendritic spine formation and maturation in the brain, and play a role in synaptic transmission and synaptic plasticity. PAK3, in particular, is known for its implication in X-linked intellectual disability. The pak3 gene is expressed in neurons as a GTPase-regulated PAK3a protein and also as three splice variants which display constitutive kinase activity. PAK1 regulation is based on its homodimerization, forming an inactive complex. Here, we analyze the PAK3 capacity to dimerize and show that although PAK3a is able to homodimerize, it is more likely to form heterodimeric complexes with PAK1. We further show that two intellectual disability mutations impair dimerization with PAK1. The b and c inserts present in the regulatory domain of PAK3 splice variants decrease the dimerization but retain the capacity to form heterodimers with PAK1. PAK1 and PAK3 are co-expressed in neurons, are colocalized within dendritic spines, co-purify with post-synaptic densities, and co-immunoprecipitate in brain lysates. Using kinase assays, we demonstrate that PAK1 inhibits the activity of PAK3a but not of the splice variant PAK3b in a trans-regulatory manner. Altogether, these results show that PAK3 and PAK1 signaling may be coordinated by heterodimerization.	[Barnier, Jean-Vianney] Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, F-91405 Orsay, France; CNRS, UMR 8195, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Barnier, JV (corresponding author), Univ Paris 11, Ctr Neurosci Paris Sud, UMR 8195, Bat 444, F-91405 Orsay, France.	vianney.barnier@u-psud.fr	Kreis, Patricia/GYJ-3521-2022	Kreis, Patricia/0000-0002-1702-4805	Agence Nationale de la Recherche [ANR-MNP-2009]; Fondation Jerome Lejeune	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Jerome Lejeune	This work was supported in part by a grant from the Agence Nationale de la Recherche (ANR-MNP-2009) and the Fondation Jerome Lejeune.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Dubos A, 2012, J NEUROSCI, V32, P519, DOI 10.1523/JNEUROSCI.3252-11.2012; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Gedeon AK, 2003, AM J MED GENET A, V120A, P509, DOI 10.1002/ajmg.a.20131; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Poea-Guyon S, 2006, J BIOL CHEM, V281, P17164, DOI 10.1074/jbc.M600927200; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rousseau V, 2003, J BIOL CHEM, V278, P3912, DOI 10.1074/jbc.M207251200; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Thevenot E, 2011, J BIOL CHEM, V286, P40044, DOI 10.1074/jbc.M111.262246; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang J, 2011, STRUCTURE, V19, P1752, DOI 10.1016/j.str.2011.10.013; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Yatime L, 2011, J MOL BIOL, V411, P486, DOI 10.1016/j.jmb.2011.06.017; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	41	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30084	30096		10.1074/jbc.M112.355073	http://dx.doi.org/10.1074/jbc.M112.355073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22815483	Green Published, hybrid			2022-12-28	WOS:000308579800004
J	Komori, H; Watanabe, H; Shuto, T; Kodama, A; Maeda, H; Watanabe, K; Kai, H; Otagiri, M; Maruyama, T				Komori, Hisakazu; Watanabe, Hiroshi; Shuto, Tsuyoshi; Kodama, Azusa; Maeda, Hitoshi; Watanabe, Kenji; Kai, Hirofumi; Otagiri, Masaki; Maruyama, Toru			alpha(1)-Acid Glycoprotein Up-regulates CD163 via TLR4/CD14 Protein Pathway POSSIBLE PROTECTION AGAINST HEMOLYSIS-INDUCED OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTOR; ACUTE-PHASE PROTEINS; TOLL-LIKE RECEPTORS; HUMAN MONOCYTES; ALPHA-1-ACID GLYCOPROTEIN; DIFFERENTIATION ANTIGEN; HEMOGLOBIN; ACTIVATION; INDUCTION; BINDING	CD163, a scavenger receptor that is expressed at high levels in the monocyte-macrophage system, is a critical factor for the efficient extracellular hemoglobin (Hb) clearance during hemolysis. Because of the enormous detrimental effect of liberated Hb on our body by its ability to induce pro-inflammatory signals and tissue damage, an understanding of the molecular mechanisms associated with CD163 expression during the acute phase response is a central issue. We report here that alpha(1)-acid glycoprotein (AGP), an acute phase protein, the serum concentration of which is elevated under various inflammatory conditions, including hemolysis, up-regulates CD163 expression in both macrophage-like differentiated THP-1 (dTHP-1) cells and peripheral blood mononuclear cells in a time- and concentration-dependent manner. Moreover, the subsequent induction of Hb uptake was also observed in AGP-treated dTHP-1 cells. Among representative acute phase proteins such as AGP, alpha(1)-antitrypsin, C-reactive protein, and haptoglobin, only AGP increased CD163 expression, suggesting that AGP plays a specific role in the regulation of CD163. Consistently, the physiological concentrations of AGP induced CD163, and the subsequent induction of Hb uptake as well as the reduction of oxidative stress in plasma were observed in phenylhydrazine-induced hemolytic model mice, confirming the in vivo role of AGP. Finally, AGP signaling through the toll-like receptor-4 (TLR4) and CD14, the common innate immune receptor complex that normally recognizes bacterial components, was identified as a crucial stimulus that induces the autocrine regulatory loops of IL-6 and/or IL-10 via NF-kappa B, p38, and JNK pathways, which leads to an enhancement in CD163 expression. These findings provide possible insights into how AGP exerts anti-inflammatory properties against hemolysis-induced oxidative stress.	[Otagiri, Masaki; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Shuto, Tsuyoshi; Watanabe, Kenji; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Komori, Hisakazu] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028471, Japan; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600822, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Japan Society for the Promotion of Science; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@kumamoto-u.ac.jp	Komori, Hisakazu/AAQ-2590-2020		Japan Society for the Promotion of Science [20390161, 23458100]; Grants-in-Aid for Scientific Research [24659076] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-aid for Scientific Research 20390161 and 23458100 from Japan Society for the Promotion of Science.	Barrabes S, 2010, ELECTROPHORESIS, V31, P2903, DOI 10.1002/elps.200900764; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Grinshtein N, 2003, BIOCHEMISTRY-US, V42, P6977, DOI 10.1021/bi020647r; HARALDSSON B, 1987, ACTA PHYSIOL SCAND, V129, P127, DOI 10.1111/j.1748-1716.1987.tb08047.x; HARALDSSON BS, 1992, KIDNEY INT, V41, P310, DOI 10.1038/ki.1992.43; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kagaya N, 2005, J BIOSCI BIOENG, V99, P81, DOI 10.1263/jbb.99.81; Kato GJ, 2009, J CLIN INVEST, V119, P2140, DOI 10.1172/JCI40258; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuzuhara H, 2006, EUR J PHARMACOL, V541, P205, DOI 10.1016/j.ejphar.2006.05.003; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Maru Y, 2009, CANCER SCI, V100, P2006, DOI 10.1111/j.1349-7006.2009.01300.x; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pioli PA, 2004, J LEUKOCYTE BIOL, V76, P500, DOI 10.1189/jlb.1203617; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ritter M, 1999, BIOCHEM BIOPH RES CO, V260, P466, DOI 10.1006/bbrc.1999.0866; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; SCHMID K, 1973, BIOCHEMISTRY-US, V12, P2711, DOI 10.1021/bi00738a026; SCHNITZER JE, 1992, AM J PHYSIOL, V263, pH48, DOI 10.1152/ajpheart.1992.263.1.H48; Schroder NWJ, 2008, IMMUNOBIOLOGY, V213, P329, DOI 10.1016/j.imbio.2007.11.003; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; SHNYRA A, 1995, INFECT IMMUN, V63, P865, DOI 10.1128/IAI.63.3.865-873.1995; Su SJ, 1999, IMMUNOPHARMACOLOGY, V41, P21, DOI 10.1016/S0162-3109(98)00048-4; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; TILG H, 1993, J EXP MED, V178, P1629, DOI 10.1084/jem.178.5.1629; Vallelian F, 2010, BLOOD, V116, P5347, DOI 10.1182/blood-2010-04-277319; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Van Molle W, 1999, J IMMUNOL, V163, P5235; VanMolle W, 1997, J IMMUNOL, V159, P3555; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Williams L, 2002, J LEUKOCYTE BIOL, V72, P800; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	49	34	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30688	30700		10.1074/jbc.M112.353771	http://dx.doi.org/10.1074/jbc.M112.353771			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807450	Green Published, hybrid			2022-12-28	WOS:000308579800058
J	Li, Z; Chen, JH; Hao, Y; Nair, SK				Li, Zhi; Chen, Jui-Hui; Hao, Yue; Nair, Satish K.			Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; DEPENDENT CONFORMATIONAL-CHANGE; HD-GYP DOMAIN; GAF-A DOMAIN; CGMP BINDING; PILZ DOMAIN; PHOSPHODIESTERASE 2A; RESPONSE REGULATOR; BIOFILM FORMATION; ESCHERICHIA-COLI	The second messenger bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) plays a vital role in the global regulation in bacteria. Here, we describe structural and biochemical characterization of a novel c-di-GMP effector PelD that is critical to the formation of pellicles by Pseudomonas aeruginosa. We present high-resolution structures of a cytosolic fragment of PelD in apo form and its complex with c-di-GMP. The structure contains a bi-domain architecture composed of a GAF domain (commonly found in cyclic nucleotide receptors) and a GGDEF domain (found in c-di-GMP synthesizing enzymes), with the latter binding to one molecule of c-di-GMP. The GGDEF domain has a degenerate active site but a conserved allosteric site (I-site), which we show binds c-di-GMP with a K-d of 0.5 mu M. We identified a series of residues that are crucial for c-di-GMP binding, and confirmed the roles of these residues through biochemical characterization of site-specific variants. The structures of PelD represent a novel class of c-di-GMP effector and expand the knowledge of scaffolds that mediate c-di-GMP recognition.	[Li, Zhi; Chen, Jui-Hui; Hao, Yue; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 427 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.	snair@illinois.edu	Hao, Yue/O-6107-2019; Hao, Yue/AAA-3530-2022; Nair, Satish/AAY-2510-2021; Li, Zhi/B-4303-2015	Hao, Yue/0000-0003-0943-0499; Li, Zhi/0000-0003-0738-6033	Department of Biochemistry	Department of Biochemistry	Supported in part by a Kade fellowship from the Department of Biochemistry.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; BLACK RA, 1980, P NATL ACAD SCI-BIOL, V77, P3879, DOI 10.1073/pnas.77.7.3879; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chappie TA, 2007, J MED CHEM, V50, P182, DOI 10.1021/jm060653b; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Gruez A, 2010, J BIOL CHEM, V285, P25033, DOI 10.1074/jbc.M110.134528; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Li TN, 2009, PROTEINS, V75, P282, DOI 10.1002/prot.22330; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Smith KD, 2011, P NATL ACAD SCI USA, V108, P7757, DOI 10.1073/pnas.1018857108; Smith KD, 2010, BIOCHEMISTRY-US, V49, P7351, DOI 10.1021/bi100671e; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vasseur P, 2007, BIOCHIMIE, V89, P903, DOI 10.1016/j.biochi.2007.04.002; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wang HC, 2010, J BIOL CHEM, V285, P38149, DOI 10.1074/jbc.M110.141614; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	91	33	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30191	30204		10.1074/jbc.M112.378273	http://dx.doi.org/10.1074/jbc.M112.378273			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22810222	Green Published, hybrid			2022-12-28	WOS:000308579800014
J	Magnacca, A; Persiconi, I; Nurzia, E; Caristi, S; Meloni, F; Barnaba, V; Paladini, F; Raimondo, D; Fiorillo, MT; Sorrentino, R				Magnacca, Adriana; Persiconi, Irene; Nurzia, Elisa; Caristi, Silvana; Meloni, Francesca; Barnaba, Vincenzo; Paladini, Fabiana; Raimondo, Domenico; Fiorillo, Maria Teresa; Sorrentino, Rosa			Characterization of a Proteasome and TAP-independent Presentation of Intracellular Epitopes by HLA-B27 Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA CLASS-I; TRANS-GOLGI NETWORK; T-CELL RECOGNITION; ANKYLOSING-SPONDYLITIS; SELF-PEPTIDE; SUBTYPES; SUSCEPTIBILITY; RESIDUE; HLA-B-ASTERISK-2705; MECHANISM	Nascent HLA-class I molecules are stabilized by proteasome-derived peptides in the ER and the new complexes proceed to the cell surface through the post-ER vesicles. It has been shown, however, that less stable complexes can exchange peptides in the Trans Golgi Network (TGN). HLA-B27 are the most studied HLA-class I molecules due to their association with Ankylosing Spondylitis (AS). Chimeric proteins driven by TAT of HIV have been exploited by us to deliver viral epitopes, whose cross-presentation by the HLA-B27 molecules was proteasome and TAP-independent and not restricted to Antigen-Presenting Cells (APC). Here, using these chimeric proteins as epitope suppliers, we compared with each other and with the HLA-A2 molecules, the two HLA-B*2705 and B*2709 alleles differing at residue 116 (D116H) and differentially associated with AS. We found that the antigen presentation by the two HLA-B27 molecules was proteasome-, TAP-, and APC-independent whereas the presentation by the HLA-A2 molecules required proteasome, TAP and professional APC. Assuming that such difference could be due to the unpaired, highly reactive Cys-67 distinguishing the HLA-B27 molecules, C67S mutants in HLA-B*2705 and B*2709 and V67C mutant in HLA-A*0201 were also analyzed. The results showed that this mutation did not influence the HLA-A2-restricted antigen presentation while it drastically affected the HLA-B27-restricted presentation with, however, remarkable differences between B*2705 and B*2709. The data, together with the occurrence on the cell surface of unfolded molecules in the case of C67S-B*2705 mutant but not in that of C67SB*2709 mutant, indicates that Cys-67 has a more critical role in stabilizing the B*2705 rather than the B*2709 complexes.	[Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Meloni, Francesca; Barnaba, Vincenzo] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Raimondo, Domenico] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Sorrentino, R (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, Via Sardi 70, I-00185 Rome, Italy.	rosa.sorrentino@uniroma1.it	Barnaba, Vincenzo/AAB-1945-2019; Sorrentino, Rosa/G-5472-2012; raimondo, domenico/J-1704-2012	Sorrentino, Rosa/0000-0002-9632-2383; PERSICONI, IRENE/0000-0002-2924-7256; Paladini, Fabiana/0000-0003-1040-452X; FIORILLO, Maria Teresa/0000-0002-6859-5851; raimondo, domenico/0000-0002-1780-7295; caristi, silvana/0000-0002-0016-7498	Italian Ministry of Education, University and Research (MIUR) through PRIN [2008C33HRL-004]; Istituto Pasteur-Fondazione Cenci Bolognetti; King Abdullah University of Science and Technology (KAUST) Fondazione Roma [KUK-11-012-43]; Sapienza through Progetti di Ateneo [C26A10CT9F]	Italian Ministry of Education, University and Research (MIUR) through PRIN(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); King Abdullah University of Science and Technology (KAUST) Fondazione Roma; Sapienza through Progetti di Ateneo	This work was supported by the Italian Ministry of Education, University and Research (MIUR) through PRIN (grant no2008C33HRL-004), by the Istituto Pasteur-Fondazione Cenci Bolognetti, King Abdullah University of Science and Technology (KAUST) (Award No. KUK-11-012-43) Fondazione Roma and by Sapienza through Progetti di Ateneo (Grant noC26A10CT9F).	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Alvarez I, 2001, J BIOL CHEM, V276, P48740, DOI 10.1074/jbc.M108882200; Appel H, 2004, J IMMUNOL, V173, P6564, DOI 10.4049/jimmunol.173.11.6564; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Bettosini F, 2005, J VIROL, V79, P15537, DOI 10.1128/JVI.79.24.15537-15546.2005; Blanco-Gelaz MA, 2001, HUM IMMUNOL, V62, P1042, DOI 10.1016/S0198-8859(01)00299-3; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Campbell EC, 2012, IMMUNOLOGY, V136, P380, DOI 10.1111/j.1365-2567.2012.03593.x; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Fiorillo MT, 1997, EUR J IMMUNOL, V27, P368, DOI 10.1002/eji.1830270205; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 1998, EUR J IMMUNOL, V28, P2508, DOI 10.1002/(SICI)1521-4141(199808)28:08<2508::AID-IMMU2508>3.0.CO;2-1; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Garcia-Fernandez S, 2001, TISSUE ANTIGENS, V58, P259, DOI 10.1034/j.1399-0039.2001.580407.x; Hendel H, 1999, J IMMUNOL, V162, P6942; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Mear JP, 1999, J IMMUNOL, V163, P6665; Montserrat V, 2003, J IMMUNOL, V170, P5778, DOI 10.4049/jimmunol.170.11.5778; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nurzia E, 2010, CLIN IMMUNOL, V135, P476, DOI 10.1016/j.clim.2010.01.009; Paladini F, 2005, ARTHRITIS RHEUM-US, V52, P3319, DOI 10.1002/art.21308; Propato A, 2001, NAT MED, V7, P807, DOI 10.1038/89930; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Santos SG, 2006, J IMMUNOL, V176, P2942, DOI 10.4049/jimmunol.176.5.2942; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Taurog JD, 2009, ADV EXP MED BIOL, V649, P245; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	43	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30358	30367		10.1074/jbc.M112.384339	http://dx.doi.org/10.1074/jbc.M112.384339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807446	hybrid, Green Published			2022-12-28	WOS:000308579800028
J	Puts, CF; Panatala, R; Hennrich, H; Tsareva, A; Williamson, P; Holthuis, JCM				Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Tsareva, Alina; Williamson, Patrick; Holthuis, Joost C. M.			Mapping Functional Interactions in a Heterodimeric Phospholipid Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSPORT; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; CDC50 PROTEINS; YEAST; TRANSLOCATION; ASYMMETRY; ROLES	Type 4 P-type ATPases (P-4-ATPases) catalyze phospholipid transport to generate phospholipid asymmetry across membranes of late secretory and endocytic compartments, but their kinship to cation-transporting P-type transporters raised doubts about whether P-4-ATPases alone are sufficient to mediate flippase activity. P-4-ATPases form heteromeric complexes with Cdc50 proteins. Studies of the enzymatic properties of purified P-4-ATPase.Cdc50 complexes showed that catalytic activity depends on direct and specific interactions between Cdc50 subunit and transporter, whereas in vivo interaction assays suggested that the binding affinity for each other fluctuates during the transport reaction cycle. The structural determinants that govern this dynamic association remain to be established. Using domain swapping, site-directed, and random mutagenesis approaches, we here show that residues throughout the subunit contribute to forming the heterodimer. Moreover, we find that a precise conformation of the large ectodomain of Cdc50 proteins is crucial for the specificity and functionality to transporter/subunit interactions. We also identified two highly conserved disulfide bridges in the Cdc50 ectodomain. Functional analysis of cysteine mutants that disrupt these disulfide bridges revealed an inverse relationship between subunit binding and P-4-ATPase-catalyzed phospholipid transport. Collectively, our data indicate that a dynamic association between subunit and transporter is crucial for the transport reaction cycle of the heterodimer.	[Holthuis, Joost C. M.] Univ Osnabruck, Mol Cell Biol Div, D-49076 Osnabruck, Germany; [Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Holthuis, Joost C. M.] Univ Utrecht, Bijvoet Ctr, Dept Membrane Enzymol, NL-3508 TC Utrecht, Netherlands; [Puts, Catheleyne F.; Panatala, Radhakrishnan; Hennrich, Hanka; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3508 TC Utrecht, Netherlands; [Tsareva, Alina; Williamson, Patrick] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	University Osnabruck; Utrecht University; Utrecht University; Amherst College	Holthuis, JCM (corresponding author), Univ Osnabruck, Mol Cell Biol Div, Barbarastr 13, D-49076 Osnabruck, Germany.	holthuis@uos.de	Holthuis, Joost/AAL-9157-2020; Panatala, Radhakrishnan/AAH-7284-2021	Panatala, Radhakrishnan/0000-0003-3663-8236; Holthuis, Joost/0000-0001-8912-1586	European Union; Dutch Organization of Sciences (NWO-CW); Utrecht High Potential Program; National Science Foundation	European Union(European Commission); Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht High Potential Program; National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the European Union Framework V Program (the Flippase Project), the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. C. M. H.), and the National Science Foundation (to P. W.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Grefen C., 2007, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0527S41; Hanson PJ, 2003, ECOL STUD-ANAL SYNTH, V166, P3; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	36	26	26	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30529	30540		10.1074/jbc.M112.371088	http://dx.doi.org/10.1074/jbc.M112.371088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791719	Green Published, hybrid			2022-12-28	WOS:000308579800045
J	Jung, HM; Phillips, BL; Patel, RS; Cohen, DM; Jakymiw, A; Kong, WW; Cheng, JQ; Chan, EKL				Jung, Hyun Min; Phillips, Brittany L.; Patel, Rushi S.; Cohen, Donald M.; Jakymiw, Andrew; Kong, William W.; Cheng, Jin Q.; Chan, Edward K. L.			Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; HUMAN BREAST-CANCER; PROGNOSTIC INDICATOR; MICRORNA EXPRESSION; GENE-EXPRESSION; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; GASTRIC-CANCER	MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression during many biological processes. Recently, the aberrant expressions of miRNAs have become a major focus in cancer research. The purpose of this study was to identify deregulated miRNAs in oral cancer and further focus on specific miRNAs that were related to patient survival. Here, we report that miRNA expression profiling provided more precise information when oral squamous cell carcinomas were subcategorized on the basis of clinicopathological parameters (tumor primary site, histological subtype, tumor stage, and HPV16 status). An innovative radar chart analysis method was developed to depict subcategories of cancers taking into consideration the expression patterns of multiple miRNAs combined with the clinicopathological parameters. Keratinization of tumors and the high expression of miR-21 were the major factors related to the poor prognosis of patients. Interestingly, a majority of the keratinized tumors expressed high levels of miR-21. Further investigations demonstrated the regulation of the tumor suppressor gene reversion-inducing cysteine-rich protein with kazal motifs (RECK) by two keratinization-associated miRNAs, miR-7 and miR-21. Transfection of miR-7 and miR-21-mimics reduced the expression of RECK through direct miRNA-mediated regulation, and these miRNAs were inversely correlated with RECK in CAL 27 orthotopic xenograft tumors. Furthermore, a similar inverse correlation was demonstrated in CAL 27 cells treated in vitro by different external stimuli such as trypsinization, cell density, and serum concentration. Taken together, our data show that keratinization is associated with poor prognosis of oral cancer patients and keratinization-associated miRNAs mediate deregulation of RECK which may contribute to the aggressiveness of tumors.	[Jung, Hyun Min; Phillips, Brittany L.; Patel, Rushi S.; Jakymiw, Andrew; Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Coll Dent, Gainesville, FL 32610 USA; [Cohen, Donald M.] Univ Florida, Dept Oral & Maxillofacial Diagnost Sci, Coll Dent, Gainesville, FL 32610 USA; [Kong, William W.; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chan, EKL (corresponding author), Univ Florida, Dept Oral Biol, Coll Dent, POB 100424, Gainesville, FL 32610 USA.	echan@ufl.edu	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503; Jakymiw, Andrew/0000-0001-6431-8753	UF/Moffitt Collaborative Initiative; National Institute of Dental and Craniofacial Research [K99DE018191, T32 DE007200]; alumni graduate fellowship; Andrew J. Semesco Foundation, Ocala, FL; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE018191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200, K99DE018191] Funding Source: NIH RePORTER	UF/Moffitt Collaborative Initiative; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); alumni graduate fellowship; Andrew J. Semesco Foundation, Ocala, FL; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by a UF/Moffitt Collaborative Initiative grant (to E. K. L. C. and J. Q. C.). This work was also supported by National Institute of Dental and Craniofacial Research Grants K99DE018191 (to A. J.) and T32 DE007200 (to R. P.), by an alumni graduate fellowship (to H. M. J.), and by the Andrew J. Semesco Foundation, Ocala, FL.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Casiglia Jeffrey, 2001, General Dentistry, V49, P72; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Cattani P, 2009, J CLIN MICROBIOL, V47, P2136, DOI 10.1128/JCM.01733-08; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furumoto K, 2001, HEPATOLOGY, V33, P189, DOI 10.1053/jhep.2001.21048; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; GIMENEZCONTI IB, 1990, CANCER RES, V50, P4441; Hatta M, 2009, CELL SIGNAL, V21, P1885, DOI 10.1016/j.cellsig.2009.08.005; Hiratsuka H, 1997, CANCER, V80, P351; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kobayashi T, 2001, EMBO REP, V2, P604, DOI 10.1093/embo-reports/kve129; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li SQ, 2008, J CELL SCI, V121, P4134, DOI 10.1242/jcs.036905; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lin WH, 2011, LARYNGOSCOPE, V121, P971, DOI 10.1002/lary.21721; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Masui T, 2003, CLIN CANCER RES, V9, P1779; Mendez E, 2009, CLIN CANCER RES, V15, P1353, DOI 10.1158/1078-0432.CCR-08-1816; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Nagini S, 2009, ORAL ONCOL, V45, pE31, DOI 10.1016/j.oraloncology.2009.01.006; Namwat N, 2011, J GASTROENTEROL, V46, P664, DOI 10.1007/s00535-010-0345-y; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; REDDY SP, 1995, AM J OTOLARYNG, V16, P103, DOI 10.1016/0196-0709(95)90040-3; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Schantz SP, 2002, ARCH OTOLARYNGOL, V128, P268, DOI 10.1001/archotol.128.3.268; Scully C, 2006, BRIT DENT J, V200, P13, DOI 10.1038/sj.bdj.4813117; Shiboski CH, 2000, COMMUNITY DENT ORAL, V28, P249, DOI 10.1034/j.1600-0528.2000.280402.x; Song SY, 2006, EUR J CANCER, V42, P101, DOI 10.1016/j.ejca.2005.09.016; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Take Y, 1999, BRIT J ORAL MAX SURG, V37, P29, DOI 10.1054/bjom.1998.0271; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhao X., 2012, ONCOGENE IN PRESS	55	70	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29261	29272		10.1074/jbc.M112.366518	http://dx.doi.org/10.1074/jbc.M112.366518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761427	Green Published, hybrid			2022-12-28	WOS:000308286900006
J	Lameu, C; Trujillo, CA; Schwindt, TT; Negraes, PD; Pillat, MM; Morais, KLP; Lebrun, I; Ulrich, H				Lameu, Claudiana; Trujillo, Cleber A.; Schwindt, Telma T.; Negraes, Priscilla D.; Pillat, Micheli M.; Morais, Katia L. P.; Lebrun, Ivo; Ulrich, Henning			Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ARGININOSUCCINATE SYNTHETASE; S-NITROSYLATION; GENE-EXPRESSION; RAT-BRAIN; IN-VITRO; INCREASES PROLIFERATION; RECEPTOR EXPRESSION; PROTEIN EXPRESSION; PRECURSOR CELLS	The diffusible messenger NO plays multiple roles in neuroprotection, neurodegeneration, and brain plasticity. Argininosuccinate synthase (AS) is a ubiquitous enzyme in mammals and the key enzyme of the NO-citrulline cycle, because it provides the substrate L-arginine for subsequent NO synthesis by inducible, endothelial, and neuronal NO synthase (NOS). Here, we provide evidence for the participation of AS and of the NO-citrulline cycle in the progress of differentiation of neural stem cells (NSC) into neurons, astrocytes, and oligodendrocytes. AS expression and activity and neuronal NOS expression, as well as L-arginine and NOx production, increased along neural differentiation, whereas endothelial NOS expression was augmented in conditions of chronic NOS inhibition during differentiation, indicating that this NOS isoform is amenable to modulation by extracellular cues. AS and NOS inhibition caused a delay in the progress of neural differentiation, as suggested by the decreased percentage of terminally differentiated cells. On the other hand, BDNF reversed the delay of neural differentiation of NSC caused by inhibition of NOx production. Alikely cause is the lack of NO, which up-regulated p75 neurotrophin receptor expression, a receptor required for BDNF-induced differentiation of NSC. We conclude that the NO-citrulline cycle acts together with BDNF for maintaining the progress of neural differentiation.	[Lameu, Claudiana; Trujillo, Cleber A.; Schwindt, Telma T.; Negraes, Priscilla D.; Pillat, Micheli M.; Ulrich, Henning] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508900 Sao Paulo, Brazil; [Morais, Katia L. P.; Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Ulrich, H (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.	henning@iq.usp.br	Lameu, Claudiana/B-9089-2012; Ulrich, Henning/AAX-8586-2021; Pillat, Micheli/AAW-3423-2020; Ulrich, Henning/C-5245-2013	Lameu, Claudiana/0000-0002-6874-5864; Ulrich, Henning/0000-0002-2114-3815; Pillat, Micheli/0000-0002-6753-6083; Ulrich, Henning/0000-0002-2114-3815; Morais, Katia/0000-0001-8877-5887	Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/61285-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 06/61285-9 and by funds from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (to H. U.).; Supported by fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.; Recipients of fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Foster JA, 2000, J COMP NEUROL, V427, P417, DOI 10.1002/1096-9861(20001120)427:3<417::AID-CNE8>3.0.CO;2-W; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Hosomi S, 2003, BIOCHEM BIOPH RES CO, V301, P1011, DOI 10.1016/S0006-291X(03)00077-9; Hsieh HY, 2010, J NEUROSCI RES, V88, P1285, DOI 10.1002/jnr.22291; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Inglis FM, 1998, J NEUROSCI, V18, P10493; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kim SJ, 2008, CELL RES, V18, P686, DOI 10.1038/cr.2008.48; Kumar A, 2006, MOL CELL BIOCHEM, V286, P43, DOI 10.1007/s11010-005-9083-5; Lameu C, 2010, HYPERTENS RES, V33, P1283, DOI 10.1038/hr.2010.208; Lameu Claudiana, 2009, Recent Pat CNS Drug Discov, V4, P137; Larsson E, 2002, EXP NEUROL, V177, P1, DOI 10.1006/exnr.2002.7992; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li TS, 2009, NEUROREPORT, V20, P295, DOI 10.1097/WNR.0b013e32832000c8; Li YF, 2006, ACTA PHARMACOL SIN, V27, P1395, DOI 10.1111/j.1745-7254.2006.00429.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moroz LL, 1999, J EXP BIOL, V202, P333; Northington Frances J., 1996, Developmental Brain Research, V95, P1, DOI 10.1016/0165-3806(96)00051-X; OLMOS G, 1994, BRIT J PHARMACOL, V111, P997, DOI 10.1111/j.1476-5381.1994.tb14842.x; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; PrugininBluger M, 1997, MECH DEVELOP, V61, P99, DOI 10.1016/S0925-4773(96)00623-5; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; Reis DJ, 1999, ANN NY ACAD SCI, V881, P65, DOI 10.1111/j.1749-6632.1999.tb09343.x; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Shen LJ, 2005, BIOCHEM PHARMACOL, V69, P97, DOI 10.1016/j.bcp.2004.09.003; Stoop R, 1996, PROG BRAIN RES, V109, P359; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Trujillo CA, 2009, CYTOM PART A, V75A, P38, DOI 10.1002/cyto.a.20666; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu WT, 1996, EXP NEUROL, V141, P190, DOI 10.1006/exnr.1996.0153; WU WT, 1994, EXP NEUROL, V129, P335, DOI 10.1006/exnr.1994.1176; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624; Xiong HB, 1999, EUR J NEUROSCI, V11, P1567, DOI 10.1046/j.1460-9568.1999.00567.x; Ye SH, 1997, J CLIN INVEST, V99, P540, DOI 10.1172/JCI119191; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007	56	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29690	29701		10.1074/jbc.M111.338095	http://dx.doi.org/10.1074/jbc.M111.338095			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22730318	Green Published, hybrid			2022-12-28	WOS:000308286900045
J	Nagano, T; Kojima, K; Hisabori, T; Hayashi, H; Morita, EH; Kanamori, T; Miyagi, T; Ueda, T; Nishiyama, Y				Nagano, Takanori; Kojima, Kouji; Hisabori, Toru; Hayashi, Hidenori; Morita, Eugene Hayato; Kanamori, Takashi; Miyagi, Tomoko; Ueda, Takuya; Nishiyama, Yoshitaka			Elongation Factor G Is a Critical Target during Oxidative Damage to the Translation System of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP PCC 6803; PROTEIN-SYNTHESIS; PHOTOSYSTEM-II; CUMENE HYDROPEROXIDE; IN-VITRO; STRESS; THIOREDOXIN; CELLS; IDENTIFICATION; INTERMEDIATE	Elongation factor G (EF-G), a key protein in translational elongation, is known to be particularly susceptible to oxidation in Escherichia coli. However, neither the mechanism of the oxidation of EF-G nor the influence of its oxidation on translation is fully understood. In the present study, we investigated the effects of oxidants on the chemical properties and function of EF-G using a translation system in vitro derived from E. coli. Treatment of EF-G with 0.5 mM H2O2 resulted in the complete loss of translational activity. The inactivation of EF-G by H2O2 was attributable to the oxidation of two specific cysteine residues, namely, Cys(114) and Cys(266), and subsequent formation of an intramolecular disulfide bond. Replacement of Cys(114) by serine rendered EF-G insensitive to oxidation and inactivation by H2O2. Furthermore, generation of the translation system in vitro with the mutated EF-G protected the entire translation system from oxidation, suggesting that EF-G might be a primary target of oxidation within the translation system. Oxidized EF-G was reactivated via reduction of the disulfide bond by thioredoxin, a ubiquitous protein that mediates dithiol-disulfide exchange. Our observations indicate that the translational machinery in E. coli is regulated, in part, by the redox state of EF-G, which might depend on the balance between the supply of reducing power and the degree of oxidative stress.	[Nagano, Takanori; Kojima, Kouji; Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; [Nishiyama, Yoshitaka] Saitama Univ, Grad Sch Sci & Engn, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Hayashi, Hidenori] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Hayashi, Hidenori] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Morita, Eugene Hayato] Ehime Univ, Fac Agr, Dept Bioresources, Matsuyama, Ehime 7908566, Japan; [Kanamori, Takashi; Miyagi, Tomoko; Ueda, Takuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan	Saitama University; Saitama University; Tokyo Institute of Technology; Ehime University; Ehime University; Ehime University; University of Tokyo	Nishiyama, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Biochem & Mol Biol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Kojima, Kouji/L-8180-2013; Ueda, Takuya/K-5217-2014; Nishiyama, Yoshitaka/K-3825-2012; Hisabori, Toru/E-5205-2014	Ueda, Takuya/0000-0002-7760-8271; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570033, 24570039]; Asahi Glass Foundation; Network Joint Research Center for Materials and Devices	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Network Joint Research Center for Materials and Devices	This work was supported, in part, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21570033 and 24570039) (to Y. N.), the Asahi Glass Foundation (to Y. N.), and the Cooperative Research Program of the Network Joint Research Center for Materials and Devices (to Y. N. and T. H.).	Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Ejima K, 2012, FEBS LETT, V586, P778, DOI 10.1016/j.febslet.2012.01.042; Ezure T, 2009, J BIOTECHNOL, V144, P287, DOI 10.1016/j.jbiotec.2009.09.017; Hirose T, 1996, EMBO J, V15, P1687, DOI 10.1002/j.1460-2075.1996.tb00514.x; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kojima K, 2009, J BIOL CHEM, V284, P18685, DOI 10.1074/jbc.M109.015131; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; NILSSON A, 1995, BBA-GENE STRUCT EXPR, V1260, P200, DOI 10.1016/0167-4781(94)00198-C; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nishiyama Y, 2009, ADV BOT RES, V52, P187, DOI 10.1016/S0065-2296(10)52007-X; POOT M, 1988, MECH AGEING DEV, V43, P1, DOI 10.1016/0047-6374(88)90093-0; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Starosta AL, 2009, CHEM BIOL, V16, P1087, DOI 10.1016/j.chembiol.2009.09.016; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vlamis-Gardikas A, 2002, J BIOL CHEM, V277, P10861, DOI 10.1074/jbc.M111024200; Yokoyama T, 2012, EMBO J, V31, P1836, DOI 10.1038/emboj.2012.22	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28697	28704		10.1074/jbc.M112.378067	http://dx.doi.org/10.1074/jbc.M112.378067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773838	hybrid, Green Published			2022-12-28	WOS:000308074600043
J	Sorensen, DM; Moller, AB; Jakobsen, MK; Jensen, MK; Vangheluwe, P; Buch-Pedersen, MJ; Palmgren, MG				Sorensen, Danny Mollerup; Moller, Annette B.; Jakobsen, Mia K.; Jensen, Michael K.; Vangheluwe, Peter; Buch-Pedersen, Morten J.; Palmgren, Michael G.			Ca2+ Induces Spontaneous Dephosphorylation of a Novel P5A-type ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; P-TYPE ATPASES; SECRETORY PATHWAY; CATION-BINDING; RETICULUM; CALCIUM; GENE; ION; CA2+-ATPASE; ARABIDOPSIS	P5 ATPases constitute the least studied group of P-type ATPases, an essential family of ion pumps in all kingdoms of life. Although P5 ATPases are present in every eukaryotic genome analyzed so far, they have remained orphan pumps, and their biochemical function is obscure. We show that a P5A ATPase from barley, HvP5A1, locates to the endoplasmic reticulum and is able to rescue knock-out mutants of P5A genes in both Arabidopsis thaliana and Saccharomyces cerevisiae. HvP5A1 spontaneously forms a phosphorylated reaction cycle intermediate at the catalytic residue Asp-488, whereas, among all plant nutrients tested, only Ca2+ triggers dephosphorylation. Remarkably, Ca2+-induced dephosphorylation occurs at high apparent [Ca2+] (K-i = 0.25 mM) and is independent of the phosphatase motif of the pump and the putative binding site for transported ligands located in M4. Taken together, our results rule out that Ca2+ is a transported substrate but indicate the presence of a cytosolic low affinity Ca2+-binding site, which is conserved among P-type pumps and could be involved in pump regulation. Our work constitutes the first characterization of a P5 ATPase phosphoenzyme and points to Ca2+ as a modifier of its function.	[Sorensen, Danny Mollerup; Moller, Annette B.; Jakobsen, Mia K.; Jensen, Michael K.; Vangheluwe, Peter; Buch-Pedersen, Morten J.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis,PUMPKIN, DK-1871 Frederiksberg C, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis,PUMPKIN, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Vangheluwe, Peter/P-5476-2017; Palmgren, Michael/A-9808-2013	Vangheluwe, Peter/0000-0002-7822-2944; Palmgren, Michael/0000-0002-9982-6114; Jensen, Michael Krogh/0000-0001-7574-4707				Ando A, 2005, MOL GENET GENOMICS, V273, P497, DOI 10.1007/s00438-005-1153-6; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; KINOSHITA T, 1995, PLANT CELL, V7, P1333; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; POST RL, 1973, J BIOL CHEM, V248, P6993; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Runions J, 2006, J EXP BOT, V57, P43, DOI 10.1093/jxb/eri289; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sorin A, 1997, J BIOL CHEM, V272, P9895; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, YEAST, V18, P1471, DOI 10.1002/yea.791; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Usenovic M., 2012, HUM MOL GEN IN PRESS; VARA F, 1982, J BIOL CHEM, V257, P2826; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925	58	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28336	28348		10.1074/jbc.M112.387191	http://dx.doi.org/10.1074/jbc.M112.387191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22730321	Green Published, hybrid			2022-12-28	WOS:000308074600011
J	Xu, YM; Pempe, EH; Liu, J				Xu, Yongmei; Pempe, Elizabeth H.; Liu, Jian			Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED THROMBOCYTOPENIA; ANTITHROMBIN-III; TERNARY COMPLEX; SULFATE; ANTICOAGULANT; BINDING; BIOSYNTHESIS; REPLACEMENT; SPECIFICITY; REVEALS	Heparan sulfate (HS) and heparin are highly sulfated polysaccharides. Heparin is a commonly used anticoagulant drug that inhibits the activities of factors Xa and IIa (also known as thrombin) to prevent blood clot formation. Here, we report the synthesis of a series of size-defined oligosaccharides to probe the minimum size requirement for an oligosaccharide with anti-IIa activity. The synthesis was completed by a chemoenzymatic approach involving glycosyltransferases, HS sulfotransferases, and C-5-epimerase. We demonstrate the ability to synthesize highly purified N-sulfo-oligosaccharides having up to 21 saccharide residues. The results from anti-Xa and anti-IIa activity measurements revealed that an oligosaccharide longer than 19 saccharide residues is necessary to display anti-IIa activity. The oligosaccharides also exhibit low binding toward platelet factor 4, raising the possibility of preparing a synthetic heparin with a reduced effect of heparin-induced thrombocytopenia. The results from this study demonstrate the ability to synthesize large HS oligosaccharides and provide a unique tool to probe the structure and function relationships of HS that require the use of large HS fragments.	[Xu, Yongmei; Pempe, Elizabeth H.; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Beard Hall,Rm 303, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu		Chappell, Elizabeth/0000-0003-4491-0631	National Institutes of Health [R01 HL094463, R01 AI050050, F31 AG040927-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG040927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094463 and R01 AI050050 (to J. L.) and F31 AG040927-01 (to E. H. P.).	Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Corbett TL, 2010, J THROMB THROMBOLYS, V30, P375, DOI 10.1007/s11239-010-0494-0; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Duncan MB, 2004, BBA-GEN SUBJECTS, V1671, P34, DOI 10.1016/j.bbagen.2003.12.010; Herbert JM, 2001, THROMB HAEMOSTASIS, V85, P852; Hu YP, 2011, NAT CHEM, V3, P557, DOI 10.1038/nchem.1073; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; Lassen MR, 2008, J AM COLL CARDIOL, V51, P1498, DOI 10.1016/j.jacc.2008.03.007; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; OOSTA GM, 1981, P NATL ACAD SCI-BIOL, V78, P829, DOI 10.1073/pnas.78.2.829; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Spinler SA, 2006, J THROMB THROMBOLYS, V21, P17, DOI 10.1007/s11239-006-5571-z; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; YAMADA SH, 1993, J BIOL CHEM, V268, P4780; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	31	39	42	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29054	29061		10.1074/jbc.M112.358523	http://dx.doi.org/10.1074/jbc.M112.358523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773834	Green Published, hybrid			2022-12-28	WOS:000308074600072
J	Calix, JJ; Porambo, RJ; Brady, AM; Larson, TR; Yother, J; Abeygunwardana, C; Nahm, MH				Calix, Juan J.; Porambo, Richard J.; Brady, Allison M.; Larson, Thomas R.; Yother, Janet; Abeygunwardana, Chitrananda; Nahm, Moon H.			Biochemical, Genetic, and Serological Characterization of Two Capsule Subtypes among Streptococcus pneumoniae Serotype 20 Strains DISCOVERY OF A NEW PNEUMOCOCCAL SEROTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE VACCINE; ASSAY; BIOSYNTHESIS; SEROGROUP-6; ANTIBODIES; CARRIAGE; CHILDREN; DISEASE; LOCUS; WCJE	The bacterial pathogen Streptococcus pneumoniae expresses one of over 90 structurally distinct polysaccharide (PS) capsule serotypes. Prior PS structural analyses of the vaccine-associated serotype 20 do not agree with reports describing the genes that mediate capsule synthesis. Furthermore, using immunized human sera-based assays, serological differences were recently noted among strains typed as serotype 20. We examined the capsule structures of two serologically dissimilar serotype 20 strains, 20 alpha and 20 beta, by extensive biochemical analysis. 20 alpha PS was composed of the previously described serotype 20 hexasaccharide repeat unit, whereas the 20 beta PS was composed of a novel heptasaccharide repeat unit containing an extra branching alpha-glucose residue. Genetic analysis of the subtypes revealed that 20 alpha may have arisen from a 20 beta progenitor following loss of function mutation to the glycosyltransferase gene whaF. Conventional serotyping methods using rabbit polyclonal or mouse monoclonal antibodies were unable to distinguish the subtypes. However, genetic analysis of multiple "serotype 20" clinical isolates revealed that all strains contain the 20 beta genotype. We propose naming bacteria that express the previously described 20 alpha capsule structure 20A and bacteria that express the novel 20 beta capsule structure 20B, a new pneumococcal serotype.	[Calix, Juan J.; Brady, Allison M.; Larson, Thomas R.; Yother, Janet; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Abeygunwardana, Chitrananda] Merck & Co Inc, Merck Res Labs, Dept Vaccine Regulatory, West Point, PA 19486 USA; [Porambo, Richard J.; Abeygunwardana, Chitrananda] Merck & Co Inc, Merck Res Labs, Dept Vaccine Analyt Dev, West Point, PA 19486 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Merck & Company; Merck & Company	Nahm, MH (corresponding author), BBRB 614,1530 3rd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu		Nahm, Moon/0000-0002-6922-1042; Brady, Allison/0000-0003-0606-1384	National Institutes of Health [AI-93103, AI007051, AI-28457, AI-31473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI031473, T32AI007051, F31AI093103, R01AI031473, R01AI028457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-93103 (to J. J. C.), AI007051 (to A. M. B.), AI-28457 (to J. Y.), and AI-31473 (to M. H. N.).	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Burton RL, 2012, CLIN VACCINE IMMUNOL, V19, P835, DOI 10.1128/CVI.00086-12; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calix JJ, 2012, J BIOL CHEM, V287, P13996, DOI 10.1074/jbc.M112.346924; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Isaacman DJ, 2007, VACCINE, V25, P2420, DOI 10.1016/j.vaccine.2006.09.011; Lee H, 2009, CLIN VACCINE IMMUNOL, V16, P376, DOI 10.1128/CVI.00344-08; Lemercinier X, 2006, CARBOHYD RES, V341, P68, DOI 10.1016/j.carres.2005.10.014; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; RICHARDS JC, 1983, CAN J BIOCHEM CELL B, V61, P178, DOI 10.1139/o83-026; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yu JG, 2005, J CLIN MICROBIOL, V43, P156, DOI 10.1128/JCM.43.1.156-162.2005	28	109	117	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27885	27894		10.1074/jbc.M112.380451	http://dx.doi.org/10.1074/jbc.M112.380451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736767	hybrid, Green Published			2022-12-28	WOS:000307840700062
J	Makkinje, A; Vanden Borre, P; Near, RI; Patel, PS; Lerner, A				Makkinje, Anthony; Vanden Borre, Pierre; Near, Richard I.; Patel, Prayag S.; Lerner, Adam			Breast Cancer Anti-estrogen Resistance 3 (BCAR3) Protein Augments Binding of the c-Src SH3 Domain to Crk-associated Substrate (p130(cas))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; GDP EXCHANGE FACTOR; CAS FAMILY-MEMBERS; CYCLIN D1 PROMOTER; CELL-MIGRATION; TYROSINE PHOSPHORYLATION; ADAPTER PROTEIN; TRANSFORMED CELLS; DEPENDENT MANNER; V-SRC	The focal adhesion adapter protein p130(cas) regulates adhesion and growth factor-related signaling, in part through Src-mediated tyrosine phosphorylation of p130(cas). AND-34/BCAR3, one of three NSP family members, binds the p130(cas) carboxyl terminus, adjacent to a bipartite p130(cas) Src-binding domain (SBD) and induces anti-estrogen resistance in breast cancer cell lines as well as phosphorylation of p130(cas). Only a subset of the signaling properties of BCAR3, specifically augmented motility, are dependent upon formation of the BCAR3-p130(cas) complex. Using GST pull-down and immunoprecipitation studies, we show that among NSP family members, only BCAR3 augments the ability of p130(cas) to bind the Src SH3 domain through an RPLPSPP motif in the p130(cas) SBD. Although our prior work identified phosphorylation of the serine within the p130(cas) RPLPSPP motif, mutation of this residue to alanine or glutamic acid did not alter BCAR3-induced Src SH3 domain binding to p130(cas). The ability of BCAR3 to augment Src SH3 binding requires formation of a BCAR3-p130(cas) complex because mutations that reduce association between these two proteins block augmentation of Src SH3 domain binding. Similarly, in MCF-7 cells, BCAR3-induced tyrosine phosphorylation of the p130(cas) substrate domain, previously shown to be Src-dependent, was reduced by an R743A mutation that blocks BCAR3 association with p130(cas). Immunofluorescence studies demonstrate that BCAR3 expression alters the intracellular location of both p130(cas) and Src and that all three proteins co-localize. Our work suggests that BCAR3 expression may regulate Src signaling in a BCAR3-p130(cas) complex-dependent fashion by altering the ability of the Src SH3 domain to bind the p130(cas) SBD.	[Lerner, Adam] Boston Univ, Hematol Oncol Sect, Dept Med, Sch Med,Boston Med Ctr, Boston, MA 02118 USA; [Lerner, Adam] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston University	Lerner, A (corresponding author), Boston Univ, Hematol Oncol Sect, Dept Med, Sch Med,Boston Med Ctr, EBRC 420,650 Albany St, Boston, MA 02118 USA.	lernwara@bu.edu		Near, Richard/0000-0003-3307-9619	National Institutes of Health, NCI [R01 CA114094]; Logica Foundation; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE [R01CA114094] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Logica Foundation; Breast Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA114094. This work was also supported by the Logica Foundation and the Breast Cancer Alliance.	Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burnham MR, 1999, MOL CARCINOGEN, V26, P20, DOI 10.1002/(SICI)1098-2744(199909)26:1<20::AID-MC3>3.0.CO;2-M; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; CHEADLE C, 1994, J BIOL CHEM, V269, P24034; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Felekkis K, 2006, METHOD ENZYMOL, V407, P55, DOI 10.1016/S0076-6879(05)07006-0; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Near RI, 2009, MOL VIS, V15, P685; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2000, J BIOL CHEM, V275, P6404, DOI 10.1074/jbc.275.9.6404; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27703	27714		10.1074/jbc.M112.389981	http://dx.doi.org/10.1074/jbc.M112.389981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711540	hybrid, Green Published			2022-12-28	WOS:000307840700044
J	Gallo, A; Lo Sterzo, C; Mori, M; Di Matteo, A; Bertini, I; Banci, L; Brunori, M; Federici, L				Gallo, Angelo; Lo Sterzo, Carlo; Mori, Mirko; Di Matteo, Adele; Bertini, Ivano; Banci, Lucia; Brunori, Maurizio; Federici, Luca			Structure of Nucleophosmin DNA-binding Domain and Analysis of Its Complex with a G-quadruplex Sequence from the c-MYC Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; AUTOMATED NOE ASSIGNMENT; BACKBONE DYNAMICS; DENATURED STATE; SMALL-MOLECULE; PROTEIN; IDENTIFICATION; RNA; PHOSPHORYLATION; RECOGNITION	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, mainly localized at nucleoli, that plays a key role in several cellular functions, including ribosome maturation and export, centrosome duplication, and response to stress stimuli. More than 50 mutations at the terminal exon of the NPM1 gene have been identified so far in acute myeloid leukemia; the mutated proteins are aberrantly and stably localized in the cytoplasm due to high destabilization of the NPM1 C-terminal domain and the appearance of a new nuclear export signal. We have shown previously that the 70-residue NPM1 C-terminal domain (NPM1-C70) is able to bind with high affinity a specific region at the c-MYC gene promoter characterized by parallel G-quadruplex structure. Here we present the solution structure of the NPM1-C70 domain and NMR analysis of its interaction with a c-MYC-derived G-quadruplex. These data were used to calculate an experimentally restrained molecular docking model for the complex. The NPM1-C70 terminal three-helix bundle binds the G-quadruplex DNA at the interface between helices H1 and H2 through electrostatic interactions with the G-quadruplex phosphate backbone. Furthermore, we show that the 17-residue lysine-rich sequence at the N terminus of the three-helix bundle is disordered and, although necessary, does not participate directly in the contact surface in the complex.	[Gallo, Angelo; Mori, Mirko; Bertini, Ivano; Banci, Lucia] Univ Florence, Magnet Resonance Ctr, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Lo Sterzo, Carlo; Di Matteo, Adele; Brunori, Maurizio] Univ Roma La Sapienza, Inst Biol & Mol Pathol, I-00185 Rome, Italy; [Lo Sterzo, Carlo; Di Matteo, Adele; Brunori, Maurizio] Univ Roma La Sapienza, Natl Res Council, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Federici, Luca] Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; [Federici, Luca] Univ G dAnnunzio, Ctr Excellence Aging, I-66013 Chieti, Italy	University of Florence; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Dept Chem, Via Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; maurizio.brunori@uniroma1.it	Di Matteo, Adele/AAC-8338-2019; Gallo, Angelo/N-3781-2017	Di Matteo, Adele/0000-0002-5921-7365; Gallo, Angelo/0000-0001-9778-4822; BANCI, LUCIA/0000-0003-0562-5774; Brunori, Maurizio/0000-0002-7795-1635	Associazione Italiana Ricerca sul Cancro [IG2007-4798, IG2011-11712]; Ministero dell'Istruzione, Universita e Ricerca of Italy [RBRN07BMCT_007, RBRN07BMCT, PRIN2009FAKHZT_001]; WeNMR project (European FP7 e-Infrastructure grant) [261572]; national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan; Latin America GRID infrastructure via the Gisela project	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, Universita e Ricerca of Italy; WeNMR project (European FP7 e-Infrastructure grant); national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan; Latin America GRID infrastructure via the Gisela project	This work was supported by Associazione Italiana Ricerca sul Cancro Grants IG2007-4798 (to M.B.) and IG2011-11712 (to L.F.) and by Ministero dell'Istruzione, Universita e Ricerca of Italy Grants RBRN07BMCT_007 (to M.B.), RBRN07BMCT (to L.B. and I.B.), and PRIN2009FAKHZT_001 (to L.B. and I.B.).; We sincerely thank Prof. Brunangelo Falini (University of Perugia, Italy) for the introduction to nucleophosmin and precious collaboration. The WeNMR project (European FP7 e-Infrastructure grant, Contract Number 261572, supported by the national GRID Initiatives of Belgium, Italy, Germany, the Netherlands (via the Dutch BiG Grid project), Portugal, UK, South Africa, Taiwan, and the Latin America GRID infrastructure via the Gisela project) is acknowledged for the use of web portals and computing and storage facilities.	BECKMANN R, 1992, EUR J BIOCHEM, V210, P45, DOI 10.1111/j.1432-1033.1992.tb17388.x; Bertini I, 2011, BIOINFORMATICS, V27, P2384, DOI 10.1093/bioinformatics/btr415; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case D. A., 2021, AMBER 2022; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo X, 2012, BIOCOMPUT-PAC SYM, P104; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Keller R., 2004, COMPUTER AIDED RESON, V1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; OREKHOV VY, 1994, EUR J BIOCHEM, V219, P887, DOI 10.1111/j.1432-1033.1994.tb18570.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Palaniswamy V, 2006, NAT STRUCT MOL BIOL, V13, P429, DOI 10.1038/nsmb1080; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	53	44	46	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26539	26548		10.1074/jbc.M112.371013	http://dx.doi.org/10.1074/jbc.M112.371013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707729	hybrid, Green Published			2022-12-28	WOS:000307386000007
J	Zhou, B; Arnett, DR; Yu, X; Brewster, A; Sowd, GA; Xie, CL; Vila, S; Gai, DH; Fanning, E; Chen, XJS				Zhou, Bo; Arnett, Diana R.; Yu, Xian; Brewster, Aaron; Sowd, Gregory A.; Xie, Charlies L.; Vila, Stefan; Gai, Dahai; Fanning, Ellen; Chen, Xiaojiang S.			Structural Basis for the Interaction of a Hexameric Replicative Helicase with the Regulatory Subunit of Human DNA Polymerase alpha-Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; LARGE TUMOR-ANTIGEN; C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN-A; B-SUBUNIT; IN-VITRO; FUNCTIONAL INTERACTIONS; MOLECULAR ARCHITECTURE	DNApolymerase alpha-primase (Pol-prim) plays an essential role in eukaryotic DNA replication, initiating synthesis of the leading strand and of each Okazaki fragment on the lagging strand. Pol-prim is composed of a primase heterodimer that synthesizes an RNA primer, a DNA polymerase subunit that extends the primer, and a regulatory B-subunit (p68) without apparent enzymatic activity. Pol-prim is thought to interact with eukaryotic replicative helicases, forming a dynamic multiprotein assembly that displays primosome activity. At least three subunits of Pol-prim interact physically with the hexameric replicative helicase SV40 large T antigen, constituting a simple primosome that is active in vitro. However, structural understanding of these interactions and their role in viral chromatin replication in vivo remains incomplete. Here, we report the detailed largeTantigen-p68 interface, as revealed in a co-crystal structure and validated by site-directed mutagenesis, and we demonstrate its functional importance in activating the SV40 primosome in cell-free reactions with purified Pol-prim, as well as in monkey cells in vivo.	[Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, VU Stn B 1634, Nashville, TN 37232 USA; [Zhou, Bo; Yu, Xian; Brewster, Aaron; Vila, Stefan; Gai, Dahai; Chen, Xiaojiang S.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Brewster, Aaron] Univ Calif Berkeley, Dept Biol Sci, Berkeley, CA 94720 USA; [Fanning, Ellen] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; University of Southern California; University of California System; University of California Berkeley; Vanderbilt University	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 1634, 2325 Stevenson Ctr,1161 21st Ave S, Nashville, TN 37232 USA.	ellen.fanning@vanderbilt.edu; xiaojiang.chen@usc.edu			National Institutes of Health [GM080338, AI055926, GM52948, T32-AI089554, P30 CA068485]; University of Southern California Wang Cancer Research Fellowship; Wise Fellowship; Vanderbilt Beckman Scholar Program; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055926, T32AI089554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948, R01GM080338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Wang Cancer Research Fellowship; Wise Fellowship; Vanderbilt Beckman Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080338 and AI055926 (to X. S. C.) and GM52948 (to E. F.).; Recipient of a University of Southern California Wang Cancer Research Fellowship and a Wise Fellowship.; Supported in part by National Institutes of Health Grant T32-AI089554.; Supported in part by the Vanderbilt Beckman Scholar Program.; We thank the staff at Advanced Light Source Beamlines 8.3.1, 8.2.1, and 5.0.2, the Lawrence Berkeley Laboratory, and the staff at beamline 23-IDD, Argonne National Laboratory, for assistance in data collection. We thank the Biophysics Core Laboratory, University of Southern California, for their support; W. J. Chazin for a p68N expression vector and discussions; J. M. Pipas for thoughtful contributions and support for this study; J. Hurwitz and V. Bermudez for p58-FLAG baculovirus; E. Kremmer for anti-p48 antibody, and U. Dadwal for assistance with mutagenesis. We also thank Dr. A. Brunger for giving us access to the pre-release version of the program DEN, designed for refining low resolution structures. The Vanderbilt-Ingram Cancer Center, Vanderbilt University, was the recipient of National Institutes of Health Grant P30 CA068485.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Brunger AT, 2012, ACTA CRYSTALLOGR D, V68, P391, DOI [10.1107/S090744491104978X, 10.1107/S09074449104978X]; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Costa A, 2009, CRIT REV BIOCHEM MOL, V44, P326, DOI 10.1080/10409230903186012; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FANNING E, 1982, EMBO J, V1, P1023, DOI 10.1002/j.1460-2075.1982.tb01290.x; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Hamdan SM, 2010, J BIOL CHEM, V285, P18979, DOI 10.1074/jbc.R109.022939; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; ISHIMI Y, 1992, J BIOL CHEM, V267, P462; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; McClain B, 2010, J MOL BIOL, V397, P587, DOI 10.1016/j.jmb.2010.01.055; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Ott RD, 2002, J VIROL, V76, P5121, DOI 10.1128/JVI.76.10.5121-5130.2002; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SS, 2011, CURR OPIN CHEM BIOL, V15, P595, DOI 10.1016/j.cbpa.2011.08.003; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sanchez-Berrondo J, 2012, NUCLEIC ACIDS RES, V40, P1366, DOI 10.1093/nar/gkr831; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Simpson AA, 1998, STRUCT FOLD DES, V6, P1355, DOI 10.1016/S0969-2126(98)00136-1; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stewart L, 1999, METH MOL B, V94, P223; TANAKA S, 1982, J BIOL CHEM, V257, P8386; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	80	26	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26854	26866		10.1074/jbc.M112.363655	http://dx.doi.org/10.1074/jbc.M112.363655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700977	Green Published, hybrid			2022-12-28	WOS:000307386000034
J	Ido, K; Kakiuchi, S; Uno, C; Nishimura, T; Fukao, Y; Noguchi, T; Sato, F; Ifuku, K				Ido, Kunio; Kakiuchi, Shusuke; Uno, Chihiro; Nishimura, Taishi; Fukao, Yoichiro; Noguchi, Takumi; Sato, Fumihiko; Ifuku, Kentaro			The Conserved His-144 in the PsbP Protein Is Important for the Interaction between the PsbP N-terminus and the Cyt b(559) Subunit of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRINSIC 23-KDA PROTEIN; WATER OXIDIZING COMPLEX; OXYGEN-EVOLVING COMPLEX; 33 KDA PROTEIN; MANGANESE BINDING; CRYSTAL-STRUCTURE; RESOLUTION; ASSEMBLY/STABILITY; PHOTOAUTOTROPHY; CRYSTALLIZATION	The PsbP protein regulates the binding properties of Ca2+ and Cl-, and stabilizes the Mn cluster of photosystem II (PSII); however, the binding site and topology in PSII have yet to be clarified. Here we report that the structure around His-144 and Asp-165 in PsbP, which is suggested to be a metal binding site, has a crucial role for the functional interaction between PsbP and PSII. The mutated PsbP-H144A protein exhibits reduced ability to retain Cl- anions in PSII, whereas the D165V mutation does not affect PsbP function. Interestingly, H144A/D165V double mutation suppresses the effect of H144A mutation, suggesting that these residues have a role other than metal binding. FTIR difference spectroscopy suggests that H144A/D165V restores proper interaction with PSII and induces the conformational change around the Mn cluster during the S-1/S-2 transition. Cross-linking experiments show that the H144A mutation affects the direct interaction between PsbP and the Cyt b(559) alpha subunit of PSII (the PsbE protein). However, this interaction is restored in the H144A/D165V mutant. In the PsbP structure, His-144 and Asp-165 form a salt bridge. H144A mutation is likely to disrupt this bridge and liberate Asp-165, inhibiting the proper PsbP-PSII interaction. Finally, mass spectrometric analysis has identified the cross-linked sites of PsbP and PsbE as Ala-1 and Glu-57, respectively. Therefore His-144, in the C-terminal domain of PsbP, plays a crucial role in maintaining proper N terminus interaction. These data provide important information about the binding characteristics of PsbP in green plant PSII.	[Ido, Kunio; Kakiuchi, Shusuke; Sato, Fumihiko; Ifuku, Kentaro] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Uno, Chihiro; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Nishimura, Taishi; Sato, Fumihiko] Kyoto Univ, Fac Agr, Sakyo Ku, Kyoto 6068502, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan; [Ifuku, Kentaro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Nagoya University; Kyoto University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Ifuku, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	ifuku@kais.kyoto-u.ac.jp	Noguchi, Takumi/I-7105-2014; Fukao, Yoichiro/E-7137-2013; Ifuku, Kentaro/H-2455-2013; Sato, Fumihiko/C-1078-2011	Sato, Fumihiko/0000-0001-9497-4452; Ifuku, Kentaro/0000-0003-0241-8008	JST PRESTO; JSPS [18770032]; Grants-in-Aid for Scientific Research [23657099] Funding Source: KAKEN	JST PRESTO(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the grant from JST PRESTO (to K. I.) and by Grant-in-Aid for Young Scientists (B) from JSPS (Grant No. 18770032, to K. I.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BERNIER M, 1995, FEBS LETT, V360, P251, DOI 10.1016/0014-5793(95)00101-E; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bondarava N, 2005, BBA-BIOENERGETICS, V1708, P63, DOI 10.1016/j.bbabio.2005.01.005; Bondarava N, 2003, J BIOL CHEM, V278, P13554, DOI 10.1074/jbc.M212842200; Bondarava N, 2007, BBA-BIOENERGETICS, V1767, P583, DOI 10.1016/j.bbabio.2007.01.001; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2010, CHEMPHYSCHEM, V11, P1160, DOI 10.1002/cphc.200900901; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; Ifuku K, 2005, PHOTOSYNTH RES, V84, P251, DOI 10.1007/s11120-004-7160-3; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ifuku K, 2003, ACTA CRYSTALLOGR D, V59, P1462, DOI 10.1107/S0907444903011004; Ifuku K, 2002, PLANT CELL PHYSIOL, V43, P1244, DOI 10.1093/pcp/pcf136; Ifuku K, 2001, BBA-PROTEIN STRUCT M, V1546, P196, DOI 10.1016/S0167-4838(01)00139-X; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Kakiuchi S, 2012, BBA-BIOENERGETICS, V1817, P1346, DOI 10.1016/j.bbabio.2012.01.009; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kohoutova J, 2009, ACTA CRYSTALLOGR F, V65, P111, DOI 10.1107/S1744309108040578; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; MIYAO M, 1988, BIOCHIM BIOPHYS ACTA, V936, P465, DOI 10.1016/0005-2728(88)90024-2; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2010, PLANT CELL PHYSIOL, V51, P718, DOI 10.1093/pcp/pcq042; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; NOGUCHI T, 1995, BBA-BIOENERGETICS, V1228, P189, DOI 10.1016/0005-2728(94)00171-Z; RASHID A, 1994, FEBS LETT, V350, P296, DOI 10.1016/0014-5793(94)00789-6; RASHID A, 1991, PHOTOSYNTH RES, V30, P123, DOI 10.1007/BF00042010; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Rivalta I, 2011, BIOCHEMISTRY-US, V50, P6312, DOI 10.1021/bi200685w; Sato N, 2010, MOL PHYLOGENET EVOL, V56, P176, DOI 10.1016/j.ympev.2009.11.021; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tohri A, 2004, EUR J BIOCHEM, V271, P962, DOI 10.1111/j.1432-1033.2004.03998.x; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; YAMAMOTO Y, 1987, BIOCHIM BIOPHYS ACTA, V893, P579, DOI 10.1016/0005-2728(87)90110-1; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Yu H, 2006, BIOCHEMISTRY-US, V45, P3404, DOI 10.1021/bi051604o	52	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26377	26387		10.1074/jbc.M112.385286	http://dx.doi.org/10.1074/jbc.M112.385286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22707728	Green Published, hybrid			2022-12-28	WOS:000306916300063
J	Scherer, T; Lindtner, C; Zielinski, E; O'Hare, J; Filatova, N; Buettner, C				Scherer, Thomas; Lindtner, Claudia; Zielinski, Elizabeth; O'Hare, James; Filatova, Nika; Buettner, Christoph			Short Term Voluntary Overfeeding Disrupts Brain Insulin Control of Adipose Tissue Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACID; GLUCOSE-PRODUCTION; NERVOUS-SYSTEM; RESISTANCE; LEPTIN; SUPPRESSION; LIVER; INHIBITION; METABOLISM; OBESITY	Insulin controls fatty acid (FA) release from white adipose tissue (WAT) through direct effects on adipocytes and indirectly through hypothalamic signaling by reducing sympathetic nervous system outflow to WAT. Uncontrolled FA release from WAT promotes lipotoxicity, which is characterized by inflammation and insulin resistance that leads to and worsens type 2 diabetes. Here we tested whether early diet-induced insulin resistance impairs the ability of hypothalamic insulin to regulate WAT lipolysis and thus contributes to adipose tissue dysfunction. To this end we fed male Sprague-Dawley rats a 10% lard diet (high fat diet (HFD)) for 3 consecutive days, which is known to induce systemic insulin resistance. Rats were studied by euglycemic pancreatic clamps and concomitant infusion of either insulin or vehicle into the mediobasal hypothalamus. Short term HFD feeding led to a 37% increase in caloric intake and elevated base-line free FAs and insulin levels compared with rats fed regular chow. Overfeeding did not impair insulin signaling in WAT, but it abolished the ability of mediobasal hypothalamus insulin to suppress WAT lipolysis and hepatic glucose production as assessed by glycerol and glucose flux. HFD feeding also increased hypothalamic levels of the endocannabinoid 2-arachidonoylglycerol after only 3 days. In summary, overfeeding impairs hypothalamic insulin action, which may contribute to unrestrained lipolysis seen in human obesity and type 2 diabetes.	[Buettner, Christoph] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Buettner, Christoph] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Buettner, C (corresponding author), Mt Sinai Sch Med, Dept Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	christoph.buettner@mssm.edu	Buettner, Christoph/F-5793-2013	Buettner, Christoph/0000-0003-0412-4062; Scherer, Thomas/0000-0003-4980-706X	National Institutes of Health [DK074873, DK083568, DK082724]; ADA basic research award; European Foundation for the Study of Diabetes; Irma T. Hirschl/Monique Weill-Caulier Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082724, R01DK083658, K08DK074873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA basic research award; European Foundation for the Study of Diabetes; Irma T. Hirschl/Monique Weill-Caulier Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK074873, DK083568, and DK082724. This work was also supported by an ADA basic research award (to C. B.) and a European Foundation for the Study of Diabetes grant (to T. S.).; Recipient of an Irma T. Hirschl/Monique Weill-Caulier Scholar Award. To whom correspondence should be addressed: Dept. of Medicine and Department of Neuroscience, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. Tel.: 212-241-3425; Fax: 212-241-4218; E-mail: christoph.buettner@mssm.edu.	ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brozoski DT, 2009, AUTON NEUROSCI-BASIC, V150, P82, DOI 10.1016/j.autneu.2009.05.243; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Coomans CP, 2011, J LIPID RES, V52, P1712, DOI 10.1194/jlr.M015396; Cornier MA, 2006, METABOLISM, V55, P1207, DOI 10.1016/j.metabol.2006.05.003; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Dean C, 2011, AM J PHYSIOL-REG I, V300, pR771, DOI 10.1152/ajpregu.00391.2010; Degerman E., 2003, DIABETES MELLITUS FU, P374; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; Hallschmid M, 2008, INT J OBESITY, V32, P275, DOI 10.1038/sj.ijo.0803722; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Li JH, 2009, DIABETES, V58, P2776, DOI 10.2337/db09-0522; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Molhoj S, 2010, EUR J PHARMACOL, V646, P38, DOI 10.1016/j.ejphar.2010.08.006; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Niederhoffer N, 2000, J PHARMACOL EXP THER, V294, P707; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; O'Hare JD, 2011, DIABETES, V60, P1055, DOI 10.2337/db10-0962; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Ramnanan CJ, 2011, J CLIN INVEST, V121, P3713, DOI 10.1172/JCI45472; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROUST LR, 1993, DIABETES, V42, P1567, DOI 10.2337/diabetes.42.11.1567; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	52	50	51	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					33061	33069		10.1074/jbc.M111.307348	http://dx.doi.org/10.1074/jbc.M111.307348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22810223	hybrid, Green Published			2022-12-28	WOS:000309168300068
J	Marutani, E; Kosugi, S; Tokuda, K; Khatri, A; Nguyen, R; Atochin, DN; Kida, K; Van Leyen, K; Arai, K; Ichinose, F				Marutani, Eizo; Kosugi, Shizuko; Tokuda, Kentaro; Khatri, Ashok; Nguyen, Rebecca; Atochin, Dmitriy N.; Kida, Kotaro; Van Leyen, Klaus; Arai, Ken; Ichinose, Fumito			A Novel Hydrogen Sulfide-releasing N-Methyl-D-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTS NEURONS; CELL-DEATH; ACTIVATION; CALCIUM	Physiological levels of H2S exert neuroprotective effects, whereas high concentrations of H2S may cause neurotoxicity in part via activation of NMDAR. To characterize the neuroprotective effects of combination of exogenous H2S and NMDAR antagonism, we synthesized a novel H2S-releasing NMDAR antagonist N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)-4-(3-thioxo-3H-1,2-dithiol-4-yl)-benzamide (S-memantine) and examined its effects in vitro and in vivo. S-memantine was synthesized by chemically combining a slow releasing H2S donor 4-(3-thioxo-3H-1,2-dithiol-4-yl)-benzoic acid (ACS48) with a NMDAR antagonist memantine. S-memantine increased intracellular sulfide levels in human neuroblastoma cells (SH-SY5Y) 10-fold as high as that was achieved by ACS48. Incubation with S-memantine after reoxygenation following oxygen and glucose deprivation (OGD) protected SH-SY5Y cells and murine primary cortical neurons more markedly than did ACS48 or memantine. Glutamate-induced intracellular calcium accumulation in primary cortical neurons were aggravated by sodium sulfide (Na2S) or ACS48, but suppressed by memantine and S-memantine. S-memantine prevented glutamate-induced glutathione depletion in SH-SY5Y cells more markedly than did Na2S or ACS48. Administration of S-memantine after global cerebral ischemia and reperfusion more robustly decreased cerebral infarct volume and improved survival and neurological function of mice than did ACS48 or memantine. These results suggest that an H2S-releasing NMDAR antagonist derivative S-memantine prevents ischemic neuronal death, providing a novel therapeutic strategy for ischemic brain injury.	[Marutani, Eizo; Kosugi, Shizuko; Tokuda, Kentaro; Nguyen, Rebecca; Kida, Kotaro; Ichinose, Fumito] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA 02129 USA; [Khatri, Ashok] Massachusetts Gen Hosp, Endocrine Unit, Charlestown, MA 02129 USA; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Charlestown, MA 02129 USA; [Van Leyen, Klaus; Arai, Ken] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Ichinose, F (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 149 13th St,4315, Charlestown, MA 02129 USA.	fichinose@partners.org	van Leyen, Klaus/C-9126-2013; Kida, Kotaro/ABD-3848-2021; Atochin, Dmitriy/Q-3150-2016; Atochin, Dmitriy/AAH-8843-2020	van Leyen, Klaus/0000-0003-1032-3754; Atochin, Dmitriy/0000-0002-2405-2070	National Institute of Health [HL101930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049430] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grant HL101930 (to F. I.).	Abe K, 1996, J NEUROSCI, V16, P1066; Garcia-Bereguiain MA, 2008, ANTIOXID REDOX SIGN, V10, P31, DOI 10.1089/ars.2007.1656; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Chen MJ, 2011, J CELL PHYSIOL, V226, P1308, DOI 10.1002/jcp.22459; Cheung NS, 2007, NEUROPHARMACOLOGY, V53, P505, DOI 10.1016/j.neuropharm.2007.06.014; DeLeon ER, 2012, ANAL BIOCHEM, V421, P203, DOI 10.1016/j.ab.2011.10.016; Gao M, 2008, EUR J PHARMACOL, V591, P73, DOI 10.1016/j.ejphar.2008.06.071; Gong QH, 2011, J ALZHEIMERS DIS, V24, P173, DOI 10.3233/JAD-2011-110128; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lee M, 2010, J BIOL CHEM, V285, P17318, DOI 10.1074/jbc.M110.115261; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Liu YY, 2011, NEUROSCIENCE, V193, P80, DOI 10.1016/j.neuroscience.2011.07.023; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Nakamura T, 2010, CELL CALCIUM, V47, P190, DOI 10.1016/j.ceca.2009.12.009; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Predmore BL, 2010, J CARDIOVASC TRANSL, V3, P487, DOI 10.1007/s12265-010-9201-y; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Ren CL, 2010, BRAIN RES, V1345, P197, DOI 10.1016/j.brainres.2010.05.017; Serra-Perez A, 2008, J NEUROCHEM, V106, P1237, DOI 10.1111/j.1471-4159.2008.05467.x; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Thal SC, 2010, J NEUROSCI METH, V192, P219, DOI 10.1016/j.jneumeth.2010.07.032; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011	33	58	59	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32124	32135		10.1074/jbc.M112.374124	http://dx.doi.org/10.1074/jbc.M112.374124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815476	Green Published, hybrid			2022-12-28	WOS:000309059400050
J	Kuhse, J; Kalbouneh, H; Schlicksupp, A; Mukusch, S; Nawrotzki, R; Kirsch, J				Kuhse, Jochen; Kalbouneh, Heba; Schlicksupp, Andrea; Muekusch, Susanne; Nawrotzki, Ralph; Kirsch, Joachim			Phosphorylation of Gephyrin in Hippocampal Neurons by Cyclin-dependent Kinase CDK5 at Ser-270 Is Dependent on Collybistin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; INHIBITORY SYNAPSES; SYNAPTIC PLASTICITY; GABAERGIC SYNAPSES; PROTEIN GEPHYRIN; SPLICE VARIANTS; BINDING; SUBUNITS; TRANSMISSION; CYTOSKELETON	Gephyrin is a scaffold protein essential for the postsynaptic clustering of inhibitory glycine and different subtypes of GABA(A) receptors. The cellular and molecular mechanisms involved in gephyrin-mediated receptor clustering are still not well understood. Here we provide evidence that the gephyrin-binding protein collybistin is involved in regulating the phosphorylation of gephyrin. We demonstrate that the widely used monoclonal antibody mAb7a is a phospho-specific antibody that allows the cellular and biochemical analysis of gephyrin phosphorylation at Ser-270. In addition, another neighbored epitope determinant was identified at position Thr-276. Analysis of the double mutant gephyrin(T276A,S277A) revealed significant reduction in gephyrin cluster formation and altered oligomerization behavior of gephyrin. Moreover, pharmacological inhibition of cyclin-dependent kinases in hippocampal neurons reduced postsynaptic gephyrin mAb7a immunoreactivities. In vitro phosphorylation assays and phosphopeptide competition experiments revealed a phosphorylation at Ser-270 depending on enzyme activities of cyclin-dependent kinases CDK1, -2, or -5. These data indicate that collybistin and cyclin-dependent kinases are involved in regulating the phosphorylation of gephyrin at postsynaptic membrane specializations.	[Kuhse, Jochen] Univ Heidelberg, Inst Anat & Zellbiol, Lehrstuhl 2, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuhse, J (corresponding author), Univ Heidelberg, Inst Anat & Zellbiol, Lehrstuhl 2, Dept Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019; Kalbouneh, Heba/P-4801-2015	Kalbouneh, Heba/0000-0002-0956-9223				Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Bluem R, 2007, J BIOL CHEM, V282, P37783, DOI 10.1074/jbc.M708301200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	36	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30952	30966		10.1074/jbc.M112.349597	http://dx.doi.org/10.1074/jbc.M112.349597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22778260	hybrid, Green Published			2022-12-28	WOS:000308791300009
J	Moravec, R; Conger, KK; D'Souza, R; Allison, AB; Casanova, JE				Moravec, Radim; Conger, Kathryn K.; D'Souza, Ryan; Allison, Anne B.; Casanova, James E.			BRAG2/GEP100/IQSec1 Interacts with Clathrin and Regulates alpha 5 beta 1 Integrin Endocytosis through Activation of ADP Ribosylation Factor 5 (Arf5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN; CELL-MIGRATION; CLASS-I; ADHESION; EFFECTOR; RECEPTOR	ADP ribosylation factors (Arfs) are small GTP-binding proteins known for their role in vesicular transport, where they nucleate the assembly of coat protein complexes at sites of carrier vesicle formation. Similar to other GTPases, Arfs require guanine nucleotide exchange factors to catalyze GTP loading and activation. One subfamily of ArfGEFs, the BRAGs, has been shown to activate Arf6, which acts in the endocytic pathway to control the trafficking of a subset of cargo proteins including integrins. We have previously shown that BRAG2 modulates cell adhesion by regulating integrin surface expression. Here, we show that, in addition to Arf6, endogenous BRAG2 also activates the class II Arfs, Arf4 and Arf5, and that surprisingly, it is Arf5 that mediates integrin internalization. We observed that cell spreading on fibronectin is enhanced upon inhibition of BRAG2 or Arf5 but not Arf6. Similarly, spreading in BRAG2-depleted cells is reverted by expression of a rapid cycling Arf5 mutant (T161A) but not by a corresponding Arf6 construct (T157A). We also show that BRAG2 binds clathrin and the AP-2 adaptor complex and that both BRAG2 and Arf5 localize to clathrin-coated pits at the plasma membrane. Consistent with these observations, depletion of Arf5, but not Arf6 or Arf4, slows internalization of beta 1 integrins without affecting transferrin receptor uptake. Together, these findings indicate that BRAG2 acts at clathrin-coated pits to promote integrin internalization by activating Arf5 and suggest a previously unrecognized role for Arf5 in clathrin-mediated endocytosis of specific cargoes.	[Moravec, Radim; Conger, Kathryn K.; D'Souza, Ryan; Casanova, James E.] Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA 22908 USA; [Allison, Anne B.] Mary Baldwin Coll, Dept Biol, Staunton, VA 24402 USA	University of Virginia	Casanova, JE (corresponding author), Univ Virginia Hlth Syst, Dept Cell Biol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	jec9e@virginia.edu		Allison, Anne/0000-0002-6941-3159	National Institutes of Health [GM078585]; Commonwealth Health Research Board of Virginia [42-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Health Research Board of Virginia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078585 (to J. E. C.). This work was also supported by the Commonwealth Health Research Board of Virginia (42-10 to A. B. A.).	Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Johnson RI, 2011, MOL BIOL CELL, V22, P4513, DOI 10.1091/mbc.E11-04-0305; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2002, J BIOL CHEM, V277, P40185, DOI 10.1074/jbc.C200481200; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shoubridge Cheryl, 2010, Small GTPases, V1, P98, DOI 10.4161/sgtp.1.2.13285; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2010, J BIOL CHEM, V285, P30698, DOI 10.1074/jbc.M110.107458; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042	34	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31138	31147		10.1074/jbc.M112.383117	http://dx.doi.org/10.1074/jbc.M112.383117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22815487	hybrid, Green Published			2022-12-28	WOS:000308791300026
J	Balyasnikova, IV; Wainwright, DA; Solomaha, E; Lee, G; Han, Y; Thaci, B; Lesniak, MS				Balyasnikova, Irina V.; Wainwright, Derek A.; Solomaha, Elena; Lee, Gina; Han, Yu; Thaci, Bart; Lesniak, Maciej S.			Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor alpha 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS EXOTOXIN; CANCER; CELLS; GLIOMA; GLYCOSYLATION; PROTEIN; CHAIN; EXPRESSION; CYTOTOXIN; CLONING	The high affinity interleukin-13 receptor alpha 2 (IL13R alpha 2) is selectively expressed at a high frequency by glioblastoma multiforme (GBM) as well as several other tumor types. One approach for targeting this tumor-specific receptor utilizes the cognate ligand, IL-13, conjugated to cytotoxic molecules. However, this approach lacks specificity because the lower affinity receptor for IL-13, IL13R alpha 1, is widely expressed by normal tissues. Here, we aimed to develop and characterize a novel monoclonal antibody (mAb) specific to IL13R alpha 2 for the therapeutic purpose of targeting IL13R alpha 2-expressing tumors. Hybridoma cell lines were generated and compared for binding affinities to recombinant human IL13R alpha 2 (rhIL13R alpha 2). Clone 47 demonstrated binding to the native conformation of IL13R alpha 2 and was therefore chosen for further studies. Clone 47 bound specifically and with high affinity (K-D = 1.39 x 10(-9) M) to rhIL13R alpha 2 but not to rhIL13R alpha 1 or murine IL13R alpha 2. Furthermore, clone 47 specifically recognized wild-type IL13R alpha 2 expressed on the surface of CHO and HEK cells as well as several glioma cell lines. Competitive binding assays revealed that clone 47 also significantly inhibited the interaction between human soluble IL-13 and IL13R alpha 2 receptor. Moreover, we found that N-linked glycosylation of IL13R alpha 2 contributes in part to the interaction of the antibody to IL13R alpha 2. In vivo, the IL13R alpha 2 mAb improved the survival of nude mice intracranially implanted with a human U251 glioma xenograft. Collectively, these data warrant further investigation of this novel IL13R alpha 2 mAb with an emphasis on translational implications for therapeutic use.	[Balyasnikova, Irina V.; Wainwright, Derek A.; Lee, Gina; Han, Yu; Thaci, Bart; Lesniak, Maciej S.] Univ Chicago, Brain Tumor Ctr, Chicago, IL 60637 USA; [Solomaha, Elena] Univ Chicago, Biophys Core Facil, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Balyasnikova, IV (corresponding author), Univ Chicago, Brain Tumor Ctr, 5841 S Maryland Ave,MC 3026, Chicago, IL 60637 USA.	ibalyasn@surgery.bsd.uchicago.edu	Han, Yu/GZA-9220-2022	Wainwright, Derek/0000-0001-7232-4264; Thaci, Bart/0000-0001-5392-7174	National Institutes of Health [R01 CA138587, R01 CA122930, R01 NS077388, U01 NS069997, F32 NS073366]; Elsa U. Pardee Foundation; American Cancer Society (ACS) Illinois Division; ACS [RSG-07-276-01]; NATIONAL CANCER INSTITUTE [R01CA122930, R01CA138587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS073366, U01NS069997, R01NS077388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elsa U. Pardee Foundation; American Cancer Society (ACS) Illinois Division(American Cancer Society); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA138587 (to M. S. L.), R01 CA122930 (to M. S. L.), R01 NS077388 (to M. S. L.), U01 NS069997 (to M. S. L.), and F32 NS073366 (to D. A. W.). This work was also supported by the Elsa U. Pardee Foundation (to I. V. B.), American Cancer Society (ACS) Illinois Division (to I. V. B.), and ACS Grant RSG-07-276-01 (to M. S. L.).	Akaiwa M, 2001, CYTOKINE, V13, P75, DOI 10.1006/cyto.2000.0814; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Debinski W, 1998, NAT BIOTECHNOL, V16, P449, DOI 10.1038/nbt0598-449; Debinski W, 1995, CLIN CANCER RES, V1, P1253; Debinski W, 2000, J NEURO-ONCOL, V48, P103, DOI 10.1023/A:1006446426611; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; HANSEN HJ, 1993, CANCER, V71, P3478, DOI 10.1002/1097-0142(19930601)71:11<3478::AID-CNCR2820711104>3.0.CO;2-A; Hsu YF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-139; Husain SR, 2000, BLOOD, V95, P3506, DOI 10.1182/blood.V95.11.3506.011k47_3506_3513; Husain SR, 1997, CLIN CANCER RES, V3, P151; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Joshi BH, 2000, CANCER RES, V60, P1168; Joshi BH, 2003, CROAT MED J, V44, P455; Kawakami K, 2006, CANCER RES, V66, P4434, DOI 10.1158/0008-5472.CAN-05-1265; Kawakami M, 2003, CLIN CANCER RES, V9, P6381; Kawakami M, 2002, MOL CANCER THER, V1, P999; Kioi M, 2008, MOL CANCER THER, V7, P1579, DOI 10.1158/1535-7163.MCT-07-2131; Kioi M, 2006, FASEB J, V20, P2378, DOI 10.1096/fj.06-5995fje; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kuan CT, 2000, INT J CANCER, V88, P962, DOI 10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Pini A, 2000, CURR PROTEIN PEPT SC, V1, P155, DOI 10.2174/1389203003381397; Puri RK, 1996, BLOOD, V87, P4333, DOI 10.1182/blood.V87.10.4333.bloodjournal87104333; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Ross JS, 2003, AM J CLIN PATHOL, V119, P472, DOI 10.1309/Y6LPC0LR726L9DX9; Sampson JH, 2000, P NATL ACAD SCI USA, V97, P7503, DOI 10.1073/pnas.130166597; Shimamura T, 2010, CLIN CANCER RES, V16, P577, DOI 10.1158/1078-0432.CCR-09-2015; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990	45	37	40	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30215	30227		10.1074/jbc.M112.370015	http://dx.doi.org/10.1074/jbc.M112.370015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778273	Green Published, hybrid			2022-12-28	WOS:000308579800016
J	Geetha, T; Zheng, C; Vishwaprakash, N; Broderick, TL; Babu, JR				Geetha, Thangiah; Zheng, Chen; Vishwaprakash, Nilmini; Broderick, Tom L.; Babu, Jeganathan Ramesh			Sequestosome 1/p62, a Scaffolding Protein, Is a Newly Identified Partner of IRS-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE-GROWTH-FACTOR; INSULIN-RECEPTOR SUBSTRATE-1; KAPPA-B ACTIVATION; KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; FULL ACTIVATION; GLUCOSE-UPTAKE; P62; TRAFFICKING	Defects in the insulin-signaling pathway may lead to the development of skeletal muscle insulin resistance, which is one of the earliest abnormalities detected in individuals with the metabolic syndrome and predisposes them to develop type 2 diabetes. Previous studies have shown that deletion of the mouse sequestosome 1/p62 gene results in mature-onset obesity that progresses to insulin and leptin resistance and, ultimately, type 2 diabetes. Sequestosome 1/p62 is involved in receptor-mediated signal transduction and functions as an intracellular signal modulator or adaptor protein. Insulin receptor substrate-1 (IRS-1) plays a central role in transducing the insulin signal via phosphorylation, protein-protein interactions, and protein modifications. Mapping studies demonstrated that the SH2 domain at the amino terminus of sequestosome 1/p62 interacts with IRS-1 upon insulin stimulation. Further, IRS-1 interacts with p62 through its YMXM motifs at Tyr-608, Tyr-628, and/or Tyr-658 in a manner similar to its interaction with p85 of phosphoinositol 3-kinase. Overexpression of p62 increased phosphorylation of Akt, GLUT4 translocation, and glucose uptake, providing evidence that p62 participates in the insulin-signaling pathway through its interactions with IRS-1.	[Geetha, Thangiah; Zheng, Chen; Vishwaprakash, Nilmini; Babu, Jeganathan Ramesh] Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA; [Broderick, Tom L.] Midwestern Univ, Dept Physiol, Lab Diabet & Exercise Metab, Glendale, AZ 85308 USA	Auburn University System; Auburn University; Midwestern University	Babu, JR (corresponding author), Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA.	jeganrb@auburn.edu	Zheng, Chen/C-3787-2015; Thangiah, Geetha/W-6796-2019	Zheng, Chen/0000-0002-3610-5715; Ramesh Babu, Jeganathan/0000-0002-3719-932X	Auburn University; Alabama Agricultural Experiment Station, Hatch/Multistate Funding Program	Auburn University; Alabama Agricultural Experiment Station, Hatch/Multistate Funding Program	This work was supported by the New Faculty Start-up Fund from Auburn University and Alabama Agricultural Experiment Station, Hatch/Multistate Funding Program (to J. R. B.).	Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bouzakri K, 2005, CURR DIABETES REV, V1, P167, DOI 10.2174/1573399054022785; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Giovannone B, 2000, DIABETES-METAB RES, V16, P434, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR159>3.0.CO;2-8; Hodgkinson CP, 2005, DIABETOLOGIA, V48, P1627, DOI 10.1007/s00125-005-1819-y; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; Okada K, 2009, HEPATOL RES, V39, P490, DOI 10.1111/j.1872-034X.2008.00478.x; Olianas MC, 2011, BRIT J PHARMACOL, V163, P624, DOI 10.1111/j.1476-5381.2011.01234.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; QUON MJ, 1994, TRENDS ENDOCRIN MET, V5, P369, DOI 10.1016/1043-2760(94)90104-X; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Sale EM, 1999, FEBS LETT, V446, P122, DOI 10.1016/S0014-5793(99)00193-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuels IS, 2001, J CELL BIOCHEM, V82, P452, DOI 10.1002/jcb.1177; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	40	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29672	29678		10.1074/jbc.M111.322404	http://dx.doi.org/10.1074/jbc.M111.322404			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761437	Green Published, hybrid			2022-12-28	WOS:000308286900043
J	Mohibi, S; Gurumurthy, CB; Nag, A; Wang, J; Mirza, S; Mian, Y; Quinn, M; Katafiasz, B; Eudy, J; Pandey, S; Guda, C; Naramura, M; Band, H; Band, V				Mohibi, Shakur; Gurumurthy, Channabasavaiah Basavaraju; Nag, Alo; Wang, Jun; Mirza, Sameer; Mian, Yousaf; Quinn, Meghan; Katafiasz, Bryan; Eudy, James; Pandey, Sanjit; Guda, Chittibabu; Naramura, Mayumi; Band, Hamid; Band, Vimla			Mammalian Alteration/Deficiency in Activation 3 (Ada3) Is Essential for Embryonic Development and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; HUMAN STAGA COMPLEX; TRANSCRIPTIONAL ADAPTER; CDK INHIBITORS; S-PHASE; DISTINCT; GCN5; PROLIFERATION; ACETYLATION; ONCOPROTEIN	Ada3 protein is an essential component of histone acetyl transferase containing coactivator complexes conserved from yeast to human. We show here that germline deletion of Ada3 in mouse is embryonic lethal, and adenovirus-Cre mediated conditional deletion of Ada3 in Ada3(FL/FL) mouse embryonic fibroblasts leads to a severe proliferation defect which was rescued by ectopic expression of human Ada3. A delay in G(1) to S phase of cell cycle was also seen that was due to accumulation of Cdk inhibitor p27 which was an indirect effect of c-myc gene transcription control by Ada3. We further showed that this defect could be partially reverted by knocking down p27. Additionally, drastic changes in global histone acetylation and changes in global gene expression were observed in microarray analyses upon loss of Ada3. Lastly, formation of abnormal nuclei, mitotic defects and delay in G(2)/M to G(1) transition was seen in Ada3 deleted cells. Taken together, we provide evidence for a critical role of Ada3 in embryogenesis and cell cycle progression as an essential component of HAT complex.	[Mohibi, Shakur; Gurumurthy, Channabasavaiah Basavaraju; Wang, Jun; Mirza, Sameer; Quinn, Meghan; Katafiasz, Bryan; Eudy, James; Pandey, Sanjit; Guda, Chittibabu; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Pharmacol & Neurosci, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah Basavaraju; Nag, Alo; Mian, Yousaf; Naramura, Mayumi; Band, Hamid; Band, Vimla] Northwestern Univ, Evanston NW Healthcare Res Inst, Dept Med, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University	Band, V (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Mohibi, Shakur/AAR-7017-2021; Band, Hamid/AAF-4701-2020; Pandey, Sanjit/D-5049-2015; Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Mohibi, Shakur/0000-0001-5539-0841; Pandey, Sanjit/0000-0001-7304-3376; Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA96844, CA144027, CA87986, CA99163, CA105489, CA116552, NCI 5U01CA151806-02]; Department of Defense [W81XWH-07-1-0351, W81XWH-11-1-0171]; Susan G. Komen Postdoctoral Fellowship [KG111248]; National Center for Research Resources [5P20RR016469]; NIGMS, a component of the National Institutes of Health [8P20GM103427]; NATIONAL CANCER INSTITUTE [R01CA096844, R01CA105489, R01CA099163, U01CA151806, R01CA087986, R01CA116552, R01CA144027] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, a component of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96844 and CA144027 (to V. B.) and CA87986, CA99163, CA105489, CA116552 and NCI 5U01CA151806-02 (to H. B.). This work was also supported by Department of Defense Grants W81XWH-07-1-0351 and W81XWH-11-1-0171 (to V. B.).; Supported by Susan G. Komen Postdoctoral Fellowship KG111248.; We acknowledge technical assistance from Valerie Tran and Poonam Joshi as well as assistance with time-lapse microscopy from Tom Dao. The University of Nebraska Medical Center (UNMC) DNA Microarray Core facility is supported by grants from the National Center for Research Resources (5P20RR016469) and the NIGMS (8P20GM103427), a component of the National Institutes of Health.	Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Germaniuk-Kurowska A, 2007, CANCER RES, V67, P11789, DOI 10.1158/0008-5472.CAN-07-2721; Grau B, 2008, MOL CELL BIOL, V28, P376, DOI 10.1128/MCB.01307-07; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2002, MOL CELL BIOL, V22, P5801, DOI 10.1128/MCB.22.16.5801-5812.2002; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; PINA B, 1993, MOL CELL BIOL, V13, P5981, DOI 10.1128/MCB.13.10.5981; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torok MS, 2004, ADV PROTEIN CHEM, V67, P181; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang M, 2008, INDIAN J TRADIT KNOW, V7, P3; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zeng MS, 2002, J BIOL CHEM, V277, P45611, DOI 10.1074/jbc.M208447200; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29442	29456		10.1074/jbc.M112.378901	http://dx.doi.org/10.1074/jbc.M112.378901			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22736770	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000308286900022
J	Raskin, A; Lange, S; Banares, K; Lyon, RC; Zieseniss, A; Lee, LK; Yamazaki, KG; Granzier, HL; Gregorio, CC; McCulloch, AD; Omens, JH; Sheikh, F				Raskin, Anna; Lange, Stephan; Banares, Katherine; Lyon, Robert C.; Zieseniss, Anke; Lee, Leonard K.; Yamazaki, Katrina G.; Granzier, Henk L.; Gregorio, Carol C.; McCulloch, Andrew D.; Omens, Jeffrey H.; Sheikh, Farah			A Novel Mechanism Involving Four-and-a-half LIM Domain Protein-1 and Extracellular Signal-regulated Kinase-2 Regulates Titin Phosphorylation and Mechanics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; PASSIVE TENSION; SKELETAL-MUSCLE; HEART-MUSCLE; EXPRESSION; STIFFNESS; SEQUENCE; COLLAGEN; ACCELERATION; INVOLVEMENT	Understanding mechanisms underlying titin regulation in cardiac muscle function is of critical importance given recent compelling evidence that highlight titin mutations as major determinants of human cardiomyopathy. We previously identified a cardiac biomechanical stress-regulated complex at the cardiac-specific N2B region of titin that includes four-and-a-half LIM domain protein-1 (Fhl1) and components of the mitogen-activated protein signaling cascade, which impacted muscle compliance in Fhl1 knock-out cardiac muscle. However, direct regulation of these molecular components in mediating titin N2B function remained unresolved. Here we identify Fhl1 as a novel negative regulator of titin N2B levels and phosphorylation-mediated mechanics. We specifically identify titin N2B as a novel substrate of extracellular signal regulated-kinase-2 (Erk2) and demonstrate that Fhl1 directly interferes with Erk2-mediated titin-N2B phosphorylation. We highlight the critical region in titin-N2B that interacts with Fhl1 and residues that are dependent on Erk2-mediated phosphorylation in situ. We also propose a potential mechanism for a known titin-N2B cardiomyopathy-causing mutation that involves this regulatory complex. These studies shed light on a novel mechanism regulating titin-N2B mechano-signaling as well as suggest that dysfunction of these pathways could be important in cardiac disease states affecting muscle compliance.	[Raskin, Anna; Lange, Stephan; Banares, Katherine; Lyon, Robert C.; Lee, Leonard K.; Yamazaki, Katrina G.; Omens, Jeffrey H.; Sheikh, Farah] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Raskin, Anna; Lee, Leonard K.; McCulloch, Andrew D.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Granzier, Henk L.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Arizona	Sheikh, F (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fasheikh@ucsd.edu	Lange, Stephan/A-1422-2010	Lange, Stephan/0000-0001-9361-6602	National Institutes of Health [5P01HL46345, 1R01HL095780-01, K99/R00]; MDA Development Grant [MDA68929, K99HL107744-01]; University of California-San Diego Cardiovascular Scholarship awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103566, T32HL007444, R01HL095780, K99HL107744, P01HL046345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA Development Grant; University of California-San Diego Cardiovascular Scholarship awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HL46345 (to A. D. M.) and 1R01HL095780-01 (to F. S.).; Supported by MDA Development Grant MDA68929, National Institutes of Health K99/R00 pathway to independence Grant K99HL107744-01, and University of California-San Diego Cardiovascular Scholarship awards.	Asher Craig R, 2002, Cardiol Rev, V10, P218, DOI 10.1097/00045415-200207000-00007; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Betocchi S, 2000, Heart Fail Rev, V5, P333, DOI 10.1023/A:1026559113044; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chu PH, 2000, MECH DEVELOP, V95, P259, DOI 10.1016/S0925-4773(00)00341-5; Fukuda N, 2005, J GEN PHYSIOL, V125, P257, DOI 10.1085/jgp.200409177; Garcia RA, 2005, AM J PHYSIOL-HEART C, V288, pH1080, DOI 10.1152/ajpheart.00860.2004; Gough NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002601; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hwang DM, 2000, GENOMICS, V66, P1, DOI 10.1006/geno.2000.6171; Hwang DM, 1997, CIRCULATION, V96, P4146; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; Kruger M, 2006, J MUSCLE RES CELL M, V27, P435, DOI 10.1007/s10974-006-9090-5; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lee SMY, 1998, GENE, V216, P163, DOI 10.1016/S0378-1119(98)00302-3; LeWinter MM, 2007, CLIN CHIM ACTA, V375, P1, DOI 10.1016/j.cca.2006.06.035; LeWinter MM, 2004, CIRCULATION, V110, P109, DOI 10.1161/01.CIR.0000137284.17083.93; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lim DS, 2001, J AM COLL CARDIOL, V38, P1175, DOI 10.1016/S0735-1097(01)01509-1; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Warren CM, 2003, CARDIOVASC RES, V59, P86, DOI 10.1016/S0008-6363(03)00328-6; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yamazaki T, 1996, MOL CELL BIOCHEM, V164, P197, DOI 10.1007/BF00408658; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	49	73	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29273	29284		10.1074/jbc.M112.372839	http://dx.doi.org/10.1074/jbc.M112.372839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778266	hybrid, Green Published			2022-12-28	WOS:000308286900007
J	Doyle, SM; Hoskins, JR; Wickner, S				Doyle, Shannon M.; Hoskins, Joel R.; Wickner, Sue			DnaK Chaperone-dependent Disaggregation by Caseinolytic Peptidase B (ClpB) Mutants Reveals Functional Overlap in the N-terminal Domain and Nucleotide-binding Domain-1 Pore Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN DISAGGREGATION; SUBSTRATE RECOGNITION; AGGREGATED PROTEINS; ATP HYDROLYSIS; AAA; HSP104; THERMOTOLERANCE; ATPASES; HSP70	Protein disaggregation in Escherichia coli is carried out by ClpB, an AAA(+) (ATPases associated with various cellular activities) molecular chaperone, together with the DnaK chaperone system. Conformational changes in ClpB driven by ATP binding and hydrolysis promote substrate binding, unfolding, and translocation. Conserved pore tyrosines in both nucleotide-binding domain-1 (NBD-1) and -2 (NBD-2), which reside in flexible loops extending into the central pore of the ClpB hexamer, bind substrates. When the NBD-1 pore loop tyrosine is substituted with alanine (Y251A), ClpB can collaborate with the DnaK system in disaggregation, although activity is reduced. The N-domain has also been implicated in substrate binding, and like the NBD-1 pore loop tyrosine, it is not essential for disaggregation activity. To further probe the function and interplay of the ClpB N-domain and the NBD-1 pore loop, we made a double mutant with an N-domain deletion and a Y251A substitution. This ClpB double mutant is inactive in substrate disaggregation with the DnaK system, although each single mutant alone can function with DnaK. Our data suggest that this loss in activity is primarily due to a decrease in substrate engagement by ClpB prior to substrate unfolding and translocation and indicate an overlapping function for the N-domain and NBD-1 pore tyrosine. Furthermore, the functional overlap seen in the presence of the DnaK system is not observed in the absence of DnaK. For innate ClpB unfolding activity, the NBD-1 pore tyrosine is required, and the presence of the N-domain is insufficient to overcome the defect of the ClpB Y251A mutant.	[Doyle, Shannon M.; Hoskins, Joel R.; Wickner, Sue] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wickner, S (corresponding author), NCI, Mol Biol Lab, NIH, 37 Convent Dr,Bldg 37,Rm 5144, Bethesda, MD 20892 USA.	wickners@mail.nih.gov			National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008710] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Barnett ME, 2002, BIOCHEMISTRY-US, V41, P11277, DOI 10.1021/bi026161s; Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chow IT, 2005, FEBS LETT, V579, P4242, DOI 10.1016/j.febslet.2005.06.055; Chow IT, 2005, FEBS LETT, V579, P4235, DOI 10.1016/j.febslet.2005.06.054; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; SHACTER E, 1984, ANAL BIOCHEM, V138, P416, DOI 10.1016/0003-2697(84)90831-5; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SKOWYRA D, 1993, J BIOL CHEM, V268, P25296; Tek V, 2002, PROTEIN SCI, V11, P1192, DOI 10.1110/ps.4860102; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	45	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28470	28479		10.1074/jbc.M112.383091	http://dx.doi.org/10.1074/jbc.M112.383091			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745126	Green Published, hybrid			2022-12-28	WOS:000308074600022
J	Fiete, D; Beranek, M; Baenziger, JU				Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.			Molecular Basis for Protein-specific Transfer of N-Acetylgalactosamine to N-Linked Glycans by the Glycosyltransferases beta 1,4-N-Acetylgalactosaminyl Transferase 3 (beta 4GalNAc-T3) and beta 4GalNAc-T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION MUTANTS; GALNAC-TRANSFERASE; GAUSSIA LUCIFERASE; IN-VIVO; OLIGOSACCHARIDES; EXPRESSION; HORMONE; N,N'-DIACETYLLACTOSEDIAMINE; GALNAC-4-SULFOTRANSFERASE; PURIFICATION	Two closely related beta 1,4-N-acetylgalactosaminyltransferases, beta 4GalNAc-T3 and beta 4GalNAc-T4, are thought to account for the protein-specific addition of beta 1,4-linked GalNAc to Asn-linked oligosaccharides on a number of glycoproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6). We have utilized soluble, secreted forms of beta 4GalNAc-T3 and beta 4GalNAc-T4 to define the basis for protein-specific GalNAc transfer in vitro to chimeric substrates consisting of Gaussia luciferase followed by a glycoprotein substrate. Transfer of GalNAc by beta 4GalNAc-T3 and beta 4GalNAc-T4 to terminal GlcNAc is divalent cation-dependent. Transfer of GalNAc to glycoprotein acceptors that contain a peptide recognition determinant is maximal between 0.5 and 1.0 mM MnCl2; however, transfer is increasingly inhibited by concentrations of MnCl2 above 1 mM and by anion concentrations above 15 mM. In contrast, transfer of GalNAc to the simple sugar acceptor N-acetylglucosamine-beta-p-nitrophenol (GlcNAc beta-pNP) is not inhibited by concentrations of MnCl2 or anions that would inhibit transfer to glycoprotein acceptors by >90%. This finding indicates that interaction with the peptide recognition determinant in the substrate is sensitive to the anion concentration. beta 4GalNAc-T3 and beta 4GalNAc-T4 have similar but distinct specificities, resulting in a 42-fold difference in the IC50 for transfer of GalNAc to chimeric glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for beta 4GalNAc-T3 and 1.2 mu M for beta 4GalNAc-T4. Our in vitro analysis indicates that enzymatic recognition of the peptide determinant and the oligosaccharide acceptor are independent events.	[Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-HD058474, R01-CA21923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD058474 and R01-CA21923 (to J. U. B.).	BAENZIGER JU, 1991, BIOL CARBOHYDRATES, V3, P1; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; HOOPER LV, 1995, J BIOL CHEM, V270, P16327, DOI 10.1074/jbc.270.27.16327; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; NYAME K, 1989, J BIOL CHEM, V264, P3235; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; REITMAN ML, 1984, METHOD ENZYMOL, V107, P163; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200	25	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29194	29203		10.1074/jbc.M112.371567	http://dx.doi.org/10.1074/jbc.M112.371567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722937	Green Published, hybrid			2022-12-28	WOS:000308074600085
J	Kalwa, H; Sartoretto, JL; Sartoretto, SM; Michel, T				Kalwa, Hermann; Sartoretto, Juliano L.; Sartoretto, Simone M.; Michel, Thomas			Angiotensin-II and MARCKS A HYDROGEN PEROXIDE- AND RAC1-DEPENDENT SIGNALING PATHWAY IN VASCULAR ENDOTHELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RESONANCE ENERGY-TRANSFER; INDUCED NEURITE OUTGROWTH; REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; SH-SY5Y CELLS; PC12 CELLS; ACTIVATION; MEMBRANE	MARCKS is an actin-binding protein that modulates vascular endothelial cell migration and cytoskeleton signaling (Kalwa, H., and Michel, T. (2011) J. Biol. Chem. 286, 2320-2330). Angiotensin-II is a vasoactive peptide implicated in vascular physiology as well as pathophysiology; the pathways connecting angiotensin-II and cytoskeletal remodeling are incompletely understood. Here we show that MARCKS is expressed in intact arterial preparations, with prominent staining of the endothelium. In endothelial cells, angiotensin-II-promoted MARCKS phosphorylation is abrogated by PEG-catalase, implicating endogenous H2O2 in the angiotensin-II response. Studies using the H2O2 biosensor HyPer2 reveal that angiotensin-II promotes increases in intracellular H2O2. We used a Rac1 FRET biosensor to show that angiotensin-II promotes Rac1 activation that is attenuated by PEG-catalase. siRN-mediated Rac1 knockdown blocks angiotensin-II-stimulated MARCKS phosphorylation. Cell imaging studies using a phosphoinositide 4,5-bisphosphate (PIP2) biosensor revealed that angiotensin-II PIP2 regulation depends on MARCKS and H2O2. siRN-mediated knockdown of MARCKS or Rac1 attenuates receptor-mediated activation of the tyrosine kinase c-Abl and disrupts actin fiber formation. These studies establish a critical role for H2O2 in angiotensin-II signaling to the endothelial cytoskeleton in a novel pathway that is critically dependent on MARCKS, Rac1, and c-Abl.	[Kalwa, Hermann; Sartoretto, Juliano L.; Sartoretto, Simone M.; Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, 75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Sartoretto, Simone/F-5622-2014; Kalwa, Hermann/ABG-2323-2021	Sartoretto, Simone/0000-0002-0771-233X; sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; Fonds National de la Recherche, Luxembourg; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to T. M.).; Supported by a postdoctoral fellowship from the Fonds National de la Recherche, Luxembourg.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Amanso Angelica M, 2012, Front Biosci (Schol Ed), V4, P1044; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Aoki K, 2008, PHILOS T R SOC B, V363, P2143, DOI 10.1098/rstb.2008.2267; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; ARNOLD TP, 1993, BIOCHEM J, V295, P155, DOI 10.1042/bj2950155; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Blackshear PJ, 1996, DEV BRAIN RES, V96, P62, DOI 10.1016/S0165-3806(96)00097-1; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; COWEN T, 1985, HISTOCHEMISTRY, V82, P205, DOI 10.1007/BF00501396; Desideri G, 2003, ARTERIOSCL THROM VAS, V23, P1218, DOI 10.1161/01.ATV.0000078521.51319.65; Dietrich U, 2009, BBA-BIOMEMBRANES, V1788, P1474, DOI 10.1016/j.bbamem.2009.04.001; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finlayson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007833; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Itoh RE, 2005, EXP CELL RES, V307, P142, DOI 10.1016/j.yexcr.2005.02.026; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Lu D, 1998, J CELL BIOL, V142, P217, DOI 10.1083/jcb.142.1.217; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Sechi AS, 2000, J CELL SCI, V113, P3685; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Tanabe A, 2012, J CELL PHYSIOL, V227, P618, DOI 10.1002/jcp.22763; Tzlil S, 2008, BIOPHYS J, V95, P1745, DOI 10.1529/biophysj.108.132522; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Yang HJ, 2010, CANCER INVEST, V28, P127, DOI 10.3109/07357900903147184; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452	48	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29147	29158		10.1074/jbc.M112.381517	http://dx.doi.org/10.1074/jbc.M112.381517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773836	hybrid, Green Published			2022-12-28	WOS:000308074600080
J	Nimonkar, AV; Dombrowski, CC; Siino, JS; Stasiak, AZ; Stasiak, A; Kowalczykowski, SC				Nimonkar, Amitabh V.; Dombrowski, Christopher C.; Siino, Joseph S.; Stasiak, Alicja Z.; Stasiak, Andrzej; Kowalczykowski, Stephen C.			Saccharomyces cerevisiae Dmc1 and Rad51 Proteins Preferentially Function with Tid1 and Rad54 Proteins, Respectively, to Promote DNA Strand Invasion during Genetic Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LOOP FORMATION; MEIOTIC RECOMBINATION; HELICAL FILAMENTS; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; BRC REPEATS; DUPLEX DNA; INITIATION; CALCIUM; BREAKS	The Saccharomyces cerevisiae Dmc1 and Tid1 proteins are required for the pairing of homologous chromosomes during meiotic recombination. This pairing is the precursor to the formation of crossovers between homologs, an event that is necessary for the accurate segregation of chromosomes. Failure to form crossovers can have serious consequences and may lead to chromosomal imbalance. Dmc1, a meiosis-specific paralog of Rad51, mediates the pairing of homologous chromosomes. Tid1, a Rad54 paralog, although not meiosis-specific, interacts with Dmc1 and promotes crossover formation between homologs. In this study, we show that purified Dmc1 and Tid1 interact physically and functionally. Dmc1 forms stable nucleoprotein filaments that can mediate DNA strand invasion. Tid1 stimulates Dmc1-mediated formation of joint molecules. Under conditions optimal for Dmc1 reactions, Rad51 is specifically stimulated by Rad54, establishing that Dmc1-Tid1 and Rad51-Rad54 function as specific pairs. Physical interaction studies show that specificity in function is not dictated by direct interactions between the proteins. Our data are consistent with the hypothesis that Rad51-Rad54 function together to promote intersister DNA strand exchange, whereas Dmc1-Tid1 tilt the bias toward interhomolog DNA strand exchange.	[Kowalczykowski, Stephen C.] Univ Calif Davis, Microbiol Sect, Dept Microbiol, Davis, CA 95616 USA; [Nimonkar, Amitabh V.; Dombrowski, Christopher C.; Siino, Joseph S.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Stasiak, Alicja Z.; Stasiak, Andrzej] Univ Lausanne, Fac Biol & Med, Ctr Integratif Genom, CH-1015 Lausanne, Switzerland	University of California System; University of California Davis; University of California System; University of California Davis; University of Lausanne	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Dept Microbiol, 1 Shields Ave,Briggs Hall,Rm 310, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Stasiak, Andrzej/E-5551-2010	Stasiak, Andrzej/0000-0002-0398-1989	National Institutes of Health [GM62653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62653 (to S. C. K.).	Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Dresser ME, 1997, GENETICS, V147, P533; Ehmsen Kirk T., 2008, V3, P91, DOI 10.1007/7050_2008_039; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fornander LH, 2012, NUCLEIC ACIDS RES, V40, P4904, DOI 10.1093/nar/gks140; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; HUNTER N, 2007, MOL GENETICS RECOMBI, P381; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kaback DB, 1999, GENETICS, V152, P1475; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; KEITH CH, 1985, P NATL ACAD SCI USA, V82, P800, DOI 10.1073/pnas.82.3.800; Kiianitsa K, 2002, J BIOL CHEM, V277, P46205, DOI 10.1074/jbc.M207967200; Klein HL, 1997, GENETICS, V147, P1533; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; MENETSKI JP, 1992, J BIOL CHEM, V267, P10400; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sambrook J., 1989, MOL CLONING LAB MANU, P92; Schmuckli-Maurer J, 2000, CHROMOSOMA, V109, P86, DOI 10.1007/s004120050415; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2003, GENETICS, V163, P1273; SOGO JM, 1987, ELECTRON MICROS, P61; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	62	36	37	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28727	28737		10.1074/jbc.M112.373290	http://dx.doi.org/10.1074/jbc.M112.373290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761450	Green Published, hybrid			2022-12-28	WOS:000308074600046
J	Su, K; Sabeva, NS; Liu, JJ; Wang, YH; Bhatnagar, S; van der Westhuyzen, DR; Graf, GA				Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; Bhatnagar, Saloni; van der Westhuyzen, Deneys R.; Graf, Gregory A.			The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY CHOLESTEROL SECRETION; DIETARY-CHOLESTEROL; SCAVENGER RECEPTOR; SR-BI; PLANT STEROLS; ER STRESS; MICE; SITOSTEROLEMIA; EZETIMIBE; ABSORPTION	ABCG5 and ABCG8 form a complex (G5G8) that opposes the absorption of plant sterols but is also expressed in liver where it promotes the excretion of cholesterol into bile. Hepatic G5G8 is transcriptionally regulated by a number of factors implicated in the development of insulin resistance and nonalcoholic fatty liver disease. Therefore, we hypothesized that G5G8 may influence the development of diet-induced obesity phenotypes independently of its role in opposing phytosterol absorption. G5G8 knock-out (KO) mice and their wild type (WT) littermates were challenged with a plant sterol-free low fat or high fat (HF) diet. Weight gain and the rise in fasting glucose were accelerated in G5G8 KO mice following HF feeding. HF-fed G5G8 KO mice had increased liver weight, hepatic lipids, and plasma alanine aminotransferase compared with WT controls. Consistent with the development of nonalcoholic fatty liver disease, macrophage infiltration, the number of TUNEL-positive cells, and the expression of proinflammatory cytokines were also increased in G5G8 KO mice. Hepatic lipid accumulation was associated with increased peroxisome proliferator activated receptor gamma, CD36, and fatty acid uptake. Phosphorylation of eukaryotic translation initiation factor 2 alpha (eiF2 alpha) and expression of activating transcription factor 4 and tribbles 3 were elevated in HF-fed G5G8 KO mice, a pathway that links the unfolded protein response to the development of insulin resistance through inhibition of protein kinase B (Akt) phosphorylation. Phosphorylation of Akt and insulin receptor was reduced, whereas serine phosphorylation of insulin receptor substrate 1 was elevated.	[Graf, Gregory A.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Bhatnagar, Saloni] Univ Kentucky, Dept Pediat, Lexington, KY 40536 USA; [van der Westhuyzen, Deneys R.] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; van der Westhuyzen, Deneys R.; Graf, Gregory A.] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Su, Kai; Sabeva, Nadezhda S.; Liu, Jingjing; Wang, Yuhuan; van der Westhuyzen, Deneys R.; Graf, Gregory A.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Graf, GA (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 345 Biol Pharmaceut Complex,789 S Limestone, Lexington, KY 40536 USA.	Gregory.Graf@uky.edu		Graf, Gregory/0000-0002-0130-9929; Sabeva, Nadezhda/0000-0002-7714-4884	National Institutes of Health [R01DK080874]; National Center for Research Resources [5P20RR021954-05]; NIGMS [8 P20 GM103527-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK080874 (to G. A. G.), 5P20RR021954-05 from the National Center for Research Resources, and 8 P20 GM103527-05 from the NIGMS.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Bao LP, 2006, J BIOL CHEM, V281, P33635, DOI 10.1074/jbc.M606339200; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; BOTHAM KM, 1995, PROG LIPID RES, V34, P71, DOI 10.1016/0163-7827(94)00007-9; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Carter BA, 2007, PEDIATR RES, V62, P301, DOI 10.1203/PDR.0b013e3181256492; de Bari O, 2012, J LIPIDS, V2012, DOI 10.1155/2012/302847; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Djouadi F, 2003, PEDIATR RES, V54, P446, DOI 10.1203/01.PDR.0000083001.91588.BB; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Freeman LA, 2004, J LIPID RES, V45, P1197, DOI 10.1194/jlr.C400002-JLR200; Graewin SJ, 2004, J SURG RES, V122, P145, DOI 10.1016/j.jss.2004.04.012; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Hyogo H, 2003, J LIPID RES, V44, P1232, DOI 10.1194/jlr.M300029-JLR200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Lutjohann D, 2008, INT J CLIN PRACT, V62, P1499, DOI 10.1111/j.1742-1241.2008.01841.x; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mendez-Gonzalez J, 2011, BBA-MOL CELL BIOL L, V1811, P1186, DOI 10.1016/j.bbalip.2011.07.019; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Sabeva NS, 2007, J BIOL CHEM, V282, P22397, DOI 10.1074/jbc.M702236200; Sabeva NS, 2011, J NUTR BIOCHEM, V22, P777, DOI 10.1016/j.jnutbio.2010.07.002; Salen G, 2006, GASTROENTEROLOGY, V130, P1853, DOI 10.1053/j.gastro.2006.02.027; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; SALEN G, 1992, J LIPID RES, V33, P945; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Wiersma H, 2009, J LIPID RES, V50, P1571, DOI 10.1194/jlr.M800434-JLR200; Wilund KR, 2004, J LIPID RES, V45, P1429, DOI 10.1194/jlr.M400167-JLR200; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J LIPID RES, V46, P1739, DOI 10.1194/jlr.M500124-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	41	36	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28564	28575		10.1074/jbc.M112.360081	http://dx.doi.org/10.1074/jbc.M112.360081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22715101	hybrid, Green Published			2022-12-28	WOS:000308074600031
J	Barry, ZT; Platt, MO				Barry, Zachary T.; Platt, Manu O.			Cathepsin S Cannibalism of Cathepsin K as a Mechanism to Reduce Type I Collagen Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROSIS; CYSTEINE PROTEASES; ENDOTHELIAL-CELLS; DEFICIENT MICE; SHEAR-STRESS; EXPRESSION; PROTEINASES; PROGRESSION; INHIBITION; SPLEEN	Cathepsins S and K are potent mammalian proteases secreted into the extracellular space and have been implicated in elastin and collagen degradation in diseases such as atherosclerosis and osteoporosis. Studies of individual cathepsins hydrolyzing elastin or collagen have provided insight into their binding and kinetics, but cooperative or synergistic activity between cathepsins K and S is less described. Using fluorogenic substrate assays, Western blotting, cathepsin zymography, and computational analyses, we uncovered cathepsin cannibalism, a novel mechanism by which cathepsins degrade each other as well as the substrate, with cathepsin S predominantly degrading cathepsin K. As a consequence of these proteolytic interactions, a reduction in total hydrolysis of elastin and type I collagen was measured compared with computationally predicted values derived from individual cathepsin assays. Furthermore, type I collagen was preserved from hydrolysis when a 10-fold ratio of cathepsin S cannibalized the highly collagenolytic cathepsin K, preventing its activity. Elastin was not preserved due to strong elastinolytic ability of both enzymes. Together, these results provide new insight into the combined proteolytic activities of cathepsins toward substrates and each other and present kinetic models to consider for more accurate predictions and descriptions of these systems.	[Platt, Manu O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Platt, Manu O.] Emory Univ, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Platt, MO (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 315 Ferst Dr,Suite 1308, Atlanta, GA 30332 USA.	manu.platt@bme.gatech.edu	Platt, Manu/ABY-6057-2022	Platt, Manu/0000-0001-6390-4320	National Institutes of Health New Innovator Grant [1DP2OD007433-01]; Office of the Director, National Institutes of Health [DP2OD007433]; Georgia Cancer Coalition, Georgia Institute of Technology startup funds; National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) [CBET-0939511]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007433] Funding Source: NIH RePORTER	National Institutes of Health New Innovator Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition, Georgia Institute of Technology startup funds; National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health New Innovator Grant 1DP2OD007433-01 and by Award DP2OD007433 from the Office of the Director, National Institutes of Health. This work was also supported by the Georgia Cancer Coalition, Georgia Institute of Technology startup funds, and the National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) Grant CBET-0939511.	Bromme D, 2009, EXPERT OPIN INV DRUG, V18, P585, DOI [10.1517/13543780902832661 , 10.1517/13543780902832661]; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Nissler K, 1999, EUR J BIOCHEM, V263, P717, DOI 10.1046/j.1432-1327.1999.00547.x; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Platt MO, 2007, AM J PHYSIOL-HEART C, V292, pH1479, DOI 10.1152/ajpheart.00954.2006; Platt MO, 2006, ARTERIOSCL THROM VAS, V26, P1784, DOI 10.1161/01.ATV.0000227470.72109.2b; Selinger CI, 2005, J CELL BIOCHEM, V96, P996, DOI 10.1002/jcb.20575; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Wilder CL, 2011, ARCH BIOCHEM BIOPHYS, V516, P52, DOI 10.1016/j.abb.2011.09.009	26	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27723	27730		10.1074/jbc.M111.332684	http://dx.doi.org/10.1074/jbc.M111.332684			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730330	Green Published, hybrid			2022-12-28	WOS:000307840700046
J	Katsushima, K; Shinjo, K; Natsume, A; Ohka, F; Fujii, M; Osada, H; Sekido, Y; Kondo, Y				Katsushima, Keisuke; Shinjo, Keiko; Natsume, Atsushi; Ohka, Fumiharu; Fujii, Makiko; Osada, Hirotaka; Sekido, Yoshitaka; Kondo, Yutaka			Contribution of MicroRNA-1275 to Claudin 11 Protein Suppression via a Polycomb-mediated Silencing Mechanism in Human Glioma Stem-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; DNA METHYLATION; INITIATING CELLS; GLIOBLASTOMA; DISEASE; BRAIN; DIFFERENTIATION; IDENTIFICATION; INVASIVENESS; TRANSITIONS	Glioblastomas show heterogeneous histological features, and tumor cells show distinct phenotypic states that confer different functional attributes and an aggressive character. However, the molecular mechanisms underlying the heterogeneity in this disease are poorly understood. Glioma stem-like cells (GSCs) are considered able to aberrantly differentiate into diverse cell types and may contribute to the establishment of tumor heterogeneity. Using a GSC model, we investigated differentially expressed microRNAs (miRNAs) and associated epigenetic mechanisms that regulate the differentiation of GSCs. miRNA profiling using microarray technology showed that 13 and 34 miRNAs were commonly up-regulated and down-regulated in two independent GSC lines during differentiation, respectively. Among this set of miRNAs, quantitative PCR analysis showed that miRNA-1275 (miR-1275) was consistently down-regulated during GSC differentiation, along with the up-regulation of its target, CLDN11, an important protein during oligodendroglial lineage differentiation. Inhibition of miR-1275 with a specific antisense oligonucleotide (anti-miR-1275) in GSCs increased the expression of CLDN11, together with significant growth suppression. Epigenetic analysis revealed that gain of histone H3 lysine 27 trimethylation (H3K27me3) in the primary microRNA-1275 promoter was closely associated with miR-1275 expression. Treatment with 3-deazaneplanocin A, an inhibitor of H3K27 methyltransferase, attenuated CLDN11 induction by serum stimulation in parallel with sustained miR-1275 expression. Our results have illuminated the epigenetic regulatory pathways of miR-1275 that are closely associated with oligodendroglial differentiation, which may contribute to the tissue heterogeneity seen in the formation of glioblastomas. Given that inhibition of miR-1275 induces expression of oligodendroglial lineage proteins and suppresses tumor cell proliferation, this may be a potential therapeutic target for glioblastomas.	[Kondo, Yutaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Shinjo, Keiko; Osada, Hirotaka; Sekido, Yoshitaka] Nagoya Grad Sch Med, Dept Canc Genet, Nagoya, Aichi 4668560, Japan; [Natsume, Atsushi] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 4648560, Japan; [Kondo, Yutaka] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Kondo, Y (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ykondo@aichi-cc.jp	Sekido, Yoshitaka/P-9756-2015; Natsume, Atsushi/I-7364-2014; katsushima, keisuke/AAV-5204-2020; Ohka, Fumiharu/A-3420-2016	Natsume, Atsushi/0000-0002-9113-0470; katsushima, keisuke/0000-0001-7770-432X; Ohka, Fumiharu/0000-0002-5569-5626; Sekido, Yoshitaka/0000-0002-2428-3848	PRESTO of JST; Japan Society for the Promotion of Science	PRESTO of JST; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from PRESTO of JST (to Y. K.) and a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to Y. K.).	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Awsare NS, 2011, ONCOL REP, V25, P1503, DOI 10.3892/or.2011.1244; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Farah MH, 2000, DEVELOPMENT, V127, P693; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soini Y, 2010, HISTOPATHOLOGY, V56, P821, DOI 10.1111/j.1365-2559.2010.03538.x; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020	49	40	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27396	27406		10.1074/jbc.M112.359109	http://dx.doi.org/10.1074/jbc.M112.359109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736761	Green Published, hybrid			2022-12-28	WOS:000307840700011
J	Peng, HY; Guerau-de-Arellano, M; Mehta, VB; Yang, YH; Huss, DJ; Papenfuss, TL; Lovett-Racke, AE; Racke, MK				Peng, Haiyan; Guerau-de-Arellano, Mireia; Mehta, Veela B.; Yang, Yuhong; Huss, David J.; Papenfuss, Tracey L.; Lovett-Racke, Amy E.; Racke, Michael K.			Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor kappa B (NF-kappa B) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; TRANSCRIPTIONAL ACTIVATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; T-BET; PHOSPHORYLATION; INDUCTION; P65; PATHWAY	Dimethyl fumarate (DMF) is an effective novel treatment for multiple sclerosis in clinical trials. A reduction of IFN-gamma-producing CD4(+) T cells is observed in DMF-treated patients and may contribute to its clinical efficacy. However, the cellular and molecular mechanisms behind this clinical observation are unclear. In this study, we investigated the effects of DMF on dendritic cell (DC) maturation and subsequent DC-mediated T cell responses. We show that DMF inhibits DC maturation by reducing inflammatory cytokine production (IL-12 and IL-6) and the expression of MHC class II, CD80, and CD86. Importantly, this immature DC phenotype generated fewer activated T cells that were characterized by decreased IFN-gamma and IL-17 production. Further molecular studies demonstrated that DMF impaired nuclear factor kappa B (NF-kappa B) signaling via reduced p65 nuclear translocalization and phosphorylation. NF-kappa B signaling was further decreased by DMF-mediated suppression of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and its downstream kinase mitogen stress-activated kinase 1 (MSK1). MSK1 suppression resulted in decreased p65 phosphorylation at serine 276 and reduced histone phosphorylation at serine 10. As a consequence, DMF appears to reduce p65 transcriptional activity both directly and indirectly by promoting a silent chromatin environment. Finally, treatment of DCs with the MSK1 inhibitor H89 partially mimicked the effects of DMF on the DC signaling pathway and impaired DC maturation. Taken together, these studies indicate that by suppression of both NF-kappa B and ERK1/2-MSK1 signaling, DMF inhibits maturation of DCs and subsequently Th1 and Th17 cell differentiation.	[Peng, Haiyan; Lovett-Racke, Amy E.; Racke, Michael K.] Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA; [Racke, Michael K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Peng, Haiyan; Guerau-de-Arellano, Mireia; Mehta, Veela B.; Yang, Yuhong; Racke, Michael K.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Lovett-Racke, Amy E.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Huss, David J.; Lovett-Racke, Amy E.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Papenfuss, Tracey L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Racke, MK (corresponding author), Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA.	Michael.Racke@osumc.edu	Peng, Haiyan/A-1258-2015; Yang, Yuhong/A-6033-2013; Lovett-Racke, Amy/E-3545-2011; Papenfuss, Tracey/E-3814-2011	Peng, Haiyan/0000-0003-2703-6081; 	National Institutes of Health [RO1 NS067441-01, RO1 NS037513-10]; National Multiple Sclerosis Society [NMSS 4358-A-13]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR022198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067441, R01NS037513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS067441-01 to A. E. L. R.) and RO1 NS037513-10 (to M. K. R.). This work was also supported by National Multiple Sclerosis Society Grant NMSS 4358-A-13 (to M.K.R.).	[Anonymous], 2011, NAT REV DRUG DISCOV, V10, P404; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fuseler JW, 2006, MICROSC MICROANAL, V12, P269, DOI 10.1017/S1431927606060260; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Handley ME, 2005, FREE RADICAL BIO MED, V38, P1637, DOI 10.1016/j.freeradbiomed.2005.02.022; Hansen BS, 2006, J NEUROIMMUNOL, V172, P94, DOI 10.1016/j.jneuroim.2005.11.006; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Karni A, 2006, J IMMUNOL, V177, P4196, DOI 10.4049/jimmunol.177.6.4196; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Papenfuss TL, 2011, J IMMUNOL, V186, P3346, DOI 10.4049/jimmunol.1001322; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schimrigk S, 2006, EUR J NEUROL, V13, P604, DOI 10.1111/j.1468-1331.2006.01292.x; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Svajger U, 2011, J LEUKOCYTE BIOL, V89, P893, DOI 10.1189/jlb.0810463; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	47	138	148	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28017	28026		10.1074/jbc.M112.383380	http://dx.doi.org/10.1074/jbc.M112.383380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733812	Green Published, hybrid			2022-12-28	WOS:000307840700075
J	Steringer, JP; Bleicken, S; Andreas, H; Zacherl, S; Laussmann, M; Temmerman, K; Contreras, FX; Bharat, TAM; Lechner, J; Muller, HM; Briggs, JAG; Garcia-Saez, AJ; Nickel, W				Steringer, Julia P.; Bleicken, Stephanie; Andreas, Helena; Zacherl, Sonja; Laussmann, Mareike; Temmerman, Koen; Contreras, F. Xabier; Bharat, Tanmay A. M.; Lechner, Johannes; Mueller, Hans-Michael; Briggs, John A. G.; Garcia-Saez, Ana J.; Nickel, Walter			Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2)-dependent Oligomerization of Fibroblast Growth Factor 2 (FGF2) Triggers the Formation of a Lipidic Membrane Pore Implicated in Unconventional Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PROTEIN SECRETION; CELL-SURFACE; IL-1-BETA SECRETION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; TRANSLOCATION; EXPORT; BAX; MACHINERY	Fibroblast growth factor 2 (FGF2) is a critical mitogen with a central role in specific steps of tumor-induced angiogenesis. It is known to be secreted by unconventional means bypassing the endoplasmic reticulum/Golgi-dependent secretory pathway. However, the mechanism of FGF2 membrane translocation into the extracellular space has remained elusive. Here, we show that phosphatidylinositol 4,5-bisphosphate-dependent membrane recruitment causes FGF2 to oligomerize, which in turn triggers the formation of a lipidic membrane pore with a putative toroidal structure. This process is strongly up-regulated by tyrosine phosphorylation of FGF2. Our findings explain key requirements of FGF2 secretion from living cells and suggest a novel self-sustained mechanism of protein translocation across membranes with a lipidic membrane pore being a transient translocation intermediate.	[Steringer, Julia P.; Andreas, Helena; Zacherl, Sonja; Laussmann, Mareike; Temmerman, Koen; Contreras, F. Xabier; Lechner, Johannes; Mueller, Hans-Michael; Nickel, Walter] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bharat, Tanmay A. M.; Briggs, John A. G.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Nickel, W (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Saez, Ana J. Garcia/U-1611-2019; Contreras, Xabier/AAA-8885-2019; Briggs, John/J-3096-2012	Bleicken, Stephanie/0000-0002-4789-0974; Muller, Hans-Michael/0000-0002-2384-7285; Briggs, John/0000-0003-3990-6910; Contreras, Xabier/0000-0003-0875-634X; Bharat, Tanmay/0000-0002-0168-0277	German Research Foundation [SFB 638, GRK 1188]; EuroMembrane Program of the European Science Foundation; AID-NET Program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	German Research Foundation(German Research Foundation (DFG)); EuroMembrane Program of the European Science Foundation; AID-NET Program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	This work was supported by German Research Foundation Grants SFB 638 and GRK 1188, the EuroMembrane Program of the European Science Foundation, the AID-NET Program of the Federal Ministry for Education and Research of Germany, and the Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks.	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Apellaniz B, 2010, BIOPHYS J, V99, P3619, DOI 10.1016/j.bpj.2010.09.027; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bleicken S, 2011, CURR PROTEIN PEPT SC, V12, P691, DOI 10.2174/138920311798841744; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Cabral M, 2010, EUKARYOT CELL, V9, P1009, DOI 10.1128/EC.00337-09; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Kastrup JS, 1997, ACTA CRYSTALLOGR D, V53, P160, DOI 10.1107/S0907444996012711; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Prudovsky I, 2002, J CELL BIOL, V158, P201, DOI 10.1083/jcb.200203084; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xie JM, 2007, ACS CHEM BIOL, V2, P474, DOI 10.1021/cb700083w; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	52	74	74	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27659	27669		10.1074/jbc.M112.381939	http://dx.doi.org/10.1074/jbc.M112.381939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730382	Green Published, hybrid			2022-12-28	WOS:000307840700040
J	Yadav, V; Zhang, XY; Liu, JG; Estrem, S; Li, SY; Gong, XQ; Buchanan, S; Henry, JR; Starling, JJ; Peng, SB				Yadav, Vipin; Zhang, Xiaoyi; Liu, Jiangang; Estrem, Shawn; Li, Shuyu; Gong, Xue-Qian; Buchanan, Sean; Henry, James R.; Starling, James J.; Peng, Sheng-Bin			Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INHIBITOR; ACQUIRED-RESISTANCE; BRAF INHIBITION; MUTATIONS; GROWTH; POTENT; MECHANISM; GENE; EXPRESSION; RESPONSES	Oncogenic B-RAF V600E mutation is found in 50% of melanomas and drives MEK/ERK pathway and cancer progression. Recently, a selective B-RAF inhibitor, vemurafenib (PLX4032), received clinical approval for treatment of melanoma with B-RAF V600E mutation. However, patients on vemurafenib eventually develop resistance to the drug and demonstrate tumor progression within an average of 7 months. Recent reports indicated that multiple complex and context-dependent mechanisms may confer resistance to B-RAF inhibition. In the study described herein, we generated B-RAF V600E melanoma cell lines of acquired-resistance to vemurafenib, and investigated the underlying mechanism(s) of resistance. Biochemical analysis revealed that MEK/ERK reactivation through Ras is the key resistance mechanism in these cells. Further analysis of total gene expression by microarray confirmed a significant increase of Ras and RTK gene signatures in the vemurafenib-resistant cells. Mechanistically, we found that the enhanced activation of fibroblast growth factor receptor 3 (FGFR3) is linked to Ras and MAPK activation, therefore conferring vemurafenib resistance. Pharmacological or genetic inhibition of the FGFR3/Ras axis restored the sensitivity of vemurafenib-resistant cells to vemurafenib. Additionally, activation of FGFR3 sufficiently reactivated Ras/MAPK signaling and conferred resistance to vemurafenib in the parental B-RAF V600E melanoma cells. Finally, we demonstrated that vemurafenib-resistant cells maintain their addiction to the MAPK pathway, and inhibition of MEK or pan-RAF activities is an effective therapeutic strategy to overcome acquired-resistance to vemurafenib. Together, we describe a novel FGFR3/Ras mediated mechanism for acquired-resistance to B-RAF inhibition. Our results have implications for the development of new therapeutic strategies to improve the outcome of patients with B-RAF V600E melanoma.	[Yadav, Vipin; Zhang, Xiaoyi; Starling, James J.; Peng, Sheng-Bin] Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA; [Liu, Jiangang; Estrem, Shawn; Li, Shuyu; Gong, Xue-Qian; Buchanan, Sean] Eli Lilly & Co, Lilly Res Labs, Translat Sci, Indianapolis, IN 46285 USA; [Henry, James R.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Peng, SB (corresponding author), Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA.	sbpeng@lilly.com	gong, xue/GYQ-8649-2022		Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Azuma K, 2011, BIOCHEM BIOPH RES CO, V407, P219, DOI 10.1016/j.bbrc.2011.03.002; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jang JH, 2001, CANCER RES, V61, P3541; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Yadav V, 2011, MOL CARCINOGEN, V50, P346, DOI 10.1002/mc.20716; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhao GS, 2011, MOL CANCER THER, V10, P2200, DOI 10.1158/1535-7163.MCT-11-0306	37	136	141	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28087	28098		10.1074/jbc.M112.377218	http://dx.doi.org/10.1074/jbc.M112.377218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730329	hybrid, Green Published			2022-12-28	WOS:000307840700082
J	Dwivedi, VP; Bhattacharya, D; Chatterjee, S; Prasad, DVR; Chattopadhyay, D; Van Kaer, L; Bishai, WR; Das, G				Dwivedi, Ved Prakash; Bhattacharya, Debapriya; Chatterjee, Samit; Prasad, Durbaka Vijay Raghva; Chattopadhyay, Debprasad; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1 beta Production in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; DRUG-RESISTANT TUBERCULOSIS; TGF-BETA; MOLECULAR-BASIS; IN-VIVO; INFECTION; IMMUNITY; INFLAMMATION; MACROPHAGES; IL-1-BETA	Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), resides and replicates within phagocytes and persists in susceptible hosts by modulating protective innate immune responses. Furthermore, M. tuberculosis promotes T helper 2 (Th2) immune responses by altering the balance of T cell polarizing cytokines in infected cells. However, cytokines that regulate Th2 cell differentiation during TB infection remain unknown. Here we show that IL-1 beta, produced by phagocytes infected by virulent M. tuberculosis strain H37Rv, directs Th2 cell differentiation. In sharp contrast, the vaccine strain bacille Calmette-Guerin as well as RD-1 and ESAT-6 mutants of H37Rv failed to induce IL-1 beta and promote Th2 cell differentiation. Furthermore, ESAT-6 induced IL-1 beta production in dendritic cells (DCs), and CD4(+) T cells co-cultured with infected DCs differentiated into Th2 cells. Taken together, our findings indicate that IL-1 beta induced by RD-1/ESAT-6 plays an important role in the differentiation of Th2 cells, which in turn facilitates progression of TB by inhibiting host protective Th1 responses.	[Bishai, William R.] Kwazulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa; [Dwivedi, Ved Prakash; Bhattacharya, Debapriya; Chatterjee, Samit; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Prasad, Durbaka Vijay Raghva] Yogi Vemana Univ, Dept Microbiol, Kadapa 516003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Vanderbilt University; Yogi Vemana University	Bishai, WR (corresponding author), Kwazulu Natal Res Inst TB & HIV, Suite Z310,Doris Duke Bldg,719 Umbilo Rd, ZA-4001 Durban, South Africa.	dasgo@icgeb.res.in	Van Kaer, Luc/H-1033-2015; Chatterjee, Samit/ABZ-2522-2022	Van Kaer, Luc/0000-0001-5275-2309; Chatterjee, Samit/0000-0001-8176-3410; CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X; Dwivedi, Ved Prakash/0000-0003-4321-2567				Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; [Anonymous], 2007, GLOB TUB CONTR SURV; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Mejri N, 2007, INT IMMUNOL, V19, P535, DOI 10.1093/intimm/dxm019; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Rook GAW, 2007, CURR MOL MED, V7, P327; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Velayati AA, 2009, EUR RESPIR J, V34, P1202, DOI 10.1183/09031936.00081909; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; World Health Organization, 2004, Weekly Epidemiological Record, V79, P27; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043	42	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33656	33663		10.1074/jbc.M112.375154	http://dx.doi.org/10.1074/jbc.M112.375154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22810226	hybrid, Green Published			2022-12-28	WOS:000309602100049
J	Qi, YF; Xia, P				Qi, Yanfei; Xia, Pu			Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Plays a Critical Role in beta-Cell Survival under Endoplasmic Reticulum Stress PROMOTING UBIQUITINATION AND DEGRADATION OF C/EBP HOMOLOGOUS PROTEIN (CHOP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; SMAC/DIABLO RELEASE; OXIDATIVE STRESS; CYTOCHROME-C; DEATH; CANCER; IAPS; EXPRESSION; DISEASE; FAMILY	Lipotoxicity in pancreatic beta-cells, arising from excess free fatty acid-induced endoplasmic reticulum (ER) stress response, has been recognized as a key pathogenic factor causing loss of beta-cell mass and contributing to type 2 diabetes. However, how the adaptive ER stress response causes cell death remains enigmatic. We report herein a critical role of cellular inhibitor of apoptosis protein-1 (cIAP1) in controlling beta-cell survival under ER stress. While both palmitate and palmitoleate induced an overt ER stress response, lipotoxicity was only observed in beta-cells exposed to palmitate but not palmitoleate. Interestingly, cells treated with palmitoleate exerted a sustainable level of cIAP1, whereas the protein quickly degraded following palmitate treatment. Enforced overexpression of cIAP1 prevented palmitate-induced cell death. In contrast, siRNA-mediated knockdown of cIAP1 in beta-cells or knock-out of cIap1 in mouse embryonic fibroblasts not only increased palmitate-induced apoptosis, but also committed cells to death in response to the nontoxic palmitoleate treatment. Of importance, we found that cIAP1 functions as an E3 ubiquitin ligase promoting ubiquitination and degradation of C/EBP homologous protein (CHOP), a key mediator of ER stress-induced cell death. These findings define a novel mechanism for beta-cell survival under ER stress and help to identify targets for therapeutic intervention against lipotoxicity in beta-cells.	[Qi, Yanfei; Xia, Pu] Univ Sydney, Centenary Inst, Signal Transduct Program, Sydney Med Sch, Sydney, NSW 2042, Australia	University of Sydney; Centenary Institute	Xia, P (corresponding author), Univ Sydney, Centenary Inst, Signal Transduct Program, Sydney Med Sch, Sydney, NSW 2042, Australia.	p.xia@centenary.org.au	Xia, Pu/G-3090-2010; Qi, Yanfei/ABC-1242-2021	Xia, Pu/0000-0003-4705-8878; Qi, Yanfei/0000-0003-1391-4111	Australian National Health and Medical Research Council (NHMRC) [349348, 571408]; NHMRC; Cancer Institute NSW Research Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Research Fellowship	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC, Project #349348 and Program #571408).; Supported by an NHMRC Scholarship.; Supported by Cancer Institute NSW Research Fellowship.	Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kandasamy K, 2003, CANCER RES, V63, P1712; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Maas C, 2010, CELL DEATH DIFFER, V17, P1613, DOI 10.1038/cdd.2010.39; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	40	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32236	32245		10.1074/jbc.M112.362160	http://dx.doi.org/10.1074/jbc.M112.362160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815481	Green Published, hybrid			2022-12-28	WOS:000309059400060
J	Hernandez-Rocamora, VM; Reija, B; Garcia, C; Natale, P; Alfonso, C; Minton, AP; Zorrilla, S; Rivas, G; Vicente, M				Hernandez-Rocamora, Victor M.; Reija, Belen; Garcia, Concepcion; Natale, Paolo; Alfonso, Carlos; Minton, Allen P.; Zorrilla, Silvia; Rivas, German; Vicente, Miguel			Dynamic Interaction of the Escherichia coli Cell Division ZipA and FtsZ Proteins Evidenced in Nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; MEMBRANE; RECONSTITUTION; RING; ASSOCIATION; MONOMER	The full-length ZipA protein from Escherichia coli, one of the essential components of the division proto-ring that provides membrane tethering to the septation FtsZ protein, has been incorporated in single copy into nanodiscs formed by a membrane scaffold protein encircling an E. coli phospholipid mixture. This is an acellular system that reproduces the assembly of part of the cell division components. ZipA contained in nanodiscs (Nd-ZipA) retains the ability to interact with FtsZ oligomers and with FtsZ polymers. Interactions with FtsZ occur at similar strengths as those involved in the binding of the soluble form of ZipA, lacking the transmembrane region, suggesting that the transmembrane region of ZipA has little influence on the formation of the ZipA.FtsZ complex. Peptides containing partial sequences of the C terminus of FtsZ compete with FtsZ polymers for binding to Nd-ZipA. The affinity of Nd-ZipA for the FtsZ polymer formed with GTP or GMPCPP (a slowly hydrolyzable analog of GTP) is moderate (micromolar range) and of similar magnitude as for FtsZ-GDP oligomers. Polymerization does not stabilize the binding of FtsZ to ZipA. This supports the role of ZipA as a passive anchoring device for the proto-ring with little implication, if any, in the regulation of its assembly. Furthermore, it indicates that the tethering of FtsZ to the membrane shows sufficient plasticity to allow for its release from noncentral regions of the cytoplasmic membrane and its subsequent relocation to midcell when demanded by the assembly of a division ring.	[Hernandez-Rocamora, Victor M.; Garcia, Concepcion; Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Natale, Paolo; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, E-28006 Madrid, Spain; [Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rivas, G (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	grivas@cib.csic.es; mvicente@cnb.csic.es	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Natale, Paolo/E-9326-2012; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Natale, Paolo/0000-0002-4759-0816; Minton, Allen/0000-0001-8459-1247; Zorrilla, Silvia/0000-0002-6309-9058; Hernandez-Rocamora, Victor M./0000-0003-2517-5707	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSIC-PIE-201020I001, BFU2010-14910, BIO2011-28941-C03]; NIDDK, National Institutes of Health	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Human Frontier Science Program through Grant RGP0050/2010, the European Commission through Contract HEALTH-F3-2009-223431 (both to M. V. and G. R.), and the Spanish Government through Grants BIO2008-04478-C03 (to M. V. and G. R.), CSIC-PIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to M. V., G. R., and S. Z.).; Supported by the Intramural Research Program of the NIDDK, National Institutes of Health.	Arumugam S, 2011, WIRES SYST BIOL MED, V3, P269, DOI 10.1002/wsbm.119; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P9146, DOI 10.1021/bi0009690; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Skoog K, 2012, BIOCHEMISTRY-US, V51, P1407, DOI 10.1021/bi2015647; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	24	36	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30097	30104		10.1074/jbc.M112.388959	http://dx.doi.org/10.1074/jbc.M112.388959			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787144	hybrid, Green Published			2022-12-28	WOS:000308579800005
J	Pin, AL; Houle, F; Fournier, P; Guillonneau, M; Paquet, ER; Simard, MJ; Royal, I; Huot, J				Pin, Anne-Laure; Houle, Francois; Fournier, Patrick; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Royal, Isabelle; Huot, Jacques			Annexin-1-mediated Endothelial Cell Migration and Angiogenesis Are Regulated by Vascular Endothelial Growth Factor (VEGF)-induced Inhibition of miR-196a Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED PROTEINS; ANNEXIN A1; PHOSPHORYLATION; ACTIVATION; KINASE; RECEPTOR; IDENTIFICATION; MEMBRANE; MOUSE; LIPOCORTIN-1	Endothelial cell migration induced in response to vascular endothelial growth factor (VEGF) is an essential step of angiogenesis. It depends in part on the activation of the p38/MAP-KAP kinase-2/LIMK1/annexin-A1 (ANXA1) signaling axis. In the present study, we obtained evidence indicating that miR-196a specifically binds to the 3'-UTR region of ANXA1 mRNA to repress its expression. In accordance with the role of ANXA1 in cell migration and angiogenesis, the ectopic expression of miR-196a is associated with decreased cell migration in wound closure assays, and the inhibitory effect of miR-196a is rescued by overexpressing ANXA1. This finding highlights the fact that ANXA1 is a required mediator of VEGF-induced cell migration. miR-196a also reduces the formation of lamellipodia in response to VEGF suggesting that ANXA1 regulates cell migration by securing the formation of lamellipodia at the leading edge of the cell. Additionally, in line with the fact that cell migration is an essential step of angiogenesis, the ectopic expression of miR-196a impairs the formation of capillary-like structures in a tissue-engineered model of angiogenesis. Here again, the effect of miR-196a is rescued by overexpressing ANXA1. Moreover, the presence of miR-196a impairs the VEGF-induced in vivo neo-vascularization in the Matrigel Plug assay. Interestingly, VEGF reduces the expression of miR-196a, which is associated with an increased level of ANXA1. Similarly, the inhibition of miR-196a with an antagomir results in an increased level of ANXA1. We conclude that the VEGF-induced decrease of miR-196a expression may participate to the angiogenic switch by maintaining the expression of ANXA1 to levels required to enable p38-ANXA1-dependent endothelial cell migration and angiogenesis in response to VEGF.	[Pin, Anne-Laure; Houle, Francois; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Huot, Jacques] Univ Laval, Le Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada; [Pin, Anne-Laure; Houle, Francois; Guillonneau, Maeva; Paquet, Eric R.; Simard, Martin J.; Huot, Jacques] Hop Hotel Dieu, Ctr Rech CHUQ, Quebec City, PQ G1R 2J6, Canada; [Fournier, Patrick; Royal, Isabelle] CRCHUM Ctr Hosp Univ Montreal, Montreal, PQ H2L 4M1, Canada; [Fournier, Patrick; Royal, Isabelle] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada	Laval University; Laval University; Universite de Montreal; Universite de Montreal	Huot, J (corresponding author), Univ Laval, Le Ctr Rech Cancerol, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	Jacques.Huot@fmed.ulaval.ca		Paquet, Eric/0000-0001-9194-1655; Royal, Isabelle/0000-0002-7548-1182; Simard, Martin/0000-0002-3189-9309	Canadian Institutes for Health Research (CIHR); Heart Stroke Foundation of Canada (HSFC); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR; CRCHUQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); CRCHUQ	This study was supported by grants (to J. H.) from the Canadian Institutes for Health Research (CIHR), The Heart Stroke Foundation of Canada (HSFC), and The Natural Sciences and Engineering Research Council of Canada (NSERC) and by CIHR grants (to M. J. S. and I. R.).; Received a studentship from CRCHUQ.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Feige JJ, 2010, B CANCER, V97, P1305, DOI 10.1684/bdc.2010.1208; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Garnier D, 2010, CANCER METAST BIOL T, V14, P243, DOI 10.1007/978-90-481-8833-8_9; Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI [10.1089/ten.tea.2010.0189, 10.1089/ten.TEA.2010.0189]; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Longatto Filho Adhemar, 2010, J Oncol, V2010, DOI 10.1155/2010/576384; Lu JI, 2005, BIOCHEM BIOPH RES CO, V334, P319, DOI 10.1016/j.bbrc.2005.05.206; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Madhyastha R, 2012, INT WOUND J, V9, P355, DOI 10.1111/j.1742-481X.2011.00890.x; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Oklu R, 2010, J VASC INTERV RADIOL, V21, P1791, DOI 10.1016/j.jvir.2010.08.009; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Traverso V, 1998, J CELL SCI, V111, P1405; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106	50	53	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30541	30551		10.1074/jbc.M112.393561	http://dx.doi.org/10.1074/jbc.M112.393561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773844	hybrid, Green Published			2022-12-28	WOS:000308579800046
J	Saito, S; Nakatsuka, K; Takahashi, K; Fukuta, N; Imagawa, T; Ohta, T; Tominaga, M				Saito, Shigeru; Nakatsuka, Kazumasa; Takahashi, Kenji; Fukuta, Naomi; Imagawa, Toshiaki; Ohta, Toshio; Tominaga, Makoto			Analysis of Transient Receptor Potential Ankyrin 1 (TRPA1) in Frogs and Lizards Illuminates Both Nociceptive Heat and Chemical Sensitivities and Coexpression with TRP Vanilloid 1 (TRPV1) in Ancestral Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; XENOPUS-TROPICALIS; CAPSAICIN RECEPTOR; MOLECULAR-CLONING; SENSORY NEURONS; COLD; EVOLUTION; THERMOSENSATION; MECHANISMS; EXPRESSION	Transient receptor potential ankyrin 1 (TRPA1) and TRP vanilloid 1 (V1) perceive noxious temperatures and chemical stimuli and are involved in pain sensation in mammals. Thus, these two channels provide a model for understanding how different genes with similar biological roles may influence the function of one another during the course of evolution. However, the temperature sensitivity of TRPA1 in ancestral vertebrates and its evolutionary path are unknown as its temperature sensitivities vary among different vertebrate species. To elucidate the functional evolution of TRPA1, TRPA1s of the western clawed (WC) frogs and green anole lizards were characterized. WC frog TRPA1 was activated by heat and noxious chemicals that activate mammalian TRPA1. These stimuli also activated native sensory neurons and elicited nocifensive behaviors in WC frogs. Similar to mammals, TRPA1 was functionally co-expressed with TRPV1, another heat- and chemical-sensitive nociceptive receptor, in native sensory neurons of the WC frog. Green anole TRPA1 was also activated by heat and noxious chemical stimulation. These results suggest that TRPA1 was likely a noxious heat and chemical receptor and co-expressed with TRPV1 in the nociceptive sensory neurons of ancestral vertebrates. Conservation of TRPV1 heat sensitivity throughout vertebrate evolution could have changed functional constraints on TRPA1 and influenced the functional evolution of TRPA1 regarding temperature sensitivity, whereas conserving its noxious chemical sensitivity. In addition, our results also demonstrated that two mammalian TRPA1 inhibitors elicited different effect on the TRPA1s of WC frogs and green anoles, which can be utilized to clarify the structural bases for inhibition of TRPA1.	[Saito, Shigeru; Fukuta, Naomi; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Nakatsuka, Kazumasa; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Dept Biol Chem, Sapporo, Hokkaido 0600810, Japan; [Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Tottori University; Hokkaido University; Graduate University for Advanced Studies - Japan	Saito, S (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	sshigeru@nips.ac.jp; tominaga@nips.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas (to M. T.), a Grant-in-aid for Young Scientists (B) (to S. S.), and a Grant-in-aid for Scientific Research (to T. O.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Dowland LK, 2000, J BIOL CHEM, V275, P37765, DOI 10.1074/jbc.M004840200; Goodman RM, 2007, J EXP ZOOL PART A, V307A, P439, DOI 10.1002/jez.397; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	45	56	60	1	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30743	30754		10.1074/jbc.M112.362194	http://dx.doi.org/10.1074/jbc.M112.362194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22791718	hybrid, Green Published			2022-12-28	WOS:000308579800063
J	Shan, B; Li, DW; Bruschweiler-Li, L; Bruschweiler, R				Shan, Bing; Li, Da-Wei; Brueschweiler-Li, Lei; Brueschweiler, Rafael			Competitive Binding between Dynamic p53 Transactivation Subdomains to Human MDM2 Protein IMPLICATIONS FOR REGULATING THE p53.MDM2/MDMX INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; ACTIVATION DOMAIN; FORCE-FIELDS; INHIBITION; PHOSPHORYLATION; MECHANISM; SEQUENCE; PATHWAY; COMPLEX; AMPLIFICATION	The interaction between the transactivation domain of p53 (p53TAD) and the N-terminal domain of MDM2 and MDMX plays an essential role for cell function. Mutations in these proteins have been implicated in many forms of cancer. The intrinsically disordered p53TAD contains two subdomains, TAD1 and TAD2. Using NMR spectroscopy, site-directed mutagenesis, and molecular dynamics simulations, we demonstrate that TAD2 directly interacts with MDM2, adopting transient structures that bind to the same hydrophobic pocket of MDM2 as TAD1. Our data show that binding of TAD1 and TAD2 to MDM2 is competitive, which is further supported by the observation that the interaction of TAD2 with MDM2 can be blocked by the small molecule inhibitor nutlin-3. Our data further indicate that TAD2 interacts with MDMX in a fashion very similar to MDM2. Because TAD2 is known to have transcriptional activity, the interaction of TAD2 with MDM2/MDMX may play a direct role in the inhibition of p53 transactivation.	[Brueschweiler, Rafael] Florida State Univ, Dept Chem & Biochem, Chem Sci Lab, Tallahassee, FL 32306 USA; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bruschweiler, R (corresponding author), Florida State Univ, Dept Chem & Biochem, Chem Sci Lab, CSL 3006, Tallahassee, FL 32306 USA.	bruschweiler@magnet.fsu.edu	Dawei, Li/F-7233-2010; Shan, Bing/G-5460-2011; Bruschweiler, Rafael/F-6624-2015	Dawei, Li/0000-0002-3266-5272; 	National Science Foundation [MCB-0918362]; National High Magnetic Field Laboratory at Florida State University; Florida Department of Health; Bankhead-Coley Cancer Research Program	National Science Foundation(National Science Foundation (NSF)); National High Magnetic Field Laboratory at Florida State University; Florida Department of Health; Bankhead-Coley Cancer Research Program	This work was supported by National Science Foundation Grant MCB-0918362 and the National High Magnetic Field Laboratory at Florida State University.; Recipient of a postdoctoral research fellowship supported by the Florida Department of Health and the Bankhead-Coley Cancer Research Program.	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Chene P, 2004, MOL CANCER RES, V2, P20; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Khoury K, 2011, MEDCHEMCOMM, V2, P246, DOI 10.1039/c0md00248h; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li DW, 2011, J CHEM THEORY COMPUT, V7, P1773, DOI 10.1021/ct200094b; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marx J, 2007, SCIENCE, V315, P1211, DOI 10.1126/science.315.5816.1211; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sanchez MC, 2010, FEBS LETT, V584, P3035, DOI 10.1016/j.febslet.2010.05.058; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	60	21	21	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30376	30384		10.1074/jbc.M112.369793	http://dx.doi.org/10.1074/jbc.M112.369793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22807444	Green Published, hybrid			2022-12-28	WOS:000308579800030
J	Halabi, A; Ditch, S; Wang, J; Grabczyk, E				Halabi, Anasheh; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed			DNA Mismatch Repair Complex MutS beta Promotes GAA.TTC Repeat Expansion in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAA TRIPLET-REPEAT; HISTONE DEACETYLASE INHIBITORS; KNOCK-IN MICE; FRIEDREICH ATAXIA; CAG REPEAT; TRINUCLEOTIDE REPEATS; SOMATIC INSTABILITY; MYOTONIC-DYSTROPHY; HMUTS-BETA; WEB SERVER	While DNA repair has been implicated in CAG.CTG repeat expansion, its role in the GAA.TTC expansion of Friedreich ataxia (FRDA) is less clear. We have developed a human cellular model that recapitulates the DNA repeat expansion found in FRDA patient tissues. In this model, GAA.TTC repeats expand incrementally and continuously. We have previously shown that the expansion rate is linked to transcription within the repeats. Our working hypothesis is that structures formed within the GAA.TTC repeat during transcription attract DNA repair enzymes that then facilitate the expansion process. MutS beta, a heterodimer of MSH2 and MSH3, is known to have a role in CAG.CTG repeat expansion. We now show that shRNA knockdown of either MSH2 or MSH3 slowed GAA.TTC expansion in our system. We further characterized the role of MutS beta in GAA.TTC expansion using a functional assay in primary FRDA patient-derived fibroblasts. These fibroblasts have no known propensity for instability in their native state. Ectopic expression of MSH2 and MSH3 induced GAA.TTC repeat expansion in the native FXN gene. MSH2 is central to mismatch repair and its absence or reduction causes a predisposition to cancer. Thus, despite its essential role in GAA.TTC expansion, MSH2 is not an attractive therapeutic target. The absence or reduction of MSH3 is not strongly associated with cancer predisposition. Accordingly, MSH3 has been suggested as a therapeutic target for CAG.CTG repeat expansion disorders. Our results suggest that MSH3 may also serve as a therapeutic target to slow the expansion of GAA.TTC repeats in the future.	[Halabi, Anasheh; Ditch, Scott; Wang, Jeffrey; Grabczyk, Ed] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Grabczyk, E (corresponding author), LSU Hlth Sci Ctr, Dept Genet, 533 Bolivar St, New Orleans, LA USA.	egrabc@lsuhsc.edu			National Institutes of Health [R01NS046567, F30AG042263]; Friedreich's Ataxia Research Alliance; LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG042263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance; LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01NS046567) (F30AG042263, to A. H.), the Friedreich's Ataxia Research Alliance, and the LSUHSC Research Enhancement Fund (to E. G.).	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Calmels N, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-46; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; COGGINS LW, 1989, NUCLEIC ACIDS RES, V17, P7417, DOI 10.1093/nar/17.18.7417; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Darlow JM, 1998, J MOL BIOL, V275, P17, DOI 10.1006/jmbi.1997.1452; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Debacker K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001257; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dowen JM, 2010, MOL CELL BIOL, V30, P3321, DOI 10.1128/MCB.01558-09; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Grabczyk E, 1999, ANAL BIOCHEM, V267, P241, DOI 10.1006/abio.1998.2962; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; KOLODNER RD, 1994, COLD SPRING HARB SYM, V59, P331, DOI 10.1101/SQB.1994.059.01.037; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marino Michael P, 2003, Methods Mol Biol, V229, P43; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pabla N, 2011, J BIOL CHEM, V286, P10411, DOI 10.1074/jbc.M110.210989; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Plotz G, 2002, NUCLEIC ACIDS RES, V30, P711, DOI 10.1093/nar/30.3.711; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Reiser J, 2000, J VIROL, V74, P10589, DOI 10.1128/JVI.74.22.10589-10599.2000; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SMITH GK, 1995, NUCLEIC ACIDS RES, V23, P4303; Soragni E, 2011, METHODS MOL BIOL, V793, P495, DOI 10.1007/978-1-61779-328-8_32; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; YU A, 1995, NUCLEIC ACIDS RES, V23, P4055, DOI 10.1093/nar/23.20.4055; Zhang H, 1999, CANCER RES, V59, P3021; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29958	29967		10.1074/jbc.M112.356758	http://dx.doi.org/10.1074/jbc.M112.356758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787155	Green Published, hybrid			2022-12-28	WOS:000308286900069
J	Wong, AHH; Yan, CY; Shi, YG				Wong, Ada Hang-Heng; Yan, Chuangye; Shi, Yigong			Crystal Structure of the Yeast Metacaspase Yca1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; REGULATES APOPTOSIS; ACTIVATION; SUBSTRATE; INHIBITION; MECHANISMS; PROTEINS; PATHWAY; BIR1P	Yca1, the only metacaspase in Saccharomyces cerevisiae, is thought to be a clan CD cysteine protease that includes the caspase subfamily. Although yeast is a single cell eukaryote, it can undergo a cell death process reminiscent of apoptosis. Yca1 has been reported to play an important role in the regulation of such apoptotic process. However, the structure and functional mechanism of Yca1 remain largely enigmatic. In this study, we report the crystal structure of the Yca1 metacaspase at 1.7 angstrom resolution, confirming a caspase-like fold. In sharp contrast to canonical caspases, however, Yca1 exists as a monomer both in solution and in the crystals. Canonical caspase contains six beta-strands, with strand beta 6 pairing up with beta 6 of another caspase molecule to form a homodimerization interface. In Yca1, an extra pair of antiparallel beta-strands forms a continuous beta-sheet with the six caspase-common beta-strands, blocking potential dimerization. Yca1 was reported to undergo autocatalytic processing in yeast; overexpression in bacteria also led to autoprocessing of Yca1 into two fragments. Unexpectedly, we found that both the autocatalytic processing and the proteolytic activity of Yca1 are greatly facilitated by the presence of calcium (Ca2+), but not other divalent cations. Our structural and biochemical characterization identifies Yca1 as a Ca2+-activated cysteine protease that may cleave specific substrates during stress response in yeast.	[Wong, Ada Hang-Heng; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China; [Yan, Chuangye] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wong, Ada Hang-Heng; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Rm C331,Med Sci Bldg, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation [30888001]; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	This work was supported by funds from the Ministry of Science and Technology (Grant 2009CB918801), National Natural Science Foundation (Project 30888001), and Beijing Municipal Commissions of Education and Science and Technology.	Bettiga M, 2004, FEMS YEAST RES, V5, P141, DOI 10.1016/j.femsyr.2004.07.005; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Carmona-Gutierrez D, 2011, CELL DEATH DIFFER, V18, P1948, DOI 10.1038/cdd.2011.115; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erhardt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009929; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Guaragnella N, 2010, FEBS LETT, V584, P3655, DOI 10.1016/j.febslet.2010.07.044; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Huesgen PF, 2011, BIOCHEM J, V435, P733, DOI 10.1042/BJ20102131; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Li XC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1418; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2012, P NATL ACAD SCI USA, V109, P7469, DOI 10.1073/pnas.1200885109; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Silva A, 2011, BBA-MOL CELL RES, V1813, P2044, DOI 10.1016/j.bbamcr.2011.09.010; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P660, DOI 10.1016/j.bbabio.2006.05.004; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Watanabe N, 2011, J BIOL CHEM, V286, P10027, DOI 10.1074/jbc.M110.194340; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208; Yu JW, 2011, P NATL ACAD SCI USA, V108, P21004, DOI 10.1073/pnas.1111708108	36	65	66	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29251	29259		10.1074/jbc.M112.381806	http://dx.doi.org/10.1074/jbc.M112.381806			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761449	Green Published, hybrid			2022-12-28	WOS:000308286900005
J	Wu, F; Li, YP; Wang, FX; Noda, NN; Zhang, H				Wu, Fan; Li, Yuping; Wang, Fuxin; Noda, Nobuo N.; Zhang, Hong			Differential Function of the Two Atg4 Homologues in the Aggrephagy Pathway in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P GRANULE COMPONENTS; C. ELEGANS; AUTOPHAGOSOME BIOGENESIS; DEGRADATION; MICE; LC3; MECHANISMS; PROTEASE; GABARAP; BALANCE	The presence of multiple homologues of the same yeast Atg protein endows an additional layer of complexity on the autophagy pathway in higher eukaryotes. The physiological function of the individual genes, however, remains largely unknown. Here we investigated the role of the two Caenorhabditis elegans homologues of the cysteine protease Atg4 in the pathway responsible for degradation of protein aggregates. Loss of atg-4.1 activity causes defective degradation of a variety of protein aggregates, whereas atg-4.2 mutants remove these substrates normally. LGG-1 precursors accumulate in atg-4.1 mutants, but not atg-4.2 mutants. LGG-1 puncta, formation of which depends on lipidation of LGG-1, are present in atg-4.1 and atg-4.2 single mutants, but are completely absent in atg-4.1; atg-4.2 double mutants. In vitro enzymatic analysis revealed that ATG-4.1 processes LGG-1 precursors about 100-fold more efficiently than ATG-4.2. Expression of a mutant form LGG-1, which mimics the processed precursor, rescues the defective autophagic degradation of protein aggregates in atg-4.1 mutants and, to a lesser extent, in atg-4.1; atg-4.2 double mutants. Our study reveals that ATG-4.1 and ATG-4.2 are functionally redundant yet display differential LGG-1 processing and deconjugating activity in the aggrephagy pathway in C. elegans.	[Wu, Fan; Li, Yuping; Wang, Fuxin; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wu, Fan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Wu, Fan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Hong] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, H (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhanghong@nibs.ac.cn	Li, Yuping/AAL-6956-2020; Noda, Nobuo/P-1397-2015	Li, Yuping/0000-0003-2057-3271; Wang, wangfuxin/0000-0003-4497-3667; Noda, Nobuo/0000-0002-6940-8069	National Basic Research Program of China [2011CB910100, 2010CB835201]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23687012]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Basic Research Program of China (2011CB910100, 2010CB835201) (to H. Z.) and Grant-in-Aid for Young Scientists (A) (23687012) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. N. N).	Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Cabrera S, 2010, AUTOPHAGY, V6, P961, DOI 10.4161/auto.6.7.13065; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huang XX, 2011, DEVELOPMENT, V138, P2059, DOI 10.1242/dev.057109; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kovacs AL, 2010, FEBS LETT, V584, P1335, DOI 10.1016/j.febslet.2010.02.002; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tian E, 2009, AUTOPHAGY, V5, P608, DOI 10.4161/auto.5.5.8624; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhao Y, 2009, AUTOPHAGY, V5, P717, DOI 10.4161/auto.5.5.8552	35	35	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29457	29467		10.1074/jbc.M112.365676	http://dx.doi.org/10.1074/jbc.M112.365676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767594	hybrid, Green Published			2022-12-28	WOS:000308286900023
J	Basturea, GN; Harris, TK; Deutscher, MP				Basturea, Georgeta N.; Harris, Thomas K.; Deutscher, Murray P.			Growth of a Bacterium That Apparently Uses Arsenic Instead of Phosphorus Is a Consequence of Massive Ribosome Breakdown	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEGRADATION	A recent study (Wolfe-Simon, F., Switzer Blum, J., Kulp, T. R., Gordon, G. W., Hoeft, S. E., Pett-Ridge, J., Stolz, J. F., Webb, S. M., Weber, P. K., Davies, P. C., Anbar, A. D., and Oremland, R. S. (2011) Science 332, 1163-1166) described the isolation of a special bacterial strain, GFAJ-1, that could grow in medium containing arsenate, but lacking phosphate, and that supposedly could substitute arsenic for phosphorus in its biological macromolecules. Here, we provide an alternative explanation for these observations and show that they can be reproduced in a laboratory strain of Escherichia coli. We find that arsenate induces massive ribosome degradation, which provides a source of phosphate. A small number of arsenate-tolerant cells arise during the long lag period prior to initiation of growth in +As/-P medium, and it is this population that undergoes the very slow, limited growth observed for both E. coli and GFAJ-1. These results provide a simple explanation for the reported growth of GFAJ-1 in arsenate without invoking replacement of phosphorus by arsenic in biological macromolecules.	[Basturea, Georgeta N.; Harris, Thomas K.; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Basturea, Georgeta/A-3116-2011		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Bremer H, 1996, ESCHERICHIA COLI SAL; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Erb T. J., 2012, AIDS RES HUM RETRO S, DOI [10.1126/science.1218455, DOI 10.1126/SCIENCE.1218455]; Hayden EC, 2011, NATURE, V474, P19, DOI 10.1038/474019a; Reaves M. L., 2012, AIDS RES HUM RETRO S, DOI [10.1126/science.1219861, DOI 10.1126/SCIENCE.1219861]; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	11	14	14	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28816	28819		10.1074/jbc.C112.394403	http://dx.doi.org/10.1074/jbc.C112.394403			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22798070	Green Published, hybrid			2022-12-28	WOS:000308074600054
J	Azakir, BA; Di Fulvio, S; Salomon, S; Brockhoff, M; Therrien, C; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Salomon, Steven; Brockhoff, Marielle; Therrien, Christian; Sinnreich, Michael			RETRACTED: Modular Dispensability of Dysferlin C2 Domains Reveals Rational Design for Mini-dysferlin Molecules (Retracted article. See vol. 292, pg. 12543, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MEMBRANE REPAIR; GENE; MUTATION; CELLS; CAVEOLIN-3; MYOPATHY; IMPACT	Dysferlin is a large transmembrane protein composed of a C-terminal transmembrane domain, two DysF domains, and seven C2 domains that mediate lipid-and protein-binding interactions. Recessive loss-of-function mutations in dysferlin lead to muscular dystrophies, for which no treatment is currently available. The large size of dysferlin precludes its encapsulation into an adeno-associated virus (AAV), the vector of choice for gene delivery to muscle. To design mini-dysferlin molecules suitable for AAV-mediated gene transfer, we tested internally truncated dysferlin constructs, each lacking one of the seven C2 domains, for their ability to localize to the plasma membrane and to repair laser-induced plasmalemmal wounds in dysferlin-deficient human myoblasts. We demonstrate that the dysferlin C2B, C2C, C2D, and C2E domains are dispensable for correct plasmalemmal localization. Furthermore, we show that the C2B, C2C, and C2E domains and, to a lesser extent, the C2D domain are dispensable for dysferlin membrane repair function. On the basis of these results, we designed small dysferlin molecules that can localize to the plasma membrane and reseal laser-induced plasmalemmal injuries and that are small enough to be incorporated into AAV. These results lay the groundwork for AAV-mediated gene therapy experiments in dysferlin-deficient mouse models.	[Azakir, Bilal A.; Di Fulvio, Sabrina; Brockhoff, Marielle; Sinnreich, Michael] Univ Basel Hosp, Dept Neurol, Neuromuscular Res Grp, CH-4031 Basel, Switzerland; [Azakir, Bilal A.; Di Fulvio, Sabrina; Brockhoff, Marielle; Sinnreich, Michael] Univ Basel Hosp, Dept Biomed, Neuromuscular Res Grp, CH-4031 Basel, Switzerland; [Azakir, Bilal A.; Di Fulvio, Sabrina; Brockhoff, Marielle; Sinnreich, Michael] Univ Basel, CH-4031 Basel, Switzerland; [Salomon, Steven; Therrien, Christian] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of Basel; University of Basel; University of Basel; McGill University	Sinnreich, M (corresponding author), Univ Basel Hosp, Dept Neurol, Neuromuscular Res Grp, Petersgraben 4, CH-4031 Basel, Switzerland.	msinnreich@uhbs.ch	Azakir, Bilal/AAP-9345-2020	Azakir, Bilal/0000-0003-3084-0265; Sinnreich, Michael/0000-0002-9835-1276	Myosuisse; Association Francaise contre les Myopathies (AFM); MDAC-ALS-CIHR Partnership; Swiss National Science Foundation (SNF); Gebert Ruf Foundation; Uniscientia Foundation; German Ministry of Education and Research (BMBF, Bonn, Germany)	Myosuisse; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); MDAC-ALS-CIHR Partnership(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Gebert Ruf Foundation; Uniscientia Foundation; German Ministry of Education and Research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF))	This work was supported by Myosuisse, the Association Francaise contre les Myopathies (AFM), the MDAC-ALS-CIHR Partnership, the Swiss National Science Foundation (SNF), the Gebert Ruf Foundation, and the Uniscientia Foundation.; We thank the Muscle Tissue Culture Collection for providing the myoblast samples used in this study. The Muscle Tissue Culture Collection is part of the German Muscular Dystrophy Network (MD-NET, service structure S1, 01GM0601), funded by the German Ministry of Education and Research (BMBF, Bonn, Germany). The Muscle Tissue Culture Collection is a partner of EuroBioBank and TREAT-NMD. We thank Dr. K. Bushby for the GFP cDNA, Beat Erne for excellent technical assistance, and Andrea Mansinho for help with the experiments.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P889, DOI 10.1038/ejhg.2010.4; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Azakir BA, 2012, J BIOL CHEM, V287, P10344, DOI 10.1074/jbc.M111.329078; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Han WQ, 2012, J CELL SCI, V125, P1225, DOI 10.1242/jcs.094565; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038036; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Sinnreich M, 2006, NEUROLOGY, V66, P1114, DOI 10.1212/01.wnl.0000204358.89303.81; Tang Y, 2010, EXPERT OPIN BIOL TH, V10, P395, DOI 10.1517/14712591003604690; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Vandre DD, 2007, BIOL REPROD, V77, P533, DOI 10.1095/biolreprod.107.062190; Wein N, 2010, HUM MUTAT, V31, P136, DOI 10.1002/humu.21160; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	29	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27629	27636		10.1074/jbc.M112.391722	http://dx.doi.org/10.1074/jbc.M112.391722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736764	Green Published, hybrid			2022-12-28	WOS:000307840700037
J	Ikeda, M; Chiba, S; Ohashi, K; Mizuno, K				Ikeda, Masanori; Chiba, Shuhei; Ohashi, Kazumasa; Mizuno, Kensaku			Furry Protein Promotes Aurora A-mediated Polo-like Kinase 1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRCP-DEPENDENT DEGRADATION; PLK1; ROLES; PHOSPHORYLATION; LOCALIZATION; BORA; CDK1	Bipolar mitotic spindle organization is fundamental to faithful chromosome segregation. Furry (Fry) is an evolutionarily conserved protein implicated in cell division and morphology. In human cells, Fry localizes to centrosomes and spindle microtubules in early mitosis, and depletion of Fry causes multipolar spindle formation. However, it remains unknown how Fry controls bipolar spindle organization. This study demonstrates that Fry binds to polo-like kinase 1 (Plk1) through the polo-box domain of Plk1 in a manner dependent on the cyclin-dependent kinase 1-mediated Fry phosphorylation at Thr-2516. Fry also binds to Aurora A and promotes Plk1 activity by binding to the polo-box domain of Plk1 and by facilitating Aurora A-mediated Plk1 phosphorylation at Thr-210. Depletion of Fry causes centrosome and centriole splitting in mitotic spindles and reduces the kinase activity of Plk1 in mitotic cells and the accumulation of Thr-210-phosphorylated Plk1 at the spindle poles. Our results suggest that Fry plays a crucial role in the structural integrity of mitotic centrosomes and in the maintenance of spindle bipolarity by promoting Plk1 activity at the spindle poles in early mitosis.	[Ikeda, Masanori; Chiba, Shuhei; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; Chiba, Shuhei/AAJ-5330-2020; Ohashi, Kazumasa/U-7028-2019	Ohashi, Kazumasa/0000-0001-7617-403X; Chiba, Shuhei/0000-0002-5144-1661	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Grants-in-Aid for Scientific Research [22616001] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan.	Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; De Luca M, 2006, CELL CYCLE, V5, P296; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Emoto K, 2011, J BIOCHEM, V150, P133, DOI 10.1093/jb/mvr080; Eot-Houllier G, 2010, J BIOL CHEM, V285, P29556, DOI 10.1074/jbc.M110.144220; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747	31	26	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27670	27681		10.1074/jbc.M112.378968	http://dx.doi.org/10.1074/jbc.M112.378968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22753416	hybrid, Green Published			2022-12-28	WOS:000307840700041
J	Petroi, D; Popova, B; Taheri-Talesh, N; Irniger, S; Shahpasandzadeh, H; Zweckstetter, M; Outeiro, TF; Braus, GH				Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Zweckstetter, Markus; Outeiro, Tiago F.; Braus, Gerhard H.			Aggregate Clearance of alpha-Synuclein in Saccharomyces cerevisiae Depends More on Autophagosome and Vacuole Function Than on the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; DEGRADATION; INHIBITION; MEMBRANE; MACROAUTOPHAGY; NEUROTOXICITY; MUTANTS; NEURONS; DNA	Parkinson disease is the second most common neurodegenerative disease. The molecular hallmark is the accumulation of proteinaceous inclusions termed Lewy bodies containing misfolded and aggregated alpha-synuclein. The molecular mechanism of clearance of alpha-synuclein aggregates was addressed using the bakers' yeast Saccharomyces cerevisiae as the model. Overexpression of wild type alpha-synuclein or the genetic variant A53T integrated into one genomic locus resulted in a gene copy-dependent manner in cytoplasmic proteinaceous inclusions reminiscent of the pathogenesis of the disease. In contrast, overexpression of the genetic variant A30P resulted only in transient aggregation, whereas the designer mutant A30P/A36P/A76P neither caused aggregation nor impaired yeast growth. The alpha-synuclein accumulation can be cleared after promoter shutoff by a combination of autophagy and vacuolar protein degradation. Whereas the proteasomal inhibitor MG-132 did not significantly inhibit aggregate clearance, treatment with phenylmethylsulfonyl fluoride, an inhibitor of vacuolar proteases, resulted in significant reduction in clearance. Consistently, a cim3-1 yeast mutant restricted in the 19 S proteasome regulatory subunit was unaffected in clearance, whereas an Delta atg1 yeast mutant deficient in autophagy showed a delayed aggregate clearance response. A cim3-1 Delta atg1 double mutant was still able to clear aggregates, suggesting additional cellular mechanisms for alpha-synuclein clearance. Our data provide insight into the mechanisms yeast cells use for clearing different species of alpha-synuclein and demonstrate a higher contribution of the autophagy/vacuole than the proteasome system. This contributes to the understanding of how cells can cope with toxic and/or aggregated proteins and may ultimately enable the development of novel strategies for therapeutic intervention.	[Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Outeiro, Tiago F.] Univ Med Gottingen, Dept Neurodegenerat & Restorat Res, D-37077 Gottingen, Germany; [Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Zweckstetter, Markus; Outeiro, Tiago F.; Braus, Gerhard H.] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37077 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany.	gbraus@gwdg.de	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Braus, Gerhard/ABC-6293-2021; Braus, Gerhard H/G-3999-2012	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Zweckstetter, Markus/0000-0002-2536-6581; Popova, Blagovesta/0000-0001-6323-374X	Deutsche Forschungsgemeinschaft; Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung [NGFN-Plus 01GS08190]; European Union [NEURA-SYNC PITNGA-2009-238316]; Volkswagen-Stiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Volkswagen-Stiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung (NGFN-Plus 01GS08190), European Union (NEURA-SYNC PITNGA-2009-238316), and the Volkswagen-Stiftung, and the Fonds der Chemischen Industrie.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603; Balija MBG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024701; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; Dyllick-Brenzinger M, 2010, NEUROTOX RES, V17, P215, DOI 10.1007/s12640-009-9094-1; Flower TR, 2007, J CELL BIOL, V177, P1091, DOI 10.1083/jcb.200610071; Forno LS, 1996, ADV NEUROL, V69, P217; Fortun J, 2003, J NEUROSCI, V23, P10672; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; LAMPHIER MS, 1992, P NATL ACAD SCI USA, V89, P5922, DOI 10.1073/pnas.89.13.5922; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Taschenberger G, 2012, ACTA NEUROPATHOL, V123, P671, DOI 10.1007/s00401-011-0926-8; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong GK, 1998, J ANTIBIOT, V51, P487, DOI 10.7164/antibiotics.51.487; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515	75	59	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27567	27579		10.1074/jbc.M112.361865	http://dx.doi.org/10.1074/jbc.M112.361865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722939	Green Published, hybrid			2022-12-28	WOS:000307840700032
J	Dey, S; Bindu, S; Goyal, M; Pal, C; Alam, A; Iqbal, MS; Kumar, R; Sarkar, S; Bandyopadhyay, U				Dey, Sumanta; Bindu, Samik; Goyal, Manish; Pal, Chinmay; Alam, Athar; Iqbal, Mohd Shameel; Kumar, Rahul; Sarkar, Souvik; Bandyopadhyay, Uday			Impact of Intravascular Hemolysis in Malaria on Liver Dysfunction INVOLVEMENT OF HEPATIC FREE HEME OVERLOAD, NF-kappa B ACTIVATION, AND NEUTROPHIL INFILTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; DRUG-INDUCED GASTROPATHY; REACTIVE OXYGEN; IN-VITRO; APOPTOSIS; MECHANISMS; HEMOGLOBIN; HEMOPEXIN; INJURY	We have investigated the impact of persistent intravascular hemolysis on liver dysfunction using the mouse malaria model. Intravascular hemolysis showed a positive correlation with liver damage along with the increased accumulation of free heme and reactive oxidants in liver. Hepatocytes overinduced heme oxygenase-1 (HO-1) to catabolize free heme in building up defense against this pro-oxidant milieu. However, in a condition of persistent free heme overload in malaria, the overactivity of HO-1 resulted in continuous transient generation of free iron to favor production of reactive oxidants as evident from 2',7'-dichlorofluorescein fluorescence studies. Electrophoretic mobility shift assay documented the activation of NF-kappa B, which in turn up-regulated intercellular adhesion molecule 1 as evident from chromatin immunoprecipitation studies. NF-kappa B activation also induced vascular cell adhesion molecule 1, keratinocyte chemoattractant, and macrophage inflammatory protein 2, which favored neutrophil extravasation and adhesion in liver. The infiltration of neutrophils correlated positively with the severity of hemolysis, and neutrophil depletion significantly prevented liver damage. The data further documented the elevation of serum TNF alpha in infected mice, and the treatment of anti-TNF alpha antibodies also significantly prevented neutrophil infiltration and liver injury. Deferoxamine, which chelates iron, interacts with free heme and bears antioxidant properties that prevented oxidative stress, NF-kappa B activation, neutrophil infiltration, hepatocyte apoptosis, and liver damage. Furthermore, the administration of N-acetylcysteine also prevented NF-kappa B activation, neutrophil infiltration, hepatocyte apoptosis, and liver damage. Thus, hepatic free heme accumulation, TNF alpha release, oxidative stress, and NF-kappa B activation established a link to favor neutrophil infiltration in inducing liver damage during hemolytic conditions in malaria.	[Dey, Sumanta; Bindu, Samik; Goyal, Manish; Pal, Chinmay; Alam, Athar; Iqbal, Mohd Shameel; Kumar, Rahul; Sarkar, Souvik; Bandyopadhyay, Uday] Indian Inst Chem Biol, Council Sci & Ind Res, Div Infect Dis & Immunol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010; Iqbal, Mohd Shameel/AAD-9641-2021	Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561; /0000-0002-5945-976X; Bindu, Samik/0000-0003-1416-2003	Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi	Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Suprainstitutional Project grants from the Council of Scientific and Industrial Research, New Delhi.; Recipient of a senior research fellowship from the Council of Scientific and Industrial Research, New Delhi.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Baniasadi S, 2010, EUR J GASTROEN HEPAT, V22, P1235, DOI 10.1097/MEG.0b013e32833aa11b; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Bombini G, 2004, EUR J PHARMACOL, V496, P197, DOI 10.1016/j.ejphar.2004.06.003; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; CARACENI P, 1995, AM J PHYSIOL-GASTR L, V269, pG132, DOI 10.1152/ajpgi.1995.269.1.G132; Cianciulli P, 2009, MEDITERR J HEMATOL I, V1, DOI 10.4084/MJHID.2009.034; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dienes HP, 2010, DIGEST DIS, V28, P57, DOI 10.1159/000282065; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Fendel R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010038; Fouad D, 2004, LIVER INT, V24, P227, DOI 10.1111/j.1478-3231.2004.00913.x; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Haldar K, 2005, TRENDS PARASITOL, V21, P402, DOI 10.1016/j.pt.2005.07.003; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hao Q, 2007, J CEREBR BLOOD F MET, V27, P1853, DOI 10.1038/sj.jcbfm.9600485; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kapralov A, 2009, J BIOL CHEM, V284, P30395, DOI 10.1074/jbc.M109.045567; Kato GJ, 2010, BRIT J HAEMATOL, V148, P690, DOI 10.1111/j.1365-2141.2009.08004.x; Kato GJ, 2009, J CLIN INVEST, V119, P2140, DOI 10.1172/JCI40258; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lokuta MA, 2005, J LEUKOCYTE BIOL, V78, P210, DOI 10.1189/jlb.0205067; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; McDonald B, 2012, TOXICOL PATHOL, V40, P157, DOI 10.1177/0192623311427570; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; ORJIH AU, 1981, SCIENCE, V214, P667, DOI 10.1126/science.7027441; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; Pal C, 2012, J BIOL CHEM, V287, P3495, DOI 10.1074/jbc.M111.307199; Pal C, 2011, BIOORG MED CHEM LETT, V21, P3563, DOI 10.1016/j.bmcl.2011.04.127; Pal C, 2010, FREE RADICAL BIO MED, V49, P258, DOI 10.1016/j.freeradbiomed.2010.04.013; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perry BC, 2011, J INVEST SURG, V24, P178, DOI 10.3109/08941939.2011.568594; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Qian Q, 2010, AM J KIDNEY DIS, V56, P780, DOI 10.1053/j.ajkd.2010.03.025; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Russo-Carbolante E.M.S., 2002, COMP CLIN PATH, V11, P71, DOI [DOI 10.1007/S005800200001, 10.1007/s005800200001]; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sajan MP, 2009, J LIPID RES, V50, P1133, DOI 10.1194/jlr.M800520-JLR200; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Sathish P, 2011, EUR J PHARMACOL, V654, P181, DOI 10.1016/j.ejphar.2010.10.080; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Seixas E, 2008, PARASITOLOGY, V135, P683, DOI 10.1017/S0031182008004344; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shimakura A, 2000, BRAIN RES, V858, P55, DOI 10.1016/S0006-8993(99)02431-2; SMITH A, 1985, J BIOL CHEM, V260, P8325; SMITH A, 1981, J BIOL CHEM, V256, P902; SMITH A, 1984, J BIOL CHEM, V259, P2049; SULLIVAN SG, 1992, BIOCHIM BIOPHYS ACTA, V1104, P38, DOI 10.1016/0005-2736(92)90129-A; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Uday Bandyopadhyay, 2011, Apicomplexan parasites: molecular approaches toward targeted drug development, P205; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Wiemer AJ, 2010, MOL IMMUNOL, V47, P894, DOI 10.1016/j.molimm.2009.10.002; Woollard KJ, 2009, J BIOL CHEM, V284, P13110, DOI 10.1074/jbc.M809095200; Yang FM, 2003, AM J PHYSIOL-LUNG C, V284, pL402, DOI 10.1152/ajplung.00115.2002; Yoshimoto T, 1998, J IMMUNOL, V160, P5500	92	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26630	26646		10.1074/jbc.M112.341255	http://dx.doi.org/10.1074/jbc.M112.341255			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22696214	hybrid, Green Published			2022-12-28	WOS:000307386000015
J	Gulshan, K; Thommandru, B; Moye-Rowley, WS				Gulshan, Kailash; Thommandru, Bernice; Moye-Rowley, W. Scott			Proteolytic Degradation of the Yap1 Transcription Factor Is Regulated by Subcellular Localization and the E3 Ubiquitin Ligase Not4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; NUCLEAR EXPORT; YEAST-CELLS; CANDIDA-ALBICANS; FACTOR GCN4; PROTEIN; ACTIVATION	Saccharomyces cerevisiae Yap1 is a transcriptional regulatory protein that serves as a central determinant of oxidative stress tolerance. Activity of this factor is regulated in large part by control of its subcellular location. In the absence of oxidants, Yap1 is primarily located in the cytoplasm. Upon oxidant challenge, Yap1 accumulates rapidly in the nucleus where it activates expression of genes required for oxidative stress tolerance such as the thioredoxin TRX2. Here, we demonstrate that Yap1 degradation is accelerated in response to oxidative stress. Yap1 is folded differently depending on the oxidant used to induce its nuclear localization but is degraded similarly, irrespective of its folded status. Mutant forms of Yap1 that are constitutively trapped in the nucleus are degraded in the absence of an oxidant signal. Degradation requires the ability of the protein to bind DNA and a domain in the amino-terminal region of the factor. Inhibition of the proteasome prevents Yap1 turnover. Screening a variety of mutants involved in ubiquitin-mediated proteolysis demonstrated an important role for the nuclear ubiquitin ligase Not4 in Yap1 degradation. Not4 was found to bind to Yap1 in an oxidant-stimulated fashion. The Candida albicans Yap1 homologue (Cap1) also was degraded after oxidant challenge. These data uncover a new, conserved pathway for regulation of the oxidative stress response that serves to temporally limit the duration of Yap1-dependent transcriptional activation.	[Gulshan, Kailash; Thommandru, Bernice; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Moye-Rowley, WS (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120	National Institutes of Health [GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by GM49825 from the National Institutes of Health.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bose S, 2005, GENETICS, V169, P1215, DOI 10.1534/genetics.104.034603; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gulshan K, 2005, J BIOL CHEM, V280, P40524, DOI 10.1074/jbc.M504716200; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; Haworth J, 2010, MOL BIOL CELL, V21, P3205, DOI 10.1091/mbc.E09-06-0452; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kitamura K, 2011, MOL MICROBIOL, V80, P739, DOI 10.1111/j.1365-2958.2011.07605.x; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lallet S, 2004, MOL GENET GENOMICS, V272, P353, DOI 10.1007/s00438-004-1063-z; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Pal B, 2007, MOL BIOL CELL, V18, P426, DOI 10.1091/mbc.E06-04-0304; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Sherman F, 1979, METHODS YEAST GENETI; Takeuchi T, 1997, FEBS LETT, V416, P339, DOI 10.1016/S0014-5793(97)01233-7; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; WEMMIE A, 1994, J BIOL CHEM, V269, P14690; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647; Zhang XT, 2000, MOL MICROBIOL, V36, P618, DOI 10.1046/j.1365-2958.2000.01877.x	55	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26796	26805		10.1074/jbc.M112.384719	http://dx.doi.org/10.1074/jbc.M112.384719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707721	Green Published, hybrid			2022-12-28	WOS:000307386000029
J	Christensen, LC; Jensen, NW; Vala, A; Kamarauskaite, J; Johansson, L; Winther, JR; Hofmann, K; Teilum, K; Ellgaard, L				Christensen, Lea Cecilie; Jensen, Njal Winther; Vala, Andrea; Kamarauskaite, Jurate; Johansson, Linda; Winther, Jakob Rahr; Hofmann, Kay; Teilum, Kaare; Ellgaard, Lars			The Human Selenoprotein VCP-interacting Membrane Protein (VIMP) Is Non-globular and Harbors a Reductase Function in an Intrinsically Disordered Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; MULTIPROTEIN COMPLEXES; TRANSMEMBRANE PROTEIN; DISULFIDE REDUCTASE; ERAD PATHWAY; DEGRADATION; THIOREDOXIN; DISLOCATION; MOTIF	The human selenoprotein VIMP (VCP-interacting membrane protein)/SelS (selenoprotein S) localizes to the endoplasmic reticulum (ER) membrane and is involved in the process of ER-associated degradation (ERAD). To date, little is known about the presumed redox activity of VIMP, its structure and how these features might relate to the function of the protein in ERAD. Here, we use the recombinantly expressed cytosolic region of VIMP where the selenocysteine (Sec) in position 188 is replaced with a cysteine (a construct named cVIMP-Cys) to characterize redox and structural properties of the protein. We show that Cys-188 in cVIMP-Cys forms a disulfide bond with Cys-174, consistent with the presence of a Cys174-Sec188 selenosulfide bond in the native sequence. For the disulfide bond in cVIMP-Cys we determined the reduction potential to -200 mV, and showed it to be a good substrate of thioredoxin. Based on a biochemical and structural characterization of cVIMP-Cys using analytical gel filtration, CD and NMR spectroscopy in conjunction with bioinformatics, we propose a comprehensive overall structural model for the cytosolic region of VIMP. The data clearly indicate the N-terminal half to be comprised of two extended alpha-helices followed by a C-terminal region that is intrinsically disordered. Redox-dependent conformational changes in cVIMP-Cys were observed only in the vicinity of the two Cys residues. Overall, the redox properties observed for cVIMP-Cys are compatible with a function as a reductase, and we speculate that the plasticity of the intrinsically disordered C-terminal region allows the protein to access many different and structurally diverse substrates.	[Christensen, Lea Cecilie; Jensen, Njal Winther; Vala, Andrea; Kamarauskaite, Jurate; Johansson, Linda; Winther, Jakob Rahr; Teilum, Kaare; Ellgaard, Lars] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Copenhagen; University of Cologne	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	lellgaard@bio.ku.dk	Teilum, Kaare/K-4340-2014; Ellgaard, Lars/I-9034-2014; Winther, Jakob R./K-4451-2014; Teilum, Kaare/S-8410-2019	Teilum, Kaare/0000-0001-6919-1982; Ellgaard, Lars/0000-0002-7018-0137; Winther, Jakob R./0000-0001-6995-9154; Christensen, Lea Cecilie/0000-0001-8594-952X	Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden; Lundbeckfonden; Alfred Benzon Foundation; Novo Scholarship	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeckfonden(Lundbeckfonden); Alfred Benzon Foundation; Novo Scholarship	This work was funded by the Danish Council for Independent Research (Natural Sciences), Novo Nordisk Fonden, Lundbeckfonden, and the Alfred Benzon Foundation.; Recipient of a Novo Scholarship 2011.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Beld J, 2007, BIOCHEMISTRY-US, V46, P5382, DOI 10.1021/bi700124p; Besse D, 1997, ANGEW CHEM INT EDIT, V36, P883, DOI 10.1002/anie.199708831; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHAU MH, 1991, FEBS LETT, V291, P296, DOI 10.1016/0014-5793(91)81305-R; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fomenko DE, 2012, ANTIOXID REDOX SIGN, V16, P193, DOI 10.1089/ars.2011.3980; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Metanis N, 2006, J AM CHEM SOC, V128, P16684, DOI 10.1021/ja0661414; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Roseler A, 2012, ANTIOXID REDOX SIGN, V17, P534, DOI 10.1089/ars.2011.4276; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williams C. H, 1992, LIPAOMIDE DEHYDROGEN; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	58	33	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26388	26399		10.1074/jbc.M112.346775	http://dx.doi.org/10.1074/jbc.M112.346775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700979	hybrid, Green Published			2022-12-28	WOS:000306916300064
J	Martin, B; Chadwick, W; Cong, WN; Pantaleo, N; Daimon, CM; Golden, EJ; Becker, KG; Wood, WH; Carlson, OD; Egan, JM; Maudsley, S				Martin, Bronwen; Chadwick, Wayne; Cong, Wei-na; Pantaleo, Nick; Daimon, Caitlin M.; Golden, Erin J.; Becker, Kevin G.; Wood, William H., III; Carlson, Olga D.; Egan, Josephine M.; Maudsley, Stuart			Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171-82Q Model of Huntington Disease Is Related to Their Physiological Efficacy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION-PROTEIN GENE; MOUSE MODEL; MUTATIONS; IDENTIFICATION; NEUROENDOCRINE; EXPRESSION; GHRELIN; BRAIN; HD	Our aim was to employ novel analytical methods to investigate the therapeutic treatment of the energy regulation dysfunction occurring in a Huntington disease (HD) mouse model. HD is a neurodegenerative disorder that is characterized by progressive motor impairment and cognitive alterations. Changes in neuroendocrine function, body weight, energy metabolism, euglycemia, appetite function, and gut function can also occur. It is likely that the locus of these alterations is the hypothalamus. We determined the effects of three different euglycemic agents on HD progression using standard physiological and transcriptomic signature analyses. N171-82Q HD mice were treated with insulin, Exendin-4, and the newly developed GLP-1-Tf to determine whether these agents could improve energy regulation and delay disease progression. Blood glucose, insulin, metabolic hormone levels, and pancreatic morphology were assessed. Hypothalamic gene transcription, motor coordination, and life span were also determined. The N171-82Q mice exhibited significant alterations in hypothalamic gene transcription signatures and energy metabolism that were ameliorated, to varying degrees, by the different euglycemic agents. Exendin-4 or GLP-1-Tf (but not insulin) treatment also improved pancreatic morphology, motor coordination, and increased life span. Using hypothalamic transcription signature analyses, we found that the physiological efficacy variation of the drugs was evident in the degree of reversal of the hypothalamic HD pathological signature. Euglycemic agents targeting hypothalamic and energy regulation dysfunction in HD could potentially alter disease progression and improve quality of life in HD.	[Martin, Bronwen; Cong, Wei-na; Daimon, Caitlin M.; Golden, Erin J.] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chadwick, Wayne; Pantaleo, Nick; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Diabet Sect, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, NIH, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Pantaleo, Nick/AAE-4452-2021; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Martin, Bronwen/0000-0002-9185-6925	National Institutes of Health Intramural Research Program, NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZIAAG000917, ZIAAG000905, ZIAAG000325, ZIAAG000916, ZIAAG000318, ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIA.	Altinova AE, 2007, ENDOCR J, V54, P221, DOI 10.1507/endocrj.K06-021; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Barkalifa R, 2010, PHYSIOL GENOMICS, V42, P445, DOI 10.1152/physiolgenomics.00042.2010; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen J, 2007, J NEUROSCI RES, V85, P1724, DOI 10.1002/jnr.21304; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Gaba AM, 2005, AM J CLIN NUTR, V81, P1335; Gossrau G, 2006, J NEURAL TRANSM, V113, P331, DOI 10.1007/s00702-005-0329-x; Head G. A., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P17, DOI 10.2174/187152506775268758; Hickey MA, 2012, MOL CELL NEUROSCI, V49, P149, DOI 10.1016/j.mcn.2011.10.007; Hong Y, 2009, NEUROTOXICOLOGY, V30, P538, DOI 10.1016/j.neuro.2009.04.011; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jankovic N, 2008, INT J NEUROSCI, V118, P391, DOI 10.1080/00207450701593103; Jarvis K, 2007, NEUROSCI LETT, V423, P184, DOI 10.1016/j.neulet.2007.06.058; Khan R. S., 2010, INT J PEPT, V2010; Kim BJ, 2010, J PHARMACOL EXP THER, V334, P682, DOI 10.1124/jpet.110.166470; Kim J, 2011, INT REV NEUROBIOL, V98, P419, DOI 10.1016/B978-0-12-381328-2.00016-X; Koop O, 2005, NEUROMUSCULAR DISORD, V15, P549, DOI 10.1016/j.nmd.2005.06.007; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Labudova O, 1998, BRAIN RES, V806, P55, DOI 10.1016/S0006-8993(98)00730-6; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; MAZUREK MF, 1986, NEUROLOGY, V36, P1133, DOI 10.1212/WNL.36.8.1133; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Niu SN, 2011, FEBS LETT, V585, P85, DOI 10.1016/j.febslet.2010.11.059; Pan W, 2007, PEPTIDES, V28, P2411, DOI 10.1016/j.peptides.2007.10.006; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Perez-Tilve D, 2007, DIABETES, V56, P143, DOI 10.2337/db05-0996; Pers TH, 2011, GENET EPIDEMIOL, V35, P318, DOI 10.1002/gepi.20580; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065; Sutherland G, 2008, AM J MED GENET B, V147B, P495, DOI 10.1002/ajmg.b.30633; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/0006-8993(96)00080-7; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Wu LLY, 2010, J BIOL CHEM, V285, P5614, DOI 10.1074/jbc.M109.073197; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	55	23	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31766	31782		10.1074/jbc.M112.387316	http://dx.doi.org/10.1074/jbc.M112.387316			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822065	Green Published, hybrid			2022-12-28	WOS:000309059400018
J	Ujfalusi, Z; Kovacs, M; Nagy, NT; Barko, S; Hild, G; Lukacs, A; Nyitrai, M; Bugyi, B				Ujfalusi, Zoltan; Kovacs, Mihaly; Nagy, Nikolett T.; Barko, Szilvia; Hild, Gabor; Lukacs, Andras; Nyitrai, Miklos; Bugyi, Beata			Myosin and Tropomyosin Stabilize the Conformation of Formin-nucleated Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; RESONANCE ENERGY-TRANSFER; F-ACTIN; DIVALENT-CATIONS; STRUCTURAL DYNAMICS; ATP HYDROLYSIS; BINDING-SITES; BARBED END; FLEXIBILITY; SUBFRAGMENT-1	The conformational elasticity of the actin cytoskeleton is essential for its versatile biological functions. Increasing evidence supports that the interplay between the structural and functional properties of actin filaments is finely regulated by actin-binding proteins; however, the underlying mechanisms and biological consequences are not completely understood. Previous studies showed that the binding of formins to the barbed end induces conformational transitions in actin filaments by making them more flexible through long range allosteric interactions. These conformational changes are accompanied by altered functional properties of the filaments. To get insight into the conformational regulation of formin-nucleated actin structures, in the present work we investigated in detail how binding partners of formin-generated actin structures, myosin and tropomyosin, affect the conformation of the formin-nucleated actin filaments using fluorescence spectroscopic approaches. Time-dependent fluorescence anisotropy and temperature-dependent Forster-type resonance energy transfer measurements revealed that heavy meromyosin, similarly to tropomyosin, restores the formin-induced effects and stabilizes the conformation of actin filaments. The stabilizing effect of heavy meromyosin is cooperative. The kinetic analysis revealed that despite the qualitatively similar effects of heavy meromyosin and tropomyosin on the conformational dynamics of actin filaments the mechanisms of the conformational transition are different for the two proteins. Heavy meromyosin stabilizes the formin-nucleated actin filaments in an apparently single step reaction upon binding, whereas the stabilization by tropomyosin occurs after complex formation. These observations support the idea that actin-binding proteins are key elements of the molecular mechanisms that regulate the conformational and functional diversity of actin filaments in living cells.	[Ujfalusi, Zoltan; Barko, Szilvia; Hild, Gabor; Lukacs, Andras; Nyitrai, Miklos; Bugyi, Beata] Univ Pecs, Sch Med, Dept Biophys, H-7624 Pecs, Hungary; [Ujfalusi, Zoltan; Barko, Szilvia; Hild, Gabor; Lukacs, Andras; Nyitrai, Miklos; Bugyi, Beata] Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Ujfalusi, Zoltan] Hungarian Acad Sci, Off Subsidized Res Units, H-1051 Budapest, Hungary; [Kovacs, Mihaly; Nagy, Nikolett T.] Eotvos Lorand Univ, Hungarian Acad Sci, Momentum Motor Enzymol Res Grp, Dept Biochem,Fac Sci, H-1117 Budapest, Hungary	University of Pecs; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences	Bugyi, B (corresponding author), Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	beata.bugyi@aok.pte.hu	Lukacs, Andras/AAF-3341-2021; Kovacs, Mihaly/A-6841-2011	Kovacs, Mihaly/0000-0002-1200-4741; Nyitrai, Miklos/0000-0002-6229-4337; Lukacs, Andras/0000-0001-8841-9823	Hungarian Science Foundation Orszagos Tudomanyos Kutatasi Alapprogramok (Hungarian Science Foundation) [K77840, PD83648, K71915, NNF2-85613, NK81950]; "Momentum" Program of the Hungarian Academy of Sciences [LP2011-006/2011]; European Union [TAMOP-4.2.1/B-09/1/KMR-2010-0003, TAMOP-4.2.1/B-10/2/KONV-2010-0002, TAMOP-4.2.2/B-10/1-2010-0029]; European Social Fund; Science, Please! Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; Hungarian Academy of Sciences; Wellcome Trust	Hungarian Science Foundation Orszagos Tudomanyos Kutatasi Alapprogramok (Hungarian Science Foundation); "Momentum" Program of the Hungarian Academy of Sciences; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Science, Please! Research Team on Innovation; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported in part by Hungarian Science Foundation Orszagos Tudomanyos Kutatasi Alapprogramok (Hungarian Science Foundation) Grant K77840 (to M. N.), PD83648 (to B. B.), and K71915, NNF2-85613, and NK81950 (to M. K.); "Momentum" Program of the Hungarian Academy of Sciences Grant LP2011-006/2011 (to M. K.); and Grant TAMOP-4.2.1/B-09/1/KMR-2010-0003 (to M. K.), TAMOP-4.2.1/B-10/2/KONV-2010-0002 (to M. N.) and TAMOP-4.2.2/B-10/1-2010-0029 (to M. N.) from the European Union, cofinanced by the European Social Fund. This work was also supported by "Science, Please! Research Team on Innovation" Grant SROP-4.2.2/08/1/2008-0011 and by the Hungarian Academy of Sciences.; Holds a Wellcome Trust International Senior Research Fellowship in Biomedical Sciences.	Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; COATES JH, 1985, BIOCHEM J, V232, P351, DOI 10.1042/bj2320351; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Hild G, 2002, EUR J BIOCHEM, V269, P842, DOI 10.1046/j.0014-2956.2001.02716.x; Hild G, 1998, BIOPHYS J, V75, P3015, DOI 10.1016/S0006-3495(98)77742-2; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kupi T, 2009, BIOPHYS J, V96, P2901, DOI 10.1016/j.bpj.2008.11.058; LABBE JP, 1992, BIOCHEM J, V284, P75, DOI 10.1042/bj2840075; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P161; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MIKI M, 1987, EUR J BIOCHEM, V168, P339, DOI 10.1111/j.1432-1033.1987.tb13425.x; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; Nyitrai M, 1997, BIOPHYS J, V73, P2023, DOI 10.1016/S0006-3495(97)78232-8; Nyitrai M, 1999, J BIOL CHEM, V274, P12996, DOI 10.1074/jbc.274.19.12996; Nyitrai M, 2000, J BIOL CHEM, V275, P41143, DOI 10.1074/jbc.M004146200; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Prochniewicz E, 2001, BIOCHEMISTRY-US, V40, P13933, DOI 10.1021/bi010893n; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 1997, BIOCHEMISTRY-US, V36, P12845, DOI 10.1021/bi971201r; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Prochniewicz E, 2009, P NATL ACAD SCI USA, V106, P7822, DOI 10.1073/pnas.0812007106; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sellers J. R., 1999, PROTEIN PROFILE MYOS; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SOMOGYI B, 1984, BIOCHEMISTRY-US, V23, P3403, DOI 10.1021/bi00310a004; Somogyi B, 2000, J PHOTOCH PHOTOBIO B, V59, P26, DOI 10.1016/S1011-1344(00)00130-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Ujfalusi Z, 2010, J PHOTOCH PHOTOBIO B, V98, P7, DOI 10.1016/j.jphotobiol.2009.10.001; Ujfalusi Z, 2009, BIOPHYS J, V96, P162, DOI 10.1529/biophysj.108.138420; Visegrady B, 2005, FEBS LETT, V579, P6, DOI 10.1016/j.febslet.2004.11.023; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; YANG YZ, 1979, J BIOL CHEM, V254, P7137; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	66	18	18	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31894	31904		10.1074/jbc.M112.341230	http://dx.doi.org/10.1074/jbc.M112.341230			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22753415	Green Published, hybrid			2022-12-28	WOS:000309059400029
J	Haque, MM; Fadlalla, MA; Aulak, KS; Ghosh, A; Durra, D; Stuehr, DJ				Haque, Mohammad Mahfuzul; Fadlalla, Mohammed A.; Aulak, Kulwant S.; Ghosh, Arnab; Durra, Deborah; Stuehr, Dennis J.			Control of Electron Transfer and Catalysis in Neuronal Nitric-oxide Synthase (nNOS) by a Hinge Connecting Its FMN and FAD-NADPH Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO COMPLEX-FORMATION; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; FLAVOPROTEIN DOMAIN; SURFACE-CHARGE; HEME REDUCTION; CALMODULIN; FLAVIN; MECHANISM	In nitric-oxide synthases (NOSs), two flexible hinges connect the FMN domain to the rest of the enzyme and may guide its interactions with partner domains for electron transfer and catalysis. We investigated the role of the FMN-FAD/NADPH hinge in rat neuronalNOS(nNOS) by constructing mutants that either shortened or lengthened this hinge by 2, 4, and 6 residues. Shortening the hinge progressively inhibited electron flux through the calmodulin (CaM)-free and CaM-bound nNOS to cytochrome c, whereas hinge lengthening relieved repression of electron flux in CaM-free nNOS and had no impact or slowed electron flux through CaM-bound nNOS to cytochrome c. How hinge length influenced heme reduction depended on whether enzyme flavins were pre-reduced with NADPH prior to triggering heme reduction. Without pre-reduction, changing the hinge length was deleterious; with pre-reduction, the hinge shortening was deleterious, and hinge lengthening increased heme reduction rates beyond wild type. Flavin fluorescence and stopped-flow kinetic studies on CaM-bound enzymes suggested hinge lengthening slowed the domain-domain interaction needed for FMN reduction. All hinge length changes lowered NO synthesis activity and increased uncoupled NADPH consumption. We conclude that several aspects of catalysis are sensitive to FMN-FAD/NADPH hinge length and that the native hinge allows a best compromise among the FMN domain interactions and associated electron transfer events to maximize NO synthesis and minimize uncoupled NADPH consumption.	[Haque, Mohammad Mahfuzul; Fadlalla, Mohammed A.; Aulak, Kulwant S.; Ghosh, Arnab; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol NC 22, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org		HAQUE, MOHAMMAD/0000-0003-0852-6368; GHOSH, ARNAB/0000-0002-7498-1994	National Institutes of Health [GM51491, CA53914, HL58883]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, CA53914, and HL58883 (to D. J. S.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Astashkin AV, 2010, J AM CHEM SOC, V132, P12059, DOI 10.1021/ja104461p; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2001, BIOCHEM SOC T, V29, P147, DOI 10.1042/0300-5127:0290147; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Forstermann U, 1998, FASEB J, V12, P773; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; KLATT P, 1992, J BIOL CHEM, V267, P11374; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Panda K, 2004, J BIOL CHEM, V279, P18323, DOI 10.1074/jbc.M310391200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Welland A, 2010, FEBS J, V277, P3833, DOI 10.1111/j.1742-4658.2010.07787.x; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532	57	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30105	30116		10.1074/jbc.M112.339697	http://dx.doi.org/10.1074/jbc.M112.339697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22722929	hybrid, Green Published			2022-12-28	WOS:000308579800006
J	Koripella, RK; Chen, Y; Peisker, K; Koh, CS; Selmer, M; Sanyal, S				Koripella, Ravi Kiran; Chen, Yang; Peisker, Kristin; Koh, Cha San; Selmer, Maria; Sanyal, Suparna			Mechanism of Elongation Factor-G-mediated Fusidic Acid Resistance and Fitness Compensation in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-G; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; RNA MOVEMENT; RIBOSOME; SENSITIVITY; TRANSLOCATION; MUTATIONS; EVOLUTION	Antibiotic resistance in bacteria is often associated with fitness loss, which is compensated by secondary mutations. Fusidic acid (FA), an antibiotic used against pathogenic bacteria Staphylococcus aureus, locks elongation factor-G (EF-G) to the ribosome after GTP hydrolysis. To clarify the mechanism of fitness loss and compensation in relation to FA resistance, we have characterized three S. aureus EF-G mutants with fast kinetics and crystal structures. Our results show that a significantly slower tRNA translocation and ribosome recycling, plus increased peptidyl-tRNA drop-off, are the causes for fitness defects of the primary FA-resistant mutant F88L. The double mutant F88L/M16I is three to four times faster than F88L in both reactions and showed no tRNA drop-off, explaining its fitness compensatory phenotype. The M16I mutation alone showed hypersensitivity to FA, higher activity, and somewhat increased affinity to GTP. The crystal structures demonstrate that Phe-88 in switch II is a key residue for FA locking and also for triggering interdomain movements in EF-G essential for its function, explaining functional deficiencies in F88L. The mutation M16I loosens the hydrophobic core in the G domain and affects domain I to domain II contact, resulting in improved activity both in the wild-type and F88L background. Thus, FA-resistant EF-G mutations causing fitness loss and compensation operate by affecting the conformational dynamics of EF-G on the ribosome.	[Koripella, Ravi Kiran; Chen, Yang; Peisker, Kristin; Koh, Cha San; Selmer, Maria; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Uppsala University	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	maria.selmer@icm.uu.se; suparna.sanyal@icm.uu.se		Selmer, Maria/0000-0001-9079-2774	Swedish Research Council; Uppsala RNA Research Centre (URRC); Knut and Alice Wallenberg Foundation (RiboCORE); Wenner-Gren Foundation; Swedish Foundation for Strategic Research; Hagbergs Foundation; Ake Wibergs Foundation; Vinnova/Department of Biotechnology, India; LEO Pharma; Carl Tryggers Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala RNA Research Centre (URRC); Knut and Alice Wallenberg Foundation (RiboCORE); Wenner-Gren Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hagbergs Foundation; Ake Wibergs Foundation; Vinnova/Department of Biotechnology, India; LEO Pharma(LEO Pharma); Carl Tryggers Foundation	This work was supported by the research grants from Swedish Research Council (individual project grants and through the Uppsala RNA Research Centre (URRC), Knut and Alice Wallenberg Foundation (RiboCORE), Wenner-Gren Foundation, and the Swedish Foundation for Strategic Research (to M. S. and S. S.); from the Hagbergs Foundation and the Ake Wibergs Foundation (to M. S.); and from Vinnova/Department of Biotechnology, India, LEO Pharma, and Carl Tryggers Foundation (to S. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Brown EM, 2002, LANCET, V359, P803, DOI 10.1016/S0140-6736(02)07869-8; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2010, ANNU REV BIOCHEM, V79, P381, DOI 10.1146/annurev-biochem-060408-173330; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo XH, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120016; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Johanson U, 1996, J MOL BIOL, V258, P420, DOI 10.1006/jmbi.1996.0259; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Khade PK, 2011, NAT STRUCT MOL BIOL, V18, P1300, DOI 10.1038/nsmb.2140; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Levin BR, 2000, GENETICS, V154, P985; Li MM, 2011, J HAZARD MATER, V186, P2031, DOI 10.1016/j.jhazmat.2010.12.101; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ticu C, 2011, J BIOL CHEM, V286, P21697, DOI 10.1074/jbc.M110.214056; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	51	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30257	30267		10.1074/jbc.M112.378521	http://dx.doi.org/10.1074/jbc.M112.378521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767604	Green Published, hybrid			2022-12-28	WOS:000308579800019
J	Fukushima, T; Nakamura, Y; Yamanaka, D; Shibano, T; Chida, K; Minami, S; Asano, T; Hakuno, F; Takahashi, SI				Fukushima, Toshiaki; Nakamura, Yusaku; Yamanaka, Daisuke; Shibano, Takashi; Chida, Kazuhiro; Minami, Shiro; Asano, Tomoichiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Phosphatidylinositol 3-Kinase (PI3K) Activity Bound to Insulin-like Growth Factor-I (IGF-I) Receptor, which Is Continuously Sustained by IGF-I Stimulation, Is Required for IGF-I-induced Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; EPITHELIAL-CELLS; FRTL-5 CELLS; TYROSINE PHOSPHORYLATION; DNA-SYNTHESIS; CYCLIN D1; ACTIVATION; DEGRADATION; SUBSTRATE-2; PATHWAY	Continuous stimulation of cells with insulin-like growth factors (IGFs) in G(1) phase is a well established requirement for IGF-induced cell proliferation; however, the molecular components of this prolonged signaling pathway that is essential for cell cycle progression from G(1) to S phase are unclear. IGF-I activates IGF-I receptor (IGF-IR) tyrosine kinase, followed by phosphorylation of substrates such as insulin receptor substrates (IRS) leading to binding of signaling molecules containing SH2 domains, including phosphatidylinositol 3-kinase (PI3K) to IRS and activation of the downstream signaling pathways. In this study, we found prolonged (>9 h) association of PI3K with IGF-IR induced by IGF-I stimulation. PI3K activity was present in this complex in thyrocytes and fibroblasts, although tyrosine phosphorylation of IRS was not yet evident after 9 h of IGF-I stimulation. IGF-I withdrawal in mid-G(1) phase impaired the association of PI3K with IGF-IR and suppressed DNA synthesis the same as when PI3K inhibitor was added. Furthermore, we demonstrated that Tyr(1316)-X-X-Met of IGF-IR functioned as a PI3K binding sequence when this tyrosine is phosphorylated. We then analyzed IGF signaling and proliferation of IGF-IR-/- fibroblasts expressing exogenous mutant IGF-IR in which Tyr(1316) was substituted with Phe (Y1316F). In these cells, IGF-I stimulation induced tyrosine phosphorylation of IGF-IR and IRS-1/2, but mutated IGF-IR failed to bind PI3K and to induce maximal phosphorylation of GSK3 beta and cell proliferation in response to IGF-I. Based on these results, we concluded that PI3K activity bound to IGF-IR, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.	[Takahashi, Shin-Ichiro] Univ Tokyo, Lab Cell Regulat, Dept Anim Sci, Grad Sch Agr & Life Sci,Bunkyo Ku, Tokyo 1138657, Japan; [Fukushima, Toshiaki; Nakamura, Yusaku; Shibano, Takashi; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Fukushima, Toshiaki; Asano, Tomoichiro] Hiroshima Univ, Lab Biomed Chem, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Yamanaka, Daisuke; Minami, Shiro] Nippon Med Sch, Dept Bioregulat, Kawasaki, Kanagawa 2118533, Japan	University of Tokyo; University of Tokyo; Hiroshima University; Nippon Medical School	Takahashi, SI (corresponding author), Univ Tokyo, Lab Cell Regulat, Dept Anim Sci, Grad Sch Agr & Life Sci,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp	柴野, 卓志/AHB-7015-2022	Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225	Japan Society for the Promotion of Science (JSPS) [16208028, 22248030]; JSPS Core-to-Core Program; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [24790928] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS) ((A) (2) 16208028 and (A) 22248030), the JSPS Core-to-Core Program, and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S.- I. T.).	AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FARIA TN, 1994, J BIOL CHEM, V269, P13922; Fukushima T, 2008, ENDOCRINOLOGY, V149, P3729, DOI 10.1210/en.2007-1443; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gunton JE, 2003, J CLIN ENDOCR METAB, V88, P1323, DOI 10.1210/jc.2002-021394; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hongo A, 1996, ONCOGENE, V12, P1231; Ito Y, 1997, BIOCHEM J, V324, P379, DOI 10.1042/bj3240379; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; KATO H, 1994, MOL ENDOCRINOL, V8, P40, DOI 10.1210/me.8.1.40; Kim B, 2005, ENDOCRINOLOGY, V146, P5350, DOI 10.1210/en.2005-0356; LEOF EB, 1982, EXP CELL RES, V141, P107, DOI 10.1016/0014-4827(82)90073-8; LEVYTOLEDANO R, 1994, J BIOL CHEM, V269, P31178; LI SW, 1994, J BIOL CHEM, V269, P32558; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ness JK, 2002, MOL CELL NEUROSCI, V20, P476, DOI 10.1006/mcne.2002.1149; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Qureshi FG, 1997, J SURG RES, V69, P354, DOI 10.1006/jsre.1997.5080; Ristow HJ, 1996, GROWTH REGULAT, V6, P96; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Rose DW, 1998, ONCOGENE, V17, P889, DOI 10.1038/sj.onc.1201997; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Stull MA, 2002, ENDOCRINOLOGY, V143, P1872, DOI 10.1210/en.143.5.1872; STURANI E, 1988, MOL CELL BIOL, V8, P1345, DOI 10.1128/MCB.8.3.1345; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TartareDeckert S, 1996, ENDOCRINOLOGY, V137, P1019, DOI 10.1210/en.137.3.1019; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; VANHORN DJ, 1994, J BIOL CHEM, V269, P29; Yam A, 2001, J BIOL CHEM, V276, P24409, DOI 10.1074/jbc.M102358200; YAMAMOTO K, 1992, ENDOCRINOLOGY, V130, P1490, DOI 10.1210/en.130.3.1490; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	43	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29713	29721		10.1074/jbc.M112.393074	http://dx.doi.org/10.1074/jbc.M112.393074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767591	hybrid, Green Published			2022-12-28	WOS:000308286900047
J	Khasnavis, S; Jana, A; Roy, A; Mazumder, M; Bhushan, B; Wood, T; Ghosh, S; Watson, R; Pahan, K				Khasnavis, Saurabh; Jana, Arundhati; Roy, Avik; Mazumder, Monalisa; Bhushan, Bharat; Wood, Tony; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			Suppression of Nuclear Factor-kappa B Activation and Inflammation in Microglia by Physically Modified Saline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; UP-REGULATION; IN-VIVO; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTION FACTOR; PRIMARY ASTROCYTES; INDUCTION; EXPRESSION; CYTOKINE	Chronic inflammation involving activated microglia and astroglia is becoming a hallmark of many human diseases, including neurodegenerative disorders. Although NF-kappa B is a multifunctional transcription factor, it is an important target for controlling inflammation as the transcription of many proinflammatory molecules depends on the activation of NF-kappa B. Here, we have undertaken a novel approach to attenuate NF-kappa B activation and associated inflammation in activated glial cells. RNS60 is a 0.9% saline solution containing charge-stabilized nanostructures that are generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. RNS60, but not normal saline, RNS10.3 (TCP-modified saline without excess oxygen), and PNS60 (saline containing excess oxygen without TCP modification) were found to inhibit the production of nitric oxide (NO) and the expression of inducible NO synthase in activated microglia. Similarly, RNS60 also inhibited the expression of inducible NO synthase in activated astroglia. Inhibition of NF-kappa B activation by RNS60 suggests that RNS60 exerts its anti-inflammatory effect through the inhibition of NF-kappa B. Interestingly, RNS60 induced the activation of type IA phosphatidylinositol (PI) 3-kinase and Akt and rapidly up-regulated I kappa B alpha, a specific endogenous inhibitor of NF-kappa B. Inhibition of PI 3-kinase and Akt by either chemical inhibitors or dominant-negative mutants abrogated the RNS60-mediated up-regulation of I kappa B alpha. Furthermore, we demonstrate that RNS60 induced the activation of cAMP-response element-binding protein (CREB) via the PI 3-kinase-Akt pathway and that RNS60 up-regulated I kappa B alpha via CREB. These results describe a novel anti-inflammatory property of RNS60 via type IA PI 3-kinase-Akt-CREB-mediated up-regulation of I kappa B alpha, which may be of therapeutic benefit in neurodegenerative disorders.	[Khasnavis, Saurabh; Jana, Arundhati; Roy, Avik; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Mazumder, Monalisa; Bhushan, Bharat] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA; [Wood, Tony; Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA 98421 USA	Rush University; University System of Ohio; Ohio State University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Ste 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Khasnavis, Saurabh/K-2249-2019		Revalesio Corporation	Revalesio Corporation	This work was supported by Revalesio Corporation.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Craig VSJ, 2011, SOFT MATTER, V7, P40, DOI 10.1039/c0sm00558d; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Dluska E, 2004, EXP THERM FLUID SCI, V28, P467, DOI 10.1016/j.expthermflusci.2003.06.003; Fan M., 2010, MINING SCI TECHNOL, V20, P0001; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Forney LJ, 2005, IND ENG CHEM RES, V44, P7306, DOI 10.1021/ie050342j; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Habich A, 2010, J PHYS CHEM B, V114, P6962, DOI 10.1021/jp911868j; Hamakawa H, 2008, J THERM SCI, V17, P175, DOI 10.1007/s11630-008-0175-x; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Jantaratnotai N, 2003, NEUROREPORT, V14, P1429, DOI 10.1097/00001756-200308060-00005; Kleinert H, 1998, BRIT J PHARMACOL, V125, P193, DOI 10.1038/sj.bjp.0702039; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Mazumder M, 2011, SOFT MATTER, V7, P9184, DOI 10.1039/c1sm05560g; Mondal S., 2012, J NEUROIMMU IN PRESS; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; OURESHI GA, 1995, NEUROREPORT, V6, P1642, DOI 10.1097/00001756-199508000-00013; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; Weijs JH, 2012, CHEMPHYSCHEM, V13, P2197, DOI 10.1002/cphc.201100807; Wood A., 2008, U. S. Patent, Patent No. [7,832,920, 7832920]; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhou ZA, 2009, MINER ENG, V22, P419, DOI 10.1016/j.mineng.2008.12.010	49	86	95	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29529	29542		10.1074/jbc.M111.338012	http://dx.doi.org/10.1074/jbc.M111.338012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22753407	hybrid, Green Published			2022-12-28	WOS:000308286900029
J	Maheshwari, M; Samanta, A; Godavarthi, SK; Mukherjee, R; Jana, NR				Maheshwari, Megha; Samanta, Ananya; Godavarthi, Swetha K.; Mukherjee, Rajarshi; Jana, Nihar Ranjan			Dysfunction of the Ubiquitin Ligase Ube3a May Be Associated with Synaptic Pathophysiology in a Mouse Model of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; ANGELMAN-SYNDROME; TRANSGENIC MICE; POLYGLUTAMINE PROTEIN; TRINUCLEOTIDE REPEAT; DECREASED EXPRESSION; PLASTICITY; GENE; DEGRADATION; PROMOTES	Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by progressive cognitive, psychiatric, and motor symptoms. The disease is caused by abnormal expansion of CAG repeats in the gene encoding huntingtin, but how mutant huntingtin leads to early cognitive deficits in HD is poorly understood. Here, we demonstrate that the ubiquitin ligase Ube3a, which is implicated in synaptic plasticity and involved in the clearance of misfolded polyglutamine protein, is strongly recruited to the mutant huntingtin nuclear aggregates, resulting in significant loss of its functional pool in different regions of HD mouse brain. Interestingly, Arc, one of the substrates of Ube3a linked with synaptic plasticity, is also associated with nuclear aggregates, although its synaptic level is increased in the hippocampus and cortex of HD mouse brain. Different regions of HD mouse brain also exhibit decreased levels of AMPA receptors and various pre- and postsynaptic proteins, which could be due to the partial loss of function of Ube3a. Transient expression of mutant huntingtin in mouse primary cortical neurons further demonstrates recruitment of Ube3a into mutant huntingtin aggregates, increased accumulation of Arc, and decreased numbers of GluR1 puncta in the neuronal processes. Altogether, our results suggest that the loss of function of Ube3a might be associated with the synaptic abnormalities observed in HD.	[Maheshwari, Megha; Samanta, Ananya; Godavarthi, Swetha K.; Mukherjee, Rajarshi; Jana, Nihar Ranjan] Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Gurgaon 122050, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Gurgaon 122050, Haryana, India.	nihar@nbrc.ac.in		Jana, Nihar/0000-0002-6549-4211; Godavarthi, Swetha/0000-0003-4665-4627	Department of Biotechnology [BT/HRD/34/18/2008]	Department of Biotechnology	This work was supported in part by a core grant from the Department of Biotechnology to the National Brain Research Centre, Government of India.; Recipient of National Bioscience Award for Career Development BT/HRD/34/18/2008 from the Department of Biotechnology. To whom correspondence should be addressed. Tel.: 91-124-284-5217; Fax: 91-124-233-8910; E-mail: nihar@nbrc.ac.in.	Andre VM, 2006, J NEUROPHYSIOL, V95, P2108, DOI 10.1152/jn.01118.2005; Browne SE, 1999, BRAIN PATHOL, V9, P147; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; FOROUD T, 1995, ANN NEUROL, V37, P657, DOI 10.1002/ana.410370516; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2003, NEUROBIOL DIS, V14, P624, DOI 10.1016/j.nbd.2003.08.024; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandal M, 2011, J BIOL CHEM, V286, P33719, DOI 10.1074/jbc.M111.236521; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Milnerwood AJ, 2006, HUM MOL GENET, V15, P1690, DOI 10.1093/hmg/ddl092; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Williams CA, 2005, BRAIN DEV-JPN, V27, P88, DOI 10.1016/j.braindev.2003.09.014; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	47	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29949	29957		10.1074/jbc.M112.371724	http://dx.doi.org/10.1074/jbc.M112.371724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787151	hybrid, Green Published			2022-12-28	WOS:000308286900068
J	Murakami, R; Mutoh, R; Iwase, R; Furukawa, Y; Imada, K; Onai, K; Morishita, M; Yasui, S; Ishii, K; Swain, JOV; Uzumaki, T; Namba, K; Ishiura, M				Murakami, Reiko; Mutoh, Risa; Iwase, Ryo; Furukawa, Yukio; Imada, Katsumi; Onai, Kiyoshi; Morishita, Megumi; Yasui, So; Ishii, Kentaro; Swain, Jonathan Orville Valencia; Uzumaki, Tatsuya; Namba, Keiichi; Ishiura, Masahiro			The Roles of the Dimeric and Tetrameric Structures of the Clock Protein KaiB in the Generation of Circadian Oscillations in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; HISTIDINE KINASE; ATPASE ACTIVITY; REAL-TIME; IN-VITRO; PHOSPHORYLATION; COMPLEX; SYSTEM	The molecular machinery of the cyanobacterial circadian clock consists of three proteins, KaiA, KaiB, and KaiC. The three Kai proteins interact with each other and generate circadian oscillations in vitro in the presence of ATP (an in vitro KaiABC clock system). KaiB consists of four subunits organized as a dimer of dimers, and its overall shape is that of an elongated hexagonal plate with a positively charged cleft flanked by two negatively charged ridges. We found that a mutant KaiB with a C- terminal deletion ( KaiB(1-94)), which lacks the negatively charged ridges, was a dimer. Despite its dimeric structure, KaiB(1-94) interacted with KaiC and generated normal circadian oscillations in the in vitro KaiABC clock system. KaiB(1-94) also generated circadian oscillations in cyanobacterial cells, but they were weak, indicating that the C- terminal region and tetrameric structure of KaiB are necessary for the generation of normal gene expression rhythms in vivo. KaiB(1-94) showed the highest affinity for KaiC among the KaiC-binding proteins we examined and inhibited KaiC from forming a complex with SasA, which is involved in the main output pathway from the KaiABC clock oscillator in transcription regulation. This defect explains the mechanism underlying the lack of normal gene expression rhythms in cells expressing KaiB(1-94.)	[Mutoh, Risa; Iwase, Ryo; Yasui, So; Swain, Jonathan Orville Valencia; Uzumaki, Tatsuya; Ishiura, Masahiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Murakami, Reiko; Mutoh, Risa; Iwase, Ryo; Onai, Kiyoshi; Morishita, Megumi; Yasui, So; Ishii, Kentaro; Swain, Jonathan Orville Valencia; Ishiura, Masahiro] Nagoya Univ, Grad Sch Sci, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Furukawa, Yukio; Imada, Katsumi; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Nagoya University; Nagoya University; Osaka University	Ishiura, M (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	ishiura@gene.nagoya-u.ac.jp	Mutoh, Risa/L-6494-2017; Namba, Keiichi/A-9406-2016	Mutoh, Risa/0000-0003-0069-8931; Ishii, Kentaro/0000-0003-1722-2673; Onai, Kiyoshi/0000-0001-9062-2548; Imada, Katsumi/0000-0003-1342-8885	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Leavanest; MBL (Tokyo, Japan); Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; SENTAN, JST	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leavanest; MBL (Tokyo, Japan); Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENTAN, JST(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. I. and K. O.).; Supported by a grant from Leavanest and MBL (Tokyo, Japan).; Research assistants supported by a Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by grants from Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. Present address: Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.; We thank Satoko Ogawa and Kumiko Tanaka for technical support and Miriam Bloom (SciWrite Biomedical Writing and Editing Services) for professional editing. Development of the automated bioluminescence monitoring apparatus CL96-4 and the plate conveyor robot CI-08L were supported by SENTAN, JST. The apparatuses CL96-4 and CI- 08Lare commercially available through Churitsu Electric Corp. (Nagoya, Japan).	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Aoki Setsuyuki, 2009, P259, DOI 10.1007/978-3-540-88431-6_15; Bunning E., 1973, PHYSL CLOCK CIRCADIA; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Mutoh R, 2011, APPL MAGN RESON, V40, P525, DOI 10.1007/s00723-011-0228-2; Mutoh R, 2010, GENES CELLS, V15, P269, DOI 10.1111/j.1365-2443.2009.01377.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Okamoto K, 2005, PLANT CELL ENVIRON, V28, P1305, DOI 10.1111/j.1365-3040.2005.01377.x; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V11, P623, DOI 10.1038/nsmb781; Vakonakis I, 2004, J MOL BIOL, V342, P9, DOI 10.1016/j.jmb.2004.07.010; Valencia J, 2012, GENES CELLS, V17, P398, DOI 10.1111/j.1365-2443.2012.01597.x; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684	42	33	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29506	29515		10.1074/jbc.M112.349092	http://dx.doi.org/10.1074/jbc.M112.349092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22722936	hybrid, Green Published			2022-12-28	WOS:000308286900027
J	Xu, KQ; Wu, XL; Tompkins, JD; Her, CT				Xu, Keqian; Wu, Xiling; Tompkins, Joshua D.; Her, Chengtao			Assessment of Anti-recombination and Double-strand Break-induced Gene Conversion in Human Cells by a Chromosomal Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MISMATCH REPAIR; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MITOTIC RECOMBINATION; MICROSATELLITE INSTABILITY; MEIOTIC RECOMBINATION; HIGH-FREQUENCY; MRE11 COMPLEX; PROTEIN HMLH1	Gene conversion is one of the frequent end results of homologous recombination, and it often underlies the inactivation of tumor suppressor genes in cancer cells. Here, we have developed an integrated assay system that allows simultaneous examination of double-strand break (DSB)-induced gene conversion events at the site of a DSB (proximal region) and at a surrounding region similar to 1 kb away from the break (distal region). Utilizing this assay system, we find that gene conversion events at the proximal and distal regions are relatively independent of one another. The results also indicate that synthesis-dependent strand annealing (SDSA) plays a major role in DSB-induced gene conversion. In addition, our current study has demonstrated that hMLH1 plays an essential role in anti-recombination and gene conversion. Specifically, the anti-recombination activity of hMLH1 is partially dependent on its interaction with hMRE11. Our data suggests that the role of hMLH1 and hMRE11 in the process of gene conversion is complex, and these proteins play different roles in DSB-induced proximal and distal gene conversions. In particular, the involvement of hMLH1 and hMRE11 in the distal gene conversion requires both hMSH2 and heteroduplex formation.	[Xu, Keqian; Wu, Xiling; Tompkins, Joshua D.; Her, Chengtao] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Her, CT (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	cher@wsu.edu			National Institutes of Health, USPHS Grant, NIGMS [GM084353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084353] Funding Source: NIH RePORTER	National Institutes of Health, USPHS Grant, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health, USPHS Grant GM084353 (to C. H.) from the NIGMS.	Auclair J, 2007, HUM MUTAT, V28, P1084, DOI 10.1002/humu.20569; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Bosch E, 2004, GENOME RES, V14, P835, DOI 10.1101/gr.2177404; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen WL, 1999, GENETICS, V151, P1299; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Datta A, 1997, P NATL ACAD SCI USA, V94, P9757, DOI 10.1073/pnas.94.18.9757; David P, 1997, J NEUROSCI, V17, P8711; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; FANG WH, 1993, J BIOL CHEM, V268, P11838; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Her CT, 2002, DNA REPAIR, V1, P719, DOI 10.1016/S1568-7864(02)00079-4; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kirkpatrick DT, 1998, GENETICS, V149, P1693; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Neuwirth EAH, 2007, MOL CELL BIOL, V27, P5261, DOI 10.1128/MCB.01852-06; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Owen BAL, 2009, NAT STRUCT MOL BIOL, V16, P550, DOI 10.1038/nsmb.1596; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Papadakis MN, 1999, HUM GENET, V104, P117, DOI 10.1007/s004390050923; Qin J, 2002, J HERED, V93, P201, DOI 10.1093/jhered/93.3.201; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Saparbaev M, 1996, GENETICS, V142, P727; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shao CS, 2004, ONCOGENE, V23, P9017, DOI 10.1038/sj.onc.1208148; Siehler SY, 2009, DNA REPAIR, V8, P242, DOI 10.1016/j.dnarep.2008.10.011; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Taghian DG, 1997, MOL CELL BIOL, V17, P6386, DOI 10.1128/MCB.17.11.6386; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Wang Q, 2006, MUTAT RES-FUND MOL M, V594, P189, DOI 10.1016/j.mrfmmm.2005.09.005; Wang Y, 2000, GENE DEV, V14, P927; Wu XL, 2011, MOL CANCER RES, V9, P1443, DOI 10.1158/1541-7786.MCR-11-0322; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan T, 2009, CLIN CANCER RES, V15, P6912, DOI 10.1158/1078-0432.CCR-09-1698; Zhang J, 2006, CANCER RES, V66, P659, DOI 10.1158/0008-5472.CAN-05-4043; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhao N, 2008, BIOCHEM BIOPH RES CO, V370, P338, DOI 10.1016/j.bbrc.2008.03.082; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	51	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29543	29553		10.1074/jbc.M112.352302	http://dx.doi.org/10.1074/jbc.M112.352302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773873	hybrid, Green Published			2022-12-28	WOS:000308286900030
J	Tran, H; Polakis, P				Hoanh Tran; Polakis, Paul			Reversible Modification of Adenomatous Polyposis Coli (APC) with K63-linked Polyubiquitin Regulates the Assembly and Activity of the beta-Catenin Destruction Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE ASSOCIATION; UBIQUITIN-PROTEASOME PATHWAY; TUMOR-SUPPRESSOR PROTEIN; F-BOX PROTEIN; GSK-3-BETA-DEPENDENT PHOSPHORYLATION; NEGATIVE REGULATOR; STRUCTURAL BASIS; DIX DOMAIN; AXIN; LIGASE	The adenomatous polyposis coli (APC) tumor suppressor forms a complex with Axin and GSK3 beta to promote the phosphorylation and degradation of beta-catenin, a key co-activator of Wnt-induced transcription. Here, we establish that APC is modified predominantly with K63-linked ubiquitin chains when it is bound to Axin in unstimulated HEK293 cells. Wnt3a stimulation induced a time-dependent loss of K63-polyubiquitin adducts from APC, an effect synchronous with the dissociation of Axin from APC and the stabilization of cytosolic beta-catenin. RNAi-mediated depletion of Axin or beta-catenin, which negated the association between APC and Axin, resulted in the absence of K63-adducts on APC. Overexpression of wild-type and phosphodegron-mutant beta-catenin, combined with analysis of thirteen human cancer cell lines that harbor oncogenic mutations in APC, Axin, or beta-catenin, support the hypothesis that a fully assembled APC-Axin-GSK3 beta-phospho-beta-catenin complex is necessary for the K63-polyubiquitylation of APC. Intriguingly, the degree of this modification on APC appears to correlate inversely with the levels of beta-catenin in cells. Together, our results indicate that K63-linked polyubiquitin adducts on APC regulate the assembly and/or efficiency of the beta-catenin destruction complex.	[Hoanh Tran; Polakis, Paul] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA	Roche Holding; Genentech	Polakis, P (corresponding author), Genentech Inc, Dept Canc Targets, 1 DNA Way, San Francisco, CA 94080 USA.	tran.hoanh@gene.com; polakis.paul@gene.com						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benhaj K, 2006, ONCOL REP, V15, P701; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Choi J, 2004, J BIOL CHEM, V279, P49188, DOI 10.1074/jbc.M404655200; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Townsley FM, 2000, CURR BIOL, V10, P1339, DOI 10.1016/S0960-9822(00)00770-3; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	61	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28552	28563		10.1074/jbc.M112.387878	http://dx.doi.org/10.1074/jbc.M112.387878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761442	Green Published, hybrid			2022-12-28	WOS:000308074600030
J	Ling, A; Soares, F; Croitoru, DO; Tattoli, I; Carneiro, LAM; Boniotto, M; Benko, S; Philpott, DJ; Girardin, SE				Ling, Arthur; Soares, Fraser; Croitoru, David O.; Tattoli, Ivan; Carneiro, Leticia A. M.; Boniotto, Michele; Benko, Szilvia; Philpott, Dana J.; Girardin, Stephen E.			Post-transcriptional Inhibition of Luciferase Reporter Assays by the Nod-like Receptor Proteins NLRX1 and NLRC3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCIBLE INFLAMMATORY MEDIATOR; I GENE-EXPRESSION; SIGNALING PATHWAYS; FAMILY-MEMBER; BACTERIAL PEPTIDOGLYCAN; HOST RECOGNITION; RIG-I; ACTIVATION; IDENTIFICATION	Luciferase reporter assays (LRAs) are widely used to assess the activity of specific signal transduction pathways. Although powerful, rapid and convenient, this technique can also generate artifactual results, as revealed for instance in the case of high throughput screens of inhibitory molecules. Here we demonstrate that the previously reported inhibitory effect of the Nod-like receptor (NLR) protein NLRX1 on NF-kappa B- and type I interferon-dependent pathways in LRAs was a nonspecific consequence of the overexpression of the NLRX1 leucine-rich repeat (LRR) domain. By comparing luciferase activity and luciferase gene expression using quantitative PCR from the same samples, we showed that NLRX1 inhibited LRAs in a post-transcriptional manner. In agreement, NLRX1 also repressed LRAs if luciferase was expressed under the control of a constitutive promoter, although the degree of inhibition by NLRX1 seemed to correlate with the dynamic inducibility of luciferase reporter constructs. Similarly, we observed that overexpression of another NLR protein, NLRC3, also resulted in artifactual inhibition of LRAs; thus suggesting that the capacity to inhibit LRAs at a post-transcriptional level is not unique to NLRX1. Finally, we demonstrate that host type I interferon response to Sendai virus infection was normal in NLRX1-silenced human HEK293T cells. Our results thus highlight the fact that LRAs are not a reliable technique to assess the inhibitory function of NLRs, and possibly other overexpressed proteins, on signal transduction pathways.	[Ling, Arthur; Soares, Fraser; Croitoru, David O.; Tattoli, Ivan; Carneiro, Leticia A. M.; Benko, Szilvia; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada; [Boniotto, Michele] Paris S Univ, Sch Med, INSERM, U1012, F-94276 Le Kremlin Bicetre, France	University of Toronto; University of Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Room 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Boniotto, Michele/AAB-4302-2020; Tattoli, Ivan/H-2600-2017; Boniotto, Michele/F-1857-2010; Carneiro, Leticia/T-8978-2019	Boniotto, Michele/0000-0002-9548-2254; Tattoli, Ivan/0000-0001-7925-4609; Boniotto, Michele/0000-0002-9548-2254; Carneiro, Leticia/0000-0001-5870-8288; Soares, Fraser/0000-0002-3977-7939	Canadian Institutes of Health Research (CIHR); Burroughs Wellcome Fund; Canadian Association for Gastroenterology (CAG)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Association for Gastroenterology (CAG)	This work was supported in part by grants from the Canadian Institutes of Health Research (CIHR) (to D. J. P.) and Burroughs Wellcome Fund (to S. E. G.).; Supported by fellowships from CIHR.; Received a Summer Studentship from the Canadian Association for Gastroenterology (CAG).	Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Meissner TB, 2010, P NATL ACAD SCI USA, V107, P13794, DOI 10.1073/pnas.1008684107; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Neerincx A, 2012, J IMMUNOL, V188, P4940, DOI 10.4049/jimmunol.1103136; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56	36	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28705	28716		10.1074/jbc.M111.333146	http://dx.doi.org/10.1074/jbc.M111.333146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22718770	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000308074600044
J	Shrestha, N; Bahnan, W; Wiley, DJ; Barber, G; Fields, KA; Schesser, K				Shrestha, Niraj; Bahnan, Wael; Wiley, David J.; Barber, Glen; Fields, Kenneth A.; Schesser, Kurt			Eukaryotic Initiation Factor 2 (eIF2) Signaling Regulates Proinflammatory Cytokine Expression and Bacterial Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OUTER-MEMBRANE PROTEIN; KINASE-A YPKA; NF-KAPPA-B; YERSINIA-PSEUDOTUBERCULOSIS; GENE-EXPRESSION; SER/THR KINASE; ACTIVATION; YOPJ; TRANSLATION	In eukaryotic cells, there are two well characterized pathways that regulate translation initiation in response to stress, and each have been shown to be targeted by various viruses. We recently showed in a yeast-based model that the bacterial virulence factor YopJ disrupts one of these pathways, which is centered on the alpha-subunit of the translation factor eIF2. Here, we show in mammalian cells that induction of the eIF2 signaling pathway occurs following infection with bacterial pathogens and that, consistent with our yeast-based findings, YopJ reduces eIF2 signaling in response to endoplasmic reticulum stress, heavy metal toxicity, dsRNA, and bacterial infection. We demonstrate that the well documented activities of YopJ, inhibition of NF-kappa B activation and proinflammatory cytokine expression, are both dependent on an intact eIF2 signaling pathway. Unexpectedly, we found that cells with defective eIF2 signaling were more susceptible to bacterial invasion. This was true for pathogenic Yersinia, a facultative intracellular pathogen, as well as for the intracellular pathogens Listeria monocytogenes and Chlamydia trachomatis. Collectively, our data indicate that the highly conserved eIF2 signaling pathway, which is vitally important for antiviral responses, plays a variety of heretofore unrecognized roles in antibacterial responses.	[Shrestha, Niraj; Bahnan, Wael; Fields, Kenneth A.; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Wiley, David J.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Barber, Glen] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, 1600 NW 10th Ave, Miami, FL 33173 USA.	kschesser@med.miami.edu			United States Public Health Service from NIAID [AI53459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053459] Funding Source: NIH RePORTER	United States Public Health Service from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by United States Public Health Service Grant AI53459 (to K. S.) from NIAID.	Bohn E, 2004, CELL MICROBIOL, V6, P129, DOI 10.1046/j.1462-5822.2003.00346.x; BOLIN I, 1982, INFECT IMMUN, V37, P506; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Huang XM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.007; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kuo TF, 2012, J CELL PHYSIOL, V227, P1130, DOI 10.1002/jcp.22833; Li X., 2009, INT J MICROBIOL, V2009; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	37	88	90	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28738	28744		10.1074/jbc.M112.375915	http://dx.doi.org/10.1074/jbc.M112.375915			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761422	hybrid, Green Published			2022-12-28	WOS:000308074600047
J	Wybenga, GG; Crismaru, CG; Janssen, DB; Dijkstra, BW				Wybenga, Gjalt G.; Crismaru, Ciprian G.; Janssen, Dick B.; Dijkstra, Bauke W.			Structural Determinants of the beta-Selectivity of a Bacterial Aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID AMINOTRANSFERASE; CRYSTAL-STRUCTURES; ACTIVE-SITE; ENZYME; TRANSAMINASE; SERVER; CRYSTALLOGRAPHY; INACTIVATION; SPECIFICITY; TOOL	Chiral beta-amino acids occur as constituents of various natural and synthetic compounds with potentially useful bioactivities. The pyridoxal 5'-phosphate (PLP)-dependent S-selective transaminase from Mesorhizobium sp. strain LUK (MesAT) is a fold type I aminotransferase that can be used for the preparation of enantiopure beta-Phe and derivatives thereof. Using x-ray crystallography, we solved structures of MesAT in complex with (S)-beta-Phe, (R)-3-amino-5-methylhexanoic acid, 2-oxoglutarate, and the inhibitor 2-aminooxyacetic acid, which allowed us to unveil the molecular basis of the amino acid specificity and enantioselectivity of this enzyme. The binding pocket of the side chain of a beta-amino acid is located on the 3'-oxygen side of the PLP cofactor. The same binding pocket is utilized by MesAT to bind the alpha-carboxylate group of an alpha-amino acid. A beta-amino acid thus binds in a reverse orientation in the active site of MesAT compared with an alpha-amino acid. Such a binding mode has not been reported before for any PLP-dependent aminotransferase and shows that the active site of MesAT has specifically evolved to accommodate both beta- and alpha-amino acids.	[Wybenga, Gjalt G.; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [Crismaru, Ciprian G.; Janssen, Dick B.] Univ Groningen, Dept Biochem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019	Dijkstra, Bauke W./0000-0001-9731-6586	Netherlands Ministry of Economic Affairs; B-Basic Partner Organizations through B-Basic, a public-private Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Advanced Chemical Technologies for Sustainability (NWO-ACTS) Program	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic Partner Organizations through B-Basic, a public-private Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Advanced Chemical Technologies for Sustainability (NWO-ACTS) Program	This work was supported by the Netherlands Ministry of Economic Affairs and the B-Basic Partner Organizations through B-Basic, a public-private Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Advanced Chemical Technologies for Sustainability (NWO-ACTS) Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; Bea HS, 2011, CHEM COMMUN, V47, P5894, DOI 10.1039/c1cc11528f; BRAUNSTEIN AE, 1964, VITAM HORM, V22, P451, DOI 10.1016/S0083-6729(08)60348-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; COLE DC, 1994, TETRAHEDRON, V50, P9517; DeLano W.L, PYMOL MOL GRAPHICS S; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; JOHN RA, 1978, BIOCHEM J, V171, P771, DOI 10.1042/bj1710771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim B, 2011, ACTA CRYSTALLOGR F, V67, P231, DOI 10.1107/S1744309110050876; Kim J, 2007, APPL ENVIRON MICROB, V73, P1772, DOI 10.1128/AEM.02119-06; Kim J, 2006, J MICROBIOL BIOTECHN, V16, P1832; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liljeblad A, 2006, TETRAHEDRON, V62, P5831, DOI 10.1016/j.tet.2006.03.109; MARCOTTE P, 1975, BIOCHEM BIOPH RES CO, V62, P677, DOI 10.1016/0006-291X(75)90452-0; MarkovicHousley Z, 1996, EUR J BIOCHEM, V236, P1025, DOI 10.1111/j.1432-1033.1996.01025.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto A, 1998, J MOL BIOL, V280, P443, DOI 10.1006/jmbi.1998.1869; Oue S, 1997, J BIOCHEM-TOKYO, V121, P161; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shin JS, 2002, J ORG CHEM, V67, P2848, DOI 10.1021/jo016115i; Soda K, 2001, CHEM REC, V1, P373, DOI 10.1002/tcr.1021; Storici P, 2004, J BIOL CHEM, V279, P363, DOI 10.1074/jbc.M305884200; TANASE S, 1976, BIOCHEM BIOPH RES CO, V68, P1301, DOI 10.1016/0006-291X(76)90338-7; Taylor PP, 1998, TRENDS BIOTECHNOL, V16, P412, DOI 10.1016/S0167-7799(98)01240-2; Tipton K.F., 1996, ENZYMOLOGY LABFAX, P115; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Weiner B, 2010, CHEM SOC REV, V39, P1656, DOI 10.1039/b919599h	41	27	28	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28495	28502		10.1074/jbc.M112.375238	http://dx.doi.org/10.1074/jbc.M112.375238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745123	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000308074600024
J	Cash, JG; Kuhel, DG; Basford, JE; Jaeschke, A; Chatterjee, TK; Weintraub, NL; Hui, DY				Cash, James G.; Kuhel, David G.; Basford, Joshua E.; Jaeschke, Anja; Chatterjee, Tapan K.; Weintraub, Neal L.; Hui, David Y.			Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE STRUCTURE CORRECTORS; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; AMYLOID-BETA PEPTIDE; DIET-INDUCED OBESITY; DOMAIN INTERACTION; LDL RECEPTOR; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE	Apolipoprotein (apo) E4 is a major genetic risk factor for a wide spectrum of inflammatory metabolic diseases, including atherosclerosis, diabetes, and Alzheimer disease. This study compared diet-induced adipose tissue inflammation as well as functional properties of macrophages isolated from human APOE3 and APOE4 mice to identify the mechanism responsible for the association between apoE4 and inflammatory metabolic diseases. The initial study confirmed previous reports that APOE4 gene replacement mice were less sensitive than APOE3 mice to diet-induced body weight gain but exhibited hyperinsulinemia, and their adipose tissues were similarly inflamed as those in APOE3 mice. Peritoneal macrophages isolated from APOE4 mice were defective in efferocytosis compared with APOE3 macrophages. Increased cell death was also observed in APOE4 macrophages when stimulated with LPS or oxidized LDL. Western blot analysis of cell lysates revealed that APOE4 macrophages displayed elevated JNK phosphorylation indicative of cell stress even under basal culturing conditions. Significantly higher cell stress due mainly to potentiation of endoplasmic reticulum (ER) stress signaling was also observed in APOE4 macrophages after LPS and oxidized LDL activation. The defect in efferocytosis and elevated apoptosis sensitivity of APOE4 macrophages was ameliorated by treatment with the ER chaperone tauroursodeoxycholic acid. Taken together, these results showed that apoE4 expression causes macrophage dysfunction and promotes apoptosis via ER stress induction. The reduction of ER stress in macrophages may be a viable option to reduce inflammation and inflammation-related metabolic disorders associated with the apoE4 polymorphism.	[Cash, James G.; Kuhel, David G.; Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Chatterjee, Tapan K.; Weintraub, Neal L.] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Dept Pathol ML 0507, Metab Dis Inst, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu		Weintraub, Neal/0000-0002-5138-3705	National Institutes of Health [DK74932]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640, R01HL076684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK74932 (to D. Y. H.).	Altenburg M, 2007, J BIOL CHEM, V282, P7817, DOI 10.1074/jbc.M610712200; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Arbones-Mainar JM, 2010, FASEB J, V24, P3809, DOI 10.1096/fj.10-159517; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cash JG, 2011, INT J OBESITY, V35, P877, DOI 10.1038/ijo.2010.215; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Eberle D, 2012, ARTERIOSCL THROM VAS, V32, P1116, DOI 10.1161/ATVBAHA.112.246389; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Johnson LA, 2011, DIABETES, V60, P2285, DOI 10.2337/db11-0466; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kodvawala A, 2005, J BIOL CHEM, V280, P38592, DOI 10.1074/jbc.M502266200; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1989, METABOLIC BASIS INHE, V1, P1195; Marques MA, 2003, J MOL NEUROSCI, V20, P327, DOI 10.1385/JMN:20:3:327; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Moore ZWQ, 2005, J LIPID RES, V46, P2083, DOI 10.1194/jlr.M500177-JLR200; Moore ZWQ, 2004, AM J PATHOL, V164, P2109, DOI 10.1016/S0002-9440(10)63769-8; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Sacre SM, 2003, FEBS LETT, V540, P181, DOI 10.1016/S0014-5793(03)00261-8; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Vaisi-Raygani A, 2007, CLIN BIOCHEM, V40, P1150, DOI 10.1016/j.clinbiochem.2007.06.010; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Xaus J, 2000, BLOOD, V95, P3823; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhu YJ, 2010, BIOCHEM J, V428, P47, DOI 10.1042/BJ20100016	58	61	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27876	27884		10.1074/jbc.M112.377549	http://dx.doi.org/10.1074/jbc.M112.377549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730380	Green Published, hybrid			2022-12-28	WOS:000307840700061
J	Ebner-Bennatan, S; Patrich, E; Peretz, A; Kornilov, P; Tiran, Z; Elson, A; Attali, B				Ebner-Bennatan, Sharon; Patrich, Eti; Peretz, Asher; Kornilov, Polina; Tiran, Zohar; Elson, Ari; Attali, Bernard			Multifaceted Modulation of K+ Channels by Protein-tyrosine Phosphatase epsilon Tunes Neuronal Excitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL CELLS; LONG-TERM POTENTIATION; ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE; DEPENDENT REGULATION; HIPPOCAMPAL-NEURONS; SCHWANN-CELLS; SPIKE AFTERDEPOLARIZATION; ACETYLCHOLINE-RECEPTOR; BURST GENERATION	Non-receptor-tyrosine kinases (protein-tyrosine kinases) and non-receptor tyrosine phosphatases (PTPs) have been implicated in the regulation of ion channels, neuronal excitability, and synaptic plasticity. We previously showed that protein-tyrosine kinases such as Src kinase and PTPs such as PTP alpha and PTP epsilon modulate the activity of delayed-rectifier K+ channels (IK). Here we show cultured cortical neurons from PTP epsilon knockout (EKO) mice to exhibit increased excitability when compared with wild type (WT) mice, with larger spike discharge frequency, enhanced fast after-hyperpolarization, increased after-depolarization, and reduced spike width. A decrease in IK and a rise in large-conductance Ca2+-activated K+ currents (mBK) were observed in EKO cortical neurons compared with WT. Parallel studies in transfected CHO cells indicate that Kv1.1, Kv1.2, Kv7.2/7.3, and mBK are plausible molecular correlates of this multifaceted modulation of K+ channels by PTP epsilon. In CHO cells, Kv1.1, Kv1.2, and Kv7.2/7.3 K+ currents were up-regulated by PTP epsilon, whereas mBK channel activity was reduced. The levels of tyrosine phosphorylation of Kv1.1, Kv1.2, Kv7.3, and mBK potassium channels were increased in the brain cortices of neonatal and adult EKO mice compared with WT, suggesting that PTP epsilon in the brain modulates these channel proteins. Our data indicate that in EKO mice, the lack of PTP epsilon-mediated dephosphorylation of Kv1.1, Kv1.2, and Kv7.3 leads to decreased IK density and enhanced after-depolarization. In addition, the deficient PTP epsilon-mediated dephosphorylation of mBK channels likely contributes to enhanced mBK and fast after-hyperpolarization, spike shortening, and consequent increase in neuronal excitability observed in cortical neurons from EKO mice.	[Ebner-Bennatan, Sharon; Patrich, Eti; Peretz, Asher; Kornilov, Polina; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Tiran, Zohar; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il		Elson, Ari/0000-0001-9808-9135	Deutsch-Israelische Projektkooperation DIP fund	Deutsch-Israelische Projektkooperation DIP fund	This work was supported by the Deutsch-Israelische Projektkooperation DIP fund to B.A.	ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; Ahn M, 2007, J NEUROSCI, V27, P11533, DOI 10.1523/JNEUROSCI.5005-06.2007; Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Chen SM, 2005, J PHYSIOL-LONDON, V567, P79, DOI 10.1113/jphysiol.2005.084590; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Gamper N, 2003, J NEUROSCI, V23, P84; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Golomb D, 2006, J NEUROPHYSIOL, V96, P1912, DOI 10.1152/jn.00205.2006; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Imbrici P, 2000, PFLUG ARCH EUR J PHY, V441, P257, DOI 10.1007/s004240000406; Jaffe DB, 2011, NEUROSCIENCE, V192, P205, DOI 10.1016/j.neuroscience.2011.06.028; Jia QZ, 2007, J NEUROSCI, V27, P2503, DOI 10.1523/JNEUROSCI.2911-06.2007; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Li Y, 2004, J BIOL CHEM, V279, P45399, DOI 10.1074/jbc.M408410200; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Peretz A, 1999, J PHYSIOL-LONDON, V519, P373, DOI 10.1111/j.1469-7793.1999.0373m.x; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhou R, 2005, CARDIOVASC RES, V68, P327, DOI 10.1016/j.cardiores.2005.06.005	68	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27614	27628		10.1074/jbc.M112.342519	http://dx.doi.org/10.1074/jbc.M112.342519			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722941	Green Published, hybrid			2022-12-28	WOS:000307840700036
J	Stauch, K; Kieken, F; Sorgen, P				Stauch, Kelly; Kieken, Fabien; Sorgen, Paul			Characterization of the Structure and Intermolecular Interactions between the Connexin 32 Carboxyl-terminal Domain and the Protein Partners Synapse-associated Protein 97 and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; GUANYLATE KINASE DOMAINS; GAP-JUNCTION CHANNELS; DICHROISM SPECTROSCOPIC DATA; SCHWANN-CELL PROLIFERATION; UNSTRUCTURED PROTEINS; RESONANCE ASSIGNMENTS; MULTIDIMENSIONAL NMR; SECONDARY STRUCTURE; MAGUK FAMILY	In Schwann cells, connexin 32 (Cx32) can oligomerize to form intracellular gap junction channels facilitating a shorter pathway for metabolite diffusion across the layers of the myelin sheath. The mechanisms of Cx32 intracellular channel regulation have not been clearly defined. However, Ca2+, pH, and the phosphorylation state can regulate Cx32 gap junction channels, in addition to the direct interaction of protein partners with the carboxyl-terminal (CT) domain. In this study, we used different biophysical methods to determine the structure and characterize the interaction of the Cx32CT domain with the protein partners synapse-associated protein 97 (SAP97) and calmodulin (CaM). Our results revealed that the Cx32CT is an intrinsically disordered protein that becomes alpha-helical upon binding CaM. We identified the GUK domain as the minimal SAP97 region necessary for the Cx32CT interaction. The Cx32CT residues affected by the binding of CaM and the SAP97 GUK domain were determined as well as the dissociation constants for these interactions. We characterized three Cx32CT Charcot-Marie-Tooth disease mutants (R219H, R230C, and F235C) and identified that whereas they all formed functional channels, they all showed reduced binding affinity for SAP97 and CaM. Additionally, we report that in RT4-D6P2T rat schwannoma cells, Cx32 is differentially phosphorylated and exists in a complex with SAP97 and CaM. Our studies support the importance of protein-protein interactions in the regulation of Cx32 gap junction channels and myelin homeostasis.	[Stauch, Kelly; Kieken, Fabien; Sorgen, Paul] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, P (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu			National Institutes of Health [2R01GM072631]; American Heart Association [11GRNT7820017]; Eppley Cancer Center [2P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Eppley Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM072631, American Heart Association Grant 11GRNT7820017, and Eppley Cancer Center Support Grant 2P30CA036727.	BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Bouvier D, 2007, BIOMOL NMR ASSIGM, V1, P155, DOI 10.1007/s12104-007-9044-x; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brokx RD, 2004, J STRUCT BIOL, V146, P272, DOI 10.1016/j.jsb.2003.12.007; Castro C, 1999, J NEUROSCI, V19, P3752; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deschenes SM, 1997, J NEUROSCI, V17, P9077; DEWAEGH S, 1990, J NEUROSCI, V10, P1855; Diez JA, 1995, ANN NY ACAD SCI, V766, P477, DOI 10.1111/j.1749-6632.1995.tb26699.x; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; ELVIRA M, 1993, J BIOL CHEM, V268, P14294; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fansa H, 2000, RESTOR NEUROL NEUROS, V16, P77; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Hahn AF, 1999, ANN NY ACAD SCI, V883, P366, DOI 10.1111/j.1749-6632.1999.tb08598.x; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Huang Y, 2005, J NEUROSCI, V25, P7111, DOI 10.1523/JNEUROSCI.1319-05.2005; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jessen Kristjan R, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-19; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lewis Kay E., 1992, J AM CHEM SOC, V114, P10663; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Massa R, 2006, MUSCLE NERVE, V33, P342, DOI 10.1002/mus.20460; MATA M, 1988, BRAIN RES, V475, P297, DOI 10.1016/0006-8993(88)90618-X; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; Meier C, 2004, J NEUROSCI, V24, P3186, DOI 10.1523/JNEUROSCI.5146-03.2004; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Ogura K, 2012, GENES CELLS, V17, P159, DOI 10.1111/j.1365-2443.2012.01580.x; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Ressot C, 2000, BRAIN RES REV, V32, P192, DOI 10.1016/S0165-0173(99)00081-8; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; Scherer SS, 2005, J NEUROSCI, V25, P1550, DOI 10.1523/JNEUROSCI.3082-04.2005; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; SMITH KJ, 1988, J NEUROL SCI, V83, P37, DOI 10.1016/0022-510X(88)90018-4; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Torok K, 1997, BIOCHEM J, V326, P479; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Verkhivker GM, 2003, P NATL ACAD SCI USA, V100, P5148, DOI 10.1073/pnas.0531373100; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamada KH, 2007, BIOCHEMISTRY-US, V46, P10039, DOI 10.1021/bi701169w; YANG JJ, 1995, J MOL BIOL, V252, P483, DOI 10.1006/jmbi.1995.0513; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	70	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27771	27788		10.1074/jbc.M112.382572	http://dx.doi.org/10.1074/jbc.M112.382572			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718765	Green Published, hybrid			2022-12-28	WOS:000307840700051
J	Wu, X; Wu, Z; Ning, G; Guo, Y; Ali, R; Macdonald, RL; De Blas, AL; Luscher, B; Chen, G				Wu, Xia; Wu, Zheng; Ning, Gang; Guo, Yao; Ali, Rashid; Macdonald, Robert L.; De Blas, Angel L.; Luscher, Bernhard; Chen, Gong			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor alpha Subunits Play a Direct Role in Synaptic Versus Extrasynaptic Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL GABAERGIC SYNAPSES; CULTURED HIPPOCAMPAL-NEURONS; COLLYBISTIN-DEFICIENT MICE; GEPHYRIN-BINDING MOTIF; LONG-TERM POTENTIATION; INHIBITORY SYNAPSES; DELTA-SUBUNIT; DENTATE GYRUS; PYRAMIDAL NEURONS; TONIC INHIBITION	GABA(A) receptors (GABA(A)-Rs) are localized at both synaptic and extrasynaptic sites, mediating phasic and tonic inhibition, respectively. Previous studies suggest an important role of gamma 2 and delta subunits in synaptic versus extrasynaptic targeting of GABA(A)-Rs. Here, we demonstrate differential function of gamma 2 and alpha 6 subunits in guiding the localization of GABA(A)-Rs. To study the targeting of specific subtypes of GABA(A)-Rs, we used a molecularly engineered GABAergic synapse model to precisely control the GABA(A)-R subunit composition. We found that in neuron-HEK cell heterosynapses, GABAergic events mediated by alpha 2 beta 3 gamma 2 receptors were very fast (rise time similar to 2 ms), whereas events mediated by alpha 6 beta 3 delta receptors were very slow (rise time similar to 20 ms). Such an order of magnitude difference in rise time could not be attributed to the minute differences in receptor kinetics. Interestingly, synaptic events mediated by alpha 6 beta 3 or alpha 6 beta 3 gamma 2 receptors were significantly slower than those mediated by alpha 2 beta 3 or alpha 2 beta 3 gamma 2 receptors, suggesting a differential role of delta subunit in receptor targeting. This was confirmed by differential targeting of the same delta-gamma 2 chimeric subunits to synaptic or extrasynaptic sites, depending on whether it was co-assembled with the alpha 2 or alpha 6 subunit. In addition, insertion of a gephyrin-binding site into the intracellular domain of alpha 6 and delta subunits brought alpha 6 beta 3 delta receptors closer to synaptic sites. Therefore, the alpha subunits, together with the gamma 2 and delta subunits, play a critical role in governing synaptic versus extrasynaptic targeting of GABA(A)-Rs, possibly through differential interactions with gephyrin.	[Wu, Xia; Wu, Zheng; Ning, Gang; Guo, Yao; Luscher, Bernhard; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ali, Rashid; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Connecticut; Vanderbilt University	Chen, G (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gongchen@psu.edu	Wu, Zheng/H-3234-2019; Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906	National Institutes of Health from NINDS [NS054858]; NIMH [MH083911, MH062391]; NINDS [NS38752, NS33300]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062391, RC1MH089111, R01MH083911, R56MH062391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752, R01NS033300, R21NS054858, R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054858 from NINDS, MH083911 from NIMH (to G. C.), NS38752 (to A. L. D.) and NS33300 from NINDS (to R. L. M.), and MH062391 from NIMH (to B. L.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Craig AM, 1996, J NEUROSCI, V16, P3166; Damgaard T, 2011, PSYCHOPHARMACOLOGY, V214, P403, DOI 10.1007/s00213-010-2039-9; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2006, J NEUROSCI, V26, P1499, DOI 10.1523/JNEUROSCI.2913-05.2006; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jedlicka P, 2009, MOL CELL NEUROSCI, V41, P94, DOI 10.1016/j.mcn.2009.02.005; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Kins S, 1999, EUR J NEUROSCI, V11, P740, DOI 10.1046/j.1460-9568.1999.00527.x; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Krogsgaard-Larsen P, 2004, BIOCHEM PHARMACOL, V68, P1573, DOI 10.1016/j.bcp.2004.06.040; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Swanwick CC, 2006, J COMP NEUROL, V495, P497, DOI 10.1002/cne.20897; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Wei WZ, 2003, J NEUROSCI, V23, P10650; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	79	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27417	27430		10.1074/jbc.M112.360461	http://dx.doi.org/10.1074/jbc.M112.360461			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711532	Green Published, hybrid			2022-12-28	WOS:000307840700015
J	Arora, G; Sajid, A; Arulanandh, MD; Singhal, A; Mattoo, AR; Pomerantsev, AP; Leppla, SH; Maiti, S; Singh, Y				Arora, Gunjan; Sajid, Andaleeb; Arulanandh, Mary Diana; Singhal, Anshika; Mattoo, Abid R.; Pomerantsev, Andrei P.; Leppla, Stephen H.; Maiti, Souvik; Singh, Yogendra			Unveiling the Novel Dual Specificity Protein Kinases in Bacillus anthracis IDENTIFICATION OF THE FIRST PROKARYOTIC DUAL SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE (DYRK)-LIKE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; SIGNAL-TRANSDUCTION; SERINE/THREONINE KINASES; PHYSIOLOGICAL ROLES; ESCHERICHIA-COLI; PYRUVATE KINASES; DYRK FAMILY; PHOSPHORYLATION	Dual specificity protein kinases (DSPKs) are unique enzymes that can execute multiple functions in the cell, which are otherwise performed exclusively by serine/threonine and tyrosine protein kinases. In this study, we have characterized the protein kinases Bas2152 (PrkD) and Bas2037 (PrkG) from Bacillus anthracis. Transcriptional analyses of these kinases showed that they are expressed in all phases of growth. In a serendipitous discovery, both kinases were found to be DSPKs. PrkD was found to be similar to the eukaryotic dual specificity Tyr phosphorylation-regulated kinase class of dual specificity kinases, which autophosphorylates on Ser, Thr, and Tyr residues and phosphorylates Ser and Thr residues on substrates. PrkG was found to be a bona fide dual specificity protein kinase that mediates autophosphorylation and substrate phosphorylation on Ser, Thr, and Tyr residues. The sites of phosphorylation in both of the kinases were identified through mass spectrometry. Phosphorylation on Tyr residues regulates the kinase activity of PrkD and PrkG. PrpC, the only known Ser/Thr protein phosphatase, was also found to possess dual specificity. Genistein, a known Tyr kinase inhibitor, was found to inhibit the activities of PrkD and PrkG and affect the growth of B. anthracis cells, indicating a possible role of these kinases in cell growth and development. In addition, the glycolytic enzyme pyruvate kinase was found to be phosphorylated by PrkD on Ser and Thr residues but not by PrkG. Thus, this study provides the first evidence of DSPKs in B. anthracis that belong to different classes and have different modes of regulation.	[Arora, Gunjan; Sajid, Andaleeb; Arulanandh, Mary Diana; Singhal, Anshika; Mattoo, Abid R.; Maiti, Souvik; Singh, Yogendra] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi 110007, India; [Pomerantsev, Andrei P.; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Singh, Y (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Mall Rd, Delhi 110007, India.	ysingh@igib.res.in	Sajid, Andaleeb/AAI-2960-2020; Arora, Gunjan/AAL-3448-2020; MATTOO, ABID/AGI-4855-2022	Sajid, Andaleeb/0000-0001-6248-4985; Arora, Gunjan/0000-0003-0575-6205; Singhal, Anshika/0000-0001-7932-5809; MATTOO, ABID/0000-0002-4947-0113	National Institutes of Health, NIAID, Intramural Research Program; Council of Scientific and Industrial Research Grant [NWP-0038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001030, ZIAAI001031] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program. This work was also supported by Council of Scientific and Industrial Research Grant NWP-0038.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bryant-Hudson KM, 2011, J BACTERIOL, V193, P1833, DOI 10.1128/JB.01401-10; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; CHARDOT T, 1995, CR ACAD SCI III-VIE, V318, P937; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P198, DOI 10.1159/000089648; Danilenko VN, 2011, CURR TOP MED CHEM, V11, P1352; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; de Been M, 2006, MICROBIOL-SGM, V152, P3035, DOI 10.1099/mic.0.29137-0; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Dias MB, 2010, P NATL ACAD SCI USA, V107, P9556, DOI 10.1073/pnas.0915002107; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johnsen U, 2003, J BIOL CHEM, V278, P25417, DOI 10.1074/jbc.M210288200; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Keim PS, 2009, NAT REV MICROBIOL, V7, P813, DOI 10.1038/nrmicro2219; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kirstein J, 2005, J MOL MICROB BIOTECH, V9, P182, DOI 10.1159/000089646; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Lai SM, 2005, MICROBIOL-SGM, V151, P1159, DOI 10.1099/mic.0.27585-0; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lee DC, 2009, TRENDS BIOCHEM SCI, V34, P351, DOI 10.1016/j.tibs.2009.03.003; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low HY, 2012, CELL MOL LIFE SCI, V69, P1523, DOI 10.1007/s00018-011-0888-y; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Mattoo AR, 2008, FEBS J, V275, P6237, DOI 10.1111/j.1742-4658.2008.06748.x; McPherson SA, 2010, MOL MICROBIOL, V76, P1527, DOI 10.1111/j.1365-2958.2010.07182.x; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Reddy MM, 2006, ARCH BIOCHEM BIOPHYS, V455, P99, DOI 10.1016/j.abb.2006.09.009; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Ruvolo VR, 2008, J BIOL CHEM, V283, P35474, DOI 10.1074/jbc.M800951200; Sajid A, 2011, J BACTERIOL, V193, P5347, DOI 10.1128/JB.05469-11; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shakir SM, 2010, J BACTERIOL, V192, P400, DOI 10.1128/JB.01221-09; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yang F, 2011, MOL BIOTECHNOL, V47, P144, DOI 10.1007/s12033-010-9322-1	77	28	28	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26749	26763		10.1074/jbc.M112.351304	http://dx.doi.org/10.1074/jbc.M112.351304			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711536	hybrid, Green Published			2022-12-28	WOS:000307386000025
J	Gao, WQ; Zhu, J; Westfield, LA; Tuley, EA; Anderson, PJ; Sadler, JE				Gao, Weiqiang; Zhu, Jian; Westfield, Lisa A.; Tuley, Elodee A.; Anderson, Patricia J.; Sadler, J. Evan			Rearranging Exosites in Noncatalytic Domains Can Redirect the Substrate Specificity of ADAMTS Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; SPACER DOMAIN; BINDING-SITE; A2 DOMAIN; PROTEOLYTIC ACTIVITIES; CRYSTAL-STRUCTURES; IN-VITRO; CLEAVAGE	ADAMTS proteases typically employ some combination of ancillary C-terminal disintegrin-like, thrombospondin-1, cysteine-rich, and spacer domains to bind substrates and facilitate proteolysis by an N-terminal metalloprotease domain. We constructed chimeric proteases and substrates to examine the role of C-terminal domains of ADAMTS13 and ADAMTS5 in the recognition of their physiological cleavage sites in von Willebrand factor (VWF) and aggrecan, respectively. ADAMTS5 cleaves Glu(373)-Ala(374) and Glu(1480)-Gly(1481) bonds in bovine aggrecan but does not cleave VWF. Conversely, ADAMTS13 cleaves the Tyr(1605)-Met(1606) bond of VWF, which is exposed by fluid shear stress but cannot cleave aggrecan. Replacing the thrombospondin-1/cysteine-rich/spacer domains of ADAMTS5 with those of ADAMTS13 conferred the ability to cleave the Glu(1615)-Ile(1616) bond of VWF domain A2 in peptide substrates or VWF multimers that had been sheared; native (unsheared) VWF-multimers were resistant. Thus, by recombining exosites, we engineered ADAMTS5 to cleave a new bond in VWF, preserving physiological regulation by fluid shear stress. The results demonstrate that noncatalytic thrombospondin-1/cysteine-rich/spacer domains are principal modifiers of substrate recognition and cleavage by both ADAMTS5 and ADAMTS13. Noncatalytic domains may perform similar functions in other ADAMTS family members.	[Sadler, J. Evan] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.	esadler@dom.wustl.edu	Gao, Wei/GXH-0380-2022	Sadler, J. Evan/0000-0001-5705-469X; Zhu, Jian/0000-0001-6679-8498	National Institutes of Health [R01 HL72917, R01 HL89746, U54 HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072917, R01HL089746, U54HL112303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL72917, R01 HL89746, and U54 HL112303.	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HUGHES CE, 1995, BIOCHEM J, V305, P799, DOI 10.1042/bj3050799; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Luken BM, 2006, THROMB HAEMOSTASIS, V96, P295, DOI 10.1160/TH06-03-0135; Majerus EM, 2003, J BIOL CHEM, V278, P46643, DOI 10.1074/jbc.M309872200; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; Miller JA, 2003, ANAL BIOCHEM, V314, P260, DOI 10.1016/S0003-2697(02)00638-3; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Nicholson AC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-11; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Pruss CM, 2008, BRIT J HAEMATOL, V143, P552, DOI 10.1111/j.1365-2141.2008.07266.x; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26944	26952		10.1074/jbc.M112.380535	http://dx.doi.org/10.1074/jbc.M112.380535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707719	Green Published, hybrid			2022-12-28	WOS:000307386000042
J	Prehna, G; Li, YL; Stoynov, N; Okon, M; Vuckovic, M; McIntosh, LP; Foster, LJ; Finlay, BB; Strynadka, NCJ				Prehna, Gerd; Li, Yuling; Stoynov, Nikolay; Okon, Mark; Vuckovic, Marija; McIntosh, Lawrence P.; Foster, Leonard J.; Finlay, B. Brett; Strynadka, Natalie C. J.			The Zinc Regulated Antivirulence Pathway of Salmonella Is a Multiprotein Immunoglobulin Adhesion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TORSION ANGLE DYNAMICS; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; PROTEINS; DOMAIN; INVASIN; BINDING; SERVER; HYPERVIRULENCE	The co-evolutionary relationship between pathogen and host has led to a regulatory cycle between virulence factors needed for survival and antivirulence factors required for host transmission. This is exemplified in Salmonella spp. by the zirTS antivirulence genes: a secretion pathway comprised of the outer membrane transporter ZirT, and its secreted partner, ZirS. ZirTS act within the gastrointestinal tract to function as a virulence modulator and during Salmonella shedding in anticipation of a new host. Together, ZirT and ZirS decrease virulence by lowering bacterial colonization at systemic sites through an unknown mechanism. To understand this mechanism, we have probed the zirTS pathway both structurally and biochemically. The NMR derived structural ensemble of the C-terminal domain of ZirS reveals an immunoglobin superfamily fold (IgSF). Stable isotope labeling by amino acids in cell culture experiments show that the ZirS IgSF domain interacts with its transporter ZirT, and reveal a new protein interaction partner of the pathway, a protein encoded adjacent to zirTS that we have designated as ZirU. ZirU is secreted by ZirT and is also a predicted IgSF. Biochemical analysis delineates ZirT into an N-terminal porin-like beta domain and C-terminal extracellular soluble IgSF domain, whereas biophysical characterization suggests that the transporter undergoes self-association in a concentration-dependent manner. We observe that ZirS and ZirU directly interact with each other and with the extracellular domains of ZirT. Here we show that the zir antivirulence pathway is a multiprotein immunoglobulin adhesion system consisting of a complex interplay between ZirS, ZirT, and ZirU.	[Prehna, Gerd; Li, Yuling; Stoynov, Nikolay; Okon, Mark; Vuckovic, Marija; McIntosh, Lawrence P.; Foster, Leonard J.; Finlay, B. Brett; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Prehna, Gerd; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Li, Yuling; McIntosh, Lawrence P.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Li, Yuling; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Stoynov, Nikolay; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z3, Canada; [Okon, Mark; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Prehna, Gerd/0000-0001-5539-7533	Human Frontier Science Program (HFSP); Michael Smith Foundation for Health Research; Canadian Institute of Health Research (CIHR); Howard Hughes Medical Institute; Canada Research Chair Program	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canada Research Chair Program(Canada Research Chairs)	This work was supported by the Human Frontier Science Program (HFSP), the Michael Smith Foundation for Health Research, the Canadian Institute of Health Research (CIHR), the Howard Hughes Medical Institute and Canada Research Chair Program. Instrument support was provided by the CIHR, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the UBC Blusson Fund, and the Michael Smith Foundation for Health Research.	Allen W. J., 2012, CURR OPIN S IN PRESS; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cano DA, 2001, INFECT IMMUN, V69, P6463, DOI 10.1128/IAI.69.10.6463-6474.2001; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Foreman-Wykert AK, 2003, TRENDS MICROBIOL, V11, P105, DOI 10.1016/S0966-842X(03)00007-6; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kongsley R. A., 2002, CURR TOP MICROBIOL I, V264, P67; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; MAYAUX JF, 1981, BIOCHEMISTRY-US, V20, P4647, DOI 10.1021/bi00519a020; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Michaux C, 2008, J MOL BIOL, V375, P1477, DOI 10.1016/j.jmb.2007.11.026; Mouslim C, 2002, MOL MICROBIOL, V45, P1019, DOI 10.1046/j.1365-2958.2002.03070.x; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Raman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014377; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsai JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014403; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Worrall LJ, 2011, CURR OPIN MICROBIOL, V14, P3, DOI 10.1016/j.mib.2010.10.009; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	65	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32324	32337		10.1074/jbc.M112.357210	http://dx.doi.org/10.1074/jbc.M112.357210			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22810234	Green Published, hybrid			2022-12-28	WOS:000309168300004
J	Osteresch, C; Bender, T; Grond, S; von Zezschwitz, P; Kunze, B; Jansen, R; Huss, M; Wieczorek, H				Osteresch, Christin; Bender, Tobias; Grond, Stephanie; von Zezschwitz, Paultheo; Kunze, Brigitte; Jansen, Rolf; Huss, Markus; Wieczorek, Helmut			The Binding Site of the V-ATPase Inhibitor Apicularen Is in the Vicinity of Those for Bafilomycin and Archazolid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CHONDROMYCES-SPECIES MYXOBACTERIA; PROTON-TRANSLOCATING ATPASE; 16-KDA PROTEOLIPID SUBUNIT; CONCANAMYCIN-A; MANDUCA-SEXTA; O-SUBUNIT; MEMBRANE; DISSOCIATION; PURIFICATION	The investigation of V-ATPases as potential therapeutic drug targets and hence of their specific inhibitors is a promising approach in osteoporosis and cancer treatment because the occurrence of these diseases is interrelated to the function of the V-ATPase. Apicularen belongs to the novel inhibitor family of the benzolactone enamides, which are highly potent but feature the unique characteristic of not inhibiting V-ATPases from fungal sources. In this study we specify, for the first time, the binding site of apicularen within the membrane spanning V-O complex. By photoaffinity labeling using derivatives of apicularen and of the plecomacrolides bafilomycin and concanamycin, each coupled to C-14-labeled 4-(3-trifluoromethyldiazirin-3-yl-) benzoic acid, we verified that apicularen binds at the interface of the V-O subunits a and c. The binding site is in the vicinity to those of the plecomacrolides and of the archazolids, a third family of V-ATPase inhibitors. Expression of subunit c homologues from Homo sapiens and Manduca sexta, both species sensitive to benzolactone enamides, in a Saccharomyces cerevisiae strain lacking the corresponding intrinsic gene did not transfer this sensitivity to yeast. Therefore, the binding site of benzolactone enamides cannot be formed exclusively by subunit c. Apparently, subunit a substantially contributes to the binding of the benzolactone enamides.	[Osteresch, Christin; Huss, Markus; Wieczorek, Helmut] Univ Osnabruck, Fachbereich Biol Chem, Abt Tierphysiol, D-49069 Osnabruck, Germany; [Bender, Tobias] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany; [Bender, Tobias; Grond, Stephanie; von Zezschwitz, Paultheo] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; [Kunze, Brigitte; Jansen, Rolf] Helmholtz Zentrum Infekt Forsch, D-38124 Braunschweig, Germany	University Osnabruck; Philipps University Marburg; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center for Infection Research	Huss, M (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Abt Tierphysiol, Barbarastr 11, D-49069 Osnabruck, Germany.	huss@biologie.uni-osnabrueck.de	Jansen, Rolf/C-1570-2011	Jansen, Rolf/0000-0002-3592-4807; Grond, Stephanie/0000-0002-7549-4936				Bender T, 2007, EUR J ORG CHEM, V2007, P3870, DOI 10.1002/ejoc.200700194; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Burkard N, 2010, EUR J ORG CHEM, V2010, P2176, DOI 10.1002/ejoc.200901463; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; DOW JAT, 1992, GENE, V122, P355, DOI 10.1016/0378-1119(92)90226-F; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; FINBOW ME, 1994, J CELL SCI, V107, P1817; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HARRISON MA, 1994, EUR J BIOCHEM, V221, P111, DOI 10.1111/j.1432-1033.1994.tb18719.x; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; Ingenhorst G, 2001, EUR J ORG CHEM, V2001, P4525; Jansen R, 2000, EUR J ORG CHEM, V2000, P913, DOI 10.1002/(SICI)1099-0690(200003)2000:6<913::AID-EJOC913>3.0.CO;2-L; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kunze B, 1998, J ANTIBIOT, V51, P1075, DOI 10.7164/antibiotics.51.1075; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Petri AF, 2005, EUR J ORG CHEM, V2005, P1865, DOI 10.1002/ejoc.200400838; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sasse F, 2003, J ANTIBIOT, V56, P520, DOI 10.7164/antibiotics.56.520; Skinner MA, 2001, J BIOL CHEM, V276, P48451, DOI 10.1074/jbc.M103569200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; von Ballmoos C, 2002, J BIOL CHEM, V277, P3504, DOI 10.1074/jbc.M110301200; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200	45	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31866	31876		10.1074/jbc.M112.372169	http://dx.doi.org/10.1074/jbc.M112.372169			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22815478	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000309059400027
J	Yuan, YY; Kadiyala, CS; Ching, TT; Hakimi, P; Saha, S; Xu, H; Yuan, C; Mullangi, V; Wang, LW; Fivenson, E; Hanson, RW; Ewing, R; Hsu, AL; Miyagi, M; Feng, ZY				Yuan, Yiyuan; Kadiyala, Chandra S.; Ching, Tsui-Ting; Hakimi, Parvin; Saha, Sudipto; Xu, Hua; Yuan, Chao; Mullangi, Vennela; Wang, Liwen; Fivenson, Elayne; Hanson, Richard W.; Ewing, Rob; Hsu, Ao-Lin; Miyagi, Masaru; Feng, Zhaoyang			Enhanced Energy Metabolism Contributes to the Extended Life Span of Calorie-restricted Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; INDUCED LONGEVITY; QUANTITATIVE PROTEOMICS; PYRUVATE-CARBOXYLASE; DIETARY RESTRICTION; SKELETAL-MUSCLE; LIPID-SYNTHESIS; ADIPOSE-TISSUE; AMINO-ACIDS	Caloric restriction (CR) markedly extends life span and improves the health of a broad number of species. Energy metabolism fundamentally contributes to the beneficial effects of CR, but the underlying mechanisms that are responsible for this effect remain enigmatic. A multidisciplinary approach that involves quantitative proteomics, immunochemistry, metabolic quantification, and life span analysis was used to determine how CR, which occurs in the Caenorhabditis elegans eat-2 mutants, modifies energy metabolism of the worm, and whether the observed modifications contribute to the CR-mediated physiological responses. A switch to fatty acid metabolism as an energy source and an enhanced rate of energy metabolism by eat-2 mutant nematodes were detected. Life span analyses validated the important role of these previously unknown alterations of energy metabolism in the CR-mediated longevity of nematodes. As observed in mice, the overexpression of the gene for the nematode analog of the cytosolic form of phosphoenolpyruvate carboxykinase caused a marked extension of the life span in C. elegans, presumably by enhancing energy metabolism via an altered rate of cataplerosis of tricarboxylic acid cycle anions. We conclude that an increase, not a decrease in fuel consumption, via an accelerated oxidation of fuels in the TCA cycle is involved in life span regulation; this mechanism may be conserved across phylogeny.	[Ching, Tsui-Ting; Fivenson, Elayne; Hsu, Ao-Lin] Univ Michigan, Dept Internal Med, Div Geriatr Med, Ann Arbor, MI 48109 USA; [Yuan, Yiyuan; Miyagi, Masaru; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kadiyala, Chandra S.; Saha, Sudipto; Xu, Hua; Yuan, Chao; Mullangi, Vennela; Wang, Liwen; Ewing, Rob; Miyagi, Masaru] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Hakimi, Parvin; Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Mullangi, Vennela] Cleveland State Univ, Dept Chem, Cleveland, OH 44114 USA; [Ewing, Rob] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Hsu, Ao-Lin] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University	Hsu, AL (corresponding author), Univ Michigan, Dept Internal Med, Div Geriatr Med, Ann Arbor, MI 48109 USA.	aolinhsu@umich.edu; masaru.miyagi@case.edu; john.feng@case.edu	Saha, Sudipto/AAF-1034-2020; Hakimi, Parvin/AAB-1643-2021; Hsu, Ao-Lin Allen/AAX-1856-2020	Ewing, Rodney/0000-0001-9472-4031; Ching, Tsui-Ting/0000-0001-7650-1766; Hsu, Ao-Lin/0000-0002-2864-3134; Ewing, Rob/0000-0001-6510-4001; Saha, Sudipto/0000-0001-9433-8894	National Institutes of Health [1R01 AG028516, P20-CA-103736]; Mt. Sinai Foundation; Proteomics Center, School of Medicine, Case Western Reserve University; Ellison Foundation [AG-SS-2420-10]; NATIONAL CANCER INSTITUTE [P20CA103736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mt. Sinai Foundation; Proteomics Center, School of Medicine, Case Western Reserve University; Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 AG028516 (to A. L. H.) and P20-CA-103736 (to R. W. H.). This work was also supported by the Mt. Sinai Foundation (to Z. F.), a pilot award from the Proteomics Center, School of Medicine, Case Western Reserve University (to Z. F. and M. M.), and by Grants AG-SS-2420-10 from the Ellison Foundation (to R. W. H.).	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; AVERY L, 1993, GENETICS, V133, P897; BALDNER GL, 1985, COMP BIOCHEM PHYS B, V82, P153, DOI 10.1016/0305-0491(85)90145-2; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALLARD FJ, 1967, BIOCHEM J, V102, P952, DOI 10.1042/bj1020952; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Braeckman Bart P, 2009, WormBook, P1, DOI 10.1895/wormbook.1.146.1; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Calvo AC, 2008, FASEB J, V22, P3046, DOI 10.1096/fj.08-108522; CHANGEUX J, 1965, SCI AM, V212, P36, DOI 10.1038/scientificamerican0465-36; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Ching TT, 2010, AGING CELL, V9, P545, DOI 10.1111/j.1474-9726.2010.00580.x; COUDRON PE, 1983, ARCH BIOCHEM BIOPHYS, V226, P324, DOI 10.1016/0003-9861(83)90299-0; Distler AM, 2009, METHOD ENZYMOL, V457, P97, DOI 10.1016/S0076-6879(09)05006-X; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; ETIEMBLE J, 1984, AM J HEMATOL, V17, P251, DOI 10.1002/ajh.2830170305; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; Fredens J, 2011, NAT METHODS, V8, P845, DOI [10.1038/NMETH.1675, 10.1038/nmeth.1675]; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, WESTERN HUM REV, V61, P6; HANSON RW, 1967, BIOCHEM J, V105, P529, DOI 10.1042/bj1050529; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Hoppel C, 2002, ANAL BIOCHEM, V302, P60, DOI 10.1006/abio.2001.5531; Horikawa M, 2008, J BIOCHEM, V144, P149, DOI 10.1093/jb/mvn055; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2006, EXP GERONTOL, V41, P1026, DOI 10.1016/j.exger.2006.05.007; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jiang JC, 2000, FASEB J, V14, P2135; JOMAIN M, 1969, J LIPID RES, V10, P674; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kadiyala CSR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015332; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; KUWABARA PE, 1994, NUCLEIC ACIDS RES, V22, P4414, DOI 10.1093/nar/22.21.4414; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lane MA, 2002, MICROSC RES TECHNIQ, V59, P335, DOI 10.1002/jemt.10214; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Li ZJ, 2010, ACTA CRYSTALLOGR F, V66, P426, DOI 10.1107/S1744309110005002; Liao VHC, 2001, DNA SEQUENCE, V12, P137, DOI 10.3109/10425170109047568; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Masoro Edward J, 2003, Sci Aging Knowledge Environ, V2003, pRE2, DOI 10.1126/sageke.2003.8.re2; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; STEFANINI M, 1972, AM J CLIN PATHOL, V58, P408; Stiernagle Theresa, 2006, WormBook, P1; Sury MD, 2010, MOL CELL PROTEOMICS, V9, P2173, DOI 10.1074/mcp.M110.000323; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; TAYLOR AL, 1967, BACTERIOL REV, V31, P332, DOI 10.1128/MMBR.31.4.332-353.1967; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; VIDNES J, 1976, ACTA PAEDIATR SCAND, V65, P307, DOI 10.1111/j.1651-2227.1976.tb04890.x; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weindruch R., 1988, RETARDATION AGING DI; Wright AJ, 2003, MOL BIOL CELL, V14, P4512, DOI 10.1091/mbc.E03-01-0017	74	46	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31414	31426		10.1074/jbc.M112.377275	http://dx.doi.org/10.1074/jbc.M112.377275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810224	hybrid, Green Published			2022-12-28	WOS:000308791300052
J	Balzarini, J; Gago, F; Kulik, W; van Kuilenburg, ABP; Karlsson, A; Peterson, MA; Robins, MJ				Balzarini, Jan; Gago, Federico; Kulik, Wim; van Kuilenburg, Andre B. P.; Karlsson, Anna; Peterson, Matt A.; Robins, Morris J.			Introduction of a Fluorine Atom at C3 of 3-Deazauridine Shifts Its Antimetabolic Activity from Inhibition of CTP Synthetase to Inhibition of Orotidylate Decarboxylase, an Early Event in the de Novo Pyrimidine Nucleotide Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE; COLON-CARCINOMA; BINDING; PURINE; ACID; PHOSPHORYLATION; 5-FLUOROURACIL; PYRAZOFURIN; CATALYSIS; TOXICITY	The antimetabolite prodrug 3-deazauridine (3DUrd) inhibits CTP synthetase upon intracellular conversion to its triphosphate, which selectively depletes the intracellular CTP pools. Introduction of a fluorine atom at C3 of 3DUrd shifts its anti-metabolic action to inhibition of the orotidylate decarboxylase (ODC) activity of the UMP synthase enzyme complex that catalyzes an early event in pyrimidine nucleotide biosynthesis. This results in concomitant depletion of the intracellular UTP and CTP pools. The new prodrug (designated 3F-3DUrd) exerts its inhibitory activity because its monophosphate is not further converted intracellularly to its triphosphate derivative to a detectable extent. Combinations with hypoxanthine and adenine markedly potentiate the cytostatic activity of 3F-3DUrd. This is likely because of depletion of 5-phosphoribosyl-1-pyrophosphate (consumed in the hypoxanthine phosphoribosyl transferase/adenine phosphoribosyl transferase reaction) and subsequent slowing of the 5-phosphoribosyl-1-pyrophosphate-dependent orotate phosphoribosyl transferase reaction, which depletes orotidylate, the substrate for ODC. Further efficient anabolism by nucleotide kinases is compromised apparently because of the decrease in pK(a) brought about by the fluorine atom, which affects the ionization state of the new prodrug. The 3F-3DUrd monophosphate exhibits new inhibitory properties against a different enzyme of the pyrimidine nucleotide metabolism, namely the ODC activity of UMP synthase.	[Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Gago, Federico] Univ Alcala de Henares, Dept Farmacol, E-28871 Alcala De Henares, Madrid, Spain; [Kulik, Wim; van Kuilenburg, Andre B. P.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Karlsson, Anna] Karolinska Inst, S-14186 Stockholm, Sweden; [Peterson, Matt A.; Robins, Morris J.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	KU Leuven; Universidad de Alcala; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Brigham Young University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be	Gago, Federico/AAS-3992-2020; Gago, Federico/H-1004-2015	Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; van Kuilenburg, Andre/0000-0002-7989-4910; Karlsson, Anna/0000-0001-6843-6685	Katholieke Universiteit Leuven [GOA 10/14]	Katholieke Universiteit Leuven(KU Leuven)	The work was supported by Katholieke Universiteit Leuven Grant GOA 10/14.	AHMED NK, 1984, CANCER, V54, P1370, DOI 10.1002/1097-0142(19841001)54:7<1370::AID-CNCR2820540723>3.0.CO;2-5; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; DAHLIGHARLEY E, 1984, CANCER RES, V44, P161; DECLERCQ E, 1987, NUCLEOS NUCLEOT NUCL, V6, P197, DOI 10.1080/07328318708056192; DIX DE, 1979, CANCER RES, V39, P4485; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; GASSEN HG, 1972, BIOCHIM BIOPHYS ACTA, V272, P560, DOI 10.1016/0005-2787(72)90511-4; GLAZER RI, 1985, BIOCHEM PHARMACOL, V34, P2535, DOI 10.1016/0006-2952(85)90539-8; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; GUPTA RS, 1982, J CELL PHYSIOL, V111, P291, DOI 10.1002/jcp.1041110310; HANDSCHUMACHER RE, 1960, J BIOL CHEM, V235, P2917; Heinrich D, 2009, CHEM-EUR J, V15, P6619, DOI 10.1002/chem.200900397; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; NESNOW S, 1973, J MED CHEM, V16, P524, DOI 10.1021/jm00263a026; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; ROBINS MJ, 1968, CHEM COMMUN, P1547; ROBINS MJ, 1975, J MED CHEM, V18, P1070, DOI 10.1021/jm00245a005; Robins MJ, 2009, J MED CHEM, V52, P3018, DOI 10.1021/jm900203h; Sakamoto E, 2007, BIOCHEM BIOPH RES CO, V363, P216, DOI 10.1016/j.bbrc.2007.08.164; SCHWALBE CH, 1972, NATURE-NEW BIOL, V238, P171, DOI 10.1038/newbio238171a0; SHIRASAKA T, 1993, CANCER RES, V53, P4004; TSUBOI KK, 1978, CANCER RES, V38, P3745; Van Kuilenburg ABP, 2004, CLIN CHEM, V50, P2117, DOI 10.1373/clinchem.2004.038869; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562; Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2002, J BIOL CHEM, V277, P28080, DOI 10.1074/jbc.M202362200	30	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30444	30454		10.1074/jbc.M112.378091	http://dx.doi.org/10.1074/jbc.M112.378091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22730407	Green Published, hybrid			2022-12-28	WOS:000308579800037
J	Bandyopadhyay, BC; Swaim, WD; Sarkar, A; Liu, XB; Ambudkar, IS				Bandyopadhyay, Bidhan C.; Swaim, William D.; Sarkar, Ankana; Liu, Xibao; Ambudkar, Indu S.			Extracellular Ca2+ Sensing in Salivary Ductal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-TRANSPORT; EPITHELIAL-CELLS; TRPC3 CHANNELS; PLASMA-MEMBRANE; FLUID SECRETION; CATION CHANNEL; AMINO-ACIDS; RECEPTOR; GLAND; LOCALIZATION	Ca2+ is secreted from the salivary acinar cells as an ionic constituent of primary saliva. Ions such as Na+ and Cl- get reabsorbed whereas primary saliva flows through the salivary ductal system. Although earlier studies have shown that salivary [Ca2+] decreases as it flows down the ductal tree into the oral cavity, ductal reabsorption of Ca2+ remains enigmatic. Here we report a potential role for the G protein-coupled receptor, calcium-sensing receptor (CSR), in the regulation of Ca2+ reabsorption by salivary gland ducts. Our data show that CSR is present in the apical region of ductal cells where it is co-localized with transient receptor potential canonical 3 (TRPC3). CSRis activated in isolated salivary gland ducts as well as a ductal cell line (SMIE) by altering extracellular [Ca2+] or by aromatic amino acid, L-phenylalanine (L-Phe, endogenous component of saliva), as well as neomycin. CSR activation leads to Ca2+ influx that, in polarized cells grown on a filter support, is initiated in the luminal region. Weshow that TRPC3 contributes to Ca2+ entry triggered by CSR activation. Further, stimulation of CSR in SMIE cells enhances the CSR-TRPC3 association as well as surface expression of TRPC3. Together our findings suggest that CSR could serve as a Ca2+ sensor in the luminal membrane of salivary gland ducts and regulate reabsorption of [Ca2+] from the saliva via TRPC3, thus contributing to maintenance of salivary [Ca2+]. CSR could therefore be a potentially important protective mechanism against formation of salivary gland stones (sialolithiasis) and infection (sialoadenitis).	[Bandyopadhyay, Bidhan C.] Vet Affairs Med Ctr, Res Serv, Calcium Signaling Lab, Washington, DC 20422 USA; [Bandyopadhyay, Bidhan C.; Sarkar, Ankana] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Swaim, William D.; Liu, Xibao; Ambudkar, Indu S.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bandyopadhyay, BC (corresponding author), DVA Med Ctr, Calcium Signaling Lab, Res Serv 151, 50 Irving St NW, Washington, DC 20422 USA.	bidhan.bandyopadhyay@va.gov	Bandyopadhyay, Bidhan/AAC-6828-2022	Bandyopadhyay, Bidhan/0000-0003-2364-8945	National Institutes of Health through NIDCR [DE 019524]; NIDCR Intramural Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	National Institutes of Health through NIDCR; NIDCR Intramural Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported, in whole or in part, by National Institutes of Health Grant DE 019524 through the NIDCR ( to B. C. B) and by NIDCR Intramural Research ( to I. S. A.).	Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Bandyopadhyay S, 2010, J NEUROSCI RES, V88, P2073, DOI 10.1002/jnr.22391; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Conigrave AD, 2007, J NUTR, V137, p1524S, DOI 10.1093/jn/137.6.1524S; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Feng SL, 2011, BIOCHEM BIOPH RES CO, V406, P278, DOI 10.1016/j.bbrc.2011.02.033; Futakuchi S, 2009, PFLUG ARCH EUR J PHY, V459, P215, DOI 10.1007/s00424-009-0731-6; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Grases F, 2003, CLIN CHIM ACTA, V334, P131, DOI 10.1016/S0009-8981(03)00227-4; Grases F, 2002, CLIN CHIM ACTA, V322, P29, DOI 10.1016/S0009-8981(02)00063-3; He XJ, 1998, PFLUG ARCH EUR J PHY, V435, P375, DOI 10.1007/s004240050526; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Homann V, 2006, HISTOCHEM CELL BIOL, V125, P583, DOI 10.1007/s00418-005-0100-2; Kasaboglu O, 2004, J ORAL MAXIL SURG, V62, P1253, DOI 10.1016/j.joms.2003.11.018; Khanal RC, 2008, CLIN EXP PHARMACOL P, V35, P1277, DOI 10.1111/j.1440-1681.2008.05053.x; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; KNAUF H, 1982, AM J PHYSIOL, V242, pF132, DOI 10.1152/ajprenal.1982.242.2.F132; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; MANGOS JA, 1978, J DENT RES, V57, P818, DOI 10.1177/00220345780570071101; MANGOS JA, 1981, J DENT RES, V60, P91, DOI 10.1177/00220345810600011801; Nakamura Y, 2010, IN VIVO, V24, P837; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; PAPANAYOTOU PH, 1973, J DENT RES, V52, P418, DOI 10.1177/00220345730520030301; Rey O, 2006, J BIOL CHEM, V281, P38730, DOI 10.1074/jbc.M605956200; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Romanenko VG, 2008, AM J PHYSIOL-GASTR L, V295, pG1058, DOI 10.1152/ajpgi.90384.2008; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Su YX, 2010, ARCH ORAL BIOL, V55, P15, DOI 10.1016/j.archoralbio.2009.11.006; Tanida T, 2003, J ORAL PATHOL MED, V32, P586, DOI 10.1034/j.1600-0714.2003.00015.x; TANNENBAUM PJ, 1976, J DENT RES, V55, P997, DOI 10.1177/00220345760550065201; Thongon N, 2008, AM J PHYSIOL-CELL PH, V294, pC1158, DOI 10.1152/ajpcell.00020.2008; Tran SD, 2005, TISSUE ENG, V11, P172, DOI 10.1089/ten.2005.11.172; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Venza M, 2001, J CHROMATOGR B, V757, P111, DOI 10.1016/S0378-4347(01)00130-X; WESTHOFEN M, 1984, VIRCHOWS ARCH A, V402, P425, DOI 10.1007/BF00734639; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; ZHAO H, 1995, J BIOL CHEM, V270, P19599, DOI 10.1074/jbc.270.33.19599	50	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30305	30316		10.1074/jbc.M112.394122	http://dx.doi.org/10.1074/jbc.M112.394122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778254	Green Published, hybrid			2022-12-28	WOS:000308579800023
J	Huang, XJ; Fruen, B; Farrington, DT; Wagenknecht, T; Liu, Z				Huang, Xiaojun; Fruen, Bradley; Farrington, Dinah T.; Wagenknecht, Terence; Liu, Zheng			Calmodulin-binding Locations on the Skeletal and Cardiac Ryanodine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE CHANNEL; 3-DIMENSIONAL RECONSTRUCTION; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; RYR1; APOCALMODULIN; LOCALIZATION; ACTIVATION; VISUALIZATION; INHIBITION	Ryanodine receptor types 1 (RyR1) and 2 (RyR2) are calcium release channels that are highly enriched in skeletal and cardiac muscle, respectively, where they play an essential role in excitation-contraction coupling. Apocalmodulin (apo-CaM) weakly activates RyR1 but inhibits RyR2, whereas Ca2+-calmodulin inhibits both isoforms. Previous cryo-EM studies showed distinctly different binding locations on RyR1 for the two states of CaM. However, recent studies employing FRET appear to challenge these findings. Here, using cryo-EM, we have determined that a CaM mutant that is incapable of binding calcium binds to RyR1 at the apo site, regardless of the calcium concentration. We have also re-determined the location of RyR1-bound Ca2+-CaM using uniform experimental conditions. Our results show the existence of the two overlapping but distinct binding sites for CaM in RyR1 and imply that the binding location switch is due to Ca2+ binding to CaM, as opposed to direct effects of Ca2+ on RyR1. We also discuss explanations that could resolve the apparent conflict between the cryo-EM and FRET results. Interestingly, apo-CaM binds to RyR2 at a similar binding location to that of Ca2+-CaM on RyR1, in seeming agreement with the inhibitory effects of these two forms of CaM on their respective receptors.	[Huang, Xiaojun; Farrington, Dinah T.; Wagenknecht, Terence; Liu, Zheng] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Huang, Xiaojun; Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Fruen, Bradley] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Minnesota System; University of Minnesota Twin Cities	Wagenknecht, T (corresponding author), SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	terry@wadsworth.org; liuz@wadsworth.org		Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01 HL095541, R01 AR040615, R01 HL076433]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL076433, R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL095541 (to Z. L.), R01 AR040615 (to T. W.), and R01 HL076433 (to B. F.).	Aracena P, 2005, DEV CARDIOVASC MED, V254, P163; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Damiani E, 2000, J MUSCLE RES CELL M, V21, P1, DOI 10.1023/A:1005635330773; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J., 2006, 3 DIMENSIONAL ELECT, P58; FRANK J, 2006, 3 DIMENSIONAL ELECT, P145; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; INUI M, 1987, J BIOL CHEM, V262, P1740; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Prosser BL, 2011, CELL CALCIUM, V50, P323, DOI 10.1016/j.ceca.2011.06.001; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wagenknecht TC, 2010, CURR TOP MEMBR, V66, P27, DOI 10.1016/S1063-5823(10)66002-4; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200	35	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30328	30335		10.1074/jbc.M112.383109	http://dx.doi.org/10.1074/jbc.M112.383109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22773841	Green Published, hybrid			2022-12-28	WOS:000308579800025
J	Yin, XM; Jin, NN; Gu, JL; Shi, JH; Zhou, JH; Gong, CX; Iqbal, K; Grundke-Iqbal, I; Liu, F				Yin, Xiaomin; Jin, Nana; Gu, Jianlan; Shi, Jianhua; Zhou, Jianhua; Gong, Cheng-Xin; Iqbal, Khalid; Grundke-Iqbal, Inge; Liu, Fei			Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Modulates Serine/Arginine-rich Protein 55 (SRp55)-promoted Tau Exon 10 Inclusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SPLICING FACTORS; SR PROTEINS; DOWN-SYNDROME; NEURODEGENERATIVE DISEASE; MICROTUBULE DYNAMICS; ALZHEIMERS-DISEASE; CONSERVED FAMILY; INCREASED DOSAGE; LOCALIZATION; EXPRESSION	Tau exon 10, which encodes the second microtubule-binding repeat, is regulated by alternative splicing. Its alternative splicing generates Tau isoforms with three-or four-microtubule-binding repeats, named 3R-tau and 4R-tau. Adult human brain expresses equal levels of 3R-tau and 4R-tau. Imbalance of 3R-tau and 4R-tau causes Tau aggregation and neurofibrillary degeneration. In the present study, we found that splicing factor SRp55 (serine/arginine-rich protein 55) promoted Tau exon 10 inclusion. Knockdown of SRp55 significantly promoted Tau exon 10 exclusion. The promotion of Tau exon 10 inclusion by SRp55 required the arginine/serine-rich region, which was responsible for the subnucleic speckle localization. Dyrk1A (dual specificity tyrosine-phosphorylated and regulated kinase 1A) interacted with SRp55 and mainly phosphorylated its proline-rich domain. Phosphorylation of SRp55 by Dyrk1A suppressed its ability to promote Tau exon 10 inclusion. Up-regulation of Dyrk1A as in Down syndrome could lead to neurofibrillary degeneration by shifting the alternative splicing of Tau exon 10 to an increase in the ratio of 3R-tau/4R-tau.	[Gong, Cheng-Xin; Iqbal, Khalid; Grundke-Iqbal, Inge; Liu, Fei] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Yin, Xiaomin; Gu, Jianlan; Shi, Jianhua] Nantong Univ, Sch Med, Dept Biochem & Mol Biol, Nantong 226001, Jiangsu, Peoples R China; [Yin, Xiaomin; Jin, Nana; Gu, Jianlan; Shi, Jianhua; Zhou, Jianhua; Gong, Cheng-Xin; Liu, Fei] Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Institute for Basic Research in Developmental Disabilities; Nantong University; Nantong University	Liu, F (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	feiliu63@hotmail.com	Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X	National Natural Science Foundation of China [30973143, 81030059]; Chinese Natural Science Foundation of Jiangsu Province [BK2009159]; U.S. Alzheimer's Association [IIRG-08-91126]; Basic Research Program of Jiangsu Education Department [10KJA310040]; Priority Academic Program Development of Jiangsu Higher Education Institution	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); U.S. Alzheimer's Association(Alzheimer's Association); Basic Research Program of Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by National Natural Science Foundation of China Grants 30973143 and 81030059 (to F. L.), Chinese Natural Science Foundation of Jiangsu Province Grant BK2009159 (to F. L.), U.S. Alzheimer's Association Grant IIRG-08-91126 (to F. L.), Basic Research Program of Jiangsu Education Department Grant 10KJA310040 (to F. L.), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Carter JG, 2011, CURR EYE RES, V36, P328, DOI 10.3109/02713683.2010.548892; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Ding SH, 2012, NEUROBIOL AGING, V33, P1389, DOI 10.1016/j.neurobiolaging.2010.11.021; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Panda D, 1999, P NATL ACAD SCI USA, V96, P12459, DOI 10.1073/pnas.96.22.12459; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Tranell A, 2011, VIRUS RES, V157, P82, DOI 10.1016/j.virusres.2011.02.010; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	45	65	69	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30497	30506		10.1074/jbc.M112.355412	http://dx.doi.org/10.1074/jbc.M112.355412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22767602	hybrid, Green Published			2022-12-28	WOS:000308579800042
J	Aziz, MH; Shen, H; Maki, CG				Aziz, Moammir H.; Shen, Hong; Maki, Carl G.			Glucocorticoid Receptor Activation Inhibits p53-induced Apoptosis of MCF10Amyc Cells via Induction of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PKC-EPSILON; MAPK ACTIVATION; BREAST-CANCER; P53-DEPENDENT APOPTOSIS; P53 PATHWAY; EXPRESSION; GENE; CHEMOSENSITIVITY; PHOSPHORYLATION; TRANSCRIPTION	Glucocorticoid receptor (GR) is a ligand-dependent transcription factor that can promote apoptosis or survival in a cell-specific manner. Activated GR has been reported to inhibit apoptosis in mammary epithelial cells and breast cancer cells by increasing pro-survival gene expression. In this study, activated GR inhibited p53-dependent apoptosis in MCF10A cells and human mammary epithelial cells that overexpress the MYC oncogene. Specifically, GR agonists hydrocortisone or dexamethasone inhibited p53-dependent apoptosis induced by cisplatin, ionizing radiation, or the MDM2 antagonist Nutlin-3. In contrast, the GR antagonist RU486 sensitized the cells to apoptosis by these agents. Apoptosis inhibition was associated with maintenance of mitochondrial membrane potential, diminished caspase-3 and -7 activation, and increased expression at both the mRNA and protein level of the anti-apoptotic PKC family member PKC epsilon. Knockdown of PKC epsilon via siRNA targeting reversed the protective effect of dexamethasone and restored apoptosis sensitivity. These data provide evidence that activated GR can inhibit p53-dependent apoptosis through induction of the anti-apoptotic factor PKC epsilon.	[Aziz, Moammir H.; Shen, Hong; Maki, Carl G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Institutes of Health from NCI [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA137598-01A1 from NCI (to C. G. M.).	Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Aziz MH, 2009, J INVEST DERMATOL, V129, P2011, DOI 10.1038/jid.2008.458; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Baines CP, 2001, BASIC RES CARDIOL, V96, P207, DOI 10.1007/s003950170051; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Dwivedi Y, 1999, J NEUROCHEM, V72, P380, DOI 10.1046/j.1471-4159.1999.0720380.x; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herr I, 2003, CANCER RES, V63, P3112; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Impicciatore G, 2010, CURR PHARM DESIGN, V16, P1427, DOI 10.2174/138161210791033932; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maddali KK, 2005, VASC PHARMACOL, V42, P153, DOI 10.1016/j.vph.2004.11.008; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Moran TJ, 2000, CANCER RES, V60, P867; Ni Chonghaile T, 2006, APOPTOSIS, V11, P1247, DOI 10.1007/s10495-006-7233-1; OConnor PM, 1997, CANCER RES, V57, P4285; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Petiti JP, 2008, MOL CELL ENDOCRINOL, V289, P77, DOI 10.1016/j.mce.2008.04.015; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Tennis M, 2006, CANCER EPIDEM BIOMAR, V15, P80, DOI 10.1158/1055-9965.EPI-05-0444; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wu GS, 1996, CLIN CANCER RES, V2, P623; Wu GS, 2002, ONCOGENE, V21, P1, DOI 10.1038/sj.onc.1205020; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	53	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29825	29836		10.1074/jbc.M112.393256	http://dx.doi.org/10.1074/jbc.M112.393256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773829	Green Published, hybrid			2022-12-28	WOS:000308286900057
J	Chan, O; Burke, JD; Gao, DF; Fish, EN				Chan, Olivia; Burke, J. Daniel; Gao, Darrin F.; Fish, Eleanor N.			The Chemokine CCL5 Regulates Glucose Uptake and AMP Kinase Signaling in Activated T Cells to Facilitate Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDEPENDENT SURVIVAL; MESSENGER-RNA TRANSLATION; PROTEIN-KINASE; PHOSPHOINOSITIDE 3-KINASE; LYMPHOCYTE ACTIVATION; MAMMALIAN TARGET; SKELETAL-MUSCLE; METABOLISM; GROWTH; MTOR	Recruitment of effector T cells to sites of infection or inflammation is essential for an effective adaptive immune response. The chemokine CCL5 (RANTES) activates its cognate receptor, CCR5, to initiate cellular functions, including chemotaxis. In earlier studies, we reported that CCL5-induced CCR5 signaling activates the mTOR/4E-BP1 pathway to directly modulate mRNA translation. Specifically, CCL5-mediated mTOR activation contributes to T cell chemotaxis by initiating the synthesis of chemotaxis-related proteins. Up-regulation of chemotaxis-related proteins may prime T cells for efficient migration. It is now clear that mTOR is also a central regulator of nutrient sensing and glycolysis. Herein we describe a role for CCL5-mediated glucose uptake and ATP accumulation to meet the energy demands of chemotaxis in activated T cells. We provide evidence that CCL5 is able to induce glucose uptake in an mTOR-dependent manner. CCL5 treatment of ex vivo activated human CD3(+) T cells also induced the activation of the nutrient-sensing kinase AMPK and downstream substrates ACC-1, PFKFB-2, and GSK-3 beta. Using 2-deoxy-D-glucose, an inhibitor of glucose uptake, and compound C, an inhibitor of AMPK, experimental data are presented that demonstrate that CCL5-mediated T cell chemotaxis is dependent on glucose, as these inhibitors inhibit CCL5-mediated chemotaxis in a dose-dependent manner. Altogether, these findings suggest that both glycolysis and AMPK signaling are required for efficient T cell migration in response to CCL5. These studies extend the role of CCL5 mediated CCR5 signaling beyond lymphocyte chemotaxis and demonstrate a role for chemokines in promoting glucose uptake and ATP production to match energy demands of migration.	[Fish, Eleanor N.] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON M5G 2M1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Fish, EN (corresponding author), Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, 67 Coll St,Rm 4-424, Toronto, ON M5G 2M1, Canada.	en.fish@utoronto.ca			Natural Sciences and Engineering Research Council of Canada [278397]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 278397.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; BECKNER ME, 1990, JNCI-J NATL CANCER I, V82, P1836, DOI 10.1093/jnci/82.23.1836; Bentley J, 2003, J BIOL CHEM, V278, P39337, DOI 10.1074/jbc.M305689200; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calder PC, 2007, CURR OPIN CLIN NUTR, V10, P531, DOI 10.1097/MCO.0b013e3281e72ad4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Deves R, 2000, J MEMBRANE BIOL, V173, P165, DOI 10.1007/s002320001017; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Juremalm M, 2002, BIOCHEM BIOPH RES CO, V297, P480, DOI 10.1016/S0006-291X(02)02244-1; KAHN BB, 1991, J CLIN INVEST, V87, P2197, DOI 10.1172/JCI115254; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Miranda L, 2010, BIOCHEM BIOPH RES CO, V396, P656, DOI 10.1016/j.bbrc.2010.04.151; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Murooka TT, 2009, BIOCHEM BIOPH RES CO, V387, P381, DOI 10.1016/j.bbrc.2009.07.035; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Somwar R, 2002, J BIOL CHEM, V277, P50386, DOI 10.1074/jbc.M205277200; Sweeney G, 2001, ENDOCRINOLOGY, V142, P4806, DOI 10.1210/en.142.11.4806; Taub DD, 1996, J IMMUNOL, V156, P2095; TURNER L, 1995, J IMMUNOL, V155, P2437; Ward SG, 1998, IMMUNITY, V9, P1, DOI 10.1016/S1074-7613(00)80583-X; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	62	51	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29406	29416		10.1074/jbc.M112.348946	http://dx.doi.org/10.1074/jbc.M112.348946			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782897	Green Published, hybrid			2022-12-28	WOS:000308286900019
J	Carvajal-Vallejos, P; Pallisse, R; Mootz, HD; Schmidt, SR				Carvajal-Vallejos, Patricia; Pallisse, Roser; Mootz, Henning D.; Schmidt, Stefan R.			Unprecedented Rates and Efficiencies Revealed for New Natural Split Inteins from Metagenomic Sources	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SPLICING ELEMENT; DNAE INTEIN; RECOMBINANT PROTEINS; ADENOSINE-TRIPHOSPHATASE; DIRECTED EVOLUTION; SYNTHETIC PEPTIDE; HIGHLY EFFICIENT; TAG; LIGATION; CLEAVAGE	Inteins excise themselves out of precursor proteins by the protein splicing reaction and have emerged as valuable protein engineering tools in numerous and diverse biotechnological applications. Split inteins have recently attracted particular interest because of the opportunities associated with generating a protein from two separate polypeptides and with trans-cleavage applications made possible by split intein mutants. However, natural split inteins are rare and differ greatly in their usefulness with regard to the achievable rates and yields. Here we report the first functional characterization of new split inteins previously identified by bioinformatics from metagenomic sources. The N- and C-terminal fragments of the four inteins gp41-1, gp41-8, NrdJ-1, and IMPDH-1 were prepared as fusion constructs with model proteins. Upon incubation of complementary pairs, we observed trans-splicing reactions with unprecedented rates and yields for all four inteins. Furthermore, no side reactions were detectable, and the precursor constructs were consumed virtually quantitatively. The rate for the gp41-1 intein, the most active intein on all accounts, was k = 1.8 +/- 0.5 x 10(-1) s(-1), which is similar to 10-fold faster than the rate reported for the Npu DnaE intein and gives rise to completed reactions within 20-30 s. No cross-reactivity in exogenous combinations was observed. Using C1A mutants, all inteins were efficient in the C-terminal cleavage reaction, albeit at lower rates. C-terminal cleavage could be performed under a wide range of reaction conditions and also in the absence of native extein residues flanking the intein. Thus, these inteins hold great potential for splicing and cleavage applications.	[Carvajal-Vallejos, Patricia; Pallisse, Roser; Schmidt, Stefan R.] ERA BIOTECH, Barcelona 08028, Spain; [Mootz, Henning D.] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Carvajal-Vallejos, P (corresponding author), ERA BIOTECH, Baldiri & Reixac 15-21, Barcelona 08028, Spain.	pcarvajal@erabiotech.com; henning.mootz@uni-muenster.de	schmidt, stefan/I-5631-2019; Carvajal-Vallejos, Patricia/E-5579-2017	schmidt, stefan/0000-0001-5584-1681; Carvajal-Vallejos, Patricia/0000-0002-4900-4593	ERA BIOTECH(R)	ERA BIOTECH(R)	This work was supported by ERA BIOTECH (R).	Amitai G, 2009, P NATL ACAD SCI USA, V106, P11005, DOI 10.1073/pnas.0904366106; Appleby JH, 2009, J BIOL CHEM, V284, P6194, DOI 10.1074/jbc.M805474200; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Brenzel S, 2006, BIOCHEMISTRY-US, V45, P1571, DOI 10.1021/bi051697+; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Chen LX, 2000, J BIOL CHEM, V275, P20431, DOI 10.1074/jbc.M000178200; Cheriyan M, 2009, ADV DRUG DELIVER REV, V61, P899, DOI 10.1016/j.addr.2009.04.021; Choi JJ, 2006, J MOL BIOL, V356, P1093, DOI 10.1016/j.jmb.2005.12.036; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dassa B, 2007, BIOCHEMISTRY-US, V46, P322, DOI 10.1021/bi0611762; Dassa B, 2009, NUCLEIC ACIDS RES, V37, P2560, DOI 10.1093/nar/gkp095; Elleuche S, 2010, APPL MICROBIOL BIOT, V87, P479, DOI 10.1007/s00253-010-2628-x; Fong BA, 2010, TRENDS BIOTECHNOL, V28, P272, DOI 10.1016/j.tibtech.2010.02.003; Hiraga K, 2009, J MOL BIOL, V393, P1106, DOI 10.1016/j.jmb.2009.08.074; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Li YF, 2011, BIOTECHNOL LETT, V33, P869, DOI 10.1007/s10529-011-0533-8; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Lu W, 2011, J CHROMATOGR A, V1218, P2553, DOI 10.1016/j.chroma.2011.02.053; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Mohlmann S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-76; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nichols NM, 2004, BIOCHEMISTRY-US, V43, P10265, DOI 10.1021/bi0494065; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shah NH, 2011, ANGEW CHEM INT EDIT, V50, P6511, DOI 10.1002/anie.201102909; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; Tan GH, 2009, GENETICS, V183, P13, DOI 10.1534/genetics.109.104794; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Telenti A, 1997, J BACTERIOL, V179, P6378, DOI 10.1128/jb.179.20.6378-6382.1997; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; Volkmann G, 2009, PROTEIN SCI, V18, P2393, DOI 10.1002/pro.249; Wei XY, 2006, RES MICROBIOL, V157, P227, DOI 10.1016/j.resmic.2005.08.004; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Wu WY, 2006, NAT PROTOC, V1, P2257, DOI 10.1038/nprot.2006.314; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	49	97	110	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28686	28696		10.1074/jbc.M112.372680	http://dx.doi.org/10.1074/jbc.M112.372680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753413	Green Published, hybrid			2022-12-28	WOS:000308074600042
J	Cui, HT; Thomas, JD; Burke, TR; Rader, C				Cui, Huiting; Thomas, Joshua D.; Burke, Terrence R., Jr.; Rader, Christoph			Chemically Programmed Bispecific Antibodies That Recruit and Activate T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; ENGAGING ANTIBODY; TUMOR-CELLS; LYSIS; IMMUNOTHERAPY; THERAPEUTICS; GENERATION; RECEPTORS; INTEGRIN; BINDING	Bispecific antibodies (biAbs) that mediate cytotoxicity by recruiting and activating endogenous immune cells are an emerging class of next-generation antibody therapeutics. Of particular interest are biAbs of relatively small size (similar to 50 kDa) that can redirect cytotoxic T cells through simultaneous binding of tumor cells. Here we describe a conceptually unique class of biAbs in which the tumor cell specificity of a humanized antibody fragment that recognizes CD3 on T cells is chemically programmed through a C-terminal selenocysteine (Sec) residue. We demonstrate that through chemically programmed specificity for integrin alpha(4)beta(1) or folate receptor 1 (FOLR1), and common specificity for CD3, these hybrid molecules exert potent and specific in vitro and ex vivo cytotoxicity toward tumor cell lines and primary tumor cells in the presence of primary T cells. Importantly, the generic nature of chemical programming allows one to apply our approach to virtually any specificity, promising a broad utility of chemically programmed biAbs in cancer therapy.	[Cui, Huiting; Rader, Christoph] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Thomas, Joshua D.; Burke, Terrence R., Jr.] NCI, Biol Chem Lab, Frederick Natl Lab Canc Res, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rader, C (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	crader@scripps.edu	Burke, Terrence R/N-2601-2014	Burke, Terrence/0000-0001-9925-8586; Rader, Christoph/0000-0001-9955-3454	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC006198] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.	ANDERSON PM, 1992, BLOOD, V80, P2826; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Bernardo PH, 2012, METHODS MOL BIOL, V800, P25, DOI 10.1007/978-1-61779-349-3_3; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Choi BD, 2011, EXPERT OPIN BIOL TH, V11, P843, DOI 10.1517/14712598.2011.572874; DeNardo SJ, 2009, J NUCL MED, V50, P625, DOI 10.2967/jnumed.108.056903; Doppalapudi VR, 2010, P NATL ACAD SCI USA, V107, P22611, DOI 10.1073/pnas.1016478108; Gavrilyuk JI, 2009, BIOORG MED CHEM LETT, V19, P3716, DOI 10.1016/j.bmcl.2009.05.047; Hofer T, 2008, P NATL ACAD SCI USA, V105, P12451, DOI 10.1073/pnas.0800800105; Hofer T, 2009, BIOCHEMISTRY-US, V48, P12047, DOI 10.1021/bi901744t; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P798, DOI 10.1038/nrd3581; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Kodadek T, 2010, CURR OPIN CHEM BIOL, V14, P713, DOI 10.1016/j.cbpa.2010.07.001; KRANZ DM, 1995, P NATL ACAD SCI USA, V92, P9057, DOI 10.1073/pnas.92.20.9057; Kurtova AV, 2009, BLOOD, V113, P4604, DOI 10.1182/blood-2008-10-185827; Li J, 2010, ACTA PHARMACOL SIN, V31, P1198, DOI 10.1038/aps.2010.120; LIU MA, 1988, SCIENCE, V239, P395, DOI 10.1126/science.3257303; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Moore PA, 2011, BLOOD, V117, P4542, DOI 10.1182/blood-2010-09-306449; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Rader C, 2003, P NATL ACAD SCI USA, V100, P5396, DOI 10.1073/pnas.0931308100; Rader C, 2011, BLOOD, V117, P4403, DOI 10.1182/blood-2011-02-337691; Rund LA, 1999, INT J CANCER, V83, P141, DOI 10.1002/(SICI)1097-0215(19990924)83:1<141::AID-IJC24>3.0.CO;2-0; SHALABY MR, 1992, J EXP MED, V175, P217, DOI 10.1084/jem.175.1.217; Spannuth WA, 2010, EXPERT OPIN BIOL TH, V10, P431, DOI 10.1517/14712591003592069; Thomas JD, 2008, BIOORG MED CHEM LETT, V18, P5785, DOI 10.1016/j.bmcl.2008.09.078; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Woodnutt G, 2008, CURR OPIN DRUG DISC, V11, P754; ZHU ZP, 1995, J IMMUNOL, V155, P1903	33	21	32	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28206	28214		10.1074/jbc.M112.384594	http://dx.doi.org/10.1074/jbc.M112.384594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761439	Green Published, hybrid			2022-12-28	WOS:000308074600001
J	Shomura, Y; Higuchi, Y				Shomura, Yasuhito; Higuchi, Yoshiki			Structural Basis for the Reaction Mechanism of S-Carbamoylation of HypE by HypF in the Maturation of [NiFe]-Hydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; O-CARBAMOYLTRANSFERASE; PROTEINS HYPC; ACYLPHOSPHATASE; CYANIDE; MODEL; BIOSYNTHESIS; HYDROGENASES	As a remarkable structural feature of hydrogenase active sites, [NiFe]-hydrogenases harbor one carbonyl and two cyano ligands, where HypE and HypF are involved in the biosynthesis of the nitrile group as a precursor of the cyano groups. HypF catalyzes S-carbamoylation of the C-terminal cysteine of HypE via three steps using carbamoylphosphate and ATP, producing two unstable intermediates: carbamate and carbamoyladenylate. Although the crystal structures of intact HypE homodimers and partial HypF have been reported, it remains unclear how the consecutive reactions occur without the loss of unstable intermediates during the proposed reaction scheme. Here we report the crystal structures of full-length HypF both alone and in complex with HypE at resolutions of 2.0 and 2.6 angstrom, respectively. Three catalytic sites of the structures of the HypF nucleotideand phosphate-bound forms have been identified, with each site connected via channels inside the protein. This finding suggests that the first two consecutive reactions occur without the release of carbamate or carbamoyladenylate from the enzyme. The structure of HypF in complex with HypE revealed that HypF can associate with HypE without disturbing its homodimeric interaction and that the binding manner allows the C-terminal Cys-351 of HypE to access the S-carbamoylation active site in HypF, suggesting that the third step can also proceed without the release of carbamoyladenylate. A comparison of the structure of HypF with the recently reported structures of O-carbamoyltransferase revealed different reaction mechanisms for carbam-oyladenylate synthesis and a similar reaction mechanism for carbamoyltransfer to produce the carbamoyl-HypE molecule.	[Shomura, Yasuhito; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Shomura, Yasuhito; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Biomet Sci Lab, Mikazuki, Hyogo 6795148, Japan	University of Hyogo; RIKEN	Shomura, Y (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	shomura@sci.u-hyogo.ac.jp; hig@sci.u-hyogo.ac.jp		Higuchi, Yoshiki/0000-0001-8284-5709	MEXT [18054029, 20051022, 22770111, 18GS0207]; JSPS [24657077, 22370061, 22657031]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research from MEXT [18054029 (to Y. S.), 20051022 (to Y. S.), 22770111 (to Y. S.), and 18GS0207 (to Y. H.)] and from JSPS [24657077(to Y. H.), 22370061 (to Y. H.), and 22657031 (to Y. H.)].	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT EL, 1984, J BACTERIOL, V158, P972, DOI 10.1128/JB.158.3.972-977.1984; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Burstel I, 2011, J BIOL CHEM, V286, P44937, DOI 10.1074/jbc.M111.309351; Cheung YY, 2005, BIOCHEMISTRY-US, V44, P4601, DOI 10.1021/bi047832k; CHRISTENSEN HEM, 1994, EUR J BIOCHEM, V224, P97, DOI 10.1111/j.1432-1033.1994.tb19999.x; COQUE JJR, 1995, GENE, V162, P21, DOI 10.1016/0378-1119(95)00308-S; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jia J, 2002, PROTEINS, V49, P139, DOI 10.1002/prot.10178; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2012, ANGEW CHEM INT EDIT, V51, P4046, DOI 10.1002/anie.201108896; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; RAGSDALE SW, 1984, J BACTERIOL, V157, P1; Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rosano C, 2002, J MOL BIOL, V321, P785, DOI 10.1016/S0022-2836(02)00713-1; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Shomura Y, 2007, J MOL BIOL, V372, P1045, DOI 10.1016/j.jmb.2007.07.023; TADDEI N, 1994, BBA-PROTEIN STRUCT M, V1208, P75, DOI 10.1016/0167-4838(94)90161-9; Teplova M, 2000, PROTEIN SCI, V9, P2557, DOI 10.1110/ps.9.12.2557; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Thunnissen MMGM, 1997, STRUCTURE, V5, P69, DOI 10.1016/S0969-2126(97)00167-6; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WANG TT, 1972, J BIOL CHEM, V247, P4437; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	48	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28409	28419		10.1074/jbc.M112.387134	http://dx.doi.org/10.1074/jbc.M112.387134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740694	hybrid, Green Published			2022-12-28	WOS:000308074600017
J	Bartoszewska, M; Williams, C; Kikhney, A; Opalinski, L; van Roermund, CWT; de Boer, R; Veenhuis, M; van der Klei, IJ				Bartoszewska, Magdalena; Williams, Chris; Kikhney, Alexey; Opalinski, Lukasz; van Roermund, Carlo W. T.; de Boer, Rinse; Veenhuis, Marten; van der Klei, Ida J.			Peroxisomal Proteostasis Involves a Lon Family Protein That Functions as Protease and Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PENICILLIUM-CHRYSOGENUM; HANSENULA-POLYMORPHA; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; CITRATE SYNTHASE; HIGH-RESOLUTION; MATRIX PROTEIN; IN-VITRO	Proteins are subject to continuous quality control for optimal proteostasis. The knowledge of peroxisome quality control systems is still in its infancy. Here we show that peroxisomes contain a member of the Lon family of proteases (Pln). We show that Pln is a heptameric protein and acts as an ATP-fueled protease and chaperone. Hence, Pln is the first chaperone identified in fungal peroxisomes. In cells of a PLN deletion strain peroxisomes contain protein aggregates, a major component of which is catalase-peroxidase. We show that this enzyme is sensitive to oxidative damage. The oxidatively damaged, but not the native protein, is a substrate of the Pln protease. Cells of the pln strain contain enhanced levels of catalase-peroxidase protein but reduced catalase-peroxidase enzyme activities. Together with the observation that Pln has chaperone activity in vitro, our data suggest that catalase-peroxidase aggregates accumulate in peroxisomes of pln cells due to the combined absence of Pln protease and chaperone activities.	[Bartoszewska, Magdalena; Opalinski, Lukasz; de Boer, Rinse; Veenhuis, Marten; van der Klei, Ida J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, NL-9700 CC Groningen, Netherlands; [Williams, Chris; Kikhney, Alexey] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [van Roermund, Carlo W. T.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Amsterdam; Academic Medical Center Amsterdam	van der Klei, IJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, POB 11103, NL-9700 CC Groningen, Netherlands.	I.J.van.der.klei@rug.nl	Williams, Chris/C-4216-2012; van der Klei, Ida J/D-1919-2012	Williams, Chris/0000-0003-1757-6156; Opalinska, Magdalena/0000-0003-1449-4243; Van der Klei, Ida J./0000-0001-7165-9679; Opalinski, Lukasz/0000-0001-9656-8714	Netherlands Organization for Scientific Research [825.08.023]; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS) [IBOS 053.63.011]; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by a Rubicon Fellowship (825.08.023) from the Netherlands Organization for Scientific Research (to C. W.).; Supported by the Research Program of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.; Supported by the Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS) (project IBOS 053.63.011).	Aksam EB, 2007, AUTOPHAGY, V3, P96, DOI 10.4161/auto.3534; Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartoszewska M, 2011, APPL ENVIRON MICROB, V77, P1413, DOI 10.1128/AEM.01531-10; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Fraaije MW, 1996, EUR J BIOCHEM, V235, P192, DOI 10.1111/j.1432-1033.1996.00192.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HILLENGA DJ, 1994, EUR J BIOCHEM, V224, P581, DOI 10.1111/j.1432-1033.1994.t01-1-00581.x; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jaenicke R, 1998, BIOL CHEM, V379, P237; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Kiel JAKW, 2000, APPL MICROBIOL BIOT, V54, P238, DOI 10.1007/s002530000378; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; Liu FF, 2011, DEV CELL, V21, P457, DOI 10.1016/j.devcel.2011.08.004; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; Okumoto K, 2011, J BIOL CHEM, V286, P44367, DOI 10.1074/jbc.M111.285197; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Opalinski L, 2010, FEBS J, V277, P3203, DOI 10.1111/j.1742-4658.2010.07726.x; Paraszkiewicz K, 2010, ARCH MICROBIOL, V192, P135, DOI 10.1007/s00203-009-0542-3; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roudiak SG, 1998, BIOCHEMISTRY-US, V37, P377, DOI 10.1021/bi971732f; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Steinberg S. J., 1993, PEROXISOME BIOGENESI; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; WEST SM, 1990, BIOCHIM BIOPHYS ACTA, V1037, P332, DOI 10.1016/0167-4838(90)90034-D	59	46	46	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27380	27395		10.1074/jbc.M112.381566	http://dx.doi.org/10.1074/jbc.M112.381566			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733816	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000307840700010
J	Conlan, BF; Colgrave, ML; Gillon, AD; Guarino, R; Craik, DJ; Anderso, MA				Conlan, Brendon F.; Colgrave, Michelle L.; Gillon, Amanda D.; Guarino, Rosemary; Craik, David J.; Anderso, Marilyn A.			Insights into Processing and Cyclization Events Associated with Biosynthesis of the Cyclic Peptide Kalata B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR PROTEINS; CYSTINE KNOT; PLANT CYCLOTIDES; MACROCYCLIC PEPTIDES; DISCOVERY; MECHANISMS; SUNFLOWER	Plant cyclotides are the largest family of gene-encoded cyclic proteins. They act as host defense molecules to protect plants and are promising candidates as insecticidal and nematocidal agents in agriculture. For this promise to be realized a greater understanding of the post-translational processing of these proteins is needed. Cyclotides are cleaved from precursor proteins with subsequent ligation of the N and C termini to form a continuous peptide backbone. This cyclization step is inefficient in transgenic plants and our work aims to shed light on the specificity requirements at the excision sites for cyclic peptide production. Using the prototypic cyclotide kalata B1 (kB1) expressed from the Oak1 gene, MALDI-TOF mass spectrometry was used to examine the cyclization efficiency when mutants of the Oak1 gene were expressed in transgenic Nicotiana benthamiana. Cleavage at the N terminus of the cyclotide domain occurs rapidly with no strict specificity requirements for amino acids at the cleavage site. In contrast, the C-terminal region of the cyclotide domain in the P2, P1, P1', and P2' positions is highly conserved and only specific amino acids can occupy these positions. The cyclization reaction requires an Asn at position P1 followed by a small amino acid (Ala, Gly, Ser) at the P1' position. The P2' position must be filled by Leu or Ile; in their absence an unusual post-translational modification occurs. Substitution of the P2' Leu with Ala leads to hydroxylation of the neighboring proline. Through mutational analysis this novel proline hydroxylation motif was determined to be Gly-Ala-Pro-Ser.	[Conlan, Brendon F.; Gillon, Amanda D.; Guarino, Rosemary; Anderso, Marilyn A.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Colgrave, Michelle L.] CSIRO Livestock Ind, Brisbane, Qld 4067, Australia; [Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Anderso, MA (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.	m.anderson@latrobe.edu.au	Colgrave, Michelle/A-5710-2012; Conlan, Brendon F/A-7013-2012; Anderson, Marilyn A/A-4259-2012; Craik, David/B-1695-2010	Colgrave, Michelle/0000-0001-8463-805X; Conlan, Brendon F/0000-0002-0934-3865; Anderson, Marilyn A/0000-0002-8257-5128; Craik, David/0000-0003-0007-6796	Australian Research Council [DP0984390]	Australian Research Council(Australian Research Council)	This work was supported by Grant DP0984390 from the Australian Research Council.	Anderson M. A., 1997, J INSECT PHYSL, V43, P833, DOI [10.1016/S0022-1910(97)00026-7, DOI 10.1016/S0022-1910(97)00026-7]; Bajaj MS, 2011, J BIOL CHEM, V286, P4329, DOI 10.1074/jbc.M110.191163; Burman R, 2010, PHYTOCHEMISTRY, V71, P13, DOI 10.1016/j.phytochem.2009.09.023; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conlan BF, 2011, CURR PHARM DESIGN, V17, P4318; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2003, J BACTERIOL, V185, P4011, DOI 10.1128/JB.185.14.4011-4021.2003; Craik DJ, 2001, LETT PEPT SCI, V8, P119, DOI 10.1007/BF02446507; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; GRAN L, 1973, LLOYDIA, V36, P207; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shimizu M, 2005, PLANT J, V42, P877, DOI 10.1111/j.1365-313X.2005.02419.x; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang J, 2009, GENE, V431, P23, DOI 10.1016/j.gene.2008.11.005	27	32	33	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28037	28046		10.1074/jbc.M112.347823	http://dx.doi.org/10.1074/jbc.M112.347823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22700963	Green Published, hybrid			2022-12-28	WOS:000307840700077
J	Hollingshead, S; Kopecna, J; Jackson, PJ; Canniffe, DP; Davison, PA; Dickman, MJ; Sobotka, R; Hunter, CN				Hollingshead, Sarah; Kopecna, Jana; Jackson, Philip J.; Canniffe, Daniel P.; Davison, Paul A.; Dickman, Mark J.; Sobotka, Roman; Hunter, C. Neil			Conserved Chloroplast Open-reading Frame ycf54 Is Required for Activity of the Magnesium Protoporphyrin Monomethylester Oxidative Cyclase in Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL ISOCYCLIC RING; RHODOBACTER-SPHAEROIDES; SP PCC-6803; IX; ESTER; BIOSYNTHESIS; PROTOCHLOROPHYLLIDE; SYSTEM; OXYGEN; BACTERIOCHLOROPHYLL	The cyclase step in chlorophyll (Chl) biosynthesis has not been characterized biochemically, although there are some plausible candidates for cyclase subunits. Two of these, Sll1214 and Sll1874 from the cyanobacterium Synechocystis 6803, were FLAG-tagged in vivo and used as bait in separate pulldown experiments. Mass spectrometry identified Ycf54 as an interaction partner in each case, and this interaction was confirmed by a reciprocal pulldown using FLAG-tagged Ycf54 as bait. Inactivation of the ycf54 gene (slr1780) in Synechocystis 6803 resulted in a strain that exhibited significantly reduced Chl levels. A detailed analysis of Chl precursors in the ycf54 mutant revealed accumulation of very high levels of Mg-protoporphyrin IX methyl ester and only traces of protochlorophyllide, the product of the cyclase, were detected. Western blotting demonstrated that levels of the cyclase component Sll1214 and the Chl biosynthesis enzymes Mg-protoporphyrin IX methyltransferase and protochlorophyllide reductase are significantly impaired in the ycf54 mutant. Ycf54 is, therefore, essential for the activity and stability of the oxidative cyclase. We discuss a possible role of Ycf54 as an auxiliary factor essential for the assembly of a cyclase complex or even a large multienzyme catalytic center.	[Kopecna, Jana; Sobotka, Roman] Inst Microbiol, Dept Phototroph Microorganisms, Trebon 37981, Czech Republic; [Hollingshead, Sarah; Jackson, Philip J.; Canniffe, Daniel P.; Davison, Paul A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Kopecna, Jana; Sobotka, Roman] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Jackson, Philip J.; Dickman, Mark J.] Univ Sheffield, Dept Chem & Biol Engn, ChELSI Inst, Sheffield S1 3JD, S Yorkshire, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Sheffield; University of South Bohemia Ceske Budejovice; University of Sheffield	Sobotka, R (corresponding author), Inst Microbiol, Dept Phototroph Microorganisms, Trebon 37981, Czech Republic.	sobotka@alga.cz	Sobotka, Roman/J-3077-2014; kopecna, jana/H-2967-2014	Sobotka, Roman/0000-0001-5909-3879; kopecna, jana/0000-0003-2863-4139; Dickman, Mark/0000-0002-9236-0788; Canniffe, Daniel/0000-0002-5022-0437	University of Sheffield; Biotechnology and Biological Sciences Research Council (United Kingdom); Grant Agency of the Czech Republic [P501/10/1000]; projects Algatech [CZ.1.05/2.1.00/03.0110, RVO61388971]; BBSRC [BB/G021546/1] Funding Source: UKRI; EPSRC [EP/E036252/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish	University of Sheffield; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); projects Algatech; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by a doctoral studentship from the University of Sheffield.; Supported by a grant from the Biotechnology and Biological Sciences Research Council (United Kingdom).; Supported by postdoctoral funds from the University of Sheffield.; Supported by the Grant Agency of the Czech Republic (projects P501/10/1000) and by projects Algatech (CZ.1.05/2.1.00/03.0110) and RVO61388971.	Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; CHERESKIN BM, 1982, PLANT PHYSIOL, V70, P987, DOI 10.1104/pp.70.4.987; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; FUESLER TP, 1984, PLANT PHYSIOL, V75, P662, DOI 10.1104/pp.75.3.662; Granick S., 1948, HARVEY LECT, V44, P220; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; McLean S, 2009, ANAL BIOCHEM, V394, P223, DOI 10.1016/j.ab.2009.07.036; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Peter E, 2010, PLANT CELL PHYSIOL, V51, P1229, DOI 10.1093/pcp/pcq071; Peter E, 2009, BBA-BIOENERGETICS, V1787, P1458, DOI 10.1016/j.bbabio.2009.06.006; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Porra R. J., 2004, FEBS J, V239, P85; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; REBEIZ CA, 1975, ARCH BIOCHEM BIOPHYS, V166, P446, DOI 10.1016/0003-9861(75)90408-7; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; SMITH KM, 1986, J ORG CHEM, V51, P657, DOI 10.1021/jo00355a015; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WALKER CJ, 1991, BIOCHEM J, V276, P691, DOI 10.1042/bj2760691; WALKER CJ, 1988, BIOCHEM J, V255, P685; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; WONG YS, 1985, PLANT PHYSIOL, V79, P725, DOI 10.1104/pp.79.3.725; WONG YS, 1984, PLANT PHYSIOL, V75, P658, DOI 10.1104/pp.75.3.658	37	65	66	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27823	27833		10.1074/jbc.M112.352526	http://dx.doi.org/10.1074/jbc.M112.352526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22711541	Green Published, hybrid			2022-12-28	WOS:000307840700056
J	Rives, ML; Rossillo, M; Liu-Chen, LY; Javitch, JA				Rives, Marie-Laure; Rossillo, Mary; Liu-Chen, Lee-Yuan; Javitch, Jonathan A.			6 '-Guanidinonaltrindole (6 '-GNTI) Is a G Protein-biased kappa-Opioid Receptor Agonist That Inhibits Arrestin Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL SENSORY NEURONS; FUNCTIONAL SELECTIVITY; IN-VIVO; ACTIVATION; TRAFFICKING; TOLERANCE; EFFICACY; STRESS; KINASE; DELTA	kappa-Opioid receptor (KOR) agonists do not activate the reward pathway stimulated by morphine-like mu-opioid receptor (MOR) agonists and thus have been considered to be promising nonaddictive analgesics. However, KOR agonists produce other adverse effects, including dysphoria, diuresis, and constipation. The therapeutic promise of KOR agonists has nonetheless recently been revived by studies showing that their dysphoric effects require arrestin recruitment, whereas their analgesic effects do not. Moreover, KOR agonist-induced antinociceptive tolerance observed in vivo has also been proposed to be correlated to the ability to induce arrestin-dependent phosphorylation, desensitization, and internalization of the receptor. The discovery of functionally selective drugs that are therapeutically effective without the adverse effects triggered by the arrestin pathway is thus an important goal. We have identified such an extreme G protein-biased KOR compound, 6'-guanidinonal-trindole (6'-GNTI), a potent partial agonist at the KOR receptor for the G protein activation pathway that does not recruit arrestin. Indeed, 6'-GNTI functions as an antagonist to block the arrestin recruitment and KOR internalization induced by other nonbiased agonists. As an extremely G protein-biased KOR agonist, 6'-GNTI represents a promising lead compound in the search for nonaddictive opioid analgesic as its signaling profile suggests that it will be without the dysphoria and other adverse effects promoted by arrestin recruitment and its downstream signaling.	[Rives, Marie-Laure; Rossillo, Mary; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Rives, Marie-Laure; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Javitch, JA (corresponding author), Columbia Univ, Dept Psychiat, Coll Phys & Surg, P&S 11-401,630 W 168th St,Box 7, New York, NY 10032 USA.	jaj2@columbia.edu		Rives, Marie-Laure/0000-0003-3324-2412; Rossillo, Mary/0000-0002-5103-0985; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [DA022413, MH054137]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA022413 and MH054137 (to J. A. J.).	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Ansonoff MA, 2010, PSYCHOPHARMACOLOGY, V210, P161, DOI 10.1007/s00213-010-1826-7; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; Beguin C, 2012, BIOORG MED CHEM LETT, V22, P1023, DOI 10.1016/j.bmcl.2011.11.128; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Berg KA, 2011, J PHARMACOL EXP THER, V338, P92, DOI 10.1124/jpet.110.177493; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Chavkin C, 2011, NEUROPSYCHOPHARMACOL, V36, P369, DOI 10.1038/npp.2010.137; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HENRY DJ, 1995, MOL PHARMACOL, V47, P551; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; SCHOFFELMEER ANM, 1988, EUR J PHARMACOL, V154, P169, DOI 10.1016/0014-2999(88)90094-5; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; TALLENT M, 1994, NEUROSCIENCE, V63, P1033, DOI 10.1016/0306-4522(94)90570-3; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vanderah TW, 2010, CLIN J PAIN, V26, pS10, DOI 10.1097/AJP.0b013e3181c49e3a; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang YH, 2010, ACTA PHARMACOL SIN, V31, P1065, DOI 10.1038/aps.2010.138; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007	38	79	81	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27050	27054		10.1074/jbc.C112.387332	http://dx.doi.org/10.1074/jbc.C112.387332			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22736766	Green Published, hybrid			2022-12-28	WOS:000307386000057
J	Somlata; Kamanna, S; Agrahari, M; Babuta, M; Bhattacharya, S; Bhattacharya, A				Somlata; Kamanna, Sathisha; Agrahari, Mridula; Babuta, Mrigya; Bhattacharya, Sudha; Bhattacharya, Alok			Autophosphorylation of Ser(428) of EhC2PK Plays a Critical Role in Regulating Erythrophagocytosis in the Parasite Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; ACTIVATION; PHAGOCYTOSIS; BINDING; VIRULENCE; DOMAIN	The protozoan parasite Entamoeba histolytica can invade both intestinal and extra intestinal tissues resulting in amoebiasis. During the process of invasion E. histolytica ingests red blood and host cells using phagocytic processes. Though phagocytosis is considered to be a key virulence determinant, the mechanism is not very well understood in E. histolytica. We have recently demonstrated that a novel C2 domain-containing protein kinase, EhC2PK is involved in the initiation of erythrophagocytosis. Because cells overexpressing the kinase-dead mutant of EhC2PK displayed a reduction in erythrophagocytosis, it appears that kinase activity is necessary for initiation. Biochemical analysis showed that EhC2PK is an unusual Mn2+-dependent serine kinase. It has a trans-autophosphorylated site at Ser(428) as revealed by mass spectrometric and biochemical analysis. The autophosphorylation defective mutants (S428A, KD Delta C) showed a reduction in auto and substrate phosphorylation. Time kinetics of in vitro kinase activity suggested two phases, an initial short slow phase followed by a rapid phase for wild type protein, whereas mutations in the autophosphorylation sites that cause defect (S428A) or conferred phosphomimetic property (S428E) displayed no distinct phases, suggesting that autophosphorylation may be controlling kinase activity through an autocatalytic mechanism. A reduction and delay in erythrophagocytosis was observed in E. histolytica cells overexpressing S428A and KD Delta C proteins. These results indicate that enrichment of EhC2PK at the site of phagocytosis enhances the rate of trans-autophosphorylation, thereby increasing kinase activity and regulating the initiation of erythrophagocytosis in E. histolytica.	[Somlata; Agrahari, Mridula; Babuta, Mrigya; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Kamanna, Sathisha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Indian Institute of Science (IISC) - Bangalore	Bhattacharya, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Mehrauli Rd, New Delhi 110067, India.	alok.bhattacharya@gmail.com		Babuta, Mrigya/0000-0001-8420-4796; Kamanna, Sathisha/0000-0001-6231-9883; , SOMLATA/0000-0003-1928-5280	CSIR, India; Department of Science and Technology; BNP Paribas; Department of Biotechnology	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); BNP Paribas; Department of Biotechnology	This work was supported in part by CSIR, India for Junior and Senior Research fellowships (to S.), the Department of Science and Technology JC Bose Fellowship and BNP Paribas (to A. B.), and the Department of Biotechnology.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Allen LAH, 2002, CURR BIOL, V12, P1762, DOI 10.1016/S0960-9822(02)01216-2; BRACHA R, 1984, J EXP MED, V160, P353, DOI 10.1084/jem.160.2.353; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Reddy MM, 2006, ARCH BIOCHEM BIOPHYS, V455, P99, DOI 10.1016/j.abb.2006.09.009; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Sahoo N, 2003, MOL BIOCHEM PARASIT, V126, P281, DOI 10.1016/S0166-6851(02)00284-0; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Wang Y., 1993, PROTEIN PHOSPHORYLAT, P121; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; YUAN CJ, 1993, J BIOL CHEM, V268, P17683	28	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10844	10852		10.1074/jbc.M111.308874	http://dx.doi.org/10.1074/jbc.M111.308874			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22753771	hybrid, Green Published			2022-12-28	WOS:000302780100013
J	Lee, HC				Lee, Hon Cheung			Cyclic ADP-ribose and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) as Messengers for Calcium Mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PANCREATIC-ACINAR-CELLS; SEA-URCHIN EGGS; REGULATES INTRACELLULAR CALCIUM; CA2+-INDUCED CA2+ RELEASE; HUMAN CD38; SMOOTH-MUSCLE; INOSITOL TRISPHOSPHATE; INSULIN-SECRETION; CRYSTAL-STRUCTURE; 2-PORE CHANNELS	Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate were discovered >2 decades ago. That they are second messengers for mobilizing Ca2+ stores has since been firmly established. Separate stores and distinct Ca2+ channels are targeted, with cyclic ADP-ribose acting on the ryanodine receptors in the endoplasmic reticulum, whereas nicotinic acid adenine dinucleotide phosphate mobilizes the endolysosomes via the two-pore channels. Despite the structural and functional differences, both messengers are synthesized by a ubiquitous enzyme, CD38, whose crystal structure and catalytic mechanism have now been well elucidated. How this novel signaling enzyme is regulated remains largely unknown and is the focus of this minireview.	Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	leehc@hku.hk	Lee, Hon Cheung/C-4329-2009		Research Grants Council of Hong Kong [768408, 769309, 770610, 771011]; Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) of Hong Kong Grant [N_HKU 722/08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) of Hong Kong Grant	This work was supported by Research Grants Council of Hong Kong Grants 768408, 769309, 770610, and 771011 and Natural Science Foundation of China (NSFC)/Research Grants Council (RGC) of Hong Kong Grant N_HKU 722/08. This article is part of the Thematic Minireview Series on Ins and Outs of Calcium Transport.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Esposito B, 2011, BLOOD, V117, P4968, DOI 10.1182/blood-2010-02-266338; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Galione A, 2011, SCI CHINA LIFE SCI, V54, P725, DOI 10.1007/s11427-011-4207-5; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GRAU UM, 1981, J MOL BIOL, V151, P289, DOI 10.1016/0022-2836(81)90516-7; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216; Kotaka M, 2012, J MOL BIOL, V415, P514, DOI 10.1016/j.jmb.2011.11.022; Kuroda R, 2001, DEVELOPMENT, V128, P4405; Lam CMC, 2009, CELL CALCIUM, V45, P346, DOI 10.1016/j.ceca.2008.12.006; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Lee HC, 2000, CHEM IMMUNOL, V75, P39; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 2000, J CELL SCI, V113, P4413; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 1996, RECENT PROG HORM RES, V51, P355; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2008, CHEM BIOL, V15, P1068, DOI 10.1016/j.chembiol.2008.08.007; Liu Q, 2007, J BIOL CHEM, V282, P24825, DOI 10.1074/jbc.M701653200; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Ohta Y, 2011, MOL CELL BIOCHEM, V352, P293, DOI 10.1007/s11010-011-0765-x; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Savarino A, 2003, FASEB J, V17, P461, DOI 10.1096/fj.02-0512fje; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shawl AI, 2009, ISLETS, V1, P216, DOI 10.4161/isl.1.3.9646; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TANAKA Y, 1995, P NATL ACAD SCI USA, V92, P3244, DOI 10.1073/pnas.92.8.3244; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; WALSETH TF, 1991, BIOCHIM BIOPHYS ACTA, V1094, P113, DOI 10.1016/0167-4889(91)90032-S; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang HM, 2011, J MOL BIOL, V405, P1070, DOI 10.1016/j.jmb.2010.11.044; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zheng J, 2010, CELL CALCIUM, V47, P449, DOI 10.1016/j.ceca.2010.03.006; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277	100	157	162	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					31633	31640		10.1074/jbc.R112.349464	http://dx.doi.org/10.1074/jbc.R112.349464			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822066	Green Published, hybrid			2022-12-28	WOS:000309059400004
J	Parazzoli, S; Harmon, JS; Vallerie, SN; Zhang, T; Zhou, HR; Robertson, RP				Parazzoli, Susan; Harmon, Jamie S.; Vallerie, Sara N.; Zhang, Tao; Zhou, Huarong; Robertson, R. Paul			Cyclooxygenase-2, Not Microsomal Prostaglandin E Synthase-1, Is the Mechanism for Interleukin-1 beta-induced Prostaglandin E-2 Production and Inhibition of Insulin Secretion in Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGE2 INHIBITION; MICE LACKING; ISOLATED RAT; IN-VIVO; EXPRESSION; IDENTIFICATION; GENE; PURIFICATION; IL-1-BETA; INDUCTION	Arachidonic acid is converted to prostaglandin E-2 (PGE(2)) by a sequential enzymatic reaction performed by two isoenzyme groups, cyclooxygenases (COX-1 and COX-2) and terminal prostaglandin E synthases (cPGES, mPGES-1, and mPGES-2). mPGES-1 is widely considered to be the final enzyme regulating COX-2-dependent PGE(2) synthesis. These generalizations have been based in most part on experiments utilizing gene expression analyses of cell lines and tumor tissue. To assess the relevance of these generalizations to a native mammalian tissue, we used isolated human and rodent pancreatic islets to examine interleukin (IL)-1 beta-induced PGE(2) production, because PGE(2) has been shown to mediate IL-1 beta inhibition of islet function. Rat islets constitutively expressed mRNAs of COX-1, COX-2, cPGES, and mPGES-1. As expected, IL-1 beta increased mRNA levels for COX-2 and mPGES-1, but not for COX-1 or cPGES. Basal protein levels of COX-1, cPGES, and mPGES-2 were readily detected in whole cell extracts but were not regulated by IL-1 beta. IL-1 beta increased protein levels of COX-2, but unexpectedly mPGES-1 protein levels were low and unaffected. In microsomal extracts, mPGES-1 protein was barely detectable in rat islets but clearly present in human islets; however, in neither case did IL-1 beta increase mPGES-1 protein levels. To further assess the importance of mPGES-1 to IL-1 beta regulation of an islet physiologic response, glucose-stimulated insulin secretion was examined in isolated islets of WT and mPGES-1-deficient mice. IL-1 beta inhibited glucose-stimulated insulin secretion equally in both WT and mPGES-1(-/-) islets, indicating that COX-2, not mPGES-1, mediates IL-1 beta-induced PGE(2) production and subsequent inhibition of insulin secretion.	[Robertson, R. Paul] Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98122 USA; [Robertson, R. Paul] Univ Washington, Div Metab Endocrinol & Nutr, Dept Pharmacol, Seattle, WA 98122 USA; [Robertson, R. Paul] Univ Washington, Pacific NW Diabet Res Inst, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pacific Northwest Diabetes Research Institute (PNDRI); University of Washington; University of Washington Seattle	Robertson, RP (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, 720 Broadway, Seattle, WA 98122 USA.	rpr@pnri.org	Roberston, R Paul/AAX-5613-2021		National Institutes of Health [NIDDK R01 38325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grant NIDDK R01 38325 (to R. P. R.).	Asano K, 1996, AM J PHYSIOL-LUNG C, V271, pL126, DOI 10.1152/ajplung.1996.271.1.L126; Bage T, 2007, BBA-MOL CELL RES, V1773, P1589, DOI 10.1016/j.bbamcr.2007.07.008; Burke SJ, 2011, CELL IMMUNOL, V271, P379, DOI 10.1016/j.cellimm.2011.08.004; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; FU JY, 1990, J BIOL CHEM, V265, P16737; Guan YF, 2001, AM J PHYSIOL-RENAL, V281, pF1173, DOI 10.1152/ajprenal.0116.2001; Han R, 2002, J BIOL CHEM, V277, P36897, DOI 10.1074/jbc.M206949200; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; METZ SA, 1981, DIABETES, V30, P551, DOI 10.2337/diabetes.30.7.551; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakatani Y, 2007, BIOCHEM BIOPH RES CO, V362, P387, DOI 10.1016/j.bbrc.2007.07.180; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Radilova H, 2009, MOL CELL BIOCHEM, V330, P131, DOI 10.1007/s11010-009-0126-1; ROBERTSON R P, 1986, Diabetes Metabolism Reviews, V2, P261; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; ROBERTSON RP, 1974, J CLIN INVEST, V54, P310, DOI 10.1172/JCI107766; ROBERTSON RP, 1977, J CLIN INVEST, V60, P747, DOI 10.1172/JCI108827; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; ROSEN GD, 1989, BIOCHEM BIOPH RES CO, V164, P1358, DOI 10.1016/0006-291X(89)91819-6; SEAQUIST ER, 1989, DIABETES, V38, P1439, DOI 10.2337/diabetes.38.11.1439; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Sweeney FJ, 2003, MOL CELL ENDOCRINOL, V205, P151, DOI 10.1016/S0303-7207(03)00091-1; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zawalich WS, 2007, METABOLISM, V56, P12, DOI 10.1016/j.metabol.2006.08.016	45	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2012	287	38					32246	32253		10.1074/jbc.M112.364612	http://dx.doi.org/10.1074/jbc.M112.364612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	009XT	22822059	Green Published, hybrid			2022-12-28	WOS:000309059400061
J	Kim, MS; Froese, CD; Xie, H; Trimble, WS				Kim, Moshe S.; Froese, Carol D.; Xie, Hong; Trimble, William S.			Uncovering Principles That Control Septin-Septin Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING; FILAMENT FORMATION; MAMMALIAN SEPTINS; YEAST SEPTINS; CYTOSKELETON; CYTOKINESIS; POLARITY; POLYMERIZATION; MICROTUBULES; ORGANIZATION	Septins comprise a conserved family of GTPases important in cytokinesis. These proteins polymerize into filaments from rod-shaped heteromeric septin complexes. Septins interact with one another at two interfaces (NC and G) that alternate within the complex. Here, we show that small mutations at the N terminus greatly enhance the formation of SEPT2 homopolymers. Taking advantage of this mutation to examine polymer formation using SEPT2 alone, we show that both NC and G interfaces are required for filament formation. However, co-expression of wild type SEPT2 with SEPT2 containing mutations at either NC or G interfaces revealed that only the NC mutant suppressed filament formation. NC mutants are able to interact with one another at putative Ginterfaces, whereas G mutants fail to interact at NC interfaces. In addition, all promiscuous septin pair-wise interactions occur at the G interface. These findings suggest that G interface interactions must occur before NC interactions during polymer formation.	[Kim, Moshe S.; Froese, Carol D.; Xie, Hong; Trimble, William S.] Univ Toronto, Hosp Sick Children, Dept Biochem, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Trimble, WS (corresponding author), Univ Toronto, Hosp Sick Children, Dept Biochem, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca			Canadian Cancer Society; Canada Research Chair	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a Canadian Cancer Society grant (to W. S. T.).; Recipient of a Canada Research Chair. To whom correspondence should be addressed: Hospital for Sick Children, 555 University Ave., Toronto, ON M5G 1X8, Canada. Tel.: 416-813-6889; Fax: 416-813-5028; E-mail: wtrimble@sickkids.ca.	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Garcia W, 2008, BBA-PROTEINS PROTEOM, V1784, P1720, DOI 10.1016/j.bbapap.2008.06.005; Garcia W, 2007, BIOCHEMISTRY-US, V46, P11101, DOI 10.1021/bi700702w; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; John CM, 2007, EMBO J, V26, P3296, DOI 10.1038/sj.emboj.7601775; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042	42	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30406	30413		10.1074/jbc.M112.387464	http://dx.doi.org/10.1074/jbc.M112.387464			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22815479	hybrid, Green Published			2022-12-28	WOS:000308579800033
J	Macheda, ML; Sun, WW; Kugathasan, K; Hogan, BM; Bower, NI; Halford, MM; Zhang, YF; Jacques, BE; Lieschke, GJ; Dabdoub, A; Stacker, SA				Macheda, Maria L.; Sun, Willy W.; Kugathasan, Kumudhini; Hogan, Benjamin M.; Bower, Neil I.; Halford, Michael M.; Zhang, You Fang; Jacques, Bonnie E.; Lieschke, Graham J.; Dabdoub, Alain; Stacker, Steven A.			The Wnt Receptor Ryk Plays a Role in Mammalian Planar Cell Polarity Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION; AXON GUIDANCE; VANGL2; GROWTH; DIFFERENTIATION; SPECIFICATION; SILBERBLICK; MOVEMENTS; DEFECTS; RHOA	Wnts are essential for a wide range of developmental processes, including cell growth, division, and differentiation. Some of these processes signal via the planar cell polarity (PCP) pathway, which is a beta-catenin-independent Wnt signaling pathway. Previous studies have shown that Ryk, a member of the receptor tyrosine kinase family, can bind to Wnts. Ryk is required for normal axon guidance and neuronal differentiation during development. Here, we demonstrate that mammalian Ryk interacts with the Wnt/PCP pathway. In vitro analysis showed that the Wnt inhibitory factor domain of Ryk was necessary for Wnt binding. Detailed analysis of two vertebrate model organisms showed Ryk phenotypes consistent with PCP signaling. In zebrafish, gene knockdown using morpholinos revealed a genetic interaction between Ryk and Wnt11 during the PCP pathway-regulated process of embryo convergent extension. Ryk-deficient mouse embryos displayed disrupted polarity of stereociliary hair cells in the cochlea, a characteristic of disturbed PCP signaling. This PCP defect was also observed in mouse embryos that were double heterozygotes for Ryk and Looptail (containing a mutation in the core Wnt/PCP pathway gene Vangl2) but not in either of the single heterozygotes, suggesting a genetic interaction between Ryk and Vangl2. Co-immunoprecipitation studies demonstrated that RYK and VANGL2 proteins form a complex, whereas RYK also activated RhoA, a downstream effector of PCP signaling. Overall, our data suggest an important role for Ryk in Wnt/planar cell polarity signaling during vertebrate development via the Vangl2 signaling pathway, as demonstrated in the mouse cochlea.	[Macheda, Maria L.; Halford, Michael M.; Zhang, You Fang; Stacker, Steven A.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, Melbourne, Vic 3002, Australia; [Macheda, Maria L.; Kugathasan, Kumudhini; Hogan, Benjamin M.; Halford, Michael M.; Zhang, You Fang; Lieschke, Graham J.; Stacker, Steven A.] Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Sun, Willy W.; Jacques, Bonnie E.; Dabdoub, Alain] Univ Calif San Diego, Sch Med, Dept Surg, Div Otolaryngol, La Jolla, CA 92093 USA; [Hogan, Benjamin M.; Bower, Neil I.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Stacker, Steven A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia	Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Queensland; Peter Maccallum Cancer Center; University of Melbourne	Stacker, SA (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	steven.stacker@petermac.org	Hogan, Benjamin M/J-1807-2014; Hogan, Benjamin/AAD-7410-2022; Bower, Neil/K-1478-2014	Hogan, Benjamin M/0000-0002-0651-7065; Hogan, Benjamin/0000-0002-0651-7065; Lieschke, Graham/0000-0003-0325-798X; Dabdoub, Alain/0000-0002-4259-2425; /0000-0003-1282-9695; Stacker, Steven/0000-0003-4096-9273; Macheda, Maria/0000-0002-8460-2046; Bower, Neil/0000-0002-6764-6063	National Health and Medical Research Council of Australia; National Institutes of Health [R01DC011104]; Pfizer Australia; National Institutes of Health NS/NINDS HHS [P30-NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011104] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Australia(PfizerPfizer Australia); National Institutes of Health NS/NINDS HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by a program grant (to S. A. S.) from the National Health and Medical Research Council of Australia and Grant R01DC011104 (to A. D.) from the National Institutes of Health.; Supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia and a Pfizer Australia Fellowship. To whom correspondence should be addressed: Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., Melbourne, Victoria 8006, Australia. Tel.: 61-3-9656-5263; Fax: 61-3-9656-1411; E-mail: steven.stacker@petermac.org.; We thank R. Moon for the super TOP-FLASH and super FOP-FLASH plasmids; A. McMahon for the Wnt3a and Wnt11 plasmids; R. Habas for the pGEX-RBD plasmid; Y. Zou for the anti-Ryk antibodies; S. Jane for providing the Vangl2<SUP>Lp</SUP> mice; A. Naughton and staff at the Biological Resource Facility at the Ludwig Institute for Cancer Research, Melbourne, Australia, for assistance with mouse experiments; S. Cody for assistance with imaging; S. Paquet-Fifield for assistance with photography; and M. Achen for critical reading of the manuscript. Fluorescent images were generated at the University of California, San Diego, Neuroscience Microscopy Shared Facility supported by National Institutes of Health NS/NINDS HHS Grant P30-NS047101.	Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Kamitori K, 2005, BIOCHEM BIOPH RES CO, V330, P446, DOI 10.1016/j.bbrc.2005.02.177; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Lindqvist M, 2010, J CELL SCI, V123, P472, DOI 10.1242/jcs.048074; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Reynolds A, 2010, MECH DEVELOP, V127, P385, DOI 10.1016/j.mod.2009.12.002; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; STACKER SA, 1993, ONCOGENE, V8, P1347; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Tada M, 2000, DEVELOPMENT, V127, P2227; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu G, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-66; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Zhong JY, 2011, DEVELOPMENT, V138, P409, DOI 10.1242/dev.061051	44	71	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29312	29323		10.1074/jbc.M112.362681	http://dx.doi.org/10.1074/jbc.M112.362681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773843	Green Published, hybrid			2022-12-28	WOS:000308286900011
J	McCallum, M; Shaw, SD; Shaw, GS; Creuzenet, C				McCallum, Matthew; Shaw, Steven D.; Shaw, Gary S.; Creuzenet, Carole			Complete 6-Deoxy-D-altro-heptose Biosynthesis Pathway from Campylobacter jejuni MORE COMPLEX THAN ANTICIPATED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-L-FUCOSE; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; ACTIVE-SITE; YERSINIA-PSEUDOTUBERCULOSIS; 6-DEOXYHEXOSE SYNTHESIS; PROTEIN GLYCOSYLATION; HELICOBACTER-PYLORI; LIPOOLIGOSACCHARIDE; RESISTANCE	The Campylobacter jejuni capsule is important for colonization and virulence in various infection models. In most strains, the capsule includes a modified heptose whose biological role and biosynthetic pathway are unknown. To decipher the biosynthesis pathway for the 6-deoxy-D-altro-heptose of strain 81-176, we previously showed that the 4,6-dehydratase WcbK and the reductase WcaG generated GDP-6-deoxy-D-manno-heptose, but the C3 epimerase necessary to form GDP-6-deoxy-D-altro-heptose was not identified. Herein, we characterized the putative C3/C5 epimerase Cjj1430 and C3/C5 epimerase/C4 reductase Cjj1427 from the capsular cluster. We demonstrate that GDP-6-deoxy-D-altro-heptose biosynthesis is more complex than anticipated and requires the sequential action of WcbK, Cjj1430, and Cjj1427. We show that Cjj1430 serves as C3 epimerase devoid of C5 epimerization activity and that Cjj1427 has no epimerization activity and only serves as a reductase to produce GDP-6-deoxy-D-altro-heptose. Cjj1430 and Cjj1427 are the only members of the C3/C5 epimerases and C3/C5 epimerase/C4 reductase families shown to have activity on a heptose substrate and to exhibit only one of their two to three potential activities, respectively. Furthermore, we show that although the reductase WcaG is not part of the main pathway, its presence and its product affect the outcome of the pathway in a complex regulatory loop involving Cjj1427. This work provides the grounds for the elucidation of similar pathways found in other C. jejuni strains and other pathogens. It provides new molecular tools for the synthesis of carbohydrate antigens useful for vaccination and for the screening of enzymatic inhibitors that may have antibacterial effects.	[McCallum, Matthew; Shaw, Steven D.; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON N6A 5C1, Canada; [Shaw, Steven D.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Creuzenet, C (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, DSB 3031, London, ON N6A 5C1, Canada.	ccreuzen@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Natural Sciences and Engineering Research Council of Canada [RGPIN 240762-2010]; Canadian Institutes of Health Research [MOP 93520]; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by Natural Sciences and Engineering Research Council of Canada Operating Grant RGPIN 240762-2010 (to C. C.) and Canadian Institutes of Health Research Grant MOP 93520 and the Canada Research Chairs Program (to G. S. S.).	ASPINALL GO, 1995, EUR J BIOCHEM, V231, P570, DOI 10.1111/j.1432-1033.1995.0570d.x; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Aspinall GO, 1995, CARBOHYD RES, V279, P227, DOI 10.1016/0008-6215(95)00283-9; Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; GABRIEL O, 1968, J BIOL CHEM, V243, P1479; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Hegeman AD, 2002, BIOCHEMISTRY-US, V41, P2797, DOI 10.1021/bi011748c; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Ito S, 2009, APPL MICROBIOL BIOT, V84, P1053, DOI 10.1007/s00253-009-2179-1; Jarvinen N, 2001, EUR J BIOCHEM, V268, P6458, DOI 10.1046/j.0014-2956.2001.02601.x; JOHN BK, 1993, J MAGN RESON SER A, V101, P113, DOI 10.1006/jmra.1993.1019; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keo T, 2011, VIRULENCE, V2, P30, DOI 10.4161/viru.2.1.14752; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; Kondakova AN, 2008, CARBOHYD RES, V343, P1383, DOI 10.1016/j.carres.2008.04.003; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Lin J, 2007, ANTIMICROB AGENTS CH, V51, P1678, DOI 10.1128/AAC.01411-06; Lindow JC, 2010, J CLIN MICROBIOL, V48, P3012, DOI 10.1128/JCM.00768-10; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; MELO A, 1968, J BIOL CHEM, V243, P1475; MELO A, 1968, J BIOL CHEM, V243, P1467; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Peng WJ, 2011, ORG LETT, V13, P5290, DOI 10.1021/ol202152r; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rizzi M, 1998, STRUCTURE, V6, P1453, DOI 10.1016/S0969-2126(98)00144-0; Shashkov AS, 2001, CARBOHYD RES, V330, P289, DOI 10.1016/S0008-6215(00)00309-8; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; XIANG SH, 1993, J BACTERIOL, V175, P4877, DOI 10.1128/JB.175.15.4877-4884.1993; YAO ZJ, 1994, J BACTERIOL, V176, P4133, DOI 10.1128/JB.176.13.4133-4143.1994; Zhao S, 2010, APPL ENVIRON MICROB, V76, P7949, DOI 10.1128/AEM.01297-10	53	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29776	29788		10.1074/jbc.M112.390492	http://dx.doi.org/10.1074/jbc.M112.390492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22787156	hybrid, Green Published			2022-12-28	WOS:000308286900053
J	Liu, YJ; Peng, LR; Seto, E; Huang, SM; Qiu, Y				Liu, Yuanjing; Peng, Lirong; Seto, Edward; Huang, Suming; Qiu, Yi			Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 CATALYTIC DOMAINS; NONHISTONE PROTEINS; RECEPTOR; YEAST; TRANSCRIPTION; COMPONENTS; INTERACTS; COMPLEX; FAMILY; CANCER	The reversible acetylation of histones and non-histone proteins by histone acetyltransferases and deacetylases (HDACs) plays a critical role in many cellular processes in eukaryotic cells. HDAC6 is a unique histone deacetylase with two deacetylase domains and a C-terminal zinc finger domain. HDAC6 resides mainly in the cytoplasm and regulates many important biological processes, including cell migration and degradation of misfold proteins. HDAC6 has also been shown to localize in the nucleus to regulate transcription. However, how HDAC6 shuttles between the nucleus and cytoplasm is largely unknown. In addition, it is not clear how HDAC6 enzymatic activity is modulated. Here, we show that HDAC6 can be acetylated by p300 on five clusters of lysine residues. One cluster (site B) of acetylated lysine is in the N-terminal nuclear localization signal region. These lysine residues in site B were converted to glutamine to mimic acetylated lysines. The mutations significantly reduced HDAC6 tubulin deacetylase activity and further impaired cell motility, but had no effect on histone deacetylase activity. More interestingly, these mutations retained HDAC6 in the cytoplasm by blocking the interaction with the nuclear import protein importin-alpha. The retention of HDAC6 in the cytoplasm by acetylation eventually affects histone deacetylation. Thus, we conclude that acetylation is an important post-translational modification that regulates HDAC6 tubulin deacetylase activity and nuclear import.	[Liu, Yuanjing; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Coll Med, Gainesville, FL 32610 USA; [Peng, Lirong; Seto, Edward] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute	Qiu, Y (corresponding author), Univ Florida, Dept Anat & Cell Biol, Coll Med, Rm 356,2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, 5R01 GM081650, R01 HL091929, R01091929-01A1S1, R01 HL090589]; Florida Bankhead Coley Research Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090589, R01HL095674, R01HL091929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL095674 (to Y. Q.); Grant 5R01 GM081650 (to E. S.); and Grants R01 HL091929, R01091929-01A1S1 (ARRA Administrative Supplement), and R01 HL090589 (to S. H.). This work was also supported by the Florida Bankhead Coley Research Foundation (to Y. Q.).	Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han Y, 2009, BIOCHEM BIOPH RES CO, V383, P88, DOI 10.1016/j.bbrc.2009.03.147; Han Y, 2008, BIOCHEM BIOPH RES CO, V375, P576, DOI 10.1016/j.bbrc.2008.08.042; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	30	87	91	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29168	29174		10.1074/jbc.M112.371120	http://dx.doi.org/10.1074/jbc.M112.371120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22778253	hybrid, Green Published			2022-12-28	WOS:000308074600082
J	Maruyama, K; Kawagoe, T; Kondo, T; Akira, S; Takeuchi, O				Maruyama, Kenta; Kawagoe, Tatsukata; Kondo, Takeshi; Akira, Shizuo; Takeuchi, Osamu			TRAF Family Member-associated NF-kappa B Activator (TANK) Is a Negative Regulator of Osteoclastogenesis and Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE INTERLEUKIN-1; DC-STAMP; C-FOS; DIFFERENTIATION; KINASE; MICE; OSTEOPETROSIS; PROTEIN; RANKL; RECOGNITION	The differentiation of bone-resorbing osteoclasts is induced by RANKL signaling, and leads to the activation of NF-kappa B via TRAF6 activation. TRAF family member-associated NF-kappa B activator (TANK) acts as a negative regulator of Toll-like receptors (TLRs) and B-cell receptor (BCR) signaling by inhibiting TRAF6 activation. Tank(-/-) mice spontaneously develop autoimmune glomerular nephritis in an IL-6-dependent manner. Despite its importance in the TCRs and BCR-activated TRAF6 inhibition, the involvement of TANK in RANKL signaling is poorly understood. Here, we report that TANK is a negative regulator of osteoclast differentiation. The expression levels of TANK mRNA and protein were up-regulated during RANKL-induced osteoclastogenesis, and overexpression of TANK in vitro led to a decrease in osteoclast formation. The in vitro osteoclastogenesis of Tank(-/-) cells was significantly increased, accompanied by increased ubiquitination of TRAF6 and enhanced canonical NF-kappa B activation in response to RANKL stimulation. Tank(-/-) mice showed severe trabecular bone loss, but increased cortical bone mineral density, because of enhanced bone erosion and formation. TANK mRNA expression was induced during osteoblast differentiation and Tank(-/-) osteoblasts exhibited enhaced NF-kappa B activation, IL-11 expression, and bone nodule formation than wild-type control cells. Finally, wild-type mice transplanted with bone marrow cells from Tank(-/-) mice showed trabecular bone loss analogous to that in Tank(-/-) mice. These findings demonstrate that TANK is critical for osteoclastogenesis by regulating NF-kappa B, and is also important for proper bone remodeling.	[Maruyama, Kenta; Kawagoe, Tatsukata; Kondo, Takeshi; Akira, Shizuo; Takeuchi, Osamu] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Kondo, Takeshi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; Kyoto University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp; otake@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; KONDO, Takeshi/AGV-4963-2022; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare in Japan; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22689016] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science, and Technology, grants from the Ministry of Health, Labour, and Welfare in Japan, the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), and a research fellowship from the JSPS for the Promotion of Science for Young Scientists.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almerigogna F, 2002, J EUR ACAD DERMATOL, V16, P214, DOI 10.1046/j.1468-3083.2002.00458.x; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chin AID, 1999, MOL CELL BIOL, V19, P6665; de Koning HD, 2007, SEMIN ARTHRITIS RHEU, V37, P137, DOI 10.1016/j.semarthrit.2007.04.001; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li HM, 2005, J EXP MED, V201, P1169, DOI 10.1084/jem.20041444; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200	33	33	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29114	29124		10.1074/jbc.M112.347799	http://dx.doi.org/10.1074/jbc.M112.347799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22773835	hybrid, Green Published			2022-12-28	WOS:000308074600077
J	Zhang, J; Hu, MM; Wang, YY; Shu, HB				Zhang, Jing; Hu, Ming-Ming; Wang, Yan-Yi; Shu, Hong-Bing			TRIM32 Protein Modulates Type I Interferon Induction and Cellular Antiviral Response by Targeting MITA/STING Protein for K63-linked Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE SENSOR; DYSTROPHY TYPE 2H; CYCLIC-DI-GMP; INTRACELLULAR DNA; DENDRITIC CELLS; CYTOSOLIC DNA; IFN-BETA; ADAPTER; TRANSCRIPTION; ACTIVATION	Viral infection activates several transcription factors including NF-kappa B and IRF3, which collaborate to induce type I interferons (IFNs) and innate antiviral response. MITA (also called STING) is a critical adaptor protein that links virus-sensing receptors to IRF3 activation upon infection by both RNA and DNA pathogens. Here we show that the E3 ubiquitin ligase tripartite motif protein 32 (TRIM32) ubiquitinated MITA and dramatically enhanced MITA-mediated induction of IFN-beta. Overexpression of TRIM32 potentiated virus-triggered IFNB1 expression and cellular antiviral response. Consistently, knockdown of TRIM32 had opposite effects. TRIM32 interacted with MITA, and was located at the mitochondria and endoplasmic reticulum. TRIM32 targeted MITA for K63-linked ubiquitination at K20/150/224/236 through its E3 ubiquitin ligase activity, which promoted the interaction of MITA with TBK1. These findings suggest that TRIM32 is an important regulatory protein for innate immunity against both RNA and DNA viruses by targeting MITA for K63-linked ubiquitination and downstream activation.	[Zhang, Jing; Hu, Ming-Ming; Wang, Yan-Yi; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			National Science Foundation of China [31130020, 30921001]; Chinese Ministry of Science and Technology [2012CB910201, 2010DFA31100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Grants from the National Science Foundation of China (31130020, 30921001), and the Chinese Ministry of Science and Technology (2012CB910201, 2010DFA31100).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sato T, 2011, J CELL SCI, V124, P3492, DOI 10.1242/jcs.088799; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	33	248	264	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28646	28655		10.1074/jbc.M112.362608	http://dx.doi.org/10.1074/jbc.M112.362608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22745133	Green Published, hybrid			2022-12-28	WOS:000308074600038
J	Ceholski, DK; Trieber, CA; Holmes, CFB; Young, HS				Ceholski, Delaine K.; Trieber, Catharine A.; Holmes, Charles F. B.; Young, Howard S.			Lethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY; HEART-FAILURE; CYTOPLASMIC DOMAIN; CONTRACTILE FUNCTION; CARDIAC-FUNCTION; CA2+-ATPASE; MUTATION; EXPRESSION; GENE	The sarcoplasmic reticulum calcium pump (SERCA) and its regulator, phospholamban, are essential components of cardiac contractility. Phospholamban modulates contractility by inhibiting SERCA, and this process is dynamically regulated by beta-adrenergic stimulation and phosphorylation of phospholamban. Herein we reveal mechanistic insight into how four hereditary mutants of phospholamban, Arg(9) to Cys, Arg(9) to Leu, Arg(9) to His, and Arg(14) deletion, alter regulation of SERCA. Deletion of Arg(14) disrupts the protein kinase A recognition motif, which abrogates phospholamban phosphorylation and results in constitutive SERCA inhibition. Mutation of Arg(9) causes more complex changes in function, where hydrophobic substitutions such as cysteine and leucine eliminate both SERCA inhibition and phospholamban phosphorylation, whereas an aromatic substitution such as histidine selectively disrupts phosphorylation. We demonstrate that the role of Arg(9) in phospholamban function is multifaceted: it is important for inhibition of SERCA, it increases the efficiency of phosphorylation, and it is critical for protein kinase A recognition in the context of the phospholamban pentamer. Given the synergistic consequences on contractility, it is not surprising that the mutants cause lethal, hereditary dilated cardiomyopathy.	[Ceholski, Delaine K.; Trieber, Catharine A.; Holmes, Charles F. B.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, 327 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Canadian Institutes of Health Research Grant [MOP53306]; Canadian Institutes of Health Research; Alberta Innovates Technology Futures	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures	This work was supported by Canadian Institutes of Health Research Grant MOP53306.; Supported by Canadian Institutes of Health Research and Alberta Innovates Technology Futures.	Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Frank KF, 2002, BASIC RES CARDIOL S1, V97, pI72, DOI DOI 10.1007/S003950200033; FUJII J, 1989, J BIOL CHEM, V264, P12950; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Kass DA, 1998, CIRC RES, V82, P519, DOI 10.1161/01.RES.82.4.519; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; LI CF, 1990, BIOCHEMISTRY-US, V29, P4535, DOI 10.1021/bi00471a005; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; MORGAN JP, 1991, NEW ENGL J MED, V325, P625; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tada M, 1976, Recent Adv Stud Cardiac Struct Metab, V9, P225; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Young HS, 1998, ANN NY ACAD SCI, V853, P103, DOI 10.1111/j.1749-6632.1998.tb08260.x; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	50	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26596	26605		10.1074/jbc.M112.382713	http://dx.doi.org/10.1074/jbc.M112.382713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707725	Green Published, hybrid			2022-12-28	WOS:000307386000012
J	DeVore, NM; Scott, EE				DeVore, Natasha M.; Scott, Emily E.			Nicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Binding and Access Channel in Human Cytochrome P450 2A6 and 2A13 Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO-SPECIFIC CARCINOGEN; AMINO-ACID-RESIDUES; METABOLIC-ACTIVATION; CYP2A13; LUNG; COUMARIN; SITE; 2E1; IDENTIFICATION; DIFFERENCE	Cytochromes P450 (CYP) from the 2A subfamily are known for their roles in the metabolism of nicotine, the addictive agent in tobacco, and activation of the tobacco procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Although both the hepatic CYP2A6 and respiratory CYP2A13 enzymes metabolize these compounds, CYP2A13 does so with much higher catalytic efficiency, but the structural basis for this has been unclear. X-ray structures of nicotine complexes with CYP2A13 (2.5 angstrom) and CYP2A6 (2.3 angstrom) yield a structural rationale for the preferential binding of nicotine to CYP2A13. Additional structures of CYP2A13 with NNK reveal either a single NNK molecule in the active site with orientations corresponding to metabolites known to form DNA adducts and initiate lung cancer (2.35 angstrom) or with two molecules of NNK bound (2.1 angstrom): one in the active site and one in a more distal staging site. Finally, in contrast to prior CYP2A structures with enclosed active sites, CYP2A13 conformations were solved that adopt both open and intermediate conformations resulting from an similar to 2.5 angstrom movement of the F to G helices. This channel occurs in the same region where the second, distal NNK molecule is bound, suggesting that the channel may be used for ligand entry and/or exit from the active site. Altogether these structures provide multiple new snapshots of CYP2A13 conformations that assist in understanding the binding and activation of an important human carcinogen, as well as critical comparisons in the binding of nicotine, one of the most widely used and highly addictive drugs in human use.	[DeVore, Natasha M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		DeVore, Natasha/0000-0003-0772-8929	National Institutes of Health Grant [GM076343]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P20GM103420, R37GM076343, R01GM076343] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076343.; Thanks are due to Linda Blake who made the CYP2A6 V117A/I208S/I300F/G301A/S369G mutant and protein. Crystals were grown using the facilities of the Protein Structure Laboratory core facility at The University of Kansas (National Institutes of Health RR017708 and GM103420). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209).	American Cancer Society, 2011, CANC FACTS FIGURES; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao ZP, 2005, DRUG METAB DISPOS, V33, P258, DOI 10.1124/dmd.104.002105; Centers for Disease Control and Prevention, 2011, MORBIDITY MORTALITY, V61, P38; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; DeVore NM, 2012, FEBS J, V279, P1621, DOI 10.1111/j.1742-4658.2011.08412.x; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; He XY, 2006, INT J CANCER, V118, P2665, DOI 10.1002/ijc.21665; He XY, 2004, DRUG METAB DISPOS, V32, P1516, DOI 10.1124/dmd.104.001370; He XY, 2004, ARCH BIOCHEM BIOPHYS, V427, P143, DOI 10.1016/j.abb.2004.03.016; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Jalas JR, 2003, DRUG METAB DISPOS, V31, P1199, DOI 10.1124/dmd.31.10.1199; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G., 1998, MOSFLM 6 0; Malaiyandi V, 2005, CLIN PHARMACOL THER, V77, P145, DOI 10.1016/j.clpt.2004.10.011; Murphy SE, 2005, DRUG METAB DISPOS, V33, P1166, DOI 10.1124/dmd.105.004549; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Schlicht KE, 2007, XENOBIOTICA, V37, P1439, DOI 10.1080/00498250701666265; Schlicht KE, 2009, DRUG METAB DISPOS, V37, P665, DOI 10.1124/dmd.108.025072; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Smith BD, 2007, J BIOL CHEM, V282, P17306, DOI 10.1074/jbc.M702361200; Stephens E. S., 2012, DRUG METAB IN PRESS; Su T, 2000, CANCER RES, V60, P5074; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; von Weymarn LB, 2006, J PHARMACOL EXP THER, V316, P295, DOI 10.1124/jpet.105.091306; Wang HJ, 2003, CANCER RES, V63, P8057; Weng Y, 2007, CANCER RES, V67, P7825, DOI 10.1158/0008-5472.CAN-07-1006; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Xu Y, 2011, J MOL GRAPH MODEL, V30, P1, DOI 10.1016/j.jmgm.2011.05.002; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	44	61	62	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26576	26585		10.1074/jbc.M112.372813	http://dx.doi.org/10.1074/jbc.M112.372813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700965	hybrid, Green Published			2022-12-28	WOS:000307386000010
J	Koeberle, A; Shindou, H; Harayama, T; Shimizu, T				Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Shimizu, Takao			Palmitoleate Is a Mitogen, Formed upon Stimulation with Growth Factors, and Converted to Palmitoleoyl-phosphatidylinositol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA DESATURASE ACTIVITY; PANCREATIC BETA-CELLS; FATTY-ACIDS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PALMITATE; GLUCOSE; OBESITY; HUMANS; INDUCE	Controversial correlations between biological activity and concentration of the novel lipokine palmitoleate (9Z-hexadecenoate, 16:1) might depend on the formation of an active 16:1 metabolite. For its identification, we analyzed the glycerophospholipid composition of mouse Swiss 3T3 fibroblasts in response to 16:1 using LC-MS/MS. 16:1 was either supplemented to the cell culture medium or endogenously formed when cells were stimulated with insulin or growth factors as suggested by the enhanced mRNA expression of 16:1-biosynthetic enzymes. The proportion of 1-acyl-2-16:1-sn-phosphatidylinositol (16:1-PI) was time-dependently and specifically increased relative to other glycerophospholipids under both conditions and correlated with the proliferation of fatty acid (16:1, palmitate, oleate, or arachidonate)-supplemented cells. Accordingly, cell proliferation was impaired by blocking 16:1 biosynthesis using the selective stearoyl-CoA desaturase-1 inhibitor CAY10566 and restored by supplementation of 16:1. The accumulation of 16:1-PI occurred throughout cellular compartments and within diverse mouse cell lines (Swiss 3T3, NIH-3T3, and 3T3-L1 cells). To elucidate further whether 16:1-PI is formed through the de novo or remodeling pathway of PI biosynthesis, phosphatidate levels and lyso-PI-acyltransferase activities were analyzed as respective markers. The proportion of 16:1-phosphatidate was significantly increased by insulin and growth factors, whereas lyso-PI-acyltransferases showed negligible activity for 16:1-coenzyme A. The relevance of the de novo pathway for 16:1-PI biosynthesis is supported further by the comparable incorporation rate of deuterium-labeled 16:1 and tritium-labeled inositol into PI for growth factor-stimulated cells. In conclusion, we identified 16:1 or 16:1-PI as mitogen whose biosynthesis is induced by growth factors.	[Koeberle, Andreas; Shindou, Hideo; Harayama, Takeshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Harayama, Takeshi/AAD-8852-2022; Koeberle, Andreas/ABB-2356-2020; Shimizu, Takao/AAV-7052-2021	Harayama, Takeshi/0000-0003-2255-4197; Koeberle, Andreas/0000-0001-6269-5088; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences; Takeda Science Foundation; Center for NanoBio Integration at The University of Tokyo; Ministry of Health, and Labour; MEXT of Japan; Uehara Memorial Foundation; Cell Science Research Foundation; Gushinkai Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences; Takeda Science Foundation(Takeda Science Foundation (TSF)); Center for NanoBio Integration at The University of Tokyo; Ministry of Health, and Labour; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Gushinkai Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. S.) and a Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences (to T.S).; Recipient of a research fellowship from the Takeda Science Foundation.; Supported by the Center for NanoBio Integration at The University of Tokyo.; Supported by Health and Labour Sciences Research grants (Research on Allergic Disease and Immunology) of the Ministry of Health, and Labour and grant-in-aid for Young Scientists (B) from the MEXT of Japan and The Uehara Memorial Foundation, The Cell Science Research Foundation, and Gushinkai Foundation.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502; GROVE RI, 1983, BIOCHEM BIOPH RES CO, V110, P200, DOI 10.1016/0006-291X(83)91280-9; Hvattum E, 1998, RAPID COMMUN MASS SP, V12, P1405, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1405::AID-RCM338>3.0.CO;2-B; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Kotani A, 2000, ANAL BIOCHEM, V284, P65, DOI 10.1006/abio.2000.4682; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Ogiso H, 2008, ANAL BIOCHEM, V375, P124, DOI 10.1016/j.ab.2007.12.027; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pettitt TR, 1998, FEBS LETT, V427, P371, DOI 10.1016/S0014-5793(98)00471-2; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Welters HJ, 2006, APOPTOSIS, V11, P1231, DOI 10.1007/s10495-006-7450-7; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wong RHF, 2010, CURR OPIN PHARMACOL, V10, P684, DOI 10.1016/j.coph.2010.08.004; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	32	29	30	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27244	27254		10.1074/jbc.M111.274829	http://dx.doi.org/10.1074/jbc.M111.274829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700983	Green Published, hybrid			2022-12-28	WOS:000307386000076
J	Lehrer, RI; Cole, AM; Selsted, ME				Lehrer, Robert I.; Cole, Alex M.; Selsted, Michael E.			theta-Defensins: Cyclic Peptides with Endless Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ANTIMICROBIAL PEPTIDES; RETROCYCLIN RC-101; ALPHA-DEFENSINS; BETA; INHIBIT; VIRUS; DISCOVERY; INFECTION; FUSION; RTD-1	theta-Defensins, the only cyclic peptides of animal origin, have been isolated from the leukocytes of rhesus macaques and baboons. Their biogenesis is unusual because each peptide is an 18-residue chimera formed by the head-to-tail splicing of nonapeptides derived from two separate precursors. theta-Defensins have multiple arginines and a ladder-like tridisulfide array spanning their two antiparallel beta-strands. Human theta-defensin genes contain a premature stop codon that prevents effective translation of the needed precursors; consequently, these peptides are not present in human leukocytes. Synthetic theta-defensins with sequences that correspond to those encoded within the human pseudogenes are called retrocyclins. Retrocyclin-1 inhibits the cellular entry of HIV-1, HSV, and influenza A virus. The rhesus theta-defensin RTD-1 protects mice from an experimental severe acute respiratory syndrome coronavirus infection, and retrocyclin- 1 protects mice from infection by Bacillus anthracis spores. The small size, unique structure, and multiple host defense activities of theta-defensins make them intriguing potential therapeutic agents.	[Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Cole, Alex M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32827 USA; [Selsted, Michael E.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Central Florida; University of Southern California	Lehrer, RI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	rlehrer@mednet.ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021341] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI022931] Funding Source: Medline; NIDCR NIH HHS [R01 DE021341] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aboye TL, 2012, BIOORG MED CHEM LETT, V22, P2823, DOI 10.1016/j.bmcl.2012.02.080; Abuja PM, 2004, FEBS LETT, V566, P301, DOI 10.1016/j.febslet.2004.03.112; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Giles FJ, 2004, LEUKEMIA RES, V28, P559, DOI 10.1016/j.leukres.2003.10.021; Gould A, 2012, MOL BIOSYST, V8, P1359, DOI 10.1039/c2mb05451e; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Kim C, 2006, TRENDS MICROBIOL, V14, P428, DOI 10.1016/j.tim.2006.08.001; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461; Liang QL, 2010, BIOTECHNOL LETT, V32, P387, DOI 10.1007/s10529-009-0167-2; Lynn DJ, 2007, DEV COMP IMMUNOL, V31, P963, DOI 10.1016/j.dci.2007.01.007; MIYATA T, 1989, J BIOCHEM, V106, P663, DOI 10.1093/oxfordjournals.jbchem.a122913; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; NAKASHIMA H, 1992, ANTIMICROB AGENTS CH, V36, P1249, DOI 10.1128/AAC.36.6.1249; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Sassi AB, 2011, ANTIMICROB AGENTS CH, V55, P2282, DOI 10.1128/AAC.01190-10; Sassi AB, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-27; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Tam JP, 2000, EUR J BIOCHEM, V267, P3289, DOI 10.1046/j.1432-1327.2000.01359.x; Tang M, 2006, BIOPHYS J, V90, P3616, DOI 10.1529/biophysj.105.062075; TANG YQ, 1993, J BIOL CHEM, V268, P6649; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tran D, 2008, ANTIMICROB AGENTS CH, V52, P944, DOI 10.1128/AAC.01090-07; Venkataraman N, 2009, PLOS BIOL, V7, P720, DOI 10.1371/journal.pbio.1000095; Wang W, 2006, J BIOL CHEM, V281, P32755, DOI 10.1074/jbc.M603614200; Welkos S, 2011, ANTIMICROB AGENTS CH, V55, P4238, DOI 10.1128/AAC.00267-11; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004; Zhao CQ, 2001, ANTIMICROB AGENTS CH, V45, P2695, DOI 10.1128/AAC.45.10.2695-2702.2001; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354	51	109	114	0	46	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27014	27019		10.1074/jbc.R112.346098	http://dx.doi.org/10.1074/jbc.R112.346098			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700960	Green Published, hybrid			2022-12-28	WOS:000307386000050
J	Matsumura, H; Kusaka, N; Nakamura, T; Tanaka, N; Sagegami, K; Uegaki, K; Inoue, T; Mukai, Y				Matsumura, Hiroyoshi; Kusaka, Nanoha; Nakamura, Taichi; Tanaka, Naoko; Sagegami, Keita; Uegaki, Koichi; Inoue, Tsuyoshi; Mukai, Yukio			Crystal Structure of the N-terminal Domain of the Yeast General Corepressor Tup1p and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; WD-REPEATS; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; PROTEIN-KINASE; HOMEO DOMAIN; COILED-COILS; BETA-SUBUNIT; COMPLEX; SSN6-TUP1	The yeast Cyc8p-Tup1p protein complex is a general transcriptional corepressor of genes involved in many different physiological processes. Herein, we present the crystal structure of the Tup1p N-terminal domain (residues 1-92), essential for Tup1p self-assembly and interaction with Cyc8p. This domain tetramerizes to form a novel antiparallel four-helix bundle. Coiled coil interactions near the helical ends hold each dimer together, whereas interdimeric association involves only two sets of two residues located toward the chain centers. A mutagenesis study confirmed that the nonpolar residues responsible for the association of the protomers as dimers are also required for transcriptional repression. An additional structural study demonstrated that the domain containing an Leu(62) -> Arg mutation that had been shown not to bind Cyc8p exhibits an altered structure, distinct from the wild type. This altered structure explains why the mutant cannot bind Cyc8p. The data presented herein highlight the importance of the architecture of the Tup1p N-terminal domain for self-association.	[Matsumura, Hiroyoshi; Nakamura, Taichi; Inoue, Tsuyoshi] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kusaka, Nanoha; Tanaka, Naoko; Sagegami, Keita; Mukai, Yukio] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Uegaki, Koichi] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Matsumura, H (corresponding author), Osaka Univ, Dept Appl Chem, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	matsumura@chem.eng.osaka-u.ac.jp		Mukai, Yukio/0000-0003-1265-0839; Matsumura, Hiroyoshi/0000-0003-0361-3796	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23121519, 2357104, 22550152, 17570093]; Science and Technology Incubation Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Incubation Program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by Grants-in-Aid for Scientific Research 23121519 and 2357104 (to H. M.), 22550152 (to T. I.), and 17570093 (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; in part by the Science and Technology Incubation Program from the Japan Science and Technology Agency (to H.M.); and in part by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy (to T. I.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amberg DC., 2005, METHODS YEAST GENETI; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrico PM, 1998, GENETICS, V148, P637; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; CLORE GM, 1995, SCIENCE, V267, P1515, DOI 10.1126/science.7878474; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jabet C, 2000, J BIOL CHEM, V275, P9011, DOI 10.1074/jbc.275.12.9011; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KOMACHI K, 1994, GENE DEV, V8, P2857, DOI 10.1101/gad.8.23.2857; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Marquez JA, 1998, EMBO J, V17, P2543, DOI 10.1093/emboj/17.9.2543; Matsumura H, 2011, J SYNCHROTRON RADIAT, V18, P16, DOI 10.1107/S090904951003445X; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; MUKAI Y, 1991, MOL CELL BIOL, V11, P3773, DOI 10.1128/MCB.11.7.3773; Mukai Y, 2003, J BIOL CHEM, V278, P18895, DOI 10.1074/jbc.M302155200; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; NOLL M, 1980, NUCLEIC ACIDS RES, V8, P21, DOI 10.1093/nar/8.1.21; Nooren IMA, 1999, NAT STRUCT BIOL, V6, P755; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SH, 1999, MOL CELL BIOL, V19, P2044; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Sambrook J., 2001, MOL CLONING LAB MANU; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SCHULTZ J, 1987, MOL CELL BIOL, V7, P3637, DOI 10.1128/MCB.7.10.3637; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; TOHE A, 1974, J BACTERIOL, V120, P608, DOI 10.1128/JB.120.2.608-617.1974; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V308, P75, DOI 10.1016/0014-5793(92)81054-P; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; WILLIAMS FE, 1990, MOL CELL BIOL, V10, P6500, DOI 10.1128/MCB.10.12.6500; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zaman Z, 2001, P NATL ACAD SCI USA, V98, P2550, DOI 10.1073/pnas.041611198; Zhao H, 1999, CELL RES, V9, P255, DOI 10.1038/sj.cr.7290024; ZHOU Z, 1992, GENETICS, V131, P851; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	83	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26528	26538		10.1074/jbc.M112.369652	http://dx.doi.org/10.1074/jbc.M112.369652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707714	hybrid, Green Published			2022-12-28	WOS:000307386000006
J	Shapira, KE; Gross, A; Ehrlich, M; Henis, YI				Shapira, Keren E.; Gross, Avner; Ehrlich, Marcelo; Henis, Yoav I.			Coated Pit-mediated Endocytosis of the Type I Transforming Growth Factor-beta (TGF-beta) Receptor Depends on a Di-leucine Family Signal and Is Not Required for Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; CYTOPLASMIC DOMAIN; DIRECT BINDING; SMAD; INTERNALIZATION; SPECIFICITY; ACTIVATION; INHIBITOR; ENDOSOMES; RESPONSES	The roles of transforming growth factor-beta (TGF-beta) receptor endocytosis in signaling have been investigated in numerous studies, mainly through the use of endocytosis inhibitory treatments, yielding conflicting results. Two potential sources for these discrepancies were the pleiotropic effects of a general blockade of specific internalization pathways and the scarce information on the regulation of the endocytosis of the signal-transducing type I TGF-beta receptor (T beta RI). Here, we employed extracellularly tagged myc-T beta RI (wild type, truncation mutants, and a series of endocytosis-defective and endocytosis-enhanced mutants) to directly investigate the relationship between T beta RI endocytosis and signaling. Our findings indicate that T beta RI is targeted for constitutive clathrin-mediated endocytosis via a di-leucine (Leu(180)-Ile(181)) signal and an acidic cluster motif. Using Smad-dependent transcriptional activation assays and following Smad2/3 nuclear translocation in response to TGF-beta stimulation, we show that T beta RI endocytosis is dispensable for TGF-beta signaling and may play a role in signal termination. Alanine replacement of Leu(180)-Ile(181) led to partial constitutive activation of T beta RI, resulting in part from its retention at the plasma membrane and in part from potential alterations of T beta RI regulatory interactions in the vicinity of the mutated residues.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Shapira, Keren E.; Gross, Avner; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il; henis@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808; Henis, Yoav/0000-0002-1408-3877	Israel Science Foundation [158/09, 1592/11]; Israel Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund	This work was supported in part by Israel Science Foundation Grants 158/09 (to Y. I. H.) and 1592/11 (to M. E.) and the Israel Cancer Research Fund (to Y. I. H.).	Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chetrit D, 2011, J BIOL CHEM, V286, P5392, DOI 10.1074/jbc.M110.161851; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck Rik, 2008, P29; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Dore JJE, 1998, J BIOL CHEM, V273, P31770, DOI 10.1074/jbc.273.48.31770; Ehrlich M, 2001, J CELL SCI, V114, P1777; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; Tugizov S, 1999, J VIROL, V73, P8677, DOI 10.1128/JVI.73.10.8677-8688.1999; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898; Zwart DE, 1996, J BIOL CHEM, V271, P907, DOI 10.1074/jbc.271.2.907	73	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26876	26889		10.1074/jbc.M112.362848	http://dx.doi.org/10.1074/jbc.M112.362848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707720	Green Published, hybrid			2022-12-28	WOS:000307386000036
J	Watanabe, M; Nakamura, O; Muramoto, K; Ogawa, T				Watanabe, Mizuki; Nakamura, Osamu; Muramoto, Koji; Ogawa, Tomohisa			Allosteric Regulation of the Carbohydrate-binding Ability of a Novel Conger Eel Galectin by D-Mannoside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECTIN-BINDING; SKIN MUCUS; ACCELERATED EVOLUTION; JAPANESE CONGER; PROTEIN; MYRIASTER; PURIFICATION; SITE; MICROFILARIAE; RECOGNITION	Conger eel has two galectins, termed congerins I and II (Con I and II), that function in mucus as biodefense molecules. Con I and II have acquired a novel protein fold via domain swapping and a new ligand-binding site by accelerated evolution, which enables recognition of some marine bacteria. In this study, we identified a new congerin isotype, congerin P (Con-P), from the peritoneal cells of conger eel. Although Con-P displayed obvious homology with galectins, we observed substitution of 7 out of 8 amino acid residues in the carbohydrate recognition domain that are conserved in all other known galectins. To understand the structure-function relationships of this unique galectin, recombinant Con-P was successfully expressed in Escherichia coli by using a Con II-tagged fusion protein system and subsequently characterized. In the presence of D-mannose, Con-P displayed 30-fold greater hemagglutinating activity than Con I; however, no activity was observed without mannose, indicating that D-mannoside can act as a modulator of Con- P. Frontal affinity chromatography analysis showed that activated Con-P, allosterically induced by mannose, displayed affinity for oligomannose-type sugars as well as N-acetyllactosamine-type beta-galactosides. Thus, Con-P represents a new member of the galectin family with unique properties.	[Watanabe, Mizuki; Muramoto, Koji; Ogawa, Tomohisa] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan; [Nakamura, Osamu] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan	Tohoku University; Kitasato University	Ogawa, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808577, Japan.	ogawa@biochem.tohoku.ac.jp		Ogawa, Tomohisa/0000-0001-8700-6330	Grants-in-Aid for Scientific Research [23380121] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bouckaert J, 1999, CURR OPIN STRUC BIOL, V9, P572, DOI 10.1016/S0959-440X(99)00007-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Hamelryck TW, 1999, J MOL BIOL, V286, P1161, DOI 10.1006/jmbi.1998.2534; Hillrichs K, 2012, PARASITOL RES, V110, P449, DOI 10.1007/s00436-011-2511-4; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; HIRABAYASHI J, 1994, GLYCOCONJUGATE J, V11, P437, DOI 10.1007/BF00731280; INGRAM GA, 1980, J FISH BIOL, V16, P23, DOI 10.1111/j.1095-8649.1980.tb03685.x; KAMIYA H, 1988, DEV COMP IMMUNOL, V12, P309, DOI 10.1016/0145-305X(88)90007-9; Kanayama Y, 2005, BIOSCI BIOTECH BIOCH, V69, P916, DOI 10.1271/bbb.69.916; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Konno A, 2007, MOL BIOL EVOL, V24, P2504, DOI 10.1093/molbev/msm185; Konno A, 2010, PROTEIN SCI ENG, P65; Konno A, 2011, STRUCTURE, V19, P711, DOI 10.1016/j.str.2011.02.014; Konno A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-43; Muramoto K, 1999, COMP BIOCHEM PHYS B, V123, P33, DOI 10.1016/S0305-0491(99)00037-1; MURAMOTO K, 1992, BIOCHIM BIOPHYS ACTA, V1116, P129, DOI 10.1016/0304-4165(92)90109-8; Nakamura O, 2006, FISH SHELLFISH IMMUN, V20, P433, DOI 10.1016/j.fsi.2005.06.004; Nakamura O, 2002, J APPL PHYSIOL, V93, P1973, DOI 10.1152/japplphysiol.00663.2002; Nakamura O, 2001, DEV COMP IMMUNOL, V25, P431, DOI 10.1016/S0145-305X(01)00012-X; Nakamura O., 2012, FISH SHELLF IN PRESS; NAYAR JK, 1995, J INVERTEBR PATHOL, V66, P277, DOI 10.1006/jipa.1995.1101; Ogawa T, 1999, BIOSCI BIOTECH BIOCH, V63, P1203, DOI 10.1271/bbb.63.1203; Ogawa T, 2006, MOL DIVERS, V10, P511, DOI 10.1007/s11030-006-9048-y; PAGE AP, 1992, PARASITOLOGY, V105, P285, DOI 10.1017/S0031182000074217; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; RHOADS ML, 1994, J PARASITOL, V80, P756, DOI 10.2307/3283254; Schallig HDFH, 1996, PARASITOL RES, V82, P38, DOI 10.1007/s004360050065; Seto M, 2008, PROTEIN EXPRES PURIF, V58, P194, DOI 10.1016/j.pep.2007.11.013; Shirai T, 1999, STRUCTURE, V7, P1223, DOI 10.1016/S0969-2126(00)80056-8; Shirai T, 2002, J MOL BIOL, V321, P879, DOI 10.1016/S0022-2836(02)00700-3; Shirai T, 2006, MOL DIVERS, V10, P567, DOI 10.1007/s11030-006-9030-8; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Tasumi S, 2004, DEV COMP IMMUNOL, V28, P325, DOI 10.1016/j.dci.2003.08.006; Than NG, 2004, EUR J BIOCHEM, V271, P1065, DOI 10.1111/j.1432-1033.2004.04004.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrelles JB, 2008, CURR DRUG TARGETS, V9, P102; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062	40	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31061	31072		10.1074/jbc.M112.346213	http://dx.doi.org/10.1074/jbc.M112.346213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22810239	Green Published, hybrid			2022-12-28	WOS:000308791300019
J	Di Costanzo, A; Troiano, A; di Martino, O; Cacace, A; Natale, CF; Ventre, M; Netti, P; Caserta, S; Pollice, A; La Mantia, G; Calabro, V				Di Costanzo, Antonella; Troiano, Annaelena; di Martino, Orsola; Cacace, Andrea; Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo; Caserta, Sergio; Pollice, Alessandra; La Mantia, Girolama; Calabro, Viola			The p63 Protein Isoform Delta Np63 alpha Modulates Y-box Binding Protein 1 in Its Subcellular Distribution and Regulation of Cell Survival and Motility Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; MESSENGER-RNA; P53 HOMOLOG; YB-1; KERATINOCYTES; EXPRESSION; CARCINOMA; GROWTH; PROLIFERATION	The Y-box binding protein 1 (YB-1) belongs to the cold-shock domain protein superfamily, one of the most evolutionarily conserved nucleic acid-binding proteins currently known. YB-1 performs a wide variety of cellular functions, including transcriptional and translational regulation, DNA repair, drug resistance, and stress responses to extracellular signals. Inasmuch as the level of YB-1 drastically increases in tumor cells, this protein is considered to be one of the most indicative markers of malignant tumors. Here, we present evidence that Delta Np63 alpha, the predominant p63 protein isoform in squamous epithelia and YB-1, can physically interact. Into the nucleus, Delta Np63 alpha and YB-1 cooperate in PI3KCA gene promoter activation. Moreover, Delta Np63 alpha promotes YB-1 nuclear accumulation thereby reducing the amount of YB-1 bound to its target transcripts such as that encoding the SNAIL1 protein. Accordingly, Delta Np63 alpha enforced expression was associated with a reduction of the level of SNAIL1, a potent inducer of epithelial to mesenchymal transition. Furthermore, Delta Np63 alpha depletion causes morphological change and enhanced formation of actin stress fibers in squamous cancer cells. Mechanistic studies indicate that alpha Np63 Delta affects cell movement and can reverse the increase of cell motility induced by YB-1 overexpression. These data thus suggest that Delta Np63 alpha provides inhibitory signals for cell motility. Deficiency of Delta Np63 alpha gene expression promotes cell mobilization, at least partially, through a YB-1-dependent mechanism.	[Di Costanzo, Antonella; Troiano, Annaelena; di Martino, Orsola; Cacace, Andrea; Pollice, Alessandra; La Mantia, Girolama; Calabro, Viola] Univ Naples Federico II, Dept Struct & Mol Biol, Ist Italiano Tecnol, I-80126 Naples, Italy; [Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo] Univ Naples Federico II, Ctr Adv Biomat Hlth Care, Ist Italiano Tecnol, I-80126 Naples, Italy; [Natale, Carlo F.; Ventre, Maurizio; Netti, Paolo] Univ Naples Federico II, Interdisciplinary Res Ctr Biomat, I-80126 Naples, Italy; [Caserta, Sergio] Univ Naples Federico II, Dept Chem Engn, I-80125 Naples, Italy	Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Calabro, V (corresponding author), Univ Naples Federico II, Dept Biol Strutturale & Funzionale, Via Cinzia Monte S Angelo, I-80126 Naples, Italy.	vcalabro@unina.it	Ventre, Maurizio/M-8029-2019; Caserta, Sergio/E-4602-2012; Calabro, Viola/H-6156-2013	Ventre, Maurizio/0000-0003-3375-9112; Caserta, Sergio/0000-0002-4400-0059; di Martino, Orsola/0000-0002-7620-0290; Calabro, Viola/0000-0002-6508-8889; NETTI, PAOLO/0000-0002-2435-7181	MIUR [PRIN 2009KFS94X_003]	MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR Grant PRIN 2009KFS94X_003 (to V. C.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Amoresana A, 2010, J PROTEOME RES, V9, P2042, DOI 10.1021/pr9011156; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Chernov K. G., 2008, BMC BIOCH, P9; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fukunishi N, 2010, NEOPLASIA, V12, P969, DOI 10.1593/neo.101054; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Ha LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021877; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Lo Iacono M, 2006, CELL CYCLE, V5, P78; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Moll UM, 2004, MOL CANCER RES, V2, P371; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Sou PW, 2010, INT J BIOCHEM CELL B, V42, P1940, DOI 10.1016/j.biocel.2010.08.021; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Wu Joyce, 2007, Transl Oncogenomics, V2, P49; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang YF, 2003, ONCOGENE, V22, P2782, DOI 10.1038/sj.onc.1206357	40	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30170	30180		10.1074/jbc.M112.349951	http://dx.doi.org/10.1074/jbc.M112.349951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787154	Green Published, hybrid			2022-12-28	WOS:000308579800012
J	Du, JT; Campau, E; Soragni, E; Ku, S; Puckett, JW; Dervan, PB; Gottesfeld, JM				Du, Jintang; Campau, Erica; Soragni, Elisabetta; Ku, Sherman; Puckett, James W.; Dervan, Peter B.; Gottesfeld, Joel M.			Role of Mismatch Repair Enzymes in GAA.TTC Triplet-repeat Expansion in Friedreich Ataxia Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOT-TTC REPEATS; SOMATIC INSTABILITY; NEURAL CONVERSION; IPS CELLS; DNA; TRANSCRIPTION; INHIBITION; SEQUENCE; REPLICATION; HUNTINGTONS	The genetic mutation in Friedreich ataxia (FRDA) is a hyper-expansion of the triplet-repeat sequence GAA.TTC within the first intron of the FXN gene. Although yeast and reporter construct models for GAA.TTC triplet-repeat expansion have been reported, studies on FRDA pathogenesis and therapeutic development are limited by the availability of an appropriate cell model in which to study the mechanism of instability of the GAA.TTC triplet repeats in the human genome. Herein, induced pluripotent stem cells (iPSCs) were generated from FRDA patient fibroblasts after transduction with the four transcription factors Oct4, Sox2, Klf4, and c-Myc. These cells were differentiated into neurospheres and neuronal precursors in vitro, providing a valuable cell model for FRDA. During propagation of the iPSCs, GAA.TTC triplet repeats expanded at a rate of about two GAA.TTC triplet repeats/replication. However, GAA.TTC triplet repeats were stable in FRDA fibroblasts and neuronal stem cells. The mismatch repair enzymes MSH2, MSH3, and MSH6, implicated in repeat instability in other triplet-repeat diseases, were highly expressed in pluripotent stem cells compared with fibroblasts and neuronal stem cells and occupied FXN intron 1. In addition, shRNA silencing of MSH2 and MSH6 impeded GAA.TTC triplet-repeat expansion. A specific pyrrole-imidazole polyamide targeting GAA.TTC triplet-repeat DNA partially blocked repeat expansion by displacing MSH2 from FXN intron 1 in FRDA iPSCs. These studies suggest that in FRDA, GAA.TTC triplet-repeat instability occurs in embryonic cells and involves the highly active mismatch repair system.	[Du, Jintang; Campau, Erica; Soragni, Elisabetta; Ku, Sherman; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Puckett, James W.; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Scripps Research Institute; California Institute of Technology	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-27,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu		Gottesfeld, Joel/0000-0002-4643-5777	National Institutes Health from NINDS [NS062856]; NIGMS [GM275681]; Friedreich's Ataxia Research Alliance; California Institute for Regenerative Medicine (CIRM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	National Institutes Health from NINDS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Friedreich's Ataxia Research Alliance; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes Health Grant NS062856 from NINDS (to J. M. G.) and Grant GM275681 from NIGMS (to P. B. D.). This work was also supported by a postdoctoral fellowship from the Friedreich's Ataxia Research Alliance (to J. D.) and by a grant from the California Institute for Regenerative Medicine (CIRM).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Dickinson LA, 1998, P NATL ACAD SCI USA, V95, P12890, DOI 10.1073/pnas.95.22.12890; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Dudouet B, 2003, CHEM BIOL, V10, P859, DOI 10.1016/j.chembiol.2003.09.001; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Foiry L, 2006, HUM GENET, V119, P520, DOI 10.1007/s00439-006-0164-7; Fujimoto J, 2008, BIOORGAN MED CHEM, V16, P5899, DOI 10.1016/j.bmc.2008.04.060; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gomes-Pereira Mario, 2004, V277, P61; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Napierala M, 2004, J BIOL CHEM, V279, P6444, DOI 10.1074/jbc.M309596200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Rindler PM, 2011, NUCLEIC ACIDS RES, V39, P526, DOI 10.1093/nar/gkq788; Rindler PM, 2006, NUCLEIC ACIDS RES, V34, P6352, DOI 10.1093/nar/gkl846; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Urbach AR, 2002, J MOL BIOL, V320, P55, DOI 10.1016/S0022-2836(02)00430-8; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	46	80	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29861	29872		10.1074/jbc.M112.391961	http://dx.doi.org/10.1074/jbc.M112.391961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22798143	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000308286900060
J	Li, Z; Liu, WH; Han, S; Peng, BW; Yin, J; Wu, YL; He, XH; Li, WX				Li, Zhi; Liu, Wan-Hong; Han, Song; Peng, Bi-Wen; Yin, Jun; Wu, Ying-Liang; He, Xiao-Hua; Li, Wen-Xin			Selective Inhibition of CCR7(-) Effector Memory T Cell Activation by a Novel Peptide Targeting Kv1.3 Channel in a Rat Experimental Autoimmune Encephalomyelitis Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; THERAPEUTIC TARGET; K+ CHANNELS; LYMPHOCYTES; TOXIN; PHOSPHORYLATION; BLOCKADE; HYPOXIA; CARMA1	The voltage-gated Kv1.3 K+ channel in effector memory T cells serves as a new therapeutic target for multiple sclerosis. In our previous studies, the novel peptide ADWX-1 was designed and synthesized as a specific Kv1.3 blocker. However, it is unclear if and how ADWX-1 alleviates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. In this study, the administration of ADWX-1 significantly ameliorated the rat experimental autoimmune encephalomyelitis model by selectively inhibiting CD4(+)CCR7(-) phenotype effector memory T cell activation. In contrast, the Kv1.3-specific peptide had little effect on CD4(+)CCR7(+) cells, thereby limiting side effects. Furthermore, we determined that ADWX-1 is involved in the regulation of NF-kappa B signaling through upstream protein kinase C-theta (PKC theta) in the IL-2 pathway of CD4(+)CCR7(-) cells. The elevated expression of Kv1.3 mRNA and protein in activated CD4(+)CCR7(-) cells was reduced by ADWX-1 engagement; however, an apparent alteration in CD4(+)CCR7(+) cells was not observed. Moreover, the selective regulation of the Kv1.3 channel gene expression pattern by ADWX-1 provided a further and sustained inhibition of the CD4(+)CCR7(-) phenotype, which depends on the activity of Kv1.3 to modulate its activation signal. In addition, ADWX-1 mediated the activation of differentiated Th17 cells through the CCR7(-) phenotype. The efficacy of ADWX-1 is supported by multiple functions, which are based on a Kv1.3(high) CD4(+)CCR7(-) T cell selectivity through two different pathways, including the classic channel activity-associated IL-2 pathway and the new Kv1.3 channel gene expression pathway.	[Wu, Ying-Liang; Li, Wen-Xin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Li, Zhi; Liu, Wan-Hong; Han, Song; Peng, Bi-Wen; Yin, Jun; He, Xiao-Hua] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Allergy & Immunol, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn; hexiaohua@whu.edu.cn		/0000-0002-5599-6779; Li, Zhi/0000-0003-4637-1504	National Basic Research Program of China [2010CB529803]; National Natural Sciences Foundation of China [81171127, 31000344, 81171577]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-028]; Natural Science Foundation of Hubei Province of China [2010CDA045]; Fundamental Research Funds for the Central Universities; National High Technology Research and Development Program of China [2012AA020304]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020304] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs; Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Basic Research Program of China Grant 2010CB529803, the National Natural Sciences Foundation of China Grants 81171127, 31000344, and 81171577, the National Science and Technology Major Projects of New Drugs Grants 2012ZX09103301-028, the Natural Science Foundation of Hubei Province of China Grant 2010CDA045, Fundamental Research Funds for the Central Universities, and National High Technology Research and Development Program of China (2012AA020304).	Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Felix JP, 1999, BIOCHEMISTRY-US, V38, P4922, DOI 10.1021/bi982954w; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fugger L, 2009, NAT REV IMMUNOL, V9, P408, DOI 10.1038/nri2554; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2011, TOXICON, V57, P348, DOI 10.1016/j.toxicon.2010.12.015; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Kuras Z, 2012, AM J PHYSIOL-CELL PH, V302, pC1504, DOI 10.1152/ajpcell.00263.2011; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Merrill JE, 2009, J NEUROL, V256, P89, DOI 10.1007/s00415-009-0075-3; Merrill JE, 2009, NEUROPSYCHOPHARMACOL, V34, P55, DOI 10.1038/npp.2008.145; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Paintlia AS, 2008, EXP NEUROL, V214, P168, DOI 10.1016/j.expneurol.2008.07.024; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Rueda D, 2005, IMMUNITY, V23, P551, DOI 10.1016/j.immuni.2005.11.007; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shapira E, 2010, J AUTOIMMUN, V35, P98, DOI 10.1016/j.jaut.2010.03.004; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Szigligeti P, 2006, J PHYSIOL-LONDON, V573, P357, DOI 10.1113/jphysiol.2006.109967; Takacs Z, 2009, P NATL ACAD SCI USA, V106, P22211, DOI 10.1073/pnas.0910123106; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a	48	38	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29479	29494		10.1074/jbc.M112.379594	http://dx.doi.org/10.1074/jbc.M112.379594			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761436	Green Published, hybrid			2022-12-28	WOS:000308286900025
J	Lopez-de los Santos, Y; Chan, H; Cantu, VA; Rettner, R; Sanchez, F; Zhang, ZG; Saier, MH; Soberon, X				Lopez-de los Santos, Yossef; Chan, Henry; Cantu, Vito A.; Rettner, Rachael; Sanchez, Filiberto; Zhang, Zhongge; Saier, Milton H., Jr.; Soberon, Xavier			Genetic Engineering of the Phosphocarrier Protein NPr of the Escherichia coli Phosphotransferase System Selectively Improves Sugar Uptake Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER CLASSIFICATION DATABASE; PHOSPHORYL TRANSFER COMPLEX; ENZYME IIA(NTR); DIHYDROXYACETONE KINASE; GLYCOGEN-PHOSPHORYLASE; SUBSTRATE-SPECIFICITY; TIGHT REGULATION; PHOSPHOENOLPYRUVATE; EXPRESSION; K-12	The Escherichia coli phosphoenolpyruvate: sugar phosphotransferase system (PTS) in prokaryotes mediates the uptake and phosphorylation of its numerous substrates through a phosphoryl transfer chain where a phosphoryl transfer protein, HPr, transfers its phosphoryl group to any of several sugar-specific Enzyme IIA proteins in preparation for sugar transport. A phosphoryl transfer protein of the PTS, NPr, homologous to HPr, functions to regulate nitrogen metabolism and shows virtually no enzymatic cross-reactivity with HPr. Here we describe the genetic engineering of a "chimeric" HPr/NPr protein, termed CPr14 because 14 amino acid residues of the interface were replaced. CPr14 shows decreased activity with most PTS permeases relative to HPr, but increases activity with the broad specificity mannose permease. The results lead to the proposal that HPr is not optimal for most PTS permeases but instead represents a compromise with suboptimal activity for most PTS permeases. The evolutionary implications are discussed.	[Chan, Henry; Zhang, Zhongge; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Soberon, Xavier] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Lopez-de los Santos, Yossef; Cantu, Vito A.; Sanchez, Filiberto; Soberon, Xavier] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62210, Morelos, Mexico	University of California System; University of California San Diego; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu; soberon@ibt.unam.mx		, Adrian/0000-0002-3168-5140	National Institutes of Health from the NIGMS [GM077402]; CONACyT [83039]; University of California Institute for Mexico [060021]; United States-CONACyT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico; United States-CONACyT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077402 from the NIGMS (to M. H. S.). This work was also supported by Grant 83039 from CONACyT and by the sabbatical Grant 060021 from University of California Institute for Mexico and the United States-CONACyT.	Aboulwafa M, 2004, J BACTERIOL, V186, P8453, DOI 10.1128/JB.186.24.8453-8462.2004; Aboulwafa M, 2002, RES MICROBIOL, V153, P667, DOI 10.1016/S0923-2508(02)01376-1; Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; Bachler C, 2005, EMBO J, V24, P283, DOI 10.1038/sj.emboj.7600517; Bahr T, 2011, J BACTERIOL, V193, P2013, DOI 10.1128/JB.01459-10; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Cases I, 2001, J BACTERIOL, V183, P5128, DOI 10.1128/JB.183.17.5128-5133.2001; Chung YJ, 2002, J BACTERIOL, V184, P2543, DOI 10.1128/JB.184.9.2543-2545.2002; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; FELDHEIM DA, 1990, J BACTERIOL, V172, P5459, DOI 10.1128/jb.172.9.5459-5469.1990; Gorke B, 1999, EMBO J, V18, P3370, DOI 10.1093/emboj/18.12.3370; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Houot L, 2010, J BACTERIOL, V192, P3055, DOI 10.1128/JB.00213-10; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Kim HJ, 2011, BIOCHEM BIOPH RES CO, V409, P556, DOI 10.1016/j.bbrc.2011.05.044; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; LENGELER J, 1975, J BACTERIOL, V124, P26, DOI 10.1128/JB.124.1.26-38.1975; Li X, 2008, AMINO ACIDS, V35, P531, DOI 10.1007/s00726-008-0079-9; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; NGUYEN T, 2006, PHARM PRAC, V22, P11; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; REPHAELI AW, 1980, J BIOL CHEM, V255, P8585; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sutrina SL, 2002, MICROBIOL-SGM, V148, P3857, DOI 10.1099/00221287-148-12-3857; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; THOMPSON J, 1985, J BACTERIOL, V162, P224, DOI 10.1128/JB.162.1.224-234.1985; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Zimmer B, 2008, FEMS MICROBIOL LETT, V286, P96, DOI 10.1111/j.1574-6968.2008.01262.x	46	3	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29931	29939		10.1074/jbc.M112.345660	http://dx.doi.org/10.1074/jbc.M112.345660			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22767600	hybrid, Green Published			2022-12-28	WOS:000308286900066
J	Neyraud, V; Aushev, VN; Hatzoglou, A; Meunier, B; Cascone, I; Camonis, J				Neyraud, Vincent; Aushev, Vasily N.; Hatzoglou, Anastassia; Meunier, Brigitte; Cascone, Ilaria; Camonis, Jacques			RalA and RalB Proteins Are Ubiquitinated GTPases, and Ubiquitinated RalA Increases Lipid Raft Exposure at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; EFFECTOR COMPLEX; BINDING PROTEINS; RAS; CANCER; ACTIVATION; EXOCYST; MIGRATION; SURVIVAL; PROGRESSION	Ras GTPases signal by orchestrating a balance among several effector pathways, of which those driven by the GTPases RalA and RalB are essential to Ras oncogenic functions. RalA and RalB share the same effectors but support different aspects of oncogenesis. One example is the importance of active RalA in anchorage-independent growth and membrane raft trafficking. This study has shown a new post-translational modification of Ral GTPases: nondegradative ubiquitination. RalA (but not RalB) ubiquitination increases in anchorage-independent conditions in a caveolin-dependent manner and when lipid rafts are endocytosed. Forcing RalA mono-ubiquitination (by expressing a protein fusion consisting of ubiquitin fused N-terminally to RalA) leads to RalA enrichment at the plasma membrane and increases raft exposure. This study suggests the existence of an ubiquitination/de-ubiquitination cycle superimposed on the GDP/GTP cycle of RalA, involved in the regulation of RalA activity as well as in membrane raft trafficking.	[Neyraud, Vincent; Aushev, Vasily N.; Hatzoglou, Anastassia; Meunier, Brigitte; Cascone, Ilaria; Camonis, Jacques] INSERM, Inst Curie, U830, Anal Transduct Pathways ATP Grp, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Camonis, J (corresponding author), INSERM, Inst Curie, U830, Anal Transduct Pathways ATP Grp, 26 Rue Ulm, F-75248 Paris 05, France.	Jacques.camonis@curie.fr	Aushev, Vasily N./A-7209-2008; Cascone, Ilaria/Q-7844-2018	Aushev, Vasily N./0000-0001-8003-358X; Cascone, Ilaria/0000-0003-4903-8926	ANR; ARC; MRT; UICC [ICRETT 06/135]; EMBO; Curie Institute	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); MRT; UICC; EMBO(European Molecular Biology Organization (EMBO)); Curie Institute	This research was supported by grants from ANR and ARC (to J. C.).; Supported by fellowships from MRT and ARC.; Supported by UICC Fellowship ICRETT 06/135. Present address: Oncogene Regulation Laboratory, Cancer Research Centre, 24 Kashyrskoye Shosse, 115478 Moscow, Russia. E-mail: vaushev@gmail.com.; Supported by fellowships from the EMBO and Curie Institute.	Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Bauer B, 1999, J BIOL CHEM, V274, P17763, DOI 10.1074/jbc.274.25.17763; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; DEICHMAN GI, 1989, INT J CANCER, V44, P908, DOI 10.1002/ijc.2910440527; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Del Pozo MA, 2004, CELL CYCLE, V3, P725; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P306, DOI 10.1038/nrm2685; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Laney Jeffrey D, 2002, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1405s29; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sowalsky AG, 2010, ONCOGENE, V29, P45, DOI 10.1038/onc.2009.307; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568	38	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29397	29405		10.1074/jbc.M112.357764	http://dx.doi.org/10.1074/jbc.M112.357764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22700969	Green Published, hybrid			2022-12-28	WOS:000308286900018
J	Tran, NQ; Tabor, S; Amarasiriwardena, CJ; Kulczyk, AW; Richardson, CC				Tran, Ngoc Q.; Tabor, Stanley; Amarasiriwardena, Chitra J.; Kulczyk, Arkadiusz W.; Richardson, Charles C.			Characterization of a Nucleotide Kinase Encoded by Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ADENYLATE KINASE; GENE-4 PROTEIN; PURIFICATION; ENZYME; GROWTH; MODEL	Gene 1.7 protein is the only known nucleotide kinase encoded by bacteriophage T7. The enzyme phosphorylates dTMP and dGMP to dTDP and dGDP, respectively, in the presence of a phosphate donor. The phosphate donors are dTTP, dGTP, and ribo-GTP as well as the thymidine and guanosine triphosphate analogs ddTTP, ddGTP, and dITP. The nucleotide kinase is found in solution as a 256-kDa complex consisting of similar to 12 monomers of the gene 1.7 protein. The two molecular weight forms co-purify as a complex, but each form has nearly identical kinase activity. Although gene 1.7 protein does not require a metal ion for its kinase activity, the presence of Mg2+ in the reaction mixture results in either inhibition or stimulation of the rate of kinase reactions depending on the substrates used. Both the dTMP and dGMP kinase reactions are reversible. Neither dTDP nor dGDP is a phosphate acceptor of nucleoside triphosphate donors. Gene 1.7 protein exhibits two different equilibrium patterns toward deoxyguanosine and thymidine substrates. The K-m of 4.4 x 10(-4) M obtained with dTTP for dTMP kinase is similar to 3-fold higher than that obtained with dGTP for dGMP kinase (1.3 x 10(-4) M), indicating that a higher concentration of dTTP is required to saturate the enzyme. Inhibition studies indicate a competitive relationship between dGDP and both dGTP, dGMP, whereas dTDP appears to have a mixed type of inhibition of dTMP kinase. Studies suggest two functions of dTTP, as a phosphate donor and a positive effector of the dTMP kinase reaction.	[Tran, Ngoc Q.; Tabor, Stanley; Kulczyk, Arkadiusz W.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Amarasiriwardena, Chitra J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			United States Public Health Service [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM54397.	Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; CENTER MS, 1970, P NATL ACAD SCI USA, V65, P242, DOI 10.1073/pnas.65.1.242; CENTER MS, 1970, J BIOL CHEM, V245, P6285; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; HAUSMANN R., 1967, J VIROL, V1, P779; JONG AYS, 1984, J BIOL CHEM, V259, P4394; Kang S, 2010, SCIENCE, V327, P42, DOI 10.1126/science.1184318; KERR C, 1972, J BIOL CHEM, V247, P305; KIELLEY RK, 1970, J BIOL CHEM, V245, P4204; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; LABAW LW, 1951, P NATL ACAD SCI USA, V37, P721, DOI 10.1073/pnas.37.11.721; LABAW LW, 1953, J BACTERIOL, V66, P429, DOI 10.1128/JB.66.4.429-436.1953; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; NELSON DJ, 1969, J BIOL CHEM, V244, P5254; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; STUDIER FW, 1972, SCIENCE, V176, P367, DOI 10.1126/science.176.4033.367; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Tran NQ, 2008, P NATL ACAD SCI USA, V105, P9373, DOI 10.1073/pnas.0804164105; Tran NQ, 2010, MOL MICROBIOL, V77, P492, DOI 10.1111/j.1365-2958.2010.07221.x; TSAI MD, 1991, BIOCHEMISTRY-US, V30, P6806, DOI 10.1021/bi00242a002	29	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29468	29478		10.1074/jbc.M112.389619	http://dx.doi.org/10.1074/jbc.M112.389619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761426	hybrid, Green Published			2022-12-28	WOS:000308286900024
J	Qadota, H; Moerman, DG; Benian, GM				Qadota, Hiroshi; Moerman, Donald G.; Benian, Guy M.			A Molecular Mechanism for the Requirement of PAT-4 (Integrin-linked Kinase (ILK)) for the Localization of UNC-112 (Kindlin) to Integrin Adhesion Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS MUSCLE; BODY-WALL MUSCLE; THICK FILAMENTS; LEUKOCYTE ADHESION; IN-VIVO; PROTEIN; DOMAIN; ACTIVATION; COMPLEXES; MEMBRANE	Caenorhabditis elegans muscle cells attach to basement membrane through adhesion plaques. PAT-3 (beta-integrin), UNC-112 (kindlin), and PAT-4 (integrin-linked kinase) are associated with these structures. Genetic analysis indicated that PAT-4 is required for UNC-112 to be properly localized. We investigated the molecular basis of this requirement. We show that the cytoplasmic tail of PAT-3 binds to full-length UNC-112 and that the N-and C-terminal halves of UNC-112 bind to each other. We demonstrate competition between the UNC-112 C-terminal half and PAT-4 for binding to the UNC-112 N-terminal half. The D382V mutation results in lack of binding to PAT-4 and lack of localization to adhesion structures. T346A or E349K mutations, which abolish interaction of the N-and C-terminal halves, permit D382V UNC-112 to localize to adhesion structures. The following model is proposed. UNC-112 exists in closed inactive and open active conformations, and upon binding of PAT-4 to the UNC-112 N-terminal half, UNC-112 is converted into the open state, able to bind to PAT-3.	[Qadota, Hiroshi; Benian, Guy M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Qadota, Hiroshi; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Emory University; University of British Columbia	Benian, GM (corresponding author), Emory Univ, Dept Pathol, Whitehead Bldg 105E,615 Michael St, Atlanta, GA 30322 USA.	pathgb@emory.edu			National Institutes of Health [AR052133]; Japan Society for the Promotion of Science; Canadian Institutes for Health Research; National Science and Engineering Research Council of Canada; American Heart Association [11GRNT7820000]; Department of Pathology at Emory University; National Center for Research Resources of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Association(American Heart Association); Department of Pathology at Emory University; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant AR052133. This work was also supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (2000) (to H. Q.), grants from the Canadian Institutes for Health Research and the National Science and Engineering Research Council of Canada (to D. G. M.), and American Heart Association Grant 11GRNT7820000 (to G. M. B.).; Supported by the Department of Pathology at Emory University.; We thank Bob Barstead for RB2, a random primed C. elegans cDNA library, Andy Fire for C. elegans expression vectors, and Kozo Kaibuchi for bacterial and yeast expression vectors. Some strains used in this work were provided by the Caenorhabditis Genetics Center, which is supported by the National Center for Research Resources of the National Institutes of Health.	Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; BRENNER S, 1974, GENETICS, V77, P71; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Hikita T, 2005, BIOCHEM BIOPH RES CO, V335, P139, DOI 10.1016/j.bbrc.2005.07.068; James P, 1996, GENETICS, V144, P1425; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Mercer KB, 2003, MOL BIOL CELL, V14, P2492, DOI 10.1091/mbc.E02-10-0676; Mercer KB, 2006, MOL BIOL CELL, V17, P3832, DOI 10.1091/mbc.E06-02-0144; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Miller RK, 2006, J CELL BIOL, V175, P853, DOI 10.1083/jcb.200608043; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Moerman Donald G., 1997, Cold Spring Harbor Monograph Series, V33, P417; Moerman Donald G, 2006, WormBook, P1; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Norman KR, 2007, DEV BIOL, V309, P45, DOI 10.1016/j.ydbio.2007.06.014; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Qadota H, 2008, J MOL BIOL, V383, P747, DOI 10.1016/j.jmb.2008.08.083; Qadota H, 2008, MOL BIOL CELL, V19, P2424, DOI 10.1091/mbc.E08-01-0053; Qadota H, 2007, MOL BIOL CELL, V18, P4317, DOI 10.1091/mbc.E07-03-0278; Qadota H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/864749; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sadler E, 2006, ARCH DERMATOL, V142, P1619, DOI 10.1001/archderm.142.12.1619; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Takita Y, 1997, YEAST, V13, P763, DOI 10.1002/(SICI)1097-0061(19970630)13:8<763::AID-YEA135>3.3.CO;2-S; Waterston R., 1988, NEMATODE C ELEGANS, P281; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8; WICK M, 1994, J BIOL CHEM, V269, P18953; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wilson KJ, 2012, MOL BIOL CELL, V23, P2623, DOI 10.1091/mbc.E12-01-0055; Yochem J, 1998, GENETICS, V149, P1323; ZENGEL JM, 1980, CELL MOTIL CYTOSKEL, V1, P73, DOI 10.1002/cm.970010107; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	47	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28537	28551		10.1074/jbc.M112.354852	http://dx.doi.org/10.1074/jbc.M112.354852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761445	Green Published, hybrid			2022-12-28	WOS:000308074600029
J	Yehezkel, G; Cohen, L; Kliger, A; Manor, E; Khalaila, I				Yehezkel, Galit; Cohen, Liz; Kliger, Adi; Manor, Esther; Khalaila, Isam			O-Linked beta-N-Acetylglucosaminylation (O-GlcNAcylation) in Primary and Metastatic Colorectal Cancer Clones and Effect of N-Acetyl-beta-D-glucosaminidase Silencing on Cell Phenotype and Transcriptome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; C-MYC; GLCNAC; GLYCOSYLATION; PROGRESSION; P53; CYTOKINESIS; METABOLISM; STABILITY; PATHWAYS	O-Linked beta-N-acetylglucosamine (O-GlcNAc) glycosylation is a regulatory post-translational modification occurring on the serine or threonine residues of nucleocytoplasmic proteins. O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase and O-GlcNAcase (OGA), which are responsible for O-GlcNAc addition and removal, respectively. Although O-GlcNAcylation was found to play a significant role in several pathologies such as type II diabetes and neurodegenerative diseases, the role of O-GlcNAcylation in the etiology and progression of cancer remains vague. Here, we followed O-GlcNAcylation and its catalytic machinery in metastatic clones of human colorectal cancer and the effect of OGA knockdown on cellular phenotype and on the transcriptome. The colorectal cancer SW620 metastatic clone exhibited increased O-GlcNAcylation and decreased OGA expression compared with its primary clone, SW480. O-GlcNAcylation elevation in SW620 cells, through RNA interference of OGA, resulted in phenotypic alterations that included acquisition of a fibroblast-like morphology, which coincides with epithelial metastatic progression and growth retardation. Microarray analysis revealed that OGA silencing altered the expression of about 1300 genes, mostly involved in cell movement and growth, and specifically affected metabolic pathways of lipids and carbohydrates. These findings support the involvement of O-GlcNAcylation in various aspects of tumor cell physiology and suggest that this modification may serve as a link between metabolic changes and cancer.	[Yehezkel, Galit; Cohen, Liz; Kliger, Adi; Khalaila, Isam] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Engn Sci, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Manor, Esther] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Inst Human Genet, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Khalaila, I (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Engn Sci, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-84105 Beer Sheva, Israel.	isam@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778	Israel Cancer Association; Israel Science Foundation [1287/08]; Kahanoff Foundation	Israel Cancer Association; Israel Science Foundation(Israel Science Foundation); Kahanoff Foundation	This work was supported by grants from the Israel Cancer Association and Israel Science Foundation Grant 1287/08.; Recipient of Ma'of Fellowship from the Kahanoff Foundation. To whom correspondence should be addressed. Tel.: 972-8-6461903; Fax: 972-8-6479074; E-mail: isam@bgu.ac.il.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Duranton B, 2003, AMINO ACIDS, V24, P63, DOI 10.1007/s00726-002-0333-5; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hewitt RE, 2000, J PATHOL, V192, P446; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katayama M, 2006, SURG TODAY, V36, P1085, DOI 10.1007/s00595-006-3301-y; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mandahl N, 1992, HUMAN CYTOGENETICS P, VII, P155; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stichelen SOV, 2012, AM J PHYSIOL-ENDOC M, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wai PY, 2008, ONCOL REV, V2, P9, DOI 10.1007/s12156-008-0051-7; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WICE BM, 1985, J BIOL CHEM, V260, P139; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999; ZIRVI KA, 1991, CANCER LETT, V60, P85, DOI 10.1016/0304-3835(91)90052-J	44	65	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28755	28769		10.1074/jbc.M112.345546	http://dx.doi.org/10.1074/jbc.M112.345546			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22730328	Green Published, hybrid			2022-12-28	WOS:000308074600049
J	Hou, SW; Suresh, PS; Qi, XM; Lepp, A; Mirza, SP; Chen, G				Hou, Songwang; Suresh, Padmanaban S.; Qi, Xiaomei; Lepp, Adrienne; Mirza, Shama P.; Chen, Guan			p38 gamma Mitogen-activated Protein Kinase Signals through Phosphorylating Its Phosphatase PTPH1 in Regulating Ras Protein Oncogenesis and Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAP KINASE; ESTROGEN-RECEPTOR; DIFFERENTIAL REGULATION; P38; PATHWAY; TRANSFORMATION; SUBSTRATE; P38-ALPHA; FEEDBACK	Phosphatase plays a crucial role in determining cellular fate by inactivating its substrate kinase, but it is not known whether a kinase can vice versa phosphorylate its phosphatase to execute this function. Protein-tyrosine phosphatase H1 (PTPH1) is a specific phosphatase of p38 gamma mitogen-activated protein kinase (MAPK) through PDZ binding, and here, we show that p38 gamma is also a PTPH1 kinase through which it executes its oncogenic activity and regulates stress response. PTPH1 was identified as a substrate of p38 gamma by unbiased proteomic analysis, and its resultant phosphorylation at Ser-459 occurs in vitro and in vivo through their complex formation. Genetic and pharmacological analyses showed further that Ser-459 phosphorylation is directly regulated by Ras signaling and is important for Ras, p38 gamma, and PTPH1 oncogenic activity. Moreover, experiments with physiological stimuli revealed a novel stress pathway from p38 gamma to PTPH1/Ser-459 phosphorylation in regulating cell growth and cell death by a mechanism dependent on cellular environments but independent of canonical MAPK activities. These results thus reveal a new mechanism by which a MAPK regulates Ras oncogenesis and stress response through directly phosphorylating its phosphatase.	[Hou, Songwang; Suresh, Padmanaban S.; Qi, Xiaomei; Lepp, Adrienne; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama P.] Med Coll Wisconsin, Dept Biochem & Biotechnol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama P.] Med Coll Wisconsin, Ctr Bioengn, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Chen, Guan] Med Coll Wisconsin, Res Serv, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu	P.S, Suresh/AAX-9666-2020		National Institutes of Health [2R01 CA91576]; Department of Veterans Affairs Merit Review; Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House); NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant 2R01 CA91576. This work was also supported by a Department of Veterans Affairs Merit Review and the Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hou S., 2010, UCSD NAT MOL PAGES, DOI 1038/mp.a001720.01; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2012, J BIOL CHEM, V287, P14681, DOI 10.1074/jbc.M112.349357; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sabio G, 2004, BIOCHEM J, V380, P19, DOI 10.1042/BJ20031628; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu CC, 2010, PROTEIN CELL, V1, P573, DOI 10.1007/s13238-010-0075-1; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543	52	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27895	27905		10.1074/jbc.M111.335794	http://dx.doi.org/10.1074/jbc.M111.335794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730326	hybrid, Green Published			2022-12-28	WOS:000307840700063
J	Shaikhali, J; Noren, L; Barajas-Lopez, JD; Srivastava, V; Konig, J; Sauer, UH; Wingsle, G; Dietz, KJ; Strand, A				Shaikhali, Jehad; Noren, Louise; Barajas-Lopez, Juan de Dios; Srivastava, Vaibhav; Koenig, Janine; Sauer, Uwe H.; Wingsle, Gunnar; Dietz, Karl-Josef; Strand, Asa			Redox-mediated Mechanisms Regulate DNA Binding Activity of the G-group of Basic Region Leucine Zipper (bZIP) Transcription Factors in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; NUCLEAR EXPRESSION; S-NITROSYLATION; SWISS-MODEL; HIGH LIGHT; PROTEIN; THALIANA; NETWORK; THIOREDOXINS	Plant genes that contain the G-box in their promoters are responsive to a variety of environmental stimuli. Bioinformatics analysis of transcriptome data revealed that the G-box element is significantly enriched in promoters of high light-responsive genes. From nuclear extracts of high light-treated Arabidopsis plants, we identified the AtbZIP16 transcription factor as a component binding to the G-box-containing promoter fragment of light-harvesting chlorophyll a/b-binding protein2.4 (LHCB2.4). AtbZIP16 belongs to the G-group of Arabidopsis basic region leucine zipper (bZIP) type transcription factors. Although AtbZIP16 and its close homologues AtbZIP68 and AtGBF1 bind the G-box, they do not bind the mutated half-sites of the G-box palindrome. In addition, AtbZIP16 interacts with AtbZIP68 and AtGBF1 in the yeast two-hybrid system. A conserved Cys residue was shown to be necessary for redox regulation and enhancement of DNA binding activity in all three proteins. Furthermore, transgenic Arabidopsis lines overexpressing the wild type version of bZIP16 and T-DNA insertion mutants for bZIP68 and GBF1 demonstrated impaired regulation of LHCB2.4 expression. Finally, overexpression lines for the mutated Cys variant of bZIP16 provided support for the biological significance of Cys330 in redox regulation of gene expression. Thus, our results suggest that environmentally induced changes in the redox state regulate the activity of members of the G-group of bZIP transcription factors.	[Shaikhali, Jehad; Noren, Louise; Barajas-Lopez, Juan de Dios; Strand, Asa] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Sauer, Uwe H.] Umea Univ, Dept Chem, Ctr Chem Biol, SE-90187 Umea, Sweden; [Srivastava, Vaibhav; Wingsle, Gunnar] Swedish Univ Agr Sci SLU, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden; [Koenig, Janine; Dietz, Karl-Josef] Univ Bielefeld, Fac Biol, D-33501 Bielefeld, Germany	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University; University of Bielefeld	Strand, A (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, SE-90187 Umea, Sweden.	Asa.Strand@plantphys.umu.se	Sauer, Uwe/Y-3556-2019; Srivastava, Vaibhav/H-1320-2015; Dietz, Karl-Josef/B-6029-2009	Srivastava, Vaibhav/0000-0003-1877-4154; Dietz, Karl-Josef/0000-0003-0311-2182; Barajas Lopez, Juan de Dios/0000-0003-1515-5059	Swedish research foundation Vetenskapsradet; Foundation for Strategic Research [FFL2]; Knut and Alice Wallenberg Foundation	Swedish research foundation Vetenskapsradet; Foundation for Strategic Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by grants from the Swedish research foundation Vetenskapsradet and a Foundation for Strategic Research FFL2 grant (to A. S.).; A Royal Swedish Academy of Sciences research fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Amoutzias GD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-107; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Baier M, 2004, PLANT CELL PHYSIOL, V45, P997, DOI 10.1093/pcp/pch114; Berger C, 1998, FEBS LETT, V425, P14, DOI 10.1016/S0014-5793(98)00156-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brautigam K, 2009, PLANT CELL, V21, P2715, DOI 10.1105/tpc.108.062018; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cranz S, 2004, BIOCHEMISTRY-US, V43, P718, DOI 10.1021/bi0355793; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Vivancos PD, 2010, BIOCHEM J, V431, P169, DOI 10.1042/BJ20100409; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fankhauser C, 2002, PLANTA, V216, P1, DOI 10.1007/s00425-002-0831-4; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; GABRIELSEN OS, 1989, NUCLEIC ACIDS RES, V17, P6253, DOI 10.1093/nar/17.15.6253; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Hernandez JM, 2004, J BIOL CHEM, V279, P48205, DOI 10.1074/jbc.M407845200; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kindgren P, 2012, MOL PLANT, V5, P901, DOI 10.1093/mp/ssr112; Kindgren P, 2012, PLANT J, V70, P279, DOI 10.1111/j.1365-313X.2011.04865.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; Metallo SJ, 1997, NAT STRUCT BIOL, V4, P115, DOI 10.1038/nsb0297-115; Montemartini M, 1998, BIOL CHEM, V379, P1137, DOI 10.1515/bchm.1998.379.8-9.1137; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Rey DA, 2003, J BIOTECHNOL, V103, P51, DOI 10.1016/S0168-1656(03)00073-7; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; SCHINDLER U, 1992, EMBO J, V11, P1275, DOI 10.1002/j.1460-2075.1992.tb05171.x; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Serpa V, 2007, BIOCHEM BIOPH RES CO, V361, P1048, DOI 10.1016/j.bbrc.2007.07.133; Shaikhali J., 2012, PLANT CELL IN PRESS; Shaikhali J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-48; Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; Srivastava V, 2009, PLANT PHYSIOL, V149, P1848, DOI 10.1104/pp.108.133371; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	53	66	75	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27510	27525		10.1074/jbc.M112.361394	http://dx.doi.org/10.1074/jbc.M112.361394			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718771	Green Published, hybrid			2022-12-28	WOS:000307840700027
J	Stanyon, HF; Viles, JH				Stanyon, Helen F.; Viles, John H.			Human Serum Albumin Can Regulate Amyloid-beta Peptide Fiber Growth in the Brain Interstitium IMPLICATIONS FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; CEREBROSPINAL-FLUID; NMR-SPECTROSCOPY; BINDING-SITES; PRION PROTEIN; P-COMPONENT; PLASMA; TOXICITY; THERAPEUTICS; QUANTITATION	Alzheimer disease is a neurodegenerative disorder characterized by extracellular accumulation of amyloid-beta peptide (A beta) in the brain interstitium. Human serum albumin (HSA) binds 95% of A beta in blood plasma and is thought to inhibit plaque formation in peripheral tissue. However, the role of albumin in binding A beta in the cerebrospinal fluid has been largely overlooked. Here we investigate the effect of HSA on both A beta (1-40) and A beta (1-42) fibril growth. We show that at micromolar cerebrospinal fluid levels, HSA inhibits the kinetics of A beta fibrillization, significantly increasing the lag time and decreasing the total amount of fibrils produced. Furthermore, we show that the amount of amyloid fibers generated directly correlates to the proportion of A beta not competitively bound to albumin. Our observations suggest a significant role for HSA regulating A beta fibril growth in the brain interstitium.	[Stanyon, Helen F.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Stanyon`, Helen/0000-0002-2329-6188	Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship; BBSRC [BB/D005027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [978364, BB/D005027/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Quota studentship.	Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Boada M, 2009, DRUG NEWS PERSPECT, V22, P325, DOI 10.1358/dnp.2009.22.6.1395256; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHRISTENSON RH, 1983, CLIN CHEM, V29, P1028; CORIA F, 1988, LAB INVEST, V58, P454; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; ELOVAARA I, 1986, ACTA NEUROL SCAND, V74, P245, DOI 10.1111/j.1600-0404.1986.tb07863.x; ELOVAARA I, 1987, EUR NEUROL, V26, P229, DOI 10.1159/000116341; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Lame ME, 2011, ANAL BIOCHEM, V419, P133, DOI 10.1016/j.ab.2011.08.010; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LICASTRO F, 1993, ADV BIOSCI, V87, P283; Liko I, 2007, NEUROSCI LETT, V412, P51, DOI 10.1016/j.neulet.2006.10.052; Mackic JB, 1998, J NEUROCHEM, V70, P210; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; PATEL SU, 1993, J AM CHEM SOC, V115, P9285, DOI 10.1021/ja00073a053; Perrone L, 2010, CHEMBIOCHEM, V11, P110, DOI 10.1002/cbic.200900474; Reyes Barcelo Adriana A, 2009, J Biol Eng, V3, P5, DOI 10.1186/1754-1611-3-5; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; STEVENS RW, 1979, J CLIN MICROBIOL, V10, P346, DOI 10.1128/JCM.10.3.346-350.1979; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Viles J. H., 2012, COORD CHEM IN PRESS; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	32	115	117	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28163	28168		10.1074/jbc.C112.360800	http://dx.doi.org/10.1074/jbc.C112.360800			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718756	Green Published, hybrid			2022-12-28	WOS:000307840700089
J	Stolovich-Rain, M; Hija, A; Grimsby, J; Glaser, B; Dor, Y				Stolovich-Rain, Miri; Hija, Ayat; Grimsby, Joseph; Glaser, Benjamin; Dor, Yuval			Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-MOUSE PANCREAS; PRIMARY MECHANISM; IN-VIVO; REGENERATION; AGE; REPLICATION; PROGENITORS; MASS; EXPRESSION; ENDOCRINE	Recent studies suggested that in old mice, beta cells lose their regenerative potential and cannot respond to mitogenic triggers. These studies examined beta cell replication in aged mice under basal conditions and in response to specific stimuli including treatment with the glucagon-like peptide-1 analog exenatide, streptozotocin injection, partial pancreatectomy, and high fat diet. However, it remains possible that the ability to mount a compensatory response of beta cells is retained in old age, but depends on the specific stimulus. Here, we asked whether partial ablation of beta cells in transgenic mice, using doxycycline-inducible expression of diphtheria toxin, triggers a significant compensatory proliferative response in 1-2-year-old animals. Consistent with previous reports, the basal rate of beta cell replication declines dramatically with age, averaging 0.1% in 2-year-old mice. Transient expression of diphtheria toxin in beta cells of old mice resulted in impaired glucose homeostasis and disruption of islet architecture (ratio of beta to alpha cells). Strikingly, the replication rate of surviving beta cells increased 3-fold over basal rate, similarly to the -fold increase in replication rate of beta cells in young transgenic mice. Islet architecture and glucose tolerance slowly normalized, indicating functional significance of compensatory beta cell replication in this setting. Finally, administration of a small molecule glucokinase activator to old mice doubled the frequency of beta cell replication, further showing that old beta cells can respond to the mitogenic trigger of enhanced glycolysis. We conclude that the potential for functionally significant compensatory proliferation of beta cells is retained in old mice, despite a decline in basal replication rate.	[Stolovich-Rain, Miri; Hija, Ayat; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Grimsby, Joseph] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Serv Endocrinol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Roche Holding; Hebrew University of Jerusalem; Hadassah University Medical Center	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000	National Institutes of Health Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation; Helmsley Foundation; Dutch friends of Hebrew University; European Union [241883]; European Research Council; DON Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41.11]	National Institutes of Health Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Helmsley Foundation; Dutch friends of Hebrew University; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); DON Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This work was supported, in whole or in part, by the National Institutes of Health Beta Cell Biology Consortium. This work was also supported by grants from Juvenile Diabetes Research Foundation, the Helmsley Foundation, and the Dutch friends of Hebrew University, the European Union Seventh Framework Programme Grant 241883 and European Research Council, the DON Foundation, the I-CORE Program of the Planning and Budgeting Committee, and The Israel Science Foundation Grant 41.11 (to Y. D.).	Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen XJ, 2009, TRANSPLANTATION, V88, P496, DOI 10.1097/TP.0b013e3181b0d2ee; DECLERCQ L, 1988, MECH AGEING DEV, V43, P11, DOI 10.1016/0047-6374(88)90094-2; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Levitt HE, 2011, DIABETOLOGIA, V54, P572, DOI 10.1007/s00125-010-1919-1; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	28	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27407	27414		10.1074/jbc.M112.350736	http://dx.doi.org/10.1074/jbc.M112.350736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740691	Green Published, hybrid			2022-12-28	WOS:000307840700012
J	Ugarte-Berzal, E; Bailon, E; Amigo-Jimenez, I; Vituri, CL; del Cerro, MH; Terol, MJ; Albar, JP; Rivas, G; Garcia-Marco, JA; Garcia-Pardo, A				Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Vituri, Cidonia L.; Hernandez del Cerro, Mercedes; Jose Terol, Maria; Albar, Juan P.; Rivas, German; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds alpha 4 beta 1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III CONNECTING SEGMENT; MIGRATION; FIBRONECTIN; ADHESION; IDENTIFICATION; ANGIOGENESIS; INVASION; DISTINCT; SURFACE; RECOGNITION	We previously showed that pro-matrix metalloproteinase-9 (proMMP-9) binds to B chronic lymphocytic leukemia (B-CLL) cells and contributes to B-CLL progression by regulating cell migration and survival. Induction of cell survival involves a non-proteolytic mechanism and the proMMP-9 hemopexin domain (PEX9). To help design specific inhibitors of proMMP-9-cell binding, we have now characterized B-CLL cell interaction with the isolated PEX9. B-CLL cells bound soluble and immobilized GST-PEX9, but not GST, and binding was mediated by alpha 4 beta 1 integrin. The ability to recognize PEX9 was observed in all 20 primary samples studied irrespective of their clinical stage or prognostic marker phenotype. By preparing truncated forms of GST-PEX9 containing structural blades B1B2 or B3B4, we have identified B3B4 as the primary alpha 4 beta 1 integrin-interacting region within PEX9. Overlapping synthetic peptides spanning B3B4 were then tested in functional assays. Peptide P3 (FPGV-PLDTHDVFQYREKAYFC), a sequence present in B4 or smaller versions of this sequence (peptides P3a/P3b), inhibited B-CLL cell adhesion to GST-PEX9 or proMMP-9, with IC50 values of 138 and 279 mu M, respectively. Mutating the two aspartate residues to alanine rendered the peptides inactive. An anti-P3 anti-body also inhibited adhesion to GST-PEX9 and proMMP-9. GST-PEX9, GST-B3B4, and P3/P3a/P3b peptides inhibited B-CLL cell transendothelial migration, whereas the mutated peptide did not. B-CLL cell incubation with GST-PEX9 induced intracellular survival signals, namely Lyn phosphorylation and Mcl-1 up-regulation, and this was also prevented by the P3 peptides. The P3 sequence may, therefore, constitute an excellent target to prevent proMMP-9 contribution to B-CLL pathogenesis.	[Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Hernandez del Cerro, Mercedes; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Madrid 28040, Spain; [Vituri, Cidonia L.] Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil; [Jose Terol, Maria] Hosp Clin Univ, Serv Hematol & Med Oncol, Valencia 46010, Spain; [Albar, Juan P.] CSIC, Ctr Nacl Biotecnol, Serv Prote, E-28049 Madrid, Spain; [Rivas, German] CSIC, Ctr Invest Biol, Phys & Chem Biol Dept, Madrid, Spain; [Garcia-Marco, Jose A.] Hosp Univ Puerta de Hierro, Serv Hematol, Madrid 28222, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidade Federal de Santa Catarina (UFSC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Ramiro de Maeztu 9, Madrid 28040, Spain.	agarciapardo@cib.csic.es	Garcia Marco, Jose/H-2554-2015; Garcia Pardo, Angeles/G-5987-2015; Bailón, Elvira/G-5057-2015; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022	Garcia Marco, Jose/0000-0002-8993-5982; Garcia Pardo, Angeles/0000-0001-5577-2954; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Terol, Maria J/0000-0002-9467-932X	Ministerio de Ciencia e Innovacion, Spain [SAF2009-07035, RTICC RD06/0020/0011, RTICC RD06/0020/0080]; Fundacion Puerta de Hierro; Ministerio de Ciencia e Innovacion; JAE program, Consejo Superior de Investigaciones Cientificas, Spain; Carolina Foundation, Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Puerta de Hierro; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); JAE program, Consejo Superior de Investigaciones Cientificas, Spain; Carolina Foundation, Spain	This work was supported by Grants SAF2009-07035 and RTICC RD06/0020/0011 (to A. G.-P.) and RTICC RD06/0020/0080 (to M. J. T.) from the Ministerio de Ciencia e Innovacion, Spain, and by a grant from the Fundacion Puerta de Hierro (to J. A. G. M.).; Supported by a fellowship from Ministerio de Ciencia e Innovacion.; Supported by the JAE program, Consejo Superior de Investigaciones Cientificas, Spain.; Supported by the Carolina Foundation, Spain.	Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Dufour A, 2011, CANCER RES, V71, P4977, DOI 10.1158/0008-5472.CAN-10-4552; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; GARCIAPARDO A, 1990, J IMMUNOL, V144, P3361; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; Kamiguti AS, 2004, BRIT J HAEMATOL, V125, P128, DOI 10.1111/j.1365-2141.2004.04877.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Moyano JV, 1997, J BIOL CHEM, V272, P24832, DOI 10.1074/jbc.272.40.24832; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; PULIDO R, 1991, J BIOL CHEM, V266, P10241; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Ramani VC, 2011, BBA-MOL CELL RES, V1813, P1525, DOI 10.1016/j.bbamcr.2011.05.007; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Roeb E, 2002, J BIOL CHEM, V277, P50326, DOI 10.1074/jbc.M207446200; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stefanidakis M, 2003, J BIOL CHEM, V278, P34674, DOI 10.1074/jbc.M302288200; Stefanidakis M, 2009, BLOOD, V114, P3008, DOI 10.1182/blood-2008-04-148643; Till KJ, 2005, BLOOD, V105, P4813, DOI 10.1182/blood-2004-10-4054; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	41	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27601	27613		10.1074/jbc.M112.354670	http://dx.doi.org/10.1074/jbc.M112.354670			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730324	Green Published, hybrid			2022-12-28	WOS:000307840700035
J	Gifford, JL; Ishida, H; Vogel, HJ				Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.			Structural Insights into Calmodulin-regulated L-selectin Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-BINDING PROTEIN-1; RESIDUAL DIPOLAR COUPLINGS; MOUSE L-SELECTIN; CYTOPLASMIC DOMAIN; ENDOPROTEOLYTIC RELEASE; LEUKOCYTE MIGRATION; CALCIUM; NMR; KINASE; ADHESION	The L-selectin glycoprotein receptor mediates the initial steps of leukocyte migration into secondary lymphoid organs and sites of inflammation. Following cell activation through the engagement of G-protein-coupled receptors or immunoreceptors, the extracellular domains of L-selectin are rapidly shed, a process negatively controlled via the binding of the ubiquitous eukaryotic calcium-binding protein calmodulin to the cytoplasmic tail of L-selectin. Here we present the solution structure of calcium-calmodulin bound to a peptide encompassing the cytoplasmic tail and part of the transmembrane domain of L-selectin. The structure and accompanying biophysical study highlight the importance of both calcium and the transmembrane segment of L-selectin in the interaction between these two proteins, suggesting that by binding this region, calmodulin regulates in an "inside-out" fashion the ectodomain shedding of the receptor. Our structure provides the first molecular insight into the emerging new role for calmodulin as a transmembrane signaling partner.	[Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institutes of Health Research; National Science and Engineering Research Council; Alberta Ingenuity Fund; Killam Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund; Killam Fellowship	This work was supported by an operating grant from the Canadian Institutes of Health Research.; Recipient of postgraduate scholarships from the National Science and Engineering Research Council and Alberta Ingenuity Fund as well as a Killam Fellowship.	Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; BAX A, 1994, J BIOMOL NMR, V4, P787, DOI 10.1007/BF00398409; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng W, 2011, J MOL BIOL, V411, P220, DOI 10.1016/j.jmb.2011.05.041; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Furukawa Y, 2008, J BIOL CHEM, V283, P12112, DOI 10.1074/jbc.M801745200; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Haribabu B, 1997, J BIOL CHEM, V272, P13961, DOI 10.1074/jbc.272.21.13961; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; IKURA M, 1991, BIOCHEMISTRY-US, V30, P5498, DOI 10.1021/bi00236a024; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2009, J BIOL CHEM, V284, P28292, DOI 10.1074/jbc.M109.025080; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krummel MF, 2010, J CLIN IMMUNOL, V30, P364, DOI 10.1007/s10875-010-9393-6; Lai ZW, 2009, ENDOCRINOLOGY, V150, P2376, DOI 10.1210/en.2008-1274; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUDANNA C, 1994, J BIOL CHEM, V269, P4021; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Locke D, 2003, J BIOL CHEM, V278, P15441, DOI 10.1074/jbc.M212338200; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Schaff U, 2008, J LEUKOCYTE BIOL, V83, P99, DOI 10.1189/jlb.0507304; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Strausbaugh HJ, 1999, NAT MED, V5, P1057, DOI 10.1038/12497; Thiel M, 1997, EUR SURG RES, V29, P160, DOI 10.1159/000129521; Tu L, 2002, J IMMUNOL, V169, P2034, DOI 10.4049/jimmunol.169.4.2034; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094; Xu T, 2008, J LEUKOCYTE BIOL, V84, P1192, DOI 10.1189/jlb.0208084; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2009, MOL IMMUNOL, V46, P2395, DOI 10.1016/j.molimm.2009.04.024; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	76	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26513	26527		10.1074/jbc.M112.373373	http://dx.doi.org/10.1074/jbc.M112.373373			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22711531	Green Published, hybrid			2022-12-28	WOS:000307386000005
J	Montalban-Lopez, M; Sanchez-Hidalgo, M; Cebrian, R; Maqueda, M				Montalban-Lopez, Manuel; Sanchez-Hidalgo, Marina; Cebrian, Ruben; Maqueda, Mercedes			Discovering the Bacterial Circular Proteins: Bacteriocins, Cyanobactins, and Pilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NATURAL-PRODUCT BIOSYNTHESIS; IV SECRETION SYSTEM; AGROBACTERIUM-TUMEFACIENS; ENTEROCIN AS-48; ANTIMICROBIAL PEPTIDE; BACILLUS-SUBTILIS; T-PILUS; BIOGENESIS; GASSERICIN; LEADER	Over recent years, several examples of natural ribosomally synthesized circular proteins and peptides from diverse organisms have been described. They are a group of proteins for which the precursors must be post-translationally modified to join the N and C termini with a peptide bond. This feature appears to confer a range of potential advantages because these proteins show increased resistance to proteases and higher thermodynamic stability, both of which improve their biological activity. They are produced by prokaryotic and eukaryotic organisms and show diverse biological activities, related mostly to a self-defense or competition mechanism of the producer organisms, with the only exception being the circular pilins. This minireview highlights ribosomally synthesized circular proteins produced by members of the domain Bacteria: circular bacteriocins, cyanobactins, and circular pilins. Wepay special attention to the genetic organization of the biosynthetic machinery of these molecules, the role of circularization, and the differences in the possible circularization mechanisms.	[Cebrian, Ruben; Maqueda, Mercedes] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain; [Montalban-Lopez, Manuel] Univ Groningen, Dept Mol Genet, NL-9747 AG Groningen, Netherlands; [Sanchez-Hidalgo, Marina] Fdn MEDINA, Granada 18100, Spain	University of Granada; University of Groningen	Maqueda, M (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain.	mmaqueda@ugr.es	Sánchez-Hidalgo, Marina/AAA-4129-2019; Montalban-Lopez, Manuel/AAA-2871-2019; CEBRIÁN, RUBÉN/M-3311-2014; Maqueda, Mercedes/K-9667-2014	Sánchez-Hidalgo, Marina/0000-0003-1920-8242; Montalban-Lopez, Manuel/0000-0002-2936-9077; CEBRIÁN, RUBÉN/0000-0003-1575-1846; Maqueda, Mercedes/0000-0002-5874-9343; Sanchez Hidalgo, Marina/0000-0002-9210-2404				Abriouel F, 2005, SYST APPL MICROBIOL, V28, P383, DOI 10.1016/j.syapm.2005.01.007; Arakawa K, 2010, LETT APPL MICROBIOL, V50, P406, DOI 10.1111/j.1472-765X.2010.02810.x; Borrero J, 2011, APPL ENVIRON MICROB, V77, P369, DOI 10.1128/AEM.01173-10; Cebrian R, 2010, APPL ENVIRON MICROB, V76, P7268, DOI 10.1128/AEM.01154-10; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Eisenbrandt R, 2000, J BACTERIOL, V182, P6751, DOI 10.1128/JB.182.23.6751-6761.2000; Fernandez M, 2007, J APPL MICROBIOL, V102, P1350, DOI 10.1111/j.1365-2672.2006.03194.x; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Houssen WE, 2010, CHEMBIOCHEM, V11, P1867, DOI 10.1002/cbic.201000305; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Ito Y, 2009, APPL ENVIRON MICROB, V75, P6340, DOI 10.1128/AEM.00195-09; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kalkum M, 2002, TRENDS MICROBIOL, V10, P382, DOI 10.1016/S0966-842X(02)02399-5; Kalmokoff ML, 1997, APPL ENVIRON MICROB, V63, P394, DOI 10.1128/AEM.63.2.394-402.1997; Katoh T, 2011, CHEM COMMUN, V47, P9946, DOI 10.1039/c1cc12647d; Kawai Y, 2004, CURR PROTEIN PEPT SC, V5, P393, DOI 10.2174/1389203043379549; Kawulka K, 2003, J AM CHEM SOC, V125, P4726, DOI 10.1021/ja029654t; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Kemperman R, 2003, APPL ENVIRON MICROB, V69, P5839, DOI 10.1128/AEM.69.10.5839-5848.2003; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Khan H, 2010, INT J FOOD MICROBIOL, V141, P1, DOI 10.1016/j.ijfoodmicro.2010.03.005; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Kohli RM, 2003, CHEM COMMUN, P297, DOI 10.1039/b208333g; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 2002, J BACTERIOL, V184, P327, DOI 10.1128/JB.184.1.327-330.2002; LEER RJ, 1995, MICROBIOL-SGM, V141, P1629, DOI 10.1099/13500872-141-7-1629; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Martin-Visscher LA, 2008, APPL ENVIRON MICROB, V74, P4756, DOI 10.1128/AEM.00817-08; Martin-Visscher LA, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P213, DOI 10.1007/978-1-4419-7692-5_12; Martin-Visscher LA, 2009, J BIOL CHEM, V284, P28674, DOI 10.1074/jbc.M109.036459; Masuda Y, 2011, APPL ENVIRON MICROB, V77, P8164, DOI 10.1128/AEM.06348-11; Montalban-Lopez M, 2008, FEBS LETT, V582, P3237, DOI 10.1016/j.febslet.2008.08.018; Montalban-Lopez M, 2011, CURR PHARM BIOTECHNO, V12, P1205, DOI 10.2174/138920111796117364; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rivera AM, 2011, MAYO CLIN PROC, V86, P1230, DOI 10.4065/mcp.2011.0514; Sanchez-Hidalgo M, 2011, CELL MOL LIFE SCI, V68, P2845, DOI 10.1007/s00018-011-0724-4; Sawa N, 2009, APPL ENVIRON MICROB, V75, P1552, DOI 10.1128/AEM.02299-08; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; van Belkum MJ, 2011, TRENDS MICROBIOL, V19, P411, DOI 10.1016/j.tim.2011.04.004; van Heel AJ, 2011, EXPERT OPIN DRUG MET, V7, P675, DOI 10.1517/17425255.2011.573478; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wirawan RE, 2007, MICROBIOL-SGM, V153, P1619, DOI 10.1099/mic.0.2006/005967-0; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	49	34	35	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27007	27013		10.1074/jbc.R112.354688	http://dx.doi.org/10.1074/jbc.R112.354688			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22700986	Green Published, hybrid			2022-12-28	WOS:000307386000049
J	Wu, SF; Levenson, A; Kharitonenkov, A; De Luca, F				Wu, Shufang; Levenson, Amy; Kharitonenkov, Alexei; De Luca, Francesco			Fibroblast Growth Factor 21 (FGF21) Inhibits Chondrocyte Function and Growth Hormone Action Directly at the Growth Plate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-GROWTH; BETA-KLOTHO; METABOLIC REGULATOR; TRANSGENIC MICE; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-21; DIFFERENTIATION; CHONDROGENESIS; OSTEOGENESIS; ACTIVATION	Fibroblast growth factor 21 (FGF21) modulates glucose and lipid metabolism during fasting. In addition, previous evidence indicates that increased expression of FGF21 during chronic food restriction is associated with reduced bone growth and growth hormone (GH) insensitivity. In light of the inhibitory effects on growth plate chondrogenesis mediated by other FGFs, we hypothesized that FGF21 causes growth inhibition by acting directly at the long bones' growth plate. We first demonstrated the expression of FGF21, FGFR1 and FGFR3 (two receptors known to be activated by FGF21) and beta-klotho (a co-receptor required for the FGF21-mediated receptor binding and activation) in fetal and 3-week-old mouse growth plate chondrocytes. We then cultured mouse growth plate chondrocytes in the presence of graded concentrations of rhFGF21 (0.01-10 mu g/ml). Higher concentrations of FGF21 (5 and 10 mu g/ml) inhibited chondrocyte thymidine incorporation and collagen X mRNA expression. 10 ng/ml GH stimulated chondrocyte thymidine incorporation and collagen X mRNA expression, with both effects prevented by the addition in the culture medium of FGF21 in a concentration-dependent manner. In addition, FGF21 reduced GH binding in cultured chondrocytes. In cells transfected with FGFR1 siRNA or ERK 1 siRNA, the antagonistic effects of FGF21 on GH action were all prevented, supporting a specific effect of this growth factor in chondrocytes. Our findings suggest that increased expression of FGF21 during food restriction causes growth attenuation by antagonizing the GH stimulatory effects on chondrogenesis directly at the growth plate. In addition, high concentrations of FGF21 may directly suppress growth plate chondrocyte proliferation and differentiation.	[Wu, Shufang; De Luca, Francesco] Drexel Univ, St Christophers Hosp Children, Coll Med, Sect Endocrinol & Diabet, Philadelphia, PA 19134 USA; [Wu, Shufang; Levenson, Amy; De Luca, Francesco] Drexel Univ, Dept Pediat, Philadelphia, PA 19134 USA; [Kharitonenkov, Alexei] Lilly Res Labs, Indianapolis, IN 46225 USA	Drexel University; Drexel University; Eli Lilly	De Luca, F (corresponding author), Drexel Univ, St Christophers Hosp Children, Coll Med, Sect Endocrinol & Diabet, 3601 A St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu						AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; De Luca F, 1999, TRENDS ENDOCRIN MET, V10, P61, DOI 10.1016/S1043-2760(98)00120-9; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; FARNUM CE, 1987, ANAT REC, V219, P221, DOI 10.1002/ar.1092190303; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Horton WA, 2009, TRENDS ENDOCRIN MET, V20, P341, DOI 10.1016/j.tem.2009.04.003; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kubicky RA, 2012, ENDOCRINOLOGY, V153, P2287, DOI 10.1210/en.2011-1909; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; Wang O, 2001, DEVELOPMENT, V128, P3867; Weinstein M, 1998, DEVELOPMENT, V125, P3615; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	33	72	78	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26060	26067		10.1074/jbc.M112.343707	http://dx.doi.org/10.1074/jbc.M112.343707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696219	Green Published, hybrid			2022-12-28	WOS:000306916300033
J	Thi, VLD; Granier, C; Zeisel, MB; Guerin, M; Mancip, J; Granio, O; Penin, F; Lavillette, D; Bartenschlager, R; Baumert, TF; Cosset, FL; Dreux, M				Viet Loan Dao Thi; Granier, Christelle; Zeisel, Mirjam B.; Guerin, Maryse; Mancip, Jimmy; Granio, Ophelia; Penin, Francois; Lavillette, Dimitri; Bartenschlager, Ralf; Baumert, Thomas F.; Cosset, Francois-Loic; Dreux, Marlene			Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; NONSTRUCTURAL PROTEIN 5A; CELL ENTRY; APOLIPOPROTEIN-E; SR-BI; NEUTRALIZING ANTIBODIES; HUMAN HEPATOCYTES; E2 GLYCOPROTEIN; MEMBRANE-FUSION; MEDIATED ENDOCYTOSIS	Hepatitis C virus (HCV) particles assemble along the very low density lipoprotein pathway and are released from hepatocytes as entities varying in their degree of lipid and apolipoprotein (apo) association as well as buoyant densities. Little is known about the cell entry pathway of these different HCV particle subpopulations, which likely occurs by regulated spatiotemporal processes involving several cell surface molecules. One of these molecules is the scavenger receptor BI (SR-BI), a receptor for high density lipoprotein that can bind to the HCV glycoprotein E2. By studying the entry properties of infectious virus subpopulations differing in their buoyant densities, we show that these HCV particles utilize SR-BI in a manifold manner. First, SR-BI mediates primary attachment of HCV particles of intermediate density to cells. These initial interactions involve apolipoproteins, such as apolipoprotein E, present on the surface of HCV particles, but not the E2 glycoprotein, suggesting that lipoprotein components in the virion act as host-derived ligands for important entry factors such as SR-BI. Second, we found that in contrast to this initial attachment, SR-BI mediates entry of HCV particles independent of their buoyant density. This function of SR-BI does not depend on E2/SR-BI interaction but relies on the lipid transfer activity of SR-BI, probably by facilitating entry steps along with other HCV entry co-factors. Finally, our results underscore a third function of SR-BI governed by specific residues in hypervariable region 1 of E2 leading to enhanced cell entry and depending on SR-BI ability to bind to E2.	[Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] INSERM, U758, Human Virol Lab, EVIR Team, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Ecole Normale Super Lyon, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Univ Lyon, UCB Lyon1, F-69007 Lyon, France; [Viet Loan Dao Thi; Granier, Christelle; Mancip, Jimmy; Granio, Ophelia; Penin, Francois; Lavillette, Dimitri; Cosset, Francois-Loic; Dreux, Marlene] Univ Lyon, LabEx Ecofect, F-69007 Lyon, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, U748, F-67000 Strasbourg, France; [Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, F-67000 Strasbourg, France; [Guerin, Maryse] INSERM, UMRS939, Paris, France; [Penin, Francois] Univ Lyon, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Baumert, Thomas F.] Hop Univ Strasbourg, F-67000 Strasbourg, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ruprecht Karls University Heidelberg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cosset, FL (corresponding author), ENS Lyon, INSERM, U758, Human Virol Dept, 46 Allee Italie, F-69364 Lyon 07, France.	flcosset@ens-lyon.fr; marlene.dreux@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019; Dreux, Marlene/M-7295-2014; Zeisel, Mirjam B/E-9205-2016; Guerin, Maryse/N-5794-2017; Baumert, Thomas/ABF-4718-2020; Bartenschlager, Ralf/L-2582-2015	Cosset, François-Loïc/0000-0001-8842-3726; Dreux, Marlene/0000-0002-6607-4796; Zeisel, Mirjam B/0000-0003-1606-0131; Baumert, Thomas/0000-0002-8864-2168; Christelle, GRANIER/0000-0001-8987-0632; GUERIN, Maryse/0000-0003-0150-1360; Lavillette, Dimitri/0000-0002-4706-1519; Bartenschlager, Ralf/0000-0001-5601-9307; Dao Thi, Viet Loan/0000-0003-2293-3592	European Research Council [ERC-2008-AdG-233130-HEPCENT]; European Union [PCIG11-GA-2012-322377]; Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS); Region Rhone-Alpes; EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Ne; Laboratoire d'excellence HEPSYS [ANR-10-LAB-28]; Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Ne; Laboratoire d'excellence HEPSYS; Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship(French National Research Agency (ANR))	This work was supported by the European Research Council (ERC-2008-AdG-233130-HEPCENT to F.-L. C.), the European Union (PCIG11-GA-2012-322377 "HepATG," to M. D.), and the Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales (ANRS).r Supported by a predoctoral fellowship from Region Rhone-Alpes.r Supported by EU INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and the Laboratoire d'excellence HEPSYS (ANR-10-LAB-28).r Supported by an Agence Nationale pour la Recherche contre le SIDA post-doctoral fellowship.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chroni A, 2005, BIOCHEMISTRY-US, V44, P13132, DOI 10.1021/bi051029o; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Iro M, 2009, ANTIVIR RES, V83, P148, DOI 10.1016/j.antiviral.2009.04.007; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; MOYA MD, 1994, ARTERIOSCLER THROMB, V14, P1056; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schwarz AK, 2009, J VIROL, V83, P12407, DOI 10.1128/JVI.01552-09; Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Viet LDT, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001785; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	96	88	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31242	31257		10.1074/jbc.M112.365924	http://dx.doi.org/10.1074/jbc.M112.365924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22767607	Green Published, hybrid			2022-12-28	WOS:000308791300037
J	Zhao, XM; Mohan, R; Ozcan, S; Tang, XQ				Zhao, Xiaomin; Mohan, Ramkumar; Oezcan, Sabire; Tang, Xiaoqing			MicroRNA-30d Induces Insulin Transcription Factor MafA and Insulin Production by Targeting Mitogen-activated Protein 4 Kinase 4 (MAP4K4) in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; KEY REGULATOR; EXPRESSION; ALPHA; MECHANISMS; CONTRIBUTE; MIRNAS	MicroRNAs (miRNAs) represent small noncoding RNAs that play a role in many diseases, including diabetes. miRNAs target genes important for pancreas development, beta-cell proliferation, insulin secretion, and exocytosis. Previously, we documented that microRNA-30d (miR-30d), one of miRNAs up-regulated by glucose, induces insulin gene expression in pancreatic beta-cells. Here, we found that the induction of insulin production by overexpression of miR-30d is associated with increased expression of MafA, a beta-cell-specific transcription factor. Of interest, overexpression of miR-30d prevented the reduction in both MafA and insulin receptor substrate 2 (IRS2) with TNF-alpha exposure. Moreover, we identified that mitogen-activated protein 4 kinase 4 (MAP4K4), a TNF-alpha-activated kinase, is a direct target of miR-30d. Overexpression of miR-30d protected beta-cells against TNF-alpha suppression on both insulin transcription and insulin secretion through the down-regulation of MAP4K4 by the miR-30d. Adecrease of miR-30d expression was observed in the islets of diabetic db/db mice, in which MAP4K4 expression level was elevated. Our data support the notion that miR-30d plays multiple roles in activating insulin transcription and protecting beta-cell functions from impaired by proinflammatory cytokines and underscore the concept that miR-30d may represent a novel pharmacological target for diabetes intervention.	[Oezcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, Lexington, KY 40536 USA; [Zhao, Xiaomin] NW A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhao, Xiaomin; Mohan, Ramkumar; Tang, Xiaoqing] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	University of Kentucky; Northwest A&F University - China; Michigan Technological University	Ozcan, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, 741 S Limestone St,B155, Lexington, KY 40536 USA.	sozcan@uky.edu; xtang2@mtu.edu	Mohan, Ramkumar/J-9037-2019	Mohan, Ramkumar/0000-0002-1308-1642; Zhao, Xiaomin/0000-0002-1814-8586	National Institutes of Health [K01 DK078648, R03 DK084166, R01 DK067581]; American Diabetes Association [1-05-CD-15]; China Scholarship Council Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078648, R03DK084166, R01DK067581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); China Scholarship Council Fellowship(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK078648 and R03 DK084166 (to X. T.). This work was also supported in part by National Institutes of Health Grant R01 DK067581 and American Diabetes Association Grant 1-05-CD-15 (to S. O.).; Partially supported by a China Scholarship Council Fellowship.	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Vanderford NL, 2008, ARCH BIOCHEM BIOPHYS, V480, P138, DOI 10.1016/j.abb.2008.10.001; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	39	95	102	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31155	31164		10.1074/jbc.M112.362632	http://dx.doi.org/10.1074/jbc.M112.362632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22733810	Green Published, hybrid			2022-12-28	WOS:000308791300028
J	Chan, NLS; Hou, CX; Zhang, TY; Yuan, FH; Machwe, A; Huang, J; Orren, DK; Gu, LY; Li, GM				Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Huang, Jian; Orren, David K.; Gu, Liya; Li, Guo-Min			The Werner Syndrome Protein Promotes CAG/CTG Repeat Stability by Resolving Large (CAG)(n)/(CTG)(n) Hairpins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; EUKARYOTIC REPLICATION FORK; TRINUCLEOTIDE REPEATS; TRIPLET REPEATS; MISMATCH REPAIR; RECQ HELICASES; IN-VITRO; SYNDROME GENE; HUMAN-DISEASE; INSTABILITY	Expansion of CAG/CTG repeats causes certain neurological and neurodegenerative disorders, and the formation and subsequent persistence of stable DNA hairpins within these repeats are believed to contribute to CAG/CTG repeat instability. Human cells possess a DNA hairpin repair (HPR) pathway, which removes various (CAG)(n) and (CTG)(n) hairpins in a nick-directed and strand-specific manner. Interestingly, this HPR system processes a (CTG)(n) hairpin on the template DNA strand much less efficiently than a (CAG)(n) hairpin on the same strand (Hou, C., Chan, N. L., Gu, L., and Li, G. M. (2009) Incision-dependent and error-free repair of (CAG)(n)/(CTG)(n) hairpins in human cell extracts. Nat. Struct. Mol. Biol. 16, 869-875), suggesting the involvement of an additional component for (CTG)(n) HPR. To identify this activity, a functional in vitro HPR assay was used to screen partially purified HeLa nuclear fractions for their ability to stimulate (CTG)(n) HPR. We demonstrate here that the stimulating activity is the Werner syndrome protein (WRN). Although WRN contains both a 3'-> 5' helicase activity and a 3'-> 5' exonuclease activity, the stimulating activity was found to be the helicase activity, as a WRN helicase mutant failed to enhance (CTG)(n) HPR. Consistently, WRN efficiently unwound large (CTG)(n) hairpins and promoted DNA polymerase delta-catalyzed DNA synthesis using a (CTG)(n) hairpin as a template. We, therefore, conclude that WRN stimulates (CTG)(n) HPR on the template DNA strand by resolving the hairpin so that it can be efficiently used as a template for repair or replicative synthesis.	[Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Orren, David K.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Chan, Nelson L. S.; Hou, Caixia; Zhang, Tianyi; Yuan, Fenghua; Machwe, Amrita; Orren, David K.; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Zhang, Tianyi; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China	University of Kentucky; University of Kentucky; Wuhan University	Li, GM (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [GM089684, CA104333, AG027258]; Chinese 111 Project [B06018]; NATIONAL CANCER INSTITUTE [R01CA113371, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 111 Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM089684 (to G. M. L.), CA104333 (to L. G.), and AG027258 (to D. K. O.). This work was also supported by Chinese 111 Project B06018.	Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bhattacharyya S, 2005, J BIOL CHEM, V280, P33311, DOI 10.1074/jbc.M503325200; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GACY AM, 1995, CELL, V81, P533; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hou CX, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-11; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kerrest A, 2009, NAT STRUCT MOL BIOL, V16, P159, DOI 10.1038/nsmb.1544; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Mankouri HW, 2012, MOL CELL, V45, P6, DOI 10.1016/j.molcel.2011.12.015; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Orren DK, 2006, FRONT BIOSCI-LANDMRK, V11, P2657, DOI 10.2741/1999; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Ramilo C, 2002, MOL CELL BIOL, V22, P2037, DOI 10.1128/MCB.22.7.2037-2046.2002; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang TY, 2012, DNA REPAIR, V11, P201, DOI 10.1016/j.dnarep.2011.10.020; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	43	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30151	30156		10.1074/jbc.M112.389791	http://dx.doi.org/10.1074/jbc.M112.389791			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22787159	Green Published, hybrid			2022-12-28	WOS:000308579800010
J	Sharma, N; Medikayala, S; Defour, A; Rayavarapu, S; Brown, KJ; Hathout, Y; Jaiswal, JK				Sharma, Nimisha; Medikayala, Sushma; Defour, Aurelia; Rayavarapu, Sree; Brown, Kristy J.; Hathout, Yetrib; Jaiswal, Jyoti K.			Use of Quantitative Membrane Proteomics Identifies a Novel Role of Mitochondria in Healing Injured Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC IDENTIFICATION; CELL-SURFACE PROTEINS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHIES; REPAIR; REGENERATION; SARCOLEMMA; DYSFERLIN; FIBERS; DIFFERENTIATION	Skeletal muscles are proficient at healing from a variety of injuries. Healing occurs in two phases, early and late phase. Early phase involves healing the injured sarcolemma and restricting the spread of damage to the injured myofiber. Late phase of healing occurs a few days postinjury and involves interaction of injured myofibers with regenerative and inflammatory cells. Of the two phases, cellular and molecular processes involved in the early phase of healing are poorly understood. We have implemented an improved sarcolemmal proteomics approach together with in vivo labeling of proteins with modified amino acids in mice to study acute changes in the sarcolemmal proteome in early phase of myofiber injury. We find that a notable early phase response to muscle injury is an increased association of mitochondria with the injured sarcolemma. Real-time imaging of live myofibers during injury demonstrated that the increased association of mitochondria with the injured sarcolemma involves translocation of mitochondria to the site of injury, a response that is lacking in cultured myoblasts. Inhibiting mitochondrial function at the time of injury inhibited healing of the injured myofibers. This identifies a novel role of mitochondria in the early phase of healing injured myofibers.	[Sharma, Nimisha; Medikayala, Sushma; Defour, Aurelia; Rayavarapu, Sree; Brown, Kristy J.; Hathout, Yetrib; Jaiswal, Jyoti K.] Childrens Natl Med Ctr, Ctr Genet Med Res, Washington, DC 20010 USA; [Rayavarapu, Sree] George Washington Univ, Inst Biomed Sci, Washington, DC 20010 USA; [Jaiswal, Jyoti K.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20010 USA	Children's National Health System; George Washington University; George Washington University	Jaiswal, JK (corresponding author), Childrens Natl Med Ctr, Ctr Genet Med Res, 111 Michigan Ave NW, Washington, DC 20010 USA.	jkjaiswal@cnmcresearch.org	Jaiswal, Jyoti/AAD-5386-2020; Jaiswal, Jyoti/ABI-1666-2020; Jaiswal, JK/M-5891-2013	Jaiswal, Jyoti/0000-0002-5992-5185; Jaiswal, JK/0000-0002-5992-5185; Brown, Kristy/0000-0002-1047-4328; Rayavarapu, Sree/0000-0002-5833-4711; defour, aurelia/0000-0002-9114-0054	National Institutes of Health [RO1AR055686, P50AR060836, P30HD040677, R24HD050846]; National Institutes of Health, NCRR [UL1RR031988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836, R01AR055686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AR055686 and P50AR060836 (to J. K. J.). The mass spectrometry and microscopy facilities used are supported by National Institutes of Health Grants P30HD040677 (Intellectual and Developmental Disabilities Research Center) and R24HD050846 (National Center for Medical Rehabilitation Research) and National Institutes of Health, NCRR, Grant UL1RR031988 (George Washington University Children's National Medical Center, Clinical and Translational Science Institute).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Brewis IA, 2010, ADV PROTEIN CHEM STR, V80, P1, DOI [10.1016/S1876-1623(10)80001-X, 10.1016/B978-0-12-381264-3.00001-1]; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; CARPENTER S, 1989, J NEUROPATH EXP NEUR, V48, P154, DOI 10.1097/00005072-198903000-00003; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHARUK JHM, 1989, BIOCHEM J, V264, P885, DOI 10.1042/bj2640885; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Donoghue P, 2010, J PROTEOMICS, V73, P1441, DOI 10.1016/j.jprot.2010.01.014; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; Elia G, 2008, PROTEOMICS, V8, P4012, DOI 10.1002/pmic.200800097; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; FAULKNER JA, 1993, PHYS THER, V73, P911, DOI 10.1093/ptj/73.12.911; Gelfi C, 2011, J PROTEOMICS, V74, P774, DOI 10.1016/j.jprot.2011.02.028; Ghosh D, 2004, J PROTEOME RES, V3, P841, DOI 10.1021/pr049937f; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Gundry RL, 2009, MOL CELL PROTEOMICS, V8, P2555, DOI 10.1074/mcp.M900195-MCP200; HONSCHA W, 1993, BIOCHIM BIOPHYS ACTA, V1153, P175, DOI 10.1016/0005-2736(93)90403-M; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huber LA, 2003, CIRC RES, V92, P962, DOI 10.1161/01.RES.0000071748.48338.25; Jarrold B, 2005, ELECTROPHORESIS, V26, P2269, DOI 10.1002/elps.200410367; Kim BW, 2010, PROTEOMICS, V10, P2498, DOI 10.1002/pmic.200900826; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kline KG, 2010, ANNU REV BIOPHYS, V39, P291, DOI 10.1146/annurev.biophys.093008.131339; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Lewis C, 2010, ANAL BIOCHEM, V404, P197, DOI 10.1016/j.ab.2010.05.017; McClatchy DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016039; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Mellgren RL, 2010, J BIOL CHEM, V285, P36597, DOI 10.1074/jbc.M110.110015; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Ohlendieck K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-6; PAPADIMITRIOU JM, 1990, J STRUCT BIOL, V103, P124, DOI 10.1016/1047-8477(90)90016-6; Peirce Matthew J., 2009, V528, P135, DOI 10.1007/978-1-60327-310-7_10; Raddatz K, 2008, PROTEOMICS, V8, P1885, DOI 10.1002/pmic.200700902; SEILER S, 1982, J BIOL CHEM, V257, P13862; SEILER S, 1988, METHOD ENZYMOL, V157, P26; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weekes Michael P, 2010, J Biomol Tech, V21, P108; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zanivan S, 2011, METHODS MOL BIOL, V757, P435, DOI 10.1007/978-1-61779-166-6_25; Zhang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-206; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	54	36	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30455	30467		10.1074/jbc.M112.354415	http://dx.doi.org/10.1074/jbc.M112.354415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778268	Green Published, hybrid			2022-12-28	WOS:000308579800038
J	Thom, SR; Bhopale, VM; Milovanova, TN; Yang, M; Bogush, M				Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina			Thioredoxin Reductase Linked to Cytoskeleton by Focal Adhesion Kinase Reverses Actin S-Nitrosylation and Restores Neutrophil beta(2) Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; MYOCARDIAL-INFARCTION; REDOX REGULATION; NITRIC-OXIDE; INHIBITION; REPERFUSION; ADHERENCE; INJURY; BETA(2)-INTEGRIN; PHOSPHORYLATION	The investigation goal was to identify mechanisms for reversal of actin S-nitrosylation in neutrophils after exposure to high oxygen partial pressures. Prior work has shown that hyperoxia causes S-nitrosylated actin (SNO-actin) formation, which mediates beta(2) integrin dysfunction, and these changes can be reversed by formylmethionylleucylphenylalanine or 8-bromo-cyclic GMP. Herein we show that thioredoxin reductase (TrxR) is responsible for actin denitrosylation. Approximately 80% of cellular TrxR is localized to the cytosol, divided between the G-actin and short filamentous actin (sF-actin) fractions based on Triton solubility of cell lysates. TrxR linkage to sF-actin requires focal adhesion kinase (FAK) based on immunoprecipitation studies. S-Nitrosylation accelerates actin filament turnover (by mechanisms described previously (Thom, S. R., Bhopale, V. M., Yang, M., Bogush, M., Huang, S., and Milovanova, T. (2011) Neutrophil beta(2) integrin inhibition by enhanced interactions of vasodilator stimulated phosphoprotein with S-nitrosylated actin. J. Biol. Chem. 286, 32854-32865), which causes FAK to disassociate from sF-actin. TrxR subsequently dissociates from FAK, and the physical separation from actin impedes denitrosylation. If SNO-actin is photochemically reduced with UV light or if actin filament turnover is impeded by incubations with cytochalasin D, latrunculin B, 8-bromo-cGMP, or formylmethionylleucylphenylalanine, FAK and TrxR reassociate with sF-actin and cause SNO-actin removal. FAK-TrxR association can also be demonstrated using isolated enzymes in ex vivo preparations. Uniquely, the FAK kinase domain is the site of TrxR linkage. We conclude that through its scaffold function, FAK influences TrxR activity and actin S-nitrosylation.	[Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina] Univ Penn, Med Ctr, Inst Environm Med, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Med Ctr, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thom, SR (corresponding author), Univ Penn, Inst Environm, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu			Office of Naval Research; National Institutes of Health [P30CA016520, ES013508-04]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the Office of Naval Research.; Mass spectrometry analysis was provided by the Proteomics Core Facility, University of Pennsylvania, supported by National Institutes of Health Grants P30CA016520 (to the Abramson Cancer Center) and ES013508-04 (to the Center of Excellence in Environmental Toxicology).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Du P, 2005, PROTEIN EXPRES PURIF, V44, P121, DOI 10.1016/j.pep.2005.04.018; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; ILLC D, 1995, NATURE, V377, P539; Juttner B, 2003, UNDERSEA HYPERBAR M, V30, P305; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; MILESKI WJ, 1990, SURGERY, V108, P206; MILESKI WJ, 1993, J SURG RES, V54, P349, DOI 10.1006/jsre.1993.1056; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; ROSS RM, 1965, LANCET, V1, P579; Sada K, 1997, EUR J BIOCHEM, V248, P827, DOI 10.1111/j.1432-1033.1997.00827.x; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tabassam FH, 1999, CELL IMMUNOL, V193, P179, DOI 10.1006/cimm.1999.1472; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; THOM SR, 1986, J INFECT DIS, V154, P504, DOI 10.1093/infdis/154.3.504; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wang XG, 2010, ANTIOXID REDOX SIGN, V13, P565, DOI 10.1089/ars.2009.2833; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wong Howard P., 1996, Surgical Forum, V47, P705; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zheng DH, 2009, BIOCHEM BIOPH RES CO, V388, P301, DOI 10.1016/j.bbrc.2009.07.156	63	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30346	30357		10.1074/jbc.M112.355875	http://dx.doi.org/10.1074/jbc.M112.355875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22778269	hybrid, Green Published			2022-12-28	WOS:000308579800027
J	Zhang, L; Zhou, FF; Li, YH; Drabsch, Y; Zhang, J; van Dam, H; ten Dijke, P				Zhang, Long; Zhou, Fangfang; Li, Yihao; Drabsch, Yvette; Zhang, Juan; van Dam, Hans; ten Dijke, Peter			Fas-associated Factor 1 Is a Scaffold Protein That Promotes beta-Transducin Repeat-containing Protein (beta-TrCP)-mediated beta-Catenin Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTRACELLULAR DOMAIN AICD; WNT SIGNALING PATHWAY; BREAST-CANCER; KAPPA-B; MAMMARY DEVELOPMENT; DUCTAL CARCINOMA; FAF1; ACTIVATION; EXPRESSION	FAS-associated factor 1 (FAF1) antagonizes Wnt signaling by stimulating beta-catenin degradation. However, the molecular mechanism underlying this effect is unknown. Here, we demonstrate that the E3 ubiquitin ligase beta-transducin repeat-containing protein (beta-TrCP) is required for FAF1 to suppress Wnt signaling and that FAF1 specifically associates with the SCF (Skp1-Cul1-F-box protein)-beta-TrCP complex. Depletion of beta-TrCP reduced FAF1-mediated beta-catenin polyubiquitination and impaired FAF1 in antagonizing Wnt/beta-catenin signaling. FAF1 was shown to act as a scaffold for beta-catenin and beta-TrCP and thereby to potentiate beta-TrCP-mediated beta-catenin ubiquitination and degradation. Data mining revealed that FAF1 expression is statistically down-regulated in human breast carcinoma compared with normal breast tissue. Consistent with this, FAF1 expression is higher in epithelial-like MCF7 than mesenchymal-like MDA-MB-231 human breast cancer cells. Depletion of FAF1 in MCF7 cells resulted in increased beta-catenin accumulation and signaling. Importantly, FAF1 knockdown promoted a decrease in epithelial E-cadherin and an increase in mesenchymal vimentin expression, indicative for an epithelial to mesenchymal transition. Moreover, ectopic FAF1 expression reduces breast cancer cell migration in vitro and invasion/metastasis in vivo. Thus, our studies strengthen a tumor-suppressive function for FAF1.	[Zhou, Fangfang] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zhou, FF (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Bldg 2,Rm S-02-05,Postzone S-1-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.zhou@lumc.nl; p.ten_dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Zhang, Long/AAT-6571-2021	Dijke, Peter ten/0000-0002-7234-342X; Zhang, Long/0000-0001-8139-0474; Li, Yihao/0000-0003-1900-8099; van Dam, Hans/0000-0002-8307-4325	Netherlands Organization for Scientific Research [NWO 918.66.066]; Centre for Biomedical Genetics	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics	This work was supported by the Netherlands Organization for Scientific Research Grant NWO 918.66.066 and by the Centre for Biomedical Genetics.	Adham IM, 2008, MOL HUM REPROD, V14, P207, DOI 10.1093/molehr/gan009; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frohlich T, 1998, J CELL SCI, V111, P2353; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Gilles C, 2003, CANCER RES, V63, P2658; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; He S., 2012, J PATHOL IN PRESS; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JX, 2012, CHEM COMMUN, V48, P398, DOI 10.1039/c1cc15341b; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rowlands TM, 2003, P NATL ACAD SCI USA, V100, P11400, DOI 10.1073/pnas.1534601100; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003; Zhang L, 2012, BIOCHEM BIOPH RES CO, V419, P83, DOI 10.1016/j.bbrc.2012.01.132; Zhang L, 2011, MOL BIOL CELL, V22, P1617, DOI 10.1091/mbc.E10-12-0985; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200; Zhou FF, 2008, BIOCHEM BIOPH RES CO, V365, P149, DOI 10.1016/j.bbrc.2007.10.138; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou FF, 2012, PROTEIN CELL, V3, P311, DOI 10.1007/s13238-012-2027-4; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhou FF, 2011, BIOCHEM BIOPH RES CO, V412, P68, DOI 10.1016/j.bbrc.2011.07.040; Zhou FF, 2011, PROTEIN CELL, V2, P377, DOI 10.1007/s13238-011-1047-9	60	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30701	30710		10.1074/jbc.M112.353524	http://dx.doi.org/10.1074/jbc.M112.353524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22730322	Green Published, hybrid			2022-12-28	WOS:000308579800059
J	Cheng, Q; Sohl, CD; Yoshimoto, FK; Guengerich, FP				Cheng, Qian; Sohl, Christal D.; Yoshimoto, Francis K.; Guengerich, F. Peter			Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLACENTAL AROMATASE; HUMAN-LIVER; ESTROGEN 2-HYDROXYLASE; DRUG-METABOLISM; STEROID 5-ALPHA-REDUCTASE; STRUCTURAL BASIS; MODEL REACTION; IN-VITRO; AROMATIZATION; MICROSOMES	Dihydrotestosterone is a more potent androgen than testosterone and plays an important role in endocrine function. We demonstrated that, like testosterone, dihydrotestosterone can be oxidized by human cytochrome P450 (P450) 19A1, the steroid aromatase. The products identified include the 19-hydroxy- and 19-oxo derivatives and the resulting Delta(1,10)-, Delta(5,10)-, and Delta(9,10)-dehydro 19-norsteroid products (loss of 19-methyl group). The overall catalytic efficiency of oxidation was similar to 10-fold higher than reported for 3 alpha-reduction by 3 alpha-hydroxysteroid dehydrogenase, the major enzyme known to deactivate dihydrotestosterone. These and other studies demonstrate the flexibility of P450 19A1 in removing the 1- and 2-hydrogens from 19-norsteroids, the 2-hydrogen from estrone, and (in this case) the 1-, 5 beta-, and 9 beta-hydrogens of dihydrotestosterone. Incubation of dihydrotestosterone with human liver microsomes and NADPH yielded the 18- and 19-hydroxy products plus the Delta(1,10)-dehydro 19-nor product identified in the P450 19A1 reaction. The 18- and 19-hydroxylation reactions were attributed to P450 3A4, and 18- and 19-hydroxydihydrotestosterone were identified in human plasma and urine samples. The change in the pucker of the A ring caused by reduction of the Delta(4,5) bond is remarkable in shifting the course of hydroxylation from the 6 beta-, 2 beta-, 1 beta-, and 15 beta-methylene carbons (testosterone) to the axial methyl groups (18, 19) in dihydrotestosterone and demonstrates the sensitivity of P450 3A4, even with its large active site, to small changes in substrate structure.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999	National Institutes of Health [R37 CA090426, R01 GM069970, T32 ES007028, P30 ES000267]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, R01 GM069970, T32 ES007028, and P30 ES000267.	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Almadhidi J, 1996, J STEROID BIOCHEM, V59, P55, DOI 10.1016/S0960-0760(96)00085-4; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200; BRODIE AMH, 1993, PHARMACOL THERAPEUT, V60, P501, DOI 10.1016/0163-7258(93)90033-A; Carey F. A., 1990, ADV ORGANIC CHEM A, P12; Carruba G, 2009, ANN NY ACAD SCI, V1155, P187, DOI 10.1111/j.1749-6632.2009.03706.x; COLE PA, 1988, J AM CHEM SOC, V110, P1284, DOI 10.1021/ja00212a043; CONNEY AH, 1967, PHARMACOL REV, V19, P317; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Frye SV, 2006, CURR TOP MED CHEM, V6, P405, DOI 10.2174/156802606776743101; GAILLARD JL, 1987, J BIOL CHEM, V262, P5717; GED C, 1989, BRIT J CLIN PHARMACO, V28, P373, DOI 10.1111/j.1365-2125.1989.tb03516.x; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAMBURGERBAR R, 1977, ACTA ENDOCRINOL-COP, V84, P813, DOI 10.1530/acta.0.0840813; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Harada N, 1998, J CLIN ENDOCR METAB, V83, P697, DOI 10.1210/jc.83.2.697; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; KERR JA, 1966, CHEM REV, V66, P465, DOI 10.1021/cr60243a001; KNOX LH, 1965, J ORG CHEM, V30, P2198, DOI 10.1021/jo01018a019; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Krauser JA, 2004, EUR J BIOCHEM, V271, P3962, DOI 10.1111/j.1432-1033.2004.04339.x; LESCHBER G, 1989, ANDROLOGIA, V21, P529; MILLER JA, 1970, CANCER RES, V30, P559; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; OH SS, 1994, J CHEM SOC PERK T 1, P2237, DOI 10.1039/p19940002237; OKAZAKI O, 1993, J BIOL CHEM, V268, P1546; Okubo K, 1996, ENDOCR J, V43, P363, DOI 10.1507/endocrj.43.363; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; RYAN KJ, 1958, BIOCHIM BIOPHYS ACTA, V27, P658, DOI 10.1016/0006-3002(58)90408-6; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; SMUK M, 1977, J CLIN ENDOCR METAB, V45, P1009, DOI 10.1210/jcem-45-5-1009; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; TOWNSLEY JD, 1968, BIOCHEMISTRY-US, V7, P33, DOI 10.1021/bi00841a005; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	57	20	20	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29554	29567		10.1074/jbc.M112.390047	http://dx.doi.org/10.1074/jbc.M112.390047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22773874	Green Published, hybrid			2022-12-28	WOS:000308286900031
J	Feng, HZ; Chen, XQ; Hossain, MM; Jin, JP				Feng, Han-Zhong; Chen, Xuequn; Hossain, M. Moazzem; Jin, Jian-Ping			Toad Heart Utilizes Exclusively Slow Skeletal Muscle Troponin T AN EVOLUTIONARY ADAPTATION WITH POTENTIAL FUNCTIONAL BENEFITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILITY; EXTENSION; ISOFORMS; FIBERS	The three isoforms of vertebrate troponin T (TnT) are normally expressed in a muscle type-specific manner. Here we report an exception that the cardiac muscle of toad (Bufo) expresses exclusively slow skeletal muscle TnT(ssTnT) together with cardiac forms of troponin I and myosin as determined using immunoblotting, cDNA cloning, and/or LC-MS/MS. Using RT-PCR and 3'- and 5'-rapid amplification of cDNA ends on toad cardiac mRNA, we cloned full-length cDNAs encoding two alternatively spliced variants of ssTnT. Expression of the cloned cDNAs in Escherichia coli confirmed that the toad cardiac muscle expresses solely ssTnT, predominantly the low molecular weight variant with the exon 5-encoded NH2-terminal segment spliced out. Functional studies were performed in ex vivo working toad hearts and compared with the frog (Rana) hearts. The results showed that toad hearts had higher contractile and relaxation velocities and were able to work against a significantly higher afterload than that of frog hearts. Therefore, the unique evolutionary adaptation of utilizing exclusively ssTnT in toad cardiac muscle corresponded to a fitness value from improving systolic function of the heart. The data demonstrated a physiological importance of the functional diversity of TnT isoforms. The structure-function relationship of TnT may be explored for the development of new treatment of heart failure.	[Feng, Han-Zhong; Chen, Xuequn; Hossain, M. Moazzem; Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Jin, JP (corresponding author), 540 E Canfield St,Scott Hall 5374, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [AR048816, HL098945]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR048816 and HL098945 (to J. P. J.).	Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; BORAL M C, 1970, Proceedings of the Indian National Science Academy Part B Biological Sciences, V36, P369; Brotto MA, 2006, AM J PHYSIOL-CELL PH, V290, pC567, DOI 10.1152/ajpcell.00422.2005; CHATTERI.CD, 1974, AM J PHYSIOL, V226, P408, DOI 10.1152/ajplegacy.1974.226.2.408; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2011, J APPL PHYSIOL, V111, P834, DOI 10.1152/japplphysiol.00031.2011; Feng HZ, 2009, J BIOL CHEM, V284, P31798, DOI 10.1074/jbc.M109.020826; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HILLMAN SS, 1988, J COMP PHYSIOL B, V157, P807, DOI 10.1007/BF00691012; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Mazza R, 2008, AM J PHYSIOL-HEART C, V295, pH113, DOI 10.1152/ajpheart.00172.2008; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Perry SV, 2008, BIOCHEM BIOPH RES CO, V369, P43, DOI 10.1016/j.bbrc.2007.11.185; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; SIMONS JR, 1957, J PHYSIOL-LONDON, V137, P12, DOI 10.1113/jphysiol.1957.sp005793; Wei B, 2011, ARCH BIOCHEM BIOPHYS, V505, P144, DOI 10.1016/j.abb.2010.10.013; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006	27	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29753	29764		10.1074/jbc.M112.373191	http://dx.doi.org/10.1074/jbc.M112.373191			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22778265	hybrid, Green Published			2022-12-28	WOS:000308286900051
J	Karkhanis, V; Wang, L; Tae, S; Hu, YJ; Imbalzano, AN; Sif, S				Karkhanis, Vrajesh; Wang, Li; Tae, Sookil; Hu, Yu-Jie; Imbalzano, Anthony N.; Sif, Said			Protein Arginine Methyltransferase 7 Regulates Cellular Response to DNA Damage by Methylating Promoter Histones H2A and H4 of the Polymerase delta Catalytic Subunit Gene, POLD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 TRIMETHYLATION; ALKYLATION DAMAGE; EXPRESSION; COMPLEXES; REPAIR; CELLS; PRMT7; TRANSCRIPTION; LYMPHOMA; FAMILY	Covalent modification of histones by protein arginine methyltransferases (PRMTs) impacts genome organization and gene expression. In this report, we show that PRMT7 interacts with the BRG1-based hSWI/SNF chromatin remodeling complex and specifically methylates histone H2A Arg-3 (H2AR3) and histone H4 Arg-3 (H4R3). To elucidate the biological function of PRMT7, we knocked down its expression in NIH 3T3 cells and analyzed global gene expression. Our findings show that PRMT7 negatively regulates expression of genes involved in DNA repair, including ALKBH5, APEX2, POLD1, and POLD2. Chromatin immunoprecipitation (ChIP) revealed that PRMT7 and dimethylated H2AR3 and H4R3 are enriched at target DNA repair genes in parental cells, whereas PRMT7 knockdown caused a significant decrease in PRMT7 recruitment and H2AR3/H4R3 methylation. Decreased PRMT7 expression also resulted in derepression of target DNA repair genes and enhanced cell resistance to DNA-damaging agents. Furthermore, we show that BRG1 co-localizes with PRMT7 on target promoters and that expression of a catalytically inactive form of BRG1 results in derepression of PRMT7 target DNA repair genes. Remarkably, reducing expression of individual PRMT7 target DNA repair genes showed that only the catalytic subunit of DNA polymerase, POLD1, was able to resensitize PRMT7 knockdown cells to DNA-damaging agents. These results provide evidence for the important role played by PRMT7 in epigenetic regulation of DNA repair genes and cellular response to DNA damage.	[Karkhanis, Vrajesh; Wang, Li; Tae, Sookil; Sif, Said] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Hu, Yu-Jie; Imbalzano, Anthony N.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University System of Ohio; Ohio State University; University of Massachusetts System; University of Massachusetts Worcester	Sif, S (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	sif.1@osu.edu	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145	National Institutes of Health, NCI [CA116093, CA101956, GM56244, DK084278]; NATIONAL CANCER INSTITUTE [P01CA101956, R01CA116093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA116093 and CA101956 (to S. S.), GM56244 (to A. N. I.), and DK084278 (to A. N. I. and S. S.).	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Gros L, 2003, CANCER RES, V63, P164; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mishina Y, 2006, J INORG BIOCHEM, V100, P670, DOI 10.1016/j.jinorgbio.2005.12.018; Ou CY, 2011, MOL CANCER RES, V9, P660, DOI 10.1158/1541-7786.MCR-10-0223; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Sedgwick B, 2006, METHOD ENZYMOL, V408, P108, DOI 10.1016/S0076-6879(06)08008-6; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089	35	98	103	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29801	29814		10.1074/jbc.M112.378281	http://dx.doi.org/10.1074/jbc.M112.378281			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22761421	Green Published, hybrid			2022-12-28	WOS:000308286900055
J	Zhang, L; Huang, M; Blair, IA; Penning, TM				Zhang, Li; Huang, Meng; Blair, Ian A.; Penning, Trevor M.			Detoxication of Benzo[a]pyrene-7,8-dione by Sulfotransferases (SULTs) in Human Lung Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PAH O-QUINONES; ALDO-KETO REDUCTASE; HUMAN DIHYDRODIOL DEHYDROGENASE; FORM PHENOL SULFOTRANSFERASES; REACTIVE OXYGEN; CYTOSOLIC SULFOTRANSFERASES; MOLECULAR-CLONING; DNA-ADDUCTS; A549 CELLS	Polycyclic aromatic hydrocarbons (PAH) are environmental and tobacco carcinogens. Human aldo-keto reductases catalyze the metabolic activation of proximate carcinogenic PAH trans-dihydrodiols to yield electrophilic and redox-active o-quinones. Benzo[a]pyrene-7,8-dione a representative PAH o-quinone is reduced back to the corresponding catechol to generate a futile redox-cycle. We investigated whether sulfonation of PAH catechols by human sulfotransferases (SULT) could intercept the catechol in human lung cells. RT-PCR identified SULT1A1, -1A3, and -1E1 as the isozymes expressed in four human lung cell lines. The corresponding recombinant SULTs were examined for their substrate specificity. Benzo[a] pyrene-7,8-dione was reduced to benzo[a] pyrene-7,8-catechol by dithiothreitol under anaerobic conditions and then further sulfonated by the SULTs in the presence of 3'-[S-35]phosphoadenosine 5'-phosphosulfate as the sulfonate group donor. The human SULTs catalyzed the sulfonation of benzo[a] pyrene-7,8-catechol and generated two isomeric benzo[a] pyrene-7,8-catechol O-monosulfate products that were identified by reversed phase HPLC and by LC-MS/MS. The various SULT isoforms produced the two isomers in different proportions. Two-dimensional H-1 and C-13 NMR assigned the two regioisomers of benzo[a] pyrene-7,8-catechol monosulfate as 8-hydroxy-benzo[a]pyrene-7-O-sulfate (M1) and 7-hydroxy-benzo[a]pyrene-8-O-sulfate (M2), respectively. The kinetic profiles of three SULTs were different. SULT1A1 gave the highest catalytic efficiency (k(cat)/K-m) and yielded a single isomeric product corresponding to M1. By contrast, SULT1E1 showed distinct substrate inhibition and formed both M1 and M2. Based on expression levels, catalytic efficiency, and the fact that the lung cells only produce M1, it is concluded that the major isoform that can intercept benzo[a] pyrene-7,8-catechol is SULT1A1.	Univ Penn, Perelman Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Pharmacol, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu	Zhang, Li/F-9782-2013	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [P30-ES-013508, R01-CA39504, PA-DOH4100038714]; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA039504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30-ES-013508, R01-CA39504, and PA-DOH4100038714 (to T. M. P.).	Adjei AA, 2002, BIOCHEM BIOPH RES CO, V292, P402, DOI 10.1006/bbrc.2002.6658; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Burczynski ME, 1998, BIOCHEMISTRY-US, V37, P6781, DOI 10.1021/bi972725u; Burczynski ME, 1999, CANCER RES, V59, P607; CAPPIELLO M, 1989, EUR J CLIN PHARMACOL, V37, P317, DOI 10.1007/BF00679793; Carlini EJ, 2001, PHARMACOGENETICS, V11, P57, DOI 10.1097/00008571-200102000-00007; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; CAVALIERI EL, 1995, XENOBIOTICA, V25, P677, DOI 10.3109/00498259509061885; CONNEY AH, 1982, CANCER RES, V42, P4875; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Ebmeier CC, 2004, J CLIN ENDOCR METAB, V89, P5597, DOI 10.1210/jc.2003-031939; Falany CN, 1995, ANN NY ACAD SCI, V774, P59, DOI 10.1111/j.1749-6632.1995.tb17372.x; FOLDES A, 1973, BIOCHIM BIOPHYS ACTA, V327, P365, DOI 10.1016/0005-2744(73)90419-1; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Glatt H, 2004, N-S ARCH PHARMACOL, V369, P55, DOI 10.1007/s00210-003-0826-0; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; Huang M, 2012, CHEM RES TOXICOL, V25, P993, DOI 10.1021/tx200463s; Hui Y, 2008, BIOL PHARM BULL, V31, P769, DOI 10.1248/bpb.31.769; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Liu MC, 2000, J BIOL CHEM, V275, P13460, DOI 10.1074/jbc.275.18.13460; MALAVEILLE C, 1977, MUTAT RES, V44, P313, DOI 10.1016/0027-5107(77)90091-4; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MURTY VS, 1992, CHEM-BIOL INTERACT, V84, P169, DOI 10.1016/0009-2797(92)90077-X; MURTY VS, 1992, BIOCONJUGATE CHEM, V3, P218, DOI 10.1021/bc00015a003; Nagar S, 2006, MOL PHARMACOL, V69, P2084, DOI 10.1124/mol.105.019240; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Nesnow S, 1995, TOXICOLOGY, V105, P403, DOI 10.1016/0300-483X(95)03238-B; Pai TG, 2002, BBA-GEN SUBJECTS, V1573, P165, DOI 10.1016/S0304-4165(02)00416-6; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Raftogianis RB, 1999, BIOCHEM PHARMACOL, V58, P605, DOI 10.1016/S0006-2952(99)00145-8; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Sakakibara Y, 1998, J BIOL CHEM, V273, P6242, DOI 10.1074/jbc.273.11.6242; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 1996, CANCER RES, V56, P2979; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Shultz CA, 2011, CHEM RES TOXICOL, V24, P2153, DOI 10.1021/tx200294c; Somers GI, 2007, DRUG METAB DISPOS, V35, P1797, DOI 10.1124/dmd.107.015966; Stanley EL, 2005, MOL CELL ENDOCRINOL, V240, P32, DOI 10.1016/j.mce.2005.06.003; Taskinen J, 2003, DRUG METAB DISPOS, V31, P1187, DOI 10.1124/dmd.31.9.1187; Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zhang L, 2011, J BIOL CHEM, V286, P25644, DOI 10.1074/jbc.M111.240739	50	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29909	29920		10.1074/jbc.M112.386052	http://dx.doi.org/10.1074/jbc.M112.386052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22782890	Green Published, hybrid			2022-12-28	WOS:000308286900064
J	Dean, JL; McClendon, AK; Knudsen, ES				Dean, Jeffry L.; McClendon, A. Kathleen; Knudsen, Erik S.			Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR-ACTIVITY; CYCLIN D; RECOMBINATION; REPAIR; PHOSPHORYLATION; SUPPRESSION; RB; ASSOCIATION; DEFICIENCY; ACTIVATION	The RB/E2F axis represents a critical node of cell signaling that integrates a diverse array of signaling pathways. Recent evidence has suggested a role for E2F-mediated gene transcription in DNA damage response and repair, as well as apoptosis signaling. Herein, we investigated how repression of E2F activity via CDK4/6 inhibition and RB activation impacts the response of triple negative breast cancer (TNBC) to frequently used therapeutic agents. In combination with taxanes and anthracyclines CDK4/6 inhibition and consequent cell cycle arrest prevented the induction of DNA damage and associated cell death in an RB-dependent manner; thereby demonstrating antagonism between the cytostatic influence of the CDK-inhibitor and cytotoxic agents. As many of these effects were secondary to cell cycle arrest, gamma-irradiation (IR) was utilized to examine effects of CDK4/6 inhibition on direct DNA damage. Although E2F controls a number of genes involved in DNA repair (e. g. Rad51), CDK4/6 inhibition did not alter the overall rate of DNA repair, rather it significantly shifted the burden of this repair from homologous recombination (HR) to non-homologous end joining (NHEJ). Together, these data indicate that CDK4/6 inhibition can antagonize cytotoxic therapeutic strategies and increases utilization of error-prone DNA repair mechanisms that could contribute to disease progression.	[Dean, Jeffry L.; McClendon, A. Kathleen; Knudsen, Erik S.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Center, Philadelphia, PA 19107 USA	Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Center, 233 S 10th St BLSB-650, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org			NATIONAL CANCER INSTITUTE [R01CA129134] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JY, 2000, CANCER RES, V60, P5934; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McClendon AK, 2011, GASTROENTEROLOGY, V141, P1439, DOI 10.1053/j.gastro.2011.06.046; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Schild D, 2010, NUCLEIC ACIDS RES, V38, P1061, DOI 10.1093/nar/gkp1063; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Trere D, 2009, ANN ONCOL, V20, P1818, DOI 10.1093/annonc/mdp209; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753	36	108	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29075	29087		10.1074/jbc.M112.365494	http://dx.doi.org/10.1074/jbc.M112.365494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733811	Green Published, hybrid			2022-12-28	WOS:000308074600074
J	Kang, MG; Nuriya, M; Guo, YR; Martindale, KD; Lee, DZ; Huganir, RL				Kang, Myoung-Goo; Nuriya, Mutsuo; Guo, Yurong; Martindale, Kevin D.; Lee, Daniel Z.; Huganir, Richard L.			Proteomic Analysis of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate Receptor Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; AMPA-RECEPTOR; GLUR1 SUBUNIT; BIOCHEMICAL-CHARACTERIZATION; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; CDC42 ACTIVATOR; PHOSPHORYLATION; BINDING; NMDA	The AMPA receptor (AMPA-R) is a major excitatory neurotransmitter receptor in the brain. Identifying and characterizing the neuronal proteins interacting with AMPA-Rs have provided important information about the molecular mechanisms underlying synaptic transmission and plasticity. In this study, to identify more AMPA-R interactors in vivo, we performed proteomic analyses of AMPA-R complexes from the brain. AMPA-Rcomplexes were isolated from the brain through various combinations of biochemical techniques for solubilization, enrichment, and immunoprecipitation. Mass spectrometry analyses of these isolated complexes identified several novel components of the AMPA-R complexes as well as some previously identified components. The identification of these novel components helps to further define the complex mechanisms involved in the regulation of AMPA receptor function and synaptic plasticity.	[Kang, Myoung-Goo; Martindale, Kevin D.; Lee, Daniel Z.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Kang, Myoung-Goo; Nuriya, Mutsuo; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Nuriya, Mutsuo] Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 1608582, Japan; [Guo, Yurong] Univ Calif San Diego, Susan Taylor Lab, La Jolla, CA 92093 USA	University of Texas System; University of Texas Medical Branch Galveston; Howard Hughes Medical Institute; Johns Hopkins University; Keio University; University of California System; University of California San Diego	Kang, MG (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	mykang@utmb.edu; rhuganir@jhmi.edu	Nuriya, Mutsuo/J-5928-2013	Nuriya, Mutsuo/0000-0002-5689-8222; Kang, Myoung-Goo/0000-0003-2649-219X	National Institutes of Health [R01NS036715, N01-HV-28180]; Epilepsy Foundation; University of Texas Medical Branch; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; University of Texas Medical Branch; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS036715 (to R. L. H.) and N01-HV-28180 (to Y. G.).; Supported by an Epilepsy Foundation Postdoctoral Fellowship and start-up fund from University of Texas Medical Branch. To whom correspondence may be addressed: Dept. of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555-1069. Tel.: 409-772-1186; Fax: 409-762-9382; E-mail: mykang@utmb.edu.	BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Chang YC, 1996, BIOCHEM J, V319, P49, DOI 10.1042/bj3190049; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Clark RAC, 1998, J NEUROCHEM, V70, P2594; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Guo YR, 2005, PROTEOMICS, V5, P4608, DOI 10.1002/pmic.200500052; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Moon IS, 2001, CEREB CORTEX, V11, P238, DOI 10.1093/cercor/11.3.238; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Rubio ME, 1999, J NEUROCHEM, V73, P942, DOI 10.1046/j.1471-4159.1999.0730942.x; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	47	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28632	28645		10.1074/jbc.M111.336644	http://dx.doi.org/10.1074/jbc.M111.336644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22753414	hybrid, Green Published			2022-12-28	WOS:000308074600037
J	Kurokawa, S; Hill, KE; McDonald, WH; Burk, RF				Kurokawa, Suguru; Hill, Kristina E.; McDonald, W. Hayes; Burk, Raymond F.			Long Isoform Mouse Selenoprotein P (Sepp1) Supplies Rat Myoblast L8 Cells with Selenium via Endocytosis Mediated by Heparin Binding Properties and Apolipoprotein E Receptor-2 (ApoER2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; NEUROLOGICAL DYSFUNCTION; GLUTATHIONE-PEROXIDASE; PROTEIN; BRAIN; IDENTIFICATION; DELETION; DEGRADATION; PLASMA; TESTIS	In vivo studies have shown that selenium is supplied to testis and brain by apoER2-mediated endocytosis of Sepp1. Although cultured cell lines have been shown to utilize selenium from Sepp1 added to the medium, the mechanism of uptake and utilization has not been characterized. Rat L8 myoblast cells were studied. They took up mouse Sepp1 from the medium and used its selenium to increase their glutathione peroxidase (Gpx) activity. L8 cells did not utilize selenium from Gpx3, the other plasma selenoprotein. Neither did they utilize it from Sepp1(Delta 240-361), the isoform of Sepp1 that lacks the selenium-rich C-terminal domain. To identify Sepp1 receptors, a solubilized membrane fraction was passed over a Sepp1 column. The receptors apoER2 and Lrp1 were identified in the eluate by mass spectrometry. siRNA experiments showed that knockdown of apoER2, but not of Lrp1, inhibited Se-75 uptake from Se-75-labeled Sepp1. The addition of protamine to the medium or treatment of the cells with chlorate also inhibited Se-75 uptake. Blockage of lysosome acidification did not inhibit uptake of Sepp1 but did prevent its digestion and thereby utilization of its selenium. These results indicate that L8 cells take up Sepp1 by an apoER2-mediated mechanism requiring binding to heparin sulfate proteoglycans. The presence of at least part of the selenium-rich C-terminal domain of Sepp1 is required for uptake. RT-PCR showed that mouse tissues express apoER2 in varying amounts. It is postulated that apoER2-mediated uptake of long isoform Sepp1 is responsible for selenium distribution to tissues throughout the body.	[Burk, Raymond F.] Vanderbilt Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med,Vanderbilt Med Ctr, Nashville, TN 37232 USA; [McDonald, W. Hayes] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Vanderbilt Prote Lab,Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Burk, RF (corresponding author), Vanderbilt Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med,Vanderbilt Med Ctr, 1030C Med Res Bldg 4, Nashville, TN 37232 USA.	raymond.burk@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	National Institutes of Health [R37 ES02497, 5P30 DK058404, 5P30 ES000267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 ES02497, 5P30 DK058404, and 5P30 ES000267.	AVISSAR N, 1994, AM J PHYSIOL, V266, pC367, DOI 10.1152/ajpcell.1994.266.2.C367; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P7854; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Hirashima M, 2003, BIOL PHARM BULL, V26, P794; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Meplan C, 2009, ANTIOXID REDOX SIGN, V11, P2631, DOI [10.1089/ars.2009.2533, 10.1089/ARS.2009.2533]; Muccioli M., 2011, J VIS EXP, V52, P2785; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Sarrazin S., 2011, CSH PERSPECT BIOL, V3; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	28	38	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28717	28726		10.1074/jbc.M112.383521	http://dx.doi.org/10.1074/jbc.M112.383521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22761431	hybrid, Green Published			2022-12-28	WOS:000308074600045
J	Batters, C; Woodall, KA; Toseland, CP; Hundschell, C; Veigel, C				Batters, Christopher; Woodall, Katy A.; Toseland, Christopher P.; Hundschell, Christian; Veigel, Claudia			Cloning, Expression, and Characterization of a Novel Molecular Motor, Leishmania Myosin-XXI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; LARGE WORKING STROKE; UBIQUITIN-BINDING; CALMODULIN; DOMAINS; ACTIN; VI; RECOGNITION; MOTILITY; COMPLEX	The genome of the Leishmania parasite contains two classes of myosin. Myosin-XXI, seemingly the only myosin isoform expressed in the protozoan parasite, has been detected in both the promastigote and amastigote stages of the Leishmania life cycle. It has been suggested to perform a variety of functions, including roles in membrane anchorage, but also long-range directed movements of cargo. However, nothing is known about the biochemical or mechanical properties of this motor. Here we designed and expressed various myosin-XXI constructs using a baculovirus expression system. Both full-length (amino acids 1-1051) and minimal motor domain constructs (amino acids 1-800) featured actin-activated ATPase activity. Myosin-XXI was soluble when expressed either with or without calmodulin. In the presence of calcium (pCa 4.1) the full-length motor could bind a single calmodulin at its neck domain (probably amino acids 809-823). Calmodulin binding was required for motility but not for ATPase activity. Once bound, calmodulin remained stably attached independent of calcium concentration (pCa 3-7). In gliding filament assays, myosin-XXI moved actin filaments at similar to 15 nm/s, insensitive to both salt (25-1000 mM KCl) and calcium concentrations (pCa 3-7). Calmodulin binding to the neck domain might be involved in regulating the motility of the myosin-XXI motor for its various cellular functions in the different stages of the Leishmania parasite life cycle.	[Veigel, Claudia] Univ Munich, Dept Cellular Physiol, D-80336 Munich, Germany; Univ Munich, Ctr Nanosci CeNS, D-80336 Munich, Germany	University of Munich; University of Munich	Veigel, C (corresponding author), Univ Munich, Dept Cellular Physiol, Schillerstr 44, D-80336 Munich, Germany.	claudia.veigel@med.uni-muenchen.de	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535	Deutsche Forschungsgemeinschaft [SFB 863]; Friedrich-Baur Stiftung; Munich Centre for Nanoscience (CeNS); EMBO long-term fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Baur Stiftung; Munich Centre for Nanoscience (CeNS); EMBO long-term fellowship(European Molecular Biology Organization (EMBO))	This work was funded by the Deutsche Forschungsgemeinschaft SFB 863, by the Friedrich-Baur Stiftung, and by the Munich Centre for Nanoscience (CeNS). This work was also supported by an EMBO long-term fellowship (to C. P. T.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; COLUCCIO LM, 1994, J CELL SCI, V107, P2279; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dunn AR, 2010, P NATL ACAD SCI USA, V107, P7746, DOI 10.1073/pnas.1002430107; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Katta SS, 2010, J CELL SCI, V123, P2034, DOI 10.1242/jcs.064725; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kron S. J., 1991, METH ENZYMOL, V196, P399, DOI [10.1016/0076-6879(91)96035-P, DOI 10.1016/0076-6879(91)96035-P]; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Molloy JE, 2000, FEBS LETT, V480, P293, DOI 10.1016/S0014-5793(00)01937-2; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; OHNO H, 1986, BIOCHEM J, V235, P553, DOI 10.1042/bj2350553; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; TRYBUS KM, 1994, J CELL BIOL, V124, P963, DOI 10.1083/jcb.124.6.963; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang B, 2004, PROTEIN SCI, V13, P3285, DOI 10.1110/ps.04928204	38	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27556	27566		10.1074/jbc.M112.381301	http://dx.doi.org/10.1074/jbc.M112.381301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22718767	Green Published, hybrid			2022-12-28	WOS:000307840700031
J	Roy, A; Cingolani, G				Roy, Ankoor; Cingolani, Gino			Structure of P22 Headful Packaging Nuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; DNA ENCAPSULATION; TERMINASE; PHAGE-P22; BINDING; BACTERIOPHAGE-P22; INITIATION; MOTOR; TRYPTOPHAN; MECHANISM	Packaging of viral genomes into preformed procapsids requires the controlled and synchronized activity of an ATPase and a genome-processing nuclease, both located in the large terminase (L-terminase) subunit. In this paper, we have characterized the structure and regulation of bacteriophage P22 L-terminase (gp2). Limited proteolysis reveals a bipartite organization consisting of an N-terminal ATPase core flexibly connected to a C-terminal nuclease domain. The 2.02 angstrom crystal structure of P22 headful nuclease obtained by in-drop proteolysis of full-length L-terminase (FL-L-terminase) reveals a central seven-stranded beta-sheet core that harbors two magnesium ions. Modeling studies with DNA suggest that the two ions are poised for two-metal ion-dependent catalysis, but the nuclease DNA binding surface is sterically hindered by a loop-helix (L-1-alpha(2)) motif, which is incompatible with catalysis. Accordingly, the isolated nuclease is completely inactive in vitro, whereas it exhibits endonucleolytic activity in the context of FL-L-terminase. Deleting the autoinhibitory L-1-alpha(2) motif (or just the loop L-1) restores nuclease activity to a level comparable with FL-L-terminase. Together, these results suggest that the activity of P22 headful nuclease is regulated by intramolecular cross-talk with the N-terminal ATPase domain. This cross-talk allows for precise and controlled cleavage of DNA that is essential for genome packaging.	[Roy, Ankoor; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu			National Institutes of Health [1R56 AI095974-01, 1R01GM100888-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56 AI095974-01 and 1R01GM100888-01A1 (to G.C.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; BOTSTEIN D, 1968, COLD SPRING HARB SYM, V33, P659, DOI 10.1101/SQB.1968.033.01.075; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; BRAVO A, 1990, NUCLEIC ACIDS RES, V18, P2881, DOI 10.1093/nar/18.10.2881; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1987, J MOL BIOL, V194, P411, DOI 10.1016/0022-2836(87)90671-1; CASJENS S, 1992, J MOL BIOL, V227, P1086, DOI 10.1016/0022-2836(92)90523-M; Casjens Sherwood, 2005, P80; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; EBELTSIPIS J, 1972, J MOL BIOL, V71, P433, DOI 10.1016/0022-2836(72)90361-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Ghosh-Kumar M, 2011, NUCLEIC ACIDS RES, V39, P2742, DOI 10.1093/nar/gkq1191; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Jain AA, 2003, BBA-GEN SUBJECTS, V1622, P73, DOI 10.1016/S0304-4165(03)00119-3; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; LASKI F, 1982, J MOL BIOL, V154, P565, DOI 10.1016/S0022-2836(82)80015-6; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; Lorenzen K, 2008, J MOL BIOL, V379, P385, DOI 10.1016/j.jmb.2008.02.017; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mitchell MS, 2004, VIROLOGY, V321, P217, DOI 10.1016/j.virol.2003.11.006; Moore SD, 2002, J MOL BIOL, V315, P975, DOI 10.1006/jmbi.2001.5275; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pedulla ML, 2003, J BACTERIOL, V185, P1475, DOI 10.1128/JB.185.4.1475-1477.2003; POTEETE AR, 1979, VIROLOGY, V95, P565, DOI 10.1016/0042-6822(79)90509-9; RAJ AS, 1974, MOL GEN GENET, V135, P175, DOI 10.1007/BF00264784; RAJESWARI MR, 1987, BIOCHEMISTRY-US, V26, P6825, DOI 10.1021/bi00395a036; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Roy A., 2011, STRUCTURE, DOI org/10.1016/j.str.2012.05.01; Roy A, 2011, ACTA CRYSTALLOGR F, V67, P104, DOI 10.1107/S174430911004697X; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	52	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28196	28205		10.1074/jbc.M112.349894	http://dx.doi.org/10.1074/jbc.M112.349894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22715098	Green Published, hybrid			2022-12-28	WOS:000307840700093
J	Zhang, XH; He, X; Baker, J; Tama, F; Chang, G; Wright, SH				Zhang, Xiaohong; He, Xiao; Baker, Joseph; Tama, Florence; Chang, Geoffrey; Wright, Stephen H.			Twelve Transmembrane Helices Form the Functional Core of Mammalian MATE1 (Multidrug and Toxin Extruder 1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; BORDER MEMBRANE-VESICLES; MOLECULAR-DYNAMICS SIMULATIONS; MAJOR FACILITATOR SUPERFAMILY; FINAL EXCRETION STEP; RAT PROXIMAL TUBULE; H+ EXCHANGER; TETRAETHYLAMMONIUM TRANSPORT; SUBSTRATE RECOGNITION; PK(A) VALUES	The x-ray structure of the prototypic MATE family member, NorM from Vibrio cholerae, reveals a protein fold composed of 12 transmembrane helices (TMHs), confirming hydropathy analyses of the majority of (prokaryotic and plant) MATE transporters. However, the mammalian MATEs are generally predicted to have a 13th TMH and an extracellular C terminus. Here we affirm this prediction, showing that the C termini of epitope-tagged, full-length human, rabbit, and mouse MATE1 were accessible to antibodies from the extracellular face of the membrane. Truncation of these proteins at or near the predicted junction between the 13th TMH and the long cytoplasmic loop that precedes it resulted in proteins that (i) trafficked to the membrane and (ii) interacted with antibodies only after permeabilization of the plasma membrane. CHO cells expressing rbMate1 truncated at residue Gly-545 supported levels of pH-sensitive transport similar to that of cells expressing the full-length protein. Although the high transport rate of the Gly-545 truncation mutant was associated with higher levels of membrane expression (than full-length MATE1), suggesting the 13th TMH may influence substrate translocation, the selectivity profile of the mutant indicated that TMH13 has little impact on ligand binding. We conclude that the functional core of MATE1 consists of 12 (not 13) TMHs. Therefore, we used the x-ray structure of NorM to develop a homology model of the first 12 TMHs of MATE1. The model proved to be stable in molecular dynamic simulations and agreed with topology evident from preliminary cysteine scanning of intracellular versus extracellular loops.	[Wright, Stephen H.] Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA; [Baker, Joseph; Tama, Florence; Wright, Stephen H.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85724 USA; [Baker, Joseph; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Arizona; University of Arizona; Scripps Research Institute	Wright, SH (corresponding author), Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA.	shwright@u.arziona.edu	tama, florence/S-2733-2019; Tama, Florence/A-7077-2016	tama, florence/0000-0003-2021-5618; Tama, Florence/0000-0003-2021-5618; Baker, Joseph/0000-0003-1286-6605	National Institutes of Health [1R01DK080801, 1U54GM094610, 5P30ES006694]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK080801, 1U54GM094610, and 5P30ES006694. This work was also supported by the Skaggs Institute for Chemical Biology.	Asaka J, 2007, MOL PHARMACOL, V71, P1487, DOI 10.1124/mol.106.032938; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen Y, 2007, J PHARMACOL EXP THER, V322, P695, DOI 10.1124/jpet.107.123554; Dangprapai Y, 2011, AM J PHYSIOL-RENAL, V301, pF520, DOI 10.1152/ajprenal.00075.2011; DANTZLER WH, 1991, AM J PHYSIOL, V261, pF386, DOI 10.1152/ajprenal.1991.261.3.F386; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVID C, 1995, PFLUG ARCH EUR J PHY, V430, P477, DOI 10.1007/BF00373884; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hiasa M, 2006, AM J PHYSIOL-CELL PH, V291, pC678, DOI 10.1152/ajpcell.00090.2006; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; HORI R, 1989, J BIOL CHEM, V264, P12232; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kobara A, 2008, ARCH BIOCHEM BIOPHYS, V469, P195, DOI 10.1016/j.abb.2007.10.010; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Komatsu T, 2011, INT J BIOCHEM CELL B, V43, P913, DOI 10.1016/j.biocel.2011.03.005; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MALO C, 1991, J MEMBRANE BIOL, V122, P127, DOI 10.1007/BF01872636; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; Matsumoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC1074, DOI 10.1152/ajpcell.00504.2007; MEIJER DKF, 1990, J PHARMACOKINET BIOP, V18, P35, DOI 10.1007/BF01063621; MONTROSERAFIZADEH C, 1987, BIOCHIM BIOPHYS ACTA, V904, P175, DOI 10.1016/0005-2736(87)90102-7; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pelis RM, 2006, AM J PHYSIOL-RENAL, V290, pF1118, DOI 10.1152/ajprenal.00462.2005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; SCHALI C, 1983, AM J PHYSIOL, V245, pF238, DOI 10.1152/ajprenal.1983.245.2.F238; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Tandon SK, 1996, FUND APPL TOXICOL, V31, P141, DOI 10.1006/faat.1996.0085; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Ullrich KJ, 1996, PFLUG ARCH EUR J PHY, V432, P471, DOI 10.1007/s004240050159; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Watanabe S, 2010, J PHARMACOL EXP THER, V334, P651, DOI 10.1124/jpet.110.169433; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; WRIGHT SH, 1995, PFLUG ARCH EUR J PHY, V429, P313, DOI 10.1007/BF00374145; WRIGHT SH, 1988, J BIOL CHEM, V263, P19494; Wright SH, 1999, PFLUG ARCH EUR J PHY, V437, P603, DOI 10.1007/s004240050823; Zhang XH, 2007, AM J PHYSIOL-RENAL, V293, pF360, DOI 10.1152/ajprenal.00102.2007; Zhang XH, 2009, AM J PHYSIOL-RENAL, V297, pF263, DOI 10.1152/ajprenal.00123.2009; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	57	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27971	27982		10.1074/jbc.M112.386979	http://dx.doi.org/10.1074/jbc.M112.386979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722930	Green Published, hybrid			2022-12-28	WOS:000307840700071
J	Aboye, TL; Camarero, JA				Aboye, Teshome L.; Camarero, Julio A.			Biological Synthesis of Circular Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLOTIDE MCOTI-I; EXPRESSED PROTEIN LIGATION; CHEMICAL LIGATION; BACKBONE CYCLIZATION; CYCLIC-PEPTIDES; BIOSYNTHESIS; SORTASE; VIVO; STABILITY; SUNFLOWER	Here, we review the use of different biochemical approaches for biological synthesis of circular or backbone-cyclized proteins and peptides. These methods allow the production of circular polypeptides either in vitro or in vivo using standard recombinant DNA expression techniques. Protein circularization can significantly impact protein engineering and research in protein folding. Basic polymer theory predicts that circularization should lead to a net thermodynamic stabilization of a folded protein by reducing the entropy associated with the unfolded state. Protein cyclization also provides a valuable tool for exploring the effects of topology on protein folding kinetics. Furthermore, the biological production of cyclic polypeptides makes possible the production of cyclic polypeptide libraries. The generation of such libraries, which was previously restricted to the domain of synthetic chemists, now offers biologists access to highly diverse and stable molecular libraries for probing protein structure and function.	[Aboye, Teshome L.; Camarero, Julio A.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA; [Camarero, Julio A.] Univ So Calif, Dept Chem, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Camarero, JA (corresponding author), Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA.	jcamarer@usc.edu	Camarero, Julio A./A-9628-2015	Camarero, Julio A./0000-0001-9150-0665	National Institutes of Health Research [R01 GM090323]; Department of Defense Congressionally Directed Medical Research Program [PC09305]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090323] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01 GM090323 and Department of Defense Congressionally Directed Medical Research Program Grant PC09305 (to J. A. C.). This is the fifth article in the Thematic Minireview Series on Circular Proteins.	Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Austin J, 2010, AMINO ACIDS, V38, P1313, DOI 10.1007/s00726-009-0338-4; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Berrade L, 2009, CELL MOL LIFE SCI, V66, P3909, DOI 10.1007/s00018-009-0122-3; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Camarero JA, 1998, J PEPT RES, V51, P303; Camarero JA, 1998, ANGEW CHEM INT EDIT, V37, P347, DOI 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5; Camarero JA, 1999, J AM CHEM SOC, V121, P5597, DOI 10.1021/ja990929n; Camarero JA, 2001, BIOORGAN MED CHEM, V9, P2479, DOI 10.1016/S0968-0896(01)00217-6; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Camarero JA, 2007, CHEMBIOCHEM, V8, P1363, DOI 10.1002/cbic.200700183; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Clark RJ, 2012, TOXICON, V59, P446, DOI 10.1016/j.toxicon.2010.12.003; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Contreras J, 2011, J CONTROL RELEASE, V155, P134, DOI 10.1016/j.jconrel.2011.08.030; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Deschuyteneer G, 2010, ACS CHEM BIOL, V5, P691, DOI 10.1021/cb100072u; Garcia AE, 2011, BIOCHEMISTRY-US, V50, P10508, DOI 10.1021/bi201430f; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Gould A, 2012, MOL BIOSYST, V8, P1359, DOI 10.1039/c2mb05451e; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kimura R, 2005, PROTEIN PEPTIDE LETT, V12, P789, DOI 10.2174/0929866054864274; Kimura RH, 2006, ANGEW CHEM INT EDIT, V45, P973, DOI 10.1002/anie.200503882; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Ohta A, 2008, CURR OPIN CHEM BIOL, V12, P159, DOI 10.1016/j.cbpa.2007.12.009; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Sancheti H, 2009, ADV DRUG DELIVER REV, V61, P908, DOI 10.1016/j.addr.2009.07.003; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Suter B, 2008, CURR OPIN BIOTECH, V19, P316, DOI 10.1016/j.copbio.2008.06.005; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; THORNTON JM, 1983, J MOL BIOL, V167, P443, DOI 10.1016/S0022-2836(83)80344-1; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Young TS, 2011, P NATL ACAD SCI USA, V108, P11052, DOI 10.1073/pnas.1108045108	50	62	66	3	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27026	27032		10.1074/jbc.R111.305508	http://dx.doi.org/10.1074/jbc.R111.305508			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22707722	hybrid, Green Published			2022-12-28	WOS:000307386000052
J	Lloris-Garcera, P; Bianchi, F; Slusky, JSG; Seppala, S; Daley, DO; von Heijne, G				Lloris-Garcera, Pilar; Bianchi, Frans; Slusky, Joanna S. G.; Seppala, Susanna; Daley, Daniel O.; von Heijne, Gunnar			Antiparallel Dimers of the Small Multidrug Resistance Protein EmrE Are More Stable Than Parallel Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ESCHERICHIA-COLI; TRANSPORTER; TOPOLOGY; EVOLUTION; MODEL	The bacterial multidrug transporter EmrE is a dual-topology membrane protein and as such is able to insert into the membrane in two opposite orientations. The functional form of EmrE is a homodimer; however, the relative orientation of the subunits in the dimer is under debate. Using EmrE variants with fixed, opposite orientations in the membrane, we now show that, although the proteins are able to form parallel dimers, an antiparallel organization of the subunits in the dimer is preferred. Blue-native PAGE analyses of intact oligomers and disulfide cross-linking demonstrate that in membranes, the proteins form parallel dimers only if no oppositely orientated partner is present. Co-expression of oppositely orientated proteins almost exclusively yields antiparallel dimers. Finally, parallel dimers can be disrupted and converted into antiparallel dimers by heating of detergent-solubilized protein. Importantly, in vivo function is correlated clearly to the presence of antiparallel dimers. Our results suggest that an antiparallel arrangement of the subunits in the dimer is more stable than a parallel organization and likely corresponds to the functional form of the protein.	[Lloris-Garcera, Pilar; Bianchi, Frans; Slusky, Joanna S. G.; Seppala, Susanna; Daley, Daniel O.; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	Bianchi, Frans/E-8796-2018; von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	Bianchi, Frans/0000-0002-9385-9695; von Heijne, Gunnar/0000-0002-4490-8569; Slusky, Joanna/0000-0003-0842-6340; Daley, Daniel/0000-0002-6425-5059; Seppala, Susanna/0000-0002-2983-3669	European Research Council [ERC-2008-AdG 232648]; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Foundation; European Communities TranSys Grant [PITN-2008-215524]; International Human Frontier Science Program Organization	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Communities TranSys Grant; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by European Research Council Grant ERC-2008-AdG 232648, the Swedish Foundation for Strategic Research, the Swedish Research Council, and the Swedish Cancer Foundation (to G. v. H.); the European Communities TranSys Grant PITN-2008-215524 (to P. L. G.); and the International Human Frontier Science Program Organization (to J. S. G. S.).	Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611	17	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26052	26059		10.1074/jbc.M112.357590	http://dx.doi.org/10.1074/jbc.M112.357590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22700980	Green Published, hybrid			2022-12-28	WOS:000306916300032
J	Tokhtaeva, E; Clifford, RJ; Kaplan, JH; Sachs, G; Vagin, O				Tokhtaeva, Elmira; Clifford, Rebecca J.; Kaplan, Jack H.; Sachs, George; Vagin, Olga			Subunit Isoform Selectivity in Assembly of Na,K-ATPase alpha-beta Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NA+-K+-ATPASE; ADHESION MOLECULE; IDENTIFICATION; EXPRESSION; ISOZYMES; GLIA; AMOG; NA+,K+-ATPASES; HETEROGENEITY	To catalyze ion transport, the Na,K-ATPase must contain one alpha and one beta subunit. When expressed by transfection in various expression systems, each of the four alpha subunit isoforms can assemble with each of the three beta subunit isoforms and form an active enzyme, suggesting the absence of selective alpha-beta isoform assembly. However, it is unknown whether in vivo conditions the alpha-beta assembly is random or isoform-specific. The alpha(2)-beta(2) complex was selectively immunoprecipitated by both anti-alpha(2) and anti-beta(2) antibodies from extracts of mouse brain, which contains cells co-expressing multiple Na,K-ATPase isoforms. Neither alpha(1)-beta(2) nor alpha(2)-beta(1) complexes were detected in the immunoprecipitates. Furthermore, in MDCK cells co-expressing alpha(1), beta(1), and beta(2) isoforms, a greater fraction of the beta(2) subunits was unassembled with alpha(1) as compared with that of the beta(1) subunits, indicating preferential association of the alpha(1) isoform with the beta(1) isoform. In addition, the alpha(1)-beta(2) complex was less resistant to various detergents than the alpha(1)-beta(1) complex isolated from MDCK cells or the alpha(2)-beta(2) complex isolated from mouse brain. Therefore, the diversity of the alpha-beta Na,K-ATPase heterodimers in vivo is determined not only by cell-specific co-expression of particular isoforms, but also by selective association of the alpha and beta subunit isoforms.	[Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Clifford, Rebecca J.; Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vagin, O (corresponding author), VAG LAHS W LA, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [DK077149, DK058333, GM39500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333, R01DK077149, R56DK058333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 (to O. V.), DK058333 (to G. S.), and GM39500 (to J. H. K.).	ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Arystarkhova E, 1997, J BIOL CHEM, V272, P22405, DOI 10.1074/jbc.272.36.22405; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Boer K, 2010, EPILEPSY RES, V91, P84, DOI 10.1016/j.eplepsyres.2010.06.015; Boer K, 2010, BRAIN PATHOL, V20, P234, DOI 10.1111/j.1750-3639.2009.00268.x; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; Clifford RJ, 2008, AM J PHYSIOL-RENAL, V295, pF1314, DOI 10.1152/ajprenal.90406.2008; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 2000, BIOCHEMISTRY-US, V39, P12688, DOI 10.1021/bi0009791; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Hirose S, 2006, EPILEPSY RES, V70, pS206, DOI 10.1016/j.eplepsyres.2005.12.007; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Lin H, 2005, J PHYSIOL-LONDON, V564, P161, DOI 10.1113/jphysiol.2004.081455; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Molinari M, 2005, MOL CELL, V20, P503, DOI 10.1016/j.molcel.2005.09.027; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Peng L, 1997, J NEUROSCI, V17, P3488; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Schmalzing G, 1997, P NATL ACAD SCI USA, V94, P1136, DOI 10.1073/pnas.94.4.1136; Senner V, 2003, NEUROPATH APPL NEURO, V29, P370, DOI 10.1046/j.1365-2990.2003.00473.x; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	58	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					26115	26125		10.1074/jbc.M112.370734	http://dx.doi.org/10.1074/jbc.M112.370734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22696220	Green Published, hybrid			2022-12-28	WOS:000306916300039
J	Grimm, C; Jors, S; Guo, ZH; Obukhov, AG; Heller, S				Grimm, Christian; Joers, Simone; Guo, Zhaohua; Obukhov, Alexander G.; Heller, Stefan			Constitutive Activity of TRPML2 and TRPML3 Channels versus Activation by Low Extracellular Sodium and Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-BOND; HAIR-CELLS; MUTATION; DEAFNESS; TRAFFICKING; BREAKING; BINDING; LEADS; SITE; ASP	The transient receptor potential channels TRPML2 and TRPML3 (MCOLN2 and MCOLN3) are nonselective cation channels. They are widely expressed in mammals. However, little is known about their physiological function(s) and activation mechanism(s). TRPML3 can be activated or rather de-inhibited by exposing it first to sodium-free extracellular solution and subsequently to high extracellular sodium. TRPML3 can also be activated by a variety of small chemical compounds identified in a high throughput screen and is inhibited by low pH. Furthermore, it was found that TRPML3 is constitutively active in low or no sodium-containing extracellular solution. This constitutive activity is independent of the intracellular presence of sodium, and whole-cell current densities are similar with pipette solutions containing cesium, potassium, or sodium. Here, we present mutagenesis data generated based on the hypothesis that negatively charged amino acids in the extracellular loops of TRPML3 may interfere with the observed sodium inhibition. We systematically mutated negatively charged amino acids in the first and second extracellular loops and found that mutating Glu-361 in the second loop has a significant impact on the sodium-mediated block of TRPML3. We further demonstrate that the TRPML3-related cation channel TRPML2 is also activated by lowering the extracellular sodium concentration as well as by a subset of small chemical compounds that were previously identified as activators of TRPML3, thus confirming the functional activity of TRPML2 at the plasma membrane and suggesting similar gating mechanisms for both TRPML channels.	[Grimm, Christian] Univ Munich, Dept Pharm, Ctr Drug Res, D-80802 Munich, Germany; [Grimm, Christian] Univ Munich, CIPSM, D-80802 Munich, Germany; [Joers, Simone; Guo, Zhaohua; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Joers, Simone; Guo, Zhaohua; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Obukhov, Alexander G.] IUPUI, Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	University of Munich; University of Munich; Stanford University; Stanford University; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis	Grimm, C (corresponding author), Univ Munich, Dept Pharm, Ctr Drug Res, D-80802 Munich, Germany.	chgrph@cup.uni-muenchen.de	Grimm, Christian/ABF-9121-2020; Obukhov, Alexander G/C-7246-2008	Grimm, Christian/0000-0002-0177-5559; Obukhov, Alexander G/0000-0002-3862-6004	National Institutes of Health [DC004563, MH083077, P30 DC010363]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH083077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004563, P30DC010363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC004563, MH083077, and P30 DC010363.	Abe K, 2011, PHYSIOLOGY, V26, P14, DOI 10.1152/physiol.00048.2010; Bach G, 2010, BIOCHEM SOC T, V38, P1432, DOI 10.1042/BST0381432; Castiglioni AJ, 2011, J COMP NEUROL, V519, P1095, DOI 10.1002/cne.22554; Chan AWE, 2010, J MED CHEM, V53, P3086, DOI 10.1021/jm901696w; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Dong XP, 2009, J BIOL CHEM, V284, P32040, DOI 10.1074/jbc.M109.037184; Flores EN, 2011, ADV EXP MED BIOL, V704, P221, DOI 10.1007/978-94-007-0265-3_12; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2012, J PHARMACOL EXP THER, V342, P236, DOI 10.1124/jpet.112.192880; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2010, J BIOL CHEM, V285, P16513, DOI 10.1074/jbc.M109.078204; Lau EY, 1999, BIOPHYS J, V77, P85, DOI 10.1016/S0006-3495(99)76874-8; Lev S, 2010, METHOD ENZYMOL, V484, P591, DOI [10.1016/S0076-6879(10)84029-7, 10.1016/B978-0-12-381298-8.00029-0]; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Noben-Trauth K, 2011, ADV EXP MED BIOL, V704, P229, DOI 10.1007/978-94-007-0265-3_13; Patel S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.295pe69; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Saldanha SA, 2011, PROBE REPORTS NIH MO; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Steenhuis P, 2010, TRAFFIC, V11, P987, DOI 10.1111/j.1600-0854.2010.01073.x; Takumida M, 2010, ACTA OTO-LARYNGOL, V130, P196, DOI 10.3109/00016480903013593; Tanaka M, 1998, BIOCHEMISTRY-US, V37, P2629, DOI 10.1021/bi9725273; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamaguchi S, 2010, CHEM BIOL, V17, P209, DOI 10.1016/j.chembiol.2010.02.009; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330	41	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22701	22708		10.1074/jbc.M112.368876	http://dx.doi.org/10.1074/jbc.M112.368876			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22753890	Green Published			2022-12-28	WOS:000306495000027
